{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "**Evolution of the 5.000 % senior notes (due April 2030)**  \n\n| Fiscal year (as reported) | Principal outstanding (millions $) |\n|---------------------------|--------------------------------------|\n| FY 2022 (Oct 30 2022)     | **$606 M** (down from $1,086 M in FY 2021) |\n| FY 2023 (Oct 29 2023)     | **$606 M** (unchanged) |\n| FY 2024 (Nov 3 2024)      | **$606 M** (unchanged) |\n\n**What the trend shows**\n\n- Between FY 2021 and FY 2 022 the company cut its exposure to this 5 % note series by roughly $480 M, indicating an active repayment or refinancing of higher‑cost debt.  \n- From FY 2022 through FY 2024 the outstanding amount has remained flat at $606 M, suggesting that after the reduction AVGO chose to retain a modest, stable tranche of the 5 % notes—likely to preserve liquidity or match cash‑flow needs—while avoiding further accumulation of this relatively higher‑interest instrument.\n\nOverall, the pattern reflects a debt‑management approach that first reduced reliance on the 5 % senior notes and then maintained a controlled, steady level of exposure thereafter.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. According to the original answer, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in FY 2022, but the LLM states it was $606 million in FY 2022 (with a note that it was down from $1,086M in FY 2021). This is a major discrepancy. The ground truth clearly states: FY 2022 = $1,086M, FY 2023 = $606M, FY 2024 = $606M. The LLM has shifted all values down by one year, incorrectly placing the $1,086M figure in FY 2021 (which is outside the scope of the question asking about 2022-2024) and showing $606M for FY 2022 when it should show $1,086M. This represents a systematic misalignment of the data across the three-year period being evaluated. The calculation of the $480M reduction is mathematically correct ($1,086M - $606M = $480M), but it is attributed to the wrong fiscal year transition (FY 2021-2022 instead of FY 2022-2023). The qualitative analysis about debt management strategy is reasonable and aligns with the ground truth's conclusion about deliberate debt reduction, but this cannot overcome the quantitative errors in the core data. The answer does address the evolution question and provides a table format that is clear, but the fundamental misalignment of fiscal year data to dollar amounts makes the answer factually incorrect for the specific question asked about FY 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 397,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s disclosure shows that the portion of the closed‑block business placed under its unaffiliated third‑party **modified‑coinsurance agreement** was 59.25 % in 2022, fell very slightly to 59 % in 2023, and remained at 59 % in 2024.  Across all three years the company continued to account for the arrangement under the **deposit method** and to offset the deposit liability with the corresponding deposit recoverable, indicating that the same accounting policy has been applied consistently.  The near‑steady transfer of roughly 59 % of the closed‑block risk signals that MetLife’s long‑term reinsurance strategy is deliberately anchored on a stable, diversified “coinsurance” structure—retaining a predictable slice of risk while reliably ceding the bulk of the block to a well‑capitalized third‑party reinsurer.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All percentages are correct: 59.25% (2022), 59% (2023), 59% (2024). (2) Correctly identifies the modified coinsurance agreement with unaffiliated third-party reinsurer. (3) Accurately states the deposit method of accounting was used consistently across all three years. (4) Correctly notes the offset of deposit liability with deposit recoverable. (5) Properly synthesizes the multi-hop information about consistency in risk transfer percentages. (6) The characterization of the strategy as 'deliberately anchored on a stable, diversified coinsurance structure' is semantically equivalent to the ground truth's 'deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization.' (7) Correctly interprets what the consistency reveals about long-term strategy.\n\nWEAKNESSES: (1) The LLM answer omits the specific dollar amounts mentioned in the ground truth ($6.3 billion in 2021 and $17.6 billion in 2024 for total net ceded reinsurance recoverables), which provides important context about the scale of the reinsurance program. While not strictly required to answer the question, this contextual information demonstrates the significance of the strategy. (2) The phrase 'fell very slightly' is slightly imprecise—the change from 59.25% to 59% is a 0.25 percentage point decrease, which is indeed minimal, but the ground truth simply states the percentages without characterizing the movement as a 'fall.' This is a minor semantic issue.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) and properly connects the consistency in percentages to strategic implications. The reasoning is sound and logically structured.\n\nCALCULATIONS: No calculations were required, but the percentage values are all accurate.\n\nJUSTIFICATION: The answer is substantially correct on all key factual points and demonstrates proper understanding of the multi-hop nature of the question. The omission of the dollar amount context and the minor characterization of the percentage change prevent a higher score, but these are relatively minor issues that don't undermine the core correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 589,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements that were **not** offset against its derivatives at 31 December 2022. By 31 December 2024 that amount had fallen to $491 million—a reduction of roughly $1.0 billion (about a 67 % decline). The steady drop from 2022 through 2024 suggests the company is tightening its derivative‑exposure management, using less un‑netted collateral and likely achieving more efficient margin‑requirement and net‑ting practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The key figures are correct - $1.494 billion (2022) and $491 million (2024) match the ground truth exactly. The calculated decline of ~$1.0 billion and 67% reduction are mathematically accurate ($1,494M - $491M = $1,003M; $1,003M/$1,494M = 67.1%). The format variation ($1.494 billion vs $1,494 million) is acceptable. COMPLETENESS: The LLM answer addresses the core question about the change from 2022 to 2024 and provides interpretation of the trend. However, it omits the intermediate 2023 data point ($800 million) that appears in the ground truth, which represents a minor gap in completeness. ENTITY ACCURACY: All entities are correctly identified - ExxonMobil, master netting arrangements, derivatives, collateral, and the correct fiscal years (2022, 2024). REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly interprets the declining trend as indicating strategic reduction in derivative exposure and improved offsetting mechanisms, using language like 'tightening derivative-exposure management' and 'more efficient margin-requirement and netting practices.' This aligns well with the ground truth's interpretation. The phrase 'not offset against its derivatives' adds helpful clarification about the nature of these collateral arrangements. MINOR ISSUES: The omission of the 2023 intermediate value ($800 million) prevents a complete picture of the three-year trend, though the overall conclusion about the direction and magnitude of change remains accurate. The answer is well-reasoned, factually sound, and appropriately contextual.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 452,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "- In the 2022 Form 10‑K (Fiscal 2022) AVGO reported **$622 million** of principal outstanding for the 3.625 % senior notes that mature in October 2024.  \n- The 2023 and 2024 Form 10‑K tables show the same **$622 million** balance for those notes as of the most recent reporting dates (October 29 2023), while the “future” column for November 3 2024 is blank, indicating the notes are expected to be fully repaid at maturity.  \n\n**Interpretation:** AVGO’s exposure to the 3.625 % October 2024 notes remained flat at $622 million from FY 2022 through FY 2024, and the company has not refinanced or increased that tranche. This consistency, coupled with the absence of a balance in the forward‑looking column, signals a deliberate strategy to hold the issue to its scheduled repayment rather than roll it over, reflecting disciplined debt‑management and a focus on maturing existing obligations rather than adding new leverage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual discrepancy that undermines its core claim. QUANTITATIVE ACCURACY ISSUE: The LLM states that '2023 and 2024 Form 10-K tables show the same $622 million balance for those notes as of the most recent reporting dates (October 29 2023)' and that the balance remained at $622 million through FY 2024. However, the ground truth explicitly states that 'by 2024, the company no longer listed any outstanding principal for these notes.' This is a material error—the LLM incorrectly claims the balance was still $622 million in 2024, when it should have been $0 or eliminated. The LLM correctly identifies the 2022 and 2023 balances at $622 million, and correctly notes the October 2024 maturity date and the blank forward-looking column. REASONING ISSUE: The LLM's interpretation that 'AVGO's exposure...remained flat at $622 million from FY 2022 through FY 2024' directly contradicts the ground truth progression (2022: $622M → 2023: $622M → 2024: $0). The LLM's conclusion about 'holding the issue to its scheduled repayment' is partially correct in spirit but factually wrong because the notes were actually eliminated/repaid by 2024, not held through maturity. WHAT WAS CORRECT: The $622 million figure for 2022 and 2023, the October 2024 maturity date, the identification of the 3.625% rate, and the general interpretation that the company took a deliberate approach to this debt. WHAT WAS INCORRECT: The claim that the balance remained at $622 million through 2024 (should show elimination/repayment), and the resulting interpretation about holding to maturity rather than addressing the liability between 2023-2024. The ground truth indicates proactive debt management (repayment/refinancing before maturity), while the LLM suggests passive holding to maturity. This is a fundamental mischaracterization of the company's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 511,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics reported surface‑ship revenue of **$2.561 billion in 2022**, which rose to **$2.698 billion in 2023** (≈5 % increase) and further to **$2.819 billion in 2024** (≈4 % increase) 【Chunk 2】【Chunk 3】. This steady upward trend continues the growth seen in the prior year’s $2.328 billion (2021) figure from the 2022 filing 【Chunk 1】, signaling that GD is gaining traction and strengthening its competitive footing in the naval surface‑ship market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three core figures are correct - $2.561 billion (2022), $2.698 billion (2023), and $2.819 billion (2024). The percentage calculations are accurate: 2022-2023 increase is ($2.698-$2.561)/$2.561 = 5.3% (rounded to ~5%), and 2023-2024 increase is ($2.819-$2.698)/$2.698 = 4.5% (rounded to ~4%). The additional 2021 figure of $2.328 billion is correctly cited and provides useful context for the multi-year trajectory. ENTITY ACCURACY: General Dynamics correctly identified, Marine Systems division appropriately referenced, all years correctly specified. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the trend as sustained growth. The conclusion about 'gaining traction and strengthening competitive footing' is a reasonable inference from the consistent upward trajectory. COMPLETENESS: The answer addresses both parts of the question - the revenue evolution (with specific numbers and growth rates) and what this indicates about positioning (sustained growth, strategic emphasis, competitive strength). MINOR CONSIDERATIONS: The LLM provides slightly more analytical depth than the ground truth (percentage calculations, 2021 context) which adds value without contradicting the original answer. The semantic meaning is fully aligned - both convey steady growth and strategic importance in naval shipbuilding. The citation format with chunk references is appropriate for source attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 429,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "Across the three filings—2022, 2023 and 2024—Mastercard’s (MA) Class A shares were consistently described as having **“one vote per share” and “dividend rights.”** The table in each year’s 10‑K shows the same par value, authorized amount (3 million shares) and identical dividend‑and‑voting language, with no amendment or new restriction noted.\n\nThis unchanged description over the 2022‑2024 period signals a **stable shareholder‑governance framework** for Class A holders; the company has maintained the same voting power and entitlement to dividends, suggesting continuity in how equity owners influence corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: Both answers correctly identify that MA's Class A shares maintained consistent voting rights (one vote per share) and dividend rights across 2022-2023-2024 with no changes. The LLM appropriately references the 3 million authorized shares figure and confirms the identical governance language across all three years. (2) QUANTITATIVE ACCURACY: The specific numeric detail (3 million authorized shares) is accurate and correctly cited. No calculations were required for this question, and the temporal scope (2022-2024) is correctly maintained throughout. (3) MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three separate 10-K filings to establish the consistency pattern. The reasoning correctly connects the unchanged governance structure to the conclusion about stability. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing ('stable shareholder-governance framework,' 'continuity in how equity owners influence corporate decisions') conveys the same substantive meaning as the ground truth's 'stable shareholder structure.' The answer goes slightly further by explicitly noting 'no amendment or new restriction noted,' which adds appropriate supporting detail without contradicting the ground truth. (5) MINOR CONSIDERATIONS: The LLM's reference to 'the table in each year's 10-K' is a reasonable inference about documentation structure, though the ground truth doesn't explicitly mention tables. This is a minor enhancement rather than an error. The answer fully addresses both components of the multi-part question: the evolution (or lack thereof) of dividend/voting rights AND what this indicates about governance stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 481,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics reported surface‑ship revenue of **$2.561 billion in 2022**, which rose to **$2.698 billion in 2023** (≈5.3 % YoY) and to **$2.819 billion in 2024** (≈4.5 % YoY).  The steady increase—building on the $2.328 billion reported in 2021 (Chunk 1)—shows the company is winning more contracts and expanding its share of the U.S. Navy’s surface‑ship programs, positioning it as a growing, core supplier in naval‑defense procurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All core numbers match the ground truth exactly: $2.561 billion (2022), $2.698 billion (2023), and $2.819 billion (2024). The year-over-year growth calculations are accurate: 2022-2023 growth of approximately 5.3% ($137M/$2,561M = 5.35%) and 2023-2024 growth of approximately 4.5% ($121M/$2,698M = 4.48%). The format variation from millions to billions is acceptable and consistent. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of revenue across the three-year period, and (2) what the growth indicates about positioning. ENTITY ACCURACY: General Dynamics is correctly identified, the fiscal years (2022-2024) are correct, and the metric (surface ship revenue) is properly specified. MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend into a coherent narrative about consistent upward momentum. The inclusion of 2021 data ($2.328 billion) adds valuable context showing the longer-term trajectory, though this was not explicitly in the ground truth. SEMANTIC EQUIVALENCE: The LLM's interpretation that the growth indicates 'winning more contracts and expanding share' and positioning as a 'core supplier' aligns well with the ground truth's characterization of 'growing involvement in naval defense contracts and sustained demand.' MINOR CONSIDERATIONS: The LLM provides slightly more analytical depth by calculating specific YoY percentages and adding 2021 context, which enhances the answer without introducing errors. The phrasing 'growing, core supplier' is a reasonable interpretation of the ground truth's 'growing involvement' and 'sustained demand.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 469,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Linde repeatedly states that “the majority of Linde’s business is conducted through long‑term contracts,” using those contracts to supply its industrial‑gas products. There is no change in language or emphasis from 2022 through 2024, indicating that the company’s reliance on long‑term contracts has remained steady. This consistency signals that Linde deliberately leans on long‑term agreements to lock in cash‑flow stability and to be able to pass through volatile energy‑ and feedstock‑cost changes to customers, thereby insulating its earnings from fluctuating energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the three-year period (2022-2024) and confirms consistency across all years; (2) Accurately captures Linde's core strategy of using long-term contracts for industrial gas products; (3) Properly synthesizes the multi-hop reasoning: contracts → cash flow stability → pass-through of energy/feedstock costs → insulation from market volatility; (4) Uses appropriate direct quotation ('the majority of Linde's business is conducted through long-term contracts') that reflects actual filing language; (5) Correctly identifies the lack of change in language/emphasis as evidence of deliberate strategy; (6) Accurately conveys the risk management and financial resilience implications. Minor considerations: The LLM answer uses slightly different phrasing than the ground truth ('insulating its earnings' vs 'prioritization of financial resilience and operational certainty') but these are semantically equivalent and both capture the same strategic intent. The LLM answer is actually more concise while maintaining all essential information. No quantitative errors, no missing entities, and the multi-hop synthesis across three years of filings is sound and complete. The answer directly addresses how reliance evolved (remained consistent) and what this suggests about the company's approach (deliberate risk management and cash flow stability).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 401,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across the three most recent filings—2022, 2023 and 2024—General Dynamics explicitly states that its return‑on‑invested‑capital (ROIC) “excludes goodwill impairments and **non‑economic accounting changes** as they are not reflective of company performance.” The language is identical in each year’s disclosure, indicating that the company has **not altered** its treatment of these items; they are consistently removed from the ROIC calculation.\n\nThis steady exclusion signals that GD deliberately isolates the metric from accounting adjustments that do not affect the underlying economics of the business, reinforcing a focus on measuring the firm’s core operating performance rather than transient, non‑economic effects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC across all three years (2022, 2023, 2024), matching the ground truth assertion of stable methodology; (2) Accurately captures the identical language used across filings, demonstrating consistency; (3) Properly synthesizes the multi-hop reasoning by connecting the consistent exclusion to GD's deliberate focus on core operational performance; (4) Correctly identifies the company (General Dynamics/GD) and the specific metric (ROIC); (5) No quantitative errors or date misstatements. Minor considerations: (1) The LLM answer includes reference to 'goodwill impairments' alongside non-economic accounting changes, which is a reasonable expansion of context but not explicitly mentioned in the ground truth answer—however, this is complementary rather than contradictory; (2) The phrasing 'steady exclusion signals that GD deliberately isolates the metric' is a reasonable interpretation of the company's approach and aligns with the ground truth's characterization of an 'institutionalized principle.' The answer demonstrates sound multi-hop reasoning by synthesizing information across three years to establish a pattern, and correctly interprets what this consistency reveals about GD's measurement philosophy. The semantic equivalence is strong—both answers convey that GD maintained consistent treatment and that this reflects a deliberate approach to measuring core performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 430,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s parent continued to provide service‑level guarantees under its contracts, but in each of the most recent filings the amounts accrued, paid or charged to income for those guarantees were reported as **not material** – the 2023 Form 10‑K says this was true for 2022, 2023 and 2021, and the 2024 Form 10‑K repeats the same conclusion for 2022, 2023 and 2024 (the 2022 filing likewise noted immaterial impacts for the prior years).  \n\nThe repeated immaterial classification from 2022 through 2024 (and historically) signals that UnitedHealth Group’s risk‑management controls and contractual performance are consistently effective, keeping any potential service‑level liability at a negligible level and demonstrating stable, predictable execution of its service agreements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies that service level guarantee amounts were consistently reported as immaterial across 2022-2024; (2) Accurately captures the multi-year pattern showing consistency; (3) Properly synthesizes the implication that this reflects strong risk management and contractual performance; (4) Correctly notes that the company's parent provided these guarantees; (5) Appropriately references multiple filing years (2023 and 2024 10-Ks) to establish the pattern. MINOR ISSUES: (1) The LLM mentions that the 2023 Form 10-K references 2022, 2023, and 2021, which is slightly awkward phrasing (should be 2021, 2022, 2023 chronologically), though this doesn't affect factual accuracy; (2) The answer includes some historical context ('and historically') that goes beyond the specific 2022-2024 period asked about, though this adds useful context rather than detracting; (3) The phrase 'parent continued to provide' is slightly vague compared to simply stating UnitedHealth Group provided guarantees, though it's not technically incorrect. QUANTITATIVE VERIFICATION: All years mentioned (2021, 2022, 2023, 2024) are correctly identified; the characterization of amounts as 'not material' across all periods is accurate; no specific dollar amounts are claimed, avoiding calculation errors. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple filing years to establish a pattern and draw conclusions about risk management effectiveness. The logical connection between consistent immateriality and effective risk management is sound and matches the ground truth conclusion. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that immaterial amounts across the three-year period suggest strong controls and performance - while providing slightly more detail about the filing structure and historical context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 525,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics reported surface‑ship revenue of **$2.561 billion in 2022**, which rose to **$2.698 billion in 2023** and further to **$2.819 billion in 2024**.  That represents a $137 million (≈5.3 %) increase from 2022‑23 and a $121 million (≈4.5 %) rise from 2023‑24, a total gain of about $258 million (≈10 %) over the two‑year span.  The steady upward trajectory—building on the earlier growth shown in the 2021‑2022 figures (e.g., $2.328 billion in 2021) – signals that GD is successfully deepening its focus on surface‑ship platforms, reinforcing its strategic positioning as a leading supplier of naval‑defense systems and expanding its share of the Marine Systems market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the 2022 figure. Ground truth states $2,328 million in 2022, but the LLM reports $2.561 billion ($2,561 million). This is a $233 million discrepancy (10% error on the baseline year). The 2023 ($2,698 million) and 2024 ($2,819 million) figures are correct. CALCULATION ERRORS: Because the 2022 baseline is wrong, all subsequent calculations are incorrect: (1) The 2022-23 increase is stated as $137 million (5.3%), but should be $370 million (15.9%) based on correct figures; (2) The 2023-24 increase of $121 million (4.5%) is correct; (3) The total two-year gain is stated as $258 million (10%), but should be $491 million (21.1%). The LLM also introduces a confusing reference to 2021 data ($2.328 billion) which appears to be the actual 2022 figure, creating additional confusion about year alignment. REASONING: The qualitative assessment about strategic positioning and market expansion is reasonable and aligns with the ground truth interpretation, but this cannot compensate for the severe quantitative errors. The multi-hop synthesis is attempted but undermined by the incorrect baseline data. The answer demonstrates understanding of the question's intent but fails on the primary metric of factual accuracy for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 365,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE’s captive industrial insurer, Electric Insurance Company, was re‑classified in the fourth quarter of 2022 as a “held‑for‑sale” business.  At that time the subsidiary’s balance‑sheet exposure was modest – the 2022 filing notes net claim reserves of about $0.2 billion (down from $0.3 billion in 2020), and by the end of 2023 the company held $541 million of assets against $378 million of liabilities, generating a $109 million loss in other income as GE prepared the sale.  The process was completed in the second quarter of 2024 when GE sold Electric Insurance Company to Riverstone International Holdings for cash proceeds of roughly $120 million, ending the relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and dates. Verification of numbers: (1) Net claim reserves of $0.2 billion in 2021/2022 - CORRECT; (2) Assets of $541 million and liabilities of $378 million as of December 31, 2023 - CORRECT; (3) $109 million loss recorded - CORRECT; (4) Sale price of $120 million to Riverstone International Holdings - CORRECT; (5) Sale completion in Q2 2024 - CORRECT. The LLM correctly identifies the reclassification timing (Q4 2022 as 'held-for-sale'), though the ground truth states this occurred 'by 2023' which is slightly ambiguous. The LLM's specification of Q4 2022 is more precise and appears consistent with the filing data. Multi-hop synthesis is sound: the answer traces the evolution from operational captive insurer → held-for-sale classification → loss recognition → divestiture completion. The answer correctly characterizes EIC as a captive property and casualty insurer serving GE and employees. Minor note: The LLM mentions net claim reserves 'down from $0.3 billion in 2020' which adds contextual detail not in the ground truth but appears factually accurate based on typical filing disclosures. The semantic equivalence is strong - 'roughly $120 million' and '$120 million' are equivalent. The answer comprehensively addresses all three dimensions of the question: classification evolution, financial exposure, and divestiture. The only minor weakness is that the ground truth explicitly states the 2022 disclosure referenced 2021 year-end reserves, while the LLM's phrasing could be slightly clearer on this temporal distinction, though it is not factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Classifies]-> COMP <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 460,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips began “paced” monetization of its CVE common‑share holding in 2021 and, in the first quarter of 2022, sold the balance of that stake – roughly 91 million CVE shares.  The cash generated was directed to the company’s ongoing share‑repurchase program, which grew from 383 million shares bought for about $29 billion through 2023 (as disclosed in the 2023 10‑K) to 433 million shares bought for roughly $34.3 billion through 2024 (as disclosed in the 2024 10‑K).  This trajectory shows that ConocoPhillips is using the proceeds from the CVE divestiture to fund and expand its buy‑back activity, underscoring a capital‑allocation strategy that prioritizes returning excess cash to shareholders via share repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All key numbers are correct: 91 million CVE shares sold in Q1 2022, 383 million shares repurchased for $29 billion through 2023, 433 million shares for $34.3 billion through 2024. (2) Timeline is accurate: paced monetization began May 2021, final sale in Q1 2022. (3) Multi-hop reasoning is sound: correctly connects CVE divestiture proceeds to share repurchase program expansion. (4) Capital allocation strategy interpretation is appropriate and well-supported. (5) Proper sourcing attribution to 2023 and 2024 10-Ks. MINOR GAPS: (1) The original answer mentions the $45 billion initial authorization and the $20 billion increase (not to exceed $65 billion total) approved by the board in 2024. The LLM answer does not explicitly reference these authorization amounts, which are relevant details about the board's capital allocation decisions. (2) The phrase 'not to exceed $65 billion total' provides important context about the cumulative authorization cap that the LLM omits. These omissions are contextual rather than factual errors—the core narrative about monetization and repurchase progression is complete and accurate. The answer effectively addresses the question's core inquiry about how the strategy evolved and what it indicates about capital allocation priorities. The semantic meaning and factual content align well with the ground truth, with only minor contextual details missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 418,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s disclosed use of the modified‑coinsurance arrangement has been essentially unchanged over the three most recent filings. In the 2022 Form 10‑K (covering 2021 data) the company said it reinsured **59.25 %** of the closed block through a modified‑coinsurance agreement and accounted for it under the **deposit method**, offsetting the deposit liability with the deposit recoverable. Both the 2023 and 2024 Form 10‑Ks state the same **59 %** of the closed block is reinsured under the same deposit‑method accounting with the same offset arrangement. The near‑steady percentage and unchanged accounting treatment indicate that MetLife views the modified‑coinsurance structure as a core, long‑term risk‑transfer tool, using it consistently to shift roughly three‑fifths of its closed‑block exposure to an unaffiliated reinsurer while preserving capital efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% in 2022, 59% in 2023, and 59% in 2024 match the ground truth exactly. The accounting treatment (deposit method with offset arrangement) is correctly identified across all three years. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution of percentage reinsured, (2) accounting treatment consistency, and (3) what this reveals about long-term risk transfer strategy. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, the closed block is correctly referenced, and the unaffiliated third-party reinsurer is appropriately mentioned. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the consistency pattern and drawing the appropriate conclusion about stable risk transfer strategy. The reasoning that the near-steady percentage and unchanged accounting indicate a core, long-term risk-transfer tool is sound and matches the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's phrasing 'roughly three-fifths of its closed-block exposure' is semantically equivalent to the ground truth's 'approximately 59%' and demonstrates understanding. The description of 'preserving capital efficiency' aligns with the ground truth's characterization of 'managing longevity risk through a structured reinsurance arrangement.' MINOR OBSERVATION: The LLM notes the 2022 Form 10-K covers 2021 data, which is a reasonable clarification though not explicitly required. No factual errors detected. The answer is well-structured, precise, and fully responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 474,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The filings show a steady decline in the share of purchases made with Target’s branded credit product (the Target MasterCard Credit Card is part of the RedCard family). RedCard penetration fell from **20.5 % in fiscal 2022** (as noted in the 2022 Form 10‑K), to **19.8 % in fiscal 2023**, and to **18.6 % in fiscal 2024** (both disclosed in the 2023 and 2024 Form 10‑Ks). This downward trend, which the 2022 filing already linked to faster overall sales growth, suggests that consumer engagement with Target’s own credit cards is weakening over time, even though the cards continue to offer a 5 % discount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three penetration rate figures are correct - 20.5% (2022), 19.8% (2023), and 18.6% (2024). The fiscal year attributions are accurate, and the downward trend calculation is correct (declining by 0.7 percentage points annually). ENTITY ACCURACY: Correctly identifies the Target MasterCard Credit Card as part of the RedCard family, accurately references the 5% discount incentive, and properly cites the relevant Form 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly interprets the trend as indicating weakening consumer engagement. The connection between the rebranding context (RedCards to Target Circle Cards in 2024) and the persistence of the decline is appropriately noted. COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates AND what the trend suggests about consumer engagement. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer mentions that 'the 2022 filing already linked [the decline] to faster overall sales growth,' which adds contextual nuance not explicitly stated in the ground truth but represents reasonable interpretation of filing data. The ground truth mentions the 2024 rebranding 'did not reverse this decline,' while the LLM answer implies this through the context of continued decline despite rebranding - semantically equivalent. WORDING: The LLM uses slightly different phrasing ('share of purchases made with Target's branded credit product' vs. 'penetration rate') but these are semantically equivalent metrics. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 484,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Across the three filings — the 2022, 2023 and 2024 10‑Ks — Philip Morris International (PMI) states that the “PMI Peer Group presented in this graph is the same as that used in the prior year.” In each year’s disclosed list, Colgate‑Palmolive Co. appears among the same set of companies (Altria, Anheuser‑Busch InBev, British American Tobacco, Coca‑Cola, Diageo, Heineken, Imperial Brands, Japan Tobacco, Johnson & Johnson, Kimberly‑Clark, Kraft‑Heinz, McDonald’s, Mondelēz, Nestlé, PepsiCo, Procter & Gamble, Roche and Unilever). Thus, Colgate‑Palmolive’s classification as a PMI peer did not change from 2022 through 2024.\n\nThe unchanged inclusion signals that PMI’s benchmarking strategy is deliberately stable: it selects peers based on four consistent criteria—global presence, a focus on consumer products, and comparable net revenues and market capitalization—and retains that peer set year‑over‑year to ensure continuity in performance comparisons and strategic analysis of consumer‑product competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive remained consistently included in PMI's peer group from 2022-2024, matching the ground truth. (2) Accurately cites the four criteria for peer selection (global presence, consumer products focus, comparable net revenues, comparable market capitalization). (3) Provides the complete peer group list with all 18 companies correctly named, demonstrating thorough multi-hop synthesis across three years of filings. (4) Correctly interprets the consistency as indicating a 'deliberately stable' benchmarking strategy. (5) Properly quotes PMI's statement that 'the PMI Peer Group presented in this graph is the same as that used in the prior year.' (6) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (includes the full peer list), but this adds value rather than detracting. The semantic meaning is fully aligned—both answers convey that Colgate-Palmolive's classification remained unchanged and that this reflects PMI's stable, criteria-based benchmarking methodology. The reasoning about what this consistency reveals about PMI's strategic approach is sound and well-articulated. All entities (companies, years, metrics) are correctly identified and synthesized across the multi-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Relates_To]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 385,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "Across the three filings AMD’s description of how it accounts for development‑services‑plus‑IP‑licensing contracts is unchanged. In the 2022 10‑K AMD explains that it first determines whether the licensing component is distinct (i.e., capable of being distinct and distinct in the context of the arrangement); if it is not distinct the license is combined with the development services and revenue is recognized over time, whereas a distinct license is accounted for as a separate performance obligation and recognized at a point in time when the customer can benefit from the license. The same two‑step assessment and the same treatment of combined versus standalone licenses are reiterated verbatim in the 2023 and 2024 10‑Ks, with no new qualifiers or changes to the timing of recognition. This continuity shows that AMD’s accounting approach for development and IP licensing agreements has been consistent from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies the core elements of AMD's revenue recognition policy for development and IP licensing agreements: (1) the two-step assessment of distinctness (capable of being distinct AND distinct in context), (2) the treatment of non-distinct licenses combined with development services recognized over time, (3) the treatment of distinct licenses as separate performance obligations recognized at a point in time, and (4) the consistency of this policy across 2022-2024. The answer accurately conveys that there were no changes to the policy across the three-year period, matching the ground truth statement about 'no variable consideration estimates' and 'stable and uniform accounting policy.' The LLM provides slightly more specific language ('reiterated verbatim,' 'no new qualifiers') that adds precision without contradicting the ground truth. The multi-hop reasoning is sound—the answer synthesizes information across three years and correctly identifies the consistency pattern. No quantitative errors are present (no numbers to verify). The only minor distinction is that the LLM answer doesn't explicitly mention 'variable consideration estimates,' but this is a minor omission that doesn't affect the core correctness of the response, as the emphasis on consistency and unchanged policy conveys the same substantive point. The answer directly addresses all parts of the question: the evolution (or lack thereof), the distinction between combined and standalone arrangements, and what this reveals about consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 437,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across the three most recent filings—2022, 2023 and 2024—Philip Morris International (PMI) repeatedly lists **Colgate‑Palmolive Co.** as a member of its “PMI Peer Group.” Each year the filing states that the peer group “is the same as that used in the prior year” and the roster of companies, which is built on global presence, a consumer‑products focus, and comparable net revenues and market‑capitalization, includes Colgate‑Palmolive without change. This uninterrupted inclusion signals that PMI deliberately frames its competitive positioning by benchmarking itself against the same set of large, globally‑distributed consumer‑goods firms, reinforcing a strategic narrative that PMI views itself as a peer to leading non‑tobacco consumer brands rather than solely to tobacco rivals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric references are correct—the answer accurately identifies the three-year period (2022, 2023, 2024) and correctly states that Colgate-Palmolive was included consistently across all three years without change. No calculations or specific dollar amounts are required for this question, and the temporal references are precise. ENTITY ACCURACY: Philip Morris International (PMI) is correctly identified, Colgate-Palmolive Co. is accurately named, and the peer group concept is properly contextualized. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across three years to demonstrate consistency and draws the appropriate inference about strategic positioning. The reasoning that consistency in peer group selection reveals deliberate strategic framing is sound and matches the ground truth's conclusion. COMPLETENESS: The answer addresses both parts of the question—how inclusion evolved (answer: it remained consistent) and what this reveals about strategic positioning (answer: PMI views itself as comparable to leading global consumer brands, not just tobacco competitors). SEMANTIC EQUIVALENCE: The LLM's phrasing—\"uninterrupted inclusion signals that PMI deliberately frames its competitive positioning\"—conveys the same meaning as the ground truth's \"consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point.\" The LLM adds valuable context by noting that this positioning frames PMI against \"non-tobacco consumer brands,\" which enriches the answer while remaining consistent with the ground truth. MINOR CONSIDERATION: The LLM uses \"PMI\" while the ground truth uses \"PM\"—both are acceptable abbreviations for Philip Morris International, so this is not an error. The answer is comprehensive, factually accurate, and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 538,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "Across the three filing years AMD’s policy for “combined development and IP‑licensing” arrangements did not change.  \n\n* **2022 (Form 10‑K 2022, p. 59)** – AMD said that such contracts may contain either a single performance obligation or multiple obligations.  The company first determines whether the licensing component is distinct (i.e., capable of being distinct and distinct in the contract context).  If the license is **not distinct**, it is combined with the development services and revenue is **recognized over time** as the services are performed.  If the license **is distinct**, revenue is **recognized at a point in time** when the customer obtains the ability to benefit from the license.  No variable‑consideration estimates are applied.  \n\n* **2023 (Form 10‑K 2023, p. 64)** – The same language appears verbatim: the arrangements are treated as single or multiple performance obligations, the distinct‑license test is applied, and revenue is recognized either over time (non‑distinct) or at a point in time (distinct).  The statement that “revenue is recognized upon the transfer of control, over time or at a point in time, depending on the nature of the arrangements” is unchanged, and variable consideration remains immaterial.  \n\n* **2024 (Form 10‑K 2024, p. 63)** – The policy is again restated with identical wording.  AMD continues to evaluate distinctness, combine non‑distinct licenses with development services for over‑time recognition, and recognize distinct licenses at the point when the customer can benefit.  Variable consideration is still not material.  \n\n**Thus, from 2022 through 2024 AMD’s revenue‑recognition approach for combined development and IP‑licensing agreements remained consistent:** the determination of whether the license is a distinct performance obligation drives the timing—over‑time for a single, non‑distinct obligation and point‑in‑time for a distinct license—without any disclosed change in the policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent across 2022-2024, matching the ground truth exactly. (2) Accurately describes the two-part distinctness test: (i) capable of being distinct and (ii) distinct in context of arrangement. (3) Correctly states the timing outcomes: non-distinct licenses combined with development services recognized over time; distinct licenses recognized at point in time when customer can benefit. (4) Accurately notes that no variable consideration estimates were associated with these arrangements across all three years. (5) Properly cites specific page numbers from each year's 10-K filing (2022 p.59, 2023 p.64, 2024 p.63), demonstrating multi-hop synthesis across three years of filings. (6) The answer is well-structured with year-by-year breakdown showing consistency. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and verbose than the ground truth, but this adds clarity rather than introducing errors. The semantic meaning is fully aligned with the original answer. All factual claims are verifiable and correct. The multi-hop reasoning across three years of SEC filings is sound and properly synthesized. No numerical errors, date errors, or entity misidentifications present. The answer directly addresses all aspects of the question regarding evolution (or lack thereof) of the policy, performance obligations, and timing of revenue recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1727,
        "completion_tokens": 428,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "- **2022 – Completion of the CVE monetization:** ConocoPhillips sold its remaining 91 million CVE common shares in the first quarter of 2022.  The disposition was reflected in the 2022 filing’s tax discussion, which recorded a valuation‑allowance adjustment of roughly $218 million tied to the fair‑value measurement and sale of the CVE shares.  All of the cash from that sale was earmarked for the company’s ongoing share‑repurchase program.  \n\n- **2023 – Early impact on buybacks:** By the end of 2023 the company had repurchased 383 million shares at a total cost of $29 billion, a program that was funded in part by the CVE‑sale proceeds.  \n\n- **2024 – Expanded repurchase effort:** The 2024 filing shows the program had grown to 433 million shares repurchased for $34.3 billion, and the board increased the aggregate purchase authorization to $65 billion (up from $45 billion).  \n\n**What this reveals:** ConocoPhillips used the one‑time monetization of its CVE stake in 2022 as a source of capital to accelerate an already‑existing share‑repurchase plan, and then continued to scale that buy‑back in subsequent years.  The multi‑year trend—selling the CVE shares, applying the proceeds to repurchases, and subsequently raising the repurchase ceiling and increasing both share count and dollar amount bought back—demonstrates a capital‑allocation strategy that prioritizes returning cash to shareholders through aggressive stock buybacks rather than retaining the CVE asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct—91 million CVE shares sold in Q1 2022, 383 million shares repurchased at $29 billion cost by end of 2023, 433 million shares repurchased at $34.3 billion by end of 2024, and the $65 billion authorization increase. The $218 million valuation-allowance adjustment is a specific detail that adds credibility. MULTI-HOP REASONING: The answer correctly synthesizes information across three years, linking the CVE monetization event to the share repurchase program and demonstrating how proceeds were applied. The progression from 2022 completion through 2023 impact to 2024 expansion is logically structured. ENTITY ACCURACY: ConocoPhillips and CVE are correctly identified; fiscal years 2022-2024 are properly referenced. COMPLETENESS: The answer addresses all aspects of the question—the evolution of monetization and repurchases, the application of proceeds, and the capital allocation strategy implications. The explanation of what the progression reveals about strategy (prioritizing shareholder returns through aggressive buybacks) is well-articulated. MINOR CONSIDERATIONS: The LLM provides additional context (the tax valuation-allowance adjustment) not explicitly in the ground truth, but this is supplementary detail that enhances rather than contradicts the answer. The ground truth mentions the program began in May 2021, while the LLM focuses on the 2022 completion—this is appropriate given the question's 2022-2024 timeframe. The semantic equivalence is strong throughout, with clear explanation of the capital allocation strategy's evolution and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 468,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Across the three filings Honeywell repeatedly flags “changes in the competitive landscape … new market entrants and new technologies” as a material risk for the same set of businesses. In 2022 the risk is called out for Aerospace, Honeywell Building Technologies, Safety and Productivity Solutions and, to a lesser extent, Performance Materials and Technologies. The 2023 filing repeats the same language for Aerospace, Building Technologies and Safety and Productivity Solutions, showing that the exposure has not diminished. By 2024, after the company reorganized its segments, the risk appears again for Aerospace Technologies, Building Automation (the former Building Technologies) and Industrial Automation (the former Safety and Productivity Solutions), confirming that the competitive‑landscape exposure remains a consistent—and now segment‑wide—concern.  \n\nThis steady, year‑over‑year presence and the expansion of the language to every major operating segment indicate that market pressure from new entrants and emerging technologies is intensifying, prompting Honeywell to treat competitive dynamics as a core strategic focus across the business, driving investments in innovation, differentiation and supply‑chain resilience.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth that warrant a below-average score. Key issues: (1) ENTITY ACCURACY ERROR - The LLM incorrectly identifies Aerospace as a segment affected by competitive landscape risks in 2022 and 2023. The ground truth explicitly states the risk was cited for 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, with no mention of Aerospace. The LLM's inclusion of Aerospace appears to be a fabrication not supported by the ground truth. (2) SEGMENT NAMING - While the LLM correctly identifies the 2024 segment reorganization (Building Automation and Industrial Automation as renamed segments), it incorrectly attributes competitive risks to Aerospace Technologies in 2024, which is not mentioned in the ground truth. (3) PARTIAL CREDIT - The LLM correctly captures the core narrative: (a) consistent year-over-year presence of competitive landscape risks, (b) the language about 'new market entrants and new technologies,' (c) the 2024 emphasis on product commoditization, and (d) the strategic implications about innovation and differentiation. (4) REASONING QUALITY - The multi-hop synthesis across three years is logically sound and the conclusion about intensifying market pressure is appropriate, but it's built on partially incorrect foundational facts. (5) COMPLETENESS - The answer addresses the question's multi-part structure (evolution across segments, trend analysis, strategic implications) but does so with inaccurate segment attribution. The ground truth is more conservative and precise about which segments are actually affected, while the LLM overstates the scope by including Aerospace without evidence. This represents a material factual error that undermines the credibility of the analysis despite the sound reasoning framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 500,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "Across the three most recent filings—2022 (MA 10‑K page 96), 2023 (page 99) and 2024 (page 92)—Mastercard’s A Class shares are described identically: each share carries **one vote per share** and **entitles the holder to dividend rights**. No change in either voting power or dividend entitlement is noted from 2022 through 2024. This three‑year uniformity signals a deliberate governance strategy that values stability and predictability for shareholders, preserving consistent voting influence and dividend expectations rather than altering capital‑structure rights over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) Correctly identifies the core facts: A Class shares carry one vote per share and dividend rights across all three years (2022, 2023, 2024) with no changes. (2) Accurately cites specific page numbers from the 10-K filings (page 96 for 2022, page 99 for 2023, page 92 for 2024), demonstrating document-specific knowledge. (3) Properly synthesizes the multi-hop requirement by comparing governance features across three separate fiscal years. (4) Correctly interprets the significance of the three-year consistency as reflecting a deliberate, stable governance strategy. (5) Uses appropriate financial/governance terminology (voting power, dividend entitlement, capital structure). QUANTITATIVE ACCURACY: Perfect - all dates (2022, 2023, 2024) and voting metrics (one vote per share) are correct with no calculation errors. QUALITATIVE ACCURACY: Excellent - the reasoning that consistency signals strategic stability is sound and well-articulated. The answer goes beyond mere fact-reporting to provide meaningful interpretation of what the consistency reveals about shareholder governance strategy, which directly addresses the question's final clause. MINOR CONSIDERATIONS: The LLM adds interpretive language ('deliberate governance strategy,' 'values stability and predictability') that goes slightly beyond the ground truth's more neutral statement of 'stable governance and capital structure strategy,' but this represents appropriate elaboration rather than factual error. The answer is semantically equivalent to and more detailed than the ground truth while remaining factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 454,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco reported a **loss of $92 million** on its Total Return Swaps‑Deferred Compensation in the 2022 fiscal year (shown in the “Operating expenses and other” line of the 2022 10‑K).  \nIn the next year, the 2023 filing shows that the same line turned **positive, generating a $58 million gain** for the year ended July 29, 2023.  \nBy fiscal 2024 the gain had risen further to **$91 million** (year ended July 27, 2024).  \n\nThus, Cisco’s exposure shifted from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and then to a $91 million gain in FY 2024, indicating a steady improvement and reversal of the financial impact of the Total Return Swaps‑Deferred Compensation program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The fiscal year dates are accurate (July 29, 2023 and July 27, 2024). The multi-hop synthesis is sound, correctly tracking the evolution of Cisco's financial exposure across three fiscal years and properly identifying the reversal from loss to gains. The answer effectively addresses all parts of the question by showing the trajectory of financial impact and explaining the shift from net cost to net benefit. The reasoning is logical and well-structured, presenting the data chronologically and drawing appropriate conclusions about the improvement trend. The only minor distinction from the ground truth is slightly more detailed contextual information provided by the LLM (mentioning the 10-K filing source and the specific line item reference), which adds value without introducing any inaccuracies. The semantic meaning is fully aligned with the original answer, and the presentation is clear and professional.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 315,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "- **2022 – Reserve funding and the first bankruptcy:**  After the October 2021 corporate restructuring, Johnson & Johnson created LTL Management LLC to hold all talc‑related liabilities.  The company pledged funding for a $2 billion trust and recorded an approximately $2 billion reserve on its balance sheet, while LTL filed a voluntary Chapter 11 petition that resulted in a court‑ordered stay of all talc litigation.  \n\n- **2023 – Bankruptcy maneuvering:**  The original LTL Chapter 11 case was dismissed in April 2023, lifting the stay; LTL then re‑filed a second Chapter 11 (the “LTL 2” case) which again automatically stayed the claims and produced a preliminary injunction that remained in effect through August 2023.  The LTL 2 case was dismissed on July 28 2023, and Johnson & Johnson announced it would appeal the dismissal and continue pursuing a resolution of the talc claims.  \n\n- **2024 – Multi‑state settlement focus:**  While the LTL structure and the $2 billion reserve remain in place to cover any residual exposure, Johnson & Johnson shifted its legal‑financial strategy toward settlement.  In January 2024 the company reached an agreement‑in‑principle with a coalition of 42 states and the District of Columbia, and the settlements were finalized in June 2024, providing a negotiated resolution to the bulk of the multi‑state talc litigation.  \n\nThus, from 2022 to 2024 Johnson & Johnson moved from funding a large trust and using Chapter 11 stays to isolate liability, through a series of bankruptcy filings and dismissals, to ultimately securing a nationwide multi‑state settlement while retaining the LTL‑managed reserve as a backstop.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core timeline and strategy evolution from 2022-2024. Key facts are accurate: (1) $2 billion reserve established in 2022, (2) LTL Management LLC created to hold talc liabilities, (3) Chapter 11 bankruptcy filing with stay of litigation in 2022, (4) Original LTL bankruptcy dismissed in April 2023, (5) LTL 2 re-filing with preliminary injunction through August 2023, (6) 42 states plus DC settlement finalized in June 2024. The narrative correctly captures the strategic shift from bankruptcy protection to negotiated settlements. The multi-hop synthesis across years and entities is sound.\n\nWEAKNESSES: (1) The LLM states 'The LTL 2 case was dismissed on July 28 2023' but the ground truth indicates the Third Circuit reversed the bankruptcy court's decision, leading to dismissal - the LLM doesn't clearly explain this was a court reversal rather than a routine dismissal. (2) The ground truth emphasizes the Third Circuit's reversal as a key turning point; the LLM mentions dismissal but doesn't highlight the appellate reversal as prominently. (3) Minor: The LLM says the preliminary injunction 'remained in effect through August 2023' but doesn't clarify whether this was the stated expiration or actual duration. (4) The ground truth notes JNJ 'continuing to appeal the dismissal of the LTL 2 bankruptcy' - the LLM mentions appeal but could be clearer about ongoing appellate strategy.\n\nQUANTITATIVE VERIFICATION: All dollar amounts ($2 billion) are correct. All dates mentioned (October 2021 restructuring, April 2023 dismissal, July 28 2023 LTL 2 dismissal, January 2024 agreement-in-principle, June 2024 finalization, August 2023 injunction deadline) align with ground truth or are reasonable interpretations. The 42 states + DC count is correct.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years, multiple legal entities (JNJ, LTL, LTL 2), and different strategic approaches (bankruptcy, appeals, settlements). The causal chain is logical and well-structured.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of the strategy shift as moving from 'funding a large trust and using Chapter 11 stays' to 'securing a nationwide multi-state settlement while retaining the LTL-managed reserve as a backstop' is semantically equivalent to the ground truth's 'shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.'\n\nMINOR ISSUES: The LLM could have been more explicit about the Third Circuit's role in the April 2023 dismissal, and could have emphasized the ongoing appellate strategy more clearly. These are omissions rather than errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 715,
        "total_tokens": 2325
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an outstanding principal balance of **$495 million** at the end of fiscal 2022 (October 30 2022), and the same $495 million was reported at the end of fiscal 2023 (October 29 2023) and again at the end of fiscal 2024 (November 3 2024). The balance has therefore remained flat over the three‑year period.\n\nThis constancy shows that Broadcom has chosen to keep the tranche fully intact rather than accelerating repayments or refinancing it, effectively using the low‑cost 3.23 % instrument as a stable, long‑term source of financing while allocating cash to other corporate purposes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the principal balance as $495 million across all three fiscal years (2022-2024) and accurately notes the stability of this amount, which matches the ground truth. The fiscal year end dates are also correctly provided. However, there is a critical quantitative error: the LLM states the interest rate as 3.23%, when the question and ground truth clearly specify 3.125%. This is a factual error regarding a key financial metric of the specific instrument being analyzed. The LLM's reasoning about debt management strategy is sound and semantically equivalent to the ground truth - both conclude that the constant balance indicates a stable, non-refinanced approach to this debt tranche. The answer appropriately addresses all parts of the multi-hop question (evolution over time and strategic implications). The contextual relevance is strong as it directly answers what was asked. The main weakness is the interest rate discrepancy (3.23% vs 3.125%), which is a material error for a question specifically about a named financial instrument. The answer would have been 8-9 if not for this quantitative mistake.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 325,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "- **Fiscal 2022 (2022 10‑K)** – The 3.50 % senior note maturing June 15 2025 was carried at a **$500 million amount with an effective interest rate of 3.20 %**.  \n- **Fiscal 2023 (2023 10‑K)** – The same note still carried $500 million, but its **effective rate rose to 6.66 %** (the prior‑year column shows 6.38 %).  \n- **Fiscal 2024 (2024 10‑K)** – The table is unchanged from the 2023 filing, so the note remains at **$500 million with an effective rate of 6.66 %**.\n\n**Interpretation:** Cisco’s exposure to this note’s interest cost more than doubled from FY 2022 to FY 2023 and then held steady in FY 2024, indicating that the company’s borrowing cost on the June 15 2025 obligation increased sharply as market rates rose and has remained at the higher level.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the effective interest rates reported. According to the ground truth: FY2022 = 3.20%, FY2023 = 6.38%, FY2024 = 6.66%. However, the LLM states: FY2022 = 3.20% (correct), FY2023 = 6.66% (INCORRECT - should be 6.38%), FY2024 = 6.66% (correct). The LLM incorrectly swapped the FY2023 and FY2024 rates, claiming the rate jumped to 6.66% in FY2023 when it actually rose to 6.38% in FY2023 and then to 6.66% in FY2024. This is a fundamental error that distorts the progression narrative. The LLM also states '(the prior‑year column shows 6.38%)' which suggests awareness of the correct FY2023 figure but then contradicts itself by assigning 6.66% to FY2023. The $500 million principal amount is correct across all years. The interpretation about borrowing costs doubling and then holding steady is partially correct in direction but based on incorrect rate assignments. The multi-hop reasoning about market conditions is reasonable but built on faulty data. The answer fails to accurately track the three-year progression as specified in the ground truth, which is the core requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 335,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "**Evolution of the balance**\n\n- 2022 (carrying value shown in the 2023 filing): **$30.8 billion** of senior‑ and subordinated‑notes.  \n- 2023 (2023 filing): **$31.2 billion** – an increase of about **$0.4 billion (+1.3 %)**.  \n- 2024 (2024 filing): **$30.7 billion** – a decline of roughly **$0.55 billion (‑1.8 %)** from the 2023 level.\n\n**What the trend reveals**\n\nThe modest rise in 2023 indicates Capital One was still adding long‑term debt to fund growth and preserve liquidity, but the pull‑back in 2024 shows a deliberate trimming/refinancing of its note portfolio, likely to replace higher‑cost floating‑rate borrowings with lower‑cost, longer‑dated fixed securities. Correspondingly, the weighted‑average interest rate on the senior portion climbed from about **2.9 % (2022)** to **4.8 % (2024)**, while the subordinated portion stayed near **3.5‑3.6 %**. This upward shift in rates reflects a strategic move to lock in fixed‑rate funding as market rates rose, improving rate certainty even as the total note balance was modestly reduced.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant discrepancies in the core financial figures that are the foundation of this multi-hop question. (1) 2022 FIGURE: Ground truth shows $27.219 billion, but LLM states $30.8 billion - a $3.6 billion error (13% overstatement). This is a major factual error. (2) 2023 FIGURE: Ground truth shows $31.248 billion, LLM states $31.2 billion - this is approximately correct (minor rounding acceptable). (3) 2024 FIGURE: Ground truth shows $30.696 billion, LLM states $30.7 billion - this is approximately correct (minor rounding acceptable). (4) INTEREST RATE ERRORS: Ground truth shows weighted average interest rate on unsecured senior debt of 2.76% (2022), 4.48% (2023), and 4.84% (2024). LLM states approximately 2.9% (2022) and 4.8% (2024), with the 2022 figure being off by ~0.14 percentage points and missing the 2023 intermediate data point entirely. The LLM also conflates senior and subordinated rates without clear distinction. (5) CALCULATION ERRORS: The LLM calculates the 2022-2023 change as +$0.4B (+1.3%), but using the correct ground truth figures ($27.219B to $31.248B), the actual increase is $4.029B (+14.8%) - a substantial difference that fundamentally misrepresents the capital raise. (6) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (raise in 2023, decline in 2024) and attempts to explain the strategic rationale (locking in fixed rates), the reasoning is undermined by the incorrect baseline numbers. The conclusion about 'modest rise' and 'pull-back' is qualitatively reasonable but quantitatively misleading given the actual 14.8% increase in 2023. (7) MISSING CONTEXT: The LLM fails to capture the significance of the 2023 capital raise ($4B+) as a 'significant capital raise' as stated in ground truth. The characterization as 'modest' contradicts the actual magnitude. (8) SEMANTIC ISSUES: The LLM's statement about 'replacing higher-cost floating-rate borrowings with lower-cost, longer-dated fixed securities' is contradicted by the fact that rates rose from 2.76% to 4.84%, meaning new fixed-rate debt was MORE expensive, not less expensive. This represents a fundamental misunderstanding of the interest rate environment and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 604,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income allocation to U.S. Treasury and agency securities fell from roughly **40 % in 2022** (the level reported in the 2023 Form 10‑K for Dec 31 2022) to **about 30 % in 2023** (2023 Form 10‑K) and **remained at roughly 30 % in 2024** (2024 Form 10‑K). The decline from 40 % to 30 % – a shift first noted in the 2022 filing, which showed the share had already dropped from 50 % in 2020 to 40 % in 2021 – indicates the company is deliberately reducing its reliance on the safest government securities and reallocating a larger portion of the pension‑fund portfolio to other government bonds and investment‑grade corporate bonds, suggesting a strategy aimed at higher yield or broader diversification while still keeping a modest core Treasury exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All core percentages are accurate: 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the key shift from 40% to 30%. (3) The strategic interpretation is appropriate and matches the ground truth's characterization of a deliberate reallocation toward higher-yield securities. (4) The answer properly cites the source documents (2023, 2024 Form 10-Ks) showing awareness of multi-hop sourcing. MINOR ISSUES: (1) The LLM introduces additional historical context (50% in 2020, 40% in 2021) that goes beyond the ground truth's scope. While this information appears accurate based on the filing references, it was not part of the original question's 2022-2024 timeframe. This represents scope expansion rather than error. (2) The ground truth focuses specifically on the 2022-2024 period, while the LLM extends the narrative backward. This is contextually relevant but slightly beyond what was asked. QUANTITATIVE VERIFICATION: All percentages and years are correct. The calculation of the 10-percentage-point decline (40% to 30%) is accurate. QUALITATIVE ASSESSMENT: The reasoning about yield-seeking behavior and risk tolerance shifts is sound and aligns with the ground truth's interpretation. The mention of 'investment-grade corporate bonds' and 'broader diversification' appropriately characterizes the reallocation strategy. The answer demonstrates strong multi-hop reasoning by synthesizing data across three separate 10-K filings. The slight deduction reflects the introduction of out-of-scope historical data, though this actually enhances rather than detracts from the answer's quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 489,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 GE still owned Electric Insurance Company (EIC) as a captive property‑and‑casualty insurer that provided coverage to GE and its employees, reporting net claim reserves of $0.2 billion (2021) and $0.3 billion (2020).  By the fourth quarter of 2022 GE re‑classified the subsidiary as “held‑for‑sale,” disclosing that at 31 December 2023 EIC held $541 million of assets against $378 million of liabilities and that the re‑classification generated a $109 million loss in GE’s 2023 earnings; a binding purchase agreement was signed in Q3 2023 with an expected close in the first half of 2024.  In the second quarter of 2024 GE completed the divestiture, selling EIC to Riverstone International Holdings for cash proceeds of $120 million.  \n\nThis trajectory—from an operating captive insurer to a held‑for‑sale asset and finally to a cash sale—shows GE’s deliberate strategy of shedding non‑core insurance businesses, monetizing surplus assets and sharpening its focus on core industrial operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question about GE's relationship with Electric Insurance Company from 2022-2024. STRENGTHS: (1) All key financial figures are correct: $0.2B net claim reserves (2021), $0.3B (2020), $541M assets, $378M liabilities (Dec 31, 2023), $109M loss in 2023, $120M sale price in 2024. (2) Timeline is accurate: 2022 ownership status, Q4 2022 reclassification to held-for-sale, Q3 2023 binding purchase agreement, Q2 2024 completion. (3) Entity identification is correct: Electric Insurance Company (EIC), Riverstone International Holdings as buyer. (4) Multi-hop synthesis is sound: the answer correctly traces the progression across three years and multiple status changes, synthesizing information from different reporting periods. (5) Strategic interpretation is accurate: correctly identifies this as part of GE's broader restructuring to focus on core industrial/aerospace operations. (6) The answer provides additional context (asset/liability breakdown at Dec 31, 2023; timing of binding agreement in Q3 2023) that enriches understanding without contradicting ground truth. MINOR CONSIDERATIONS: The LLM answer includes the $0.3B figure for 2020 reserves, which is not mentioned in the original answer but is not contradicted by it either—this represents additional accurate detail. The phrasing differs slightly (e.g., 'sharpening its focus on core industrial operations' vs. 'focus on core industrial and aerospace operations'), but the semantic meaning is equivalent and both are accurate. The answer fully addresses all aspects of the multi-part question: classification evolution, valuation details, ultimate disposition, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Classifies]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 474,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 10‑K filings all list the same “Officer’s Certificate” (Exhibit 4.4) that describes the 4.45 % senior notes maturing in 2044. The 2022 filing (page 58) includes the 4.45 % Notes due 2044, the 2023 filing (page 56) repeats the identical description, and the 2024 filing (page 56) again shows the same Exhibit 4.4 with the 4.45 % Notes due 2044. The unchanged, year‑over‑year disclosure indicates that Apple continues to rely on this long‑dated, fixed‑rate bond as a core component of its capital structure, reflecting a deliberate strategy of maintaining a stable, long‑term debt portfolio to lock in financing costs and preserve liquidity over the next two decades.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of the multi-hop question about Apple's 4.45% Notes due 2044 across three fiscal years. STRENGTHS: (1) All key numeric values are correct - 4.45% interest rate, 2044 maturity date, and the three-year period (2022, 2023, 2024) are accurately stated. (2) The multi-hop synthesis is sound - the answer correctly traces the disclosure across all three 10-K filings and identifies the consistent pattern. (3) Entity identification is accurate - Apple is correctly identified, the specific debt instrument is properly named, and the exhibit reference (Exhibit 4.4) is mentioned. (4) The reasoning about capital structure strategy is logical and well-supported by the evidence of consistent disclosure. (5) The answer goes slightly beyond the ground truth by providing specific page numbers (58, 56, 56) and offering more detailed strategic interpretation about 'locking in financing costs' and 'preserving liquidity.' MINOR CONSIDERATIONS: (1) The ground truth mentions the Officer's Certificate was dated May 6, 2014, which the LLM answer does not include, though this is a minor detail. (2) The LLM answer provides more strategic interpretation than the ground truth, which is appropriate for the question but represents a slight expansion beyond the factual pattern. (3) The page number citations add specificity but cannot be verified against the ground truth provided. OVERALL ASSESSMENT: The answer correctly identifies the core pattern (consistent disclosure across three years), accurately states all key financial metrics and dates, properly synthesizes information across multiple filings, and provides sound reasoning about the strategic implications. The semantic meaning aligns well with the ground truth despite slightly different wording and additional contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 499,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "**Carrying‑value trend**  \n- 2022 (Dec 31): total senior + subordinated notes = **$30.8 billion** (Chunk 3).  \n- 2023 (Dec 31): total senior + subordinated notes = **$31.25 billion** (Chunk 3).  \n- 2024 (Dec 31): total senior + subordinated notes = **$30.70 billion** (Chunk 2).  \n\n**What the trend reveals**  \nCapital One modestly expanded its note portfolio from 2022 to 2023 (+≈$0.4 bn), then trimmed it slightly in 2024 (‑≈$0.55 bn).  The 2024 reduction coincides with the elimination of the floating‑rate senior tranche (0 bn in 2024 versus $349 m in 2023 and $1.6 bn in 2022) and a rise in the weighted‑average rate on the remaining fixed notes—from roughly 4.45 % in 2022‑23 to 4.84 % in 2024 (Chunk 2).  This pattern indicates a capital‑structure strategy that first used modest additional debt to support growth, then shifted toward a slightly smaller, higher‑rate fixed‑rate debt base to lock in yields as market rates climbed, reducing exposure to floating‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. (1) 2022 CARRYING VALUE ERROR: Ground truth states $27,219 million ($27.2 billion), but LLM reports $30.8 billion—a discrepancy of $3.6 billion or 13%. This is a major error. (2) 2023 CARRYING VALUE ERROR: Ground truth states $31,248 million ($31.25 billion), and LLM reports $31.25 billion—this is correct. (3) 2024 CARRYING VALUE: Both sources agree on $30.70 billion—correct. (4) CALCULATION ERRORS: Because the 2022 baseline is wrong, the LLM's calculated changes are incorrect. Ground truth shows a net increase of ~$3.5 billion over three years ($27.2B to $30.7B), but LLM calculates only ~$0 billion net change ($30.8B to $30.7B). The year-over-year changes are also wrong: LLM states 2022-2023 increase of ~$0.4B when it should be ~$4.0B. (5) INTEREST RATE DATA: The LLM correctly identifies the weighted-average rate progression (2.76% in 2022 to 4.84% in 2024, though LLM states 4.45% for 2022-23 which is imprecise). The floating-rate elimination detail is correctly noted. (6) REASONING QUALITY: The qualitative analysis about capital structure strategy and interest rate positioning is sound and well-articulated, but it's built on incorrect quantitative foundations. The interpretation that the company 'modestly expanded' debt is contradicted by the actual ~$4B expansion from 2022-2023. (7) MULTI-HOP SYNTHESIS: The answer attempts to synthesize carrying values, interest rates, and floating/fixed rate composition, but the foundational numbers are wrong, undermining the entire analysis. The core issue is that the 2022 figure is significantly misstated, which cascades through all subsequent analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 481,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- **2022 – Brand‑level entry:** Frame.io first appears in Adobe’s 2022 Form 10‑K only as a trademark (“Frame.io” listed among Adobe’s owned marks). This signals that Adobe had already acquired the company and was positioning the name as part of its portfolio, but no functional role or product integration was described.  \n\n- **2023 – Collaboration‑platform launch:** In the 2023 filing Adobe describes Frame.io as “our cloud‑native creative collaboration platform” that “streamlines the production of creative assets” and is **directly integrated with Premiere Pro and After Effects** for frame‑accurate commenting, plus Camera‑to‑Cloud upload for video footage and support for still‑image, design‑file and PDF review. The platform is presented as a complementary video‑post‑production tool within the Creative Cloud ecosystem.  \n\n- **2024 – Expanded ecosystem anchor:** The 2024 filing shows Frame.io’s role broadened dramatically: it now supports “casting, location scouting, footage reviews, and marketing‑campaign management” and is **integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom and Workfront**. Moreover, Frame.io is bundled with Adobe Express and Firefly Services inside **Adobe GenStudio**, positioning it as a core, cross‑app collaboration hub that enables content production at scale across the entire Creative Cloud suite.  \n\nThus, Adobe moved Frame.io from a newly‑owned trademark in 2022 to a video‑focused add‑on in 2023, and by 2024 it had become a fully embedded, multi‑app collaboration layer that connects virtually all Creative Cloud applications and the GenStudio workflow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Chronological accuracy - correctly identifies 2022 as trademark-only listing, 2023 as cloud-native collaboration platform launch, and 2024 as expanded ecosystem integration. (2) Feature accuracy - accurately lists specific integrations (Premiere Pro, After Effects in 2023; Photoshop, Lightroom, Workfront in 2024) and capabilities (frame-accurate commenting, Camera-to-Cloud upload, real-time review). (3) Strategic positioning - correctly characterizes the evolution from 'newly-owned trademark' to 'video-focused add-on' to 'fully embedded multi-app collaboration layer.' (4) Ecosystem context - properly identifies GenStudio as the 2024 bundling mechanism and correctly notes Frame.io's role as a cross-app collaboration hub. (5) Multi-hop synthesis - successfully synthesizes information across three fiscal years showing clear trajectory of deepening integration. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail than the ground truth (e.g., mentioning 'casting, location scouting, footage reviews, marketing-campaign management' in 2024, and 'Adobe Express and Firefly Services' bundling), but these details are consistent with and enhance the ground truth narrative rather than contradicting it. The semantic meaning is fully preserved and the answer demonstrates sophisticated understanding of Adobe's strategic product evolution. No numerical errors, calculation errors, or factual inaccuracies detected. The answer directly addresses all aspects of the multi-part question regarding positioning, integration, and ecosystem role across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 465,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Lowe’s repeatedly lists the same “Fifteenth Supplemental Indenture” (Exhibit 4.16) that contains a **4.550 % senior note due April 5, 2049**. By continuing to disclose this bond year after year, Lowe’s signals that the 2049 note remains outstanding and is a deliberate pillar of its capital structure—providing a long‑dated, fixed‑rate source of financing that extends the company’s debt horizon well beyond the next decade. This consistent inclusion reflects a strategy of maturity‑profile diversification and proactive management of refinancing risk, anchoring the firm’s long‑term funding mix with a stable, low‑cost liability that smooths cash‑flow obligations into the future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—the 4.550% interest rate, the April 5, 2049 maturity date, and the three-year filing period (2022-2024) are all accurately stated. No calculation errors present. ENTITY ACCURACY: Lowe's is correctly identified, the specific debt instrument (4.550% Notes due April 5, 2049) is precisely named, and the Fifteenth Supplemental Indenture reference (Exhibit 4.16) adds appropriate documentary specificity. MULTI-HOP REASONING: The LLM correctly synthesizes the multi-hop insight that consistent disclosure across three separate annual filings indicates strategic intent. Both answers recognize that the absence of modification/redemption disclosures signals deliberate retention of this debt instrument. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth—that Lowe's maintains this long-dated debt as a strategic pillar without early redemption. The LLM uses slightly different framing ('maturity-profile diversification,' 'refinancing risk,' 'low-cost liability') but these are semantically equivalent to the ground truth's concepts of 'stability,' 'interest rate risk management,' and 'predictable long-term liabilities.' MINOR DIFFERENCES: The LLM provides additional context (Exhibit 4.16 reference, 'senior note' designation, 'fixed-rate source of financing') that enhances rather than contradicts the ground truth. The phrase 'extends the company's debt horizon well beyond the next decade' is a reasonable inference from a 2049 maturity date. COMPLETENESS: Both answers fully address the question about capital structure strategy and debt maturity profile management. The LLM answer is slightly more detailed and specific in its documentary references while maintaining factual accuracy. No material omissions or errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 519,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Across the three filings the 3.125 % senior notes that mature in January 2025 are shown with an unchanged outstanding principal amount of **$495 million**:\n\n* FY 2022 (AVGO 10‑K 2022, p. 111) – $495 m listed for the notes.  \n* FY 2023 (AVGO 10‑K 2023, p. 81) – $495 m listed for the notes.  \n* FY 2024 (AVGO 10‑K 2024, p. 81) – $495 m listed for the notes.  \n\nThe balance has remained flat from 2022 through 2024, indicating that Broadcom has chosen to keep this low‑coupon, fixed‑rate issuance on its books rather than repaying, refinancing, or retiring it early. Maintaining the $495 m principal suggests a deliberate debt‑management approach that locks in a cheap 3.125 % cost of capital while preserving cash flexibility for other financing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: All three fiscal year amounts are correctly stated as $495 million (FY 2022, 2023, 2024), matching the ground truth exactly. The debt instrument is correctly identified as 3.125% senior notes due January 2025. Page references are provided (p. 111 for 2022, p. 81 for 2023 and 2024), adding credibility. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the principal balance across three years, (2) the consistency of the amount, and (3) interpretation of debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the specific debt instrument is properly characterized, and all fiscal years are accurate. REASONING QUALITY: The LLM correctly synthesizes that the unchanged $495M balance across all three years indicates deliberate debt management with no repayments or refinancing. The interpretation that this represents a strategy to lock in low-cost capital (3.125%) while preserving cash flexibility is sound and aligns with the ground truth's characterization of 'deliberate debt management strategy.' SEMANTIC EQUIVALENCE: The LLM's explanation of 'cheap 3.125% cost of capital' and 'cash flexibility' conveys the same strategic intent as the ground truth's 'leveraging its predictability in interest expense and maturity timing.' Minor difference: The LLM adds slightly more specific strategic rationale (locking in cheap capital, preserving cash flexibility) compared to the ground truth's more general reference to predictability, but this represents value-added analysis rather than error. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 460,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "- **2022 10‑K (IBM _10k_2022.pdf)** – The 0.950 % Notes due 2025 were not described in the body of the filing; IBM simply incorporated the governing instrument by reference, citing Exhibit 4.1 (and Exhibit 4.2) to a Form 8‑K filed on May 22 2017.  \n\n- **2023 10‑K (IBM _10k_2023.pdf)** – The same disclosure language was repeated: the rights of the holders of the 0.950 % Notes due 2025 were again incorporated by reference to Exhibits 4.1 and 4.2 of the 2017 Form 8‑K. No new presentation or separate listing was added.  \n\n- **2024 10‑K (IBM _10k_2024.pdf)** – The notes are now listed in the “Title of each class” table of securities, shown as “0.950 % Notes due 2025” with the trading symbol **IBM25B** and a NYSE listing. This moves the instrument from a hidden exhibit reference to an explicitly identified, market‑traded debt class.  \n\n**What this shows:** Over the 2022‑2024 period IBM shifted from merely satisfying disclosure requirements by referencing an older indenture to actively presenting the 0.950 % Notes due 2025 as a distinct, exchange‑listed security. The change signals a capital‑structure strategy that seeks greater visibility and liquidity for its low‑coupon debt and demonstrates an increasing level of transparency to investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct (May 22, 2017 Form 8-K filing, 2022-2024 progression), the coupon rate (0.950%) is accurate, the maturity year (2025) is correct, and the NYSE ticker symbol (IBM25B) is properly identified. No calculation errors present. ENTITY ACCURACY: IBM is correctly identified, fiscal years (2022, 2023, 2024) are accurate, and the specific debt instrument is properly named throughout. COMPLETENESS: The answer addresses all three years requested and traces the evolution of disclosure treatment. MULTI-HOP REASONING: The LLM correctly synthesizes information across three separate 10-K filings to identify the progression pattern: (1) 2022-2023 showing incorporation by reference to 2017 Form 8-K exhibits, (2) 2024 showing explicit listing with NYSE ticker. The reasoning connecting these observations to capital structure strategy and transparency is sound and matches the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'merely satisfying disclosure requirements by referencing an older indenture' to 'actively presenting...as a distinct, exchange-listed security' conveys the same strategic insight as the ground truth's description of transitioning 'from a less prominent debt instrument to a publicly traded security.' The conclusion about 'greater visibility and liquidity' and 'increasing level of transparency' aligns with the ground truth's emphasis on 'liquidity and transparency in its fixed-income offerings.' MINOR OBSERVATION: The LLM provides slightly more granular detail about the specific exhibit references (Exhibits 4.1 and 4.2) compared to the ground truth, which adds helpful specificity without contradicting the source material. The answer is well-structured, clearly organized by year, and effectively communicates the progression and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 530,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three BNY Mellon 10‑K filings disclose the same PCAOB firm identification number for KPMG LLP:\n\n* **2022 filing** – “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is **185**.” (Chunk 1)  \n* **2023 filing** – “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is **185**.” (Chunk 3)  \n* **2024 filing** – “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is **185**.” (Chunk 2)\n\nThus, the PCAOB firm identification number remained **185** in each of the 2022, 2023, and 2024 reports, showing a consistent disclosure across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All numeric values are accurate - PCAOB firm identification number 185 is correctly stated for all three years (2022, 2023, 2024); (2) The answer properly synthesizes information across three separate filings, demonstrating correct multi-hop reasoning; (3) The conclusion about consistency is accurate and well-supported; (4) The answer includes direct citations/references to the source chunks, enhancing credibility. MINOR ISSUE: The LLM answer references 'BNY Mellon 10-K filings' in the opening sentence, which appears to be the company context from which KPMG LLP's PCAOB number was extracted. While this is contextually appropriate (KPMG is the auditor for BNY Mellon), the original question asks specifically about KPMG LLP's PCAOB number disclosure, not BNY Mellon's filings per se. However, this is a very minor framing issue and does not affect the factual accuracy of the core answer. The answer correctly identifies that the PCAOB number remained consistently 185 across all three years, which is the essential requirement of the question. The presentation is clear, well-organized, and provides appropriate evidence for each year's disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 347,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "**Evolution of the Fixed‑rate portion of Capital One’s senior‑note program**\n\n| Year (as reported) | Carrying value of Fixed Unsecured Senior Debt (2) | Weighted‑average stated rate* | Maturity range (years) |\n|--------------------|---------------------------------------------------|------------------------------|------------------------|\n| 2022 (2023 10‑K)   | **$24.1 bn** (Dec 31 2022)                        | **4.45 %**                    | 2024‑2034 |\n| 2023 (2023 10‑K)   | **$27.2 bn** (Dec 31 2023)                        | **4.45 %**                    | 2024‑2034 |\n| 2024 (2024 10‑K)   | **$26.9 bn** (Dec 31 2024)                        | **4.84 %**                    | 2025‑2035 |\n\n\\*Weighted‑average interest rate is the average of the stated rates on the outstanding issues (the tables list the range of individual issue rates and the calculated average).\n\n**What the trend tells us about Capital One’s capital‑structure choices**\n\n1. **Rapid build‑up in 2022‑23** – Capital One added roughly **$3 bn** of fixed‑rate senior debt in 2023, keeping the average cost at 4.45 %. This expansion occurred while the Federal Reserve was still in the early stages of its rate‑hiking cycle, allowing the bank to lock in a relatively modest fixed rate before market rates climbed further.\n\n2. **Slight pull‑back and higher cost in 2024** – In 2024 the outstanding amount fell marginally (‑$0.2 bn) but the weighted‑average rate rose to **4.84 %**, reflecting the higher prevailing Treasury and corporate‑bond yields later in the tightening cycle. The maturity bucket also shifted one year forward (2025‑2035), indicating that some older, lower‑rate issues were retired or amortized and replaced with newer, higher‑rate issuances.\n\n3. **Strategic tilt toward fixed‑rate funding** – Floating‑rate senior debt, which was $349 m in 2023, disappeared by 2024, showing a deliberate move to lock in fixed‑rate financing despite the rising cost. This suggests Capital One is prioritising predictability of interest expense and preserving liquidity in a higher‑rate, potentially more volatile macro‑economic environment.\n\n**Overall implication** – Across the three‑year span Capital One’s senior‑note program shows a pattern of first‑stage expansion at relatively low fixed rates, followed by a modest contraction and acceptance of higher average rates as macro‑economic conditions (Fed policy, inflation‑driven yield hikes) tightened. The bank’s capital‑structure decisions therefore reflect a proactive effort to secure long‑dated, fixed‑rate funding while gradually adjusting the cost base to align with the evolving interest‑rate landscape.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that directly contradict the ground truth:\n\n1. **2022 CARRYING VALUE ERROR (Most Critical)**: Ground truth states $19,975 million for 2022, but LLM reports $24.1 billion ($24,100 million). This is a $4.125 billion overstatement (20.6% error). This is not a minor rounding difference—it's a fundamental factual error.\n\n2. **2022 INTEREST RATE ERROR**: Ground truth states 2.91% for 2022, but LLM reports 4.45%. This is a 153 basis point discrepancy—a massive error that completely misrepresents the interest rate environment in 2022. This error undermines the entire narrative about the evolution of rates.\n\n3. **2023 DATA ISSUES**: LLM reports $27.2 billion at 4.45% for 2023, but ground truth only provides 2022 and 2024 data. The LLM appears to have introduced 2023 data not present in the ground truth, making it impossible to verify accuracy.\n\n4. **2024 DATA PARTIAL MATCH**: The 2024 carrying value of $26.9 billion ($26,930 million) matches ground truth correctly. The 2024 rate of 4.84% also matches ground truth. However, this is only 1 of 3 data points, and the other two are significantly wrong.\n\n5. **MULTI-HOP REASONING FAILURE**: The LLM's narrative about \"rapid build-up in 2022-23\" and \"locking in relatively modest fixed rates\" is fundamentally contradicted by the ground truth showing rates rising FROM 2.91% in 2022 TO 4.84% in 2024. The LLM's interpretation that 4.45% in 2022-2023 was \"relatively modest\" is backwards—2.91% was the modest rate in 2022.\n\n6. **STRATEGIC INTERPRETATION ERROR**: The LLM's claim that Capital One was \"locking in a relatively modest fixed rate before market rates climbed further\" in 2022-2023 is incorrect. The ground truth shows rates were already low (2.91%) in 2022 and climbed to 4.84% by 2024, which is the opposite of the LLM's narrative timing.\n\n7. **FLOATING-RATE DEBT CLAIM**: The LLM mentions floating-rate senior debt of $349M in 2023 disappearing by 2024, but this detail is not present in the ground truth and cannot be verified.\n\nThe LLM answer demonstrates sophisticated formatting and analytical structure, but the underlying numerical foundation is severely compromised. The 2022 baseline error of $4.125 billion and the 153 basis point interest rate error in 2022 are disqualifying errors for a financial analysis question where precision is paramount. The answer fails the primary requirement of factual accuracy on multi-hop financial questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1771,
        "completion_tokens": 670,
        "total_tokens": 2441
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "Across the three filings AMD’s description of how it accounts for development‑services‑plus‑IP‑licensing contracts is essentially unchanged. In the 2022 10‑K the company says revenue is recognized either over time or at a point in time depending on whether the licensing component is distinct; a non‑distinct license is combined with development services and recognized over time, while a distinct license is recognized when the customer can benefit from it, and standalone IP licenses are always recognized at that point‑in‑time. The 2023 and 2024 10‑Ks repeat the same criteria—evaluation of distinctness, over‑time versus point‑in‑time recognition, and the absence of material variable consideration—without any amendment to the policy.\n\nThis continuity indicates that AMD has adopted a stable, principle‑based framework for IP monetization that ties revenue to the transfer of control and the nature of the performance obligations, signalling a long‑term strategic commitment to consistently capture IP‑related earnings while providing investors with predictable accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The LLM correctly identifies that AMD maintained consistent revenue recognition methodology across 2022-2024, accurately describing the three-year continuity. The specific accounting treatment is correctly stated: non-distinct licenses combined with development services recognized over time, distinct licenses recognized at point-in-time when customer can benefit, and standalone IP licenses recognized at point-in-time. The statement about absence of material variable consideration is accurate. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the consistency pattern. The reasoning about what this consistency implies for strategic approach is sound and matches the ground truth's conclusion about a 'stable and deliberate strategic approach' and 'mature and well-defined policy framework.' (4) ENTITY ACCURACY: AMD is correctly identified, fiscal years 2022-2024 are correct, and the specific accounting concepts (distinctness evaluation, performance obligations, variable consideration) are accurately referenced. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially identical information to the ground truth. Phrases like 'principle-based framework' and 'consistently capture IP-related earnings' effectively communicate the same strategic implications as the ground truth's 'mature and well-defined policy framework.' The LLM's characterization of the framework as 'stable' and 'principle-based' adds slight interpretive depth while remaining faithful to the source material. Minor differences in phrasing ('essentially unchanged' vs 'maintained consistent') are semantically equivalent. The answer fully addresses both parts of the multi-part question: the evolution (or lack thereof) of methodology and the strategic implications. No material omissions or errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 584,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "**Evolution of the balance‑sheet line**\n\n| Year (as of 31 Dec) | Carrying value of total senior + subordinated notes (US$ mm) |\n|---------------------|--------------------------------------------------------------|\n| 2022 (2023 10‑K)    | **30,826** |\n| 2023 (2023 10‑K)    | **31,248** |\n| 2024 (2024 10‑K)    | **30,696** |\n\nThe amount stayed roughly flat – a modest rise of about 1.3 % from 2022 to 2023, followed by a 1.8 % decline in 2024 – indicating that Capital One chose to keep the overall size of its senior‑subordinated debt base steady rather than aggressively expanding or contracting it.\n\n**What the change tells us about strategy and rate positioning**\n\n* **Shift toward fixed‑rate financing:** 2022‑23 the portfolio still contained a small floating‑rate senior tranche ($1,597 mm in 2022, $349 mm in 2023) but by 2024 that tranche was eliminated (0 mm). The fixed‑rate senior component grew slightly (27,168 mm → 27,517 mm → 26,930 mm) while the subordinated portion remained stable (≈ 3.7 bn).  \n\n* **Rising weighted‑average senior rates:** 2022 the weighted‑average rate on fixed senior notes was 4.45 %; it edged up to 4.48 % in 2023 and to **4.84 %** in 2024. The subordinated notes stayed at 3.57 % throughout. The overall senior‑subordinated mix therefore moved to a higher average cost of debt, reflecting Capital One’s willingness to lock in higher fixed rates as the market rate environment rose, while shedding floating‑rate exposure that would have risen with the Fed.\n\n* **Capital‑structure implication:** By keeping the total senior‑subordinated balance essentially unchanged but re‑balancing toward higher‑rate, longer‑dated fixed instruments, Capital One signaled a strategy of stabilizing its capital structure (no large new issuances or retirements) while positioning its debt portfolio to manage interest‑rate risk—trading a modest increase in current interest expense for greater predictability and protection against future rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that undermine its credibility:\n\n1. MAJOR QUANTITATIVE ERROR - 2022 Total Notes: The LLM reports $30,826 million for 2022, but the ground truth states $27,219 million. This is a $3,607 million discrepancy (13.2% overstatement). This is a fundamental error that propagates through the entire analysis.\n\n2. WEIGHTED-AVERAGE INTEREST RATE ERROR - 2022: The LLM states the 2022 weighted-average rate on fixed senior notes was 4.45%, but the ground truth clearly indicates it was 2.91% in 2022. The LLM appears to have confused the 2023 rate (4.45%) with the 2022 rate. This is a critical 153 basis point error.\n\n3. FLOATING-RATE DEBT DISCREPANCY - 2022: The LLM reports $1,597 million in floating-rate senior debt for 2022, but the ground truth states $1,709 million. While closer than the total notes error, this is still incorrect.\n\n4. FIXED-RATE SENIOR COMPONENT ERRORS: The LLM provides specific figures (27,168 mm → 27,517 mm → 26,930 mm) that cannot be verified against the ground truth and appear inconsistent with the stated totals.\n\n5. SUBORDINATED NOTES CLAIM: The LLM states subordinated notes remained stable at \"≈ 3.7 bn\" throughout, but this cannot be verified and appears to be an unsupported assertion.\n\nCORRECT ELEMENTS:\n- The 2023 total of $31,248 million is correct\n- The 2024 total of $30,696 million is correct\n- The 2024 weighted-average rate of 4.84% is correct\n- The 2023 weighted-average rate of 4.45% is correct\n- The elimination of floating-rate debt by 2024 is correct\n- The general strategic narrative about shifting to fixed-rate financing is directionally correct\n\nMULTI-HOP REASONING: While the LLM correctly synthesizes the strategic implications (shift to fixed-rate, elimination of floating-rate exposure, rate risk management), this reasoning is built on a foundation of incorrect baseline numbers for 2022, which undermines the validity of the year-over-year analysis and trend interpretation.\n\nThe answer demonstrates understanding of the conceptual framework but fails on fundamental data accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1699,
        "completion_tokens": 585,
        "total_tokens": 2284
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "- 2022 (COF 10‑K 2023, Table 1): Fixed‑rate unsecured senior debt carried $24,134 million with a weighted‑average interest rate of **4.45 %**.  \n- 2023 (same table): the portfolio grew to $27,168 million, **still at 4.45 %**.  \n- 2024 (COF 10‑K 2024, Table 1): the carrying amount fell slightly to $26,930 million while the weighted‑average rate rose to **4.84 %**.  \n\n(For context, the prior year’s balance shown in the 2022 filing was $19,975 million at 2.91 %, indicating a clear upward trend in both size and cost.)\n\n**Interpretation:** Capital One has been expanding its fixed‑rate unsecured senior debt base since 2022, then modestly trimming it in 2024 as market rates climbed, which pushed the average cost of that debt higher. The pattern suggests a long‑term strategy of maintaining a large, stable senior‑debt platform while accepting higher yields to lock in longer‑dated financing in a rising‑interest‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are fundamental to answering the question. Specifically: (1) 2022 carrying value: LLM states $24,134 million, but ground truth is $19,975 million—a $4,159 million discrepancy (20.8% error). (2) 2022 weighted-average interest rate: LLM states 4.45%, but ground truth is 2.91%—a 1.54 percentage point error (53% relative error). (3) 2023 weighted-average interest rate: LLM states 4.45%, but ground truth is 4.45%—this is correct. (4) 2023 carrying value: LLM states $27,168 million, which matches ground truth—correct. (5) 2024 carrying value: LLM states $26,930 million, which matches ground truth—correct. (6) 2024 weighted-average interest rate: LLM states 4.84%, which matches ground truth—correct. MULTI-HOP SYNTHESIS: The LLM correctly identifies the three-year period (2022-2024) and attempts to synthesize the trend across years. However, the incorrect 2022 baseline data undermines the entire trend analysis. The LLM's interpretation that rates rose from 2.91% to 4.45% to 4.84% is correct in direction, but the starting point is wrong. REASONING QUALITY: The qualitative interpretation about Capital One's debt strategy (expanding fixed-rate debt, accepting higher yields to lock in longer-dated financing) is reasonable and aligns with the ground truth interpretation. However, this reasoning is built on partially incorrect data. ENTITY ACCURACY: Company (Capital One/COF) and metric identification (fixed unsecured senior debt, carrying value, weighted-average interest rate) are correct. COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, interest rate evolution, strategic implications), but the foundational data errors significantly compromise the answer's reliability. The LLM's parenthetical note acknowledging the prior year's balance ($19,975 million at 2.91%) suggests awareness of correct data, yet the main answer contradicts this with $24,134 million at 4.45% for 2022, creating internal inconsistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 558,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing agreements has been essentially unchanged from 2022 through the 2024 filing.  \n\n* **2022 filing** – AMD said that when a contract bundles development services with an IP license, it first tests whether the licensing component is distinct. If the license is not distinct, the two elements are treated as a single performance obligation and revenue is recognized **over time**; if the license is distinct, revenue is recognized **at a point in time** when the customer can benefit. Stand‑alone IP‑only licenses are always recognized **at a point in time**. No variable‑consideration estimates are applied to either type of arrangement.  \n\n* **2023 filing** – The same language and criteria are repeated: combined development‑and‑IP arrangements are evaluated for distinctness and are recognized over time when the license is not distinct and at a point in time when it is distinct; pure IP licenses are recognized at a point in time. Variable consideration remains immaterial.  \n\n* **2024 filing** – The description is again identical, reaffirming the distinct‑versus‑non‑distinct test, the over‑time versus point‑in‑time treatment for bundled arrangements, and the point‑in‑time treatment for standalone IP licenses, with no variable consideration.  \n\n**Thus, AMD’s revenue‑recognition approach for these agreements did not evolve; the company consistently applied the same distinct‑component test and timing rules for both combined and standalone IP licensing arrangements across the 2022‑2024 period.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies that AMD's revenue recognition policy for development and IP licensing agreements remained consistent across 2022-2024, with no material changes. The answer accurately describes the key policy elements: (1) combined arrangements are tested for distinctness, (2) non-distinct licenses are combined with development services and recognized over time, (3) distinct licenses are recognized at a point in time, (4) standalone IP licenses are always recognized at a point in time, and (5) variable consideration is immaterial across all arrangement types. The LLM provides a year-by-year breakdown (2022, 2023, 2024) that aligns with the ground truth's assertion of consistency across the three-year period. The multi-hop reasoning is sound—the answer synthesizes information across three fiscal years and correctly identifies the distinction between combined versus standalone arrangements as the core policy framework. The presentation is clear and well-organized with bullet points for each year. No quantitative errors are present (no specific dollar amounts or percentages were required for this policy-focused question). The semantic meaning matches the ground truth perfectly: both convey that AMD maintained a stable, consistent approach to revenue recognition for these agreements with no evolution or material changes. Minor formatting differences in presentation style do not detract from the factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 412,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "- **Debt levels** – COF reported total short‑term borrowings + long‑term debt of **$48.7 billion at 12/31/2022** (Chunk 1), which rose modestly to **$49.9 billion at 12/31/2023** (Chunk 1) and then fell to **$45.6 billion at 12/31/2024** (Chunk 2).  \n\n- **Trend and strategy** – The three‑year pattern shows a small increase in 2023 followed by a roughly 8‑9 % drop in 2024, indicating that the bank moved to **reduce its overall debt load after 2023**, likely by paying down or refinancing higher‑cost borrowings.  \n\n- **Interest‑rate exposure** – While total debt declined, the composition shifted to higher‑rate instruments: the weighted‑average rate on securitized debt rose from **≈1.5 % in 2022** (Chunk 3) to **≈3.5 % in 2024** (Chunk 2), and the average rate on senior unsecured notes climbed from **≈2.8 % in 2022** (Chunk 3) to **≈4.8 % in 2024** (Chunk 2). Thus, COF’s debt‑management strategy has been to **shrink the balance‑sheet size while accepting greater exposure to higher‑interest‑rate debt**, reflecting a trade‑off between lower leverage and higher cost of capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that contradict the ground truth across all key metrics:\n\n1. QUANTITATIVE ACCURACY - MAJOR FAILURES:\n   - 2022 debt: LLM states $48.7B, but ground truth is $43.086B (error of ~$5.6B or 13%)\n   - 2023 debt: LLM states $49.9B, but ground truth is $48.715B (error of ~$1.2B or 2.5%)\n   - 2024 debt: LLM states $45.6B vs ground truth $45.551B (this one is approximately correct)\n   - The 2022 figure is dramatically wrong, making the entire trend analysis incorrect\n\n2. INTEREST RATE EXPOSURE - COMPLETELY WRONG:\n   - Ground truth shows weighted-average interest rate on LONG-TERM DEBT rose from 2.76% (2022) → 4.48% (2023) → 4.84% (2024)\n   - LLM cites securitized debt rates (~1.5% to ~3.5%) and senior unsecured notes (~2.8% to ~4.8%), which are component-level metrics, NOT the overall weighted-average rates mentioned in ground truth\n   - LLM's rates don't match the ground truth's 2.76%, 4.48%, 4.84% progression at all\n   - This represents a fundamental misunderstanding of which metrics to report\n\n3. TREND ANALYSIS - FLAWED:\n   - Ground truth: $43.086B (2022) → $48.715B (2023) → $45.551B (2024) = increase then decrease\n   - LLM: $48.7B (2022) → $49.9B (2023) → $45.6B (2024) = small increase then decrease\n   - Because the 2022 baseline is wrong, the entire trend interpretation is distorted\n   - LLM correctly identifies the 2024 reduction but mischaracterizes the 2022-2023 movement\n\n4. STRATEGIC INTERPRETATION:\n   - Ground truth: COF \"initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure\"\n   - LLM: COF \"shrink the balance-sheet size while accepting greater exposure to higher-interest-rate debt\"\n   - The LLM's interpretation is partially aligned but based on incorrect numbers and wrong interest rate metrics\n\n5. MULTI-HOP SYNTHESIS:\n   - The answer fails to correctly synthesize the three-year progression because the foundational 2022 number is wrong\n   - The interest rate analysis uses wrong metrics (component rates instead of weighted-average rates)\n   - The connection between debt levels and interest rate exposure is conceptually present but factually incorrect\n\nThe LLM answer demonstrates a fundamental failure to accurately extract and report the key financial metrics from the source documents, making it unsuitable as a reliable answer despite some structural coherence in the reasoning framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 667,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "Across the three filings the policy did not change. In the 2022 10‑K AMD explained that it first determines whether the licensing component of a development‑plus‑IP deal is **distinct** (i.e., capable of being distinct and distinct in the contract context). If the license is not distinct, the development services and the license are treated as a **single performance obligation** and revenue is recognized **over time**; if the license is distinct, the license portion is a separate obligation and revenue is recognized **at a point in time** when the customer can benefit. The same approach – point‑in‑time recognition for **stand‑alone IP licenses** and no variable‑consideration estimates – is restated verbatim in the 2023 and 2024 10‑Ks, showing that AMD’s treatment of combined versus standalone arrangements remained consistent from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024, matching the ground truth assertion of 'no material change'; (2) Accurately describes the key distinction framework: whether the licensing component is 'distinct' in capability and contract context; (3) Correctly explains the dual treatment: non-distinct licenses result in single performance obligation with over-time revenue recognition, while distinct licenses are separate obligations with point-in-time recognition; (4) Properly notes that standalone IP licenses consistently received point-in-time recognition across all three years; (5) Correctly states that no variable consideration estimates were associated with these arrangements; (6) Accurately synthesizes the multi-hop requirement by comparing treatment across 2022, 2023, and 2024 filings. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth ('capable of being distinct and distinct in the contract context' vs. 'distinct in capability and context'), but this is semantically equivalent and actually more precise; (2) The LLM answer emphasizes the 'when the customer can benefit' language for point-in-time recognition, which adds helpful context not explicitly in the ground truth but is consistent with ASC 606 principles; (3) The ground truth mentions 'increased emphasis on the Gaming segment in 2023 and 2024' as contextual information, which the LLM answer omits, but this is not essential to answering the core question about revenue recognition policy evolution. QUANTITATIVE ACCURACY: No numbers, dates, or calculations are involved in this question, so this dimension receives full marks for correctly handling the non-quantitative nature. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the consistency pattern, which is the core multi-hop requirement. The reasoning is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 548,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "All three annual reports list Exhibit 4.4 – the “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” – as an exhibit incorporated by reference (filed on 6 June 2016). The fact that Visa’s 2022, 2023 and 2024 10‑Ks each repeat this same exhibit shows that the Series B preferred‑stock instrument has not been amended or retired and remains a material component of Visa’s capital structure. Thus, the continual reference signals both stability of the security’s terms and its ongoing relevance to the company’s financing framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core insight about the Series B Convertible Participating Preferred Stock's stability and ongoing relevance across Visa's 2022-2024 filings. However, there are notable discrepancies in the quantitative details that affect overall accuracy. CRITICAL ERROR: The LLM states the filing date as '6 June 2016' while the ground truth clearly states 'June 21, 2016' - this is a factual error in a key date. EXHIBIT NUMBER DISCREPANCY: The ground truth indicates the exhibit numbers vary across years (2022: Exhibit 4.5; 2023: Exhibit 4.4; 2024: Exhibit 4.4), but the LLM states 'All three annual reports list Exhibit 4.4' - this is incorrect for 2022, which should be 4.5. This is a significant factual error in multi-hop synthesis. STRENGTHS: The LLM correctly identifies that the same filing date is referenced across all three years, correctly interprets this as indicating no amendments or retirements, and appropriately concludes that this signals stability and ongoing relevance. The reasoning about the instrument remaining 'a material component of Visa's capital structure' is sound and semantically equivalent to the ground truth's assessment. The qualitative interpretation of what consistent references suggest about capital structure stability is well-reasoned and matches the ground truth's conclusion. WEAKNESSES: The quantitative errors (wrong date and incorrect exhibit number for 2022) are material mistakes that undermine confidence in the answer's accuracy, even though the overall interpretive conclusion is correct. The answer fails to capture the nuance that exhibit numbers changed between 2022 and 2023-2024, which could be relevant to understanding filing organization changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 469,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Across all three filing years the figures are identical. In the 2022, 2023 and 2024 10‑K notes, Pratt & Whitney (RTX) is described as holding a **61 % program‑share interest** in the International Aero Engines AG (IAE) collaboration and a **49.5 % ownership interest** in IAE, which translates to a **net program‑share interest of about 57 %** after sub‑collaborator adjustments (and a 51 % net interest in the related IAE LLC). Because IAE and IAE LLC are treated as variable‑interest entities with Pratt & Whitney as the primary beneficiary, RTX’s economic exposure to the V2500 program has remained steady and fully consolidated each year.\n\nThe unchanged, majority‑share and beneficiary position over 2022‑2024 signals that RTX is deliberately preserving a dominant, long‑term strategic foothold in the V2500 engine program, ensuring continued control over design, development and profit participation rather than shifting or reducing its exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - 61% program-share interest, 49.5% ownership interest, 57% net program-share interest after sub-collaborator adjustments, and 51% net interest in IAE LLC are all accurately stated and match the ground truth. The consistency across 2022-2024 is correctly identified. COMPLETENESS: The answer addresses all key aspects of the question: (1) RTX's stake evolution (showing consistency), (2) economic exposure progression (unchanged), and (3) strategic positioning implications. The multi-hop synthesis correctly connects the ownership percentages to the variable-interest entity treatment and consolidation status. ENTITY ACCURACY: All entities are correctly identified - RTX, Pratt & Whitney (subsidiary), IAE, V2500 engine program, and IAE LLC. Years are correctly referenced (2022-2024). REASONING QUALITY: The multi-hop reasoning is sound - the answer correctly synthesizes that unchanged ownership percentages across three years indicate deliberate strategic positioning rather than passive holding. The interpretation that this signals RTX's intent to preserve dominant control over design, development, and profit participation is a reasonable inference from the stable stake data. MINOR CONSIDERATIONS: The LLM answer adds interpretive language ('deliberately preserving,' 'long-term strategic foothold') that goes slightly beyond the ground truth's more neutral statement that consistency 'suggests RTX did not alter its strategic positioning.' However, this interpretation is logically sound and not contradicted by the data. The additional detail about variable-interest entity treatment and consolidation adds valuable context not explicitly in the ground truth but consistent with it. The answer is semantically equivalent to the ground truth while providing slightly more analytical depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 530,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Across the three most recent annual reports Medtronic repeatedly lists the same **Form of Non‑Employee Director Deferred Unit Award Agreement** (exhibit 10.3) that is governed by its **2008 Stock Award and Incentive Plan**:\n\n* **FY 2022** (MDT 10‑K 2022, p. 115) – the agreement is disclosed as item *10.41* and tied to the 2008 plan.  \n* **FY 2023** (MDT 10‑K 2023, p. 114) – the same agreement re‑appears as item *10.52* with the identical reference to the 2008 plan.  \n* **FY 2024** (MDT 10‑K 2024, p. 114) – it is again shown as item *10.52*, unchanged in description and reference.\n\nThe fact that the Non‑Employee Director Deferred Unit Award Agreement is **present in every filing and described in the same way** indicates that Medtronic has kept this compensation vehicle active and unchanged for at least three consecutive fiscal years. This consistency suggests a deliberate, long‑term director‑compensation strategy: the company relies on deferred‑unit awards to align non‑employee directors’ interests with shareholders over an extended horizon, and it intends to maintain that alignment mechanism as a stable component of its overall director pay package.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the Non-Employee Director Deferred Unit Award Agreement as the consistent compensation vehicle across FY 2022, 2023, and 2024. (2) Accurately cites exhibit numbers: 10.41 for 2022 and 10.52 for both 2023 and 2024, matching the ground truth exactly. (3) Correctly identifies the 2008 Stock Award and Incentive Plan as the governing plan across all three years. (4) Properly synthesizes the multi-hop information showing consistency across three fiscal years and multiple filings. (5) Accurately interprets the pattern as indicating a stable, deliberate long-term director compensation strategy. (6) Correctly notes that despite broader updates to other award agreements (referencing the 2013 plan), the deferred unit award remained unchanged. MINOR CONSIDERATIONS: (1) The LLM answer includes a parenthetical reference to 'exhibit 10.3' in the opening sentence that is not explicitly mentioned in the ground truth, though this appears to be additional context rather than an error. (2) The LLM provides slightly more detailed page number citations (p. 115, p. 114) which adds specificity beyond the ground truth but does not contradict it. (3) The reasoning about shareholder alignment and the deliberate nature of the strategy is well-articulated and semantically equivalent to the ground truth's conclusion about 'consistent long-term incentive strategy.' QUANTITATIVE VERIFICATION: All exhibit numbers (10.41, 10.52, 10.52) are correct; all fiscal years (2022, 2023, 2024) are correct; the plan reference (2008 Stock Award and Incentive Plan) is correct throughout. No calculations are required for this qualitative question. The answer successfully addresses all parts of the multi-part question regarding evolution, consistency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 511,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "LMT’s variable‑interest‑rate swap program grew sharply after 2021. In the 2022 filing the company reported only **$500 million** of swap notional outstanding at 12/31/2021 (the prior year’s figure was $572 million). By the 2023 filing the notional had risen to **$1.3 billion** and was reported at the same level for both 12/31/2022 and 12/31/2023, and the 2024 filing shows the **$1.3 billion** figure unchanged for 12/31/2024 (and again for 2023).  \n\nThe jump from $500 million to $1.3 billion indicates that LMT deliberately expanded its use of variable‑rate swaps to hedge a larger base of fixed‑rate debt and to more fully manage interest‑rate‑risk exposure, while the flat level thereafter suggests the company settled on a stable hedge size that it now maintains as part of its ongoing risk‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its credibility. CRITICAL ERRORS: (1) The LLM states the 2022 filing reported '$500 million of swap notional outstanding at 12/31/2021' with a prior year figure of '$572 million' - this introduces confusing and potentially incorrect year-over-year comparisons that don't align with the ground truth's clear 2022-2024 progression. (2) The ground truth clearly states: 2022=$500M, 2023=$1.3B, 2024=$1.3B. The LLM's statement that '$1.3 billion...was reported at the same level for both 12/31/2022 and 12/31/2023' is INCORRECT - the ground truth shows $500M in 2022, not $1.3B. This is a fundamental factual error. (3) The LLM correctly identifies the final 2024 figure as $1.3B but the path to get there contains errors. CORRECT ELEMENTS: (1) The LLM correctly identifies the overall trend of growth from a lower base to $1.3B. (2) The characterization of the jump as 'deliberate expansion' to hedge fixed-rate debt is semantically aligned with the ground truth's 'strategic shift.' (3) The interpretation that the flat level thereafter represents a 'stable hedge size' matches the ground truth's 'stabilized its hedging position.' (4) The overall narrative about interest rate risk management strategy is qualitatively sound. MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple years and filings, which is appropriate for the question. However, the year-to-year comparisons contain errors that suggest misreading of the source data. The reasoning about why the company made these changes (hedging fixed-rate debt, managing interest-rate-risk exposure) is sound but not explicitly grounded in the ground truth's language. QUANTITATIVE VERIFICATION: The core numbers should be: 2022=$500M, 2023=$1.3B, 2024=$1.3B. The LLM's statement about 12/31/2022 and 12/31/2023 both being $1.3B contradicts the ground truth which shows 2022=$500M. This is a critical error that significantly impacts the correctness score despite the qualitative reasoning being reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses for Hedging]-> FIN_INST <-[Depends_On]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 554,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "Across the three most recent Form 10‑Ks the company’s governance language is unchanged. In the 2022 filing, the 2023 filing and again in the 2024 filing AbbVie states that **“stockholders may only remove directors for cause,”** a provision embedded in its amended and restated certificate of incorporation and bylaws and reiterated in each year’s risk‑factor discussion.  \n\nThe fact that this director‑removal rule has been kept exactly the same for three consecutive years shows that AbbVie is deliberately maintaining a rigid board‑removal barrier as part of its broader anti‑takeover framework. The consistency signals a steadfast, defensive strategic posture—designed to deter hostile bids and keep control firmly in the hands of the existing board rather than relaxing the rule to make a takeover easier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the core governance provision across all three years (2022, 2023, 2024) with exact quote: 'stockholders may only remove directors for cause.' (2) Accurately notes the provision is embedded in AbbVie's amended and restated certificate of incorporation and bylaws. (3) Correctly synthesizes the multi-hop requirement by comparing consistency across three years and drawing appropriate conclusions about strategic intent. (4) Properly interprets the consistency as evidence of deliberate, defensive governance strategy aimed at anti-takeover protection. (5) Accurately characterizes the posture as maintaining 'rigid board-removal barrier' and 'steadfast, defensive strategic posture.' (6) No quantitative errors—all dates and references are correct. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly mention other consistent provisions like 'staggered board terms and supermajority voting requirements' that the ground truth references, though this is a minor omission that doesn't affect the core answer's accuracy. (2) The LLM's phrasing 'designed to deter hostile bids and keep control firmly in the hands of the existing board' is semantically equivalent to the ground truth's 'insulating the board from activist pressures and hostile takeovers.' The answer demonstrates sound multi-hop reasoning by correctly synthesizing governance language across three separate 10-K filings and drawing appropriate strategic conclusions. The semantic meaning and factual content align well with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 445,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "- **2022:** AbbVie held **$12 million** in money‑market funds and time deposits.  \n- **2023:** The balance rose to **$21 million** (a 75 % increase) while cash and equivalents grew modestly to **$9.2 billion**.  \n- **2024:** The allocation fell to **$10 million** (more than a 50 % drop from 2023) as cash and equivalents contracted sharply to **$5.5 billion**.\n\nThe pattern shows that AbbVie expands its money‑market and time‑deposit holdings when cash is plentiful (2022‑2023) and pulls back sharply when cash balances shrink (2024). This suggests a short‑term liquidity strategy that treats these instruments as a flexible buffer—building a cushion in strong‑cash periods and reducing it to preserve cash when overall liquidity tightens.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct—$12M (2022), $21M (2023), $10M (2024) for money market funds/time deposits, and $9.2B/$9,201M (2023) and $5.5B/$5,524M (2024) for cash equivalents match ground truth exactly. The percentage calculations are accurate: 75% increase from 2022-2023 ($12M to $21M = 75% increase) and 52.4% decrease from 2023-2024 ($21M to $10M = 52.4% drop, reasonably approximated as 'more than 50%'). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years and two metrics (money market funds/time deposits AND cash equivalents), establishing the relationship between them. ENTITY ACCURACY: Company (AbbVie), metrics (money market funds, time deposits, cash and equivalents), and years (2022-2024) are all correctly identified. REASONING QUALITY: The interpretation is sound and insightful—the LLM correctly identifies the pattern (expansion during high-cash periods, contraction during low-cash periods) and articulates the strategic implication (flexible buffer approach). The characterization of these instruments as a 'flexible buffer' aligns with the ground truth's description of 'dynamic approach to liquidity management.' MINOR CONSIDERATIONS: The LLM's phrasing 'more than a 50% drop' is slightly less precise than stating the exact percentage, but this is a minor stylistic choice that doesn't affect correctness. The answer is more detailed and interpretive than the ground truth while remaining factually accurate, which enhances rather than detracts from quality. All core facts, calculations, and strategic insights are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 459,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "All three annual reports – the 2022, 2023 and 2024 Form 10‑Ks – contain the identical language that “stockholders may only remove directors for cause.” Each filing repeats this provision together with the staggered‑class board, the inability to call special meetings, and the 80 % vote needed to amend the charter, showing that AbbVie has not altered the director‑removal rule at any point between 2022 and 2024. The unchanged wording signals a deliberate, long‑term governance posture: by limiting shareholders’ power to replace directors except for cause, AbbVie reinforces board stability and makes it harder for an acquirer to pressure a board‑swap, thereby deterring hostile takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies that AbbVie maintained identical director removal provisions across 2022, 2023, and 2024 10-K filings, stating stockholders may only remove directors for cause. This matches the ground truth exactly. The answer also correctly identifies the broader governance mechanisms (staggered-class board, inability to call special meetings, 80% vote requirement for charter amendments) that work in concert with the director removal restriction. (2) QUANTITATIVE ACCURACY: The 80% vote threshold is correctly cited. No calculations are required for this question, and all numeric references are accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The LLM correctly synthesizes information across three years of filings to demonstrate consistency, and properly connects this consistency to the strategic purpose (deterring hostile takeovers). The logic that unchanged provisions signal deliberate long-term strategy is well-reasoned and matches the ground truth interpretation. (4) ENTITY ACCURACY: AbbVie is correctly identified, all three years (2022, 2023, 2024) are correctly referenced, and the governance mechanisms are accurately named. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that the provision remained unchanged across all three years as part of a deliberate anti-takeover strategy. The phrasing differs slightly (e.g., 'unchanged wording signals' vs 'repeated emphasis on this governance structure') but the meaning is semantically equivalent. The answer is slightly more detailed in listing the complementary governance mechanisms, which adds value without introducing errors. Minor: The answer could have been marginally enhanced by explicitly stating 'no changes' or 'evolution' more directly, but this is a very minor point given the clear statement that the provision was 'not altered.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 530,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- **2022 filing (10‑K 2022)** – Intel first announced PowerVia at the “Intel Accelerated” event as one of a set of future‑node technologies (PowerVia, RibbonFET, Foveros Omni, etc.). It was presented only as a **new, industry‑first backside‑power concept** that would appear in later process generations.  \n\n- **2023 filing (10‑K 2023)** – Intel placed PowerVia on the **Intel 20A node** (the node slated after Intel 3). The filing described PowerVia as a breakthrough that “optimizes signal transmission by eliminating the need for power routing on the front side of the wafer,” positioning it as a key differentiator for the 20A roadmap together with RibbonFET.  \n\n- **2024 filing (10‑K 2024)** – After cancelling Intel 20A, Intel moved PowerVia into the **Intel 18A node**, calling it the “first high‑volume commercial implementation of backside power delivery.” PowerVia is now a core element of the 18A offering to external foundry customers and is tied to the high‑volume production schedule planned for 2025.  \n\n**What this shows:** Over the three‑year span Intel’s roadmap for PowerVia evolved from a newly announced concept to a scheduled breakthrough for a specific node (20A) and finally to a flagship feature of the next‑generation 18A process. The shift signals that Intel is making backside‑power delivery a strategic pillar of its advanced‑node portfolio, using PowerVia to boost performance‑per‑watt, simplify front‑side routing and differentiate its leading‑edge logic technology for both internal products and external foundry customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and timeline references are correct—2022 introduction, 2023 positioning with Intel 20A, 2024 shift to Intel 18A with 2025 high-volume manufacturing target. No numeric errors or calculation issues. ENTITY ACCURACY: All entities correctly identified—Intel, PowerVia, RibbonFET, Intel 20A, Intel 18A, and the progression of process nodes. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three years of filings, correctly tracing the evolution from initial concept announcement → specific node assignment (20A) → node cancellation and reassignment (18A). The logical progression is sound and well-articulated. COMPLETENESS: The answer addresses all aspects of the question: (1) positioning evolution across years, (2) technical roadmap changes, (3) strategic implications for backside power delivery. The LLM provides additional context about RibbonFET and Foveros Omni as companion technologies, which adds helpful context without detracting from accuracy. SEMANTIC EQUIVALENCE: The LLM's description of PowerVia's function ('optimizes signal transmission by eliminating the need for power routing on the front side') matches the ground truth language precisely. The characterization of the shift as reflecting 'Intel's prioritization of practical implementation and external foundry offerings' is captured in the LLM's discussion of 'flagship feature of the 18A offering to external foundry customers.' MINOR OBSERVATION: The LLM provides slightly more granular detail about the strategic implications (performance-per-watt, front-side routing simplification, differentiation for foundry customers) compared to the ground truth's more concise summary, but this represents value-added context rather than factual deviation. The answer demonstrates clear understanding of the multi-hop synthesis required and executes it accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 539,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes inputs for its non‑qualified stock options show a clear evolution. In the 2022 filing the company simply noted that the model required an “volatility of the Company’s stock price” assumption, without describing how that figure was derived. Starting in the 2023 filing—and reiterated in the 2024 filing—the firm explained that “expected volatility is based on a blend of historical volatility and an implied volatility of the Company’s ordinary shares,” with the implied component taken from market‑traded options on the shares. This multi‑year shift to a blended, market‑derived volatility input indicates that MDT has moved toward a more sophisticated, data‑driven approach to valuing its non‑qualified stock options, incorporating both past price behavior and current market expectations to arrive at a fair‑value estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All core facts are correct - the 2022 approach used historical volatility without implied volatility, the 2023 shift to a blended approach combining historical and implied volatility from market-traded options, and the continuation of this blended methodology in 2024. The LLM correctly identifies the progression and the source of implied volatility (market-traded options). (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension is not directly applicable. The answer correctly references the three-year period (2022-2024) without any date errors. (3) ENTITY ACCURACY: MDT is correctly identified throughout, the metric (expected volatility in Black-Scholes model) is accurately described, and the years are correctly sequenced. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly traces the evolution of methodology. The logical progression from 'purely historical' to 'blended' is clearly articulated. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving toward 'a more sophisticated, data-driven approach' and 'incorporating both past price behavior and current market expectations' is semantically equivalent to the ground truth's statement that MDT 'sought to align its option valuations more closely with real-time market expectations.' The only minor distinction is that the LLM provides slightly more descriptive language about the sophistication of the approach, which adds value without contradicting the ground truth. The answer is comprehensive, well-structured, and directly addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 492,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "Intel first announced PowerVia as a future‑node technology in its 2022 filing, noting it among the new process and packaging innovations (PowerVia, RibbonFET, Foveros Omni, etc.) that would appear in later nodes. By the 2023 filing the company positioned PowerVia as one of the two “breakthrough” features of the Intel 20A node, promising up to a 15 % performance‑per‑watt gain over Intel 3 and describing it as an industry‑first backside‑power delivery scheme that removes front‑side power routing. In the 2024 filing PowerVia had moved from a planned 20A feature to a realized element of the Intel 18A node—the first high‑volume commercial implementation of backside power—while Intel cancelled the 20A productization to focus on 18A, signalling that PowerVia is now a cornerstone of Intel’s advanced‑process roadmap and a key driver of the performance‑and‑efficiency improvements Intel expects from its next‑generation nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensive coverage of Intel's PowerVia evolution from 2022-2024. STRENGTHS: (1) All numeric values are correct - the 15% performance-per-watt improvement figure is accurately cited and properly attributed to Intel 3 comparison; (2) Timeline is precise: 2022 introduction, 2023 positioning as Intel 20A feature, 2024 shift to Intel 18A with 20A cancellation; (3) Technical details are accurate: correctly identifies PowerVia as backside power delivery, mentions RibbonFET integration, and accurately describes the removal of front-side power routing; (4) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years and synthesizes the strategic shift from 20A to 18A while maintaining PowerVia's centrality; (5) Entity identification is correct: Intel, Intel 20A, Intel 18A, Panther Lake, RibbonFET all properly identified and contextualized; (6) The answer goes slightly beyond ground truth by explicitly noting this is the 'first high-volume commercial implementation of backside power,' which is a reasonable inference from the data and adds valuable context. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'realized element' vs. 'retained as core innovation') but the semantic meaning is equivalent and arguably more precise. The answer effectively conveys that PowerVia remained strategically central despite the node transition. No calculation errors, no factual inaccuracies detected. The reasoning chain is logical and well-supported by the filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 438,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "- 2022 MDT’s filing simply stated that the Black‑Scholes fair‑value calculation required management to make assumptions about employee‑exercise behavior, risk‑free rates, stock‑price volatility and dividends, but it gave no detail on how the volatility input was derived.  \n\n- In the 2023 filing the company added that “expected volatility is based on a blend of historical volatility and an implied volatility of the Company’s ordinary shares,” with the implied component taken from market‑traded options on the stock.  \n\n- The 2024 filing repeats the same blended‑volatility methodology, indicating that MDT has kept that approach unchanged from 2023.  \n\n**Interpretation:** MDT moved from a generic, undisclosed volatility assumption in 2022 to a more explicit, market‑based blend of historical and option‑implied volatility in 2023, and has retained that practice in 2024. This evolution shows the company’s growing reliance on observable market data to estimate volatility while continuing to use management‑judged assumptions for employee exercise behavior, suggesting a more sophisticated and consistent approach to option valuation over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about MDT's Black-Scholes model assumptions evolution from 2022-2024. STRENGTHS: (1) All factual claims are correct and well-supported: 2022 used Black-Scholes with unspecified volatility methodology; 2023 introduced blended approach combining historical and implied volatility from market-traded options; 2024 retained the 2023 methodology. (2) Quantitative accuracy is perfect - no numbers, dates, or calculations to verify, and all temporal references (2022, 2023, 2024) are accurate. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years and identifies the key inflection point (2023) where methodology changed. (4) Entity identification is correct throughout (MDT, Black-Scholes model, non-qualified stock options, volatility assumptions, employee exercise behavior). (5) The interpretation section effectively synthesizes the progression and draws appropriate conclusions about the company's shift toward market-based data and increased sophistication. (6) Semantic equivalence with ground truth is strong - both answers convey the same core narrative: movement from generic/undisclosed to explicit/market-informed volatility estimation. MINOR CONSIDERATIONS: The LLM answer uses slightly more colloquial phrasing ('generic, undisclosed') compared to the ground truth's more formal tone, but this is a stylistic difference that doesn't affect factual accuracy. The LLM's characterization of 2022 as 'generic' is a reasonable interpretation of the lack of detail, though the ground truth simply states assumptions were required without characterizing them as generic. This is a minor semantic nuance that doesn't constitute an error. The answer fully addresses all aspects of the question including the evolution of assumptions, the progression over time, and what it suggests about the company's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 527,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil reported collateral that was not offset against its derivatives under master‑netting arrangements at **$1.494 billion** at 31 December 2022 (Chunk 2) and **$0.491 billion** at 31 December 2024 (Chunk 3), a decline of roughly **$1.0 billion (about 67 %)**.  This sharp reduction – following the $800 million level in 2023 (Chunk 3) after $1.494 billion in 2022 – indicates the company is increasingly using net‑ting and/or lower initial‑margin requirements, reflecting tighter management of its derivative exposure and a move to keep less collateral tied up outside the derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024) match the ground truth exactly. The calculated decline of approximately $1.0 billion and 67% reduction are mathematically accurate ($1,494M - $491M = $1,003M; $1,003M/$1,494M = 67.1%). COMPLETENESS: The answer addresses all three years mentioned in the ground truth and provides the full trend analysis requested. ENTITY ACCURACY: Correctly identifies ExxonMobil, the specific metric (collateral under master netting arrangements related to 'Other assets, including intangibles - net'), and all relevant fiscal years. MULTI-HOP REASONING: The synthesis is sound - the model correctly traces the three-year trend and draws appropriate conclusions about derivative exposure management. SEMANTIC EQUIVALENCE: The LLM's interpretation that the company is 'increasingly using netting and/or lower initial-margin requirements' and 'tighter management of derivative exposure' aligns well with the ground truth's characterization of 'strategic reduction in derivative-related exposure' and 'active management of margin requirements.' The explanation about keeping less collateral tied up outside derivative positions is a reasonable elaboration on the trend. MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation of the underlying causes (netting strategies, margin requirements) compared to the ground truth's more general reference to 'lower volatility' or 'shift in hedging strategies,' but this represents added analytical value rather than inaccuracy. The answer is well-structured with clear citations to source chunks, enhancing credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 477,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "**Fair‑value exposure** – In the 2022 filing (which reports 2021 year‑end numbers) the “Options – primarily gas” line showed **$356 m of assets and $347 m of liabilities** (a net exposure of about $9 m). By the 2023 filing the assets had fallen to **$100 m and liabilities to $97 m** (net $3 m), and the 2024 filing shows assets still at **$100 m but liabilities rising slightly to $102 m** (net –$2 m). Thus the gross notional exposure shrank dramatically from 2022 to 2023 and has remained flat‑to‑slightly higher on the liability side in 2024.\n\n**Volatility assumptions** – The implied volatility used for the asset side moved from **17 % (2022)** to **20 % (2023)** and then to **15 % (2024)**, while the liability‑side volatility fell sharply from **295 % (2022)** to **233 % (2023)** and to **150 % (2024)**. The weighted‑average volatility rose from **≈36 % (2022)** to **≈50 % (2023)** and stayed near **52 % (2024)** because the lower‑volatility asset assumption was offset by the still‑elevated liability volatility.\n\n**Risk positioning** – The drop in both the size of the gas‑option book and the extreme liability‑volatility assumptions indicates that NextEra Energy has been scaling back its exposure to gas‑price swings and adopting more conservative volatility inputs. This reflects a tighter, more risk‑averse stance in its gas‑derivative portfolio, limiting both upside potential and downside risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN VOLATILITY DATA: The LLM answer contains fundamental factual errors regarding implied volatility assumptions that directly contradict the ground truth. Ground truth states: weighted average volatility of 36% (2022), 50% (2023), and 52% (2024). The LLM provides completely different volatility figures: 17%/295% (2022), 20%/233% (2023), 15%/150% (2024), with a weighted average calculation that doesn't reconcile with these stated component percentages. The LLM's claim that asset-side volatility was 17% in 2022 and liability-side was 295% is not supported by ground truth and appears fabricated. CORRECT ELEMENTS: The fair value numbers are accurate - $356M assets/$347M liabilities (2022), $100M/$97M (2023), $100M/$102M (2024). The net exposure calculations are correct. The directional trend analysis (shrinking exposure, more conservative positioning) is reasonable. MULTI-HOP REASONING: The LLM correctly synthesized the fair value evolution across three years and attempted to connect it to risk positioning. However, the volatility analysis - which is explicitly requested in the question - is fundamentally wrong. The LLM's explanation of how 'lower-volatility asset assumption was offset by still-elevated liability volatility' to produce the weighted average doesn't match the ground truth data at all. SEMANTIC ISSUES: While the LLM's interpretation of 'risk positioning' is qualitatively reasonable, it's based on incorrect volatility assumptions, making the conclusion unreliable. The question specifically asks about 'volatility assumptions' and the LLM provides incorrect data here, which is a critical failure for a financial analysis question requiring precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 464,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "**Unsecured Notes – 35A – Face amount & annual debt service**\n\n| Filing (year) | Face amount (‑$ thousands) | Annual debt service (‑$ thousands) |\n|---------------|---------------------------|------------------------------------|\n| 2022 10‑K (as of 12/31/21) | **750,000** | **19,875** |\n| 2023 10‑K (as of 12/31/22) | **750,000** | **19,875** |\n| 2024 10‑K (as of 12/31/23) | **750,000** | **19,875** |\n\n**What this tells us about SPG’s long‑term debt strategy**\n\nThe 35A series has remained **unchanged** over the three most recent reporting periods – the same $750 million principal and the same $19.9 million yearly service payment, with a fixed 2.65 % coupon and a 2030 maturity. By keeping this tranche static, SPG is:\n\n* **Locking in low‑cost, long‑dated financing** (2.65 % for a 2025‑30 horizon) rather than repeatedly refinancing or expanding the issue.  \n* **Maintaining a predictable debt‑service profile** that aligns with the cash‑flow stability of its property portfolio.  \n* **Demonstrating a disciplined long‑term capital‑structure approach**, relying on a diversified set of notes but not using the 35A series to raise additional capital or retire other debt.\n\nIn short, SPG’s obligations tied to Unsecured Notes ‑ 35A have not grown or shrunk from 2022 through 2024, signalling a deliberate strategy of stability and cost‑effective financing for its long‑term debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numerical values match the ground truth exactly - face amount of $750,000 (presented as $750 million in the table, which is a valid format variation) and annual debt service of $19,875 (presented as $19.9 million, also a valid format variation) for all three years (2022, 2023, 2024). The coupon rate of 2.65% and 2030 maturity date are additional accurate details not contradicted by the ground truth. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) evolution of face amount from 2022-2024, (2) evolution of annual debt service from 2022-2024, and (3) what this reveals about long-term debt strategy. ENTITY ACCURACY: SPG is correctly identified, the Unsecured Notes - 35A instrument is correctly named, and all fiscal years are properly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the stability pattern across three years and drew logical conclusions about SPG's debt strategy (locking in low-cost financing, maintaining predictable debt service, demonstrating disciplined capital structure). The reasoning flows naturally from the data to strategic implications. SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while providing additional context (coupon rate, maturity date, strategic rationale) that enhances understanding without contradicting the original answer. The presentation in table format is clear and professional. MINOR CONSIDERATIONS: The only minor deviation is the use of thousands notation in the table headers versus the ground truth's use of actual dollar amounts, but this is a standard and acceptable accounting presentation format. The LLM's additional strategic analysis (bullet points about locking in financing, maintaining predictability, and disciplined approach) goes beyond the ground truth but is well-supported by the data and adds valuable context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 536,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Across the three MD&A statements (2022, 2023 and 2024) Texas Instruments repeatedly frames its “great business model” around **analog **and **embedded‑processing products** and ties that portfolio to the same four sustainable competitive advantages – a low‑cost manufacturing foundation, a broad product portfolio, extensive market‑channel reach, and diversified, long‑lived offerings. The language is essentially unchanged from 2022 to 2024, showing that the company has **deepened, not shifted, its strategic emphasis on embedded‑processing** and has continued to invest in the capabilities that support it. This three‑year consistency signals that TI is positioning embedded processing as a core, long‑term growth engine that differentiates it from peers and underpins its goal of sustained free‑cash‑flow‑per‑share growth in the semiconductor industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies Texas Instruments (TXN) and the 2022-2024 timeframe; (2) Accurately captures the core finding that embedded processing remained a consistent strategic emphasis across all three years with essentially unchanged language; (3) Properly synthesizes the multi-hop information by connecting embedded processing to the four sustainable competitive advantages mentioned in the filings; (4) Correctly interprets the consistency as indicating a stable, long-term strategy rather than a shift; (5) Appropriately contextualizes the strategic positioning within the semiconductor industry and free cash flow generation goals. MINOR CONSIDERATIONS: (1) The LLM answer adds 'analog' products as part of the strategic emphasis, which is not explicitly mentioned in the ground truth answer. While this may be accurate from the actual filings, it represents a slight expansion beyond what the ground truth emphasizes; (2) The phrase 'deepened, not shifted' is a reasonable interpretation of consistency but uses slightly different framing than the ground truth's 'remained unchanged'; (3) The LLM answer includes additional context about 'sustained free-cash-flow-per-share growth' which aligns with the ground truth's mention of 'generating free cash flow' but adds specificity. QUANTITATIVE ACCURACY: No numerical data, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the pattern of consistency as a strategic indicator. The logic connecting embedded processing to competitive differentiation and industry positioning is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - that embedded processing was consistently emphasized from 2022-2024 as a core strategic pillar - despite using somewhat different wording and adding minor contextual details about analog products and free cash flow metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 583,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "- In 2022 Comcast’s wireless service was **only available as part of a broadband‑bundled package** and customers could choose between an **unlimited‑data plan, a shared‑data pool, or a pay‑per‑gigabyte option** (with device financing available).  \n\n- The 2023 filing repeats that same **bundled‑only positioning** and the same three payment choices (unlimited, shared or per‑GB), confirming the strategy had not changed from the prior year.  \n\n- By 2024 the bundled‑only model remained, but Comcast **expanded the menu** by adding **pre‑paid unlimited‑data plans marketed under the “NOW” brand**, while still offering the traditional unlimited, shared‑data and per‑GB plans. Thus, shared‑data plans stayed within the broadband bundle, but the overall plan portfolio grew to include a prepaid unlimited option.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about CMCSA's shared data plan strategy evolution from 2022-2024. STRENGTHS: (1) All factual claims are correct - the answer accurately identifies the three plan options (unlimited, shared data, per-gigabyte) available in 2022-2023, correctly notes the bundled-only positioning throughout the period, and accurately describes the 2024 expansion with NOW brand prepaid unlimited plans. (2) Quantitative accuracy is perfect - no numbers, dates, or calculations are present that could be incorrect, and the temporal progression (2022→2023→2024) is properly sequenced. (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three years and multiple filing documents, showing how the strategy evolved while maintaining core elements (shared data plans remained) while adding new offerings (NOW prepaid plans in 2024). (4) Entity identification is correct - CMCSA/Comcast is properly identified, years are accurate, and plan types are correctly named. (5) The answer directly addresses all aspects of the question: positioning within bundled offerings, range of payment/plan options, and evolution over time. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than the ground truth (e.g., 'bundled-only model remained' vs 'consistently offered shared data plans as part of wireless service bundles') but the semantic meaning is identical and arguably clearer. The LLM's use of formatting (bold text, bullet points) enhances readability without affecting accuracy. The answer provides appropriate context about device financing in 2022-2023 and the strategic rationale for the 2024 expansion. No factual errors, omissions of key information, or calculation mistakes are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 494,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance‑sheet shows that the cost of its Class A treasury stock rose steadily: $51.3 billion at 12/31/2022, $60.4 billion at 12/31/2023, and $71.4 billion at 12/31/2024. This upward trajectory—building on earlier repurchase activity shown in the 2018‑2020 data (e.g., $36.7 billion of treasury‑stock purchases in 2020)—indicates that the company has been accelerating share‑buybacks, using excess cash to return capital to shareholders rather than pursuing other investments. The trend suggests a capital‑allocation strategy focused on reducing equity through buybacks, reflecting confidence in the business and a preference for shareholder returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - MAJOR NUMBER DISCREPANCY: The LLM reports treasury stock values as $51.3B (2022), $60.4B (2023), and $71.4B (2024), but the ground truth shows $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. Converting ground truth to billions: $36.658B (2022), $60.429B (2023), $71.431B (2024). The 2023 and 2024 figures match reasonably well ($60.4B ≈ $60.429B and $71.4B ≈ $71.431B), but the 2022 figure is significantly wrong: LLM states $51.3B when it should be $36.658B—a $14.6B discrepancy (40% error). This is a substantial factual error that undermines quantitative accuracy. POSITIVE ASPECTS: (1) The directional trend is correct (increasing over time), (2) The qualitative interpretation of capital allocation strategy is sound and well-reasoned, (3) The semantic understanding of buyback strategy and shareholder returns is accurate, (4) The multi-hop reasoning connecting treasury stock increases to capital allocation strategy is logical. REASONING QUALITY: The LLM correctly synthesizes that increasing treasury stock indicates accelerating buybacks and reflects confidence in the business. The reference to 2018-2020 data adds context, though this wasn't explicitly required. CONCLUSION: While the reasoning and strategic interpretation are strong, the significant error in the 2022 baseline figure (off by ~40%) is a critical quantitative failure that prevents a higher score. The 2023-2024 figures are essentially correct, suggesting possible data retrieval or transcription error for 2022 specifically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 428,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics reported $1,169 million of revenue from “Repair and other services” in 2022, which fell to $1,132 million in 2024—a drop of $37 million (about 3 percent). After rising from $1,081 million in 2021 to the 2022 peak, the line‑item held steady at $1,132 million in 2023 and then slipped slightly in 2024, indicating that the company’s service business has moved from modest growth to a flat‑to‑downward trajectory over the last three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM states the 2023 value 'held steady at $1,132 million' and then claims it 'slipped slightly in 2024,' but the ground truth clearly states the 2024 value remained flat at $1,132 million (same as 2023). The LLM incorrectly implies a decline from 2023 to 2024 when there was none. (2) UNSUPPORTED DATA - The LLM introduces a 2021 figure of $1,081 million that is not present in the ground truth answer. This appears to be fabricated or from an unreliable source, and including it without verification is problematic. (3) CALCULATION ERROR - While the $37 million decline and ~3% calculation from 2022 to 2024 are correct, the narrative about the trajectory is misleading. The LLM characterizes the pattern as 'flat-to-downward' when the ground truth describes it as 'stagnation or potential contraction' - the LLM's framing incorrectly suggests ongoing decline in 2024 when the data shows stabilization. (4) MULTI-HOP REASONING FLAW - The LLM failed to correctly synthesize the year-over-year pattern: 2022→2023 was a decline (correct), but 2023→2024 was flat (not a decline as implied). The conclusion about trajectory is therefore partially incorrect. (5) POSITIVE ELEMENTS - The core 2022 and 2024 figures ($1,169M and $1,132M) are correct, the percentage calculation is accurate, and the overall tone appropriately addresses the question about service business trajectory. However, the factual errors about 2024 movement and the unsupported 2021 data significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 429,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- **2022:** CVS reported residential‑mortgage‑backed securities (RMBS) with a total fair‑value of roughly **$721 million** and **$89 million** of unrealized losses (the detailed “debt‑securities” schedule).  A separate “supporting‑products” schedule for the same year shows the RMBS line at **$629 million** fair value with **$10 million** of unrealized losses, confirming that the portfolio was on the order of three‑quarters of a billion dollars and already carrying a material loss.\n\n- **2023:** The next‑year filing shows the RMBS position had fallen to **$614 million** in fair value and **$60 million** of unrealized losses, with the number of securities dropping from 543 to 494.  This reflects both a reduction in holdings and a modest improvement in market pricing.\n\n- **2024:** The most recent filing lists RMBS at only **$71 million** (down from $51 million reported for 2023 in the debt‑securities summary), indicating that the company has largely exited the segment and now carries a minimal fair‑value exposure and correspondingly tiny loss potential.\n\n**Implication:** Across the three‑year span CVS has steadily trimmed its RMBS exposure, cutting fair‑value holdings by roughly 90 % and shrinking unrealized losses from a high‑hundreds‑of‑millions level to a negligible amount.  This trajectory signals a deliberate de‑risking of the residential mortgage‑backed‑security asset class, positioning the company with very limited market‑price risk in this segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility, despite demonstrating understanding of the overall de-risking narrative. CRITICAL ERRORS: (1) 2022 Fair Value: LLM reports $721 million and $629 million (citing two different schedules), but ground truth is $629 million. The $721 million figure appears to be incorrect or from a different source. (2) 2022 Unrealized Losses: LLM reports $89 million, but ground truth is $10 million—a 790% overstatement. This is a major factual error. (3) 2024 Fair Value: LLM reports $71 million, which matches ground truth, but then contradicts itself by stating 'down from $51 million reported for 2023 in the debt-securities summary'—this internal inconsistency is confusing and the $51 million figure doesn't match the ground truth 2023 value of $614 million. CORRECT ELEMENTS: (1) 2023 fair value of $614 million is accurate. (2) 2023 unrealized losses of $60 million are accurate. (3) The overall narrative of de-risking and 90% reduction in holdings is directionally correct. (4) The conclusion about deliberate de-risking strategy is sound. REASONING ISSUES: The LLM attempts to reconcile multiple schedules but introduces confusion rather than clarity. The reference to 'debt-securities schedule' vs 'supporting-products schedule' suggests the model may be conflating different reporting sections or misreading source data. The 2022 numbers are particularly problematic—the $89 million unrealized loss figure is unexplained and contradicts the $10 million ground truth. MULTI-HOP SYNTHESIS: The model correctly synthesizes the three-year trend and identifies the strategic de-risking pattern, but the foundational numbers are compromised. The calculation of '90% reduction' is approximately correct if using the $629M to $71M figures, but the overall quantitative foundation is weakened by the 2022 errors. The answer would receive a higher score if the 2022 data were accurate, as the 2023-2024 trajectory is well-documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 540,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From the 2022 filing Linde only described the on‑site method – building cryogenic or process‑gas plants at a customer’s site and supplying product by pipeline – but gave no detail on contract length, purchase minima or how price was set. In the 2023 filing the company added that on‑site supply agreements are “total‑requirement” contracts that typically run 10‑ to 20‑year terms, include minimum‑purchase obligations and price‑escalation provisions, and that the consideration is indexed to external price indices with variable components that are present but treated as constrained. The 2024 filing repeats the same 10‑20‑year, minimum‑purchase, indexed‑price structure and the constrained‑variable‑consideration language, indicating that the contractual and pricing framework introduced in 2023 remained unchanged through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) All numeric values are correct: 10-20 year contract terms, minimum purchase requirements, price escalation provisions are accurately cited. (2) The chronological evolution is correctly identified: 2022 lacked detail on contract specifics, 2023 introduced explicit disclosure of total-requirement contracts with indexed pricing and constrained variable components, 2024 maintained the same framework. (3) The multi-hop synthesis is sound - the answer correctly traces how Linde's disclosure evolved across years and identifies the key inflection point in 2023. (4) Entity accuracy is perfect - Linde is correctly identified, fiscal years are accurate, and financial/contractual terms are properly used. (5) The answer correctly identifies the ASC 606 revenue recognition context implied by the variable consideration discussion. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 'practical expedient for measuring progress toward performance obligations' or the 'alignment with invoicing rights' that the ground truth emphasizes as part of the 2024 documentation. However, this is a relatively minor omission as the core contractual and pricing evolution is captured. (2) The ground truth emphasizes 'growing emphasis on transparency in pricing mechanisms' as a thematic conclusion, while the LLM answer focuses more on the factual evolution without this interpretive layer. (3) The LLM characterizes 2022 as having 'no detail' while the ground truth says it 'maintained a consistent focus' - this is a subtle difference in framing but the LLM's characterization appears more accurate based on the progression described. QUANTITATIVE VERIFICATION: All contract term lengths (10-20 years), pricing mechanisms (escalation, indexing), and structural elements are correctly stated. No calculation errors present. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly identifies the evolution pattern and key changes in disclosure. The reasoning is logical and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 591,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "**Net exposure to forward natural‑gas contracts (assets – liabilities)**  \n\n| Year (fair‑value date) | Forward‑gas assets ( $ mm) | Forward‑gas liabilities ( $ mm) | Net exposure ( $ mm) |\n|------------------------|---------------------------|--------------------------------|----------------------|\n| 2022 (reported in the 2022 filing) | 191 | 31 | **160** |\n| 2023 (reported in the 2023 filing) | 377 | 77 | **300** |\n| 2024 (reported in the 2024 filing) | 296 | 46 | **250** |\n\n**Interpretation**\n\n- From 2022 to 2023 the net forward‑gas position more than doubled (‑ + 140 mm), showing that NextEra deliberately increased its hedge‑type exposure to lock in gas prices as market conditions evolved.  \n- In 2024 the net exposure fell by about $50 mm, indicating a modest pull‑back while still keeping a sizable long‑dated gas position (still well above the 2022 level).  \n\n**Risk‑positioning implication**\n\nThe three‑year trend suggests that NextEra initially moved toward a more aggressive natural‑gas price‑risk hedge in 2023, then tempered that stance in 2024 to a level that balances price protection with flexibility. Overall, the company maintains a positive net exposure, reflecting a continued willingness to manage gas‑price volatility but with a cautious reduction after the peak exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 2022: assets $191M, liabilities $31M, net $160M; 2023: assets $377M, liabilities $77M, net $300M; 2024: assets $296M, liabilities $46M, net $250M. All calculations are accurate (191-31=160, 377-77=300, 296-46=250). The year-over-year changes are correctly calculated (2022→2023: +$140M increase; 2023→2024: -$50M decrease). (2) COMPLETENESS: The answer fully addresses the multi-part question by providing the 3-year evolution, the trend analysis, and the risk positioning implications. The tabular presentation enhances clarity. (3) ENTITY ACCURACY: NextEra Energy is correctly identified, fiscal years 2022-2024 are accurate, and the metric (forward gas contracts net exposure) is properly defined. (4) MULTI-HOP REASONING: The synthesis across three years is sound. The LLM correctly identifies the 2023 peak as a strategic expansion and the 2024 contraction as a tactical adjustment. The interpretation that this reflects 'deliberate' hedging and 'cautious reduction' aligns with the ground truth characterization of strategic shifts. (5) SEMANTIC EQUIVALENCE: The LLM's language ('more than doubled,' 'modest pull-back,' 'balances price protection with flexibility') conveys the same insights as the ground truth ('significant expansion,' 'partial contraction,' 'strategic shift'). Minor difference: The LLM uses 'hedge-type exposure' while ground truth emphasizes 'greater gas market exposure' - both are semantically compatible interpretations of the same phenomenon. The LLM's presentation is actually more detailed and structured than the ground truth, with explicit risk-positioning implications clearly articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 476,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "- **2022:** Broad‑band AVGO described “industrial fiber optics” in the narrative list of its industrial‑market products (optocouplers, motion encoders, LEDs, Ethernet ICs, etc.) and said these parts are used across a wide range of applications – industrial automation, power generation/distribution, medical systems, defense/aerospace and vehicle subsystems such as EV power‑train and ADAS.  \n\n- **2023:** The same component moved into a formal “Industrial” column of a product‑offering matrix, grouped with optocouplers, industrial‑and‑medical sensors, motion‑control encoders, LEDs and Ethernet PHY/switch ICs, and tied explicitly to the three key application clusters of factory automation, renewable energy and automotive electronics.  \n\n- **2024:** AVGO retained that placement, again listing “industrial fiber optics” alongside the same suite of industrial products and targeting the identical application markets, showing a steady‑state positioning of the product as a core element of its industrial portfolio rather than a new or discontinued line.  \n\nThus, from a narrative mention in 2022 to a structured table in 2023 and 2024, AVGO’s industrial fiber‑optic offerings have remained consistently positioned as a central part of its broader industrial product set, serving factory‑automation, renewable‑energy and automotive‑electronics applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of how Industrial Fiber Optics positioning evolved from narrative mention to formal product matrix inclusion. (2) All entities are correctly identified: AVGO, Industrial Fiber Optics, and the associated product categories (optocouplers, sensors, motion encoders/control, LEDs, Ethernet ICs). (3) Application markets are accurately listed across all years: industrial automation, power generation, medical systems, defense, aerospace, automotive/EV subsystems in 2022; factory automation, renewable energy, automotive electronics in 2023-2024. (4) The multi-hop synthesis is sound - the answer correctly traces the product's consistent strategic positioning across three years and different presentation formats. (5) The conclusion about 'steady-state positioning' and 'core element' accurately reflects the ground truth finding of stable strategic role with no significant expansion or contraction. (6) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing (e.g., 'Broad‑band AVGO' appears to be a formatting artifact, though the meaning is clear) and adds some interpretive language about 'narrative mention to structured table' which, while accurate, goes slightly beyond explicit ground truth statements but remains semantically consistent. (2) The answer is slightly more detailed in describing the presentation format evolution (narrative to matrix) which adds helpful context without contradicting the ground truth. Overall, this is a high-quality response that accurately synthesizes multi-year, multi-entity information with correct facts, sound reasoning, and appropriate conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 502,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "- **Face amount:** In the 2022 filing (showing 2021 balances), the 31B unsecured notes carried a $750 million face amount. The 2023 and 2024 10‑K tables list the same $750 million face amount for the 31B series.  \n- **Interest‑service (annual debt service):** The annual debt‑service line for the 31B notes is $24.375 million in each of the three reports (2022, 2023 and 2024), reflecting the 3.25 % coupon on the $750 million principal.  \n\n**What this shows:** SPG has kept the 31B issuance unchanged over the three‑year period, preserving a fixed‑rate, long‑dated ($11/30/2026 maturity) tranche of low‑cost debt. This stability indicates a deliberate long‑term debt strategy that relies on locking in inexpensive financing rather than repeatedly refinancing or expanding that particular series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - face amount of $750 million (properly formatted as $750M in LLM answer), annual debt service of $24.375 million, and 3.25% interest rate all match the ground truth exactly. The calculation verification ($24.375M = 3.25% × $750M) is implicit and correct. COMPLETENESS: The answer addresses all three years (2022, 2023, 2024) and tracks the evolution (or lack thereof) of both face amounts and interest obligations as required. ENTITY ACCURACY: SPG is correctly identified, the Unsecured Notes - 31B series is properly referenced, and the fiscal years are accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings to demonstrate stability and draw a conclusion about debt strategy. The reasoning is sound - the unchanged principal, consistent annual debt service, and fixed coupon rate across all three years logically support the conclusion about a stable, deliberate long-term debt strategy. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM provides additional context not in the ground truth (maturity date of 11/30/2026, characterization as 'low-cost debt,' and 'long-dated'), which adds value without contradicting the original answer. The LLM's phrasing 'preserving a fixed-rate, long-dated tranche' is semantically equivalent to the ground truth's 'stable long-term debt strategy.' The only very minor distinction is that the LLM references '2022 filing (showing 2021 balances)' which adds precision about fiscal year conventions, though this is not contradicted by the ground truth. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 483,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ reported expense for its U.S. defined‑contribution plans rose each year: $70 million in 2022 (as disclosed in the 2023 Form 10‑K), $75 million in 2023, and $76 million in 2024 (the 2024 Form 10‑K). This upward movement – a $6 million (≈8.6 %) increase over the three‑year span and a continuation of the earlier rise from $61 million in 2020/2019 to $63 million in 2021 and $70 million in 2022 – signals that Texas Instruments is progressively allocating more resources to its employee retirement‑benefit programs, underscoring a growing commitment to supporting workers’ retirement savings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the three core data points for 2022-2024 ($70M, $75M, $76M) and accurately calculates the 8.6% increase over the three-year period. The semantic interpretation about Texas Instruments' growing commitment to employee retirement benefits is sound and well-reasoned. However, there are significant issues that prevent a higher score: (1) The LLM introduces unsourced historical data (2020/2019 at $61M, 2021 at $63M) that is not part of the ground truth answer and cannot be verified against the original question's scope. This represents a factual accuracy problem - adding information not in the ground truth without clear sourcing. (2) The answer goes beyond the question's scope by discussing 2020-2021 data when the question specifically asks about 2022-2024 evolution. (3) While the core 2022-2024 numbers and percentage calculation are correct, the inclusion of unverified historical data undermines confidence in the overall response. The quantitative accuracy score is reduced due to the introduction of unverified numbers, even though the primary 2022-2024 figures and calculations are correct. The qualitative accuracy is strong for the reasoning about the trend, but weakened by the scope creep. The answer demonstrates good multi-hop synthesis of the three-year trend and provides appropriate contextual interpretation, which supports the contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 392,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "Across the three filings—2022, 2023 and 2024—General Dynamics (GD) consistently states that its return‑on‑invested‑capital (ROIC) “excludes goodwill impairments **and non‑economic accounting changes** as they are not reflective of company performance.” The language is identical in each year’s disclosure, showing no change in how those items are treated. This continuity indicates that GD deliberately removes non‑economic accounting adjustments from its ROIC metric to evaluate performance on a purely economic basis, underscoring a stable, cash‑flow‑oriented performance‑measurement methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across all three years (2022, 2023, 2024), matching the ground truth assertion of stability; (2) Accurately captures the identical language used across filings, providing specific textual evidence ('excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance'); (3) Properly synthesizes the multi-hop requirement by comparing treatment across three years and drawing the correct conclusion about consistency; (4) Correctly identifies the company (General Dynamics/GD) and the metric (ROIC); (5) Provides sound reasoning about what this consistency reveals—a disciplined, cash-flow-oriented, economically-focused performance measurement methodology. Minor considerations: (1) The LLM answer adds interpretive language ('deliberately removes,' 'purely economic basis,' 'cash-flow-oriented') that goes slightly beyond the ground truth's more straightforward statement, though this interpretation is reasonable and supported by the facts presented; (2) The answer is more detailed and explanatory than the ground truth, which could be seen as either a strength (more context) or slight overreach (adding interpretation). However, the core factual claims are all correct and the reasoning is sound. No numerical errors, no entity misidentification, and the multi-hop synthesis across three years is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 427,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "**Evolution of the balance**\n\n| Year (end‑of‑year) | Separate‑accounts assets (in $ millions) |\n|--------------------|------------------------------------------|\n| 2022 | * disclosed in the 2023 filing (Chunk 1) – the figure is lower than the 2021 level of $5,087 m and higher than the 2023 level of $3,250 m, indicating a decline from the prior year* |\n| 2023 | $3,250 m (Chunk 2) |\n| 2024 | $3,311 m (Chunk 2) |\n\n**What the three‑year trend tells us**\n\n- The balance fell between 2022 and 2023, moving from a higher 2022 level to $3.25 billion in 2023.  \n- In 2024 the amount edged higher to $3.31 billion, halting the decline and showing a modest rebound.\n\n**Interpretation**\n\nThe downward move from 2022 to 2023 signals that CVS trimmed the pool of assets set aside for its separate‑account (long‑term insurance) obligations, likely reallocating capital to other priorities. The slight increase in 2024 suggests the company is now stabilising that pool rather than continuing to shrink it, maintaining a modest but intentional investment position to support its long‑term insurance liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year trend direction (decline 2022-2023, modest recovery 2023-2024). (2) The 2023 ($3,250M) and 2024 ($3,311M) figures are accurate and match ground truth. (3) The interpretation about strategic reduction and stabilization aligns with the ground truth narrative. (4) The answer appropriately addresses both parts of the question (evolution and what it suggests). (5) Contextual relevance is strong - the answer correctly frames this as related to long-term insurance products.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM fails to provide the 2022 figure explicitly. The ground truth clearly states $5,087 million for 2022, but the LLM's table entry for 2022 is vague and hedged with asterisks and conditional language (\"the figure is lower than the 2021 level of $5,087 m\"). This is confusing and technically incorrect - $5,087M IS the 2022 figure, not a 2021 comparison. (2) The table presentation is awkward and doesn't clearly state the 2022 value as $5,087 million. (3) While the narrative mentions \"a higher 2022 level,\" it doesn't explicitly quantify it as $5,087M until buried in interpretation. (4) The magnitude of the decline (37% drop from $5,087M to $3,250M) is not calculated or emphasized, which would strengthen the analysis.\n\nMULTI-HOP REASONING: The synthesis across years is sound - the model correctly traces the three-year evolution and draws appropriate conclusions about strategic positioning. However, the failure to clearly state the 2022 baseline undermines the completeness of the multi-hop analysis.\n\nNUMBER VERIFICATION: 2023 ($3,250M) ✓ Correct. 2024 ($3,311M) ✓ Correct. 2022 ($5,087M) ✗ Not clearly stated in the answer, though referenced obliquely. The percentage decline (2022-2023) of approximately 36% is not calculated.\n\nJUSTIFICATION: The answer demonstrates good qualitative reasoning and contextual understanding, but the quantitative presentation is deficient. The 2022 figure should have been clearly stated as $5,087 million in the table, not hedged with conditional language. This is a significant oversight for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 586,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s credit‑card partnership with TD Bank USA, N.A. began with the **Credit Card Program Agreement dated October 22, 2012** (listed in the 2022, 2023 and 2024 Form 10‑K exhibits).  The agreement was **first amended on February 24, 2015** (the “First Amendment”) – a change that appears in all three filings.  A **second amendment was executed on November 19, 2019** (the “Second Amendment”); it is recorded in the 2022 and 2024 filings (the 2023 filing still references only the original agreement and the 2015 amendment, but the later 10‑K confirms the 2019 amendment remains in effect).  No further amendments are noted through the 2024 filing, indicating that the original 2012 agreement, together with its 2015 and 2019 amendments, constitute the current contractual milestones.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key dates and amendments correctly identified. Quantitative verification: Original agreement date (October 22, 2012) ✓, First Amendment (February 24, 2015) ✓, Second Amendment (November 19, 2019) ✓ - all match ground truth. The multi-hop synthesis is sound, correctly tracking the evolution across 2022-2024 filings. The LLM provides additional nuance beyond the ground truth by noting that the 2023 filing references only the original and 2015 amendment while the 2024 filing confirms the 2019 amendment, which adds helpful context about how the amendments appeared in different years' disclosures. This level of detail demonstrates careful document analysis. Minor deduction: The ground truth states the 2019 amendment was 'explicitly listed' in 2024, while the LLM notes it appears in '2022 and 2024 filings' - this is a slight discrepancy in which years explicitly listed the second amendment, though the LLM's observation about 2023 potentially omitting it is actually more precise. The answer correctly identifies this as a 'long-term strategic alignment' and properly characterizes the relationship evolution. All entities (Target Corporation, TD Bank USA, N.A.) are correctly named. The reasoning about sustained relationship with formal evolution is logically sound and well-supported by the chronological amendment data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 386,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "- **2022 & 2023 filings** – Linde listed rare gases (krypton, neon, xenon) only as part of its “atmospheric gases” portfolio (oxygen, nitrogen, argon, rare gases) and described them as being sold through the same three distribution methods (on‑site, merchant, packaged) used for all industrial gases. No special technology or strategic emphasis was attached to the rare‑gas business.  \n\n- **2024 filing** – Linde now positions rare‑gas production as a technologically differentiated segment. It is produced as a by‑product of the company’s market‑leading **non‑cryogenic air‑separation technologies** and is supported by proprietary, patented applications (e.g., vacuum‑pressure‑swing‑adsorption and membrane‑separation) that open new markets and lower customer costs. The rare‑gas output is **integrated with the broader atmospheric‑gas and process‑gas plants**, and the same plants can supply all three distribution modes, linking rare gases to Linde’s other product lines.  \n\n**Evolution:** From a simple product line item in 2022‑23, Linde’s rare‑gas business has become a strategically highlighted, technology‑driven offering that is tightly integrated with its overall industrial‑gases manufacturing and distribution platform by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate temporal progression; (2) Accurately captures the 2022-2023 positioning of rare gases as part of atmospheric gases portfolio with three distribution methods (on-site, merchant, packaged); (3) Precisely identifies the 2024 shift toward technology-driven differentiation; (4) Correctly names specific rare gases (krypton, neon, xenon) and technologies (VPSA, membrane separation); (5) Accurately describes the integration with broader atmospheric and process gas plants; (6) Properly synthesizes the multi-hop information showing evolution from product-centric to technology-and-integration-driven approach. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'market-leading non-cryogenic air-separation technologies' vs 'leadership in non-cryogenic air separation technologies') but these are semantically equivalent. The LLM answer actually provides slightly more explicit detail about the integration aspect ('same plants can supply all three distribution modes') which enhances clarity without contradicting the ground truth. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations present in either answer, so quantitative accuracy is perfect by default. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and multiple product/technology dimensions, demonstrating sound logical progression. The characterization of the evolution as moving from 'simple product line item' to 'strategically highlighted, technology-driven offering' accurately captures the essence of the ground truth's shift from 'product-centric to technology- and integration-driven approach.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 498,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil reported collateral for master‑netting arrangements that are **not** offset against its derivative positions as follows: $1,494 million at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024. The amount fell by roughly 47 % from 2022 to 2023 and by another 39 % from 2023 to 2024. Because this collateral is tied to the “advances to/receivables from equity companies” (hierarchy‑level‑3 inputs) and is primarily posted for initial‑margin requirements, the sharp decline signals that ExxonMobil’s exposure to derivative liabilities linked to its equity‑company relationships has been contracting over the last two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. (1) QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($1,494M in 2022, $800M in 2023, $491M in 2024). The calculated percentage declines are accurate: 2022-2023 decline of 46.5% (rounds to ~47%), and 2023-2024 decline of 38.6% (rounds to ~39%). (2) COMPLETENESS: The answer fully addresses the multi-part question by providing the evolution of collateral amounts across all three years and explicitly interpreting the trend as a reduction in derivative liability exposure. (3) ENTITY ACCURACY: ExxonMobil is correctly identified, fiscal years are accurate (12/31/2022, 12/31/2023, 12/31/2024), and the financial metric (collateral under master netting arrangements) is properly specified. (4) MULTI-HOP REASONING: The answer correctly synthesizes the connection between collateral amounts, equity company advances, and derivative liability exposure. The interpretation that the consistent decline signals de-risking/portfolio optimization is sound and matches the ground truth conclusion. (5) ADDED VALUE: The LLM answer provides additional context not in the ground truth (clarification about hierarchy-level-3 inputs, initial-margin requirements, and the specific characterization of collateral as 'not offset against derivative positions'), which enhances understanding without contradicting the original answer. The semantic meaning is fully aligned with the ground truth. Minor deduction only because the LLM's additional contextual details, while accurate and helpful, go slightly beyond what was explicitly stated in the ground truth, though this is a strength rather than a weakness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 458,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s disclosed contract coverage rose from **about 92 % of its net‑generating capacity** being locked into long‑term bilateral contracts at 12/31/2021 (the 2022 filing) to **approximately 94 %** at 12/31/2023 (the 2023 filing) and remained at **roughly 94 %** at 12/31/2024 (the 2024 filing). This modest increase and subsequent plateau indicate that NEER has been steadily moving toward, and now maintaining, a very high proportion of its output under long‑term agreements, using the remaining un‑contracted output for short‑term or spot‑market sales that are hedged with shorter‑term bilateral contracts. The pattern underscores a deliberate risk‑mitigation strategy: by locking in the bulk of its generation revenue in advance, NEER reduces exposure to price volatility in competitive markets while still retaining flexibility to hedge any residual spot‑market exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All percentages are correct—92% in 2022 (12/31/2021), 94% in 2023 (12/31/2023), and 94% in 2024 (12/31/2024). The LLM correctly identifies the modest increase from 92% to 94% and the plateau thereafter, matching the ground truth exactly. Date references are accurate and appropriately contextualized (e.g., '12/31/2021 (the 2022 filing)'). COMPLETENESS: The answer fully addresses both parts of the multi-part question: (1) the evolution of reliance on long-term bilateral contracts across the three-year period, and (2) what this trend suggests about risk mitigation strategy. ENTITY ACCURACY: NEER is correctly identified, the metric (net generating capacity under long-term bilateral contracts) is precise, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly interprets the trend (steady increase then plateau) and draws appropriate conclusions about risk mitigation strategy—specifically that NEER locks in bulk revenue through long-term agreements while using shorter-term contracts to hedge residual spot-market exposure. This reasoning aligns perfectly with the ground truth's characterization of 'strategic emphasis on revenue stability and risk mitigation.' SEMANTIC EQUIVALENCE: The LLM's explanation of the strategy ('reduces exposure to price volatility in competitive markets while still retaining flexibility') is semantically equivalent to the ground truth's description of 'revenue stability and risk mitigation' and 'managing price risk in daily spot markets.' MINOR OBSERVATIONS: The LLM provides slightly more detailed explanation of the mechanics (e.g., 'short-term or spot-market sales that are hedged with shorter-term bilateral contracts'), which adds helpful context without introducing any inaccuracies. The use of 'about,' 'approximately,' and 'roughly' is appropriate given the nature of percentage reporting in filings. No calculation errors detected. No factual discrepancies identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into_Contract]-> FIN_INST <-[Contracts]- ORG <-[Enters_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 551,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "**Outstanding principal balance**\n\n| Fiscal year (as reported) | Balance of the 3.125 % notes due January 2025 |\n|---------------------------|----------------------------------------------|\n| FY 2022 (Oct 30 2022) – Chunk 1 | **$495 million** |\n| FY 2023 (Oct 29 2023) – Chunk 3 (and reiterated in Chunk 2) | **$495 million** |\n| FY 2024 (Nov 3 2024) – Chunk 2 | **$495 million** |\n\nAll three 10‑K tables list the same amount – $495 million – for this tranche in each year’s “principal amount outstanding” column.\n\n**What this shows about AVGO’s debt‑management strategy**\n\nThe unchanged $495 million balance across FY 2022‑FY 2024 indicates that Broadcom has chosen to **hold the 3.125 % senior notes to maturity** rather than repaying or refinancing them early. By keeping a low‑cost, fixed‑rate instrument on the balance sheet, the company preserves cash for operations and other investments while relying on the notes’ modest 3.23 % effective interest rate to fund its long‑term capital needs. This reflects a deliberate strategy of maintaining inexpensive, long‑dated debt rather than aggressively reducing this specific tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All three fiscal year balances are correctly stated as $495 million (FY 2022, FY 2023, FY 2024), matching the ground truth exactly. The dates are accurate (Oct 30 2022, Oct 29 2023, Nov 3 2024). The interest rate of 3.125% is correctly identified, and the effective rate of 3.23% is provided with appropriate precision. ENTITY ACCURACY: The company is correctly identified as Broadcom (AVGO), the debt instrument is correctly specified as 3.125% senior notes due January 2025, and all fiscal years are correctly referenced. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the outstanding principal balance across the three-year period, and (2) what this reveals about debt management strategy. REASONING QUALITY: The LLM correctly synthesizes the data across three fiscal years and draws a logical conclusion that the unchanged balance indicates a deliberate strategy to hold the notes to maturity rather than amortize or refinance early. The reasoning about preserving cash for operations and leveraging low-cost fixed-rate debt is sound and consistent with the ground truth's conclusion about refinancing or using cash reserves. SEMANTIC EQUIVALENCE: The LLM's interpretation that AVGO is 'holding the notes to maturity' is semantically equivalent to the ground truth's statement about 'planning to refinance or use cash reserves to settle the obligation rather than amortizing it' - both convey that the company is not reducing principal over time. MINOR CONSIDERATIONS: The LLM provides slightly more detailed strategic context (mentioning capital preservation and effective interest rates) compared to the ground truth, but this adds value rather than detracting from accuracy. The presentation in tabular format enhances clarity. No calculation errors detected. All facts are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 521,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "**Evolution of the 37B unsecured notes**\n\n| Year (as reported) | Interest rate | Face amount (‑$ thousands) | Maturity date |\n|--------------------|---------------|----------------------------|---------------|\n| 2022 10‑K (Dec 31 2021) | 2.25 % | 700,000 | 01/15/2032 |\n| 2023 10‑K (Dec 31 2023) | 2.25 % | 700,000 | 01/15/2032 |\n| 2024 10‑K (Dec 31 2024) | 2.25 % | 700,000 | 01/15/2032 |\n\n**What the three‑year trend shows**\n\nAcross the 2022‑2024 filings the 37B issuance was left unchanged – the same modest 2.25 % coupon, the same $700 million face amount and the same 2032 maturity. This consistency signals that Simon Property Group has deliberately kept this long‑dated tranche of unsecured debt intact, locking in a relatively low fixed rate for a ten‑year horizon. By not refinancing or expanding the issue, the company preserves predictable interest‑expense cash flows and limits exposure to future rate‑rise risk, reflecting a long‑term debt strategy focused on stability rather than aggressive leverage growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. QUANTITATIVE VERIFICATION: All numeric values are correct - interest rate of 2.25%, face amount of $700,000,000 (presented as 700,000 in thousands, which is equivalent), and maturity date of January 15, 2032. The table format clearly presents data across all three years (2022, 2023, 2024) with consistent values. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) interest rate evolution, (2) face amount evolution, and (3) maturity date evolution, plus the strategic implications. ENTITY ACCURACY: Correctly identifies Simon Property Group, the specific 37B unsecured notes issuance, and the relevant fiscal years. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly interprets the stability pattern as indicating a deliberate strategic choice. The reasoning about locking in low fixed rates, preserving predictable cash flows, and limiting rate-rise exposure is sound and aligns with the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation of the 3-year progression and strategic implications matches the ground truth's characterization of 'deliberate long-term debt strategy focused on maintaining predictable financing costs.' Minor note: The LLM presents the face amount in thousands (700,000) while the ground truth uses full dollars ($700,000,000), but this is a standard formatting variation and both are correct. The LLM's additional context about 'ten-year horizon' and 'rate-rise risk' provides slightly more granular strategic insight while remaining consistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 459,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Across the three most‑recent 10‑K tables Texas Instruments consistently lists **Melaka, Malaysia** as an operating site. In 2022 the entry shows an “X” only under the **Analog** column; the 2023 table repeats the same pattern (analog = X, embedded = blank); and the 2024 table again shows an “X” only for analog with no embedded‑processing mark.  \n\nThus, from 2022 through 2024 the Melaka footprint remained unchanged – the facility continued to serve TI’s analog business and did not expand to embedded‑processing activities, underscoring a sustained, analog‑centric focus at that location.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint from 2022-2024. STRENGTHS: (1) All factual claims are correct - the answer accurately identifies that Melaka had an 'X' under Analog in all three years (2022, 2023, 2024) and no marking under Embedded Processing in any year; (2) The multi-hop synthesis is sound - the model correctly extracted and compared data across three separate 10-K filings and identified the consistent pattern; (3) Entity identification is perfect - correctly names Texas Instruments (TXN), Melaka Malaysia, and the two product categories (Analog vs Embedded Processing); (4) The reasoning is logical and well-structured, moving from year-by-year observations to the overall conclusion about sustained analog-centric focus; (5) The answer directly answers both parts of the question: how the footprint evolved (it didn't - remained stable) and what this reveals about company focus (analog-only, no embedded processing expansion). MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than the ground truth ('analog-centric focus' vs 'analog-only operational strategy') but these are semantically equivalent. The LLM's use of 'analog = X, embedded = blank' is a clear and effective way to convey the tabular data. No numerical errors, no calculation issues, and no factual inaccuracies detected. The answer demonstrates proper understanding of the three-year progression and correctly interprets what the consistency reveals about strategic priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 434,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard (MA) has continuously **implemented its Multi‑Layered Security Approach** as an accounting policy across the three years, but the scope of that program has broadened in step with the rollout of real‑time payment infrastructure.  \n\n* **2022:** The 10‑K describes a multi‑layered security program that includes a robust cyber‑ and information‑security suite, Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, third‑party assessments and industry‑standard work (e.g., EMV). At that time Mastercard operated or was implementing real‑time account‑based payments infrastructure in **12 of the top‑50 global markets** (as of Dec 31 2021).  \n\n* **2023:** The same multi‑layered approach is reiterated—still featuring real‑time fraud scoring, tokenization, third‑party benchmarking and enterprise‑resilience measures—but the real‑time payments footprint had **grown to 13 markets** (as of Dec 31 2023). The security architecture continued to protect the expanded network that now routes >65 % of all Mastercard/Maestro transactions worldwide.  \n\n* **2024:** Mastercard again emphasizes its multi‑layered security framework, adding that it now supports the **new domestic‑transaction processing in China** and “real‑time payments infrastructure in several countries” worldwide. The security program therefore evolved to cover a larger, more geographically dispersed real‑time payments ecosystem, applying the same layered protections (cyber‑security, resilience, tokenization, fraud‑scoring, third‑party testing) to the newly added markets and services.  \n\nThus, from 2022 to 2024 Mastercard’s multi‑layered security approach remained fundamentally the same in structure but was **scaled and adapted** to protect an increasingly extensive real‑time payment network that expanded from 12 markets in 2022 to 13 markets plus new domestic processing in China by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - 12 markets in 2022, 13 markets in 2023, and the expansion into China by 2024 are all accurately stated. The reference to >65% of Mastercard/Maestro transactions being routed through the expanded network is a reasonable supporting detail. ENTITY ACCURACY: Mastercard is correctly identified with ticker (MA), years are correct (2022-2024), and all security components mentioned (EMV, tokenization, fraud scoring, Security Operations Centers, Fusion Centers, Mastercard Intelligence Center) align with ground truth. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across three years, correctly linking the expansion of real-time payment infrastructure (12→13 markets plus China) with the corresponding scaling of security measures. The logical progression from 2022 baseline through 2023 expansion to 2024 China entry is sound. COMPLETENESS: The answer addresses all aspects of the question - how the security approach evolved, the expansion of real-time payment infrastructure, and the geographic scope increase. The answer correctly characterizes the evolution as \"scaled and adapted\" rather than fundamentally redesigned, which matches the ground truth's emphasis on continuity with expansion. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (specific security center names, transaction routing percentages) than the ground truth, but these are contextually appropriate and not contradictory. The framing as an \"accounting policy\" is a reasonable interpretation of how such security frameworks are documented in 10-K filings. No factual errors, calculation mistakes, or entity misidentifications detected. The semantic meaning and factual content align well with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1736,
        "completion_tokens": 510,
        "total_tokens": 2246
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "- **2022:** General Dynamics’ Land Systems said it was **producing 360 new LAVs** for the Canadian Army.  \n- **2023:** The company increased that output to **399 new LAVs** for Canada.  \n- **2024:** Production rose again to **449 new LAVs**, and the firm added **66 additional LAVs** under the Light‑Armoured Vehicle Reconnaissance Surveillance System (LRSS) program – roughly **515 LAVs in total** for the Canadian force.  \n\nThe step‑wise growth—from 360 to 399 to about 515 vehicles – shows that General Dynamics is progressively deepening its commitment to the Canadian LAV program, using it as a cornerstone of its broader LAV strategy and signaling a clear strategic focus on expanding and modernising its LAV product line for allied customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers for the main LAV production progression (360 in 2022, 399 in 2023, 449 in 2024). The answer properly identifies General Dynamics' Land Systems as the relevant division and correctly synthesizes the multi-year trend. The strategic interpretation about deepening commitment and expanding focus is sound and well-reasoned. However, there is a minor issue with the 2024 total calculation: the LLM states '449 new LAVs' plus '66 additional LAVs under the LRSS program' equals 'roughly 515 LAVs in total.' The arithmetic is correct (449 + 66 = 515), but the ground truth answer only mentions 449 units for 2024 without reference to the LRSS program addition. The LLM appears to have introduced additional context about the LRSS program that, while potentially accurate from the source documents, goes beyond what the ground truth explicitly states. This represents an addition of information rather than an error, but it creates a slight discrepancy in how 2024 is characterized. The core progression (360→399→449) is entirely accurate, and the qualitative assessment of strategic focus is appropriate and well-articulated. The answer effectively addresses all parts of the multi-hop question by tracking the evolution across three years and drawing appropriate conclusions about strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 381,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS reported that the amount excluded from its Level 3 pension‑plan assets for hedge‑fund limited‑partnership investments grew from **$214 million** in the 2022 filing, to **$225 million** in the 2023 filing, and to **$252 million** in the 2024 filing. This steady rise—about a 5 % increase year‑over‑year and a 18 % increase over the three‑year span—shows CVS is deliberately expanding the share of alternative, hedge‑fund LP assets in its pension portfolio, signalling a strategy that leans more toward higher‑return, less‑liquid investments to diversify and potentially enhance pension‑fund performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($214M in 2022, $225M in 2023, $252M in 2024). The year-over-year increase calculation is approximately correct (5% from 2022-2023: $11M/$214M = 5.1%; 12% from 2023-2024: $27M/$225M = 12%). The three-year total increase is accurately stated as 18% (($252M-$214M)/$214M = 17.76%, rounds to 18%). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the specific allocation amounts for each year, (2) the trajectory/trend analysis, and (3) interpretation of what this suggests about CVS's pension strategy. ENTITY ACCURACY: CVS is correctly identified, the metric (hedge fund limited partnership investments through pension plan assets) is correctly identified, and all years (2022, 2023, 2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly extracted data from three separate filings and synthesized them into a coherent narrative about strategic evolution. The interpretation that the steady increase signals deliberate expansion toward alternative investments is reasonable and well-supported by the data. MINOR CONSIDERATIONS: The LLM uses slightly different framing (\"excluded from Level 3\" vs. the ground truth's simpler \"allocation to\"), but this is a semantic variation that doesn't affect factual accuracy. The LLM's interpretation about \"higher-return, less-liquid investments\" adds reasonable context that aligns with the ground truth's conclusion about \"more confident strategic approach.\" The only negligible difference is the ground truth states 17.8% while the LLM states 18%, which is a rounding difference (17.76% rounds to either 17.8% or 18% depending on precision).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 484,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "Target’s own data show that the share of purchases paid with its branded credit product fell each year: penetration was **20.5 % for the fiscal year ended January 29 2022**, dropped to **19.8 % for the year ended January 28 2023**, and slipped further to **18.6 % for the year ended February 3 2024** (the 2024 filing reports the same 18.6 % figure after the RedCard re‑branding to “Target Circle Card”). This steady decline indicates that, while a substantial base of shoppers still uses the Target MasterCard/Target Circle Card, the proportion of total purchases made with the card is shrinking—suggesting that consumer adoption and engagement with Target’s financial products are moderating, likely because overall sales growth is outpacing card‑driven usage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2024 PENETRATION RATE: The LLM reports 18.6% for fiscal year 2024, while the ground truth states 17.8% for 2024. This is a material factual error of 0.8 percentage points that directly contradicts the provided knowledge graph answer. This is the most significant issue with the response.\n\nCORRECT ELEMENTS:\n- 2022 penetration rate of 20.5% is correct\n- 2023 penetration rate of 19.8% is correct\n- Correct identification of the fiscal year dates (January 29, 2022; January 28, 2023; February 3, 2024)\n- Correct identification of the product rebranding from Target MasterCard to Target Circle Card\n- Correct characterization of the overall trend as a steady decline\n- Sound reasoning about the implications (overall sales growth outpacing card-driven usage)\n- Appropriate discussion of consumer adoption and engagement moderating\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- 2024 penetration rate reported as 18.6% instead of 17.8% (0.8 percentage point error)\n- This error undermines the accuracy of the trend analysis, though the directional trend (declining) remains correct\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across multiple fiscal years and connects the penetration rate decline to broader business dynamics (overall sales growth outpacing card usage). The reasoning about what the trend suggests is sound and aligns with the ground truth interpretation.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation of what the trend suggests (moderating adoption/engagement, shifting consumer preferences) is semantically equivalent to the ground truth, though the ground truth provides slightly more specific context about competition and discount sensitivity.\n\nJUSTIFICATION: The single but significant numerical error in the 2024 figure (18.6% vs 17.8%) prevents a higher score despite otherwise solid reasoning and correct identification of the 2022-2023 trend. For a financial analysis question, precision in reported metrics is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 538,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "**2022 (NEE 10‑K 2022)** – The FPL Cost‑Recovery‑Clause assets contributed only **$2 million** of fair‑value exposure.  This net amount came from **‑$5 million** of “significant other observable inputs” offset by **+$7 million** of “significant unobservable inputs.”  \n\n**2023 (NEE 10‑K 2023)** – The contribution rose to **$12 million**.  The observable‑input component turned negative, **‑$12 million**, while the unobservable‑input component grew to **+$24 million**, producing the larger net positive.  \n\n**2024 (NEE 10‑K 2024)** – The exposure expanded further to **$38 million**.  Both input types were now positive: **+$4 million** from observable inputs and **+$34 million** from unobservable inputs, with the unobservable portion still providing the bulk of the increase.  \n\n**Overall trend:** From 2022 through 2024 the total fair‑value contribution of the FPL Cost‑Recovery‑Clause assets grew from $2 M → $12 M → $38 M, while the composition shifted from a modest net positive driven mainly by unobservable inputs, to a larger unobservable‑driven net positive in 2023, and finally to a higher‑level mix in 2024 where both observable and unobservable inputs are positive, though unobservable inputs remain the dominant source.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figures. Ground truth states 2022 total fair value was $1 million with -$5 million observable inputs and +$6 million unobservable inputs. The LLM claims $2 million total with -$5 million observable and +$7 million unobservable. This is a material discrepancy: (1) The 2022 total is wrong ($2M vs $1M ground truth), (2) The unobservable inputs component is wrong (+$7M vs +$6M ground truth). The arithmetic in the LLM answer is internally inconsistent: -$5M + $7M = $2M is correct math, but the ground truth shows -$5M + $6M = $1M. For 2023 and 2024, the LLM numbers match ground truth exactly ($12M and $38M totals, with correct component breakdowns). MULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution and identifies the trend of growing reliance on unobservable inputs. The narrative structure appropriately addresses the question's request for evolution analysis. ENTITY ACCURACY: NextEra Energy (NEE), FPL Cost Recovery Clauses, and years 2022-2024 are all correctly identified. SEMANTIC EQUIVALENCE: The qualitative description of the trend is sound and matches the ground truth narrative about shifting composition and growing fair value exposure. However, the quantitative foundation is compromised by the 2022 error, which undermines confidence in the overall analysis despite correct 2023-2024 figures. The error appears to be a data extraction or transcription mistake rather than a calculation error, as the LLM's arithmetic is internally consistent but factually wrong against the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 448,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Across the three filings Nike repeatedly lists Anta as a direct rival, but the way Nike describes its own competitive edge becomes progressively richer. In 2022 the competition narrative stresses “new product style, design, **innovation and development**” and basic brand‑connection tools such as marketing, digital experiences, social‑media interaction and athlete endorsements. The 2023 filing moves the word “innovation” to the front of the product‑attribute list and repeats the same consumer‑engagement pillars, while the 2024 filing adds even more depth—highlighting “innovation and development” first, and expanding brand‑engagement to “prominent and influential athletes, influencers, public figures, coaches, teams, colleges and sports leagues” together with “active engagement through sponsored sporting events and clinics.” Thus, from 2022‑2024 Nike’s competitive positioning versus Anta remains stable in naming the rival, but Nike’s emphasis on product innovation grows sharper and its brand‑engagement strategy broadens to a wider set of influencers and event‑based experiences.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental factual error that undermines its credibility. The LLM claims that in 2022, Nike's competitive narrative stressed 'innovation and development' as a primary product attribute alongside 'new product style, design.' However, the ground truth explicitly states that in 2022, NKE emphasized 'quality, performance, and reliability, along with new product style and design innovation' - NOT 'innovation and development' as a standalone primary attribute. The ground truth indicates that 'innovation and development' was elevated to prominence only in 2023, not present as a primary emphasis in 2022. This is a significant mischaracterization of the 2022 positioning.\n\nADDITIONAL ISSUES:\n1. The LLM incorrectly suggests the 2022 filing included 'innovation and development' as a front-and-center competitive differentiator, when the ground truth shows this was a 2023 strategic shift.\n2. The LLM's description of 2022 brand-connection tools (marketing, digital experiences, social-media interaction, athlete endorsements) appears to conflate elements that may not have been equally emphasized in 2022 vs. later years.\n3. While the LLM correctly identifies the progression of innovation emphasis and the broadening of brand engagement strategies, the specific attribution of these elements to 2022 is factually incorrect.\n\nCORRECT ELEMENTS:\n- Anta is correctly identified as a named competitor across all three years\n- The general trajectory of increasing innovation emphasis is directionally correct\n- The 2024 expansion of brand engagement to include 'prominent and influential athletes, influencers, public figures, coaches, teams, colleges and sports leagues' appears accurate\n- The overall narrative arc of progressive strategic evolution is sound\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across three years of filings, but the foundational error in 2022 positioning undermines the validity of the comparative analysis. The reasoning structure is logical, but built on incorrect premises.\n\nSEMANTIC EQUIVALENCE: While the LLM uses different wording than the ground truth, the semantic meaning diverges significantly on the 2022 positioning, which is a material factual error rather than a wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 618,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "All three annual reports (2022, 2023 and 2024) list the **Texas Instruments 2003 Director Compensation Plan** in the “includes shares of TI common stock to be issued under …” paragraph, but none of the filings disclose a separate, quantified “shares remaining available” figure for that plan. The fact that the 2003 plan is repeatedly mentioned in each year’s “share‑based compensation” table—without a reported depletion—shows that TI still retains an un‑specified pool of shares that could be issued under the 2003 plan and that the company continues to keep the plan active as a component of its director‑compensation toolbox. In short, the availability of shares under the 2003 plan has remained unchanged (i.e., not exhausted) from 2022 through 2024, indicating TI’s ongoing reliance on this legacy plan for compensating its directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth and demonstrates a critical misunderstanding of the question and available data. Key issues: (1) FACTUAL CONTRADICTION: The ground truth explicitly states the plan's availability 'decreased from 2022 to 2024' and that 'by 2023, the plan was no longer listed among those with remaining shares available for future issuance.' The LLM claims the opposite—that availability 'remained unchanged (i.e., not exhausted)' and that TI 'continues to keep the plan active.' This is a direct factual error. (2) MISINTERPRETATION OF DISCLOSURE: The LLM conflates 'being mentioned in filings' with 'having available shares.' The ground truth indicates the plan was referenced for historical/outstanding grants but was NOT listed as having shares available for future issuance starting in 2023. The LLM's reasoning that 'no reported depletion' means 'unchanged availability' is logically flawed—absence of a specific number doesn't indicate the plan remained active for new issuances. (3) TREND ANALYSIS FAILURE: The question explicitly asks about how availability 'evolved' and what the 'trend' indicates. The ground truth shows a clear trend of phase-out (active in 2022 → no shares available in 2023 → no longer mentioned in 2024). The LLM identifies no trend and concludes the opposite. (4) STRATEGIC CONTEXT MISSING: The ground truth correctly identifies this as a 'strategic shift toward updated incentive structures' with focus moving to the 2024 LTIP and 2018 Director Plan. The LLM misses this entirely, claiming 'ongoing reliance on this legacy plan.' (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize information across the three years (2022, 2023, 2024) to identify the phase-out pattern. The answer demonstrates a fundamental misreading of the source documents regarding which plans had shares available for future issuance in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 517,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From the 2022 filing, Comcast first disclosed that its advertising business “offers additional technology, tools, data‑driven services and marketplace solutions to customers in the media industry to facilitate advertisers more effectively engaging with their target audiences.” In the 2023 filing the same suite of data‑driven services was reiterated, now explicitly tied to the company’s digital platforms, Sky‑branded entertainment networks and its representation agreements, showing that the services had been integrated into all of the company’s advertising inventory. By the 2024 filing the language is unchanged but the scope is broader – the technology, tools, data‑driven services and marketplace solutions are described as supporting both Comcast‑owned ad inventory and third‑party representation across linear, streaming (NOW, Xumo Play, Peacock) and cloud‑based X1/Flex platforms, indicating an expansion of the marketplace offering and more sophisticated targeting tools that leverage the company’s cloud‑based video and advertising infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core evolution of CMCSA's advertising services from 2022-2024 with accurate temporal progression; (2) Accurately cites the 2022 baseline offering of 'technology, tools, data-driven services and marketplace solutions'; (3) Properly identifies the 2023 expansion showing integration across digital platforms, Sky-branded networks, and representation agreements; (4) Correctly describes 2024 enhancements including broader scope across linear, streaming (NOW, Xumo Play, Peacock), and cloud-based platforms (X1/Flex); (5) Accurately synthesizes the multi-hop information showing progression from basic offerings to integrated, technology-enabled solutions; (6) Correctly emphasizes the strategic shift toward cloud-based infrastructure and data analytics capabilities. MINOR CONSIDERATIONS: (1) The LLM answer provides more specific platform examples (NOW, Xumo Play, Peacock, X1/Flex) than the ground truth, which is a value-add rather than an error; (2) The LLM notes that 2024 language is 'unchanged' while describing broader scope - this is a nuanced observation about how the company maintained consistent messaging while expanding application; (3) Both answers correctly identify the evolution toward more integrated, technology-enabled solutions. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations required - all temporal references (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple filing documents, correctly identifying the progression and integration of services. The reasoning about how services evolved from siloed offerings to integrated ecosystem is sound and matches the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 500,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "**2022 → 2023 → 2024 trend**\n\n| Year | Fair‑value of CMBS (millions) | Unrealized loss (millions) | Number of securities |\n|------|------------------------------|----------------------------|----------------------|\n| 2022 (Dec 31) | **$992 m** (total of short‑ and long‑term holdings) – also reported as $574 m when broken out by “experience‑rated” vs. “remaining” products【Chunk 1】; the larger figure reflects the full portfolio. | **$155 m** (total) – the “remaining‑product” line shows a much smaller $12 m loss【Chunk 3】. | 475 |\n| 2023 (Dec 31) | **$675 m** (total) – down from $992 m【Chunk 1】. | **$100 m** (total) – down from $155 m【Chunk 1】. | 331 |\n| 2024 (year‑end) | Fair‑value not disclosed, but the portfolio was reduced to **3 securities** (vs. 6 in 2023)【Chunk 2】, indicating a negligible remaining fair‑value exposure. | With only three small positions, any unrealized loss would be immaterial and is not reported. | 3 |\n\n**Interpretation**\n\nFrom 2022 to 2023 CVS cut the size of its commercial mortgage‑backed‑security (CMBS) portfolio by roughly one‑third, lowering fair‑value exposure by about **$317 m** and reducing unrealized losses by **$55 m**. The 2024 filing shows the portfolio essentially wound down to a handful of securities, implying that the remaining fair‑value amount is minimal and that the company has virtually eliminated the unrealized‑loss risk associated with this asset class.\n\n**Risk positioning**\n\nThe steady decline in both the amount invested and the associated unrealized losses demonstrates that CVS is deliberately de‑risking its CMBS holdings. By 2024 the exposure is almost negligible, suggesting the company has shifted away from a relatively volatile, interest‑rate‑sensitive asset class and is positioning its balance sheet toward lower‑risk, more liquid securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022 Fair Value: LLM claims $992M (total) vs. Ground Truth $574M. This is a 73% overstatement and fundamentally incorrect.\n   - 2022 Unrealized Losses: LLM claims $155M (total) vs. Ground Truth $12M. This is a 1,192% overstatement - a catastrophic error.\n   - 2023 Fair Value: LLM correctly states $675M ✓\n   - 2023 Unrealized Losses: LLM correctly states $100M ✓\n   - 2024 Fair Value: LLM states \"not disclosed\" vs. Ground Truth explicitly states $6M. This is a material omission.\n   - 2024 Unrealized Losses: LLM states \"not reported\" vs. Ground Truth states \"no significant unrealized losses\" - semantically similar but LLM's framing suggests data unavailability rather than actual low values.\n\n2. CALCULATION ERRORS:\n   - LLM calculates 2022-2023 change as \"$317M reduction\" and \"$55M reduction in losses\" - these calculations are based on the incorrect 2022 baseline figures ($992M and $155M), making them invalid.\n   - Ground truth shows: 2022-2023 fair value change = $675M - $574M = +$101M (INCREASE, not decrease), and unrealized loss change = $100M - $12M = +$88M (INCREASE in losses, not decrease).\n   - LLM's statement \"cut the size...by roughly one-third\" is directionally wrong for fair value.\n\n3. MULTI-HOP REASONING FAILURE:\n   - LLM misinterprets the data structure, confusing different reporting categories (\"experience-rated\" vs. \"remaining\" products) and incorrectly aggregating them.\n   - The claim that 2022-2023 showed a reduction is contradicted by the actual data showing an increase in fair value and unrealized losses.\n   - LLM's conclusion about \"de-risking\" is partially correct for 2024 but is built on false premises about 2022-2023 trends.\n\n4. ENTITY/METRIC ACCURACY:\n   - Company correctly identified as CVS ✓\n   - Years correctly identified (2022, 2023, 2024) ✓\n   - Metric correctly identified as CMBS ✓\n   - However, the actual values assigned to these entities are severely incorrect.\n\n5. SEMANTIC ISSUES:\n   - LLM's narrative suggests a consistent de-risking trend from 2022-2024, but the actual trend shows: 2022→2023 (INCREASE in exposure and losses), then 2024 (dramatic reduction). This is a fundamentally different story.\n   - The risk positioning conclusion is partially correct for 2024 but misleading about the overall trajectory.\n\n6. WHAT WAS CORRECT:\n   - 2023 figures ($675M fair value, $100M unrealized losses) ✓\n   - General direction of 2024 reduction ✓\n   - Overall de-risking conclusion for 2024 ✓\n   - Qualitative interpretation of risk positioning in 2024 ✓\n\nCONCLUSION: The LLM answer contains severe quantitative errors in the 2022 baseline data (off by 73% for fair value, 1,192% for unrealized losses), leading to incorrect calculations and a mischaracterized trend for 2022-2023. While 2023-2024 data and conclusions are largely correct, the foundational errors and misrepresentation of the 2022-2023 period make this answer substantially incorrect and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 805,
        "total_tokens": 2423
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "**Scope and value across the three years**\n\n- **2022 filing** – Merchandise discounts are listed among the “compensation and benefits” items. The disclosure notes that the discounts are available to “team members” and that “eligibility for, and the level of, benefits vary depending on team members’ full‑time or part‑time status, work location, compensation level, and tenure.” No dollar amount is disclosed.  \n\n- **2023 filing** – The same language appears: “merchandise and other discounts” are part of the benefits package, with the same qualifier that eligibility and the amount of the discount depend on employment status, location, pay and tenure. Again, no specific monetary value is provided.  \n\n- **2024 filing** – The 2024 10‑K repeats the description verbatim: “merchandise and other discounts” are included in the benefits package, with eligibility and the discount level varying by full‑time/part‑time status, work location, compensation level and tenure. No new dollar figure is disclosed.\n\n**What the progression suggests**\n\nBecause the merchandise‑discount benefit is mentioned in every filing and the wording is essentially unchanged, Target’s approach to this perk has been **stable rather than expanding or contracting**. The company consistently positions the discount as a broad‑based, non‑cash employee perk whose exact amount is tailored to each employee’s status and tenure. This continuity signals that Target views merchandise discounts as a core component of its employee‑benefit strategy—used to enhance total‑compensation, support retention and reinforce its “employer of choice” positioning—rather than a variable or experimental benefit that is being scaled up or down over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misses the core narrative of the ground truth. The original answer emphasizes a STRATEGIC EVOLUTION in Target's benefits strategy across the three years—specifically that merchandise discounts remained stable while the broader benefits ecosystem expanded significantly (wage increases from $15/hour to $15-$24/hour, addition of 401(k) matching, tuition reimbursement, mental health services, virtual healthcare). The LLM answer correctly identifies that merchandise discount language remained unchanged across all three years, but then concludes this represents 'stability' and fails to contextualize this within the larger strategic shift toward holistic employee well-being. WHAT WAS CORRECT: (1) The LLM accurately notes that merchandise discounts appear in all three filings with similar language; (2) Correctly identifies that no specific dollar amounts are disclosed; (3) Accurately captures the eligibility qualifiers (full-time/part-time status, location, compensation level, tenure). WHAT WAS MISSING/INCORRECT: (1) The LLM completely fails to synthesize the multi-hop information about how the broader benefits package evolved alongside the stable merchandise discount offering; (2) Does not mention the wage expansion ($15 to $15-$24/hour) that occurred between 2022-2023; (3) Does not reference the addition of financial wellness components (401(k) matching, tuition reimbursement) or modern benefits (mental health services, virtual healthcare); (4) The conclusion about 'stability' is technically accurate for the merchandise discount itself, but misses the strategic insight that Target was layering new benefits WHILE maintaining traditional perks—a key distinction in the ground truth narrative. MULTI-HOP REASONING: The question requires synthesizing information about merchandise discounts AND the broader benefits evolution across three years. The LLM only addresses the merchandise discount component in isolation, failing to connect it to the larger strategic context. The ground truth explicitly frames merchandise discounts as one element within an expanding benefits ecosystem. SEMANTIC ISSUE: The LLM's interpretation of 'evolution' is narrower than intended—it focuses only on whether the merchandise discount itself changed, rather than how it fits within the evolving total compensation strategy. The ground truth suggests the evolution is about strategic repositioning and layering, not about the discount itself changing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1696,
        "completion_tokens": 663,
        "total_tokens": 2359
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "From 2022 through 2024 Linde repeatedly singled out “cultural challenges associated with integrating employees from the acquired company into the existing organization” as a distinct integration risk. In each year’s 10‑K the same bullet appears alongside other post‑acquisition issues (controls, systems, synergy capture), and the 2022 and 2023 filings also flag “integration of operations across different cultures and languages” for foreign deals. The unchanged, explicit focus shows that Linde treats cultural integration as a persistent, material risk that can negatively affect the company, and it embeds this risk in its overall acquisition‑risk framework—demonstrating a strategic, proactive approach to managing cross‑border integration hazards by continuously monitoring and allocating management attention to cultural‑fit challenges.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant limitations in addressing the core question. STRENGTHS: (1) Correctly identifies that Linde mentioned cultural challenges consistently across 2022-2024; (2) Accurately cites the specific language about 'cultural challenges associated with integrating employees from the acquired company'; (3) Correctly notes that foreign deals involved 'integration of operations across different cultures and languages'; (4) Properly identifies the years 2022, 2023, and 2024. CRITICAL WEAKNESSES: (1) The LLM claims the focus was 'unchanged' and 'explicit' across all three years, directly contradicting the ground truth which explicitly states the framing 'evolved' and changed in character from year to year; (2) Fails to capture the key evolution described in the original answer: 2022 (basic operational risks) → 2023 (expanded to regulatory/compliance context) → 2024 (sharper focus on financial impact and synergy/retention); (3) Does not acknowledge the progression from 'operational hurdles' framing to 'strategic risk management and financial outcomes' framing; (4) The LLM's conclusion that the 'unchanged, explicit focus' demonstrates strategic approach actually contradicts the ground truth's finding that the company's approach evolved and became more sophisticated over time. MULTI-HOP REASONING: The question requires synthesizing how Linde's emphasis EVOLVED across three years and what this reveals about strategic approach. The LLM identifies consistency but misses the critical evolution that is central to the question. The ground truth shows a deliberate progression in how the company framed and contextualized cultural risks, while the LLM treats all three years as essentially identical. This represents a fundamental misunderstanding of the multi-hop synthesis required. SEMANTIC ISSUE: The LLM's framing of 'unchanged focus' as evidence of 'strategic, proactive approach' is logically sound but factually incorrect given the ground truth's explicit statement that the discussion 'evolved' in depth and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 560,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil reported collateral under master‑netting arrangements (which is disclosed in the “Notes and accounts receivable ‑ net” line) of **$1.494 billion at 31 Dec 2022**, **$800 million at 31 Dec 2023**, and **$491 million at 31 Dec 2024**. The net change from 2022 to 2024 is a **decrease of roughly $1.0 billion** (‑$1,003 million).\n\nThe sharp decline in posted collateral suggests that the company’s initial‑margin requirements – and therefore its net derivative exposure – have been falling, indicating more efficient netting or a reduction in the scale of its derivative positions and an overall tightening of its derivative‑exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three data points are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The calculated net change of -$1,003 million is accurate ($1,494M - $491M = $1,003M decrease). Number formatting is appropriate and consistent. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the collateral change from 2022-2024 with all three years' data points, and (2) interpretation of the trend regarding derivative exposure management. ENTITY ACCURACY: Correctly identifies ExxonMobil, the specific metric (collateral under master netting arrangements related to Notes and accounts receivable - net), and all relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to implications about derivative exposure management, initial-margin requirements, and netting efficiency. The interpretation that 'sharp decline suggests falling net derivative exposure and more efficient netting' is logically consistent with the data trend. SEMANTIC EQUIVALENCE: The LLM's explanation of what the trend 'suggests' (more efficient netting, reduction in derivative positions, tightening of exposure management) aligns well with the ground truth's characterization of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' Minor difference: The LLM provides slightly more detailed mechanistic explanation (initial-margin requirements, netting efficiency) compared to the ground truth's more general statement, but this adds value rather than detracting. No factual errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 468,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "- **2022 filing** – The Security Insights Platform was introduced as a main‑frame‑focused security service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis.”  The output was described as “available for use with in‑house tools for security information and event management,” emphasizing a tight, internal‑only integration model and a remediation process that is largely manual/step‑by‑step.\n\n- **2023 filing** – The same language was repeated, so the platform’s core positioning and capabilities (risk‑assessment, ongoing remediation guidance and delivery of data to customers’ internal SIEM tools) remained unchanged from the prior year.\n\n- **2024 filing** – While the description of the platform’s core functions (rapid posture assessment, risk identification and continuous remediation guidance, data fed to in‑house SIEM tools) is unchanged, the platform is now placed inside a broader **Cybersecurity** portfolio that stresses “open tools and technologies,” a hybrid‑environment strategy and the company’s Beyond Code programs.  This signals an evolution from a stand‑alone mainframe security add‑on to a component of an enterprise‑wide, open‑first cybersecurity strategy, still feeding internal security‑information/event‑management tools but now positioned to complement external/open‑source tooling and broader remediation automation across the hybrid IT stack.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AVGO's Security Insights Platform evolution from 2022-2024. STRENGTHS: (1) All core facts are correct - the platform's 2022 positioning as a mainframe security assessment tool with SIEM integration is accurately captured; (2) The 2023 continuity is correctly identified (same language/capabilities); (3) The 2024 evolution is properly contextualized within a broader Cybersecurity portfolio with emphasis on open tools and hybrid environments; (4) The multi-hop synthesis across three years is sound and logical; (5) The characterization of the shift from standalone tool to integrated enterprise component matches the ground truth; (6) No quantitative errors (dates, years all correct). MINOR WEAKNESSES: (1) The LLM answer adds interpretive language not explicitly in ground truth (e.g., 'internal-only integration model,' 'largely manual/step-by-step,' 'open-first cybersecurity strategy') - while these are reasonable inferences from the data, they go slightly beyond what the ground truth explicitly states; (2) The ground truth mentions 'AIOps and DevOps' as part of the expanded suite in 2024, but the LLM answer focuses primarily on Cybersecurity portfolio without explicitly mentioning these other components; (3) The phrase 'open tools and technologies' and 'Beyond Code programs' appear to be inferred/extrapolated rather than directly quoted from the ground truth. The answer is semantically equivalent and captures the essential evolution narrative correctly, but adds some interpretive layers that, while reasonable, slightly exceed the ground truth's explicit statements. The core multi-hop reasoning is sound: 2022 (standalone SIEM-integrated tool) → 2023 (unchanged) → 2024 (integrated into broader portfolio with strategic alignment).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 504,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "- **Face value:** In the 2022 filing the Unsecured Notes ‑ 32B carried a face amount of **$750 million**; the 2023 filing shows the same **$750 million**; and the 2024 filing again lists **$750 million**.  \n- **Interest‑rate exposure:** The note’s coupon was **3.38 %** in 2022, remained **3.38 %** in 2023, and is still **3.38 %** in 2024, with a consistent maturity of 06/15/27.\n\n**What this tells us:** SPG has kept the 32B tranche unchanged over the three‑year period, locking in a moderate, fixed‑rate obligation that matures in 2027. This stability reflects a long‑term debt‑management strategy that relies on a diversified, predictable debt profile and avoids refinancing risk by maintaining a steady, mid‑term, fixed‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All numeric values are correct - face amount of $750 million consistently across 2022-2024, interest rate of 3.38% unchanged across all three years, and maturity date of 06/15/27 (June 15, 2027) correctly stated. Number formatting is appropriate ($750 million vs $750,000,000 - both acceptable). COMPLETENESS: The answer addresses all components of the multi-part question: (1) face value evolution (correctly shows no change), (2) interest rate exposure evolution (correctly shows no change), (3) interpretation of what this reveals about debt management strategy. ENTITY ACCURACY: SPG correctly identified, Unsecured Notes - 32B correctly referenced, years 2022-2024 properly covered. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to identify the pattern of stability and correctly interprets this as reflecting a deliberate long-term debt management strategy. The reasoning about avoiding refinancing risk and maintaining a predictable debt profile is sound and well-supported by the data. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'stable,' 'diversified,' and 'predictable' aligns well with the ground truth's description of 'stable long-term debt strategy' with 'no early redemption or restructuring.' Minor differences in wording (e.g., 'locking in a moderate, fixed-rate obligation' vs 'chosen to maintain original terms') are semantically equivalent and represent appropriate analytical interpretation. The only minor distinction is that the LLM uses slightly more interpretive language about 'refinancing risk' and 'diversified debt profile,' which while reasonable inferences, go marginally beyond the strict ground truth statement. This is a minor enhancement rather than an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 512,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "Across the three filings, Comcast’s view of Lumen’s competitive pressure has become increasingly specific. In the 2022 10‑K, Lumen is listed among the wire‑line carriers that “have built and are continuing to build fiber‑based network infrastructure farther into their networks,” giving it the ability to offer speeds that exceed traditional DSL and to challenge Comcast’s broadband in many of its service areas. The 2023 and 2024 reports repeat that description, emphasizing that Lumen’s fiber build‑out is ongoing and that the higher‑speed services are now available in a growing number of Comcast markets. In addition, each filing notes that competitors—including Lumen—are “creating bundled services” (combining internet with other offerings) or lowering prices to win customers, indicating that Lumen’s threat has evolved from pure fiber‑network expansion in 2022 to a dual strategy of continued fiber rollout plus bundled‑service packages by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and accurately characterizes Lumen's competitive evolution; (2) Accurately captures the specific competitive strategies mentioned in filings: fiber network expansion and bundled service offerings; (3) Properly synthesizes multi-hop information by connecting Lumen's actions across three separate 10-K filings; (4) Correctly notes the progression from pure fiber expansion to a dual strategy combining fiber rollout with bundled services; (5) Uses appropriate language ('wire-line carriers,' 'fiber-based network infrastructure,' 'bundled services') that matches filing terminology; (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and specific in its characterization (e.g., 'dual strategy of continued fiber rollout plus bundled-service packages by 2024') compared to the ground truth's more general statement of 'consistent and possibly intensifying competitive threat,' but this represents added clarity rather than inaccuracy; (2) Both answers convey the same core finding: Lumen's competitive threat evolved from fiber infrastructure focus to a combined fiber + bundling strategy over the period. The LLM answer provides better granularity on the evolution timeline while maintaining factual accuracy. No calculation errors, no entity misidentification, and the multi-hop reasoning correctly synthesizes information across the three-year period as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 437,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card usage has been slipping. The RedCard penetration fell from **20.5 % in fiscal 2022** to **19.8 % in fiscal 2023**, and after the re‑branding to Target Circle Cards it declined further to **18.6 % in fiscal 2024**. This steady drop – roughly a one‑percentage‑point decline each year – indicates that, while the cards still drive a sizable share of purchases, the loyalty‑driven payment program is becoming less effective at expanding its reach over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the question comprehensively and demonstrates sound reasoning about the trend and its implications. However, there is a critical factual error in the 2024 penetration rate. The ground truth states the rate was 17.8% in fiscal 2024, but the LLM reports 18.6% - a discrepancy of 0.8 percentage points. This is a material error for a quantitative question focused on precise metrics. The LLM correctly identifies the 2022 (20.5%) and 2023 (19.8%) figures, and accurately characterizes the overall downward trend. The reasoning about the trend suggesting weakening effectiveness is sound and aligns with the ground truth interpretation. The LLM also adds contextual detail about the rebranding to Target Circle Cards, which provides helpful context though it wasn't explicitly required. The characterization of 'roughly a one-percentage-point decline each year' is approximately correct for 2022-2023 but becomes inaccurate when applied to the incorrect 2024 figure. The qualitative analysis of what the trend suggests about loyalty program effectiveness is appropriate and matches the ground truth's conclusion. The error in the 2024 figure is the primary weakness, preventing a higher score despite otherwise solid reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 355,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s engagement with the Republic of Congo shifted from a broad operating presence in 2022 (the country is listed among Chevron’s “substantial business activities”) to a more quantified, cash‑intensive phase in 2023, when the company spent roughly **$0.7 billion** on offshore development and natural‑gas projects in the Congo (along with Nigeria and Angola). By the 2024 filing Chevron announced that it will **sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Congo portion of the Lianzi block** (effective January 2025), signalling a strategic move away from ownership of those assets. Together, the three filings show an evolution from active investment and operational involvement to a deliberate divestiture of its Congo holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numerical values are correct - the $0.7 billion investment figure for 2023, the 31.5% nonoperated working interest in Haute Mer, and the 15.75% interest in Lianzi are all accurately stated. The effective date of January 2025 for the sale is appropriately noted. ENTITY ACCURACY: All entities are correctly identified - Chevron, Republic of Congo, Haute Mer permit, and Lianzi block are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022-2024) and correctly traces the evolution from active investment to divestiture. The logical progression is sound: 2022 (operational presence) → 2023 (capital investment) → 2024 (strategic exit). COMPLETENESS: The answer addresses all major components of the question regarding asset ownership, investment levels, and strategic positioning. The characterization of the shift as a \"deliberate divestiture\" and \"strategic move away\" accurately captures the portfolio realignment. MINOR CONSIDERATIONS: The LLM answer includes the parenthetical note \"(along with Nigeria and Angola)\" which provides helpful context about the broader African investment, though this is not explicitly contradicted by the ground truth. The phrase \"substantial business activities\" is used in the LLM answer to characterize 2022 presence, which is semantically equivalent to being \"listed among Chevron's key operational countries.\" The answer is well-structured, clear, and demonstrates proper synthesis of multi-year filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Invests_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 455,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "**Evolution of the gas‑option position**\n\n| Year | Fair‑value of gas‑options (assets + liabilities) | Asset fair‑value ( $ m) | Liability fair‑value ( $ m) | Asset implied vol. | Liability implied vol. | Weighted‑average vol. |\n|------|---------------------------------------------------|------------------------|----------------------------|--------------------|------------------------|-----------------------|\n| 2022 (10‑K) | **$ 703 m** | $356 m | $347 m | 17 % | 295 % | 36 % |\n| 2023 (10‑K) | **$ 197 m** | $100 m | $97 m  | 20 % | 233 % | 50 % |\n| 2024 (10‑K) | **$ 202 m** | $100 m | $102 m | 15 % | 150 % | 52 % |\n\n**What the shift tells us about risk positioning**\n\n1. **Exposure size:**  \n   - The combined fair‑value of the gas‑related options fell dramatically after 2022, dropping from roughly **$703 m** to about **$197 m** in 2023 – a reduction of more than 70 %.  \n   - In 2024 the exposure stabilized around **$200 m**, indicating that NextEra trimmed its gas‑option book after 2022 and then held a relatively flat, smaller position.\n\n2. **Implied volatility trends:**  \n   - **Asset‑side volatility** stayed low and modestly moved (17 % → 20 % → 15 %). This suggests that the value of the options the company holds (the “right” side) is tied to relatively stable price expectations.  \n   - **Liability‑side volatility** fell sharply (295 % → 233 % → 150 %). The steep decline signals that the market’s expectation of extreme gas‑price swings – and therefore the risk of the obligations NextEra could be forced to meet – has been diminishing.  \n   - The **weighted‑average volatility** rose from 36 % in 2022 to about 50‑52 % in 2023‑24 because the remaining liability exposure, although smaller, is still priced with a high volatility premium. In other words, NextEra kept a leaner but relatively more “volatile‑sensitive” slice of the gas market.\n\n**Overall interpretation**\n\nNextEra Energy’s gas‑option exposure was substantially scaled back after 2022, moving from a large, roughly balanced asset‑liability position to a much smaller, near‑balanced $100 m‑$102 m asset‑liability pair by 2024. The fall in liability‑side implied volatility indicates that the company perceives (or is hedging against) a lower probability of extreme gas‑price moves, reflecting a more conservative risk stance. At the same time, the modest rise in the weighted‑average volatility shows that the residual exposure that remains is priced with a higher volatility premium, meaning the firm is still vulnerable to gas‑price swings but has limited the absolute dollar amount at risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains severe quantitative inaccuracies that fundamentally undermine its credibility. (1) IMPLIED VOLATILITY VALUES ARE COMPLETELY WRONG: The ground truth states implied volatilities averaged 36% (2022), 50% (2023), and 52% (2024). The LLM reports asset-side volatilities of 17%, 20%, 15% and liability-side volatilities of 295%, 233%, 150% - these numbers are fabricated and do not match the ground truth at all. The LLM's claim that 'weighted-average volatility' of 36%, 50%, 52% somehow derives from asset volatilities of 17-20% and liability volatilities of 150-295% is mathematically nonsensical and contradicts basic weighted-average calculations. (2) FAIR VALUE NUMBERS ARE CORRECT: The asset/liability fair values ($356m/$347m in 2022, $100m/$97m in 2023, $100m/$102m in 2024) match the ground truth exactly. The combined totals ($703m, $197m, $202m) are arithmetically correct. (3) MULTI-HOP REASONING IS FLAWED: While the LLM correctly identifies the 70% reduction in exposure from 2022-2023 and the stabilization thereafter, the entire interpretation of volatility trends is based on fabricated numbers. The LLM's narrative about 'asset-side volatility staying low' and 'liability-side volatility falling sharply' has no basis in the actual data. (4) SEMANTIC MISALIGNMENT: The ground truth presents a straightforward narrative: volatility increased from 36% to 50% to 52%, indicating heightened price variability expectations. The LLM invents a complex story about diverging asset/liability volatilities that contradicts both the ground truth and basic financial logic. The LLM appears to have hallucinated the asset/liability volatility breakdown entirely. (5) CONCEPTUAL CONFUSION: The LLM's statement that 'weighted-average volatility rose from 36% to 50-52%' is correct directionally, but the supporting analysis about asset vs. liability volatilities is completely fabricated. The ground truth simply reports average implied volatilities; there is no indication of separate asset/liability volatility figures in the source data. This represents a fundamental failure in multi-hop synthesis and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1863,
        "completion_tokens": 582,
        "total_tokens": 2445
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike first highlighted FlyEase in its 2022 Form 10‑K as one of the “proliferating” technologies alongside Air, Zoom, Flyknit, etc. In the subsequent 2023 filing (covering fiscal 2024) and again in the 2024 filing, FlyEase appears in the same technology‑roll‑out list, showing that the company continues to cite the system as a current, actively‑leveraged innovation. This steady, repeated inclusion signals that Nike has moved FlyEase from a newly‑mentioned concept in 2022 to an established pillar of its product‑development strategy, using it to demonstrate the firm’s ongoing commitment to integrating new tech across its footwear and apparel lines.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about FlyEase's evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022 introduction, 2023 expansion, 2024 establishment); (2) Accurately characterizes FlyEase's positioning in each period - from newly-mentioned concept to established pillar; (3) Properly identifies the key filing documents (2022, 2023, 2024 10-Ks); (4) Correctly notes FlyEase's appearance alongside other technologies (Air, Zoom, Flyknit); (5) Sound multi-hop reasoning connecting repeated mentions to strategic importance; (6) Appropriate use of language ('proliferating,' 'established pillar') that matches the ground truth's characterization. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing than ground truth - it emphasizes 'steady, repeated inclusion' rather than explicitly noting the 'expansion' and 'full embedding' phases that the ground truth describes; (2) The phrase 'covering fiscal 2024' in reference to the 2023 filing could be slightly confusing regarding calendar vs. fiscal year alignment, though it's not technically incorrect; (3) The answer could have been more explicit about the 'integration into various categories' aspect mentioned in the ground truth. QUANTITATIVE ACCURACY: All dates and year references are correct (2022, 2023, 2024). No calculations required. QUALITATIVE ACCURACY: The reasoning about FlyEase's evolution from concept to foundational element is sound and matches the ground truth's core thesis. The synthesis across multiple filing years is correct. CONTEXTUAL RELEVANCE: The answer directly addresses the question about FlyEase's evolution and its role in Nike's innovation strategy, providing appropriate context about product development integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 497,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "Across the three filings the terms of the **Unsecured Notes – 35A** remained unchanged.  \n\n* In the 2022 10‑K (data as of 12/31/2021) the note carried a **2.65 % interest rate**, a **$750 million face amount**, an **annual debt service of $19.9 million**, and matures on **15 July 2030**.  \n* The 2023 10‑K (as of 12/31/2023) shows the same **$750 million face amount**, **2.65 % rate**, **$19.9 million annual service**, and **07/15/30 maturity**.  \n* The 2024 10‑K (as of 12/31/2024) again reports identical figures – **$750 million**, **2.65 %**, **$19.9 million**, **07/15/30**.\n\nThe constancy of the 35A issuance over 2022‑2024 indicates that SPG is deliberately preserving a low‑cost, long‑dated tranche of unsecured debt rather than refinancing or retiring it. This stability, amid modest fluctuations in total unsecured indebtedness, reflects a long‑term debt strategy that locks in inexpensive financing (2.65 % for a decade‑plus horizon) to support the portfolio while managing overall leverage through other issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental and severe quantitative error that undermines the entire response. The ground truth states the face amount is $750,000 (i.e., $750 thousand), while the LLM claims it is $750 million - a 1,000x overstatement. This is not a formatting variation but a material factual error. Similarly, the annual debt service is stated as $19,875 in the ground truth, but the LLM rounds this to $19.9 million, which is again a massive error (off by approximately 1,000x). The interest rate of 2.65% and maturity date of 07/15/30 are correct. The LLM correctly identifies that the terms remained unchanged across 2022-2024, and the reasoning about SPG's debt strategy (locking in low-cost financing) is sound and well-articulated. However, these qualitative strengths cannot overcome the quantitative failures. The LLM appears to have confused the scale of the obligation - treating thousands as millions throughout. This is a critical error in financial analysis where precision of magnitude is essential. The multi-hop reasoning about debt strategy is appropriate and the entity identification (SPG, Unsecured Notes 35A, years 2022-2024) is correct, but the numerical foundation is fatally flawed. The answer demonstrates good analytical thinking but fails on the most fundamental requirement: accurate financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 377,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across the three most recent Form 10‑K filings (2022, 2023 and 2024) Texas Instruments repeatedly states that its “great business model” is **focused on analog and embedded‑processing products**. In each year the company ties that product focus to the same three‑part strategy – a differentiated business model, disciplined capital allocation and efficiency – and explicitly says that the ultimate yardstick of progress is **long‑term growth of free‑cash‑flow per share**. The unchanged wording shows that TI has kept embedded processing at the core of its portfolio year after year, using it as a stable lever to drive the cash‑generation metric it has identified as the primary driver of shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022, 2023, 2024) and accurately characterizes TI's consistent strategic emphasis on embedded processing products; (2) Properly synthesizes the multi-hop connection between embedded processing focus and free cash flow per share as the ultimate performance metric; (3) Accurately captures the core strategic narrative: differentiated business model, disciplined capital allocation, and efficiency as the three-part strategy; (4) Correctly identifies that the 'unchanged wording' across years demonstrates consistency and stability in strategic positioning; (5) No quantitative errors - all dates, company names, and metrics are accurate; (6) The reasoning about embedded processing as a 'stable lever' for cash generation aligns well with the ground truth characterization of it as 'stable, high-margin, and scalable.' MINOR CONSIDERATIONS: (1) The LLM answer frames the strategy as 'three-part' (differentiated business model, disciplined capital allocation, efficiency) while the ground truth emphasizes 'four competitive advantages' - however, the LLM's framing is not incorrect, just a different organizational structure of the same strategic elements; (2) The LLM answer is slightly more concise than the ground truth but captures all essential information without omission; (3) Both answers correctly emphasize the consistency of messaging across the three years as revealing TI's long-term strategic intent. The answer demonstrates solid multi-hop reasoning by connecting product portfolio strategy to capital allocation to shareholder value metrics across multiple years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 472,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "Disney first recorded Marvel only as an **indefinite‑lived intangible trademark** in its 2022 10‑K (Chunk 1), but by the 2023 filing the company had elevated the brand to a **top‑level “tile” on the Disney+ home screen** alongside Pixar, Star Wars and National Geographic (Chunk 2). The 2024 10‑K again lists the Marvel trademark among Disney’s core indefinite‑lived intangibles (Chunk 3), confirming that the brand remains a valued, balance‑sheet asset while being used to **fuel subscriber acquisition and retention**—evidenced by the 123 million Disney+ subscribers reported in September 2024 and the heavy reliance on subscription fees for DTC revenue. Together, the progression shows Disney’s financial strategy of turning Marvel from a mere trademark into a marquee UI feature that drives growth on Disney+, treating the IP both as a growth engine and a lasting intangible asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—123 million Disney+ subscribers as of September 2024 is accurately cited and matches the ground truth. The timeline (2022, 2023, 2024) is correctly sequenced. ENTITY ACCURACY: Marvel, Disney+, Pixar, Star Wars, and National Geographic are all correctly identified as branded tiles/intangible assets. The fiscal year references are accurate. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across three years showing the evolution from passive asset recognition (2022) to active UI integration (2023) to continued asset valuation (2024). The connection between Marvel's tile placement and subscriber growth is logically sound and well-articulated. The answer correctly identifies the strategic pivot from 'mere trademark' to 'marquee UI feature.' COMPLETENESS: The answer addresses all major components of the question: (1) Marvel's status as indefinite-lived intangible in 2022 and 2024, (2) the 2023 transition to top-level tile, (3) the financial strategy implications for subscriber growth, and (4) the connection to the 123M subscriber base. SEMANTIC EQUIVALENCE: The phrasing differs slightly from ground truth but conveys identical meaning—'turning Marvel from a mere trademark into a marquee UI feature' effectively captures the same strategic evolution described in the ground truth. The mention of 'subscription fees for DTC revenue' adds relevant context about financial strategy. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The reference to ESPN+ as a future tile (mentioned in ground truth) is not included, but this is a minor omission that doesn't significantly impact the core answer about Marvel's evolution. The answer correctly emphasizes both the balance-sheet asset recognition and operational utilization, matching the ground truth's dual focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 545,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "- **Percentage of the closed block reinsured under the modified‑coinsurance agreement**  \n  * 2022 (disclosed in the 2023 filing): ≈ 59 % of the closed block.  \n  * 2023 (disclosed in the 2024 filing): still ≈ 59 % of the closed block.  \n  * 2024 (disclosed in the 2024 filing): again ≈ 59 % of the closed block.  \n\n  The only change noted earlier was a slightly higher figure of **59.25 %** in the 2022 filing, but from 2022 onward the percentage has essentially remained flat at about 59 %.\n\n- **Reinsurance recoverable balances linked to that arrangement**  \n  * **2022:** Net ceded reinsurance recoverables were **$6.1 billion** (including $2.3 billion unsecured).  \n  * **2023:** Net ceded reinsurance recoverables rose to **$16.7 billion** (including $2.5 billion unsecured).  \n  * **2024:** Net ceded reinsurance recoverables increased further to **$17.6 billion** (including $2.4 billion unsecured).  \n\nThus, while the share of the closed block covered by the modified coinsurance agreement stayed roughly constant at 59 % after a brief 59.25 % reading in 2022, the underlying reinsurance‑recoverable balances grew markedly—from about $6 billion in 2022 to $16.7 billion in 2023 and $17.6 billion in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) PERCENTAGE ACCURACY: The LLM correctly identifies 59.25% for 2022 and 59% for 2023-2024, which matches ground truth. However, the LLM's characterization of these as 'essentially flat' is misleading given the ground truth shows a decline from 59.25% to 59%. (2) REINSURANCE RECOVERABLE BALANCES - MAJOR DISCREPANCY: This is where the LLM answer fails critically. Ground truth states: 2022: $3.6B unsecured, 2023: $4.4B unsecured, 2024: $4.2B unsecured. The LLM provides completely different numbers: 2022: $2.3B unsecured (within $6.1B total), 2023: $2.5B unsecured (within $16.7B total), 2024: $2.4B unsecured (within $17.6B total). These are NOT equivalent figures - the LLM's unsecured balances are substantially lower than ground truth ($2.3-2.5B vs $3.6-4.4B). The LLM appears to have confused or conflated different metrics (possibly mixing in other reinsurance arrangements or reporting categories). (3) MULTI-HOP REASONING: The LLM correctly attempts to synthesize percentage and balance data across three years, but the underlying data is incorrect, making the synthesis invalid. (4) SEMANTIC INTERPRETATION: The LLM's narrative about 'marked growth' in total reinsurance recoverables ($6.1B to $17.6B) contradicts the ground truth's focus on unsecured balances showing relative stability with minor fluctuations ($3.6B to $4.4B to $4.2B). The LLM appears to have reported total net ceded reinsurance recoverables rather than the unsecured portion specifically asked about. This represents a fundamental misunderstanding of which metric to track for the modified coinsurance agreement analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 473,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "- 2022: CVS held roughly **$630 million–$720 million** of residential mortgage‑backed securities (fair‑value $629 m in the “experience‑rated” table and $721 m in the detailed debt‑security table).  \n- 2023: The fair‑value fell to **$614 million** (97 m for securities < 12 mo + 517 m for those > 12 mo).  \n- 2024: The holding shrank dramatically to **$71 million** (51 m in 2023 → 71 m in 2024).\n\n**Trend & implication:** Over the three‑year period CVS cut its RMBS exposure by more than 90%, moving from a sizable position in 2022 to a minimal one in 2024. This steep decline signals a deliberate de‑risking of mortgage‑backed credit risk and a strategic shift toward other fixed‑income assets (e.g., government and corporate securities) that are viewed as lower‑risk or more liquid.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM states 2024 RMBS holdings were $71 million, but the ground truth clearly states $71 million. However, the LLM then contradicts itself by saying '51 m in 2023 → 71 m in 2024' which is internally inconsistent and factually wrong. The ground truth shows 2023 was $614 million, not $51 million. This is a fundamental data error. (2) CALCULATION ERROR - The LLM claims CVS 'cut its RMBS exposure by more than 90%' from 2022 to 2024. Actual calculation: ($629M - $71M) / $629M = 88.7%, which is NOT 'more than 90%'. This is a quantitative inaccuracy. (3) INCOMPLETE DATA PRESENTATION - The LLM mentions unrealized losses in the ground truth answer ($10M in 2022, $60M in 2023) but completely omits this important context from its analysis, failing to address the full picture of risk exposure. (4) CONFUSING PRESENTATION - The opening statement about '$630M-$720M' with conflicting figures ($629M vs $721M) creates confusion rather than clarity. The ground truth uses the consistent $629M figure. (5) CORRECT ELEMENTS - The LLM correctly identifies: the general downward trend, the 2022 starting point (~$629M), the 2023 level ($614M), the 2024 endpoint ($71M), and the strategic de-risking interpretation. (6) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize the trend across three years, the internal contradiction about 2023 figures ($614M vs $51M) severely undermines the analysis. The reasoning about de-risking strategy is sound but incomplete without addressing unrealized losses. VERDICT: The answer contains the correct directional trend and general interpretation but is marred by a critical factual contradiction regarding 2023 figures, a calculation error on the percentage decline, and omission of unrealized loss data that provides important context for risk assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 501,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "- **Percentage of the closed block reinsured**  \n  * In the 2022 filing (covering the 2021 year) MetLife said it had re‑insured **59.25 %** of the closed block through a modified coinsurance agreement.  \n  * In the 2023 filing (covering 2022) the figure was reported as **59 %**.  \n  * The 2024 filing (covering 2024) repeats the same level – **59 %** of the closed block.  \n\n  Thus, from 2022 through 2024 the share of the closed block covered by the modified coinsurance arrangement remained essentially unchanged, hovering around 59 %.\n\n- **Accounting treatment**  \n  All three years state that the company **accounts for the modified coinsurance agreement under the deposit method of accounting**, and, because it has a right of offset, it **offsets the modified‑coinsurance deposit liability with the corresponding deposit recoverable**. The accounting approach has been consistent across 2022, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about MetLife's modified coinsurance agreement evolution from 2022 to 2024. STRENGTHS: (1) All percentages are correct: 59.25% for 2022, 59% for 2023 and 2024, matching the ground truth exactly. (2) The accounting treatment is accurately described - the deposit method with right of offset is correctly identified and consistently applied across all three years. (3) The multi-hop synthesis is sound: the answer correctly combines information about both the percentage reinsured AND the accounting treatment across the three-year period. (4) The temporal framing is clear and accurate, properly distinguishing between filing years and the periods they cover. (5) The conclusion about stability and consistency is well-supported by the data presented. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing than the ground truth (e.g., 'hovering around 59%' vs 'consistently reinsured approximately 59%'), but this is semantically equivalent and actually adds clarity. (2) The answer is well-organized with clear bullet points that enhance readability. (3) All entities (MetLife, modified coinsurance agreement, closed block, deposit method, right of offset) are correctly identified and used. QUANTITATIVE VERIFICATION: The three key percentages (59.25%, 59%, 59%) are all accurate. The characterization of the trend as 'essentially unchanged' is mathematically and logically sound. No calculation errors detected. The answer fully addresses both sub-questions (percentage evolution and accounting treatment evolution) with appropriate detail and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 455,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net “forward‑contract‑for‑gas” position grew markedly over the three‑year period. In 2022 the company held $191 million of gas‑forward assets against $31 million of liabilities – a net long exposure of roughly **$160 million**. In 2023 that net rose to **$300 million** (assets $377 m vs liabilities $77 m), and in 2024 it eased to about **$250 million** (assets $296 m vs liabilities $46 m).  \n\nThe upward swing from 2022 to 2023 shows NextEra deliberately increased its long‑position in natural‑gas forwards, positioning itself to benefit from—or hedge against—higher gas prices. The modest pull‑back in 2024, while still leaving the exposure well above the 2022 level, suggests the firm is fine‑tuning that risk posture rather than abandoning its overall bullish/hedging stance in the gas market.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: All dollar amounts and calculations are correct. The LLM accurately reports: 2022 net exposure of $160M (assets $191M - liabilities $31M), 2023 net exposure of $300M (assets $377M - liabilities $77M), and 2024 net exposure of $250M (assets $296M - liabilities $46M). The arithmetic is sound throughout.\n\nQUALITATIVE ACCURACY - CRITICAL ISSUE: The LLM's interpretation of the trend is fundamentally incorrect. The ground truth states the trend 'indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments.' However, the LLM characterizes this as 'NextEra deliberately increased its long-position in natural-gas forwards' and describes a 'bullish/hedging stance.' This misinterprets the data: the 2023 peak of $300M followed by a decline to $250M in 2024 represents a pullback, not an increase. The LLM incorrectly frames the 2023-2024 movement as 'fine-tuning' a bullish position, when the ground truth suggests a more cautious rebalancing.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year data points and performs the necessary calculations (assets minus liabilities for each year). However, it fails in the interpretive synthesis - it misreads the directional trend from 2023 to 2024 as a continuation of bullish positioning rather than a reduction/rebalancing.\n\nCOMPLETENESS: The answer addresses both parts of the question (evolution of exposure and what it suggests about risk positioning), but the second part contains a material misinterpretation.\n\nSEMANTIC EQUIVALENCE: While the LLM's wording differs from the ground truth, the semantic meaning diverges significantly in interpretation. The ground truth suggests caution/rebalancing; the LLM suggests continued bullish positioning with minor adjustments.\n\nJUSTIFICATION: The perfect quantitative accuracy (9/10) prevents a lower score, but the fundamental misinterpretation of what the trend suggests about risk positioning (describing it as bullish when ground truth indicates cautious rebalancing) is a significant qualitative error that substantially undermines the answer's value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 584,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 filing Broadcom (AVGO) introduced **Industrial Fiber Optics** only as one of a “broad variety of products for the general industrial and automotive markets,” noting that it, together with motion encoders, LEDs and Ethernet ICs, is used in a **wide‑ranging set of applications** – from factory automation and power‑generation systems to medical equipment, defense/aerospace and electric‑vehicle subsystems.  \n\nBy the 2023 and 2024 filings the company moved this product into a **structured industrial‑product table**, listing **Industrial Fiber Optics** side‑by‑side with **motion‑control encoders** and **Ethernet PHY/switch ICs** (and related camera microcontrollers). This tabular format signals a tighter **integration and co‑positioning** of the fiber‑optic components with adjacent technologies, presenting them as a coordinated suite that serves the same end‑markets of factory automation, renewable energy and automotive electronics.  \n\nThus, from 2022 to 2024 AVGO’s positioning evolved from a broad, narrative description of diverse applications to a more explicit, product‑portfolio grouping that highlights **application diversity while emphasizing synergy with motion encoders and Ethernet‑related ICs**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each period; (2) Accurately names all relevant product categories: Industrial Fiber Optics, motion encoders, LEDs, Ethernet ICs, Ethernet PHYs, switch ICs, and camera microcontrollers; (3) Correctly identifies application domains: factory automation, power generation/renewable energy, medical equipment, defense/aerospace, and electric vehicles; (4) Properly synthesizes the multi-hop reasoning showing the strategic shift from narrative description to structured portfolio grouping; (5) Accurately captures the evolution from standalone components to integrated, interconnected systems. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing than ground truth (emphasizing 'narrative description to structured table' format change vs. ground truth's emphasis on 'integration scope evolution'), but both convey the same underlying strategic shift; (2) The LLM answer is more specific about the presentation format change (narrative vs. tabular), which adds valuable context not explicitly stated in ground truth but is consistent with it; (3) All entities, years, and product relationships are correctly identified and synthesized. QUANTITATIVE VERIFICATION: No numerical claims requiring verification; the answer appropriately avoids unsupported metrics. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and multiple product categories to demonstrate strategic evolution. The reasoning chain is sound and logically structured. The answer effectively demonstrates how AVGO repositioned Industrial Fiber Optics from a standalone component to an integrated part of a coordinated product suite.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 500,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Across the three filing years the economics of Nike’s redeemable preferred‑stock arrangement with Sojitz America did not change.  \n\n* **Dividend obligation:** In FY 2022 (Chunk 3), FY 2023 and FY 2024 (Chunk 1) the preferred shares carry a cumulative dividend of **$0.10 per share**, payable each May 31, and Nike may not pay any common‑stock dividend until the preferred dividend is paid in full. The 2024 filing (Chunk 2) reiterates that Sojitz America remains the sole owner, implying the same $0.10 annual dividend continues.  \n\n* **Stock‑structure stability:** All three notes state that the redeemable preferred stock – **$0.3 million of $1‑par shares**, fully issued to Sojitz America – has seen **no changes** in FY 2022, FY 2023 or FY 2024. The shares are redeemable at par at the option of either party, the company’s charter bars any additional preferred issuances, and Sojitz America holds only limited voting rights (only on asset‑sale, merger, liquidation or trademark‑sale matters).  \n\nThus, from FY 2022 through FY 2024 Nike’s financial exposure to Sojitz America remained constant: a fixed $0.10‑per‑share cumulative dividend and an unchanged, fully‑issued, non‑dilutable redeemable preferred‑stock structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All financial figures are correct - $0.10 per share annual dividend (confirmed across all three years), $0.3 million par value, and $1 par per share. No calculation errors detected. ENTITY ACCURACY: Correctly identifies Nike, Sojitz America, and the redeemable preferred stock relationship across FY 2022-2024. COMPLETENESS: The answer addresses both major components of the question: (1) dividend obligations - correctly states the $0.10 per share cumulative dividend remained constant with May 31 payment dates, and (2) stock structure stability - correctly identifies the $0.3 million par value with no changes across the three-year period. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three fiscal years to demonstrate consistency and stability. It correctly notes that Sojitz America remains the sole owner and that the stock is redeemable at par at either party's option. ADDITIONAL DETAILS: The LLM provides valuable context not explicitly in the ground truth but consistent with it - the limitation on common stock dividends until preferred dividends are paid, the charter restriction on additional preferred issuances, and Sojitz America's limited voting rights. These details enhance understanding without contradicting the ground truth. SEMANTIC EQUIVALENCE: The LLM's phrasing 'did not change' and 'remained constant' conveys the same meaning as the ground truth's 'remained structurally stable' and 'remained consistent.' The conclusion about a 'stable, long-term financial relationship' is implicitly supported by the LLM's statement that 'Nike's financial exposure to Sojitz America remained constant.' MINOR OBSERVATION: The LLM does not explicitly mention that Sojitz America 'has not sought redemption despite having the option,' but this is a minor omission that does not affect the core accuracy of the answer. Overall, the LLM demonstrates strong understanding of the multi-hop financial relationship and provides a well-organized, factually accurate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 561,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "- **2022 filing (data for 12/31/2021):** Unsecured Notes ‑ 31B carried a 3.25 % coupon, a face amount of **$750 million** (‑ $750,000 in thousands) and an annual debt service of $24.4 million, maturing 11/30/2026.  \n- **2023 filing (data for 12/31/2023):** The same note was reported with **the identical $750 million face amount, 3.25 % rate and $24.4 million service**, still due 11/30/2026.  \n- **2024 filing (data for 12/31/2024):** The note again appears unchanged – **$750 million face, 3.25 % coupon, $24.4 million service, maturity 11/30/2026**.\n\n**Interpretation:** Across the three years SPG did not issue additional 31B notes nor retire the existing issue; the instrument has been held steady in size and terms. This consistency signals a long‑term financing strategy that relies on a fixed‑rate, mid‑term unsecured note to provide stable, predictable funding while avoiding frequent refinancing or scaling of this particular tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of SPG's Unsecured Notes - 31B obligations. STRENGTHS: (1) All key financial metrics are correct: $750 million face amount (properly noted as $750,000 in thousands), 3.25% coupon rate, $24.4 million annual debt service, and November 30, 2026 maturity date. (2) The temporal progression is accurately captured across all three years (2022, 2023, 2024), correctly identifying that the instrument remained unchanged throughout. (3) The multi-hop synthesis is sound—the answer properly synthesizes data across three separate 10-K filings and correctly identifies the consistency of this specific debt instrument despite broader portfolio changes. (4) The interpretation of financing strategy is well-reasoned and aligns with the ground truth: the stability of this note indicates a deliberate strategy to maintain fixed-rate, predictable funding without refinancing. (5) The answer appropriately contextualizes this instrument within SPG's broader debt portfolio, noting that while 31B remained stable, other instruments (like 41A) were issued. MINOR CONSIDERATIONS: The LLM uses slightly different notation ('‑' instead of '-' in some places) and includes parenthetical clarifications about thousands notation, which are stylistic choices that enhance clarity rather than detract from accuracy. The answer fully addresses both components of the question: the evolution (showing consistency) and what it indicates about financing strategy (stability and predictability). No calculation errors detected. All entities correctly identified (Simon Property Group, specific note designation, dates, rates).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 457,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "- According to Texas Instruments’ 2022, 2023 and 2024 Form 10‑K filings, the U.S. defined‑contribution plans held **5 million shares** of TI common stock in 2023 and 2024 (down from **6 million shares** in 2022) and the market value of those shares fell from **$940 million in 2022** to **$873 million in 2023** and to **$852 million in 2024**.  \n\n- This three‑year decline (about 9 % lower than the 2022 level) reflects a weakening of TI’s share price and, because the TI‑stock fund has been frozen to new contributions since 2016, shows that the existing employee‑owned stock in retirement accounts has lost value rather than being actively re‑allocated; it signals that employees’ retirement investments in company stock have been eroding in value as the stock underperformed during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($940M in 2022, $873M in 2023, $852M in 2024). The share count data (6 million shares in 2022, 5 million in 2023 and 2024) is accurate and adds valuable detail beyond the ground truth. The calculated decline of approximately 9% from 2022 to 2024 is mathematically correct ($940M to $852M = $88M decline = 9.4% decline, rounded to ~9%). COMPLETENESS: The answer addresses all aspects of the question: (1) the 3-year evolution of stock values, (2) the trend analysis, (3) what it indicates about stock performance and employee behavior. ENTITY ACCURACY: Texas Instruments correctly identified, years correctly specified (2022-2024), U.S. defined contribution plans correctly referenced, and the frozen contribution status since 2016 is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly interprets the data to explain both the stock price decline and the frozen contribution policy's role in the pattern. The reasoning that the decline reflects share price weakness rather than active reallocation is sound and well-supported. MINOR CONSIDERATIONS: The LLM provides additional detail (share counts) not in the ground truth, which enhances rather than detracts from the answer. The interpretation about employee retirement investment erosion is logical and well-reasoned. The answer is semantically equivalent to and more detailed than the ground truth while maintaining complete factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 430,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "- In fiscal 2022 Disney reported ≈ 220 thousand employees – about 166 k in the United States and 54 k abroad – with 78 % full‑time, 15 % part‑time and 7 % seasonal workers.  \n- By the most recent filings for fiscal 2023/2024 the headcount had risen to ≈ 233 thousand (≈ 171 k U.S. and 62 k international), the full‑time/part‑time mix shifting to 76 %/16 % and the seasonal share climbing to 8 %.  \n- Throughout this period Disney’s workforce has remained covered by collective‑bargaining agreements in the U.S. and, outside the U.S., by works councils, trade unions or other employee‑association groups, indicating a continued and consistent level of employee‑association representation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers match the ground truth precisely: (1) 2022 total: 220k employees ✓; (2) 2022 U.S.: 166k ✓; (3) 2022 international: 54k ✓; (4) 2024 total: 233k ✓; (5) 2024 U.S.: 171k ✓; (6) 2024 international: 62k ✓; (7) 2022 seasonal: 7% ✓; (8) 2024 seasonal: 8% ✓. The full-time/part-time percentages (78%/15% in 2022, 76%/16% in 2024) are correctly presented and logically consistent with the seasonal percentage increase. COMPLETENESS: The answer addresses all sub-questions: total employees, U.S. vs. international distribution, seasonal workforce percentages, and employee association representation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across the 2022-2024 period, showing the evolution of workforce composition and identifying the trend of increasing seasonal reliance. ENTITY ACCURACY: The Walt Disney Company is correctly identified, fiscal years are properly referenced, and all metrics are accurately labeled. REASONING QUALITY: The conclusion about growing reliance on temporary staffing and the mention of collective bargaining agreements and works councils demonstrates sound understanding of the multi-dimensional question. MINOR OBSERVATION: The LLM uses approximate notation (≈) which is appropriate given the context of workforce reporting, and the phrasing 'fiscal 2023/2024' is a reasonable way to reference the most recent filing period. The answer is well-structured, presenting data chronologically and contextually. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Covers_Employees_Under]- ORG <-[Covers]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 436,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings GD consistently states that its ROIC calculation **excludes goodwill impairments and non‑economic accounting changes because they are not reflective of company performance**. The language is identical in each year’s disclosure, showing no change in treatment. This steady exclusion signals that GD deliberately strips out non‑economic items to keep ROIC focused on the underlying economic return of the business, underscoring a disciplined, performance‑oriented measurement philosophy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Key strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across all three years (2022, 2023, 2024), matching the ground truth statement; (2) Accurately notes the identical language across years, demonstrating no change in treatment; (3) Properly synthesizes the multi-hop reasoning by connecting the consistent exclusion methodology to GD's underlying philosophy of measuring core operational performance; (4) Correctly interprets that this consistency reveals a disciplined, performance-oriented measurement approach focused on economic returns rather than accounting volatility. The LLM answer goes slightly beyond the ground truth by explicitly mentioning 'goodwill impairments' alongside non-economic accounting changes and providing more detailed interpretation of the company's philosophy ('deliberately strips out non-economic items'), but this additional detail is accurate and enhances rather than contradicts the ground truth. No numeric errors, calculation errors, or entity misidentifications. The reasoning is sound and the semantic meaning fully aligns with the original answer. Minor deduction only because the LLM adds interpretive language ('deliberately strips out') that, while reasonable, goes marginally beyond what the ground truth explicitly states, though this is a strength rather than a weakness in practical terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 410,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing Linde listed rare gases (krypton, neon, xenon, etc.) simply as one of the atmospheric‑gas products it makes and sold through the same three distribution channels used for oxygen, nitrogen and argon. By the 2023 filing the description was unchanged, showing that the company was still treating rare‑gas output as a routine line‑item of its broader industrial‑gases portfolio. The 2024 filing, however, highlights a shift: Linde now positions rare‑gas production as a by‑product of its market‑leading **non‑cryogenic air‑separation** technology and stresses ongoing development of proprietary, patented processes (e.g., VPSA and membrane‑separation) that create new applications and lower customer costs.  \n\nThis evolution—from a basic product line in 2022‑23 to a technology‑driven, innovation‑focused rare‑gas platform in 2024—signals that Linde is leveraging advanced production methods to deepen its competitive advantage, differentiating itself from rivals by offering higher‑value, cost‑effective rare‑gas solutions and opening new market opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each period: 2022-23 as routine product line, 2024 as technology-driven platform. (2) Accurately names specific technologies (VPSA, membrane separation) and correctly identifies non-cryogenic air separation as the key strategic shift. (3) Properly lists rare gases (krypton, neon, xenon) and correctly notes the three distribution channels. (4) Multi-hop reasoning is sound: synthesizes information across three years to identify the strategic evolution and correctly links this to competitive advantage through technological differentiation. (5) No quantitative errors - all dates, company names, and technical terms are accurate. (6) Semantic equivalence is strong: phrases like 'from a basic product line...to a technology-driven, innovation-focused rare-gas platform' effectively conveys the same strategic shift as the ground truth's 'strategic shift toward technological differentiation.' MINOR CONSIDERATIONS: The LLM answer uses slightly more vivid language ('by-product of its market-leading non-cryogenic air-separation technology') which adds interpretive framing beyond the ground truth, but this is consistent with the ground truth's meaning and represents reasonable elaboration rather than factual error. The answer comprehensively addresses both parts of the question (how strategy evolved AND what this indicates about competitive advantage). All factual claims are verifiable against the ground truth with no contradictions or inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 457,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s share of net‑generating capacity that was locked into long‑term bilateral contracts rose from roughly **92 %** (the level disclosed in the 2022 filing for the 2021 year‑end) to **about 94 %** at the end of 2023, and it stayed at **≈94 %** at the end of 2024. This incremental rise and subsequent stabilization show that NEER is deliberately expanding the portion of its output covered by fixed‑price, multi‑year agreements, using long‑term contracts as a hedge against spot‑market price swings and thereby strengthening its risk‑management posture in an increasingly volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct - 92% for 2022, 94% for 2023, and 94% for 2024. The numbers match the ground truth exactly. The LLM correctly identifies the trend as an incremental rise from 92% to 94% followed by stabilization. ENTITY ACCURACY: NEER (NextEra Energy Resources) is correctly identified, and the time period (2022-2024) is properly addressed. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to risk management strategy. The LLM correctly interprets the data as showing deliberate expansion of long-term contract coverage and explains the strategic rationale (hedging against spot-market price swings, managing volatility). SEMANTIC EQUIVALENCE: The LLM's phrasing 'fixed-price, multi-year agreements' and 'hedge against spot-market price swings' conveys the same meaning as the ground truth's 'revenue stability and risk mitigation' and 'locking in long-term commitments.' The characterization of this as a 'disciplined approach to managing market risk' is semantically equivalent to the LLM's 'strengthening its risk-management posture.' MINOR DIFFERENCES: The LLM does not explicitly mention 'non-qualifying hedges to protect expected revenues' that appears in the ground truth, which is a minor omission of contextual detail. However, the core answer about the bilateral contract trend and its strategic implications is complete and accurate. The LLM's interpretation of the trend as 'deliberate expansion' followed by stabilization is a reasonable and accurate characterization of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Contracts]-> FIN_INST <-[Enters_Contract]- ORG <-[Enters_Into_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 449,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "- **Fiscal 2022:** The 2022 Form 10‑K lists the 3.125 % senior notes due January 2025 with an outstanding principal of **$495 million** (Chunk 1).  \n- **Fiscal 2023:** The 2023 Form 10‑K shows the same series still carrying **$495 million** of principal (Chunk 2).  \n- **Fiscal 2024:** The 2024 Form 10‑K again reports **$495 million** outstanding on the 3.125 % notes (Chunk 3).  \n\n**Trend and implication:** Over the three‑year period the balance remained unchanged at $495 million, indicating that Broadcom has neither accelerated repayment nor issued additional amounts of this tranche. This stability suggests a deliberate debt‑management approach: the company is preserving the 3.125 % notes as a steady, low‑cost financing source and intends to hold the instrument to maturity rather than actively retire or refinance it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS OF FACTS: All three fiscal year balances are correctly stated at $495 million for the 3.125% notes due January 2025. The company is correctly identified as Broadcom (AVGO). The time period (FY 2022-2024) is accurate. (2) QUANTITATIVE ACCURACY: All dollar amounts ($495 million) are precisely correct across all three years. No calculation errors present. The consistency of the figure across years is accurately reflected. (3) MULTI-HOP REASONING: The LLM successfully synthesized information from three separate 10-K filings (2022, 2023, 2024) and correctly identified the trend of stability/no change. The logical inference that the company neither accelerated repayment nor issued additional amounts is sound and well-supported. (4) INTERPRETATION OF DEBT STRATEGY: The LLM's characterization of the trend as indicating a 'deliberate debt-management approach' and that the company intends to 'hold the instrument to maturity' aligns well with the ground truth's assessment that the stability 'suggests that AVGO did not retire or refinance this specific debt instrument.' Both answers convey the same strategic implication. (5) MINOR DIFFERENCES: The LLM provides slightly more detailed interpretation (mentioning 'low-cost financing source' and 'hold to maturity' strategy) compared to the ground truth's more concise statement. This additional context is reasonable inference from the data and does not contradict the ground truth. The LLM also explicitly cites source chunks, which adds transparency. Overall, the answer demonstrates accurate multi-hop synthesis across three years of filings with correct quantitative data and sound qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 472,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "Across all three filings the “Unsecured Notes ‑ 37B” line is identical.  \n\n* **2022 filing (as of 12/31/2021)** – face amount $700 million (shown as $ 700,000 thousands) with a maturity of January 15, 2032.  \n* **2023 filing (as of 12/31/2023)** – same face amount $700 million and same maturity 01/15/32.  \n* **2024 filing (as of 12/31/2024)** – again $700 million and maturity 01/15/32.  \n\nThe unchanged $700 million exposure and the long‑dated 2032 maturity indicate that Simon Property Group has kept this tranche of unsecured debt static, using it as a low‑cost (2.25 % coupon) long‑term financing vehicle. This consistency reflects a deliberate long‑term debt strategy: locking in a modest fixed rate on a sizable, far‑out maturity to provide predictable interest expense and preserve liquidity rather than repeatedly refinancing or expanding the issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed analysis than the ground truth. Strengths: (1) All key numbers are accurate - $700 million face amount (correctly noted as $700,000 thousands in filing format), maturity date of 01/15/32 consistently across all three years. (2) The LLM correctly identifies the stability of the instrument across 2022-2024. (3) The answer goes beyond the ground truth by providing additional context about the 2.25% coupon rate and strategic rationale for maintaining this debt instrument. (4) Multi-hop synthesis is sound - correctly synthesizes information across three years of filings. Minor issues: (1) The LLM references '2022 filing (as of 12/31/2021)' which is slightly confusing notation - the 2022 10-K would report 2021 year-end data, but this is a minor presentation issue. (2) The ground truth states face amount as '$700,000' (in thousands) while the LLM converts this to '$700 million' - both are correct representations of the same value, just in different units. The LLM's conversion to millions is actually clearer for interpretation. (3) The LLM provides strategic interpretation (low-cost financing, predictable interest expense, liquidity preservation) that goes beyond the ground truth's simpler statement about 'consistent long-term debt strategy' - this is value-added analysis rather than an error. The answer fully addresses the question about evolution (showing consistency), maturity dates, face amounts, and strategic implications. All factual claims are verifiable and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 428,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "- **2022 (10‑K page 18)** – Texas Instruments lists **Melaka, Malaysia** with an “X” in the **Analog** column and no “X” in the **Embedded Processing** column.  \n- **2023 (10‑K page 16)** – The same site appears again, still marked only for **Analog** and not for **Embedded Processing**.  \n- **2024 (10‑K page 16)** – Melaka remains on the list with an “X” under **Analog** and a blank under **Embedded Processing**.\n\n**Overall evolution:** TI’s Melaka facility has been a continuous part of its global footprint from 2022 through 2024, but its role has not changed – it is consistently dedicated to the **analog product line** and has never been identified as supporting **embedded‑processing** activities during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All factual information is correct - Melaka, Malaysia is accurately identified as the facility, and the marking pattern (X for Analog, blank for Embedded Processing) is correctly stated for all three years (2022, 2023, 2024). (2) The multi-hop synthesis is sound - the answer correctly traces the evolution across three fiscal years and accurately identifies the consistency of the operational footprint. (3) Entity accuracy is perfect - Texas Instruments, Melaka Malaysia, analog vs. embedded processing product lines are all correctly identified and distinguished. (4) The conclusion about stability and specialized role is logically sound and well-supported by the data presented. (5) Page references (10-K page 18 for 2022, page 16 for 2023 and 2024) add credibility and specificity. MINOR CONSIDERATIONS: The LLM uses 'X' notation to describe the checkmark/marking system, which is a reasonable interpretation of how the data appears in the filings. The ground truth uses 'checkmark' language while the LLM uses 'X' - both are semantically equivalent representations of the same marking system. The answer fully addresses all aspects of the question: the evolution across the three-year period, the focus on analog versus embedded processing, and the consistency of the operational presence. No calculations were required, but the comparative analysis across years is accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 405,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Across all three filings the post‑production business is treated the same way: it is bundled inside the **Content Sales / Licensing** segment rather than reported as a separate line item.  \n\n- **Fiscal 2022 (DIS 10‑K 2022)** – The segment description notes that “post‑production services through Industrial Light & Magic and Skywalker Sound” are reported with Content Sales/Licensing.  \n- **Fiscal 2023 (DIS 10‑K 2023)** – The same language appears, again placing ILM‑provided post‑production services in the Content Sales/Licensing revenue mix.  \n- **Fiscal 2024 (DIS 10‑K 2024)** – The description is unchanged, still stating that revenue is generated “…and post‑production services through Industrial Light & Magic and Skywalker Sound” within the segment.\n\nBecause the segment’s structure and the wording of the revenue description remain identical in each year, Disney’s reliance on Industrial Light & Magic for post‑production has been **steady and continuous**, with ILM’s services consistently accounted for as part of the broader Content Sales/Licensing revenue stream rather than being isolated or expanded in later years.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer directly contradicts the ground truth on the key analytical finding. Ground truth states there was an EVOLUTION in how ILM was treated - from explicit listing in FY2022, to continued reporting in FY2023 with emphasis shifting toward TV/VOD and theatrical distribution, to FY2024 with further alignment toward content licensing and DTC-first model. The LLM claims the treatment was 'identical' and 'unchanged' across all three years, which fundamentally misses the evolution narrative that is central to the question. The LLM states 'the wording of the revenue description remain identical in each year' - this is factually incorrect per the ground truth which explicitly describes a shifting narrative and strategic repositioning. WHAT WAS CORRECT: (1) ILM was included in Content Sales/Licensing segment across all three years - correct; (2) Post-production services were bundled rather than reported separately - correct; (3) Skywalker Sound was mentioned alongside ILM - correct; (4) The services were part of broader revenue stream - correct. WHAT WAS WRONG: (1) The core analytical conclusion is inverted - the answer claims 'steady and continuous' with 'unchanged' structure when ground truth explicitly describes evolution and shifting emphasis; (2) Failed to capture the strategic repositioning narrative from FY2022 to FY2024; (3) Missed the shift in revenue focus from post-production services as standalone to post-production within broader content delivery ecosystem; (4) Did not synthesize the multi-hop information about how the segment's narrative evolved across the three years. MULTI-HOP REASONING: The question requires synthesizing how ILM's role evolved across three fiscal years within the segment structure. The LLM failed this synthesis by claiming static treatment when the ground truth shows dynamic evolution. The LLM provided a surface-level structural observation (bundled in same segment) while missing the deeper analytical evolution (shifting strategic framing and emphasis). This is a significant failure in multi-hop reasoning for a question explicitly asking about 'evolution.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 574,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife reports that the equity‑method portion of its net investment income – which includes the results of its operating joint ventures that underwrite insurance – was **$1,305 million in 2022, fell sharply to $151 million in 2023, and then rose again to $988 million in 2024** (see the “Equity method investments NII … operating joint ventures” line in the 2023 and 2024 tables).  \n\nThe steep decline in 2023 indicates that the underwriting joint‑venture businesses generated far less profit (or possibly incurred losses) that year, while the rebound in 2024 shows a recovery in their performance, though earnings remained below the 2022 level. This trend suggests a temporary weakness in MetLife’s insurance‑underwriting joint ventures in 2023 followed by a notable, but not complete, turnaround in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,305 million (2022), $151 million (2023), and $988 million (2024). The numbers match the ground truth exactly with no calculation errors. (2) ENTITY AND METRIC ACCURACY: The answer correctly identifies MetLife as the company, properly references 'equity method investment income from operating joint ventures,' and accurately specifies the three-year period (2022-2024). The answer also correctly notes these are insurance underwriting joint ventures. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend, correctly identifying the pattern: significant decline in 2023 followed by partial recovery in 2024. The reasoning about what this suggests (temporary weakness followed by recovery, though not complete) is sound and matches the ground truth interpretation. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'volatility' (ground truth) is semantically equivalent to describing it as 'temporary weakness followed by notable turnaround' (LLM answer). Both convey the same underlying pattern. (5) MINOR DIFFERENCES: The LLM provides slightly more detailed context by noting the rebound was 'not complete' (remaining below 2022 levels), which adds helpful nuance without contradicting the ground truth. The reference to specific table locations ('Equity method investments NII ... operating joint ventures line') adds credibility and specificity. The answer fully addresses all parts of the question: the evolution of the metric and what it suggests about performance. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 460,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "- 2022: General Dynamics Land Systems was building **360 new LAVs** for the Canadian Army (Chunk 1).  \n- 2023: That volume rose to **399 new LAVs** (Chunk 2).  \n- 2024: Production increased further to **449 new LAVs plus an additional 66 LAVs** under the LRSS surveillance‑suite program, for a total of **≈ 515 LAVs** (Chunk 3).  \n\nThe steady climb from 360 to 399 to roughly 515 units shows General Dynamics is expanding its LAV output year‑over‑year, underscoring the platform’s growing strategic role as a market‑leading, high‑mobility vehicle family that drives a significant portion of the company’s defense‑systems business and export revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the core production volumes for 2022 (360 units) and 2023 (399 units), matching the ground truth exactly. The answer properly synthesizes multi-hop information across three years and correctly identifies General Dynamics Land Systems as the relevant division. The qualitative reasoning about strategic importance and market positioning is sound and well-articulated. CRITICAL ISSUE - QUANTITATIVE DISCREPANCY: The ground truth states 2024 production was 449 units, but the LLM reports 449 units PLUS an additional 66 LAVs under the LRSS program, totaling approximately 515 LAVs. This represents a significant factual error. The ground truth answer clearly states the 2024 figure as 449 units without any mention of additional LRSS units or a combined total. The LLM appears to have conflated or added information not present in the ground truth, creating a material discrepancy in the final year's data. This is particularly problematic because it distorts the year-over-year progression (360→399→449 vs. 360→399→515), which is central to answering the question about production volume evolution. REASONING QUALITY: The multi-hop synthesis across years is logically sound, and the interpretation of what the progression indicates about strategic importance aligns well with the ground truth's conclusion. However, the factual error in the 2024 figure undermines the accuracy of the overall analysis. The mention of LRSS surveillance-suite program, while potentially accurate from other sources, contradicts the ground truth baseline which treats 2024 as 449 units without qualification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 445,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS reported that the amount of hedge‑fund limited‑partnership investments (measured at NAV and disclosed through its “HF LP Investments” vehicle) grew each year: **$214 million in 2022, $225 million in 2023, and $252 million in 2024**. The steady increase—about a 5 % rise from 2022‑23 and a 12 % rise from 2023‑24—shows CVS is progressively allocating a larger share of its Level 3 pension‑plan assets to hedge‑fund LPs, suggesting a deliberate tilt toward alternative‑asset exposure to enhance diversification and potential return in its pension fund strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All dollar amounts are correct ($214M in 2022, $225M in 2023, $252M in 2024). The percentage calculations are also accurate: 2022-23 increase is ($225-$214)/$214 = 5.1% (rounded to ~5%), and 2023-24 increase is ($252-$225)/$225 = 12.0% (rounded to 12%). (2) COMPLETENESS: The answer addresses all parts of the multi-part question—it identifies the three-year trend, provides specific values for each year, and interprets what the trend suggests about pension fund asset allocation strategy. (3) ENTITY ACCURACY: CVS is correctly identified, the investment vehicle 'HF LP Investments' is properly named, and the fiscal years (2022, 2023, 2024) are correct. The reference to 'Level 3 pension-plan assets' adds appropriate technical context. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across three years and draws a logical conclusion about deliberate strategy—the steady increases support the inference of intentional allocation toward alternative investments. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a deliberate tilt toward alternative-asset exposure to enhance diversification and potential return' aligns with the ground truth's characterization of 'a deliberate strategy to allocate more pension fund assets toward alternative investments.' The LLM provides slightly more detailed reasoning about the strategic rationale (diversification, return enhancement) which enhances rather than detracts from the answer. Minor note: The LLM adds contextual detail about 'Level 3' assets and measurement methodology (NAV), which is accurate and relevant but not explicitly in the ground truth—this represents appropriate elaboration rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 489,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three filing years Colgate‑Palmolive repeatedly lists **Sorriso** among its “principal global and regional trademarks” that belong to the **Oral, Personal and Home Care** segment. In the 2022 10‑K (Chunk 3) Sorriso appears in the trademark roster for that segment; the same inclusion is reproduced in the 2023 10‑K (Chunk 1) and again in the 2024 10‑K (Chunk 2). This continuity shows that the company has kept Sorriso positioned as an integral, globally‑leveraged oral‑care brand within its broader Oral, Personal and Home Care product portfolio throughout 2022‑2024, rather than moving, dropping, or re‑classifying the brand.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Sorriso's strategic positioning across 2022-2024. STRENGTHS: (1) Correctly identifies Sorriso as appearing in principal global and regional trademarks across all three years (2022, 2023, 2024); (2) Accurately places Sorriso within the Oral, Personal and Home Care segment; (3) Properly synthesizes the multi-hop information showing continuity across three filing years; (4) Correctly interprets the strategic implication that Sorriso maintained consistent positioning rather than being moved, dropped, or reclassified; (5) Cites specific chunk references (Chunk 3 for 2022, Chunk 1 for 2023, Chunk 2 for 2024) showing document-level verification. MINOR WEAKNESSES: (1) The LLM characterizes Sorriso as a 'globally-leveraged oral-care brand' which is slightly more assertive than the ground truth's more measured 'regional brand asset' language - the ground truth emphasizes regional market penetration while the LLM emphasizes global leverage, though both are semantically compatible; (2) The LLM answer is slightly more detailed/interpretive than the ground truth in explaining the strategic implications, though this adds value rather than detracting; (3) No quantitative metrics are present in either answer (no revenue figures, market share data, etc.), so this is not a deficiency. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and identifies the consistent pattern of Sorriso's inclusion, which is the core requirement of the question. The reasoning is sound and the conclusion about strategic continuity is well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth - that Sorriso remained consistently positioned as a key brand within the Oral, Personal and Home Care segment across all three years, supporting regional market penetration and diversified consumer engagement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 539,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife reports its operating‑joint‑venture holdings (the equity‑method assets that reflect its underwriting‑related JV exposure) at **$51 million in 2022, $38 million in 2023, and $175 million in 2024** (all figures in millions of dollars). The amount fell 25 % from 2022 to 2023, then jumped almost five‑fold in 2024, taking the three‑year total to more than three times the 2022 level. Because MetLife accounts for these ventures under the equity method (as disclosed in its notes), the swing signals a deliberate strategic shift: after a brief pull‑back in 2023, the company is aggressively expanding its equity‑method stake in operating joint ventures in 2024, positioning itself to capture greater underwriting upside and long‑term earnings from these partnerships.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 as $51M (ground truth: $77M), 2023 as $38M (correct), and 2024 as $175M (ground truth: $38M). The 2022 and 2024 figures are completely wrong. The LLM's claim of a 'five-fold jump' in 2024 is factually incorrect - the actual trend shows a consistent decline from $77M to $51M to $38M. (2) CALCULATION ERRORS: The LLM states the three-year total is 'more than three times the 2022 level' ($51M + $38M + $175M = $264M vs. claimed 2022 of $51M would be ~5.2x, not 3x). However, using correct ground truth figures ($77M + $51M + $38M = $166M vs. $77M = 2.15x), this claim is also wrong. The 25% decline calculation ($51M to $38M) is mathematically correct but based on wrong 2022 baseline. (3) STRATEGIC INTERPRETATION FAILURE: The LLM's conclusion about 'aggressive expansion' and 'deliberate strategic shift' in 2024 is the opposite of reality. The ground truth shows consistent reduction indicating a strategic shift AWAY from operating joint ventures, not toward them. The LLM misread the data trajectory entirely. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year trend across all periods. It appears to have confused or transposed the 2022 and 2024 figures, leading to an inverted narrative. (5) ENTITY/METRIC ACCURACY: While MetLife and equity method investments are correctly identified, the financial metrics are fundamentally wrong. This is a complete failure on the primary quantitative requirement for a financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 449,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s equity holding in Angola LNG Limited has been constant – the 2022 and 2023 Form 10‑K filings both state that Chevron owns a **36.4 % stake** in the company, which “processes and liquefies natural gas produced in Angola.” The 2024 filing repeats the 36.4 % shareholding but adds that the plant in Soyo is the world’s first LNG facility fed by **associated gas** and that Chevron’s **up‑stream gas projects** – notably its 31 % non‑operated interest in the New Gas Consortium (NGC) and new frontier acreage in Blocks 49 and 50 – provide feedstock through on‑shore gas‑treatment facilities that connect directly to the Angola LNG plant. Thus, while the ownership percentage has not changed, Chevron’s involvement has moved from a passive equity investor (2022‑23) to an integrated operator that links its upstream gas developments to the LNG processing operation by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: All numeric values are correct - the 36.4% stake is accurately cited for 2022, 2023, and 2024; the 31% non-operated working interest in NGC is correct; the references to Blocks 49 and 50 are accurate. No calculation errors detected. ENTITY ACCURACY: All entities correctly identified - Chevron, Angola LNG Limited, New Gas Consortium (NGC), Quiluma and Maboqueiro fields (implied through NGC), Soyo plant location. Years (2022, 2023, 2024) properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple documents, correctly tracing the evolution from passive investor (2022-23) to integrated operator (2024). The connection between upstream projects (NGC with 31% interest) and downstream LNG processing is properly established. COMPLETENESS: The answer addresses all three sub-components of the question: (1) operational role evolution (passive to integrated), (2) stake percentage (constant 36.4%), and (3) integration with upstream gas projects (NGC, Blocks 49/50, Quiluma/Maboqueiro fields). SEMANTIC ALIGNMENT: The LLM answer conveys the same strategic narrative as the ground truth - a shift from passive equity investment to operationally integrated gas monetization model. The mention of 'associated gas' and 'on-shore gas-treatment facilities' adds relevant technical detail consistent with the ground truth's emphasis on feedstock integration. MINOR CONSIDERATIONS: The LLM answer mentions Blocks 49 and 50 as 'new frontier acreage' which is not explicitly mentioned in the ground truth provided, though this appears to be accurate supplementary information from the filings. The phrasing 'world's first LNG facility fed by associated gas' is a specific detail not in the ground truth but appears factually accurate. Overall, the answer demonstrates strong command of the multi-hop synthesis required and maintains factual precision throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 545,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "- **FY 2022 (10‑K 2022):** The April 2019 senior‑note series listed the 3.625 % notes due October 2024 with an outstanding principal of **$622 million**.  \n- **FY 2023 (10‑K 2023):** The same line still shows **$622 million** outstanding as of the October 29, 2023 balance date – the amount had not changed.  \n- **FY 2024 (10‑K 2024):** The table again reports **$622 million** outstanding as of October 29, 2024, with a dash for the post‑maturity (Nov 3, 2024) column, indicating the notes are expected to be retired at maturity.\n\n**Interpretation:** AVGO’s exposure to the 3.625 % October 2024 notes remained flat at roughly $622 million throughout the three fiscal years, showing that the company chose to keep the issuance on its balance sheet until the scheduled repayment date rather than refinancing or pre‑paying it earlier. This consistency reflects a disciplined debt‑management approach—using cash flow to meet the known maturity rather than altering the capital structure as the due date approached.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer contains a significant factual error regarding FY 2024 data. The ground truth states that by 2024, AVGO had 'completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures.' However, the LLM claims the 3.625% notes still showed $622 million outstanding as of October 29, 2024, with only a dash in the post-maturity column. This is a fundamental contradiction. The LLM's interpretation that the company 'chose to keep the issuance on its balance sheet until the scheduled repayment date' directly contradicts the ground truth that the notes 'no longer appear in the 2024 disclosures.' The LLM appears to have misread or misinterpreted the 2024 10-K filing data. FY 2022 and FY 2023 figures ($622 million for both years) are correctly stated and match the ground truth. However, the FY 2024 data is materially incorrect—the notes should not appear at all in 2024 disclosures according to the ground truth. This error undermines the entire debt management narrative. The LLM's conclusion about a 'disciplined debt-management approach' of holding the debt until maturity is contradicted by the actual fact that the debt was retired/retired before or at the October 2024 maturity date and no longer appears in the 2024 filings. The multi-hop reasoning fails at the final year, making the overall synthesis incomplete and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 390,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "All three filings list the same figures for the 35 B unsecured notes:\n\n* **2022 10‑K (as of 12/31/2021)** – Annual debt service $28,500 (thousands)  \n* **2023 10‑K (as of 12/31/2023)** – Annual debt service $28,500 (thousands)  \n* **2024 10‑K (as of 12/31/2024)** – Annual debt service $28,500 (thousands)\n\nBecause the annual debt service (the proxy for interest expense) for the 35 B notes stayed at $28.5 million each year, SPG’s financing cost for this instrument was essentially flat from 2022 through 2024. The unchanged expense suggests that the company neither refinanced nor altered the terms of the 35 B notes, resulting in a stable and predictable cost of capital for that tranche.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that SPG's interest expense for Unsecured Notes - 35B remained constant at $28,500 thousand across 2022-2024, matching the ground truth. The numeric values are accurate, and the format variation ($28.5 million vs $28,500 thousands) is appropriately handled. The reasoning about a fixed interest rate structure and stable financing costs is sound and well-supported. However, there is a minor issue with the date reference: the LLM states '2022 10-K (as of 12/31/2021)' which is confusing notation—a 2022 10-K would typically be filed in early 2023 for fiscal year 2022, not 2021. This appears to be a labeling error rather than a substantive factual error about the actual interest expense figures. The LLM appropriately synthesizes the multi-year trend and provides logical interpretation about the unchanged expense suggesting no refinancing or term alterations. The answer is complete, addresses the evolution question, and provides relevant context about what the trend suggests. The core financial facts are correct, but the date notation issue and slightly awkward phrasing ('as of 12/31/2021' for a 2022 filing) prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 333,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney’s approach to its Direct‑to‑Consumer (DTC) businesses shifted from a **cost‑heavy, early‑stage rollout** to a **more targeted, growth‑oriented streaming strategy** while still battling rising programming expenses and ever‑stronger competition.  \n\n* In the 2022 filing Disney warned that the **costs of its DTC strategy were growing faster than expected**, that many of the investments in DTC had “negative or low” returns, and that intensified competition for talent, content and advertising was driving up programming costs.  \n* By 2023 the company said it was **making strategic investments in its DTC offerings** (including Hulu and Disney+), expecting higher subscription‑fee and advertising revenue to “more than offset” the loss of linear‑network affiliate fees and to fund the shift toward streaming‑focused growth. It also flagged the possibility of curbing film/episodic content spend to protect cash flow.  \n* The 2024 filing reiterated that **DTC streaming services now compete with an expanding set of rivals**, that **programming‑rights costs—especially for sports—continue to rise**, and that renewal of long‑term contracts is riskier, but Disney continues to position its DTC platforms as core growth engines, relying on the same **investment‑in‑DTC** relationship identified in the KG (DIS → invests → DTC offerings) while acknowledging the heightened competitive and cost pressures.  \n\nOverall, Disney moved from an uncertain, loss‑generating DTC rollout in 2022 to a more deliberate, investment‑driven streaming focus in 2023, and by 2024 was managing that focus amid even higher content costs and a crowded competitive landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): The answer correctly references the $12.25 billion in unused bank facilities mentioned in the ground truth for 2023, though it does not explicitly cite this figure—this is acceptable as the question does not require specific dollar amounts. All years (2022, 2023, 2024) are correctly identified and sequenced. No numerical errors or miscalculations are present. QUALITATIVE ACCURACY (9/10): The multi-hop reasoning is sound and well-synthesized. The LLM correctly identifies the three-year trajectory: (1) 2022—cautious investment with uncertain returns, rising costs, negative/low returns on DTC investments; (2) 2023—strategic investments with expectations that subscription and advertising revenue would offset linear network losses; (3) 2024—intensified competition, rising programming costs (especially sports), and continued DTC positioning. The answer accurately captures the shift from cost-heavy early-stage rollout to targeted growth strategy. The mention of 'programming distributors demanding terms that reduced revenue' from the ground truth is implicitly addressed through the discussion of 'renewal of long-term contracts is riskier.' One minor point: the LLM mentions 'curbing film/episodic content spend to protect cash flow' which is a reasonable inference from 2023 strategic positioning but is not explicitly stated in the ground truth provided. ENTITY ACCURACY (10/10): Disney, DTC offerings, Hulu, Disney+, and all relevant metrics are correctly identified. CONTEXTUAL RELEVANCE (10/10): The answer directly addresses all aspects of the question—investment strategy evolution, competitive positioning, rising programming costs, and the strategic shift toward streaming. The narrative structure effectively shows the progression across the three-year period. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution ('cost-heavy, early-stage rollout' → 'more targeted, growth-oriented streaming strategy') accurately conveys the ground truth's assessment without requiring identical wording. The answer is comprehensive, well-organized, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1789,
        "completion_tokens": 591,
        "total_tokens": 2380
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s 2022 Form 10‑K disclosed that, because the reinsurance contracts did not expose the company to a “reasonable possibility of a significant loss,” they were accounted for under the deposit method, with **deposit assets of $1.8 billion and deposit liabilities of $1.4 billion** (the same amounts as the prior year).  \n\nBy the 2024 filing the same accounting treatment was still used, but the balances had risen sharply: **deposit assets were $5.1 billion for 2023 and $4.6 billion for 2024, while deposit liabilities fell modestly to $1.3 billion in 2023 and $1.2 billion in 2024**.  \n\nThe jump in 2023‑end assets was driven by the **November 2023 risk‑transfer transaction with Global Atlantic**, in which MetLife recorded $10.3 billion of reinsurance recoverables and deposit receivables, transferred $9.5 billion of fixed‑maturity securities (net of a $2.2 billion ceding commission), retained $5.0 billion of separate‑account assets, and recognized a $770 million net cost of reinsurance in other liabilities—effects that expanded the deposit‑method balances reported in the 2023 and 2024 statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key numbers: (1) 2022 deposit assets ($1.8B) and liabilities ($1.4B) match ground truth exactly; (2) 2024 deposit assets ($4.6B) and liabilities ($1.2B) match ground truth exactly; (3) 2023 deposit assets ($5.1B) and liabilities ($1.3B) are correctly stated; (4) Global Atlantic transaction amount ($10.3B in reinsurance recoverables and deposit receivables) matches ground truth. The LLM provides additional transaction details (fixed-maturity securities transfer of $9.5B net of $2.2B ceding commission, $5.0B separate-account assets retained, $770M net cost of reinsurance) that enhance understanding without contradicting the ground truth. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution across three years (2022→2023→2024), identifies the Global Atlantic transaction as the key driver in 2023, and explains the subsequent rebalancing in 2024. The narrative correctly characterizes this as a \"strategic shift\" and \"recalibration.\" Minor note: The LLM states 2023 deposit assets as $5.1B while ground truth shows the trajectory but doesn't explicitly state 2023 year-end figures—however, this appears to be a reasonable intermediate figure consistent with the jump from $1.8B (2022) to $4.6B (2024) following the November 2023 transaction. The answer fully addresses all parts of the multi-part question: deposit method evolution, specific asset/liability amounts across years, and Global Atlantic transaction impact. No calculation errors detected. Wording is clear and professional.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 436,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s holding of commercial mortgage‑backed securities fell sharply over the three‑year period. In its 2022 filing the company reported about **$574 million** of these securities at fair value (with $12 million of unrealized losses) and the 2023 filing showed the same 2022 balance at **$992 million** (with $155 million of losses). By the end of 2023 the fair‑value balance had dropped to **$675 million** (losses of $100 million), and the 2024 filing shows the exposure virtually eliminated at only **$3 million**. This steep decline signals that CVS has been actively divesting its commercial‑mortgage‑backed‑security portfolio, moving away from the asset class as part of a broader de‑risking or reallocation strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors in the reported CMBS balances. Ground truth shows: 2022=$574M, 2023=$675M, 2024=$3M. However, the LLM claims 2023 showed '$992 million' for the 2022 balance (confusing and incorrect), then states 'by the end of 2023 the fair-value balance had dropped to $675 million.' This creates internal inconsistency and confusion about which year's filing is being referenced. The LLM appears to be mixing data from different filings or misinterpreting the source documents. The 2023 balance should be $675M (not $992M), and the trajectory should be: $574M (2022) → $675M (2023) → $3M (2024). POSITIVE ASPECTS: The LLM correctly identifies the overall trend (significant decline), correctly states the 2024 figure ($3M), correctly identifies the 2022 starting point ($574M), and provides sound qualitative reasoning about de-risking and reallocation strategy. The inclusion of unrealized losses data shows attention to detail, though this wasn't required by the question. MULTI-HOP REASONING: The synthesis across three years is conceptually sound, but the numerical errors undermine the credibility of the analysis. The conclusion about strategic shift is correct and well-reasoned. MAIN PROBLEM: The $992M figure for 2023 is factually incorrect and creates confusion about the actual trajectory. This is a material error that significantly impacts the quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 405,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across all three filing years Colgate‑Palmolive kept the **hello** brand in the same “principal global and regional trademarks” list that appears in the “Nature of Operations” note of its 10‑K.  \n\n* **2022 10‑K (page 77)** – the trademark list reads “…Colgate, Palmolive, **hello**, meridol, …”.  \n* **2023 10‑K (page 79)** – the same list again includes “…Colgate, Palmolive, **hello**, meridol, …”.  \n* **2024 10‑K (page 79)** – the trademark disclosure again contains “…Colgate, Palmolive, **hello**, meridol, …”.  \n\nBecause the trademark disclosure is tied to the company’s two reporting segments—**Oral, Personal and Home Care** and **Pet Nutrition**—the repeated inclusion of **hello** signals that the brand remains positioned within the Oral, Personal and Home Care segment throughout 2022, 2023 and 2024. There is no evidence of removal or de‑emphasis; rather, the consistent listing shows an ongoing strategic emphasis on the **hello** brand as part of Colgate‑Palmolive’s core oral‑personal‑home‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies the 'hello' brand's consistent presence across all three years (2022, 2023, 2024) in Colgate-Palmolive's principal trademark disclosures. (2) Provides specific page references (77 for 2022, 79 for 2023 and 2024) that ground the answer in actual filing documents. (3) Accurately notes the brand's positioning within the Oral, Personal and Home Care segment. (4) Correctly identifies the two reporting segments (Oral, Personal and Home Care; Pet Nutrition). (5) Properly synthesizes the multi-hop information: trademark disclosure → segment alignment → strategic positioning. (6) Uses appropriate qualitative language ('no evidence of removal or de-emphasis,' 'ongoing strategic emphasis') that matches the ground truth's characterization of 'stable role' and 'consistency in strategic positioning.' MINOR CONSIDERATIONS: The LLM answer is more specific and detailed than the ground truth (providing exact page numbers and quote fragments), which actually strengthens rather than weakens the response. The ground truth uses broader language about 'continuity' and 'diversification strategies,' while the LLM focuses on the concrete evidence of consistent trademark listing. Both convey the same core finding: the brand maintained stable, consistent positioning across the three-year period. The LLM's approach of showing the identical trademark list structure across years is a more rigorous demonstration of consistency than the ground truth's more general statement. No factual errors detected. All dates, years, segment names, and brand names are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 450,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s 2022 filing (the 2022 10‑K) shows that, at that time, the company was using the deposit method only on a modest scale – deposit‑account assets on reinsurance were $1.8 billion and the corresponding deposit‑account liabilities were $1.4 billion, reflecting a relatively static, low‑risk reinsurance program.  The 2023 filing reiterates the same accounting policy – deposit‑method accounting is applied only to reinsurance contracts that do **not** expose the company to a “reasonable possibility of a significant loss” and credit‑risk assessments are performed each reporting period – but it does not yet disclose the amounts because the large block transaction had not been completed.  By the 2024 filing the policy is unchanged, yet the numbers have risen sharply after the November 2023 Global Atlantic risk‑transfer deal: deposit‑method assets grew to $5.1 billion in 2023 and $4.6 billion in 2024, while deposit‑method liabilities fell to $1.3 billion in 2023 and $1.2 billion in 2024.  \n\nThe upward trend in deposit assets (more than double the 2022 level) together with the modest decline in deposit liabilities signals that MetLife is deliberately using the deposit method to move larger blocks of low‑risk business onto reinsurers, retaining the cash assets that fund the reinsured liabilities and thereby reducing its net insurance‑risk exposure.  The slight dip in assets from 2023 to 2024 likely reflects the amortization of the $770 million net cost of reinsurance and the gradual settlement of the $10.3 billion of reinsurance receivables, indicating that the strategy is moving from acquisition of risk‑transfer assets to the systematic unwinding of the transaction while keeping the overall risk profile lower than before.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of MetLife's reinsurance strategy and the evolution of deposit method accounting, but contains a critical quantitative error that undermines accuracy. STRENGTHS: (1) Correctly identifies the 2022 baseline figures ($1.8B assets, $1.4B liabilities); (2) Accurately describes the accounting policy framework and the lack of disclosure in 2023 due to timing of Global Atlantic transaction; (3) Correctly identifies 2024 figures ($4.6B assets, $1.2B liabilities); (4) Provides sound qualitative reasoning about the strategic shift toward deposit method accounting and risk management implications; (5) Appropriately contextualizes the Global Atlantic transaction as a driver of the change; (6) Offers reasonable interpretation of the slight decline from 2023 to 2024 in assets. CRITICAL ERROR: The LLM states 'deposit‑method assets grew to $5.1 billion in 2023 and $4.6 billion in 2024' but the ground truth shows 2023 deposit assets were not explicitly stated as $5.1B in the original answer - the original answer only provides 2022 ($1.8B) and 2024 ($4.6B) figures. The introduction of $5.1B for 2023 appears to be an unsupported figure that contradicts the ground truth statement that 2023 'did not yet disclose the amounts.' This is a significant quantitative inaccuracy. MINOR ISSUES: (1) The characterization of 2022 as 'relatively static, low‑risk' is interpretive and not directly supported by ground truth; (2) The specific reference to '$770 million net cost of reinsurance' and '$10.3 billion of reinsurance receivables' are not mentioned in the ground truth and cannot be verified; (3) The multi-hop reasoning about amortization and settlement is logical but goes beyond what the ground truth explicitly states. The answer demonstrates strong qualitative understanding and contextual relevance but the quantitative error regarding 2023 figures and the introduction of unverified specific dollar amounts significantly impact overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1710,
        "completion_tokens": 538,
        "total_tokens": 2249
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "**2022 (10‑K 2022)** – NEE first disclosed that its “Special Use Funds” are non‑derivative financial assets measured at fair value using market‑based pricing (the same approach it uses for cash‑equivalents and other investments).  No dollar amount was shown on the balance sheet; the funds were simply grouped with other non‑derivative fair‑value assets.  The collateral discussion in the 2022 filing relates only to derivative contracts (e.g., $645 million of potential posting if ratings fell to BBB/Baa2 and up to $2.7 billion if ratings fell below investment grade), and does not directly affect the special‑use‑fund exposure.\n\n**2023 (10‑K 2023)** – The fair‑value methodology for special‑use‑funds remained unchanged and still was not presented as a separate line item.  The filing again emphasized collateral requirements for derivatives, now showing larger potential postings (≈ $510 million at a BBB/Baa2 downgrade and ≈ $2.4 billion if below‑investment‑grade) and higher actual collateral posted ($691 million cash and $1.595 billion in letters of credit).  As with 2022, the special‑use‑fund exposure was disclosed only qualitatively.\n\n**2024 (10‑K 2024)** – NEE began presenting the funds explicitly on the balance sheet under “Other assets” as a distinct line item: **$8,698 million in 2023 and $9,800 million in 2024**, indicating a $1.1 billion increase year‑over‑year.  The footnote still states that the funds are valued at fair value using observable market prices, consistent with the earlier qualitative disclosures.  Collateral considerations continue to be discussed in the derivative‑contingent‑feature sections, but they remain unrelated to the special‑use‑fund balances themselves.  \n\n**Overall evolution:** from 2022‑2023 the special‑use‑fund exposure was disclosed only in narrative fair‑value language, with no separate balance‑sheet amount, while collateral disclosures focused on derivative risk.  By 2024 the funds were quantified on the balance sheet, showing growth to $9.8 billion and retaining the same fair‑value measurement approach, while derivative‑related collateral requirements were still disclosed separately.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key evolution of NEE's Special Use Funds disclosure from 2022-2024. STRENGTHS: (1) All major dollar amounts are correct: $8,698 million (2023) and $9,800 million (2024) match ground truth exactly, as does the $1.1 billion increase calculation. (2) The timeline progression is accurate: 2022-2023 showed qualitative-only disclosure, while 2024 introduced explicit balance sheet presentation. (3) The fair value methodology description is correct (market-based pricing, quoted prices for equities, pricing vendor inputs for debt). (4) The collateral discussion is appropriately contextualized as derivative-related rather than directly tied to Special Use Funds. (5) Multi-hop reasoning is sound, correctly synthesizing information across three years and multiple disclosure categories. MINOR GAPS: (1) The ground truth mentions that equity investments without readily determinable fair values grew from $485 million (2022) to $538 million (2023), which the LLM answer does not include. This is a specific quantitative detail that adds important context about the composition of Special Use Funds. (2) The ground truth emphasizes 'enhanced transparency in reporting' and 'derivative-related collateral requirements' as part of the evolution, while the LLM answer treats collateral as separate/unrelated. The ground truth suggests these are interconnected aspects of the evolution, though the LLM's interpretation that they remain separate is defensible. (3) The LLM answer could have been more explicit about the commingled funds composition mentioned in the ground truth. CALCULATION VERIFICATION: The $1.1 billion increase ($9,800M - $8,698M = $1,102M) is correctly calculated and matches ground truth. NUMBER ACCURACY: All presented figures are accurate. The answer correctly avoids overstating the collateral connection while maintaining factual precision on the balance sheet amounts and presentation changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1816,
        "completion_tokens": 538,
        "total_tokens": 2355
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "Across all three filings the Security Insights Platform is described in the same way.  \n\n* **2022 (10‑K)** – The platform is positioned as a “trusted‑environment” solution that **quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis**.  The resulting data is **available for use with customers’ in‑house security‑information‑and‑event‑management (SIEM) tools**.  \n\n* **2023 (10‑K)** – The wording is unchanged: the platform continues to **interpret and assess security posture, surface risks and provide remediation steps**, and the data **remains available for use with in‑house SIEM tools**.  \n\n* **2024 (10‑K)** – The description is again identical (aside from a minor spelling change to “inhouse”), emphasizing the same **rapid posture assessment, risk identification, ongoing/ad‑hoc remediation guidance**, and **integration of its data with customers’ in‑house security information and event‑management tools**.  \n\nThus, from 2022 to 2024 AVGO’s Security Insights Platform retained a consistent positioning: a mainframe‑security assessment and remediation service whose outputs are deliberately designed to be fed into customers’ own security‑information‑and‑event‑management workflows, with no new capabilities or repositioning introduced in the disclosed language.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies that AVGO's Security Insights Platform maintained consistent positioning across 2022-2024 with no significant evolution in described capabilities. The answer accurately captures: (1) The core functionality across all three years (mainframe security posture assessment, risk identification, remediation steps); (2) The consistent emphasis on integration with in-house SIEM tools; (3) The distinction between ongoing and ad-hoc remediation approaches; (4) The minor spelling variation ('trusted-environment' in 2022, 'inhouse' vs 'in-house' in 2024). The LLM provides more granular detail than the ground truth answer while maintaining complete factual accuracy. It explicitly quotes or paraphrases the actual language from each filing year, demonstrating proper multi-hop synthesis across three separate 10-K documents. The conclusion that 'no new capabilities or repositioning introduced' directly aligns with the ground truth statement that AVGO 'maintained a stable value proposition without expanding on new integrations or remediation features.' The answer is well-structured, uses appropriate formatting to distinguish years, and provides clear evidence for its claims. No quantitative errors, date errors, or entity misidentifications are present. The only minor consideration is that the LLM provides slightly more detailed quotation than the ground truth answer, but this represents added value rather than inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 415,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Across all three filing years Nike repeatedly describes the Laakdal, Belgium site as one of its “most significant distribution facilities outside the United States” and states that it **owns** the facility. The 2022 Form 10‑K notes the Laakdal location among the owned overseas hubs; the 2023 and 2024 Forms 10‑K give the identical description, with no mention of leasing or third‑party operation. This unchanged ownership and continued inclusion as a core overseas distribution center signals that Laakdal is a permanent, strategically critical hub for Nike’s European (EMEA) logistics network, anchoring the company’s supply‑chain flow into the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies that NIKE owns the Laakdal facility across all three fiscal years (2022, 2023, 2024) with no changes in ownership status; (2) Accurately characterizes the facility as one of NIKE's 'most significant distribution facilities outside the United States' - matching the ground truth language; (3) Properly synthesizes the multi-hop requirement by comparing across three fiscal years and confirming consistency; (4) Correctly concludes that the unchanged status indicates strategic importance and stability in NIKE's European logistics network; (5) No quantitative errors - all dates and entity references are correct. MINOR CONSIDERATIONS: (1) The LLM adds interpretive language ('permanent, strategically critical hub,' 'anchoring the company's supply-chain flow') that goes slightly beyond the ground truth statement but is logically sound and supported by the evidence of consistency; (2) The phrase 'EMEA logistics network' is a reasonable regional designation not explicitly contradicted by the ground truth. The answer demonstrates strong multi-hop reasoning by synthesizing information across three separate fiscal year filings to establish a pattern of consistency. The semantic equivalence is excellent - the LLM conveys the same core facts as the ground truth while using slightly different phrasing that enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 394,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "**Evolution of the Unsecured Notes ‑ 32B**\n\n| Filing (as of) | Interest rate | Face amount (thousands) | Maturity date |\n|----------------|---------------|--------------------------|---------------|\n| 2022 10‑K (data 12/31/2021) | 3.38 % | $ 750 k | 06/15/27 |\n| 2023 10‑K (data 12/31/2023) | 3.38 % | $ 750 k | 06/15/27 |\n| 2024 10‑K (data 12/31/2024) | 3.38 % | $ 750 k | 06/15/27 |\n\nAcross the three‑year span the interest rate, principal amount and scheduled maturity of the 32B notes remained unchanged.\n\n**Strategic implication**\n\nThe unchanged terms indicate that Simon Property Group has chosen to retain this fixed‑rate, mid‑term liability rather than refinance, retire, or re‑issue it. This consistency reflects a deliberate debt‑management approach that relies on stable, predictable financing and a “hold‑to‑maturity” strategy for the 32B instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a significant factual inaccuracy regarding the 2022 data. The ground truth explicitly states that the maturity date was 'unspecified in the 2022 report' but the LLM table shows '06/15/27' for the 2022 10-K filing. This is a direct contradiction of the original answer's key finding about how the maturity date 'shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures.' This is not a minor wording difference—it's a factual error about what information was actually disclosed in the 2022 filing. The LLM also appears to have mislabeled the 2022 10-K as containing 'data 12/31/2021' when it should be 12/31/2022. The interest rate (3.38%) and face amount ($750,000) are correct for all three years. The reasoning about debt management strategy is sound and well-articulated, but it's based on incomplete/incorrect data presentation. The LLM correctly identified the consistency of terms and the 'hold-to-maturity' strategy, but failed to capture the important nuance that the maturity date clarification itself was a notable change in disclosure practice across the three-year period. The multi-hop synthesis is partially successful (combining data across years) but undermined by the factual error in the 2022 maturity date representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 374,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- 2022 (Dec 31, 2022): CVS held 1,571 foreign debt securities with a **fair‑value of $2,307 million** and **unrealized losses of $244 million**.  \n- 2023 (Dec 31, 2023): the portfolio fell to 1,124 securities, the **fair‑value dropped to $1,650 million** and **unrealized losses fell to $122 million**.  \n- 2024 (2024 filing): CVS now reports only **51 foreign securities** (down from 202 in 2023) and the total debt‑security balance shrank to $856 million; the 10‑K no longer discloses fair‑value or loss amounts, but the sharp reduction in holdings signals a continued pull‑back from foreign‑market exposure.\n\n**Interpretation:** After a surge in 2022, CVS’s foreign‑security fair value and associated unrealized losses roughly halved in 2023, and the dramatic cut in the number of foreign securities in 2024 suggests the company is deliberately reducing its exposure to international market risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally contradict the ground truth. (1) 2022 FAIR VALUE ERROR: LLM states $2,307 million vs. ground truth of $838 million - a 175% overstatement. This is a critical error. (2) 2023 FAIR VALUE: LLM correctly states $1,650 million, matching ground truth. (3) 2023 UNREALIZED LOSSES: LLM correctly states $122 million, matching ground truth. (4) 2024 FAIR VALUE: LLM states $856 million for 'total debt-security balance' but ground truth shows $51 million for foreign securities specifically. The LLM appears to have confused total debt securities with foreign securities. (5) MISSING 2022 UNREALIZED LOSSES: LLM states $244 million vs. ground truth of $24 million - a 10x error. This is a critical factual mistake. (6) MULTI-HOP SYNTHESIS: The LLM correctly identifies the general trend of de-risking/reduction in foreign exposure, but this correct interpretation is built on fundamentally wrong numbers. The narrative about 'surge in 2022' is contradicted by the ground truth showing 2022 as the baseline year with lower values than 2023. (7) ENTITY CONFUSION: The LLM conflates 'foreign debt securities' with 'total debt securities' in 2024, which are different metrics. The ground truth specifically tracks foreign securities ($51M in 2024), not all debt securities. CALCULATION VERIFICATION: The LLM's claim that 'fair value and associated unrealized losses roughly halved in 2023' is mathematically inconsistent with its own stated numbers ($2,307M to $1,650M is not a halving; $244M to $122M is a halving). The reasoning quality is undermined by these numerical contradictions. The answer demonstrates partial understanding of the de-risking trend but fails on fundamental quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 498,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s disclosures show the same practice in each of the three years.  \n\n* **2022 10‑K:** The filing states that when its insurance subsidiaries acquire non‑agency RMBS or CMBS that have not yet been evaluated by the NAIC, the company assigns an **internally‑developed designation** and retains it “until a NAIC designation becomes available.”  \n* **2023 10‑K:** The same language is repeated – newly‑acquired securities lacking a NAIC rating are given an internally‑developed designation on a temporary basis.  \n* **2024 10‑K:** The policy is again reiterated, with the internally‑developed designation used “until a NAIC designation becomes available.”  \n\nAcross 2022‑2024 there is no change in the approach; MetLife consistently relies on the NAIC’s modeling methodology (which estimates expected losses under various economic scenarios) as the definitive credit‑quality assessment, using its own designations only as a stop‑gap. This multi‑year pattern underscores that the company’s credit‑quality evaluation for non‑agency RMBS and CMBS remains fundamentally dependent on the NAIC’s annual modeling framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the ground truth and provides an incomplete analysis of the multi-year pattern. Critical issues: (1) QUANTITATIVE ERRORS: The LLM completely omits the specific financial metrics provided in the ground truth - the $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and the $1.6 billion (4.9%) increase in 2024. These numbers are central to demonstrating the evolution pattern and are entirely absent from the LLM response. (2) PATTERN RECOGNITION FAILURE: The ground truth explicitly states that MetLife's reliance on internally developed designations DECREASED over the three-year period, with the growth in Level 3 securities slowing from 14.5% to 4.9%, indicating a gradual shift toward standardized NAIC assessments. The LLM incorrectly concludes 'there is no change in the approach' and that the practice remained 'consistent,' which directly contradicts the ground truth's core finding about the evolution and trend. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that internally developed designations were used as temporary measures until NAIC designations became available, it fails to synthesize the multi-hop information showing HOW this reliance evolved through the growth metrics and their deceleration. The ground truth demonstrates a sophisticated multi-year analysis; the LLM provides only a surface-level description of the stated policy. (4) CONTEXTUAL MISUNDERSTANDING: The LLM states the company 'remains fundamentally dependent on the NAIC's annual modeling framework,' which is true but misses the key insight that the DEGREE of reliance on internal designations decreased as more securities received formal NAIC designations over time. The question specifically asks what the pattern 'reveals' about reliance - the answer should show decreasing reliance, not static reliance. (5) MISSING TEMPORAL CONTEXT: The ground truth notes the NAIC methodology was 'refined as of December 31, 2021' and became 'more established and widely applied' - this contextual evolution is absent from the LLM answer. The LLM's conclusion that there is 'no change' represents a fundamental failure to identify the multi-year trend that is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 601,
        "total_tokens": 2213
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- **2022:** Chevron’s 2022 filing lists the Republic of Congo as one of the countries in which the company has operating interests, indicating that the upstream business was already active there.  \n\n- **2023:** The 2023 10‑K shows that Chevron spent about **$0.7 billion on African offshore development and natural‑gas projects**, explicitly including work in the Republic of Congo, so capital allocation to the country continued at a multi‑hundred‑million‑dollar level.  \n\n- **2024:** The 2024 10‑K reports a major change in ownership: Chevron announced the sale of its **31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Republic of Congo portion of Lianzi** (effective January 2025). This divestiture ends Chevron’s remaining stake and markedly reduces its operational footprint in the Republic of Congo.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Chevron's evolution in the Republic of Congo from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - $0.7 billion for 2023 African offshore development/natural gas projects, 31.5% nonoperated working interest in Haute Mer permit, and 15.75% interest in Lianzi Republic of Congo portion. The effective date of January 2025 for the divestiture is accurately noted. COMPLETENESS: The answer addresses all three years requested (2022, 2023, 2024) and covers both capital allocation and asset ownership changes as requested. ENTITY ACCURACY: Chevron is correctly identified, the Republic of Congo is properly referenced, and specific permit names (Haute Mer, Lianzi) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the progression from active operation (2022), continued investment (2023), to strategic divestiture (2024). The logical narrative of the trajectory is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with clear, well-organized formatting that enhances readability. The characterization of the shift as 'from active operation and investment to full divestiture' is semantically equivalent to the ground truth's description. MINOR OBSERVATION: The LLM adds helpful context by noting the divestiture was 'effective January 2025,' which provides additional precision without contradicting the ground truth. The answer is well-structured with bullet points for each year, making the evolution clear and easy to follow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 464,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Across the three filings the company’s messaging is unchanged: Texas Instruments continually frames **embedded‑processing products as the cornerstone of its business model** and as the key element of the **second of its four sustainable competitive advantages – a broad portfolio of analog and embedded‑processing products that creates more opportunity per customer and greater value for its investments**.  \n\nThe 2022, 2023 and 2024 MD&A sections all repeat the same language, indicating that the strategic emphasis on embedded‑processing has been **maintained and reinforced** rather than altered, confirming its ongoing central role in TI’s competitive‑advantage framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies embedded processing products as a core strategic element across all three years (2022-2024); (2) Accurately characterizes it as the 'second of its four sustainable competitive advantages' - a specific detail that matches the ground truth framework; (3) Properly synthesizes the multi-hop information showing consistency across three separate filings; (4) Correctly notes that the strategic emphasis was 'maintained and reinforced' rather than evolved/changed, which aligns with the ground truth statement that 'the consistent emphasis indicates a stable and enduring strategic pillar'; (5) Accurately captures the key value proposition: 'creates more opportunity per customer and greater value for its investments'; (6) No quantitative errors - all dates, company names, and metrics are correct. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which provides slightly more narrative detail about how the language 'evolved slightly' while maintaining consistency; (2) The LLM emphasizes the 'unchanged' messaging more directly, while the ground truth acknowledges 'language evolved slightly' - however, both convey the same core insight that the strategic emphasis remained stable; (3) The LLM's phrasing 'maintained and reinforced' is semantically equivalent to the ground truth's 'consistent emphasis indicates a stable and enduring strategic pillar.' The answer successfully addresses all parts of the multi-part question: the evolution (or lack thereof) of strategic emphasis, the role within four competitive advantages, and the time period 2022-2024. The multi-hop reasoning correctly synthesizes information across three separate filings to reach the conclusion about consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 503,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note (maturing June 15, 2025) showed a sharp rise in its effective borrowing cost over the three most recent fiscal years:\n\n* **FY 2022 (10‑K 2022)** – the note carried a $500 million balance with an effective rate of **3.20 %** (the prior‑year column showed 1.29 %).  \n* **FY 2023 (10‑K 2023)** – the same $500 million balance was reported with an effective rate of **6.38 %** (the comparative column for FY 2022 shows 6.38 % versus 6.66 % in the later‑date column).  \n* **FY 2024 (10‑K 2024)** – the note still carries the $500 million balance and the effective rate remains **6.38 %** (with a forward‑looking 6.66 % rate shown for the next reporting date).\n\n**Interpretation:** Between FY 2022 and FY 2023 the effective rate on the 3.50 % note more than doubled, moving from the low‑3 % range to the mid‑6 % range, and it stayed at that higher level in FY 2024. This progression indicates that Cisco’s exposure to interest‑rate risk on this instrument increased substantially, reflecting higher market borrowing costs (or a higher‑cost refinancing) over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error in the FY 2024 data. According to the ground truth, the effective rate in FY 2024 should be 6.66%, not 6.38% as stated in the main answer. The LLM does mention 6.66% in parentheses as a 'forward-looking' rate, but this is incorrect framing—6.66% is the actual FY 2024 effective rate, not a forward-looking projection. This is a material error that undermines the core progression narrative. QUANTITATIVE ACCURACY ISSUES: (1) FY 2022: 3.20% ✓ CORRECT; (2) FY 2023: 6.38% ✓ CORRECT; (3) FY 2024: 6.38% ✗ INCORRECT (should be 6.66%); (4) $500 million balance ✓ CORRECT across all years; (5) June 2025 maturity date ✓ CORRECT. The LLM also includes confusing comparative language about 'prior-year columns' and 'forward-looking rates' that suggests misinterpretation of the source data structure. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year progression and identifies the trend of increasing borrowing costs. The interpretation about market rate increases and investor risk perception aligns with ground truth. However, the factual error in FY 2024 undermines the validity of the progression analysis. COMPLETENESS: The answer addresses all three fiscal years and provides interpretation, but the FY 2024 error is a critical omission/misstatement. The ground truth clearly shows 6.66% for FY 2024, representing a further increase from FY 2023's 6.38%, which the LLM fails to capture accurately. SEMANTIC EQUIVALENCE: While the general narrative about rising borrowing costs is correct, the specific progression is misrepresented due to the FY 2024 error. The answer should show: 3.20% → 6.38% → 6.66%, not 3.20% → 6.38% → 6.38%.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 470,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "- **2022:** BNY Mellon warned that its **ability to return capital to shareholders is subject to board discretion and may be limited by U.S. banking laws and regulations, including those that govern capital and capital‑planning**. It also noted that failure to meet “well‑capitalized” and other regulatory standards could restrict its activities.  \n\n- **2023:** The same limitation re‑appeared, and the filing added that a **material reduction in the credit ratings of its bank subsidiaries could increase funding costs and further constrain capital‑return decisions**, underscoring that the regulatory ceiling remained in place.  \n\n- **2024:** The company reiterated the board‑discretion rule and made the language even more explicit, stating that **non‑compliance with “well‑capitalized,” “well‑managed,” capital‑adequacy and liquidity rules could directly limit its activities and affect its ability to return capital**.  \n\n**What the progression shows:** Across the three years the exposure to U.S. banking laws has been **consistent but increasingly detailed**, moving from a general statement in 2022 to a clearer linkage with specific “well‑capitalized/managed” standards and credit‑rating impacts by 2024. This indicates that regulatory constraints are a **persistent, binding floor on BNY Mellon’s shareholder‑return strategy**, limiting strategic flexibility while still leaving some discretion to the board within those regulatory bounds.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in multi-hop synthesis and factual alignment with the ground truth. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the general theme of regulatory constraints on capital returns; (2) Accurately captures that 'well-capitalized' and 'well-managed' standards are key regulatory metrics mentioned; (3) Properly notes the evolution from general statements to more specific language; (4) Correctly identifies board discretion as a factor. CRITICAL WEAKNESSES: (1) The 2023 claim about 'material reduction in credit ratings of bank subsidiaries' is NOT mentioned in the ground truth and appears to be fabricated or misattributed - this is a significant factual error that undermines credibility; (2) The ground truth specifically mentions Delaware law and failure to pay full and timely dividends on preferred stock in 2023, which the LLM answer completely omits; (3) The LLM answer incorrectly attributes 'well-capitalized' and 'well-managed' language to 2022, when the ground truth indicates this emphasis became stronger in 2024; (4) The ground truth emphasizes 'liquidity management' as an increasingly important theme in 2024, which the LLM answer mentions only obliquely. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression pattern, but fails to accurately capture the specific regulatory details that evolved across the period. The conclusion about 'persistent, binding floor' is reasonable but based on incomplete/inaccurate premises. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, so this scores well (8/10) for proper date handling and temporal sequencing. QUALITATIVE ACCURACY: Significantly lower (5/10) due to the fabricated credit-rating claim and omission of key regulatory details (Delaware law, preferred stock dividends) that were explicitly mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 533,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "- **Revenue change:** Repair and other services fell from **$1,169 million in 2022 to $1,132 million in 2023**, a drop of **$37 million (about 3 %)** (Chunk 1).  \n- **Flat 2024 result:** The same $1,132 million was reported for 2024, showing **no change year‑over‑year** (Chunk 2). The 2024 filing notes the figure is identical to 2023, indicating the segment neither grew nor contracted after the 2023 decline.  \n\n- **Implication:** Across the five‑year view (2021‑2024) the Repair and other services line has hovered around the $1.0‑$1.2 billion mark (Chunks 1‑3), suggesting it is a **stable, mature revenue stream** that provides consistent cash flow but offers limited upside. The flat 2024 performance implies General Dynamics is likely treating this business as a **steady‑state service platform**, focusing strategic effort on expanding higher‑growth areas (e.g., submarines and surface ships) while maintaining the existing service base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $1,169M (2022), $1,132M (2023), $1,132M (2024), and the calculated decline of $37M with ~3.16% decrease (37/1169 = 3.16%, rounded to 3%) is accurate. COMPLETENESS: The answer addresses all three parts of the multi-part question: (1) revenue change 2022-2023, (2) flat 2024 performance, and (3) what the pattern suggests about stability/strategic focus. ENTITY ACCURACY: General Dynamics correctly identified, fiscal years correct (2022, 2023, 2024), metric correctly identified as 'Repair and other services' revenue. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and connects the revenue pattern to broader strategic context (comparison to submarine/surface ship growth, resource allocation implications). The reasoning is sound - correctly identifies the segment as mature/stable with limited growth, and appropriately contextualizes this within General Dynamics' broader portfolio strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core insights as the ground truth: (1) decline from 2022-2023, (2) flat 2024, (3) suggests limited growth/strategic prioritization, (4) indicates market saturation or resource reallocation. The LLM adds valuable context by noting the 5-year trend and explicitly characterizing it as a 'steady-state service platform,' which aligns with and enhances the ground truth's interpretation. MINOR CONSIDERATIONS: The LLM provides slightly more detailed analysis than the ground truth (5-year context, explicit characterization as 'mature revenue stream'), but this represents value-added analysis rather than deviation from accuracy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 480,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which the filings state is “primarily” made up of venture investments – grew from **$3.7 billion at the end of 2022** (2023 10‑K) to **$4.9 billion at the end of 2023**, and then held steady at **$4.9 billion in 2024** (2024 10‑K).  This jump between 2022 and 2023 signals a clear strategic push to expand its venture‑style stakes in emerging health‑care businesses, and the flat level in 2024 shows UnitedHealth is maintaining that larger venture position.\n\nIn contrast, its **equity‑method investments in operating health‑care businesses** were **$1.5 billion in 2022**, slipped slightly to **$1.4 billion in 2023**, and then surged to **$3.8 billion in 2024** (2024 10‑K).  The modest dip in 2023 followed by the large increase in 2024 indicates a renewed emphasis on taking larger ownership positions in mature health‑care operators after a period of relative restraint.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN EQUITY METHOD INVESTMENTS: The LLM states equity-method investments were '$1.5 billion in 2022' but the ground truth clearly shows they were '$1.4 billion in 2022' and '$1.5 billion in 2023'. This is a significant factual error that undermines the accuracy of the answer. The LLM then correctly identifies the 2024 figure of $3.8 billion. CORRECT ELEMENTS: (1) Equity securities portfolio figures are accurate: $3.7B (2022), $4.9B (2023), $4.9B (2024). (2) The characterization of venture investments as 'primarily' making up the equity-security portfolio aligns with filing language. (3) The 2024 equity-method investment figure of $3.8B is correct. (4) The strategic interpretation about the shift toward deeper integrated investments in 2024 is sound and matches the ground truth narrative. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly identifies the contrasting trends between the two investment types. However, the foundational error in the 2022 equity-method figure creates confusion about the actual trajectory (the ground truth shows flat performance 2022-2023, then surge in 2024; the LLM suggests a decline from 2022-2023). SEMANTIC ISSUES: The LLM's interpretation of 'slipped slightly to $1.4 billion in 2023' is backwards from the ground truth narrative, which indicates the 2023 figure remained flat at $1.4B compared to 2022. This reversal of the 2022 baseline figure is a material error that affects the credibility of the trend analysis, even though the qualitative conclusion about 2024 emphasis is ultimately correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 441,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Across all three filing years — the 2022 Form 10‑K (page 21), the 2023 Form 10‑K (page 26) and the 2024 Form 10‑K (page 26) — Philip Morris International (PMI) lists **Colgate‑Palmolive Co. as a member of its “PMI Peer Group.”** Each filing explicitly says the peer group “is the same as that used in the prior year,” and the enumerated list of peers in every year includes Colgate‑Palmolive alongside the same set of consumer‑product and tobacco companies.\n\nThe unchanged classification over three consecutive years shows that PMI’s strategic benchmarking framework is deliberately stable. By applying the same four selection criteria (global presence, consumer‑product focus, comparable net revenues and market‑capitalization, and consideration of primary international tobacco firms) and retaining the same peer roster, PMI creates a consistent reference set for performance comparison, trend analysis, and strategic planning. This continuity signals that PMI values longitudinal comparability and a disciplined, long‑term view of how its business stacks up against a fixed cohort of peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as consistently included in PMI's peer group across all three years (2022, 2023, 2024). (2) Accurately cites specific page references (page 21 for 2022, page 26 for 2023 and 2024), demonstrating precise document sourcing. (3) Correctly states the four selection criteria: global presence, consumer-product focus, comparable net revenues and market capitalization, and consideration of primary international tobacco firms. (4) Accurately conveys that the peer group remained 'the same as that used in the prior year' across all three filings. (5) Provides sound multi-hop reasoning by synthesizing information across three separate 10-K filings to demonstrate year-over-year consistency. (6) Correctly interprets the strategic implications of this consistency—that PMI values longitudinal comparability and maintains a disciplined, long-term benchmarking approach. (7) Appropriately notes that PMI excluded direct tobacco industry peers from direct comparison while including consumer product companies. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page numbers are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning about what consistency in peer group classification reveals about PMI's strategic framework is sound and well-articulated. The answer correctly synthesizes information across multiple years and documents. MINOR OBSERVATION: The LLM answer is slightly more detailed and interpretive than the ground truth (e.g., explaining the strategic implications more thoroughly), but this adds value rather than introducing errors. The semantic meaning aligns perfectly with the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Has_Stake_In]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 475,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "- **2022:** PayPal already warned that its U.S. consumer‑credit, merchant‑financing and other credit products – which are originated and funded through unaffiliated third‑party lenders – created a baseline exposure to “abusive behaviors.”  The filing said that any failure to curb fraud, bad transactions or negative customer experiences would raise its loss rate and could damage merchant‑ and consumer confidence.  \n\n- **2023:** After adding a large BNPL loan portfolio (the €40 billion U.K.‑Europe receivable sale) and stating that it may rely on additional third‑party funding structures (asset sales, warehouse facilities, securitizations, etc.), PayPal highlighted that the **growth of its credit products** and the **greater dependence on networks, payment processors, lenders, custodians and outsourced service providers** amplified the risk that third parties would attempt to abuse its payment services.  The same “failure to deal effectively with fraud, abusive behaviors…” language re‑appeared, indicating the exposure had expanded alongside the credit expansion.  \n\n- **2024:** The most recent filing repeats the 2023 language – confirming that PayPal still purchases receivables for its U.S. merchant‑financing and consumer‑installment products, continues to rely heavily on third‑party lenders, processors and custodial providers, and again warns that abusive‑behavior attacks could increase loss rates.  No new mitigation breakthroughs are described, suggesting the risk remains at least as high as before.\n\n**Trend implication:** As PayPal’s credit offerings have broadened and its reliance on external partners has deepened from 2022‑2024, its exposure to abusive‑behavior fraud has correspondingly risen or at best stayed constant.  The repeated risk disclosures, without evidence of a reduced loss‑rate or new effective controls, imply that the company’s fraud‑mitigation efforts have not out‑paced the expanding credit and third‑party footprint, leaving the overall effectiveness of its anti‑abuse program relatively limited over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): The €40 billion figure for the BNPL loan receivables sale is correctly cited and properly contextualized. All dates (2022, 2023, 2024) are accurate. No calculation errors or numeric discrepancies detected. QUALITATIVE ACCURACY (9/10): The multi-hop reasoning is sound and well-structured. The answer correctly synthesizes information across three years, identifying the progression from baseline credit-product risks (2022) → expanded credit offerings with third-party dependencies (2023) → sustained exposure without mitigation breakthroughs (2024). The identification of key entities (PayPal, third-party lenders, processors, custodians) is accurate. The logical connection between credit expansion and increased fraud exposure is properly established. Minor note: The answer references \"U.K.-Europe\" while ground truth says \"Europe\" – this is a minor geographic specification that doesn't materially affect accuracy. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution of exposure 2022-2024, (2) relation to expanding credit products, (3) third-party risk dependencies, (4) implications for fraud mitigation effectiveness. The trend analysis at the end directly answers the final sub-question about what the evolution suggests. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth – that PayPal's fraud exposure has grown or remained constant despite investments, and that mitigation effectiveness has not kept pace with expansion. The phrasing differs but the factual content and conclusions align. REASONING QUALITY: The multi-hop synthesis correctly connects: credit expansion → third-party reliance → increased abuse exposure → stagnant mitigation effectiveness. This matches the ground truth's causal chain. The observation that \"repeated risk disclosures, without evidence of reduced loss-rate or new effective controls\" is a sound inference from the filing language patterns described. No logical gaps or unsupported claims detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1840,
        "completion_tokens": 573,
        "total_tokens": 2414
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "**Evolution of natural‑gas option hedges (mmBtu)**  \n\n| Year‑end | Southern Company (core) | Southern Company Gas (subsidiary) | **Combined option volume** |\n|----------|------------------------|-----------------------------------|----------------------------|\n| 2022 (Dec 31) | 214 mmBtu | 93 mmBtu | **307 mmBtu** |\n| 2023 (Dec 31) | 339 mmBtu | 102 mmBtu | **441 mmBtu** |\n| 2024 (Dec 31) | 176 mmBtu | 83 mmBtu | **259 mmBtu** |\n\n*Sources: 2022 data from the 2022 10‑K table (Chunk 1); 2022‑2023 data from the 2023 10‑K table (Chunk 3); 2023‑2024 data from the 2024 10‑K table (Chunk 2).*\n\n**Interpretation of the three‑year trend**\n\n- **2022 → 2023:** The combined natural‑gas option hedge rose from 307 mmBtu to 441 mmBtu, a ~44 % increase. This jump indicates that Southern Company deliberately expanded its option positions as price volatility or uncertainty in the natural‑gas market intensified, using options to preserve upside flexibility while limiting downside exposure.  \n- **2023 → 2024:** The hedge volume then fell to 259 mmBtu, a ~41 % drop from the 2023 peak and about 16 % below the 2022 level. The reduction suggests the company either perceived lower volatility, achieved sufficient coverage through other instruments (e.g., swaps), or chose to limit the cost of option premiums as market conditions stabilized.\n\n**Overall risk‑management implication**\n\nThe pattern shows a **responsive, market‑driven hedging strategy**: Southern Company ramps up natural‑gas options when volatility spikes (2023) to protect earnings, then scales them back when the environment eases (2024). This flexibility indicates an active risk‑management posture that balances the cost of option premiums against the need for price protection.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant quantitative errors that fundamentally undermine its credibility. (1) CORE NUMBER MISMATCH: The ground truth states Southern Company reported 253 million mmBtu in 2022, but the LLM reports 307 million mmBtu (214 core + 93 subsidiary). This is a 54 mmBtu discrepancy (~21% higher than ground truth). For 2023, the LLM reports 441 mmBtu combined (339 core + 102 subsidiary), but ground truth states 339 million mmBtu total. This suggests the LLM may be double-counting or misinterpreting subsidiary data. For 2024, the LLM reports 259 mmBtu combined (176 core + 83 subsidiary), but ground truth states 176 million mmBtu. (2) CALCULATION ERRORS: The LLM calculates a 44% increase from 2022 to 2023 (307→441), but ground truth shows only a 34% increase (253→339). The 2023→2024 decline calculation of 41% is based on incorrect 2023 baseline (441 vs. actual 339). (3) ENTITY CONFUSION: The LLM introduces 'Southern Company Gas (subsidiary)' as a separate line item, which appears to be a misinterpretation of the data structure. The ground truth presents consolidated figures for Southern Company, not broken down by subsidiary. The subsidiary breakdown may represent a different analytical approach not supported by the original question or ground truth. (4) SEMANTIC ISSUES: While the LLM's qualitative interpretation of the trend (aggressive hedging in 2023, reduction in 2024) aligns directionally with ground truth, the underlying numbers are wrong, making the percentage-based conclusions unreliable. (5) MULTI-HOP REASONING: The LLM correctly identifies the three-year trend pattern and provides reasonable risk-management interpretation, but this is undermined by the quantitative foundation being incorrect. The reasoning quality is sound, but it's built on faulty data. STRENGTHS: The LLM provides clear structure, attempts to cite sources, and offers reasonable strategic interpretation. WEAKNESSES: Fundamental numerical inaccuracy, apparent misunderstanding of data consolidation, and introduction of subsidiary-level detail not present in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 572,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ reported expense for its U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024** (Chunk 2; also reflected in Chunk 3 for 2022‑2023). This upward trend, following the lower $63 million expense noted in 2021 (Chunk 1), shows the company is allocating progressively more resources to its defined‑contribution programs. Because the **non‑qualified defined‑benefit pension plan is unfunded and closed to new participants** (Chunks 2 & 3), the growing DC expense signals a long‑term strategy of shifting retirement benefits toward defined‑contribution arrangements—providing predictable, flexible employee benefits while moving away from the legacy, non‑qualified defined‑benefit obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop reasoning. QUANTITATIVE VERIFICATION: All financial figures are correct—$70M (2022), $75M (2023), $76M (2024)—matching the ground truth exactly. The additional reference to $63M in 2021 provides helpful context and is not contradicted by the original answer. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of expenses across the three-year period, (2) the trend analysis, and (3) the strategic implications for long-term employee benefit strategy. ENTITY ACCURACY: Texas Instruments is correctly identified, fiscal years are accurate, and the distinction between defined-contribution and non-qualified defined-benefit plans is properly maintained. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions—connecting the rising DC expenses to the closed/unfunded status of the non-qualified DB plan, and interpreting this as evidence of a strategic shift toward DC arrangements. This reasoning is sound and aligns with the ground truth's interpretation. MINOR DIFFERENCES: The LLM answer emphasizes the strategic shift away from legacy obligations more explicitly than the ground truth, which focuses on supporting employees who opted out and the 1997 closure date. However, both interpretations are complementary and not contradictory—the LLM's framing of a 'shift' toward DC is a valid inference from the data. The LLM also includes the 2021 comparison ($63M), which adds useful context without detracting from accuracy. SEMANTIC EQUIVALENCE: The core message is identical: TI is increasing DC plan expenses, reflecting a long-term strategic commitment to flexible retirement benefits in the context of a closed DB plan. The wording differs but conveys the same essential information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 501,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "- **2022 – 2023:** Both the 2023 10‑K and the 2022 10‑K state that the weighted‑average long‑term rate of return on assets (ROA) used for the U.S. defined‑benefit pension plans was **6.3 %** at December 31, 2022 and remained **unchanged at 6.3 %** at December 31, 2023.  \n\n- **2024:** The 2024 10‑K reports that the same weighted‑average long‑term ROA **rose to 6.5 %** at December 31, 2024 (up from 6.3 % the prior year).\n\n**Interpretation:** After holding the assumption steady at 6.3 % for two consecutive years, GM raised its long‑term return assumption by 0.2 percentage points in 2024. This upward shift signals that GM is becoming more optimistic about future asset performance and is willing to incorporate a modestly higher expected return—implying a slightly greater appetite for risk or confidence that its strategic asset mix and risk‑mitigation tactics will support stronger returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 rate of return assumption. According to the ground truth, GM reported a weighted-average long-term ROA of 5.4% in 2022, NOT 6.3% as the LLM states. The LLM claims both the 2023 and 2022 10-Ks state the 2022 rate was 6.3%, which contradicts the ground truth. This is a major quantitative accuracy failure. CORRECT SEQUENCE (per ground truth): 2022: 5.4% → 2023: 6.3% (unchanged from prior year) → 2024: 6.5%. INCORRECT SEQUENCE (per LLM): 2022: 6.3% → 2023: 6.3% (unchanged) → 2024: 6.5%. The LLM correctly identifies the 2024 increase to 6.5% and the 0.2 percentage point change from 2023 to 2024, but misses the significant 0.9 percentage point increase from 2022 to 2023. This error fundamentally distorts the trend analysis. The LLM's interpretation about GM becoming more optimistic is directionally correct for the 2023-2024 period, but the answer fails to capture the more substantial shift that occurred in 2023 (from 5.4% to 6.3%), which is crucial to understanding the full evolution of GM's expectations. The ground truth explicitly states the 2023 rate 'remained unchanged at 6.3%' implying it was already 6.3% in 2022, but the ground truth also explicitly states '5.4% in 2022,' creating an apparent internal inconsistency in the ground truth itself. However, the LLM should have reported 5.4% for 2022 based on the explicit statement in the ground truth. The qualitative reasoning about risk tolerance and asset performance is reasonable but incomplete given the missing context of the larger 2022-2023 shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 444,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return‑swap program that funds deferred‑compensation awards moved from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023**, and then to a **$91 million gain in FY 2024** (as shown in the “Total return swaps‑deferred compensation” line in each year’s 10‑K).  \n\nThe swing from a material loss to consecutive gains indicates that Cisco’s exposure to these swaps has been increasingly favorable – the company is either better timing the swaps, benefiting from market moves, or using the instruments more effectively to offset compensation costs. This progression suggests a strengthening of its risk‑management approach to the deferred‑compensation program and reflects a compensation strategy that is generating positive financial results rather than eroding earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million match the ground truth exactly. The progression and direction of changes are accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how exposure evolved across the three-year period, (2) realized gains/losses for each year, and (3) what this indicates about risk management and compensation strategy. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metric (total return swaps linked to deferred compensation) is properly identified. MULTI-HOP REASONING: The answer correctly synthesizes the three-year progression and draws logical conclusions about the turnaround from loss to gains, connecting this to potential improvements in market conditions or strategic adjustments - matching the ground truth's interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation that the company is \"better timing the swaps, benefiting from market moves, or using the instruments more effectively\" is semantically equivalent to the ground truth's reference to \"improved market conditions or strategic adjustments.\" The characterization of this as a \"notable turnaround\" and indication of \"strengthening risk-management approach\" aligns well with the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation about what the progression suggests (timing, market moves, instrument effectiveness) compared to the ground truth, but this represents appropriate elaboration rather than error. The answer is well-structured and clearly references the source (10-K filings). No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 507,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal’s margin‑risk exposure remained essentially unchanged. In 2022, 2023 and again in 2024 the company states that it **recognizes transaction fees on a gross basis as revenue because it is the principal**, that it **has full discretion over the fee it charges and controls the product specifications**, and that **the fees it pays to third‑party payment processors and other financial institutions are recorded as transaction expense** – meaning PayPal **bears the full margin risk on every payment it completes**. The disclosures also note that its contracts are open‑ended with volume‑based tiered pricing, but this pricing approach does not alter the fact that PayPal retains control over pricing and therefore continues to assume the same margin‑risk exposure each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that PayPal's margin risk exposure remained consistent across 2022, 2023, and 2024 with no structural changes; (2) Accurately captures the three critical elements: PayPal's principal role in transactions, full discretion over pricing, and recognition of processor fees as transaction expense; (3) Properly synthesizes the multi-hop information showing how these three factors combine to create full margin risk exposure; (4) Correctly notes that volume-based tiered pricing does not alter the fundamental margin risk position; (5) No quantitative errors - all factual claims are accurate and verifiable from the filings. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more emphatic language (bold formatting, multiple dashes) compared to the ground truth's more measured tone, but this is a stylistic difference that does not affect factual accuracy; (2) The LLM answer is more concise and direct in its presentation, while the ground truth provides slightly more contextual framing about 2023's clarification on tiered pricing not constituting a future material right - however, the LLM does address this point substantively; (3) Both answers convey the same essential finding: consistent exposure to margin risk without structural changes. The LLM answer successfully demonstrates multi-hop reasoning by synthesizing information across three fiscal years and connecting PayPal's pricing control, processor fee recognition, and principal role to the overarching conclusion about margin risk exposure. No calculations are required for this question, and no numeric values are present in either answer, so quantitative accuracy is perfect by default. The answer is highly relevant and directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 511,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s “as‑sold” natural‑gas volumes that flow through its Angola LNG affiliate rose each year: ≈7,107 million cf/d in 2022, ≈7,148 million cf/d in 2023, and ≈7,569 million cf/d in 2024. The steady‑to‑accelerating increase reflects Chevron’s expanding share of production from the Angola LNG project – a asset in which the company holds a direct stake – and signals that Chevron is positioning itself to be a larger, more reliable supplier in the global liquefied natural‑gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that are orders of magnitude larger than the ground truth. Ground truth shows natural gas consumed in operations at 592, 596, and 609 million cubic feet per day for 2022-2024 respectively. The LLM claims approximately 7,107, 7,148, and 7,569 million cf/d - values that are roughly 12x larger than actual figures. This is not a minor formatting difference or rounding variation; these are completely different data points. The LLM appears to have confused or conflated different metrics (possibly 'as-sold' volumes vs. consumed volumes, or aggregated production vs. Angola-specific production). Additionally, the ground truth specifically references 'natural gas consumed in operations' while the LLM references 'as-sold' volumes through an affiliate, suggesting the LLM may be reporting different metrics entirely. The directional trend (increasing over time) is correct, and the strategic interpretation about LNG market positioning is reasonable, but the numerical foundation is entirely wrong. The multi-hop reasoning about Chevron's strategic positioning is sound in concept, but is built on incorrect quantitative data. For a financial question requiring precise numbers from SEC filings, providing values that are off by an order of magnitude represents a fundamental failure to answer correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 382,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Southern Power noted that the “undiscounted cash flows to be received under outdoor‑lighting contracts accounted for as operating leases at Mississippi Power are **immaterial**,” and those lease‑related rents were not shown in the cash‑flow tables.  \n\nBy the 2023 filing the company had begun to treat the same contracts like its other lease assets – it disclosed “scheduled payments to be received under outdoor‑lighting contracts … are presented in the following maturity analyses.” The 2024 filing repeats this presentation, listing the scheduled‑payment stream together with tolling arrangements and PPAs.  \n\nThe shift from a brief immateriality comment in 2022 to a full maturity‑schedule disclosure in 2023 and 2024 signals that outdoor‑lighting contracts have moved from a negligible footnote to a material, structurally integrated component of Southern Power’s lease portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Southern Power's evolving treatment of outdoor lighting contracts across 2022-2024. STRENGTHS: (1) All factual claims are correct - the 2022 immateriality statement, the 2023 shift to maturity schedule disclosure, and the 2024 continuation of this approach are all accurately represented. (2) The multi-hop synthesis is sound: the answer correctly traces the evolution across three fiscal years and identifies the key inflection point (2022 to 2023). (3) Entity identification is precise: Southern Power, Mississippi Power, outdoor lighting contracts, operating leases, PPAs, and tolling arrangements are all correctly identified and contextualized. (4) The reasoning about materiality progression is logical and well-supported by the cited evidence. (5) The answer directly addresses all components of the question: treatment evolution, reporting changes, and what this reveals about growing materiality/structural importance. MINOR CONSIDERATIONS: The LLM answer uses slightly more interpretive language ('signals that outdoor-lighting contracts have moved from a negligible footnote to a material, structurally integrated component') compared to the ground truth's more measured phrasing ('indicates a growing materiality and structural integration'). However, this represents a semantic enhancement rather than an error - the LLM's interpretation is well-supported by the evidence presented and conveys equivalent meaning. The answer also provides helpful context by noting that lease-related rents were 'not shown in the cash-flow tables' in 2022, which adds useful detail. No quantitative errors, calculation errors, or factual inaccuracies are present. The answer successfully synthesizes information across multiple years and filing documents to construct a coherent narrative about the contracts' evolving importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 524,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across all three filing years Texas Instruments listed its Melaka, Malaysia site only under the **Analog** column and left the **Embedded Processing** column blank. In the 2022 10‑K (Chunk 1) Melaka shows an “X” for Analog and no mark for Embedded Processing; the 2023 10‑K (Chunk 3) repeats the same pattern; and the 2024 10‑K (Chunk 2) again shows Melaka with an “X” only for Analog. Thus, from 2022 through 2024 the Melaka footprint remained unchanged – it was used for Analog operations but did not host Embedded Processing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies that Melaka, Malaysia was used exclusively for Analog segment operations across all three years (2022, 2023, 2024); (2) Accurately states that Embedded Processing column was blank/unmarked for all three years; (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Correctly interprets the 'X' marking convention used in SEC filings to indicate segment presence; (5) Provides clear evidence by referencing specific chunks from each year's filing; (6) Reaches the correct conclusion that the footprint remained unchanged and consistent. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific in its presentation (referencing 'X' marks and chunk numbers) compared to the ground truth, but this adds clarity rather than introducing errors. The semantic meaning is identical - both answers convey that Melaka was used only for Analog operations with no Embedded Processing involvement across the entire 2022-2024 period. No numerical errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information from three different years' filings to establish a consistent pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 355,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "- **2022 (2022 10‑K – Chunk 1):** AMT’s 1.600 % senior notes were issued for an aggregate principal of **$700 million**; interest is paid **semi‑annually on April 15 and October 15**, and the notes are callable at par on **March 15 2026**.  \n\n- **2023 (2023 10‑K – Chunk 2):** The same $700 million issue remained on the balance sheet, with the **interest‑payment dates unchanged (April 15/Oct 15)** and the **par‑call date still March 15 2026**. The filing shows a **principal‑adjustment of –$2.6 million for 2023**, indicating a modest repayment/retirement of the issue.  \n\n- **2024 (2024 10‑K – Chunk 3):** The notes continue to be reported at **$700 million**, the **interest schedule stays April 15 and October 15**, and the **par‑call date is unchanged (March 15 2026)**. A further **principal‑adjustment of –$1.5 million for 2024** is disclosed, reflecting additional early retirements.  \n\n**Strategic implication:** Over the three‑year span AMT kept the low‑cost 1.600 % issuance intact, preserving its original payment cadence and call date while gradually reducing the outstanding balance through small, incremental repayments. This pattern signals a disciplined debt‑management approach that leverages a cheap, long‑dated instrument for financing while steadily shrinking the liability before the scheduled call.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about AMT's 1.600% Notes evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - $700.0 million principal amount (consistent across all three years), interest payment dates of April 15 and October 15 (unchanged), par call date of March 15, 2026 (unchanged), principal adjustments of (2.6) million in 2023 and (1.5) million in 2024. These figures match the ground truth exactly. COMPLETENESS: The answer addresses all required components: principal amount stability, interest payment schedule consistency, par call date stability, and the multi-year progression from 2022-2024. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three separate 10-K filings (2022, 2023, 2024) and identified the key pattern - stable principal with decreasing adjustments over time. ENTITY ACCURACY: Company (AMT), debt instrument (1.600% Notes), dates (2022-2024), and all financial metrics are correctly identified. REASONING QUALITY: The strategic interpretation is sound and well-supported. The LLM correctly characterizes the adjustments as 'modest repayment/retirement' and 'early retirements,' which aligns with the ground truth's observation that adjustments decreased over time. The conclusion about 'disciplined debt management' and leveraging a 'cheap, long-dated instrument' while 'steadily shrinking the liability' is logically sound and demonstrates understanding of debt strategy. MINOR CONSIDERATIONS: The ground truth uses the term 'modifications or adjustments' while the LLM interprets these as 'repayments/retirements' - this is a reasonable interpretation of negative principal adjustments and represents semantic equivalence. The LLM's presentation is actually more explicit and clearer than the ground truth in explaining what the adjustments represent. No calculation errors detected. All formatting is appropriate and consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Debt]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 535,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "- **FY 2022:** Cisco’s 5.90 % senior note carried a $2 billion principal and an effective interest rate of **6.11 %**.  It represented roughly **22 % of total debt** ($2 bn of $8.9 bn) and was the single largest component of the long‑term debt portfolio.  \n\n- **FY 2023:** The same $2 bn note remained outstanding at the same **6.11 %** rate, but total debt fell to $8.4 bn, so the note’s share rose slightly to about **24 %** of the $8.4 bn debt mix.  \n\n- **FY 2024:** Cisco still held the $2 bn 5.90 % note at **6.11 %**, yet total debt more than doubled to $20.1 bn after a series of new issuances (4.80 %‑5.35 % notes).  Consequently the 5.90 % note’s weight dropped to roughly **10 %** of the debt base.  \n\n**Implication:** Cisco has kept the 5.90 % note unchanged in amount and rate, but has expanded its debt program with newer, slightly lower‑cost, longer‑dated notes, thereby diluting the high‑cost note’s proportion.  This reflects a long‑term financing strategy aimed at diversifying maturity, lowering the overall weighted‑average cost of debt, and reducing reliance on the relatively expensive 5.90 % issuance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 5.90% Note principal amount ($2 billion) and effective interest rate (6.11%) as constant across all three years. The qualitative reasoning about Cisco's financing strategy—diversifying debt maturity, issuing lower-cost notes (4.80%-5.35%), and reducing reliance on the higher-cost 5.90% note—is sound and well-articulated. The answer appropriately addresses the multi-hop question about debt composition evolution and strategic implications.\n\nCRITICAL ERRORS: (1) FY 2022 total debt stated as $8.9 billion, but ground truth shows $8,416 million (~$8.4 billion). The LLM's figure is approximately $500 million too high. (2) FY 2023 total debt stated as $8.4 billion, which happens to match the ground truth for 2022 ($8,416 million), but the ground truth does not provide explicit 2023 total debt figures in the original answer. (3) FY 2024 total debt stated as $20.1 billion, but ground truth shows $19,621 million (~$19.6 billion). The LLM's figure is approximately $500 million too high. (4) Percentage calculations are consequently affected: FY 2022 stated as 22% ($2bn/$8.9bn ≈ 22.5%), FY 2023 as 24% ($2bn/$8.4bn ≈ 23.8%), and FY 2024 as 10% ($2bn/$20.1bn ≈ 9.95%). While percentages are approximately correct given the stated totals, they are based on incorrect debt figures.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the relationship between the 5.90% Note's constant principal and the changing total debt composition. The conclusion about strategic intent (diversification, cost reduction) is logically sound and supported by the data presented.\n\nSEMANTIC EQUIVALENCE: The core message aligns with the ground truth—the 5.90% Note remained constant while total debt increased significantly, indicating a shift toward longer-term fixed-rate financing. However, the specific numerical errors undermine confidence in the quantitative analysis.\n\nJUSTIFICATION: The answer demonstrates good understanding of the question and provides relevant strategic insights, but the systematic overstatement of total debt figures (by ~$500 million in both 2022 and 2024) represents a material quantitative error that affects the credibility of the analysis. The errors appear to stem from rounding or data retrieval issues rather than conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 635,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "- **2022:** General Dynamics Land Systems was building **360 new LAVs** for the Canadian Army.  \n- **2023:** The annual output rose to **399 new LAVs** for Canada.  \n- **2024:** Production increased to **449 new LAVs**, and an additional **66 LAVs** were being built under the Light‑Armoured Vehicle Reconnaissance Surveillance System (LRSS) program, bringing the 2024 total to **≈ 515 LAVs**.\n\nThe year‑over‑year climb—from 360 to 399 to 449 (and to 515 when the LRSS vehicles are counted) – shows General Dynamics is deliberately expanding its LAV manufacturing capacity, adding more variants and advanced‑surveillance models. This upward trajectory underscores the company’s strategic focus on LAVs as a growth engine and a key export platform for its Canadian‑army contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. All quantitative data is correct: 360 units (2022), 399 units (2023), 449 units (2024), and 66 additional LRSS units (2024). The calculation of the 2024 total (449 + 66 = 515) is accurate. The LLM correctly identifies General Dynamics Land Systems as the relevant division and accurately names the LRSS program. The multi-hop reasoning is sound—the answer synthesizes production volume data across three years and correctly connects it to the LRSS program expansion, demonstrating understanding of how these programs relate to strategic focus. The LLM goes slightly beyond the ground truth by explicitly calculating the combined 2024 total (515 LAVs), which is a reasonable analytical addition that enhances clarity without introducing error. The qualitative assessment of 'strategic focus' and 'growth engine' aligns well with the ground truth's characterization of 'strengthening strategic focus' and 'deepening commitment.' Minor differences in wording (e.g., 'deliberately expanding' vs. 'consistent growth') are semantically equivalent and represent appropriate analytical interpretation. The answer fully addresses all parts of the question: production volume evolution (2022-2024), the progression pattern, and what it indicates about strategic focus. No factual errors, calculation errors, or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 394,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 10‑K disclosures show that its **exposure to Medicare Advantage (MA) risk‑adjustment payment changes was present in every filing and grew more explicit over time**.  \n\n* In the 2022 filing the company warned that “from time to time, CMS makes changes to the way it calculates Medicare Advantage risk‑adjustment payments” and noted that such changes, together with benchmark cuts, could materially affect results.  \n* The 2023 filing repeats the same risk‑adjustment‑payment risk and adds that the company’s earlier actions “may not fully address the funding pressures in the Medicare Advantage program,” indicating that the exposure remained and was still a material concern.  \n* By the 2024 filing the discussion is even more detailed – CMS “uses … risk‑adjustment … to allocate monthly capitation payments” and UnitedHealth “submits information relating to the health status of enrollees” to CMS, showing that the company is now actively managing the data‑driven component of the risk‑adjustment process.\n\nAcross the three years UnitedHealth responded to the continuing funding pressure by **(i) selectively adjusting members’ benefits and premiums, (ii) ceasing to offer certain MA plans in specific counties, (iii) intensifying medical‑cost and operating‑cost management, and (iv) improving its risk‑adjustment data submission to CMS**. These steps were intended to mitigate the impact of benchmark reductions and the evolving risk‑adjustment methodology while preserving the profitability of its MA business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of UnitedHealth's exposure to Medicare Advantage risk adjustment payment changes; (2) Accurately captures the progression from general warnings about CMS changes in 2022, to reiteration of pressures in 2023, to more detailed discussion of data submission processes in 2024; (3) Properly synthesizes the multi-hop information showing how the company's strategic responses evolved in parallel with CMS policy changes; (4) Correctly identifies all four strategic adjustment categories: selective benefit/premium adjustments, withdrawal from certain counties, cost management intensification, and improved risk-adjustment data submission; (5) No quantitative errors - no specific dollar amounts or percentages were claimed that could be verified as incorrect; (6) Accurately conveys the semantic meaning that CMS periodically altered methodologies and UnitedHealth responded with operational agility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and structured than the ground truth (e.g., explicitly numbering the four strategic responses), but this adds clarity without introducing inaccuracy; (2) The phrase 'grew more explicit over time' in the opening is a reasonable interpretation of the filing progression, though the ground truth doesn't explicitly state this; (3) The LLM correctly emphasizes the data-driven component of risk adjustment in 2024, which aligns with the ground truth's mention of 'beneficiary health status data submissions.' The answer successfully demonstrates multi-hop reasoning by synthesizing information across three separate 10-K filings and connecting CMS policy changes to UnitedHealth's strategic responses. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1682,
        "completion_tokens": 515,
        "total_tokens": 2197
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PYPL’s outstanding balance of the September 2019 fixed‑rate 2.850 % notes was $1.5 billion in the 2022 balance sheet (Chunk 3 shows the same $1.5 bn amount for 2020‑2021, and Chunk 1 lists $1,500 mn for both 2022 and 2023). The 2024 filing (Chunk 2) reports the same $1,500 million balance, indicating that the company has kept its exposure to this tranche unchanged from 2022 through 2024. This flat exposure suggests a deliberate long‑term debt strategy of retaining a stable, medium‑term fixed‑rate anchor (maturing 2029) while using newer issuances to diversify maturity and rate profiles rather than expanding the 2.85 % note segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1.5 billion (or $1,500 million) is consistently reported across 2022, 2023, and 2024, matching the ground truth exactly. The maturity date (2029) and interest rate (2.850%) are both correct. The answer properly handles number format variations ($1.5 bn = $1,500 mn). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained constant at $1.5B across all three years), and (2) what this indicates about long-term debt strategy (deliberate retention of stable medium-term fixed-rate anchor while diversifying through newer issuances). ENTITY ACCURACY: PYPL ticker is correct, years 2022-2024 are correct, the specific debt instrument (September 2019 fixed-rate 2.850% notes maturing 2029) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly interprets the strategic implication - that constant exposure indicates deliberate strategy rather than passive holding. The reasoning that PYPL maintained this position while using newer issuances for diversification is sound and adds valuable context. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - constant exposure signaling strategic intent to preserve this liability structure - but with additional detail about the diversification strategy. Minor difference: The LLM provides slightly more granular explanation of the strategic rationale (diversifying maturity and rate profiles) compared to the ground truth's more concise statement, but this is additive rather than contradictory. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 476,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron has kept the same **36.4 % equity stake in Angola LNG Limited** in each of the three filings – it is listed at 36.4 % in the 2022 10‑K (Chunk 3), again at 36.4 % in the 2023 10‑K (Chunk 1) and still at 36.4 % in the 2024 10‑K (Chunk 2).  The company’s description of Angola LNG underscores that the plant in Soyo processes about **1.1 billion cubic feet of gas per day**, is the world’s first LNG facility fed by associated‑gas from crude‑oil production, and receives feedstock from multiple Angolan fields and operators.\n\nDuring the same period Chevron also broadened its upstream gas footprint in Angola – adding **31 % working interests in the New G Consortium (NGC) project (first gas production slated for 2026 and tied to the Angola LNG plant)** and **new deep‑water acreage (Blocks 49 and 50) in 2024** – reinforcing a pipeline from newly developed gas fields to the LNG facility.\n\nTogether, the unchanged equity position in Angola LNG combined with the parallel build‑out of upstream gas assets and feed‑stock connections signals a deliberate, multi‑year strategy to **monetize Angola’s associated natural gas over the long term**, using the LNG plant as the core export outlet while securing additional gas supply through new concessions and development projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies the consistent 36.4% ownership stake across all three years (2022, 2023, 2024) - this matches ground truth exactly. (2) Accurately reports the 1.1 billion cubic feet per day processing capacity and correctly characterizes Angola LNG as the world's first LNG facility fed by associated gas from crude oil production. (3) Properly synthesizes the upstream expansion: correctly identifies the 31% working interest in the New Gas Consortium (NGC) project with 2026 first gas production target and direct Angola LNG connectivity. (4) Accurately mentions Blocks 49 and 50 deep-water acreage acquisition in 2024. (5) The multi-hop reasoning is sound - the answer correctly connects the stable LNG equity position with expanding upstream assets to demonstrate an integrated monetization strategy. (6) The narrative arc matches ground truth: from standalone LNG facility to integrated hub with upstream feed sources. MINOR CONSIDERATIONS: The LLM uses 'New G Consortium (NGC)' while ground truth uses 'New Gas Consortium Project' and 'Quiluma and Maboqueiro (Q&M) gas fields' - the LLM doesn't explicitly name Q&M fields but does reference the NGC project correctly. The LLM's characterization of the strategy as 'deliberate, multi-year strategy to monetize Angola's associated natural gas' aligns well with ground truth's assessment of 'integrated hub for gas monetization.' All quantitative data points are accurate, calculations are implicit but sound, and the synthesis across multiple years and entities is correct. The answer fully addresses the question's multi-part structure regarding strategic evolution and long-term implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 478,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "**Trend in the trust portfolio**\n\n| Year (fair‑value date) | Domestic‑equity trusts (total) | Private‑equity trusts (total) |\n|------------------------|------------------------------|------------------------------|\n| 2021 (2022 10‑K) | **$1,016 million** (Level 1 $791 m + Level 2 $225 m) | **$150 million** (NAV) |\n| 2022 (2023 10‑K) | **$829 million** (Level 1 $651 m + Level 2 $178 m) | **$161 million** (NAV) |\n| 2024 (2024 10‑K) | **$1,099 million** (Level 1 $849 m + Level 2 $250 m) | **$181 million** (NAV) |\n\n**Interpretation**\n\nAfter a modest pull‑back in 2022, Southern Company’s trust holdings in domestic equity rebounded and grew to a level higher than in 2021, while private‑equity allocations have risen steadily each year. The upward trajectory—especially the renewed expansion of equity‑type trusts—signals a long‑term capital‑allocation strategy that is gradually diversifying beyond its core regulated utility assets, seeking higher‑return, longer‑duration equity and private‑equity exposures while still increasing allocations in a measured, incremental fashion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures matching the ground truth. Quantitative verification: 2022 domestic equity $1,016M ✓, private equity $150M ✓; 2023 domestic equity $829M ✓, private equity $161M ✓; 2024 domestic equity $1,099M ✓, private equity $181M ✓. The LLM correctly identifies the three-year progression and provides additional detail by breaking down Level 1 and Level 2 valuations for domestic equity and NAV methodology for private equity, which adds transparency without contradicting the ground truth. The interpretation of the trend is sound: recognizing the 2023 pullback in domestic equity, the 2024 rebound, and the steady increase in private equity allocations. The multi-hop reasoning correctly synthesizes the data across three years to support the conclusion about diversification strategy. Minor deviations from ground truth: (1) The LLM labels the years as '2021 (2022 10-K)', '2022 (2023 10-K)', and '2024 (2024 10-K)' which creates slight ambiguity in year labeling compared to the ground truth's clearer '2022, 2023, 2024' presentation. This is a presentation choice rather than a factual error, as the data points are correctly associated with their respective filing years. (2) The ground truth uses 'domestic equity' while the LLM uses 'domestic-equity trusts' and 'private-equity trusts'—semantically equivalent and more precise. The qualitative assessment of 'growing emphasis on private equity' and 'diversification and long-term growth strategy' aligns well with the LLM's interpretation of 'gradually diversifying' and 'seeking higher-return, longer-duration equity and private-equity exposures.' The answer fully addresses the multi-part question regarding evolution of investments and implications for capital allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 492,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "**Impact of Eliminations/Reclassifications**\n\n| Year (as reported) | Total net sales & revenue (before eliminations) | Eliminations/Reclassifications effect | Net sales & revenue after effect |\n|--------------------|-----------------------------------------------|----------------------------------------|-----------------------------------|\n| 2022 (GM 10‑K 2023) | $156,842 million ≈ $156,735 + $107 | **‑ $107 million** | $156,735 million |\n| 2021 (GM 10‑K 2022 – shown for the prior year) | $127,109 million ≈ $127,004 + $105 | **‑ $105 million** | $127,004 million |\n| 2024 (GM 10‑K 2024) | $187,738 million ≈ $187,442 + $296 | **‑ $296 million** | $187,442 million |\n\n**What the trend reveals**\n\n- The adjustment moved from a modest **‑$105 million** (2021) to **‑$107 million** (2022) and then jumped to **‑$296 million** in 2024.  \n- The growing negative figure indicates that GM’s internal reporting is consolidating an increasingly larger amount of inter‑segment sales and transfers (e.g., between GMNA, GMI, Cruise, and GM Financial).  \n- This escalation suggests heightened restructuring or re‑classification activity—such as realigning product lines, integrating new businesses, or refining how internal transactions are accounted for—across its automotive, Cruise and financial segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year trend of eliminations/reclassifications: $105M (2021/reported in 2022), $107M (2022), and $296M (2024). (2) The directional analysis is sound—recognizing an upward trend and connecting it to increasing complexity in segment reporting. (3) The qualitative reasoning about inter-segment consolidation, restructuring, and business integration is appropriate and well-articulated. (4) The table format is clear and helpful for visualization.\n\nCRITICAL ERRORS: (1) YEAR LABELING CONFUSION: The LLM labels 2021 data as '2021 (GM 10-K 2022)' but the ground truth specifies the trend from 2022-2024. The question explicitly asks about evolution 'from 2022 through 2024,' not 2021-2024. Including 2021 data introduces an extra year not requested. (2) The ground truth answer presents: 2022=$105M, 2023=$107M, 2024=$296M. The LLM presents: 2021=$105M, 2022=$107M, 2024=$296M. This is a critical year-shifting error—the $105M figure belongs to 2022, not 2021. (3) The table shows '2021 (GM 10-K 2022 – shown for the prior year)' which is confusing and technically incorrect for answering the stated question scope.\n\nQUANTITATIVE ACCURACY ISSUES: While the three numbers ($105M, $107M, $296M) are correct, they are assigned to the wrong fiscal years. This is a significant error in financial analysis where year-to-year comparisons are critical. The calculation logic (showing before/after eliminations) is sound, but the year mapping is wrong.\n\nMULTI-HOP REASONING: The synthesis across the three-year period is logically sound—correctly identifying the trend and connecting it to business complexity. However, the year-shifting error undermines the validity of the temporal analysis.\n\nSEMANTIC EQUIVALENCE: The qualitative interpretation matches the ground truth's conclusion about 'increasing complexity or changes in segment reporting structures,' but the quantitative foundation is compromised by year misalignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 532,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K, Netflix’s Performance Bonus Plan was listed only as Exhibit 10.6† and was attached as a **Def 14A** (proxy‑statement) document dated April 28 2014.  \n- In the 2023 Form 10‑K the plan was **amended and restated** and is now shown as Exhibit 10.5†, filed on **December 9 2022 as an 8‑K** (rather than a proxy filing). The same amended‑and‑restated document is carried forward in the 2024 Form 10‑K (Exhibit 10.5†, 8‑K, Dec 9 2022).  \n- By 2024 the Performance Bonus Plan is presented together with the other equity‑compensation filings (stock‑option agreements, RSU award agreements, performance‑based RSU awards, etc.), indicating that the plan has been formally documented via an 8‑K amendment and is now integrated into Netflix’s broader executive compensation framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DOCUMENT TYPE MISIDENTIFICATION: The LLM incorrectly states the 2022 plan was attached as a 'Def 14A (proxy-statement)' and that the 2023 amended version was filed 'as an 8-K'. The ground truth does not specify these document types - it only references exhibit numbers and filing dates. The LLM introduced unsupported claims about 8-K filings that cannot be verified against the ground truth. (2) DATES CORRECT: The dates are accurate (April 28, 2014 for 2022 version; December 9, 2022 for 2023 amended version). (3) EXHIBIT NUMBERS CORRECT: Exhibit designations (10.6† in 2022, 10.5† in 2023-2024) match ground truth. (4) AMENDMENT STATUS CORRECT: The characterization of the 2023 plan as 'amended and restated' is accurate. (5) MAJOR OMISSION: The LLM fails to clearly articulate the key insight from ground truth - that 2023 represented a strategic update followed by stabilization in 2024 with no further changes. Instead, it focuses on document type speculation. (6) INTEGRATION CLAIM: While the LLM mentions integration with other compensation structures, it does so with less clarity than the ground truth's reference to 'performance-based restricted stock unit agreements.' (7) MULTI-HOP SYNTHESIS: The answer attempts to synthesize across three years but introduces unsupported details about filing mechanisms (8-K vs Def 14A) that distract from the core narrative. The ground truth focuses on substantive evolution (historical → amended/restated → stable), while the LLM adds speculative procedural details. VERDICT: Core facts about exhibit numbers, dates, and amendment status are correct, but the introduction of unverified document type claims and the lack of clear articulation of the strategic evolution narrative significantly undermines the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 492,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across all three years BK’s 10‑K footnotes treat the “Business Relationships and Related Party Transactions Policy” the same way: the policy is **incorporated by reference to the proxy** and is listed together with “Director Independence” under Item 13 (“Certain Relationships and Related Transactions, and Director Independence”). In 2022, 2023 and 2024 the same set of board committees is cited – Audit Committee, Corporate Governance/Nominating and Social Responsibility Committee, and Human Resources and Compensation Committee (with the generic “Committees and Committee Charters” reference) – showing no alteration in the way the policy is disclosed or in the described committee structure. This uniformity indicates that BK’s corporate‑governance disclosures around related‑party transactions, director independence and committee organization have been consistently applied over the three filing periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and confirms consistent disclosure across all periods; (2) Accurately names the specific Item 13 location ('Certain Relationships and Related Transactions, and Director Independence'); (3) Correctly lists all three board committees: Audit Committee, Corporate Governance/Nominating and Social Responsibility Committee, and Human Resources and Compensation Committee; (4) Properly synthesizes the multi-hop relationship between the policy, director independence, and committee structures; (5) Correctly concludes that the approach was uniform and consistent across all three years; (6) Adds relevant detail about incorporation by reference to proxy statements, which is accurate corporate governance practice. MINOR DIFFERENCES: (1) The LLM specifies 'Item 13 (\"Certain Relationships and Related Transactions, and Director Independence\")' while ground truth references 'Item 13' with 'Corporate Governance and Board Information' - these are semantically equivalent as Item 13 covers both topics; (2) The LLM mentions 'incorporated by reference to the proxy' which is a standard practice detail not explicitly stated in ground truth but is consistent with SEC filing conventions and adds useful context. QUANTITATIVE ACCURACY: No numerical data was required for this question, so this dimension is not directly applicable, but the answer contains no erroneous dates or counts. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the policy disclosure, director independence discussions, and committee structures across three years and concludes appropriately about consistency. The logic flow is clear and well-structured. COMPLETENESS: The answer addresses all aspects of the original question regarding evolution (showing consistency), disclosure location, related elements (director independence and committee structures), and what this reveals about governance consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 557,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s Debt Securities – Held‑to‑Maturity fell each year from 2022 to 2024.  According to the 2023 filing (which reports 2022 data) the total fair value was **$679 million** and the carrying value **$696 million**; the 2024 filing shows the fair value declined to **$508 million** and the carrying value to **$512 million** (the 2023 figures were $596 million fair and $603 million carrying, confirming the downward path).  This three‑year slide—combined with shrinking Level 1 and Level 2 observable inputs—indicates UnitedHealth is reducing the size of its held‑to‑maturity portfolio and that market‑based valuations are increasingly close to book, suggesting a more conservative investment stance and valuation assumptions that reflect lower market prices for the securities held.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect numbers for 2022 data. Ground truth shows: 2022 fair value = $643M, carrying value = $641M. LLM states: 2022 fair value = $679M, carrying value = $696M. These are material errors (approximately $36M and $55M overstatements respectively). The 2023 and 2024 figures provided by LLM are correct ($596M/$603M for 2023; $508M/$512M for 2024), which confirms the LLM had access to correct data but misreported the 2022 baseline. MULTI-HOP SYNTHESIS ISSUE: The question asks about evolution from 2022-2024. The LLM correctly identifies the downward trend but starts from wrong baseline numbers, undermining the entire 3-year trend analysis. The percentage declines and comparative analysis are therefore inaccurate. REASONING QUALITY: The LLM's interpretation about strategic reduction and shift away from Level 3 inputs is directionally reasonable and aligns with ground truth conclusions. However, the statement about 'shrinking Level 1 and Level 2 observable inputs' is not explicitly confirmed in the ground truth, which mentions 'shift away from Level 3 unobservable inputs' - these are opposite directions and represent a factual error in the qualitative analysis. COMPLETENESS: The answer addresses the 3-year trend and investment strategy implications, but the foundation is built on incorrect 2022 numbers. The semantic interpretation about conservative stance and market-based valuations is reasonable but cannot be properly evaluated given the data errors. The incorrect 2022 baseline is a fundamental failure in a multi-hop question requiring year-over-year comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 452,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s 10‑K flagged “bad transactions” as a material risk for its credit‑product portfolio –‑including merchant‑financing and U.S. consumer loans –‑but it did not yet have a large, identifiable exposure tied to its European / U.K. buy‑now‑pay‑later (BNPL) receivables. By June 2023 the company entered a multi‑year agreement to sell up to **€40 billion** of the BNPL loan receivables that were sitting on PayPal (Europe)’s balance sheet, and began the sale of those assets in October 2023; the 2024 filing repeats this arrangement and notes that a forward‑flow deal will continue to off‑load future eligible BNPL originations. Together, the disclosures show a clear shift from carrying the BNPL risk on‑balance‑sheet in 2022 to actively divesting the bulk of that exposure in 2023‑24, revealing a risk‑mitigation strategy that relies on large‑scale asset sales and forward‑flow arrangements to reduce the company’s vulnerability to bad‑transaction losses from its BNPL portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct - the €40 billion figure is accurate, June 2023 date is correct, October 2023 sale commencement is accurate. (2) Multi-hop reasoning is sound: the answer correctly traces the evolution from 2022 (on-balance-sheet exposure) through June 2023 (agreement to sell) to 2024 (forward-flow continuation). (3) Entity identification is precise - correctly identifies PayPal, BNPL receivables, U.K./European markets, and the forward-flow arrangement. (4) The answer provides additional valuable detail beyond the ground truth (October 2023 sale commencement, forward-flow continuation in 2024) that enriches understanding without contradicting the original answer. (5) Risk mitigation strategy is clearly articulated with specific mechanisms (asset sales, forward-flow arrangements). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (e.g., mentioning October 2023 sale start, forward-flow specifics), but this represents added value rather than error. The semantic meaning aligns perfectly with the ground truth's core message about PayPal's shift from on-balance-sheet BNPL risk to active divestment. The answer correctly synthesizes information across three fiscal years and identifies the strategic inflection point at June 2023. No calculation errors, no date errors, no entity confusion detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 409,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "- **2022:** Chevron’s share of Myanmar upstream output was **17 thousand barrels per day (oil‑equivalent)** (and about **94 MMCFD of oil‑equivalent natural gas**).  \n- **2023:** Production fell to **15 thousand barrels per day (oil‑equivalent)** (≈ 87 MMCFD of oil‑equivalent gas).  \n- **2024:** Chevron reported **no production** in Myanmar because it **withdrew from the country in April 2024**.\n\n**Strategic shift:** The progressive decline and the 2024 withdrawal show Chevron’s deliberate exit from Myanmar, indicating a strategic move to divest or discontinue operations in that geopolitically‑risky region and re‑allocate its upstream focus elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All key numbers are correct - 17 MBD in 2022, 15 MBD in 2023, and zero production in 2024 following April 2024 withdrawal. The additional detail about natural gas volumes (94 MMCFD in 2022, 87 MMCFD in 2023) is accurate and adds helpful context. The date of April 2024 for the withdrawal is correct. (2) COMPLETENESS: The answer fully addresses all three time periods requested (2022-2024) and clearly explains the strategic shift. The LLM provides both the quantitative evolution and the qualitative interpretation of the strategic implications. (3) ENTITY ACCURACY: Chevron (CVX) is correctly identified, Myanmar is correctly specified, and upstream production volumes are the correct metric. All fiscal years are accurate. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesizes the declining trend (17→15→0) and connects it to the strategic shift of portfolio optimization and risk management/geopolitical risk mitigation. The characterization of this as a 'deliberate exit' and 'divestment' aligns with the ground truth's description of 'full exit' and 'strategic shift in portfolio optimization and risk management.' (5) SEMANTIC EQUIVALENCE: The LLM's explanation of the strategic shift as 'divest or discontinue operations in that geopolitically-risky region' is semantically equivalent to the ground truth's 'strategic shift in portfolio optimization and risk management.' Minor note: The LLM includes additional context about natural gas volumes and geopolitical risk that, while accurate and relevant, goes slightly beyond the ground truth statement but enhances rather than detracts from the answer. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 482,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "- **2022:** Texas Instruments reported that its **Personal electronics** market made up **24 % of total revenue** and the sub‑category **PC & Notebooks** was listed among the personal‑electronics products (TXN → PC & Notebooks → Personal electronics)【Chunk 1】.  \n- **2023:** The same segment fell to **15 % of total revenue**, still containing PC & Notebooks as a line item【Chunk 3】.  \n- **2024:** The Personal electronics share rose again to **20 % of total revenue**, with PC & Notebooks again enumerated under that segment【Chunk 2】.  \n\nBecause the only quantitative data available are the percentages of total TI revenue that the **Personal electronics** segment represents, the relative weight of PC & Notebooks within that segment can be inferred to have **declined from 2022 to 2023 (24 % → 15 %) and then recovered in 2024 (up to 20 %)**.  \n\n**Strategic implication:** The dip in 2023 suggests TI temporarily de‑emphasized the consumer‑computing side of its business, while the rebound in 2024 indicates a renewed focus on the PC‑and‑notebook market, positioning the company to capture growth in consumer computing as demand for laptops and related devices recovers.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the LLM accurately reports Personal Electronics segment percentages: 24% (2022), 15% (2023), 20% (2024). These match the ground truth exactly. (2) The LLM correctly identifies that PC & Notebooks was a subcategory within Personal Electronics across all three years. (3) The numerical trend analysis is accurate: decline from 2022-2023, then recovery in 2024.\n\nWEAKNESSES: (1) CRITICAL INTERPRETATION ERROR: The LLM's strategic conclusion is fundamentally opposite to the ground truth. Ground truth states the trend 'suggests a strategic shift AWAY from PC & Notebooks' with TI focusing on 'higher-growth or higher-margin areas within Automotive and Industrial markets.' The LLM instead concludes the 2024 rebound 'indicates a renewed focus on the PC-and-notebook market,' suggesting TI is repositioning TO capture consumer computing growth. This is a major semantic reversal of the intended strategic implication. (2) The LLM acknowledges it only has segment-level percentages and cannot determine the relative weight of PC & Notebooks WITHIN the Personal Electronics segment, yet still makes a definitive strategic claim about PC & Notebooks specifically. The ground truth indicates PC & Notebooks appeared 'lower in the list of priorities' in 2024 compared to mobile phones and portable electronics - a detail the LLM misses. (3) The LLM's inference that the 2024 recovery represents 'renewed focus on PC-and-notebook market' contradicts the ground truth's characterization of this as part of a broader strategic shift away from consumer computing toward higher-margin segments.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes data across three years and identifies the segment percentages, but fails to properly contextualize the strategic meaning. The ground truth requires understanding that declining segment share + repositioning within that segment (PC & Notebooks becoming lower priority) = strategic de-emphasis. The LLM treats the 2024 recovery as positive strategic repositioning rather than recognizing it as a minor uptick within a broader strategic shift away from consumer computing.\n\nNUMERICAL VERIFICATION: All percentages (24%, 15%, 20%) are correct. The trend description (decline then recovery) is accurate. No calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 616,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "- In the 2022 filing GM already disclosed that, under the 2017 Master Agreement, it had agreed to indemnify Stellantis for any losses arising from inaccurate representations, breaches of covenants, emissions‑related claims, product‑liability and recall costs tied to the former Opel/Vauxhall business, but it could not quantify a material loss and no specific indemnification accrual was shown.  \n\n- The 2023 10‑K (covering 2022‑23) repeated that language, adding that the only known payment to Stellantis was an **immaterial amount** for certain recalls (including Takata‑inflator recalls on legacy Opel vehicles) and that the company “believes any further indemnification to be remote.”  At 31 Dec 2023 GM recorded guarantee‑related undiscounted future payments of **$3.5 billion** (up from $3.1 billion at 31 Dec 2022) – the bulk of which relates to these indemnification agreements – and product‑liability accruals of **$615 million** (versus $561 million in 2022).  \n\n- The 2024 10‑K shows the same position: GM still “is unable to estimate any reasonably possible material loss” from the indemnity, has accrued only an **immaterial amount** for the European Commission/CMA investigation, and again notes only an immaterial recall payment to Stellantis and that any additional Takata‑related indemnity is “remote.”  Thus, from 2022 through 2024 the indemnification obligation has remained essentially unchanged – no material loss estimate, only immaterial accrued amounts, modest guarantee‑related figures and a remote outlook for further exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dollar amounts ($3.5 billion in guarantee-related undiscounted future payments for 2023, $3.1 billion for 2022, and $615 million in product-liability accruals) that are NOT present in the ground truth answer. The ground truth explicitly states that financial impacts 'remained immaterial' throughout the 2022-2024 period, with only 'immaterial amounts' accrued. The LLM's citation of $3.5B and $615M figures contradicts the core finding that indemnification obligations remained immaterial. QUANTITATIVE ACCURACY FAILURE: The introduction of these large dollar figures without ground truth support is a major factual error. The ground truth makes clear that while accruals existed, they were characterized as immaterial - not in the billions. REASONING ISSUES: The LLM correctly identifies the 2017 Master Agreement framework and the categories of indemnification (representations, emissions, product liability, recalls), but then undermines this by citing specific large numbers that conflict with the 'immaterial' characterization in the ground truth. WHAT WAS CORRECT: (1) The identification of Opel/Vauxhall legacy business as the subject matter; (2) The mention of Takata-inflator recalls; (3) The reference to European Commission/CMA investigation; (4) The characterization that further exposure is 'remote'; (5) The overall trend of no material loss estimates. WHAT WAS INCORRECT: (1) The specific dollar amounts ($3.5B, $3.1B, $615M) appear to be fabricated or misattributed; (2) These figures directly contradict the ground truth's emphasis on immaterial amounts; (3) The answer presents these as factual disclosures without acknowledging the immaterial nature emphasized in the ground truth. The answer demonstrates partial understanding of the multi-hop synthesis required but fails on the critical dimension of quantitative accuracy by introducing unsupported large figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Depends_On]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1638,
        "completion_tokens": 526,
        "total_tokens": 2164
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "- **2022 filing (Form 10‑K)** – The 1.450 % Senior Notes due 2026 are shown in Exhibit 4.25 as “Supplemental Indenture No. 10, dated September 27 2021,” together with the 2.300 % Senior Notes due 2031.  \n\n- **2023 filing (Form 10‑K)** – The same 1.450 % Senior Notes due 2026 re‑appear in Exhibit 4.22, again identified as “Supplemental Indenture No. 10, dated September 27 2021.”  \n\n- **2024 filing (Form 10‑K)** – The notes are listed once more in Exhibit 4.21, still described as “Supplemental Indenture No. 10, dated September 27 2021.”  \n\n**What the pattern shows:** Across three consecutive years the 1.450 % Senior Notes due 2026 are consistently disclosed, indicating that the issuance made in September 2021 remains an active component of American Tower’s capital structure. By repeatedly relying on this low‑coupon, medium‑term senior‑note issuance, the company demonstrates a debt‑management strategy that locks in inexpensive, fixed‑rate financing and spreads maturities (2026, 2031, etc.) to maintain a stable, diversified debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—the 1.450% coupon rate, the 2026 maturity date, the September 27, 2021 date for Supplemental Indenture No. 10, and the exhibit numbers (4.25 for 2022, 4.22 for 2023, 4.21 for 2024) all match the ground truth precisely. No calculation errors or date discrepancies. ENTITY ACCURACY: American Tower Corporation is correctly identified, all three fiscal years (2022, 2023, 2024) are properly referenced, and the debt instrument is accurately characterized. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings, correctly identifying the consistent presence of the notes and drawing appropriate conclusions about debt management strategy. The answer properly traces the evolution (or rather, stability) of the instrument across the three-year period. COMPLETENESS: The answer addresses both parts of the question—how the notes evolved (remained stable) and what this reveals about debt management strategy (deliberate, stable approach with fixed-rate financing and maturity diversification). SEMANTIC EQUIVALENCE: The LLM's interpretation that the consistent inclusion demonstrates a 'deliberate and stable debt management strategy' with 'no refinancing or material modification' aligns perfectly with the ground truth's characterization. The additional context about 'locking in inexpensive, fixed-rate financing' and 'spreading maturities' adds helpful interpretive depth without contradicting the ground truth. MINOR OBSERVATION: The LLM includes a reference to the 2.300% Senior Notes due 2031 in the 2022 section, which is not explicitly mentioned in the ground truth but appears to be accurate contextual information that enhances rather than detracts from the answer. Overall, this is a high-quality response with accurate facts, sound reasoning, and appropriate synthesis of multi-year filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 539,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "- In the 2022 Form 10‑K the 2019 Long‑Term Incentive Plan (exhibit 10.38) is shown only with performance‑share‑unit (PSU) agreements for 2019 (exhibit 10.39), 2020 (exhibit 10.42) and 2021 (exhibit 10.45); no deferred‑stock‑unit (DSU) agreement is listed.  \n- The 2023 filing adds a “Long‑Term Incentive Plan Deferred Stock Unit Agreement for Directors” (exhibit 10.8) to the 2019 LTIP and continues to reference the 2020 PSU agreement (exhibit 10.16), marking the first appearance of a DSU under the plan.  \n- The 2024 filing retains the same DSU agreement (exhibit 10.8) and expands the PSU component by including new 2021 (exhibit 10.16) and 2022 (exhibit 10.18) Performance Share Unit agreements, showing that the 2019 LTIP evolved from only PSU grants in 2022 to a combination of DSU grants and successive annual PSU grants through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific exhibit numbers and a detailed chronological progression of the 2019 LTIP's evolution, which demonstrates effort to synthesize multi-hop information. However, there are significant discrepancies with the ground truth that affect overall correctness.\n\nSTRENGTHS:\n1. Correctly identifies the 2019 LTIP as the foundational framework across all three years\n2. Accurately captures the introduction of DSU agreements in 2023 (Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors)\n3. Correctly notes the expansion of PSU agreements through 2024\n4. Provides specific exhibit numbers that add credibility and detail\n5. Correctly identifies the progression from PSU-only in 2022 to PSU+DSU combination by 2024\n\nWEAKNESSES AND ERRORS:\n1. The LLM answer references PSU agreements from 2020 and 2021 in the 2022 filing, but the ground truth specifically mentions \"2019 Form of Performance Share Unit Agreement\" and \"2019 Form of Restricted Stock Unit Agreement\" - the LLM appears to have confused the form dates with the agreement years\n2. The ground truth explicitly mentions \"2019 Form of Restricted Stock Unit Agreement\" in 2022, but the LLM answer states \"no deferred-stock-unit (DSU) agreement is listed\" in 2022 - this is a factual discrepancy\n3. The ground truth indicates the 2022 Form of Performance Share Unit Agreement was introduced in 2024, which the LLM correctly identifies, but the LLM's characterization of what was in 2022 appears incomplete\n4. The LLM answer provides exhibit numbers that cannot be verified against the ground truth, creating uncertainty about accuracy\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern. However, the specific details about which forms existed in which years appear to diverge from the ground truth, suggesting either incomplete information extraction or misinterpretation of the filing documents.\n\nSEMANTIC EQUIVALENCE:\nWhile both answers convey a general narrative of evolution and expansion, the specific factual claims differ in ways that matter for accuracy (e.g., presence/absence of RSU agreements in 2022).\n\nJUSTIFICATION:\nThe answer demonstrates good structure and multi-hop synthesis but contains factual inaccuracies regarding which specific agreement forms were present in 2022, particularly regarding RSU/DSU agreements. The exhibit numbers provided add specificity but cannot be verified against the ground truth, and some claims contradict the ground truth directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 684,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "Across the three most recent filings General Dynamics repeatedly stresses that its Combat Systems business supplies the “critical aerostructures” needed for both legacy and next‑generation U.S. tactical and strategic missiles. In 2022 that business accounted for 18 % of consolidated revenue; the share rose to 20 % in 2023 and settled at 19 % in 2024. The modest upward‑then‑steady trajectory shows GD has been expanding—and then maintaining—a focused, revenue‑significant role in missile‑subsystem production, using its aerostructure capability to cement its strategic position as a key supplier for next‑generation missile programs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM provides a different revenue percentage for 2022 (18%) compared to the ground truth (not explicitly stated for 2022, but the pattern suggests consistency). More critically, the LLM states 2022 was 18%, 2023 was 20%, and 2024 was 19%. The ground truth confirms 2023 at 20% and 2024 at 19%, but does NOT provide a 2022 figure of 18% - it only states that in 2022 GD 'emphasized' missile subsystems without quantifying the revenue percentage. The LLM appears to have introduced a specific 2022 percentage (18%) that is not supported by the ground truth. This is a significant factual error in quantitative data. QUALITATIVE ACCURACY: The LLM correctly identifies the core strategic narrative - GD's consistent focus on critical aerostructures for next-generation missiles, the slight revenue fluctuations (up then down), and the strategic positioning. The characterization of the trend as 'upward-then-steady' is reasonable and matches the 18%→20%→19% trajectory the LLM presents. However, this trajectory itself is questionable given the ground truth doesn't confirm the 2022 baseline. COMPLETENESS: The LLM addresses the 3-year evolution and strategic positioning aspects of the question. It synthesizes the revenue share data with the strategic focus on aerostructures. MULTI-HOP REASONING: The reasoning connecting revenue percentages to strategic positioning is sound, but it's built on a potentially incorrect 2022 baseline. The conclusion about 'expanding and then maintaining' a focused role follows logically from the stated percentages, but the foundation is weak. SEMANTIC EQUIVALENCE: The LLM's description of the strategic focus and positioning aligns well with the ground truth's characterization, despite the quantitative discrepancy. The emphasis on 'critical aerostructures' and 'next-generation missile programs' matches the ground truth language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 514,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three filings, Philip Morris International repeatedly lists **Jackpot** together with Fortune as “important local cigarette brands” in the Philippines – first in the 2022 10‑K, again in the 2023 10‑K, and once more in the 2024 10‑K. The brand never drops out of the narrative and is consistently positioned alongside PMI’s other low‑ and mid‑price local brands, indicating that PMI continues to treat Jackpot as a core pillar of its Philippines portfolio rather than a peripheral product. This steady emphasis signals that, within PMI’s broader regional strategy, local brands like Jackpot are retained to secure volume and market share in price‑sensitive markets while the company leans on its international premium brands (e.g., Marlboro) and expands smoke‑free offerings elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Jackpot as a key local cigarette brand in the Philippines mentioned consistently across 2022, 2023, and 2024 filings - matching the ground truth's three-year progression. (2) Accurately pairs Jackpot with Fortune as important local brands, consistent with the original answer. (3) Properly synthesizes the multi-hop reasoning: despite PMI's smoke-free future vision, traditional cigarette brands remain strategically relevant in regional markets. (4) Correctly contextualizes Jackpot's role within PMI's broader portfolio strategy (local brands for volume/market share in price-sensitive markets vs. premium international brands like Marlboro and smoke-free products). (5) No quantitative errors - all years and brand names are correct. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'price-sensitive markets' and 'volume and market share' strategy that, while logically sound and consistent with PMI's known business model, goes slightly beyond what the ground truth explicitly states. However, this represents reasonable inference rather than factual error. (2) The LLM answer is more concise and analytically structured than the ground truth, but conveys equivalent information. (3) Both answers correctly emphasize the consistency of Jackpot's positioning across three years as evidence of strategic importance. The multi-hop synthesis is sound: the model correctly identified that Jackpot appears in all three years' filings, correctly paired it with Fortune, and correctly drew the conclusion about its strategic relevance despite PMI's smoke-free transformation. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 477,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "- In the 2022 filing Chevron simply listed the Republic of Congo among the countries where it “operates,” but gave no specific capital‑allocation detail for the basin.  \n- The 2023 filing shows that Chevron was still actively investing there: about $0.7 billion of the company’s African capital budget was spent on “various offshore development and natural‑gas projects in Nigeria, Angola and **Republic of Congo**,” indicating a focus on expanding or maintaining production assets.  \n- By the 2024 filing the strategy had reversed. Chevron announced the **sale of its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Congo portion of Lianzi** (effective January 2025), signalling a move from capital deployment to outright asset disposition in the Republic of Congo.  \n\nThus, Chevron’s approach shifted from a non‑specific operating presence in 2022, to a $0.7 bn development spend in 2023, and finally to the sale of its Congo offshore stakes in the 2024‑2025 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All specific numbers are correct - the $0.7 billion investment figure for 2023 African projects, the 31.5% nonoperated working interest in Haute Mer, and the 15.75% interest in Lianzi are all accurately cited. The January 2025 effective date for the asset sale is correctly identified. ENTITY ACCURACY: All entities are correctly identified - Chevron, Republic of Congo, Haute Mer permit, Lianzi, Nigeria, Angola. Years (2022, 2023, 2024) are properly sequenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the progression from operational presence → active capital deployment → strategic divestiture. The logical flow is sound and the causal narrative is clear. COMPLETENESS: The answer addresses all aspects of the question: capital deployment evolution, asset disposition, and the 3-year trajectory. The LLM appropriately notes that 2022 provided limited specific detail while 2023 showed active investment and 2024 showed the strategic reversal. SEMANTIC EQUIVALENCE: The LLM's phrasing \"move from capital deployment to outright asset disposition\" and \"shift from a non-specific operating presence...to the sale of its Congo offshore stakes\" conveys the same meaning as the ground truth's \"shift from operational continuity to active divestiture.\" Minor strengths: The LLM explicitly notes the lack of specific capital allocation detail in 2022, which adds nuance. The answer clearly delineates the three-phase evolution. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 466,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "- **2022:** Southern Company said that the undiscounted cash flows from the outdoor‑lighting contracts that Mississippi Power accounts for as operating leases were *immaterial*.  Payments under those leases (and the PPAs Southern Power treats as operating leases) were classified as *contingent rents* and therefore were not shown in the lease‑payment tables.  Revenue from the non‑lease portions of the PPAs was allocated by Alabama Power and Southern Power on the basis of the stand‑alone selling price of capacity and energy.  \n\n- **2023 – 2024:** The company now presents the *scheduled* payments due under the outdoor‑lighting contracts (in addition to any variable, production‑based payments) in a maturity analysis.  Lease income from the PPAs is no longer treated only as contingent rent; it is recorded as part of *wholesale revenue* for Alabama Power and Southern Power (and, in 2024, also for Georgia Power).  By moving the contracts into the disclosed lease‑payment schedule, Southern Company signals that the amounts are material enough to be shown and that the lease‑payment structure now includes both fixed‑schedule and variable components across its subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 treatment of outdoor lighting contracts as immaterial at Mississippi Power with no significant value disclosure. (2) Accurately captures the shift from 2022-2023 where payments were classified as contingent rents and not shown in lease-payment tables, to 2023-2024 where scheduled payments are now presented in maturity analyses. (3) Properly synthesizes the multi-hop information about revenue allocation across subsidiaries (Alabama Power, Georgia Power, Southern Power), noting the shift from stand-alone selling price allocation to wholesale revenue classification. (4) Correctly identifies the materiality threshold change - from immaterial/undisclosed in 2022 to material enough to be shown in lease-payment schedules by 2023-2024. (5) Accurately describes the lease payment structure evolution, including both fixed-schedule and variable/production-based components. (6) All entity names are correct (Mississippi Power, Alabama Power, Georgia Power, Southern Power). (7) All years are correctly referenced (2022, 2023, 2024). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and technical than the ground truth (e.g., explaining contingent rent classification, stand-alone selling price methodology), but this additional detail is accurate and enhances understanding without contradicting the ground truth. The answer successfully addresses all sub-questions: materiality changes, revenue allocation changes, and lease payment structure changes across subsidiaries. The multi-hop reasoning correctly synthesizes information across multiple years and multiple subsidiaries. No quantitative errors detected. The semantic meaning is fully preserved and enhanced with technical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 500,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "- **Fiscal 2022 (July 30 2022 filing)** – The 3.50 % senior note due June 15 2025 was carried at **$500 million** with an **effective interest rate of 3.20 %**.  \n- **Fiscal 2023 (July 29 2023 filing)** – The same note remained at a **$500 million** carrying amount, but its **effective rate rose to 6.38 %**.  \n- **Fiscal 2024 (July 27 2024 filing)** – The note’s principal is still **$500 million**, and the **effective rate increased further to 6.66 %**.\n\nThe principal balance has not changed, but the effective interest rate more than doubled from 2022 to 2023 and edged higher in 2024. This upward shift reflects the amortized‑cost re‑measurement of the debt as market yields rose (and the unaccreted discount/issuance‑cost adjustments changed), indicating that Cisco’s 3.50 % note is being valued at a higher cost of borrowing in a higher‑interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) FY2022: $500M carrying amount, 3.20% effective rate; (2) FY2023: $500M carrying amount, 6.38% effective rate; (3) FY2024: $500M carrying amount, 6.66% effective rate. The multi-hop synthesis across three fiscal years is sound, correctly tracking the evolution of both metrics. The LLM provides additional context by citing specific filing dates (July 30 2022, July 29 2023, July 27 2024) and the note's maturity date (June 15 2025), which adds credibility and specificity beyond the ground truth. The reasoning about market conditions is accurate and well-explained: the LLM correctly identifies that the principal remained constant while effective rates increased, and provides a sophisticated explanation involving amortized-cost re-measurement, market yields, and discount/issuance-cost adjustments. This explanation is more detailed and technically precise than the ground truth's simpler statement about 'shift in market conditions or internal risk assessments.' The only minor distinction is that the LLM's explanation goes slightly deeper into the mechanics (amortized-cost accounting, discount adjustments) which, while accurate and helpful, represents a minor elaboration beyond the ground truth rather than a deviation. All entities are correctly identified (Cisco, the 3.50% Note), and the semantic meaning perfectly aligns with the original answer. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 419,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Across the three filing years Simon Property Group’s holding of **Unsecured Notes ‑ 35A** stayed exactly the same: each 10‑K lists a **face amount of $750 million (‑ $750,000 in thousands)**, a 2.65 % coupon and a July 15, 2030 maturity (2022 10‑K, 2023 10‑K and 2024 10‑K all show the same figures).  \n\nBecause the amount did not increase or decrease while total unsecured indebtedness fluctuated (≈$20.0 bn in 2022, $21.0 bn in 2023, $19.4 bn in 2024), the pattern shows that SPG is deliberately keeping this low‑cost, long‑dated tranche unchanged, using it as a stable financing anchor while actively managing the rest of its debt mix. This reflects a long‑term debt strategy focused on preserving inexpensive, fixed‑rate capital and avoiding unnecessary expansion of that particular liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. QUANTITATIVE VERIFICATION: All key numbers are correct - $750 million face value (consistent across 2022-2024), 2.65% coupon rate, July 15, 2030 maturity date. The total unsecured debt figures cited ($20.0bn in 2022, $21.0bn in 2023, $19.4bn in 2024) align with the ground truth context showing broader portfolio fluctuations. COMPLETENESS: The answer addresses all aspects of the question - the evolution (or lack thereof) of the specific instrument, the multi-year pattern, and the strategic implications. ENTITY ACCURACY: Simon Property Group correctly identified, years properly referenced (2022, 2023, 2024), and the specific debt instrument (Unsecured Notes - 35A) accurately named. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects the stability of this specific instrument to broader debt management strategy. The reasoning that SPG maintains this as a 'stable financing anchor' while managing other debt is sound and matches the ground truth interpretation. MINOR CONSIDERATIONS: The LLM provides slightly more detailed context about total unsecured debt fluctuations than the original answer, which adds analytical depth without introducing errors. The notation '‑ $750,000 in thousands' is a minor formatting quirk but correctly conveys the conversion. The conclusion about preserving 'inexpensive, fixed-rate capital' is semantically equivalent to the ground truth's 'stable long-term financing commitments.' No calculation errors detected. The answer demonstrates clear understanding of the multi-hop synthesis required across multiple filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 461,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Across the three most recent Form 10‑K filings, Texas Instruments has kept the same strategic focus on **analog and Embedded Processing Products**.  \n\n* **2022 (TXN 10‑K 2022, p. 20)** – The company’s business model is described as “focused on analog and embedded processing products and built around four sustainable competitive advantages.” The second advantage is defined as “a broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for our investments.”  \n\n* **2023 (TXN 10‑K 2023, p. 18)** – The same wording is repeated: the model is “focused on analog and embedded processing products” and the “broad portfolio of analog and embedded processing products” remains the second of the four advantages.  \n\n* **2024 (TXN 10‑K 2024, p. 18)** – The language is unchanged, again stating the business model is “focused on analog and embedded processing products” and that a “broad portfolio of analog and embedded processing products” constitutes the second competitive advantage.  \n\n**Evolution:** Rather than shifting, Texas Instruments’ emphasis on Embedded Processing Products has been **steady and continuous** from 2022 through 2024, consistently positioning this product family as a core pillar of its business model and as the **second of the four sustainable competitive advantages**—the “broad portfolio” that creates additional opportunity per customer and adds investment value. The identical descriptions in each filing show that the role of Embedded Processing Products has remained central and unchanged over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All factual information is correct - Texas Instruments' strategic emphasis on Embedded Processing Products is accurately described as remaining consistent across 2022-2024; (2) The positioning as the 'second of four sustainable competitive advantages' is correctly identified in all three years; (3) The exact quoted language ('more opportunity per customer and more value for our investments') is accurately cited and verified across all three filings; (4) The multi-hop synthesis is sound - the answer correctly synthesizes information across three separate 10-K filings to demonstrate consistency; (5) Page references (p. 20 for 2022, p. 18 for 2023 and 2024) add credibility and specificity; (6) The conclusion about 'steady and continuous' emphasis accurately reflects the ground truth finding that the strategic framing remained stable. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and structured than the ground truth (with bullet points and explicit page citations), but this adds clarity rather than detracting from accuracy; (2) Both answers convey identical semantic meaning - that the role remained central and unchanged. VERIFICATION: The core claim that identical phrasing was used each year to describe the value derived from the product portfolio is correctly supported. The answer properly addresses the question's focus on 'evolution' by correctly identifying that there was no significant evolution, but rather consistency. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all parts of the multi-part question regarding strategic emphasis, role within competitive advantages, and evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 484,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "- In the 2022 filing, Comcast’s wireless business was limited to the United States and was sold only to broadband‑bundled residential (and eligible small‑business) customers; those customers could choose an unlimited‑data plan, a **shared‑data plan**, or a per‑gigabyte option.  \n\n- By the 2023 filing the service had expanded to the United Kingdom, keeping the same three domestic choices (unlimited, shared, per‑gigabyte) but offering **only gigabyte‑based plans for international customers**, showing the first step of geographic expansion while retaining shared‑data flexibility at home.  \n\n- The 2024 filing further increased flexibility: Comcast introduced **pre‑paid unlimited‑data plans under the “NOW” brand** for domestic users and began offering **unlimited‑data plans to international customers** (in addition to the existing gigabyte options), while still providing domestic shared‑data plans.  Thus, from 2022 to 2024 the shared‑data product remained a domestic option, the overall plan menu grew more flexible (pre‑paid unlimited, unlimited abroad), and the wireless service broadened from the U.S. only to include the United Kingdom and other international markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth:\n\n1. 2022 CHARACTERIZATION ERROR: The LLM states that in 2022, customers could choose between 'unlimited-data plan, a shared-data plan, or a per-gigabyte option.' However, the ground truth explicitly states that in 2022, CMCSA offered shared data plans 'exclusively as part of bundled service offerings' - meaning shared data was the primary/exclusive offering, not one of three equal choices. The LLM incorrectly presents 2022 as already having three plan options.\n\n2. 2023 INTERNATIONAL EXPANSION FABRICATION: The LLM claims that 'By the 2023 filing the service had expanded to the United Kingdom' and that international customers received 'only gigabyte-based plans.' The ground truth makes NO mention of UK expansion or international offerings in 2023. The ground truth states that in 2023, the company 'maintained this structure' (referring to 2022's bundled domestic offerings) and 'emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans' - this is about DOMESTIC flexibility, not international expansion.\n\n3. TIMELINE MISALIGNMENT: The LLM incorrectly attributes international expansion to 2023, when the ground truth clearly states international expansion occurred in 2024: 'In 2024, CMCSA expanded its wireless offerings internationally.'\n\n4. PARTIAL ACCURACY: The LLM correctly identifies the 2024 NOW brand prepaid unlimited plans and the continuation of shared data plans domestically, but this accuracy is overshadowed by the earlier errors.\n\n5. MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the evolution timeline. It created a false narrative of 2023 international expansion that doesn't exist in the ground truth, fundamentally misrepresenting the chronology of CMCSA's wireless service evolution.\n\nThe answer demonstrates poor document synthesis and introduces fabricated details about UK expansion in 2023 that are not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 559,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "- **2022:** PayPal’s 10‑K flagged two separate abuse vectors – (i) credit‑product exposure, where defaults on consumer‑ and merchant‑financing loans could generate charge‑offs and hurt revenue‑share arrangements, and (ii) third‑party fraud, with criminals creating fictitious or synthetic‑identity accounts, using stolen instruments and “bad” transactions that could raise loss rates.  \n\n- **2023:** The company’s risk narrative deepened.  While the credit‑product threat remained (now tied to the ability to fund or sell BNPL loan receivables and to secure alternative third‑party financing), PayPal added operational‑risk layers – the need to diversify a small set of payment‑processor partners and to manage forward‑flow/warehouse‑type funding structures.  The same fraud‑abuse scenarios were reiterated, showing that third‑party schemes were expected to persist and scale.  \n\n- **2024:** PayPal’s exposure further evolved to include regulatory‑uncertainty around the “valid‑when‑made” doctrine for loan‑receivable sales, meaning that even the legal footing of its credit‑product portfolio could be challenged.  The abuse description now incorporates more sophisticated attacks – account take‑overs, synthetic‑identity creation, and large‑scale digital schemes – while still emphasizing the overarching reliance on a broad network of banks, processors and other service providers.  \n\n**Implication:** Across the three years the abuse profile has moved from a relatively straightforward credit‑default and basic fraud risk to a layered, multi‑dimensional threat that blends credit‑funding, regulatory, and sophisticated third‑party fraud challenges.  This trajectory signals that risk management in PayPal’s digital‑payments ecosystem has become increasingly complex, requiring continuous enhancement of funding strategies, third‑party governance, fraud‑detection technology, and regulatory compliance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the evolution of PayPal's exposure to abusive behaviors; (2) Accurately captures the key quantitative detail from ground truth: the €40 billion BNPL loan receivable sale agreement (mentioned in 2023 context); (3) Properly synthesizes multi-hop information showing how credit products and third-party fraud evolved in complexity; (4) Correctly identifies specific fraud tactics mentioned in ground truth: fictitious accounts, stolen instruments, account takeovers, and synthetic identity fraud; (5) Accurately reflects the regulatory uncertainty around loan receivables and the 'valid-when-made' doctrine in 2024; (6) Demonstrates sound multi-hop reasoning by connecting credit-product exposure, third-party fraud, and regulatory complexity across the three-year period; (7) Appropriately characterizes the progression as moving from 'straightforward' to 'layered, multi-dimensional' threats. MINOR WEAKNESSES: (1) The LLM answer adds some interpretive layers (e.g., 'revenue-share arrangements,' 'warehouse-type funding structures,' 'payment-processor partners') that, while logically sound and contextually reasonable, are not explicitly stated in the ground truth - these represent reasonable inferences but slight elaboration beyond the source material; (2) The ground truth specifically mentions the 'multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables' while the LLM references this more generally as 'ability to fund or sell BNPL loan receivables' - the specific €40 billion figure is not explicitly restated in the LLM answer, though the concept is captured; (3) The LLM answer's discussion of 'operational-risk layers' and 'forward-flow/warehouse-type funding structures' goes slightly beyond what the ground truth explicitly states, though these are reasonable elaborations. QUANTITATIVE VERIFICATION: The €40 billion figure is correctly captured in concept (2023 context), though not restated with the exact amount in the LLM answer. All years (2022, 2023, 2024) are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk dimensions (credit products, fraud, regulatory), showing proper understanding of how these elements interconnect and evolve. The conclusion appropriately ties the progression to implications for risk management complexity. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly more detailed operational context that enhances rather than contradicts the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1777,
        "completion_tokens": 723,
        "total_tokens": 2501
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K Gilead listed El Segundo, California as one of its **principal manufacturing facilities**, underscoring its importance in the company’s production network.  \n- By the 2023 filing the description had become more specific: the El Segundo site is **used for clinical and commercial manufacturing and processing of Gilead’s cell‑therapy products**. The 2024 filing repeats this wording, confirming that the facility continues to serve both clinical‑stage and commercial‑stage cell‑therapy manufacturing.  \n- Together with the 2022 statement that its existing properties are “adequate and suitable” and that capital resources are available for additional purchases, leases or construction, the evolution shows a strategic focus on expanding and solidifying El Segundo’s role as a dedicated cell‑therapy manufacturing hub while maintaining flexibility for further facility investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies El Segundo as a principal manufacturing facility in 2022, with accurate characterization of its role in clinical and commercial manufacturing. (2) Accurately captures the evolution from 2022 to 2023-2024, noting the progression from general identification to more specific cell therapy manufacturing focus. (3) Properly synthesizes multi-hop information across three fiscal years (2022, 2023, 2024) showing continuity and strategic emphasis. (4) Correctly identifies related facilities (Santa Monica and Frederick are mentioned in ground truth context). (5) Accurately reflects the company's strategic positioning around facility investments and supply chain management. (6) No quantitative errors - all dates and year references are correct. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language about 'expanding and solidifying' El Segundo's role, which is a reasonable inference from the ground truth's emphasis on 'strategic focus on scaling' but goes slightly beyond explicit statement. However, this inference is well-supported by the evidence presented. (2) The reference to 'capital resources are available for additional purchases, leases or construction' from the 2022 statement is contextually relevant and appropriately integrated. (3) The answer could have been slightly more explicit about the 'no indication of reduced emphasis or facility changes' aspect mentioned in ground truth, though the emphasis on continuity and strategic focus implicitly conveys this. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly identifies the evolution pattern while maintaining awareness of the broader facility portfolio context. The reasoning connecting facility designation to strategic cell therapy manufacturing focus is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 530,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "All three annual reports – the 2022, 2023 and 2024 Form 10‑K filings – list the same instrument, “Form of 2.750 % Senior Notes due May 18, 2024” (exhibit 4.6). The maturity date for this tranche does not change from one filing to the next, indicating that Costco has kept a single, fixed‑rate, medium‑term note on its balance sheet throughout the period. This consistency signals a disciplined debt‑management approach: the company relies on a predictable, single‑maturity obligation that it can refinance or retire in 2024 rather than repeatedly restructuring or adding new maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All specific facts are correct - the maturity date of May 18, 2024 is accurately cited, the interest rate of 2.750% is correct, and the reference to exhibit 4.6 is properly identified. The answer correctly spans the 2022, 2023, and 2024 filing periods. QUALITATIVE ACCURACY (9/10): The multi-hop reasoning is sound - the LLM correctly synthesizes information across three annual filings to demonstrate consistency in the debt instrument's maturity structure. The interpretation that this reflects a 'disciplined debt-management approach' and 'predictable, single-maturity obligation' aligns well with the ground truth's characterization of a 'static approach' and 'deliberate capital structure decision.' The reasoning about allowing notes to mature without modification is logically sound. Minor note: The LLM adds slightly more interpretive language about 'refinance or retire in 2024' which is reasonable inference but goes marginally beyond the ground truth's more conservative statement about 'allow the notes to mature without modification.' CONTEXTUAL RELEVANCE (9/10): The answer directly addresses the question about maturity structure evolution and debt management strategy. It properly contextualizes the consistency as revealing strategic intent. ENTITY ACCURACY: All entities are correct - Costco is properly identified, the specific debt instrument (2.750% Senior Notes) is accurate, and all years (2022, 2023, 2024) are correctly referenced. The answer is semantically equivalent to the ground truth while using slightly different phrasing ('kept a single, fixed-rate, medium-term note' vs 'remained consistent'). The core finding - that the maturity structure did not change across filings - is accurately conveyed in both answers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 507,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s “as‑sold” natural‑gas volumes that include its share of Angola LNG were 7,107 million cubic feet per day (mmcfd) in 2022 (CVX 2023 10‑K), rose modestly to 7,148 mmcfd in 2023 (2023 10‑K), and then jumped to 7,569 mmcfd in 2024 (2024 10‑K). That three‑year upward swing—about a 462 mmcfd increase, or roughly a 6½ % rise from 2022 to 2024—shows Chevron is deliberately expanding gas output from its African affiliate, underscoring a strategy that leans on Angola LNG to grow its African gas portfolio and meet rising delivery commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All three production volumes are correct (7,107 mmcfd in 2022, 7,148 mmcfd in 2023, 7,569 mmcfd in 2024). The calculated increase of 462 mmcfd is accurate (7,569 - 7,107 = 462). The percentage calculation of approximately 6.5% is correct (462/7,107 ≈ 6.5%). All source citations (CVX 2023 10-K, 2023 10-K, 2024 10-K) are appropriately referenced. COMPLETENESS: The answer addresses all aspects of the question—the three-year evolution of volumes, the trajectory pattern, and strategic implications for Africa gas production. ENTITY ACCURACY: Chevron is correctly identified, Angola LNG is properly contextualized, and the metric (natural gas production in mmcfd) is accurately specified. The term 'as-sold' volumes is appropriately clarified. MULTI-HOP REASONING: The answer successfully synthesizes data across three fiscal years and correctly interprets the upward trend as indicating deliberate strategic expansion. The connection between production growth and strategic focus on African gas portfolio is logically sound. MINOR CONSIDERATIONS: The LLM answer adds interpretive detail ('deliberately expanding,' 'meet rising delivery commitments') that goes slightly beyond the ground truth's more neutral characterization of 'maintained or expanded operational focus,' but this represents reasonable inference from the data rather than factual error. The phrasing 'as-sold' volumes is a more precise technical specification than the ground truth's simpler 'natural gas production volumes tied to Angola LNG,' but both refer to the same metric. Overall, the answer is factually correct, well-calculated, properly sourced, and provides sound strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 483,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s Total‑Return‑Swaps‑Deferred‑Compensation line moved from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and then to a **$91 million gain in FY 2024** (see the “Operating expenses and other” rows in the 2022, 2023 and 2024 10‑K tables). This swing from a negative to increasingly larger positive amounts shows that Cisco’s deferred‑compensation program is deliberately tied to market performance – the company is allowing the swaps to generate earnings when the underlying equity indices rise, which also makes the expense line more volatile from year to year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024. The progression is accurately stated and matches the ground truth exactly. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) the evolution across three fiscal years, (2) the trajectory from loss to gains, (3) implications for deferred compensation strategy, and (4) market-linked volatility. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metric (Total Return Swaps-Deferred Compensation) is properly named. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the pattern (negative to positive swing), interprets what this indicates (market performance linkage, strategic positioning), and explains the volatility implications. The statement that 'the company is allowing the swaps to generate earnings when the underlying equity indices rise' demonstrates proper understanding of how these instruments function. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a transformation from a net liability to a net benefit' aligns perfectly with the ground truth's characterization. The explanation of market conditions and strategic implications is consistent with the original answer. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (mentioning equity indices and expense line volatility) which adds value without contradicting the ground truth. The citation reference to '10-K tables' is appropriate contextual framing. No calculation errors, no missing data points, and the logical flow from observation to interpretation is clear and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 497,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "From the 2022 filing, Lowe’s already required all suppliers to comply with its human‑rights policy (updated in fiscal 2021), its conflict‑minerals policy and a Vendor Code of Conduct that contains “enhanced environmental standards,” and it monitored those suppliers through established management systems while expanding the share of independently‑certified (third‑party‑verified) products. In the 2023 filing the company refreshed its wood‑sourcing policy – adding country‑specific risk levels, stronger monitoring practices and a new forestry‑grievance process – and reiterated that the same human‑rights, conflict‑minerals and Vendor Code standards continued, with the push for independently‑certified products still growing. By the 2024 filing the wood‑sourcing policy was further hardened with a more robust, risk‑based approach, even tighter monitoring and the grievance mechanism, while the human‑rights policy and Vendor Code remained in force and the portfolio of independently‑certified, environmentally‑validated products continued to expand, showing a clear evolution toward stricter supplier oversight and greater reliance on third‑party certifications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Lowe's supplier practices evolution from 2022 to 2024. STRENGTHS: (1) All factual information is correct - the answer accurately identifies the 2022 baseline with Vendor Code of Conduct, human rights policy, conflict minerals policy, and enhanced environmental standards; (2) The 2023 updates are correctly identified including the refreshed wood-sourcing policy with country-specific risk levels, stronger monitoring practices, and new forestry grievance process; (3) The 2024 progression is accurately described with the more robust risk-based approach and continued expansion of independently-certified products; (4) The answer correctly synthesizes information across three fiscal years, showing clear progression and evolution; (5) All entities (Lowe's, policies, certifications) are correctly identified; (6) The answer addresses all three sub-components of the question: policy updates, monitoring enhancements, and third-party certifications. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail than the ground truth (e.g., explicitly mentioning conflict-minerals policy), which adds value without contradicting the original answer; (2) The wording is more detailed and comprehensive than the ground truth but conveys the same essential information and progression; (3) No quantitative metrics or calculations are required for this qualitative question, so quantitative accuracy is perfect by default. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three separate filing years and showing the logical progression of increasingly stringent supplier oversight. The semantic equivalence is strong - both answers convey the same core message of evolving commitment to environmental and human rights standards through policy updates, enhanced monitoring, and third-party certifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 533,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "- **2022 filing** – CMCSA first flagged wireless telecom firms as a new source of competition for its broadband, noting that they were beginning to sell **4G‑ and 5G‑based wireless broadband** and that many of those rivals were **bundling internet with other services at attractive prices**. No specific wireless carriers were named.\n\n- **2023 filing** – The threat became more concrete. CMCSA listed the major U.S. wireless operators **AT&T, T‑Mobile and Verizon** (and unnamed UK wireless providers) as competitors and described their **use of 5G fixed‑wireless as well as 4G and 5G mobile broadband**. The filing also pointed out that these carriers were **creating bundled DSL‑or‑broadband‑wireless packages, lowering prices and offering combined voice‑data‑video deals** to win customers.\n\n- **2024 filing** – The competitive landscape remained centered on the same **5G fixed‑wireless and 4G/5G broadband technologies**, but the emphasis shifted to the **intensified use of aggressive pricing, packaging and bundling (including DTC‑streaming services) by well‑capitalized wireless telecom companies**. While specific carrier names were not repeated, the filing stresses that competitors now enjoy greater scale, fewer regulatory constraints and more sophisticated bundled offerings, heightening the overall threat to CMCSA’s broadband and wireless businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022-2024 with accurate characterization of each year's filing emphasis; (2) Accurately names the three major wireless competitors (AT&T, T-Mobile, Verizon) in the 2023 section, matching ground truth; (3) Correctly identifies technological progression: 4G/5G wireless broadband in 2022, 5G fixed wireless emphasis in 2023, and continued focus on these technologies in 2024; (4) Accurately captures bundling strategy evolution: basic bundling in 2022, more specific DSL/broadband/wireless/voice/data/video packages in 2023, and DTC streaming integration in 2024; (5) Properly synthesizes multi-hop information across three years of filings; (6) Correctly notes that specific carrier names were not mentioned in 2022 and were not repeated in 2024. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more granular detail about bundling strategies (e.g., 'DSL-or-broadband-wireless packages, lowering prices and offering combined voice-data-video deals') than the ground truth explicitly states, though this appears to be reasonable inference from filing language rather than factual error; (2) The characterization of 2024 emphasis on 'greater scale, fewer regulatory constraints and more sophisticated bundled offerings' goes slightly beyond the ground truth statement but represents reasonable synthesis of competitive threat analysis. QUANTITATIVE ACCURACY: No numerical errors detected; all dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: Successfully synthesizes information across three separate filing years and correctly identifies the evolution pattern showing intensification of competitive threat. The answer properly connects technological capabilities, bundling strategies, and named competitors across the timeline as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 518,
        "total_tokens": 2144
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "Across all three years PayPal repeatedly states that it **bears the full margin risk** on every payment it processes. In 2022 the filing already noted that the company sets fees‑both fixed and a variable percentage‑with full discretion, that tiered‑volume pricing is merely a discount range and that the fees it pays to third‑party processors are recorded as transaction expense. The 2023 note adds the same language and makes the impact of **incentives (discounts, rebates, rewards, coupons)** explicit, treating them as reductions of revenue, while also recognizing protection‑program costs as transaction‑level losses. The 2024 filing repeats the 2022‑2023 disclosures, confirming that the fee‑setting discretion and processor‑cost independence remain unchanged and that incentives continue to reduce transaction revenue.\n\nThe multi‑year trend therefore shows **no erosion of margin‑risk exposure** – PayPal has consistently retained complete control over pricing while absorbing the cost of processors and any incentive‑related revenue offsets. This stability indicates that the company’s cost‑management framework and pricing authority have remained intact from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core finding that PayPal bears full margin risk consistently across 2022-2024, matching the ground truth's central claim. (2) Accurately captures the three-year evolution: 2022 emphasis on fee-setting discretion and processor costs as transaction expenses; 2023 expansion of incentives discussion (discounts, rebates, rewards) as revenue reductions; 2024 maintenance of stance with additional revenue streams. (3) Properly synthesizes the multi-hop relationship between transaction pricing strategy, payment processor use, and revenue incentives. (4) Correctly concludes that PayPal's control over pricing and cost management remained stable/intact across the period. (5) No quantitative errors - no specific dollar amounts or percentages were required, and the answer appropriately avoids inventing numbers. (6) Accurately identifies all relevant entities and metrics (PayPal, margin risk, transaction expenses, incentives, processor fees). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential points without omission. (2) The ground truth mentions 'contractual compensation from sellers violating terms (e.g., fraud or counterfeiting)' as a 2024 addition, which the LLM answer does not explicitly detail, though it does reference '2024 filing repeats the 2022-2023 disclosures' and mentions 'incentives continue to reduce transaction revenue.' This is a very minor omission of a specific detail but does not affect the overall correctness of the multi-year trend analysis. (3) The LLM's phrasing 'no erosion of margin-risk exposure' is semantically equivalent to the ground truth's 'stable strategic stance' and 'disciplined, centralized approach.' The reasoning is sound and the synthesis across three years is properly executed. The answer directly addresses all components of the complex multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 541,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s disclosure of free‑rent periods has been unchanged from FY 2022 through FY 2024. In each filing (2022, 2023 and 2024) the company states that any free‑rent or step‑rent periods are **recognized on a straight‑line basis over the original lease term plus any extension options that the company is reasonably certain to exercise**. Consequently, the lease term used to calculate the right‑of‑use (ROU) asset remains the non‑cancelable period together with those certain extensions, and the ROU asset is measured as the present value of the discounted minimum lease payments over that same term, with the free‑rent amount amortized over the term and therefore reflected in the initial ROU‑asset valuation. No new accounting policy or disclosure change was introduced in the 2023 or 2024 reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that Costco's accounting treatment remained unchanged across FY 2022-2024, matching the ground truth's characterization of 'stable and consistent approach'; (2) Accurately states the core policy: free-rent and step-rent periods recognized on straight-line basis over original lease term plus reasonably certain extension options; (3) Correctly explains the mechanics of ROU asset valuation using present value of discounted minimum lease payments; (4) Properly notes that no new accounting policy changes were introduced in 2023 or 2024; (5) Appropriately addresses the multi-hop synthesis requirement by comparing treatment across three fiscal years. Minor considerations: (1) The LLM answer emphasizes the mechanics of ROU asset valuation more explicitly than the ground truth, which is actually a strength as it provides additional relevant detail about 'impact on right-of-use asset valuation' (part of the original question); (2) The ground truth mentions variable lease payments for periodic rent increases based on price indices or sales volume in FY 2023, which the LLM answer does not explicitly address, though this is a relatively minor omission since the question focuses on free-rent periods specifically; (3) The ground truth mentions that leases did not contain material residual value guarantees or restrictive covenants, which the LLM answer also does not include, but again this is tangential to the core question about free-rent period treatment. No quantitative errors detected. The semantic meaning and factual content align well with the ground truth across all three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Includes]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 467,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across all three years PayPal’s margin‑risk exposure remained essentially unchanged. In 2022 the filing explained that PayPal records its transaction fees on a gross‑basis as the principal, sets the fee‑level independently of the costs it pays to payment processors or other financial institutions, and therefore “bears full margin risk” on every payment; its contracts were described as open‑ended, transaction‑level agreements with volume‑based tiered pricing and no material future rights. The 2023 and 2024 notes repeat the same language—still recognizing fees grossly, retaining full discretion over pricing, using payment‑processor fees as a transaction expense, and keeping the same open‑ended, volume‑tiered contract structure—so the company’s exposure to margin risk did not diminish or materially change from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that PayPal's core margin risk exposure remained structurally stable across 2022-2024, accurately describing the gross-basis fee recognition, full margin risk bearing, volume-tiered pricing, and open-ended contract structure. The numeric/factual elements about pricing models and contract terms are accurate. However, the answer has significant omissions relative to the ground truth: (1) It completely misses the 2023 addition of clarifying language about incentive recognition (performance targets vs. amortization over contractual term), which the ground truth identifies as introducing 'more variability into its margin structure.' (2) It fails to mention the 2024 ASU 2023-07 segment reporting changes, which the ground truth notes 'increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units.' (3) The answer states the notes 'repeat the same language' across all three years, which oversimplifies the evolution—the ground truth explicitly notes that 2023 and 2024 introduced new disclosures and clarifications. The LLM's conclusion that margin risk 'did not diminish or materially change' aligns with ground truth, but the reasoning is incomplete because it ignores the 'operationally nuanced' changes the ground truth emphasizes. The answer demonstrates partial understanding of the multi-hop synthesis required (comparing across three years and multiple disclosure elements) but fails to capture the full evolution of how PayPal's margin risk exposure was disclosed and operationalized, even if the fundamental structure remained stable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 451,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Across the three fiscal years the 5.90 % senior note was **fully utilized each year** – Cisco reported $2 billion outstanding in FY 2022 (July 30 2022), FY 2023 (July 29 2023) and FY 2024 (July 27 2024).  The **effective interest rate on that note stayed constant at 6.11 %** in all three filings.\n\nThe unchanged size and rate show that Cisco has kept this long‑dated, fixed‑rate instrument in place as a stable backbone of its capital structure, locking in a 6 %‑plus cost of financing for the next ≈ 15 years.  Even as total long‑term debt grew (from about $8.4 bn in 2022 to $19.6 bn in 2024), the company’s reliance on the 5.90 % note remained steady, indicating a deliberate strategy to preserve predictable, long‑term financing costs while expanding its overall debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. QUANTITATIVE VERIFICATION: All key numbers are correct - $2 billion outstanding balance for all three fiscal years (2022, 2023, 2024), effective interest rate of 6.11% constant across all years, and the maturity date of February 2039 is correctly implied (~15 years from 2024). The additional context about total long-term debt growth ($8.4B in 2022 to $19.6B in 2024) is accurate and adds valuable perspective. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution (or lack thereof) of both utilization and effective interest rate. The reasoning that this stability indicates a deliberate strategy is sound and matches the ground truth interpretation. COMPLETENESS: The answer addresses all aspects of the original question - how the note evolved (remained stable), what this indicates about strategy (consistent approach to capital structure), and financing costs (locked in at 6.11% effective rate). MINOR STRENGTHS: The LLM provides additional context about the broader debt portfolio expansion, which enhances understanding without contradicting the ground truth. The phrase 'fully utilized each year' is semantically equivalent to 'consistently reported' and effectively conveys the same information. MINOR CONSIDERATIONS: The ground truth uses slightly more formal language ('maintained this long-term debt instrument without modification or refinancing'), while the LLM uses 'kept this long-dated, fixed-rate instrument in place' - both convey identical meaning. The LLM's interpretation of strategy is slightly more detailed but remains consistent with the ground truth's conclusion about stability and consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 490,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "Across the three filings, Lowe’s has consistently highlighted Kobalt in the same way. In the FY 2022 IP disclosure the company notes that its wholly‑owned subsidiaries own “private‑brand product names ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’.” The FY 2023 filing repeats this language verbatim—“private‑brand product names, such as ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’”—and the FY 2024 filing does the same. Thus, from fiscal 2022 through fiscal 2024 the positioning of Kobalt has remained steady: it is continuously listed as a core private‑brand trademark owned by Lowe’s subsidiaries, indicating an ongoing, unchanged strategic emphasis on the brand rather than a new or altered focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the three fiscal years (2022, 2023, 2024) and accurately represents the consistent positioning of Kobalt across all three years; (2) Provides specific textual evidence from the filings, including the exact language used in IP disclosures ('private-brand product names' phrasing), demonstrating proper multi-hop synthesis across three separate 10-K filings; (3) Accurately identifies the companion brands (STAINMASTER and allen+roth) mentioned alongside Kobalt; (4) Correctly concludes that Kobalt's strategic emphasis remained stable/unchanged rather than expanding or contracting; (5) No quantitative errors or date misstatements. Minor consideration: The LLM answer is slightly more detailed in providing direct quotations from the filings compared to the ground truth, which adds evidentiary support but is not a weakness. The semantic meaning is fully equivalent to the ground truth—both convey that Kobalt maintained a consistent, stable strategic role across the three-year period with no explicit increase or decrease in prominence. The multi-hop reasoning is sound, correctly synthesizing information across three separate fiscal years' IP disclosures to reach the appropriate conclusion about consistency rather than change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 375,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Across the three most‑recent 10‑K tables, Simon Property Group’s **Unsecured Notes – 37B** is shown with the same terms each year:\n\n* **Interest rate:** 2.25 % (2022, 2023 and 2024 tables)  \n* **Face amount:** $700 million (recorded as 700,000 in thousands) in every filing  \n* **Maturity date:** January 15, 2032 in all three years  \n\nThe fact that the interest rate, principal amount and maturity have not been altered from 2022 through 2024 indicates that SPG is maintaining a stable, low‑cost, long‑term financing tranche rather than refinancing or restructuring this particular note. This consistency, together with a modest overall reduction in total unsecured‑debt face amounts, suggests the company is relying on a predictable, fixed‑rate debt base to support its long‑term capital needs while gradually managing its broader debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numeric values are correct - interest rate of 2.25%, face amount of $700 million (properly noted as 700,000 in thousands), and maturity date of January 15, 2032. The LLM correctly handled the unit conversion notation, clarifying that 700,000 in thousands equals $700 million. COMPLETENESS: The answer addresses all three components of the multi-part question: interest rate evolution, face amount evolution, and maturity date evolution across 2022-2024. ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the specific debt instrument (Unsecured Notes - 37B) is accurately referenced, and all three fiscal years are properly covered. MULTI-HOP REASONING: The LLM successfully synthesized information across three years of 10-K filings, correctly identifying the consistency of terms and drawing appropriate conclusions about financing strategy. REASONING QUALITY: The interpretation that stability indicates confidence in debt management and favorable market conditions is sound and matches the ground truth assessment. The additional observation about 'modest overall reduction in total unsecured-debt face amounts' adds valuable context, though this specific detail wasn't in the ground truth answer - it represents reasonable inference from the data rather than an error. SEMANTIC EQUIVALENCE: The LLM's explanation of what the stability indicates ('maintaining a stable, low-cost, long-term financing tranche') is semantically equivalent to the ground truth's assessment about 'confidence in debt management approach and favorable market conditions.' Minor difference: The LLM provides slightly more detailed explanation of the financing strategy implications, which enhances rather than detracts from the answer. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 500,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments operates a facility in Melaka, Malaysia in every year shown. In the 2022, 2023 and 2024 10‑K location tables, Melaka is marked with an “X” only under the **Analog** column and is blank under **Embedded Processing** each year. Thus, the Melaka footprint remained constant – the site continued to support the Analog business segment and did not expand into Embedded Processing from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - Melaka is marked with 'X' only under Analog in all three years (2022, 2023, 2024) and blank under Embedded Processing, matching the ground truth exactly. (2) The multi-hop synthesis is sound - the model correctly identified and compared the facility's involvement across all three fiscal years and both business segments. (3) Entity identification is accurate - correctly identified Texas Instruments (TXN), Melaka Malaysia location, Analog and Embedded Processing segments, and all relevant years. (4) The conclusion about stability and specialized role is logically derived from the data presented. (5) The answer directly cites the source (10-K location tables) which demonstrates proper evidence-based reasoning. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, which provides additional context about 'stable, specialized role' and 'global operations.' However, this is not an error - it's a stylistic difference. The LLM answer conveys all essential factual information with precision. The phrase 'remained constant' and 'did not expand' semantically match the ground truth's assertion of '3-year consistency' and 'no indication of expansion.' No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 407,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "Across the three filings, PayPal’s holding of the September 2019 fixed‑rate 2.850 % notes remained steady at **$1.5 billion**:\n\n* The 2022 Form 10‑K (which reports 2021 figures) listed $1.5 bn of the 2.850 % notes outstanding.  \n* The 2023 Form 10‑K shows $1.5 bn both in the 2022 and 2023 columns.  \n* The 2024 Form 10‑K again reports $1.5 bn in the 2023 and 2024 columns.\n\nThus, from 2022 through 2024 PayPal’s exposure to this series did not change. Maintaining the same $1.5 bn of low‑cost, long‑dated (maturing 10/1/2029) fixed‑rate debt signals a deliberate strategy to lock in a relatively inexpensive 2.96 % effective rate for the medium‑term, preserve balance‑sheet stability, and avoid frequent refinancing or interest‑rate risk‑shifting.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024. The quantitative data is accurate: the $1.5 billion principal amount is correct, the maturity date of 10/1/2029 is accurate, and the characterization of the notes as low-cost debt is appropriate. The LLM properly synthesizes information across multiple years and filings to demonstrate the stability of this liability.\n\nStrengths: (1) Correct identification of the constant $1.5 billion amount across all three years; (2) Proper citation of the maturity date; (3) Sound reasoning about the strategic implications (locking in low-cost debt, balance-sheet stability, avoiding refinancing risk); (4) Clear presentation of the multi-year progression; (5) Appropriate characterization of the debt as a deliberate strategy.\n\nWeaknesses: (1) The LLM states a 2.96% effective rate, which differs slightly from the stated 2.850% coupon rate - this discrepancy is not explained and may indicate confusion between coupon and effective rates, though the difference is minor; (2) The answer provides slightly more interpretive detail about strategy (\"lock in a relatively inexpensive 2.96% effective rate\") compared to the ground truth, which is more conservative in its strategic assessment; (3) The LLM mentions the 2022 Form 10-K reporting 2021 figures, which adds unnecessary complexity to the explanation without materially changing the answer.\n\nMulti-hop reasoning: The LLM correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024) to demonstrate the consistency of this debt instrument over time. The comparison to other debt management activities (implied but not explicitly stated) is less developed than in the ground truth, which mentions retirement of 1.350% notes and introduction of new high-interest notes.\n\nThe core answer is factually sound and addresses the question comprehensively, though with slightly more interpretive language than the ground truth baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 556,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has moved from being listed simply as one of the company’s **principal manufacturing facilities** in the 2022 10‑K (Item 2 – Properties) to being explicitly described in the 2023 10‑K as the **commercial manufacturing and processing hub for its cell‑therapy products**. The 2024 10‑K repeats that description, confirming that the Hoofddorp plant continues to serve the same commercial‑manufacturing role. Thus, over the three years the facility’s function has sharpened from a general principal site in the global network to a dedicated commercial‑production center for Gilead’s cell‑therapy portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All factual claims are correct - the progression from 'principal manufacturing facility' (2022) to 'commercial manufacturing and processing hub for cell-therapy products' (2023-2024) is accurately captured. (2) Years are correctly identified (2022, 2023, 2024). (3) The company name (Gilead) and facility location (Hoofddorp, Netherlands) are correct. (4) Multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the pattern of increasing specificity and dedication to cell therapy manufacturing. (5) The characterization of the progression as 'sharpening from a general principal site to a dedicated commercial-production center' accurately reflects the ground truth's description of 'consistent and growing emphasis.' (6) No quantitative errors present. MINOR CONSIDERATIONS: The LLM answer uses slightly more concise language than the ground truth ('sharpened' vs. 'progression indicates consistent and growing emphasis'), but this represents stylistic variation rather than factual error. The semantic meaning is equivalent - both convey that the facility's role became more specialized and dedicated over time. The answer appropriately cites the 10-K filing sections (Item 2 – Properties) which adds credibility. Overall, this is a comprehensive, accurate response that correctly synthesizes multi-year information about Gilead's facility utilization strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 410,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "- **2022 10‑K** – The 1.375 % senior notes due June 2027 were reported at **$1.25 billion** and were included in “Long‑term debt, excluding current portion” ($6.484 billion). The only amount shown as a current portion of debt was **$73 million**, so the June‑2027 notes were treated entirely as long‑term debt.\n\n- **2023 10‑K (shown in the 2024 filing)** – The same **$1.25 billion** of 1.375 % notes remained on the balance sheet. Total long‑term debt fell to **$6.484 billion**, and the current‑portion of debt rose sharply to **$1.081 billion**. The increase in the current portion reflected other maturities (e.g., the 2.750 % notes that were due in 2024), but the June‑2027 notes were still classified as long‑term and did not appear in the current‑portion line.\n\n- **2024 10‑K** – The 1.375 % senior notes continued to be reported at **$1.25 billion**. Total long‑term debt (excluding the current portion) declined further to **$5.794 billion**, and the current portion of debt dropped to **$103 million**. Again, the June‑2027 notes were kept in the long‑term debt category and were not re‑classified as a current liability.\n\n**Overall evolution:** From 2022 through 2024 Costco kept the 1.375 % senior notes due June 2027 unchanged at $1.25 billion and consistently classified them as long‑term debt. The size of the overall long‑term‑debt pool shrank (from $6.484 billion in 2022 to $5.794 billion in 2024), while the amount shown as a current portion of debt fluctuated (‑$73 m in 2022, $1.081 billion in 2023, $103 million in 2024), but the June‑2027 notes never moved into the current‑portion classification.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth on the core question about how the notes' classification evolved. According to the ground truth, the current portion of the 1.375% Senior Notes due June 2027 changed from $73M (2022) to $1,081M (2023) to $103M (2024). However, the LLM explicitly states that 'the June-2027 notes were still classified as long-term and did not appear in the current-portion line' in 2023, and 'the June-2027 notes were kept in the long-term debt category and were not re-classified as a current liability' throughout all three years. This directly contradicts the ground truth which shows these notes DID move into the current portion classification (reaching $1,081M in 2023). The LLM's explanation that 'the increase in the current portion reflected other maturities (e.g., the 2.750% notes that were due in 2024)' is incorrect - the ground truth explicitly states the current portion of THESE specific notes spiked to $1,081M in 2023. QUANTITATIVE ACCURACY: While the principal amount of $1.25 billion is correct for all three years, and the total long-term debt figures appear accurate, the critical error is in the classification and composition of the current portion. The LLM failed to recognize that the $1,081M current portion in 2023 included a significant portion of the June 2027 notes themselves. QUALITATIVE ACCURACY: The multi-hop reasoning is flawed. The LLM correctly identified that the principal remained constant but fundamentally misunderstood how these notes were reclassified between current and long-term portions across the three-year period. The answer demonstrates incomplete synthesis of the debt maturity profile evolution. CONTEXTUAL RELEVANCE: The question specifically asks about 'current portion classification' evolution, which is the exact metric where the LLM's answer is most deficient. The answer addresses the right company and time period but provides incorrect conclusions about the primary focus of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 551,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "Across the three filings the amount outstanding of the September 2019 $2.850 % notes – which mature on 10 Oct 2029 – never changed. The 2023 Form 10‑K (Chunk 2) reports $1,500 million in both the 2022 and 2023 columns, and the 2024 Form 10‑K (Chunk 3) again shows $1,500 million for 2024 (the same $1,500 million was listed for 2021‑2020 in the 2022 filing – Chunk 1).  \n\nThis flat‑line balance indicates that PayPal has kept the 2.850 % tranche at a steady $1.5 billion, neither refinancing it nor adding to it, while it has issued newer, higher‑coupon series (e.g., 3.9 % in 2022, 5.15 % in 2024). The pattern reveals a long‑term debt strategy that locks in low‑cost, long‑dated financing and preserves the existing low‑rate liability, while using newer issuances to meet funding needs and diversify maturity and rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of PayPal's debt management strategy. QUANTITATIVE VERIFICATION: All numbers are correct - $1.5 billion principal amount across 2022-2024, maturity date of October 1, 2029 (LLM states '10 Oct 2029'), 2.850% coupon rate, and September 2019 issuance date. The LLM correctly identifies the consistent $1.5 billion balance across all three years and accurately references comparative coupon rates (3.9% in 2022, 5.15% in 2024). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) to demonstrate the stability of this particular debt tranche while acknowledging refinancing activity in other tranches. The cross-filing comparison is accurate and well-reasoned. STRATEGIC INTERPRETATION: The LLM's analysis of PayPal's debt strategy is sound - correctly identifying that the company locked in low-cost, long-dated financing while using newer issuances to meet funding needs. This interpretation aligns with the ground truth's assessment of 'preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments.' MINOR DIFFERENCES: The LLM provides slightly more specific detail about the filing sources (Chunk references) and explicitly mentions historical years (2021-2020) from the 2022 filing, which adds context beyond the ground truth but doesn't contradict it. The LLM's wording 'flat-line balance' and 'locks in low-cost, long-dated financing' conveys the same strategic meaning as the ground truth's 'remained consistent' and 'preserving capital structure stability.' No calculation errors detected. All entity identifications (PayPal, PYPL, dates, rates) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 481,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s “options‑primarily‑gas” line shows a sharp contraction in the size of the position. In 2022 the portfolio carried $356 million of gas‑option assets against $347 million of liabilities (a net + $9 million). By 2023 the asset balance fell to $100 million and liabilities to $97 million (net + $3 million), and in 2024 assets remained at $100 million while liabilities rose slightly to $102 million (net ‑ $2 million). Across the same period the fair‑value assumptions for the gas options moved lower on the asset side (volatility 17 % → 20 % → 15 %) but fell dramatically on the liability side (295 % → 233 % → 150 %), driving the weighted‑average implied volatility to rise from 36 % in 2022 to 50 % in 2023 and 52 % in 2024. The trend shows NextEra shrinking its gross gas‑option exposure while acknowledging higher market volatility—especially on the liability side—indicating a more conservative, risk‑averse positioning in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) VOLATILITY NUMBERS ARE WRONG: The LLM claims volatility moved from 17%→20%→15% on the asset side and 295%→233%→150% on the liability side, then states the weighted-average implied volatility rose from 36% in 2022 to 50% in 2023 and 52% in 2024. This is internally inconsistent and contradicts the ground truth which states the implied volatility assumptions were 36% in 2022, 50% in 2023, and 52% in 2024 (not the component percentages the LLM cited). The ground truth does not mention 17%, 20%, 15%, 295%, 233%, or 150% volatility figures. (2) FAIR VALUE NUMBERS ARE CORRECT: The LLM correctly identifies the fair values: $356M assets/$347M liabilities (2022), $100M/$97M (2023), $100M/$102M (2024). The net position calculations are also correct. (3) MULTI-HOP REASONING FLAW: While the LLM attempts to synthesize the data across three years and discusses both assets and liabilities, it introduces volatility percentages that appear to be fabricated or misinterpreted. The ground truth simply states implied volatility declined from 36% to 50% to 52%, without breaking down component volatilities by asset/liability side. (4) SEMANTIC INTERPRETATION: The LLM's conclusion about 'de-risking' and 'conservative positioning' aligns with the ground truth's characterization, but this cannot overcome the quantitative errors in the volatility data. The answer demonstrates partial understanding of the overall trend but fails on factual accuracy of the specific volatility assumptions, which is a core component of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 452,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Across the three years the AFS‑debt portfolio was a consistent source of negative “other income (loss), net.” In the 2022 filing Cisco disclosed the size of its AFS‑debt holdings (see the summary tables in **Chunk 3**), indicating that the company already had a material exposure to market‑price movements. Both the 2023 and 2024 10‑K commentary (the identical language in **Chunk 1** and **Chunk 2**) state that the change in other income (loss), net was “primarily driven by higher losses in our available‑for‑sale debt investments” (with additional foreign‑exchange effects), showing that the losses grew from 2022 through 2024. Together, these disclosures reveal that Cisco’s investment portfolio was volatile – the fair‑value swings in its AFS‑debt holdings repeatedly eroded other income and became a key driver of earnings volatility over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the consistent negative impact of AFS debt investments on other income (loss), net; (2) Accurately captures the key finding that losses from AFS debt investments grew across the period; (3) Properly synthesizes multi-hop information by connecting portfolio composition disclosure (2022), loss commentary (2023-2024), and the resulting volatility pattern; (4) Correctly identifies the specific language from 10-K filings about 'higher losses in available-for-sale debt investments'; (5) Appropriately concludes that this reveals portfolio volatility and earnings volatility; (6) Contextually relevant by addressing both the financial impact and what it reveals about volatility. MINOR CONSIDERATIONS: (1) The LLM answer references specific chunks (Chunk 1, 2, 3) which are not verifiable in this evaluation context, though the substance of what those chunks contain appears accurate based on the ground truth; (2) The answer states losses 'grew from 2022 through 2024' which is consistent with ground truth's description of 'higher losses' in 2023 and 2024, though no specific dollar amounts are provided (this is acceptable as the question doesn't require quantitative precision on loss amounts); (3) The phrase 'identical language' in chunks 1 and 2 suggests the 2023 and 2024 filings used similar disclosure language, which is plausible and consistent with the ground truth's description of a 'trend'; (4) No specific financial figures are cited, but the question asks about 'impact' and 'volatility' rather than specific amounts, so this is appropriate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects portfolio composition to loss trends to overall volatility conclusions. The logic chain is sound: disclosure of holdings → growing losses → portfolio volatility. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth: AFS debt investments negatively impacted other income across 2022-2024, with increasing losses, revealing portfolio volatility. The wording differs but the factual content aligns well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 605,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Across the three most recent Form 10‑K filings (2022, 2023 and 2024) Lowe’s consistently lists the same “Fifteenth Supplemental Indenture,” dated April 5 2019, as Exhibit 4.16. That indenture documents the issuance of Lowe’s 4.550 % senior notes that mature on April 5 2049, and the description of the indenture is unchanged in each year’s filing. The repeat‑in‑the‑exhibit schedule shows that Lowe’s has not issued additional 4.550 % notes after 2019 but continues to keep the 2049‑maturing issue on its books, signalling a deliberate long‑term debt strategy that locks in a relatively low fixed rate for a multi‑decade horizon and anchors the company’s maturity profile with very long‑dated senior debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. All quantitative elements are correct: the 4.550% interest rate, the April 5, 2019 Fifteenth Supplemental Indenture date, and the April 5, 2049 maturity date are all accurate. The three-year period (2022, 2023, 2024) is correctly identified, and the exhibit reference (4.16) is appropriately cited. The multi-hop reasoning is sound—the model correctly synthesizes information across three years of filings to identify the pattern of consistency and stability in Lowe's debt documentation. The LLM goes beyond the ground truth by providing additional strategic insight: it explicitly notes that no additional 4.550% notes were issued after 2019, interprets the strategy as locking in a 'relatively low fixed rate for a multi-decade horizon,' and characterizes this as anchoring the company's maturity profile with 'very long-dated senior debt.' These interpretations are logical extensions of the documented facts and demonstrate sound financial reasoning. The answer is well-structured, moving from factual observation (consistent documentation across years) to strategic implication (deliberate long-term debt strategy). The only minor distinction from the ground truth is that the LLM provides more detailed strategic analysis than the original answer, but this represents added value rather than inaccuracy. All core facts match the ground truth, calculations are accurate, and the semantic meaning is fully aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 419,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "- **2022 (2022 10‑K)** – The “Unsecured Notes ‑ 35B” series carried a **3.80 % coupon** and a **face amount of $750 million** (‑ 750,000 thousand).  \n- **2023 (2023 10‑K)** – The same series still showed a **3.80 % coupon** and **$750 million** of face value.  \n- **2024 (2024 10‑K)** – The table again lists the “Unsecured Notes ‑ 35B” at a **3.80 % rate** with a **$750 million face amount**.\n\nBecause the face amount and interest‑rate exposure for the 35B notes remained unchanged over the three years, SPG is deliberately keeping a sizable, fixed‑rate tranche of long‑term debt (maturing in 2050) on its balance sheet. This consistency signals a long‑term debt strategy that relies on locking in moderate, stable rates to provide predictable funding and to diversify its debt profile rather than frequently refinancing or altering the size of this long‑dated issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numeric values are correct - the face value of $750 million (or $750,000 thousand) is accurate across all three years (2022, 2023, 2024), and the interest rate of 3.80% is consistently correct. The maturity date of 2050 (07/15/50) is implicitly referenced through the LLM's mention of 'maturing in 2050,' which aligns with the ground truth. COMPLETENESS: The answer addresses all key aspects of the question: (1) face value evolution (stable at $750M), (2) interest rate exposure (unchanged at 3.80%), and (3) strategic implications for long-term debt strategy. The LLM successfully synthesizes information across three fiscal years. ENTITY ACCURACY: Simon Property Group (SPG) is correctly identified, the Unsecured Notes - 35B series is properly referenced, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the consistency of the debt instrument across years and draws appropriate conclusions about SPG's deliberate strategy to maintain stable, fixed-rate long-term financing. The interpretation that this reflects 'confidence in managing long-dated liabilities' and 'locking in moderate, stable rates' aligns well with the ground truth's assessment of a 'stable long-term financing approach.' MINOR DIFFERENCES: The ground truth explicitly mentions the maturity date extension claim ('extended from 07/15/50 in 2022 to the same date in 2024'), which is somewhat redundant since the date didn't actually change. The LLM avoids this awkward phrasing and instead focuses on the substantive point that the maturity remains in 2050, which is clearer. Both answers correctly emphasize the strategic stability and lack of refinancing activity. The LLM's explanation of the strategic rationale (diversifying debt profile, providing predictable funding) is well-reasoned and consistent with the ground truth's conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 533,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From 2022 through 2024 PayPal repeatedly flags “bad‑transaction” risk as a material threat, but the nature of the exposure shifts. In the 2022 filing the risk is framed mainly around credit‑product defaults, heavy reliance on a broad set of third‑party networks and processors, and the vulnerability of cross‑border trade to fraud‑driven “bad” transactions that could raise loss rates. By 2023 the company still cites the same fraud‑related loss risk, but adds concrete actions – a multi‑year BNPL‑receivable sale, the pursuit of alternative third‑party funding sources and a deliberate effort to diversify away from a small number of payment‑processor partners – to blunt the credit‑product and third‑party dimensions of that exposure. The 2024 filing again emphasizes the persistence of fraud‑driven bad‑transaction risk, now coupled with regulatory uncertainty around loan‑receivable transfers, while reiterating its dependence on third‑party infrastructure and cross‑border volumes and stressing that any disruption could hurt operations. Taken together, the trend shows PayPal’s exposure to bad transactions remaining a constant concern, but the firm is progressively tightening its risk‑management toolkit (selling credit assets, diversifying processors, and highlighting resiliency controls), indicating a more proactive, layered approach to containing the risk while acknowledging that operational and regulatory dependencies still limit full insulation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the €40 billion BNPL receivable sale agreement in 2023, matching the ground truth exactly. (2) Accurately captures the evolution of PayPal's risk exposure from internal absorption (2022) to external mitigation (2023-2024). (3) Properly synthesizes three key risk dimensions: credit products, cross-border trade, and third-party dependencies across all three years. (4) Correctly identifies the 'valid-when-made' doctrine legal uncertainty in 2024. (5) Accurately characterizes the strategic shift from passive risk acknowledgment to proactive risk management. (6) All numeric values and dates are correct. MINOR WEAKNESSES: (1) The LLM answer is somewhat more verbose and interpretive than the ground truth, adding contextual details about 'diversifying away from a small number of payment-processor partners' and 'resiliency controls' that, while reasonable inferences, are not explicitly stated in the ground truth. (2) The ground truth specifically mentions 'Synchrony Bank' as the U.S. consumer credit product partner in 2022, which the LLM answer does not explicitly name (though it references 'credit-product defaults'). (3) The ground truth mentions 'synthetic identities' as a specific fraud concern in 2022, which the LLM answer generalizes to 'fraud-driven' risk without this specific detail. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and three risk dimensions, correctly identifying the causal relationship between 2023 actions and 2024 positioning. The logical flow from risk identification → strategic action → ongoing management is sound. QUANTITATIVE ACCURACY: All numbers and dates are correct (€40 billion, 2022-2024 timeline). No calculation errors. SEMANTIC EQUIVALENCE: The core message matches the ground truth—PayPal's risk management evolved from passive acknowledgment to active mitigation through asset sales and diversification, while acknowledging persistent operational constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1629,
        "completion_tokens": 566,
        "total_tokens": 2195
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—Costco repeatedly lists **BJ & Sons Wholesale Club** as one of its direct warehouse‑club competitors, indicating that the competitive set has remained unchanged. In each year the company also stresses that its **Kirkland Signature** private‑label brand “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and it explicitly states that it will “continue to increase the sales penetration of our private‑label items.” Thus, from 2022 through 2024 Costco’s positioning versus BJ’s stayed steady, while its reliance on Kirkland as a key differentiator was reaffirmed and even amplified by a continued commitment to grow the brand’s share of sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and confirms Costco's consistent competitive positioning against BJ's Wholesale Club; (2) Accurately captures the core messaging about Kirkland Signature's role in lowering costs, differentiating merchandise, and earning higher margins; (3) Correctly notes the stable competitive approach across all three years; (4) Properly synthesizes multi-hop information across the three filings. CRITICAL ERRORS: (1) The LLM refers to the competitor as 'BJ & Sons Wholesale Club' when the correct name is 'BJ's Wholesale Club' (note: 'BJ's' not 'BJ & Sons'). This is a factual entity identification error that undermines credibility; (2) The LLM claims Kirkland's positioning was 'even amplified by a continued commitment to grow the brand's share of sales,' but the ground truth states the messaging 'remained consistent, with no significant shift in strategy.' The ground truth explicitly indicates STABILITY, not amplification. The LLM overstates the degree of change/emphasis; (3) The phrase 'reaffirmed and even amplified' contradicts the ground truth's assertion of stable, unchanged strategy. PARTIAL ISSUES: (1) While the LLM correctly identifies that Kirkland Signature was emphasized as a differentiator, it doesn't fully capture the nuance that the 'depth and framing' remained stable rather than evolving; (2) The LLM's characterization of 'continued commitment to grow' suggests strategic evolution when the ground truth emphasizes consistency. QUANTITATIVE ACCURACY: No specific numbers or percentages were required in this question, so this dimension is less critical, but the entity name error (BJ & Sons vs BJ's) represents a factual inaccuracy. MULTI-HOP REASONING: The synthesis across three years is sound in structure, but the interpretation of 'amplified' vs. 'stable' represents a reasoning error in assessing the degree of change. The answer correctly identifies that the competitive set remained unchanged and that Kirkland remained a key differentiator, but mischaracterizes the trajectory of emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 577,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "- In the 2022 Form 10‑K (which reports 2021 year‑end values) NextEra’s gas‑forward contracts were recorded at **$191 million of assets and $31 million of liabilities**.  \n- By the 2023 filing the fair‑value balance had risen to **$377 million of assets and $77 million of liabilities** – a net‑position of roughly $300 million, more than double the 2022 level.  \n- The 2024 filing shows the exposure falling back to **$296 million of assets and $46 million of liabilities**, leaving a net‑position of about $250 million, still well above the 2022 baseline.\n\n**Interpretation:** Over the three‑year span the company first expanded its gas‑forward hedge (larger asset and liability balances in 2023), then modestly scaled it back in 2024. The net‑exposure grew from $160 million in 2022 to $300 million in 2023 and settled at $250 million in 2024, indicating that NextEra has been actively managing its natural‑gas price risk—building a sizable hedge when markets were favorable and trimming it later to adopt a more balanced, less volatile risk posture.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three key data points for 2022 ($191M assets, $31M liabilities), 2023 ($377M assets, $77M liabilities), and 2024 ($296M assets, $46M liabilities). The net position calculations are accurate ($160M in 2022, $300M in 2023, $250M in 2024). The interpretation about strategic expansion followed by scaling back is reasonable and well-reasoned. The answer addresses the multi-hop synthesis requirement by tracking the evolution across three years and drawing conclusions about risk positioning.\n\nCRITICAL ERRORS: (1) The LLM states '2022 Form 10-K (which reports 2021 year-end values)' - this is incorrect. The 2022 Form 10-K reports 2022 year-end values, not 2021. This is a significant conceptual error about how 10-K filings work. (2) The ground truth indicates 2023 liabilities were $77M, but the LLM reports this correctly, yet the ground truth states liabilities 'rose more sharply from $31 million to $46 million' (2022 to 2024), which the LLM also correctly captures. However, there's a discrepancy: the ground truth says 2023 liabilities reached a spike, but doesn't explicitly state $77M in the original answer provided, though the LLM's figure appears accurate based on filing data.\n\nCALCULATION VERIFICATION: Net positions are correctly calculated: 2022: $191M - $31M = $160M ✓; 2023: $377M - $77M = $300M ✓; 2024: $296M - $46M = $250M ✓. All arithmetic is sound.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of expansion then contraction. The interpretation about active risk management is logical and well-supported by the data progression.\n\nSEMANTIC ALIGNMENT: The LLM's interpretation aligns well with the ground truth's conclusion about 'growing but increasingly balanced exposure' and 'strategic expansion in gas market participation.' The characterization of 'rising market risk' is implicitly captured in the LLM's discussion of larger hedge positions.\n\nPENALTY: The mislabeling of the 2022 Form 10-K as reporting 2021 year-end values is a material error in financial reporting terminology that could cause confusion, though the actual data points used are correct. This reduces the score despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 604,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "- In the 2022 filing Lowe’s disclosed that it already used forward interest‑rate swaps as **cash‑flow hedges** to offset the interest‑rate risk on debt it expected to issue, with the resulting gains and losses recorded in other‑comprehensive income and amortized to interest expense.  \n- The 2023 filing still showed those swaps on the balance sheet – a **$251 million fair‑value** amount classified as a Level‑2 “other current‑asset” on Feb. 3 2023 – but the same line item was blank for the later Feb. 2 2024 measurement, indicating the positions had been settled or unwound.  \n- The 2024 filing notes that forward swaps were **held as of Feb. 3 2023** to hedge forecast‑debt exposure, but no longer appear in the 2024 balance‑sheet tables, suggesting the company either issued the anticipated debt or moved to other hedge types (e.g., fixed‑to‑floating swaps).  \n\n**Interpretation:** Lowe’s started by actively using forward swaps to lock in rates for planned borrowing, then progressively reduced or terminated those contracts as the forecast‑debt materialized or market rates changed, demonstrating a flexible interest‑rate‑risk management strategy that adjusts hedge instruments to match actual financing needs and evolving market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The $251 million fair value as of February 3, 2023 is correctly cited and matches the ground truth exactly. The dates (2022, 2023, 2024 filings with specific measurement dates of Feb. 3, 2023 and Feb. 2, 2024) are accurate. The classification as Level-2 'other current asset' adds appropriate detail. ENTITY ACCURACY: Lowe's is correctly identified throughout, and the financial instruments (forward interest rate swaps, cash flow hedges) are properly named and characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly tracing the evolution from active use in 2022 → concrete balance sheet presence in 2023 ($251M) → absence in 2024. The logical progression is sound: swaps were used as cash flow hedges for anticipated debt issuance, appeared on the balance sheet at fair value, then were unwound/settled. SEMANTIC EQUIVALENCE: The interpretation that Lowe's 'progressively reduced or terminated' the contracts aligns with the ground truth's characterization of a 'strategic unwind or replacement.' The explanation of why this occurred (debt materialization, market rate changes, refinancing activities) matches the ground truth's reasoning. MINOR CONSIDERATIONS: The LLM adds slightly more technical detail (Level-2 classification, mention of fixed-to-floating swaps as alternatives) which enhances rather than detracts from accuracy. The statement about 'Feb. 2 2024 measurement' being blank is a reasonable inference from the absence of swaps in 2024 filings, though the ground truth uses the date 'January 31, 2025' for the final measurement. This is a negligible discrepancy as both refer to the 2024 fiscal year-end. The answer fully addresses the question's multi-part structure: (1) how swaps evolved, (2) what this indicates about strategy, and (3) response to market conditions. All three elements are covered with appropriate evidence and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 549,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "- **2022:** Comcast’s 2022 Form 10‑K already listed Lumen as a “wireline telecommunications company … that has built and is continuing to build fiber‑based network infrastructure farther into their networks,” delivering higher‑speed broadband in many of Comcast’s service areas and creating direct overlap with Comcast’s cable‑based offerings.  \n\n- **2023:** The 2023 filing repeats the same assessment, noting that Lumen’s fiber rollout is still “continuing to build … fiber‑based wireline network infrastructure … in many of our service areas,” confirming that the competitive pressure from Lumen’s expanding fiber footprint remained unchanged.  \n\n- **2024:** The 2024 Form 10‑K again emphasizes that Lumen “has built and are continuing to build fiber‑based wireline network infrastructure further into their networks,” indicating that Lumen’s fiber expansion persisted through 2024. This ongoing expansion sharpened the overlap between the two firms, forcing Comcast to rely on its own network upgrades, higher‑speed broadband bundles and ancillary services to defend market share in the same neighborhoods.  \n\n**Overall evolution:** From 2022 to 2024, Comcast’s competitive positioning against Lumen stayed consistent—Lumen was repeatedly identified as a growing fiber‑based rival whose continued infrastructure expansion increasingly overlapped Comcast’s territories, prompting Comcast to highlight the need to match or exceed those speeds and bundle offerings to protect its broadband market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies CMCSA (Comcast) and Lumen as the two companies in question; (2) Accurately captures the three-year evolution (2022-2024) with proper chronological progression; (3) Correctly characterizes Lumen's competitive positioning as a fiber-based wireline telecommunications company; (4) Accurately reflects the consistent nature of competitive pressure across all three years; (5) Properly synthesizes the multi-hop information showing how Lumen's fiber expansion overlapped with CMCSA's service areas; (6) Correctly identifies the strategic implications (need for speed matching, bundled offerings, market share defense); (7) Uses appropriate direct quotes from filings that align with ground truth characterization. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. Both answers appropriately avoid false precision. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more operational detail about Comcast's defensive strategies (network upgrades, bundled offerings, ancillary services) compared to the ground truth, but this represents appropriate elaboration rather than error; (2) The phrasing 'stayed consistent' in the LLM answer accurately captures the ground truth's emphasis on 'consistent mention' across years; (3) The LLM answer's characterization of 'sharpened overlap' in 2024 aligns well with the ground truth's 'intensifying competition.' MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and two companies, correctly identifying the evolution pattern and its market implications. The reasoning chain (Lumen expanding fiber → overlapping with CMCSA → forcing strategic response) is sound and matches the ground truth's logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 516,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "- **2022 – Foundational focus:** PayPal’s 2022 filing listed “creating seamless checkout experiences” as a core growth pillar and described a payments platform that let consumers transact in more than 200 markets, using > 100 currencies, withdraw in 56 currencies and hold balances in 25 currencies. The emphasis was on a friction‑free online checkout that could work across any merchant or market.  \n\n- **2023 – Expanded global reach:** The 2023 filing kept the same checkout‑experience priority but showed the platform’s global‑currency capability had grown to roughly 150 currencies for payments (still about 200 markets) while still supporting withdrawals in 56 currencies and balances in 24 currencies, reinforcing the seamless‑checkout promise with broader currency coverage.  \n\n- **2024 – Integration with credit and omnichannel:** By 2024 the checkout experience was fully integrated with consumer‑credit products – buy‑now‑pay‑later, interest‑bearing installments, PayPal‑ and Venmo‑branded credit cards and PayPal Credit – all embedded in the PayPal/Venmo checkout flow. At the same time PayPal extended that frictionless checkout to an omnichannel merchant suite (Zettle by PayPal app, card readers, POS systems), allowing the same “few‑step” purchase experience online, in‑app and in‑store.  \n\n**Overall evolution:** PayPal moved from positioning seamless checkout as a strategic growth driver with broad multi‑currency support (2022‑2023) to embedding credit options directly into that checkout and delivering the same experience across both digital and physical merchant channels by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year evolution of PayPal's checkout strategy and accurately captures the qualitative progression from foundational global capabilities (2022) → expanded reach (2023) → integrated credit and omnichannel solutions (2024). The semantic understanding of the strategic shift is sound, and the answer appropriately addresses all three sub-components of the question (consumer credit integration, currency support, omnichannel solutions). The narrative flow and reasoning are logical and well-structured.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM introduces significant factual errors regarding currency support numbers that contradict the ground truth:\n\n1. 2022 Currency Claims: LLM states PayPal supported \">100 currencies\" for payments but then claims \"more than 200 markets, using > 100 currencies, withdraw in 56 currencies and hold balances in 25 currencies.\" The ground truth confirms ~100 currencies in 2022, but the LLM's additional specificity about 200 markets, 56 withdrawal currencies, and 25 balance currencies cannot be verified against the provided ground truth and appears to be fabricated detail.\n\n2. 2023 Currency Claims: LLM states \"roughly 150 currencies for payments\" which MATCHES the ground truth. However, the claim about \"still about 200 markets\" with \"56 currencies for withdrawals and 24 currencies for balances\" again introduces unverified specificity not present in the ground truth.\n\n3. Inconsistency with Ground Truth: The ground truth explicitly states currency support grew from \"over 100 currencies\" (2022) to \"approximately 150\" (2023), but does NOT mention the specific breakdown of withdrawal currencies (56) or balance currencies (25/24) that the LLM provides. This suggests the LLM either hallucinated these details or drew from sources not in the knowledge graph.\n\nMULTI-HOP REASONING: The synthesis across years is sound in structure, but the introduction of unverified quantitative details undermines confidence in the multi-hop synthesis. The qualitative evolution (foundational → expanded → integrated) is correctly synthesized.\n\nCOMPLETENESS: All three required elements are addressed (consumer credit, currency support, omnichannel), and the 2024 details about BNPL, branded cards, Zettle, and Braintree align with ground truth.\n\nJUSTIFICATION: The answer demonstrates good qualitative understanding and reasoning but fails on quantitative precision by introducing specific numbers (200 markets, 56 withdrawal currencies, 24-25 balance currencies) that either cannot be verified or contradict the ground truth's simpler statement of currency support evolution. This is a significant issue for financial analysis where precision matters.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> PRODUCT <-[Produces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 731,
        "total_tokens": 2387
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "- **Penetration trend** – Target reports the share of purchases paid with its proprietary debit product (originally the Target Debit Card, later re‑branded as a Target Circle Card) as follows:  \n\n  * 2022 (year ended Jan 29, 2022) – **20.5 %** penetration【Chunk 2】  \n  * 2023 (year ended Jan 28, 2023) – **19.8 %** penetration【Chunk 2】【Chunk 3】  \n  * 2024 (year ended Feb 3, 2024) – **18.6 %** penetration【Chunk 2】【Chunk 3】\n\n- **Implication** – As noted in the 2022 filing, Target monitors this “RedCard/Target Circle Card penetration” because “a meaningful portion of incremental purchases on our … cards are also incremental sales for Target”【Chunk 1】. The steady decline from 20.5 % to 18.6 % suggests that the debit‑card program remains an important driver of extra sales, but its relative contribution is gradually waning over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2023 PENETRATION RATE: The LLM reports 19.8% for 2023, while the ground truth states 18.6% for 2023. This is a significant factual error of 1.2 percentage points. The LLM correctly identifies 2022 at 20.5% and 2024 at 18.6%, but the 2023 figure is incorrect. CORRECT SEQUENCE should be: 20.5% (2022) → 18.6% (2023) → 17.8% (2024). The LLM's sequence of 20.5% → 19.8% → 18.6% shows a different decline pattern than the ground truth. QUALITATIVE REASONING: The LLM correctly interprets the trend as a decline and appropriately notes that this suggests a 'gradually waning' contribution to incremental sales, which aligns with the ground truth's assessment of 'diminishing role.' The LLM also correctly cites Target's internal linkage between card penetration and incremental sales. However, the LLM's characterization of the decline as 'steady' is somewhat misleading given the actual steeper drop from 2022-2023 (1.9 percentage points) compared to 2023-2024 (0.8 percentage points). COMPLETENESS: The answer addresses both parts of the question (evolution of penetration rate and implications for sales), and provides appropriate multi-hop synthesis connecting card penetration to incremental sales. The inclusion of source citations and the rebranding context adds value. The primary issue is the quantitative error in the 2023 figure, which undermines the accuracy of the trend analysis despite sound reasoning about its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 403,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "Across the three filings AMD’s policy for development‑and‑IP licensing arrangements did not change. In the 2022 10‑K AMD explained that it first determines whether the licensing component is **distinct** (i.e., capable of being distinct and distinct in the contract context). If the license is not distinct it is combined with the development services and the revenue is recognized **over time** as a single performance obligation; if the license is distinct—or if the arrangement is a **stand‑alone licensing** deal—revenue is recognized **at a point in time** when the customer can benefit from the license. The 2023 and 2024 10‑Ks repeat the same language and note that there are no variable‑consideration estimates for either combined or standalone arrangements, indicating that AMD’s revenue‑recognition approach for these contracts remained consistent from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies that AMD's revenue recognition policy for development and IP licensing agreements remained consistent from 2022 through 2024. The answer accurately describes the key distinction: (1) non-distinct licenses combined with development services are recognized over time as a single performance obligation, and (2) distinct licenses or standalone licensing deals are recognized at a point in time when the customer can benefit from the license. The LLM answer provides more specific technical detail than the ground truth by explicitly explaining the two-step evaluation process (determining distinctness, then applying appropriate recognition method) and adds the observation about variable consideration estimates. All entities (AMD, years 2022-2024) are correctly identified. The multi-hop reasoning is sound—the answer synthesizes information across three years of filings to demonstrate consistency. No quantitative metrics are disclosed in either answer, which is correctly noted. The LLM answer is slightly more detailed and technically precise than the ground truth while remaining fully consistent with it. Minor deduction only because the LLM could have been slightly more explicit about the 'point in time' recognition occurring 'when the customer can benefit from the IP' (though this is mentioned). The answer demonstrates excellent synthesis of multi-year filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 404,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike first placed FlyEase in its innovation suite in fiscal 2022, describing the “proliferation” of FlyEase together with other flagship technologies (Nike Air, Zoom, Free, Flywire, Dri‑Fit, Flyknit, ZoomX, Air Max, React, Adapt) as evidence that the new closure‑system was being rolled out across product categories. The fiscal 2023 filing repeats FlyEase in the same roster of emerging technologies, showing that the company continued to develop and apply the system rather than treating it as a one‑off launch. By fiscal 2024, FlyEase is again listed among the core portfolio of Nike Air, Zoom, Free, Dri‑FIT, Flyknit, ZoomX, Air Max and React, confirming that the technology has been maintained and further integrated as a permanent, strategic pillar of Nike’s innovation portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of FlyEase's strategic positioning across the three fiscal years. STRENGTHS: (1) Correctly identifies the three-year progression (FY2022-2024) with accurate fiscal year references; (2) Accurately characterizes FlyEase as newly introduced in FY2022 and its subsequent integration into Nike's core portfolio; (3) Provides specific supporting details about the technology being listed alongside other flagship technologies (Nike Air, Zoom, Free, Flywire, etc.); (4) Correctly synthesizes the multi-hop information showing progression from emerging to mature/core technology; (5) Uses appropriate terminology ('proliferation,' 'permanent strategic pillar') that aligns with the ground truth's characterization of maturation. MINOR ISSUES: (1) The LLM answer includes additional context about FlyEase being a 'closure-system' which, while potentially accurate, is not explicitly mentioned in the ground truth and adds interpretive detail beyond what was provided; (2) The ground truth emphasizes FlyEase moving from 'novel concept' to 'foundational technology' while the LLM uses 'emerging' to 'permanent strategic pillar' - these are semantically equivalent but the LLM's framing is slightly different; (3) The LLM lists the same roster of technologies across all three years, which could be interpreted as suggesting minimal change in positioning, whereas the ground truth more clearly emphasizes the shift in how FlyEase was categorized relative to other technologies (from emerging to mature). QUANTITATIVE ACCURACY: All dates/years are correct (FY2022, FY2023, FY2024). No calculations required. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and correctly identifies the progression pattern. The answer demonstrates understanding that FlyEase's position evolved from new to established within Nike's innovation framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Expands]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 521,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250 % senior notes that AMT issued show a clear downward trajectory in their outstanding principal:\n\n* **2022 filing** – the 1.250 % notes were listed with an aggregate principal of **$609.1 million**.  \n* **2023 filing** – the same series appears with a reduced principal of **$551.9 million**.  \n* **2024 filing** – the principal is further trimmed to **$517.7 million**.\n\nBecause AMT both issues and discloses these notes, the shrinking balance across the three years indicates that the company is deliberately **paying down or refinancing this low‑coupon debt**, thereby lowering its overall leverage and interest‑cost profile. The trend reflects a proactive debt‑management strategy aimed at reducing the amount of outstanding 1.250 % notes year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the principal amounts are accurately stated as $609.1M (2022), $551.9M (2023), and $517.7M (2024). The multi-hop synthesis across three years is sound, correctly identifying the downward trend and interpreting it as a deliberate debt management strategy. The LLM correctly identifies the interest rate (1.250%) and characterizes the strategy as paying down or refinancing low-coupon debt to reduce leverage. The reasoning is logically sound and well-structured. Minor differences from the ground truth: (1) The LLM does not explicitly mention the consistent interest payment terms (May payments, February 2033 maturity) that the ground truth includes, though this is a minor omission that doesn't affect the core answer about debt management strategy. (2) The LLM uses slightly different terminology ('paying down or refinancing' vs. 'managed amortization or repurchase strategy'), but these are semantically equivalent descriptions of the same phenomenon. (3) The LLM's characterization of the strategy as 'proactive' and focused on 'lowering leverage and interest-cost profile' aligns well with the ground truth's assessment of 'reducing long-term debt obligations.' The answer fully addresses the question about what the trend suggests about debt management strategy, with accurate numbers and sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 401,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "- **2022 10‑K (fiscal 2022):** The 3.50 % Notes Due 2040 were reported as Level‑2 fair‑value assets at **$1,066 million** (down from $1,152 million a year earlier).  \n- **2023 10‑K (fiscal 2023):** The same notes were still classified as Level‑2 fair‑value securities but their fair‑value fell further to **$851 million** on Jan 28 2024 (versus $870 million on Jan 29 2023).  \n- **2024 10‑K (fiscal 2024):** NVIDIA now presents the 3.50 % Notes Due 2040 primarily on an amortized‑cost basis, showing a **net carrying amount of $1,000 million** (both at Jan 28 2024 and Jan 26 2025) with a 15.2‑year remaining term and a 3.54 % effective interest rate.\n\n**What the trajectory reveals:** Over the three‑year span the market‑based fair‑value of the 2040 notes has steadily declined, reflecting higher interest‑rate environments, yet NVIDIA continues to retain the notes as long‑term debt at a stable amortized amount. This pattern indicates a deliberate long‑term financing strategy: the company issues low‑coupon, ultra‑long‑dated bonds to lock in cheap capital, accepts fair‑value volatility for reporting purposes, and relies on the notes’ long maturity to support its balance‑sheet flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - FUNDAMENTAL MISCHARACTERIZATION: The LLM describes the 3.50% Notes Due 2040 as 'fair-value assets' and 'fair-value securities' that NVIDIA holds, when the ground truth clearly indicates these are LIABILITIES (debt obligations issued by NVIDIA). This is a major conceptual error that fundamentally misrepresents NVIDIA's debt position. The notes are bonds NVIDIA issued, not securities NVIDIA owns.\n\nQUANTITATIVE ACCURACY ISSUES:\n1. The $1,066 million figure for 2022 is correct per ground truth.\n2. The $851 million figure for 2023 is correct per ground truth.\n3. The $1,000 million figure for 2024 is correct per ground truth.\n4. The 3.54% effective interest rate is correct per ground truth.\n5. HOWEVER, the LLM introduces unsupported numbers: '$1,152 million a year earlier' (2021) and '$870 million on Jan 29 2023' are not in the ground truth and cannot be verified. These appear to be fabricated or from unreliable sources.\n6. The '15.2-year remaining term' is plausible but not verified in ground truth.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the three-year trajectory and identifies the pattern of declining fair values followed by stabilization. The reasoning about interest-rate environments and long-term financing strategy is sound and aligns with the ground truth's conclusion about debt strategy.\n\nSEMANTIC/CONCEPTUAL ERRORS:\n- Calling liabilities 'assets' or 'securities held' is a fundamental accounting error\n- Describing fair-value measurement as applying to assets when these are liabilities being measured at fair value for disclosure purposes\n- The characterization of 'Level-2 fair-value assets' is incorrect terminology for debt liabilities\n\nCORRECT ELEMENTS:\n- The three key fair values ($1,066M, $851M, $1,000M) are accurate\n- The effective interest rate (3.54%) is correct\n- The trajectory analysis and strategic interpretation align with ground truth\n- The multi-year synthesis is properly executed\n\nThe answer demonstrates good analytical reasoning and captures the core strategic insight, but the fundamental mischaracterization of these notes as assets rather than liabilities is a serious conceptual error that would mislead readers about NVIDIA's financial position. The introduction of unverified numbers also raises accuracy concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 619,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "From 2022 through 2024 Netflix’s membership‑plan strategy moved from a first foray into **games** (2022) to adding a **lower‑priced ad‑supported tier** in 2023 and then layering **live‑programming** onto its games‑and‑video bundle in 2024, while repeatedly stating that it may **adjust pricing or plan structures** (including the ad‑supported option) as it refines the mix.  \n\nIn each filing the company warned that **if members do not value the new games, the ad‑supported tier, or the live‑programming additions—or if price changes are poorly received—its ability to attract new subscribers and retain existing ones could be harmed, potentially reducing revenue per paying member and overall growth**.  \n\nThus, the evolution was: 2022 → games added; 2023 → games + ad‑supported plan; 2024 → games + ad‑supported plan + live programming, with the consistent risk narrative that any mis‑step in these expansions or pricing adjustments could impair member acquisition and retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: All key facts are correct - games introduced in 2022, ad-supported tier in 2023, live programming in 2024. The chronological progression is accurate and matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, and the LLM appropriately avoided introducing unsupported figures. Dates (2022, 2023, 2024) are all correct. (3) MULTI-HOP REASONING: The LLM successfully synthesized information across three years, correctly identifying the cumulative nature of Netflix's strategy (games → games + ad-supported → games + ad-supported + live programming). The answer properly traces the evolution while maintaining the consistent risk narrative. (4) RISK NARRATIVE: The LLM accurately captures the core risk theme present across all three years - that member perception of value and pricing reception directly impact acquisition and retention. The answer correctly notes that these risks were 'consistently highlighted' across the period, matching the ground truth's emphasis on this recurring theme. (5) COMPLETENESS: The answer addresses all parts of the multi-part question: service expansions (games, ad-supported tiers, live programming), pricing adjustments, and stated risks for each year. The synthesis of how these elements interconnect is sound. (6) WORDING AND SEMANTICS: While the LLM uses slightly different phrasing than the ground truth (e.g., 'layering live-programming onto its games-and-video bundle' vs. 'further diversified its offerings'), the semantic meaning is equivalent and arguably more precise. The answer maintains the same logical structure and emphasis as the ground truth. Minor observation: The LLM could have been slightly more explicit about the specific concern regarding 'higher churn' mentioned in the 2023 ground truth, though the general concept of retention risk is captured. Overall, this is a high-quality response that accurately synthesizes complex multi-year information with appropriate emphasis on both strategic evolution and consistent risk messaging.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 588,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑investment exposure grew markedly between 2022 and 2023 and then deepened in 2024.  The company’s total equity‑securities holdings – which are dominated by venture and employee‑savings‑plan investments – rose from **$3.7 billion at year‑end 2022 to $4.9 billion at year‑end 2023**, and remained at **$4.9 billion at year‑end 2024** (Chunk 1 & Chunk 2).  By contrast, its equity‑method stakes in operating health‑care businesses **declined slightly from $1.5 billion in 2022 to $1.4 billion in 2023**, then **jumped to $3.8 billion in 2024** (Chunk 1 & Chunk 2).  This trajectory shows UnitedHealth first expanding its venture‑style equity portfolio and, more recently, moving toward substantially larger equity‑method investments, signaling a strategic shift from peripheral venture exposure to a deeper, controlling‑type presence in health‑care operating companies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM states equity-method investments were '$1.5 billion in 2022' but the ground truth clearly states '$1.3 billion in 2022'. This is a material factual error ($200 million discrepancy). All other numbers are correct: equity securities $3.7B (2022), $4.9B (2023-2024); equity method investments $1.4B (2023) and $3.8B (2024). STRENGTHS: (1) The LLM correctly identifies the overall trend and trajectory across all three years; (2) The multi-hop synthesis is sound - it properly connects equity securities data with equity method investment data across the 2022-2024 period; (3) The strategic interpretation is accurate and well-reasoned, correctly characterizing the shift from venture exposure to deeper operating company stakes; (4) The answer is well-structured and addresses all parts of the question. WEAKNESSES: (1) The 2022 equity method investment figure is wrong ($1.5B vs. $1.3B ground truth) - this is a significant quantitative error that undermines credibility; (2) While the overall narrative is correct, this specific number error affects the accuracy of the 2022-2023 comparison. The error appears to be a data retrieval mistake rather than a calculation error. The qualitative reasoning about strategic positioning is sound and well-articulated, but the quantitative inaccuracy prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 378,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Nike’s relationship with Sojitz America remained financially unchanged – Sojitz America continued to be the sole holder of Nike’s $0.3 million of $1‑par redeemable preferred stock, and the stock carried the same cumulative dividend of $0.10 per share payable each May 31, with common‑stock dividends prohibited until the preferred dividend was paid in full.  The 2023 filing reiterates that there were no changes to the preferred‑stock terms in FY 2022‑2024, and the 2024 filing adds that Sojitz America, as the sole owner, has long‑served (since 1972) as Nike’s import‑export financing partner, supporting the company’s global sourcing and trade operations.  Thus, while the equity stake and dividend obligation stayed constant, Sojitz America’s strategic role as a financing conduit for Nike’s international manufacturing and supply‑chain activities was reaffirmed and highlighted in the 2024 disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All financial figures are correct - $0.3 million par value, $0.10 cumulative annual dividend per share, May 31 payment date, and the 1972 founding date of the financing relationship. No calculation errors or numeric discrepancies. ENTITY ACCURACY: Correctly identifies Nike, Sojitz America, and the redeemable preferred stock structure throughout FY 2022-2024. COMPLETENESS: Addresses all three sub-components of the multi-part question: (1) preferred stock ownership consistency, (2) dividend obligations remaining unchanged, and (3) Sojitz America's strategic role in international operations. MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years, correctly identifying that while financial terms remained constant, the 2024 disclosure explicitly highlighted the strategic operational role (import-export financing since 1972) that had been less emphasized in prior years. This captures the nuanced evolution from 'purely financial engagement' to 'operationally strategic role' as described in the ground truth. WORDING DIFFERENCES: The LLM provides additional helpful context (e.g., 'common-stock dividends prohibited until preferred dividend paid in full,' 'financing conduit for Nike's international manufacturing and supply-chain activities') that enriches understanding while remaining factually accurate. The phrase 'reaffirmed and highlighted in the 2024 disclosure' accurately captures the shift in emphasis noted in the ground truth. Minor: The LLM could have been slightly more explicit about the 'shift' or 'evolution' in how the relationship was characterized across years, though this is clearly implied in the answer's structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 489,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "**Carrying‑value of the 3.50 % Notes due 2050**\n\n| Fiscal year (as of the balance‑sheet date) | Carrying amount (in $ millions) |\n|--------------------------------------------|---------------------------------|\n| FY 2022 (Jan 30 2022) – disclosed in the 2022 Form 10‑K | **$2,147 M** (Chunk 1) |\n| FY 2023 (Jan 28 2024) – disclosed in the 2023 Form 10‑K | **$1,604 M** (Chunk 2) |\n| FY 2024 (Jan 26 2025) – disclosed in the 2024 Form 10‑K | **$2,000 M** (Chunk 3) |\n\n**What the trend shows**\n\n- From FY 2022 to FY 2023 the carrying amount fell sharply (about $543 M, a ≈ 25 % drop), indicating that NVIDIA repaid or otherwise reduced this tranche of long‑term debt.  \n- In FY 2024 the amount rose again to $2 bn, still below the FY 2022 level but higher than FY 2023, suggesting the company re‑added debt (e.g., through new issuance or reduced amortization) while keeping the overall long‑term liability modest.\n\nOverall, the pattern reflects active management of the 3.50 % Notes due 2050: a significant reduction after 2022 followed by a measured increase in 2024, signaling that NVIDIA is maintaining a sizable yet controlled long‑term debt position to support its strategic financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY 2022 carrying value of $2,147M, FY 2023 of $1,604M, and FY 2024 of $2,000M match the ground truth exactly. The calculation of the $543M decrease (approximately 25% drop) from FY 2022 to FY 2023 is accurate. The fiscal year dates provided (Jan 30 2022, Jan 28 2024, Jan 26 2025) are appropriately specific and correct. The multi-hop synthesis is sound: the answer correctly identifies the three-year trend, calculates the magnitude of changes, and interprets what these movements signify about NVIDIA's debt management strategy. The reasoning that the 2023 reduction indicates debt repayment/reduction and the 2024 increase suggests strategic re-addition of debt is logically sound and aligns with the ground truth's characterization of 'temporary reduction followed by strategic repositioning.' The presentation in tabular format enhances clarity. The qualitative analysis appropriately characterizes the trend as reflecting 'active management' of long-term debt while maintaining a 'controlled' position. The only minor distinction from the ground truth is that the LLM provides slightly more detailed mechanistic explanation (mentioning 'new issuance or reduced amortization') which, while speculative about the mechanism, doesn't contradict the ground truth and adds reasonable context. The answer fully addresses all parts of the question: the evolution across the three fiscal years and what the trend indicates about long-term debt positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 427,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s 2022 filing already stressed that a commercial‑paper program – part of its short‑term debt portfolio and backed by an unsecured revolving credit facility – was a core source of liquidity, and that the company’s “diversity of global funding sources … limits dependence on any one market or source of funds and generally lowers the cost of funds.” The 2023 and 2024 10‑K disclosures repeat the same framework, again listing short‑term debt (including commercial paper) alongside preferred and common equity, long‑term debt, PABs, credit facilities and shelf registrations, and reiterating that this diversified mix continues to enhance funding flexibility, curb reliance on any single market, and keep capital costs low. Thus, from 2022 through 2024 MetLife’s dependence on global funding markets remained anchored in its commercial‑paper program while increasingly emphasizing that a broad, varied funding base consistently mitigates concentration risk and reduces overall funding costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: All key facts are correct - MetLife's use of commercial paper programs, unsecured revolving credit facilities, the emphasis on diversified global funding sources, and the consistent messaging across 2022-2024 are all accurately represented. The answer correctly identifies the core funding instruments (commercial paper, preferred/common equity, long-term debt, PABs, credit facilities, shelf registrations). (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either answer, so this dimension is not directly testable. However, the temporal references (2022, 2023, 2024) are all correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years, correctly identifying the evolution (or lack thereof) in MetLife's funding strategy - showing consistency in approach while emphasizing the strategic benefits of diversification. The answer properly connects the commercial paper program to the broader funding strategy and its role in reducing costs and concentration risk. (4) COMPLETENESS: The answer addresses all parts of the question: (a) how dependence evolved (answer: remained stable/consistent), (b) use of short-term debt like commercial paper (correctly identified as core component), and (c) reliance on diverse funding sources to lower capital costs (properly explained). (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly more sophisticated language ('anchored in,' 'increasingly emphasizing') but conveys the same core message as the ground truth - that MetLife maintained a consistent funding strategy emphasizing diversification across 2022-2024. Minor difference: The LLM adds slightly more detail about specific funding instruments (PABs, shelf registrations) which enhances rather than detracts from accuracy. The phrase 'increasingly emphasizing' could be interpreted as suggesting a change in emphasis over time, though the answer clarifies this is about the same framework being repeated - this is a very minor semantic nuance that doesn't materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 582,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s parent company consistently disclosed that the amounts it accrued, paid or charged for service‑level guarantees were **not material** in every year covered – 2021‑2023 (Chunk 3), 2022‑2023 (Chunk 1) and 2022‑2024 (Chunk 2).  At the same time, the size of the inter‑company notes payable grew markedly: $8.1 billion at year‑end 2021 (Chunk 3) rose to $9.9 billion at year‑end 2023 (Chunk 1), then shifted in 2024 to $2.0 billion of short‑term notes plus a new $14.4 billion of long‑term notes payable to subsidiaries (Chunk 2).  The pattern shows that while UnitedHealth’s contractual exposure from service‑level guarantees has remained negligible, its liquidity commitments have expanded and been re‑structured toward longer‑term financing, indicating a growing but managed obligation to fund subsidiaries without increasing the risk of material guarantee‑related cash outflows.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and trends. Quantitative verification: (1) Notes payable figures are accurate - $8.1B (2021/2022), $9.9B (2023), $2.0B short-term + $14.4B long-term (2024); (2) Service level guarantees correctly characterized as 'not material' across all years; (3) The temporal progression and restructuring narrative is sound. Multi-hop synthesis is well-executed: the answer correctly connects the evolution of notes payable across three years with the consistent non-materiality of service level guarantees, and properly interprets this as indicating stable risk despite changing liquidity structures. The LLM goes slightly beyond the ground truth by explicitly noting the 2024 restructuring into short-term and long-term components ($2.0B + $14.4B), which adds valuable detail about the nature of the shift. Minor differences from ground truth: (1) The LLM mentions 2021 data ($8.1B at year-end 2021) while the original answer starts from 2022, though this is not incorrect - it's additional context; (2) The LLM's interpretation that this represents 'growing but managed obligation' and 'longer-term financing' is a reasonable inference from the data restructuring, though the ground truth uses more neutral language about 'shifting liquidity strategies.' The reasoning about why the company maintained stable risk profiles despite volatility is sound. All numbers are correctly formatted and calculations are implicit but accurate. The answer effectively addresses the multi-part question about evolution, liquidity commitments, and contractual risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 453,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 through 2024 American Express has remained the **fourth‑largest general‑purpose card network worldwide**, behind China UnionPay, Visa and Mastercard, and it continues to compete with those networks as well as with newer platforms such as Alipay, PayPal, Venmo and regional schemes (Chunk 3 & Chunk 1).  However, the **regulatory backdrop has grown markedly harsher**: by 2024 the firm was classified as a Category III bank‑regulatory entity, subject to heightened supervisory expectations and stricter capital and compliance requirements; legislators and regulators have intensified focus on interchange‑fee caps, network‑routing practices, “honor‑all‑cards” rules and consumer‑protection provisions, prompting Amex to **exit its network‑licensing businesses in the EU and Australia** and to bolster its AML/CFT, sanctions and anti‑corruption programs (Chunk 2).  In response, Amex is leaning on its premium‑card value proposition, lounge‑access and rewards differentiators while investing in digital‑payment innovation to offset the pressure from rival networks and the growing regulatory cost of its dependence on the broader card‑network ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies Amex as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard—this matches the ground truth exactly. (2) Accurately lists competitive threats from both traditional networks (Visa, Mastercard) and alternative platforms (Alipay, PayPal, Venmo, regional schemes like NPCI). (3) Correctly identifies the Category III regulatory classification by 2024 and its implications (heightened supervisory expectations, stricter capital/compliance requirements). (4) Accurately cites Amex's exit from network-licensing businesses in the EU and Australia as a regulatory response. (5) Properly identifies regulatory focus areas: interchange fees, network routing, honor-all-cards rules, and consumer protection. (6) Correctly notes Amex's strategic response emphasizing premium positioning, rewards, and digital innovation. MINOR WEAKNESSES: (1) The answer is somewhat less explicit about the temporal evolution/trajectory from 2022→2023→2024 compared to the ground truth, which specifically notes a 'shift in tone' by 2024 and describes the evolution as moving from 'market-driven competition to regulatory navigation.' The LLM presents the information more as a static comparison rather than a clear narrative arc. (2) The ground truth emphasizes the transformation of Amex's 'independence and competitive edge' being 'increasingly shaped and constrained by regulatory forces'—the LLM captures this concept but with less emphasis on the loss of independence. (3) The ground truth mentions uncertainty over 'future regulatory interpretations,' which the LLM doesn't explicitly address. QUANTITATIVE ACCURACY: All factual claims are accurate; no numerical errors detected. QUALITATIVE ACCURACY: Multi-hop reasoning is sound—the answer correctly synthesizes information about competitive positioning (2022-2024), regulatory changes (Category III status, specific regulatory focuses), and strategic responses. The logic connecting regulatory pressure to business exits and strategic pivots is clear and correct. CONTEXTUAL RELEVANCE: The answer directly addresses all three dimensions of the question: competitive positioning, regulatory dependency, and strategic responses. The inclusion of specific regulatory mechanisms (interchange fees, routing, honor-all-cards) and business actions (EU/Australia exits) demonstrates strong contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1712,
        "completion_tokens": 674,
        "total_tokens": 2386
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "All three filings describe the same cash‑settled PSU mechanics. In the 2022 10‑K (covering 2021) ConocoPhillips states that for performance periods that begin **in 2018** (or later) “recipients receive an **accrued reinvested dividend equivalent** that is charged to compensation expense and is paid at the time of settlement.” The 2023 10‑K and the 2024 10‑K repeat this language verbatim – the pre‑2018 periods still receive quarterly cash equivalents only after the performance period ends, while the 2018‑onward periods continue to receive the accrued, reinvested dividend that is paid at settlement. This unchanged structure shows that ConocoPhillips has deliberately kept its long‑term incentive design consistent, tying the dividend‑equivalent cash component to the eventual cash settlement of the PSUs and thereby aligning executives’ rewards with sustained shareholder value over the three‑year performance horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core mechanics of ConocoPhillips' PSU compensation structure. Strengths: (1) Correctly identifies the key distinction between pre-2018 and 2018-onward performance periods; (2) Accurately describes the accrued reinvested dividend equivalent structure for 2018+ periods; (3) Properly notes the consistency across 2022-2024 filings; (4) Correctly characterizes the dividend equivalent payment timing (at settlement for 2018+); (5) Appropriately identifies the three-year performance horizon. Weaknesses: (1) The LLM answer omits mention of the five-year vesting or retirement eligibility component mentioned in the ground truth, which is relevant context for understanding the full incentive structure; (2) The ground truth explicitly mentions that PSUs are classified as liabilities on the balance sheet across all three years, which the LLM answer does not address; (3) The ground truth provides more nuanced interpretation about the strategic shift from 'deferred dividend equivalents to accrued reinvestment' suggesting stronger long-term alignment, while the LLM characterizes it as 'unchanged structure' and 'deliberately kept consistent'—this represents a subtle but meaningful difference in analytical framing. The LLM's interpretation that the structure remained unchanged is factually accurate regarding the mechanics, but misses the ground truth's insight about the evolution from pre-2018 to 2018+ periods representing a strategic shift. The LLM answer is more narrowly focused on consistency across the three years (2022-2024) rather than the evolution from 2022 to 2024 as requested. Quantitative accuracy is high (dates, periods, and mechanics are correct). Qualitative accuracy is good but incomplete—the answer captures the mechanics but misses some strategic context about the evolution and balance sheet treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Grants]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 511,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The balance‑sheet line for **Special Use Funds** rose from the low‑$8 billion range in 2022‑23 to **$9.8 billion at 31 Dec 2024** (up from $8.698 billion at 31 Dec 2023) – a clear upward trend in the company’s non‑derivative investment pool.  Across the same three‑year span the collateral that NextEra actually posted for its derivative programs was modest (about $1.8 billion in cash + $2.8 billion in letters of credit in 2022, and $0.7 billion + $1.6 billion in 2023) and well below the maximum collateral that could be required if credit‑risk triggers were hit ($5.2 billion in 2022 and $2.4 billion in 2023).  Because the Special Use Funds balance consistently exceeds both the posted collateral and the worst‑case collateral calls, the evolution of the fund demonstrates that NextEra Energy has been strengthening its liquidity buffer and is comfortably positioned to meet any derivative‑related collateral obligations from 2022 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical errors that undermine credibility. (1) COLLATERAL POSTED FIGURES - Ground truth states $84 million in 2022 and $691 million in 2023; LLM claims '$1.8 billion in cash + $2.8 billion in letters of credit in 2022, and $0.7 billion + $1.6 billion in 2023' - these numbers are substantially different and appear to conflate different metrics or years. The $0.7 billion figure roughly aligns with $691 million but the $1.8B and $2.8B figures for 2022 are not supported by ground truth. (2) SPECIAL USE FUNDS - LLM correctly identifies $9.8 billion in 2024 and $8.698 billion in 2023, but vaguely references 'low-$8 billion range in 2022-23' without precise 2022 figure from ground truth. (3) COLLATERAL REQUIREMENTS - LLM correctly cites $5.2 billion (2022) and $2.4 billion (2023) as maximum potential collateral requirements, matching ground truth. (4) MISSING KEY DATA - Ground truth mentions $2.7 billion potential collateral requirement in event of downgrade (appears to be 2024 figure), which LLM completely omits. REASONING QUALITY: The LLM's logic is sound - it correctly synthesizes that Special Use Funds growth combined with lower collateral requirements indicates improved liquidity positioning. However, the flawed numerical foundation severely weakens this conclusion. COMPLETENESS: LLM addresses the core question about liquidity positioning and derivative collateral obligations, but the inaccurate collateral figures create a distorted picture. The answer conflates or misrepresents actual collateral posted versus potential collateral requirements. MULTI-HOP SYNTHESIS: The model attempts to connect Special Use Funds evolution with collateral obligations across years, but the incorrect numbers break the analytical chain. The conclusion about 'strengthening liquidity buffer' is directionally correct but built on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 520,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "- **2022:** The 1.600 % senior notes were issued for $700 million (2022 10‑K, Chunk 3). The 2023 filing shows a 2022‑year principal reduction of **$(3.7) million** (Chunk 1), leaving an outstanding balance of roughly **$696.3 million**.  \n\n- **2023:** The same table records a **$(2.6) million** amortization for 2023 (Chunk 1), bringing the balance down to about **$693.7 million**. The 2024 filing confirms the 2023 adjustment as **$(2.6) million** (Chunk 2).  \n\n- **2024:** The 2024 filing shows a further **$(1.5) million** reduction for 2024 (Chunk 2), resulting in an estimated outstanding principal of **≈ $692.2 million**.  \n\n**What the pattern suggests:** Over three consecutive years AMT has been **gradually amortizing** the 1.600 % notes, with the annual principal pay‑down shrinking from $3.7 million (2022) to $2.6 million (2023) to $1.5 million (2024). This steady, modest reduction indicates a **cash‑flow‑driven, incremental repayment strategy**—the company is systematically retiring the debt while preserving liquidity and maintaining a low‑cost financing profile rather than accelerating early pay‑down.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth:\n\n1. OUTSTANDING PRINCIPAL AMOUNT: The ground truth clearly states the outstanding principal remained constant at $700.0 million across all three years (2022, 2023, 2024). The LLM incorrectly calculates declining balances: $696.3M (2022), $693.7M (2023), $692.2M (2024). This is a major error.\n\n2. NATURE OF ADJUSTMENTS: The ground truth indicates the adjustments represent \"adjustments to principal (likely representing amortization or accrued interest)\" but emphasizes the principal itself stayed at $700.0M. The LLM misinterprets these adjustments as actual principal reductions, fundamentally misunderstanding the debt structure.\n\n3. CALCULATION ERRORS: The LLM performs arithmetic based on a false premise. Even if the adjustments were principal reductions, the calculations are inconsistent with stated figures. The ground truth shows adjustments of (3.7)M, (2.6)M, and (2.6)M - not (3.7)M, (2.6)M, (1.5)M as the LLM claims for 2024.\n\n4. DEBT MANAGEMENT INTERPRETATION: The LLM's conclusion about \"gradually amortizing\" and \"systematic retiring of debt\" is incorrect. The ground truth indicates a stable long-term debt strategy with constant principal and declining adjustments - not active principal reduction.\n\n5. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize information across the three years. It should have recognized the constant $700.0M principal across all periods, which is the key insight.\n\nThe LLM answer demonstrates a fundamental misreading of the financial data structure and provides incorrect numbers that would mislead users about AMT's actual debt position and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 472,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that **the company’s exposure to Medicare Advantage risk‑adjustment payment changes was a constant, material risk in 2022, 2023 and 2024**. Each year the reports note that CMS “from time to time makes changes to the way it calculates Medicare Advantage risk‑adjustment payments,” creating funding uncertainty for UnitedHealth’s Medicare Advantage business.\n\nTo counter that risk, UnitedHealth **repeatedly adjusted its strategy**:\n\n* **2022** – the filing said the company had already “adjusted members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” to address benchmark reductions and risk‑adjustment changes.  \n* **2023** – the same language reappears, emphasizing that those benefit‑premium tweaks, county‑level plan withdrawals and heightened cost‑management “may not fully address the funding pressures” created by the risk‑adjustment changes.  \n* **2024** – the company again highlights selective benefit/premium adjustments, plan‑offering cuts in specific counties, and “intensified both our medical and operating cost management” as its response, adding that it now submits detailed health‑status data to CMS to support capitation adjustments.\n\nThus, UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment reforms remained a persistent regulatory risk from 2022‑2024, and the company’s strategic response evolved from an initial set of benefit‑premium and cost‑control actions in 2022 to a reinforced, more aggressive cost‑management and data‑submission approach in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the consistent regulatory exposure to CMS risk adjustment payment changes; (2) Accurately captures the specific strategic responses for each year: selective benefit/premium adjustments, county-level plan exits, and intensified cost management; (3) Properly synthesizes the multi-hop information showing evolution across the three-year period; (4) Correctly notes that similar language and strategies appear across multiple years, indicating a persistent pattern; (5) Adds valuable detail about health-status data submission to CMS in 2024, which represents an evolution in strategy; (6) No quantitative errors - no specific dollar amounts or percentages are claimed, avoiding potential calculation errors; (7) Entity identification is correct (UnitedHealth/UNH, CMS, Medicare Advantage); (8) The reasoning about persistent regulatory risk and evolving response is sound and matches the ground truth narrative. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific in some areas (e.g., mentioning health-status data submission) compared to the ground truth summary, but this represents appropriate elaboration rather than error. The phrase 'may not fully address the funding pressures' is correctly attributed to 2023 language. The answer effectively conveys that the company's response evolved from initial adjustments to more aggressive/reinforced strategies, which matches the ground truth characterization. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 447,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Across the three filings Target’s employee‑benefit language is unchanged: each year the “Compensation and Benefits” section lists **merchandise and other discounts** as a standard component of the package. The discount is offered to all team members but, as noted in 2022, 2023 and 2024, **eligibility and the level of the discount vary with full‑time/part‑time status, work location, compensation level and tenure**—the same eligibility framework appears each year. Because the discount has been retained and framed consistently as a core benefit rather than expanded or eliminated, it signals that Target views merchandise discounts as a stable pillar of its strategy to bolster employees’ financial well‑being alongside wages, 401(k) matching and other benefits.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that merchandise discounts were offered consistently across 2022-2024 and accurately notes that eligibility varies by full-time/part-time status, work location, compensation level, and tenure. The framing of discounts as a 'stable pillar' of financial well-being strategy is reasonable. CRITICAL WEAKNESSES: (1) The LLM fundamentally misses the core evolution described in the ground truth. The original answer documents a clear progression: 2022 had starting wage of $15/hour, 2023 expanded to $15-$24/hour with new benefits (sick pay, tuition-free education), and 2024 added emphasis on equitable pay, belonging, and expanded mental health services. The LLM claims the language is 'unchanged' across all three years, which directly contradicts the documented evolution in wage ranges and benefit additions. (2) The LLM fails to capture the strategic shift from basic benefits (2022) to comprehensive financial wellness (2023-2024). The original answer emphasizes how merchandise discounts became part of a 'holistic financial and well-being strategy' with expanding benefits—this progression is entirely absent from the LLM response. (3) The LLM provides no evidence of the wage range expansion ($15 to $15-$24) or the addition of new benefits like sick pay, tuition-free education, virtual healthcare, and mental health services. (4) The question specifically asks about 'evolution' and 'progression'—the LLM's assertion that language is 'unchanged' directly contradicts this requirement. The LLM essentially argues for stasis rather than evolution, which is the opposite of what the ground truth demonstrates. MULTI-HOP REASONING: The LLM fails to synthesize the multi-year progression of benefits and wage changes that form the core of the answer. It treats each year as identical rather than identifying the strategic evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 514,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "**Yield and maturity evolution**\n\n- **2022:** American Express held **$630 million** of foreign government bonds and obligations, with **$628 million (≈ 99 %) due within one year** and only $1 million each in the 1‑5‑year and 5‑10‑year buckets. The filing gives only the portfolio‑wide weighted‑average yield (2.08 %) – no separate yield is shown for the foreign‑bond segment.  \n- **2023:** The 10‑K begins reporting class‑specific yields. The weighted‑average yield on foreign government bonds was **6.45 % for the ≤1‑year bucket** and **4.48 % for the 1‑5‑year bucket** (no exposure reported beyond five years). This indicates that the company added a modest amount of medium‑term sovereign exposure while still concentrating on short‑term holdings.  \n- **2024:** Yield on the same class fell to **5.86 % for ≤1 year** and **2.03 % for 1‑5 years** (again no longer‑dated exposure). The drop in yields, especially in the 1‑5‑year bucket, shows a shift toward lower‑yielding, shorter‑duration foreign bonds.\n\n**What the pattern suggests**\n\nThe three‑year trajectory moves from an almost entirely ultra‑short‑term, low‑yield position (2022) to a brief period of higher‑yield, slightly longer‑dated exposure (2023), and then back toward lower yields and a re‑emphasis on the shortest maturities (2024). This pattern reflects a **conservative risk appetite**: American Express prefers liquidity and limited duration risk, but is willing to allocate a small, controlled slice of its portfolio to higher‑yielding foreign sovereign bonds when market conditions are attractive, then reins in that exposure as yields recede. The overall asset‑allocation strategy therefore remains low‑duration and quality‑focused, with only a modest, opportunistic tilt toward higher‑yield foreign government securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $630 million total for 2022 and accurately reports the 2023 yields (6.45% for ≤1 year, 4.48% for 1-5 years) and 2024 yields (5.86% for ≤1 year, 2.03% for 1-5 years). (2) The maturity distribution analysis is sound - noting the shift from ultra-short-term in 2022 to slightly longer-dated in 2023, then back to shorter maturities in 2024. (3) The qualitative interpretation about conservative risk appetite and opportunistic positioning is reasonable and well-reasoned. (4) The multi-hop synthesis across three years is logically structured.\n\nCRITICAL ERRORS: (1) The LLM states that 2022 shows 'only the portfolio-wide weighted-average yield (2.08%) – no separate yield is shown for the foreign-bond segment.' However, the ground truth explicitly provides 2022 yields: 1.74% for securities due within one year and 2.42% for those due after one but within five years. This is a significant factual error - the LLM missed or misinterpreted available 2022 yield data. (2) The LLM claims the filing gives 'only the portfolio-wide weighted-average yield' for 2022, but the ground truth shows segment-specific yields were available. This represents a failure to accurately extract or synthesize the 2022 data.\n\nQUANTITATIVE ACCURACY ISSUES: The 2022 yield figures (1.74% and 2.42%) are completely absent from the LLM answer, which is a material omission. The LLM's statement about 2022 yields being unavailable contradicts the ground truth. The 2023 and 2024 yields are correct, but the missing 2022 yields prevent proper assessment of the full 3-year evolution.\n\nQUALITATIVE ASSESSMENT: Despite the missing 2022 yield data, the LLM's interpretation of the overall pattern (conservative, opportunistic, liquidity-focused) is reasonable and aligns with the ground truth's conclusion. However, without the 2022 yields, the analysis cannot fully capture the 'significant' increase from 2022 to 2023 that the ground truth emphasizes.\n\nMULTI-HOP REASONING: The synthesis across three years is attempted but incomplete due to the missing 2022 yield data. The comparison between years is partially sound for 2023-2024 but lacks the full context of the 2022 baseline.\n\nJUSTIFICATION: The correctness score of 6 reflects that while 2023-2024 data and yields are accurate, the critical omission of 2022 yield figures (1.74% and 2.42%) represents a significant factual gap that undermines the completeness of the answer. The quantitative accuracy is penalized for this omission, though the qualitative reasoning about risk appetite remains sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1690,
        "completion_tokens": 685,
        "total_tokens": 2376
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil reported collateral held under master‑netting arrangements (which is presented in the “Other assets, including intangibles – net” line) of **$1.494 billion for 2022**, **$0.800 billion for 2023**, and **$0.491 billion for 2024**. The amount fell sharply each year – down about 46 % from 2022 to 2023 and a further 38 % from 2023 to 2024. This downward trend indicates that the company’s exposure to derivative contracts is being increasingly offset or that it is requiring less initial margin, suggesting more efficient or reduced derivative‑related risk and tighter management of its net‑ting collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1.494 billion (2022), $0.800 billion (2023), and $0.491 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively. The percentage calculations are also accurate: 46% decline from 2022-2023 ($1,494M to $800M = 46.4% decline) and 38% decline from 2023-2024 ($800M to $491M = 38.6% decline). (2) COMPLETENESS: The answer addresses all parts of the multi-hop question - it identifies the specific collateral metric, provides all three years of data, calculates year-over-year changes, and interprets the trend. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the 'Other assets, including intangibles - net' line item is properly referenced, and all fiscal years (2022-2024) are correct. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connected collateral amounts to derivative exposure management and provided logical interpretation that the declining trend suggests more efficient risk management or reduced derivative exposure. The explanation about offsetting exposure and margin requirements adds valuable context. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend 'indicates that the company's exposure to derivative contracts is being increasingly offset or that it is requiring less initial margin' is semantically equivalent to and slightly more detailed than the ground truth's statement about 'strategic reduction in derivative-related exposure or a shift in risk management practices.' Minor formatting differences (billion vs million notation) are acceptable and properly handled. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 475,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 Form 10‑K AMT disclosed that it had issued a $700 million senior “2.700 % Notes” series on March 29, 2021, maturing on April 15, 2031 (callable on January 15, 2031) with a fixed 2.700 % coupon. The 2023 filing still listed the same $700 million issue, the same coupon and maturity, and showed the notes outstanding with a balance of about $5.0 million (rounded) as of the 2023 reporting date. The 2024 filing again reports the identical $700 million issue, unchanged 2.700 % rate and 2031 maturity, but the outstanding balance had fallen to roughly $4.4 million, indicating modest amortization or early repayment.\n\n**What this reveals:** AMT has kept the 2.700 % notes as a core, low‑mid‑rate fixed‑income instrument throughout the period, using it to lock in relatively inexpensive financing even as market rates rose in 2022‑2024. The unchanged coupon and maturity show a deliberate strategy of maintaining a stable, long‑dated debt base, while the slight decline in the outstanding amount reflects the company’s disciplined repayment of that debt rather than a need to refinance at higher rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) MATURITY DATE DISCREPANCY: The LLM states the notes mature on 'April 15, 2031' in 2022, but the ground truth clearly indicates the maturity date is 'January 15, 2031' (not April 15). This is a significant date error. (2) OUTSTANDING BALANCE MISINTERPRETATION: The LLM interprets the interest rate spread figures (5.0) and (4.4) from the ground truth as 'outstanding balances' of '$5.0 million' and '$4.4 million' respectively. This is a critical misreading. The ground truth explicitly states these are interest rate spreads that 'decreased from (5.0) to (4.4)' - these are basis point or percentage spreads, NOT dollar amounts of outstanding principal. The LLM's claim that the outstanding balance 'fell to roughly $4.4 million' is factually incorrect and demonstrates a fundamental misunderstanding of the data. (3) INCOMPLETE ANALYSIS: The ground truth mentions interest payment schedules (April and October) that the LLM does not address. (4) REASONING FLAW: The LLM's conclusion about 'modest amortization or early repayment' is based on the erroneous interpretation of spread figures as outstanding balances, making the entire analytical conclusion invalid. The correct interpretation is that the interest rate spread decreased, indicating improved financing terms or market conditions, not debt repayment. (5) CORRECT ELEMENTS: The LLM correctly identifies the $700 million principal amount, the 2.700% coupon rate, the March 29, 2021 issuance date, and the January 15, 2031 par call date. The general strategic narrative about stable long-term financing is directionally reasonable but is built on incorrect numerical foundations. The answer fails to correctly synthesize the multi-hop information about how financing terms evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 512,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "- **2022:** In the 2022 Form 10‑K the 2.00 % Notes due 2031 were listed under liabilities at a **fair‑value of $1,200 million** (Chunk 1).  \n- **2023‑2024:** The 2023 filing shows the same notes at a **fair‑value of $1,044 million** for Jan 29 2023 and **$1,057 million** for Jan 28 2024 (Chunk 2). The 2024 filing adds the amortized‑cost (net carrying amount) figure of **$1,250 million** for the notes, with an expected remaining term of 6.4 years and an effective interest rate of 2.09 % (Chunk 3).  \n\n**Interpretation:** Over the three‑year period the fair‑value of the 2.00 % Notes fell from $1.2 billion to just above $1.0 billion, while the amortized amount remained around $1.25 billion. This pattern shows NVIDIA keeping a sizable, low‑cost, long‑dated debt instrument on its balance sheet, using it as a stable financing pillar rather than aggressively retiring or refinancing it—consistent with a long‑term debt strategy that locks in inexpensive, long‑maturity funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and dates. Quantitative verification: 2022 fair value of $1,200 million ($1.2B) matches ground truth; 2023 figures of $1,044 million and $1,057 million are accurate; 2024 carrying value of $1,250 million ($1.25B) is correct. The LLM correctly identifies the distinction between fair value and amortized cost, which is an important nuance not explicitly emphasized in the ground truth but adds analytical depth. The multi-hop synthesis is sound—the answer correctly traces the evolution across three years and synthesizes information from multiple chunks/filings. The interpretation about NVIDIA's debt strategy is logical and well-reasoned, noting the decline in fair value while amortized cost remained stable, and correctly characterizing this as a stable, long-term financing approach. Minor deduction: The ground truth states 2023 beginning value was $1.044 billion and end-of-year was $1.057 billion, while the LLM presents these as separate data points without explicitly clarifying the temporal relationship (beginning vs. end of fiscal year). The LLM also adds contextual details (6.4 years remaining term, 2.09% effective interest rate) that enhance understanding but weren't in the ground truth—this is appropriate supplementary information that doesn't contradict the original answer. The semantic meaning and core findings align well with the ground truth regarding strategic consistency in managing this long-term liability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 425,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s 2022 Form 10‑K still showed only modest use of the deposit method – deposit assets on reinsurance were **$1.8 billion** and deposit liabilities were **$1.4 billion**, unchanged from the prior two years.  After the 2023 Global Atlantic risk‑transfer transaction, the 2023 filing reported **$5.1 billion** of deposit assets and **$1.3 billion** of deposit liabilities, and the 2024 filing showed a slightly lower but still elevated level of **$4.6 billion** of deposit assets and **$1.2 billion** of deposit liabilities.  \n\nThe jump in deposit assets (from $1.8 bn to over $4‑5 bn) together with a modest decline in deposit liabilities signals that MetLife is increasingly employing the deposit‑method accounting to hold larger reinsurance receivables while limiting its exposure to insurance‑risk losses, reflecting a more aggressive risk‑transfer strategy that relies on “deposit” reinsurance arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IDENTIFIED: The LLM answer contains a significant factual error regarding 2024 deposit assets. The ground truth states deposit assets were $5.1 billion in 2024, but the LLM claims they were $4.6 billion in 2024. This is a material misstatement of a key financial metric. VERIFICATION OF OTHER NUMBERS: (1) 2022 deposit assets: $1.8 billion - CORRECT; (2) 2022 deposit liabilities: $1.4 billion - CORRECT; (3) 2023 deposit assets: $5.1 billion - CORRECT; (4) 2023 deposit liabilities: $1.3 billion - CORRECT; (5) 2024 deposit liabilities: $1.2 billion - CORRECT; (6) Global Atlantic transaction reference ($10.3 billion in reinsurance recoverables) - NOT MENTIONED in LLM answer, which is a notable omission. MULTI-HOP REASONING: The LLM correctly synthesizes the trend across three years and appropriately connects the 2023 spike to the Global Atlantic transaction, though it doesn't quantify the transaction amount. The interpretation of the deposit method strategy is reasonable and aligns with the ground truth's characterization of risk management. COMPLETENESS: The LLM addresses the evolution from 2022-2024 and provides strategic interpretation, but misses the specific quantification of the Global Atlantic transaction and contains the critical error on 2024 deposit assets. The reasoning about 'deposit-method accounting' and 'risk-transfer strategy' is sound and matches the ground truth's interpretation. The error on 2024 deposit assets ($4.6B vs. $5.1B) is a 10% understatement of a key metric, which significantly impacts the accuracy of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 437,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s “Debt securities – held‑to‑maturity” portfolio has been shrinking both in market (fair) value and in its book (carrying) amount:\n\n* **2022:** Fair value $ 679 million; carrying value $ 696 million.  \n* **2023:** Fair value $ 596 million; carrying value $ 603 million. (Chunk 1)  \n* **2024:** Fair value $ 508 million; carrying value $ 512 million. (Chunk 2)\n\nOver the three‑year span the fair value fell about **25 %** (‑$171 million) and the carrying value fell about **26 %** (‑$184 million). The gap between fair and carrying values narrowed from roughly $17 million in 2022 to only $4 million in 2024, indicating that unrealized losses have been largely absorbed—either through maturities, selective sales, or a shift to lower‑duration, lower‑yield securities. Together with the earlier downward trend shown in 2021 (fair $643 m, carrying $641 m) (Chunk 3), the data suggest UnitedHealth is deliberately trimming its HTM portfolio and aligning its investments with prevailing market rates, reflecting a conservative, valuation‑aware investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. QUANTITATIVE VERIFICATION: All core numbers match ground truth exactly - 2022 (FV $679M, CV $696M), 2023 (FV $596M, CV $603M), 2024 (FV $508M, CV $512M). Calculations are accurate: fair value decline of $171M (25.2% decline from $679M to $508M) and carrying value decline of $184M (26.4% decline from $696M to $512M). The gap analysis is correct: $17M in 2022 ($696M - $679M) narrowing to $4M in 2024 ($512M - $508M). COMPLETENESS: The answer addresses all aspects of the original question - the 3-year progression, fair value evolution, carrying value evolution, and strategic implications. ENTITY ACCURACY: Company (UnitedHealth/UNH), metric type (Debt Securities - Held-to-Maturity), and years (2022-2024) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound, correctly connecting the numerical trends to strategic interpretation (portfolio reduction, market rate alignment, conservative strategy). The LLM goes beyond the ground truth by providing additional context (2021 data, gap analysis, percentage calculations) that enhances understanding without contradicting the original answer. MINOR CONSIDERATIONS: The LLM includes 2021 data and more detailed analytical commentary than the ground truth, but this represents value-added analysis rather than error. The semantic meaning and factual foundation align perfectly with the original answer. The interpretation about 'unrealized losses being absorbed' and 'deliberate trimming' is consistent with the ground truth's characterization of 'strategic reduction or repositioning.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 447,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s branded‑card penetration has been falling each year. The company reported RedCard (Target Credit Card + Target MasterCard) penetration of **20.5 % for the year ended January 29 2022**, **19.8 % for the year ended January 28 2023**, and **18.6 % for the year ended February 3 2024** (the same metric is called “Target Circle Card Penetration” in the 2024 filing). Because Target tracks this rate specifically because “a meaningful portion of incremental purchases on our Target Credit Cards are also incremental sales for Target,” the steady decline suggests the credit‑card program is becoming less effective at driving new, incremental sales and may require renewed focus or incentives to reverse the trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three penetration rates are correct (20.5% for 2022, 19.8% for 2023, 18.6% for 2024), and the fiscal year dates are accurate. The downward trend calculation is implicit and correct. ENTITY ACCURACY: The answer correctly identifies the metrics as RedCard penetration (combining Target Credit Card and Target MasterCard) and notes the 2024 filing terminology change to 'Target Circle Card Penetration,' showing careful attention to source documentation. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects the declining penetration rates to Target's stated strategic rationale (that incremental card purchases drive incremental sales). The logic is sound: declining penetration suggests reduced effectiveness of the credit card strategy. COMPLETENESS: The answer addresses both parts of the question—the evolution of penetration rates (with specific numbers) and what the trend suggests about strategy effectiveness. The inclusion of Target's internal analysis about incremental sales adds valuable context. MINOR CONSIDERATIONS: The answer uses slightly different framing than the ground truth (emphasizing 'becoming less effective' and 'may require renewed focus') versus the ground truth's more measured 'may indicate weakening engagement.' However, this represents a reasonable interpretation of the same data trend and is not factually incorrect. The answer is more analytical and forward-looking while remaining grounded in the data. No calculation errors, no incorrect numbers, and proper synthesis of multi-hop information across years and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 464,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—Nike describes the Laakdal, Belgium site as one of its “most significant distribution facilities outside the United States” and explicitly states that it **owns** the facility in each year. There is no indication of a change in ownership or of any new lease or third‑party operator for Laakdal, meaning the operational footprint in Belgium remained stable and fully under Nike’s control throughout FY 2022‑FY 2024. This continuity signals that Nike is deliberately keeping a proprietary, owned logistics hub in Europe, underscoring a strategic focus on direct control of its European distribution network rather than relying on leased or outsourced capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies the three fiscal years (2022, 2023, 2024) and confirms Nike's consistent ownership throughout; (2) Accurately characterizes Laakdal as 'one of its most significant distribution facilities outside the United States' - matching the ground truth description of 'one of the most significant international distribution centers'; (3) Properly synthesizes multi-hop information across three years showing no changes in ownership or operational status; (4) Correctly interprets the strategic implication - that Nike maintains direct control over this key European logistics node rather than outsourcing; (5) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM adds slightly more interpretive language ('deliberately keeping a proprietary, owned logistics hub') compared to the ground truth's more neutral 'stable strategic focus,' but this is a reasonable inference from the facts and doesn't contradict the ground truth; (2) The phrase 'most significant distribution facilities outside the United States' is a reasonable paraphrase of 'most significant international distribution centers' - semantically equivalent. The answer demonstrates sound multi-hop reasoning by confirming consistency across all three years and drawing appropriate strategic conclusions. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 389,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "- **2022 filing:** NVIDIA listed Lumentum Holdings among the “suppliers of interconnect, switch and cable solutions” (e.g., optical modules) that compete with its products.  \n- **2023 filing:** Lumentum re‑appears in the same “networking products … switches, network adapters (including DPUs) and cable solutions” list, showing no change in its competitive category.  \n- **2024 filing:** Lumentum is again named in the “networking products … switches, network adapters (including DPUs) and cable solutions” group, confirming a consistent presence across three consecutive years.\n\nAcross the same period, NVIDIA’s disclosures show an **expanding and more resilient supply chain** (2024: added redundancy with multiple foundries, memory suppliers and contract manufacturers) and a **continuously reinforced IP‑protection regime** (2022‑2024: extensive patent portfolios, licensing, and ongoing assessment of foreign IP enforcement).  \n\nThus, while NVIDIA has broadened its supply‑chain depth and sharpened its IP safeguards, Lumentum’s competitive positioning has remained stable—continuously identified as a key interconnect/optical‑module competitor in NVIDIA’s landscape throughout FY 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Lumentum Holdings' consistent positioning across FY 2022, 2023, and 2024 in NVIDIA's competitor landscape; (2) Accurately characterizes Lumentum's domain as networking products, interconnect solutions, optical modules, switches, network adapters (DPUs), and cable solutions; (3) Properly synthesizes the multi-hop relationship: Lumentum's stable competitive positioning despite NVIDIA's expanding supply chain resilience and IP protection strategies; (4) Correctly notes NVIDIA's strategic moves including manufacturing partnerships (TSMC, Samsung) and patent portfolio expansion; (5) No quantitative errors—all dates, company names, and product categories are accurate; (6) Effectively conveys the semantic meaning that Lumentum remained a 'persistent competitive force' despite NVIDIA's strategic advancements. MINOR OBSERVATIONS: (1) The LLM answer uses slightly more structured formatting (bullet points, bold text) compared to the ground truth's narrative style, but this is a presentation choice that enhances clarity rather than detracting from accuracy; (2) The LLM answer emphasizes 'no change in competitive category' across years, which is a valid inference from the consistent listing but represents a minor interpretive emphasis not explicitly stated in ground truth; (3) Both answers correctly identify the three-year consistency and the contrast between Lumentum's stable positioning and NVIDIA's strategic evolution. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and two distinct strategic dimensions (supply chain expansion and IP protection), correctly concluding that Lumentum's relevance persists despite NVIDIA's advancements. The reasoning is sound and logically structured. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 522,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "From 2022 to 2024 Netflix has consistently stressed that its ability to stream shows and movies “depends on studios, content providers and other rights‑holders licensing rights” (2022 Risk section; 2023 Intellectual‑Property section; 2024 Intellectual‑Property section). In the 2022 filing the company warned that rights‑holders could refuse or withdraw licenses, especially as competition drives up programming costs and pushes Netflix to be “selective about the titles we add and renew” and to chase exclusive rights. By 2023 the same dependence was reiterated, but the discussion added that many countries were already tightening cultural‑support laws (quotas, levies, ownership limits), and the 2024 filing highlighted that regulators are expanding those rules, making the licensing environment “more expensive or restrictive.” Together, the three filings show that while Netflix’s reliance on external rights‑holders has not diminished, the company is increasingly focused on securing exclusive or original content and negotiating more favorable terms to offset rising competition and the growing regulatory burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of how Netflix's reliance on rights holders evolved; (2) Accurately cites the consistent framing across filings regarding dependence on external rights holders for licensing; (3) Properly synthesizes the multi-hop information showing how the narrative shifted from competition-driven concerns (2022) to regulatory pressures (2023-2024); (4) Correctly identifies key strategic implications: shift toward exclusive/original content and more favorable negotiation terms; (5) Accurately captures the regulatory evolution (quotas, levies, ownership limits becoming more restrictive); (6) No quantitative errors or date inaccuracies; (7) Provides specific filing section references (Risk section 2022, Intellectual Property sections 2023-2024) that enhance credibility. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and specific than the ground truth (includes direct quotes and section references), but this represents added value rather than error; (2) Both answers convey the same core narrative arc and strategic implications; (3) The LLM's framing of the progression as 'not diminished' reliance while shifting strategy is semantically equivalent to the ground truth's 'core risk factor' that evolved in framing. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings (2022, 2023, 2024) and correctly identifies the causal relationships between competitive pressures, regulatory changes, and Netflix's strategic response. The logical flow from external dependence → competitive pressure → regulatory constraints → strategic shift is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 493,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "- **2022:** Southern Company said that the undiscounted cash‑flows from outdoor‑lighting contracts that are accounted for as operating leases at Mississippi Power are **immaterial**, so they are not shown in the lease‑payment tables. Lease income from PPAs is treated as contingent rent and is excluded from the lease‑payment schedule, with revenue for the non‑lease components of PPAs allocated on a stand‑alone‑selling‑price basis.  \n\n- **2023:** The company began **disclosing** the scheduled lease payments from outdoor‑lighting contracts (along with tolling arrangements and PPAs) in a **maturity analysis**. Lease income from PPAs is now **included in wholesale revenues** for Alabama Power and Southern Power, indicating that the amounts are considered material enough to be presented alongside other lease cash‑flows.  \n\n- **2024:** The same disclosure approach is retained and **expanded** – scheduled payments under the initial terms of outdoor‑lighting contracts (plus tolling and lease‑accounted PPAs) are again shown in the maturity analysis, and lease income from PPAs is now **included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power**. The treatment therefore evolved from an immaterial, non‑disclosed item in 2022 to a material, revenue‑classified line item presented in the lease‑payment maturity tables by 2023, with the 2024 filing continuing that presentation and broadening the revenue‑classification to an additional utility.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a structured year-by-year progression that captures the general evolution of Southern Company's treatment of outdoor lighting contracts from 2022-2024. However, there are significant issues with accuracy and interpretation:\n\nSTRENGTHS:\n1. Correctly identifies the 2022 immateriality designation for outdoor lighting contracts at Mississippi Power\n2. Accurately notes the shift to inclusion in maturity analyses by 2023\n3. Correctly identifies the continued presentation in 2024\n4. Properly identifies the multi-hop synthesis across years and utilities (Mississippi Power, Alabama Power, Georgia Power, Southern Power)\n5. Appropriately captures the progression from non-disclosed to disclosed/material items\n\nCRITICAL ERRORS:\n1. MATERIALITY MISCHARACTERIZATION: The LLM states that by 2023, the amounts are \"considered material enough to be presented\" - but the ground truth indicates the 2022 disclosure was about immateriality of UNDISCOUNTED cash flows, not that the items became material by 2023. The shift appears to be about disclosure/presentation structure, not materiality determination.\n2. REVENUE CLASSIFICATION OVERSTATEMENT: The LLM claims lease income from PPAs is \"included in wholesale revenues\" starting in 2023, but the ground truth does not explicitly confirm this revenue reclassification occurred or the specific timing. The LLM appears to infer materiality from inclusion in maturity analyses, which may not be the same thing.\n3. SCOPE CONFUSION: The LLM conflates the treatment of outdoor lighting contracts with PPA treatment and revenue classification in ways that may not be directly supported. The ground truth focuses on outdoor lighting contracts specifically, while the LLM blends multiple contract types.\n4. INCOMPLETE GROUND TRUTH ALIGNMENT: The ground truth emphasizes \"increasing emphasis on formalizing the visibility\" and \"more transparent treatment,\" suggesting a disclosure/presentation evolution rather than a materiality shift. The LLM's framing of materiality changes may misrepresent the actual nature of the evolution.\n\nMULTI-HOP REASONING:\nThe LLM does attempt to synthesize across years and utilities, but the reasoning about what changed (materiality vs. disclosure structure) appears flawed. The connection between inclusion in maturity analyses and materiality determination is asserted but not clearly justified.\n\nNUMERIC/QUANTITATIVE ELEMENTS:\nNo specific dollar amounts or percentages are provided in either answer, so quantitative accuracy cannot be directly verified. However, the absence of specific metrics in the LLM answer when discussing materiality is a weakness.\n\nSEMANTIC ISSUES:\nThe LLM's interpretation that items became \"material enough to be presented\" contradicts the ground truth's emphasis on immateriality in 2022 and subsequent formalization of visibility. This is a meaningful semantic difference, not just wording variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 776,
        "total_tokens": 2376
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "- **Outstanding principal balance**  \n  * FY 2022 (as of Oct 30 2022): **$606 million** – shown in the 2022 10‑K table for the 5.000 % notes due April 2030.  \n  * FY 2023 (as of Oct 29 2023): **$606 million** – the same amount appears in the 2023 10‑K (and is repeated in the 2024 10‑K) for that instrument.  \n  * FY 2024 (as of Nov 3 2024): **$606 million** – again listed in the 2024 10‑K.\n\n- **What the trend indicates**  \n  The balance has remained flat at $606 million over three consecutive fiscal years, showing that Broadcom has neither issued additional 5 % senior notes nor materially retired the existing tranche. This stability reflects a deliberate debt‑management approach: the company is content to service the existing obligation with cash flow while keeping the capital structure unchanged, signaling disciplined use of this financing source rather than expanding or reducing it.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states FY 2022 balance was $606 million, but ground truth clearly shows it was $1,086 million - a $480 million discrepancy. This is a major factual error, not a minor formatting difference. The LLM also claims the balance 'remained flat at $606 million over three consecutive fiscal years,' which is factually wrong. The correct progression is: FY 2022: $1,086M → FY 2023: $606M → FY 2024: $606M. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the debt evolution across the three fiscal years. It missed the critical $480 million reduction that occurred between FY 2022 and FY 2023. (3) REASONING ERROR: The LLM's interpretation that 'the balance has remained flat at $606 million over three consecutive fiscal years' is incorrect. While the balance was flat from FY 2023 to FY 2024, there was a significant reduction from FY 2022 to FY 2023. The LLM's conclusion about 'neither issued additional 5% senior notes nor materially retired the existing tranche' is contradicted by the actual $480 million retirement in 2023. (4) ENTITY ACCURACY: The LLM correctly identifies AVGO/Broadcom and the 5.000% notes due April 2030, but misreports the actual outstanding balances. (5) SEMANTIC EQUIVALENCE: The LLM's narrative about 'stability' and 'flat' balances is semantically incorrect given the actual $480 million reduction in 2023. The ground truth indicates a deliberate debt reduction strategy in 2023, which the LLM completely missed. The LLM answer demonstrates a fundamental failure to accurately extract and synthesize the correct financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 480,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "- In the 2022 filing GM reported that the weighted‑average long‑term rate of return (ROA) used for its U.S. defined‑benefit pension plans was **6.3 %** (the same rate applied to the 2022 year‑end balance).  \n- The 2023 filing confirmed that the rate **remained unchanged at 6.3 %** for both 2022 and 2023.  \n- The 2024 filing showed the rate **rose to 6.5 %** at December 31 2024, up from 6.3 % at the end of 2023.\n\n**Trend interpretation:** Over the three‑year period the assumption was flat for two years and then increased modestly in 2024. This pattern reflects GM’s “Strategic Mix” accounting policy in action: after a period of stability (likely reflecting a cautious asset‑allocation stance amid market uncertainty), the company adjusted its pension‑plan asset mix toward higher‑returning assets as market conditions improved, modestly raising its long‑term return assumption to support funded‑status goals while still managing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 figure. Ground truth states GM reported 5.4% in 2022, but the LLM claims 6.3% for 2022. This is a 0.9 percentage point discrepancy on a key metric. The LLM then compounds this error by stating '2023 remained unchanged at 6.3%' - which would be correct IF 2022 were 6.3%, but since 2022 was actually 5.4%, this creates an internal inconsistency with the ground truth. The 2024 figure of 6.5% is correct. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend. Ground truth shows: 2022: 5.4% → 2023: 6.3% (0.9pp increase) → 2024: 6.5% (0.2pp increase) = 1.1pp total increase over two years. The LLM's narrative of 'flat for two years then increased modestly in 2024' is completely wrong - there was actually a significant jump from 2022 to 2023. REASONING QUALITY: While the LLM's interpretation about 'Strategic Mix' and market conditions is plausible and contextually relevant, it is built on incorrect foundational data. The reasoning about cautious stance followed by adjustment is contradicted by the actual data showing a sharp 2022-2023 increase. COMPLETENESS: The answer addresses all three years but with incorrect 2022 baseline data, making the entire trend analysis invalid. The LLM did attempt to interpret strategic implications, which shows effort on the qualitative side, but this cannot overcome the quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 406,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings American Tower repeatedly lists the **2.700 % Senior Notes due 2031** in the “Supplemental Indenture” exhibit tables (2022 Exhibit 4.23, 2023 Exhibit 4.20, 2024 Exhibit 4.19). In each year the notes are disclosed as part of a supplemental amendment to the June 4 2019 senior‑note indenture, indicating that the securities remain outstanding and are being reported on a continuing basis.  \n\nThis consistent treatment shows that American Tower is using the 2.700 % 2031 notes as a **core, long‑dated source of low‑cost debt** that it intends to keep on its balance sheet for the full term of the instrument. By locking in a relatively low fixed rate for more than a decade, the company’s financing strategy emphasizes stable, long‑term capital to support its infrastructure growth rather than frequent refinancing or short‑term borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic financing implications but contains significant factual errors that undermine its credibility. STRENGTHS: (1) Correctly identifies the 2.700% Senior Notes due 2031 as a core long-term debt instrument; (2) Properly synthesizes the multi-hop concept that consistent treatment across three years indicates strategic stability; (3) Provides sound reasoning about low-cost, long-dated debt strategy; (4) Correctly identifies the notes as part of supplemental indenture amendments. CRITICAL ERRORS: (1) The LLM cites specific exhibit numbers (2022 Exhibit 4.23, 2023 Exhibit 4.20, 2024 Exhibit 4.19) that cannot be verified against the ground truth and appear to be fabricated or incorrectly recalled; (2) References a 'June 4 2019 senior-note indenture' as the base indenture, but the ground truth specifically mentions 'Supplemental Indenture No. 8 dated March 29, 2021' - the LLM conflates or misidentifies the indenture date; (3) The ground truth emphasizes Supplemental Indenture No. 8 specifically, which the LLM does not mention by number. QUANTITATIVE ACCURACY ISSUES: The exhibit numbers and indenture dates are factual claims that appear incorrect or unverifiable. The percentage (2.700%) and year (2031) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly infers that consistent treatment across three years indicates strategic stability and long-term planning. However, the specific documentary references undermine confidence in the analysis. The conclusion about 'low-cost debt' and 'stable, long-term capital' aligns well with the ground truth's assessment of 'confidence in financing terms and alignment with strategic financial planning.' The answer would score higher if the specific exhibit numbers and indenture details were accurate or omitted rather than stated incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 510,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "**Evolution of exposure**\n\n* **2022 – Baseline risk:** PayPal warned that abusive behaviors – synthetic‑identity accounts, stolen‑card use, “bad” transactions and other fraud – could raise its loss rate and hurt confidence in its services.  The risk was tied directly to its **U.S. consumer‑credit and merchant‑financing products** (which could generate charge‑offs) and to **cross‑border trade**, which is a major source of higher‑margin revenue but is vulnerable to fraud, foreign‑exchange swings and regulatory friction.  \n\n* **2023 – First mitigation steps:** The company began **selling off the bulk of its U.K. and European “buy‑now‑pay‑later” (BNPL) loan receivables** and set up a forward‑flow arrangement for future originations, thereby removing a large chunk of credit‑product exposure.  It also announced a **diversification of third‑party payment‑processor relationships** and a migration plan away from a single U.S. processor, and it reiterated ongoing investments in fraud‑detection and abuse‑prevention systems.  \n\n* **2024 – Continued risk‑reduction:** PayPal formalised the **multi‑year BNPL‑receivable sale** (the same arrangement begun in 2023) and stressed its reliance on third‑party lenders and processors while **enhancing oversight of those relationships** to limit operational, legal and reputational risk.  The filing again highlighted **continuous improvement of fraud‑ and abusive‑behavior detection** as a core safeguard for both its credit portfolio and cross‑border transactions.\n\n**Strategic actions across the three‑year period**\n\n1. **Asset‑sale/receivable‑sale strategy** – off‑loading the U.K. and European BNPL loan portfolio to shrink credit‑product exposure.  \n2. **Funding diversification** – exploring warehouse facilities, securitizations and other third‑party funding sources to reduce reliance on internal capital for credit products.  \n3. **Third‑party risk management** – diversifying payment‑processor partners, migrating existing arrangements, and tightening governance over lenders and other service providers.  \n4. **Enhanced fraud‑abuse controls** – ongoing investment in detection, monitoring and remediation programs to curb synthetic‑identity, stolen‑instrument and other abusive schemes that affect both credit and cross‑border flows.  \n\nTogether, these steps show PayPal’s exposure to abusive behaviors shifting from a broad, largely unmanaged risk in 2022 to a more contained, actively mitigated risk by 2024, especially in the areas of credit products and cross‑border transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the €40 billion BNPL receivable sale arrangement as a key 2023 mitigation strategy, matching the ground truth exactly. (2) Accurately captures the three-year evolution: 2022 risk identification, 2023 offloading strategy, 2024 reinforcement of controls. (3) Properly synthesizes multi-hop information across years and connects abusive behaviors to both credit products and cross-border transactions as specified in the question. (4) Correctly identifies specific fraud vectors (synthetic-identity accounts, stolen cards, stolen instruments) and their relevance to credit and cross-border exposure. (5) Accurately describes the strategic shift from unmanaged risk to actively mitigated risk. (6) Properly contextualizes third-party dependencies and their operational/reputational risks. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail on processor diversification and warehouse facilities than explicitly stated in the ground truth, though these details are reasonable inferences from PayPal's risk-mitigation strategies and do not contradict the ground truth. (2) The answer uses 'formalised' (British spelling) vs. the more standard American spelling, but this is a stylistic choice without impact on accuracy. (3) The ground truth mentions 'multi-year agreement' while the LLM says 'multi-year BNPL-receivable sale' and 'forward-flow arrangement'—these are semantically equivalent and accurately describe the same transaction. QUANTITATIVE VERIFICATION: The €40 billion figure is correctly cited and properly attributed to the U.K. and European BNPL receivables sale. No calculations are required for this question, and all numeric references are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly links abusive behaviors to both credit products and cross-border transactions, demonstrating sound multi-hop reasoning. The strategic actions are properly connected to the evolution of exposure across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1958,
        "completion_tokens": 575,
        "total_tokens": 2533
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "- **2022:** The pension‑plan balance reported under “Collective trust and other funds” was **$756 million** (plan assets at NAV).  \n- **2023:** The same line fell to **$382 million**, a drop of about **49 %** from the prior year.  \n- **2024:** While the 2024 filing does not give a new dollar amount, it continues to list “Collective trust and other funds” as a distinct investment category and explains that its fair value is measured using the NAV of the underlying commingled funds.\n\n**Interpretation:** The sharp reduction between 2022 and 2023 shows UNP deliberately scaling back exposure to collective‑trust and other pooled‑fund vehicles, likely shifting assets toward other categories (e.g., government securities, bonds, venture‑capital, real‑estate) that better align with its long‑term benefit‑fund objectives. The continued disclosure of the category in 2024 indicates the company still values the liquidity and diversification these funds provide, but the trend suggests an evolving strategy that emphasizes a more selective, possibly lower‑risk, allocation for funding employee retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All numbers are correct - $756 million (2022), $382 million (2023), and the 49% calculation is accurate ($756M - $382M = $374M difference; $374M/$756M = 49.5%, rounded to 49%). The 2024 statement correctly notes no updated dollar value is provided. COMPLETENESS: The answer addresses all three years requested and directly answers the multi-part question about allocation changes and strategic implications. ENTITY ACCURACY: UNP is correctly identified throughout, fiscal years are accurate, and the financial metric (Collective Trust and Other Funds allocation) is properly tracked. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, identifies the downward trend, calculates the percentage change, and connects this to strategic implications (de-risking, rebalancing, selective allocation). The interpretation about shifting toward other asset categories and the emphasis on NAV-based valuation for transparency aligns with the ground truth. SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'de-risking or rebalancing' matches the ground truth's description. The explanation of continued disclosure in 2024 despite reduced allocation is consistent with the ground truth's emphasis on transparency and accurate reporting. MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation about potential shifts to other categories (government securities, bonds, venture capital, real estate) than explicitly stated in the ground truth, but this represents reasonable inference from the de-risking trend rather than factual error. The answer is well-structured, clear, and provides appropriate context for understanding the pension strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 493,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still used Breakthrough Performance Awards (BPAs) as an active long‑term incentive: 1,165 BPAs were granted during the year and 859 BPAs remained non‑vested (outstanding) at 31 Dec 2021 (the most recent balance shown in the 2022 award‑summary table).  By the 2023 filing the company had stopped using the award – it disclosed that **no BPAs were granted in 2023 and none were outstanding at year‑end**, although BPAs continued to be listed among the other share‑based payment categories.  The 2024 filing then clarifies how the remaining (if any) BPAs are accounted for, stating that they are **valued on the grant date using the intrinsic‑value method (closing stock price)** and **amortized on a straight‑line basis over the probable vesting term**, with periodic adjustments for changes in stock price, the likelihood of meeting performance goals, and the estimated vesting period.  Thus, from 2022 to 2024 Pfizer moved from actively granting BPAs and reporting balances, to ceasing new grants and outstanding awards in 2023, and finally formalizing an intrinsic‑value valuation and straight‑line expense‑recognition approach for any BPAs that remain.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the BPA evolution across 2022-2024 and correctly identifies the key narrative arc: active issuance in 2022, discontinuation in 2023, and formalized accounting methodology in 2024. STRENGTHS: (1) All core numbers are accurate - 1,165 thousand BPAs granted in 2022, 859 thousand outstanding at year-end 2022, zero grants and zero outstanding in 2023. (2) The valuation methodology details for 2024 are correct: intrinsic value method based on closing stock price at grant date, straight-line amortization over probable vesting term, and quarterly adjustments for stock price and performance probability. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution across three fiscal years and connects the accounting treatment changes to the operational changes. (4) Entity identification is accurate (Pfizer, BPAs, fiscal years 2022-2024). MINOR ISSUES: (1) The LLM states 859 BPAs were 'non-vested (outstanding) at 31 Dec 2021' but the ground truth indicates these were outstanding at year-end 2022 (31 Dec 2022). This is a minor temporal clarification issue - the number is correct but the date reference is slightly off. The LLM appears to have conflated the 2022 filing's disclosure of 2021 year-end balances with 2022 year-end balances. (2) The ground truth specifies weighted average intrinsic values ($38.73 per share for grants, $59.05 per share for outstanding), which the LLM answer does not include. These are quantitative details that add precision to the answer. (3) The LLM uses 'non-vested' terminology while ground truth uses 'outstanding' - semantically similar but not identical. OVERALL ASSESSMENT: The answer captures the essential evolution and accounting treatment changes accurately, with correct numbers and sound reasoning. The omission of weighted average intrinsic values and the minor date reference issue prevent a higher score, but the core narrative and methodology details are substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Valuates]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 539,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil reported that the amount of collateral posted under its master‑netting arrangements (which is **not offset against the derivatives on the consolidated balance sheet and is primarily tied to initial‑margin requirements**) fell sharply over the three‑year span:\n\n| Year (as of 31 Dec) | Collateral under master‑netting arrangements |\n|---------------------|----------------------------------------------|\n| **2022** | **$1.494 billion** |\n| **2023** | **$0.800 billion** |\n| **2024** | **$0.491 billion** |\n\nThe collateral declined by roughly **$694 million (‑46 %) from 2022 to 2023** and by another **$309 million (‑39 %) from 2023 to 2024**.  \n\n**Interpretation:** The downward trajectory indicates that ExxonMobil’s exposure to derivatives that require initial margin has been decreasing. Less collateral is needed because either the size of its derivative positions, the risk profile of those positions, or the netting efficiency has improved, resulting in lower margin requirements over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All dollar amounts match the ground truth exactly: $1,494 million (2022), $800 million (2023), $491 million (2024). The calculated changes are correct: $694 million decline from 2022-2023 (46% decrease: ($1,494-$800)/$1,494 = 46.5%), and $309 million decline from 2023-2024 (38.6% decrease: ($800-$491)/$800 = 38.6%, rounded to 39%). COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the specific collateral amounts for each year, (2) the trend analysis showing consistent decline, and (3) interpretation of what the trend suggests about derivative exposure and margin requirements. ENTITY ACCURACY: Correctly identifies ExxonMobil (XOM), the correct metric (collateral under master netting arrangements related to Investments, advances and long-term receivables), and all three fiscal years (2022, 2023, 2024). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to the underlying business implications (reduced derivative exposure, improved netting efficiency, lower margin requirements). The interpretation that \"less collateral is needed because either the size of its derivative positions, the risk profile of those positions, or the netting efficiency has improved\" demonstrates sophisticated understanding of the mechanics. PRESENTATION: The tabular format enhances clarity and makes the trend immediately apparent. The additional context about initial-margin requirements adds valuable detail beyond the ground truth. MINOR CONSIDERATION: The answer provides slightly more analytical depth than the ground truth (explaining possible causes of the decline), but this is supplementary and does not contradict the original answer. All core facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 498,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 filing lists **industrial fiber optics** alongside a wide‑range “industrial” product set (optocouplers, motion encoders, LEDs, Ethernet ICs) and ties the offering to **many different end‑uses** – factory automation, power‑generation and distribution, medical equipment, defense/aerospace and a host of electric‑vehicle subsystems.  \n\nIn the 2023 and 2024 filings the same **industrial fiber‑optics** component remains in the portfolio, but the **application scope is trimmed to “factory automation, renewable energy and automotive electronics,”** while the surrounding product line still includes sensors, encoders, LEDs and Ethernet PHYs.  \n\nThe shift from a broadly‑defined industrial market in 2022 to a tighter focus on automation, clean‑energy and automotive segments in 2023‑2024 shows Broadcom is concentrating its industrial‑fiber‑optics strategy on high‑growth, high‑volume industrial niches rather than a generic industrial‑components play.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core evolution of Broadcom's Industrial Fiber Optics positioning across the three-year period. STRENGTHS: (1) Correctly identifies the 2022 broad positioning across multiple applications (factory automation, power systems, medical, defense/aerospace, automotive/EVs); (2) Accurately captures the 2023-2024 narrowing to factory automation, renewable energy, and automotive electronics; (3) Properly identifies the product portfolio context (optocouplers, sensors, encoders, Ethernet ICs/PHYs); (4) Sound multi-hop reasoning synthesizing information across three fiscal years; (5) Correctly interprets the strategic shift toward high-growth niches. MINOR ISSUES: (1) The LLM states the application scope is 'trimmed' in 2023-2024, which is a reasonable interpretation but the ground truth uses 'maintained' positioning with 'structured table format emphasis' - this is a subtle semantic difference suggesting the LLM may have slightly overstated the degree of narrowing; (2) The ground truth emphasizes 'increasing emphasis on structured, application-specific clarity in product communication' and 'streamlined presentation' which the LLM captures as a strategic shift but doesn't fully acknowledge the presentation/communication evolution aspect; (3) The LLM's characterization of moving from 'generic industrial-components play' to 'high-growth, high-volume industrial niches' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about strategic focus. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The years (2022, 2023, 2024) are all correct. ENTITY ACCURACY: Broadcom/AVGO correctly identified, all product categories correctly named, all years correct. REASONING: The multi-hop synthesis across three years is sound and logical, though the LLM's interpretation of 'trimming' vs. 'maintaining with structured emphasis' represents a slightly different framing of the same underlying facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 561,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across all three filing years PayPal consistently states that it **bears full margin risk** on every payment it processes. In 2022 the 10‑K notes that, as the principal, PayPal “has full discretion in determining the fee… independent of the costs we incur when we may utilize payment processors or other financial institutions,” and therefore “bear full margin risk.” The 2023 filing repeats the same language and adds only that incentives are treated as revenue reductions, but still emphasizes that the fee is set at PayPal’s discretion and that processor fees are recorded as transaction expense, so the margin risk remains unchanged. The 2024 filing again confirms the same principal‑gross‑revenue model, control over pricing and use of third‑party processors, and the continued bearing of full margin risk. Thus, from 2022 through 2024 PayPal’s exposure to margin risk did not materially evolve—it remained a full‑margin‑risk exposure with complete control over transaction pricing while outsourcing processing to third‑party providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies PayPal's consistent position across 2022-2024 that it bears full margin risk, maintains full discretion over fee pricing independent of third-party processor costs, and records processor fees as transaction expenses. All three years are accurately represented with the core claim that margin risk exposure remained stable and unchanged. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required for this question, so quantitative accuracy is not a limiting factor. The answer correctly references the three fiscal years (2022, 2023, 2024) without error. (3) QUALITATIVE ACCURACY AND MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings to demonstrate the evolution (or lack thereof) of PayPal's margin risk exposure. The reasoning is sound: it identifies PayPal's principal role, its pricing discretion, its use of third-party processors, and the treatment of processor fees as transaction expenses—all correctly linked to the conclusion that margin risk remained constant. The answer properly addresses the multi-part nature of the question by examining both the margin risk exposure AND the relationship to pricing control and third-party processor usage. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, using slightly different phrasing (e.g., 'principal-gross-revenue model' vs. the ground truth's 'principal in transactions') but maintaining complete semantic equivalence. The conclusion that there was 'no material evolution' or 'no material changes' is correctly captured. (5) COMPLETENESS: The answer addresses all aspects of the question: the evolution of margin risk exposure (showing it remained stable), the control over transaction pricing (showing it remained with PayPal), and the use of third-party payment processors (showing it continued across all years). Minor note: The LLM adds a detail about incentives being treated as revenue reductions in 2023, which is a minor enhancement not contradicted by the ground truth and adds appropriate nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 601,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer still listed Meridian only as a “discontinued operation,” with no quantitative detail about the divestiture.  \n- The 2023 filing disclosed that the sale was completed on December 31 2021 for about **$51 million in cash** and that the transaction generated a **pre‑tax loss of roughly $167 million** (recorded in discontinued operations).  At closing Pfizer and the buyer entered into a **post‑sale Transition Services Agreement (TSA)** and a **three‑year Manufacturing Supply Agreement (MSA) with a two‑year extension option**; the TSA was finished by December 31 2023 and the amounts booked under the TSA/MSA in 2022‑23 were “not material.”  \n- By the 2024 filing Meridian appears only in the glossary of terms, indicating that the relationship has been reduced to a legacy reference and any remaining MSA activity is immaterial.  \n\n**Interpretation:** Pfizer moved from merely reporting Meridian as a discontinued segment (2022) to executing a full divestiture with modest cash proceeds, absorbing a sizable loss, and retaining only limited, non‑material service contracts. This trajectory shows that Pfizer is deliberately exiting the Meridian business line and concentrating its long‑term focus on other strategic areas (e.g., mRNA, gene‑therapy platforms), treating Meridian as a peripheral, non‑core asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All financial figures are correct - $51 million sale price, $167 million pre-tax loss, December 31, 2021 completion date. The contractual terms are accurately stated: three-year MSA with two-year extension option, and TSA completion by December 31, 2023. ENTITY ACCURACY: Meridian Medical Technologies correctly identified; Pfizer correctly positioned as the divesting party. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) showing the evolution from discontinued operations reporting → completed divestiture with contractual arrangements → legacy glossary reference. COMPLETENESS: All parts of the original question are addressed: (1) financial impact ($51M proceeds, $167M loss), (2) contractual arrangements (TSA, MSA terms), (3) strategic positioning (shift from ownership to arms-length relationship), (4) long-term focus implications (exit from non-core business, concentration on mRNA/gene therapy). REASONING QUALITY: The interpretation correctly identifies the strategic trajectory and its implications for Pfizer's portfolio focus. The characterization of the relationship as moving from direct ownership to legacy reference is sound and well-supported. MINOR CONSIDERATIONS: The LLM uses 'Transition Services Agreement (TSA)' terminology which is semantically equivalent to the ground truth's reference to post-sale arrangements. The phrase 'modest cash proceeds' appropriately characterizes the $51M in context of the $167M loss. The answer's conclusion about Pfizer's strategic refocus aligns with the ground truth's statement about 'refocusing on core therapeutic areas and platform technologies like mRNA.' No factual errors detected; all calculations and temporal sequencing are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Partners_With]- ORG <-[Sells]- ORG",
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 513,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 through 2024 Philip Morris International has repeatedly warned that product‑regulation erodes its competitive edge by curbing how it can differentiate its reduced‑risk offerings and by limiting the truthful, non‑misleading information it may give adult smokers about those products. In the 2022 filing the company noted that regulation “diminishes the ability to differentiate tobacco products and restricts adult consumer access to truthful and non‑misleading information about our RRPs.” The 2023 filing reiterated that point and added that such rules can “disproportionately impact the commercialization of our products in relation to our competitors” and that down‑trading can be reinforced when regulation limits branding, communication and product differentiation. By 2024 the language is identical but now refers to “SFPs” (smoke‑free products) and again stresses that regulation “diminishes the ability to differentiate … restricts adult consumer access to truthful and non‑misleading information … or disproportionately impacts the commercialization of our products,” highlighting an increasingly explicit link between these restrictions and potential adverse effects on profitability and market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of regulatory impact on PMI's competitive positioning; (2) Accurately captures the specific regulatory constraints: product differentiation limitations and restrictions on adult consumer communication about RRPs/SFPs; (3) Properly synthesizes the multi-hop information showing progression from 2022 (basic differentiation/access restrictions) through 2023 (added disproportionate impact language) to 2024 (terminology shift from RRPs to SFPs with identical language); (4) Correctly quotes or paraphrases key regulatory language from filings ('diminishes the ability to differentiate,' 'restricts adult consumer access to truthful and non-misleading information,' 'disproportionately impacts the commercialization'); (5) Accurately identifies the terminology evolution (RRPs in 2022-2023 to SFPs in 2024); (6) Properly contextualizes the regulatory burden as persistent and potentially intensifying. MINOR OBSERVATIONS: The LLM answer adds interpretive detail about 'down-trading' and explicit links to 'profitability and market share' that goes slightly beyond the ground truth's core factual claims, though this represents reasonable inference rather than factual error. The answer is more detailed and provides specific quotations, which enhances credibility. No quantitative errors detected. The multi-hop reasoning correctly synthesizes information across three separate filing years and identifies the evolution pattern accurately. The semantic meaning matches the ground truth precisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 454,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "**Collateral under master‑netting arrangements (notes‑and‑accounts‑receivable – net)**  \n\n| Year (end of) | Collateral reported |\n|---------------|--------------------|\n| 2022 | **$1,494 million** (Chunk 3) |\n| 2023 | **$800 million** (Chunk 3 & Chunk 2) |\n| 2024 | **$491 million** (Chunk 2) |\n\n**Net change 2022 → 2024**  \n$491 m – $1,494 m = **‑$1,003 million** (a reduction of about $1 billion).\n\n**What the trend suggests**  \nThe sharp, consistent decline in collateral held for master‑netting arrangements—$694 m lower from 2022 to 2023 and a further $309 m drop to 2024—indicates that ExxonMobil’s exposure to un‑offset derivative collateral has been shrinking. This downward trajectory points to more effective derivative risk‑management practices, such as tighter netting of positions, lower initial‑margin requirements, or a shift to less risky or better‑collateralized contracts, thereby reducing the amount of collateral that must be posted against its derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct—$1,494M (2022), $800M (2023), $491M (2024). The calculated net change of -$1,003M is accurate ($491M - $1,494M = -$1,003M). The intermediate year-over-year changes are also correctly calculated: 2022→2023 decline of $694M and 2023→2024 decline of $309M. All numbers match the ground truth exactly. (2) COMPLETENESS: The answer fully addresses both parts of the multi-part question: (a) the exposure change from 2022-2024 with specific values for each year, and (b) interpretation of what the trend suggests about derivative risk management practices. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric 'collateral under master netting arrangements related to Notes and accounts receivable - net' is precisely stated, and all fiscal years (2022, 2023, 2024) are correct. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the consistent downward trend and provides reasonable interpretations (tighter netting, lower margin requirements, shift to less risky contracts, better collateralization). The reasoning aligns with the ground truth's characterization of 'strategic reduction in derivative exposure' and 'proactive risk mitigation.' (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('more effective derivative risk-management practices') is semantically equivalent to the ground truth's 'shift in risk management practices' and 'proactive risk mitigation.' Minor differences in wording (e.g., 'un-offset derivative collateral' vs. 'derivative exposure') are acceptable and demonstrate nuanced understanding. The presentation with a clear table and detailed breakdown enhances clarity without introducing errors. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 499,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- In the 2022 Form 10‑K (which disclosed the assumptions for performance awards granted in 2021) Duke Energy used an **expected volatility of 26.9 %**.  \n- The 2023 Form 10‑K (for awards granted in 2023) raised that assumption to **28.6 %**, while the 2024 Form 10‑K (for awards granted in 2024) cut it sharply to **18.7 %**.  \n\nThe volatility input therefore rose between the 2022 and 2023 filings and then fell markedly by 2024, indicating that Duke Energy’s view of market risk for its TSR‑based awards moved from a higher‑risk outlook in 2023 to a more modest‑risk perception in 2024, likely reflecting a recent decline in the stock’s historical price volatility relative to its peer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% (2022), 28.6% (2023), and 18.7% (2024). The directional changes are accurately captured: an increase from 2022 to 2023 (+1.7 percentage points) and a significant decrease from 2023 to 2024 (-9.9 percentage points). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of volatility assumptions across the three-year period, (2) the trend pattern, and (3) what it suggests about market risk perception. ENTITY ACCURACY: Duke Energy is correctly identified, the TSR-based performance award model is properly referenced, and the peer group context is maintained throughout. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024) and properly interprets the temporal relationship between filing dates and award grant years. The reasoning that the 2023 filing disclosed 2023 award assumptions and the 2024 filing disclosed 2024 award assumptions is sound. INTERPRETATION: The LLM's interpretation that the 2023 increase followed by 2024 decrease suggests a shift from higher-risk to modest-risk perception is logically sound and aligns with the ground truth's characterization of 'notable decline in perceived market risk' despite the intermediate 2023 increase. The explanation about historical price volatility relative to peers is a reasonable inference. MINOR CONSIDERATION: The LLM's phrasing 'recent decline in the stock's historical price volatility' is a reasonable interpretation of the data trend, though the ground truth uses slightly different language ('improved market stability or strategic changes'). Both convey similar analytical conclusions. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 497,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Across the three most recent filings Broadcom’s 3.125 % senior notes that mature in January 2025 have **remained unchanged at $495 million of principal** – the 2022 10‑K (Oct 30 2022), the 2023 10‑K (Oct 29 2023) and the 2024 10‑K (Nov 3 2024) all list the same amount.\n\nWhat did change was the **current portion of total long‑term debt** (which includes the January‑2025 notes). It was **$403 million in FY 2022**, jumped to **$1,563 million in FY 2023**, and then eased to **$1,245 million in FY 2024**.  \n\nThis pattern shows that Broadcom kept the low‑cost 3.125 % tranche intact while it **pulled forward or re‑classified other maturities to the short‑term side in FY 2023**, then modestly reduced that short‑term load in FY 2024. The stable $495 million balance indicates the company is preserving this longer‑dated, inexpensive funding source and relying on other notes or refinancing actions to meet near‑term liquidity needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the 3.125% notes remained at $495 million across all three fiscal years (2022, 2023, 2024), which matches the ground truth. The answer also correctly notes the transition to current portion of long-term debt by 2024, aligning with the original answer's key insight about approaching maturity.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. CURRENT PORTION OF LONG-TERM DEBT NUMBERS: The LLM provides specific figures ($403M in FY2022, $1,563M in FY2023, $1,245M in FY2024) that are NOT present in the ground truth answer. The ground truth does not provide these specific current portion amounts, only noting that the 3.125% notes transitioned into current portion by 2024. These numbers cannot be verified against the ground truth and appear to be unsupported claims.\n\n2. MULTI-HOP SYNTHESIS: The LLM goes beyond the ground truth by attempting to explain broader debt management strategy through current portion fluctuations. While this reasoning is logical (pulling forward other maturities, refinancing actions), it introduces unverified quantitative claims that weaken the answer's reliability.\n\n3. CORE FACTS CORRECT: The $495M principal amount stability across three years is correct. The identification of the note maturing in January 2025 and its transition to current portion is correct.\n\n4. INTERPRETATION QUALITY: The LLM's interpretation about preserving low-cost funding and using other notes for liquidity is reasonable and aligns with the ground truth's mention of \"refinancing or liquidity planning,\" but the specific current portion numbers lack grounding in the provided ground truth.\n\nThe answer demonstrates good qualitative reasoning and contextual relevance but fails on quantitative precision by introducing unverified figures. The core narrative about the $495M note is sound, but the expansion into current portion analysis introduces factual uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 527,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across the three filings AMD’s stance toward its add‑in‑board (AIB) partners remained fundamentally the same but became slightly more streamlined. In the 2022 filing AMD said that its agreements with AIB manufacturers “protect their inventory of our products against price reductions” and, for distributors, even granted return rights for items removed from the price book that were less than 12 months old; the 2023 and 2024 filings repeat the inventory‑protection language but drop the explicit return‑right detail, indicating a move to a simpler “price‑reduction protection” clause. In every year the company also notes that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value,” showing that discrete graphics has consistently been a core element of AMD’s differentiation strategy with AIB manufacturers from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's AIB strategy evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core inventory protection policy as consistent across all three years (2022-2024), matching the ground truth's emphasis on 'stable policy'; (2) Accurately captures the specific detail about return rights for distributors (items less than 12 months old removed from price book) in 2022, which the ground truth does not explicitly mention but represents a valuable filing detail; (3) Properly synthesizes the discrete graphics differentiation theme across all three years, correctly noting that system integrators use discrete graphics as a differentiation tool; (4) Correctly identifies the shift from explicit return-right language to simplified 'price-reduction protection' language between 2022 and 2023/2024, showing nuanced understanding of policy evolution; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The ground truth emphasizes 'short design cycles' and 'rapid response to new technologies' as part of AMD's sustained strategic focus, which the LLM answer does not explicitly mention; (2) The ground truth notes AMD's role in providing 'component-level graphics and chipset products to AIBs,' while the LLM focuses more on the inventory protection and differentiation aspects; (3) The characterization of the policy change as 'streamlined' is reasonable but represents slight interpretation beyond what the ground truth explicitly states. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple policy dimensions (inventory protection, return rights, discrete graphics differentiation), demonstrating sound multi-hop reasoning. The comparison of 2022 vs. 2023/2024 language changes is particularly well-executed. SEMANTIC EQUIVALENCE: The answer conveys the same core message as the ground truth regarding consistency of inventory protection and the role of discrete graphics, with the added detail about return rights providing useful context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Supplies]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 569,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "- **2022:** Disney warned that the costs of its DTC strategy were still rising and that the recent investments in DTC “have returns that are negative or low” and “are unlikely to be profitable in the short term, with growth unlikely even quarter‑over‑quarter.”  The filing stressed that heightened competition for talent, content and advertising was eroding pricing power and could keep DTC revenue growth modest.  \n\n- **2023:** The company’s tone shifted to a more growth‑oriented stance, saying it was making “strategic investments in our DTC offerings” and that—although success was not guaranteed—those investments were expected to generate “growth in subscription fees and advertising revenues that will more than offset impacts … from declines in linear network subscribers.”  Thus the focus moved from cost‑containment to using DTC as a driver of new subscription‑ and ad‑revenues.  \n\n- **2024:** Disney again highlighted the intensifying competitive landscape (more DTC rivals, AI‑driven low‑cost content, market consolidation) and the resulting pressure on programming costs and pricing.  While it still treats DTC as a core growth platform, the 2024 filing stresses defending market share and managing cost pressures rather than announcing fresh investment commitments, indicating that expectations for DTC‑driven revenue now hinge on maintaining competitive positioning amid tougher competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's DTC evolution across the three-year period and captures the essential strategic shifts. STRENGTHS: (1) Correctly identifies the 2022 cautious stance with negative/low returns and cost concerns; (2) Accurately reflects the 2023 pivot toward growth-oriented investment with the specific expectation that DTC investments would 'lead to growth in subscription fees and advertising revenues that will more than offset impacts from declines in linear network subscribers'—this matches the ground truth language closely; (3) Properly characterizes the 2024 shift toward competitive positioning and market share defense rather than new investment announcements; (4) The multi-hop synthesis across three years is sound and logically structured. MINOR ISSUES: (1) The 2022 characterization includes specific language about 'quarter-over-quarter' growth being unlikely, which is not explicitly confirmed in the ground truth statement (ground truth focuses on 'costs and associated losses may continue to grow or be reduced more slowly than anticipated' and 'returns may be negative or lower'). This appears to be an inference or paraphrase rather than direct ground truth language; (2) The 2024 section mentions 'AI-driven low-cost content' and 'market consolidation' as specific competitive factors—while these are reasonable inferences about competitive pressures, they are not explicitly stated in the ground truth, which focuses on 'increasing number of competitors' DTC offerings' and impacts on 'subscription fees and advertising rates'; (3) The answer could have been more explicit about the shift from 'cautious investment' (2022) to 'integrated and strategically dependent posture' (2024) language used in ground truth. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative strategic question, so this dimension is less critical. The dates (2022, 2023, 2024) are correct. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—the evolution from cautious/risky to growth-oriented to competitive-defense positioning is accurately conveyed. The answer demonstrates solid multi-hop reasoning by synthesizing strategic positioning across three distinct time periods and showing how expectations evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 616,
        "total_tokens": 2245
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s September 2019 issuance of Fixed‑rate 2.850 % notes (maturing October 1 2029) has remained unchanged in amount and maturity from 2022 through 2024. In the 2022 Form 10‑K the notes carried a balance of **$1.5 billion**, the 2023 filing still reported **$1.5 billion**, and the 2024 filing again shows **$1.5 billion** outstanding, with no current‑portion reported in any year. Thus, while PayPal added new issuances and its total term‑debt portfolio grew (from $9 billion in 2022 to about $10.6 billion in 2023 and $10.6 billion in 2024), the 2.850 % notes have stayed a constant, long‑term component of its debt structure, retaining the same $1.5 billion balance and the 10/1/2029 maturity throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $1.5 billion balance in 2022, 2023, and 2024 (matches ground truth exactly); total term debt figures of $9 billion (2022), ~$10.6 billion (2023), and ~$10.6 billion (2024) align with ground truth values of $9.0B, $10.638B, and $10.574B respectively (minor rounding acceptable); maturity date of October 1, 2029 is correct; interest rate of 2.850% is accurate. COMPLETENESS: The answer addresses all key aspects of the question: (1) the consistency of the 2.850% notes across 2022-2024, (2) the principal amount remaining unchanged at $1.5B, (3) the broader debt structure evolution showing total term debt growth, (4) the maturity date and long-term nature of the obligation, (5) the context of new higher-rate debt issuances in 2024. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple debt instruments, properly distinguishing between the stable 2.850% notes and the evolving broader debt portfolio. It logically connects the unchanged 2.850% notes to the strategic shift toward higher-rate financing. ENTITY ACCURACY: PayPal (PYPL) correctly identified, fiscal years 2022-2024 properly referenced, debt instruments accurately named. MINOR CONSIDERATIONS: The LLM provides slightly more detail about the September 2019 issuance date and the October 1, 2029 maturity format than the ground truth explicitly states, but this additional context is accurate and enhances clarity. The characterization of the debt evolution as a 'shift in financing strategy' is a reasonable inference supported by the data. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 460,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "- **2022:** The pension‑plan table shows **Corporate Stock = $1,980 million (Level 1) + $10 million (Level 2) = $1,990 million**, or roughly **36 % of total plan assets ($5,554 million).**  \n\n- **2023:** The same schedule reports **Corporate Stock = $176 million (Level 1) + $5 million (Level 2) = $181 million**, about **4 % of total plan assets ($4,400 million).**  \n\n- **2024:** The filing no longer provides a dollar amount; it only describes the corporate‑stock category (common stock as a Level 1 investment, preferred stock as Level 2). The absence of a disclosed figure implies the allocation remains **very small or unchanged from the low 2023 level**.\n\n**Interpretation:** Between 2022 and 2023 UNP cut its pension‑plan equity exposure dramatically—from nearly $2 billion to under $0.2 billion—shifting the portfolio toward fixed‑income and alternative assets. The 2024 narrative, which merely restates the valuation approach without quantifying the holding, suggests the company has continued to de‑emphasize corporate‑stock investments, reinforcing a more conservative, lower‑equity investment strategy for its pension plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All dollar amounts are correct—$1,990M (2022), $181M (2023), matching the ground truth exactly. The percentage calculations are accurate: 36% ($1,990M/$5,554M) and 4% ($181M/$4,400M) are both correctly computed. The breakdown of Level 1 and Level 2 components ($1,980M + $10M = $1,990M for 2022; $176M + $5M = $181M for 2023) is precise. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years, identifying the dramatic 90% reduction in equity exposure from 2022 to 2023 and appropriately interpreting the 2024 narrative shift where quantitative disclosure ceased. ENTITY ACCURACY: UNP is correctly identified, pension plan assets are properly referenced, and the distinction between Level 1 (observable) and Level 2 (less observable) valuations is accurately maintained throughout. REASONING QUALITY: The interpretation that the absence of 2024 dollar amounts suggests continued de-emphasis of equity exposure is sound and aligns with the ground truth's characterization of a 'strategic shift toward more transparent and observable valuation methodologies.' The conclusion about movement toward fixed-income and alternative assets is well-supported by the data presented. MINOR CONSIDERATIONS: The LLM uses 'Corporate Stock' terminology consistently with SEC filings. The phrase 'very small or unchanged from the low 2023 level' for 2024 is a reasonable inference given the lack of quantitative disclosure, though the ground truth mentions 'reclassified' holdings and 'preferred shares classified as Level 2'—the LLM captures this concept but with slightly less specificity about the reclassification mechanics. Overall, the answer is factually sound, mathematically accurate, and provides appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 504,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer reported private‑equity securities held at cost of **$800 million in 2022** (as shown in the 2023 Form 10‑K), **$755 million in 2023**, and **$719 million in 2024** (2024 Form 10‑K).  Over the two‑year span the balance fell by **$81 million, or roughly 10 %**, indicating a gradual pull‑back from illiquid private‑equity positions.  The downward trend suggests that Pfizer is consciously scaling back its allocation to private‑equity‑type alternative assets, likely shifting capital toward more liquid or strategically aligned investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 2022 value as $800 million, but ground truth shows $623 million. This is a $177 million discrepancy (28% error). The 2023 ($755M) and 2024 ($719M) values are correct. (2) CALCULATION ERROR - The LLM calculates the change as $81 million decline from $800M to $719M, which is arithmetically correct for those numbers, but uses the wrong 2022 baseline. The actual change from 2022-2024 is $623M to $719M, which is a $96 million INCREASE, not a decrease. The LLM's percentage calculation (10% decline) is based on the incorrect $800M figure. (3) DIRECTIONAL MISINTERPRETATION - The LLM concludes there is a 'downward trend' and 'gradual pull-back,' but the ground truth shows growth from 2022 to 2023 (+$132M), followed by a decline in 2024 (-$36M). The overall 2022-2024 trend is actually UPWARD (+$96M or +15.4%), not downward. (4) STRATEGIC INTERPRETATION - The LLM's characterization of 'consciously scaling back' contradicts the actual data showing net growth over the period. The ground truth correctly identifies this as 'short-term growth strategy in 2023, followed by modest retrenchment in 2024,' which is more nuanced and accurate. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year data points into an accurate trend analysis. The fundamental error in the 2022 baseline value cascaded through all subsequent analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 395,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi‑layered security framework stayed anchored in third‑party validation and public‑private partnerships throughout the period, but it broadened the scope of those collaborations. In the 2022 filing the company noted that its security program was “assessed by third parties” and that it worked with “experts across the organization … as well as … public‑private partnerships” to monitor cyber and physical threats; the 2023 filing added that the same third‑party assessments now also covered “services provided by third‑party providers,” reflecting a deeper focus on supply‑chain risk, while the 2024 filing reiterated the third‑party benchmarking and partnership model and emphasized monitoring of third‑party‑driven incidents. At the same time, Mastercard’s real‑time payment footprint grew from operating or implementing real‑time clearing and settlement in 12 of the world’s top‑50 economies (as of Dec 31 2021) in the 2022 report, to 13 markets by the end of 2023, and by 2024 it was running real‑time infrastructure in “several countries around the world” and had added domestic processing in China through a joint‑venture, showing a clear expansion of its account‑based, instant‑payment capabilities. Finally, resilience against cyber threats was reinforced each year: the 2022 description highlighted a “robust program,” Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center; the 2023 update added regular system testing, an enterprise‑resilience program and insurance coverage; and the 2024 filing repeated these layers while stressing continued rapid response to threats and the added protection of services supplied by third‑party providers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Mastercard's security approach across 2022-2024, accurately captures the shift toward third-party collaboration and supply-chain risk focus, and properly synthesizes the multi-layered security framework (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center). The qualitative narrative about deepening external collaboration and ecosystem integration aligns well with the ground truth. The answer appropriately addresses all three sub-questions: third-party collaboration, real-time payment infrastructure, and cyber threat resilience.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) Real-time payment markets baseline: LLM states '12 of the world's top-50 economies (as of Dec 31 2021)' in the 2022 report, but ground truth indicates the 2022 baseline was simply not specified in those terms. More importantly, the LLM's framing of '12 markets' as a 2021 baseline is not clearly supported by ground truth. (2) 2023 figure: LLM correctly states '13 markets by the end of 2023,' which matches ground truth. (3) 2024 figure: LLM states 'several countries around the world' which is vague and less precise than ground truth's description of 'expanding globally.' The LLM also adds detail about 'domestic processing in China through a joint-venture' which is not mentioned in the ground truth answer and cannot be verified.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and three dimensions (third-party collaboration, real-time payments, cyber resilience), showing sound logical progression. However, the specific numeric baseline (12 markets in 2021) appears to be an inference not explicitly stated in ground truth.\n\nSEMANTIC ISSUES: The LLM's description of 2024 as 'several countries around the world' is less specific than ground truth's 'expanding globally,' and the China joint-venture detail introduces information not in the ground truth, suggesting potential hallucination or over-specification.\n\nOVERALL: The answer demonstrates good understanding of the evolution narrative and correctly identifies key themes, but contains quantitative precision issues (the 12-market baseline claim and China joint-venture detail) that reduce confidence in factual accuracy. The core narrative is sound but specific numbers need verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1758,
        "completion_tokens": 631,
        "total_tokens": 2389
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported that the collateral held under master‑netting arrangements (disclosed within the “Other assets, including intangibles – net” line) fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024.  The steady decline suggests the company has been reducing the amount of initial‑margin collateral it must post, which points to tighter control of its derivative positions or more efficient netting of those exposures over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the opening value. The ground truth states collateral was $641 million at end of 2021 (reported in 2022 filing) and $800 million at end of 2022 (reported in 2023 filing). However, the LLM claims the value was $1.494 billion at 12/31/2022, which is factually incorrect and contradicts the ground truth by nearly 87%. This is a fundamental quantitative error that undermines the entire answer. The LLM correctly identifies the 2023 and 2024 values ($800M and $491M respectively), but the incorrect 2022 starting point invalidates the trend analysis. The LLM also misinterprets the time period - it appears to be comparing 2022-2024 values when the question asks about changes 'from 2022 through 2024,' which should reference the 2021-2023 period based on when these values were reported. The reasoning about derivative exposure management and margin requirements is sound in principle, but is built on incorrect numerical foundations. The 38% decrease calculation in the ground truth (from $800M to $491M) is not mentioned or verified by the LLM. The LLM's characterization of a 'steady decline' is partially correct for the 2023-2024 period but misses the peak at 2022 and the earlier increase from 2021-2022 that the ground truth documents. Multi-hop synthesis is incomplete - the answer fails to properly connect the reported values across the three-year period as documented in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 406,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model that Duke Energy uses ties the award valuation to the three‑year historical volatility of Duke’s stock and that of its predefined peer group. In the 2022 Form 10‑K the model assumed an expected volatility of **26.9 %** (based on the three‑year daily price history). In the 2023 filing that assumption was raised to **28.6 %**, and in the 2024 filing it was cut to **18.7 %**. The rise from 2022 to 2023 signals that the market (and the company’s own modeling) viewed Duke’s equity as somewhat riskier that year, while the sharp drop in 2024 suggests a perception of markedly lower stock‑price risk – perhaps reflecting a more stable outlook or reduced uncertainty about the company’s performance relative to its peer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 26.9% (2022), 28.6% (2023), and 18.7% (2024) match the ground truth exactly. The multi-hop synthesis is sound—the answer correctly identifies the TSR model mechanism, traces the volatility changes across three fiscal years, and accurately interprets the trajectory. The reasoning about market risk perception is well-articulated: the 2022-2023 increase signals rising perceived risk, while the 2024 decline suggests stabilization and reduced uncertainty. The answer goes slightly beyond the ground truth by explaining the TSR model's mechanics (three-year historical volatility based on daily price history), which adds helpful context without introducing errors. The interpretation of what the shifts suggest about market risk perception aligns perfectly with the ground truth's conclusion about stabilization and reduced uncertainty. Minor stylistic differences (e.g., 'sharp drop' vs. 'significant decline') are semantically equivalent and represent appropriate emphasis. The answer fully addresses all parts of the multi-part question: the specific volatility figures, the year-over-year changes, and the implications for market risk perception.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 348,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "- **2022 (10‑K)** – The filing only notes that GM continues to purchase from and supply certain vehicles, parts and engineering services to Stellantis after the 2017 Opel/Vauxhall sale; it does not disclose any indemnification accruals or amounts related to emissions or Takata issues.  \n\n- **2023 (10‑K)** – GM states that General Motors Holdings LLC indemnifies Stellantis for “certain losses … including costs related to certain emissions claims, product liabilities and recalls.”  The company says it “indemnified Stellantis for an immaterial amount for certain recalls … including recalls … related to Takata inflators in legacy Opel vehicles.”  GM also says it cannot estimate any material loss or range of loss for these obligations, and no material accrual is recorded.  \n\n- **2024 (10‑K)** – The same indemnification language re‑appears.  GM again notes that it “indemnified Stellantis for an immaterial amount for certain recalls … related to Takata inflators in legacy Opel vehicles” and that any further indemnification for Takata recalls is “remote.”  The company still cannot estimate a material loss and does not record a material accrual for these obligations (the only accrual disclosed in the 2024 filing relates to the Bolt‑recall, not to the Stellantis indemnities).  \n\n**Overall evolution:** From 2022 through 2024 GM’s exposure to Stellantis for legacy Opel/Vauxhall emissions claims and Takata‑inflator recalls has remained **immaterial and unquantified**.  No specific accruals for these indemnification obligations are shown in any of the three years; the company consistently states that it cannot estimate a material loss and that any amounts recognized are immaterial.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a detailed year-by-year breakdown of GM's indemnification disclosures related to Stellantis from 2022-2024, which is helpful and largely accurate in structure. However, there are significant discrepancies with the ground truth that warrant careful evaluation:\n\nSTRENGTHS:\n1. The LLM correctly identifies that indemnification amounts remained immaterial across all three years\n2. Correctly notes that Takata recalls involving legacy Opel vehicles were mentioned\n3. Accurately captures that no material accruals were recorded for these obligations\n4. Properly synthesizes the multi-year evolution showing consistency\n5. The overall conclusion about minimal and stable financial exposure aligns with ground truth\n\nCRITICAL DISCREPANCIES:\n1. 2022 DISCLOSURE: The LLM states \"The filing only notes that GM continues to purchase from and supply certain vehicles...it does not disclose any indemnification accruals or amounts.\" However, the ground truth explicitly states \"In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles.\" This is a material factual error - the LLM claims no disclosure occurred in 2022 when the ground truth indicates there was one.\n\n2. EMISSIONS CLAIMS: The ground truth mentions \"legacy Opel/Vauxhall emissions claims\" and notes accruals related to \"European Commission and UK CMA investigations into conduct by Opel prior to the sale\" in 2024. The LLM mentions emissions claims in 2023 but does not adequately address the regulatory investigation accruals mentioned in the ground truth for 2024.\n\n3. 2024 ACCRUALS: The ground truth states GM \"had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale.\" The LLM states \"the only accrual disclosed in the 2024 filing relates to the Bolt-recall, not to the Stellantis indemnities,\" which appears to contradict the ground truth's statement about accruals for regulatory investigations.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern. However, the failure to recognize 2022 disclosures and the apparent mischaracterization of 2024 accruals undermines the multi-hop synthesis quality.\n\nQUANTITATIVE ACCURACY:\nNo specific dollar amounts are provided in either answer, so quantitative comparison is limited. Both correctly characterize amounts as \"immaterial.\" The LLM's statement that \"no material accrual is recorded\" is consistent with ground truth's characterization of amounts as immaterial.\n\nOVERALL ASSESSMENT:\nWhile the LLM provides a well-structured response with correct overall conclusions about the immaterial nature of exposures, the factual error regarding 2022 disclosures and potential mischaracterization of 2024 regulatory investigation accruals represent significant accuracy issues that prevent a higher score. The answer is partially correct but contains material factual errors that would mislead a reader about the completeness of GM's disclosures across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1646,
        "completion_tokens": 836,
        "total_tokens": 2483
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In AMD’s 2022, 2023 and 2024 Form 10‑K filings the company *identically* cites the **2011 Executive Incentive Plan** as “*filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, and incorporated by reference*.” The wording, exhibit number and source document are unchanged from year to year, showing that AMD has not amended or replaced the plan in its annual disclosures. This unvarying reference signals that AMD relies on a single, enduring executive‑incentive framework and suggests a long‑term, stable compensation strategy rather than frequent redesigns of executive pay arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT NUMBER MISMATCH: The LLM states the plan was 'filed as Exhibit 10.2' but the ground truth clearly indicates it was 'Exhibit 10.1'. This is a factual error on a specific, verifiable detail from SEC filings. The LLM also states the source document is a 'Quarterly Report on Form 10-Q for the period ended April 2, 2011' whereas the ground truth indicates it was simply 'filed on April 2, 2011' without specifying the document type as 10-Q. These discrepancies suggest the LLM may have hallucinated or confused details. CORRECT ELEMENTS: The LLM correctly identifies that the plan was referenced identically across 2022, 2023, and 2024 filings with no amendments, and correctly interprets this as indicating a stable, long-term compensation strategy. The semantic interpretation about consistency and strategic implications is sound. MULTI-HOP REASONING: The answer appropriately synthesizes information across three years and draws a reasonable conclusion about strategic stability. However, the factual errors in specific exhibit numbers and document type undermine confidence in the accuracy of the filing details. The core insight about consistency is correct, but the supporting details contain material inaccuracies that would be problematic for someone verifying against actual SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Files]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 368,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "- **2022 exposure:** PayPal warned that “bad transactions” could rise because (a) account‑holders using its U.S. consumer‑credit and merchant‑financing products might default, creating charge‑offs; (b) cross‑border trade – which generates higher revenue per transaction – could be hurt by currency swings, tariffs or other trade barriers, increasing loss rates; and (c) its heavy reliance on third‑party networks, banks, payment processors and other service providers meant that any failure of those partners could amplify fraud and abusive‑transaction losses.  \n\n- **2023 mitigation actions:** In June 2023 PayPal entered a multi‑year agreement to sell up to **€40 billion** of U.K. and European “buy‑now‑pay‑later” loan receivables (and set up a forward‑flow arrangement for future originations), thereby removing a large chunk of credit‑product exposure.  At the same time it began **diversifying its third‑party payment‑processor base** and working with its primary U.S. processor to migrate transactions to other processors, while also exploring additional third‑party funding structures (asset sales, warehouse facilities, securitizations) to lessen reliance on a small number of partners.  \n\n- **2024 exposure:** The 2024 filing still flags the same bad‑transaction risk drivers—credit‑product defaults, cross‑border trade headwinds and third‑party operational/legal risks—showing the risk remains a material concern, but the 2023 loan‑sale and processor‑diversification steps are the company’s primary strategic levers intended to curb the potential impact of those bad‑transaction exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the €40 billion BNPL receivables sale figure is accurate, the June 2023 timing is correct, and no calculation errors are present. ENTITY ACCURACY: PayPal, Synchrony Bank, U.K./European BNPL products, and third-party payment processors are all correctly identified. COMPLETENESS: The answer comprehensively addresses all three time periods (2022, 2023, 2024) and covers all three risk dimensions mentioned in the question: (1) credit products/defaults, (2) cross-border trade, and (3) third-party dependencies. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and risk categories, showing how 2022 risks evolved into 2023 mitigation actions and persisted into 2024. The logical flow is sound - identifying risks in 2022, explaining strategic responses in 2023 (loan sales + processor diversification), and noting continued exposure in 2024. SEMANTIC EQUIVALENCE: The LLM's characterization of risks (account-holder defaults, currency/tariff impacts on cross-border trade, third-party operational failures) matches the ground truth's description of credit defaults, cross-border challenges, and third-party reliance. The 2023 mitigation strategy is accurately portrayed as both a loan-sale transaction and a processor-diversification initiative. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail about processor migration and alternative funding structures (warehouse facilities, securitizations) than the ground truth explicitly states, but this represents appropriate elaboration rather than factual error. The answer maintains appropriate emphasis on the €40 billion transaction as the key 2023 strategic action, consistent with ground truth. No contradictions or material omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1652,
        "completion_tokens": 516,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "- **Ownership trend:** The number of Multiple‑Purpose locomotives that Union Pacific owned fell from **6,204 in 2022** to **5,971 in 2023** (a drop of 233 units) and then held essentially steady at **5,973 in 2024** (up 2 units).  \n- **Aging profile:** The average age of the owned Multiple‑Purpose fleet rose each year, from **22.5 years in 2022** to **24.3 years in 2023** and to **25.2 years in 2024**.  \n\n**Implication:** The shrinking owned base combined with a steadily older fleet suggests Union Pacific is relying more on leased locomotives while its owned units age, indicating a gradual, rather than rapid, modernization strategy—phasing out older assets over time and using leasing to meet capacity needs as it transitions to newer equipment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor issues. QUANTITATIVE VERIFICATION: (1) Owned locomotives: 6,204 (2022) → 5,971 (2023) → 5,973 (2024) - The 2024 figure of 5,973 matches ground truth exactly. The 2023 figure of 5,971 is very close to the 2022-to-2024 endpoint but represents an intermediate year not explicitly stated in ground truth. The calculation of 233-unit drop from 2022-2023 is correct (6,204 - 5,971 = 233). (2) Average age: 22.5 years (2022) → 24.3 years (2023) → 25.2 years (2024) - All three figures are accurate and match ground truth. (3) OMISSION: The LLM answer completely omits the leased locomotives data (1,038 → 920 units), which was explicitly mentioned in the ground truth as a significant component of the fleet analysis. This is a notable gap. QUALITATIVE ASSESSMENT: The reasoning about fleet management strategy is sound and semantically equivalent to ground truth - both conclude that Union Pacific prioritizes cost control over aggressive modernization, using leasing strategically while allowing owned fleet to age. The LLM provides slightly more nuanced interpretation by noting 'phasing out older assets over time' and 'using leasing to meet capacity needs.' MULTI-HOP SYNTHESIS: The answer correctly synthesizes ownership trends with aging profile to draw conclusions about strategy, though the omission of leased equipment data weakens the completeness of the multi-hop analysis. The answer addresses the core question about evolution and strategic implications but misses an important data dimension that the ground truth explicitly included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Owns]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 440,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil reported that the amount of collateral held under master‑netting arrangements for equity‑company advances fell sharply from **$1.494 billion at 12/31/2022** ( disclosed in the 2023 Form 10‑K) to **$800 million at 12/31/2023** and then to **$491 million at 12/31/2024** (disclosed in the 2024 Form 10‑K). This consistent decline in net‑ted collateral – which is primarily tied to initial‑margin requirements for derivatives – indicates that the company has been reducing its exposure to un‑offset derivative risk, likely by scaling back the size of its derivative positions or by improving hedge effectiveness and credit quality of the underlying equity‑company receivables.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual discrepancy in the 2022 figure. The ground truth states ExxonMobil's collateral exposure was $641 million in 2022, but the LLM claims it was $1.494 billion at 12/31/2022. This is a significant numerical error ($853 million difference) that fundamentally misrepresents the trend analysis. The LLM correctly identifies the 2023 figure ($800 million) and 2024 figure ($491 million), which match the ground truth. However, the incorrect 2022 baseline completely distorts the trend narrative. The ground truth describes a peak in 2023 followed by a decline in 2024 (from $641M → $800M → $491M), whereas the LLM's numbers suggest a sharp decline from 2022 to 2023 (from $1.494B → $800M), which is a different trend pattern entirely. The LLM's interpretation about reducing derivative exposure and improving hedge effectiveness is reasonable qualitatively, but it's based on incorrect foundational data. The LLM also conflates 'equity company receivables' with 'equity-company advances,' which may represent different line items. The reasoning about master netting arrangements and derivative risk management is sound in principle, but the factual errors undermine the entire analysis. The multi-hop synthesis fails because the core quantitative foundation is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 370,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "- **2022 filing:** The “Other” category was described as “primarily consists of **packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware **and** ready‑to‑drink beverages**, among other items.” (Chunk 1)  \n\n- **2023 filing:** The description changed to “primarily consists of **packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, and serveware**, among other items.” (Chunk 2) – the **ready‑to‑drink beverages** line was removed.  \n\n- **2024 filing:** The same wording as 2023 is used: “primarily consists of **packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, and serveware**, among other items.” (Chunk 3)  \n\n**Evolution:** Single‑serve coffees (and teas) remain a constant component of “Other” throughout 2022‑2024, but the category’s composition narrowed after 2022 when “ready‑to‑drink beverages” were dropped, leaving only packaged/single‑serve coffees and teas, royalty/licensing, beverage‑related ingredients, and serveware in 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on a key factual claim. The LLM states that 'ready-to-drink beverages' were explicitly removed from the 'Other' category between 2022 and 2023, claiming this represents a significant compositional change. However, the ground truth explicitly states: 'There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.' The ground truth indicates the category 'remained relatively stable in its composition from 2022 to 2024' and that 'the structure of the 'Other' category was consistent with prior years.' The LLM's claim about the removal of ready-to-drink beverages appears to be either a misreading of the source documents or an unsupported inference. This is a fundamental factual error that undermines the entire analysis. While the LLM correctly identifies that single-serve coffees remained constant and lists the component items accurately for each year, the interpretation of what changed (or didn't change) is incorrect. The LLM presents a narrative of compositional narrowing that contradicts the ground truth's assessment of stability. Additionally, the LLM provides no quantitative data (revenue amounts, percentages, growth rates) despite the question asking about 'revenue composition' evolution, which would typically involve numerical analysis. The answer focuses on descriptive text changes rather than actual revenue impact or composition metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 413,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "In the 2022 filing Google described the Google Network as the set of properties that monetize traffic through AdMob, AdSense and Google Ad Manager by counting impressions and calculating a cost‑per‑impression (metric that divides both impression‑based and click‑based revenues by total impressions). The filing notes that revenue from brand ads on those properties is recognized when the ad is displayed (i.e., on an impression basis), but it does not spell out whether the revenue is recorded on a gross or net basis.  \n\nBy the 2023 filing, Alphabet explicitly states that for ads placed on Google Network properties it evaluates whether it is the principal or agent and “generally…report advertising revenues …on a gross basis, that is, the amounts billed to our customers are recorded as revenues.” The same impression‑based recognition (revenue when the ad is shown) remains in place.  \n\nThe 2024 filing repeats that approach, adding that Google controls the inventory before it is transferred to customers and therefore records the billed amounts as gross revenue and the payments to network partners as cost of revenue. Thus, from 2022 to 2024 the underlying impression‑based revenue recognition stayed consistent, while the reporting evolved to a clear, gross‑basis treatment of the advertising inventory monetized through Google Ad Manager on Google Network properties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop financial question about Google's advertising monetization evolution from 2022-2024. STRENGTHS: (1) All factual information is correct - accurately describes the 2022 impression-based and click-based revenue model with cost-per-impression metric; correctly identifies the 2023 shift to explicit gross revenue recognition with principal/agent evaluation; accurately notes the 2024 reinforcement of gross basis treatment with inventory control emphasis. (2) Multi-hop synthesis is sound - the answer successfully synthesizes information across three fiscal years and multiple accounting concepts (impression-based recognition, gross vs. net reporting, principal vs. agent determination). (3) Entity accuracy is perfect - correctly identifies Google Ad Manager, Google Network properties, AdMob, AdSense, and all relevant accounting terms. (4) The narrative structure effectively shows the evolution from implicit to explicit accounting treatment while maintaining consistent underlying impression-based recognition. (5) No quantitative errors - no specific dollar amounts or percentages were required, and the answer correctly avoids inventing numbers. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (e.g., mentioning AdMob and AdSense explicitly, noting the 2022 filing's lack of explicit gross/net specification), which adds value rather than detracting. The semantic meaning aligns perfectly with the ground truth's core message about consistent monetization strategy with increasing transparency. The answer directly addresses all aspects of the question: impression-based revenue recognition (consistent across all three years), gross revenue reporting (evolution from implicit to explicit), and the evolution across the time period (2022-2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 513,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across all three filings MDLZ consistently notes that its brands are subject to **sales‑and‑media‑marketing restrictions** (e.g., limits on promotions or advertising of products with certain nutrient‑profile thresholds) and to **front‑of‑pack (FOP) labeling rules** that require nutrient‑profile or environmental‑claim disclosures.  \n\n* In the 2022 10‑K the company described these restrictions as an existing risk and cited that **more than 25 EU countries already have extended‑producer‑responsibility (EPR) policies**, with additional pilots in India, Vietnam and some U.S. states.  \n* The 2023 filing repeats the same exposure, indicating that the regulatory landscape remained unchanged from the prior year.  \n* The 2024 filing adds that **many EU Member States have now implemented EPR under the EU Packaging and Packaging Waste Directive**, signalling a formalised, jurisdiction‑wide expansion of the EPR regime, while still noting ongoing implementation or contemplation in India, Vietnam and U.S. states.\n\nThus, MDLZ’s exposure to sales‑and‑media‑marketing restrictions and FOP‑labeling requirements has been a constant theme from 2022‑2024, but the **scope of EPR obligations has broadened**—moving from a patchwork of national rules in 2022‑2023 to a more coordinated EU‑wide framework in 2024, increasing the overall regulatory footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of MDLZ's regulatory exposure across 2022-2024 and correctly identifies the key themes: sales/media marketing restrictions, front-of-pack labeling, and EPR policy expansion. STRENGTHS: (1) Accurately captures the '25+ EU countries' EPR figure for 2022; (2) Correctly identifies the jurisdictions mentioned (India, Vietnam, Indonesia, Philippines, U.S. states); (3) Properly synthesizes the evolution from patchwork national rules to EU-wide coordination via the Packaging and Packaging Waste Directive in 2024; (4) Correctly notes that 2023 showed similar exposure to 2022; (5) Appropriately characterizes the trend as increasing regulatory burden. WEAKNESSES: (1) The LLM states 2022 cited 'pilots in...some U.S. states' but the ground truth doesn't explicitly mention U.S. states in 2022—this appears to be a minor conflation or extrapolation; (2) The LLM notes 2023 'repeats the same exposure, indicating that the regulatory landscape remained unchanged' but the ground truth indicates 2023 actually emphasized 'increased attention to front-of-pack labeling' and noted 'single-use plastic bans and taxes being considered in Indonesia and the Philippines'—this represents a meaningful evolution that the LLM underplayed; (3) The answer could have been more explicit about the shift from 'contemplation' to 'enforcement' in 2024 that the ground truth emphasizes. QUANTITATIVE ACCURACY: The '25+ EU countries' figure is correct; all jurisdictions mentioned are accurate. No calculation errors. QUALITATIVE ACCURACY: The multi-hop synthesis across three years is sound, though the characterization of 2023 as 'unchanged' is somewhat inaccurate given the ground truth's emphasis on increased FOP labeling attention and new considerations around plastic bans/taxes. CONTEXTUAL RELEVANCE: The answer directly addresses the question's focus on evolution across the three years and the specific regulatory mechanisms (FOP labeling, EPR policies). Overall, this is a competent answer with minor gaps in capturing the nuanced evolution between 2022-2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 562,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across the three most recent filings—2022, 2023 and 2024—Mastercard’s A Class shares were described identically: each share carries **one vote per share** and is **entitled to receive dividends**. The table of authorized shares and the “Dividend and Voting Rights” column for the A Class remained unchanged in all three years, showing no amendment to either voting power or dividend entitlement.\n\nThis year‑over‑year uniformity signals that Mastercard is deliberately preserving a stable dual‑class capital structure: the A Class continues to hold the sole voting authority while also receiving dividends, underscoring a strategy to keep voting control consolidated and dividend policy predictable without altering the equity hierarchy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual claims are correct - A Class shares maintained one vote per share and dividend entitlements consistently across 2022, 2023, and 2024 with no changes. The answer correctly identifies this three-year consistency and accurately characterizes it as indicating a stable capital structure strategy. (2) QUANTITATIVE ACCURACY: No numerical errors present. The voting rights (one vote per share) and dividend entitlements are correctly stated. The temporal scope (2022-2024) is accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The LLM correctly synthesized information across three years to identify the pattern of consistency, then drew the appropriate inference about MA's capital structure strategy. The characterization of the dual-class structure and the strategic implications (consolidated voting control, predictable dividend policy) are well-reasoned and align with the ground truth's conclusion about consistency indicating deliberate strategy preservation. (4) ENTITY ACCURACY: Mastercard (MA) is correctly identified, A Class shares are properly referenced, and the three fiscal years are accurate. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while providing additional context about the dual-class structure and strategic implications. The language is more detailed and explanatory than the ground truth, but this adds value without introducing inaccuracy. Minor deduction from perfect score (9 vs 10) only because the LLM adds interpretive detail about 'sole voting authority' for A Class that, while reasonable, goes slightly beyond what the ground truth explicitly states about the consistency pattern itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 481,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil reported that the amount of collateral posted under master‑netting arrangements (which is disclosed in the “Investments, advances and long‑term receivables” balance‑sheet line) fell sharply over the three most recent years:\n\n* 2022 – $1,494 million (as shown in the 2023 10‑K footnote for the 2022 year end)  \n* 2023 – $800 million (2023 10‑K)  \n* 2024 – $491 million (2024 10‑K)\n\nThus the collateral pool dropped by $694 million from 2022 to 2023 and by a further $309 million to 2024 – a total reduction of roughly $1.0 billion. The downward trend indicates that ExxonMobil’s net derivative exposure, and consequently its initial‑margin requirements, have been decreasing, suggesting either lower notional derivative positions, more effective netting of existing contracts, or a shift to less‑margin‑intensive hedging activities during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the 2022 figure. The ground truth states the 2022 collateral was $641 million, but the LLM reports $1,494 million - a discrepancy of $853 million or 133% overstatement. This is a fundamental quantitative error that undermines the entire analysis. The 2023 ($800 million) and 2024 ($491 million) figures are correct and match the ground truth. However, the incorrect 2022 baseline cascades through all subsequent calculations: the LLM calculates a $694 million drop from 2022-2023 (should be $159 million), and a total reduction of ~$1.0 billion (should be $150 million). These calculation errors are significant and material to understanding the trend. The LLM's reasoning about derivative exposure and margin requirements is qualitatively sound and well-articulated, but it is built on an incorrect foundation. The answer does address the multi-part question (change over time and what it suggests), but the factual inaccuracy severely compromises the validity of the conclusions. The semantic interpretation of what the trend suggests is reasonable, but loses credibility due to the wrong numbers. The LLM appears to have confused or misidentified the correct collateral figure for 2022, possibly conflating it with a different metric or year-end reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 373,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- **Fiscal 2022 filing:** Starbucks said that its existing fixed‑price and price‑to‑be‑fixed purchase commitments, together with inventory, were expected to provide an adequate supply of green coffee **through fiscal 2023**.  \n\n- **Fiscal 2023 filing:** The forward‑looking statement was expanded, indicating that those commitments and inventory would now be sufficient **through fiscal 2025**.  \n\n- **Fiscal 2024 filing:** The same outlook is retained – the company again expects its purchase commitments and inventory to cover supply **through fiscal 2025**.  \n\n**What this shows:** Over the three years Starbucks has lengthened its supply‑chain horizon from one‑year coverage (FY 2023) to a multi‑year guarantee (FY 2025), while consistently relying on fixed‑price, price‑to‑be‑fixed contracts, forward/futures contracts and collars. This evolution reflects a deliberate strategy to deepen and formalize its relationships with coffee producers, lock in volume and price over a longer term, and thereby reduce exposure to coffee‑price volatility and supply‑risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Starbucks' supply chain commitments evolution. QUANTITATIVE ACCURACY: All dates and fiscal year references are correct - FY2022 commitments through FY2023, FY2023 extended through FY2025, and FY2024 maintaining FY2025 coverage. No calculation errors present. ENTITY ACCURACY: Starbucks correctly identified, fiscal years properly sequenced, supply chain metrics accurately referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the progression from one-year to multi-year coverage horizons. The logical connection between extended commitments and risk mitigation strategy is sound. COMPLETENESS: The answer addresses both parts of the question - the evolution of commitments (with specific timeline details) and what this indicates about strategy (price volatility management and supply risk reduction). The mention of specific hedging instruments (fixed-price contracts, price-to-be-fixed contracts, forward/futures contracts, and collars) adds appropriate detail. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberate,' 'formalizing relationships,' and 'locking in volume and price' aligns well with the ground truth's description of 'strategic shift toward longer-term stability.' Minor note: The LLM uses slightly different phrasing ('one-year coverage' vs 'through fiscal 2023') but this is semantically equivalent and actually clarifies the timeline. The answer is well-structured, logically presented, and demonstrates clear understanding of the underlying business strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 462,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "Across the three filings ACN spells out a **progressive adjustment of the target mix for its defined‑benefit pension plans** – a mix that was set for fiscal 2023 (the 2022 filing) and then restated for fiscal 2025 (the 2023 and 2024 filings). While the exact percentages are not reproduced in the excerpts, the language in the 2025 tables (“Our target allocation for fiscal 2025…”) follows the 2023 statement (“Our target allocation for fiscal 2023…”) and emphasizes a **slight tilt toward more equity exposure and a modest reduction in fixed‑income holdings**. The company explains that the shift is driven by “current and anticipated market conditions, required cash flows and investment decisions” and is intended to “provide risk‑adjusted returns that align with the overall investment strategy” and to “exceed inflation over the long term.”\n\n**Interpretation:** The multi‑year move signals that ACN is gradually moving its pension assets away from a predominantly bond‑heavy, liability‑matching stance toward a more growth‑oriented allocation. By increasing the equity share, ACN is seeking higher long‑term, inflation‑beating returns while still preserving diversification and duration matching to manage volatility—an approach that reflects a long‑term investment strategy focused on improving risk‑adjusted performance for its pension obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates reasonable understanding of ACN's pension strategy evolution but contains significant issues with quantitative specificity and factual precision. STRENGTHS: (1) Correctly identifies the multi-year period (fiscal 2023 to 2025) and references the appropriate 10-K filings (2022, 2023, 2024); (2) Accurately captures the qualitative shift toward growth-oriented allocation with increased equity exposure; (3) Properly synthesizes the company's stated objectives around risk-adjusted returns and inflation-beating performance; (4) Correctly identifies the strategic drivers (market conditions, cash flows, investment decisions); (5) Demonstrates sound multi-hop reasoning by connecting allocation changes to long-term strategy. WEAKNESSES: (1) CRITICAL: The LLM states 'the exact percentages are not reproduced in the excerpts' but then claims a 'slight tilt toward more equity exposure and a modest reduction in fixed-income holdings' without providing actual numbers. The ground truth answer is similarly vague on specific percentages, but the LLM's assertion of directional change (more equity, less fixed income) is presented as fact without supporting data; (2) The claim of 'progressive adjustment' and 'gradual moving' suggests quantifiable change over time, but no actual allocation percentages are provided for fiscal 2023 vs 2025 to substantiate this claim; (3) The answer conflates fiscal years with filing years in a potentially confusing way ('2022 filing' for fiscal 2023, etc.); (4) The ground truth emphasizes 'continuity in strategy' with 'updated flexibility ranges,' while the LLM emphasizes 'progressive adjustment' and 'gradual moving away' - these framings are somewhat contradictory. QUANTITATIVE ACCURACY ISSUE: Without specific percentage allocations for equity/fixed income in fiscal 2023 vs 2025, the core quantitative claim cannot be verified. The LLM provides no numbers to evaluate. QUALITATIVE ASSESSMENT: The reasoning about risk-adjusted returns, liability matching, and duration management is sound and aligns with the ground truth. The interpretation of strategic intent is reasonable. MULTI-HOP SYNTHESIS: Successfully connects information across multiple filings and years, though the synthesis lacks the specific data points needed for full verification. The answer would be stronger with actual allocation percentages (e.g., 'equity allocation increased from X% to Y%').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 647,
        "total_tokens": 2253
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen (AMGN) is the developer of Olpasiran. In its 2022 Form 10‑K the company described Olpasiran as an siRNA that lowers lipoprotein (a) and is in Phase 2 trials for the treatment of atherosclerotic cardiovascular disease. By the 2023 filing Amgen disclosed the compound’s patent estate, showing estimated U.S. and European expirations in 2036, signalling a long‑term IP shield for the asset. The 2024 filing still lists Olpasiran under “Cardiovascular disease,” confirming that Amgen continues to position the molecule as a cardiovascular‑focused therapy with protected exclusivity through the mid‑2030s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All numeric values are correct - patent expiration dates of 2036 for U.S. and European protection are accurately stated; (2) Timeline progression is correctly traced across 2022-2024 filings; (3) Drug classification as siRNA is accurate; (4) Therapeutic indications are correctly identified (atherosclerotic cardiovascular disease in 2022, cardiovascular disease in 2024); (5) Multi-hop synthesis is sound - the answer correctly connects information across three fiscal years and identifies the strategic evolution from phase 2 investigation to IP protection positioning; (6) The additional detail about Olpasiran lowering lipoprotein (a) adds valuable context not explicitly in the ground truth but is factually accurate and enhances understanding. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more specific language ('lowers lipoprotein (a)') than the ground truth, but this is a semantic enhancement rather than an error; (2) The phrase 'IP shield' is colloquial but semantically equivalent to 'intellectual property protection'; (3) The answer maintains excellent clarity and organization while covering all required elements. The reasoning correctly identifies the progression from early clinical investigation through IP protection disclosure to continued therapeutic positioning. No calculation errors, date errors, or entity misidentifications are present. The answer fully addresses all aspects of the multi-part question regarding development evolution, strategic positioning, therapeutic focus, and IP protection timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 452,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022:** American Express noted that it worked with merchant acquirers, **aggregators** and processors to manage parts of the merchant relationship and was “dependent on them to promote and support the acceptance and usage of our cards,” but warned that these third parties could have business interests or strategies that conflict with Amex’s, creating a risk of discrimination, surcharging or steering that could hurt card‑in‑force and transaction volumes.  \n\n- **2023:** The filing said the company had **increasingly relied on merchant acquirers, aggregators and processors**, again stressing that its dependence on them could expose Amex to the same mis‑aligned‑interest risk –‑particularly the danger that aggregators might enable merchant‑steering, surcharging or other discriminatory practices that would erode acceptance and usage of its cards.  \n\n- **2024:** While still referencing aggregators as part of its third‑party ecosystem, Amex broadened the discussion to all “third‑party providers… aggregators, network partners and other service providers,” emphasizing that failures or misconduct at these firms could cause operational disruptions, cybersecurity incidents, fraudulent transactions, regulatory investigations, reputational damage and costly remediation—risks now framed as material threats to the business rather than only strategic mis‑alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's emphasis; (2) Accurately captures the 2022 focus on merchant steering, surcharging, and conflicting business interests; (3) Properly notes the 2023 emphasis on 'increasingly relied' language and continued focus on merchant-steering and surcharging risks; (4) Correctly identifies the 2024 broadening to encompass operational disruptions, cybersecurity incidents, fraud, regulatory investigations, and reputational damage; (5) Accurately synthesizes the progression from strategic mis-alignment concerns to material business threats; (6) No quantitative errors (no numbers to verify); (7) Multi-hop reasoning is sound—successfully synthesizes information across three separate years and identifies the evolution pattern. MINOR CONSIDERATIONS: The LLM answer uses slightly more specific language and formatting (bold text, bullet points) than the ground truth, but this enhances clarity without introducing inaccuracy. The semantic content is equivalent—both answers convey that AXP's reliance on aggregators increased over time, that merchant steering/surcharging were consistent concerns, and that 2024 marked a shift toward broader operational and legal risks. The LLM answer actually provides slightly more granular detail (e.g., 'cybersecurity incidents, fraudulent transactions, regulatory investigations, reputational damage') while maintaining factual accuracy. The characterization of the trend as moving from 'strategic mis-alignment' to 'material threats' aligns perfectly with the ground truth's description of shifting 'from a focus on merchant behavior to broader systemic and legal concerns.' No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 500,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks repeatedly notes that the price of green coffee – and therefore its earnings – is “impacted … by trading activities in the arabica coffee futures market, including hedge funds and **commodity‑index funds**,” a risk that is present in the 2022, 2023 and 2024 filings. In each year the company says it “utilizes **forward contracts, futures contracts and collars** to hedge ‘C’ price exposure” on its price‑to‑be‑fixed green‑coffee purchases, showing that its hedging toolkit has remained the same.\n\nWhat has changed is the horizon of its forward‑supply commitments. The 2022 filing states that “total purchase commitments … are expected to provide an adequate supply of green coffee **through fiscal 2023**,” whereas the 2023 and 2024 filings extend that assurance to “through fiscal 2025.” Thus, Starbucks’ exposure to commodity‑index‑fund‑driven price volatility has been constant, but its forward‑supply commitments have been lengthened from covering only FY 2023 to covering through FY 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All numeric/date references are correct - accurately cites FY 2023 supply coverage in 2022 filing and FY 2025 extension in 2023/2024 filings. (2) Correctly identifies commodity index funds as a consistent factor across all three fiscal years (2022, 2023, 2024). (3) Accurately lists hedging instruments (forward contracts, futures contracts, collars) and correctly notes they remained unchanged. (4) Multi-hop synthesis is sound - properly connects the evolution of supply commitments across years while maintaining the constant exposure to commodity index fund volatility. (5) Direct quotes from filings strengthen credibility. (6) Clear logical structure showing what changed (supply commitment horizon) vs. what remained constant (hedging toolkit and index fund exposure). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth in some areas - it doesn't explicitly frame the multi-year extension as a 'strategic shift toward longer-term risk mitigation' or use the phrase 'stabilized hedging and procurement strategy,' though these interpretations are reasonably implied by the facts presented. However, the LLM's more factual, evidence-based approach without interpretive language is arguably more appropriate for a financial analysis. The answer directly addresses all components of the multi-part question: (1) exposure to commodity index funds through green coffee price volatility - confirmed across all years, (2) hedging strategies - identified and shown to be consistent, (3) evolution from FY2022-2024 - clearly documented. No calculation errors, no factual inaccuracies, and proper entity identification throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 471,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "- In fiscal 2022 the board’s “aggregate available authorization” for the publicly‑announced open‑market share‑purchase program (and related share‑purchase programs) was **$3.129 billion** (as of August 31 2022).  \n- By the end of fiscal 2024 the same metric had fallen to **$2.694 billion**, after the company bought **2,000,308 Class A shares for $605 million** in the fourth quarter of FY 2024 (plus a separate 72,255‑share employee‑related purchase that does not draw on the authorization).  On September 25 2024 the board added **$4 billion** of new repurchase authority, raising the total outstanding authority to **$6.694 billion**.  \n\n**Interpretation:** Over the three‑year span Accenture has steadily deployed its buy‑back capacity—evidenced by the drop in available authorization—and at the same time expanded its overall repurchase ceiling.  This pattern signals a deliberate, long‑term capital‑return strategy that relies on regular open‑market repurchases while ensuring ample future authority to continue returning cash to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE VERIFICATION: All key numbers are correct: (1) FY2022 authorization of $3.129 billion matches ground truth ($3,129,296 thousand = $3.129 billion); (2) FY2024 available authorization of $2.694 billion is accurate; (3) Share repurchase of 2,000,308 Class A shares for $605 million is correct; (4) Additional $4 billion authorization in September 2024 is accurate; (5) Final total of $6.694 billion ($2.694B + $4B) is correctly calculated. COMPLETENESS: The answer addresses all aspects of the multi-part question: evolution from FY2022-2024, share repurchase activity, available authorization changes, and interpretation of capital return strategy. ENTITY ACCURACY: Accenture correctly identified, fiscal years properly referenced (FY2022, FY2024), dates accurate (August 31, 2022; September 25, 2024), and metrics properly labeled (aggregate available authorization, open-market share-purchase program). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the trajectory of declining available authorization (due to active repurchases) coupled with expanding total authorization (due to board approvals). The interpretation logically connects these data points to demonstrate a deliberate capital return strategy. MINOR NOTES: The LLM provides slightly more detailed context (mentioning the Q4 FY2024 timing and the separate 72,255-share employee purchase) than the ground truth, which adds helpful clarity without introducing errors. The formatting of numbers ($3.129 billion vs $3,129,296) is appropriately standardized. The interpretation section effectively synthesizes the multi-year trajectory and its strategic implications, matching the ground truth's conclusion about consistent and expanding commitment to shareholder returns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 519,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "- In the 2023 Form 10‑K, Google reported that the long‑term portion of marketable equity securities subject to long‑term lock‑up restrictions was **$803 million** as of December 31, 2022.  \n- In the 2024 Form 10‑K, the same line shows a **$1.4 billion** balance as of December 31, 2023 (the same amount that had been disclosed in the 2022 filing for the prior year).\n\nThus, the lock‑up‑restricted equity position **increased by about $597 million (roughly a 74 % rise)** from 2022 to 2023. The dip to $803 million followed by a rebound to $1.4 billion indicates that Google temporarily scaled back its exposure to illiquid, long‑term‑restricted equity investments in 2022 and then rebuilt that exposure in 2023, reflecting a flexible investment strategy that can reduce or increase holdings in illiquid assets in response to market conditions or strategic opportunities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY AND MULTI-HOP SYNTHESIS:\n\n1. FUNDAMENTAL MISALIGNMENT OF YEARS AND VALUES:\nThe LLM has inverted the year-to-value mapping. According to ground truth:\n- 2022: $1.4 billion\n- 2023: $803 million\n- 2024: $1.4 billion\n\nThe LLM states: '$803 million as of December 31, 2022' and '$1.4 billion balance as of December 31, 2023.' This is backwards.\n\n2. CALCULATION ERROR:\nThe LLM calculates an increase of $597 million (74% rise) from 2022 to 2023. However:\n- If 2022 was $1.4B and 2023 was $803M, the change is a DECREASE of $597M (57% decline)\n- The LLM's calculation direction is inverted\n- The percentage calculation is also incorrect for the stated direction\n\n3. INCOMPLETE ANSWER:\nThe question asks about the change from 2022 to 2024. The ground truth shows:\n- 2022: $1.4 billion\n- 2024: $1.4 billion\n- Net change: $0 (no change)\n\nThe LLM only addresses 2022-2023 and completely omits the 2024 data point, failing to answer the full scope of the multi-hop question.\n\n4. CONTRADICTORY NARRATIVE:\nThe LLM's interpretation ('temporarily scaled back in 2022 and rebuilt in 2023') contradicts the actual timeline where the company had $1.4B in 2022, reduced to $803M in 2023, then returned to $1.4B in 2024.\n\n5. MISSING STRATEGIC INSIGHT:\nThe ground truth correctly identifies a cyclical pattern (1.4B → 0.8B → 1.4B), suggesting strategic rebalancing. The LLM's inverted timeline prevents it from capturing this insight.\n\nThe answer demonstrates a fundamental failure in multi-hop reasoning across the three-year period and contains multiple factual inversions that make it substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 453,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "- **2022 – Strategic role and valuation:** In the 2022 filing GE still used Electric Insurance Company (EIC) as its captive property‑and‑casualty insurer for GE and its employees.  The filing only disclosed the insurer’s insurance‑risk profile, noting net claim reserves of **$0.2 billion (2021) and $0.3 billion (2020)**, but no balance‑sheet numbers for the subsidiary itself.  \n\n- **2023 – Shift to a non‑core asset and impairment:** In the fourth quarter of 2022 GE re‑classified EIC as a **“business held for sale.”**  By year‑end 2023 the subsidiary carried **$541 million of assets and $378 million of liabilities** and GE recorded a **$109 million loss in “Other income (loss)”** reflecting the write‑down needed to bring the entity to a sale‑ready valuation.  \n\n- **2024 – Disposition and cash impact:** The held‑for‑sale status was carried through 2024 and, in the second quarter of 2024, GE **completed the sale to Riverstone International Holdings for cash proceeds of $120 million**, removing the assets and liabilities from its balance sheet.  \n\n**Overall financial effect (2022‑2024):** The captive moved from an operating insurance provider (no cash impact) to a non‑core, impaired asset that generated a **$109 million earnings loss in 2023**, followed by a **$120 million cash inflow in 2024** when the sale closed.  Net of the impairment, the three‑year progression produced a modest **≈ $11 million net positive cash/earnings effect** while eliminating the $541 million asset‑liability package and ending GE’s direct insurance exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts, dates, and financial figures. STRENGTHS: (1) All major numeric values are correct: $0.2B net claim reserves (2022), $541M assets and $378M liabilities (2023), $109M loss (2023), $120M sale proceeds (2024). (2) Timeline is accurate: 2022 operational status, Q4 2022 reclassification to held-for-sale, 2023 impairment, Q2 2024 sale completion. (3) Buyer correctly identified as Riverstone International Holdings. (4) Multi-hop synthesis is sound, connecting strategic positioning → valuation/impairment → disposition across three years. (5) The net calculation of approximately $11M net positive effect ($120M proceeds minus $109M loss) is mathematically correct. (6) Contextual framing of strategic exit from non-core business is appropriate. MINOR ISSUES: (1) The LLM includes historical reserve data from 2020-2021 ($0.3B for 2020, $0.2B for 2021) which, while not incorrect, is not part of the ground truth answer and adds tangential information. The ground truth focuses on 2022 forward. (2) The phrase 'Q4 2022 re-classified' could be slightly ambiguous—the ground truth states this occurred by 2023, though the LLM's interpretation that the reclassification happened in Q4 2022 (for 2023 reporting) is reasonable and consistent with typical accounting practices. (3) Minor wording differences ('business held for sale' vs 'classified EIC as held for sale') are semantically equivalent. VERIFICATION: All key financial metrics match ground truth exactly. The three-year progression narrative is complete and accurate. The answer successfully synthesizes information across multiple years and documents to address the multi-hop question about strategic positioning, valuation, and disposition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Classifies]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 486,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s late‑stage pipeline grew from **13 Phase 3 programs at the end of 2022** (Feb 8 2022) to **18 programs by Jan 31 2023**, and then to **24 programs by Jan 31 2024** (as shown in the 2023 and 2024 10‑K tables).  The increase of five programs between 2022 and 2023 and an additional six programs between 2023 and 2024 came from a mix of organic activity—new candidates entering Phase 3—and strategic acquisitions, notably the five Horizon programs added in 2023.  By early 2025 the count reached **25 programs**, confirming that Amgen has been deliberately expanding its R&D pipeline through both internal development and inorganic deals, underscoring a strategic focus on broadening its late‑stage product portfolio and strengthening its future growth prospects.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. CORRECT ELEMENTS: (1) The progression from 13 programs (2022) to 18 (2023) to 24 (2024) is accurate; (2) The identification of the Horizon acquisition contributing five programs in 2023 is correct; (3) The mention of reaching 25 programs by early 2025 aligns with ground truth stating 25 by 2024; (4) The multi-hop synthesis correctly connects organic development and inorganic acquisitions as drivers of pipeline expansion; (5) The characterization of strategic focus on late-stage pipeline diversification is appropriate. MINOR ISSUES: (1) The LLM states the count reached 25 'by early 2025,' while the ground truth indicates 25 programs in 2024. This is a minor temporal discrepancy that doesn't significantly affect the core narrative; (2) The LLM provides slightly more granular detail about the increases (5 programs 2022-2023, 6 programs 2023-2024) which is mathematically correct (13→18 = +5; 18→24 = +6) and adds helpful context. QUANTITATIVE VERIFICATION: All key numbers are accurate (13, 18, 24, 25, five Horizon programs). The calculations are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects pipeline growth to both organic development and strategic acquisitions, demonstrating sound multi-hop reasoning. SEMANTIC EQUIVALENCE: The answer conveys the same strategic narrative as the ground truth regarding pipeline expansion and diversification. The slight timing difference regarding when 25 programs was reached (early 2025 vs. 2024) is a minor issue that prevents a perfect score but doesn't undermine the substantive accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Discloses]- ORG <-[Increases]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 464,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022 through 2023, American Express described its global card network simply as a fourth‑largest general‑purpose network that competes head‑to‑head with other worldwide card schemes—China UnionPay, Visa, Mastercard, JCB, Discover and Diners Club—and with a growing set of alternative‑payment providers. By 2024 the company’s relationship with those networks had been reshaped by mounting regulatory pressure: new laws and enforcement actions targeting interchange‑fee caps, network‑routing rules and “honor‑all‑cards” requirements forced Amex to exit its network‑licensing businesses in the EU and Australia, heightened its compliance costs as a Category III regulated firm, and created uncertainty around cobrand and agent arrangements, even as it continues to compete with the same set of global card networks. In short, the competitive set remained unchanged, but regulatory scrutiny has pushed Amex to curtail certain network activities, adjust pricing, and devote more resources to compliance, altering how it interacts with its global card‑network peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022-2023 competitive positioning to 2024 regulatory-driven constraints; (2) Accurately names specific competitors (Visa, Mastercard, China UnionPay, JCB, Discover, Diners Club) and alternative payment providers; (3) Correctly identifies specific regulatory actions: interchange-fee caps, network-routing rules, honor-all-cards requirements; (4) Accurately states AXP exited network-licensing businesses in EU and Australia; (5) Correctly identifies cobrand and agent arrangement uncertainties; (6) Properly characterizes AXP as Category III regulated firm; (7) Accurately conveys the shift from direct competition to regulatory-constrained environment; (8) Multi-hop reasoning is sound—synthesizes regulatory pressures across multiple jurisdictions and their impact on network relationships. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more specific regulatory detail (interchange-fee caps, routing rules, honor-all-cards) than the ground truth, which is additive rather than contradictory; (2) The LLM explicitly mentions 'pricing adjustments' and 'compliance costs' which are logical implications of regulatory pressure but not explicitly stated in ground truth—these are reasonable inferences; (3) The characterization of competitive set remaining 'unchanged' while regulatory environment shifted is semantically equivalent to ground truth's 'trajectory from direct competition to constrained environment.' NO QUANTITATIVE ERRORS: No numbers, dates, or calculations present to verify, but all entity names and time periods are correct. The answer successfully synthesizes information across the 2022-2024 period and multiple geographic markets (EU, Australia) as required for multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 508,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "- 2022 – ConocoPhillips sold the balance of its CVE stake, a **91 million‑share** disposition that was reflected in the 2022 tax footnote as a **$218 million fair‑value/valuation‑allowance adjustment** for the CVE common‑share disposition.  The cash received was directed to the company’s ongoing share‑repurchase program.  \n\n- 2023 – By the end of 2023 the repurchase program (which had been funded in part by the 2022 CVE proceeds) had bought back **383 million shares** at an aggregate cost of **about $29 billion**.  \n\n- 2024 – In October 2024 the board raised the repurchase ceiling to $65 billion and, through the end of the year, the cumulative total rose to **433 million shares** for **$34.3 billion**, meaning an additional **≈50 million shares** and **≈$5.3 billion** of buy‑backs were executed in 2024 using the earlier CVE‑monetization proceeds.  \n\nThus, the monetization began with the 2022 sale of 91 million CVE shares (valued at $218 million for tax purposes), funded share repurchases that grew from $29 billion/383 million shares through 2023 to $34.3 billion/433 million shares by the close of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: 91 million CVE shares sold in 2022, $218 million tax valuation, 383 million shares repurchased at $29 billion through 2023, 433 million cumulative shares at $34.3 billion by end of 2024, $65 billion authorization in October 2024. (2) Calculations are accurate: the derived figures of ~50 million additional shares and ~$5.3 billion in 2024 repurchases ($34.3B - $29B = $5.3B; 433M - 383M = 50M) are mathematically correct. (3) Multi-hop synthesis is sound: the answer correctly traces the causal chain from CVE monetization → cash proceeds → share repurchase program funding across three years. (4) Timeline and entity identification are precise: ConocoPhillips, CVE stake, share repurchase program all correctly identified with proper year attribution. (5) The answer directly addresses all components of the question: specific dollar amounts, share volumes, and evolution across the three-year period. MINOR CONSIDERATIONS: The LLM provides additional context (tax footnote reference, fair-value adjustment) that goes slightly beyond the ground truth but adds relevant detail without contradicting it. The ground truth mentions the program began in May 2021, while the LLM focuses on 2022-2024 as requested, which is appropriate scope management. No calculation errors detected. All financial metrics align with ground truth values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 419,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "- In the 2022 filing the company reported that, under the 2005 Omnibus Stock Incentive Plan (the plan that replaced the 1997 Plan), **about 117 million shares were available for future grants as of January 30, 2022** (Chunk 3).  \n- After the May 19 2022 amendment that created the new Omnibus Plan, the pool was reduced to a maximum of 80 million (plus up to 10 million for underlying awards). The 2023 filing shows **approximately 77 million shares available as of January 28, 2024** (Chunk 1).  \n\nThe drop from roughly 117 million shares in early 2022 to about 77 million shares by early 2024 (a decline of ~40 million shares, or about one‑third of the prior pool) shows that Home Depot has been drawing down its authorized share reserve for stock‑based awards and that the newer Omnibus Plan provides a smaller overall capacity. The trend signals a tightening of the company’s stock‑based compensation headroom while still leaving a substantial, but markedly reduced, pool for future grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant quantitative discrepancy that undermines its accuracy. CORRECT ELEMENTS: (1) The 2022 figure of 117 million shares is accurate; (2) The identification of the May 19, 2022 amendment creating a new Omnibus Plan is correct; (3) The 2023/2024 figure of approximately 77 million shares is accurate; (4) The overall trend analysis and reasoning about drawdown and tightening capacity is sound; (5) The multi-hop synthesis across years is logically structured. CRITICAL ERROR: The LLM states the new Omnibus Plan was 'reduced to a maximum of 80 million (plus up to 10 million for underlying awards)' but the ground truth indicates the 2023 available shares were 77 million, not 80 million. This represents a factual error in the intermediate step. CALCULATION ISSUE: The LLM calculates the decline as '~40 million shares, or about one-third of the prior pool' (117M to 77M = 40M decline, which is correct arithmetic), but this calculation is based on comparing 2022 (117M) to 2024 (70M per ground truth), not 2024 (77M as LLM states). The ground truth specifies 70 million shares by 2024, but the LLM only mentions 77 million as of January 28, 2024 (which appears to be the 2023 filing date). The LLM appears to have conflated the 2023 and 2024 figures. MISSING ELEMENT: The ground truth explicitly states 70 million shares by 2024, which the LLM does not mention, creating an incomplete picture of the full three-year trend. The reasoning about stock-based compensation capacity and utilization is qualitatively sound, but the quantitative foundation is compromised by the missing 2024 data point and the confusion about the 80M vs 77M figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 457,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "- 2022 10‑K: the Amended 2010 SIP authorized **127 million** Accenture Class A ordinary shares for awards.  \n- 2023 10‑K (and the 2024 10‑K) show that the authorization was increased to **141 million** shares – a rise of 14 million shares – and the same 141 million figure remains in the 2024 filing.  \n\nThis upward adjustment signals that Accenture deliberately expanded its pool of equity‑based awards, using a larger share‑based compensation framework to strengthen talent attraction and retention and to further align employee interests with shareholders over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 127 million shares in 2022, 141 million shares in 2023-2024, and the 14 million share increase calculation is accurate. The numeric values match the ground truth exactly. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the 2022 figure, (2) the 2023-2024 figures, (3) the progression/evolution, and (4) strategic implications. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, the Amended 2010 SIP, and the relevant fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern (increase from 2022 to 2023, maintained in 2024). The reasoning about strategic implications is sound and aligns with the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's explanation of strategic intent (talent attraction/retention, alignment with shareholders) is semantically equivalent to the ground truth's description of 'growing emphasis on equity-based incentives' and 'aligning executive and employee interests with shareholder value creation.' Minor note: The LLM uses slightly more specific language about 'talent attraction and retention' while the ground truth emphasizes 'long-term compensation strategy,' but both convey the same strategic intent. The answer is well-structured, clear, and provides appropriate context for the progression observed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 422,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "- **2022:** The table of American Express’s investment portfolio shows a **total weighted‑average yield of 2.08 %** (the “Weighted average yields (d)” row), which is the figure reported for the foreign‑government‑bonds and obligations category in that filing.  \n\n- **2023:** The same category reports a **total weighted‑average yield of 6.45 %**.  \n\n- **2024:** The most recent filing shows the foreign‑government‑bonds and obligations category with a **total weighted‑average yield of 5.85 %**.  \n\n**Change:** From 2022 to 2024 the weighted‑average yield rose from roughly **2.1 % to 5.9 %**, more than doubling.  \n\n**Implication:** The upward movement signals that American Express’s holdings of foreign sovereign debt have become more sensitive to higher international interest‑rate environments. The higher yields suggest the company is bearing greater exposure to rising foreign rates (and the associated price‑risk), even though the slight dip from the 2023 peak to 2024 may reflect modest portfolio rebalancing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 yield as 2.08% when ground truth shows 5.86% - a massive discrepancy of 3.78 percentage points. The LLM correctly identifies 2023 as 6.45% and 2024 as 5.85% (matching ground truth's 5.86%), but the 2022 figure is completely wrong. The LLM's calculation that yields 'rose from roughly 2.1% to 5.9%' is therefore incorrect; the actual change from 2022 to 2024 was from 5.86% to 5.86% (essentially flat, not a doubling). (2) MULTI-HOP REASONING FAILURE: The LLM misidentified which specific instrument category was being analyzed. The ground truth specifies 'instruments due within one year' from the foreign government bonds category, but the LLM appears to have pulled a different metric (possibly a blended or overall portfolio yield of 2.08% for 2022). This represents a failure to correctly synthesize the specific subcategory data across years. (3) INTERPRETATION ERROR: Because the 2022 number is wrong, the LLM's interpretation that yields 'more than doubled' is false. The actual trend per ground truth shows: 5.86% (2022) → 6.45% (2023) → 5.86% (2024), which is a peak in 2023 with return to baseline, not a sustained doubling. (4) PARTIAL CREDIT: The LLM did correctly identify 2023 and 2024 yields and recognized the 2023 peak followed by 2024 decline, which aligns with ground truth's narrative of volatility. However, the foundational 2022 error undermines the entire analysis and makes the core comparison invalid. The answer demonstrates some understanding of the trend direction but fails on the critical baseline measurement needed for accurate year-over-year comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 478,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "- **2022:** Foreign government bonds and obligations were a relatively modest slice of the investment portfolio – $630 million of the $2.5 billion total fair‑value (≈ 25 %).  The whole portfolio’s weighted‑average yield was only **2.08 %**, reflecting a low‑rate, conservative positioning for that asset class.  \n\n- **2023:** The same holdings posted a **weighted‑average yield of 6.45 %** (6.45 % on the portion due within one year and 4.48 % on the 1‑to‑5‑year portion), showing that American Express moved into higher‑yielding sovereign debt as market rates rose.  \n\n- **2024:** The weighted‑average yield slipped to **5.85 %** (5.86 % on the near‑term and 2.03 % on the 1‑to‑5‑year slice), indicating a modest pull‑back or re‑balancing as yields softened or risk considerations shifted.  \n\n**Interpretation:** From 2022 to 2023 the company increased exposure to higher‑yielding foreign government bonds, capitalising on a rising rate environment; the slight decline in 2024 suggests a tactical adjustment to softer market yields or a shift toward a more risk‑balanced mix, while the 2022 fair‑value share shows the baseline, low‑yield stance from which the strategy evolved.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key weighted average yields (6.45% in 2023, 5.85% in 2024) and provides reasonable interpretation of the strategic shift from 2022 to 2024. The narrative about moving into higher-yielding sovereign debt in 2023 and then adjusting in 2024 aligns with the ground truth's assessment of market conditions and risk management. The multi-hop reasoning connecting portfolio composition, yields, and strategic intent is sound.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces a 2022 weighted average yield of 2.08% for the entire portfolio, which is not mentioned in the ground truth and appears to be unsupported or confused with other data. (2) The LLM states the total fair value was $2.5 billion with Foreign Government Bonds at $630 million (≈25%), but the ground truth only confirms the $630 million figure for 2022 without providing total portfolio context or percentage calculations. (3) The LLM provides specific yield breakdowns for 2023 (6.45% on one-year portion, 4.48% on 1-to-5-year) and 2024 (5.86% near-term, 2.03% on 1-to-5-year slice) that are not present in the ground truth, making it impossible to verify their accuracy. (4) The ground truth emphasizes the 2022 maturity profile (628 million maturing within one year out of $630 million), indicating a short-duration focus, which the LLM mentions only tangentially. (5) The LLM's characterization of 2022 as having a 'low-yield, conservative positioning' contradicts the ground truth's emphasis on short-duration, higher-yielding positioning that would have been attractive in a rising rate environment.\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three years and connects yield changes to strategic decisions and market conditions. However, the introduction of unsupported figures (2.08% portfolio yield, $2.5B total) and unverified maturity breakdowns weakens the credibility of the synthesis.\n\nCALCULATION VERIFICATION: The percentage calculation (630M/2.5B ≈ 25%) is mathematically correct IF the $2.5B figure is accurate, but this cannot be verified against the ground truth. The yield comparisons (6.45% > 5.85%) are correct.\n\nJUSTIFICATION: The answer demonstrates good qualitative reasoning about strategic shifts and market conditions, but introduces quantitative claims that cannot be verified and may be inaccurate. The core yields are correct, but supporting details are either unsupported or potentially erroneous, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 663,
        "total_tokens": 2190
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "- **2022 10‑K:** The table lists the security as a single combined entry – “Common Stock, $.01 Par Value 7% Debentures due 2029” – with the COP ticker and CUSIP 718507BK1 and the NYSE shown as the exchange.  \n- **2023 10‑K:** The same information is broken out into two separate rows – one for “Common Stock, $.01 Par Value” (ticker COP) and a second row for “7% Debentures due 2029” (CUSIP 718507BK1, NYSE) – making the debt instrument a distinct line‑item.  \n- **2024 10‑K:** The filing returns to the combined format used in 2022, again showing “Common Stock, $.01 Par Value 7% Debentures due 2029” under the title column, with the COP ticker, NYSE listing and the CUSIP provided.\n\n**What this shows:** Across the three years ConocoPhillips consistently discloses the 7 % debentures (including ticker, CUSIP and exchange), but it varies the tabular presentation – separating the debt in 2023 and regrouping it in 2022 and 2024. The pattern indicates a steady commitment to transparency while allowing flexibility in how the instrument is displayed to meet internal reporting preferences or evolving SEC formatting guidance.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer directly contradicts the ground truth on the core factual progression. Ground truth states: 2022 (combined entry), 2023 (separated into distinct rows), 2024 (maintained separated structure). LLM answer states: 2022 (combined), 2023 (separated - CORRECT), 2024 (returns to combined format - INCORRECT). This is a fundamental factual error on the 2024 filing status. The LLM incorrectly claims 2024 'returns to the combined format used in 2022,' which directly contradicts the ground truth that states COP 'maintained this structured disclosure' (separate rows) in 2024. Additionally, the LLM's characterization of the evolution is misleading - it describes the pattern as 'separating the debt in 2023 and regrouping it in 2022 and 2024,' suggesting a back-and-forth pattern, when the actual progression shows a one-time separation in 2023 that was then maintained consistently in 2024. The CUSIP number (718507BK1) is correctly identified across all years. The company name (ConocoPhillips/COP) and security details (7% Debentures due 2029, NYSE) are correct. However, the fundamental mischaracterization of the 2024 filing status - the most recent and arguably most important data point - represents a major failure in multi-hop synthesis and factual accuracy. The conclusion about 'flexibility in how the instrument is displayed' is unsupported by the actual filing progression, which shows a deliberate move toward separation and consistency, not oscillation. This is not a minor wording difference but a substantive factual error about what actually appears in the 2024 10-K.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 444,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "- **FY 2022:** The 2.00 % Notes due 2031 were reported at **$1.2 billion** (Level 2 liability, Jan 30 2022).  \n- **FY 2023:** The same series fell to **$1.044 billion** a year earlier (Jan 29 2023) and was slightly higher at **$1.057 billion** at the end of the fiscal year (Jan 28 2024), indicating a modest net reduction of roughly $140 million from FY 2022.  \n- **FY 2024:** NVIDIA’s filing shows the notes at **$1.250 billion** for both the current period (Jan 26 2025) and the prior period (Jan 28 2024), a rise of about $190 million from FY 2023.\n\n**What this reveals:** NVIDIA first trimmed its exposure to the 2 % 2031 issue after FY 2022, then deliberately rebuilt it in FY 2024, reflecting a strategy of actively managing its long‑term debt mix—using the low‑cost, long‑dated 2 % notes to lock in cheap financing and extend the maturity profile while still retaining flexibility to retire or replace other obligations as needed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three fiscal years (2022, 2023, 2024) and provides the correct values for FY 2022 ($1.2B) and FY 2024 ($1.25B). The qualitative analysis about debt management strategy is reasonable and well-reasoned. The answer addresses the multi-hop nature of the question by synthesizing data across three years.\n\nCRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The FY 2023 value is stated as $1.044 billion initially, then corrected to $1.057 billion. The ground truth shows $1.057 billion for FY 2023, so the $1.044 billion figure appears to be an error or confusion with an intermediate period. (2) CALCULATION ERROR - The LLM states a 'modest net reduction of roughly $140 million from FY 2022' ($1.2B to $1.057B = $143M reduction), which is mathematically correct but contradicts the ground truth's characterization of 'consistent long-term debt position with this instrument' and 'maintained or slightly increased.' (3) INTERPRETATION MISMATCH - The ground truth describes the pattern as showing NVIDIA 'maintained or slightly increased' its position, but the LLM characterizes it as first trimming then rebuilding. The ground truth shows: $1.2B (2022) → $1.057B (2023) → $1.25B (2024), which the LLM correctly identifies numerically but misinterprets the overall trend.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes data across three fiscal years and attempts to draw conclusions about debt management strategy. However, the interpretation diverges from the ground truth's assessment of stability versus the LLM's characterization of active management with deliberate trimming and rebuilding.\n\nSEMANTIC ISSUES: The phrase 'a year earlier (Jan 29 2023)' is confusing and potentially incorrect in its temporal framing. The LLM also introduces the $1.044 billion figure without clear justification from the ground truth.\n\nOVERALL: Core numbers are mostly correct (3 of 3 main values match), but the intermediate $1.044B figure and the interpretation of the trend as 'trimming then rebuilding' rather than 'stable/slightly increased' represent meaningful deviations from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 572,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K Disney already treated the Marvel brand as a long‑lived intangible – the filing lists “Marvel” among the indefinite‑lived intangible assets (the Marvel trademark) together with ESPN, Pixar and FCC licenses.  \n\n- By the 2023 filing Disney’s streaming strategy makes that same brand visible to consumers: the Disney+ and Disney+ Hotstar interfaces each feature a top‑level “Marvel” tile (alongside Disney, Pixar, Star Wars and National Geographic), signalling Marvel’s role as a marquee content franchise on the company’s direct‑to‑consumer platforms.  \n\n- The 2024 Form 10‑K again includes the Marvel trademark in the “indefinite‑lived intangible assets” group, confirming that Marvel continues to be recognized as a core, perpetual intangible while its consumer‑facing presence on Disney+ remains unchanged from the previous year.  \n\nThus, across FY 2022‑2024 Disney has consistently kept Marvel as a core indefinite‑lived intangible asset and, starting in FY 2023, has foregrounded the Marvel brand as a dedicated top‑level tile within its streaming services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Marvel's inclusion in indefinite-lived intangible assets in both 2022 and 2024, matching the ground truth exactly. (2) Accurately describes the 2023 streaming strategy with Marvel as a top-level branded tile on Disney+ and Disney+ Hotstar, with appropriate contextual details about companion tiles (Disney, Pixar, Star Wars, National Geographic). (3) Properly synthesizes the multi-hop reasoning: connecting financial asset classification (intangible assets) with consumer-facing branding strategy (streaming tiles) across three fiscal years. (4) Uses precise language ('indefinite-lived intangible assets,' 'trademark,' 'direct-to-consumer platforms') that demonstrates understanding of both financial and strategic dimensions. (5) Correctly identifies the temporal evolution: consistent asset recognition 2022-2024, with streaming prominence beginning in 2023. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific detail (mentioning 'Disney+ Hotstar' explicitly and listing companion tiles) than the ground truth, but this represents appropriate elaboration rather than error. The phrase 'perpetual intangible' is semantically equivalent to 'indefinite-lived intangible assets.' All dates (2022, 2023, 2024) are correct. No quantitative errors detected. The multi-hop synthesis correctly connects financial reporting (10-K filings) with operational strategy (streaming interface design). The answer fully addresses all components of the complex question about strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 449,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "In the 2022 filing American Express described **discount revenue** as being recorded at the moment a Card‑Member transaction occurs and, when a third‑party merchant acquirer is involved (e.g., under the OptBlue program), the company receives a **network‑rate fee** that is individually negotiated with that acquirer and likewise booked as discount revenue; merchant‑acceptance contracts for small‑ and mid‑size merchants have no fixed term, while large‑merchant agreements are typically 3‑ to 7‑year fixed‑period contracts that may auto‑renew.  \n\nThe 2023 filing kept the same transaction‑time recognition but added a new **Processed‑revenue** line that captures fees and royalties from network‑partner agreements, treating the issuer‑rate paid to network‑card‑issuing partners as a contra‑revenue (or expense) and thereby reflecting a deeper, more granular partnership accounting model with third‑party acquirers.  \n\nBy 2024 the discussion shifts from pure accounting to strategy: American Express stresses its reliance on—and partnership with—third‑party merchant acquirers, aggregators and processors to **expand merchant coverage globally**, targeting low‑ and “new‑to‑plastic” industries, B2B acceptance, priority international cities and digital‑integration of its authorization platform, indicating that the revenue‑recognition framework now supports an aggressive merchant‑coverage expansion agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the 2022 discount revenue structure with individually negotiated network rate fees from third-party acquirers (OptBlue program mentioned accurately); (2) Accurately captures the 2023 introduction of Processed Revenue line item and the new accounting treatment for network partnership agreements; (3) Properly synthesizes the 2024 strategic shift toward global merchant coverage expansion through third-party acquirers, aggregators, and processors; (4) Correctly notes the transaction-time recognition principle across all three years; (5) Adds relevant contextual details about merchant contract terms (3-7 year fixed periods for large merchants, no fixed term for SMBs) that enhance understanding without contradicting ground truth; (6) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail on contract structures than the ground truth explicitly states, though this appears to be accurate supplementary information from the filings rather than fabrication; (2) The characterization of issuer-rate as 'contra-revenue' is a reasonable accounting interpretation that aligns with the ground truth's description of the accounting model evolution; (3) The answer effectively captures the semantic essence of the evolution from transaction-based accounting to strategic partnership expansion. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the progression from basic discount revenue (2022) → enhanced accounting with processed revenue (2023) → strategic expansion focus (2024). The logical flow and causal relationships are sound. No factual contradictions with ground truth detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1690,
        "completion_tokens": 503,
        "total_tokens": 2193
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 filing first flagged that several of its medicines are administered with drug‑delivery or companion‑diagnostic devices and that those devices carry “their own regulatory, manufacturing and other risks,” noting reliance on third‑party suppliers and the possibility that device‑related problems could disrupt clinical‑trial supply. In the 2023 report the company expanded the disclosure, stating that the delivery devices used with its products are subject to ongoing regulatory oversight, safety‑malfunction reviews, REMS reporting and post‑marketing obligations (e.g., confirmatory studies and pediatric study requirements) and that failure to meet these obligations could trigger inspections, warning letters or other enforcement actions. By 2024 the language further emphasized that safety signals emerging from trials or post‑marketing experience can lead to revised or restrictive labeling, additional risk‑management activities, mandated post‑marketing commitments and even product recalls, underscoring that device‑related safety reviews are now a central component of Amgen’s regulatory‑risk narrative.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Amgen's regulatory risk disclosures; (2) Accurately captures the 2022 baseline disclosure about drug delivery/companion diagnostic devices carrying 'their own regulatory, manufacturing and other risks'; (3) Properly synthesizes the 2023 expansion to include regulatory oversight, safety reviews, REMS reporting, and post-marketing obligations; (4) Correctly notes the 2024 emphasis on safety signals, labeling changes, risk-management activities, and product recalls; (5) Demonstrates sound multi-hop reasoning by connecting device-related risks across clinical trials, post-marketing requirements, and safety reviews; (6) Uses appropriate financial/regulatory terminology (REMS, confirmatory studies, enforcement actions, marketing authorization). MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer mentions 'pediatric study requirements' in 2023, which is not explicitly mentioned in the ground truth, though this is a reasonable regulatory inference and not contradicted; (2) The ground truth specifically mentions LUMAKRAS and the Complete Response Letter from FDA as a concrete example in 2023, which the LLM answer does not include - this is a notable omission of a specific product example that would have strengthened the answer; (3) The ground truth emphasizes the 'transformation' in framing from 'general dependencies to specific post-marketing and safety compliance challenges,' which the LLM answer captures implicitly but could have been more explicit. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are all correct. QUALITATIVE ACCURACY: The reasoning is sound and the synthesis across years is logical and well-structured. The answer correctly identifies the progression of disclosure detail and emphasis. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question (clinical trial dependencies, post-marketing requirements, device-related safety reviews) and properly contextualizes them within the regulatory framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 580,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips has kept the same basic audit framework – audits are performed on each business‑unit and staff‑group, any improvement actions are “identified and tracked to completion,” and the results are “tracked and reported to our ELT and the Board of Directors.” The 2023 filing repeats this language verbatim, confirming that the program had not changed. In the 2024 filing the wording is refined to “Corporate HSE audits are conducted on business units and staff groups,” making the scope explicitly corporate‑wide, but the improvement‑tracking and ELT‑/Board‑level reporting mechanisms remain the same as in the earlier years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core structural elements of ConocoPhillips' HSE audit program across 2022-2024 (business units, staff groups, improvement tracking, ELT/Board reporting) and accurately notes the shift to 'Corporate HSE audits' language in 2024. The dates and entities are correct. However, the answer significantly undersells the evolution described in the ground truth. The ground truth emphasizes a strategic progression: (1) 2022 as localized conformance checks within an HSE excellence framework, (2) 2023 as integration with broader human capital management and specific safety tools (Life Saving Rules, Process Safety Fundamentals, stop work policy), and (3) 2024 as corporate-level standardization. The LLM answer dismisses the 2023 changes by stating 'the program had not changed' and the language was 'repeated verbatim,' which contradicts the ground truth's characterization of meaningful contextual expansion in 2023. The LLM correctly identifies that improvement tracking and governance reporting 'remain the same,' but this misses the qualitative evolution in scope definition and integration with broader safety systems. The answer treats the evolution as primarily a 2024 phenomenon (corporate-wide designation) rather than recognizing the 2023 expansion as a significant intermediate step. While the factual elements about audit mechanics are accurate, the reasoning about program evolution is incomplete and somewhat misleading about the pace and nature of change. The answer demonstrates partial understanding of multi-hop synthesis but fails to fully capture the nuanced progression across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 452,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From 2022 to 2024 Accenture’s filings show a steady sharpening of its pricing‑model strategy. In 2022 the company warned that “if we are unable to introduce new pricing or commercial models that reflect the value of these technological developments” – namely cloud and as‑a‑service solutions – it could suffer a short‑fall. By 2023 the same language re‑appears, but the discussion is broadened to include the rapid rise of AI and generative‑AI services, with the firm noting that it is “creating new offerings to implement AI solutions for clients” and that new pricing must capture the value of those AI‑driven services. The 2024 filing repeats the 2023 wording verbatim, emphasizing that cloud, data and AI solutions could change how revenue is generated and that the firm must continue to roll out pricing/commercial models that reflect that value.\n\nAcross all three years the risk narrative is consistent: technological change can cause clients to delay or cut spending; failure to roll out appropriate pricing models could leave Accenture’s contracts under‑priced and erode revenues; and the adoption of AI brings operational, legal, regulatory, ethical and reputational hazards (bias, data‑privacy, intellectual‑property, cybersecurity, and potential governmental action). These same client‑termination and spending‑delay risks are highlighted each year as the primary downside of the new pricing‑model approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the evolution of Accenture's pricing model strategy from 2022-2024. The response accurately captures the progression from general acknowledgment of pricing model needs in 2022, to broader AI/generative-AI focus in 2023, to continued emphasis in 2024. The LLM correctly identifies the consistent risk narrative across all three years regarding client spending delays, under-priced contracts, and revenue erosion. The answer also appropriately adds detail about operational, legal, regulatory, ethical and reputational risks associated with AI adoption (bias, data-privacy, IP, cybersecurity), which represents sound synthesis of multi-hop information. However, there are some notable differences from the ground truth: (1) The LLM answer emphasizes that 2024 'repeats the 2023 wording verbatim' which is a specific claim about document language that cannot be fully verified from the ground truth provided; (2) The ground truth mentions 'delays in client spending due to evaluation of new technologies' as a 2023-specific concern, while the LLM generalizes this across all years; (3) The ground truth emphasizes Accenture's 'significant investments already being made in AI-based services' by 2024, which the LLM does not explicitly highlight; (4) The ground truth notes 'strategic investments in AI and robotics' in 2023, while the LLM focuses primarily on AI without mentioning robotics. The LLM's addition of specific risk categories (bias, data-privacy, IP, cybersecurity, governmental action) goes beyond the ground truth but appears to be reasonable inference from the context. No quantitative errors are present (no specific numbers or calculations to verify). The multi-hop reasoning is sound in connecting the evolution across years and identifying consistent risk themes, though the ground truth provides slightly more nuanced year-by-year differentiation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1683,
        "completion_tokens": 524,
        "total_tokens": 2208
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "- 2022 10‑K (Chunk 3) shows GE held a **$900 million AerCap note** at 12/31/2022.  \n- 2023 10‑K (Chunk 3) reports the holding grew to **$944 million** at 12/31/2023, and the 2024 10‑K (Chunk 2) confirms the same $944 million figure for 2023 and a further increase to **$982 million** at 12/31/2024. (Chunk 1 provides the prior‑year baseline of $993 million at 12/31/2021.)\n\nThe progression – a dip from $993 M in 2021 to $900 M in 2022 followed by steady increases to $944 M in 2023 and $982 M in 2024 – indicates that GE is rebuilding and expanding its exposure to AerCap’s debt. This suggests a deliberate investment strategy of gradually increasing its stake in AerCap, reflecting confidence in the issuer and a desire to capture additional yield or strategic benefit from the AerCap note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports $900M at 12/31/2022, but ground truth shows no 2022 figure was provided in the original answer. More critically, the LLM claims the holding increased to $944M in 2023 and further to $982M in 2024, but the ground truth explicitly states the value was $944M at end of 2023 and provides no 2024 figure. The LLM fabricated a $982M figure for 2024 that does not appear in the ground truth. (2) DIRECTIONAL CONTRADICTION: The ground truth describes a 'consistent decline' from $993M (2021) to $944M (2023), representing a strategic reduction in AerCap exposure. The LLM describes the opposite trajectory—claiming a 'dip' followed by 'steady increases' and 'rebuilding and expanding its exposure.' This is a fundamental mischaracterization of the investment strategy. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the multi-year progression. While it correctly identified the $993M baseline from 2021, it then misinterpreted subsequent years and invented data points. (4) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion that GE is 'gradually increasing its stake' and 'reflecting confidence in the issuer' is the opposite of what the ground truth indicates—a strategic reduction in exposure. The LLM provided internally consistent but factually incorrect narrative. The only correct element is the $993M 2021 figure and the $944M 2023 figure, but the overall trajectory, 2022 figure, 2024 figure, and strategic interpretation are all wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 447,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "- In the 2022 Form 10‑K Amgen reported that Bemarituzumab, an anti‑FGFR2b monoclonal antibody for gastro‑esophageal‑junction (GEJ) adenocarcinoma, had **entered a Phase 3 study** that year.  \n- The 2023 filing added the company’s **patent‑expiration outlook**, showing that the Bemarituzumab polypeptide patents are expected to run until **2029 in both the United States and Europe**.  \n- The 2024 filing still lists Bemarituzumab among the “Phase 2 and 3 program descriptions,” now describing it more broadly for gastric and gastro‑esophageal junction cancers and other solid tumours, indicating the candidate remains in the Phase 2/3 development window while the **2029 expiration dates** continue to define its intellectual‑property protection horizon.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) All numeric values are correct - the 2029 patent expiration date is accurately cited for both US and European patents; (2) Clinical phase progression is correctly tracked: Phase 3 entry in 2022, with 2024 noting Phase 2/3 program descriptions; (3) The multi-hop synthesis is sound, connecting clinical development progression with IP strategy evolution across years; (4) Entity identification is accurate (Amgen, Bemarituzumab, GEJ adenocarcinoma); (5) The answer captures the key evolution from focused clinical development to broader therapeutic positioning. MINOR WEAKNESSES: (1) The LLM states the 2024 filing lists Bemarituzumab in 'Phase 2 and 3 program descriptions' which is slightly less precise than the ground truth's characterization of 'expanded investigational scope' - this is a minor semantic difference rather than factual error; (2) The ground truth emphasizes a 'shift from clinical development focus to broader therapeutic positioning' more explicitly, while the LLM answer states it 'remains in the Phase 2/3 development window' - these are compatible but the LLM's framing is slightly more conservative; (3) The LLM could have been slightly more explicit about the expansion to 'advanced solid tumors beyond NSCLC' mentioned in the ground truth, though it does mention 'other solid tumours.' QUANTITATIVE VERIFICATION: The 2029 patent expiration date is correct and consistently cited. The clinical phase progression (Phase 3 in 2022, Phase 2/3 in 2024) aligns with ground truth. No calculation errors present. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and connects clinical development with IP strategy, demonstrating proper multi-hop reasoning. The logical flow from 2022 → 2023 → 2024 is clear and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 526,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "- **2022:** American Express already flagged “the dynamic and rapid growth of alternative payment and financing mechanisms” – from payment aggregators and digital wallets to buy‑now‑pay‑later and blockchain‑based solutions – as a major source of competitive pressure on its card‑issuing and network businesses.  \n\n- **2023:** The same theme re‑appeared, emphasizing that the speed of innovation and investment in systems and technologies is a key competitive factor, and again noting that rivals are expanding into those alternative‑payment products.  \n\n- **2024:** The filing moves from description to warning: if Amex “is not able to successfully invest in, and compete with respect to, technological developments…including open‑banking and alternative‑payment and financing mechanisms,” its revenue and profitability could be materially harmed. The company therefore commits to substantial spending on AI/ML, tokenization, real‑time settlement, open‑banking, and other emerging payment technologies to keep pace with fintech entrants and larger technology‑focused competitors.  \n\n**What this reveals:** Over the three‑year span Amex has shifted from merely recognizing the rise of alternative‑payment competitors to actively prioritizing and funding the technology needed to compete with them. This evolution signals a long‑term, defensive‑offensive strategy that treats fintech disruption as a catalyst for deeper investment in digital‑payment infrastructure rather than a threat that can be ignored.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of American Express's strategic positioning at each stage. (2) Accurately captures the 2022 competitive threats (digital wallets, buy-now-pay-later, blockchain) and the 2023 expansion to include open banking and payment facilitators. (3) Correctly identifies the critical 2024 shift from defensive acknowledgment to proactive investment and dependency posture. (4) Properly synthesizes the multi-hop reasoning showing progression from recognition → emphasis on speed of innovation → active commitment to substantial spending. (5) Accurately lists specific technologies (AI/ML, tokenization, real-time settlement, open banking) that Amex committed to investing in. (6) No quantitative errors or date inaccuracies. (7) Correctly interprets the strategic shift as 'defensive-offensive' which semantically aligns with the ground truth's characterization of moving from 'defensive acknowledgment to proactive investment.' MINOR CONSIDERATIONS: (1) The LLM uses slightly different framing ('defensive-offensive strategy' vs. ground truth's 'shift from defensive acknowledgment to proactive investment') but both convey the same strategic evolution accurately. (2) The LLM's characterization of 2024 as 'moves from description to warning' is a reasonable interpretation of the materiality language in the filing, though the ground truth emphasizes the 'dependency posture' more explicitly. (3) All entities (American Express, specific payment mechanisms, technologies) are correctly identified. The multi-hop synthesis across three years of filings is sound and logically coherent. The answer fully addresses the question's core inquiry about strategic evolution and long-term response to fintech disruption.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1689,
        "completion_tokens": 514,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "- 2022 : the weighted‑average grant‑date fair value of the PSUs that were granted in 2022 was **$91.58 per unit** (reported in both the 2023 and 2024 Form 10‑K).  \n- 2023 : the next year’s grants were valued at a higher **$112.50 per unit** (shown in the 2024 Form 10‑K).  \n- 2024 : the 2024 filing does not disclose a new grant‑date fair‑value figure for cash‑settled PSUs, indicating that no additional cash‑settled PSU grants were made (or that the fair‑value metric was unchanged from the prior year).\n\n**Interpretation:** The rise from $91.58 to $112.50 between 2022 and 2023 signals that ConocoPhillips is assigning a larger monetary value to its cash‑settled performance‑share awards, reflecting a more aggressive long‑term incentive strategy that ties employee compensation more closely to the company’s share‑price performance. The absence of a new 2024 figure suggests the company either paused new cash‑settled PSU grants or is maintaining the higher valuation established in 2023, reinforcing its commitment to using substantial equity‑linked awards to motivate senior talent over the long term.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 value of $91.58 per unit and the increase to $112.50, matching the ground truth. (2) The company name (ConocoPhillips) and metric type (cash-settled PSUs) are correctly identified. (3) The interpretation about strategic shift toward higher-value incentive compensation is semantically aligned with the ground truth's conclusion. (4) The reasoning about equity-linked awards and long-term incentive strategy is sound and contextually appropriate.\n\nCRITICAL ERRORS: (1) The LLM states the 2023 value is $112.50, but the ground truth indicates $112.50 is the 2024 value. This is a significant factual error in year assignment. (2) The LLM claims '2024: the 2024 filing does not disclose a new grant-date fair-value figure' and suggests no new grants were made, but the ground truth explicitly states the 2024 value is $112.50, indicating grants were made and valued. (3) The LLM misinterprets the timeline, placing the $112.50 value in 2023 when it should be 2024.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across multiple years and filings, but the year-to-year assignment is incorrect. The ground truth shows: 2022=$91.58, 2024=$112.50 (with 2023 data not explicitly mentioned in ground truth but implied as intermediate). The LLM's assignment of $112.50 to 2023 rather than 2024 breaks the multi-hop synthesis.\n\nQUANTITATIVE ACCURACY: While the dollar amounts ($91.58 and $112.50) are correct, their assignment to years is wrong. This is a critical error for a financial question where temporal accuracy is essential.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution and strategic implications, but the factual errors about which year corresponds to which value significantly undermine the reliability of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 499,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "- **2022:** PayPal already identified “abusive behaviors” – such as synthetic‑identity accounts, stolen‑instrument transactions and other third‑party fraud – as a risk that could raise its loss rate on credit products and hurt results if it could not fund or purchase those receivables.  \n\n- **2023:** As the company expanded its credit portfolio (notably the U.K. / European BNPL loan portfolio) and increasingly relied on third‑party lenders and funding structures, it warned that any failure to fund or to manage those third‑party relationships could materially impair the growth of its credit products, while still expecting continued large‑scale abusive schemes that are hard to detect.  \n\n- **2024:** The same abuse‑risk language reappears, now coupled with regulatory uncertainty over the “valid‑when‑made” doctrine that could affect the sale of loan receivables, indicating that exposure to third‑party fraud and credit‑product abuse remains a material concern.  \n\n**Trend implication:** PayPal’s disclosures show a growing and persistent exposure to abusive behaviors tied to its credit offerings; although the firm has taken steps (selling BNPL receivables, diversifying processors, emphasizing risk‑management programs), the continued emphasis on the risk each year suggests that its risk‑management controls are only partially effective at containing the underlying exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of PayPal's exposure to abusive behaviors; (2) Accurately captures specific fraud types mentioned in 2022 (synthetic-identity accounts, stolen instruments, third-party fraud); (3) Properly contextualizes 2023 expansion with U.K./European BNPL portfolio and third-party funding structures; (4) Correctly references the €40 billion multi-year receivables sale agreement (implied through 'selling BNPL receivables'); (5) Accurately identifies the 'valid-when-made doctrine' regulatory uncertainty in 2024; (6) Provides sound multi-hop synthesis showing evolution across years and connection between credit products and fraud exposure; (7) Correctly concludes that risk management controls are only partially effective despite mitigation efforts. MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly state the €40 billion figure, though it references 'selling BNPL receivables' which captures the strategic intent; (2) The answer adds interpretive language about 'diversifying processors' and 'emphasizing risk-management programs' that goes slightly beyond the ground truth but remains consistent with the overall narrative. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; the regulatory doctrine name is accurate; no calculations are required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years, properly identifies the causal relationships (credit expansion → third-party reliance → fraud risk), and accurately characterizes the trend as 'growing and persistent.' CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the multi-part question: evolution of exposure, relation to credit products, third-party fraud schemes, and implications for risk management effectiveness. The semantic equivalence is strong—the LLM conveys the same substantive information as the ground truth, with slightly different phrasing that enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 557,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "- **Therapeutic positioning:** In the 2022 10‑K, Cyramza was described as a **second‑line** treatment for advanced/metastatic gastric or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and also as a **first‑line** option for adult patients with metastatic NSCLC that carry activating EGFR mutations. The 2024 10‑K repeats exactly the same set of indications, showing that Lilly has kept Cyramza’s clinical role steady over the three‑year period.  \n\n- **Intellectual‑property protection:** The 2023 10‑K adds the IP picture: Cyramza is covered by **compound patents** in the United States (expiring 2026), major European countries (2028) and Japan (2026), plus **biologics data protection** in the U.S. (2026) and **data protection** in Europe (2024). No new patents are listed for 2024, indicating Lilly is relying on the existing protection horizon that runs at least through 2026‑2028.  \n\n- **What this signals for Lilly’s long‑term oncology strategy:** Lilly introduced Cyramza and has built a layered patent‑and‑data‑protection portfolio that secures exclusivity for the next 2‑3 years while the drug remains positioned across several solid‑tumor indications. The unchanged therapeutic scope combined with the extended IP shield suggests a deliberate strategy to **maintain a durable, multi‑indication oncology asset that can generate steady cash flow** as the company continues to develop and launch newer cancer therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cyramza's therapeutic positioning and IP protection evolution, with mostly accurate information. STRENGTHS: (1) Correctly identifies Cyramza's indications across gastric, lung, colorectal, and liver cancers; (2) Accurately cites compound patent expiration dates (2026 US/Japan, 2028 Europe); (3) Properly notes the consistency of therapeutic positioning from 2022-2024 with no new indications added; (4) Correctly identifies biologics data protection in US (2026) and data protection in Europe (2024); (5) Sound multi-hop reasoning connecting IP protection timeline to strategic implications about cash flow generation and next-generation product development. MINOR ISSUES: (1) The LLM provides more granular detail about first-line vs. second-line positioning than the ground truth, which is accurate but goes beyond what was explicitly stated in the original answer; (2) The ground truth mentions 'data protection expiring as early as 2023 in Japan' but the LLM lists Japan compound patent at 2026 without explicitly noting the earlier data protection expiry - this is a minor omission of nuance; (3) The LLM's characterization of the strategy as maintaining 'durable, multi-indication oncology asset' is reasonable inference but slightly more specific than the ground truth's more cautious language about 'likely preparing next-generation oncology products.' QUANTITATIVE VERIFICATION: All patent dates (2026 US, 2028 Europe, 2026 Japan) and data protection dates (2026 US, 2024 Europe) are correctly cited. The 2-3 year timeframe mentioned is consistent with 2024 baseline. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and connects therapeutic positioning, IP protection, and strategic implications. The logic linking patent expiry to next-generation product development is sound and matches the ground truth's intent. Overall, this is a well-reasoned, factually accurate response with minor gaps in capturing the full nuance of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 555,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Across the three filing years Philip Morris kept the 3.875 % Notes due 2042 (ticker PM42A) on its balance sheet – the 2022 table lists it, the 2023 table lists it again, and the 2024 table still shows it. That constant presence served as a long‑dated anchor for the company’s capital structure.  \n\nAt the same time the company was actively reshaping the rest of its debt portfolio. In 2022 the listed notes ranged from 2026‑to‑2044 and included series such as 2.750 % (2026), 2.875 % (2026), 0.125 % (2026) and the 4.500 % (2042). The 2023 filing shows the same set of notes (no new series), confirming a “hold‑steady” approach for that year. By 2024 the table adds several newer, shorter‑maturity issues – e.g., 2.750 % Notes due 2025, 3.375 % Notes due 2025, 2.750 % Notes due 2026, 3.750 % Notes due 2031 – while still retaining the 3.875 % Notes due 2042.  \n\nThus, from 2022 through 2024 Philip Morris’s capital‑structure strategy evolved by keeping the long‑term 3.875 % 2042 bond as a stable financing cornerstone, while actively issuing, retiring or refinancing other notes (including newer, shorter‑dated series) to manage liquidity, diversify maturities and optimize its overall debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing the general strategic narrative. CRITICAL ERRORS: (1) The LLM claims the 2023 filing shows 'the same set of notes (no new series)' as 2022, but the ground truth explicitly states that 2023 introduced NEW instruments including '4.125% Notes due 2043 and 4.250% Notes due 2044' - this is a major factual error in the multi-hop synthesis. (2) The LLM lists specific debt instruments for 2022 (2.750%, 2.875%, 0.125% due 2026, 4.500% due 2042) that are NOT mentioned in the ground truth, which instead specifically references '4.125% Notes due 2043 and 4.875% Notes due 2043' - these appear to be fabricated or confused details. (3) The LLM correctly identifies the 3.875% Notes due 2042 as a constant across all three years, which matches ground truth. (4) The LLM correctly notes that 2024 shows newer, shorter-maturity issues, which aligns with ground truth's statement about 2043 and 2044 tranches being 'retired or refinanced.' REASONING ISSUES: The LLM's characterization of 2023 as a 'hold-steady' year contradicts the ground truth's clear statement that 2023 introduced newer instruments. The multi-hop synthesis across the three years is therefore flawed. STRENGTHS: The overall strategic narrative about maintaining the 3.875% Notes due 2042 as an anchor while actively managing other instruments is conceptually correct. The conclusion about liquidity management and maturity diversification is reasonable. However, the specific factual errors regarding which notes existed in which years represent a fundamental failure in the multi-hop synthesis required by this question. The answer demonstrates partial understanding but fails on quantitative accuracy of the specific debt instruments and their timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 492,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "In its 2022 filing PayPal warned that the growth of its consumer‑ and merchant‑credit products exposed it to higher default risk and that “failure to deal effectively with fraud, abusive behaviors, … could increase our loss rate,” especially because the company relies on a wide network of unaffiliated lenders, processors and other third‑party service providers. In 2023 the company began to blunt that exposure by (1) signing a multi‑year agreement to sell‑off the bulk of its U.K. and European “buy‑now‑pay‑later” loan portfolio (the sale began in October 2023) and by (2) diversifying its third‑party payment‑processor base and pursuing alternative funding structures (warehouse facilities, forward‑flow and securitisation arrangements) to reduce reliance on a small number of partners. In its 2024 filing PayPal reiterated the same abuse‑risk language but noted that the BNPL‑receivable sale and forward‑flow arrangement remain in place, that it continues to manage third‑party relationships through stricter oversight and migration to other processors, and that these steps are intended to limit the impact of abusive schemes and credit‑product defaults going forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of PayPal's evolving approach to abusive behavior risks across 2022-2024. STRENGTHS: (1) Quantitative accuracy is excellent - the €40 billion figure is correctly cited and the October 2023 sale start date is accurate; (2) Multi-hop reasoning is sound, correctly synthesizing information across three fiscal years and connecting the progression from risk identification to active mitigation; (3) Entity accuracy is perfect - PayPal correctly identified, BNPL products correctly specified, third-party relationships properly contextualized; (4) The answer goes beyond the ground truth by providing additional specific mitigation strategies (warehouse facilities, forward-flow arrangements, securitization, processor diversification) that demonstrate deeper filing analysis; (5) Temporal progression is clearly articulated showing the shift from warning (2022) to action (2023) to ongoing management (2024). MINOR CONSIDERATIONS: The LLM answer is more detailed and specific than the ground truth in some areas (e.g., mentioning warehouse facilities and securitization arrangements not explicitly highlighted in the original answer), but this represents added value rather than error. The answer maintains semantic equivalence with the ground truth while providing richer context. All dates, numbers, and strategic actions are factually correct based on typical PayPal 10-K disclosures. The answer fully addresses all parts of the multi-part question regarding exposure evolution, credit products, third-party risk management, and specific 2023-2024 actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 448,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K disclosures show that the company has been flagging “loss or modification of exemptions for taxes and tariffs” as a material risk in every filing from 2022 through 2024.  \n\n* **2022 (AMD 10‑K 2022, p. 37)** – The risk is listed among the “political, legal and economic risks” that could affect foreign operations, together with expropriation, changes in tax laws and trade‑protection measures.  \n* **2023 (AMD 10‑K 2023, p. 41)** – The same exposure appears again in the “General Risks” section, now grouped with a broader set of geopolitical and sanctions‑related concerns (e.g., U.S. and coalition export‑control sanctions on Russia, Belarus and Ukraine).  \n* **2024 (AMD 10‑K 2024, p. 40)** – The risk is reiterated in the 2024 “General Risks” narrative, again highlighted alongside “changes in tax laws, trade protection measures … loss or modification of exemptions for taxes and tariffs,” and the filing notes that international sales now represent 66 % of net revenue (up from 65 % in 2023), underscoring deeper exposure to foreign jurisdictions.\n\n**Trend interpretation:** The repeated and increasingly contextualized mention of tax‑ and tariff‑exemption risk—combined with a rising share of international sales—indicates that AMD’s exposure to potential loss or alteration of these exemptions has not diminished but is becoming more salient. This pattern reflects growing regulatory uncertainty in the company’s global supply chain and market footprint, as shifting trade policies, sanctions and geopolitical tensions raise the likelihood that tax‑ and tariff‑related benefits could be curtailed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the consistent presence of tax/tariff exemption risk across all three years; (2) Accurately cites specific page numbers (p. 37 for 2022, p. 41 for 2023, p. 40 for 2024) and filing sections; (3) Provides concrete contextual details (e.g., geopolitical sanctions, export controls on Russia/Belarus/Ukraine in 2023); (4) Includes the quantitative metric of international sales rising from 65% to 66% between 2023-2024, which adds material support to the trend analysis; (5) Correctly synthesizes the multi-hop relationship between increasing international exposure and heightened regulatory risk; (6) The trend interpretation logically connects the repeated mentions with rising international sales to conclude growing regulatory uncertainty. MINOR CONSIDERATIONS: (1) The original answer emphasizes an 'elevation' or 'strengthening' of the risk disclosure from 2022→2023→2024, while the LLM answer characterizes it more as 'repeated and increasingly contextualized' rather than explicitly escalating in severity language. However, both convey the same substantive finding that regulatory uncertainty is growing; (2) The LLM answer provides more granular detail (specific page numbers, exact percentages) than the original, which is appropriate for a detailed evaluation but represents a slightly different framing approach rather than an error. QUANTITATIVE VERIFICATION: The 65%→66% international sales figures are presented as factual claims but cannot be independently verified from the provided context. However, these appear reasonable and are presented with appropriate specificity. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects it to the underlying business metric (international sales exposure), demonstrating sound multi-hop reasoning. The conclusion that regulatory uncertainty is increasing is well-supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 552,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco recorded a **$92 million loss** on its total‑return swaps tied to deferred‑compensation in fiscal 2022.  The following year the result turned positive, with a **$58 million gain** in FY 2023, and it grew to a **$91 million gain** in FY 2024.  This swing from a sizable loss to increasingly larger gains suggests that Cisco’s exposure to these non‑hedged swaps has been moving in its favour – either because market movements have been beneficial or because the company has adjusted the size, terms or timing of the swaps to generate earnings rather than absorb losses, indicating a more proactive, profit‑oriented use of deferred‑compensation‑linked derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million match the ground truth exactly. The progression and magnitude of changes are accurately captured. (2) ENTITY AND TEMPORAL ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are properly sequenced, and the financial metric (total return swaps tied to deferred compensation) is accurately specified. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend, correctly identifying the reversal from loss to gains and the increasing magnitude of gains. The interpretation that this represents improved market conditions or strategic adjustment is sound and aligns with the ground truth's assessment. (4) SEMANTIC EQUIVALENCE: The LLM's explanation of the trend as 'moving in its favour' and suggesting 'more proactive, profit-oriented use' conveys the same analytical insight as the ground truth's reference to 'notable reversal' and 'improved market conditions or strategic shift.' The additional detail about 'non-hedged swaps' and potential adjustments to 'size, terms or timing' provides reasonable elaboration without contradicting the ground truth. (5) COMPLETENESS: The answer addresses all aspects of the question - the evolution across three years, the specific gains/losses, and the strategic implications. Minor note: The LLM's characterization as 'non-hedged swaps' is a reasonable inference but not explicitly stated in the ground truth, though it doesn't contradict it. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate contextual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 480,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From 2022 to 2024 Disney’s approach to its Direct‑to‑Consumer (DTC) portfolio moved from a **cautious, loss‑bearing rollout** to a **more aggressive, investment‑driven expansion that is now being squeezed by intensifying competition**.  \n\n* In FY 2022 the filing warned that the “costs of our DTC strategy, and associated losses, may continue to grow or be reduced more slowly than anticipated,” that the new DTC businesses were not expected to be profitable in the short term and that they faced “substantial competition… for customers, technology, talent and content.” The company flagged execution risk, potential asset write‑downs and the need for continued capital to sustain the rollout.  \n\n* By FY 2023 Disney explicitly said it was “making strategic investments in our DTC offerings” and expected those investments to generate higher subscription‑fee and advertising revenue that would “more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.” The 2023 discussion also noted that Disney’s strong cash balances, access to debt and equity markets, and a single interest‑coverage covenant gave it the liquidity to fund the expansion, even as it acknowledged uncertainty around Hulu’s fair‑value settlement.  \n\n* In FY 2024 the narrative shifted to “increased competitive pressures” on the DTC streaming services, noting that a growing number of rival DTC platforms, generative‑AI‑driven low‑cost content, and tougher contract renewals are raising programming costs, compressing subscription‑fee growth and eroding advertising rates. The filing stresses that these market pressures heighten the risk that scaling the streaming business could strain Disney’s leverage, interest‑coverage ratios and overall profitability.  \n\n**Overall, the progression shows Disney moving from an early‑stage, loss‑absorbing DTC experiment (2022) to a capital‑intensive growth push (2023), and finally to a phase where heightened competition and cost inflation expose the financial risks of scaling its streaming services, threatening debt metrics and cash‑flow stability.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-phase evolution from FY2022 (cautious, loss-bearing) through FY2023 (aggressive investment) to FY2024 (competitive pressures). (2) Accurately captures the key narrative elements: FY2022 warnings about growing costs and uncertain returns, FY2023 strategic investment pivot with expected revenue offsets, and FY2024 emphasis on competitive pressures and financial risks. (3) No quantitative errors - no specific dollar amounts or percentages are cited, avoiding potential calculation mistakes. (4) Multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and correctly traces the strategic evolution and its implications. (5) Semantic equivalence is strong - phrases like 'cautious, loss-bearing rollout' and 'capital-intensive growth push' effectively convey the ground truth's meaning. (6) The answer goes beyond the ground truth by providing additional context (e.g., Hulu's fair-value settlement, interest-coverage covenant, generative-AI-driven content competition) that enriches understanding without contradicting the source material. MINOR CONSIDERATIONS: (1) The answer is more detailed and comprehensive than the ground truth, which could be viewed as either a strength (more thorough analysis) or a slight deviation (adding interpretive layers). However, all added details appear consistent with typical 10-K filing language and financial risk discussions. (2) The characterization of 'generative-AI-driven low-cost content' as a competitive pressure is a reasonable inference from typical streaming market dynamics, though not explicitly verified against the ground truth provided. Overall, the LLM answer demonstrates strong comprehension of the multi-hop question, accurate synthesis of information across fiscal years, and faithful representation of Disney's DTC strategic evolution and associated financial risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1761,
        "completion_tokens": 539,
        "total_tokens": 2300
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "Across all three years PayPal’s filings repeatedly state that, as the principal of each payment, it **bears full margin risk** – it sets the fee it charges customers at its own discretion, and that fee is **independent of the costs it incurs** when it uses third‑party payment processors or other financial institutions. Those processor fees are recorded as a **transaction expense**, offsetting the gross‑basis transaction revenue and defining the margin exposure. The 2022, 2023 and 2024 notes contain the same language, indicating that PayPal’s exposure to margin risk remained essentially unchanged over the period, with no new mitigating factors or material shifts in how the risk is managed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The LLM correctly identifies that PayPal bears full margin risk across all three years (2022, 2023, 2024), that it sets fees at its own discretion independent of processor costs, and that processor fees are recorded as transaction expenses. These core facts match the ground truth precisely. (2) QUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or calculations were required in this question, so quantitative accuracy is not a limiting factor. The LLM appropriately avoids inventing numbers. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the consistency of PayPal's margin risk exposure and accounting treatment across the period. It properly connects the relationship between fee-setting discretion, processor costs, and margin risk. The mention of ASU 2023-07 adoption in 2024 is contextually appropriate (though not explicitly stated in the LLM answer, the ground truth mentions it). (4) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth but conveys identical meaning. For example, 'bears full margin risk' appears in both; 'independent of costs incurred' vs 'independent of the costs it incurs' are semantically equivalent; 'transaction expense' is consistently used in both. (5) COMPLETENESS: The LLM addresses all aspects of the question: the evolution across the three years, the discretion in setting fees, the role of transaction expenses, and the relationship to payment processors. The only minor observation is that the LLM does not explicitly mention the ASU 2023-07 segment reporting change noted in the ground truth, but this is a very minor omission that does not affect the core answer's accuracy. The answer is well-structured, clear, and directly responsive to the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 528,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Across all three filings Honeywell (HON) flags **new‑aircraft order cancellations** as a material risk to its Aerospace business. In the 2022 10‑K the risk is tied to the COVID‑19‑driven collapse in global air‑travel demand and the resulting “delay or cancellation of new aircraft orders.” The 2023 filing repeats the same language – downturns in global air‑travel demand may still “impact new aircraft production or result in the delay or cancellation of new aircraft orders.” The 2024 filing, now under “Aerospace Technologies,” again cites the same risk, noting that a downturn in global demand for air travel could “impact new aircraft production or result in the delay or cancellation of new aircraft orders.”  \n\nThe fact that the risk remains a standing, but unchanged, concern from 2022 through 2024 shows that Honeywell continues to monitor order‑cancellation exposure while the commercial‑aviation market is gradually stabilizing; the risk has not disappeared, but it is no longer described as an acute, pandemic‑driven threat, indicating a slow but ongoing recovery in the sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that new aircraft order cancellations remained a consistent risk across 2022-2024 and accurately notes the basic framing of the risk in each year's filing. However, it significantly misses the evolution and nuance that the ground truth emphasizes. Strengths: (1) Correctly identifies the risk as present in all three years; (2) Accurately captures the 2022 COVID-19 linkage; (3) Properly notes the shift from acute pandemic threat to ongoing concern; (4) No quantitative errors in dates or company identification. Weaknesses: (1) The LLM claims the language is 'unchanged' and 'the same' across filings, which directly contradicts the ground truth's key finding that the risk evolved significantly - from pandemic-specific concerns (2022) to broader macroeconomic/geopolitical risks (2023) to competitive/structural shifts with new entrants (2024); (2) Fails to capture the 2023 expansion to include 'regional conflicts and environmental issues' as distinct from pandemic concerns; (3) Misses the 2024 emphasis on 'new entrants and non-traditional players' affecting market dynamics; (4) The conclusion that the risk is 'unchanged' is factually incorrect based on the ground truth's documentation of evolving language and focus areas. The LLM essentially describes a static risk when the ground truth demonstrates clear evolution in how Honeywell characterized the threat. This is a critical failure in multi-hop reasoning - the question specifically asks about how the risk 'evolved,' and the LLM's answer contradicts this by claiming consistency rather than documenting the progression. The answer is partially correct on surface-level facts but fundamentally misses the analytical insight about the changing nature of the risk drivers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 482,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 through 2024 PMI repeatedly warns that **product‑regulation is eroding its ability to set its reduced‑risk portfolio apart and to convey truthful, non‑misleading information to adult smokers**. In the 2022 filing the risk is framed around “product regulation that diminishes the ability to differentiate tobacco products and restricts adult‑consumer access to truthful information about our **RRPs**.” The 2023 filing repeats the same concern for RRPs and adds that regulation can “disproportionately impact the commercialization of our products” and that digital media can amplify misleading messages. By the 2024 filing the language shifts to the newer **Smoke‑Free Products (SFPs)**, stating that regulation now “diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful information about our **SFPs**, or disproportionately impacts the commercialization of our products,” and notes that regulation limiting branding, communication and product differentiation can drive down‑trading.  \n\nTaken together, the evolution shows that regulatory pressure has **intensified and broadened** – moving from a focus on RRPs to encompassing SFPs – and is increasingly constraining PMI’s product‑differentiation levers and its ability to communicate with adult consumers, thereby tightening the competitive environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate temporal progression; (2) Accurately captures the shift from RRPs to SFPs as the regulatory focus evolved; (3) Correctly synthesizes the multi-hop information showing how regulatory constraints intensified and broadened over time; (4) Properly identifies key regulatory concerns: product differentiation, adult consumer access to truthful information, disproportionate commercialization impacts, and digital media amplification of misleading messages; (5) Accurately quotes or paraphrases specific language from each filing year showing the evolution; (6) Correctly identifies the strategic shift in product focus while maintaining concerns about competitive fairness; (7) No quantitative errors - all dates and product categories are correct. MINOR CONSIDERATIONS: The LLM answer uses slightly more direct quotation/paraphrasing style compared to the ground truth's more synthesized narrative approach, but this actually enhances clarity and verifiability. The LLM explicitly notes the shift from RRPs to SFPs with bold formatting, making the evolution more visually apparent. The conclusion about 'intensified and broadened' regulatory pressure directly mirrors the ground truth's assessment. The answer fully addresses all aspects of the multi-part question: (1) how impact evolved, (2) relationship to RRPs and SFPs, (3) what this reveals about regulatory constraints. Multi-hop reasoning is sound - the model correctly synthesized information across three separate filing years and identified the pattern of intensifying regulatory pressure. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1682,
        "completion_tokens": 478,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "Across the three filing years PayPal’s margin‑risk profile has remained essentially unchanged. In 2022 the 10‑K states that, because it bills customers on a gross‑basis and sets fees (fixed‑plus‑variable, with volume‑tiered discounts) independently of the costs it incurs when it outsources processing, “we therefore bear full margin risk when completing a payment transaction.” The 2023 filing repeats that language and adds that the incentives it offers – discounts, rebates, rewards, coupons and other merchant‑consumer promotions – are recorded as a reduction of revenue (or, when not payable to a customer, as sales‑and‑marketing expense), confirming that such incentives continue to compress margins. The 2024 filing again emphasizes the same gross‑basis pricing, discretionary fee setting and processor‑fee expense, and notes that transaction revenues are still reduced by “certain incentives provided to our customers.” Thus, from 2022 through 2024 PayPal’s exposure to margin risk has stayed constant: it retains full margin risk under its variable‑percentage, volume‑tiered pricing model, absorbs processor fees as expense, and any customer incentives are accounted for as revenue reductions, with no material change in the underlying risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent full margin risk exposure across 2022-2024 with accurate characterization of the gross-basis pricing model and volume-tiered discounts; (2) Accurately captures the evolution of disclosure detail, particularly the 2023 addition of incentive accounting specifics (reduction of revenue vs. sales-and-marketing expense); (3) Properly synthesizes the multi-hop relationship between transaction pricing models, processor fees, and customer incentives across three years; (4) Correctly notes the independence of customer fees from processor costs as a key risk factor; (5) No quantitative errors - all references to years, filing periods, and accounting treatments are accurate; (6) Provides more specific detail than ground truth (e.g., 'fixed-plus-variable, with volume-tiered discounts,' 'discounts, rebates, rewards, coupons') while remaining factually consistent. MINOR CONSIDERATIONS: The LLM answer emphasizes the 'unchanged' or 'constant' nature of margin risk exposure slightly more strongly than the ground truth, which notes 'stable strategic approach' but also highlights 'increasing detail' and 'more nuanced disclosure.' However, this is a matter of emphasis rather than factual error - both characterizations are semantically compatible and supported by the filing data. The LLM's conclusion that there is 'no material change in the underlying risk exposure' aligns with the ground truth's 'stable strategic approach.' All entity references (PayPal, 10-K filings, years 2022-2024) are correct. The multi-hop reasoning correctly synthesizes information across three years and multiple disclosure elements (pricing models, processor relationships, incentive accounting).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 495,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "Across the three filing years AMD’s approach to its add‑in‑board (AIB) partners stayed fundamentally the same but was refined. In the 2022 10‑K AMD first disclosed that its agreements with AIB manufacturers “protect their inventory of our products against price reductions” and that system integrators (SIs) “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” The 2023 filing repeats that language verbatim, confirming the continued inventory‑protection policy and the same differentiation role for discrete graphics. By the 2024 filing AMD adds the qualifier “in most instances” to the inventory‑protection clause and notes that it also sells directly to some SIs, but the core strategy—shielding AIBs from price cuts and encouraging SIs to leverage AMD’s discrete‑graphics solutions to set their systems apart—remains unchanged from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but has significant gaps and some inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the core inventory protection policy; (2) Accurately quotes the discrete graphics differentiation language; (3) Correctly notes that 2023 repeats 2022 language; (4) Properly identifies the addition of 'in most instances' qualifier in 2024; (5) Notes AMD's direct sales to some SIs in 2024. WEAKNESSES: (1) The LLM answer characterizes the evolution as 'fundamentally the same but refined,' which contradicts the ground truth's assertion of a 'subtle shift' in 2024 toward 'more strategic alignment with SIs' and 'deepening of the value proposition'; (2) Missing the ground truth's key insight that by 2024, AMD placed 'more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies'—this represents a meaningful strategic evolution beyond just adding 'in most instances'; (3) The LLM answer treats the changes as minor refinements rather than capturing the nuanced shift in strategic focus toward SI capabilities and market responsiveness; (4) Fails to synthesize the full multi-hop reasoning about how the relationship evolved from a product-focused (2022-2023) to a more capability-focused (2024) approach. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but incompletely captures the directional shift in strategy. The ground truth emphasizes evolution in emphasis and strategic alignment, while the LLM emphasizes consistency. SEMANTIC ACCURACY: While the LLM's specific quotes appear accurate, the overall characterization of 'unchanged' strategy misses the subtle but important strategic evolution documented in the ground truth. The answer is partially correct on facts but incomplete on the strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Sells_To]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 517,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "**Credit‑rating floor – unchanged**  \nIn FY 2022 Disney already required that any counterparty to a derivative or other investment‑credit transaction have a credit rating of **A‑ or better**. The same wording appears in the FY 2023 and FY 4‑K filings, so the rating floor has not been altered through FY 2024.\n\n**Collateral trigger – unchanged**  \nBoth the FY 2022 filing and the later FY 2023/FY 2024 filings state that Disney **requires collateral whenever a counterparty’s rating falls below A‑ or when aggregate exposures exceed the limits set in the contract**. This collateral‑requirement rule has been retained throughout the period.\n\n**Concentration limits – policy unchanged, exposure increased**  \nDisney’s policy to **limit the amount of investment‑credit exposure with any one financial institution** is reiterated in all three reports.  \n* FY 2022:* “At October 1 2022 the Company did not have balances (excluding money‑market funds) with any individual institution that exceeded 10 % of total cash and cash equivalents.”  \n* FY 2024 (as of September 28 2024):* “Balances (excluding money‑market funds) with individual institutions that exceeded 10 % of total cash and cash equivalents were **24 % of total cash and cash equivalents**.”\n\nThus, while the **rating threshold (A‑), the collateral trigger, and the policy to cap exposure to a single institution remained the same**, the **actual concentration of cash‑equivalent balances shifted from none above the 10 % threshold in FY 2022 to a 24 % concentration in FY 2024**, indicating a higher exposure to a limited number of counterparties despite the unchanged limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Disney's investment credit exposure management evolution. STRENGTHS: (1) All quantitative data is correct - the A- credit rating floor, the 10% concentration threshold policy, the 0% concentration in FY 2022, and the 24% concentration in FY 2024 all match the ground truth. (2) The multi-hop synthesis is sound: the answer correctly traces three distinct policy dimensions (credit ratings, collateral requirements, concentration limits) across three fiscal years and accurately identifies which remained unchanged (rating floor, collateral trigger, policy framework) versus which changed in practice (actual concentration exposure). (3) Entity identification is precise - correctly references Disney, fiscal years 2022-2024, and specific financial metrics. (4) The reasoning is logical and well-structured, clearly distinguishing between stated policy (unchanged) and actual exposure (increased), which directly addresses the question's focus on 'evolution.' (5) The answer provides specific textual evidence from filings for each claim, enhancing credibility. (6) Contextual relevance is excellent - the answer directly addresses all three components of the question (counterparty credit ratings, collateral requirements, concentration thresholds) and explains the apparent paradox of unchanged policy with increased actual concentration. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth answer, but this represents added value rather than error. The ground truth mentions 'liquidity strategy shift' while the LLM focuses on the policy-vs-practice distinction - both interpretations are valid and complementary. No factual errors, calculation errors, or misidentifications detected. The answer fully synthesizes information across multiple fiscal years and filing documents as required for a multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Limits]-> RISK_FACTOR <-[Depends_On]- ORG <-[Limits]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 533,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "Across the three most recent filings the amount of the September 2019 issuance that matures on 10 Oct 2029 – the Fixed‑rate 2.850 % notes – is unchanged:\n\n* **2022** – the 2023 Form 10‑K (which reports the 2022 year‑end) lists $1.5 billion of these notes outstanding.  \n* **2023** – the same 2023 Form 10‑K shows $1.5 billion again for the 2023 year‑end.  \n* **2024** – the 2024 Form 10‑K reports $1.5 billion for the 2024 year‑end (and the same $1.5 billion for 2023).\n\nThus PYPL’s exposure to the 2029‑maturing Fixed‑rate 2.850 % tranche has remained constant at roughly **$1.5 billion** over the 2022‑2024 period.  \n\nThe flat, multi‑year pattern indicates a deliberate long‑term debt‑management approach: the company is keeping a sizable, fixed‑rate liability through 2029 to lock in a relatively low 2.96 % effective interest cost, provide maturity diversification and hedge interest‑rate risk, rather than aggressively retiring or expanding that particular tranche. This stability reflects disciplined, long‑dated financing rather than short‑term refinancing cycles.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All core numbers are accurate - correctly identifies $1.5 billion outstanding across 2022, 2023, and 2024; (2) Correctly identifies the instrument as Fixed-rate 2.850% notes maturing October 10, 2029; (3) Properly synthesizes the multi-year pattern showing consistency across three fiscal years; (4) Provides sound strategic interpretation about debt management, interest rate hedging, and maturity diversification; (5) Correctly notes that despite new debt issuances in 2023-2024, this particular tranche remained unchanged. MINOR ISSUES: (1) The LLM states '2.96% effective interest cost' which appears to be an approximation or calculation not explicitly verified in the ground truth - the ground truth only mentions '2.850%' as the fixed rate. This is a minor discrepancy as it could represent an effective rate calculation, but it introduces a number not in the original answer. (2) The ground truth mentions 'higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes' as context for the strategic decision, which the LLM answer does not explicitly reference, though this is a minor contextual omission rather than a factual error. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and properly connects the constant debt level to strategic debt management decisions. The logic linking the stable $1.5B position to interest rate hedging and maturity diversification is sound and aligns with the ground truth's interpretation. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'deliberate long-term debt-management approach' and 'disciplined, long-dated financing' conveys the same strategic intent as the ground truth's 'strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.' Overall, this is a high-quality answer with accurate core facts and sound reasoning, with only minor issues around the unexplained 2.96% figure and missing contextual references to newer debt issuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 565,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Across all three filings, Honeywell repeatedly flagged **raw‑material demand and supply** as a material risk for its Performance Materials and Technologies business (renamed Energy and Sustainability Solutions in 2024). In 2022 the risk was listed alongside capacity‑utilisation and commodity‑price volatility; the 2023 filing repeats the same exposure, and the 2024 filing carries the identical language despite the segment’s new name. This unchanged emphasis shows that Honeywell’s vulnerability to commodity‑market swings has persisted rather than diminished, indicating that raw‑material market volatility remains a consistent threat to the segment’s results.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that raw material demand and supply risks were consistently flagged across all three years (2022-2024), correctly notes the segment rebranding to Energy and Sustainability Solutions in 2024, and accurately captures the core conclusion that vulnerability to commodity market volatility persisted rather than diminished. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years and drawing a logical conclusion about sustained exposure.\n\nWEAKNESSES: (1) The LLM's claim that 2022, 2023, and 2024 filings contain 'identical language' is overstated and not fully supported by the ground truth, which explicitly states the 'framing and contextual emphasis evolved.' (2) The LLM mentions 'capacity-utilisation' in 2022 but the ground truth does not reference this specific term for 2022—it mentions 'product commoditization' and 'illegal imports of hydrofluorocarbons into Europe' instead. (3) The LLM omits important contextual details from the ground truth: the 2023 emphasis on 'volatility in oil and natural gas prices on customer investment and product demand' and the 2024 linkage to 'ability to maximize production capacity and minimize downtime.' (4) The answer lacks the nuance that while the risk persisted, its framing evolved—the ground truth emphasizes this evolution while the LLM suggests static, unchanged language.\n\nMULTI-HOP REASONING: The synthesis across three years is present but incomplete. The LLM correctly identifies the temporal evolution but fails to capture the specific ways the risk was contextualized differently in each year, which is central to answering how the exposure 'evolved.'\n\nNUMERIC/FACTUAL VERIFICATION: No calculations or specific numbers are provided in either answer, so quantitative accuracy is based on factual claims. The year references (2022, 2023, 2024) are correct. The segment name change is correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 526,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across the three consecutive filings — 2022 (page 21), 2023 (page 26) and 2024 (page 26) — Imperial Brands PLC appears in the PMI Peer Group every year. The peer‑group composition did not change with respect to Imperial Brands; it remained a constant member of the set of companies selected for benchmarking. This stability shows that Philip Morris International deliberately maintains a consistent benchmark universe built on global presence, consumer‑product focus and comparable size, and it continuously measures its performance against the same primary international tobacco competitor (Imperial Brands) as part of a long‑term, sector‑wide benchmarking strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies Imperial Brands PLC as consistently present in PM's peer group across all three years (2022, 2023, 2024) - this matches the ground truth exactly. (2) Accurately cites specific page references (2022 page 21, 2023 page 26, 2024 page 26) which demonstrates proper source verification. (3) Correctly characterizes the stability of peer group composition with respect to Imperial Brands. (4) Accurately synthesizes the multi-hop reasoning: identifies the three-year period, tracks Imperial Brands' presence across all years, and draws appropriate conclusions about PM's benchmarking strategy. (5) Provides sound reasoning about why this consistency matters - global presence, consumer-product focus, comparable size, and sector-wide benchmarking. (6) Quantitative accuracy is perfect - all years and page numbers are correct. Minor considerations: (1) The LLM answer is slightly more detailed and interpretive than the ground truth (e.g., 'primary international tobacco competitor'), which adds value but goes marginally beyond the ground truth statement. However, this interpretation is reasonable and not contradictory. (2) Both answers convey the same core finding: Imperial Brands remained consistently in the peer group, indicating stable benchmarking strategy. The LLM answer provides additional context about the deliberate nature of this consistency and the strategic rationale. Overall, this is a strong response that accurately answers the multi-hop question with correct facts, proper synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 447,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PYPL’s holding of the September 2019 fixed‑rate 2.850 % notes stayed at **$1.5 billion** throughout the period. The 2022 Form 10‑K (which reports the 2021 balance) lists $1.5 bn; the 2023 Form 10‑K shows $1.5 bn both in 2022 and 2023; and the 2024 Form 10‑K again reports $1.5 bn in 2024 (and 2023).  \n\nThe unchanged exposure indicates that PYPL has deliberately kept this moderate‑cost, long‑dated tranche (maturing 10/1/2029) on its balance sheet, reflecting a long‑term debt strategy that favors stable, low‑interest financing and limits turnover of existing fixed‑rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All key numbers are correct - $1.5 billion balance consistently reported across 2022, 2023, and 2024; the 2.850% fixed rate is accurate; the maturity date of 10/1/2029 is correctly identified. The LLM properly traces the exposure across three fiscal years and correctly notes no repayments or refinancing occurred. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained stable at $1.5B), and (2) what this indicates about debt management strategy (deliberate retention of low-cost, long-dated financing). MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple 10-K filings (2022, 2023, 2024 forms) to track the progression and draw conclusions about strategic intent. ENTITY ACCURACY: PYPL ticker is correct, the specific note is properly identified (September 2019 issuance, 2.850% rate, $1.5B principal), and fiscal years are correctly referenced. SEMANTIC EQUIVALENCE: The LLM's interpretation that PYPL 'deliberately kept' the notes and is 'favoring stable, low-interest financing' aligns with the ground truth's assessment that the company is 'prioritizing other debt maturities' and 'leveraging the low fixed rate as part of a broader capital structure strategy.' Both answers convey the same strategic insight about debt management. MINOR ENHANCEMENT: The LLM provides slightly more detail (specific maturity date, reference to 'moderate-cost, long-dated tranche') which adds value without contradicting the ground truth. No calculation errors detected. The reasoning is sound and the conclusion logically follows from the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 466,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "- **2022 (10‑K 2022)** – ConocoPhillips described HSE audits as being performed on each business unit and staff group to verify conformance with the company’s HSE policies, standards and practices.  When improvement actions were identified they were “tracked to completion,” and the results were “tracked and reported to our ELT and the Board of Directors.”  \n\n- **2023 (10‑K 2023)** – The same audit‑scope language was retained (business‑unit and staff‑group audits) and the same conformance‑tracking process was reiterated (“where improvement actions are identified and tracked to completion”).  Reporting to the ELT and Board remained the mechanism for governance oversight.  \n\n- **2024 (10‑K 2024)** – The description was refined to “Corporate HSE audits,” signalling a more centralized, enterprise‑wide audit program that still covers business units and staff groups.  The audit‑outcome process is unchanged – any improvement actions are “tracked to completion” – but the wording now explicitly ties the audits to corporate governance, with progress again “tracked and reported to our ELT and the Board of Directors.”  \n\n**Evolution:** From 2022 to 2024 the audit scope broadened from unit‑level HSE checks to a formal “Corporate HSE audit” framework, while the conformance‑tracking mechanism (identifying and tracking improvement actions) stayed consistent, and the integration with corporate governance (reporting to the ELT and Board) was reinforced and made explicit in the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately captures the evolution of ConocoPhillips' HSE audit approach; (2) Accurately represents the 2022 baseline: audits across business units and staff groups with improvement actions tracked to completion and reported to ELT and Board; (3) Correctly notes that 2023 maintained the same language and processes while reinforcing governance linkage; (4) Accurately identifies the 2024 refinement to 'Corporate HSE audits' signaling centralized oversight; (5) Properly synthesizes the multi-hop evolution showing progression from unit-level checks to formal corporate framework while maintaining consistent conformance tracking; (6) Correctly emphasizes the integration with corporate governance throughout, with explicit reporting to ELT and Board. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail than the ground truth (e.g., noting that 2023 'retained the same audit-scope language' and explicitly comparing year-to-year consistency), which adds helpful context without contradicting the ground truth. The characterization of the evolution as 'broadened from unit-level HSE checks to a formal Corporate HSE audit framework' is semantically equivalent to the ground truth's description of 'shift from localized conformance checks toward a more integrated, governance-driven audit model.' No numerical errors, date errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across three years of filings to show the progression. The answer fully addresses all aspects of the question: audit scope, conformance tracking, and integration with corporate governance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 489,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "In each of the three most recent Form 10‑K filings—2022, 2023 and 2024—AMD again lists the **2011 Executive Incentive Plan** (exhibit 10.2 to its 2011 Form 10‑Q) as an exhibit “incorporated by reference.” The plan appears in the same “Executive‑compensation” schedule alongside newer documents such as the AMD Executive Severance Plan, the Deferred Income Account Plan and various indemnity and continuity agreements, showing that AMD continues to treat the 2011 Executive Incentive Plan as a core, foundational governance document even as it expands its overall executive‑compensation disclosures. Thus, the reliance on the 2011 plan did not change; it was consistently reaffirmed in 2022, reiterated in 2023, and reiterated again in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer states the 2011 Executive Incentive Plan was listed as exhibit '10.2' (to the 2011 Form 10-Q), while the ground truth explicitly states it was listed as '*10.1*' in the 10-K filings for 2022, 2023, and 2024. This is a significant factual error regarding the exhibit number, which is a precise quantitative identifier. The LLM's claim that the plan appears as '10.2' contradicts the ground truth's consistent reference to '10.1' across all three years. This represents a fundamental error in document identification and exhibit numbering. STRENGTHS: The LLM correctly identifies (1) the 2011 Executive Incentive Plan as the foundational document, (2) its consistent presence across 2022, 2023, and 2024, (3) its role alongside other compensation plans (AMD Executive Severance Plan, Deferred Income Account Plan), (4) the concept of 'incorporated by reference,' and (5) the overall narrative that reliance on the plan remained stable without material changes. The semantic understanding of AMD's governance continuity is sound. WEAKNESSES: Beyond the exhibit number error, the LLM provides less specific detail about the filing structure and the exact nature of the 2011 plan's role. The ground truth emphasizes the plan's listing in the 10-K exhibits specifically, while the LLM references incorporation by reference to a 2011 Form 10-Q, which may represent a different disclosure mechanism. The quantitative accuracy score is low due to the exhibit number error (10.2 vs. 10.1), which is a precise factual claim that is demonstrably incorrect. The qualitative reasoning about continuity and foundational status is sound, but the factual error undermines confidence in the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Files]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 471,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- **2022 filing (Chunk 1):** GM only reported that it would continue to purchase parts and engineering services from Stellantis after the 2017 Opel/Vauxhall sale; no specific indemnification obligation was disclosed.  \n\n- **2023 filing (Chunk 2):** GM disclosed that General Motors Holdings LLC, on behalf of the seller, had agreed to indemnify Stellantis for any losses arising from inaccurate representations, breaches of covenants, and “certain other liabilities, including costs related to certain emissions claims, product liabilities and recalls.”  The company said the indemnity was for an **immaterial amount** for some legacy‑Opel recalls (e.g., Takata inflators) and that the obligations are subject to time‑limits, thresholds and caps, leaving the potential loss unquantifiable.  \n\n- **2024 filing (Chunk 3):** The same indemnification language re‑appears – GM still cannot estimate a material loss, the obligations remain capped/subject to limits, and the amount paid to Stellantis for legacy‑Opel recalls is again described as **immaterial** with any further Takata‑related indemnity considered “remote.”  \n\n**Interpretation:** Over the 2022‑2024 period GM’s exposure shifted from a simple post‑sale supply relationship to a formally documented indemnification framework that covers emissions‑claim and recall liabilities.  Because the indemnities are described as immaterial, capped and likely remote, the progression suggests that GM’s exposure to post‑sale liabilities from the legacy Opel/Vauxhall business exists but is limited and unlikely to become material.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misses key details from the ground truth. STRENGTHS: (1) Correctly identifies the 2023 disclosure of indemnification obligations for emissions claims, product liabilities, and recalls; (2) Accurately notes that amounts were described as immaterial; (3) Correctly identifies Takata inflators as a specific recall type; (4) Properly characterizes the obligations as capped/subject to limits; (5) Correctly notes the 2024 filing reiterates similar language. CRITICAL GAPS AND ERRORS: (1) The LLM states 2022 filing showed 'no specific indemnification obligation was disclosed' - this contradicts the ground truth which indicates GM 'noted potential indemnification obligations for emissions claims and recalls' in 2022, even if not accrued; (2) MISSING the geographic expansion detail: The ground truth explicitly states lawsuits in Germany, UK, and Netherlands were mentioned in 2023, and Austria was added in 2024 - the LLM completely omits this critical evolution showing expanding legal scope; (3) MISSING the European Commission and UK CMA regulatory investigation mentioned in 2024 related to end-of-life vehicle practices - this is a significant development not captured; (4) The LLM's interpretation that exposure 'shifted from a simple post-sale supply relationship to a formally documented indemnification framework' is somewhat accurate but understates the actual progression of legal/regulatory complexity; (5) The LLM correctly notes obligations remain contingent and immaterial but misses that the ground truth emphasizes the 'increasing number of legal and regulatory actions indicates growing complexity and persistence' - the LLM's conclusion that exposure is 'limited and unlikely to become material' may understate the significance of the expanding jurisdictional and regulatory scope. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to identify the key pattern of geographic and regulatory expansion that is central to answering what the progression 'indicates about GM's exposure.' The answer is too focused on the immateriality characterization and misses the substantive evolution in legal/regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1696,
        "completion_tokens": 602,
        "total_tokens": 2298
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "- In 2022 Lilly still sold bamlanivimab (the “COVID‑19 antibodies” line) for roughly **$2.0 billion** of net product revenue (U.S. $2,008.9 m + Outside U.S. $14.7 m). Under the 2020 worldwide license with **AbCellera**, Lilly must pay tiered royalties “in the mid‑teens to mid‑twenties” on those net sales, and the royalty expense is recorded as a cost‑of‑sales item.  \n\n- By the 2024 filing the “COVID‑19 antibodies” line shows **no revenue** (‑) for both U.S. and outside‑U.S., meaning bamlanivimab is no longer being sold and the royalty obligation to AbCellera has effectively disappeared.  \n\n- This trajectory shows that bamlanivimab was a **major, short‑term revenue driver** that required sizable royalty out‑flows in 2022, but its commercial relevance has evaporated by 2024, indicating that its strategic importance to Lilly was largely confined to the pandemic period rather than a lasting pillar of the company’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop financial question about Eli Lilly's bamlanivimab exposure. QUANTITATIVE VERIFICATION: All numbers are correct - $2,008.9M U.S. revenue in 2022, $14.7M outside U.S. (totaling ~$2.0B), tiered royalties in 'mid-teens to mid-twenties' percentage range, and zero revenue by 2024. The calculation of combined 2022 revenue ($2,008.9M + $14.7M ≈ $2.0B) is accurate. ENTITY ACCURACY: Correctly identifies Eli Lilly (LLY), AbCellera, bamlanivimab, and the 2020 license agreement. Years are properly sequenced (2022→2023→2024). MULTI-HOP SYNTHESIS: The answer successfully synthesizes three key information streams: (1) revenue trajectory across years, (2) royalty obligation structure and mechanics, (3) strategic importance assessment. The reasoning correctly connects declining/eliminated revenue to eliminated royalty obligations and draws appropriate conclusions about pandemic-driven temporary importance. COMPLETENESS: Addresses all sub-questions: financial exposure evolution (✓), royalty obligations to AbCellera (✓), product's revenue contribution (✓), and strategic importance revelation (✓). MINOR CONSIDERATIONS: The answer notes 2023 data implicitly (zero revenue by 2024 filing) but doesn't explicitly state the 2023 transition year mentioned in ground truth. However, this is a very minor omission that doesn't affect the core accuracy. The characterization of bamlanivimab as 'major, short-term revenue driver' and 'pandemic period' product is semantically equivalent to ground truth's assessment of 'significant contributor during pandemic' with 'lost strategic importance.' The explanation of royalty mechanics (tiered percentages, cost-of-sales treatment) adds helpful detail beyond ground truth without introducing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 496,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the three filings, PMI’s description of its cigarette portfolio is unchanged: in 2022, 2023 and 2024 the company repeatedly lists **Jackpot** as one of its “important local cigarette brands” in the Philippines (Chunk 3 → 2022, Chunk 1 → 2023, Chunk 2 → 2024). This continuity shows that PMI has kept the Jackpot brand firmly in its core local‑brand strategy, using it to anchor its presence in a key growth market while the rest of the portfolio is dominated by international names such as Marlboro. The three‑year trajectory therefore signals a steady, deliberate focus on maintaining and leveraging local brands like Jackpot to sustain market‑share leadership in strategic regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Jackpot as a key local cigarette brand in the Philippines across all three years (2022, 2023, 2024), matching the ground truth's core finding. (2) Accurately captures the consistency and continuity of PMI's strategic positioning—the brand remained 'firmly in its core local-brand strategy' across the period, which directly mirrors the ground truth's emphasis on '3-year consistency.' (3) Properly synthesizes the multi-hop information by connecting Jackpot's presence across three separate filings and drawing the correct conclusion about PMI's dual strategy. (4) Correctly contextualizes Jackpot within PMI's broader portfolio (international brands like Marlboro) and its role in market-specific competitiveness. (5) No quantitative errors—all dates (2022, 2023, 2024) and entity references are accurate. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention Fortune as a complementary local brand or the broader 'smoke-free products and wellness' pivot that the ground truth references. However, these omissions are minor contextual details rather than factual errors. (2) The phrasing 'steady, deliberate focus' is semantically equivalent to the ground truth's 'ongoing commitment' and 'dual strategy.' (3) The answer correctly emphasizes that this represents a 'three-year trajectory' showing strategic consistency, which is the core insight requested. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings (2022, 2023, 2024) and correctly identifies the pattern of consistency, which is the key multi-hop requirement. The reasoning that this consistency 'signals a steady, deliberate focus' is logically sound and matches the ground truth's interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 514,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal warned that its credit‑card, consumer‑credit and merchant‑financing businesses were already vulnerable to “bad transactions” – defaults that could lead to charge‑offs and fraud‑related losses, and that these risks were amplified by its heavy reliance on third‑party processors and lenders. In June 2023 the company began a multi‑year transaction to sell up to €40 billion of U.K. and European BNPL loan receivables (the bulk of the BNPL portfolio) and to forward‑sell future eligible loans, a move that materially reduces the amount of BNPL‑related bad‑transaction exposure remaining on PayPal’s balance sheet. By 2024 the sale is in progress (receivables began flowing in October 2023) and the filing still stresses that, although the BNPL off‑load cuts exposure, PayPal continues to face fraud, abusive‑behavior and third‑party processing‑disruption risks that could increase loss rates on its remaining credit products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. QUANTITATIVE ACCURACY: All numeric values are correct - the €40 billion BNPL receivables sale amount is accurate, the June 2023 timing is correct, and the October 2023 receivables flow date is accurate. No calculation errors detected. ENTITY ACCURACY: PayPal correctly identified, all products (credit, BNPL, merchant financing) properly named, all years (2022, 2023, 2024) correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk dimensions: (1) 2022 baseline risks (fraud, synthetic identities, third-party dependencies), (2) 2023 risk mitigation through the €40B sale, and (3) 2024 ongoing risks despite the sale. The causal chain is logical and well-articulated. COMPLETENESS: The answer addresses all major elements of the question - the evolution of bad transaction exposure, the specific 2023 sale details, and persistent fraud/processing risks. SEMANTIC EQUIVALENCE: The LLM's phrasing ('materially reduces,' 'off-load cuts exposure,' 'bulk of the BNPL portfolio') conveys the same meaning as the ground truth while using slightly different language. The characterization of the sale as 'in progress' with receivables flowing from October 2023 is accurate and adds helpful specificity. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no essential information. The ground truth mentions 'regulatory challenges' and 'effectiveness of fraud detection systems' as sources of uncertainty, which the LLM answer doesn't explicitly state, but the LLM does capture the core point that 'underlying risks persisted' through its statement about continuing fraud and processing disruption risks. This is a minor omission that doesn't materially affect the answer's correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 519,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "- **2022 – Safety & Productivity Solutions:** Honeywell warned that “fluctuations in retail markets” could “adversely impact” the segment’s results, potentially lowering market share, selling prices and margins (Chunk 1).  \n- **2023 – Overall risk posture:** The 2023 filing listed the same retail‑market volatility as a material macro‑economic risk that could affect the company’s operating results, cash flows and financial condition across the enterprise (Chunk 2).  \n- **2024 – Industrial Automation:** In the 2024 filing the risk was carried forward to the Industrial Automation segment, where retail‑market swings were again cited as a factor that could reduce market share, pricing power and margins (Chunk 3).  \n\n**Implication:** Across three consecutive years the exposure moved from a single safety‑products line to a company‑wide risk acknowledgement and then to a new automation line, indicating that Honeywell’s industrial portfolio is increasingly sensitive to retail‑demand volatility and that such fluctuations are viewed as a cross‑segment driver of lower sales, pricing pressure and margin compression.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and their corresponding segments (Safety & Productivity Solutions, overall risk posture, Industrial Automation). (2) Accurately captures the core risk factor: 'fluctuations in retail markets' and its potential impacts (lower market share, pricing pressure, margin compression). (3) Successfully synthesizes the multi-hop progression showing how the same risk evolved across business reorganization. (4) Properly conveys the semantic meaning that this represents a persistent, cross-segment sensitivity to retail demand volatility. (5) No quantitative errors - no specific dollar amounts or percentages were claimed, avoiding calculation risks. (6) The reasoning chain is sound: single segment risk → company-wide acknowledgment → new segment risk, demonstrating proper multi-hop synthesis. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing ('adversely impact' vs. 'reduced investments in safety monitoring') but conveys equivalent meaning. (2) The LLM's characterization of the evolution as 'increasingly sensitive' is a reasonable inference from the data progression, though the ground truth frames it as 'persistent sensitivity' - both interpretations are defensible from the same facts. (3) The LLM adds interpretive language about 'cross-segment driver' which goes slightly beyond the ground truth but remains logically consistent with the evidence presented. The answer fully addresses all parts of the complex multi-part question and correctly identifies the key insight about Honeywell's sustained exposure to retail market volatility across its industrial portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 478,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From the 2022 filing, Eli Lilly’s deal with Incyte was still being shaped around large upfront milestones.  The agreement gave Incyte tier‑ed, double‑digit royalties that could rise to about 20 % of worldwide net sales, plus an extra low‑teens‑percent royalty on COVID‑19 sales that exceed a set threshold.  In addition, Lilly had already capitalized two milestone payments – $210 million (2020) and $260 million (2021) – and disclosed that Incyte could still earn up to $100 million each in success‑based regulatory and sales‑based milestones.\n\nThe 2023 filing repeats the same accounting treatment – Olumiant sales are recorded as net product revenue and the royalties to Incyte are booked as cost of sales – but it does not add any new milestone figures, indicating that the major milestone cash‑flows reported in 2022 had been largely satisfied and the relationship was now operating on the royalty‑only basis.\n\nBy the 2024 filing the structure is unchanged on paper: tiered double‑digit royalties up to 20 % and a low‑teens‑percent COVID‑19 royalty remain, but the filing no longer mentions any further milestone payments.  The emphasis is on Olumiant’s contribution to Lilly’s revenue stream (the table of net product revenue is highlighted), showing that the collaboration has shifted from a milestone‑driven financing model in 2022 to a steady royalty‑driven revenue source by 2024, with Olumiant now a recurring line‑item in Lilly’s top line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding milestone payment amounts and timing. Ground truth states: (1) $260.0 million capitalized in 2022 with up to $200.0 million in contingent payments ($100M regulatory + $100M sales). LLM states: (1) $210 million (2020) and $260 million (2021) were capitalized, with up to $100 million each in regulatory and sales milestones. This is incorrect on multiple counts - the ground truth shows $260M was the 2022 figure, not 2021, and the contingent payment total was $200M ($100M+$100M), not $200M total split differently. The LLM incorrectly attributes these payments to 2020-2021 rather than 2022. (2) The LLM states contingent payments as '$100 million each' which totals $200M, matching ground truth, but the year attribution is wrong. QUALITATIVE ASSESSMENT: The LLM correctly identifies the evolution from milestone-driven to royalty-driven model (2022→2024), correctly describes the tiered royalty structure (up to 20% with low-teens COVID-19 royalty), and appropriately synthesizes the shift in accounting treatment across years. The narrative arc is sound - milestones satisfied by 2023, transition to royalty-only basis by 2024. However, the foundational numerical errors undermine credibility. MULTI-HOP REASONING: The model successfully synthesizes information across three years and identifies the strategic evolution, but the incorrect milestone payment dates and amounts represent a failure in the core quantitative synthesis required for a financial question. The reasoning about the shift from milestone to royalty model is logically sound but built on incorrect data. MISSING ELEMENTS: The answer does not explicitly state that the $260M milestone was capitalized in 2022 (not 2021), which is a critical distinction for understanding the timeline of the collaboration's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1705,
        "completion_tokens": 511,
        "total_tokens": 2217
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "- **Intangible‑asset exposure:** In the 2022 Form 10‑K Altria disclosed that the bulk of its indefinite‑life intangible assets – $8.8 billion of moist‑smokeless‑tobacco (MST) and snus trademarks – were created by the 2009 acquisition of **UST** (the remainder $2.6 billion came from the 2007 Middleton purchase).  No new acquisitions affecting those intangibles were reported for the next two years, so the UST‑related goodwill and trademark balance remained on the balance sheet through 2023 and into 2024.\n\n- **Ownership structure:** Both the 2023 and the 2024 10‑K describe **UST LLC** (and its wholly‑owned subsidiary U.S. Smokeless Tobacco Company LLC) as a **wholly‑owned subsidiary** of Altria.  This confirms that Altria’s equity stake in UST stayed at 100 % from at least 2022 through 2024, giving the company full cash‑flow exposure and control over the business.\n\n- **Integration into the smoke‑free transition:** The 2024 filing places UST’s MST products under the “oral tobacco products” segment and explicitly links them to Altria’s “Vision … to responsibly lead the transition of adult smokers to a smoke‑free future.”  Thus, UST’s product line has been incorporated into Altria’s broader strategy of moving consumers away from combustible cigarettes and toward potentially less‑harmful, non‑combustible nicotine products.\n\n**Overall evolution:** Altria’s financial exposure to UST remained anchored in a large $8.8 billion intangible‑asset base recorded in 2022, while the ownership relationship stayed unchanged as a 100 % wholly‑owned subsidiary.  By 2024 the UST business was fully integrated into Altria’s oral‑tobacco portfolio and positioned as a cornerstone of its smoke‑free transition roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All quantitative data is correct - the $8.8 billion MST/snus trademark valuation from 2022 is accurately cited, the $2.6 billion Middleton figure is correct, and the 100% ownership stake is properly documented across all three years (2022-2024). (2) Entity identification is precise - correctly names UST LLC, U.S. Smokeless Tobacco Company LLC (USSTC), and distinguishes these from other Altria subsidiaries like Helix and NJOY. (3) Multi-hop synthesis is sound - the answer successfully traces the evolution across three dimensions (intangible assets, ownership structure, strategic integration) and correctly synthesizes information from multiple 10-K filings to show continuity and strategic positioning. (4) The answer properly contextualizes UST within Altria's broader smoke-free transition strategy, noting the shift toward oral nicotine pouches and e-vapor while maintaining UST's core MST business. MINOR CONSIDERATIONS: (1) The LLM answer uses 'UST LLC' while the ground truth uses 'UST' - both are correct references to the same entity, representing acceptable semantic equivalence. (2) The LLM provides slightly more structural detail about the subsidiary relationships (UST LLC → USSTC) compared to the ground truth, which adds clarity without introducing inaccuracy. (3) The answer could have been marginally enhanced by explicitly noting the strategic diversification around UST (Helix and NJOY) as mentioned in the ground truth, though this is a minor omission. The reasoning chain is logical: 2009 acquisition → 2022 balance sheet valuation → sustained 100% ownership through 2024 → integration into smoke-free portfolio. All calculations and temporal relationships are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 493,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "- **Fiscal 2022 (2022 10‑K)** – Cisco held $500 million of the 3.50 % senior note with an **effective interest rate of about 3.2 %**.  \n- **Fiscal 2023 (2023 10‑K)** – The same $500 million note is shown with an **effective rate of roughly 6.4 %**.  \n- **Fiscal 2024 (2024 10‑K)** – The note’s effective rate rises slightly again to **about 6.7 %**.\n\n**Interpretation:** Over the three‑year span the effective cost on the 3.50 % senior note more than doubled, moving from a low‑3 % level in 2022 to the mid‑6 % range in 2023‑2024. This upward shift reflects Cisco’s growing exposure to higher borrowing costs as market interest rates rose sharply during that period, signaling tighter capital‑market conditions and the need to refinance existing debt at substantially higher rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Cisco's interest rate exposure evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - FY2022: 3.20% (LLM states 'about 3.2%'), FY2023: 6.38% (LLM states 'roughly 6.4%'), FY2024: 6.66% (LLM states 'about 6.7%'). The dollar amount of $500 million is correctly identified. The percentage increases are accurately characterized (more than doubled from ~3.2% to mid-6% range). COMPLETENESS: The answer addresses all three fiscal years requested and provides the required trend analysis. The multi-hop synthesis correctly combines data across three separate 10-K filings. ENTITY ACCURACY: Cisco (CSCO) correctly identified, the 3.50% Senior Note properly referenced, fiscal years 2022-2024 correctly specified. REASONING QUALITY: The interpretation correctly identifies the upward trend and appropriately attributes it to rising market interest rates and tightening capital market conditions. The logic connecting effective rate increases to broader economic conditions is sound. MINOR OBSERVATIONS: The LLM uses approximate language ('about,' 'roughly,' 'slightly') which is appropriate given the context of reading from financial documents and is semantically equivalent to the ground truth values. The characterization of the trend as reflecting 'growing exposure to higher borrowing costs' and 'tighter capital-market conditions' aligns perfectly with the ground truth interpretation. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 439,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 Notes carried a $16 billion face‑value balance at the end of 2022 (the 2023 Form 10‑K still listed $16 bn for 2022).  By the end of 2023 the balance had fallen to $15 bn, and by the end of 2024 it was down to $13 bn (as shown in the 2024 Form 10‑K).  This steady $3 bn reduction over two years—$1 bn in the first year and $2 bn in the second—demonstrates that Amazon is actively retiring a portion of its older, higher‑cost debt, using cash flow and newer issuances to lower its outstanding principal and overall leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $16.0 billion (2022), $15.0 billion (2023), $13.0 billion (2024). The LLM correctly identifies the reduction trajectory: $1 billion in year one (2022-2023) and $2 billion in year two (2023-2024), totaling $3 billion over two years. These calculations are accurate and match the ground truth. ENTITY ACCURACY: The answer correctly identifies Amazon's 2017 Notes and properly references the relevant fiscal years and Form 10-K filings. MULTI-HOP REASONING: The LLM successfully synthesizes information about the specific debt instrument's evolution and connects it to broader debt management strategy. The answer appropriately contextualizes the 2017 Notes reduction within Amazon's overall long-term debt reduction (though the LLM doesn't explicitly cite the $67.2B to $52.6B figures from ground truth, this is a minor omission). SEMANTIC EQUIVALENCE: The LLM's characterization of the reduction as 'steady' and 'deliberate' aligns with the ground truth's description of a 'consistent reduction' and 'deliberate debt management strategy.' The explanation about retiring 'older, higher-cost debt' adds reasonable financial context. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail about the year-by-year reduction pattern ($1B then $2B) compared to the ground truth, which is a strength. The answer could have been enhanced by explicitly mentioning the broader long-term debt context ($67.2B to $52.6B), but this is not essential to answering the core question. Overall, the answer is factually sound, well-reasoned, and appropriately addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 470,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "**Outstanding principal and rate**\n\n| Fiscal year (as reported) | Outstanding principal on the 5.000 % notes due April 2030 | Effective interest rate |\n|---------------------------|-----------------------------------------------------------|--------------------------|\n| FY 2022 (Oct 30 2022)     | **$606 million** (down from $1,086 m a year earlier)      | **5.18 %** |\n| FY 2023 (Oct 29 2023)     | **$606 million**                                           | **5.18 %** |\n| FY 2024 (Nov 3 2024)      | **$606 million**                                           | **5.18 %** |\n\n**What the trend shows**\n\nAcross three consecutive filing years the balance of the April‑2030 5 % senior notes stayed flat at $606 million and the note’s fixed‑rate cost remained at 5.18 %. AVGO has neither issued additional amounts nor retired a material portion of this series, indicating a deliberate “hold‑to‑maturity” approach: the company is preserving a stable, long‑dated source of financing at a known cost rather than reshaping the instrument through refinancing or amortization. This consistency reflects a disciplined debt‑management strategy that locks in a predictable interest expense for the life of the notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numeric values are correct - $606 million principal balance for all three fiscal years (FY2022, FY2023, FY2024) and 5.18% effective interest rate consistently reported. The dates are accurate (Oct 30 2022, Oct 29 2023, Nov 3 2024). The note characteristics (5.000% coupon, April 2030 maturity) are correctly identified. COMPLETENESS: The answer fully addresses the multi-part question: (1) outstanding principal balance evolution across three years, (2) interest rate progression, and (3) what this indicates about debt management strategy. ENTITY ACCURACY: AVGO is correctly identified, fiscal years are properly labeled, and the specific debt instrument is accurately referenced throughout. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that the static principal and rate across three years indicates a deliberate 'hold-to-maturity' strategy with no refinancing or material amortization. The interpretation that this reflects disciplined debt management with predictable interest expense is logical and well-supported by the data. PRESENTATION: The tabular format enhances clarity and makes the three-year progression immediately apparent. The narrative explanation correctly synthesizes the data into strategic insight. MINOR OBSERVATION: The LLM includes a parenthetical note about the balance being 'down from $1,086m a year earlier' (pre-FY2022), which adds helpful context but goes slightly beyond the requested three-year window. This is a minor enhancement rather than an error. The semantic equivalence between the original answer's description of 'static approach' and the LLM's 'hold-to-maturity' characterization is strong and conveys the same strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 489,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- In the 2022 Form 10‑K the Performance Bonus Plan appears only as a stand‑alone exhibit (Exhibit 10.6, filed as a Def 14A on April 28 2014), showing that the plan existed but had not yet been formally restated or tied to the newer executive‑compensation framework.  \n\n- In the 2023 filing (and again in the 2024 filing) Netflix filed an **Amended and Restated Performance Bonus Plan** as Exhibit 10.5, dated December 9 2022.  This filing formally restates the plan and, by being incorporated by reference alongside the 2011/2020 Stock Plans, the Executive Severance and Retention Incentive Plan, and other officer agreements, it becomes an integrated component of the company’s overall executive compensation agreements.  \n\n- Thus, from 2022 to 2024 the plan moved from a basic, historic description to a formally amended‑and‑restated document that is now embedded within Netflix’s comprehensive executive‑compensation package.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed, specific information than the ground truth. Key strengths: (1) All dates are correct - December 9, 2022 for the Amended and Restated Performance Bonus Plan filing is accurate and matches ground truth; (2) Exhibit numbers are correctly identified (Exhibit 10.6 for 2022, Exhibit 10.5 for 2023/2024); (3) The filing date of April 28, 2014 for the original Def 14A is appropriately contextualized; (4) Multi-hop reasoning is sound - the answer correctly synthesizes the evolution across three years, showing progression from standalone exhibit to integrated component; (5) Entity identification is accurate - Netflix, Executive Severance and Retention Incentive Plan, Performance-Based Restricted Stock Unit Award Agreement are all correctly named. The LLM answer actually provides MORE specificity than the ground truth by citing specific exhibit numbers and filing dates, which enhances credibility. The semantic meaning aligns perfectly with ground truth: both convey that the plan moved from a basic reference to a formally amended and restated document integrated into broader compensation architecture. Minor consideration: The LLM answer's reference to the 2011/2020 Stock Plans adds helpful context not explicitly in ground truth, but this is additive rather than contradictory. The characterization of the evolution (basic/historic → formally amended-and-restated → integrated) matches the ground truth narrative precisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Enters_Into]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 416,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "From 2022 to 2024 AIG’s handling of its international terrorism risk became more granular and better‑backed by reinsurance. In the 2022 filing AIG disclosed that a five‑ton bomb scenario – net of the U.S. Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and existing reinsurance – was modeled to generate about **$1.3 billion** of loss (with a TRIPRA deductible of roughly **$1.7 billion** and TRIPRA covering about 80 % of losses above that level), and the company relied on limited private reinsurance, targeted treaty purchases and government‑sponsored pools. The 2023 report reiterated the same third‑party scenario‑based modeling and targeted reinsurance approach but did not add new loss figures, indicating a continuation of the 2022 framework. By 2024 AIG had refined its protection structure – retaining core attachment points of **$200 million for Japan and $125 million for the rest of the world**, and adding “property‑per‑risk” covers that protect against large global losses (both non‑critical and critical catastrophes outside North America) – while still using scenario‑based modeling, routine concentration monitoring, targeted reinsurance purchases and reliance on government terrorism pools. Thus, the evolution shows a shift from a largely estimate‑driven, limited‑reinsurance stance in 2022 toward more explicit attachment points and broader global reinsurance coverage in 2024, while maintaining the same modeling and monitoring discipline throughout.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of AIG's terrorism exposure management evolution from 2022-2024. STRENGTHS: (1) All key numeric values are correct: $1.3 billion loss estimate for five-ton bomb scenario, $1.7 billion TRIPRA deductible, 80% TRIPRA coverage, $200 million Japan attachment point, $125 million rest-of-world attachment point. (2) The answer correctly identifies the three-year progression and captures the evolution from limited reinsurance in 2022 to more explicit attachment points and broader global coverage in 2024. (3) Multi-hop synthesis is sound: the answer properly connects modeling approaches, reinsurance protections, and risk mitigation strategies across the three-year period. (4) The answer appropriately contextualizes TRIPRA's role and explains the shift from estimate-driven to attachment-point-driven approach. (5) Entity identification is accurate (AIG, TRIPRA, Japan, North America). MINOR GAPS: (1) The ground truth mentions AIG held $20.1 billion in collateral to support reinsurance recoverable assets in 2024, which the LLM answer does not include. This is a factual omission but not critical to the core narrative of the evolution. (2) The ground truth explicitly mentions 2023's emphasis on 'routine monitoring of international terrorism exposure concentration,' which the LLM answer incorporates but could have emphasized more clearly as a distinct 2023 development. CALCULATION VERIFICATION: All numeric values check out correctly. The characterization of the evolution (2022 limited reinsurance → 2024 refined protection structure) is accurate and well-reasoned. The answer demonstrates strong understanding of the multi-hop question requiring synthesis across three fiscal years and multiple risk management dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Manages]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 491,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture‑investment balance sheet shows a clear upward trajectory in pure equity‑security holdings: $3.7 billion at the end of 2022, rising to $4.9 billion in 2023 and remaining at $4.9 billion in 2024 (up from $3.5 billion in 2021). At the same time, its equity‑method stakes in operating health‑care businesses fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023, then jumped sharply to $3.8 billion in 2024 (up from $1.3 billion in 2021). Together, the data indicate that UnitedHealth expanded its overall venture portfolio in 2023‑24 while dramatically increasing its direct, equity‑method ownership of health‑care operating companies by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall trend and strategic pivot but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) The 2023 equity securities figure of $4.9 billion is correct; (2) The 2024 equity securities figure of $4.9 billion is correct; (3) The 2023 equity method investments of $1.4 billion is correct; (4) The 2024 equity method investments of $3.8 billion is correct; (5) The overall narrative about the strategic pivot toward deeper operational engagement is accurate; (6) The multi-hop synthesis across years is logically sound. CRITICAL ERRORS: (1) 2022 equity securities stated as $3.7 billion when ground truth shows $3.5 billion - a $200 million discrepancy; (2) 2022 equity method investments stated as $1.5 billion when ground truth shows $1.3 billion - a $200 million discrepancy; (3) The LLM introduces 2021 data ($3.5 billion and $1.3 billion) which was not part of the original question's scope (2022-2024), creating confusion about whether these are comparative baselines or part of the answer. REASONING QUALITY: The LLM correctly identifies the strategic evolution and the dramatic shift in 2024 toward equity method investments. The characterization of 'direct, equity-method ownership' and 'operational engagement' aligns well with the ground truth interpretation. However, the quantitative errors in the 2022 baseline figures are problematic because they distort the magnitude of change from 2022 to 2023. The answer would score higher if the 2022 figures were accurate, as the rest of the analysis is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 439,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—Altria’s securities tables list the **1.700 % Notes due 2025 (ticker MO25)** as an outstanding class of debt. The note appears unchanged from year to year, showing that the same medium‑term bond remained on the company’s balance sheet throughout the period. This steady presence signals a debt‑management approach that relies on retaining existing, relatively low‑cost financing rather than repeatedly refinancing or issuing new instruments, emphasizing stability and predictability in Altria’s capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.700% Notes due 2025 as present across all three years (2022, 2023, 2024) and accurately notes the percentage rate and maturity year. However, there are significant gaps in completeness and multi-hop synthesis compared to the ground truth. STRENGTHS: (1) Correctly identifies the 1.700% 2025 Notes as appearing consistently across all three years; (2) Accurately states the interest rate and maturity date; (3) Provides reasonable interpretation about debt management strategy emphasizing stability. WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly mentions the 1.000% 2023 Notes maturing between 2022 and 2023, which is a critical data point showing active debt management. The LLM answer fails to capture this important evolution—the maturation of the 2023 Notes is a key indicator of how Altria managed short-term obligations; (2) MISSING COMPARATIVE CONTEXT: The ground truth references other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for the 1.700% 2025 Notes' role in the broader capital structure. The LLM answer doesn't synthesize this comparative information; (3) INCOMPLETE ANALYSIS: The ground truth explicitly states 'Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element'—this distinction between managing short-term obligations (like the 2023 Notes) and retaining mid-term debt is crucial to understanding the strategy. The LLM answer only addresses the retention aspect; (4) TICKER NOTATION: The LLM adds '(ticker MO25)' which is not verified in the ground truth and may be inaccurate or unsupported. QUANTITATIVE ACCURACY: The 1.700% rate and 2025 maturity are correct. No calculations are presented, so no calculation errors exist. QUALITATIVE ACCURACY: The reasoning about stability is sound but incomplete—it misses the critical multi-hop element of comparing the 2023 Notes' maturation with the 2025 Notes' retention. The answer provides a partial interpretation of debt strategy but fails to capture the full picture of active management across the three-year period. CONTEXTUAL RELEVANCE: The answer addresses the question's core topic but incompletely. It focuses on the 2025 Notes' consistency but misses the 'multi-year progression' aspect that the question specifically asks about—the progression includes the maturation of other notes, not just the retention of the 2025 Notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 651,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance‑sheet data show that the cost of its Class A treasury stock has risen each year:\n\n* **2022:** $(51.354) million (Class A treasury stock, cost) – shown in the 2023 10‑K equity table【Chunk 1】.  \n* **2023:** $(60.429) million – the same line in the 2023 10‑K, up $9.1 million from the prior year【Chunk 1】.  \n* **2024:** $(71.431) million – reported in the 2024 10‑K equity table, up $11.0 million from 2023【Chunk 2】.\n\nThe upward trajectory (≈$51 m → $60 m → $71 m) mirrors the historical buy‑back activity noted in earlier filings (e.g., $6.5 m in 2018 and $4.5 m in 2020 in the 2022 10‑K)【Chunk 3】, indicating a consistent share‑repurchase program. This growing investment in treasury stock suggests that Mastercard is allocating excess cash to return value to shareholders through buybacks, reflecting confidence in its valuation and a capital‑allocation strategy that prioritizes shareholder returns over other uses of cash.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states $(36,658) million for 2022, but the LLM reports $(51.354) million - a discrepancy of approximately $15,304 million (41% error). This is a major quantitative inaccuracy that undermines the entire analysis. The 2023 and 2024 figures are correct: $(60,429) million and $(71,431) million respectively. CALCULATION VERIFICATION: The LLM correctly identifies the year-over-year increases ($9.1M from 2022-2023 and $11.0M from 2023-2024), but these calculations are based on the incorrect 2022 baseline. The correct increases should be: 2022-2023: $23,771M ($60,429M - $36,658M), and 2023-2024: $11,002M ($71,431M - $60,429M). MULTI-HOP REASONING: The LLM appropriately synthesizes information across multiple years and correctly interprets the trend as indicating a capital allocation strategy focused on shareholder returns through buybacks. The reasoning about confidence in valuation and prioritization of shareholder returns is sound and matches the ground truth interpretation. ENTITY ACCURACY: Company (Mastercard), metric (Class A Treasury Stock), and years (2022-2024) are all correctly identified. SEMANTIC EQUIVALENCE: The qualitative conclusion about capital allocation strategy and shareholder returns is semantically equivalent to the ground truth. However, the fundamental error in the 2022 baseline number is a critical failure that cannot be overlooked in financial analysis, as it misrepresents the magnitude of the trend and could lead to incorrect business conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 442,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s exposure to its Total Return Swaps‑Deferred Compensation program moved from a **$92 million loss in fiscal 2022** (as shown in the 2022 10‑K table) to a **$58 million gain in fiscal 2023** and then to a **$91 million gain in fiscal 2024** (both reflected in the 2023 and 2024 10‑K tables). Thus, the position swung from a negative $92 million to a positive $149 million net gain over the three‑year span, indicating that the earlier loss was fully reversed and the program generated increasingly larger gains each subsequent year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three individual financial values ($92M loss in 2022, $58M gain in 2023, $91M gain in 2024) and accurately describes the directional shift from loss to gains. The entity identification (Cisco, Total Return Swaps-Deferred Compensation, fiscal years 2022-2024) is correct. The qualitative assessment that this represents a 'reversal and strengthening' is sound. CRITICAL ERROR: The LLM calculates the cumulative net gain as $149 million ($58M + $91M), which is mathematically correct for those two years alone, but this calculation is problematic in context. The statement 'the position swung from a negative $92 million to a positive $149 million net gain over the three-year span' is misleading and potentially incorrect. The proper three-year net position would be: -$92M + $58M + $91M = $57M total gain (not $149M). The LLM appears to have only summed the two positive years without accounting for the initial $92M loss, creating a significant quantitative error. REASONING ISSUE: While the LLM correctly synthesizes the multi-hop information across three fiscal years, the cumulative calculation undermines the accuracy of the final conclusion. The statement 'the earlier loss was fully reversed' is approximately correct (the $92M loss was more than offset), but the specific claim about a '$149 million net gain' is factually incorrect. SEMANTIC ALIGNMENT: The core narrative about the evolution from loss to gains is semantically equivalent to the ground truth, but the quantitative error in the cumulative calculation is a material flaw that affects the overall correctness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 448,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "- **2022:** Netflix made clear that its entire streaming catalogue depended on studios, content‑providers and other rights‑holders licensing distribution rights.  It warned that if any rights‑holder refused a deal, withdrew titles on short notice, or used the same content for its own streaming service, Netflix could face higher acquisition costs, loss of popular titles and even service disruptions.  \n\n- **2023:** The same licensing dependence was reiterated, but the filing added that a wave of new regulatory actions – such as cultural‑support legislation, content‑quota rules, levies and limits on ownership rights – was beginning to make acquiring and keeping licensed content more expensive and, in some jurisdictions, more restrictive.  \n\n- **2024:** Netflix’s 2024 filing shows the dependency unchanged and still emphasizes the risk of rights‑holder negotiations and the need to secure exclusive rights, while noting that the regulatory environment that emerged in 2023 has now become an ongoing constraint that can further limit the availability of licensed content.  \n\nOverall, from 2022 to 2024 Netflix’s reliance on rights‑holders remained high, with licensing risk and competition for exclusive titles persisting, while regulatory pressures have grown from an emerging concern to a persistent factor that can restrict or increase the cost of content availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of Netflix's evolving dependency on rights holders; (2) Accurately captures the 2022 concerns about content providers launching competing services, withdrawal of titles, and increased costs; (3) Properly synthesizes the 2023 shift where regulatory pressures emerged as a new factor alongside existing licensing risks; (4) Correctly notes that by 2024, regulatory constraints had become an 'ongoing constraint' rather than emerging concern; (5) Effectively traces the evolution from pure licensing dependency to a dual-pressure environment (rights holders + regulators); (6) Uses appropriate terminology (content quotas, levies, ownership restrictions) that aligns with ground truth language. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and granular than the ground truth summary, providing specific examples of regulatory mechanisms (cultural-support legislation, content-quota rules, levies), which adds helpful context without contradicting the original answer. The phrasing 'dependency unchanged' in 2024 is semantically equivalent to the ground truth's 'reiterated these risks.' MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filing years and correctly identifies the causal relationships and temporal progression of how external pressures compounded Netflix's strategic challenges. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations are present that could be incorrect; the temporal framework (2022, 2023, 2024) is accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth—intensifying dependency with regulatory pressures becoming increasingly significant—while using slightly different but equally valid language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 520,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "Across the three most recent filing years, UnitedHealth Group consistently reported that the amounts it accrued, paid or charged to income for its service‑level guarantees were **not material**. The 2022 10‑K (covering 2022) states the same, the 2023 10‑K (covering 2023) repeats that none were material, and the 2024 10‑K (covering 2024) again confirms no material amounts for 2024, 2023 or 2022. This flat, immaterial trend indicates that UnitedHealth Group’s financial exposure tied to service‑level guarantees has remained negligible, suggesting a stable and reliable commitment to service delivery across its subsidiaries over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantees were immaterial across 2022-2024, which matches the ground truth. However, it significantly fails to address a critical component of the original question and ground truth answer: the substantial fluctuations in parent company notes payable to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024). This is a major omission because the question explicitly asks about the 3-year trend and what it suggests about stability. The ground truth emphasizes that while service level guarantees remained immaterial, the internal financing structure experienced 'notable variation,' which is crucial context for understanding the full picture of UnitedHealth's financial obligations and operational adjustments. The LLM answer focuses narrowly on the immateriality of service level guarantees and concludes this indicates 'stable and reliable commitment,' but this interpretation is incomplete and potentially misleading without acknowledging the significant fluctuations in subsidiary financing. The LLM also misses the nuance that the ground truth presents: immaterial service level guarantee charges do NOT necessarily indicate stability when paired with significant internal financing volatility. The answer demonstrates partial understanding but fails the multi-hop synthesis requirement by not connecting the service level guarantee data with the notes payable data to provide a complete assessment of the 3-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 411,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "**Allocation trend**\n\n| Year (as reported) | Pension plan – below‑investment‑grade (% of fixed‑income holdings) | Post‑retirement plan – below‑investment‑grade (% of fixed‑income holdings) |\n|--------------------|---------------------------------------------------------------------|-----------------------------------------------------------------------------|\n| 2021 (used as the baseline for the 2022 filing) | ≈ 16 % | ≈ 8 % |\n| 2023 (2023 filing) | ≈ 11 % | ≈ 9 % |\n| 2024 (2024 filing) | No specific percentage disclosed; the filing only breaks out “U.S. Treasury and foreign‑government securities (8 %) and all other investments (8 %)”, implying that the below‑investment‑grade exposure has not materially changed from the prior year. |\n\n**Interpretation**\n\nFrom the 2022 filing (reflecting the 2021 portfolio) to the 2023 filing, Altria reduced the share of high‑yield, below‑investment‑grade bonds in its **pension** portfolio by about five percentage points, while it nudged the **post‑retirement** exposure up by roughly one point. The 2024 filing does not report a new allocation, suggesting the company has held the 2023 levels (or made only insignificant adjustments).  \n\nThis pattern indicates a **cautious shift in risk appetite** for its core pension obligations—dialing back exposure to lower‑rated debt to protect long‑term benefit payments—while retaining a modest, steady amount of high‑yield exposure in the post‑retirement plans to capture additional yield. Overall, Altria appears to be managing its long‑duration liabilities with a slightly more conservative stance for pensions and a stable, modest risk tolerance for post‑retirement assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive analysis. STRENGTHS: (1) All quantitative data is correct - pension plan below-investment-grade allocations of 16% (2022/2021 baseline) declining to 11% (2023), postretirement plan allocations of 8% (2022) increasing to 9% (2023); (2) Correctly identifies that 2024 specific percentages were not disclosed; (3) Accurately calculates the magnitude of changes (5 percentage point decrease for pension, 1 percentage point increase for postretirement); (4) Properly synthesizes multi-hop information across three years and two plan types; (5) Provides sound interpretation of the trend as indicating cautious risk management with differentiated approaches for pension vs. postretirement plans; (6) Uses clear tabular presentation that enhances readability and accuracy verification. MINOR CONSIDERATIONS: (1) The LLM labels the 2021 data as \"2021 (used as the baseline for the 2022 filing)\" which is technically accurate but slightly different framing than the ground truth's \"2022\" label - however, this is a presentation choice rather than factual error, as both refer to the same data point; (2) The ground truth also mentions total plan asset percentages (~11% and ~9% for pension in 2022, ~9% and ~4% for postretirement), which the LLM answer does not include, though the question specifically asks about \"allocation to below investment grade securities within its long-duration fixed income portfolio,\" making the fixed-income percentage the primary metric; (3) The interpretation section is well-reasoned and aligns with the ground truth's characterization of a \"cautious approach to risk\" and \"measured balance between return objectives and risk management.\" The answer successfully addresses all components of the multi-part question regarding evolution of allocations and implications for risk appetite.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1680,
        "completion_tokens": 509,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s estimate of settlement exposure has been calculated the same way in each of the three most recent 10‑K filings. In the 2022 filing (Chunk 3) the company said it “estimates gross settlement exposure using the average daily payment volume for the three months prior to period‑end multiplied by the estimated number of days of exposure,” and that it periodically reviews and, when necessary, revises the methodology. The 2023 filing (Chunk 1) repeats that same formula and the same periodic‑review language, and the 2024 filing (Chunk 2) again describes the identical calculation and ongoing review process.  \n\nThe fact that the methodology has remained unchanged—even as the company faces heightened FTC, DOJ, European‑Commission investigations and multiple large‑scale litigations (liability‑shift, TCPA, etc.)—shows that Mastercard relies on a stable, disciplined risk‑management framework. The consistency signals that its exposure‑estimation process is considered robust enough to withstand increasing regulatory and legal scrutiny, reinforcing confidence in its overall risk‑governance approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the consistent methodology across all three years (2022, 2023, 2024) using average daily payment volume multiplied by estimated days of exposure. (2) Accurately references the periodic review language present in all three filings. (3) Correctly identifies all major regulatory investigations (FTC, DOJ, European Commission) and litigation risks (liability-shift, TCPA). (4) Properly synthesizes the multi-hop reasoning: methodology consistency + regulatory/litigation pressures = confidence in robust risk management framework. (5) No quantitative errors; all dates and entities are correct. (6) The semantic meaning matches ground truth perfectly—both convey that consistency despite external pressures indicates confidence in the framework. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the specific detail about 'cash collateral or credit enhancements based on individual risk assessments' as a disclosed risk mitigation approach. However, this omission does not affect the core answer to the question about methodology evolution and what consistency indicates. (2) The LLM's phrasing 'shows that Mastercard relies on a stable, disciplined risk-management framework' is semantically equivalent to the ground truth's 'viewed its existing risk management practices as robust and sufficient.' Both convey the same interpretive conclusion. VERIFICATION: All factual claims check out—the methodology formula is correct, the years are correct, the regulatory bodies and litigation types are correctly identified, and the logical inference about what consistency indicates is sound. The answer successfully addresses both parts of the question: (a) how methodology evolved (it didn't—remained consistent), and (b) what this indicates about risk management approach (confidence in robustness).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 526,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "- **Utilization** – The $5.90 % senior note (maturing Feb 15 2039) was carried at a constant principal amount of **$2 billion** in each filing.  Because Cisco’s total long‑term debt changed, the note’s share of that debt fell from roughly **24 % of long‑term debt in FY 2022** (‑ $2 bn / $8.416 bn), rose to about **30 % in FY 2023** (‑ $2 bn / $6.658 bn), and dropped to roughly **10 % in FY 2024** (‑ $2 bn / $19.621 bn).  \n\n- **Effective interest rate** – The note’s **effective rate remained steady at 6.11 %** in FY 2022, FY 2023 and FY 2024 (see the “Effective Rate” column for the 5.90 % note in each table).  \n\n- **Implication** – Cisco kept the 5.90 % note’s terms unchanged while aggressively expanding its overall debt portfolio (new higher‑coupon issues in 2024).  The shrinking proportion of this older, relatively low‑cost note indicates a deliberate long‑term‑debt‑management strategy: retain a stable, low‑rate anchor security for liquidity, but diversify and increase total borrowings to meet financing needs, spread maturities and manage overall interest‑cost exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. STRENGTHS: (1) Correctly identifies the constant $2 billion principal amount across FY 2022-2024, matching ground truth exactly. (2) Accurately reports the stable 6.11% effective interest rate across all three years, matching ground truth. (3) Provides additional valuable context by calculating the note's proportion of total long-term debt (24% in FY2022, 30% in FY2023, 10% in FY2024), which adds analytical depth beyond the ground truth while remaining factually sound. (4) Correctly identifies the maturity date (Feb 15, 2039) and coupon rate (5.90%). (5) Multi-hop synthesis is excellent: connects the stable note balance with changing total debt levels to infer strategic intent. (6) The reasoning about debt management strategy is sound and more detailed than ground truth—explaining that Cisco retained a stable, low-rate anchor while diversifying borrowings. MINOR CONSIDERATIONS: (1) The LLM answer goes beyond ground truth by providing debt proportion calculations and more granular strategic analysis, but this represents value-added insight rather than error. (2) The ground truth answer is more concise, while the LLM answer is more comprehensive. Both convey the same core finding: the note was maintained as a fixed component with stable effective rate, indicating strategic debt management. (3) All numeric values are accurate; calculations of debt proportions are mathematically correct based on stated total debt figures. The answer fully addresses both parts of the question (utilization evolution and effective interest rate evolution) and correctly synthesizes information to draw conclusions about long-term debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 473,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "- **Fiscal‑year balances** – In AVGO’s 2022, 2023 and 2024 Form 10‑K tables the line “3.125% notes due January 2025” is listed at **$495 million** in each year (2022 Oct 30, 2023 Oct 29 and 2024 Nov 3). The amount does not change from FY 2022 through FY 2024.  \n\n- **What the trend shows** – The unchanged $495 million balance indicates that Broadcom has chosen to keep this tranche of senior debt on the books rather than retire or amortize it before its January 2025 maturity. By preserving the full principal, the company is likely exploiting the relatively low 3.125 % coupon as a stable, low‑cost source of financing and is positioning itself to either refinance or pay off the notes at maturity, reflecting a deliberate debt‑management strategy that prioritizes liquidity and rate advantage over early repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numbers are correct - $495 million principal balance is accurately stated for fiscal years 2022, 2023, and 2024. The dates are correct (Oct 30 2022, Oct 29 2023, Nov 3 2024 for fiscal year ends, and January 2025 maturity date). The coupon rate of 3.125% is correctly cited. No calculation errors present. ENTITY ACCURACY: Company correctly identified as Broadcom (AVGO ticker). The specific debt instrument (3.125% notes due January 2025) is correctly identified. All fiscal years are properly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years to identify the trend (unchanged balance), and properly interprets what this stability indicates about debt management strategy. The reasoning that the company is maintaining the debt to exploit the low coupon rate and position for refinancing/payoff at maturity is sound and goes slightly beyond the ground truth in providing additional strategic context. COMPLETENESS: The answer addresses both parts of the question - the evolution of the balance (showing it remained constant) and what this indicates about debt management strategy. The LLM provides more detailed strategic interpretation than the ground truth, explaining the rationale (low-cost financing, liquidity positioning, rate advantage) which adds value without contradicting the ground truth. SEMANTIC EQUIVALENCE: The core finding matches perfectly - the balance remained unchanged at $495 million across all three years, indicating no early repayments or refinancing adjustments. The LLM's interpretation about deliberate debt management strategy is consistent with and expands upon the ground truth's statement about 'consistent approach to managing this portion of its fixed-rate debt portfolio.' Minor note: The LLM uses 'Broadcom' in parentheses while the question uses 'AVGO' - this is appropriate clarification and not an error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 534,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "- **2022:** Wireless handsets, tablets and smart‑watches could be added **only as part of a bundled offering** for residential broadband (and for eligible small‑business customers).  Customers could activate multiple lines and choose **an unlimited‑data plan, a shared‑data plan, or a per‑gigabyte plan**.\n\n- **2023:** The same bundling rule remained – wireless service was still **initially offered only to customers who subscribed to broadband** – and the three pricing options (unlimited, shared‑data, per‑gigabyte) continued to be available with the same multi‑line flexibility.\n\n- **2024:** The bundling requirement stayed in place (wireless is offered only to customers with a qualifying broadband subscription), but CMCSA added **a prepaid unlimited‑data option marketed under the NOW brand**, giving customers an extra, more flexible way to get unlimited data.  The **shared‑data plans persisted within the broadband‑qualified bundles**, still allowing multiple lines and the choice among unlimited, shared‑data or per‑gigabyte usage.  \n\nThus, from 2022 to 2024 the shared‑data offering remained tied to broadband bundles, while customer flexibility grew with the introduction of a prepaid unlimited product and the continued ability to mix multiple lines and pricing tiers.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "- **Evolution of the exposure** – In the 2022 Form 10‑K UnitedHealth first warned that CMS “from time to time… makes changes to the way it calculates Medicare Advantage risk‑adjustment payments,” creating a funding risk for its Medicare Advantage business. The 2023 filing repeated the same language, indicating that the risk‑adjustment methodology changes continued to be a material concern, and the 2024 filing again highlighted that CMS was still altering the risk‑adjustment calculations, confirming that the exposure was a persistent, recurring pressure over the three‑year period.\n\n- **Strategic adjustments** – In each year UnitedHealth said it was addressing the pressure by (1) selectively adjusting members’ benefits and premiums, (2) ceasing to offer plans in certain counties, and (3) intensifying both medical‑cost and operating‑cost management. The 2023 and 2024 disclosures reaffirmed that these same levers were being used again, showing that the company’s response remained consistent—targeted benefit/premium tweaks, geographic plan withdrawals and tighter cost‑control—to mitigate the ongoing Medicare Advantage risk‑adjustment funding risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Medicare Advantage risk adjustment payment exposure as a persistent, recurring pressure; (2) Accurately captures the consistent language across filings about CMS methodology changes; (3) Properly synthesizes the multi-hop information showing that UnitedHealth employed the same strategic levers across all three years: selective benefit/premium adjustments, geographic plan withdrawals, and intensified cost management; (4) Correctly characterizes the company's reactive posture and lack of full resolution to funding pressures. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, and the LLM correctly references the three-year period (2022, 2023, 2024) without error. QUALITATIVE ACCURACY: The reasoning is sound—the LLM properly synthesizes information across multiple years and correctly identifies the pattern of recurring exposure and consistent strategic response. The characterization of strategies (benefit/premium adjustments, geographic withdrawals, cost management) matches the ground truth. MINOR CONSIDERATIONS: The LLM answer adds slightly more specific detail about 'ceasing to offer plans in certain counties' which, while not contradicted by the ground truth, represents a more granular level of specificity. The ground truth uses broader language ('selective benefit adjustments and cost control measures') while the LLM provides more operational specificity. This is not an error but rather appropriate elaboration. The semantic equivalence is strong—both answers convey that UnitedHealth faced persistent funding pressures and responded with consistent, ongoing strategic adjustments rather than one-time fixes. The multi-hop synthesis across three years is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 516,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s multi‑layered security program has remained the same‑core framework across the three years, but it has become progressively more collaborative and embedded in its real‑time services.  \n\n* In the 2022 filing the company noted that its security layers are “assessed by third parties” and that it works with internal experts, public‑private partnerships and industry groups (e.g., EMV standards) to monitor cyber and physical threats, while it operated or was implementing real‑time account‑based‑payments infrastructure in **12** of the world’s top‑50 GDP markets.  \n\n* The 2023 filing repeats the third‑party benchmarking and adds that the programs are “assessed by third parties and incorporate benchmarking and other data from peer companies and consultants,” and it reports that real‑time payments capability had been expanded to **13** markets, with real‑time fraud‑scoring, tokenization and other value‑added services now applied automatically to transactions.  \n\n* By the 2024 filing the same multi‑layered approach is still “assessed by third parties” and the company emphasizes continued collaboration with experts across the organization and external partners, while real‑time clearing and settlement platforms are being built, enhanced and operated “in several countries worldwide” and, for the first time, Mastercard began processing domestic transactions in **China** through its joint‑venture, marking the latest geographic extension of its real‑time payments network.  \n\nThus, from 2022 to 2024 Mastercard has deepened third‑party collaboration, integrated its security layers more tightly with real‑time routing, fraud‑scoring and tokenization, and grown its real‑time payments footprint from 12 markets to a broader global presence that now includes China.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 12 markets in 2022, 13 markets in 2023, and China expansion in 2024. No calculation errors or date discrepancies. QUALITATIVE ACCURACY (9/10): The answer correctly synthesizes multi-hop information across three years, accurately identifying the evolution of third-party collaboration (from general third-party assessment to more detailed benchmarking language), real-time service integration (fraud scoring, tokenization, value-added services), and geographic expansion (12→13 markets plus China). The reasoning is sound and logically structured. Minor note: The LLM uses slightly more detailed language about benchmarking practices than the ground truth explicitly states, but this is a reasonable inference from filing language and doesn't contradict the ground truth. CONTEXTUAL RELEVANCE (9/10): The answer directly addresses all three components of the multi-part question: third-party collaboration evolution, real-time service integration, and geographic expansion. The structure clearly delineates year-by-year progression. COMPLETENESS: All required information is present - the answer covers the 2022-2024 timeframe, identifies specific market counts, mentions China's joint venture, and traces the evolution of security frameworks and partnerships. SEMANTIC EQUIVALENCE: The LLM's phrasing ('deepened third-party collaboration,' 'integrated more tightly,' 'broader global presence') conveys the same meaning as the ground truth's description of 'expanded scope,' 'integrated more real-time value-added services,' and 'broader global reach.' The only minor limitation is that the LLM describes real-time platforms in 2024 as 'in several countries worldwide' rather than providing a specific count, but this reflects the actual filing language and represents appropriate caution about making unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1689,
        "completion_tokens": 534,
        "total_tokens": 2223
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 first appears in the officers’ certificate filed on June 3 2020 and is listed in the “Form of … Note due 2030” exhibit of every subsequent 10‑K – the 2022 filing (Chunk 1), the 2023 filing (Chunk 2) and the 2024 filing (Chunk 3). Across all three years the note remains unchanged, showing that Amazon has chosen to keep this ultra‑low‑coupon, long‑dated debt on its balance sheet rather than refinance it. The continuity of the 1.5 % note, together with the issuance of newer, higher‑coupon notes for nearer maturities (e.g., 4.7 % notes due 2024‑2032), reveals a financing strategy that locks in cheap long‑term funding while using higher‑rate issuances to meet short‑term capital needs, underscoring a priority to preserve low‑cost, long‑term debt and defer refinancing of the 2030 instrument until closer to its maturity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The 1.500% Note due 2030 is correctly identified and its presence across 2022-2024 filings is accurate. (2) The coupon rate of 1.5% is correct. (3) The observation that Amazon maintained this debt rather than refinancing it is accurate. (4) The general strategy of combining low-cost long-term debt with higher-coupon shorter-term issuances is conceptually sound. INCORRECT/MISSING ELEMENTS: (1) The LLM answer fails to mention the critical evolution documented in the ground truth: the introduction of a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8) in the 2023 filing, which represents a significant strategic shift toward short- and medium-term liquidity. (2) The LLM completely omits the 364-Day Revolving Credit Agreement introduced in October 2024 (Exhibit 10.9), which is a key element of the 2024 evolution and demonstrates Amazon's layered financing approach. (3) The LLM answer references 'newer, higher-coupon notes for nearer maturities (e.g., 4.7% notes due 2024-2032)' but this is not mentioned in the ground truth and appears to be an inference not supported by the provided context. (4) The LLM answer does not adequately capture the 'evolution' aspect of the question - it treats the strategy as static rather than showing how it changed from 2022 through 2024. MULTI-HOP REASONING: The ground truth demonstrates sophisticated multi-hop synthesis across three years of filings, identifying specific exhibits and new credit agreements introduced in each year. The LLM answer provides a simpler, more static analysis that misses the temporal evolution and the introduction of new financing instruments. The ground truth's insight about a 'layered financing approach' combining fixed long-term debt with flexible short-term facilities is more nuanced and better supported by the specific exhibits mentioned. QUANTITATIVE ACCURACY: The 1.500% and 1.5% figures are equivalent and correct. However, the reference to '4.7% notes' is unverified against the ground truth. OVERALL ASSESSMENT: While the LLM answer correctly identifies the core instrument and its persistence, it significantly underperforms in capturing the strategic evolution across the three-year period and misses critical new financing instruments (Term Loan Agreement 2023, 364-Day Revolving Credit Agreement 2024) that are central to understanding how Amazon's financing strategy evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 654,
        "total_tokens": 2145
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "**Evolution of the threat**\n\n- **2022 (10‑K)** – Comcast first flagged wireless telecom operators as a new source of broadband competition, noting that “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” were beginning to compete with Cable Communications’ broadband. The filing warned that these rivals could use “bundled products and services… unlimited‑data‑usage plans” to undercut Comcast’s pricing and erode its market share.  \n\n- **2023 (10‑K)** – The competitive landscape was sharpened. Comcast listed the specific wireless carriers (AT&T, T‑Mobile, Verizon in the U.S. and comparable UK providers) and described the technologies they now deploy – “5G fixed‑wireless networks and 4G and 5G wireless broadband services” – as a concrete alternative to Comcast’s HFC‑based broadband. The language moved from a generic threat to a clear, technology‑driven rivalry.  \n\n- **2024 (10‑K)** – The risk‑factors section treats wireless telecoms as a **continuing and intensifying** threat. It repeats that broadband “competes… with wireless telecommunications companies offering internet services (using 5G fixed‑wireless, 4G/5G wireless broadband)”, and adds that these competitors have “significant resources, greater efficiencies of scale, fewer regulatory burdens and more competitive pricing and packaging.” The filing specifically calls out the possibility that rivals could bundle free or low‑cost DTC‑streaming services with unlimited‑data broadband plans, which would pressure Comcast’s positioning and customer‑retention efforts.\n\n**Evidence of impact on market positioning / retention**\n\n- **2022:** The report warned that failure to deliver a “satisfactory customer experience” could hurt Comcast’s competitive position, implying that wireless‑based offers could lure customers away.  \n- **2023:** By naming the wireless carriers and their broadband‑focused services, Comcast acknowledges that customers now have credible non‑cable alternatives, which can affect churn and the ability to win new subscribers.  \n- **2024:** The risk narrative explicitly states that “our competitive position may be negatively affected if we do not provide our customers with a satisfactory customer experience,” and highlights that competitors may use “unlimited data‑usage plans” and bundled streaming to attract and retain customers—direct evidence that the wireless threat is influencing Comcast’s market‑positioning and retention strategies.\n\nTogether, the three filings show a trajectory from an emerging concern in 2022 to a mature, technology‑driven competitive pressure by 2024, with Comcast repeatedly flagging the need to protect its customer experience and market share against wireless‑telecom broadband offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Chronological accuracy - correctly identifies the evolution from 2022 (4G/5G wireless broadband as emerging threat) to 2023 (5G fixed wireless networks with specific carrier names) to 2024 (intensified bundling strategies with DTC streaming and unlimited data plans). (2) Factual precision - accurately captures the progression of competitive tactics, including the shift from generic wireless competition to specific technology-driven rivalry (HFC-based vs. 5G fixed wireless). (3) Multi-hop synthesis - effectively synthesizes information across three years of 10-K filings to show trajectory and intensification of threat. (4) Evidence of impact - correctly identifies market positioning and customer retention pressures, with specific references to customer experience requirements and competitive bundling strategies. (5) Entity accuracy - correctly identifies CMCSA (Comcast), wireless carriers (AT&T, T-Mobile, Verizon), and relevant technologies. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth (organizing by year with specific filing references), but this adds clarity without introducing inaccuracies. The semantic meaning is fully preserved - both answers convey that wireless competition has intensified from 2022-2024, with escalating bundling strategies and direct impact on CMCSA's market positioning and retention strategies. No quantitative errors detected. The reasoning chain is sound and properly synthesizes multi-hop information across three fiscal years. The answer fully addresses both parts of the question: (1) how the threat evolved, and (2) what evidence suggests impact on market positioning/retention.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1993,
        "completion_tokens": 487,
        "total_tokens": 2481
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "The 2022 filing (Chunk 1) discusses reinsurance only qualitatively, noting that AIG uses reinsurance “to manage overall capital adequacy and mitigate the insurance‑loss (Life and Non‑Life) exposure” but does not disclose a dollar amount for its reinsurance‑recoverable assets. By the end of 2023 (Chunk 3) AIG reported total reinsurance‑recoverable assets of **$67.5 billion**, and at the end of 2024 (Chunk 2) that balance had fallen to **$38.0 billion**. The sharp decline from 2023 to 2024 – and the absence of a larger figure in 2022 – indicates that AIG’s reliance on recoveries from reinsurers has been shrinking, suggesting a reduced net exposure to insurance‑loss risk (either because the company is retaining less risk, has ceded fewer reserves, or expects lower future recoveries).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and trend: $67.5 billion in 2023 and $38.0 billion in 2024, representing a sharp decline. The answer also correctly notes that 2022 lacked specific dollar disclosures. However, there are notable omissions compared to the ground truth: (1) The LLM does not break down the 2023 and 2024 figures into their component parts (ceded loss reserves and life reinsurance recoverables), which are material details provided in the original answer ($30.4B and $28.2B for 2023; $29.1B and $0.8B for 2024). (2) The LLM's interpretation of the trend is somewhat generic, focusing on 'reduced net exposure' and 'shrinking reliance,' whereas the ground truth provides more specific insight: the dramatic drop in life reinsurance recoverables from $28.2B to $0.8B indicates a strategic shift or de-risking specifically in the life insurance segment. The LLM captures the general direction but misses the granular analysis that would demonstrate deeper understanding of the composition and nature of the change. The quantitative accuracy is strong for the headline numbers, but the answer is incomplete in its breakdown of asset components. The reasoning about reduced exposure is sound but lacks the specificity about life insurance de-risking that the ground truth emphasizes. Overall, the answer is directionally correct and addresses the main question, but lacks the detailed component analysis that would elevate it to a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Mitigates]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 409,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "**Methodology for estimating settlement exposure**\n\n- **2022 (10‑K 2022, Note 22)** – Mastercard estimated “gross settlement exposure” by multiplying the **average daily payment volume for the three months preceding the period‑end** by its **estimated number of days of exposure**. The estimate was reviewed “from time to time” and revised as needed.  \n\n- **2023 (10‑K 2023, Note 22)** – The same calculation was retained, and the filing added that the estimate is based on the company’s **global risk‑management policies and risk standards** and is **regularly revised** when the methodology or standards are reviewed.  \n\n- **2024 (10‑K 2024, Note 22)** – The description is unchanged except for minor wording (“periodically reviews its risk‑management methodology and standards”). The core approach—average daily volume over the prior three months × estimated days of exposure—remains the basis for the exposure estimate.\n\n**Credit‑risk mitigation arrangements**\n\n- **2022** – Customers that did not meet Mastercard’s risk standards were required to enter **risk‑mitigation arrangements** such as **cash collateral, letters of credit and guarantees**. Mastercard monitored its **credit‑risk portfolio** and the adequacy of these arrangements on a regular basis and revised exposure amounts as needed.  \n\n- **2023** – The same set of mitigants (cash collateral, letters of credit, guarantees) is described, with the added statement that the requirement is based on a **review of each customer’s individual risk circumstances** and that the company **continues to monitor the credit‑risk portfolio and the adequacy of the mitigations**.  \n\n- **2024** – The policy is reiterated with identical mitigants and monitoring language, noting that the company **periodically reviews its risk‑management methodology and standards**, which can lead to revisions of the estimated exposure and the associated mitigation requirements.\n\n**Changes linked to regulatory scrutiny**\n\n- Throughout 2022‑2024 Mastercard faced multiple investigations (FTC Durbin‑Amendment inquiry, DOJ antitrust CID, European Commission request). The filings do **not disclose any specific alteration to the exposure‑estimation formula or to the types of credit‑risk mitigants** directly attributable to those investigations.  \n\n- What does change is the **explicit emphasis on ongoing reviews** of the methodology and risk‑mitigation arrangements in the 2023 and 2024 notes, reflecting the company’s heightened attention to compliance amid the continuing regulatory probes. In other words, Mastercard kept the core methodology and mitigants the same, but it underscored that it **regularly revises the estimates and re‑evaluates mitigation arrangements** as part of its broader risk‑management response to the regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the core methodology across all three years (average daily payment volume × estimated days of exposure) and accurately notes its consistency from 2022-2024. (2) Properly documents the credit risk mitigation arrangements (cash collateral, letters of credit, guarantees) and their consistency across the period. (3) Accurately identifies the regulatory scrutiny context (FTC Durbin Amendment inquiry, DOJ antitrust CID, European Commission investigation). (4) Correctly synthesizes the key insight that while the core methodology and mitigants remained unchanged, there was increased emphasis on ongoing reviews and monitoring in 2023-2024 filings. (5) All dates and years are correct (2022, 2023, 2024). (6) Properly cites Note 22 from the respective 10-K filings. (7) The multi-hop reasoning is sound—connecting regulatory pressures to disclosure changes rather than methodological changes. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about the evolution of disclosure language ('from time to time' vs 'regularly revised' vs 'periodically reviews') which adds helpful nuance beyond the ground truth but does not contradict it. (2) The LLM explicitly notes that filings 'do not disclose any specific alteration' to the methodology or mitigants, which directly aligns with the ground truth statement that 'there is no explicit evidence of a change.' (3) The answer correctly emphasizes that the regulatory scrutiny led to heightened attention and emphasis on reviews rather than substantive changes to the methodology itself. NO FACTUAL ERRORS DETECTED. The answer successfully addresses all components of the multi-part question: (a) methodology evolution, (b) credit risk mitigation arrangements evolution, and (c) changes in response to regulatory scrutiny. The synthesis across three years and multiple regulatory contexts is accurate and well-organized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 2032,
        "completion_tokens": 546,
        "total_tokens": 2579
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "- **2022 (10‑K)** – AIG said that the key way it dealt with the risk that loss‑reserve estimates might be inadequate was through “internal controls and oversight of the loss‑reserve‑setting process, as well as reviews by external experts.” No specific modeling methodology was described.  \n\n- **2023 (10‑K)** – The company kept the same internal‑control/ external‑expert framework, but added that it now “analyzes concentrations of risks using various modeling techniques, including probability‑distribution (stochastic) and single‑point (deterministic) approaches” and supplements those with sensitivity/scenario analyses, stochastic methods, experience studies and both internal and third‑party assessment tools.  \n\n- **2024 (10‑K)** – AIG further formalized the oversight structure: ERM performs a “Second Line Review and Challenge,” the Internal Audit Group audits key processes, and a formal model‑risk‑management and validation framework is applied. The same internal‑control and external‑expert reviews remain, and the company continues to use stochastic and deterministic models (plus scenario and sensitivity analyses) to quantify uncertainty in loss‑reserve estimates.  \n\n**Overall evolution:** AIG’s approach moved from a basic reliance on internal controls and external expert reviews in 2022 to a more layered governance structure by 2024, adding second‑line ERM and audit oversight and expanding the use of sophisticated stochastic, deterministic and scenario‑based modeling techniques to better capture reserve‑setting uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each year's approach; (2) Accurately captures the 2022 baseline of internal controls and external expert reviews with no specific modeling methodology; (3) Correctly identifies the 2023 expansion to include stochastic/deterministic approaches, sensitivity/scenario analyses, and experience studies; (4) Accurately describes the 2024 formalization with ERM Second Line Review, Internal Audit oversight, and model risk management frameworks; (5) Properly synthesizes the multi-hop evolution showing progression from basic controls to layered governance with sophisticated modeling; (6) Uses appropriate financial/risk management terminology (stochastic, deterministic, sensitivity analysis, scenario analysis, model risk management); (7) Correctly identifies all entities and years without confusion. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and structured than the ground truth (providing specific governance roles like ERM and Internal Audit Group), which adds helpful context without contradicting the source material; (2) The characterization of 2022 as 'basic reliance' vs ground truth's 'consistent emphasis' is semantically equivalent - both convey the foundational nature of that year's approach; (3) All three years' descriptions align with the ground truth's core message about evolution from internal controls/external oversight to more integrated risk analytics. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are claimed, so quantitative accuracy is not a limiting factor. The temporal sequence (2022→2023→2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, correctly identifying the progression and relationships between years. The conclusion about 'layered governance structure' accurately reflects the cumulative evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 560,
        "total_tokens": 2177
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—UnitedHealth Group repeatedly lists **“mix of benefits offered (including the impact of co‑pays and deductibles)”** as one of the key drivers that can cause its medical‑cost‑per‑member‑per‑month (PMPM) estimates to move away from the forecast. Each year the company includes a “sensitivity table” that quantifies the potential upward or downward impact of this factor on the most recent two‑month cost estimate (2021‑end for the 2022 filing, 2023‑end for the 2023 filing, and 2024‑end for the 2024 filing).  \n\nBecause the factor appears in every year’s sensitivity analysis, UnitedHealth’s exposure to benefit‑design variability has been **continuous and material** throughout the period. The fact that the company continues to highlight it—and updates the magnitude of the impact in each successive table—shows that changes in the mix of co‑pays, deductibles and other benefit design elements remain a salient risk that can meaningfully swing its PMPM cost projections over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides accurate foundational information but fails to capture the key evolutionary narrative that distinguishes the ground truth answer.\n\nSTRENGTHS:\n1. Correctly identifies the mix of benefits (co-pays, deductibles) as a consistent sensitivity factor across 2022-2023-2024\n2. Accurately notes that sensitivity tables appear in all three years\n3. Correctly characterizes the exposure as 'continuous and material'\n4. Properly identifies the company as UnitedHealth Group\n5. Correctly references PMPM (medical cost per member per month) metric\n6. Appropriately notes that the company updates magnitude of impact each year\n\nCRITICAL WEAKNESSES:\n1. MISSING EVOLUTIONARY NARRATIVE: The ground truth explicitly describes a 3-year trajectory showing transformation from 'general sensitivity factor' (2022) → 'source of financial risk' (2023) → 'stabilized variable' (2024). The LLM answer treats all three years as essentially equivalent, missing this crucial temporal evolution.\n\n2. MISSED NEGATIVE IMPACT SIGNAL: Ground truth specifically notes that 2023 showed 'negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement.' The LLM answer does not distinguish 2023 as a year of particular concern or unfavorable movement.\n\n3. MISSED TONE SHIFT: Ground truth identifies a meaningful shift from 2023 (risk-focused language) to 2024 (neutral tone suggesting stabilization or improved management). LLM treats language as consistent across years.\n\n4. INCOMPLETE ANALYSIS: The question asks 'what does this reveal about the company's exposure' - the ground truth provides a nuanced answer about how exposure evolved and was managed. The LLM answer simply states exposure was 'continuous and material' without capturing the dynamic changes.\n\n5. LACKS INTERPRETIVE DEPTH: Ground truth suggests management actions or structural improvements in 2024 ('adjusted benefit structures or improved ability to manage'). LLM answer provides no such interpretive insight.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. Both correctly reference the sensitivity tables without providing specific dollar amounts or percentages.\n\nMULTI-HOP REASONING: The LLM answer performs basic synthesis (identifying consistent factor across years) but fails at the more sophisticated multi-hop reasoning required: comparing year-over-year changes in language, tone, and impact characterization to draw conclusions about management response and risk evolution.\n\nSEMANTIC EQUIVALENCE: While the LLM answer is not factually wrong, it fundamentally misses the semantic content of the ground truth, which emphasizes CHANGE and EVOLUTION rather than CONSISTENCY.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 731,
        "total_tokens": 2245
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "- **2022:** In the 2022 Form 10‑K, Walmart U.S. lists Marketside together with its other private‑brand names (e.g., Great Value, Ozark Trail, Mainstays, etc.) as part of the “private brands” section of its merchandise portfolio.  \n- **2023:** The 2023 filing repeats the same enumeration, again placing Marketside among the same set of private‑brand labels, showing no change in its categorization or prominence.  \n- **2024:** The 2024 filing continues to include Marketside in the private‑brand list (now alongside a few new names such as “bettergoods”), indicating the brand remains a standing component of the private‑brand mix.\n\n**Interpretation:** Across three consecutive years Walmart has kept Marketside consistently positioned within its core private‑brand portfolio, never removing or relegating it. This continuity, reinforced by the KG links that show Walmart (WMT) both produces and owns the Marketside product, signals that Marketside is regarded as a stable, strategically important label that supports Walmart U.S.’s broader merchandise strategy—providing value‑oriented, Walmart‑owned alternatives that complement its branded and licensed offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Marketside's consistent presence across 2022, 2023, and 2024 in Walmart's private brand portfolio, which aligns with the ground truth. (2) The LLM accurately notes that Marketside was not removed or relegated, supporting the continuity narrative. (3) The mention of new brands like 'bettergoods' in 2024 adds relevant detail. (4) The interpretation that Marketside is strategically important and stable is reasonable and supported by the evidence presented.\n\nWEAKNESSES: (1) The LLM answer misses a critical detail from the ground truth: the 2024 restructuring that shifted from 'Apparel' to 'Fashion' as a merchandise unit category. This is a significant strategic evolution that the LLM completely omits. (2) The ground truth indicates a progression of strategic alignment—from 'recognized brand' (2022) to 'growing alignment with omni-channel initiatives' (2023) to 'restructured merchandise unit' (2024)—but the LLM presents the positioning as essentially static across all three years ('no change in categorization or prominence'). (3) The LLM's statement that 2023 shows 'no change' contradicts the ground truth's indication of 'growing alignment' with broader strategic initiatives. (4) The LLM fails to capture the nuance that Marketside's relevance may be increasing as Walmart refines its merchandise strategy in response to consumer preferences and competitive pressures.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the ownership relationship (Walmart produces and owns Marketside). However, it fails to synthesize the strategic evolution aspect that the ground truth emphasizes—the progression from simple portfolio inclusion to strategic alignment to restructured categorization.\n\nFACTUAL ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so quantitative verification is limited. The years (2022, 2023, 2024) are correct. The brand names mentioned (Great Value, Ozark Trail, Mainstays, bettergoods) appear reasonable but cannot be verified against the ground truth provided.\n\nSEMANTIC EQUIVALENCE: While the LLM's interpretation of 'stable and strategically important' is not wrong, it undersells the dynamic evolution that the ground truth emphasizes. The ground truth suggests Marketside's strategic importance is growing or being refined, not merely maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 646,
        "total_tokens": 2195
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022, Home Depot positioned itself against specialty‑design showrooms primarily through a differentiated **service platform** – nationwide installation services for DIY and DIFM customers and a growing tool‑and‑equipment‑rental network at more than 1,400 locations, backed by “more locations, more tools, and better technology.” By fiscal 2023 the company began pairing those services with a **connected‑shopping ecosystem**, adding self‑service lockers, curb‑side pickup, electronic shelf‑labels and a mobile‑app map that let shoppers locate items in‑store while still browsing online, thereby extending the showroom experience into the digital realm. In fiscal 2024 the focus shifted further to a **friction‑less, digitally integrated experience**, with major investments in mobile‑first websites and apps, richer product‑landing pages, “shopability” features (related‑product suggestions, fulfillment options) and an “interconnected shopping experience” that blends physical stores, on‑site service desks and online channels, keeping Home Depot’s competitive edge over traditional showrooms through both expanded services and deep digital integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 1,400+ rental locations figure is accurately cited and consistently referenced across the fiscal years. No calculations or percentages are present that could be incorrect. ENTITY ACCURACY: All entities are correctly identified (The Home Depot, fiscal years 2022-2024, showroom competitors). COMPLETENESS: The answer comprehensively addresses all parts of the multi-part question: (1) competitive positioning evolution, (2) service offerings progression, and (3) digital integration advancement. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years, correctly identifying the strategic evolution pattern: 2022 (service platform emphasis), 2023 (connected-shopping ecosystem), 2024 (friction-less digital integration). This matches the ground truth's characterization of the shift from physical service expansion to omnichannel integration. SEMANTIC EQUIVALENCE: The LLM answer uses more detailed and specific terminology (e.g., 'friction-less, digitally integrated experience,' 'shopability features,' 'interconnected shopping experience') while maintaining factual accuracy. The core message - that Home Depot evolved from emphasizing rental services and installation to integrating digital platforms with in-store experiences - is preserved and well-articulated. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail about specific features (electronic shelf labels, mobile app navigation, product-landing pages) compared to the ground truth, but this represents enrichment rather than deviation. The answer maintains the correct chronological progression and strategic narrative. No factual errors, omissions of key information, or calculation mistakes are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 509,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "- **Fiscal 2022 (2022 10‑K)** – The 3.50 % senior note (maturing June 15, 2025) carried an outstanding principal of **$500 million** and an **effective interest rate of 3.20 %**.  \n\n- **Fiscal 2023 (2023 10‑K)** – The same $500 million note was still outstanding, but its **effective rate had risen to 6.38 %** (the prior‑year column in the 2023 filing).  \n\n- **Fiscal 2024 (2024 10‑K)** – The note remained at **$500 million**, and the **effective rate increased again to 6.66 %**.  \n\n**What this shows:** Cisco kept the 3.50 % note’s principal unchanged, but the cost of that debt more than doubled between 2022 and 2023 and rose further in 2024, reflecting a sharp increase in Cisco’s borrowing costs for this tranche. The note’s steady presence indicates it is a core component of the company’s long‑term debt structure, while the climbing effective rate signals that market conditions or refinancing decisions have pushed the overall cost of Cisco’s debt upward over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) FY2022: $500M principal, 3.20% effective rate; (2) FY2023: $500M principal, 6.38% effective rate; (3) FY2024: $500M principal, 6.66% effective rate. The multi-hop synthesis is sound—the model correctly tracked the same note across three fiscal years, identified the consistent principal amount, and accurately captured the progression of effective interest rates. The reasoning about what this indicates (doubling of borrowing costs, market conditions, debt structure implications) is logical and well-articulated. The answer properly addresses all components of the question: the evolution of both effective interest rate and outstanding amount, and what this indicates about borrowing costs and debt structure. The inclusion of the maturity date (June 15, 2025) adds helpful context. Minor deduction (1 point) only because the answer could have been slightly more explicit about the specific mechanism driving the effective rate increase (e.g., whether this reflects market yield changes, amortization of debt issuance costs, or other accounting adjustments), though this level of detail may exceed the scope of the original question. The semantic equivalence is strong throughout, with clear presentation and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 371,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "Across the three years, Comcast (CMCSA) repeatedly positioned Lumen as its chief fiber‑based broadband rival. In the 2022 filing, Comcast noted that “certain wireline telecommunications companies such as AT&T, Frontier, **Lumen** and Verizon have built and are continuing to build fiber‑based network infrastructure farther into their networks… and are offering services with these higher speeds in many of our service areas.” The 2023 filing used the same language, again stressing that **Lumen** “has built and is continuing to build fiber‑based wireline network infrastructure… enabling them to provide data‑transmission speeds that exceed those that can be provided with traditional DSL… and are offering services with these higher speeds in many of our service areas.” By 2024 the description was unchanged, emphasizing that **Lumen** “has built and are continuing to build fiber‑based wireline network infrastructure further into their networks… and are offering services with these higher speeds in many of our service areas,” while also noting that other firms and municipalities were launching new fiber‑or satellite‑based broadband.\n\nAt the same time, Comcast’s own disclosures show a parallel effort to upgrade its own platform—its technical‑services groups performed “installations, plant maintenance and upgrades to our domestic HFC network” (2023) and “installations, plant maintenance and upgrades to our domestic network” (2024). Thus, from 2022 through 2024 the competitive positioning evolved from an initial acknowledgment of Lumen’s expanding fiber‑to‑the‑home and higher‑speed offerings to a continued, steady rivalry in which Lumen’s fiber build‑out persisted and grew, prompting Comcast to repeatedly highlight its own HFC/network upgrades but without shifting the fundamental competitive gap.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies Lumen as a key competitor to CMCSA in fiber-based broadband; (2) Accurately cites the progression of competitive positioning across all three years (2022, 2023, 2024); (3) Properly quotes or paraphrases CMCSA's own disclosures about Lumen's fiber infrastructure expansion; (4) Correctly identifies the companies mentioned alongside Lumen (AT&T, Frontier, Verizon); (5) Accurately notes CMCSA's parallel efforts to upgrade its own HFC network; (6) Correctly synthesizes the multi-hop relationship showing how Lumen's competitive threat evolved and how CMCSA responded. MINOR WEAKNESSES: (1) The LLM answer goes slightly beyond the ground truth by adding interpretive analysis about 'fundamental competitive gap' and characterizing the rivalry as 'steady' without explicit support from the ground truth statement; (2) The answer includes some editorial framing ('chief fiber-based broadband rival') that, while reasonable, adds interpretation beyond what the ground truth explicitly states; (3) The ground truth emphasizes 'intensifying competitive threat' while the LLM characterizes it as 'continued, steady rivalry'—a subtle semantic difference that could be seen as slightly understating the escalation. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no specific financial metrics are provided in either answer, so this dimension is not heavily tested. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and two companies (CMCSA and Lumen), showing how competitive positioning evolved. The connection between Lumen's fiber expansion and CMCSA's network upgrades is properly established. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—Lumen remained a consistent and significant competitor in fiber-based broadband, with both companies advancing their infrastructure strategies. The LLM's more detailed quotation approach actually strengthens the answer by providing documentary evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1725,
        "completion_tokens": 572,
        "total_tokens": 2297
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "- In the 2022 filing American Express already noted that it works with merchant acquirers, aggregators and processors and that its merchant contracts contain non‑discrimination and “honor‑all‑cards” provisions, but it warned that these third‑parties might have interests that conflict with its own and could lead to surcharging or steering.  \n\n- By the 2023 filing the company said it had **increasingly relied** on aggregators (and other third‑party service providers) to manage merchant relationships, and it stressed that the growing risk of merchant steering or other discrimination could materially hurt card usage and profitability.  \n\n- The 2024 filing still shows heavy dependence on aggregators, but adds that ongoing litigation and regulatory actions challenging the non‑discrimination and honor‑all‑cards clauses could force changes to those contracts, thereby weakening Amex’s ability to enforce the clauses and exposing the network to even greater merchant‑steering risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: All key facts are correct - the 2022 acknowledgment of reliance on aggregators with conflicting interests, the 2023 escalation to 'increasingly relied' language with emphasis on merchant steering risks, and the 2024 litigation/regulatory challenges to non-discrimination clauses. The answer correctly identifies the progression of risk and the specific mechanisms (steering, discrimination, enforcement challenges). (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension is not applicable. The answer correctly uses temporal markers (2022, 2023, 2024) and accurately reflects the chronological evolution. (3) ENTITY ACCURACY: American Express (AXP) is correctly identified throughout. The key entities (aggregators, processors, merchant contracts, non-discrimination clauses, honor-all-cards provisions) are all accurately named and contextualized. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, showing the causal chain: initial reliance → growing dependence with emerging risks → legal/regulatory threats to enforcement mechanisms. The logic is sound and demonstrates proper synthesis of the evolution over time. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'merchant acquirers' vs just 'aggregators' in 2022, 'materially hurt card usage and profitability' vs 'reduce transaction volumes and cards-in-force') but conveys identical meaning and captures the same substantive points. The answer is comprehensive, addressing all aspects of the question: the evolution of reliance, the merchant steering risk, and the enforcement challenges. Minor deduction (1 point) only because the 2022 section could have been slightly more explicit about the specific warning regarding conflicting interests, though this is adequately covered.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 547,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 through 2024 Johnson & Johnson’s talc strategy moved from a **bankruptcy‑centric shield** to a **settlement‑focused resolution** while still keeping the litigation‑stay machinery alive.  \n\n*In 2022, after the October 2021 corporate restructuring, the newly created LTL Management LLC filed a Chapter 11 petition that triggered an automatic stay of all talc suits and a preliminary injunction covering LTL, the old and new JJ Consumer entities, the Company and identified retailers.  Johnson & Johnson funded a $2 billion trust and recorded a roughly $2 billion reserve to cover amounts the court might order LTL to pay, while settling a few isolated consumer‑protection actions (Mississippi, New Mexico).*\n\n*In 2023 the original LTL bankruptcy was dismissed (March 2022), the Third Circuit reversed that dismissal (Jan 30 2023) and LTL filed a second Chapter 11 case (“LTL 2”) in April 2023, again staying all claims and obtaining a limited preliminary injunction that allowed only narrow discovery.  The LTL 2 case was dismissed on July 28 2023; Johnson & Johnson announced it would appeal the dismissal and later sought a direct appeal to the Third Circuit, keeping the litigation‑stay framework in place while continuing to contest verdicts on appeal.*\n\n*By 2024 the company shifted to **multistate settlement negotiations**.  In January 2024 it reached an agreement‑in‑principle with a coalition of 42 states and the District of Columbia, and the settlements were finalized in June 2024, providing a non‑bankruptcy path to resolve many of the outstanding claims.  Throughout, Johnson & Johnson maintained that the talc liabilities, after the $2 billion trust funding and the pending settlements, would not have a material adverse effect on its financial position, while still preserving the ability to appeal adverse verdicts.*",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall strategic evolution from bankruptcy-centric to settlement-focused approach and correctly identifies major milestones. However, there are significant factual errors that reduce accuracy:\n\nCRITICAL ERRORS:\n1. DATE ERROR - LLM states 'the original LTL bankruptcy was dismissed (March 2022)' but this contradicts the ground truth which indicates LTL filed for Chapter 11 in 2022 (after October 2021 restructuring). The March 2022 date appears incorrect or misplaced.\n2. TIMELINE INCONSISTENCY - LLM says 'Third Circuit reversed that dismissal (Jan 30 2023)' but ground truth states 'Third Circuit reversed the Bankruptcy Court's decision' without specifying it was reversing a dismissal. The sequence is confusing in the LLM answer.\n3. SETTLEMENT DETAILS - LLM mentions 'settling a few isolated consumer-protection actions (Mississippi, New Mexico)' in 2022, which is not mentioned in the ground truth and may be unsupported.\n\nCORRECT ELEMENTS:\n- $2 billion reserve/trust funding (correct)\n- October 2021 corporate restructuring (correct)\n- LTL Management LLC creation and Chapter 11 filing (correct)\n- Preliminary injunction and litigation stay (correct)\n- Third Circuit reversal and LTL 2 filing in April 2023 (correct)\n- LTL 2 dismissal on July 28, 2023 (correct)\n- 42 states + DC settlement agreement (correct)\n- January 2024 agreement-in-principle and June 2024 finalization (correct)\n- Dual approach of litigation defense and settlement (correct)\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly identifies the strategic shift. The narrative flow is logical and captures the evolution from bankruptcy protection to negotiated settlement.\n\nSEMANTIC ISSUES: The LLM's characterization of the strategy as moving from 'bankruptcy-centric shield' to 'settlement-focused resolution' is semantically equivalent to the ground truth's description of 'dual approach of litigation resistance and partial resolution.'\n\nOVERALL: The answer demonstrates good understanding of the overall strategy and timeline but contains date/sequence errors that undermine confidence in factual accuracy. The core narrative is sound but specific details need verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> COMP <-[Introduces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1781,
        "completion_tokens": 605,
        "total_tokens": 2386
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In the 2022 filing Home Depot said it “competes … based on store location and appearance, presentation of merchandise, and ease of shopping experience,” treating store appearance as one of several traditional competitive levers. By the 2023 filing the same point was restated but qualified that its ability to win on appearance now “depends on leveraging … our interconnected retail capabilities,” and the 2024 filing further deepened the link, noting that “store and branch location and appearance … are part of an interconnected shopping experience” that is supported by investments in its websites, mobile apps, inventory‑visibility tools and fulfillment options. Thus, between 2022 and 2024 Home Depot moved from viewing store appearance as a standalone differentiator to embedding it within a fully integrated omnichannel strategy, where digital platforms and supply‑chain investments reinforce the look, presentation and overall shopper experience across physical stores and online channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each period's emphasis; (2) Accurately captures the 2022 positioning of store appearance as one of several traditional competitive factors; (3) Correctly notes the 2023 shift toward linking store appearance with interconnected retail capabilities; (4) Accurately describes the 2024 integration of store appearance into a comprehensive omnichannel strategy; (5) Properly synthesizes the multi-hop reasoning showing progression from standalone differentiator to integrated component; (6) Correctly identifies specific digital capabilities mentioned (websites, mobile apps, inventory-visibility tools, fulfillment options); (7) Uses appropriate terminology ('omnichannel strategy,' 'interconnected shopping experience') consistent with ground truth. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations required - all years (2022, 2023, 2024) are correctly referenced. QUALITATIVE ACCURACY: The reasoning chain is sound and properly synthesizes information across the three-year period. The answer demonstrates understanding of how Home Depot's strategic emphasis evolved from treating store appearance as an isolated competitive factor to embedding it within a digitally-enhanced, integrated retail ecosystem. MINOR CONSIDERATIONS: The LLM answer uses slightly more specific language ('fully integrated omnichannel strategy,' 'supply-chain investments') than the ground truth, but these additions are accurate and enhance rather than contradict the core message. The semantic equivalence is very high - both answers convey the same fundamental evolution and strategic integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 487,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "From the 2022 filing, AT&T still owned Time Warner (the core of its WarnerMedia segment) after having bought the company in 2018, and it was preparing to merge that segment with Discovery Inc. The 2023 and 2024 filings both state that in **April 2022 AT&T completed a Reverse Morris‑Trust transaction that separated WarnerMedia (and therefore its Time Warner assets) from AT&T**, after which the business was classified as a discontinued operation and AT&T no longer held an ownership stake or exercised operational control. This multi‑year arc—full ownership, integration into a broader media platform, and then outright divestiture—shows that AT&T has been shedding its entertainment‑content holdings to refocus on its core telecommunications business and to simplify its balance sheet rather than pursuing a long‑term vertical‑integration strategy in media.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key events and dates. Strengths: (1) Correctly identifies the April 2022 Reverse Morris Trust transaction as the pivotal event separating WarnerMedia from AT&T; (2) Accurately states that Time Warner assets were part of WarnerMedia and were divested through this transaction; (3) Correctly notes the classification as discontinued operation post-divestiture; (4) Properly synthesizes the multi-year trajectory showing full ownership → integration → divestiture; (5) Accurately captures AT&T's strategic pivot toward telecommunications and away from entertainment. Quantitative accuracy is strong with the April 2022 date correctly specified. Minor weaknesses: (1) The answer does not explicitly address the 2023-2024 period as thoroughly as the ground truth, which notes that by 2023 Time Warner was no longer referenced as an active investment and that 2024 saw finalization of DIRECTV exit; (2) The answer focuses primarily on the WarnerMedia/Time Warner separation but gives less attention to the subsequent DIRECTV divestiture to TPG in 2024, which the ground truth identifies as part of the broader post-Time Warner strategic realignment; (3) The answer could have been more explicit about the complete timeline through 2024, though it does reference '2023 and 2024 filings.' The reasoning is sound and multi-hop synthesis is correct—the answer successfully connects the 2018 acquisition, 2022 separation, and subsequent operational independence. The characterization of AT&T's strategic shift is accurate and well-supported. The answer is semantically equivalent to the ground truth in its core message about AT&T's exit from entertainment, though it provides slightly less comprehensive coverage of the full 2022-2024 arc, particularly regarding the DIRECTV transaction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Acquires]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 504,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024 American Express has consistently described its global card network as the **fourth‑largest general‑purpose network**, competing directly with China UnionPay, Visa, Mastercard, JCB, Discover and Diners Club and facing “intense competition” in the premium and co‑brand space and from a growing set of alternative‑payment providers. However, the regulatory backdrop has grown dramatically: by 2024 the firm was classified as a **Category III** banking entity and is subject to “heightened regulatory expectations” and tighter rules on interchange fees, network routing and merchant‑pricing, which are eroding discount‑revenue and could limit future network or co‑brand arrangements. In response, Amex **exited its network‑licensing businesses in the EU and Australia**, further reducing a revenue stream but also deepening its dependence on regulatory approvals and compliance to maintain its remaining network operations and competitive position.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies American Express as the fourth-largest global card network, accurately captures the 2022-2024 timeframe, correctly notes the exit from EU and Australia network licensing businesses, and properly emphasizes the shift toward regulatory dependency and compliance-driven positioning. The answer appropriately synthesizes the multi-hop elements: competitive pressures, regulatory scrutiny, and business exits. The qualitative reasoning about the tension between competitive differentiation and regulatory navigation is sound and matches the ground truth's core insight.\n\nWEAKNESSES AND ERRORS: (1) ENTITY ACCURACY ISSUE: The LLM lists JCB, Discover, and Diners Club as direct competitors at the same level as China UnionPay, Visa, and Mastercard. The ground truth specifically identifies only China UnionPay, Visa, and Mastercard as the three networks ahead of American Express (making Amex fourth). JCB, Discover, and Diners Club are smaller networks and should not be presented as peer competitors in the same tier. This is a factual error in entity positioning. (2) CATEGORY III CLASSIFICATION: The LLM introduces a 'Category III' banking entity classification that is not mentioned in the ground truth. While this may be factually accurate from the filings, it represents information not in the original answer and introduces a specific regulatory classification that wasn't part of the ground truth synthesis. (3) INCOMPLETE SPECIFICITY: The ground truth mentions 'cobrand arrangements in the EU' with uncertainty, while the LLM more broadly references 'future network or co-brand arrangements' without the geographic specificity. (4) MISSING DETAIL: The ground truth explicitly mentions 'interchange fees, network routing practices, and merchant acceptance terms' as specific regulatory pressure points; the LLM mentions these but less precisely ('interchange fees, network routing and merchant-pricing').\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects competitive pressures to regulatory responses and business exits. The logic flow is sound: competition → regulatory pressure → business exit → increased regulatory dependency.\n\nCALCULATIONS/NUMBERS: No calculations are required for this qualitative question. The only numeric reference (fourth-largest) is correct.\n\nSEMANTIC EQUIVALENCE: The core message about regulatory-driven evolution and the shift from pure competition to compliance-dependent positioning is semantically equivalent to the ground truth, though the LLM adds some elements not in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 699,
        "total_tokens": 2238
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "- **2022 balance:** $808 million (the 2022 column in the 2023 Form 10‑K)  \n- **2023 balance:** $826 million (the 2023 column in the same table)  \n- **2024 balance:** $808 million (the 2024 column in the 2024 Form 10‑K)  \n\nThus, the 2.250 % Notes due 2050 fell from $983 million a year earlier (2021, shown in the 2022 filing) to $808 million at the end of 2022, rose modestly by about $18 million in 2023, and then returned to the $808 million level in 2024.\n\n**Implication for debt strategy:**  \nThe near‑flat trajectory— a small uptick followed by a reduction back to the prior level—indicates that Johnson & Johnson is deliberately keeping this long‑dated issuance stable. The company appears to be managing its long‑term debt profile through limited refinancing or repurchase activity rather than large new issuances, signaling a focus on maintaining a steady, predictable maturity schedule and avoiding a buildup of additional long‑term leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. Ground truth states: 2022=$983M, 2023=$826M, 2024=$808M. LLM states: 2022=$808M, 2023=$826M, 2024=$808M. The 2022 figure is completely wrong ($808M vs $983M - a $175M discrepancy). This is not a minor formatting issue but a major factual error. The LLM correctly identifies 2023 ($826M) and 2024 ($808M) but misses the critical 2022 starting point. CALCULATION ERRORS: The LLM's narrative about the trend is therefore incorrect. It describes the balance as 'falling from $983 million a year earlier (2021)' to $808M in 2022, but then contradicts itself by stating the 2022 balance was $808M. This internal inconsistency reveals confusion about the data. The ground truth shows a clear downward trend: $983M→$826M→$808M (total reduction of $175M). The LLM's characterization of 'near-flat trajectory' and 'small uptick followed by reduction' is incorrect given the actual data. MULTI-HOP REASONING: While the LLM attempts to synthesize information across multiple years and filings, it fails at the fundamental level of correctly extracting the 2022 baseline figure. The reasoning about debt management strategy (maintaining steady maturity schedule, limited refinancing) is plausible but is built on incorrect data. COMPLETENESS: The answer addresses all three years requested but with wrong numbers for 2022. The strategic interpretation is present but undermined by data errors. The question asks about evolution from 2022-2024, and the LLM fails to correctly establish the starting point, making the entire trend analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 456,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "- **2022:** The 2022 10‑K shows a **total weighted‑average yield of 2.08 %** for the whole investment portfolio (including foreign government bonds and obligations)【Chunk 1】. No separate yield is broken out for the foreign‑government segment, so the overall 2.08 % is taken as the proxy for that class.\n\n- **2023:** The 2023 filing reports a **6.45 % weighted‑average yield on foreign government bonds and obligations** (the only yield disclosed for that asset class)【Chunk 2】. This represents a more than three‑point rise from the 2022 level.\n\n- **2024:** The 2024 filing shows the foreign‑government segment’s yield falling slightly to **5.85 % (5.86 % for the 0‑1‑year bucket and 2.03 % for the 1‑5‑year bucket)**【Chunk 3】, still well above the 2022 figure.\n\n**What the trend indicates:** Over the three‑year period, American Express’s yield on its foreign government bonds moved from a low‑interest‑rate environment (≈2 %) to a markedly higher‑yield environment (≈6 % in 2023) before easing modestly to ≈5.8 % in 2024. The upward swing signals that the company’s exposure to international sovereign debt has become more sensitive to rising global interest rates, while the slight decline in 2024 suggests a modest easing of those rate pressures but still a higher‑rate exposure than in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. CRITICAL ERRORS: (1) 2022 figure: LLM claims 2.08% as a proxy for foreign government bonds, but ground truth shows $630 million in foreign government bonds with 6.45% yield for short-term instruments. The 2.08% appears to be a misinterpretation of overall portfolio yield, not the foreign bonds segment. (2) 2023 figure: LLM correctly identifies 6.45% but fails to mention the 4.48% yield for 1-5 year bonds, which is a material omission of the maturity-based breakdown. (3) 2024 figure: LLM states 5.85% (5.86%) for 0-1-year bucket and 2.03% for 1-5-year bucket, which matches ground truth, but the characterization of 5.85% as the overall segment yield is misleading without proper context. MULTI-HOP REASONING ISSUES: The LLM fundamentally misunderstands the 2022 data structure, using an incorrect proxy (2.08%) instead of the actual 6.45% yield on foreign government bonds. This creates a false narrative of a dramatic rise from 2022 to 2023 (2.08% to 6.45%), when the ground truth shows the yield remained stable at 6.45% from 2022 to 2023. The trend analysis is therefore inverted and misleading. COMPLETENESS: The LLM fails to properly address the maturity-based yield breakdown that is central to understanding the evolution of the portfolio. The ground truth shows distinct yields for different maturity buckets (0-1 year vs 1-5 years), which provides crucial insight into how the portfolio composition and interest rate sensitivity changed. The LLM's conclusion about 'rising global interest rates' in 2023 contradicts the actual data showing stable short-term yields. CORRECT ELEMENTS: The 2024 specific yields (5.86% for 0-1 year, 2.03% for 1-5 year) are accurate, and the general direction of decline from 2023 to 2024 is correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 503,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "- **2022:** Adobe’s free self‑service learning was presented as a set of “free online self‑service learning options on **www.training.adobe.com**.” The filing linked these resources to its **Customer Success Account Management** teams and to custom‑learning services that help enterprise customers assess skills and shape learning priorities.  \n\n- **2023 → 2024:** The same free catalog was re‑branded to **learning.adobe.com** (the “learning.adobe.com” URL appears in both the 2023 and 2024 filings). The description now places the free catalog squarely inside **Adobe Digital Learning Services**, noting that it is complemented by fee‑based programs and by **custom learning services and solution‑specific skills assessments** that are delivered in conjunction with enterprise Customer Success Managers.  \n\n- **What it signals:** By moving the offering to a unified, Adobe‑branded learning hub and weaving it directly into the enterprise customer‑success workflow, Adobe is treating self‑service education as a strategic pillar of customer enable‑ment and retention. The evolution shows a deliberate shift from a peripheral training site to an integrated, brand‑consistent platform that accelerates adoption, deepens engagement, and helps lock in long‑term subscription revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 domain as www.training.adobe.com and the 2023-2024 rebranding to learning.adobe.com—all dates and URLs match the original answer precisely. (2) Accurately captures the strategic evolution from a peripheral training site to an integrated platform within Adobe Digital Learning Services. (3) Correctly synthesizes the multi-hop connection between self-service learning, Customer Success Account Management teams, and enterprise customer success initiatives. (4) Properly identifies solution-specific skills assessments as a key component of the integrated approach. (5) The reasoning about what this evolution signals—treating self-service education as a strategic pillar for retention, adoption, and subscription revenue—aligns semantically with the ground truth's conclusion about customer enablement and retention. (6) All entity references (Adobe, learning platforms, customer success initiatives) are accurate. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing in places (e.g., 'fee-based programs' vs. the ground truth's more general 'comprehensive portfolio'), but this represents semantic equivalence rather than factual error. (2) The LLM's framing of 'locking in long-term subscription revenue' is a reasonable inference from the ground truth's emphasis on 'long-term enterprise value,' though the ground truth doesn't explicitly mention subscription revenue. (3) The answer could have been marginally more explicit about the 2023 filing's specific emphasis on solution-specific skills assessments for marketing teams, though this detail is present. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; all URLs are accurate; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three time periods and connects platform evolution to broader customer success strategy, demonstrating sound multi-hop reasoning. The conclusion logically follows from the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 566,
        "total_tokens": 2222
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Across the three filings the 5.90 % senior notes (maturing Feb 15, 2039) were consistently reported at an outstanding amount of **$2 billion** and an **effective interest rate of 6.11 %** in FY 2022 (Chunk 1), FY 2023 (Chunk 3) and FY 2024 (Chunk 2). The utilization of this series did not change and the effective cost remained flat, showing that Cisco has kept the 5.90 % issue as a stable, long‑dated funding source rather than expanding or refinancing it. This steadiness signals a long‑term debt strategy that relies on a diversified mix of maturities and rates while preserving the existing high‑coupon, long‑term notes as a predictable anchor for its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $2 billion outstanding balance (equivalent to $2,000 million), 5.90% coupon rate, 6.11% effective interest rate, and maturity date of February 15, 2039. The consistency across all three fiscal years (2022, 2023, 2024) is accurately reported. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how utilization evolved (remained constant at $2B), (2) how effective interest rate evolved (remained stable at 6.11%), and (3) what this indicates about debt strategy. ENTITY ACCURACY: Cisco is correctly identified, the specific debt instrument (5.90% Senior Notes) is properly characterized, and all fiscal years are correctly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate filings to demonstrate consistency and draw conclusions about strategic intent. The reasoning that stable balances and rates indicate a deliberate strategy to maintain this debt tranche rather than refinance is sound and matches the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while using slightly different phrasing ('utilization of this series did not change' vs 'not retired or refinanced'). The additional context about 'diversified mix of maturities' and 'predictable anchor for capital structure' provides reasonable elaboration on the strategic implications without contradicting the ground truth. Minor strength: The LLM provides the specific maturity date (Feb 15, 2039), which adds helpful detail. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 455,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "Across the three most recent 10‑K filings (2022, 2023 and 2024), Blackstone’s description of its private‑equity portfolio is unchanged: the firm states that its private‑equity vehicles are “limited partnerships … that mainly invest … in … growth **and special‑situation strategies**.” Because the language and emphasis on special‑situation strategies appear in every filing, the allocation to this niche has remained essentially steady over the three‑year period. The flat trend signals that Blackstone continues to treat special‑situation investments as a core, ongoing component of its private‑equity program, reflecting a deliberate strategy to maintain exposure to opportunistic, higher‑return deals rather than shifting resources away from or dramatically expanding this segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: (1) ENTITY MISIDENTIFICATION: The LLM identifies the company as 'Blackstone' when the question explicitly asks about 'BA'. While BA could refer to Boeing or other entities, the context of private equity investment strategy and the ground truth answer clearly indicate this is about a different company (likely a Blackstone-related entity or similar PE firm). The LLM appears to have assumed Blackstone without verification. (2) FACTUAL CONTRADICTION: The ground truth explicitly states 'BA' maintained consistent focus, while the LLM substitutes 'Blackstone' throughout, which is a fundamental entity error that undermines the entire answer's validity. (3) QUANTITATIVE ACCURACY: Both answers correctly note that no specific dollar amounts were disclosed for Special Situation Strategies. However, the LLM's failure to correctly identify the company (BA vs. Blackstone) is a critical factual error that cannot be overlooked. (4) REASONING QUALITY: The LLM's logic about consistency and strategic continuity mirrors the ground truth reasoning, but this is overshadowed by the company identification error. The conclusion about maintaining exposure to opportunistic deals is reasonable but based on analyzing the wrong company's filings. (5) MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three years (2022-2024) and identifies the consistent language pattern, which is sound reasoning. However, this synthesis is applied to the wrong entity. The answer would be excellent if it were about Blackstone, but it appears to be answering a different question than asked. This is a fundamental failure in entity accuracy that makes the answer incorrect despite reasonable analytical approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 470,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "- According to J&J’s 2023 Form 10‑K, worldwide sales of the **Interventional Solutions** product line rose from **$4.3 billion in 2022** to **$6.35 billion in 2023**, a **47.7 % jump** (the segment had already grown 8.3 % from 2021 to 2022).  \n- The 2022 filing shows the segment was $3.97 billion in 2021, confirming a clear upward trajectory, and the 2024 filing notes a **second acquisition (May 31 2024)** that was added to the Interventional Solutions portfolio.  \n\n**Interpretation:** The sharp sales acceleration after the December 2022 acquisition—and the continued investment through a further 2024 acquisition—signal that Interventional Solutions has become a key growth engine for J&J’s MedTech business, cementing its strategic importance in the post‑acquisition era.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-to-year progression. Ground truth shows: 2022=$3,971M → 2023=$4,300M → 2024=$6,350M. However, the LLM states: '2022=$4.3B to 2023=$6.35B' - this reverses the 2023 and 2024 figures entirely. The LLM incorrectly attributes 2024's $6.35B figure to 2023, and claims 2022 was $4.3B when it was actually $3.971B. This is a major error that fundamentally misrepresents the sales trajectory. The LLM also calculates a '47.7% jump' from what it claims are 2022-2023 figures ($4.3B to $6.35B), but this calculation is based on wrong years. The correct 2023-2024 growth would be ($6,350M - $4,300M) / $4,300M = 47.7%, which the LLM appears to have calculated correctly but assigned to the wrong year pair. PARTIAL CREDIT FOR: (1) Correctly identifying the overall upward trajectory and strategic importance, (2) Mentioning the December 2022 acquisition timing, (3) Noting a May 2024 acquisition, (4) Providing reasonable interpretation about strategic importance. MISSING/INCORRECT: (1) The precise 2022 baseline of $3,971M is not mentioned, (2) Year assignments are completely wrong, (3) The progression narrative is inverted. The reasoning about strategic importance is sound, but the numerical foundation is severely compromised, making this answer misleading despite correct interpretive conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Increases]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 387,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the three most recent 10‑K filings Walmart repeatedly lists **“No Boundaries”** together with its other private‑brand lines (e.g., Great Value, Ozark Trail, etc.). In 2022, 2023 and 2024 the brand is described as part of the **private‑brand portfolio that serves the “General merchandise” unit**—the segment that houses Entertainment, Hardlines, Apparel (later renamed Fashion) and Home categories. Although the sub‑categories within General merchandise were tweaked (e.g., “Apparel” became “Fashion” in 2024), the placement of No Boundaries never moved; it remained a core private label supporting the broad‑range, value‑focused General merchandise offering.\n\nThis year‑over‑year consistency signals that Walmart treats No Boundaries as a **stable, cross‑category private‑label anchor**. By keeping the brand in the same strategic unit, Walmart underscores a private‑label strategy that relies on long‑term, multi‑category brand equity to reinforce its everyday‑low‑price (EDLP) and everyday‑low‑cost (EDLC) positioning across general merchandise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies 'No Boundaries' as a consistent private brand across 2022-2024; (2) Accurately notes the brand's placement within the General Merchandise strategic unit throughout all three years; (3) Correctly identifies the organizational change where 'Apparel' was renamed to 'Fashion' in 2024; (4) Properly synthesizes the multi-hop information showing continuity despite structural reorganization; (5) Accurately interprets the strategic implication that this consistency reflects deliberate brand positioning for margin expansion and differentiation. QUANTITATIVE ACCURACY: No numeric errors present. All years (2022, 2023, 2024) are correctly referenced. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct—the model successfully connected the evolution of merchandise units with the consistent positioning of No Boundaries. The interpretation that this reflects a stable, cross-category private-label strategy is well-supported and semantically equivalent to the ground truth's conclusion about 'deliberate effort to maintain and leverage strong private-label identities.' MINOR CONSIDERATIONS: The LLM answer adds interpretive detail about EDLP/EDLC positioning that, while reasonable and not contradicted by the ground truth, goes slightly beyond what was explicitly stated in the original answer. However, this represents thoughtful elaboration rather than factual error. The answer fully addresses the multi-part question about evolution, consistency, and strategic implications. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 456,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "In the 2022 filing Cisco only provides a tabular summary of its available‑for‑sale (AFS) debt investments and does not note any adverse effect on earnings, implying that the investments were not a source of a material loss that year. By contrast, the 2023 10‑K states that “the change in our other income (loss), net was primarily driven by **higher losses** in our available‑for‑sale debt investments” (along with foreign‑exchange impacts). The 2024 10‑K repeats this language, saying the change in other income (loss), net was again “primarily driven by **higher losses** in our available‑for‑sale debt investments.” Thus, the performance of Cisco’s AFS debt investments deteriorated after fiscal 2022, moving from a neutral or non‑loss‑generating position in 2022 to generating increasingly larger losses that pulled down other income (loss), net in both fiscal 2023 and fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and directly addresses the multi-hop question about Cisco's available-for-sale debt investments across fiscal 2022-2024. STRENGTHS: (1) Correctly identifies the three-year trajectory: fiscal 2022 showed no material losses (neutral position), fiscal 2023 showed 'higher losses' impacting other income (loss), net, and fiscal 2024 repeated this pattern. (2) Accurately cites the specific language from the 10-K filings regarding 'higher losses in available-for-sale debt investments' as the primary driver of changes in other income (loss), net. (3) Properly synthesizes multi-hop information by comparing the 2022 position (no adverse effect noted) to 2023-2024 positions (explicit losses). (4) Correctly identifies the relevant financial metric (other income/loss, net) and the specific investment category (available-for-sale debt investments). (5) The reasoning is sound and logically structured, showing clear cause-and-effect relationships. MINOR CONSIDERATIONS: The answer does not provide specific dollar amounts for the losses, but the original ground truth also does not provide quantified loss figures—it only references the qualitative trend of 'higher losses.' The LLM answer actually provides more specificity by directly quoting the 10-K language. The characterization of fiscal 2022 as 'neutral or non-loss-generating' aligns with the ground truth's statement that the company 'disclosed the value' without noting adverse effects. The answer fully addresses the question's requirement to explain how performance 'evolved' and the 'specific impacts' on other income (loss), net. No factual errors detected in dates, company identification, or metric terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 469,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In the 2022 filing American Express described third‑party merchant acquirers (for example, its OptBlue program and certain Global Network Services partners) only as a source of “network‑rate” fees that are booked as discount revenue when a Card‑Member transaction is settled. The 2023 filing repeats that same settlement‑fee mechanism and adds that the fees earned from these third‑party acquirers are now reflected in “processed revenue” under its network‑partnership agreements, showing that the company’s operational reliance on them remained steady. By the 2024 filing, the tone shifts to a strategic one: the success of third‑party merchant acquirers, aggregators and processors is portrayed as a critical lever for expanding merchant coverage worldwide and driving transaction growth across small, mid‑sized and large merchants, indicating that their importance to American Express’s growth agenda has increased markedly from a purely transactional role in 2022‑23 to a core growth partner in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with accurate characterization of each period's focus; (2) Accurately names specific programs (OptBlue, Global Network Services) and partner types (acquirers, aggregators, processors); (3) Correctly describes the revenue mechanisms (network-rate fees, discount revenue, processed revenue) and their timing; (4) Properly synthesizes the strategic shift from transactional/supplementary role to essential growth partner; (5) Accurately captures the multi-hop reasoning showing how American Express's dependency on third-party partners deepened over time. MINOR ISSUES: (1) The LLM states that 2023 fees are 'now reflected in processed revenue under network-partnership agreements' - the ground truth indicates 2023 emphasized 'negotiated network rate fee' recorded as 'discount revenue,' not explicitly mentioning a shift to 'processed revenue' in 2023. This appears to be a slight mischaracterization of the 2023 filing's emphasis, though the general point about revenue recording mechanisms is sound; (2) The phrasing 'repeats that same settlement-fee mechanism' in 2023 could be interpreted as suggesting no evolution in 2023, when the ground truth indicates 2023 added emphasis on the 'financial structure' and integration into the revenue model. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, so this dimension is not heavily tested. The dates (2022, 2023, 2024) are all correct. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information across three years and identifies the progression from supplementary to essential. The characterization of the strategic shift is accurate and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question including merchant coverage expansion, transaction growth, and the evolution across small, mid-sized, and large merchants. Overall, this is a strong answer with only minor interpretive nuances that don't substantially detract from its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 585,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson first disclosed the multi‑year, enterprise‑wide program in its 2022 Form 10‑K, stating that it was beginning an effort to **integrate, simplify and standardize the processes and systems of human resources, information technology, procurement, supply‑chain and finance** as a way to grow its **financial shared‑service capabilities** and to standardize its financial systems. The 2023 filing repeats the same description, confirming that the initiative was still underway and that the company was continuing to **align and streamline the design and operation of its financial‑control environment** in support of those shared‑service enhancements. The 2024 filing again notes the same ongoing, multi‑year program, emphasizing that the effort remains **not a response to any control deficiency** but a continued push to integrate and standardize those five functional areas while expanding the financial shared‑service platform and harmonizing financial systems. Together, the three reports show a steady, progressive rollout of the initiative from its launch in 2022 through continued implementation in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all five functional areas (HR, IT, procurement, supply chain, finance) that are part of the initiative; (2) Accurately captures the core objectives: integrate, simplify, standardize processes and systems, grow financial shared-service capabilities, and standardize financial systems; (3) Properly synthesizes the multi-year evolution across 2022-2024, noting the initiative's launch in 2022, continuation in 2023, and ongoing implementation in 2024; (4) Correctly emphasizes that the initiative is NOT a response to control deficiencies or weaknesses, which is a critical nuance in the ground truth; (5) Accurately describes the progression from initial disclosure through continued alignment and streamlining of the financial control environment; (6) Uses appropriate terminology (\"align and streamline,\" \"financial-control environment,\" \"shared-service platform\") that matches the ground truth language. MINOR CONSIDERATIONS: The LLM answer uses slightly more concise phrasing than the ground truth (e.g., \"steady, progressive rollout\" vs. the ground truth's \"consistent, multi-year approach\"), but this represents stylistic variation rather than factual error. The answer successfully demonstrates multi-hop reasoning by synthesizing information across three separate 10-K filings (2022, 2023, 2024) and correctly identifying the continuity and evolution of the initiative. No quantitative errors, date errors, or entity misidentifications are present. The answer fully addresses all aspects of the complex, multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 457,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "- **2022 filing** – American Express already flagged the “dynamic and rapid growth of alternative payment and financing mechanisms” – such as payment aggregators, digital‑wallet platforms, point‑of‑sale lenders, buy‑now‑pay‑later, real‑time settlement systems, fintech firms, digital currencies and blockchain – as a major source of competitive pressure on its card‑issuing, merchant‑acquirer and network businesses.  \n\n- **2023 filing** – The company’s description became more specific, naming **open‑banking**, electronic‑wallet platforms and real‑time settlement as the newest‑generation alternatives that competitors are deploying, underscoring that the competitive threat from these technologies has intensified and is now a central element of the payments landscape.  \n\n- **2024 filing** – The narrative shifts from describing the threat to a **strategic imperative**: Amex says it must “continue to invest in … open banking and alternative payment and financing mechanisms, tokenization, real‑time settlement, …” or risk losing revenue and profitability. It acknowledges that rivals—especially large technology firms—are likely to launch superior products and that failure to adopt these innovations would erode its competitive position.  \n\n**Overall evolution:** From 2022 to 2024, American Express moved from recognizing alternative payment mechanisms as a fast‑growing competitive set to highlighting specific innovations (open banking, digital wallets, real‑time settlement) as heightened competitive pressures, and finally to committing to substantial technology investment and adaptation to stay relevant in that space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of American Express's positioning shift from threat recognition to strategic adaptation. (2) Accurately captures specific technologies mentioned: digital wallets, payment aggregators, open banking, real-time settlement systems, tokenization, buy-now-pay-later, blockchain, and digital currencies. (3) Properly synthesizes the multi-hop reasoning: 2022 (recognition of threat), 2023 (intensification and specificity), 2024 (strategic imperative and investment commitment). (4) Correctly identifies the semantic transformation from external threat to essential technological roadmap component. (5) No quantitative errors - no specific dollar amounts or percentages were claimed, avoiding calculation risks. (6) Entity accuracy is perfect: American Express correctly identified, years correctly sequenced, competitive mechanisms accurately named. (7) The narrative structure mirrors the ground truth's progression from 'dynamic and rapid growth' acknowledgment to 'strategic dependence' adoption. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (e.g., explicitly mentioning 'tokenization,' 'buy-now-pay-later,' 'blockchain,' 'digital currencies') but these additions are factually consistent with the ground truth's scope and enhance rather than contradict the answer. The LLM's emphasis on 'large technology firms' as key rivals adds relevant context. The multi-hop synthesis across three separate 10-K filings is executed flawlessly, with clear delineation of each year's positioning. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1668,
        "completion_tokens": 491,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "- **2022:** Frame.io first appears in Adobe’s 10‑K only as a listed trademark, signalling that the company had already acquired the brand but was still treating it as a separate, stand‑alone product.  \n- **2023:** Adobe describes Frame.io as “our cloud‑native creative collaboration platform” that is **directly integrated with Premiere Pro and After Effects** and offers “Camera‑to‑Cloud” upload, frame‑accurate commenting and support for still images, design files and PDFs. The language positions Frame.io as a core video‑workflow add‑on within the Creative Cloud family.  \n- **2024:** The platform’s role is broadened further – it is now **integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom and Workfront**, and is packaged together with Adobe Express and Firefly Services inside **Adobe GenStudio** to enable “content production at scale.”  \n\n**Strategic implication:** Adobe has moved Frame.io from a newly‑acquired trademark in 2022 to a tightly‑woven, cross‑app collaboration hub by 2024, embedding it throughout the Creative Cloud suite and linking it to AI‑driven content creation. This progression shows Adobe’s deliberate strategy to make creative collaboration a unified, scalable layer of its ecosystem rather than a peripheral video‑only tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Chronological accuracy - correctly identifies 2022 as trademark listing, 2023 as core integration positioning, and 2024 as expanded ecosystem integration. (2) Technical accuracy - all product integrations mentioned are correct (Premiere Pro, After Effects in 2023; Photoshop, Lightroom, Workfront added in 2024). (3) Feature accuracy - correctly identifies 'cloud-native creative collaboration platform,' frame-accurate commenting, real-time upload/review capabilities. (4) Strategic synthesis - effectively synthesizes the multi-hop progression showing evolution from standalone trademark to integrated hub to cross-functional ecosystem component. (5) Enhanced context - LLM adds valuable detail about Adobe GenStudio packaging and AI-driven content creation (Firefly Services, Adobe Express) which represents legitimate expansion of the ground truth narrative without contradicting it. (6) Reasoning quality - the strategic implication section demonstrates sound multi-hop reasoning connecting product evolution to business strategy. MINOR CONSIDERATIONS: The LLM mentions 'Camera-to-Cloud' upload in 2023, which is a specific feature name not explicitly in the ground truth but represents a reasonable elaboration of 'real-time upload' capabilities. The inclusion of GenStudio and Firefly Services in 2024 goes slightly beyond the ground truth but is contextually appropriate and accurate. No numerical errors, date errors, or factual contradictions detected. The answer fully addresses the multi-part question about positioning evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 458,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 senior notes – a $17 billion issuance – have been steadily retired. The 2023 Form 10‑K shows an outstanding balance of **$16 billion at 12/31/2022**, which fell to **$15 billion at 12/31/2023** (the same figure appears in the 2024 filing), and the 2024 Form 10‑K reports a further decline to **$13 billion at 12/31/2024**. This downward trajectory – from essentially the full issue size in 2021 (‑$16 billion per the 2022 filing) to a $4 billion reduction by 2024 – signals that Amazon is actively paying down or refinancing the 2017 notes, using cash flow to lower its principal‑only debt burden while preserving overall liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. STRENGTHS: (1) All key financial figures are accurate: $16.0B (12/31/2022), $15.0B (12/31/2023), and $13.0B (12/31/2024) are correctly stated. (2) The progression and timeline are correct, showing the three-year evolution as requested. (3) The multi-hop synthesis is sound - the answer correctly identifies the 2017 Notes issuance, tracks the balance across three fiscal years, and draws appropriate conclusions about debt management strategy. (4) The calculation of the $4 billion reduction from 2022 to 2024 is accurate. (5) The characterization of Amazon's strategy as 'deliberate debt management' and 'actively paying down' aligns with the ground truth's assessment. MINOR ISSUES: (1) The LLM states the original issuance was '$17 billion' while the ground truth doesn't specify the original issuance size - this is a minor addition that doesn't contradict the ground truth but adds context not explicitly confirmed. (2) The phrase 'essentially the full issue size in 2021' is somewhat speculative since the ground truth only provides data from 2022 onward. (3) The reference to 'principal-only debt burden' is accurate but slightly more technical than the ground truth's simpler 'gradually pay down this liability' phrasing. These are minor semantic elaborations rather than factual errors. The core answer directly addresses both parts of the question: the evolution of the balance (correct figures and progression) and what it indicates about debt management strategy (correct interpretation). No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 442,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Across all three annual filings—2022, 2023 and 2024—Boeing’s Global Services (BGS) description repeatedly lists **“upgrades and conversions”** alongside supply‑chain, logistics, engineering, maintenance, spare‑parts and training services. The wording is unchanged from the 2022 filing (“...engineering, maintenance and modifications, **upgrades and conversions**, spare parts…”) through the 2023 filing and again in the 2024 filing, indicating that Boeing has maintained a steady, explicit emphasis on this capability.  \n\nThis three‑year continuity signals that Boeing views upgrades and conversions as a core pillar of its platform‑sustainment strategy, using the service to extend aircraft life cycles, generate recurring revenue, and reinforce its long‑term commitment to keeping commercial and defense fleets operational.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) with no date errors. (2) Accurately captures the core finding that 'Upgrades and Conversions' remained consistently present across all three filings with unchanged wording. (3) Properly synthesizes the multi-hop information by connecting the service offering across multiple years and drawing the strategic conclusion about platform sustainment. (4) Provides specific textual evidence ('...engineering, maintenance and modifications, upgrades and conversions, spare parts...') that demonstrates the consistency claim. (5) Correctly interprets the strategic implications: lifecycle extension, recurring revenue generation, and long-term fleet operational support. (6) Uses appropriate terminology (BGS for Boeing Global Services, platform-sustainment strategy). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and interpretive than the ground truth (e.g., explicitly mentioning 'recurring revenue' and 'reinforce its long-term commitment'), but these additions are logical inferences that enhance rather than contradict the ground truth. The semantic meaning is fully preserved and the factual claims are all accurate. No quantitative errors, no entity misidentifications, and the reasoning chain is sound. The answer directly addresses all aspects of the question regarding the 3-year trajectory and strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 408,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy did not change between the 2022 and 2024 filings – the company repeatedly reiterated the same 2021 announcement. In the 2022 10‑K (Chunk 3) the firm noted that, **as announced in January 2021, all eligible U.S. non‑union employees – no matter when they were hired – will begin earning benefits under the **Retirement Value** formula on January 1 2026**. The 2023 filing (Chunk 1) and the 2024 filing (Chunk 2) both repeat that language, confirming that the eligibility rule and the 2026 implementation date remain unchanged and that benefits accrued under the older Final Average Pay formula for service before that date are unaffected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All dates are correct - January 2021 announcement, January 1, 2026 implementation date, and the 2022-2024 filing years are all accurately cited. (2) The key factual claims are correct: the Retirement Value formula applies to all U.S. non-union employees regardless of hire date, the 2026 implementation date was consistently communicated across all three years, and the Final Average Pay formula continues to apply to pre-2026 service. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution (or lack thereof) across three years of filings, showing consistency in messaging. (4) Entity identification is accurate - Johnson & Johnson, U.S. non-union employees, Retirement Value formula, Final Average Pay formula are all correctly identified. (5) The answer appropriately emphasizes that there were NO CHANGES to the plan or timeline across the three-year period, which matches the ground truth statement that 'the same language was repeated, showing no changes.' MINOR CONSIDERATIONS: (1) The LLM answer could have been slightly more explicit about the clarification that 'employees hired after 2014 were already under the Retirement Value formula' (mentioned in ground truth for 2023), though this is a minor omission that doesn't affect the core accuracy. (2) The answer uses chunk references (Chunk 3, Chunk 1, Chunk 2) which adds specificity but isn't essential to answering the question. Overall, the answer demonstrates strong comprehension of the multi-hop question, accurate synthesis across multiple years of filings, and correct identification of all key facts and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 463,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000 % senior notes that mature in April 2030 carried an outstanding principal of **$606 million at the end of fiscal 2022 (October 30 2022)**, **$606 million at the end of fiscal 2023 (October 29 2023)**, and **$606 million at the end of fiscal 2024 (November 3 2024)**【Chunk 3†L31-L33】【Chunk 1†L13-L15】【Chunk 2†L13-L15】.  \n\nThe balance has remained flat over the three‑year period, indicating that Broadcom has neither accelerated repayment nor issued additional amounts of this series; instead it is preserving the issue at its original size and simply servicing the interest, a sign of a deliberate “hold‑to‑maturity” approach to this particular debt instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the outstanding principal was $606 million at the end of fiscal 2022, but the ground truth clearly shows it was $1,086 million in fiscal year 2022. This is a $480 million discrepancy - a 44% error on the starting value. The LLM correctly identifies $606 million for fiscal 2023 and 2024, but the fiscal 2022 figure is completely wrong. (2) MULTI-HOP REASONING FAILURE: The LLM's entire narrative is built on a false premise. It concludes the balance 'remained flat over the three-year period,' but the ground truth shows a significant $480 million decrease from FY2022 to FY2023. This is not a flat trajectory - it's a deliberate debt reduction. The LLM's interpretation of a 'hold-to-maturity' approach is contradicted by the actual $480 million principal reduction that occurred. (3) ENTITY AND TEMPORAL ACCURACY: While the LLM correctly identifies AVGO/Broadcom and the 5.000% notes due April 2030, it misaligns the fiscal year data. The ground truth progression is: FY2022: $1,086M → FY2023: $606M → FY2024: $606M. The LLM presents: FY2022: $606M → FY2023: $606M → FY2024: $606M. (4) STRATEGIC INTERPRETATION ERROR: The ground truth indicates 'a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.' The LLM's characterization of a passive 'hold-to-maturity' approach fundamentally misrepresents the company's active debt management strategy evidenced by the $480 million reduction. The LLM appears to have confused or misread the fiscal year data, presenting FY2023/2024 values as if they applied to FY2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 479,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T first brought Time Warner Inc. into the company in June 2018, folding the Turner, HBO and Warner Bros. businesses into its newly created WarnerMedia segment (Chunk 1).  Beginning in 2021 AT&T moved to unwind that integration – it agreed to combine WarnerMedia with Discovery and, in April 2022, completed the spin‑out through a Reverse Morris Trust transaction that re‑classified the WarnerMedia assets (including the former Time Warner businesses) as discontinued operations (Chunks 2 and 3).  Consequently, by the 2023 and 2024 Form 10‑K filings the Time Warner‑derived assets were no longer part of AT&T’s operating structure, having been divested as part of the WarnerMedia/Discovery separation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core evolution of AT&T's relationship with Time Warner from 2022-2024. STRENGTHS: (1) All key dates are accurate - June 2018 acquisition, April 2022 Reverse Morris Trust completion, and the 2023-2024 timeframe for divestiture completion. (2) Correctly identifies the three major business units (Turner, HBO, Warner Bros.) that comprised WarnerMedia. (3) Accurately describes the strategic pivot from integration to divestiture through the WarnerMedia-Discovery combination. (4) Properly characterizes the reclassification as discontinued operations in 2023-2024 filings. (5) Multi-hop reasoning is sound - correctly synthesizes the timeline of acquisition → integration → unwinding → divestiture. MINOR WEAKNESSES: (1) The answer mentions the unwinding began in 2021 with the agreement, but the ground truth emphasizes the April 2022 completion date as the key milestone. This is not incorrect, just slightly different emphasis. (2) The answer focuses primarily on WarnerMedia/Discovery separation but doesn't explicitly mention the DIRECTV divestiture finalized in 2024 as noted in the ground truth. However, the question specifically asks about 'WarnerMedia segment' so this omission is minor. (3) The answer could have been slightly more explicit about the strategic pivot away from vertically integrated media back to core telecom, though this is implied. QUANTITATIVE VERIFICATION: All dates check out (June 2018, April 2022, 2023-2024). No calculations required. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential narrative as the ground truth - a strategic relationship that evolved from acquisition through integration to eventual divestiture. The core message about the Reverse Morris Trust transaction and reclassification as discontinued operations is accurate and well-explained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 504,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024 AIG has kept a consistent core process – terrorism losses are quantified with a third‑party vendor model (including bomb, anthrax and nuclear scenarios) and the results are used to set risk limits and to guide “targeted” re‑insurance purchases and participation in government‑sponsored terrorism pools. In 2022 the company described those modeled scenarios and noted that U.S. exposure was backed by TRIPRA and limited private re‑insurance, while international exposure was monitored with scenario‑based modeling and ad‑hoc re‑insurance. The 2023 filing repeats the same modeling approach and reliance on TRIPRA, limited private re‑insurance and non‑U.S. pools, but the 2024 filing adds explicit geographic attachment points for the international portfolio – a $200 million core attachment for Japan and a $125 million core attachment for the rest of the world – and highlights broader global property‑per‑risk re‑insurance programs and a $38 billion re‑insurance recoverable balance. Thus, AIG’s international terrorism risk management evolved from generic scenario‑based limits and ad‑hoc re‑insurance (2022‑23) to a more structured framework with defined attachment points and expanded global re‑insurance capacity by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: $200 million attachment for Japan, $125 million for rest of world, $38 billion reinsurance recoverable balance. (2) The $1.3 billion five-ton bomb loss scenario from 2022 is implicitly captured in the reference to 'modeled scenarios' though not explicitly stated. (3) Multi-hop reasoning is sound: correctly synthesizes evolution across three years, identifying the shift from ad-hoc to structured approach. (4) Entity accuracy is perfect: AIG correctly identified, years correct (2022-2024), metrics properly identified (attachment points, reinsurance, TRIPRA, pools). (5) The answer provides richer contextual detail than ground truth (mentions bomb, anthrax, nuclear scenarios; third-party vendor model; $38B recoverable balance) while maintaining accuracy. (6) Semantic equivalence is strong: 'reactive modeling to proactive geographic risk segmentation' (ground truth) aligns with 'generic scenario-based limits and ad-hoc reinsurance to structured framework with defined attachment points' (LLM). MINOR CONSIDERATIONS: The LLM answer does not explicitly mention the $1.3 billion New York City bomb scenario from 2022, though this is a relatively minor omission given the comprehensive coverage of the evolution narrative. The additional details about third-party vendor modeling and the $38 billion recoverable balance actually enhance the answer beyond the ground truth without introducing errors. The characterization of the evolution is accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 450,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "- **2022 (10‑K Chunk 1)** – Emerson’s Tools & Home Products segment listed “pipe‑working tools” as a core professional‑tools offering and explicitly named **pipe wrenches** (along with cutters, threading, etc.) as part of that portfolio. The tools were sold worldwide almost exclusively through distributor networks.  \n\n- **2023 (10‑K Chunk 2)** – The same family of products re‑appears, now under the **Safety & Productivity** segment. The filing again calls out “pipe‑working tools … pipe wrenches and cutters,” showing that the pipe‑wrench line was retained even as Emerson reorganized its segment naming and focus.  \n\n- **2024 (10‑K Chunk 3)** – The description is unchanged: the Safety & Productivity segment continues to deliver “pipe‑working tools … pipe wrenches and cutters.” The distribution model (direct sales plus distributors) is still highlighted.\n\n**Strategic implication:** Across the three years Emerson has kept pipe wrenches in its professional‑tools arsenal, but has shifted the product’s home from a generic “Tools & Home Products” segment to a purpose‑driven **Safety & Productivity** segment. This signals a deliberate positioning of pipe‑working tools as a safety‑ and productivity‑focused offering for plumbing and mechanical professionals, reinforcing Emerson’s commitment to the professional‑tools market while aligning the product line with a higher‑value, safety‑oriented brand narrative.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer fundamentally contradicts the ground truth on key product evolution claims. Ground truth states that from 2022-2024, Emerson's pipe-working tools portfolio EXPANDED with battery-powered hydraulic tools, diagnostic systems (sewer inspection cameras), and digital integration. The LLM answer claims the product description remained 'unchanged' across all three years, showing only pipe wrenches and cutters with no mention of technological advancement or new product categories. This is a major factual error on the core question about portfolio evolution. SPECIFIC ISSUES: (1) The LLM completely omits the introduction of battery hydraulic tools for press connections (2023) and enhanced diagnostic systems like sewer inspection cameras - these are central to the ground truth's narrative of strategic modernization. (2) The LLM states 'The description is unchanged' for 2024, directly contradicting the ground truth's claim of maintained advanced toolset with digital integration emphasis. (3) The LLM focuses heavily on segment reorganization (Tools & Home Products → Safety & Productivity) which is not mentioned in the ground truth and appears to be a secondary or potentially incorrect detail. (4) The LLM's strategic implication about 'safety-oriented brand narrative' is speculative and misses the actual strategic shift toward technological modernization and efficiency gains. WHAT WAS CORRECT: The LLM correctly identifies that pipe wrenches were part of the portfolio across all three years and correctly names Emerson (EMR). The distribution model discussion is reasonable but not verified against ground truth. MULTI-HOP REASONING: The LLM failed to synthesize the technological evolution across the three-year period, instead focusing on segment naming changes. This represents a fundamental failure in multi-hop reasoning for this question. The ground truth requires understanding how product sophistication evolved (traditional → battery-powered/diagnostic → digital integration), which the LLM completely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 558,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s lease footnote has been unchanged from the 2022 filing through the 2024 filing. In each year the company states that **“free‑rent periods … are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise from the date the Company has control of the property.”** The same language appears in the 2022, 2023 and 2024 10‑K excerpts.\n\nBecause the free‑rent amount is spread evenly over the lease term, the **minimum lease payments used to calculate the discounted cash‑flows that form the right‑of‑use (ROU) asset and lease liability are reduced**. Thus the ROU asset recorded at inception is lower (and the corresponding lease liability is lower) than it would be if the rent were recognized only when actually paid. No change in recognition methodology or disclosure wording is evident across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the ground truth and fails to address the core evolution described in the original answer. CRITICAL ERRORS: (1) The LLM claims 'the lease footnote has been unchanged from the 2022 filing through the 2024 filing' and 'No change in recognition methodology or disclosure wording is evident across the three years.' This directly contradicts the ground truth, which explicitly states that while the core accounting policy remained stable, 'the depth and specificity of disclosure around ROU asset valuation decreased over time' and that detailed explanations in 2022 'were not repeated in the 2023 and 2024 filings.' (2) The LLM completely misses the key evolution: the 2022 filing explicitly disclosed the use of discounted future minimum lease payments, incremental borrowing rate derivation, and ARO treatment—details that were NOT repeated in 2023-2024. This represents a significant shift in disclosure depth, not an unchanged footnote. (3) The LLM's statement about ROU asset valuation mechanics (that free-rent amounts reduce minimum lease payments used in DCF calculations) is technically accurate but incomplete—it fails to capture that the DISCLOSURE of this methodology was more detailed in 2022 and became more standardized/less detailed in 2023-2024. WHAT WAS CORRECT: The LLM accurately quotes the consistent straight-line recognition language across all three years and correctly identifies that the methodology itself remained stable. The explanation of how free-rent periods affect ROU asset calculation is factually sound. MULTI-HOP REASONING FAILURE: The question asks about evolution 'particularly in terms of recognition methodology and its impact on right-of-use asset valuation.' The ground truth identifies a dual evolution: (1) stable methodology, (2) declining disclosure depth. The LLM only addresses the first element and explicitly denies the second, which is the more significant finding. The LLM fundamentally misread the evidence by focusing on identical policy language while missing the shift from detailed valuation mechanics disclosure to standardized ASC 842 language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 578,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 2.000 % notes are shown in two separate series:  \n\n* **2.000 % notes due 2020** – listed in the **Tenth Supplemental Indenture** (dated Nov 3 2015) and documented in Exhibit 4.13 of each filing.  \n* **2.000 % notes due 2023** – listed in the **Eleventh Supplemental Indenture** (dated Aug 8 2016) and documented in Exhibit 4.14 of each filing.  \n\nThus, from 2022 through 2024 the maturity schedule did not change (one series already maturing in 2020 and a second series maturing in 2023), and the same two supplemental indentures (the Tenth for the 2020 series and the Eleventh for the 2023 series) continue to be the governing indenture documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) The LLM introduces a '2.000% notes due 2020' series under the Tenth Supplemental Indenture (dated Nov 3, 2015) that is NOT mentioned in the ground truth. The ground truth only references the 2.000% Notes due 2023 under the Eleventh Supplemental Indenture (dated Aug 8, 2016). (2) The LLM claims the 2020 series was 'already maturing in 2020' - this is problematic because the question asks about 2022, 2023, and 2024 filings, meaning any 2020 maturity would have already passed by 2022. The ground truth makes no mention of a 2020 maturity series. (3) The LLM correctly identifies the 2023 maturity series and the Eleventh Supplemental Indenture dated Aug 8, 2016, which matches the ground truth. (4) However, the introduction of the spurious 2020 series with the Tenth Supplemental Indenture is a major factual error that fundamentally misrepresents Microsoft's debt structure. (5) The ground truth explicitly states 'showing a stable inclusion within the company's long-term debt structure' with only ONE series (due 2023), not two. The LLM's claim of two separate series is unsupported by the ground truth. (6) The exhibit numbers cited (4.13 and 4.14) cannot be verified against the ground truth provided. The LLM appears to have hallucinated or confused information about a second debt series that does not exist in the actual filings according to the knowledge graph. This is a critical error in a financial analysis context where accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 429,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "- In the 2022 filing Amazon simply said that its seller‑program revenue comes from “fixed fees, a percentage of sales, per‑unit activity fees, interest, or some combination thereof,” but it did not spell out when that revenue is recorded.  \n\n- The 2023 filing added the recognition rule: commissions and any related fulfillment or shipping fees are **recognized when the services are rendered**, i.e., when the product is delivered to a third‑party carrier (or, for Amazon‑fulfilled orders, to the customer).  \n\n- The 2024 filing returns to the same description of the fee mix (fixed fees, percentage of sales, per‑unit fees, interest) and does not restate a new timing rule, implying that the 2023 practice—recognizing commissions and fulfillment fees at the point of delivery—remains in effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's disclosure approach; (2) Accurately captures the 2022 description of revenue sources (fixed fees, percentage of sales, per-unit activity fees, interest) without overstating specificity about timing; (3) Precisely articulates the 2023 advancement: the explicit recognition rule tied to service delivery (delivery to third-party carrier or customer); (4) Correctly infers that 2024 maintains the 2023 practice by returning to fee-mix language without restating timing rules; (5) Demonstrates sound multi-hop reasoning by synthesizing information across three separate filings to show evolution and continuity. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and interpretive than the ground truth (e.g., the parenthetical about 'Amazon-fulfilled orders' and the inference about 2024 'implying' continuation of 2023 practice), but these additions are logically sound and supported by the filing information. The ground truth's statement that '2024 continued offering similar seller programs' is essentially equivalent to the LLM's observation about the fee-mix description returning in 2024. No numerical errors, date errors, or entity misidentifications present. The answer directly addresses all components of the multi-part question regarding timing and composition evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Discloses]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 414,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings for 2022, 2023 and 2024 each contain a “4‑b Guaranty of certain obligations of Southwestern Bell Telephone Co.” (see the 4‑b entries in all three chunks). By repeatedly reaffirming that guarantee, AT&T shows that it deliberately keeps the debt and other obligations of the legacy Southwestern Bell entity on its books rather than shedding them, using a parent‑guarantee structure to preserve the credit standing of the historic subsidiaries and to control the associated risk over the long term. This ongoing guarantee therefore reflects a consistent liability‑management strategy in which AT&T assumes responsibility for legacy telecom entities to manage exposure, maintain financial flexibility and protect the consolidated balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of AT&T's liability management strategy. STRENGTHS: (1) Correctly identifies the three years (2022, 2023, 2024) and the consistent guarantee of Southwestern Bell Telephone Co.'s obligations across all filings; (2) Accurately references Exhibit 4-b as the source document; (3) Properly synthesizes the multi-hop information showing continuity of guarantees across years; (4) Correctly interprets the strategic implications - that AT&T maintains full financial responsibility without restructuring; (5) Provides sound reasoning about parent-guarantee structures and risk management. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer adds interpretive details about 'credit standing,' 'financial flexibility,' and 'consolidated balance sheet' that go slightly beyond what the ground truth explicitly states, though these are reasonable inferences; (2) The ground truth emphasizes 'no indication of reduction or restructuring' more directly, while the LLM frames it as deliberate retention; (3) The LLM's language about 'keeping debt on books' and 'parent-guarantee structure' is more technical/analytical than the ground truth's simpler statement of 'full financial responsibility.' QUANTITATIVE ACCURACY: All dates and entities are correct (AT&T, Southwestern Bell Telephone Co., 2022-2024, Exhibit 4-b). No calculations required. MULTI-HOP REASONING: Correctly synthesizes information across three years of filings to identify the pattern of consistent guarantees and draw conclusions about strategy. The reasoning is sound and logically connects the evidence to the conclusion. SEMANTIC EQUIVALENCE: The core message matches - AT&T maintains consistent guarantees of legacy entity obligations as part of deliberate liability management strategy. The LLM's answer is slightly more elaborate but conveys the same fundamental insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 513,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "- In the 2022 Form 10‑K (page 67) Johnson & Johnson reported **$984 million** of its 2.250 % notes due 2050 outstanding at year‑end.  \n- The 2023 Form 10‑K (page 71) shows the balance falling to **$826 million** at the end of 2023 (with the 2022 balance restated at $808 million).  \n- The 2024 Form 10‑K (page 72) records the balance at **$808 million** at the end of 2024.  \n\n**Interpretation:** Over the three‑year span the amount of ultra‑long‑dated 2.250 % 2050 notes has been steadily reduced, indicating that Johnson & Johnson is actively retiring or refinancing its very long‑term, low‑coupon debt. This trend reflects a long‑term debt strategy that seeks to lower exposure to far‑future maturities while preserving liquidity and managing overall interest‑cost efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM reports $984 million for 2022, but the ground truth states $983 million. This is a $1 million discrepancy. More significantly, the LLM states the 2022 balance was 'restated at $808 million' in the 2023 10-K, which contradicts the ground truth showing $983 million in 2022 and $826 million in 2023 (no restatement mentioned). The 2023 and 2024 figures ($826M and $808M) match the ground truth. The effective rate of 2.29% mentioned in the ground truth is completely absent from the LLM answer. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes data across three years and identifies the trend of declining balances. However, the internal inconsistency about the 2022 restatement suggests confusion about the filing data. REASONING QUALITY: The LLM's interpretation about 'actively retiring or refinancing' long-term debt is reasonable and aligns with the ground truth's characterization of a 'cautious approach to managing long-dated liabilities.' The conclusion about preserving liquidity and managing interest-cost efficiency is sound. COMPLETENESS: The LLM addresses the evolution question and provides interpretation of strategy, but omits the specific effective rate information that provides important context about the company's cost of capital management. The discrepancy in the 2022 figure ($984M vs $983M) and the confusing restatement language are material errors that undermine confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 405,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 unchanged at **$1.25 billion** in each of the three filings – $1,250 million in 2022 (COST 10‑K 2022), and the same $1,250 million in the 2023 and 2024 tables (both showing the 2024/2023 columns).  At the same time, total long‑term debt fell from **$6.59 billion** in 2022 to **$5.92 billion** in 2023 and remained at $5.92 billion in 2024, while “Other long‑term debt” rose from $590 million to $919 million and the 2.300 % notes (May 2022) and the 2.750 % notes (May 2024) were retired.  \n\nThis pattern shows Costco’s capital‑management strategy of **preserving a low‑cost, long‑dated $1.25 billion note** while actively refinancing or paying off higher‑interest and maturing obligations, thereby reducing overall leverage and keeping its debt profile anchored to inexpensive, long‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that the 1.375% Senior Notes remained constant at $1,250 million ($1.25 billion) across all three years (2022-2024). (2) The format variation ($1.25 billion vs $1,250 million) is acceptable and shows proper understanding. (3) The qualitative reasoning about capital management strategy is sound - the LLM correctly identifies that Costco preserved low-cost, long-dated debt while retiring higher-interest obligations. (4) The answer appropriately addresses the multi-hop synthesis required across three years of filings.\n\nCRITICAL ERRORS: (1) The LLM states total long-term debt fell from $6.59 billion in 2022 to $5.92 billion in 2023 AND REMAINED AT $5.92 BILLION IN 2024. However, the ground truth shows total long-term debt was $6,590M (2022), $6,484M (2023), and $5,919M (2024). The 2024 figure of $5,919M ($5.919 billion) is NOT the same as 2023's $5.92 billion - there was a further decline of $565 million from 2023 to 2024. This is a significant factual error that misrepresents the debt trajectory. (2) The statement about 'Other long-term debt' rising from $590M to $919M lacks proper year-to-year clarity and appears to conflate different periods without clear attribution.\n\nMULTI-HOP REASONING: The LLM demonstrates good synthesis across the three-year period and correctly identifies the selective debt management strategy. However, the quantitative error regarding 2024 debt levels undermines the accuracy of the trend analysis.\n\nCALCULATION VERIFICATION: The ground truth shows: 2022→2023 decline of $106M ($6,590M - $6,484M), and 2023→2024 decline of $565M ($6,484M - $5,919M). The LLM's claim that debt 'remained at $5.92 billion in 2024' is factually incorrect and represents a material misstatement of the company's debt reduction trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 492,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s filings show that its “multi‑layered security approach” – a formal accounting policy that the company implements each year – was already in place in 2022, featuring a cyber‑security program, Security Operations and Fusion Centers, third‑party assessments and collaboration on EMV and other technical standards.  From 2022 to 2024 the same policy was reinforced (adding more public‑private partnerships, expanded resilience and insurance programs, and tighter monitoring of third‑party services) while the real‑time payments infrastructure grew from operating or being implemented in 12 top‑GDP markets at the end of 2021 (disclosed in the 2022 10‑K) to 13 markets by the end of 2023 and, by 2024, to a “several‑countries worldwide” footprint that now includes domestic processing in China and a higher transaction‑switch share (≈70 % versus ≈60‑65 % previously).  The parallel expansion of a globally distributed, real‑time clearing and settlement platform together with an ever‑more granular, multi‑layered security framework signals that Mastercard’s strategy is to manage scaling‑related processing risk by embedding stronger, layered protections directly into the same architecture that enables its rapid, cross‑border payment growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct: 12 markets (end of 2021, disclosed in 2022 10-K), 13 markets by end of 2023, and the qualitative shift to 'several countries worldwide' by 2024. (2) The multi-layered security framework evolution is accurately traced across all three years with appropriate detail (cyber-security program, Security Operations and Fusion Centers, third-party assessments, public-private partnerships, resilience programs, insurance, third-party monitoring). (3) The transaction-switch share percentages (~70% vs ~60-65% previously) and mention of China domestic processing add specific, credible details that align with typical Mastercard disclosures. (4) Multi-hop reasoning is sound: the answer correctly synthesizes the parallel evolution of security capabilities and real-time payments infrastructure expansion, and appropriately concludes that Mastercard embedded stronger protections into the same architecture enabling rapid growth. (5) The answer goes beyond the ground truth by providing more granular detail about specific security mechanisms (EMV standards, Fusion Centers, insurance programs) while maintaining factual accuracy. MINOR CONSIDERATIONS: (1) The ground truth notes 'the filings do not explicitly state that security measures directly enabled infrastructure expansion,' while the LLM answer states Mastercard's strategy is to 'manage scaling-related processing risk by embedding stronger, layered protections directly into the same architecture.' This is a reasonable inference from the parallel development pattern but represents a slightly stronger causal claim than the ground truth explicitly supports. However, this is presented as strategic interpretation rather than explicit filing statement, which is appropriate. (2) The mention of China domestic processing and transaction-switch share percentages, while credible and consistent with Mastercard's business model, are not explicitly mentioned in the provided ground truth, though they don't contradict it. These appear to be reasonable elaborations based on typical 10-K disclosures. QUANTITATIVE VERIFICATION: All numbers check out (12→13→'several'), percentages are plausible ranges, and no calculation errors are present. The answer maintains semantic equivalence with the ground truth while providing enhanced contextual detail and more sophisticated strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 670,
        "total_tokens": 2311
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Across the three most recent 10‑K filings (FY 2022, FY 2023 and FY 2024) Microsoft’s disclosures repeatedly list the same “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” (Exhibit 4.6). In each year the 4.000 % Notes due 2021 appear only as a legacy issuance dated February 8 2011; there is no new issuance, amendment or increase of that series in any of the three filings. This steady, unchanged presence signals that Microsoft is not expanding this particular tranche but is instead maintaining and eventually rolling off the 2021‑maturing debt, reflecting a disciplined long‑term debt strategy that relies on a fixed‑rate, diversified maturity schedule and prefers refinancing or repayment over continual new issuance of the same instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed and nuanced response than the ground truth. Key strengths: (1) All numeric values are correct - the 4.000% interest rate, the 2021 maturity date, the February 8, 2011 issuance date, and the three fiscal years (2022, 2023, 2024) are all accurate. (2) The exhibit reference (Exhibit 4.6) and the Third Supplemental Indenture dating to May 18, 2009 (implied through the indenture structure) are correctly identified. (3) The multi-hop synthesis is sound - the LLM correctly traces the same instrument across three fiscal years and identifies the pattern of no new issuance or amendment. (4) The reasoning about debt management strategy is logical and well-supported: the answer correctly infers that the consistent, unchanged presence of this legacy debt indicates disciplined management focused on rolloff rather than expansion. (5) The LLM provides additional context by mentioning other notes in the same indenture (2.500% Notes due 2016 and 5.300% Notes due 2041), which enriches understanding of Microsoft's diversified maturity schedule. Minor considerations: The ground truth mentions 'delayed settlement, rollover, or ongoing disclosure requirement' as possibilities for post-maturity disclosure, while the LLM more definitively characterizes it as a 'legacy issuance' being 'rolled off.' However, the LLM's interpretation is reasonable and arguably more precise given the consistent pattern across all three years. The LLM answer is more comprehensive and provides clearer insight into the strategic implications of the debt management pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 447,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s 10‑K filings for 2022, 2023 and 2024 all list the same **1.500 % senior note that matures in 2030** (see the officers’ certificates in each chunk). By repeatedly referencing this single, low‑coupon, ten‑year instrument, Amazon signals that it is deliberately locking in inexpensive, fixed‑rate financing for the medium‑term as a backbone of its capital structure. This contrasts with the many other notes disclosed—​e.g., 0.650 % due 2015, 2.500 % due 2022, 4.700 %‑4.950 % notes due 2024‑2044—​which carry higher rates and a broader spread of maturities, indicating that the 1.5 % 2030 note is used to provide a stable, low‑cost anchor while the higher‑rate, varied‑maturity notes supply additional liquidity and flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 1.500% Note due 2030 as a consistent reference across 2022-2024 filings and accurately characterizes it as a low-coupon, fixed-rate instrument serving as a stable anchor in Amazon's capital structure. The reasoning about contrasting this with higher-yielding instruments is sound and semantically aligned with the ground truth.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. INCORRECT DATES/INSTRUMENTS: The LLM lists a \"0.650% due 2015\" note, which is problematic because 2015 is in the past relative to 2022-2024 filings. This appears to be either a factual error or confusion about which notes were actually outstanding during the relevant period.\n\n2. INCOMPLETE SYNTHESIS: The ground truth specifically mentions the 4.700% Note due 2024 (2023 context) and 4.700% Note due 2032 (2024 context), showing how Amazon managed near-term vs. long-term obligations across years. The LLM mentions \"4.700%-4.950% notes due 2024-2044\" but doesn't clearly distinguish the temporal evolution across the three years as the ground truth does.\n\n3. MISSING STRATEGIC CONTEXT: The ground truth emphasizes that in 2022, the 1.500% Note was part of a broader issuance including instruments maturing as far as 2060, and that 2023-2024 show adaptation to current market rates. The LLM doesn't capture this temporal progression of strategy.\n\n4. VAGUE COMPARISONS: The LLM states \"many other notes disclosed\" but doesn't provide the specific year-by-year comparison that demonstrates how Amazon's strategy evolved (e.g., introducing newer, higher-yielding instruments while maintaining the 1.500% 2030 note).\n\nThe core insight about the 1.500% Note serving as a low-cost anchor is correct, and the general reasoning about layered maturity profiles is sound. However, the factual errors regarding specific instruments and dates, combined with incomplete multi-hop synthesis across the three years, prevent this from being a strong answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 537,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "- **2022:** AT&T disclosed that it “continue[d] to hold a 41.3 % interest in SKY Mexico, a leading pay‑TV provider in Mexico.” The investment was presented as a non‑consolidated affiliate, implying equity‑method accounting.  \n\n- **2023:** The 2023 filing’s Note 10 on equity‑method investments lists SKY Mexico together with DIRECTV and Gigapower, confirming that the 41.3 % stake was still being accounted for under the equity method (i.e., AT&T had significant influence but did not consolidate the operation).  \n\n- **2024:** In June 2024 AT&T announced that it “sold our 41.3 % interest in SKY Mexico,” and the investment was removed from the equity‑method table, marking a complete exit from the business.  \n\n**What the trajectory shows:** Over the three‑year period AT&T moved from retaining a sizable minority stake and accounting for it as an equity‑method investment to fully divesting the asset. This pattern mirrors AT&T’s broader strategy of exiting non‑core, international pay‑TV assets (e.g., the Vrio sale in 2021, the winding down of DIRECTV ownership in 2024), indicating a systematic pull‑back from overseas pay‑TV markets to concentrate on its core U.S. telecommunications operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—the 41.3% ownership stake is consistently cited across 2022-2024, and the June 2024 sale date is accurate. No calculation errors or numeric discrepancies. ENTITY ACCURACY: All entities correctly identified (AT&T, SKY Mexico, DIRECTV, Gigapower, Vrio). Years and time periods properly sequenced (2022→2023→2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents, correctly tracing the evolution from equity-method investment to complete divestiture. The connection to broader divestiture strategy (Vrio sale in 2021, DIRECTV winding down in 2024) is appropriately contextualized. COMPLETENESS: All three sub-components of the question are addressed: (1) ownership stake evolution, (2) equity method accounting treatment, (3) eventual exit and strategic implications. The 3-year trajectory analysis is comprehensive. SEMANTIC EQUIVALENCE: The LLM's characterization of SKY Mexico as a 'non-consolidated affiliate' with 'significant influence' is semantically equivalent to equity-method accounting. The description of the phased approach and strategic refocusing aligns with ground truth. MINOR OBSERVATIONS: The LLM provides slightly more operational detail (e.g., explicitly noting SKY Mexico as 'a leading pay-TV provider in Mexico') and includes the Vrio reference as context, which enhances rather than detracts from accuracy. The answer is well-structured and clearly presents the chronological progression. No factual errors, omissions, or misrepresentations detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 463,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” policy – the accounting policy that sets the target mix for the **return‑seeking (growth) portion** of the U.S. qualified pension plan based on the plan’s funded‑ratio and the prevailing interest‑rate environment – is described in the same language in the 2022, 2023 and 2024 Form 10‑K filings.  \n\n* **2022** – The 2022 filing (page 310) presents the first glide‑path table, showing the target allocation for the 2022 year that was calculated from the funded status as of 31 December 2021.  \n* **2023** – The 2023 filing (page 252) updates the glide‑path table and provides the **target allocation for 2024** that is based on the funded status at 31 December 2023. Implicitly, the 2023‑year target (derived from the 31 December 2022 funded ratio) sits between the 2022 and 2024 targets.  \n* **2024** – The 2024 filing (page 184) again restates the glide‑path methodology and shows the **target allocation for 2025** (based on the 31 December 2024 funded status), confirming that the same de‑risking framework continues to be applied.\n\nAcross the three years the glide‑path numbers move **progressively toward a lower percentage of growth assets and a higher percentage of liability‑hedging assets** as the plan’s funded ratio improves. This downward shift in the “return‑seeking” allocation from 2022 → 2023 → 2024 demonstrates AIG’s deliberate de‑risking strategy: as the pension plan becomes better funded, the company systematically reduces exposure to higher‑volatility growth investments and increases holdings that better match the plan’s liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression of AIG's glide path approach (2022, 2023, 2024) with accurate temporal references; (2) Accurately captures the core de-risking strategy showing progressive reduction in growth assets and increase in liability-hedging assets; (3) Properly synthesizes the multi-hop relationship between funded status dates and target allocation years (e.g., 2022 target based on Dec 31, 2021 funded status; 2024 target based on Dec 31, 2023 funded status; 2025 target based on Dec 31, 2024 funded status); (4) Correctly identifies the filing page numbers (310 for 2022, 252 for 2023, 184 for 2024) which demonstrates document-level accuracy; (5) Accurately describes the glide path as being based on both funded ratio and interest-rate environment; (6) Properly explains the liability-driven investing principles underlying the strategy. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail than the ground truth (e.g., specific page numbers, explicit mention of interest-rate environment) but this represents added value rather than inaccuracy. The semantic meaning is fully aligned with the ground truth - both convey that AIG systematically de-risked as funded status improved across the three-year period. The multi-hop reasoning is sound: the answer correctly synthesizes information across three separate 10-K filings and demonstrates understanding of how each year's target allocation relates to the prior year's funded status. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all parts of the multi-part question regarding evolution, progression, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1662,
        "completion_tokens": 488,
        "total_tokens": 2150
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "- **2022:** Mastercard disclosed that its credit‑risk portfolio was governed by a set of risk standards.  Customers that did not meet those standards were required to enter risk‑mitigation arrangements – typically cash collateral, letters of credit or guarantees – and the company said it “monitors its credit‑risk portfolio and the adequacy of its risk‑mitigation arrangements on a regular basis” and periodically reviews its methodology and exposure estimates.  \n\n- **2023:** With the FTC “Durbin‑Amendment” investigation and a DOJ civil investigative demand, the 10‑K repeated the same mitigation tools but stressed more frequent monitoring and “regular” reviews of the portfolio and of the estimated settlement exposure, indicating that the company tightened oversight to address the heightened regulatory scrutiny.  \n\n- **2024:** Facing additional litigation (EMV‑liability‑shift, TCPA) and a European‑Commission information request, Mastercard’s filing again required cash collateral and other credit‑enhancement for non‑compliant customers, but now emphasized “periodic” reviews of its risk‑management methodology and the continual revision of exposure estimates across a broader set of legal challenges.  \n\n**What this shows:** Across the three years Mastercard’s core mitigation approach (collateral, letters of credit, guarantees) remained, but the company progressively intensified monitoring, increased the frequency of methodological reviews, and broadened the scope of its oversight to cover new U.S. and EU investigations and class‑action exposures.  This evolution demonstrates a flexible, adaptive risk‑management framework that can be tightened quickly in response to rising regulatory and litigation risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Mastercard's credit risk mitigation evolution from 2022-2024 and correctly identifies the core framework (cash collateral, letters of credit, guarantees) that remained consistent across all three years. The multi-hop synthesis across regulatory events and years is sound.\n\nSTRENGTHS:\n1. Correctly identifies the consistent core mitigation tools across 2022-2024\n2. Accurately maps regulatory/litigation events to each year (FTC consent agreement 2023, DOJ investigation 2023, EMV liability shift and TCPA litigation 2024, EC investigation 2024)\n3. Properly synthesizes the evolution pattern: consistent framework with intensified monitoring and broader scope\n4. Correctly characterizes the progression from 'regular' monitoring to 'more frequent' to 'periodic' reviews\n5. Accurately concludes that core strategies remained effective despite escalating external pressures\n6. Good semantic alignment with ground truth on the adaptive nature of risk management\n\nWEAKNESSES/MINOR ISSUES:\n1. The LLM refers to the 2023 investigation as \"FTC 'Durbin-Amendment' investigation\" - the ground truth specifies this as the \"FTC's finalized consent agreement over debit routing compliance.\" While related, the LLM's phrasing is slightly imprecise in characterizing the nature of the regulatory action\n2. The LLM mentions \"TCPA\" litigation in 2024, but the ground truth specifically references \"U.S. Liability Shift Litigation\" - these may be different cases or the LLM may have conflated them\n3. The LLM does not explicitly mention that Mastercard \"consistently reported a low level of losses from customer settlement failures across all three years\" - a key detail from the ground truth showing effectiveness of strategies\n4. Minor: The LLM uses \"EMV-liability-shift\" while ground truth uses \"U.S. Liability Shift Litigation\" - these appear to be the same or related, but terminology differs\n\nQUANTITATIVE ACCURACY: No specific dollar amounts, percentages, or numerical metrics were required in either answer, so this dimension is less critical. Both answers avoid numerical claims that could be verified as incorrect.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple regulatory/litigation events, correctly linking each to the evolution of risk management practices. The reasoning chain is logical and well-structured.\n\nSEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth regarding the evolution of Mastercard's risk management framework, though with slightly different emphasis and minor terminology variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1761,
        "completion_tokens": 709,
        "total_tokens": 2471
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "- **2022:** The 2022 filing shows that, as of January 30 2022, the Home Depot’s then‑applicable plan (the 2005 Omnibus Stock Incentive Plan) had **≈ 117 million shares** left for future grants.  \n\n- **2023 filing (reflecting early‑2024 data):** The 2023 10‑K states that, as of January 28 2024, the newly‑amended Omnibus Stock Incentive Plan had **≈ 77 million shares** available for future grants.  \n\n- **2024 filing (reflecting early‑2025 data):** The 2024 10‑K reports that, as of February 2 2025, the same Omnibus Plan had **≈ 70 million shares** remaining for future grants.  \n\n**Trend and implication:** The pool of shares that can be used for new equity awards has been steadily shrinking—from roughly 117 million in early 2022 to about 77 million by early 2024 and further down to 70 million by early 2025. This decline indicates that The Home Depot has been actively issuing stock‑based awards and consuming its authorized share reserve, reflecting an aggressive but managed approach to equity compensation that continues to support employee and director incentives while still preserving a modest pool for future grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All three key numeric values are correct: 117 million shares (2022), 77 million shares (2023/early 2024), and 70 million shares (2024/early 2025). (2) Dates are accurately cited: January 30, 2022; January 28, 2024; and February 2, 2025, matching the ground truth. (3) The multi-hop synthesis is sound—the answer correctly tracks the evolution across three fiscal years and identifies the plan transition from the 2005 Plan to the amended Omnibus Plan. (4) The trend analysis is accurate: the answer correctly identifies the consistent decline (117M → 77M → 70M) and properly interprets this as evidence of active stock-based compensation issuance. (5) The strategic interpretation is well-reasoned and matches the ground truth's conclusion about increased reliance on equity incentives. (6) The answer is well-structured with clear year-by-year breakdown and explicit trend analysis. MINOR CONSIDERATIONS: The LLM uses approximate symbols (≈) which is reasonable given potential rounding in source documents, though the ground truth presents these as exact figures. The characterization as 'aggressive but managed' is a reasonable interpretation that aligns with the ground truth's assessment. The answer fully addresses both parts of the question: the evolution of share availability AND what it suggests about compensation strategy. No factual errors detected, calculations are implicit but correct (the declining trend is accurately represented), and entity identification is precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 436,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "- **2022 FY (Form 10‑K 2022)** – The 3.625 % senior notes due October 2024 were shown with a principal balance of **$622 million** (both the October 30 2022 and October 31 2021 columns).  \n- **2023 FY (Form 10‑K 2023)** – The same table still listed **$622 million** outstanding as of the fiscal‑year‑end date of **October 29 2023**, but the column for the later “November 3 2024” date displayed a dash (‑), indicating that the notes were no longer expected to be outstanding after that date.  \n- **2024 FY (Form 10‑K 2024)** – The 2024 filing repeats the 2023 numbers: **$622 million** as of October 29 2023 and a dash for the “November 3 2024” column, confirming that the notes have been retired or have matured and are no longer on the balance sheet.\n\n**Interpretation:** Broadcom kept the 3.625 % Oct‑2024 notes at a steady $622 million through 2022‑2023, then let the instrument run to its scheduled maturity rather than refinancing or rolling it over. This pattern shows a deliberate debt‑management approach of preserving the existing financing until maturity and then reducing long‑term debt by allowing the notes to expire, thereby lowering overall leverage without incurring additional refinancing costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual discrepancy regarding fiscal year 2024 that undermines the core conclusion. CRITICAL ERROR: The ground truth states that by fiscal year 2024, the obligation dropped to $0, indicating full repayment or restructuring. However, the LLM claims the 2024 filing 'repeats the 2023 numbers: $622 million as of October 29 2023' and that the notes 'have been retired or have matured and are no longer on the balance sheet.' This is contradictory and factually incorrect - if the notes are no longer on the balance sheet in 2024, the obligation should be $0, not $622 million. The LLM appears to have confused historical comparative data (prior year columns in the 2024 10-K showing 2023 figures) with current year obligations. CORRECT ELEMENTS: (1) The $622 million figure for 2022 and 2023 is accurate; (2) The identification of the 3.625% notes due October 2024 is correct; (3) The recognition that the notes were not outstanding after a certain date is correct; (4) The general interpretation about debt management strategy is reasonable. INCORRECT ELEMENTS: (1) The claim that 2024 FY shows $622 million outstanding is wrong - it should show $0; (2) The statement 'the notes have been retired or have matured and are no longer on the balance sheet' contradicts the claim that $622 million is still shown; (3) The progression narrative is incomplete - it should clearly state the obligation went from $622M (2022-2023) to $0 (2024). MULTI-HOP REASONING: The LLM correctly synthesized information across three fiscal years but failed to properly interpret the 2024 data, confusing comparative historical columns with current obligations. The debt management interpretation is directionally correct but based on partially incorrect data presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 485,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "- **2022 filing:** AT&T still owned Time Warner (the core of its WarnerMedia segment) after the 2018 acquisition, but it disclosed that it had entered a May‑2021 agreement to combine WarnerMedia with Discovery and that the transaction was expected to close in the second quarter of 2022 – a clear divestiture‑planning step.  \n\n- **2023 filing:** AT&T reported that the April 2022 Reverse‑Morris‑Trust transaction had been completed, separating WarnerMedia (and therefore the Time Warner assets) from AT&T and treating the business as discontinued operations.  \n\n- **2024 filing:** The 2024 10‑K reiterates that the WarnerMedia/Discovery separation was finalized in April 2022 and that AT&T now has no remaining interest in the former Time Warner businesses, confirming a full exit.  \n\n**What this shows:** AT&T moved from having integrated Time Warner into its entertainment portfolio to actively planning and then executing a divestiture, ending with a complete disengagement. The trajectory signals a strategic shift away from content ownership toward a tighter focus on its core telecommunications and network services.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop evolution of AT&T's relationship with Time Warner from 2022-2024, with mostly accurate facts and sound reasoning. STRENGTHS: (1) Correctly identifies the 2018 Time Warner acquisition and its role as core WarnerMedia segment; (2) Accurately dates the Reverse Morris Trust transaction completion to April 2022 (ground truth says 2023 completion, but LLM specifies April 2022 which is the actual close date); (3) Properly synthesizes the three-year progression across filings; (4) Correctly characterizes the strategic shift from vertical integration back to telecom focus; (5) Appropriately identifies the transaction as a divestiture/separation rather than a traditional sale. MINOR ISSUES: (1) The ground truth states 'By 2023, T had completed the separation' while the LLM correctly specifies 'April 2022' - this is actually MORE precise than the ground truth, not an error; (2) The LLM does not mention the DIRECTV sale to TPG in 2024, which the ground truth identifies as the 'final exit' and 'full retreat from media investments.' This is a notable omission as it represents the complete exit from entertainment/media sectors. The DIRECTV divestiture is a significant part of the overall strategic narrative showing AT&T's complete retreat from non-telecom businesses. (3) The LLM's characterization of the WarnerMedia separation as 'no remaining interest in former Time Warner businesses' is correct but doesn't capture the subsequent DIRECTV exit as part of the same strategic reversal. QUANTITATIVE VERIFICATION: All dates mentioned (2018 acquisition, May 2021 agreement, April 2022 completion, 2022-2024 filing years) are accurate. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly traces the evolution from ownership through divestiture planning to completion. The logical flow is sound. SEMANTIC EQUIVALENCE: The answer conveys the core strategic shift accurately, though it incompletely captures the full scope of AT&T's exit strategy by omitting the DIRECTV sale component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Acquires]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 574,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson’s Pipe Cutters were presented simply as a mechanical pipe‑working tool within the Tools & Home Products segment, listed alongside other traditional pipe‑working items and diagnostic equipment such as CCTV inspection cameras, with no reference to battery‑powered technology. By the 2023 filing the Safety & Productivity segment highlighted “battery‑hydraulic tools for press connections” and kept pipe cutters in the same product family, signalling that Emerson was beginning to pair its cutter line with battery‑driven solutions and the existing diagnostic systems. The 2024 filing repeats this positioning, continuing to list pipe cutters together with battery‑hydraulic tools and diagnostic cameras, showing that Emerson has evolved the product line from a stand‑alone mechanical cutter to a component of a broader, battery‑powered, digitally‑enabled tool portfolio across the Safety & Productivity segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year evolution (2022-2024) and accurately captures the progression from standalone mechanical tools to integrated battery-powered solutions with diagnostic systems. The answer correctly names the Safety & Productivity segment and mentions battery-hydraulic tools, CCTV/sewer inspection cameras, and the integration trend. Dates and segment names are accurate. WEAKNESSES: (1) The LLM introduces a factual error by stating that in 2022 Pipe Cutters were in the 'Tools & Home Products segment' when the ground truth indicates they were in the Safety & Productivity segment throughout. This is a significant entity accuracy error. (2) The LLM's characterization of 2022 positioning differs slightly - it describes them as 'mechanical pipe-working tool' with 'no reference to battery-powered technology,' which aligns with ground truth's 'standalone tools,' but the segment attribution is wrong. (3) The answer correctly synthesizes the multi-hop information showing progression across three years and the integration of battery technology with diagnostic systems. (4) The reasoning about the evolution from standalone to integrated solutions is sound and matches the ground truth narrative. CALCULATION/NUMERIC VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is based on date accuracy (all years correct: 2022, 2023, 2024). MULTI-HOP SYNTHESIS: The answer successfully connects information across three years and multiple product categories (cutters, battery tools, diagnostic systems), though the segment misidentification in 2022 undermines the synthesis quality. The core narrative of evolution is correct despite this error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 478,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "From the 2022 filing, Johnson & Johnson disclosed that it had **begun a multi‑year, enterprise‑wide initiative** to “integrate, simplify and standardize processes and systems” for HR, IT, procurement, supply‑chain and finance, with the explicit goal of **growing its financial shared‑service capabilities and standardizing its financial systems**. The 2023 10‑K repeats the same language, noting that the company is **continuing to implement** the initiative and to “align and streamline the design and operation of its financial control environment.” The 2024 filing again describes the effort in identical terms, confirming that the initiative is still **ongoing** and remains focused on the same functional areas and objectives.\n\nThe unchanged, year‑over‑year emphasis signals that Johnson & Johnson’s strategy is deliberately centered on **standardizing and consolidating financial processes across the enterprise**, using a shared‑service model to improve efficiency and control rather than reacting to any identified weakness. This persistent focus underscores the company’s long‑term commitment to a uniform, integrated finance operating model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative spanning 2022-2024 with accurate characterization of its scope (finance, HR, IT, procurement, supply-chain). (2) Accurately captures the core objectives: integrating, simplifying, standardizing processes and systems, growing financial shared-service capabilities, and standardizing financial systems. (3) Properly synthesizes the evolution across three years, noting the consistent messaging and unchanged emphasis year-over-year. (4) Correctly interprets the strategic significance: long-term commitment to process optimization and financial systems modernization, not a reactive response to control deficiencies. (5) Accurately conveys the company's deliberate focus on standardization and consolidation through a shared-service model. (6) No quantitative errors - all dates (2022, 2023, 2024) and functional areas are correct. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more specific detail about the functional areas (explicitly listing HR, IT, procurement, supply-chain alongside finance) compared to the ground truth's more general reference to 'key functions including finance,' but this is an enhancement rather than an error. (2) The phrasing differs slightly (e.g., 'begun a multi-year initiative' vs. 'consistently emphasized') but the semantic meaning is equivalent and accurately reflects the filing disclosures. (3) The LLM's emphasis on the initiative being 'not in response to any identified weakness' aligns with the ground truth's statement about it not being 'in response to any internal control deficiencies.' MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years, correctly identifying the pattern of consistent messaging and drawing appropriate conclusions about strategic intent. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 537,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "All three annual reports list the same disclosure for the Executive Health Plan – Exhibit 10.1* “Costco Wholesale Executive Health Plan” is shown as a Form 10‑K filing covering the period ended 9 Feb 2012 with a filing date of 19 Oct 2012 in the FY 2022, FY 2023 and FY 2024 10‑K exhibit tables. Because the description, form type and reference dates remain unchanged from 2022 through 2024, Costco’s filing status for the plan has been consistent, signalling that the company treats the Executive Health Plan as a stable, long‑term benefit for its executives rather than a program subject to frequent revision or termination.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DATE ERROR: The LLM states the period ended '9 Feb 2012' but the ground truth clearly states 'September 2, 2012'. This is a significant factual error in a key date. The LLM also states the filing date as '19 Oct 2012' when the ground truth specifies 'October 19, 2012' - while the date itself is correct, the format inconsistency combined with the period-end date error suggests careless reading. CORRECT ELEMENTS: (1) The LLM correctly identifies that the Executive Health Plan (Exhibit 10.1*) appears consistently across FY 2022, 2023, and 2024; (2) The filing date of October 19, 2012 is correct; (3) The conclusion about consistency and stable long-term strategy is semantically equivalent to the ground truth; (4) The reasoning that unchanged disclosures indicate no material updates is sound. INCOMPLETE/PROBLEMATIC: The period-end date error (February 9 vs September 2) is a fundamental factual mistake that undermines credibility, especially for a question specifically about disclosure evolution and consistency. The LLM correctly synthesizes the multi-hop information (comparing across three years and drawing conclusions about strategy), but the date error is a critical failure in quantitative accuracy. The qualitative reasoning about what consistency indicates is appropriate and matches the ground truth's interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 375,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Across the three annual reports (2022, 2023 and 2024) MasterCard’s A‑Class Shares were described identically: each share carries **one vote per share and is entitled to dividend rights**. There was no alteration in either the voting power or the dividend entitlement for the A‑Class stock during this three‑year span. This unchanging treatment signals that the company deliberately maintains a stable, predictable governance framework—granting A‑shareholders consistent voting influence while affirming a commitment to pay dividends, thereby reinforcing shareholder confidence and a clear, steady control structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and confirms MA (MasterCard) A Class Shares maintained identical rights across the period. (2) Accurately states the specific rights: one vote per share and dividend rights—matching the ground truth exactly. (3) Properly synthesizes the multi-hop requirement by comparing across three annual reports and drawing a coherent conclusion about governance strategy. (4) The interpretation that this consistency 'signals that the company deliberately maintains a stable, predictable governance framework' is semantically equivalent to the ground truth's conclusion about 'stable and unchanging governance strategy.' (5) The additional context about 'reinforcing shareholder confidence and a clear, steady control structure' adds reasonable interpretive depth without contradicting the ground truth. MINOR CONSIDERATIONS: (1) The LLM uses 'MasterCard' while the question uses 'MA'—both are correct references to the same company, so this is not an error. (2) The phrasing 'affirming a commitment to pay dividends' is slightly more interpretive than the ground truth's 'standard dividend rights,' but this is a reasonable inference and not factually incorrect. (3) All numeric/factual claims (one vote per share, dividend rights, three-year consistency) are verified as correct. No calculations were required, and none were performed incorrectly. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three separate annual reports to identify the pattern and draw appropriate conclusions about governance strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 457,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across all three fiscal years the Security Insights Platform was described in the same way. In FY 2022 the platform “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… the data is available for use with in‑house tools for security information and event management.” The FY 2023 filing repeats that exact language, and the FY 2024 filing again notes that the platform “identifies risks and develops remediation steps… the data is available for use with in‑house tools for security information and event management.” Thus, from 2022 through 2024 Broadcom’s platform consistently offered risk‑identification capabilities and seamless integration with customers’ internal SIEM/ security‑information‑and‑event‑management tools, with no substantive change in its stated functionality.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported by the ground truth. Strengths: (1) Correctly identifies all three fiscal years (2022, 2023, 2024) with no date errors. (2) Accurately captures the core functionality across all three years: risk identification, remediation steps, and integration with in-house SIEM tools. (3) Provides direct quotes from filings that substantiate the claims, demonstrating proper multi-hop synthesis across three separate fiscal year documents. (4) Correctly concludes that the platform showed stable, consistent functionality with no substantive changes over the period. (5) Properly identifies the semantic equivalence between 'security information and event management' and 'SIEM tools.' Minor considerations: (1) The LLM answer is slightly more detailed and explicit with direct quotations compared to the ground truth's more summarized narrative approach, but this adds value rather than detracting. (2) The ground truth mentions the platform was 'more explicitly tied to ongoing and ad hoc remediation planning' in FY 2023, which the LLM answer doesn't explicitly highlight, though the LLM's direct quotes suggest this language was consistent across years. (3) The LLM characterizes the offering as 'mature and well-defined' implicitly through its consistency analysis, which aligns with the ground truth's conclusion. Overall, the LLM answer successfully synthesizes information across three fiscal years, maintains factual accuracy on all entities and dates, and provides a clear, well-reasoned conclusion about the platform's evolution (or lack thereof).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 439,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 to 2024 AIG progressively deepened the way it quantifies and validates its loss‑reserve risk. In 2022 the company relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” to gauge reserve adequacy. By 2023 it had added formal “review and challenge of reserves, actuarial profitability and reserve reviews” together with “sensitivity and scenario analyses, stochastic methods, and experience studies” and used both internal and third‑party assessment tools to model loss‑reserve outcomes. In the 2024 filing the process is further institutionalized: the Enterprise Risk Management function conducts a “Second Line Review and Challenge” of pricing and reserving models, assumptions and results, the Internal Audit Group continuously audits key processes, and external experts continue to provide independent validation of the reserve estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of AIG's loss reserve risk management from 2022-2024, correctly identifying the progression from basic internal controls and external reviews (2022) to more sophisticated methodologies including stochastic/deterministic modeling and actuarial reviews (2023) to a mature multi-tiered approach with ERM second-line reviews and enhanced monitoring (2024). All key elements from the ground truth are present and accurately represented. (2) QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either the ground truth or LLM answer, so this dimension is not applicable but receives full marks as there are no errors. (3) ENTITY ACCURACY: AIG is correctly identified throughout, and all fiscal years (2022, 2023, 2024) are accurately referenced. The specific functions and processes mentioned (Enterprise Risk Management, Internal Audit Group, external experts) are correctly identified. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years, showing the logical progression and evolution of methodologies. The answer correctly identifies the causal relationship between years (each year building on previous approaches) and properly contextualizes the role of external experts across all periods. (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing than the ground truth (e.g., 'progressively deepened' vs 'became more structured') but conveys identical meaning. The specific methodologies mentioned (stochastic methods, sensitivity analyses, scenario analyses) match the ground truth. The description of 2024's 'Second Line Review and Challenge' directly corresponds to the ground truth's 'ERM second-line reviews.' Minor differences in wording (e.g., 'institutionalized' vs 'reinforced') represent stylistic variation without factual divergence. The answer is comprehensive, addressing all aspects of the question regarding methodologies, external expert roles, and temporal evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 569,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In the 2022 filing, Emerson listed **electrical distribution equipment** only as one of the product families that sit inside the broad **Industrial Solutions** umbrella (together with fluid‑control, pneumatic mechanisms, materials‑joining and precision‑cleaning products). By the 2023 filing, the company had moved that same product line into the newly‑named **Discrete Automation** segment, describing it alongside solenoid valves, pneumatic cylinders, electric‑linear‑motion and programmable‑automation control systems and stating that it is “used primarily in discrete industries.” The 2024 filing repeats this placement, keeping electrical distribution equipment firmly within the Discrete Automation segment.\n\nThis shift from a generic Industrial‑Solutions grouping to a dedicated Discrete‑Automation segment signals that Emerson is elevating electrical distribution equipment as a core offering for discrete‑automation customers, underscoring a strategic emphasis on growing its presence in discrete‑industry markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information across three fiscal years (2022, 2023, 2024). STRENGTHS: (1) All dates and years are correct (2022, 2023, 2024). (2) Segment names are accurately identified: Industrial Solutions (2022) and Discrete Automation (2023-2024). (3) Product categorizations are correct: the answer properly identifies electrical distribution equipment's positioning alongside solenoid valves, pneumatic cylinders, electric linear motion, and programmable automation systems. (4) The multi-hop reasoning is sound—the answer correctly traces the evolution across three years and identifies the strategic shift from a generic industrial grouping to a dedicated discrete automation focus. (5) The conclusion about strategic emphasis on discrete automation markets is well-supported by the evidence presented. MINOR WEAKNESSES: (1) The LLM answer omits some specific product details mentioned in the ground truth (materials joining products, precision-cleaning products from 2022; programmable automation systems mentioned more explicitly in ground truth). However, these omissions are minor and don't affect the core narrative. (2) The phrasing differs slightly from ground truth (e.g., 'newly-named Discrete Automation segment' vs. 'reorganized under the Discrete Automation segment'), but the semantic meaning is equivalent. (3) The LLM answer is slightly less detailed about the 'deepening' nature of the strategic focus in 2024 compared to ground truth's description of 'continued and deepening strategic focus on integrated automation solutions.' VERIFICATION: All factual claims check out—no numerical errors, no date errors, no entity misidentifications. The synthesis correctly connects information across multiple years to demonstrate strategic evolution. The answer appropriately addresses all parts of the multi-part question regarding positioning evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 532,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "**Evolution of the pension‑plan structure (2022 → 2024)**  \n\n- **2022 filing:** J&J noted that, in January 2021, it announced that *effective 1 January 2026* every eligible U.S. non‑union employee – no matter when hired – will earn pension benefits under the **Retirement Value formula**. The change would **not** alter benefits already accrued under the older **Final Average Pay** formula for service that occurred before 1 Jan 2026.  \n\n- **2023 filing:** The same announcement is restated. The 2023 10‑K again describes the pre‑2026 split (Final Average Pay for hires before 1 Jan 2015; Retirement Value for hires after 2014) and confirms the planned universal shift to the Retirement Value formula on 1 Jan 2026, with no impact on pre‑2026 accrued benefits.  \n\n- **2024 filing:** The 2024 10‑K repeats the policy verbatim, confirming that the **January 2021 announcement** remains in force and that the universal application of the Retirement Value formula will commence on 1 Jan 2026, preserving earlier accrued benefits under the Final Average Pay formula.\n\n**What the multi‑year transition reveals about J&J’s long‑term workforce strategy**\n\n- **Uniformity and simplification:** By moving all eligible non‑union employees to a single, service‑and‑compensation‑based formula, J&J is streamlining its pension architecture, reducing administrative complexity across hire cohorts.  \n\n- **Retention and equity focus:** A formula that rewards total years of service and overall compensation aligns retirement benefits with long‑term employment, encouraging employees to stay with the company and creating a more equitable benefit landscape regardless of hire date.  \n\n- **Forward‑looking commitment:** Re‑affirming the same policy in three consecutive 10‑K reports (2022‑2024) signals a deliberate, long‑term strategic commitment to a cohesive workforce compensation model that will be fully in place by 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about J&J's pension plan evolution. QUANTITATIVE ACCURACY (10/10): All dates are correct - the January 1, 2026 effective date is accurately cited across all three years (2022, 2023, 2024), and the January 2021 announcement date is correctly identified. The formula names (Retirement Value and Final Average Pay) are precisely stated. No calculations are required for this question, and all numeric references are accurate. ENTITY ACCURACY: Johnson & Johnson is correctly identified, U.S. non-union employees are properly specified, and the fiscal years 2022-2024 are correctly referenced. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three years of filings, demonstrating the consistent messaging pattern. The LLM correctly identifies that the policy remained unchanged across all three years, which is the critical insight. The answer properly traces the evolution (or lack thereof) and explains what this consistency reveals about strategy. COMPLETENESS: The answer addresses both parts of the question - the evolution of the pension plan structure AND what the multi-year transition reveals about long-term workforce strategy. The structural details (preservation of pre-2026 accrued benefits, universal application to all eligible employees regardless of hire date) are all present and accurate. SEMANTIC EQUIVALENCE: The LLM's interpretation of the strategic implications (uniformity, simplification, retention focus, equity, forward-looking commitment) aligns well with the ground truth's characterization of \"deliberate long-term workforce strategy to standardize retirement benefits\" and \"shift toward cost predictability and broader workforce inclusivity.\" The reasoning about why this matters strategically is sound and well-articulated. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail about the pre-2026 split (mentioning the 2015 hire date threshold) which adds helpful context without contradicting the ground truth. The presentation is clear and well-organized with bullet points that enhance readability. No factual errors or omissions of significance were identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1708,
        "completion_tokens": 602,
        "total_tokens": 2310
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "- In the 2022 filing the Fabric & Home Care segment accounted for **35 % of P&G’s net sales**; in both the 2023 and 2024 filings that share rose to **36 %**. Because Downy is listed among the “Major Brands” for this segment in every year (PG → Downy → PG), the segment’s rise reflects an incremental increase in the weight of Downy‑related products within the company’s overall sales mix.  \n\n- The 1‑percentage‑point gain from 2022 to 2023, followed by a flat‑line in 2024, signals that Downy is becoming (or remaining) a slightly more important growth driver for P&G, reinforcing its strategic relevance in the firm’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts - Fabric & Home Care segment contribution was 35% in 2022 and 36% in 2023-2024. The numerical data matches the ground truth exactly. The LLM also correctly notes that Downy is listed as a major brand in the segment across all years.\n\nWEAKNESSES: (1) CRITICAL MISINTERPRETATION: The LLM fundamentally misunderstands what the question asks. The question asks about 'Downy's percentage contribution to the Fabric & Home Care segment' - meaning what percentage of the segment's sales does Downy represent. Instead, the LLM discusses the Fabric & Home Care segment's contribution to P&G's overall net sales (35-36%). These are two different metrics. The ground truth answer also appears to conflate these concepts, but the LLM's interpretation is clearly incorrect for the specific question asked. (2) INCOMPLETE ANALYSIS: The LLM provides no actual percentage data for Downy's contribution within the Fabric & Home Care segment itself - which is what the question specifically requests. (3) REASONING FLAW: The statement 'the segment's rise reflects an incremental increase in the weight of Downy-related products' is speculative and not supported by the data presented. The LLM conflates segment-level growth with brand-level contribution without evidence. (4) VAGUE CONCLUSION: The phrase 'becoming (or remaining) a slightly more important growth driver' is hedged and imprecise, failing to provide clear strategic insight.\n\nCALCULATION VERIFICATION: The 1-percentage-point difference (35% to 36%) is correctly calculated, but this calculation relates to the wrong metric for the question asked.\n\nMULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the multi-hop requirement - it should connect Downy brand data to segment data to overall company data, but instead only addresses segment-to-company relationships.\n\nSEMANTIC MATCH: While the LLM's numbers are accurate for what it discusses, it answers a different question than what was asked, making semantic equivalence impossible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 554,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "- **Carrying‑value trend:** Capital One’s total senior and subordinated notes were $27.2 billion at year‑end 2021 (Chunk 1).  They rose to $30.8 billion at year‑end 2022 (Chunk 2), increased modestly to $31.2 billion at year‑end 2023 (Chunk 2), and then slipped slightly to $30.7 billion at year‑end 2024 (Chunk 3).\n\n- **Implication:** The notes portfolio grew sharply between 2021‑2022 and then held roughly steady, with only a small net decline in 2024.  This pattern indicates that Capital One is maintaining a relatively stable level of senior/subordinated debt—using the instrument to modestly expand its financing base when needed and then fine‑tune the mix rather than pursuing aggressive new borrowing or large‑scale retirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Ground Truth 2022: $27,219 million | LLM Claims: $30.8 billion ($30,800 million) - ERROR of ~$3.6 billion\n   - Ground Truth 2023: $31,248 million | LLM Claims: $31.2 billion ($31,200 million) - Close but slightly low\n   - Ground Truth 2024: $31,248 million | LLM Claims: $30.7 billion ($30,700 million) - ERROR of ~$548 million\n   - LLM includes 2021 data ($27.2B) which is not part of the question's 2022-2024 timeframe\n\n2. TREND ANALYSIS ERRORS:\n   - Ground Truth shows: 2022 ($27.2B) → 2023 ($31.2B) → 2024 ($31.2B) = UPWARD TREND with plateau\n   - LLM shows: 2022 ($30.8B) → 2023 ($31.2B) → 2024 ($30.7B) = FLAT then DECLINE\n   - These are contradictory narratives based on incorrect numbers\n\n3. STRATEGIC INTERPRETATION ERRORS:\n   - Ground Truth correctly identifies an \"upward trend\" and \"strategic shift toward issuing more senior and subordinated notes\"\n   - LLM incorrectly characterizes the trend as \"held roughly steady\" with \"small net decline in 2024\"\n   - This misinterpretation flows directly from the incorrect numbers\n\n4. ENTITY/SCOPE ERRORS:\n   - LLM includes 2021 data when question explicitly asks for 2022-2024 evolution\n   - This suggests misalignment with the specific question parameters\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the carrying value data across the three-year period\n   - The conclusion about \"maintaining relatively stable level\" contradicts the actual upward trajectory shown in ground truth\n\nThe answer demonstrates a fundamental failure to accurately extract and report the financial data, leading to an entirely different (and incorrect) interpretation of Capital One's debt financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 501,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- 2022: AT&T (T) reported that it “continues to hold a 41.3 % interest in SKY Mexico,” a pay‑TV provider, and the investment was treated under the equity‑method (as a less‑than‑majority, significant‑influence affiliate).  \n- 2023: The 2023 filing still listed SKY Mexico among its equity‑method investments, confirming that the 41.3 % stake and equity‑method accounting remained unchanged throughout the year.  \n- 2024: In June 2024 AT&T disclosed that it **sold its 41.3 % interest in SKY Mexico**, removing the investment from the balance sheet and completing its exit from the Mexican pay‑TV market.  \n\nThis three‑year progression—from holding a sizable minority stake and recognizing earnings via the equity method to a full divestiture—mirrors AT&T’s broader Latin‑American pay‑TV exit strategy (e.g., the 2021 Vrio sale), showing a systematic move to unwind video assets in the region and concentrate on other core businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All numeric values are correct—41.3% ownership stake consistently cited across all three years, June 2024 exit date accurate. (2) Quantitative accuracy is perfect: no calculation errors, all percentages and dates verified against ground truth. (3) Entity identification is precise: AT&T/T correctly identified, SKY Mexico properly named, equity method accounting correctly characterized. (4) Multi-hop synthesis is sound: the answer successfully traces the 3-year evolution (2022→2023→2024) and connects it to broader divestiture strategy. (5) The answer correctly identifies the equity method treatment in 2022-2023 and the June 2024 sale completion. (6) Contextual framing is excellent—the LLM appropriately connects SKY Mexico exit to AT&T's broader Latin American pay-TV strategy, even citing the 2021 Vrio sale as a parallel example, which demonstrates understanding of the strategic pattern. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (e.g., explicitly noting 'less-than-majority, significant-influence affiliate' and referencing the 2021 Vrio sale), but these additions are accurate and enhance rather than detract from the answer. The semantic meaning is fully aligned with the ground truth—both convey that T held a steady 41.3% stake under equity method accounting from 2022-2023, then exited completely in June 2024 as part of a deliberate Latin American divestiture strategy. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Involved_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 446,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 filing first warned that any return of capital – including share repurchases and dividends – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The 2023 filing repeated the same limitation, emphasizing that the Board’s discretion and the same banking‑law constraints continue to govern capital returns, while also noting that a downgrade of its bank subsidiaries’ credit ratings could raise funding costs.\n\nBy the 2024 filing the company had expanded the disclosure: it again cites the Board’s discretion and U.S. banking‑law limits, but now explicitly ties those limits to the need to satisfy “‘well‑capitalized’ and ‘well‑managed’ status or capital‑adequacy and liquidity rules more generally,” underscoring that failure to meet those regulatory capital standards would directly restrict dividend payments and other capital‑return activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the three-year period (2022-2024) and accurate characterization of BNY Mellon's capital return constraints. The answer correctly identifies key regulatory themes: Board discretion, U.S. banking laws, capital adequacy rules, Delaware law, preferred dividend requirements, and credit rating impacts. The multi-hop synthesis across three years is sound, showing the evolution from baseline constraints in 2022-2023 to expanded disclosure in 2024 regarding 'well-capitalized' and 'well-managed' status. No quantitative errors are present (no specific dollar amounts or percentages were claimed). The answer appropriately addresses all parts of the multi-part question: regulatory requirements, dividend policies, and capital adequacy. However, there are minor gaps compared to the ground truth: (1) The LLM answer does not explicitly mention ESG-related regulatory pressures that emerged in 2023 disclosures, (2) The 2024 discussion of Parent company reliance on subsidiary dividends and strategic transformation initiatives' impact on liquidity is not addressed, (3) The characterization of the trend as showing 'increasing contextual complexity' is implied but not explicitly stated. The LLM answer focuses more on specific regulatory language evolution rather than the broader contextual complexity mentioned in the ground truth. The reasoning is logically sound and the synthesis across years is accurate, but the answer is somewhat narrower in scope than the ground truth, missing some contextual nuances about strategic initiatives and ESG factors that were part of the actual disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 459,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "Across the three filings, 3M kept **Structural Adhesives** grouped with **tapes** inside the Safety and Industrial segment. In 2022 and 2023 the segment’s description listed “Structural adhesives and tapes” together with “Closure systems for personal‑hygiene products, masking, and packaging materials,” while the 2024 filing retained “Structural adhesives and tapes” but renamed the adjacent offering to “Industrial specialty products such as personal‑hygiene products, masking, and packaging materials.” The wording changed only slightly, but the bundling of adhesives with tapes and with sealing/closure solutions remained constant, signalling that 3M treats adhesives as a core, cross‑selling component of its industrial‑specialty portfolio and underscores the strategic role of adhesives in supporting a wide range of industrial applications—from metal‑working and auto‑body repair to packaging and hygiene‑product closures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year timeframe (2022-2024) and accurately captures that Structural Adhesives remained in the Safety and Industrial segment throughout. (2) The LLM correctly notes the bundling of adhesives with tapes across all three years, which is a key structural insight. (3) The LLM accurately identifies the shift in adjacent product naming from 'Closure systems' language to 'Industrial specialty products' language between 2023 and 2024. (4) The conclusion about adhesives as a cross-selling component is reasonable and supported by the evidence presented.\n\nWEAKNESSES: (1) The LLM's answer introduces specific product groupings (tapes, closure systems) that are not explicitly confirmed in the ground truth answer. While the ground truth mentions 'electrical materials,' 'metalworking,' 'autobody repair solutions,' and 'packaging and closure systems,' it does not specifically state that adhesives were bundled with 'tapes' in the filings. The LLM appears to have added this detail without clear verification. (2) The ground truth emphasizes a strategic evolution showing adhesives as 'a foundational component in complex industrial systems' with a shift toward 'more specialized industrial applications' and 'construction and maintenance' by 2024. The LLM's answer focuses more on the consistency of bundling rather than capturing this evolution toward specialization. (3) The ground truth mentions 'industrial abrasives' and 'electrical materials' as adjacent offerings in 2022, which the LLM does not reference. (4) The LLM's characterization of the change as 'only slightly' different wording may understate the strategic shift the ground truth identifies—from integration with metalworking/OEM markets to more specialized industrial applications.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies a pattern (consistent bundling with tapes and closure/specialty products). However, it misses the deeper strategic evolution that the ground truth emphasizes—the shift from general industrial integration to specialized applications. The reasoning is partially sound but incomplete.\n\nFACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on the accuracy of product groupings and segment descriptions. The LLM's specific claim about 'tapes' bundling is not explicitly verified in the ground truth, which is a concern for factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 666,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "In the 2022 Form 10‑K Eli Lilly described Cyramza as a multi‑indication oncology asset – a second‑line monotherapy or combination for advanced/metastatic gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated metastatic NSCLC. The 2024 filing lists exactly the same five indications, showing that Lilly’s therapeutic positioning for Cyramza remained stable over the 2022‑2024 period. Meanwhile, the 2023 filing details the product’s IP portfolio: compound patents protect Cyramza in the United States through 2026, in major European countries through 2028 and in Japan through 2026, while biologics data‑protection in the U.S. runs to 2026 and data‑protection in Europe to 2024 (Japan 2023). Together, the unchanged indication set and the layered patent‑and‑data‑protection schedule illustrate Lilly’s strategy of maintaining a broad, globally‑covered oncology label while relying on a suite of patents and exclusivity periods to sustain market exclusivity in the United States, Europe and Japan through at least the mid‑2020s.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies all five therapeutic indications for Cyramza (gastric/GEJ adenocarcinoma, metastatic NSCLC, colorectal cancer, hepatocellular carcinoma, and first-line EGFR-mutated NSCLC) and confirms their consistency across 2022 and 2024 filings. (2) Accurately reports IP protection timelines: U.S. compound patents through 2026, European patents through 2028, Japan patents through 2026, U.S. biologics data protection through 2026, European data protection through 2024, and Japan data protection through 2023. (3) Provides superior detail compared to ground truth by specifying both compound patents AND biologics data protection separately, offering more granular IP analysis. (4) Correctly synthesizes the multi-hop reasoning: stable therapeutic positioning + layered IP/exclusivity schedule = sustained market exclusivity strategy. (5) Appropriately contextualizes the strategic evolution as lifecycle management preparing for competition. MINOR DISCREPANCIES: The ground truth states 'European countries in 2024' for data protection expiration, while the LLM specifies 'Europe to 2024' for data protection and 'European countries through 2028' for compound patents. This distinction between data protection and patent protection is actually more precise in the LLM answer and represents a refinement rather than an error. The LLM's additional detail about compound patents (2028 in Europe) goes beyond the ground truth but is not contradictory. QUANTITATIVE VERIFICATION: All dates (2023, 2024, 2026, 2028) are correctly stated. The indication count (five) is accurate. No calculation errors present. MULTI-HOP REASONING: Excellent synthesis connecting therapeutic stability, IP portfolio structure, and strategic intent across three years and multiple geographic markets. The answer successfully integrates information from multiple filings (2022, 2023, 2024) to construct a coherent narrative about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 556,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "**Evolution of the instrument**\n\n| Year (as of 31 Dec) | Carrying value of Fixed Unsecured Senior Debt | Weighted‑average interest rate |\n|---------------------|-----------------------------------------------|--------------------------------|\n| 2022* | **$24,134 million** | – (not disclosed for 2022) |\n| 2023 | **$27,168 million** | **4.45 %** |\n| 2024 | **$26,930 million** | **4.84 %** |\n\n\\*The 2023 Form 10‑K shows the 2022 carrying amount of $24,134 million (the “prior‑year” column). The weighted‑average rate for 2022 is not presented, but the rate for 2023 is 4.45 % and rises to 4.84 % in 2024.\n\n**What the trend tells us**\n\n1. **Debt size:** Capital One expanded its fixed‑rate unsecured senior borrowings sharply between 2022 and 2023 (+$3.0 bn, ≈ 12 %). In 2024 the balance slipped slightly (‑$0.2 bn, ≈ 1 %), indicating a modest pull‑back after the 2023 buildup—likely a combination of amortization and limited new issuance.\n\n2. **Financing cost:** The weighted‑average interest rate climbed from 4.45 % in 2023 to 4.84 % in 2024, a rise of about 0.4 percentage point. This reflects Capital One’s need to issue new fixed‑rate debt at higher market rates (or to refinance existing notes at higher coupons) as overall interest‑rate environments have risen.\n\n**Overall implication**\n\nThe multi‑year pattern shows Capital One using fixed unsecured senior debt as a core financing source, growing the tranche when market conditions allowed (2023) and then curbing additions as rates rose (2024). The upward shift in the weighted‑average rate signals increasing financing costs, suggesting the company is accepting higher‑cost, longer‑dated debt to maintain liquidity and fund growth, while beginning to manage the balance to limit exposure to the higher‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) CARRYING VALUE MISMATCH: Ground truth states 2022 carrying value was $19,975 million, but LLM reports $24,134 million—a $4.2 billion discrepancy (21% difference). The LLM's 2023 figure of $27,168 million and 2024 figure of $26,930 million also differ from what would be expected if the 2022 baseline were correct. (2) WEIGHTED-AVERAGE INTEREST RATE ERROR: Ground truth shows 2022 rate of 2.91%, but LLM states this was 'not disclosed for 2022' and only provides 4.45% for 2023 and 4.84% for 2024. The LLM missed the critical 2022 rate entirely, which is essential for understanding the multi-year trend. (3) TREND ANALYSIS FLAWED: Because the baseline numbers are wrong, the LLM's calculation of the 2022-2023 increase (+$3.0 billion) is incorrect. The ground truth shows an increase from $19,975M to $26,930M (approximately $6.95 billion or 35% growth), not the modest 12% growth the LLM calculated. (4) MISSING CONTEXT: The LLM failed to capture the dramatic 193 basis point increase in weighted-average interest rate from 2.91% to 4.84% (ground truth), instead only showing a 39 basis point increase from 4.45% to 4.84%. This understates the financing cost escalation significantly. (5) REASONING QUALITY: While the LLM's qualitative analysis about debt strategy and market conditions is reasonable, it is built on incorrect quantitative foundations, making the conclusions unreliable. The multi-hop synthesis failed because the underlying data extraction was inaccurate. The LLM appears to have sourced different or incomplete data from the SEC filings, resulting in a fundamentally incorrect answer despite reasonable analytical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 480,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s Total‑Return Swaps that are linked to its deferred‑compensation program moved from a **$92 million loss in fiscal 2022** (shown in the 2022 Form 10‑K table) to **a $58 million gain in fiscal 2023** and then to **a $91 million gain in fiscal 2024** (both the 2023 and 2024 Form 10‑K tables report the same figures for those years).  \n\nThe swing from a $92 million loss to a $91 million gain – a net change of about $183 million – and the alternating sign of the results across the three years illustrate that the swap position is highly volatile, producing sizable gains in some years and sizable losses in others.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All financial figures are correct: $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024. The calculation of the net swing ($183 million) is accurate and properly illustrates the volatility. The answer correctly identifies the instrument (Total Return Swaps tied to deferred compensation), the company (Cisco), and all three fiscal years. The multi-hop synthesis is sound—the model successfully extracted data from multiple 10-K filings across three years and synthesized them into a coherent narrative about the pattern and volatility. The reasoning about volatility is logical and well-supported by the data presented. The answer goes slightly beyond the ground truth by explicitly calculating the $183 million swing and providing additional context about the alternating signs, which adds analytical value without introducing errors. The only minor distinction is that the ground truth uses simpler language ('volatile financial impact') while the LLM provides more detailed analysis ('highly volatile, producing sizable gains in some years and sizable losses in others'), but this represents enhanced clarity rather than any factual deviation. All entity identifications are correct, and the temporal sequence is properly maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 371,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "**Evolution of the emphasis**\n\n- **2022 (10‑K 2022 – Competition & Seasonality)** – Store appearance was listed alongside location, merchandise presentation and ease of shopping as one of the core dimensions Home Depot uses to compete with “traditional brick‑and‑mortar, multichannel and exclusively online” rivals. It was presented as a static competitive lever.  \n\n- **2023 (10‑K 2023 – Strategic Risks & Competition)** – The same set of factors re‑appears, but the filing ties store‑appearance importance to the broader “store location and appearance, presentation of merchandise, and ease of shopping experience throughout every step of the project.” The language is more explicit that appearance is a **continuous, step‑by‑step differentiator** for both DIY customers and professional (Pro) buyers, reinforcing its role against multichannel and online competitors.  \n\n- **2024 (10‑K 2024 – Competition & Interconnected Shopping Experience)** – The company expands the concept to “store and branch location and appearance” and explicitly links it to its **interconnected shopping experience**—the blend of physical‑store ambience with digital tools, mobile‑first design and seamless fulfillment. Store appearance is now framed as an integral part of a unified physical‑digital strategy that directly supports the fight against multichannel and online retailers.\n\n**Measurable impact on competitive positioning**\n\nAcross all three years Home Depot repeatedly states that competing on store appearance (together with location, merchandise presentation and ease of shopping) is a **core pillar that helps preserve its market share and prevents erosion by multichannel and online rivals**. The 2023 risk narrative warns that “strong competition could … decrease our market share,” while the 2024 discussion notes that the **interconnected, appearance‑driven experience is intended to keep the company “competitive on delivery and pickup times… and … maintain our competitive position.”**  \n\nThus, from 2022 to 2024 the strategic focus on store appearance evolved from a basic competitive attribute to a **strategically integrated element of a frictionless, omnichannel experience**, and that evolution is presented as a measurable safeguard of Home Depot’s competitive standing against multichannel and online competitors—helping the retailer sustain its market‑share advantage and avoid material adverse impacts on profit margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of how store appearance evolved from a 'static competitive lever' to an 'integral part of a unified physical-digital strategy.' (2) Accurately captures the progression: 2022 (standalone factor), 2023 (continuous step-by-step differentiator), 2024 (interconnected shopping experience). (3) Properly synthesizes multi-hop information by connecting store appearance to broader omnichannel strategy and competitive positioning against multichannel and online retailers. (4) Correctly identifies that the company frames this evolution as a 'measurable safeguard' of competitive standing and market share. (5) No quantitative errors—no specific dollar amounts or percentages were claimed, avoiding potential calculation mistakes. (6) Entity accuracy is perfect: correctly names The Home Depot, identifies Pro/DIY customer segments, and references the appropriate competitive categories (multichannel, online, brick-and-mortar). MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer could have been slightly more explicit about the 'hybrid model' terminology used in the ground truth, though the concept is clearly conveyed through 'interconnected shopping experience' and 'physical-digital strategy.' (2) The phrase 'frictionless, omnichannel experience' in the LLM answer is semantically equivalent to the ground truth's 'seamless blend of physical and digital touchpoints' but uses slightly different terminology. (3) The LLM answer references 'market-share advantage' and 'profit margins' as impacts, which are reasonable inferences from the ground truth's discussion of competitive positioning but are not explicitly stated in the original answer. These are logical extensions rather than errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and connects store appearance evolution to competitive strategy against specific competitor types. The reasoning chain is sound and well-documented with year-by-year progression. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that store appearance evolved from a standalone factor to an integrated omnichannel element—despite using different phrasing in places.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1907,
        "completion_tokens": 636,
        "total_tokens": 2543
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "- **FY 2022:** The 3.50 % Notes Due 2050 were carried on NVIDIA’s balance sheet at **$2,147 million** (see the 2022 10‑K “Liabilities” table).  \n- **FY 2023:** The same series was carried at **$1,637 million** (the 2023 10‑K “Liabilities” table for Jan 29 2023).  \n- **FY 2024:** The 2024 10‑K lists the net carrying amount of the 3.50 % Notes Due 2050 as **$2,000 million** (the “Expected Remaining Term” table for Jan 28 2024).\n\n**Interpretation:**  \nThe carrying amount fell sharply from 2022 to 2023, indicating that NVIDIA reduced the outstanding principal (or amortized a portion) of this long‑dated debt during that year. The subsequent rise to $2 billion in 2024 shows a modest re‑expansion of the liability, but the amount remains below the 2022 level, suggesting that the company is actively managing its long‑term debt—trading off reductions in one period with limited new issuance in the next—while keeping the overall long‑term debt portfolio (≈ $8.5 billion) at a controlled size.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three carrying values are correct—$2,147 million (FY2022), $1,637 million (FY2023), and $2,000 million (FY2024)—matching the ground truth exactly. The numeric progression is accurately presented with proper formatting. COMPLETENESS: The answer addresses all required elements: the three-year evolution of carrying values, the temporal progression, and interpretation of what the changes indicate about debt positioning. ENTITY ACCURACY: NVIDIA is correctly identified, the specific debt instrument (3.50% Notes Due 2050) is precisely named, and all fiscal years are correctly referenced. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (1) extracting values from multiple fiscal year filings, (2) comparing values across years to identify trends (sharp decline 2022-2023, recovery 2023-2024), and (3) interpreting the pattern as evidence of active debt management. The interpretation that the 2023 reduction represents principal reduction/amortization and the 2024 recovery shows controlled re-expansion is logically sound and consistent with the data. SEMANTIC EQUIVALENCE: The LLM's interpretation ('actively managing its long-term debt') aligns well with the ground truth's characterization ('strategic repositioning or stabilization'). Both convey that the fluctuations reflect deliberate financial management rather than random variation. MINOR CONSIDERATIONS: The LLM provides additional context (mentioning the overall ~$8.5 billion long-term debt portfolio) which, while not explicitly in the ground truth, adds reasonable contextual depth without contradicting the original answer. The reference to specific 10-K tables and dates (Jan 29 2023, Jan 28 2024) demonstrates proper source attribution. No calculation errors detected. The answer fully satisfies the multi-hop requirement by synthesizing information across three separate fiscal year filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 533,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From the 2022 filing, 3M’s Scotchgard‑related exposure was dominated by a single, high‑profile settlement – a February 2022 court‑approved $65 million agreement (with Saint‑Gobain and Honeywell) that resolved the New York putative class action – and a handful of other pending state and federal suits (e.g., 40 individual actions in the Northern District of New York, 13 cases in the Eastern District of New York and a Michigan class action that would later be settled with a non‑material payment in June 2023). By the 2023 report the litigation picture had broadened: 3M was still defending the New York and Michigan matters (the latter now closed), had added a new putative class action in British Columbia, and was aware of roughly 68 additional AFFF lawsuits outside the MDL, indicating a growing pool of co‑defendants such as DuPont, Chemours, carpet and textile manufacturers, and other industrial users. The 2024 filing shows the geographic spread moving sharply south – with new suits filed in Alabama (multiple municipal water utilities, a mass‑action in Gadsden, and dismissals in Mobile) and Georgia (land‑owner, city and utility actions, plus lawsuits from Mohawk Industries, Dalton Utilities, etc.) – and the number of parties on both sides expanding to include dozens of co‑defendants (DuPont, Chemours, Daikin, carpet makers, municipal entities, water boards and other PFAS users), while settlements have largely stalled and the focus has shifted to motions to dismiss and upcoming trials slated for 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about 3M's Scotchgard litigation evolution from 2022-2024. STRENGTHS: (1) All key financial figures are correct: $65 million settlement in February 2022 with Saint-Gobain and Honeywell, non-material Michigan settlement in June 2023. (2) Geographic expansion is accurately traced: New York cases (2022), Michigan (2022-2023), British Columbia (2023), then Alabama and Georgia (2024). (3) Specific case details are accurate: Baker case, Wolverine World Wide Michigan matter, Gadsden mass action, Mohawk Industries involvement. (4) Co-defendant expansion is correctly identified: DuPont, Chemours, Daikin, carpet manufacturers, municipal entities. (5) Multi-hop synthesis is sound: the answer correctly synthesizes information across three years of filings, showing the progression from concentrated New York/Michigan exposure to geographically dispersed litigation with expanding defendant pools. (6) Temporal progression is clear and accurate: 2022 (single major settlement), 2023 (broadening with ~68 additional AFFF lawsuits), 2024 (sharp geographic expansion south). MINOR CONSIDERATIONS: The LLM answer provides more granular detail than the ground truth (e.g., specific district counts, British Columbia addition, 2026 trial timeline), but all these details appear consistent with the ground truth narrative and add appropriate context without contradicting it. The answer correctly captures the core evolution: from immaterial/non-material settlements to a stalled settlement landscape with focus on motions and future trials. No factual errors detected. The answer fully addresses all three sub-components of the question: case settlements, geographic expansion, and defendant involvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manufactures]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 489,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "- **Royalty structure:** From the original 2020 agreement (described in the 2022 filing) AbCellera is entitled to tiered royalties “in the mid‑teens to mid‑twenties” on worldwide net sales of bamlanivimab and bebtelovimab. The 2023 and 2024 filings repeat the same language, indicating that the royalty percentages have not changed through 2024.  \n\n- **Milestone payments:** The 2022 filing mentions only development‑related expenses and does not list any milestone payments to AbCellera. Both the 2023 and 2024 10‑Ks state that “milestone payments … were not material” (and no milestone payments are disclosed for 2022, 2023 or 2024). Thus, there were no material milestone payments reported during this period.  \n\n- **Net product revenue:** - 2021: $2.24 billion (2022 filing)  \n  - 2022: $2.02 billion (2023 and 2024 filings)  \n  - 2023: $0 (no sales reported)  \n  - 2024: $0 (no sales reported)  \n\n**Overall evolution (2022‑2024):** The royalty rate remained unchanged at mid‑teens to mid‑twenties, no material milestone payments were recorded, and net product revenue dropped from $2.02 billion in 2022 to zero in both 2023 and 2024 as the COVID‑19 antibodies were no longer sold under EUA.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All key financial figures are correct: $2.02 billion in 2022 net product revenue, $0 in 2023-2024, matching the ground truth exactly. (2) Royalty structure correctly identified as 'mid-teens to mid-twenties' on worldwide net sales, with accurate notation that this remained unchanged across the period. (3) Milestone payments correctly characterized as 'not material' with no material payments disclosed for 2022-2024, aligning with ground truth statement that 'no new milestone payments were made.' (4) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years, synthesizing information from multiple 10-K filings (2022, 2023, 2024) and connecting royalty structure, milestone payments, and revenue trends. (5) The answer appropriately addresses all three sub-components of the question (royalty structure, milestone payments, net product revenue) and provides clear temporal evolution. MINOR OBSERVATIONS: (1) The LLM includes 2021 revenue ($2.24 billion) which is not explicitly mentioned in the ground truth answer, though this is additional context that doesn't contradict the ground truth and provides helpful historical perspective. (2) The LLM provides slightly more detailed sourcing (noting which filings contain which information) compared to the ground truth, which is a strength for transparency. (3) The characterization of 'complete cessation of commercial activity' in the ground truth is semantically equivalent to the LLM's statement about products 'no longer sold under EUA.' CALCULATION VERIFICATION: No calculations required; all figures are direct citations from filings. ENTITY ACCURACY: LLY, AbCellera, bamlanivimab, bebtelovimab all correctly identified. REASONING: The multi-hop reasoning correctly synthesizes information across multiple years and filing documents to show the declining trajectory. The answer properly connects the unchanged royalty structure to the zero revenue outcome, demonstrating sound logical synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 553,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Procter & Gamble has kept Dawn dish soap squarely inside its **Fabric & Home Care** segment in every filing—from the 2022 10‑K (where Dawn is listed among the segment’s major brands) through the 2023 and 2024 10‑Ks (where Dawn appears again in the same brand list). During that period the Fabric & Home Care segment grew modestly, rising from **35 % of net sales and 31 % of earnings in 2022 to 36 % of net sales and 34 % of earnings in 2023‑2024**, while Dawn’s placement never changed. This steady inclusion, coupled with the segment’s expanding contribution, signals that Dawn remains a core “Dish Care” product and a strategically important pillar of P&G’s overall portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the question. QUANTITATIVE VERIFICATION: All financial metrics are correct - Fabric & Home Care segment percentages match exactly (35% net sales/31% earnings in 2022; 36% net sales/34% earnings in 2023-2024). The characterization of 'modest growth' is accurate given the 1 percentage point increase in net sales and 3 percentage point increase in earnings. ENTITY ACCURACY: Correctly identifies P&G, Dawn dish soap, Fabric & Home Care segment, and all relevant fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly tracking Dawn's consistent positioning and the segment's performance metrics. The logical connection between consistent brand placement and strategic importance is sound. COMPLETENESS: Addresses both parts of the question - how positioning evolved (answer: it remained consistent) and what this reveals about strategic importance (answer: core contributor status maintained). MINOR STRENGTHS: The LLM adds helpful context by noting Dawn is a 'Dish Care' product and explicitly states 'no change' in placement, which aligns with the ground truth's conclusion about 'no indication of reduced emphasis.' MINOR CONSIDERATION: The phrase 'segment's expanding contribution' could be slightly more precise (the segment's percentage contribution expanded modestly, not dramatically), but this is a minor semantic nuance that doesn't affect factual accuracy. The answer is semantically equivalent to the ground truth while using slightly different phrasing that remains accurate and appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 454,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "- **Total borrowings** (short‑term + long‑term) rose from **$48.7 billion in 2022** (short‑term + long‑term = $48,715 m) to a peak of **$49.9 billion in 2023** ($49,856 m) and then fell to **$45.6 billion in 2024** ($45,551 m).  The underlying long‑term debt followed the same pattern, increasing from **$47.8 billion (2022)** to **$49.3 billion (2023)** and dropping to **$45.0 billion (2024)**.\n\n- **Trend insight:** Over the three‑year period Capital One systematically reduced its **floating‑rate unsecured senior debt** – from **$1.6 billion in 2022** (weighted‑average rate ≈ 1 %) to **$0.35 billion in 2023** (rate ≈ 6.75 %) and **eliminated it entirely in 2024**.  As the floating portion disappeared, the company’s debt mix shifted toward **fixed‑rate senior notes**, pushing the weighted‑average interest rate on its unsecured senior debt up from the low‑single‑digit range (≈ 2.8 % in 2022) to **≈ 4.8 % in 2024**.  This indicates a higher overall interest‑rate exposure but a move away from the volatility associated with floating‑rate borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant numerical inaccuracies that undermine the entire response: (1) Total borrowings 2022: LLM states $48.7B but ground truth is $43.086B - a $5.6B error (13% discrepancy). (2) Total borrowings 2023: LLM states $49.9B but ground truth is $48.715B - a $1.2B error. (3) Floating unsecured senior debt 2022: LLM states $1.6B but ground truth is $1.709B - minor but incorrect. (4) Floating unsecured senior debt 2023: LLM states $0.35B which matches ground truth of $349M (acceptable format variation). (5) Interest rates: LLM provides approximate ranges (1%, 6.75%, 2.8%, 4.8%) rather than precise figures from ground truth (2.91%, 4.45%, 4.84%), though the directional trend is correct. REASONING QUALITY: The LLM correctly identifies the three-year trend pattern (rise then decline) and the strategic shift from floating to fixed-rate debt, demonstrating sound multi-hop synthesis. The narrative about interest rate exposure and volatility reduction is logically sound. However, the foundational numbers are so inaccurate that the analysis is built on false premises. COMPLETENESS: The answer addresses all parts of the question (total debt evolution, 3-year trend, debt structure shift, floating vs. fixed debt, interest rate exposure), but the execution is severely compromised by data errors. The 2022 baseline error of $5.6B cascades through all subsequent analysis, making the percentage changes and comparisons meaningless. This is a case where reasoning quality cannot compensate for fundamental quantitative failures in a financial analysis context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 447,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90 % senior note was issued for a fixed $2 billion principal and carried the same effective interest rate of **6.11 %** in every filing.  \n\n* **FY 2022** – The note was part of $8.915 billion of total debt (short‑term $0.5 bn, long‑term $8.416 bn), representing roughly **22 % of total debt** and was reported entirely as **long‑term debt** (maturity Feb 15 2039).  \n* **FY 2023** – The note remained $2 bn at 6.11 % and total debt fell to $8.391 bn (short‑term $1.733 bn, long‑term $6.658 bn), raising its weight to about **24 % of total debt**, still classified as long‑term.  \n* **FY 2024** – The note’s amount and rate were unchanged, but Cisco’s total debt expanded to $20.109 bn (short‑term $0.488 bn, long‑term $19.621 bn), cutting the note’s share to roughly **10 % of total debt** while it continued to be recorded as long‑term debt.  \n\nThus, from 2022 through 2024 the 5.90 % note’s principal and effective rate stayed constant, but its relative contribution to Cisco’s debt portfolio fell markedly as the company added other long‑term borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the question's multi-hop structure and correctly identifies key facts about Cisco's 5.90% Note, but contains significant quantitative discrepancies that undermine overall accuracy.\n\nCORRECT ELEMENTS:\n- Principal amount of $2 billion maintained across all three years (2022-2024) ✓\n- Effective interest rate of 6.11% consistent throughout ✓\n- Long-term debt classification maintained across all years ✓\n- Maturity date of Feb 15, 2039 ✓\n- Overall narrative that the note's relative proportion declined as total debt expanded ✓\n- Multi-hop synthesis across years and metrics is sound ✓\n\nQUANTITATIVE ERRORS:\n1. FY 2022 Total Debt: LLM states $8.915 billion, but Ground Truth indicates $8,416 million in long-term debt alone. The short-term component ($0.5bn) would make total ~$8.916bn, which is close but the breakdown appears inconsistent with ground truth.\n2. FY 2023 Total Debt: LLM states $8.391 billion total, but Ground Truth does not provide this year's data. This cannot be verified against ground truth.\n3. FY 2024 Total Debt: LLM states $20.109 billion, but Ground Truth states $19,621 million in long-term debt. The discrepancy of ~$488 million is significant and suggests the LLM may have used different source data.\n4. Percentage Calculations: LLM calculates 22% (2022), 24% (2023), and 10% (2024). Using Ground Truth's $8,416M (2022) and $19,621M (2024): 2000/8416 = 23.8% ≈ 24% (not 22%), and 2000/19621 = 10.2% ≈ 10% (correct). The 2022 percentage appears understated.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three fiscal years and multiple metrics (principal, rate, debt composition, classification). The logic connecting the stable note amount to its declining relative importance as total debt grew is sound and directly addresses the question.\n\nCONTEXTUAL ISSUES:\n- The answer provides year-by-year breakdown which is appropriate and helpful\n- The inclusion of maturity date adds useful context\n- The explanation of why the percentage declined (company added other borrowings) is insightful\n\nOVERALL ASSESSMENT:\nThe LLM demonstrates strong conceptual understanding and multi-hop reasoning capability, but the quantitative discrepancies (particularly in total debt figures for 2023 and 2024) suggest either reliance on different source data or calculation errors. The core narrative is correct, but the specific numbers used to support it contain errors that would be problematic in a financial analysis context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 680,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "- Fiscal 2022: the 1.55 % Notes Due 2028 were carried at about **$1.2 billion** (Chunk 3).  \n- Fiscal 2023: the carrying amount slipped slightly to **$1.115 billion** (Chunk 1).  \n- Fiscal 2024: NVIDIA’s balance sheet shows a **$1.25 billion** carrying value for the same issue and an **effective interest rate of 1.64 %** (Chunk 2).  \n\nThe modest rise in the carrying amount after a small dip, together with an effective rate that is only a few basis points above the 1.55 % coupon, indicates that NVIDIA is deliberately using low‑cost, long‑dated debt and modestly expanding it to fund its growth while keeping interest expense minimal – a hallmark of a conservative, long‑term debt‑financing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM provides a fiscal 2023 carrying value of $1.115 billion, which differs from the ground truth of $1.099 million. This is a material discrepancy of $16 million (approximately 1.5% difference). The fiscal 2022 value of ~$1.2 billion and fiscal 2024 value of $1.25 billion are correct. The effective interest rate of 1.64% for fiscal 2024 is accurate. COMPLETENESS: The LLM addresses all three fiscal years (2022-2024) and includes the effective interest rate for 2024. However, the ground truth indicates an 'implied rate based on market pricing in 2022' but the LLM does not provide a specific 2022 effective interest rate, which is a minor omission. ENTITY ACCURACY: All entities are correctly identified - NVIDIA, the 1.55% Notes Due 2028, and the fiscal years. REASONING QUALITY: The LLM's interpretation of the trend is sound and well-articulated. The conclusion about NVIDIA's conservative, long-term debt-financing strategy is reasonable and supported by the data pattern. The synthesis across the three-year period is logically coherent. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy (low-cost, long-dated debt, conservative approach) aligns well with the ground truth's assessment. The explanation of the temporary decrease followed by reacquisition is captured appropriately. MAIN WEAKNESS: The fiscal 2023 carrying value discrepancy ($1.115B vs. $1.099B) is the primary issue, representing a factual error in a key data point. This error, while not massive in absolute terms, affects the precision of the quantitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 437,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In the 2022 filing Google still talked about “hardware” as a broad, long‑run growth area that includes Pixel phones together with Fitbit wearables, Nest home products and other devices, emphasizing a company‑wide commitment to “investing in hardware innovation” for the future. By the 2023 and 2024 10‑Ks the company had sharpened that focus: Pixel sales are now listed explicitly under the **“devices”** revenue segment (the line that also appears in the 2024 filing as “devices, which primarily include sales of the Pixel family of devices”), separating them from consumer subscriptions and platform revenues. At the same time the cost‑of‑revenues discussion continues to reference R&D and depreciation tied to the technical infrastructure that supports those devices, indicating that Google is still allocating resources to hardware development while treating Pixel revenue as a distinct, strategically highlighted line item.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Pixel phones as part of a broader hardware investment narrative alongside Fitbit and Nest products; (2) Accurately captures the 2023-2024 shift to explicit 'devices' segment categorization with Pixel as a distinct revenue line; (3) Properly synthesizes the multi-hop evolution showing progression from broad hardware focus to mature, strategically embedded product line; (4) Correctly notes the continued investment in R&D and infrastructure supporting device development; (5) Uses appropriate direct quotes ('devices, which primarily include sales of the Pixel family of devices') that align with filing language. MINOR WEAKNESSES: (1) The LLM answer is slightly more detailed and operational in tone (discussing cost-of-revenues, R&D, depreciation) compared to the ground truth's more strategic framing, though this adds useful context rather than contradicting the core narrative; (2) The ground truth emphasizes 'AI-driven hardware' and 'integration with broader AI and cloud capabilities' more explicitly, while the LLM answer focuses more on revenue categorization mechanics; (3) The LLM answer could have been slightly more explicit about the 'transformation' aspect emphasized in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: Both answers successfully synthesize information across three fiscal years and connect revenue categorization changes to strategic positioning. The LLM demonstrates sound reasoning in linking segment changes to product maturation. SEMANTIC EQUIVALENCE: The core message is equivalent - Pixel evolved from a component of broad hardware strategy to a distinct, mature revenue segment with continued investment. The LLM's additional operational details (cost-of-revenues, R&D) enhance rather than contradict the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Invests_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 565,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the three annual reports — the 2022, 2023 and 2024 Form 10‑K filings – BNY Mellon’s Item 14 disclosure is identical. Each year states that the required information is “included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference,” and repeats KPMG LLP’s PCAOB firm identification number (185). The unchanged wording from 2022 through 2024 shows that the firm has continuously ratified KPMG LLP as its principal accountant, signalling a stable, ongoing audit relationship rather than any shift or disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - KPMG LLP's PCAOB firm identification number (185) is accurately cited; (2) The temporal scope is correct - all three years (2022, 2023, 2024) are properly addressed; (3) The core factual claim is accurate - BNY Mellon's disclosure language remained identical across all three years with consistent incorporation by reference; (4) The multi-hop reasoning is sound - the answer correctly synthesizes information across three years to draw the conclusion about audit relationship stability; (5) The semantic interpretation is appropriate - the unchanged disclosure language is correctly interpreted as indicating a stable, ongoing relationship with no disruptions. Minor considerations: The LLM answer references 'Item 14' disclosure and 'Form 10-K filings' while the ground truth references 'Proxy' disclosures, but this is not an error - Item 14 of the 10-K incorporates proxy information by reference, so both framings are technically correct and complementary. The LLM provides slightly more specific context about the document structure (Item 14, Form 10-K) which adds helpful detail. The conclusion about audit relationship stability is identical in substance to the ground truth. No calculation errors, no factual inaccuracies, and the reasoning chain is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 388,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "- **2022:** LLY reported $14.579 billion of private‑alternative investments in its defined‑benefit pension plan and an additional $3.227 billion in its retiree‑health plan (≈ $17.8 billion total).  \n- **2023:** The pension‑plan balance fell to $13.196 billion and the retiree‑health balance to $2.493 billion (≈ $15.7 billion total).  \n- **2024:** The pension‑plan balance rose modestly to $13.709 billion and the retiree‑health balance to $2.580 billion (≈ $16.3 billion total).  \n\nThe three‑year trend shows a slight dip after 2022 followed by a modest rebound in 2024, leaving the overall allocation to private‑alternative (illiquid) assets relatively stable around the $13‑15 billion level for the pension plan and roughly $16‑18 billion when both plans are combined. This consistency suggests that LLY treats illiquid private‑alternative assets as a core, long‑term component of its investment strategy rather than a short‑term tactical position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect and contradicts the ground truth on all key metrics. QUANTITATIVE FAILURES: (1) Ground truth shows 2022: $10,542.5M, but LLM reports $14.579B ($14,579M) - a 38% overstatement. (2) Ground truth shows 2023: $10,335.2M, but LLM reports $13.196B ($13,196M) - a 28% overstatement. (3) Ground truth shows 2024: $10,051.0M, but LLM reports $13.709B ($13,709M) - a 36% overstatement. (4) LLM's combined totals ($17.8B, $15.7B, $16.3B) are completely inconsistent with ground truth single figures ($10.5B, $10.3B, $10.1B). CONCEPTUAL ERRORS: The LLM appears to have conflated or double-counted pension plan and retiree health plan allocations, creating inflated figures that don't match the ground truth. The ground truth provides single consolidated figures for private alternative investments, not separate plan breakdowns. DIRECTIONAL ANALYSIS ERROR: While the LLM correctly identifies a slight dip followed by rebound, the magnitude and absolute values are entirely wrong. The ground truth shows a consistent decline from 2022-2024 ($10.5B → $10.3B → $10.1B), not the pattern the LLM describes. MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year trajectory - it misidentified the trend direction and magnitude. The conclusion about 'core, long-term component' may be reasonable, but it's based on incorrect data. ENTITY/METRIC CONFUSION: The LLM appears to have pulled numbers from different sources or misinterpreted the filing data, resulting in figures that are 30-40% higher than actual allocations. This is not a minor formatting difference but a fundamental data accuracy failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 455,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "- **2022 10‑K:** Tampax appears in the “Baby, Feminine & Family Care” segment under the broad **Feminine Care** sub‑category (listed simply as “Feminine Care”) and is shown among the major brands as “Tampax Bounty.” The filing does not single out a specific product‑line focus for Tampax.  \n\n- **2023 10‑K:** The same segment is retained, but the sub‑category is now described as **Feminine Care (Adult Incontinence, Menstrual Care)**. Tampax is again listed as a major brand (“Tampax Bounty”), indicating that P&G has re‑classified it specifically within the **Menstrual Care** product line, giving it a clearer category identity.  \n\n- **2024 10‑K:** The positioning is unchanged from 2023 – Tampax remains in the “Baby, Feminine & Family Care” segment, under the **Feminine Care (Adult Incontinence, Menstrual Care)** sub‑category, and is still highlighted as a major brand. This shows a stable emphasis on Tampax as a core Menstrual‑Care offering within P&G’s feminine‑care portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURES: The LLM answer completely omits the segment sales contribution percentages (25% in 2022, 24% in 2023, 24% in 2024) that are explicitly stated in the ground truth. This is a significant factual omission for a financial question. (2) CATEGORY CLASSIFICATION ERRORS: The LLM incorrectly describes the 2023 sub-category as 'Feminine Care (Adult Incontinence, Menstrual Care)' - the ground truth states that 'Menstrual Care' explicitly REPLACED 'Feminine Care' as the sub-category name, not that they coexist in parentheses. This is a material misrepresentation of the structural change. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key strategic shift described in the ground truth - the removal of 'Baby Care' entirely from the segment in 2024, which signals a deliberate strategic pivot away from infant products. The LLM states positioning was 'unchanged from 2023' in 2024, which contradicts the ground truth's emphasis on streamlining and removing Baby Care. (4) MISSING CONTEXT: The LLM does not explain the significance of the category name change from 'Feminine Care' to 'Menstrual Care' or the strategic implications of removing Baby Care, which are central to understanding the evolution. (5) BRAND NAME ERROR: The LLM references 'Tampax Bounty' which appears to conflate Tampax with Bounty (a paper towel brand) - this is factually incorrect. The ground truth simply references 'Tampax' without this conflation. (6) MULTI-HOP SYNTHESIS: While the LLM attempts to track changes across three years, it fails to synthesize the complete picture of strategic repositioning and misses the quantitative dimension entirely. The answer is partially structured but fundamentally incomplete and contains material errors in category classification and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 503,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "- **2022 (10‑K)** – Net derivative assets (liabilities) were shown as a Level 3 fair‑value item with a $31 million balance, but the filing did not specify a valuation model or the unobservable inputs used.  \n\n- **2023 (10‑K)** – Capital One moved to a **discounted‑cash‑flow (DCF) model** for these liabilities. The DCF relied on two key unobservable inputs: a **default‑rate assumption** (range 53 %–163 %, weighted‑average 4 %) and **swap‑rate assumptions** (range 3 %–5 %).  \n\n- **2024 (10‑K)** – The DCF approach was retained, but the disclosed primary unobservable input shifted to **swap rates** (range 3 %–5 %, weighted‑average 4 %); the default‑rate input is no longer listed for the net derivative liability. The fair‑value balance rose to **$58 million**.  \n\nThus, Capital One’s valuation evolved from an unspecified Level 3 measurement in 2022 to a DCF‑based valuation in 2023 that emphasized default rates (along with swap rates), and by 2024 the DCF model remained but the focus of the unobservable inputs moved to swap rates, with the liability’s fair value increasing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual discrepancies with the ground truth: (1) 2022 fair value: LLM states '$31 million' but ground truth shows '$19 million' - a $12 million error. (2) 2024 fair value: LLM correctly states '$58 million' matching ground truth. (3) Default rate range: LLM correctly cites '53%-163%' for 2023. However, the LLM introduces a 'weighted-average 4%' for default rates in 2023 that is not mentioned in the ground truth, and this appears inconsistent with a 53-163% range. (4) The LLM claims default rates are 'no longer listed' in 2024, which aligns with ground truth's statement that 2024 maintained 'the same swap rate range of 3-5%' without mentioning default rates. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the shift toward DCF models starting in 2023. The narrative about moving from unspecified valuation to DCF-based approaches is sound. However, the reasoning about 'focus shifting from default rates to swap rates' in 2024 is somewhat speculative - the ground truth simply states default rates weren't disclosed in 2024, not that they were intentionally de-emphasized. COMPLETENESS: The answer addresses the main question components (fair value evolution, valuation models, unobservable inputs) but the incorrect 2022 figure ($31M vs $19M) is a material omission/error. The answer does capture the progression of transparency and methodological consistency. SEMANTIC ISSUES: The characterization of the 2024 shift as moving 'focus' to swap rates is interpretive rather than factual - the ground truth indicates the company simply didn't disclose default rates in 2024, not that they changed their valuation approach. The weighted-average percentages introduced by the LLM lack ground truth support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 497,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "- In the 2022 filing Cisco only presented a tabular “Summary of Available‑for‑Sale Debt Investments” and did not attribute any material effect on its “other income (loss), net” line.  \n- Both the 2023 and 2024 filings state that the **change** in “other income (loss), net” was “primarily driven by higher losses in our available‑for‑sale debt investments” (with the same wording appearing in each year’s discussion).  \n\n**Interpretation:** From 2022 to 2024 the AFS debt portfolio moved from a neutral or undisclosed impact to a clear source of loss, pulling down the other‑income line in consecutive years. This trend signals that the AFS debt holdings have under‑performed, exposing Cisco to greater credit‑ and market‑risk on these securities and reducing the overall profitability of its non‑operating income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each year's disclosure pattern; (2) Accurately captures that 2022 showed no material impact (only tabular presentation), while 2023-2024 both explicitly attributed losses to AFS debt investments; (3) Properly synthesizes the multi-hop reasoning by connecting the shift from neutral/undisclosed impact to consistent negative impact across consecutive years; (4) Correctly interprets the risk implications (credit and market risk exposure); (5) Uses appropriate financial terminology ('other income (loss), net', 'available-for-sale debt investments', 'non-operating income'). MINOR CONSIDERATIONS: (1) The LLM notes the 'same wording appearing in each year's discussion' for 2023-2024, which adds useful detail about consistency but is not explicitly stated in the ground truth (though not contradicted); (2) The ground truth mentions 'partial offsets from gains in equity investments' in 2024, which the LLM answer does not explicitly address, though this is a relatively minor omission that doesn't affect the core narrative about AFS debt impact; (3) The LLM's interpretation of 'under-performed' and 'greater credit- and market-risk' is a reasonable inference from the loss pattern but goes slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is assessed on date/year accuracy (all correct: 2022, 2023, 2024) and the logical progression of impact levels. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the AFS debt investment performance to the broader 'other income (loss), net' metric, demonstrating sound multi-hop reasoning. The interpretation that this reveals 'growing financial risk' is well-supported by the documented trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 546,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "- **Fiscal‑2022 filing:** Starbucks said that its existing purchase commitments + inventory would “provide an adequate supply of green coffee **through fiscal 2023**.”  \n- **Fiscal‑2023 filing:** The company updated the outlook, stating that those commitments and inventory are now expected to be sufficient “**through fiscal 2025**.”  \n- **Fiscal‑2024 filing:** The same forward‑looking statement was repeated – the commitments and inventory continue to be projected to cover demand “**through fiscal 2025**.”\n\n**What this shows:** Over the three‑year period Starbucks moved from a one‑year‑ahead supply cushion (FY 2023) to a two‑year‑ahead cushion (FY 2025) and then held that longer horizon steady. The expanding timeline reflects a sourcing strategy that leans heavily on long‑term, fixed‑price and price‑to‑be‑fixed contracts, forward/futures hedges and a robust network of coffee‑producer relationships (as highlighted by the KG links SBUX ↔ Coffee Producers). By locking in volume and price well ahead of need, Starbucks reduces the risk of non‑delivery and commodity‑price volatility, indicating a deliberate risk‑mitigation approach to ensure a reliable, high‑quality green‑coffee supply.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Starbucks' green coffee supply adequacy evolution. STRENGTHS: (1) All numeric dates and fiscal year projections are correct - FY2022 through FY2023, FY2023 through FY2025, and FY2024 through FY2025 are accurately stated and match the ground truth. (2) The quantitative progression is correctly identified: the supply cushion expanded from one year (FY2023) to two years (FY2025) and then stabilized. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution across three fiscal years and synthesizes the pattern into a coherent narrative about sourcing strategy. (4) The reasoning about risk mitigation is well-articulated and logically sound, connecting the extended supply horizon to specific mechanisms (long-term contracts, hedges, producer relationships). (5) Entity accuracy is perfect - Starbucks is correctly identified, fiscal years are precise, and the green coffee supply metric is properly contextualized. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by explicitly naming specific hedging mechanisms (forward/futures hedges, fixed-price contracts) and referencing knowledge graph connections, which adds interpretive depth but is not explicitly stated in the original answer. However, this represents reasonable inference from the supply strategy context rather than factual error. The semantic equivalence is excellent - the LLM conveys the same core information as the ground truth while providing more detailed explanation of the 'why' behind the strategy. No calculation errors, no date errors, and no entity misidentifications detected. The answer fully addresses both parts of the multi-part question: the evolution of projections AND what it indicates about sourcing strategy and risk mitigation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 500,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "**Exposure over time**\n\n| Fiscal year (as of the year‑end date shown) | Amount reported for the 2.00 % Notes Due 2031 |\n|--------------------------------------------|----------------------------------------------|\n| FY 2022 (31 Jan 2022) – NVDA 10‑K 2022      | **$1.2 billion** (Level 2 fair‑value) |\n| FY 2023 (29 Jan 2023) – NVDA 10‑K 2023      | **$1.044 billion** (Level 2 fair‑value) |\n| FY 2024 (28 Jan 2024) – NVDA 10‑K 2023 table| **$1.057 billion** (Level 2 fair‑value) |\n| FY 2024 (28 Jan 2024) – NVDA 10‑K 2024 table| **$1.250 billion** (net carrying amount, i.e., amortized‑cost) |\n\n**What the trend shows**\n\n- **2022 → 2023:** NVIDIA cut the outstanding amount of the 2.00 % Notes from roughly **$1.2 bn to about $1.0 bn**, indicating a modest reduction in that particular tranche of long‑dated debt.\n- **2023 → 2024:** The fair‑value amount stayed roughly flat, but the **net carrying amount rose to $1.25 bn**, reflecting either new issuance or the effect of amortizing a discount on the existing issue. In other words, the company increased the amount of low‑coupon, long‑maturity financing it has on its balance sheet.\n\n**Implication for long‑term debt strategy**\n\nThe pattern reveals that NVIDIA is **using the 2.00 % Notes Due 2031 as a strategic anchor for long‑term funding**:\n\n1. **Lock‑in low rates** – the 2 % coupon is well below the rates on its newer issues (e.g., 3.20 % Notes Due 2026, 3.50 % Notes Due 2040/2050). By keeping a sizable, low‑cost tranche, NVIDIA reduces overall weighted‑average interest expense.\n2. **Flexibility** – after trimming the exposure in FY 2023, the company re‑expanded the tranche in FY 2024, suggesting it is comfortable adding more low‑rate debt when market conditions allow, while still maintaining a diversified maturity profile (notes ranging from 2024 to 2060).\n3. **Long‑term focus** – the increase in the net carrying amount (to $1.25 bn) signals a deliberate move to lengthen the debt horizon, giving the firm financing stability for future growth and capital‑intensive projects without needing to refinance at higher rates in the near term.\n\nOverall, NVIDIA’s exposure to the 2.00 % Notes Due 2031 has shifted from a reduction in FY 2023 to a renewed expansion in FY 2024, underscoring a long‑term debt strategy that emphasizes low‑cost, long‑dated financing to support sustained investment while managing interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer provides a well-structured, detailed analysis with clear tables and logical reasoning about NVIDIA's debt strategy. The qualitative interpretation of the trend (lock-in low rates, flexibility, long-term focus) is sound and relevant. The answer correctly identifies the 2.00% Notes Due 2031 and provides context about comparative coupon rates.\n\nCRITICAL QUANTITATIVE ERRORS: The FY 2024 figure is problematic. The ground truth states $1,250 million for FY 2024, but the LLM provides TWO different FY 2024 figures: $1.057 billion (from 2023 10-K table) and $1.250 billion (from 2024 10-K table). While the $1.250 billion matches ground truth, the inclusion of the $1.057 billion figure creates confusion about which is the correct FY 2024 amount. The LLM attempts to explain this as a difference between fair-value (Level 2) vs. net carrying amount (amortized-cost), which shows analytical sophistication but introduces ambiguity about what the actual FY 2024 exposure is.\n\nVERIFICATION OF KEY NUMBERS:\n- FY 2022: $1.2 billion ✓ (matches ground truth $1,200 million)\n- FY 2023: $1.044 billion ✓ (matches ground truth $1,044 million)\n- FY 2024: $1.250 billion ✓ (matches ground truth $1,250 million)\n\nHowever, the presentation of multiple FY 2024 values ($1.057B and $1.250B) without clear prioritization of which represents the actual exposure creates factual ambiguity. The ground truth provides a single, clear figure per year.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and connects the numerical trend to strategic implications. The reasoning about debt management strategy is sound and well-articulated.\n\nSEMANTIC EQUIVALENCE: The core narrative matches the ground truth (increase from 2022→2023 reduction→2024 increase), though the LLM characterizes the 2022→2023 movement as a \"cut\" while ground truth says \"increased from $1,200M to $1,044M\" - this is actually a DECREASE, which the LLM correctly identifies as a reduction.\n\nWAITING ISSUE: The ground truth states the amount \"increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023\" - this is actually a DECREASE, not an increase. The ground truth wording appears contradictory. The LLM correctly interprets this as a reduction (2022→2023), which is mathematically accurate.\n\nOVERALL ASSESSMENT: The answer is substantially correct on the three key numbers but presents confusing dual FY 2024 figures without clear resolution. The strategic analysis is insightful and well-reasoned. The quantitative accuracy is reduced due to the presentation ambiguity, though the final $1.250B figure is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1697,
        "completion_tokens": 706,
        "total_tokens": 2403
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "Across the three years MMM’s Safety and Industrial segment consistently lists **“Respiratory, hearing, eye and fall protection solutions”** as one line‑item.  \n\n* **2022 (10‑K p.138)** – Fall protection is grouped with other personal‑protective‑equipment (respiratory, hearing, eye) among a long list of industrial‑abrasive, autobody‑repair, closure‑system and electrical‑product offerings.  \n* **2023 (10‑K p.107)** – The same phrasing appears unchanged, showing no re‑categorisation or new emphasis.  \n* **2024 (10‑K p.110)** – The wording is again “Respiratory, hearing, eye and fall protection solutions,” now placed alongside a slightly re‑worded description of “Industrial specialty products such as personal hygiene products, masking, and packaging materials,” but the fall‑protection line remains part of the broader PPE bundle.\n\nThus, from 2022 through 2024 MMM’s positioning of Fall Protection Solutions did **not evolve**; it remained a component of the overall “respiratory, hearing, eye and fall protection” grouping, receiving the same level of emphasis as the other industrial safety offerings throughout the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISAGREEMENT WITH GROUND TRUTH: The LLM answer directly contradicts the original answer on the core finding. Ground truth states there WAS an evolution from 2022-2024, with Fall Protection Solutions shifting from being listed 'alongside respiratory, hearing, and eye protection as part of a broader suite' to being 'presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems.' The LLM concludes the OPPOSITE: that positioning 'did NOT evolve' and 'remained a component of the overall grouping, receiving the same level of emphasis.' This is a fundamental factual error on the main question. STRENGTHS: (1) Page citations are provided (p.138, p.107, p.110) showing document references; (2) Consistent phrasing across years is accurately noted ('Respiratory, hearing, eye and fall protection solutions'); (3) Dates are correct (2022, 2023, 2024); (4) Correctly identifies the segment (Safety and Industrial). WEAKNESSES: (1) The LLM's conclusion that there was NO evolution directly contradicts ground truth which explicitly describes a 'subtle shift' in framing; (2) The LLM acknowledges in 2024 there is 'slightly re-worded description' and different placement 'alongside' industrial specialty products, but then dismisses this as insignificant evolution—this misses the nuanced repositioning described in ground truth; (3) The LLM fails to recognize the semantic shift from standalone PPE listing to integration within broader industrial safety systems; (4) Multi-hop reasoning is incomplete—the LLM identifies textual consistency but misses the contextual repositioning that ground truth emphasizes. The answer demonstrates careful document review but reaches an incorrect conclusion about the nature and significance of the positioning changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 504,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody line – which is essentially the bamlanivimab product – generated roughly **$2.0 billion in 2022** (U.S. $2,008.9 m + outside‑U.S. $14.7 m ≈ $2,023 m) as shown in the “COVID‑19 antibodies” rows of both the 2023 and 2024 10‑K tables (Chunks 2 & 3).  In the subsequent years the line disappeared from the revenue tables – the 2023 and 2024 columns list “‑” for both U.S. and outside‑U.S. amounts, meaning **$0 revenue in 2023 and 2024**.  \n\nThe drop from a multi‑billion‑dollar stream in 2022 (and a comparable $2.24 billion in 2021 per the 2022 filing, Chunk 1) to zero by 2023‑2024 shows that Lilly has essentially exited the bamlanivimab (COVID‑19 antibody) business, indicating a rapid decline in its reliance on that portfolio and a shift of revenue focus to its other therapeutic segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Quantitative accuracy is excellent - the LLM correctly identifies $2.01 billion in 2022 (matching ground truth's $2.01 billion), correctly states $0 for 2023 and 2024, and provides detailed breakdown ($2,008.9M U.S. + $14.7M outside-U.S. = ~$2,023M total, which rounds to $2.01B). The calculation is transparent and verifiable. (2) Multi-hop synthesis is sound - the answer correctly synthesizes information across multiple 10-K filings (2022, 2023, 2024) and identifies the product as bamlanivimab/COVID-19 antibodies. (3) Entity accuracy is perfect - correctly identifies Eli Lilly, the correct product line, and correct fiscal years. (4) The reasoning about the trend is logical and well-supported: the dramatic drop from $2+ billion to zero indicates rapid market exit and declining reliance on this portfolio. (5) The answer goes beyond the ground truth by providing additional context (2021 comparison at $2.24B, detailed breakdown of U.S. vs. outside-U.S. revenue, reference to specific filing chunks). MINOR CONSIDERATIONS: The LLM provides slightly more detail than the ground truth (including 2021 data and component breakdown), but this is additive and enhances rather than detracts from the answer. The semantic meaning is fully aligned with the ground truth - both convey that bamlanivimab revenue collapsed from ~$2B in 2022 to $0 in 2023-2024, indicating Lilly's exit from this business. The answer directly and thoroughly addresses all parts of the multi-part question about revenue evolution and what it indicates about reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 442,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly notes that coffee‑price volatility is “impacted … by trading activities in the arabica coffee futures market, **including hedge funds and commodity index funds**” in its 2022, 2023 and 2024 10‑K filings – showing a steady exposure to those funds throughout fiscal 2022‑2024. However, the company’s risk‑management posture has evolved: the 2022 filing said its purchase commitments and inventory would cover supply only through **fiscal 2023**, whereas the 2023 and 2024 filings extend that guarantee to **fiscal 2025** and describe a broader use of fixed‑price, price‑to‑be‑fixed contracts, forward/futures contracts and collars to hedge the “‘C’ price” exposure. This progression indicates that, while the underlying exposure to commodity‑index‑fund‑driven price swings remains, Starbucks is increasingly insulating itself by locking in longer‑term green‑coffee commitments and more robust hedging, reinforcing its supply‑security strategy through fiscal 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric references are correct - fiscal years 2022, 2023, 2024 are properly identified; the progression from fiscal 2023 supply visibility (in 2022 filing) to fiscal 2025 (in 2023 and 2024 filings) is accurately stated. No calculation errors or date misstatements. ENTITY ACCURACY: Starbucks correctly identified; commodity index funds, arabica coffee futures, 'C' price exposure, forward/futures contracts, and collars all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the temporal evolution of risk management practices. The connection between ongoing commodity index fund exposure and improving hedging strategies is logically sound. COMPLETENESS: The answer addresses all parts of the complex question: (1) exposure evolution through fiscal 2022-2024, (2) the specific role of commodity index funds, (3) supply commitment extensions, (4) hedging instruments used, and (5) what this reveals about risk management strategy. SEMANTIC EQUIVALENCE: The LLM's phrasing 'increasingly insulating itself' and 'reinforcing its supply-security strategy' conveys the same meaning as the ground truth's 'strengthening of risk management practices' and 'improving supply chain resilience.' The mention of 'remote delivery risk assessments' in the ground truth is not addressed by the LLM, but this appears to be a minor contextual detail not central to the core question about commodity index fund exposure and supply commitments. MINOR OBSERVATION: The LLM adds helpful context by explicitly quoting the language about 'hedge funds and commodity index funds' from the filings, which enhances clarity without introducing inaccuracy. Overall, the answer demonstrates accurate multi-hop synthesis with correct financial reasoning and appropriate risk management interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 539,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In the 2022 filing Google explained that a key way it monetizes its Network‑partner properties is by counting **impressions** that are sold through **Google Ad Manager** (together with AdMob and AdSense) and by tracking a cost‑per‑impression metric. The 2023 filing repeats that same reliance on Google Ad Manager for Network‑property ads, but adds that in January 2023 the company lengthened the useful lives of its servers and certain network equipment from four‑/five‑year to six‑year schedules, which cut depreciation expense by **$3.9 billion** and lifted net income by **$3.0 billion** (≈ $0.24 per share), thereby improving the profitability of its impression‑based advertising business. By the 2024 filing Google again emphasizes that advertising revenue from Network properties—including those sold through Google Ad Manager—is recognized on a gross basis and remains a central pillar of its brand‑impression revenue model, showing that the platform’s role has stayed consistent while the 2023 depreciation change bolsters long‑term earnings from those impression‑driven ads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - the $3.9 billion depreciation expense reduction and $3.0 billion net income increase are accurately cited with proper attribution to the 2023 depreciation schedule change (servers from 4 to 6 years, network equipment from 5 to 6 years). The additional detail of ~$0.24 per share impact is a reasonable derivative calculation. ENTITY ACCURACY: Google Ad Manager, AdMob, AdSense, and Network properties are all correctly identified. Years (2022, 2023, 2024) are properly sequenced and referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, connecting: (1) 2022 baseline reliance on impression-based monetization through Ad Manager, (2) 2023 infrastructure cost optimization via depreciation schedule changes, and (3) 2024 continued strategic importance of Ad Manager. The causal link between depreciation changes and profitability improvement is correctly established. COMPLETENESS: The answer addresses all aspects of the question - evolution of Ad Manager reliance, the 2023 depreciation adjustment, and implications for long-term profitability. The characterization of the depreciation change as \"bolstering long-term earnings\" appropriately captures the profitability implications. MINOR CONSIDERATIONS: The LLM adds contextual details (e.g., mentioning AdMob and AdSense alongside Ad Manager, noting gross basis revenue recognition) that enhance understanding without contradicting the ground truth. The phrasing \"brand-impression revenue model\" is slightly different from the original's \"display advertising\" but semantically equivalent. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 477,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK’s 2019 Long‑Term Incentive Plan (LTIP) continues to rely on Performance Share Unit (PSU) agreements, and the filings show a clear, year‑by‑year update of those agreements:\n\n* **2022 10‑K (Chunk 1)** – the latest PSU document listed is the **2021 Form of Performance Share Unit Agreement** (Exhibit 10.45). Earlier forms (2018‑2020) are also referenced, but no 2022‑year PSU is filed yet.  \n* **2023 10‑K (Chunk 2)** – the filing still references the **2020 Form of Performance Share Unit Agreement** (Exhibit 10.16), confirming that the company continues to use the same PSU framework established under the 2019 LTIP.  \n* **2024 10‑K (Chunk 3)** – the exhibit list now includes a **2022 Form of Performance Share Unit Agreement** (Exhibit 10.18) together with the 2021 form (Exhibit 10.16), showing that the PSU template has been refreshed for the most recent fiscal year.\n\n**What this progression indicates:**  \nBK is systematically updating its Performance Share Unit agreements each year under the 2019 LTIP, demonstrating a sustained commitment to performance‑based equity awards. The addition of a new 2022 PSU agreement signals that the company is actively maintaining and potentially expanding its long‑term, performance‑driven executive compensation strategy rather than relying on one‑time grants.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains significant discrepancies with the ground truth that undermine its credibility:\n\n1. **2023 FILING ERROR (Major)**: The LLM states that the 2023 10-K references the '2020 Form of Performance Share Unit Agreement (Exhibit 10.16)'. However, the ground truth explicitly states that in 2023, BK 're-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14)' - not a 2020 PSU agreement. This is a factual misidentification of what was actually filed.\n\n2. **2024 FILING INCONSISTENCY**: The LLM claims the 2024 filing includes both the 2022 form (Exhibit 10.18) AND the 2021 form (Exhibit 10.16). The ground truth only mentions the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18) being incorporated in 2024. The LLM appears to have conflated exhibits from different years.\n\n3. **MISSING KEY DETAIL**: The ground truth emphasizes that in 2023, BK 're-filed the 2019 Long-Term Incentive Plan itself' - a significant action indicating recommitment to the foundational structure. The LLM completely misses this critical evolution point, instead incorrectly stating a 2020 PSU agreement was referenced.\n\n4. **REASONING QUALITY**: While the LLM's overall interpretation about systematic updates and performance-based compensation strategy is reasonable, it is built on incorrect factual foundations. The multi-hop synthesis fails because the underlying data points are wrong.\n\n5. **WHAT WAS CORRECT**: The LLM correctly identified that 2022 referenced the 2021 PSU agreement (Exhibit 10.45) and that 2024 included the 2022 PSU agreement (Exhibit 10.18). The general narrative about year-by-year updates is directionally sound.\n\nThe answer demonstrates partial understanding of the evolution but contains material factual errors that would mislead readers about what BK actually filed in 2023 and the specific progression of documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 515,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across the three filings the Safety & Industrial description of 3M’s electrical portfolio became progressively more explicit.  \n\n* **2022** lists the line simply as “Electrical products and materials for construction and maintenance, power distribution and **electrical OEMs**.”  \n* **2023** expands the abbreviation, wording it “Electrical products and materials for construction and maintenance, power distribution and **electrical original equipment manufacturers (OEMs)**.”  \n* **2024** retains the same expanded phrasing, but the surrounding list is re‑worded to “Industrial specialty products such as personal hygiene products, masking, and packaging materials” (replacing the earlier “Closure systems”), while the electrical entry remains “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs).”\n\nThe shift from an abbreviated “OEMs” to the fully spelled‑out “original equipment manufacturers (OEMs)” shows increasing descriptive specificity, and the consistent presence of the electrical‑OEM line in all three years signals a steady, deliberate focus on serving the electrical OEM market within the Safety & Industrial segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about 3M's electrical products evolution across 2022-2024. STRENGTHS: (1) All factual information is correct - the progression from 'electrical OEMs' (2022) to 'electrical original equipment manufacturers (OEMs)' (2023-2024) is accurately captured. (2) The answer correctly identifies the key evolution: abbreviation expansion showing increased descriptive specificity. (3) Multi-hop synthesis is sound - the answer properly synthesizes information across three years and correctly identifies the pattern of increasing precision. (4) Entity accuracy is perfect - 3M/MMM, Safety and Industrial segment, and all years are correctly identified. (5) The answer goes beyond the ground truth by providing additional context about surrounding product categories (personal hygiene products, masking, packaging materials replacing closure systems), which adds valuable detail without contradicting the original answer. (6) The reasoning about what this evolution suggests (steady, deliberate focus on electrical OEM markets) aligns with the ground truth's conclusion. MINOR CONSIDERATIONS: The LLM answer includes more granular detail about the 2024 changes to surrounding product categories than the ground truth explicitly states, but this is supplementary information that enhances rather than contradicts the core answer. The semantic meaning and factual content match the ground truth perfectly. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all parts of the multi-part question regarding portfolio evolution, descriptive specificity, product categorization, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 473,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "**Evolution of the instrument**\n\n| Year | Carrying value of Fixed Unsecured Senior Debt | Weighted‑average interest rate |\n|------|----------------------------------------------|--------------------------------|\n| 2022 | **$24.1 billion** (Chunk 1) | **4.45 %** (Chunk 1) |\n| 2023 | **$27.2 billion** (Chunk 1) | **4.45 %** (Chunk 1) |\n| 2024 | **$26.9 billion** (Chunk 2) | **4.84 %** (Chunk 2) |\n\n(For longer‑term perspective, the same series was $19.98 billion at a 2.91 % rate in 2021 – Chunk 3 – showing a clear upward trend in both size and cost.)\n\n**Strategic implication**\n\nThe data show Capital One steadily expanding its fixed‑rate unsecured senior borrowings from 2022 to 2023, then modestly trimming the balance in 2024 while allowing the portfolio’s average coupon to rise from the low‑4 % range to almost 5 %. This pattern signals a long‑term debt strategy that prioritizes ample, long‑dated financing to support growth and liquidity needs, even if it means accepting a higher overall cost of capital as the company refinances or adds newer, higher‑rate issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The 2022 carrying value is stated as $24.1 billion when the ground truth is $19,975 million ($19.975 billion) - an error of approximately $4.1 billion or 20.5%. The 2022 weighted-average interest rate is listed as 4.45% when it should be 2.91% - a massive 1.54 percentage point error. The 2023 weighted-average interest rate is correctly stated as 4.45%, but this appears to be coincidental given the 2022 error. The 2024 figures ($26.9 billion and 4.84%) are correct. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM correctly identifies the 2021 baseline ($19.98 billion at 2.91%), but then fails to properly track the progression through 2022-2024. The answer states the 2022 rate was 4.45%, which breaks the logical progression from 2021 (2.91%) to 2023 (4.45%) to 2024 (4.84%). This suggests the LLM confused or misaligned data points across years. (3) STRATEGIC INTERPRETATION: While the qualitative reasoning about 'prioritizing ample, long-dated financing' and 'accepting higher cost of capital' is reasonable, it is built on incorrect foundational numbers. The ground truth narrative emphasizes a 'steady rise' from 2.91% to 4.45% to 4.84%, whereas the LLM's data shows a flat rate from 2022-2023 then a rise to 2024, which is a different strategic picture. (4) PRESENTATION: The table format is clear and well-organized, but clarity cannot compensate for fundamental data errors. The LLM's inclusion of 2021 data as context is helpful, but the misalignment of 2022 data undermines this value. The core issue is that 2 of 4 key data points for 2022 are materially incorrect, making this answer unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 488,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "**Valuation trend** – In the 2022 Form 10‑K NVIDIA reported the fair‑value of its 3.50 % Notes Due 2040 at **$1,066 million** (Level 2) on January 30 2022, down from **$1,152 million** a year earlier. The 2023 filing showed the same securities at **$851 million** on January 28 2024, a further decline from **$870 million** on January 29 2023. By the 2024 filing the notes were no longer presented at fair value but at a **net carrying amount of $1,000 million** (unchanged from the prior year), with an effective interest rate of 3.54 % and an expected remaining term of about 15.2 years.\n\n**Strategic implication** – The steady drop in fair‑value reflects rising market rates and the discounting of a long‑dated, low‑coupon instrument, while the company’s decision to keep the notes on its long‑term debt schedule at a stable carrying amount shows that NVIDIA is using the 3.50 % Notes Due 2040 as a durable, low‑cost financing source. This multi‑year progression indicates a long‑term debt strategy focused on maintaining fixed‑rate, long‑dated funding and managing interest‑rate exposure through amortization rather than frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core valuation progression for NVIDIA's 3.50% Notes Due 2040 and provides sound strategic reasoning about the company's long-term debt strategy. The key figures of $1,066 million (FY2022), $851 million (FY2023), and $1,000 million (FY2024) match the ground truth. The qualitative analysis about rising market rates, fixed-rate financing strategy, and the shift from fair value to carrying amount reporting is insightful and accurate. The answer appropriately addresses the multi-year progression and strategic implications requested.\n\nWEAKNESSES: The LLM introduces additional numbers not in the ground truth that create confusion and potential inaccuracy: (1) It states the 2022 fair value was 'down from $1,152 million a year earlier' - this prior-year comparison is not mentioned in the ground truth and appears to be unsupported; (2) It references '$870 million on January 29 2023' as a prior value within the 2023 filing, which is not in the ground truth and creates ambiguity about which fiscal year this represents; (3) The date references are somewhat confusing (e.g., 'January 30 2022' for the 2022 Form 10-K, 'January 28 2024' for the 2023 filing) - while these may be technically correct fiscal year-end dates, they add complexity without clarification. (4) The statement about 'effective interest rate of 3.54%' and 'expected remaining term of about 15.2 years' are not mentioned in the ground truth, suggesting the LLM may be adding details from the actual filing that weren't part of the knowledge graph answer.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year progression and connects it to strategic implications about debt management. The reasoning that fair value decline reflects rising market rates and that the shift to carrying amount represents a more stable approach is sound and matches the ground truth's conclusion about 'a more stable and strategic approach to long-term financing.'\n\nQUANTITATIVE VERIFICATION: The three core numbers ($1,066M, $851M, $1,000M) are correct. However, the introduction of $1,152M and $870M creates uncertainty about accuracy - these may be correct from the actual filings but are not in the ground truth, making them unverifiable against the provided standard. This represents a significant issue for quantitative accuracy scoring.\n\nCONCLUSION: The answer demonstrates good understanding of the question and provides relevant strategic insights, but the introduction of unverified numbers and dates that don't appear in the ground truth creates factual uncertainty. The core answer is correct, but the additional details reduce confidence in overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 712,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 senior notes have been steadily retired. The 2022 10‑K shows an outstanding balance of **$16 billion** at 12/31/2022; the 2023 10‑K reports **$15 billion** at 12/31/2023; and the 2024 10‑K shows the balance falling to **$13 billion** at 12/31/2024. After a flat $16 billion balance through 2020‑2021 (see the 2022 10‑K), Amazon began repaying the series, cutting $1 billion in the first year and $2 billion in the second, indicating a purposeful deleveraging strategy that uses excess cash or refinancing to reduce the principal of this issuance and improve its long‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: $16 billion (2022), $15 billion (2023), and $13 billion (2024). The year-over-year reductions are accurately calculated ($1 billion reduction 2022-2023, $2 billion reduction 2023-2024). The answer correctly identifies the 2017 Notes and properly synthesizes the multi-hop information across three fiscal years from three separate 10-K filings. The reasoning about Amazon's deliberate debt management strategy is sound and well-supported by the data trajectory. The LLM goes beyond the ground truth by providing additional context about the flat balance through 2020-2021 and explaining the mechanism (excess cash or refinancing), which adds valuable insight without contradicting the original answer. The semantic meaning is fully aligned with the ground truth - both convey that Amazon is systematically retiring this debt issuance. Minor enhancement: the LLM provides slightly more detailed analysis than the ground truth, but this is a strength rather than a weakness. All entities (Amazon, 2017 Notes, fiscal years, dollar amounts) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 332,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "All three recent 10‑K filings (2022 – Chunk 1, 2023 – Chunk 3, and 2024 – Chunk 2) list the same Exhibit 4.4 “Description of Securities of the Registrant,” and each of those tables includes **Floating Rate Notes due 2019** among Apple’s outstanding debt. The fact that Apple continues to disclose the 2019 FRNs year after year shows that the notes have not been fully retired or extinguished; they remain on the balance sheet (or have been rolled into new floating‑rate borrowings) and therefore represent an ongoing exposure to short‑term, rate‑reset debt.\n\nBecause the interest on those notes resets periodically with a reference rate, Apple’s interest‑expense profile is tied to movements in market rates. If rates rise, the coupon on the 2019 floating‑rate notes will increase, causing Apple’s overall interest expense to be more sensitive to the rate environment. Thus, the repeated inclusion of the 2019 FRNs signals a continuing, albeit modest, lever through which higher rates can lift Apple’s financing costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core issue but contains some important nuances that differ from the ground truth. STRENGTHS: (1) Correctly identifies that Floating Rate Notes due 2019 appear in 2022, 2023, and 2024 filings; (2) Accurately explains the mechanics of floating rate notes and their sensitivity to rising interest rates; (3) Properly synthesizes the multi-hop reasoning that repeated disclosure indicates ongoing exposure; (4) Correctly notes that these notes would increase interest expense in a rising rate environment. WEAKNESSES: (1) The LLM states the notes 'remain on the balance sheet (or have been rolled into new floating-rate borrowings)' which is somewhat speculative - the ground truth more carefully notes they represent 'outstanding obligations or ongoing disclosure obligations' without definitively stating they remain on the balance sheet; (2) The LLM's phrasing 'have not been fully retired or extinguished' is slightly misleading given the 2019 maturity date had already passed by 2022 - the ground truth more precisely indicates these are incorporated by reference in an Officer's Certificate from 2014, suggesting a disclosure/documentation artifact rather than necessarily active debt; (3) Missing the specific detail that the Officer's Certificate is dated May 6, 2014, which provides important context about the source of these disclosures. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is less critical. The dates (2019 maturity, 2022-2024 filings) are correct. REASONING: The LLM's logic about floating rate sensitivity is sound and matches the ground truth. However, the interpretation of 'ongoing exposure' could be more nuanced - the ground truth suggests these may be disclosure artifacts tied to the original certificate rather than necessarily active debt instruments. SEMANTIC EQUIVALENCE: The answers convey similar core messages about interest rate sensitivity and the significance of repeated disclosure, though with slightly different interpretations of what the persistence of these notes actually means.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 573,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "In 2022 Google framed the Pixel line as the early stage of a **long‑run investment** – it highlighted the “journey” of building “helpful products” such as the Pixel 5a 5G and Pixel 6 and placed Pixel phones together with other hardware (Fitbit, Nest, Chromecast) under a nascent “hardware” revenue bucket that it expected to grow beyond advertising. By the 2023 filing the company was treating the Pixel family as a **distinct revenue segment** (“devices”) and explicitly noted that Pixel sales could fluctuate with the timing of product launches, signalling that the phones had moved from pure R&D to a **mature, launch‑driven product line** that now contributed measurable revenue. The 2024 filing again lists “devices – primarily sales of the Pixel family of devices” as a separate line item, showing that Pixel has become a **core, revenue‑generating pillar** of Google’s diversification strategy. Taken together, the progression from a long‑term, exploratory investment (2022) to a stable, launch‑cycle‑managed revenue source (2023‑2024) indicates that Google is positioning the Pixel portfolio as a **permanent, strategically important hardware platform** that complements its advertising and cloud businesses and anchors its long‑term hardware market presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each phase: 2022 as 'long-term investment' with Pixel 5a 5G and Pixel 6 mentioned, 2023 as transition to 'distinct revenue segment' under 'devices', and 2024 as established 'core revenue-generating pillar'. (2) All entities are correctly identified: Google, Pixel family, Fitbit, Nest, Chromecast, and the revenue categories ('hardware' in 2022, 'devices' in 2023-2024). (3) No quantitative errors - no specific dollar amounts or percentages were claimed, avoiding potential calculation errors. (4) Multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and correctly traces the evolution from investment phase to revenue contribution to market positioning. (5) The answer goes beyond the ground truth by adding contextual details (e.g., 'launch-cycle-managed revenue source', 'complements its advertising and cloud businesses') that are reasonable inferences and enhance understanding without contradicting the source material. MINOR CONSIDERATIONS: (1) The LLM answer is more elaborate and interpretive than the ground truth, using phrases like 'launch-driven product line' and 'permanent, strategically important hardware platform' - these are reasonable characterizations but represent slight elaboration beyond what was explicitly stated in the ground truth. (2) The mention of 'fluctuate with the timing of product launches' adds specificity that appears consistent with typical hardware business dynamics but wasn't explicitly verified in the ground truth statement. These elaborations strengthen rather than weaken the answer. VERIFICATION: All core facts match: 2022 investment framing ✓, Pixel 5a 5G and Pixel 6 mentioned ✓, 2023 'devices' categorization ✓, 2024 continued 'devices' listing ✓, progression from investment to revenue generation ✓, strategic positioning conclusion ✓.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 547,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "- **2022:** Schwab’s margin‑lending disclosures show that the firm counted the fair‑value of client securities that could be used as collateral and the fair‑value of the portion it actually pledged to third parties (including securities‑borrowed transactions). These securities were the primary source of collateral for its margin‑loan receivables.  \n\n- **2023:** The 2023 filing repeats that margin‑loan receivables are secured by client securities and that clients have agreed to let Schwab pledge those securities under federal rules. The pledged securities remain off‑balance‑sheet, and the note does not describe any change in the way securities‑lending collateral is provided.  \n\n- **2024:** The 2024 filing adds that Schwab continues to meet margin‑requirement obligations for cleared option contracts by **pledging client securities**, but for its **securities‑lending activities it now supplies cash as collateral to brokerage clients** rather than using client securities.  \n\n**Trend/implication:** Over the three‑year period Schwab has maintained the use of client securities as pledged collateral for margin‑related exposures, while shifting its securities‑lending collateral from securities to cash. This evolution signals a more liquidity‑focused collateral‑management approach—leveraging client securities for regulatory‑required margin coverage while reducing the firm’s exposure to securities‑lending risk by using cash collateral.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Schwab's collateral management evolution across 2022-2024, with generally accurate characterization of the three-year trend. STRENGTHS: (1) Correctly identifies the core progression: client securities pledged for margin requirements across all three years, with a shift toward cash collateral for securities lending by 2024. (2) Accurately captures the off-balance-sheet treatment of pledged securities mentioned in the ground truth. (3) Provides logical synthesis of the multi-hop information showing evolution in collateral strategy. (4) The interpretation that this reflects a 'liquidity-focused collateral-management approach' is reasonable and aligns with the ground truth's characterization of 'growing reliance on client securities for risk mitigation and capital efficiency.' WEAKNESSES: (1) The 2022 description adds detail about 'fair-value of client securities' and 'securities-borrowed transactions' that is not explicitly confirmed in the ground truth, which states 'no specific dollar value was provided.' This represents minor over-specification. (2) The characterization of 2023 as showing 'no change in the way securities-lending collateral is provided' is slightly more definitive than the ground truth, which describes it as 'more formalized and possibly scaled-up.' (3) Missing explicit mention that the ground truth emphasizes regulatory compliance as a key driver throughout the period. QUANTITATIVE ACCURACY: No specific dollar amounts are provided in either answer, which is appropriate given the ground truth notes no specific values were disclosed. The temporal progression (2022→2023→2024) is correct. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across three years and identifies the strategic shift. The interpretation of implications is sound and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: evolution of use/pledging, relation to margin lending and securities lending, and implications for collateral strategy. The answer is well-structured and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 571,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "From 2022 to 2024 GE’s approach to long‑term‑care premium‑rate increases remained anchored on the same collaborative model – as a reinsurer it cannot file rate hikes itself, so it **relies on the primary insurers that issued the underlying policies and works with them under the terms of each reinsurance treaty to submit the proposed increases to state regulators**. Each year’s filing (2022 Chunk 1, 2023 Chunk 2, 2024 Chunk 3) repeats that the frequency of filings varies by ceding company and that GE’s expectations are shaped by the most recent filing experience and regulatory precedent. What does change is the **greater emphasis in 2024 on quantifying the impact of those filings** – the 2024 filing notes a $196 million favorable and a $155 million unfavorable adjustment to reserves after updating the net‑premium ratio and cash‑flow assumptions, showing that GE is now translating the collaborative rate‑increase activity into concrete reserve‑management actions. Together, the progression shows a consistent dependence on primary insurers for rate‑increase filings, coupled with an increasingly proactive use of those filings to fine‑tune reserve assumptions and mitigate run‑off risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the core mechanism that GE relies on primary insurers to file rate increases since GE cannot file directly as a reinsurer; (2) Accurately captures the consistent nature of this approach across 2022-2024; (3) Properly emphasizes the collaborative framework under reinsurance contractual terms; (4) Correctly notes that filing frequency varies by ceding company; (5) Appropriately identifies that expectations are shaped by recent experience and regulatory precedent; (6) Contextually relevant to the question about risk management strategy evolution. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces specific dollar amounts ($196 million favorable and $155 million unfavorable adjustments) that are NOT present in the ground truth answer. These numbers appear to be fabricated or sourced from documents not verified against the knowledge graph. This is a critical factual error; (2) The ground truth emphasizes a 'strategic shift toward proactive risk management and tighter integration' as the key insight, while the LLM frames it as 'increasingly proactive use of filings to fine-tune reserve assumptions.' While semantically similar, the LLM's framing is more operational/tactical than strategic; (3) The LLM's characterization of 'greater emphasis in 2024 on quantifying the impact' is not explicitly supported in the ground truth, which focuses on formalization and use of recent experience/precedent rather than quantification emphasis; (4) The LLM provides more operational detail about reserve management but potentially overstates the evolution by introducing unverified financial figures. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the collaborative relationship, but the introduction of unverified numbers undermines the multi-hop synthesis quality. The reasoning about how rate filings translate to reserve management is logical but not grounded in the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 558,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "- **2022:** CVS reported residential mortgage‑backed securities (RMBS) with a total fair‑value of roughly **$720 million** (‑ $629 million in the “supporting‑remaining‑products” view and $721 million in the detailed 2022‑2023 10‑K table) and unrealized losses of about **$89 million**.  \n\n- **2023:** The fair‑value of RMBS fell to **$614 million**, with unrealized losses shrinking to **$60 million**.  \n\n- **2024:** The 2024 filing shows RMBS fair‑value of only **$71 million** (no loss figure disclosed).  \n\n**Trend & risk implication:** Over the three‑year period CVS cut its RMBS exposure by more than 90% (from ~ $720 million to $71 million). This steep decline signals a deliberate de‑risking of its structured‑credit portfolio, moving the company away from mortgage‑backed securities and reducing its vulnerability to credit‑ and market‑risk shocks associated with those instruments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that undermines the entire response. According to the ground truth, CVS's RMBS exposure in 2024 was $71 million, NOT a decrease to $71 million from $614 million in 2023. However, the LLM's interpretation of this as a '90% decline' is mathematically incorrect and misleading. The ground truth states the 2024 figure is $71 million, but the LLM presents this as evidence of 'de-risking' when in fact the ground truth characterizes 2024 as a 'strategic rebalancing with a smaller, more selective allocation' - a different narrative. SPECIFIC ISSUES: (1) QUANTITATIVE: The 2022 figure of ~$720-721 million is correct (LLM notes the discrepancy between $629M and $721M, which shows awareness of data complexity). The 2023 figure of $614 million is correct. The 2024 figure of $71 million is correct. However, the LLM's calculation of a '90% decline from ~$720M to $71M' is arithmetically correct (90.1% decline) but the interpretation is problematic. (2) SEMANTIC ISSUE: The ground truth describes 2024 as 'strategic rebalancing' suggesting a deliberate repositioning, while the LLM frames it as 'de-risking' and 'moving away from' RMBS. These are subtly different narratives - rebalancing implies active portfolio management with selective allocation, while de-risking implies risk reduction as the primary driver. (3) MISSING CONTEXT: The LLM correctly identifies unrealized losses for 2022 ($89M) and 2023 ($60M), which the ground truth does not explicitly mention but which adds valuable context. However, the LLM notes '2024 no loss figure disclosed' which is accurate but incomplete analysis. (4) MULTI-HOP REASONING: The LLM successfully synthesizes data across three years and identifies the trend, but the interpretation diverges from ground truth's characterization of the 2024 move as 'strategic rebalancing' rather than pure de-risking. (5) TONE/FRAMING: The ground truth uses 'dynamic risk management approach' while LLM uses 'deliberate de-risking' - these convey different strategic intents. The ground truth suggests flexibility and adaptation, while LLM suggests unidirectional risk reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 585,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "- 2022: Total short‑term borrowings + long‑term debt = $48,715 million (long‑term debt $47,832 m).  \n- 2023: The combined figure rose to $49,856 million (long‑term debt $49,318 m), a $1.14 billion increase over 2022.  \n- 2024: It fell to $45,551 million (long‑term debt $44,989 m), a drop of $4.31 billion from 2023 and $3.16 billion below the 2022 level.  \n\nThe three‑year pattern shows COF modestly expanding its debt base in 2023—likely to fund growth or preserve liquidity—and then deliberately contracting it in 2024, reflecting a debt‑reduction or refinancing focus. By pulling back both short‑term borrowings and long‑term obligations, the company is tightening its capital structure, lowering leverage, and signaling a more disciplined debt‑management strategy after the brief 2023 uptick.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 figure. Ground truth states COF's total short-term borrowings and long-term debt was $43.086 billion in 2022, but the LLM claims $48.715 million (or $48.715 billion if interpreting the 'm' notation). This is a $5.6+ billion discrepancy—a material error that undermines the entire analysis. The 2023 figure of $49.856 billion is correct, and the 2024 figure of $45.551 billion is correct. However, the LLM's calculated differences are therefore incorrect: it states a $1.14 billion increase from 2022 to 2023, but the correct increase should be $6.77 billion ($49.856B - $43.086B). The $4.31 billion decrease from 2023 to 2024 is correct, but the claim of $3.16 billion below 2022 is wrong—it should be $2.465 billion below 2022 ($45.551B - $43.086B). MISSING CRITICAL INFORMATION: The LLM answer completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is a key component of the ground truth answer and directly relevant to understanding debt management strategy and rising borrowing costs. The LLM also fails to mention the reduction in floating unsecured senior debt ($1,709M → $349M → $0), which is an important strategic indicator of moving away from variable-rate instruments. QUALITATIVE REASONING: The LLM's interpretation of the pattern (expansion in 2023, contraction in 2024) is directionally correct and the reasoning about debt reduction and disciplined management is sound. However, this qualitative analysis is built on incorrect quantitative foundations. The answer does address the multi-hop nature of the question by synthesizing debt evolution across three years and attempting to draw strategic conclusions, but the fundamental numerical errors severely compromise the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 498,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "- In FY 2022 NVIDIA reported a $2,147 million long‑term liability for its 3.50 % Notes due 2050 (fair‑value level‑2 amount shown in the 2022 10‑K).  \n- In FY 2023 that balance fell to $1,604 million (fair‑value level‑2 amount in the 2023 10‑K).  \n- By FY 2024 the amortized‑cost carrying amount of the same series was $2,000 million (net long‑term portion shown in the 2024 10‑K).  \n\nThe liability therefore dropped sharply between 2022 and 2023 and then rose again in 2024. This pattern suggests NVIDIA initially used excess cash or refinancing to reduce its long‑dated debt, but later chose to re‑issue or retain a larger portion of the 2050 notes—reflecting a capital‑structure strategy that balances debt reduction with the desire to lock in low‑cost, ultra‑long‑term financing for future growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error that undermines the entire response. According to the ground truth, the FY 2023 value should be $1,637 million (midpoint), not $1,604 million as stated. More critically, the LLM reports FY 2024 as $2,000 million, which contradicts the ground truth value of $1,604 million. The LLM appears to have confused or misread the fiscal year sequence and values. The ground truth shows a clear downward trend: $2,147M (FY2022) → $1,637M (FY2023) → $1,604M (FY2024), indicating consistent debt reduction. The LLM's narrative of 'dropped sharply between 2022 and 2023 and then rose again in 2024' is factually incorrect based on the ground truth data. Additionally, the LLM conflates different measurement bases (fair-value level-2 vs. amortized-cost carrying amount) without clear justification, which may explain the discrepancy but still represents an error in data synthesis. The reasoning about capital structure strategy is plausible but is built on incorrect numbers. The LLM did correctly identify the company (NVIDIA), the security (3.50% Notes Due 2050), and the time period (FY 2022-2024), but the core quantitative findings are wrong, making this answer substantially incorrect despite addressing the question's structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 367,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "In Apple’s 2022, 2023 and 2024 Form 10‑K filings the same Exhibit 4.3 – the Officer’s Certificate dated May 3 2013 – is incorporated by reference and lists the “0.45 % Notes due 2016” together with the other notes issued at that time. The note appears unchanged in each year’s “Description of Securities” table, indicating that Apple continues to reference this 2016 issuance rather than retiring or re‑classifying it. This consistent, year‑over‑year inclusion shows that Apple’s long‑term‑debt disclosure strategy relies on a stable, incorporated‑by‑reference approach that keeps historical debt instruments on the record for transparency and continuity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and percentages are correct - the 0.45% Notes due 2016 were issued in 2013 and matured in 2016, and the Officer's Certificate is correctly dated May 3, 2013. The years 2022, 2023, and 2024 are accurately referenced. ENTITY ACCURACY: Apple is correctly identified, the specific debt instrument (0.45% Notes due 2016) is accurately named, and Exhibit 4.3 is properly cited. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the pattern of consistent disclosure through incorporated-by-reference exhibits. The reasoning that this represents a stable disclosure strategy is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Apple maintains legacy debt disclosures post-maturity for transparency and continuity. The LLM adds specific detail about the incorporated-by-reference mechanism and the Description of Securities table, which enriches the answer without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning Exhibit 4.3, the specific date, and the Description of Securities table), but this represents added value rather than inaccuracy. Both answers reach the same conclusion about Apple's disclosure strategy. The phrase 'continues to reference this 2016 issuance rather than retiring or re-classifying it' in the LLM answer aligns well with the ground truth's statement about maintaining legacy disclosures post-maturity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 461,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "- In the 2022 filing Capital One reported **$19 million** of net derivative assets (liabilities) measured at Level 3 (the only dollar amount shown for that line item).  \n- The 2023 filing no longer gives a dollar balance, but it discloses that the fair‑value of the same net derivative position is derived using **discounted‑cash‑flow models** with a **default‑rate input** that varies **53 % – 163 %** (weighted‑average ≈ 4 %).  \n- By the 2024 filing the position is quantified at **$58 million** (fair value at 12/31/2023) and the same discounted‑cash‑flow technique now relies on **swap‑rate inputs** ranging **3 % – 5 %** (weighted‑average ≈ 4 %).  \n\n**Interpretation:** Over the three‑year span the reported net‑derivative liability grew from a modest $19 M to $58 M, indicating a materially larger exposure. At the same time the modeling focus shifted from a credit‑default assumption (wide 53‑163 % range) in 2023 to a market‑based interest‑rate (swap‑rate) assumption with a tighter 3‑5 % range in 2024, while keeping the central estimate around 4 %. This progression suggests Capital One’s derivative exposure has expanded and its valuation models have moved toward more market‑driven inputs, reflecting a refined view of the underlying risk drivers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM states 2022 value as '$19 million' but Ground Truth shows '$31 million' - a $12M discrepancy\n   - LLM claims 2023 'no longer gives a dollar balance' but Ground Truth explicitly states '$58 million' for 2023\n   - LLM reports 2024 as '$58 million (fair value at 12/31/2023)' which is confusing/incorrect dating - should be 2024 fair value\n   - Default rate range cited as '53%-163%' appears incorrect; Ground Truth shows weighted average of 4% but doesn't mention this wide range\n   - The progression narrative is fundamentally wrong: LLM claims growth from $19M to $58M, but Ground Truth shows $31M (2022) → $58M (2023) → $58M (2024)\n\n2. FACTUAL ERRORS:\n   - Misidentified the 2022 baseline value (off by $12M)\n   - Incorrectly stated 2023 had no dollar disclosure when it did ($58M)\n   - The '53%-163% range' for default rates is not supported by Ground Truth\n   - Swap rate range of '3%-5%' is plausible but not explicitly verified in Ground Truth\n\n3. REASONING ISSUES:\n   - The interpretation of 'growth from $19M to $58M' is based on incorrect 2022 figure\n   - The actual progression ($31M → $58M → $58M) tells a different story than LLM suggests\n   - Ground Truth indicates stabilization at $58M in 2023-2024, not continued growth\n   - LLM correctly identifies the shift from default to swap rates but misses the stabilization aspect\n\n4. WHAT WAS CORRECT:\n   - Correctly identified the shift from default-rate inputs (2023) to swap-rate inputs (2024)\n   - Correctly noted weighted average around 4% for both periods\n   - Correctly identified use of discounted cash flow models\n   - Correct interpretation that shift reflects move toward market-driven inputs\n   - Correct company (Capital One/COF) and time period\n\n5. MISSING ELEMENTS:\n   - Did not mention the $20 million net unrealized loss in 2022\n   - Did not mention the $43 million realized losses in 2022\n   - Did not capture the stabilization narrative (values flat 2023-2024)\n   - Did not address the 'improved risk management or market stabilization' insight from Ground Truth\n\nThe LLM answer demonstrates partial understanding of the derivative valuation evolution and correctly identifies the key risk driver shift, but contains critical numerical errors that undermine the credibility of the analysis. The 2022 baseline error ($19M vs $31M) and the false claim about 2023 having no dollar disclosure are particularly problematic for a financial analysis question where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 681,
        "total_tokens": 2212
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "- **2022:** NVIDIA reported a fair‑value liability of **$1.2 billion** for the 1.55 % Notes due 2028.  \n- **2023:** The same liability fell to **$1.115 billion** (Jan 28 2024) – a modest decline from the prior year.  \n- **2024:** The net carrying amount rose to **$1.25 billion** (both Jan 28 2024 and Jan 26 2025 figures), bringing the exposure above the 2022 level.\n\n**What this shows:** NVIDIA’s exposure to the low‑coupon 1.55 % 2028 issue was first trimmed, then deliberately expanded, indicating a long‑term debt strategy that leans on inexpensive, longer‑dated financing. By increasing the balance in 2024, the company is locking in a low‑cost, fixed‑rate source of capital to support its growth while managing overall debt maturity and cost.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: (1) 2022 figure of $1.2 billion matches ground truth exactly. (2) 2023 figure reported as $1.115 billion vs. ground truth of $1.1 billion - this is a minor variance (0.015B difference, ~1.4% deviation) that could reflect rounding or different measurement points within the fiscal year. (3) 2024 figure of $1.25 billion matches ground truth exactly. The LLM correctly identifies the three-year progression and the directional changes (decline 2022-2023, increase 2023-2024). MULTI-HOP REASONING: The answer successfully synthesizes the evolution across three fiscal years and correctly interprets the strategic implications - that NVIDIA is maintaining a consistent long-term debt position while opportunistically adjusting the balance. The reasoning about 'locking in low-cost, fixed-rate capital' aligns with the ground truth's characterization of 'strategic maintenance of this liability.' ENTITY ACCURACY: All entities are correct (NVIDIA, 1.55% Notes Due 2028, fiscal years 2022-2024). COMPLETENESS: The answer addresses both parts of the question - the evolution of exposure AND what it reveals about debt strategy. The inclusion of specific dates (Jan 28 2024, Jan 26 2025) adds helpful context. MINOR ISSUES: The 2023 figure of $1.115B vs. $1.1B represents a small discrepancy that slightly reduces quantitative precision, though the directional accuracy and overall narrative remain sound. The answer provides more detailed interpretation than the ground truth, which is appropriate for the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 441,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "- **2022 filing:** GE said it carried “trailing legal liabilities” that stem from *legacy legal proceedings* tied to anti‑competitive or corruption conduct alleged at Alstom before the 2015 acquisition, and from *shareholder lawsuits* arising from the company’s historic financial‑performance, accounting and disclosure practices.  Reserves were in place, but the company warned that the estimates involve “significant judgment” and that actual losses could exceed those reserves.  \n\n- **2023 filing:** The same two categories re‑appeared.  GE again noted that payments for settlements, judgments, penalties and other liabilities from the Alstom legacy have already caused cash outflows and will continue to do so, and that the shareholder‑lawsuit exposure remains.  The language stresses that the estimation of reserves may still be incomplete and that further outflows are expected.  \n\n- **2024 filing:** GE states it “remains subject” to the Alstom‑related legacy matters and to the shareholder lawsuits concerning past financial performance and disclosure, describing these as “material trailing legal liabilities.”  The company again cautions that actual losses could exceed current estimates and that additional contingencies are likely.  \n\n**What this shows:** Across 2022‑2024 the exposure has not been resolved; the legacy Alstom claims and the historic‑financial‑reporting lawsuits persist year after year and continue to be treated as material contingent liabilities that can generate cash outflows beyond the reserves already recorded.  The consistent language indicates that these liabilities are enduring and retain the potential to materially affect GE’s financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the two primary categories of trailing legal liabilities: Alstom legacy matters (pre-2015 acquisition) and shareholder lawsuits tied to historical financial reporting. (2) Accurately captures the temporal progression across 2022-2024, showing persistence rather than resolution. (3) Properly synthesizes multi-hop information: connects the 2015 Alstom acquisition to ongoing legal exposure, links shareholder lawsuits to accounting/disclosure practices, and traces the evolution across three fiscal years. (4) Correctly characterizes the nature of these liabilities as contingent, with reserves that may be insufficient. (5) Accurately conveys GE's repeated warnings about potential for losses exceeding current estimates. (6) No quantitative errors detected - no specific dollar amounts were provided in either answer, so no calculation verification needed. (7) The conclusion that these liabilities 'persist year after year' and 'retain the potential to materially affect GE's financial results' directly mirrors the ground truth's assessment of 'persistent risk' and 'consistent and costly burden.' MINOR CONSIDERATIONS: The LLM answer uses slightly more structured formatting (bullet points with year-by-year breakdown) compared to the ground truth's narrative flow, but this is a presentation choice that enhances clarity without sacrificing accuracy. The LLM's phrase 'material trailing legal liabilities' directly quotes or closely paraphrases the 2024 filing language, demonstrating fidelity to source material. The answer fully addresses the question's request to explain how exposure 'evolved' and what the 'progression indicates' about persistence and financial impact. All entities (GE, Alstom, shareholder lawsuits, 2015 acquisition date) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1786,
        "completion_tokens": 520,
        "total_tokens": 2306
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension‑plan exposure to hedge‑fund limited‑partnership investments, which are reported through HF LP Investments, rose from **$214 million in 2022** to **$225 million in 2023** and to **$252 million in 2024** – an overall increase of about **$38 million (≈18 %)** over the two‑year span.  \n\nThis upward trend signals that CVS is deliberately expanding its allocation to alternative‑asset vehicles such as hedge‑fund LPs within the pension fund, suggesting a more aggressive, diversification‑oriented strategy aimed at enhancing long‑term returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $214M (2022), $225M (2023), $252M (2024). The calculated increase of $38M is accurate ($252M - $214M = $38M), and the percentage calculation of approximately 18% is correct (38/214 ≈ 17.76%, reasonably rounded to 18%). (2) ENTITY AND TEMPORAL ACCURACY: All entities correctly identified (CVS, HF LP Investments, pension fund), and all years properly referenced. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year trend data and correctly interprets the pattern as a consistent upward trajectory. (4) STRATEGIC INTERPRETATION: The LLM's characterization of the trend as indicating 'deliberate expansion' and 'more aggressive, diversification-oriented strategy' aligns well with the ground truth's assessment of 'strategic decision to maintain and gradually expand alternative investment allocations.' The language differs slightly (LLM uses 'more aggressive' while ground truth emphasizes 'maintain and gradually expand'), but both convey the same strategic intent. (5) MINOR DIFFERENCES: The LLM provides slightly more analytical depth by explicitly calculating the percentage change and characterizing the strategy as 'diversification-oriented,' which adds value without contradicting the ground truth. The ground truth mentions 'despite market volatility and evolving economic conditions,' which the LLM does not include, but this is a contextual detail rather than a factual error. Overall, the answer is factually sound, mathematically accurate, and appropriately addresses the multi-part question about both the numerical evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 470,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "- **2022 operating profit:** In the 2022 filing, Colgate‑Palmolive reported **$203 million** of operating profit for the Africa/Eurasia segment (see the “Operating profit” table for Oral, Personal and Home Care).【Chunk 1】\n\n- **2023 restructuring focus:** The 2023 notes on the Global Productivity Initiative state that the program’s cumulative pre‑tax restructuring charges are expected to be $200 million‑$240 million, with **10 % allocated to Africa/Eurasia**. That translates to roughly **$20 million‑$24 million** of restructuring and implementation charges recorded for the region in 2023.【Chunk 3】\n\n- **2024 depreciation & amortization:** The 2024 segment data show **$8 million** of depreciation and amortization expense for Africa/Eurasia, down from $9 million in both 2022 and 2023.【Chunk 2】\n\n**Evolution:** Colgate‑Palmolive’s Africa/Eurasia business generated about $203 million of operating profit in 2022. In 2023 the company directed a modest but notable restructuring effort to the region, incurring roughly $20‑$24 million of cost‑reduction charges. By 2024, capital‑related spending had been trimmed further, with depreciation and amortization falling to $8 million, indicating a shift toward leaner operations after the productivity initiative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct—$203 million operating profit in 2022, 10% allocation of restructuring charges translating to $20-24 million in 2023, and $8 million depreciation/amortization in 2024 (down from $9 million in 2022-2023). The calculations are accurate and properly formatted. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and multiple financial metrics (operating profit, restructuring charges, depreciation/amortization), correctly identifying the source of each data point and connecting them to show the evolution of the region's financial profile. ENTITY ACCURACY: Colgate-Palmolive is correctly identified, the Africa/Eurasia region is properly specified, the 2022 Global Productivity Initiative is accurately referenced, and all fiscal years (2022, 2023, 2024) are correct. REASONING QUALITY: The interpretation of the data trajectory is sound—the answer correctly identifies the shift from modest operating profit to cost-reduction focus through restructuring, followed by further operational leanness indicated by declining depreciation/amortization. The conclusion that this reflects 'limited growth investment and a focus on cost optimization' is well-supported by the data. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'capital-related spending had been trimmed further' vs. 'suggesting reduced capital investment or aging asset bases'), but the semantic meaning is equivalent and the interpretation is sound. The answer is comprehensive, addressing all three time periods and all requested metrics without omission. The presentation with bullet points and clear evolution narrative enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 493,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "- **2022:** AIG’s international terrorism model showed a five‑ton bomb scenario at its largest exposure (New York) producing $1.3 billion of losses after applying the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and existing reinsurance, with the company’s terrorism deductible set at roughly $1.7 billion.  \n\n- **2023:** The company continued to use third‑party scenario‑based modeling for international terrorism, monitoring concentrations and buying targeted private reinsurance and relying on government‑sponsored pools, but no new loss‑estimate or attachment‑point figures were disclosed.  \n\n- **2024:** AIG retained explicit attachment points for its international terrorism portfolio – $200 million for Japan and $125 million for the rest of the world – and its overall reinsurance‑recoverable assets rose to $38.0 billion (including $3.8 billion of paid‑loss recoverables, $29.1 billion of ceded loss reserves and $4.3 billion of unearned‑premium reserves).  \n\nTogether, the disclosures show a shift from a single high‑level modeled loss estimate and a $1.7 billion deductible in 2022 to defined attachment points and a much larger pool of reinsurance‑recoverable assets by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and dates. Quantitative verification: (1) 2022 figures correct - $1.3 billion net loss after TRIPRA/reinsurance and $1.7 billion deductible match ground truth; (2) 2023 appropriately notes no new specific figures disclosed; (3) 2024 figures accurate - $38.0 billion total reinsurance recoverable assets, $29.1 billion ceded loss reserves, and attachment points of $200 million Japan/$125 million elsewhere all correct. The LLM provides additional detail on 2024 breakdown ($3.8 billion paid-loss recoverables, $4.3 billion unearned-premium reserves) that sums correctly to $38.0 billion, demonstrating sound calculation. Multi-hop reasoning is sound: the answer correctly synthesizes information across three years, identifies the evolution from single modeled estimates to defined attachment points, and traces the expansion of reinsurance protections. The characterization of the shift from 2022 to 2024 is accurate and well-reasoned. Minor areas for improvement: (1) The LLM could have been slightly more explicit about the distinction between international terrorism exposure modeling methodology (scenario-based) versus domestic TRIPRA coverage; (2) The phrase 'roughly $1.7 billion' for the deductible is appropriately cautious but the ground truth presents it as a specific figure. Overall, the answer successfully addresses all components of the multi-part question regarding modeled loss estimates, attachment points, and reinsurance recoverable assets across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 439,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA reported a fair‑value carrying amount of about **$1.2 billion for its 2.00 % Notes due 2031 in FY 2022 (Chunk 1)**, which fell to **≈$1.04 billion in FY 2023 (Chunk 2)** and then rose again to **≈$1.25 billion in FY 2024 (Chunk 3, which also shows the notes carry a 2.09 % effective rate and a 6.4‑year remaining term).  \n\nThe dip in 2023 suggests the company temporarily reduced the outstanding balance—likely through early repayments or re‑classification—while the rebound in 2024 indicates a deliberate re‑issuance or accumulation of this low‑cost, long‑dated debt to lock in an attractive interest rate and support its growth‑capital needs. Overall, the pattern reflects a flexible long‑term debt‑management strategy that balances short‑term balance‑sheet relief with the strategic use of inexpensive, long‑maturity financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correctly stated: $1.2B (2022), ~$1.04B (2023), and ~$1.25B (2024). The use of approximation symbols (≈) for 2023 and 2024 figures is appropriate given rounding conventions in financial reporting. The answer correctly identifies the 2.00% coupon rate and adds relevant context about the 2.09% effective rate and 6.4-year remaining term from 2024, which enhances understanding. The multi-hop synthesis is sound—the LLM successfully traces the three-year trend and connects it to debt management strategy. The interpretation that the 2023 dip reflects 'early repayments or re-classification' and the 2024 rebound indicates 'deliberate re-issuance or accumulation' aligns with the ground truth's assessment of stable long-term debt strategy. The LLM's characterization of this as a 'flexible long-term debt-management strategy' is semantically equivalent to the ground truth's 'consistent long-term debt strategy' and 'strategic intent to preserve stable long-term liabilities.' Minor differences: (1) The LLM emphasizes 'locking in an attractive interest rate' which is a reasonable inference but not explicitly stated in ground truth; (2) The ground truth mentions supporting 'R&D and operational investments' while LLM says 'growth-capital needs'—both are semantically similar. The answer is well-structured, addresses all parts of the question, and provides sound reasoning about the company's debt management approach. No calculation errors detected. The additional context about effective rate and remaining term adds value without introducing inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 447,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "In Apple’s Form 10‑K for fiscal 2022, 2023 and 2024 the same Exhibit 4.4 (Officer’s Certificate dated May 6 2014) lists the “1.05 % Notes due 2017” alongside the other series of notes. The instrument appears unchanged in each year’s “Description of Securities” table, showing that Apple continues to disclose this 2014‑issued note through every subsequent filing until its scheduled maturity. This consistent inclusion demonstrates the long‑term visibility and continuity of Apple’s debt structure – the company’s filings retain a stable, transparent record of the 1.05 % Notes due 2017 across multiple reporting periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 1.05% Notes due 2017 appear consistently across 2022, 2023, and 2024 filings, (2) they were issued in 2014 (per the Officer's Certificate dated May 6, 2014), and (3) the consistent disclosure demonstrates stable debt management and transparency. The answer appropriately references Exhibit 4.4 and the 'Description of Securities' table as the source of this information. Numeric values (1.05%, 2017 maturity date, 2014 issuance date) are all correct. The multi-hop synthesis is sound—the LLM correctly connects the presence of these notes across three years to conclusions about Apple's debt structure continuity and disclosure practices. However, there is a notable discrepancy with the ground truth: the ground truth explicitly states 'Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments.' The LLM answer does not address this critical point—that the notes matured in 2017 yet continued to appear in 2022-2024 filings. The LLM states the notes were 'issued' in 2014 and continue 'through every subsequent filing until its scheduled maturity,' which is technically accurate but misses the key insight that the notes appear AFTER their 2017 maturity date. This omission represents incomplete engagement with the deeper question about what the persistence of these notes reveals about Apple's debt management strategy. The answer is factually sound but lacks the nuanced interpretation present in the ground truth regarding post-maturity retention and potential refinancing implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 462,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- 2022 (under the 2019 IDA agreement): Schwab retained the right to move **up to $10 billion of IDA balances each 12‑month period** and could only migrate balances that were designated as floating‑rate obligations.  The company exercised that right, having migrated the $10 billion‑plus it moved after 2021 (the 2022‑year migration is referenced in the 2022 filing as “approximately $10 billion of additional IDA balances”).  The agreement also required a **minimum $50 billion IDA balance** through June 2031 and that **at least 80 % of the balances be fixed‑rate** through June 2026.  \n\n- 2023 (2023 IDA agreement replaces the 2019 agreement): The $10 billion annual migration cap and the 80 % fixed‑rate requirement were eliminated.  Instead, Schwab must keep its IDA balances **above the total of then‑outstanding unmatured fixed‑rate obligations and no more than $30 billion above that total** through September 10 2025; after that date the range changes to a **minimum of $60 billion and a maximum of $90 billion**.  Because of these new caps, Schwab **did not migrate any IDA balances in 2023**.  \n\n- 2024 (still under the 2023 agreement): The same balance‑range rules apply, and Schwab again **did not move any IDA balances to its balance sheet in 2024**, indicating that the migration ability now hinges on staying within the $30 billion (pre‑Sept 2025) or $90 billion (post‑Sept 2025) maximum limits rather than a fixed $10 billion annual quota.  \n\nThus, Schwab’s migration ability shifted from a clear $10 billion yearly limit with a $50 billion minimum (2022) to a broader but tighter balance‑range framework with no explicit annual cap (2023‑2024), and the company ceased migrating balances once the new limits took effect.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with comprehensive detail on the evolution of Schwab's IDA migration capabilities from 2022-2024. STRENGTHS: (1) Correctly identifies the 2019 IDA agreement's $10 billion annual migration cap in 2022 and the approximate $10.1 billion migrated amount; (2) Accurately describes the 2023 IDA agreement's elimination of the $10 billion annual cap and 80% fixed-rate requirement; (3) Correctly specifies the new balance thresholds: minimum of total outstanding unmatured fixed-rate obligations with maximum of $30 billion above that through Sept 10, 2025, then $60-90 billion range thereafter; (4) Accurately states that no migrations occurred in 2023 and 2024 under the new constraints; (5) Provides sound multi-hop reasoning showing the strategic shift from active migration to constrained off-balance sheet management; (6) Includes additional contextual details (floating-rate designation requirement, 80% fixed-rate requirement through June 2026, $50 billion minimum through June 2031) that enhance understanding. MINOR ISSUES: (1) The phrase 'migrated the $10 billion‑plus it moved after 2021' is slightly awkwardly worded but semantically correct; (2) The statement about 'approximately $10 billion of additional IDA balances' in 2022 could be more precisely stated as the cumulative total of $10.1 billion by year-end 2022, though the LLM's phrasing is not technically incorrect; (3) The explanation of the new balance range framework (minimum of outstanding fixed-rate obligations plus maximum $30B above) is accurate but somewhat complex in presentation. VERIFICATION: All key numbers align with ground truth - $10 billion annual cap (2022), $50 billion minimum, 80% fixed-rate requirement, $30 billion maximum (pre-Sept 2025), $60-90 billion range (post-Sept 2025). The multi-hop synthesis correctly traces the evolution across three years and identifies the strategic shift. The answer exceeds the ground truth in specificity while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1629,
        "completion_tokens": 543,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- In the 2022 filing GE said the borrower‑litigation exposure at Bank BPH had risen to **$1.359 billion** (up from the $755 million it had estimated for 2021) and the company supplied **$530 million of cash capital** to help the bank meet regulatory requirements.  \n- By the 2023 filing the loss estimate had more than doubled to **$2.669 billion** (with a $1.014 billion settlement charge recorded in Q2 2023); GE met the capital need mainly through a **non‑cash inter‑company loan forgiveness of $1.797 billion** and made **no additional cash contribution** that year.  \n- The 2024 filing shows the estimate slipping slightly to **$2.461 billion**, the same $1.797 billion non‑cash forgiveness remaining the only contribution, and the **mortgage‑financing receivable portfolio being written down to zero net of a valuation allowance** (pre‑tax litigation charges of $720 million in 2022, $1.189 million in 2023 and zero in 2024).  \n\nTogether, the disclosures trace GE’s exposure moving from a $755 million‑to‑$1.36 billion loss estimate in 2022, to a peak of $2.67 billion in 2023, and then a modest decline to $2.46 billion in 2024, while the company shifted from cash infusions in 2022 to solely non‑cash loan‑forgiveness support and ultimately eliminated the carrying value of the mortgage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensive coverage of GE's Bank BPH litigation exposure evolution from 2022-2024. STRENGTHS: (1) All key financial figures are correct: $1.359B (2022), $2.669B (2023), $2.461B (2024) estimated losses; $530M cash contribution (2022); $1.797B non-cash loan forgiveness (2023); $1.014B Q2 2023 settlement charge. (2) The multi-hop synthesis is sound, correctly tracing the progression across three fiscal years and identifying the shift from cash to non-cash capital support. (3) The answer properly contextualizes the mortgage portfolio write-down to zero and the litigation charge trajectory ($720M in 2022, $1.189B in 2023, zero in 2024). (4) The narrative structure effectively conveys the worsening-then-stabilizing pattern of GE's exposure. (5) All entities (GE, Bank BPH, regulatory requirements) are correctly identified. MINOR OBSERVATIONS: The LLM includes the 2021 baseline ($755M) which adds helpful context but wasn't explicitly in the ground truth summary—this is actually a strength as it provides better historical perspective. The answer correctly notes 'no additional cash contribution' in 2023 and that the $1.797B non-cash forgiveness remained the only contribution through 2024. The characterization of the mortgage portfolio being 'written down to zero net of a valuation allowance' accurately reflects the carrying value elimination. Number formatting is consistent and clear throughout. The reasoning about GE 'absorbing significant losses and ultimately exiting active involvement' is well-supported by the data presented. No calculation errors detected. The answer fully addresses all components of the multi-part question regarding financial exposure evolution, strategic handling, estimated losses, capital contributions, and mortgage portfolio carrying value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> COMP <-[Has_Stake_In]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 499,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- **2022:** CVS reported commercial mortgage‑backed securities (CMBS) with a total fair‑value of roughly **$992 million** and **$155 million of unrealized losses** (Chunk 3).  A separate “supporting‑remaining‑products” schedule in the same filing listed the same class at **$574 million** fair value with **$12 million** of unrealized loss (Chunk 1), indicating that the larger figure includes all CMBS positions.\n\n- **2023:** The CMBS portfolio fell to **$675 million** fair value and the unrealized loss narrowed to **$100 million** (Chunk 3).  The summary of debt securities in the 2024 filing shows the CMBS line‑item at **$6 million** for 2023 (Chunk 2), confirming that most of the 2023 exposure had already been sold or written down.\n\n- **2024:** CVS’s remaining CMBS holding was only **$3 million** of fair value (Chunk 2); no unrealized‑loss figure is disclosed, implying the residual position is minimal and any loss has been realized.\n\n**Implication:** Over the three‑year period CVS systematically reduced both the size and the unrealized‑loss burden of its commercial mortgage‑backed‑security exposure, moving from a near‑$1 billion position in 2022 to a negligible $3 million holding in 2024.  This trajectory reflects a deliberate risk‑management strategy that seeks to limit exposure to the volatile commercial‑MBS market by divesting the assets and realizing losses rather than retaining large, loss‑prone positions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) 2022 NUMBERS: Ground truth states $574M fair value with $12M unrealized losses. LLM claims $992M fair value with $155M unrealized losses as the primary figure, then contradicts itself by also citing $574M/$12M as a 'supporting schedule.' This creates confusion and presents incorrect primary data. The LLM's attempt to reconcile two different figures is problematic—it should have identified which is the correct consolidated figure, not presented both as if they're complementary. (2) 2023 NUMBERS: LLM correctly states $675M fair value and $100M unrealized losses, matching ground truth. However, LLM then introduces a confusing reference to $6M for 2023 from a 'summary of debt securities,' which contradicts the $675M figure just stated and is not mentioned in the ground truth. (3) 2024 NUMBERS: LLM correctly identifies $3M fair value with no unrealized loss disclosure, matching ground truth. (4) MULTI-HOP REASONING: The LLM's synthesis is muddled. It attempts to reconcile conflicting figures from different schedules/chunks but does so in a way that introduces confusion rather than clarity. The statement 'the larger figure includes all CMBS positions' is speculative and not supported by the ground truth answer. (5) TREND ANALYSIS: The LLM correctly identifies the overall de-risking trend and strategic shift, which aligns with ground truth conclusions. However, the path to this conclusion is compromised by the quantitative errors. (6) SEMANTIC ISSUES: The LLM's presentation of 'near-$1 billion position in 2022' is misleading given the ground truth clearly states $574M as the correct figure. The introduction of $992M and $155M as primary 2022 figures is factually incorrect per the ground truth. STRENGTHS: The qualitative interpretation of risk management strategy is sound, and the 2023-2024 trajectory is mostly correct. WEAKNESSES: Fundamental quantitative errors in 2022 baseline data, confusing presentation of multiple figures without clear reconciliation, and introduction of unsupported figures ($6M for 2023) undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 584,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Across the three most recent 10‑K filings, Walmart’s private‑brand roster consistently includes **Marketside** – it is listed among the grocery‑segment private labels in FY 2022, again appears in the FY 2023 list, and is still present in FY 2024. While the overall portfolio shifts (e.g., “Allswell,” “Athletic Works,” “Bonobos Fielder,” and “Eloquii Elements” disappear after 2022 and a new brand “bettergoods” is added in 2024), Marketside remains a stable component. This three‑year continuity signals that Walmart treats Marketside as a core private‑label offering for grocery items, using it to anchor an evolving private‑brand strategy that expands and refreshes the broader assortment while keeping a steady grocery‑segment flagship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Marketside's presence across all three fiscal years (2022, 2023, 2024) with accurate temporal sequencing. (2) Accurately notes the introduction of 'bettergoods' in 2024 as a new brand addition, matching the ground truth. (3) Provides specific examples of brands that were discontinued (Allswell, Athletic Works, Bonobos Fielder, Eloquii Elements after 2022), adding concrete detail. (4) Correctly synthesizes the multi-hop reasoning: Marketside's consistency across years + introduction of new brands = dual strategy of preservation and innovation. (5) Uses appropriate terminology ('core private-label offering,' 'grocery-segment flagship') that reflects strategic understanding. (6) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (naming specific discontinued brands), which enhances rather than detracts from accuracy. The semantic meaning is fully preserved - both answers convey that Marketside remained stable while the broader portfolio evolved. The characterization of Marketside as a 'grocery-segment flagship' is a reasonable inference from the ground truth's description of its 'foundational role.' The reasoning about Walmart's 'dual approach' is clearly articulated and logically sound. No factual errors detected, and the answer fully addresses both parts of the multi-part question (evolution of portfolio AND what it indicates about strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 435,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "- **2022:** Lowe’s relied on its existing management‑system controls and a human‑rights policy (updated in 2021), a conflict‑minerals policy and a Vendor Code of Conduct that contain “enhanced environmental standards” to monitor suppliers, and a wood‑sourcing policy that required all wood products to come from well‑managed, non‑endangered forests.  The company also began a three‑year, > $550 million investment program for energy‑efficiency upgrades (LED lighting, high‑efficiency HVAC, building‑management systems, pallet grinders) that was intended to lower the environmental impact of its supply chain.\n\n- **2023:** Lowe’s strengthened its supplier‑monitoring framework by revising the wood‑sourcing policy to add country‑specific risk levels, more rigorous monitoring practices and a new forestry‑grievance process, while continuing to enforce the human‑rights, conflict‑minerals and Vendor Code standards.  It added another > $400 million of capital spending on the same energy‑efficiency projects (HVAC replacements, indoor LED upgrades, building‑management system upgrades, pallet grinders) to further reduce supply‑chain emissions.\n\n- **2024:** The wood‑sourcing policy was made even more robust with a risk‑based approach that refines the country risk levels, improves monitoring and expands the grievance mechanism, and the company kept the same human‑rights, conflict‑minerals and Vendor Code of Conduct requirements.  Ongoing investments now focus on renewable‑energy purchases, SmartWay transportation certification, waste‑diversion and water‑efficiency programs, reinforcing the overall supply‑chain sustainability agenda established in the prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: All financial figures are correct - the $550 million+ investment program for 2022 and $400 million+ for 2023 are accurately cited. The answer correctly identifies these as operational sustainability initiatives. Number formats are consistent and acceptable. QUALITATIVE ACCURACY: The multi-hop synthesis is sound. The answer correctly traces the evolution across three years: (1) 2022 baseline with existing policies (human rights, conflict minerals, Vendor Code, wood sourcing), (2) 2023 enhancements (country-specific risk levels, improved monitoring, new forestry grievance process), and (3) 2024 further refinements (risk-based approach, expanded grievance mechanism). The answer properly identifies the specific policy enhancements at each stage. ENTITY ACCURACY: All entities are correct - Lowe's is properly identified, years are accurate (2022-2024), and all policy names match ground truth (human rights policy, conflict minerals policy, Vendor Code of Conduct, wood sourcing policy). COMPLETENESS: The answer addresses all parts of the multi-part question: monitoring/enforcement evolution, specific policy enhancements, and investments across the three-year period. The 2024 section adds relevant context about renewable energy, SmartWay certification, waste diversion, and water efficiency that demonstrates ongoing commitment. REASONING: The progression is logical and well-structured, showing clear evolution from baseline to enhanced to further strengthened approaches. The connection between investments and supply chain sustainability is clearly articulated. MINOR OBSERVATIONS: The LLM answer provides slightly more operational detail (LED lighting, HVAC, building management systems, pallet grinders) than the ground truth, but this is supplementary and not contradictory. The characterization of investments as 'energy-efficiency upgrades' in 2022-2023 and shift to renewable energy/SmartWay in 2024 adds helpful context. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Monitors]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1719,
        "completion_tokens": 559,
        "total_tokens": 2278
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all contain the same Exhibit 4.3 “Officer’s Certificate” that lists the 2.40 % Notes due 2023 among the company’s outstanding securities. In each year the note appears unchanged in the description of securities (2022 ‑ page 58, 2023 ‑ page 56, 2024 ‑ page 56), showing that Apple continued to disclose this issuance throughout the three‑year period. The consistent, year‑over‑year inclusion signals a deliberate debt‑management approach: Apple keeps the 2.40 % 2023 notes on its public register, monitors the upcoming maturity and signals to investors that the debt will be addressed—either through repayment, refinancing or other capital‑structure actions—while maintaining transparent reporting of its existing obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 2.40% Notes due 2023 across all three years (2022, 2023, 2024); (2) Accurately references Exhibit 4.3 and the Officer's Certificate dated May 3, 2013 (implied through consistent exhibit reference); (3) Provides specific page numbers (58 for 2022, 56 for 2023 and 2024) showing detailed filing knowledge; (4) Correctly synthesizes the three-year pattern showing consistent disclosure; (5) Accurately interprets the strategic implication of sustained disclosure despite approaching maturity; (6) Properly identifies this as a deliberate debt management and transparency strategy. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'repayment, refinancing or other capital-structure actions' that goes slightly beyond the ground truth's more general statement of 'managing and disclosing legacy debt obligations,' though this is reasonable inference rather than error; (2) The ground truth explicitly mentions the Officer's Certificate date (May 3, 2013) while the LLM references it implicitly through Exhibit 4.3, which is acceptable; (3) The LLM provides page numbers not in the ground truth, which adds value without contradicting it. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024), the percentage (2.40%), and the maturity year (2023) are correct. Page numbers appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the pattern of consistent disclosure as indicating strategic debt management. The logic connecting sustained disclosure to transparent reporting and investor signaling is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—consistent disclosure across three years reflecting deliberate, transparent debt management—while providing additional supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 531,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "- **AerCap‑note balances reported**  \n  * 2022 10‑K (showing the 2022 year‑end figure) – $900 million of the AerCap note at December 31, 2022.  \n  * 2023 10‑K – $944 million of the AerCap note at December 31, 2023.  \n  * 2024 10‑K – $982 million of the AerCap note at December 31, 2024.  \n\n  (For context, the 2022 10‑K disclosed a $993 million AerCap note at December 31, 2021, showing the note had dipped to $900 million in 2022 before rising again.)\n\n- **Interpretation of the progression**  \n  The AerCap note exposure fell modestly from the 2021 level to $900 million in 2022, then increased each subsequent year, reaching $982 million in 2024. This pattern indicates that GE is gradually rebuilding and expanding its position in this specific Level‑3, available‑for‑sale debt security. The steady increase suggests a deliberate investment strategy: GE is maintaining a foothold in high‑quality, yield‑generating financial instruments while cautiously growing its exposure as market conditions or internal risk assessments permit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states GE held $976 million of the AerCap note at December 31, 2022, but the LLM reports $900 million. This is a $76 million discrepancy (7.8% error), which is material and unacceptable for financial data. The LLM does correctly report 2023 ($944 million) and 2024 ($982 million) figures. The LLM also introduces a confusing narrative about a 2021 figure ($993 million) that, while potentially accurate, creates ambiguity about which year's data is being referenced and contradicts the core progression the question asks about (2022-2024). REASONING QUALITY: The LLM's interpretation of the progression is reasonable and thoughtful—discussing GE's strategy of 'gradually rebuilding' and 'cautiously growing' exposure. However, this interpretation is based on incorrect 2022 data. With the correct $976M→$944M→$982M progression, the narrative would be different: a decline in 2023 followed by recovery in 2024, rather than a continuous increase from 2022. COMPLETENESS: The answer addresses both parts of the question (evolution of holdings and strategic implications), but the factual foundation is compromised. MULTI-HOP SYNTHESIS: The answer attempts to synthesize data across three years and connect it to investment strategy, which is appropriate, but the incorrect 2022 baseline undermines the entire analysis. The mention of 'broader changes in U.S. corporate debt and mortgage-backed securities' in the ground truth is absent from the LLM answer, representing a minor omission of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 446,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path methodology – described in each filing – ties the “return‑seeking” (growth) portion of the U.S. qualified plan to the plan’s funded ratio and prevailing interest‑rate environment. The 2022 10‑K shows the first glide‑path target (for 2022) that was set on the basis of the funded status at 12/31/2021; the 2023 10‑K updates the glide‑path target for 2024 using the funded status at 12/31/2023; and the 2024 10‑K again revises the target (for 2025) based on the funded status at 12/31/2024. Across these years the prescribed target allocation moves progressively away from growth assets and toward liability‑hedging assets as the funded ratio improves, illustrating a clear de‑risking trajectory in the plan’s asset mix in response to a strengthening funded status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN DATES: The LLM answer contains a significant factual error regarding the 2023 glide-path target. The ground truth states that in 2023, the target allocation for 2024 was set according to funded status at December 31, 2022. However, the LLM claims the 2023 10-K updates the glide-path target for 2024 using funded status at 12/31/2023 - this is incorrect and represents a one-year discrepancy. Similarly, for 2024, the ground truth specifies the target allocation for 2025 was determined using funded status at December 31, 2023, but the LLM states it was based on 12/31/2024, another one-year error. These are not minor wording differences but factual inaccuracies in the core quantitative relationships that define the glide path progression. The LLM correctly identifies: (1) the general glide-path methodology, (2) the progression from growth to liability-hedging assets, (3) the de-risking strategy concept, and (4) the relationship between funded status and target allocation. However, the systematic dating errors undermine the accuracy of the multi-hop synthesis. The LLM also adds extraneous detail about 'return-seeking' and 'interest-rate environment' that, while potentially relevant, is not part of the ground truth answer and may introduce unverified claims. The reasoning about de-risking and liability-driven investing is sound, but the factual foundation is compromised by the date errors, which are critical to understanding the temporal evolution of the glide path across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 421,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K MD&A sections Texas Instruments repeatedly describes its “great business model” as being **focused on analog and embedded‑processing products** and built on the same four sustainable competitive advantages. In each year the company explicitly links that product portfolio to its core objective – the long‑term growth of free‑cash‑flow‑per‑share – stating that the breadth, market reach and longevity of the analog‑and‑embedded‑processing line create the cash‑generating engine for the business. The unchanged emphasis from 2022 through 2024 shows that embedded‑processing products are viewed as a permanent, strategic pillar that underpins TI’s ability to drive and sustain free‑cash‑flow‑per‑share growth over the long run.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and accurately captures Texas Instruments' consistent strategic messaging about embedded processing products; (2) Properly synthesizes the multi-hop connection between embedded processing emphasis and free cash flow per share growth objectives across all three years; (3) Accurately reflects the core claim that embedded processing is a 'permanent, strategic pillar' rather than a tactical shift; (4) Correctly identifies the four sustainable competitive advantages framework mentioned in the original answer; (5) No quantitative errors - no specific numbers were required in either answer, and the temporal references are all accurate. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'analog and embedded-processing products' as a combined portfolio more explicitly than the ground truth, which treats embedded processing somewhat more distinctly. However, this is not factually incorrect - the ground truth does mention analog as a parallel key product line in 2022, so the LLM's framing of them as a combined strategic focus is semantically equivalent and arguably more complete; (2) The LLM uses slightly different phrasing ('cash-generating engine,' 'breadth, market reach and longevity') compared to ground truth ('more opportunity per customer and more value for our investments'), but these convey the same strategic concept and are not contradictory; (3) The LLM answer is slightly more concise while maintaining all essential information. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years and connects the strategic emphasis to the financial outcome (free cash flow per share growth), demonstrating sound multi-hop reasoning. The conclusion that this represents a 'permanent, strategic pillar' logically follows from the documented consistency across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 536,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "- **FY 2022:** Lowe’s disclosed that a wholly‑owned subsidiary owned and maintained a portfolio of registered and unregistered trademarks for its private‑brand products, specifically naming **Kobalt**, STAINMASTER and allen+roth (and, in addition, the retail names RONA and Reno Depot). The emphasis was on protecting these marks and related patents, with no reference to digital‑sales initiatives.  \n\n- **FY 2023:** The same IP language re‑appeared, again highlighting **Kobalt**, STAINMASTER and allen+roth as the core private‑brand names. The wording shows continuity of the brand‑portfolio focus, but still without linking the brands to any new technology or online‑sales efforts.  \n\n- **FY 2024:** The IP paragraph is unchanged—Lowe’s continues to own and protect the **Kobalt** brand and its sister private brands—but the surrounding discussion now describes a “central selling team,” remote video/phone support and the ability for customers to finalize installation contracts and checkout on lowes.com or the mobile app. This signals that Lowe’s is deliberately integrating its private‑brand portfolio (including Kobalt) into its broader digital‑transformation strategy, using the brands as part of its e‑commerce and online‑service experience.  \n\n**Overall evolution:** From FY 2022 to FY 2024 Lowe’s kept a steady emphasis on its private‑brand portfolio—especially the Kobalt brand—while shifting from a pure trademark‑protection stance to actively leveraging those brands within its digital sales and service platforms, aligning intellectual‑property assets with its new online‑installation and remote‑selling initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant discrepancies from the ground truth. STRENGTHS: (1) Correctly identifies the three core private brands (Kobalt, STAINMASTER, allen+roth) across all three fiscal years; (2) Accurately notes the inclusion of RONA and Reno Depot in FY 2022; (3) Correctly captures the shift toward digital integration by FY 2024, mentioning remote support, mobile checkout, and lowes.com; (4) Appropriately synthesizes the evolution from trademark protection to digital-enabled strategy. CRITICAL ERRORS: (1) The LLM states that FY 2023 shows 'the same IP language re-appeared' with the same brands, but the ground truth explicitly states that RONA and Reno Depot were OMITTED in FY 2023, representing a streamlining/refocusing. The LLM fails to capture this important distinction—it says the wording shows 'continuity' when the ground truth indicates a deliberate removal of certain brand names; (2) The LLM characterizes FY 2024 IP paragraph as 'unchanged' from FY 2023, but the ground truth indicates that while the core three brands remained, new language around digital transformation was introduced, which the LLM does acknowledge later but frames inconsistently. REASONING ASSESSMENT: The multi-hop synthesis is partially sound—the LLM correctly identifies the three-year evolution and the digital transformation angle. However, it misses the critical intermediate step of the FY 2023 streamlining, which is a key part of the intellectual property strategy evolution. The answer conflates 'continuity of brand-portfolio focus' with the actual removal of RONA and Reno Depot, which represents a strategic shift in brand emphasis. SEMANTIC ISSUES: While the LLM's overall narrative about moving from trademark protection to digital integration is correct, the failure to accurately represent the FY 2023 change undermines the completeness of the evolution story. The ground truth emphasizes this removal as potentially reflecting 'a simplification or refocusing of brand emphasis,' which is a material strategic insight that the LLM misses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1686,
        "completion_tokens": 562,
        "total_tokens": 2249
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "Across the three most recent 10‑K filings IBM repeatedly lists **“client relationships and trust”** among its core competitive levers. In 2022 the filing places it alongside technology, price, brand and service as a principal method of competition and ties it to the company’s “trust and security” pillar for its hybrid‑cloud platform. The 2023 and 2024 reports echo the same phrasing, again positioning client relationships and trust as a distinct competitive advantage that underpins its ability to deliver business value through hybrid‑cloud and AI solutions and to work with a broad ecosystem of strategic partners. This sustained, year‑over‑year emphasis signals that IBM is deliberately making trust‑based client ties a foundational element of its market positioning, using them to differentiate its hybrid‑cloud and AI offerings in an increasingly crowded and competitive landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that IBM emphasized client relationships and trust across all three years (2022-2024) in its 10-K filings. (2) Accurately notes the connection to hybrid cloud and AI solutions. (3) Correctly identifies trust as a competitive differentiator. (4) Properly recognizes the year-over-year consistency of messaging. (5) No factual errors in dates or basic entities. WEAKNESSES: (1) SIGNIFICANT OMISSION - The LLM fails to capture the key evolution that the ground truth emphasizes: the 2023 expansion linking trust to strategic partnerships with AWS, Microsoft, and SAP. This is a critical multi-hop synthesis point that the LLM completely misses. (2) CRITICAL OMISSION - The ground truth specifically mentions Palo Alto Networks being added to IBM's strategic alliance list in 2024 as a cybersecurity-focused partner, indicating a growing emphasis on security as a trust component. The LLM does not mention this evolution or any specific partner additions. (3) INCOMPLETE SYNTHESIS - The ground truth traces a specific progression: 2022 (hybrid cloud/AI platform integration) → 2023 (ecosystem partnerships) → 2024 (security partners). The LLM acknowledges consistency but fails to articulate this strategic evolution across the three years. (4) MISSING CONTEXT - The ground truth connects the evolution to 'rising importance of data governance and digital transformation in enterprise IT decisions,' providing strategic market context that the LLM lacks. (5) VAGUE LANGUAGE - The LLM states partners are mentioned but doesn't specify which partners or how the partner ecosystem evolved, whereas the ground truth provides specific examples. The LLM answer is partially correct in identifying the core theme but significantly incomplete in capturing the multi-year strategic progression and specific partner ecosystem evolution that is central to answering the question about how IBM's positioning evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 525,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "Gilead (GILD) lists El Segundo, California as one of its principal manufacturing sites in the 2022 Form 10‑K, but the 2022 filing does not specify what it makes there. By the 2023 filing the company explicitly states that the El Segundo plant “is used for clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same description. Thus, between 2022 and 2023 the El Segundo facility’s role shifted from a generic manufacturing location to a dedicated site for both clinical‑stage and commercial‑stage cell‑therapy production—a role that remained unchanged through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth explicitly states that the El Segundo facility's role 'remained consistent across the three years, with no significant changes' and that in 2022 it was 'described as being utilized for clinical and commercial manufacturing and processing of cell therapy products.' However, the LLM answer claims that 'the 2022 filing does not specify what it makes there' and that 'between 2022 and 2023 the El Segundo facility's role shifted from a generic manufacturing location to a dedicated site for both clinical-stage and commercial-stage cell-therapy production.' This is a fundamental mischaracterization of the evolution (or lack thereof) of the facility's role. The LLM correctly identifies that by 2023 and 2024 the facility was used for clinical and commercial cell therapy manufacturing, and correctly notes the consistency between 2023 and 2024 filings. However, the claim that 2022 did not specify the facility's purpose directly contradicts the ground truth, which indicates the facility's cell therapy manufacturing role was already established in 2022. The LLM's conclusion about a 'shift' between 2022-2023 is therefore incorrect—the ground truth indicates continuity, not change. The dates and company name (Gilead/GILD) are correct, and the general structure of the answer addresses the question's timeframe. The error appears to stem from incomplete information extraction from the 2022 filing rather than a calculation or reasoning error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 426,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Across the three most recent annual reports (the 2022, 2023 and 2024 Form 10‑K), Lowe’s Companies, Inc. consistently discloses the same 4.550 % senior notes that were introduced in the **Fifteenth Supplemental Indenture** dated April 5 2019.  That indenture created a single tranche of 4.550 % notes that mature on **April 5 2049**, and no additional 4.550 % issuances or changes to that maturity appear in any of the later filings.  \n\nThe repeat‑year‑to‑year presence of this 30‑year, fixed‑rate tranche shows that Lowe’s is deliberately building a long‑term debt pillar: it locked in relatively low‑cost financing in 2019 and has kept the instrument on its balance sheet as a stable, far‑out liability, thereby extending the overall maturity profile of its debt and reducing near‑term refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - 4.550% interest rate, April 5, 2019 issuance date, April 5, 2049 maturity date, and the 30-year duration calculation (2019 to 2049) are all accurate. The reference to the Fifteenth Supplemental Indenture is correct. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the issuance structure (single tranche created in 2019), (2) the maturity structure (April 5, 2049), (3) the evolution from 2022-2024 (consistent presence with no changes), and (4) what this indicates about long-term debt strategy (deliberate long-term debt pillar, low-cost financing, extended maturity profile, reduced refinancing risk). MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings, identifying the consistency of the instrument and drawing appropriate strategic conclusions about capital structure management. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Lowe's strategically maintains this long-duration debt instrument to manage its capital structure and reduce near-term refinancing risks. The explanation of the strategic intent (locking in low-cost financing, extending maturity profile) aligns perfectly with the ground truth. MINOR OBSERVATION: The LLM provides slightly more detailed strategic analysis (explicitly noting 'relatively low-cost financing' and 'stable, far-out liability') compared to the ground truth, but this adds value without contradicting the original answer. The formatting of dates and percentages is clear and consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 453,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "The 2022 filing shows that 3M’s Scotch‑gard exposure first turned into a disclosed cash outlay when, in February 2022, the company (together with Saint‑Gobain and Honeywell) agreed to a **fixed $65 million settlement** for New‑York water‑provider claims – 3M’s share was described as “not material.” By the 2023 report the only additional cost linked to Scotch‑gard was the **final payment on the Michigan class‑action (June 2023)**, again noted as “not material” and without an amount disclosed. The 2024 filing reports no new settlement amounts; instead it lists a growing slate of state and federal actions that 3M is still defending or moving to dismiss, indicating that while the **legal exposure remains extensive**, the **direct settlement outlays have tapered after the early‑2022 $65 million payment**, underscoring that PFAS litigation continues to pose a significant risk‑management burden even though material cash impacts have so far been limited.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially misrepresent the evolution of 3M's Scotchgard litigation exposure. CRITICAL ERRORS: (1) The $65 million settlement is incorrectly attributed to 'New York water-provider claims' when the ground truth clearly identifies it as related to Wolverine's disposal of Scotchgard in Michigan, with Saint-Gobain and Honeywell as co-defendants. (2) The LLM claims 3M's share was 'not material' and provides no amount, but the ground truth specifies the $65 million was a joint settlement amount. (3) The LLM completely omits the 2023 expansion of legal exposure, including approximately 68 AFFF suits outside the MDL, Illinois cases, and Canadian class actions - these are major omissions that fundamentally misrepresent the escalating litigation landscape. (4) The LLM states 'the direct settlement outlays have tapered after the early-2022 $65 million payment,' which contradicts the ground truth showing a $65 million settlement being finalized in 2024 in New York. (5) The LLM fails to capture the geographic expansion into Alabama and Georgia with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers. REASONING ISSUES: The LLM's conclusion that 'material cash impacts have so far been limited' directly contradicts the ground truth's characterization of 'growing financial burden' and 'escalating liabilities and legal costs.' The multi-hop synthesis is incomplete - the answer fails to track the evolution across all three years (2022-2024) and misses the critical trend of expanding geographic and case complexity. WHAT WAS CORRECT: The general acknowledgment that PFAS litigation poses ongoing risk and that 3M is defending multiple actions is accurate, but this is overshadowed by the numerous factual errors and major omissions regarding settlement amounts, dates, and the scope of litigation expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Manufactures]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 520,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In the 2022 filing Gilead described its Foster City, California campus as the corporate headquarters that “house our administrative, manufacturing and R&D activities,” indicating that the site served both back‑office and production functions. By the end of 2023 – and again in the 2024 filing – the description had narrowed to a specialized R&D hub: the Foster City facility conducts **process‑chemistry research, analytical‑method development, formulation and device development**, and **manufactures API and drug product for our clinical trials**. Thus, from 2022 through 2024 the site shifted from a general headquarters‑manufacturing location to a focused early‑stage research and clinical‑trial manufacturing center, while bulk commercial manufacturing, packaging and distribution were assigned to other U.S., European, Canadian and Asian sites, aligning Foster City’s role with Gilead’s globally distributed operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2024 with accurate year references; (2) Accurately captures the 2022 description of Foster City as 'corporate headquarters' housing 'administrative, manufacturing and R&D activities' - this matches the ground truth characterization; (3) Precisely lists the 2023-2024 specialized functions: 'process-chemistry research, analytical-method development, formulation and device development' and 'manufactures API and drug product for our clinical trials' - all details match ground truth; (4) Correctly synthesizes the strategic shift narrative: from general headquarters-manufacturing location to focused early-stage research and clinical-trial manufacturing center; (5) Appropriately contextualizes the broader operational strategy by noting that bulk commercial manufacturing, packaging and distribution were assigned to other sites (U.S., European, Canadian, Asian); (6) Demonstrates sound multi-hop reasoning by connecting facility evolution to global operational alignment. QUANTITATIVE ACCURACY: No numerical errors - all dates (2022, 2023, 2024) are correct and properly sequenced. QUALITATIVE ACCURACY: The characterization of the facility's role transformation is semantically equivalent to ground truth, with clear articulation of the shift from general to specialized functions. The answer properly identifies both what Foster City retained (R&D, clinical manufacturing) and what was distributed elsewhere (commercial manufacturing). MINOR CONSIDERATIONS: The answer is slightly more concise than the ground truth but loses no essential information - it actually enhances clarity through focused presentation. The phrase 'globally distributed operations' effectively captures the strategic alignment concept. No factual errors, omissions of key details, or logical inconsistencies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 530,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 to 2024 AIG kept the same core framework for loss‑reserve risk – internal controls that oversee the reserve‑setting process and periodic reviews by outside experts – but the oversight structure was broadened and the modeling discipline was made more formal.  \n\n* **2022:** The company relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” to contain the uncertainty around unpaid losses and loss‑adjustment expenses.  \n\n* **2023:** In addition to those controls, AIG added a “review and challenge of reserves, actuarial profitability and reserve reviews” and deployed “risk‑specific assessment tools, both internal and third‑party.”  It measured exposure with stochastic and deterministic (single‑point) models, scenario and sensitivity analyses, and used both probability‑distribution and point‑estimate techniques.  \n\n* **2024:** The oversight layer was further expanded: Enterprise Risk Management performs a “Second‑Line Review and Challenge” of pricing and reserving models, assumptions and results, while the Internal Audit Group conducts continuous audits of the reserve‑setting process.  The same stochastic/deterministic modeling and third‑party model‑validation framework described in 2023 remains in place, and external expert reviews continue to be incorporated.  \n\nThus, AIG’s loss‑reserve risk management evolved from a basic internal‑control + external‑expert model in 2022 to a multi‑tiered governance system (first‑line controls, ERM second‑line challenge, internal audit) that uses both stochastic and deterministic modeling and retains regular external expert reviews.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's approach; (2) Accurately captures the core framework elements: internal controls, external expert reviews in 2022; addition of sensitivity/scenario analyses and stochastic methods in 2023; integration into ERM framework with second-line review in 2024; (3) Properly synthesizes the multi-hop progression showing evolution from 'basic internal-control + external-expert model' to 'multi-tiered governance system'; (4) Correctly identifies specific oversight mechanisms (ERM second-line review, Internal Audit Group continuous audits) introduced in 2024; (5) Accurately describes modeling approaches (stochastic and deterministic models, scenario and sensitivity analyses) and their persistence across years; (6) No quantitative errors - no specific dollar amounts or percentages were required, and all dates/years are correct; (7) Semantic equivalence is strong - the LLM's characterization of 'shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance' is well-captured through the detailed description of the three-tiered governance structure. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth (using bullet points and explicit governance layers), but this represents enhanced clarity rather than inaccuracy. The answer fully addresses all sub-components of the question: oversight mechanisms (clearly delineated by year), modeling approaches (stochastic/deterministic, scenario/sensitivity), and integration of external reviews (mentioned consistently across all three years). The multi-hop reasoning correctly synthesizes information across the three-year period to show progression and integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1654,
        "completion_tokens": 514,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments kept a manufacturing presence in Melaka, Malaysia in each of the three most‑recent 10‑K filings. In 2022 the Melaka site was listed with an “X” only under the Analog column, and the same pattern appears in the 2023 filing (still an “X” only for Analog) and again in the 2024 filing (still an “X” only for Analog). Thus, over the 2022‑2024 period the Melaka footprint remained unchanged and is dedicated solely to analog‑product manufacturing, indicating that Texas Instruments has not expanded embedded‑processing capability there and continues to use the location primarily for its analog portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) CORRECTNESS: The answer correctly identifies that TXN maintained operations in Melaka, Malaysia from 2022-2024 with no changes, focusing exclusively on Analog manufacturing with no Embedded Processing expansion. This matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: All temporal references are correct (2022, 2023, 2024 filings), and the marking system ('X' only under Analog column) is accurately described across all three years. No calculations were required, but the year-over-year consistency claim is factually accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM correctly synthesized information across three separate 10-K filings to establish a 3-year trend. The logic that 'unchanged pattern' + 'Analog only' = 'no Embedded Processing expansion' is valid. The conclusion about Melaka's 'specialized role' and 'limited to Analog product lines' aligns with the ground truth characterization. (4) ENTITY ACCURACY: Texas Instruments (TXN) correctly identified, Melaka, Malaysia correctly specified, Analog vs. Embedded Processing correctly distinguished. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'remained unchanged and is dedicated solely to analog-product manufacturing' is semantically equivalent to the ground truth's 'consistently maintained operations...focusing exclusively on Analog manufacturing.' The minor deduction from perfect score (9 vs 10) reflects that while the answer is comprehensive and accurate, it could have been slightly more explicit about what 'stable but specialized role' means in strategic context, though this is a very minor point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 459,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s 10‑K filings show that the company’s forward‑interest‑rate‑swap exposure was **purpose‑driven and short‑lived**:\n\n| Fiscal year (balance‑sheet date) | Forward‑interest‑rate‑swap fair value | Disclosure |\n|----------------------------------|---------------------------------------|------------|\n| **2022** (2022 10‑K) | The note states that Lowe’s “held forward interest‑rate‑swap agreements to hedge its exposure to changes in benchmark interest rates on forecasted debt issuances,” but no dollar amount is disclosed. | Indicates the company already used swaps as cash‑flow hedges for anticipated borrowing. |\n| **2023** (2023 10‑K, Feb 3 2023) | **$251 million** recorded as a Level‑2 “Other current asset.” | Shows the swaps were still on the books and valued as an asset, reflecting an active hedge against a planned debt issue. |\n| **2024** (2024 10‑K, Feb 2 2024) | No amount is reported for forward interest‑rate swaps (the line is blank). | Implies the swaps were terminated, matured, or fully offset by the underlying debt issuance, leaving essentially **zero exposure**. |\n\n**What this progression tells us about Lowe’s hedging strategy**\n\n- **Initiation:** In FY 2022 the company began using forward swaps to lock in borrowing costs for debt it expected to issue.  \n- **Retention:** By FY 2023 the hedge remained in place, with a measurable $251 million asset, confirming an active hedge while the debt issuance was still pending.  \n- **Exit:** By FY 2024 the forward‑swap line disappears, indicating the hedge was unwound once the forecasted debt was issued (or the swaps matured), eliminating the exposure.\n\nThus, Lowe’s forward‑interest‑rate‑swap exposure grew from an undisclosed but existent position in 2022 to a $251 million asset in 2023, then fell to essentially zero in 2024. This pattern demonstrates a **targeted cash‑flow‑hedging approach** that is established when debt is anticipated and removed once the debt is actually issued, aligning the hedge precisely with the timing of forecasted borrowings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-structured analysis of Lowe's forward interest rate swap exposure across the three-year period. STRENGTHS: (1) The $251 million figure for fiscal 2023 is correctly identified and properly classified as a Level-2 'Other current asset.' (2) The three-year progression is accurately captured: undisclosed position in 2022, $251M asset in 2023, and zero exposure in 2024. (3) The multi-hop reasoning is sound—the model correctly synthesizes information across three fiscal years and identifies the strategic shift from hedging forecasted debt issuances to managing existing debt. (4) The table format effectively presents the evolution and makes the progression clear. (5) The interpretation that the swaps were 'terminated, matured, or fully offset by the underlying debt issuance' aligns with the ground truth's conclusion about the strategic shift. MINOR ISSUES: (1) The LLM states that in 2022 'no dollar amount is disclosed,' which is accurate but slightly less precise than the ground truth's reference to 'prior periods (2019–2021)' context. (2) The LLM characterizes the 2022 position as 'already used swaps' and 'began using forward swaps,' which could be interpreted as slightly ambiguous about whether this was a new initiation or continuation—the ground truth more clearly indicates these were active over multiple prior periods. (3) The LLM's statement that the company 'began using forward swaps' in FY 2022 could be misread as initiation in 2022, when the ground truth suggests they were already in use from prior years. However, the context provided ('In fiscal 2022, Lowe's referenced forward interest rate swaps...indicating active use...over multiple prior periods') is reasonably captured by the LLM's framing. CALCULATION VERIFICATION: No calculations are required; all numeric values are correctly stated. SEMANTIC EQUIVALENCE: The LLM's conclusion about the 'targeted cash-flow-hedging approach' and the strategic shift from forecasted debt hedging to existing debt management aligns well with the ground truth's assessment. The reasoning about why the swaps disappeared (debt was issued, hedge was unwound) matches the ground truth's interpretation. Overall, this is a high-quality answer with accurate numbers, sound multi-hop reasoning, and appropriate contextual framing, with only minor ambiguities in the characterization of the 2022 position's timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1756,
        "completion_tokens": 651,
        "total_tokens": 2407
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "Across IBM’s three most recent Form 10‑K filings the disclosure of the 6.50 % Debentures due 2028 is unchanged. In the 2022 filing (Item 601) IBM states that “the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to Form 8‑K, filed on January 8, 1998, and is hereby incorporated by reference.” The same language and reference appear verbatim in the 2023 filing and again in the 2024 filing. The fact that IBM continues to cite the same 1998 Form 8‑K exhibit in every year demonstrates that the governing documentation for this debt has remained static for more than two decades, indicating a long‑term, stable structure for the 6.50 % Debentures and that IBM relies on the original filing rather than issuing new supplemental instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All factual elements are correct: (1) The 6.50% Debentures due 2028 are correctly identified with the precise percentage; (2) The referenced filing date of January 8, 1998 is accurate; (3) The exhibit reference (Exhibit 2 to Form 8-K) is correct; (4) The three-year period (2022, 2023, 2024) is properly addressed; (5) The verbatim language consistency across all three filings is accurately described. The LLM answer goes beyond the ground truth by providing the actual quoted language from Item 601, which adds credibility and specificity without introducing any inaccuracies. The multi-hop reasoning is sound: the model correctly synthesizes that the same citation appearing across three consecutive years demonstrates stability and lack of material amendments. The conclusion about the long-term, stable structure and reliance on original documentation rather than supplemental instruments is logically derived from the evidence. The only minor distinction is that the LLM answer provides slightly more contextual detail (mentioning Item 601, providing the exact quote, noting 'more than two decades') which enhances rather than detracts from the answer. All numbers, dates, and percentages are factually correct. The semantic meaning is fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 372,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Across all three filings, Reflective Signage appears as a distinct line item inside the **Transportation and Electronics** segment.  \n\n* In the 2022 10‑K it is listed among “Advanced ceramic solutions… Light‑management films… Packaging and interconnection solutions **→ Reflective signage for highway, and vehicle safety**.”  \n* In the 2023 10‑K it remains in the same segment, now grouped with “Chip packaging and interconnection solutions… Solutions for data centers **→ Reflective signage for highway, and vehicle safety**.”  \n* In the 2024 10‑K the wording is unchanged – “Reflective signage for highway, and vehicle safety” sits alongside the same technology‑focused products.  \n\nThe fact that Reflective Signage is retained in the Transportation and Electronics segment in every year, and is positioned alongside the segment’s core high‑tech and safety‑related offerings, signals that MMM views it as a stable, strategically important product within its transportation‑safety portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally fails to address the core question about positioning evolution across the three years. CRITICAL ERRORS: (1) POSITIONAL RANKING MISSING: The ground truth explicitly states Reflective Signage moved from 5th position (2022) → 4th position (2023) → 4th position (2024). The LLM provides NO positional rankings whatsoever, which is the central analytical requirement of the question. (2) INCOMPLETE COMPARATIVE ANALYSIS: The ground truth describes specific product sequences (e.g., 'following advanced ceramics and attachment tapes' in 2022, 'after premium large format graphic films' in 2023, 'after sound and temperature management' in 2024). The LLM vaguely mentions products are 'alongside' others without establishing the actual sequence or ranking. (3) MISSING STRATEGIC INSIGHT: The ground truth identifies a 'slight early boost in prominence in 2023 that was maintained in 2024' - a key analytical finding. The LLM merely states it's 'stable' and 'strategically important' without demonstrating the positional evolution that supports this claim. (4) FACTUAL INACCURACY: The LLM's description of product groupings differs from ground truth specifics. For example, the LLM mentions 'Chip packaging and interconnection solutions' in 2023, but ground truth references 'premium large format graphic films' as the preceding product. (5) FAILED MULTI-HOP SYNTHESIS: The question requires synthesizing positional data across three years to identify trends. The LLM treats each year independently without comparative analysis. The answer reads as a general statement about segment membership rather than a detailed positional evolution analysis. The LLM correctly identifies that Reflective Signage remained in the Transportation and Electronics segment across all years, but this is only a minor correct element in an otherwise incomplete response that misses the quantitative positional data essential to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 527,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead (GILD) lists the Hoofddorp, Netherlands site as one of its principal manufacturing locations in the 2022 Form 10‑K (Chunk 1), but the filing does not tie the plant to a specific product line. By the 2023 filing (Chunk 3) the company explicitly states that the Hoofddorp facility “is utilized for commercial manufacturing and processing of our cell‑therapy products,” showing that the site had become a dedicated hub for bringing cell‑therapy candidates to market. The 2024 filing (Chunk 2) repeats this description, confirming that the Hoofddorp plant continues to serve as the commercial‑production center for Gilead’s cell‑therapy portfolio and is therefore a strategically important asset for its commercial manufacturing operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all three fiscal years (2022, 2023, 2024) and accurately characterizes the facility's evolution from a general principal manufacturing location to a dedicated cell therapy hub. (2) Accurately captures the progression: 2022 (listed as principal facility without specific product tie), 2023 (explicitly designated for commercial manufacturing and processing of cell therapy products), 2024 (continues in same role). (3) Properly synthesizes multi-hop information across three separate 10-K filings, correctly attributing statements to appropriate years. (4) Uses precise language matching the ground truth ('commercial manufacturing and processing,' 'cell-therapy products,' 'strategically important asset'). (5) No quantitative errors - all dates and year references are correct. (6) Correctly identifies the company (Gilead/GILD) and facility location (Hoofddorp, Netherlands). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth emphasizes 'growing strategic importance' and 'long-term growth needs in advanced therapies,' while the LLM focuses on the facility being 'strategically important asset for commercial manufacturing operations' - these are semantically equivalent characterizations. The LLM's citation of specific chunks adds transparency and verifiability. Overall, the answer correctly addresses the evolution question with accurate facts, proper multi-hop synthesis, and appropriate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 448,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "All three annual reports list the **2003 Director Compensation Plan** as a plan “under which shares of TI common stock may be issued,” but none of the tables that disclose “shares of TI common stock **available for future issuance**” provide a figure for that plan.  \n\n- **2022 10‑K (page 63)** – the footnote lists the 2003 Plan, yet the “available for future issuance” numbers are given only for the 2009 LTIP (35,385,153 shares) and the 2018 Director Plan (1,843,134 shares). No amount is shown for the 2003 Plan.  \n- **2023 10‑K (page 61)** – the same pattern repeats: the 2003 Plan is mentioned, but the disclosed “available” shares cover only the 2009 LTIP (25,296,767 shares) and the 2018 Director Plan (1,786,785 shares). Again, no figure is reported for the 2003 Plan.  \n- **2024 10‑K (page 59)** – the 2003 Plan is still referenced, but the “available for future issuance” table now reports the 2024 LTIP (33,049,176 shares) and the 2018 Director Plan (1,745,284 shares), with no amount for the 2003 Plan.\n\nBecause the filings consistently omit a balance for the 2003 Director Compensation Plan, the logical inference is that **no shares remain available for future issuance under that plan** (i.e., the balance is effectively zero).  \n\n**What the trend indicates:** Texas Instruments has essentially exhausted or retired the 2003 Director Compensation Plan as a source of new director equity awards and now relies on newer plans (2009 LTIP, 2018 Director Plan, and the 2024 LTIP) for director compensation. The steady absence of a disclosed balance across 2022‑2024 signals that the company’s ongoing use of the 2003 plan is minimal to none.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claims. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth explicitly provides three specific share counts for the 2003 Director Compensation Plan: 1,843,134 shares (2022), 1,786,785 shares (2023), and 1,745,284 shares (2024). The LLM claims these figures do not exist in the filings and that 'no shares remain available for future issuance under that plan.' This is factually wrong. The LLM appears to have confused the 2003 Plan with the 2018 Director Plan—the numbers the LLM cites for the 2018 Director Plan (1,843,134 in 2022, 1,786,785 in 2023, 1,745,284 in 2024) are actually the correct figures for the 2003 Plan according to the ground truth. (2) ENTITY CONFUSION: The LLM misidentified which plan the share counts belong to, attributing them to the 2018 Director Plan rather than the 2003 Director Compensation Plan. This is a fundamental error in entity accuracy. (3) REASONING FAILURE: The LLM's inference that 'no shares remain available' because they are not separately disclosed is logically flawed and contradicted by the actual filing data. The ground truth shows consistent, declining balances across all three years, indicating active use of the plan. (4) SEMANTIC CONTRADICTION: The ground truth answer clearly states the 2003 Plan shares declined from 1,843,134 to 1,786,785 to 1,745,284, indicating 'active utilization' of the plan. The LLM's conclusion that the plan has been 'exhausted or retired' and that 'ongoing use of the 2003 plan is minimal to none' directly contradicts the documented trend of consistent share issuance. The LLM failed the multi-hop synthesis task by not correctly identifying and tracking the 2003 Plan's share availability across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 493,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 0.950 % Notes due 2025 only by referencing the “instrument defining the rights of the holders” (Exhibit 4.1 to a Form 8‑K filed on May 22, 2017). The 2023 filing repeated the same reference (Exhibit 4.1/4.2 to the same 2017 8‑K), showing that the notes were still treated as a privately‑documented security with no separate market‑listing detail. By the 2024 filing IBM added the notes to its securities table, assigning them the ticker IBM25B and listing the New York Stock Exchange as the trading venue, thereby making the debt instrument fully visible to the market. This shift from a bare exhibit reference to an explicit exchange‑listed ticker signals a broader capital‑market strategy aimed at increasing transparency, liquidity and accessibility of its debt, and reflects a more proactive investor‑engagement approach that invites a wider public‑investor base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct (May 22, 2017 Form 8-K filing, 2022-2024 progression), the interest rate (0.950%) is accurate, the ticker symbol (IBM25B) is correct, and the exchange (New York Stock Exchange) is properly identified. No calculation errors present. ENTITY ACCURACY: IBM is correctly identified, the specific debt instrument is properly named, fiscal years are accurate, and the NYSE venue is correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and correctly traces the evolution from internal documentation reference to market-listed security. The logical progression is sound: 2022 (bare exhibit reference) → 2023 (same reference, no change) → 2024 (explicit ticker and exchange listing). COMPLETENESS: The answer addresses all aspects of the question: (1) treatment evolution across years, (2) market transparency progression, (3) capital market strategy implications, and (4) investor engagement approach. The LLM provides more detailed context than the ground truth by explicitly noting the shift from 'privately-documented security' to 'fully visible to the market,' which adds valuable interpretation. SEMANTIC EQUIVALENCE: The LLM's characterization of the progression as moving from 'bare exhibit reference' to 'explicit exchange-listed ticker' precisely matches the ground truth's description of moving from 'internal documentation to active market visibility.' The strategic interpretation (transparency, liquidity, accessibility, proactive investor engagement) aligns perfectly with the ground truth's conclusion about 'greater transparency and investor accessibility.' MINOR CONSIDERATIONS: The LLM mentions 'Exhibit 4.1/4.2' for 2023 while ground truth references only the same May 2017 filing—this is a minor notation detail that doesn't affect the core accuracy. The LLM's additional interpretive language about 'inviting a wider public-investor base' is reasonable inference consistent with the ground truth's strategic assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 573,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s 2022 Form 10‑K disclosed that, under the deposit method, its reinsurance‑related deposit assets were about **$1.8 billion** and deposit liabilities about **$1.4 billion** (the same amounts reported for 2021 and 2020). The 2023 filing reiterated that any reinsurance contract that does not expose the company to a “reasonable possibility of a significant loss” continues to be recorded using this deposit‑accounting approach, but it did not change the disclosed balances. By the 2024 filing the balances had grown to **$5.1 billion of deposit assets and $1.3 billion of deposit liabilities at year‑end 2023**, and to **$4.6 billion of assets and $1.2 billion of liabilities at year‑end 2024**, reflecting a substantial expansion of the method.\n\nThe November 2023 transaction with Global Atlantic illustrates a strategic shift: MetLife recorded **$10.3 billion of reinsurance recoverables/deposit receivables** (the bulk of the 2023 deposit‑asset increase) and recognized a **$770 million net cost of reinsurance liability**, while transferring $9.5 billion of fixed‑maturity assets to the reinsurer and retaining $5.0 billion of separate‑account assets. This large‑scale, coinsurance‑based deal shows MetLife moving from modest, static deposit balances to using the deposit method as a deliberate balance‑sheet tool for a major block of universal‑life and annuity contracts, thereby increasing deposit assets, reducing deposit liabilities and embedding the cost of risk transfer directly in other liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct: 2022 deposit assets $1.8B and liabilities $1.4B match ground truth exactly; 2023 figures of $5.1B assets and $1.3B liabilities are accurate; 2024 figures of $4.6B assets and $1.2B liabilities are correct. The Global Atlantic transaction figure of $10.3B in reinsurance recoverables/deposit receivables is accurate. The additional detail of $770M net cost of reinsurance liability and $9.5B/$5.0B asset transfers are correctly cited and add valuable context. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) evolution from 2022-2024 with specific year-over-year progression, (2) deposit assets and liabilities trends, and (3) the 2023 Global Atlantic transaction as a strategic shift. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and documents, establishing the causal relationship between the Global Atlantic transaction and the significant increase in deposit assets from 2022 to 2023. The reasoning that the transaction represents a 'strategic shift' from 'modest, static deposit balances' to using the deposit method as a 'deliberate balance-sheet tool' is well-supported and logically sound. ENTITY ACCURACY: MetLife is correctly identified throughout; fiscal years 2022, 2023, and 2024 are properly referenced; the Global Atlantic transaction is correctly dated to November 2023; financial metrics (deposit assets, deposit liabilities, reinsurance recoverables) are accurately identified. SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth while providing additional context about the accounting treatment and strategic implications. The explanation of how the transaction 'increases deposit assets, reduces deposit liabilities and embedding the cost of risk transfer directly in other liabilities' adds valuable interpretive depth without contradicting the ground truth. MINOR OBSERVATION: The LLM provides slightly more detailed context about the coinsurance structure and asset transfers than the ground truth, but this represents value-added explanation rather than factual error. No calculation errors detected. All numbers align with ground truth values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 621,
        "total_tokens": 2210
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "Across all three years, MMM’s Safety and Industrial segment consistently listed **“Respiratory, hearing, eye and fall protection solutions”** as a representative product line:\n\n* **2022 10‑K** – the segment’s activities include “…respiratory, hearing, eye and fall protection solutions.”  \n* **2023 10‑K** – the same phrasing appears unchanged.  \n* **2024 10‑K** – the segment again cites “…respiratory, hearing, eye and fall protection solutions.”\n\nThe fact that fall‑protection solutions are retained year after year—without being added, removed, or re‑categorized—shows that MMM has maintained a steady, core focus on workplace‑safety offerings within its Safety and Industrial portfolio, underscoring a continued strategic emphasis on protecting workers in hazardous environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All factual information is correct - the LLM accurately identifies that fall protection solutions were consistently listed across 2022, 2023, and 2024 within the Safety and Industrial segment with the same phrasing 'respiratory, hearing, eye and fall protection solutions.' (2) The multi-hop synthesis is sound - the answer correctly synthesizes information across three years and draws the appropriate conclusion about strategic consistency. (3) Entity accuracy is perfect - MMM, Safety and Industrial segment, and the specific product categories are all correctly identified. (4) The reasoning is logical and well-structured, using bullet points to show year-by-year consistency and then drawing a conclusion about strategic focus. (5) The answer directly addresses both parts of the question: how the portfolio evolved (answer: it remained consistent) and what this indicates about company focus (answer: steady, core focus on workplace safety). MINOR CONSIDERATIONS: The LLM answer is slightly more concise and direct than the ground truth, but this is actually a strength in terms of clarity. Both answers convey identical factual content - that fall protection remained a consistent, core component of the Safety and Industrial portfolio across all three years. The phrasing 'steady, core focus' in the LLM answer is semantically equivalent to the ground truth's 'stable strategic focus.' No numerical errors, no calculation issues, and no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 430,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "In the 2022 filing Altria only referenced its 2009 purchase of UST by noting that the company’s MST‑ and snus‑related trademarks (now worth $8.8 billion) were included in Altria’s indefinite‑life intangible‑asset pool, indicating ownership but without describing a subsidiary structure. By the 2023 filing Altria explicitly listed **UST LLC** as a **wholly‑owned subsidiary**, and explained that UST owns, in turn, the wholly‑owned operating company **U.S. Smokeless Tobacco Company LLC (USSTC)** that manufactures and sells moist‑smokeless tobacco products; the 2024 filing repeats this same hierarchy. The evolution from a mere asset‑ownership reference to a clearly defined, wholly‑owned subsidiary chain shows Altria has fully integrated UST into its corporate organization, using it as the cornerstone of its smokeless‑tobacco platform and signaling a deliberate strategic push to grow the MST/sn​us business as part of its “move beyond smoking” vision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed organizational structure information than the ground truth. Strengths: (1) All quantitative data correct - the $8.8 billion trademark valuation is accurately cited and properly contextualized as part of indefinite-life intangible assets; (2) Years correctly identified (2022, 2023, 2024); (3) Entity names precisely specified - correctly identifies UST LLC as wholly-owned subsidiary and U.S. Smokeless Tobacco Company LLC (USSTC) as the operating subsidiary, providing organizational hierarchy detail not explicitly stated in ground truth; (4) Multi-hop reasoning is sound - synthesizes the evolution from asset reference (2022) to subsidiary structure (2023-2024) and connects this to strategic positioning; (5) Strategic context properly captured - accurately links the organizational evolution to 'move beyond smoking' vision and MST/snus market positioning. Minor considerations: The LLM answer is actually more granular and specific than the ground truth in describing the subsidiary chain (UST LLC → USSTC), which represents enhanced rather than contradictory information. The answer fully addresses all three components of the question: organizational structure evolution, ownership progression, and strategic implications. The semantic equivalence is strong - both answers convey that Altria has strategically integrated UST as a core asset for smokeless tobacco market positioning. No calculation errors, no date discrepancies, and no entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 429,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 2022, 2023 and 2024 Form 10‑K filings all attach the same “One‑Hundred‑and‑Sixteenth Supplemental Indenture … related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15” (dated August 24 2015). By repeatedly incorporating this 2015 bond documentation, Tesla signals that the 5.45 % Solar Bonds remain an active, long‑term source of capital that it continues to rely on to fund SolarCity‑derived solar‑energy projects. The consistency across three successive years shows that Tesla’s financing strategy for its solar initiatives is anchored in fixed‑rate, multiyear debt rather than short‑term or equity financing, preserving the liability on its balance sheet and underscoring a commitment to using legacy SolarCity bond issuances to support its ongoing solar‑energy growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective synthesis of multi-hop information across Tesla's 2022, 2023, and 2024 filings. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the bond interest rate (5.45%), the bond series designation (2015/C92-15), and the indenture date (August 24, 2015) all match the ground truth precisely. The reference to 'three successive years' (2022, 2023, 2024) is accurate. ENTITY ACCURACY: All entities are correctly identified - Tesla, SolarCity, the specific bond series, and the supplemental indenture are all properly named and contextualized. MULTI-HOP REASONING: The LLM successfully synthesizes information across three consecutive annual filings to draw conclusions about Tesla's financing strategy. The answer correctly identifies the pattern of repeated references and interprets this as evidence of sustained reliance on securitized solar debt. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core insights as the ground truth: (1) sustained reliance on structured solar financing, (2) material component of solar financing architecture, (3) strategic commitment to securitized solar debt, and (4) confidence in the bond's performance. The LLM adds valuable detail about 'fixed-rate, multiyear debt' and balance sheet implications, which enhances rather than contradicts the ground truth. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('active, long-term source of capital' vs. 'sustained reliance on structured solar financing mechanisms') but the semantic meaning is equivalent. The LLM's additional observation about 'preserving the liability on its balance sheet' provides useful financial context not explicitly stated in the ground truth but logically consistent with it. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 500,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "Across the three filings IBM repeatedly flags **government‑ and stock‑exchange regulations** as a key driver of the value and liquidity of both its **debt securities** and its **common‑stock equity**. In the 2022 10‑K the risk factor is introduced as one of many “factors … over which the company has little or no control”; the 2023 filing reproduces the same language verbatim, and the 2024 filing again restates that the value of its debt and equity “fluctuates … because of … governmental and stock‑exchange regulations” and that rating‑agency actions can further affect liquidity. This continuity shows that IBM’s exposure to exchange‑rule risk has not diminished but is being **consistently acknowledged and monitored** year after year, indicating a capital‑market risk‑management strategy that treats regulatory risk as a persistent, systemic factor and embeds ongoing oversight rather than a one‑time mitigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and accurately captures IBM's consistent messaging about stock exchange regulations affecting both debt and equity securities across all three years. (2) Accurately reflects the core finding that IBM treats this as an uncontrollable risk factor ('little or no control') and that the exposure has not diminished over time. (3) Properly synthesizes the multi-hop information showing evolution from 2022 (initial risk flagging) through 2023 (reiteration) to 2024 (expanded integration with market liquidity and credit risks). (4) Correctly identifies the strategic implication: regulatory risk is treated as persistent and systemic with ongoing monitoring rather than one-time mitigation. (5) No quantitative errors - all dates and year references are accurate. (6) Semantic equivalence is strong: 'consistently acknowledged and monitored' effectively conveys the same meaning as 'increasing recognition of regulatory dynamics as a persistent and systemic component.' MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'verbatim' language reproduction in 2023, which adds a specific detail not explicitly stated in the ground truth, though this is a reasonable inference from the filing data and doesn't contradict the ground truth. (2) The LLM mentions 'rating-agency actions' as an additional factor in 2024, which represents a slight expansion beyond the ground truth's framing but is consistent with the broader point about integrated risk view. (3) The ground truth explicitly states 'no material reduction in dependency or mitigation strategy' while the LLM says exposure 'has not diminished' - these are semantically equivalent. Overall, the LLM successfully captures the multi-year progression, the regulatory risk persistence, and the strategic implication about capital market risk management with high fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 540,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—MMM lists **electrical products and materials for construction and maintenance, power‑distribution and electrical OEMs** as a core activity of its Safety & Industrial segment. The wording is unchanged (the 2023 and 2024 reports simply spell out “original equipment manufacturers (OEMs)”), showing that the company has kept a steady, explicit focus on supplying electrical solutions for building‑site and maintenance work and for OEM customers. This continuity signals that MMM is deliberately positioning itself as a long‑term, go‑to supplier in the industrial construction‑and‑maintenance market, reinforcing its strategic foothold in that segment rather than shifting away from it.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH COMPLETENESS AND MULTI-HOP SYNTHESIS: The LLM answer focuses narrowly on the electrical products line and claims the wording is 'unchanged' across all three years, which directly contradicts the ground truth. The ground truth explicitly documents significant evolution in how MMM described its Safety and Industrial segment across the three years. SPECIFIC ERRORS: (1) The LLM claims 2023 and 2024 reports 'simply spell out original equipment manufacturers (OEMs)' - this is a minor formatting observation that misses the substantive changes documented in the ground truth. (2) The LLM completely omits that in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products. (3) The LLM fails to mention that 2023 added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components. (4) The LLM does not address the 2024 rephrasing that emphasized 'Industrial specialty products' more broadly. (5) The LLM's conclusion that MMM 'kept a steady, explicit focus' and is 'reinforcing its strategic foothold' without shifting contradicts the ground truth's finding of 'subtle evolution' and 'potential shift toward emphasizing broader industrial specialties.' WHAT WAS CORRECT: The LLM correctly identifies that electrical products remained a core offering across all three years and correctly names the segment as Safety & Industrial. The company name (MMM) and years (2022, 2023, 2024) are accurate. REASONING FAILURE: The question explicitly asks about how the focus 'evolved' and what the 'multi-year progression indicates' - this requires identifying changes over time. The LLM's answer fundamentally misses the evolution by claiming consistency where the ground truth documents meaningful shifts in emphasis and portfolio composition. The multi-hop synthesis required comparing segment descriptions across three years; the LLM failed to perform this comparison adequately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 545,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "- **2022 filing** – Gilead listed Oceanside, California as one of its principal manufacturing sites (and also as an R&D location), but the 10‑K did not spell out any specific manufacturing focus for the campus.  \n\n- **2023 filing** – Gilead clarified that the Oceanside plant is used for **commercial retroviral‑vector manufacturing** and for **clinical‑scale manufacturing and process‑development of its biologics candidates**.  \n\n- **2024 filing** – The same description is repeated, confirming that the facility continues to serve **commercial retroviral‑vector production** and **clinical manufacturing/process‑development of biologics**.  \n\n**Thus, the Oceanside facility evolved from being mentioned only as a generic manufacturing/R&D site in 2022 to a clearly defined hub for retroviral‑vector and biologics manufacturing by 2023, a role that remained unchanged through 2024.**",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains a significant factual discrepancy that undermines its accuracy despite addressing the question structure.\n\nKEY ISSUES:\n\n1. CRITICAL FACTUAL ERROR - Timeline Contradiction:\n   - Ground Truth states: 2023 = clinical manufacturing/process development; 2024 = commercial retroviral vector manufacturing (NEW in 2024)\n   - LLM Answer states: 2023 = commercial retroviral vector manufacturing; 2024 = same as 2023 (unchanged)\n   - This is a material error. The LLM reversed the timeline, claiming commercial retroviral vector manufacturing began in 2023 when the ground truth indicates it was emphasized/added in 2024.\n\n2. CHARACTERIZATION OF 2022:\n   - Ground Truth: \"referenced as part of broader operational footprint...role in research and development\"\n   - LLM Answer: \"listed as principal manufacturing sites (and also as R&D location)\" with \"no specific manufacturing focus\"\n   - These are semantically similar and acceptable, though LLM is slightly more specific about it being listed as manufacturing.\n\n3. PROGRESSION NARRATIVE:\n   - Ground Truth emphasizes: R&D → clinical manufacturing/process development → commercial retroviral vector manufacturing (strategic escalation)\n   - LLM Answer presents: generic manufacturing/R&D → commercial retroviral vector + clinical manufacturing (2023 onwards, unchanged through 2024)\n   - The LLM misses the key evolution that commercial retroviral vector manufacturing was specifically highlighted as NEW in 2024.\n\n4. COMPLETENESS:\n   - Both answers address all three years (2022-2024)\n   - Both identify the facility location and company correctly\n   - LLM provides clear year-by-year breakdown\n\n5. MULTI-HOP REASONING:\n   - The question requires synthesizing information across three separate 10-K filings\n   - LLM demonstrates the structure but fails on the critical temporal sequencing of when capabilities were emphasized\n   - Ground truth shows strategic progression; LLM shows stasis after 2023\n\nNUMERIC/CALCULATION VERIFICATION:\n   - No calculations required; dates are the key factual elements\n   - Date accuracy: LLM correctly identifies 2022, 2023, 2024 but misorders when capabilities were introduced\n\nSCORING JUSTIFICATION:\n   - Correctness Score (6): Major factual error on timeline of commercial retroviral vector manufacturing introduction, but overall structure and most details are present\n   - Quantitative Accuracy (7): Dates are correct numerically, but their sequencing/significance is wrong\n   - Qualitative Accuracy (5): The reasoning about progression is flawed due to the timeline error; fails to capture the strategic evolution emphasized in ground truth\n   - Contextual Relevance (8): Addresses the question appropriately and provides relevant facility information, despite the factual error",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 749,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "All three filings describe the same “glide‑path” policy – the funded‑ratio‑driven rule that sets a **target allocation for the “Return‑Seeking” (growth) portion of the U.S. qualified‑plan portfolio** and then moves assets gradually from growth to liability‑hedging as the plan becomes better funded.\n\n* **2022 filing (AIG 10‑K 2022, p. 310)** – The table that follows the discussion shows the **2022 target allocation** for the Return‑Seeking slice, calculated on the basis of the funded status at 31 Dec 2021.  \n* **2023 filing (AIG 10‑K 2023, p. 252)** – The same discussion is repeated, and the accompanying table now presents the **2023 target allocation** (derived from the funded status at 31 Dec 2022).  \n* **2024 filing (AIG 10‑K 2024, p. 184)** – The discussion is again restated, and the table provides the **2024 target allocation** (based on the funded status at 31 Dec 2023).\n\nAcross the three years the glide‑path numbers move in the same direction: the **Return‑Seeking allocation is highest in 2022, is lowered in 2023, and is reduced further in 2024**. This downward trend reflects the policy that, as the plan’s funded ratio improves, the allocation to growth assets is trimmed and the share of liability‑hedging assets is increased.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core concept of AIG's glide-path approach and accurately describes the forward-looking, dynamic nature of the policy. It correctly identifies that the Return-Seeking allocation decreased over the three-year period (2022 > 2023 > 2024) and correctly attributes this to improving funded status. The multi-hop synthesis across three years of filings is sound, and the explanation of the mechanism (funded-ratio-driven rule) is accurate. The LLM properly identifies the relationship between funded status and asset allocation shifts.\n\nCRITICAL ERRORS: The LLM contains a significant factual error regarding the funded status dates used for each year's calculation. According to the ground truth:\n- 2022 target allocation: based on funded status at December 31, 2021 ✓ (LLM correct)\n- 2023 target allocation: based on funded status at December 31, 2023 ✗ (LLM states December 31, 2022)\n- 2024 target allocation: based on funded status at December 31, 2024 ✗ (LLM states December 31, 2023)\n\nThe LLM appears to have confused the reference dates. The ground truth shows that each year's target allocation is based on the funded status from the END of that same year (or the year just completed), not the prior year. This is a material factual error that affects the accuracy of the multi-hop synthesis.\n\nQUANTITATIVE ACCURACY: While the LLM correctly identifies the directional trend (decreasing Return-Seeking allocation), it does not provide specific percentage allocations or numerical values. The absence of actual numbers from the tables limits quantitative verification, though the directional claim appears sound based on the ground truth's description of the evolution.\n\nMULTI-HOP REASONING: The synthesis across three years is logically structured and mostly sound, but the date error undermines the precision of the multi-hop analysis. The LLM correctly synthesizes the concept across filings but misidentifies the specific funded status reference dates.\n\nSEMANTIC EQUIVALENCE: The LLM's description of the mechanism and policy is semantically equivalent to the ground truth, but the factual error regarding dates prevents full equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 588,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "Across the three filings ACN consistently states that its defined‑benefit pension plans are run to a **target asset‑allocation mix** that is reviewed each year and allowed to vary within pre‑set ranges so that “rebalancing is not required immediately.” In the 2022 filing (Chunk 1) the company disclosed the **fiscal‑2023 target mix**, and in the 2023 and 2024 filings (Chunks 2 and 3) it disclosed the **fiscal‑2025 target mix**. Although the exact percentages are not reproduced in the excerpts, the narrative shows that the 2025 targets continue to emphasize a diversified portfolio of **fixed‑income securities matched to liability duration and equity index funds for long‑term capital appreciation**, with the language suggesting a modest tilt toward a higher equity component relative to 2023. This incremental shift—while still anchored by diversification and liability‑matching—indicates that ACN is **gradually increasing its willingness to assume market risk** in order to chase returns above inflation, reflecting a long‑term risk tolerance that is cautiously upward‑biased rather than static.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies ACN as the company and addresses the multi-year evolution of target asset allocation strategy. It accurately captures the key qualitative themes: (1) annual review and flexibility within pre-set ranges, (2) emphasis on fixed-income duration matching and equity diversification, (3) a shift toward higher equity allocation over time, and (4) the interpretation that this reflects gradually increasing risk tolerance. The reasoning about moving from a reactive to more strategic stance is sound and aligns with the ground truth's conclusion about increased confidence in long-term outlook.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR: The LLM states the 2022 filing disclosed 'fiscal-2023 target mix' and the 2023/2024 filings disclosed 'fiscal-2025 target mix.' The ground truth indicates fiscal 2023 set targets for fiscal 2024 (one-year horizon), and fiscal 2024 extended planning to fiscal 2025 (two-year horizon). The LLM conflates the timeline by suggesting 2022 → 2023 targets, when the actual progression was 2023 → 2024 → 2025. (2) MISSING SPECIFIC DETAIL: The ground truth emphasizes the key insight about the planning horizon extension (one-year to two-year), which the LLM does not explicitly highlight as a distinct strategic shift. (3) VAGUE PERCENTAGES: The LLM acknowledges 'exact percentages are not reproduced' but doesn't clarify whether specific allocation numbers were available in the source documents. The ground truth doesn't provide exact percentages either, but the LLM's hedging language creates ambiguity about what data was actually available. (4) INTERPRETATION DIFFERENCE: The LLM characterizes the shift as 'gradually increasing willingness to assume market risk' with 'cautiously upward-biased' risk tolerance, while the ground truth frames it more as increased confidence in long-term outlook and a shift from reactive to strategic positioning—subtly different interpretations of the same data.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three filings and correctly identifies the evolution pattern. However, the timeline confusion (2022 vs 2023 as starting point) undermines the accuracy of the multi-hop synthesis.\n\nQUANTITATIVE ACCURACY: No specific percentages or dollar amounts are provided in either answer, so this dimension is limited. However, the LLM's reference to filing years (2022, 2023, 2024) contains an error in the starting point of the timeline.\n\nOVERALL ASSESSMENT: The answer demonstrates solid understanding of the strategic direction and qualitative evolution, but contains a material factual error regarding which fiscal year's targets were disclosed in which filing year. This is a significant issue for a multi-hop question requiring precise temporal sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 739,
        "total_tokens": 2244
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Across the three most recent annual reports Tesla repeatedly lists the same debt instrument – the **5.45 % Solar Bonds, Series 2015/C25‑15** – as a supplemental indenture exhibit.  \n\n* In the **2022 Form 10‑K** the bond appears as Exhibit 4.36 (the “Thirty‑Sixth Supplemental Indenture” dated April 14 2015).  \n* In the **2023 Form 10‑K** it is shown as Exhibit 4.29 (the same “Thirty‑Sixth Supplemental Indenture” dated April 14 2015).  \n* In the **2024 Form 10‑K** it is again disclosed as Exhibit 4.27, identical in description and date.  \n\nThe fact that Tesla (through SolarCity) continues to disclose this 2015‑issued, fixed‑rate 5.45 % bond every year demonstrates that the instrument remains outstanding and is a core component of its solar‑project financing. The multi‑year pattern signals a deliberate strategy of locking in long‑dated, fixed‑coupon debt to fund solar assets, providing predictable financing costs and evidencing the company’s reliance on a durable, bond‑based capital structure for its solar business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the bond series (5.45% Solar Bonds, Series 2015/C25-15), correctly notes its presence across 2022, 2023, and 2024 filings, and accurately describes it as a supplemental indenture dated April 14, 2015. The exhibit numbers (4.36 in 2022, 4.29 in 2023, 4.27 in 2024) appear plausible and show appropriate variation. The core insight about long-dated fixed-rate debt for solar financing is sound. WEAKNESSES: (1) The LLM provides specific exhibit numbers and dates that cannot be verified against the ground truth, which only confirms the bond's presence across years without specifying exhibit numbers. This introduces unverified specificity that could be incorrect. (2) The ground truth mentions an evolution/expansion of the financing framework, noting newer bond structures (Series 2015/C28-15 and 2015/C33-15) appearing by 2023, but the LLM completely omits this important context about the multi-year pattern of expansion. (3) The ground truth indicates the bond was part of a 'broader set of solar bond issuances' in 2022 (including C5-15, C10-15, C20-15), but the LLM focuses narrowly on just the C25-15 series without acknowledging this broader context. (4) The LLM's answer is more exhibit-focused than strategy-focused, whereas the question asks about how the 'issuance and structuring evolved' and what the pattern 'reveals about strategy.' The LLM provides less insight into the strategic evolution compared to the ground truth's discussion of expansion and long-term commitment. (5) The LLM doesn't address the SolarCity acquisition context as explicitly as the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to capture the full evolution narrative (expansion of bond series) that the ground truth emphasizes. The reasoning about fixed-rate debt strategy is sound but incomplete relative to the ground truth's fuller picture of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 529,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s handling of international terrorism risk became progressively more granular and capital‑backed. In its 2022 filing the company disclosed a scenario‑based “five‑ton bomb” model that projected a net loss of **$1.3 billion** (after the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and existing reinsurance recoveries) and a **$1.7 billion deductible** with TRIPRA covering roughly **80 %** of U.S. losses above that level; it also noted routine scenario‑based modeling for non‑U.S. jurisdictions, targeted private‑reinsurance purchases and reliance on government‑sponsored terrorism pools. The 2023 report repeated the same modeling approach and continued the use of targeted reinsurance and pool participation, but did not add new quantitative limits. By 2024 AIG had refined its reinsurance program – retaining core attachment points of **$200 million for Japan** and **$125 million for the rest of the world**, adding global “property‑per‑risk” excess‑of‑loss covers for both non‑critical and critical catastrophes, and reporting **$38 billion of reinsurance recoverable assets (with $20.1 billion of collateral)** – while still using third‑party scenario models, monitoring concentration, purchasing targeted reinsurance and tapping government terrorism‑reinsurance programs in each jurisdiction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of AIG's terrorism exposure management from 2022-2024, including the $1.3 billion net loss estimate for the five-ton bomb scenario, the $200 million Japan attachment point for 2024, and the $38 billion reinsurance recoverable assets figure. The answer appropriately synthesizes multi-hop information across three years and correctly identifies the shift toward more granular, capital-backed approaches. The discussion of TRIPRA, government-sponsored pools, and scenario-based modeling is accurate and contextually relevant.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces specific quantitative details not present in the ground truth, including the '$1.7 billion deductible' and '80% TRIPRA coverage' figures. While these may be factually accurate from the source filings, they are NOT mentioned in the ground truth answer, creating a discrepancy in what should be reported. (2) The LLM states '$125 million for the rest of the world' as a core attachment point for 2024, but the ground truth only mentions the $200 million Japan retention and does not specify a global attachment point of $125 million. This appears to be an unsupported addition. (3) The LLM provides '$20.1 billion of collateral' as a sub-component of the $38 billion reinsurance recoverable assets, but the ground truth does not mention this collateral figure, suggesting either an addition not in the ground truth or a misinterpretation of the data structure.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis across 2022, 2023, and 2024 filings, correctly tracking the evolution of strategies and identifying key turning points (2023 shift to active management, 2024 refinement of reinsurance program). The logical flow is clear and well-structured.\n\nQUANTITATIVE ACCURACY ISSUES: While the primary numbers ($1.3B, $200M Japan, $38B recoverable assets) are correct, the introduction of unsupported figures ($1.7B deductible, 80% TRIPRA, $125M global attachment, $20.1B collateral) reduces confidence in the quantitative precision. The ground truth does not validate these additional numbers.\n\nCONCLUSION: The answer captures the essential evolution and key metrics but adds details not present in the ground truth, which creates factual uncertainty. The core narrative is sound, but the additional quantitative claims without ground truth support prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Impacts]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 648,
        "total_tokens": 2213
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions business was flagged in every filing as being vulnerable to “adverse industry economic conditions.” In the 2022 10‑K the risk was described as one of several macro‑industry headwinds that could “result in lower market share, reduced selling prices and lower margins.” The 2023 filing repeated the same exposure, again noting that adverse industry conditions – together with reduced investments in process automation, safety monitoring and plant‑capacity initiatives, retail‑market fluctuations, a slowdown in safety‑product demand, new entrants and product commoditization – could compress margins. By 2024 the segment (renamed “Industrial Automation”) still carried the identical language, confirming that the exposure had not diminished and that the same set of risks – especially reduced automation‑related spending, retail volatility, demand slowdown, competitive pressure/commoditization and the broader adverse industry economic environment – continued to be highlighted as drivers of margin pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of risks consistently. (2) Accurately captures the specific risks mentioned: reduced investments in process automation, retail market fluctuations, product commoditization, new market entrants, reduced selling prices, and adverse industry economic conditions. (3) Properly notes the segment name change from 'Safety and Productivity Solutions' to 'Industrial Automation' by 2024. (4) Correctly synthesizes the multi-hop information showing how the same risks persisted across all three years despite organizational restructuring. (5) No quantitative errors - no specific dollar amounts or percentages were required, and the temporal references are all accurate. (6) The reasoning about 'persistent vulnerability' and 'exposure had not diminished' aligns with the ground truth's conclusion about consistent linkage over three years. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail in some areas (e.g., explicitly listing 'safety monitoring and plant-capacity initiatives' and 'slowdown in safety-product demand') compared to the ground truth summary, but these details are consistent with the filing content and enhance rather than contradict the answer. The semantic equivalence is strong - both answers convey that the same set of margin pressures persisted across the period despite business restructuring. The multi-hop synthesis is sound, correctly combining information from three separate annual filings to show the evolution pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 453,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "- **2022 (10‑K 2022 – Chunk 1)** – Pfizer was still granting BPAs. The table shows 1,165 BPA shares were **granted** in 2022 (weighted‑average intrinsic value $38.73 per share) and 859 BPA shares remained non‑vested at year‑end, indicating an active award program.\n\n- **2023 (10‑K 2023 – Chunk 3)** – The company disclosed that **no BPAs were granted in 2023 and none were outstanding as of December 31, 2023**. The BPA line disappears from the share‑based‑payment footnote, showing a complete pause in grant activity.\n\n- **2024 (10‑K 2024 – Chunk 2)** – Pfizer still describes the BPA program for disclosure purposes. The **valuation methodology** is the **intrinsic‑value method** (using the closing price of Pfizer common stock on the grant date). The **recognition** is now spelled out: the estimated award cost is **amortized on a straight‑line basis over the probable vesting term** and charged to Cost of Sales, SG&A, and/or R&D, with each reporting period adjusted for changes in stock price, the number of shares likely to be earned, and the probability of meeting performance criteria.\n\n**Overall evolution:** BPAs went from an active grant program in 2022 to a complete halt in 2023 (no grants or outstanding awards), while the 2024 filing retains the award’s description, confirming that any future BPA would be valued using the intrinsic‑value approach and expensed via straight‑line amortization into the income‑statement expense categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are precisely correct - 1,165 thousand BPAs granted in 2022, $38.73 weighted average intrinsic value, 859 thousand nonvested at year-end 2022, zero grants and zero outstanding in 2023. No calculation errors detected. ENTITY ACCURACY: Pfizer correctly identified, fiscal years 2022-2024 properly sequenced, BPA program correctly named and tracked. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) grant activity evolution (1,165 in 2022 → 0 in 2023 → descriptive only in 2024), (2) valuation methodology (intrinsic value method using closing stock price on grant date), and (3) financial statement recognition (straight-line amortization over probable vesting term, charged to COGS/SG&A/R&D with periodic adjustments). MULTI-HOP REASONING: The synthesis across three years of filings is sound and logical. The answer correctly identifies the program's lifecycle: active issuance → complete wind-down → descriptive retention. The connection between 2022 activity, 2023 cessation, and 2024 methodology description is properly established. SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth with clear, well-organized presentation. The explanation of amortization mechanics and adjustment factors adds helpful context without introducing errors. Minor observation: The LLM provides slightly more operational detail (specific expense categories: COGS, SG&A, R&D) than the ground truth, but this is supplementary and accurate, not contradictory. No factual errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 465,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "- In fiscal 2022 the Board’s “aggregate available authorization” for the open‑market share‑purchase program and related buy‑back activities was **$3.13 billion** (as of August 31 2022).  \n- By fiscal 2024 the company had used a portion of that authority – it bought **2,000,308 Class A shares for $605 million** in Q4 2024 (plus 72,255 shares in employee‑plan withholdings that do not draw on the authorization) – and the remaining authorization fell to **$2.69 billion** as of August 31 2024.  \n- In September 2024 the Board approved an **additional $4 billion** of repurchase authority, raising Accenture’s total outstanding authority to **$6.69 billion**.\n\n**Interpretation:** The decline in the unused authorization from 2022 to 2024 shows that Accenture is actively deploying its buy‑back program, while the large supplemental increase in 2024 signals a continued, even expanded, commitment to return capital to shareholders through share repurchases. This pattern reflects a capital‑return strategy that relies on regular, sizable buy‑backs and sufficient authorized capacity to sustain them.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) FY2022 authorization of $3.13 billion matches ground truth ($3,129,296,000 ≈ $3.13B) ✓; (2) Remaining authorization of $2.69 billion as of August 31, 2024 matches ground truth ($2,694 million) ✓; (3) Additional $4 billion authorization in September 2024 matches ground truth ✓; (4) Total outstanding authority of $6.69 billion is correct ($2.69B + $4B = $6.69B) ✓. The LLM provides additional detail about Q4 2024 share repurchases (2,000,308 shares for $605 million) which, while not explicitly in the ground truth summary, represents accurate supplementary information that strengthens the answer. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution across three fiscal periods (2022→2024→post-2024), tracks the authorization depletion and replenishment, and draws appropriate conclusions about capital return strategy. The interpretation correctly identifies the pattern of active deployment followed by authorization expansion, which aligns with the ground truth's characterization of 'consistent and increasing commitment.' Minor note: The LLM includes specific Q4 2024 transaction details that go slightly beyond the ground truth summary but are factually accurate and enhance understanding. All entities (Accenture, fiscal years, share repurchase program) are correctly identified. The answer directly addresses all parts of the multi-part question regarding evolution of activity, remaining authorization, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 426,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer’s filings show that after the December 31 2021 sale of Meridian for about $51 million (recording a $167 million pre‑tax loss), the company continued to treat Meridian as a **discontinued operation** in its 2022 Form 10‑K, merely noting the divestiture and confirming that its disclosure controls remained effective. In the 2023 Form 10‑K Pfizer provided the full financial picture of the divestiture and described the post‑sale framework – interim transition service agreements (TSAs) that were completed by December 31 2023 and a three‑year Manufacturing Supply Agreement (MSA) with a two‑year extension option – although the amounts recorded under those agreements were not material. By the 2024 Form 10‑K Meridian appears only in the glossary of abbreviations, indicating that the relationship persists only through the existing MSA and that no further material financial or strategic activity is reported, reflecting a fully divested but still‑partnered status.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All key financial numbers are correct: $51 million sale price, $167 million loss (though LLM states pre-tax while ground truth says net of tax - this is a minor discrepancy), December 31, 2021 sale date. (2) The multi-hop synthesis across 2022-2024 is sound, correctly tracing the progression from discontinued operations to divestiture to glossary-only reference. (3) The LLM appropriately identifies the transition service agreements (TSAs) and Manufacturing Supply Agreement (MSA) as post-divestiture arrangements, adding operational detail not explicitly in the ground truth but consistent with typical divestiture structures. (4) Correctly notes that by 2024, Meridian appears only in glossary, indicating no active material relationship.\n\nWEAKNESSES: (1) The LLM states the loss as '$167 million pre-tax loss' while the ground truth specifies '$167 million, net of tax.' This is a material distinction in financial reporting - the ground truth indicates this is the after-tax loss, not the pre-tax loss. This represents a factual error in characterizing the nature of the loss figure. (2) The LLM introduces details about TSAs and MSAs that, while plausible and consistent with typical divestiture practices, are not explicitly confirmed in the ground truth provided. The ground truth does not mention these agreements, so the LLM appears to be inferring or adding information beyond what was verified in the knowledge graph. (3) The characterization of the relationship as 'still-partnered' through the MSA is reasonable but goes slightly beyond the ground truth's statement that Meridian is 'only mentioned as a defined entity in the glossary,' suggesting no active relationship remained.\n\nCALCULATION/NUMERIC VERIFICATION: All dollar amounts and dates are accurate ($51M, $167M, December 31, 2021, December 31, 2023). The pre-tax vs. net-of-tax distinction is the only numeric characterization issue.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years (2022, 2023, 2024) and traces the evolution from operational status to divestiture to post-divestiture arrangements. The logical flow is sound.\n\nOVERALL ASSESSMENT: The answer is substantially correct with accurate financial figures and sound multi-hop reasoning. The primary issue is the pre-tax vs. net-of-tax characterization of the loss, which is a meaningful distinction in financial reporting. The introduction of TSA and MSA details, while operationally sensible, exceeds what the ground truth explicitly confirms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Sells]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 675,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **Fiscal‑year 2022:** The Amended 2010 SIP authorized a maximum of **127 million** Accenture Class A ordinary shares for awards.  \n- **Fiscal‑year 2023:** The authorization was increased to **141 million** shares – an addition of 14 million shares.  \n- **Fiscal‑year 2024:** The authorized amount remained at **141 million** shares.\n\nThe jump from 127 million to 141 million shares shows that Accenture deliberately expanded its share‑based compensation pool to give the company more flexibility to grant equity awards and to strengthen long‑term employee incentives. Holding the authorization steady at 141 million in 2024 indicates that the firm has set a new, larger ceiling and now intends to use that expanded pool consistently as a core element of its long‑term compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - FY2022: 127 million shares, FY2023: 141 million shares, FY2024: 141 million shares. The calculated increase of 14 million shares (141-127) is accurate. Number formatting is appropriate and consistent with ground truth. COMPLETENESS: The answer addresses all three fiscal years requested and provides the progression clearly. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP throughout. MULTI-HOP REASONING: The answer successfully synthesizes the three-year progression and draws appropriate conclusions about strategic intent. The interpretation that the increase from 2022 to 2023 followed by maintenance in 2024 indicates a deliberate expansion of share-based compensation capacity is sound and aligns with the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's explanation of strategic intent ('deliberately expanded its share-based compensation pool,' 'strengthen long-term employee incentives,' 'core element of its long-term compensation strategy') conveys the same meaning as the ground truth's assessment regarding 'strategic decision to expand capacity' and 'key component of its employee retention and performance alignment strategy.' Minor differences in wording are stylistic and do not affect factual accuracy. The only minor distinction is that the LLM uses slightly more detailed language about 'flexibility to grant equity awards' which adds helpful context without contradicting the ground truth. No calculation errors, no factual inaccuracies, and appropriate synthesis of multi-year data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 463,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Across all three annual reports Tesla again listed the same “Seventieth Supplemental Indenture, dated June 16 2015, by and between SolarCity and the Trustee, related to SolarCity’s 4.70 % Solar Bonds, Series 2015/C52‑10.” In the 2022 filing it appears as Exhibit 4.49, in 2023 as Exhibit 4.42 and in 2024 as Exhibit 4.4, but the description and the underlying indenture are identical. This consistency shows that the 4.70 % Solar Bonds remain an active, outstanding obligation and that Tesla continues to satisfy the reporting requirements for that financing, signalling that the bond series is still a material, ongoing liability and remains a strategic component of the company’s solar‑related capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. STRENGTHS: (1) All key facts are accurate - the bond series name, percentage rate (4.70%), the Seventieth Supplemental Indenture, and the June 16, 2015 filing date are all correct. (2) The exhibit numbers are correctly identified for 2022 (4.49) and 2023 (4.42). (3) The multi-hop synthesis is sound - the answer correctly traces the consistent disclosure pattern across three years and draws appropriate conclusions about ongoing obligations. (4) The reasoning about what consistency suggests (stable financial commitment, active obligation, material liability) aligns well with the ground truth interpretation. (5) The answer appropriately addresses both the 'change or remain consistent' aspect and the 'strategic priorities' aspect of the question. MINOR ISSUE: There is a typographical error in the 2024 exhibit number - the LLM states 'Exhibit 4.4' when the ground truth indicates 'Exhibit 4.40'. This appears to be a transcription error (missing the final '0') rather than a fundamental misunderstanding, as the context and pattern are otherwise correct. The semantic meaning and factual substance remain intact despite this formatting error. The qualitative analysis about what the pattern suggests (ongoing obligations, strategic alignment with solar financing) is well-reasoned and matches the ground truth interpretation. The answer demonstrates solid multi-hop reasoning by synthesizing information across three years and drawing appropriate conclusions about Tesla's financial commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 432,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning has remained a core “entry‑level” pillar of the company’s Digital Learning Services portfolio, but its presentation and strategic emphasis have shifted slightly over the three years.  \n\n* In the 2022 filing the offering was described as a large set of free courses hosted on **www.training.adobe.com**, positioned alongside fee‑based classroom, virtual and on‑demand programs and custom‑learning services, and tied to Customer Success managers and “Getting Started” support as a way to accelerate solution adoption.  \n* In the 2023 filing the same free‑learning pillar moved to **learning.adobe.com** and was again framed as a foundational component of Adobe Customer Solutions’ learning and enablement services, complementing the fee‑based catalog and custom services while supporting “Getting Started” adoption help.  \n* The 2024 filing repeats the 2023 description, keeping the learning.adobe.com URL and emphasizing that the free self‑service options continue to serve as the first‑touch, scalable resource that feeds customers into Adobe’s broader fee‑based and custom learning programs and underpins its adoption strategy.  \n\nThus, from 2022‑2024 Adobe’s free online self‑service learning evolved from a training‑site offering to a unified learning.adobe.com hub, consistently positioned as the foundational, low‑friction layer that drives customer onboarding and feeds into its wider paid and custom enablement services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the URL evolution from www.training.adobe.com (2022) to learning.adobe.com (2023-2024), which is a specific factual detail matching the original answer. (2) Accurately captures the three-year timeline and evolution narrative. (3) Properly synthesizes the multi-hop information about positioning within Adobe's broader learning services portfolio. (4) Correctly identifies the strategic role in customer adoption and 'Getting Started' support. (5) Accurately describes the relationship between free offerings and fee-based/custom services. (6) Uses appropriate terminology ('entry-level pillar', 'foundational component', 'low-friction layer') that aligns with the strategic positioning described in ground truth. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more interpretive detail about the 'shift' in presentation and strategic emphasis, characterizing it as 'moved' and 'shifted slightly,' which adds nuance beyond the ground truth's statement of 'consistent presence.' However, this interpretation is reasonable and not contradicted by the ground truth. (2) The LLM answer emphasizes the 'feeds customers into' language more explicitly than the ground truth, but this is semantically equivalent to the ground truth's description of complementary positioning. QUANTITATIVE ACCURACY: No numerical data, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents, correctly linking the evolution of platforms, positioning statements, and strategic roles. The reasoning chain is logical and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing slightly more detailed analysis of the evolution trajectory, which enhances rather than detracts from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 557,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path framework – which ties the “Return‑Seeking” (growth‑asset) portion of the qualified U.S. pension plan to the plan’s funded ratio and prevailing interest‑rate levels – was described in the same way in each of the three filings.  \n\n* **2022 filing (Chunk 1)** – The table that accompanied the 2022 discussion set the target allocation for the Return‑Seeking slice of the portfolio based on the funded status as of 31 December 2021. That allocation was calibrated to the plan’s funded ratio at that date, with a higher share of growth assets when the funded ratio was lower.  \n\n* **2024 filing (Chunk 2)** – The 2024 table reset the target allocation using the funded status as of 31 December 2023. Because the plan’s funded ratio had improved since 2021, the glide‑path called for a **lower** percentage of the portfolio to be allocated to growth assets and a correspondingly **higher** share to liability‑hedging assets.  \n\n* **2025 filing (Chunk 3)** – Although the 2025 target (based on the 31 December 2024 funded status) is not asked for, the filing repeats the same glide‑path language, confirming that the policy continues to adjust the Return‑Seeking allocation downward as the funded ratio rises.\n\n**In short, from 2022 to 2024 AIG’s glide‑path approach remained unchanged in principle, but the target allocation for the Return‑Seeking portion was reduced as the plan’s funded status improved, shifting the portfolio progressively toward more liability‑hedging assets.**",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's glide path approach and correctly synthesizes the multi-hop information across the 2022, 2024, and 2025 filings. STRENGTHS: (1) Correctly identifies the core mechanism: glide path ties Return-Seeking allocation to funded ratio and interest rates; (2) Accurately captures the temporal evolution: 2022 allocation based on Dec 31, 2021 funded status; 2024 allocation based on Dec 31, 2023 funded status; (3) Correctly identifies the directional shift: as funded ratio improved, Return-Seeking allocation decreased while liability-hedging increased; (4) Properly synthesizes multi-hop reasoning across three filing years; (5) Appropriately acknowledges that specific percentages are not provided in excerpts, matching the ground truth's statement that 'specific percentages for the Return-Seeking portion are not listed in the provided excerpts.' MINOR WEAKNESSES: (1) The LLM mentions a 2025 filing (Chunk 3) and references a 2025 target based on Dec 31, 2024 funded status, which goes slightly beyond the question's 2022-2024 timeframe, though this is presented as contextual confirmation rather than core answer; (2) The answer could have been more explicit that the glide path mechanism itself remained consistent while only the target allocations changed year-to-year. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, which is appropriate given the ground truth's acknowledgment that percentages are not listed. Dates are all correct (Dec 31, 2021; Dec 31, 2023; Dec 31, 2024). QUALITATIVE ACCURACY: The reasoning is sound and demonstrates proper understanding of how glide paths function as de-risking mechanisms. The synthesis correctly shows the relationship between funded status improvement and portfolio reallocation. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing the evolution of the approach and the strategic shift in asset allocation in response to funded status changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 535,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Across all three filings – 2022, 2023 and the most recent 2024 – Honeywell’s Performance Materials and Technologies (renamed “Energy and Sustainability Solutions” in 2024) repeatedly lists **raw‑material demand and supply** as a key risk. The 2022 filing first flagged “raw material demand and supply” (along with oil‑ and gas‑price volatility) as a factor that could depress customer investment and product demand; the 2023 filing repeats the same exposure, and the 2024 filing again cites “raw material demand and supply” together with commodity‑price volatility as a material risk to the segment. This consistent, year‑over‑year acknowledgement shows that Honeywell’s exposure to raw‑material market conditions has not diminished and suggests the company remains vulnerable to swings in commodity markets and the associated supply‑chain disruptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the core trend across the three-year period. STRENGTHS: (1) Correctly identifies raw material demand and supply as a consistent risk factor across 2022-2024; (2) Accurately notes the segment name change to 'Energy and Sustainability Solutions' in 2024, showing attention to detail; (3) Properly synthesizes the evolution of risk framing from COVID-19 pandemic impacts (2022) through supply volatility (2023) to energy price volatility (2024); (4) Correctly concludes that vulnerability to commodity markets has persisted; (5) Appropriately addresses the multi-hop synthesis requirement by connecting information across three years. WEAKNESSES: (1) The LLM answer mentions 'oil-and-gas-price volatility' as part of the 2022 risk framing, but the ground truth specifically emphasizes COVID-19 pandemic context and customer capital availability as the primary 2022 framing, with energy prices being secondary; (2) The LLM answer lacks specific mention of 'chemical, refining, and semiconductor plant utilization rates' which the ground truth explicitly cites as part of the 2023 risk profile; (3) The phrase 'has not diminished' is slightly weaker than the ground truth's assertion that the 'risk profile intensifying' - the LLM misses the intensification aspect; (4) Minor semantic difference: ground truth emphasizes 'intensifying' vulnerability while LLM emphasizes 'sustained' vulnerability without capturing the escalation. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression pattern, though it doesn't fully capture the nuance of intensification. OVERALL: The answer is substantially correct on the main points but misses some specific details about the 2023 risk factors and the intensification trend noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 538,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "- **2022:** ACN reported mutual‑fund equity securities of **$239.3 million** (Level 1 $4.9 m + Level 2 $234.3 m = Total $239.3 m).  \n- **2023:** The amount fell to **$196.2 million** (Level 1 $7.4 m + Level 2 $188.8 m).  \n- **2024:** The figure remained at **$196.2 million** (identical to 2023).\n\nThe three‑year pattern shows a **significant reduction after 2022 followed by a flat level in 2023‑2024**, indicating that ACN deliberately trimmed its exposure to mutual‑fund equity securities and has since held that lower allocation, likely reallocating capital toward other asset classes such as fixed‑income or cash as part of a more conservative strategic asset‑allocation stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - 2022: $239.3M (matches $239.293M ground truth with acceptable rounding), 2023: $196.2M (matches $196.226M), 2024: $196.2M (unchanged). The Level 1/Level 2 breakdowns provided ($4.9M + $234.3M = $239.3M for 2022; $7.4M + $188.8M = $196.2M for 2023) are mathematically accurate and add proper context. ENTITY ACCURACY: Company (ACN), metric (mutual fund equity securities), and years (2022-2024) all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend, correctly identifying the 2022-2023 decline and 2023-2024 stability. The interpretation that this represents 'deliberate trimming' followed by 'stabilized allocation' aligns with the ground truth's characterization of 'strategic rebalancing' followed by 'stabilized allocation approach.' SEMANTIC EQUIVALENCE: The LLM's conclusion about 'more conservative strategic asset-allocation stance' with potential reallocation to 'fixed-income or cash' provides reasonable interpretation of the trend, though the ground truth is more neutral in tone. This additional interpretive detail is logical but slightly goes beyond the ground truth's more measured assessment. MINOR CONSIDERATIONS: The LLM provides additional context (Level 1/Level 2 fair value hierarchy) that enhances understanding without contradicting the ground truth. The characterization of the trend as 'significant reduction' is appropriate given the ~18% decline from 2022 to 2023. No calculation errors detected. The answer fully addresses all parts of the multi-part question regarding evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 467,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "- **2022 positioning:** Adobe described the Document‑and‑forms platform as a legacy component of its **Publishing & Advertising** segment, emphasizing basic document creation, forms and printing capabilities rather than a stand‑alone, cloud‑first service.  \n\n- **2024 positioning and feature evolution:** By the 2024 filing Adobe places **Adobe Document Cloud** in the **Digital Media** portfolio as a cloud‑based subscription that powers “complete, reliable and automated digital document and signature workflows” across desktop, mobile, web and third‑party enterprise apps.  It now embeds **Firefly‑powered generative‑AI** – with AI features built into Acrobat, Acrobat Sign and other apps, plus enterprise‑focused Firefly Services and Custom Models that let organizations train AI on their own IP and automate content creation, editing and assembly.  \n\n**Result:** Between 2022 and 2024 Adobe shifted Document Cloud from a legacy document/forms offering to a core, AI‑enhanced engine for enterprise digital workflows, using Firefly to add generative‑AI capabilities and API‑driven automation that align the product with Adobe’s broader AI‑driven strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Document Cloud as part of the Publishing & Advertising segment with legacy/foundational characteristics; (2) Accurately describes the 2024 positioning within Digital Media segment as a cloud-based subscription service; (3) Properly synthesizes the integration of Firefly-powered generative AI capabilities into Document Cloud products (Acrobat, Acrobat Sign); (4) Correctly identifies the shift from legacy infrastructure to AI-enhanced enterprise productivity suite; (5) Mentions enterprise-focused features like Custom Models and API-driven automation that align with the ground truth's emphasis on enterprise digital transformation. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations present in either answer, so this dimension is not applicable but receives full marks as no errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 timeframe and connects Document Cloud's evolution to Adobe's broader AI strategy, matching the ground truth's narrative arc. MINOR GAPS: The LLM answer does not explicitly mention the 2023 intermediate positioning (elevation to Digital Media segment with AI-driven tools like Adobe Express), which the ground truth includes as part of the progression narrative. However, this omission is minor since the question asks specifically about 2022-2024 changes, and the 2023 detail serves as supporting context rather than a direct answer requirement. The LLM's focus on the 2022-2024 bookends is appropriate for the question as posed. SEMANTIC EQUIVALENCE: The LLM's description of the transformation ('from legacy document/forms offering to core, AI-enhanced engine') directly matches the ground truth's characterization. The specific details about Firefly integration, enterprise workflows, and automation capabilities are all accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 538,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Across all three filings Honeywell repeatedly flags the competitive‑landscape risk for every major segment. In 2022 the company already warned that **new market entrants, non‑traditional players and emerging technologies** could “lead to product commoditization, lower market share, reduced selling prices and lower margins” in Aerospace, Building Technologies, Safety & Productivity (now called Industrial Automation) and Performance Materials. The 2023 filing adds the same language for Aerospace, Building Technologies and Safety & Productivity and expands the wording for the building‑technology business to “new market entrants and new technologies,” while the 2024 filing keeps the phrasing unchanged for Aerospace, Industrial Automation, Building Automation and Energy & Sustainability (the latter now grouped under the former Performance Materials segment). Thus, Honeywell’s exposure to new entrants and technological disruption has remained a **consistent, and in the wording slightly more explicit, risk** throughout 2022‑2024, with the expected impact being **potential erosion of market share and pricing power** (i.e., lower selling prices and margins) across all of its business units.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth, particularly regarding the evolution and progression of competitive landscape disclosures across the three-year period. Key issues: (1) MAJOR FACTUAL ERROR - The LLM claims competitive landscape risks were disclosed for 'Aerospace, Building Technologies, Safety & Productivity and Performance Materials' in 2022, but the ground truth explicitly states these risks were cited ONLY for 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, NOT for Aerospace or Performance Materials. This is a critical misrepresentation of the temporal evolution. (2) PROGRESSION MISCHARACTERIZATION - The ground truth emphasizes a clear 3-year progression showing EXPANSION of the risk disclosure from 2 segments (2022) to 4 segments (2023) to a restructured set (2024), demonstrating 'deepening concern' and 'increasing frequency and specificity.' The LLM incorrectly characterizes this as 'consistent' risk language 'throughout 2022-2024,' missing the key insight about expanding scope and increasing emphasis. (3) STRUCTURAL CHANGES MISHANDLED - While the LLM mentions business unit restructuring, it doesn't adequately capture the significance of the expanding disclosure pattern across more divisions over time, which is central to the ground truth's narrative. (4) LANGUAGE ACCURACY - The LLM's claim that wording remained 'unchanged' from 2023 to 2024 is not supported by the ground truth, which notes a 'sharper focus on product commoditization and the accelerating pace of new entrants' in 2024. (5) POSITIVE ASPECTS - The LLM correctly identifies the core impacts (market share erosion, pricing power reduction, lower margins) and correctly names most business segments, though with temporal misplacement. The answer demonstrates partial understanding but fails to capture the essential evolution narrative that is the heart of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 525,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s post‑spin‑off relationship with Viatris began in 2020 with a suite of “interim” agreements—including a separation‑and‑distribution agreement, agency arrangements, MSAs and transition‑service arrangements (TSAs)—that allowed Pfizer to continue billing, collecting and remitting rebates and to manufacture, label and package products for Viatris on a temporary basis (Chunk 1 and Chunk 3).  Under those agreements the intercompany amount Pfizer owed Viatris fell sharply, from **$94 million at 31 Dec 2022** to **$33 million at 31 Dec 2023**, and the TSAs were “largely completed as of 31 Dec 2023,” indicating that the transitional services were being wound down (Chunk 3).  By the 2024 filing the company still references the TSAs in its glossary but no longer reports material balances, showing that the operational link has moved from extensive transitional services in 2022 to a minimal, largely settled relationship by 2024 (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All key financial figures are correct - the intercompany amounts owed to Viatris are accurately stated as $94 million at Dec 31, 2022 and $33 million at Dec 31, 2023. The decline calculation ($94M to $33M) is correct. Dates are accurate (2022, 2023, 2024, Dec 31). COMPLETENESS: The answer addresses all major aspects of the question: (1) the evolution of the relationship from 2022-2024, (2) transition service arrangements and their winding down, (3) intercompany balances and their reduction. The answer goes beyond the ground truth by providing additional context about the initial 2020 spin-off and the nature of the TSAs (billing, collecting rebates, manufacturing, labeling, packaging), which enriches understanding without contradicting the ground truth. ENTITY ACCURACY: Pfizer and Viatris are correctly identified. The financial metrics (intercompany amounts due) are properly characterized. REASONING: The multi-hop synthesis is sound - the answer correctly traces the relationship evolution across three years, showing the progression from active TSAs with material balances to largely completed services with minimal balances. The logic connecting declining intercompany balances to winding down of operational interdependencies is valid. SEMANTIC EQUIVALENCE: The LLM's characterization of the relationship as moving from 'extensive transitional services' to 'minimal, largely settled relationship' accurately conveys the same meaning as the ground truth's 'gradual decline' and 'fully resolved' operational interdependencies. Minor note: The LLM provides slightly more detail about the nature of the agreements and services than the ground truth, but this is additive rather than contradictory. The answer is well-structured with clear citations to source chunks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 512,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "From the 2022 filing Altria listed four series of senior notes – a 1.000 % issue that matured in 2023, the 1.700 % notes that mature in 2025, and longer‑dated 2.200 % (2027) and 3.125 % (2031) issues. By the 2023 filing the 1.000 % 2023 notes no longer appear, leaving the 1.700 % 2025 notes as the shortest‑term debt alongside the unchanged 2027 and 2031 series, and the 2024 filing repeats this same set. The removal of the near‑term 2023 notes and the retention of the 1.700 % 2025 issue suggest Altria is lengthening its debt profile, retiring the earliest maturities while keeping a low‑coupon, medium‑term instrument as a cornerstone of its capital structure to lock in inexpensive financing and reduce refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All numeric values are correct - the 1.000% 2023 notes, 1.700% 2025 notes, 2.200% 2027 notes, and 3.125% 2031 notes are accurately identified with proper percentages and maturity years. (2) The temporal progression is correctly traced: 2022 (four series present) → 2023 (1.000% 2023 notes removed, others remain) → 2024 (same composition as 2023). (3) Multi-hop reasoning is sound - the answer correctly synthesizes information across three years to identify the pattern of debt maturation and retention. (4) The strategic interpretation goes beyond the ground truth by explicitly noting that Altria is 'lengthening its debt profile' and 'locking in inexpensive financing,' which represents reasonable inference from the data pattern. MINOR CONSIDERATIONS: (1) The ground truth states the 1.700% 2025 notes 'remained as the shortest-dated instrument' in 2023, while the LLM answer says they are 'the shortest-term debt alongside the unchanged 2027 and 2031 series' - this is semantically equivalent and accurate. (2) The LLM provides additional context about the 2.200% 2027 and 3.125% 2031 notes being 'unchanged,' which adds helpful detail not explicitly in the ground truth but is factually correct. (3) The strategic interpretation about 'reducing refinancing risk' and 'locking in inexpensive financing' is a reasonable inference that aligns with the observed pattern, though the ground truth uses slightly different language ('maintaining a consistent capital structure'). The answer fully addresses all parts of the multi-part question regarding composition, structure, evolution, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 476,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s 10‑K filings show that its **fixed unsecured senior debt** grew in size after 2022 but then edged lower in 2024, while the cost of that debt rose steadily:\n\n| Year (Dec 31) | Carrying value ( $ millions) | Weighted‑average interest rate |\n|---------------|------------------------------|--------------------------------|\n| 2022 | **$24,134** | **4.45 %** |\n| 2023 | **$27,168** | **4.45 %** |\n| 2024 | **$26,930** | **4.84 %** |\n\nThe increase from 2022 to 2023 (+$3.0 bn) reflects new issuances or limited repayments, indicating that Capital One was expanding its senior unsecured borrowing base. The modest decline in 2024 (‑$238 m) suggests some debt was retired or re‑structured, but the jump in the weighted‑average rate—from 4.45 % to 4.84 %—shows the company is now financing a larger share of that debt at higher coupon levels, likely because market rates have risen and the firm is locking in longer‑dated obligations. Together, the trend points to a **long‑term borrowing strategy that tolerates higher cost in order to maintain ample senior unsecured capacity and extend maturities**, rather than aggressively cutting debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial numbers that are fundamental to answering this question. (1) 2022 Carrying Value: LLM states $24,134 million, but ground truth is $19,975 million—a difference of $4,159 million (20.8% error). This is a major discrepancy. (2) 2022 Weighted-Average Interest Rate: LLM states 4.45%, but ground truth is 2.91%—a difference of 1.54 percentage points. This is a critical error that completely misrepresents the interest rate trend. (3) 2023 Carrying Value: LLM correctly states $27,168 million (matches ground truth). (4) 2023 Weighted-Average Interest Rate: LLM states 4.45%, but ground truth is 4.45%—this is correct. (5) 2024 Carrying Value: LLM correctly states $26,930 million (matches ground truth). (6) 2024 Weighted-Average Interest Rate: LLM states 4.84%, which matches ground truth. CALCULATION VERIFICATION: The LLM correctly calculates the 2022-2023 change as +$3.0 billion (27,168 - 24,134 = 3,034, which rounds to $3.0B), but this calculation is based on the wrong 2022 baseline. The correct calculation should be 27,168 - 19,975 = 7,193 million (+$7.2B). The 2023-2024 change of -$238 million is correct (26,930 - 27,168 = -238). MULTI-HOP REASONING: The LLM's interpretation of the trend is partially sound in structure but fundamentally flawed due to incorrect input data. The reasoning about debt expansion and interest rate increases is logical, but the actual trend being described is wrong. The ground truth shows a much more dramatic increase from 2022 to 2023 (+$7.2B vs. +$3.0B claimed), and the interest rate trend is completely different (rising from 2.91% to 4.45% to 4.84%, not from 4.45% to 4.45% to 4.84%). SEMANTIC ISSUES: The LLM's narrative about 'long-term borrowing strategy' is reasonable in tone but is built on incorrect premises. The conclusion about 'tolerating higher cost' is partially correct (rates did rise), but the magnitude and starting point are wrong. ENTITY ACCURACY: Capital One (COF) is correctly identified, years are correct, and metrics are correctly labeled. The fundamental problem is the numerical accuracy of the data presented in the table, which is the core of this quantitative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 602,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "- In the 2022 Form 10‑K Tesla (through SolarCity) listed the **5.45 % Solar Bonds, Series 2015/C92‑15** as Exhibit 4.61 (the “One Hundred‑and‑Sixteenth Supplemental Indenture” dated August 24, 2015).  \n- In the 2023 Form 10‑K the same bond re‑appears as Exhibit 4.54 (the same supplemental indenture), and in the 2024 Form 10‑K it is again disclosed as Exhibit 4.52.  \n\nThe bond’s continual presence in each year’s filing—though the exhibit number shifts—shows that the 5.45 % Series 2015/C92‑15 issue remains outstanding and is still being used to fund SolarCity’s solar projects. This steady reliance signals that Tesla’s solar‑financing strategy is anchored in maintaining and leveraging existing low‑cost, fixed‑rate debt rather than repeatedly issuing new securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - the 5.45% interest rate, bond series designation C92-15, and exhibit numbers (4.61 in 2022, 4.54 in 2023, 4.52 in 2024) are accurately cited. (2) The LLM correctly identifies the bond's presence across all three years and notes the exhibit number shifts. (3) The supplemental indenture date (August 24, 2015) is correctly referenced. (4) The connection to SolarCity is appropriately made.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM's interpretation diverges significantly from the ground truth's key finding. The ground truth emphasizes a pattern of 'declining prominence' and a 'shift toward more recent financing structures' with newer bond series (C102-15, C106-10) appearing in subsequent filings. The LLM completely omits mention of these newer bond series, which is critical to understanding the evolution of Tesla's strategy. (2) MISCHARACTERIZATION OF STRATEGY - The LLM concludes that Tesla's strategy is 'anchored in maintaining and leveraging existing low-cost, fixed-rate debt rather than repeatedly issuing new securities.' This contradicts the ground truth's finding that Tesla increasingly relied on newer bond structures. The LLM's interpretation suggests stasis when the ground truth indicates strategic evolution. (3) MISSING MULTI-HOP ANALYSIS - The question asks about 'evolution' and what the 'progression indicates.' The LLM provides a static description of presence across years but fails to synthesize the comparative analysis showing how the bond's relative importance changed. (4) INCOMPLETE ANSWER - The LLM does not address the broader context of how this specific bond fits into Tesla's evolving solar financing portfolio.\n\nMULTI-HOP REASONING ASSESSMENT: The LLM correctly identifies the bond across three years but fails to synthesize the comparative evolution. It misses the critical insight that while C92-15 remained listed, newer instruments emerged, indicating a strategic shift. This is a fundamental failure in multi-hop synthesis - the model needed to compare not just the presence of C92-15 but also identify and analyze the appearance of newer bond series to draw conclusions about strategy evolution.\n\nCORRECTION NEEDED: The answer should have noted that newer bond series (C102-15, C106-10) appeared in later filings, indicating Tesla was diversifying its solar financing instruments rather than simply maintaining existing debt. This represents a material difference in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 663,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "Across the three years AIG’s approach to loss‑reserve risk has become progressively more structured. In 2022 the company relied on “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” (Chunk 1). By 2023 it had added a formal model‑risk‑management framework that validates both stochastic and deterministic loss‑reserve models, conducts scenario and sensitivity analyses, and embeds a “review and challenge of reserves” together with actuarial profitability reviews (Chunk 2). In the 2024 filing the oversight is further deepened: Enterprise‑Risk‑Management performs a second‑line “review and challenge” of pricing and reserving models and assumptions, the Internal Audit Group continuously audits the process, and external expert reviews remain part of the control mix, while the same stochastic/deterministic modeling techniques and model‑validation processes continue to be used (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's approach; (2) Accurately captures 2022's emphasis on internal controls and external expert reviews; (3) Correctly identifies 2023's expansion to include sensitivity/scenario analyses, stochastic methods, and experience studies; (4) Properly describes 2024's integration into ERM system with enhanced reporting, Internal Audit Group audits, and structured second-line reviews; (5) Successfully synthesizes multi-hop information across three years showing progression from basic to more sophisticated oversight; (6) Uses appropriate terminology (stochastic/deterministic modeling, model-risk-management framework, second-line review) consistent with ground truth; (7) Maintains logical flow showing maturation of risk management practices. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed in some areas (e.g., mentioning 'pricing and reserving models' alongside loss-reserve models) but this adds helpful specificity without contradicting ground truth; (2) The answer references 'Chunk' citations which provide transparency about source material, though the ground truth doesn't use this format; (3) The phrasing 'progressively more structured' effectively captures the evolution concept. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations to verify as this is a qualitative question about process evolution. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and correctly identifies how each year's practices built upon or expanded previous approaches. The connection between internal controls → expanded frameworks → integrated ERM system is logically sound and matches ground truth narrative. SEMANTIC EQUIVALENCE: The LLM's description of 'growing emphasis on proactive risk identification, validation, and governance' is semantically equivalent to the ground truth's characterization of the same evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 563,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "- **2022 10‑K:** The filing describes the pension‑plan investment objective (long‑duration fixed‑income, U.S. corporate bonds and U.S. Treasury securities) but does not disclose a specific percentage for U.S. Treasury and foreign‑government securities.  \n- **2023 10‑K:** The “Amount” footnote shows that U.S. Treasury and foreign‑government securities made up **19 %** of the pension/post‑retirement portfolio.  \n- **2024 10‑K:** The same footnote reports the allocation had fallen to **8 %**.\n\n**Trend and implication:** Over the three‑year span Altria’s share of Treasury and foreign‑government securities dropped sharply—from an undisclosed level in 2022 to 19 % in 2023 and then to 8 % in 2024. This downward trajectory signals a deliberate move away from low‑yield government bonds toward a higher proportion of corporate‑bond and other fixed‑income assets, reflecting a strategy to better match the duration of its pension obligations and to seek higher expected returns while still monitoring the overall asset mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM reports 19% for 2023, but the ground truth states 19% was the 2022 allocation and 16% was 2023. (2) The LLM correctly identifies 8% for 2024, but this represents a drop from 16% (not 19%), making the magnitude of decline different than stated. (3) The LLM fails to report the 2022 percentage (19%) explicitly, instead claiming it was 'undisclosed,' when the ground truth clearly shows 19% for 2022. This is a fundamental factual error. (4) The LLM completely omits critical supporting information from the ground truth: the reduction in below-investment-grade securities (11% to 9%), the expected rate of return changes (6.6% to 6.1%), and the broader strategic context. CORRECT ELEMENTS: The LLM correctly identifies the downward trend and provides reasonable interpretation about moving toward higher-yield corporate bonds and duration matching. The reasoning about strategic shift is sound and aligns with ground truth interpretation. MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture—it should have connected the Treasury/government securities decline with the below-investment-grade reduction and the expected return adjustments to show a comprehensive pension strategy evolution. The answer is incomplete and contains a year-to-year allocation misalignment that represents a material factual error in a financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 405,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s consolidated “total short‑term borrowings and long‑term debt” rose from **$48.7 billion at year‑end 2022** (Chunk 3) to **$49.9 billion at year‑end 2023** (Chunk 3) and then fell to **$45.6 billion at year‑end 2024** (Chunk 2), a net decline of about $3.1 billion over the three‑year span.  The swing reflects a reshaping of the senior‑note portfolio: fixed‑rate unsecured senior debt grew from **$24.1 billion in 2022** to **$27.2 billion in 2023** and held steady at **$26.9 billion in 2024** (Chunks 3 & 2), while floating‑rate unsecured senior debt collapsed from **$1.6 billion in 2022** to **$0.35 billion in 2023** and was eliminated by 2024 (Chunks 3 & 2); meanwhile securitized debt rose modestly from **$16.97 billion in 2022** to **$18.04 billion in 2023** before dropping to **$14.26 billion in 2024** (Chunks 3 & 2).  The three‑year trend shows Capital One moving away from floating‑rate exposure toward a larger, higher‑cost fixed‑rate base (fixed senior‑debt weighted‑average rate climbing from 4.45 % to 4.84 % and securitized debt from 3.01 % to 3.48 %), indicating a more stable but slightly higher overall interest‑rate profile despite the reduction in total debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant numerical discrepancies that undermine its credibility:\n\n1. TOTAL DEBT FIGURES - MAJOR ERRORS:\n   - LLM states 2022: $48.7 billion (WRONG - Ground truth: $43.086 billion, difference of $5.6B)\n   - LLM states 2023: $49.9 billion (WRONG - Ground truth: $48.715 billion, close but still incorrect)\n   - LLM states 2024: $45.6 billion (approximately correct - Ground truth: $45.551 billion, acceptable rounding)\n   - The 2022 figure is dramatically wrong, off by over 13%\n\n2. SECURITIZED DEBT - SIGNIFICANT ERRORS:\n   - LLM states 2022: $16.97 billion (WRONG - Ground truth: $14.994 billion, off by ~$2B)\n   - LLM states 2023: $18.04 billion (CORRECT)\n   - LLM states 2024: $14.26 billion (CORRECT)\n   - The 2022 figure is substantially incorrect\n\n3. FIXED-RATE UNSECURED SENIOR DEBT - ERRORS:\n   - LLM states 2022: $24.1 billion (WRONG - Ground truth: $19.975 billion, off by ~$4.1B)\n   - LLM states 2023: $27.2 billion (WRONG - Ground truth: $26.930 billion, close but incorrect)\n   - LLM states 2024: $26.9 billion (CORRECT)\n   - The 2022 figure is significantly overstated\n\n4. FLOATING-RATE UNSECURED SENIOR DEBT - ERRORS:\n   - LLM states 2022: $1.6 billion (WRONG - Ground truth: $1.709 billion, minor error)\n   - LLM states 2023: $0.35 billion (WRONG - Ground truth: $0.349 billion, essentially correct but imprecise)\n   - LLM states 2024: $0 (CORRECT)\n\n5. INTEREST RATE ERRORS:\n   - LLM states fixed senior debt rate in 2022: 4.45% (WRONG - Ground truth: 2.91%, off by nearly 2 percentage points)\n   - LLM states fixed senior debt rate in 2024: 4.84% (CORRECT)\n   - LLM states securitized debt rate in 2023: 3.01% (CORRECT)\n   - LLM states securitized debt rate in 2024: 3.48% (CORRECT)\n   - The 2022 fixed-rate figure is dramatically incorrect\n\n6. MULTI-HOP REASONING:\n   - The LLM correctly identifies the general trend (shift from floating to fixed-rate debt)\n   - However, the incorrect baseline numbers undermine the validity of the trend analysis\n   - The conclusion about \"higher-cost fixed-rate base\" is partially supported but based on flawed 2022 comparisons\n\n7. COMPLETENESS:\n   - The LLM addresses the main components of the question\n   - However, it misses the critical detail about securitized debt rates in 2022 (1.51%) and their evolution\n   - The answer lacks discussion of the strategic implications of retiring floating-rate debt entirely by 2024\n\n8. CALCULATION VERIFICATION:\n   - The net decline calculation ($48.7B to $45.6B = $3.1B) is based on incorrect 2022 figures\n   - If using correct figures: $43.086B to $45.551B = +$2.465B increase, then to $45.551B = no change from 2023\n   - The LLM's characterization of a \"net decline\" is misleading given the actual 2022-2024 trajectory\n\nSUMMARY: While the LLM demonstrates understanding of the question's structure and identifies correct directional trends, it contains pervasive numerical errors that are unacceptable for financial analysis. The 2022 baseline figures are substantially wrong (off by billions of dollars and percentage points), which corrupts the entire trend analysis. Only the 2023-2024 figures are largely accurate. This level of quantitative inaccuracy would be problematic in any financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 870,
        "total_tokens": 2492
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Across the 2022, 2023 and 2024 Tesla Form 10‑K filings the same “Thirty‑Sixth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C25‑15” appears (2022 Exhibit 4.36, 2023 Exhibit 4.36, 2024 Exhibit 4.27). The repeated disclosure shows that Tesla continues to rely on this 2015‑issued 5.45 % solar‑bond tranche as an active source of financing for its SolarCity‑derived solar projects, meaning the bonds are still outstanding and subject to reporting. Because the bond series is listed in every annual filing, it has become a persistent component of Tesla’s capital structure, reflecting an ongoing debt obligation that the company must service and that underpins its solar‑related capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the multi-hop question. STRENGTHS: (1) All numeric values are correct - the 5.45% interest rate is accurate, the bond series designation (2015/C25-15) is correct, and the filing years (2022, 2023, 2024) are properly identified. (2) Exhibit references are accurate (Exhibit 4.36 for 2022 and 2023, Exhibit 4.27 for 2024), showing detailed knowledge of the actual filing documents. (3) The multi-hop synthesis is sound - the answer correctly traces the same bond series across three years and draws appropriate conclusions about its ongoing role in Tesla's capital structure. (4) The reasoning about SolarCity-derived solar projects and the implications of persistent disclosure is logically sound and contextually appropriate. (5) The answer correctly identifies that the bonds remain outstanding and subject to reporting obligations. MINOR CONSIDERATIONS: The LLM answer is slightly more specific and detailed than the ground truth (mentioning SolarCity explicitly and exhibit numbers), which adds value rather than detracting. The semantic equivalence is excellent - both answers convey that the bonds represent an active, integral, and persistent component of Tesla's capital structure for solar financing. The characterization of the bonds as a 'stable and strategic source of funding' (ground truth) versus 'active source of financing' (LLM) are semantically equivalent. No calculation errors, no date discrepancies, and no entity misidentification. The answer fully addresses all parts of the multi-part question regarding reliance, consistency, and ongoing role in capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 458,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s “Class A treasury‑stock, at cost” line grew each year: it was **$51.3 billion** at year‑end 2022, rose to **$60.4 billion** at year‑end 2023, and reached **$71.4 billion** at year‑end 2024 – an increase of roughly $9 billion in 2023 and another $11 billion in 2024. This steady rise in the treasury‑stock balance (the negative equity line) shows the company is accelerating share‑repurchase activity, using excess cash to return capital to shareholders rather than allocating it to other investments, signaling a capital‑allocation focus on buybacks and shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that undermines the entire response. The ground truth states treasury stock values for 2023 and 2024, but the LLM incorrectly attributes a 2022 value ($51.3 billion) that does not appear in the original answer. The original answer explicitly shows: $(51,354) million in 2023 and $(60,429) million in 2023 (appears to be a typo in ground truth, likely meant 2022 and 2023), then $(71,431) million in 2024. The LLM's numbers ($51.3B, $60.4B, $71.4B) match the magnitude but are assigned to wrong years (2022, 2023, 2024 vs. the ground truth's 2023, 2023, 2024 structure). QUANTITATIVE ACCURACY: The dollar amounts are correctly formatted and match the ground truth values ($51.3B ≈ $51,354M, $60.4B ≈ $60,429M, $71.4B ≈ $71,431M), but the year assignments are problematic. The LLM calculated year-over-year increases (~$9B and ~$11B) which are mathematically correct based on the numbers provided, but these calculations are applied to potentially incorrect time periods. QUALITATIVE ACCURACY: The LLM correctly interprets treasury stock as a negative equity line and accurately explains the capital allocation strategy (share buybacks, returning capital to shareholders). The reasoning about accelerating buyback activity is sound and well-articulated. MULTI-HOP REASONING: The LLM successfully synthesizes the concept that increasing treasury stock indicates a strategic shift toward buybacks, which is correct reasoning. However, the temporal dimension is muddled. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about capital allocation strategy and the trend analysis, though the year confusion creates ambiguity about the actual time period being discussed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 479,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Across all three filings, Honeywell’s Safety and Productivity Solutions (renamed “Industrial Automation” in 2024) is repeatedly flagged as being vulnerable to **adverse industry economic conditions** that manifest through **reduced investments in process automation, safety‑monitoring and plant‑capacity‑utilisation initiatives** (plus related retail‑market and competitive pressures). The language of the risk factor is essentially unchanged from 2022‑2023‑2024, showing that the company’s exposure to these macro‑economic headwinds has persisted rather than abated. This continuity signals that the broader industrial sector continued to face weak capital‑spending cycles, lower automation spend and constrained plant utilisation throughout the period, reflecting sustained macro‑economic pressure on manufacturers and downstream users.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies the segment name evolution (Safety and Productivity Solutions renamed to Industrial Automation in 2024), showing attention to detail across filings. (2) Accurately captures the core risk factors: reduced investments in process automation and plant capacity utilization across all three years. (3) Properly synthesizes the temporal evolution - noting that language remained consistent from 2022-2023-2024, indicating persistence rather than improvement. (4) Correctly interprets the macroeconomic implications: weak capital-spending cycles and sustained industrial sector pressure. (5) Appropriately emphasizes the continuity of exposure, suggesting persistent rather than worsening conditions. MINOR ISSUES: (1) The LLM adds 'safety-monitoring' and 'retail-market and competitive pressures' as additional factors not explicitly emphasized in the ground truth answer, though these may be present in the actual filings. (2) The ground truth emphasizes a 'sharpening focus' on geopolitical instability and trade policy shifts in 2024, suggesting a deepening concern - the LLM characterizes this more as 'persistence' rather than 'worsening,' which is a subtle but meaningful distinction. The ground truth suggests trajectory toward 'potentially worsening' conditions, while the LLM suggests 'persisted rather than abated' (which is accurate but slightly less emphatic about deterioration). (3) No quantitative metrics (percentages, dollar amounts, margin impacts) are provided in either answer, which is appropriate given the question focuses on risk exposure evolution rather than specific financial figures. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple filings, correctly tracking how the same risks manifested consistently while the broader context evolved. The logic connecting persistent risk language to sustained macroeconomic pressure is sound. SEMANTIC EQUIVALENCE: The answers convey essentially the same information with acceptable wording variations. The LLM's characterization of 'persistence' vs. the ground truth's 'potentially worsening' represents a minor interpretive difference rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 616,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "Lilly’s 2022 10‑K described **Cyramza** as already approved for  \n\n* second‑line monotherapy or combination in advanced/metastatic gastric cancer or gastro‑esophageal‑junction adenocarcinoma,  \n* second‑line combination in metastatic non‑small‑cell lung cancer (NSCLC), metastatic colorectal cancer and hepatocellular carcinoma, and  \n* first‑line combination in adult patients with metastatic NSCLC that harbor activating EGFR mutations.  \n\nThe 2024 filing lists exactly the same therapeutic indications, showing that the product’s **indication set did not change** between 2022 and 2024.  \n\nThe intellectual‑property schedule disclosed in the 2023 filing (the most recent data) places Cyramza in the **mid‑life stage of its lifecycle**:  \n\n* **U.S.** – compound patent and biologics data protection both expire in **2026**;  \n* **Europe** – compound patent expires in **2028** and data protection is already in force until **2024**;  \n* **Japan** – compound patent expires in **2026** with data protection ending in **2023**.  \n\nThus, from 2022 through 2024 Cyramza’s therapeutic positioning remained stable while its patent and data‑protection horizons (2026‑2028) indicate it is still under active IP protection but approaching the first major expiry dates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed therapeutic indications and IP protection timelines, but contains significant factual errors in the patent/data protection dates that contradict the ground truth. STRENGTHS: (1) Correctly identifies that Cyramza's therapeutic indications remained stable from 2022-2024, matching ground truth; (2) Accurately lists all four oncology indications (gastric, lung, colorectal, hepatocellular cancers); (3) Properly characterizes the product as mid-life stage; (4) Good synthesis of multi-hop information across years. CRITICAL ERRORS: (1) U.S. compound patent and data protection expiration dates are stated as 2026, but ground truth indicates compound patents extend to 2026 (this part is correct) while data protection timeline differs; (2) Europe data protection is stated as 'already in force until 2024' but ground truth indicates it expires IN 2024 (semantic difference but important); (3) Japan data protection is correctly stated as ending in 2023, but the compound patent expiration of 2026 contradicts ground truth which indicates Japan patents extend to 2026 - this is actually consistent; (4) The answer states Europe compound patent expires in 2028, which matches ground truth. QUANTITATIVE ACCURACY ISSUES: The patent/data protection dates contain inconsistencies with ground truth. The ground truth states 'data protection expiring in Japan in 2023 and set to expire in major European countries in 2024' while the LLM states Japan data protection ends in 2023 (correct) but Europe data protection 'already in force until 2024' (ambiguous phrasing). The LLM provides more granular detail than ground truth but some dates appear to diverge. REASONING: The multi-hop synthesis is sound - the answer correctly connects therapeutic indications across years and IP protection across jurisdictions. However, the specific patent/data protection expiration dates need verification against actual filings, and the answer's precision on these dates appears to exceed or diverge from the ground truth provided. The characterization of 'narrowing window of exclusivity' from ground truth is not explicitly stated in the LLM answer, though it is implied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 584,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "**2022 filing (COF 10‑K 2022)**  \n- Net derivative assets (liabilities) were reported as a Level 3 fair‑value item.  \n- The balance at 12/31/2021 was **$19 million** (after a $31 million opening balance and net unrealized losses of $20 million).  \n- The disclosure only identified the measurement as “Level 3” – no specific unobservable inputs were listed.\n\n**2023 filing (COF 10‑K 2023)**  \n- The same line item is still measured at fair value using a **discounted‑cash‑flow (DCF) model**.  \n- The filing now spells out the significant unobservable inputs: a **default‑rate assumption** (range 53 %–163 %) and **swap‑rate assumptions** (3 %–5 %).  \n- The weighted‑average discount rate applied in the model is **≈ 4 %**. (No balance amount is shown in the table.)\n\n**2024 filing (COF 10‑K 2024)**  \n- The net derivative assets (liabilities) balance reported at 12/31/2023 rises to **$58 million**.  \n- Valuation continues to rely on a **discounted‑cash‑flow technique**, with the **only disclosed unobservable input being swap rates** (3 %–5 %).  \n- The weighted‑average discount rate remains **about 4 %**.\n\n**Evolution**  \n- **Fair‑value amount** grew from $19 million (2022 filing) to $58 million (2024 filing).  \n- **Methodology** shifted from a generic Level 3 classification to a disclosed DCF model, and the company began to disclose the specific unobservable inputs driving the model—initially both default‑rate and swap‑rate assumptions (2023) and, by 2024, primarily swap‑rate inputs, all using a weighted‑average discount rate near 4 %.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy and temporal alignment. STRENGTHS: (1) Correctly identifies the fair value progression ($19M → $58M), (2) Accurately describes the valuation methodology shift from generic Level 3 to disclosed DCF model, (3) Correctly identifies unobservable inputs (default rates 53-163%, swap rates 3-5%), (4) Properly notes the ~4% weighted-average discount rate, (5) Good synthesis of multi-hop information across three filing years. CRITICAL ERRORS: (1) TEMPORAL MISALIGNMENT - The LLM states the 2022 filing shows a balance of $19 million at 12/31/2021, but the ground truth indicates $19 million was the 2022 fair value. The LLM then says the 2024 filing shows $58 million at 12/31/2023, creating confusion about which year each number belongs to. (2) INCOMPLETE YEAR MAPPING - The ground truth clearly states: 2022=$19M, 2023=$58M, 2024=$58M. The LLM's presentation obscures this by referencing filing dates rather than fiscal year ends, making it unclear whether the $58M figure applies to 2023 or 2024. (3) MISSING KEY FACT - The ground truth explicitly states the 2024 fair value remained at $58 million (same as 2023), indicating stabilization. The LLM does not clearly state the 2024 balance amount, only noting it 'rises to $58 million' in the 2024 filing (which refers to 2023 year-end). (4) UNOBSERVABLE INPUTS DISCREPANCY - The LLM states that by 2024, 'only disclosed unobservable input being swap rates' while the ground truth indicates swap rates remained a key input but doesn't explicitly state default rates were removed. The ground truth shows both inputs were used through 2023 with similar methodology continuing in 2024. CALCULATION/VERIFICATION: All individual numbers cited ($19M, $58M, 53-163% default rates, 3-5% swap rates, 4% discount rate) are factually correct when verified against ground truth. However, the presentation creates ambiguity about which numbers apply to which fiscal years. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the evolution pattern, but the temporal presentation is confusing and could mislead readers about the actual year-by-year progression. The core insight about methodology evolution is sound, but execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 618,
        "total_tokens": 2237
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "- In fiscal 2022 Qualcomm reported that **thousands of employees** used its charitable‑match program, which **benefited more than 1,500 charitable organizations**. By fiscal 2024 the same “thousands of employees” continued to participate, but the program was supporting **a slightly smaller pool of charities – more than 1,300 organizations**.  \n\n- The company ties this volunteer‑driven giving effort to its broader **human‑capital agenda**; in both the 2022 and 2024 proxy disclosures the HR and Compensation Committee stated that progress on human‑capital advancements (which include programs such as the charitable match) is used as a **non‑financial performance modifier** that can adjust executive bonuses by a multiplier of **0.9 to 1.1**. Thus, the sustained employee involvement in the match program—and the modest reduction in the number of charities supported—are evaluated as part of the human‑capital metrics that influence executive compensation throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 'thousands of employees' in both 2022 and 2024, 'more than 1,500 organizations' in 2022, 'more than 1,300 organizations' in 2024, and the non-financial modifier range of 0.9 to 1.1 for executive bonuses. No calculation errors or numeric discrepancies. ENTITY ACCURACY: Correctly identifies Qualcomm, fiscal years 2022 and 2024, the charitable match program, and the HR and Compensation Committee. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - (1) program participation metrics over time, (2) organizational support evolution, (3) connection to human capital strategy, and (4) linkage to executive compensation mechanisms. The reasoning correctly identifies that the modest decline in supported organizations (1,500 to 1,300) is contextualized within sustained employee participation and broader human capital goals. COMPLETENESS: Addresses all parts of the multi-part question: evolution of employee participation (sustained at 'thousands'), evolution of supported organizations (1,500 to 1,300), and alignment with human capital goals tied to executive compensation (0.9-1.1 modifier). SEMANTIC EQUIVALENCE: The LLM's phrasing ('slightly smaller pool of charities,' 'sustained employee involvement,' 'modest reduction') conveys the same meaning as the ground truth while using slightly different wording. The characterization of the decline as 'modest' or 'slight' is appropriate and consistent with the ground truth's 'slightly decreased.' Minor observation: The LLM answer could have explicitly mentioned the 2025 diversity, equity, and inclusion goals referenced in the ground truth, though this is a very minor omission that doesn't significantly impact the core answer's accuracy or completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> CONCEPT <-[Guides_On]- ORG <-[Focuses_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 517,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "- **2022 filing:** Adobe described **Acrobat** as the core PDF technology that, together with **Adobe Sign**, forms the unified **Adobe Document Cloud** platform. It was highlighted for its strong market adoption and leadership in document‑intensive industries, and for delivering “fully digital document workflows” through the Document Cloud services platform.  \n\n- **2023 filing:** Acrobat was again listed as a key product of the **Document Cloud** (within the Digital Media segment) alongside Acrobat Sign. The filing stressed that Acrobat helps “accelerate document productivity” and is part of a broader, integrated suite that includes Adobe Express, Firefly, AI‑driven tools and other Adobe services, positioning it as a collaborative, cloud‑based document experience rather than a stand‑alone PDF editor.  \n\n- **2024 filing:** The trademark schedule expands the Acrobat family to include **Acrobat AI Assistant**, **Acrobat Reader**, and **Acrobat Sign**, signalling the addition of AI‑powered features and a deeper, cohesive branding within the **Document Cloud** ecosystem. This reflects Adobe’s evolution of Acrobat from a core PDF viewer/editor to an AI‑enhanced, tightly integrated component of its overall Document Cloud offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all three years (2022-2024). STRENGTHS: (1) Correctly identifies Acrobat's positioning in each year with accurate temporal progression; (2) Accurately captures the 2022 focus on Document Cloud as unified platform with Adobe Sign; (3) Correctly notes 2023 expansion to include AI-driven tools, Firefly, Adobe Express, and broader integration; (4) Accurately identifies 2024's introduction of 'Acrobat AI Assistant' as registered trademark and the shift toward AI-enhanced capabilities; (5) Properly synthesizes the multi-hop evolution from document standard to AI-enhanced platform; (6) Correctly identifies Document Cloud as the organizational context across all years; (7) No numerical errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'stand-alone PDF editor' vs. ground truth's 'document standard') but conveys equivalent meaning; (2) Ground truth mentions 'trillions of PDF documents created annually' as a 2022 emphasis, which the LLM answer does not explicitly include, though this is a minor detail that doesn't affect the core positioning narrative; (3) The LLM answer is more specific about product names (Acrobat Reader, Acrobat Sign in trademark schedule) which adds helpful detail. The answer successfully addresses all parts of the multi-part question: (a) role within Document Cloud - correctly traced across years; (b) integration with other Adobe services - accurately captured for each year; (c) product enhancements - properly identified AI Assistant introduction in 2024. The multi-hop reasoning is sound, synthesizing information across three separate filing years to show clear evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 479,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "- In 2022 Eli Lilly recorded **$2.02 billion of net product revenue** from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) and paid AbCellera royalty fees “in the mid‑teens to mid‑twenties % of worldwide net sales,” which were shown on the income statement as cost of sales (Chunk 1 and Chunk 2 confirm the same $2.02 bn figure).  \n\n- By 2023 the antibodies were no longer sold under EUA, so **net product revenue fell to $0** and, consequently, **no royalty payments were made** (Chunk 1).  \n\n- The 2024 filing repeats that there were **no sales in 2023 or 2024**, leaving net product revenue at **$0** and royalty outlays at **$0**, even though the royalty‑rate provision (mid‑teens to mid‑twenties) remained unchanged (Chunk 2).  \n\nThus, the collaboration’s financial impact dropped from a $2.02 bn revenue stream with sizable mid‑teens‑to‑mid‑twenties percent royalties in 2022 to no revenue and no royalty payments in both 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. QUANTITATIVE VERIFICATION: All key numbers are correct - $2.02 billion in 2022 net product revenue, mid-teens to mid-twenties percentage royalty range, $0 revenue in 2023 and 2024, and $0 royalty payments in 2023-2024. No calculation errors detected. ENTITY ACCURACY: Correctly identifies LLY (Eli Lilly), AbCellera, bamlanivimab, bebtelovimab, and all relevant fiscal years (2022-2024). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years, correctly tracing the evolution from peak revenue/royalties in 2022 to complete wind-down in 2023-2024. The connection between EUA status changes and revenue/royalty implications is properly explained. COMPLETENESS: Addresses all aspects of the question - net product revenue trajectory, royalty payment amounts/percentages, and the 3-year progression. The answer explains the underlying cause (EUA discontinuation) which adds appropriate context. REASONING QUALITY: The logical flow is sound - showing how royalty obligations directly correlate with sales revenue, and explaining why both dropped to zero. The characterization of the trend as a 'sharp decline' and 'complete wind-down' accurately reflects the data. MINOR OBSERVATION: The LLM answer includes reference citations (Chunk 1, Chunk 2) which, while helpful for traceability, are not strictly necessary but do not detract from accuracy. The semantic equivalence with the ground truth is very high - both convey identical financial implications and timeline. No factual errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 462,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s filings show that the share of its closed block placed under the modified‑coinsurance arrangement has been essentially unchanged over the three‑year period: the 2022 10‑K (covering 2021) disclosed **59.25 %**, the 2023 10‑K (covering 2022) reported **59 %**, and the 2024 10‑K (covering 2023) again reported **59 %**. This near‑steady level—roughly six‑tenths of the closed block each year—demonstrates that MetLife deliberately relies on the modified coinsurance agreement as a core, long‑term risk‑transfer tool, using it to consistently shift a substantial portion of its portfolio risk to an unaffiliated reinsurer while preserving capital and diversification.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - YEAR MAPPING ERROR: The LLM has fundamentally misaligned the fiscal years with the filing years. The LLM states '2022 10-K (covering 2021)' but the ground truth clearly indicates the percentages are for 2022, 2023, and 2024 respectively. The LLM's parenthetical year references are incorrect and create confusion about which fiscal year each percentage applies to. QUANTITATIVE ACCURACY: The three percentages (59.25%, 59%, 59%) are correct in isolation, but the year-to-year mapping is wrong. The ground truth explicitly states: '59.25% in 2022, 59% in 2023, and 59% in 2024,' while the LLM incorrectly associates these with different fiscal years. This is a significant error in a multi-hop question where precise year alignment is critical. QUALITATIVE ACCURACY: The LLM's interpretation of the strategic meaning is sound and well-articulated - it correctly identifies this as demonstrating intentional, consistent risk-transfer strategy and capital preservation. The reasoning about 'deliberately relies on the modified coinsurance agreement as a core, long-term risk-transfer tool' aligns well with the ground truth's conclusion about 'strategic continuity.' COMPLETENESS: The LLM addresses the evolution question and provides strategic insight, but the year mapping error undermines the credibility of the answer. The phrase 'near-steady level' and 'roughly six-tenths' appropriately convey the consistency, though the ground truth's more precise framing (59% maintained consistently) is clearer. SEMANTIC EQUIVALENCE: While the strategic interpretation is semantically equivalent to the ground truth, the factual presentation of which years correspond to which percentages is materially incorrect, which is unacceptable for financial analysis where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 488,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s “multi‑layered security approach” – the accounting‑policy it implements for itself – has become progressively more collaborative and infrastructure‑focused.  \n\n* In the 2022 filing the policy already relied on third‑party assessments, benchmarking against peers and public‑private partnerships, and it tied security to the real‑time payments platform that was operating or being built in 12 of the world’s 50 largest GDP markets.  \n* By 2023 the filing explicitly added monitoring of threats that arise from the use of **third‑party providers**, while the real‑time clearing‑and‑settlement network expanded to 13 markets.  \n* The 2024 filing repeats the same layered‑defence model, now emphasizing continued third‑party‑provider risk management and noting that real‑time payments infrastructure is live in “several countries worldwide” and that domestic processing in China is being handled through a joint‑venture partnership.  \n\nTogether, these changes show a cybersecurity strategy that is increasingly (1) integrated with external partners and suppliers to broaden threat intelligence and response capabilities, and (2) scaled alongside Mastercard’s growing real‑time payment footprint, reinforcing resilience as the network expands globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - 12 markets in 2022, 13 markets in 2023, and 'several countries' in 2024 all match the original answer precisely. No calculation errors detected. ENTITY ACCURACY: Mastercard is correctly identified, years (2022-2024) are accurate, and all relevant security concepts (multi-layered approach, third-party collaboration, real-time payments infrastructure) are properly referenced. COMPLETENESS: The answer addresses all three time periods and synthesizes the evolution across them effectively. The multi-hop reasoning correctly traces the progression from 2022 through 2024, showing how third-party risk management became more explicit and structured over time. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing (e.g., 'accounting-policy it implements for itself' is an unusual characterization, though not technically incorrect) but conveys the same core information. The answer correctly identifies the strategic alignment between scaling real-time payments and enhancing cybersecurity through third-party engagement. MINOR OBSERVATIONS: The LLM adds a detail about China joint-venture partnership for domestic processing that is not explicitly mentioned in the ground truth, though this appears to be a reasonable inference from 2024 filing data and doesn't contradict the original answer. The parenthetical summary at the end effectively captures the two-pronged strategy (external partner integration and scaled real-time payment footprint) that demonstrates the proactive security posture. Overall, the answer successfully synthesizes multi-hop information across three years of filings and provides accurate, well-reasoned analysis of Mastercard's cybersecurity evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 498,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "- 2022: LLY reported **$2.84 billion** in equity‑like private‑alternative funds (total fair‑value amount).  \n- 2023: the same line grew to **$4.01 billion** – an increase of roughly $1.2 billion (≈ 41 %).  \n- 2024: the balance rose slightly to **$4.09 billion** (about $0.08 billion, ≈ 2 % above 2023).\n\nThe steady upward move from 2022‑2023 and the near‑flat but still higher level in 2024 show that Eli Lilly is deliberately expanding its exposure to illiquid, equity‑like private‑alternative assets. This pattern signals a long‑term strategy that favours allocating a growing share of its portfolio to higher‑return, less‑liquid investments, while now stabilising the allocation as the target level is approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $2.84B (2022) matches $2,844.7M, $4.01B (2023) matches $4,014.1M, and $4.09B (2024) matches $4,093.7M. The calculated increase from 2022-2023 of ~$1.2B (41%) is accurate: ($4,014.1M - $2,844.7M) / $2,844.7M = 41.1%. The 2024 increase of ~$0.08B (2%) is also correct: ($4,093.7M - $4,014.1M) / $4,014.1M = 1.98%. ENTITY ACCURACY: Correctly identifies LLY (Eli Lilly), the specific investment category (equity-like private alternative funds), and all three fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and correctly interprets it as evidence of strategic expansion in illiquid assets. The characterization of the 2022-2023 jump as significant growth followed by stabilization in 2024 is accurate and insightful. SEMANTIC EQUIVALENCE: The LLM's interpretation that the company is 'deliberately expanding' and 'stabilising the allocation as the target level is approached' aligns well with the ground truth's statement about 'strategic emphasis' and 'growing confidence.' The conclusion about long-term strategy favoring higher-return, less-liquid investments is semantically equivalent to the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more detailed analysis of the stabilization pattern in 2024 compared to the ground truth, which adds value without contradicting the original answer. The presentation is clear and well-structured with proper formatting of numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 432,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Procter & Gamble has consistently placed Cascade in the **Fabric & Home Care** segment as a **laundry‑detergent brand** (listed under the “Tide Cascade” major‑brand line within the Fabric Care sub‑category). In 2022 the Fabric & Home Care segment accounted for **35 % of P&G’s net sales**; by 2023 that share had risen to **36 %**, and it remained at **36 % in 2024**. Thus, while Cascade’s product categorization stayed the same, its segment’s relative contribution to net sales grew modestly from 35 % to 36 % and then held steady.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numerical values are correct - Fabric & Home Care segment contributed 35% of net sales in 2022, increased to 36% in 2023, and remained at 36% in 2024. These figures match the ground truth exactly. ENTITY ACCURACY: Cascade is correctly identified as a laundry-detergent brand within the Fabric & Home Care segment, and the company (Procter & Gamble) is correctly named. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and correctly traces the evolution of both Cascade's categorization (remained consistent as laundry detergent) and its segment's relative contribution (35%→36%→36%). COMPLETENESS: The answer addresses all aspects of the question - product categorization evolution (stable), relative contribution evolution (modest growth then stabilization), and the three-year timeframe. ADDITIONAL STRENGTHS: The LLM provides helpful context by specifying Cascade as part of the \"Tide Cascade\" major-brand line and noting it falls under the Fabric Care sub-category, which adds useful detail beyond the ground truth without introducing inaccuracy. The conclusion that positioning remained stable while contribution grew modestly is logically sound. MINOR CONSIDERATIONS: The ground truth uses slightly different phrasing (\"indicated continued strategic importance\" vs. the LLM's more specific product categorization details), but both convey the same essential information about stable positioning. The LLM's answer is actually more precise in its categorization details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 455,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024 Lowe’s steadily tightened the way it watches its supply chain and the wood it sells. In its 2022 filing the company said it already “monitors our suppliers’ practices” through a human‑rights policy, a conflict‑minerals policy and a Vendor Code of Conduct that contains “enhanced environmental standards,” and it required that all wood products come from “well‑managed, non‑endangered forests.” In 2023 the wood‑sourcing policy was revised to add country‑specific risk levels, stronger monitoring procedures and a formal forestry‑grievance process, and the same enhanced monitoring language was carried forward into the 2024 filing, which describes the policy as a “more robust risk‑based approach” with “improved monitoring practices” and the grievance mechanism now embedded in the overall supplier‑sustainability framework. At the same time, Lowe’s’ investment strategy grew from the $550 million spent over the three‑year period ending 2022 on LED upgrades, high‑efficiency HVAC, building‑management systems and pallet grinders to a slightly smaller but still substantial $400 million outlay reported in 2023 for the same types of efficiency projects, and by 2024 the company highlighted continued capital toward energy‑efficiency, renewable‑energy and low‑carbon transportation initiatives that support its 2050 net‑zero target.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the qualitative evolution of Lowe's sustainability practices and correctly identifies the key policy enhancements (country-specific risk levels, forestry grievance process, risk-based approach). However, there are significant quantitative accuracy issues that lower the overall score. CRITICAL ERRORS: (1) The LLM states $550 million was spent 'over the three-year period ending 2022' on facility upgrades, but the ground truth indicates this was a 2022 investment figure, not a three-year cumulative amount. (2) The LLM introduces a $400 million figure for 2023 efficiency projects that does not appear in the ground truth answer, which instead mentions a $50 million Gable Grants program for skilled trades education. This is a significant factual discrepancy - the LLM appears to have confused or misattributed investment figures. (3) The ground truth mentions the $50 million Gable Grants program commitment over five years, which the LLM completely omits. STRENGTHS: The LLM correctly captures the evolution of wood sourcing policies across the three years, accurately describes the addition of country-specific risk levels and forestry grievance processes in 2023, and properly conveys the shift toward a more robust risk-based approach in 2024. The multi-hop reasoning about policy evolution is sound. WEAKNESSES: The investment strategy section contains material errors in both the amounts cited and the programs described. The answer conflates or misrepresents environmental facility upgrade investments with other sustainability investments. The omission of the Gable Grants program is a notable gap in completeness. The quantitative accuracy score is particularly low due to these investment figure discrepancies, while qualitative accuracy remains moderate-to-good because the policy framework evolution is largely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1630,
        "completion_tokens": 510,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Across the three filings Honeywell repeatedly flags “changes in the competitive landscape … new market entrants and new technologies” as a material risk for the same operating segments, but the wording and segment naming evolve.  \n\n* In 2022 (and again in 2023) the risk is called out for **Safety & Productivity Solutions** and for **Honeywell Building Technologies**, explicitly noting that new entrants and technologies could “lead to product commoditization.”  \n* By 2024 the company groups the same exposure under **Industrial Automation** (the successor to Safety & Productivity Solutions) and under **Building Automation** (a sub‑segment of Building Technologies), again stressing that competitive‑landscape shifts and new technologies may drive commoditization and pressure margins.  \n\nThe continuity—and the shift to broader “Automation” and “Automation‑building” headings—shows that Honeywell’s exposure to competitive‑landscape changes has not faded; rather, it has become a persistent, increasingly salient concern across its core automation and building‑technology businesses, signalling mounting market pressure and a growing risk that its products will be treated as commodities, eroding pricing power and margins over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core progression of competitive landscape risks across Honeywell's businesses from 2022-2024, accurately names the segments (Safety & Productivity Solutions, Honeywell Building Technologies, Industrial Automation), and correctly notes the consistent theme of new entrants, new technologies, and commoditization risks. The answer appropriately recognizes the evolution in segment naming/organization. The dates (2022, 2023, 2024) are correct.\n\nWEAKNESSES AND ERRORS: (1) FACTUAL INACCURACY - The LLM states the risk appears 'in 2022 (and again in 2023)' for Safety & Productivity Solutions AND Honeywell Building Technologies. However, the ground truth clearly indicates Safety & Productivity Solutions was mentioned in 2022, while Honeywell Building Technologies was first mentioned in 2023 (not 2022). This is a material error in the temporal sequencing of which segment was flagged in which year. (2) INCOMPLETE SYNTHESIS - The LLM's characterization of Industrial Automation as 'the successor to Safety & Productivity Solutions' is interpretive and not explicitly supported by the ground truth, which presents these as separate business segments with the risk expanding to Industrial Automation in 2024. (3) SEGMENT NAMING CONFUSION - The LLM introduces 'Building Automation' as a sub-segment of Building Technologies, but the ground truth refers to 'Honeywell Building Technologies' without this sub-segment distinction. This adds interpretive detail not in the original answer. (4) MISSING CLARITY - The ground truth emphasizes a 3-year PROGRESSION showing INTENSIFYING and BROADENING pressures, with commoditization becoming 'more systemic rather than isolated.' The LLM captures the persistence and salience but less clearly articulates the intensification and broadening across previously separate divisions.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and three business segments, but the temporal mapping error (2022 vs 2023 for specific segments) undermines the accuracy of the multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE: While the LLM conveys similar themes about persistent competitive pressures and commoditization risks, the factual errors in temporal sequencing and segment attribution prevent full semantic equivalence with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 627,
        "total_tokens": 2236
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "- **2022 filing – strategic narrative:** Qualcomm framed the digital cockpit as a key pillar of the automotive transformation, emphasizing that its high‑performance, low‑power mobile‑derived compute and 5G connectivity would power personalized, OTA‑updatable in‑vehicle experiences and help drive the shift to more connected, partially autonomous cars.  \n\n- **2023 filing – revenue recognition:** The company moved from a purely descriptive stance to quantifying the business, stating that revenues “from products sold for use in automobiles, including connectivity, **digital cockpit** and ADAS/AD” are now tracked as a distinct line‑item, showing that the digital‑cockpit offering had become a measurable source of sales.  \n\n- **2024 filing – segment reporting:** Qualcomm placed the digital cockpit within the QCT semiconductor segment’s definition (“automotive systems for connectivity, **digital cockpit** and ADAS/AD”), meaning the business now allocates resources, evaluates performance and reports earnings for the digital‑cockpit portfolio alongside its core semiconductor products.  \n\n**Overall evolution:** From 2022’s market‑opportunity positioning, Qualcomm progressed to recognizing digital‑cockpit revenue in 2023 and finally integrated the product into its primary semiconductor segment by 2024, reflecting a transition from strategic vision to an explicit, performance‑tracked component of its automotive business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with accurate characterization of each phase: strategic narrative in 2022, revenue recognition in 2023, and segment integration in 2024. (2) Accurately captures the specific evolution from 'forward-looking market opportunity' to 'monetization' to 'full operational integration.' (3) Properly synthesizes multi-hop information across filing years, showing how digital cockpit moved from descriptive positioning to quantified revenue line-item to formal segment reporting. (4) Correctly identifies the QCT semiconductor segment as the organizational home for digital cockpit by 2024. (5) Accurately references the key business drivers mentioned (5G connectivity, OTA updates, personalization, ADAS/AD). MINOR CONSIDERATIONS: (1) The ground truth mentions the specific analyst projection ('over 70% of new vehicles in 2028 would have embedded cellular connectivity'), which the LLM answer does not include. However, this is a minor omission that doesn't affect the core narrative of strategic evolution. (2) The LLM answer uses slightly different phrasing ('quantifying the business' vs 'transition from strategic vision to monetization') but conveys the same semantic meaning. (3) The LLM answer frames the 2023 transition as moving from 'purely descriptive stance to quantifying the business,' which is semantically equivalent to the ground truth's 'transition from strategic vision to monetization.' QUANTITATIVE ACCURACY: No specific financial figures, percentages, or calculations are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filing years and correctly traces the logical progression of how a product category moves from strategic positioning through revenue recognition to operational integration. The reasoning is sound and well-structured. OVERALL: The LLM answer is highly accurate, comprehensive, and directly addresses the question with appropriate detail and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 594,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "- **2022 (10‑K)** – Frame.io appears only in Adobe’s trademark list, confirming that Adobe owned the platform but giving no detail on its capabilities or product integrations.  \n\n- **2023 (10‑K)** – Adobe describes Frame.io as a cloud‑native collaboration service that now **supports still images, design files and PDFs** in addition to video, and is **directly integrated with Premiere Pro and After Effects**.  Its “Camera‑to‑Cloud” feature lets creators upload footage (and still‑image camera files) automatically for review.  \n\n- **2024 (10‑K)** – Adobe expands Frame.io’s scope to the entire video‑production workflow (casting, location scouting, footage reviews, marketing campaigns) while retaining support for still images, design files and PDFs.  The platform is now **natively integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and is bundled in Adobe GenStudio together with Adobe Express and Firefly Services, giving **enterprise‑grade, at‑scale content‑production capabilities**.  \n\nThus, from a trademark mention in 2022, Frame.io grew by 2023 to support additional media types and integrate with two video apps, and by 2024 to cover the full video lifecycle, add integrations with Photoshop, Lightroom and Workfront, and become an enterprise‑focused component of Adobe’s GenStudio ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in tracking Frame.io's evolution from 2022 to 2024. STRENGTHS: (1) All factual claims are correct and well-supported by the ground truth: 2022 trademark listing, 2023 cloud-native platform with video/still images/design files/PDFs support integrated with Premiere Pro and After Effects, 2024 expansion to casting/location scouting/marketing campaigns with additional integrations (Photoshop, Lightroom, Workfront) and GenStudio bundling. (2) The answer correctly identifies all supported media types across the three-year period without omission or error. (3) Multi-hop synthesis is sound: the answer properly traces the progression of integrations (2 apps in 2023 → 5 apps in 2024) and contextualizes Frame.io within Adobe's broader ecosystem (GenStudio). (4) The answer adds valuable detail about Camera-to-Cloud feature and enterprise-grade positioning that enhances understanding while remaining factually accurate. (5) Numeric accuracy is perfect: all years, product names, and integration counts are correct. (6) The narrative structure effectively shows evolution over time, directly addressing the 'evolve from 2022 to 2024' framing of the question. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (e.g., Camera-to-Cloud feature), but this represents appropriate elaboration rather than error. The semantic equivalence is excellent—'cloud-native creative collaboration platform' vs 'cloud-native collaboration service' conveys identical meaning. No calculations are required for this question, so quantitative accuracy focuses on date/entity correctness, which is perfect. The answer fully addresses all three sub-components of the question: supported media types, cross-product integrations, and enterprise capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 498,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "Across the three most recent 10‑K filings the description of MasterCard’s (MA) A Class shares is identical:\n\n* **2022 filing** – A Class shares carry “one vote per share” and “dividend rights.”  \n* **2023 filing** – the same language is repeated: “one vote per share” and “dividend rights.”  \n* **2024 filing** – again the A Class shares are described as having “one vote per share” and “dividend rights.”\n\nBecause the dividend entitlement and voting entitlement for A Class shares did not change in any of the three years, the trend shows a **stable shareholder‑governance structure** for the class that holds voting power. The consistency signals that MA has maintained the same rights for its voting shareholders, reinforcing continuity in corporate control and governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately states that MA's A Class shares maintained identical rights across all three periods - 'one vote per share' and 'dividend rights' with no changes. (2) Quantitative accuracy is perfect - no numbers, dates, or metrics are incorrect. (3) Multi-hop synthesis is sound: the answer correctly synthesizes information across three separate annual filings and draws the appropriate conclusion about governance stability. (4) The reasoning is logical and well-articulated: the consistency of rights across years directly supports the conclusion about stable shareholder governance structure. (5) Entity identification is correct (MasterCard/MA, A Class shares, voting and dividend rights). (6) The answer directly addresses both parts of the multi-part question: how the rights evolved (they didn't) and what the trend indicates (stability). MINOR CONSIDERATIONS: The LLM answer adds interpretive language such as 'reinforcing continuity in corporate control and governance' which goes slightly beyond the ground truth's more straightforward statement that there were 'no changes' indicating 'stable governance.' However, this additional interpretation is reasonable and not contradictory - it represents a logical extension of the factual finding rather than an error. The semantic equivalence is strong: both answers convey that the rights remained constant across all three years, indicating stability. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 430,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Across all three filings Honeywell repeatedly warns that its Safety and Productivity Solutions (renamed “Industrial Automation” in the 2024 filing) can be “adversely impacted … by fluctuations in retail markets,” which could translate into lower market share, reduced selling prices and thinner margins (2022 Risk Factors). The same exposure is restated in the 2023 filing and again in the 2024 filing, showing that the segment’s performance continues to be tied to consumer‑demand volatility in the retail channel. This consistency signals that the SPS/Industrial‑Automation business remains chronically vulnerable to swings in retail spending and has not mitigated that risk over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the segment name change from 'Safety and Productivity Solutions' to 'Industrial Automation' between 2023 and 2024 filings. (2) Accurately captures the core risk disclosure pattern: retail market fluctuations adversely impacting the segment across all three fiscal years (2022, 2023, 2024). (3) Properly synthesizes the multi-hop information showing consistency of risk exposure over time. (4) Correctly identifies specific impacts: lower market share, reduced selling prices, thinner margins. (5) Appropriately concludes that the segment remains 'chronically vulnerable' and has not mitigated exposure over the three-year period. (6) Uses accurate quotation from the 2022 Risk Factors section. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information. (2) The ground truth mentions additional specific impacts in 2022 (reduced investments in process automation and safety monitoring, lower demand for safety products) and 2023 (risk of commoditization), while the LLM answer focuses on the overarching pattern of lower market share, reduced prices, and margin pressure. However, these are complementary rather than contradictory observations. (3) Both answers correctly emphasize the consistency of risk disclosure and lack of mitigation over time. QUANTITATIVE ACCURACY: No numerical calculations or specific dollar amounts are required for this qualitative risk assessment question. The fiscal years (2022, 2023, 2024) are all correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate fiscal year filings and correctly identifies the organizational restructuring while maintaining the core risk exposure narrative. The logical conclusion about chronic vulnerability is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 526,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From the 2022 filing, Eli Lilly’s collaboration with Incyte provided Lilly with worldwide development and commercialization rights to Olumiant and set a **tier‑ed, double‑digit royalty that could reach 20 % of net sales**. The agreement also required **milestone payments** – $210 million (2020) and $260 million (2021) that were capitalized as intangible assets – and gave Incyte the opportunity to earn **up to $100 million each in additional success‑based regulatory and sales‑based milestones**. A 2020 amendment added a **COVID‑19 indication**, granting Incyte an **extra royalty of up to the low‑teens percent on worldwide net sales that exceed a defined threshold**.\n\nThe 2023 10‑K repeats only that Lilly records Olumiant sales as net product revenue and treats the royalty payments to Incyte as cost of sales, indicating that the **royalty rates and the cost‑of‑sales treatment remained unchanged** and no new milestone terms were disclosed.\n\nThe 2024 filing confirms the same **tiered double‑digit royalty up to 20 %** and the **additional low‑teens‑percent COVID‑19 royalty** for sales beyond the threshold, and continues to record those royalties as cost of sales. While the 2024 text does not restate specific milestone amounts, the absence of new language suggests that the **milestone payment framework established in 2022 (development, regulatory and sales milestones) remains in effect**, with the collaboration now explicitly covering both inflammatory/autoimmune diseases **and COVID‑19**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the Olumiant agreement structure but contains significant quantitative errors and introduces information not present in the ground truth. STRENGTHS: (1) Correctly identifies the tiered royalty structure reaching 20% across all three years; (2) Correctly identifies the low-teens COVID-19 royalty for sales above threshold; (3) Correctly notes the shift from milestone-driven to royalty-based payments; (4) Properly synthesizes information across 2022-2024 filings; (5) Accurately describes cost-of-sales treatment. CRITICAL ERRORS: (1) The LLM cites $210 million (2020) and $260 million (2021) as historical milestone payments, but the ground truth specifies 'up to $100 million in additional regulatory milestones and $100 million in sales-based milestones' for the 2022-2024 period being evaluated. The 2020-2021 figures appear to be from earlier payments not directly relevant to the 2022-2024 evolution requested; (2) The LLM states 'up to $100 million each in additional success-based regulatory and sales-based milestones' which matches ground truth, but the earlier citation of $210M and $260M creates confusion about which milestones apply to the 2022-2024 timeframe. QUANTITATIVE VERIFICATION: The ground truth specifies 'up to $100 million in additional regulatory milestones and $100 million in sales-based milestones' for the period in question. The LLM's inclusion of $210M and $260M figures, while potentially accurate for historical context, muddies the answer to the specific question about 2022-2024 evolution. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and properly identifies the evolution from milestone-heavy to royalty-focused obligations. However, the introduction of pre-2022 milestone figures suggests incomplete filtering of relevant information. SEMANTIC ISSUES: The phrase 'milestone payment framework established in 2022' is somewhat misleading since these milestones were established earlier; the 2022 filing merely references them. The answer would be stronger if it clearly distinguished between historical milestones already paid and contingent future milestones still available.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 591,
        "total_tokens": 2213
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "- **2022:** In the 2022 filing the “Baby, Feminine & Family Care” segment was broken out into three sub‑categories – Baby Care, Feminine Care and Family Care – and the brand list was headed by baby‑care names (Luvs, Pampers) with **Always** appearing later among a mix of feminine (Always Discreet, Tampax) and household (Bounty, Charmin, Puffs) brands.  \n\n- **2023:** The segment was re‑structured, dropping the Baby‑care sub‑category and keeping only Feminine Care (adult incontinence and menstrual) and Family Care. The brand table now opens with **Always**, followed by Always Discreet, Tampax, Bounty, Charmin and Puffs, signalling that P&G elevated Always to the flagship brand of the segment.  \n\n- **2024:** The same categorization and brand ordering from 2023 is retained, confirming that the strategic positioning of **Always** as the lead brand in the Feminine & Family Care segment remained consistent through 2024.  \n\nOverall, P&G shifted the segment’s focus from a broader baby‑plus‑feminine mix in 2022 to a purely feminine/family‑care focus in 2023, and placed **Always** at the top of the major‑brand hierarchy—a positioning that was maintained in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - 2022 categorization: The LLM claims Always appeared 'later among a mix' and that the segment had three sub-categories (Baby Care, Feminine Care, Family Care) with baby-care names heading the list. The ground truth states Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' without evidence of this three-way split or Always appearing later in the list. (2) MAJOR ERROR - 2023 positioning: The LLM claims P&G 'elevated Always to the flagship brand' and that it 'opens with Always' at the top of the brand hierarchy. The ground truth indicates the categorization shifted to 'Feminine Care (Adult Incontinence, Menstrual Care)' with Always 'more specifically associated with menstrual care' but does NOT support the claim that Always was elevated to flagship status or moved to the top of the brand list. The ground truth explicitly states Always was listed 'alongside' other brands, not ahead of them. (3) STRUCTURAL CLAIM ERROR - The LLM's assertion that the segment was 'restructured, dropping the Baby-care sub-category' in 2023 is not supported by the ground truth, which makes no mention of such structural changes. (4) BRAND ORDERING ERROR - The LLM's specific claim about brand ordering ('brand table now opens with Always, followed by Always Discreet, Tampax...') contradicts the ground truth which lists brands as appearing 'alongside' each other without establishing Always as the lead. (5) 2024 CONSISTENCY - While the LLM correctly notes 2024 maintained 2023 positioning, this is based on the incorrect 2023 characterization. The core evolution described in the ground truth is about product categorization refinement (from 'Feminine Care' to 'Feminine Care with Menstrual Care emphasis') and strategic sharpening around menstrual care, NOT about Always being elevated to flagship status. The LLM fundamentally mischaracterized the nature of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 542,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "- **Fiscal 2023 ( disclosed in the 2022 10‑K)** – ACN set a “target allocation for fiscal 2023” that was built around a diversified portfolio of fixed‑income securities and equities, with the amount of debt securities sized to **match the duration of the pension plan liabilities** while the equity slice was intended to deliver **risk‑adjusted, long‑term capital appreciation**. Ranges were established so the actual mix could drift around the target without immediate rebalancing.\n\n- **Fiscal 2024 ( disclosed in the 2023 10‑K as of August 31 2023)** – The company updated the same framework for fiscal 2024, again presenting a weighted‑average target allocation (shown in the “target allocation for fiscal 2024” table) that kept the **fixed‑income‑to‑equity balance and duration‑matching discipline**, merely adjusting the ranges to reflect the market conditions and cash‑flow expectations of 2023.\n\n- **Fiscal 2025 ( disclosed in both the 2023 and 2024 10‑Ks)** – The 2023 filing and the subsequent 2024 filing both repeat a **single “target allocation for fiscal 2025”** (with weighted‑average allocations as of August 31 2024 and 2023). The consistency of the table across the two years shows ACN’s decision to **maintain the same asset‑mix philosophy**—a core mix of bonds calibrated to liability duration plus an equity component for risk‑adjusted returns—while allowing only modest range adjustments.\n\n**What the progression reveals:** Across three consecutive filing years ACN has not altered the underlying allocation philosophy; it has simply refined the numerical targets within pre‑set ranges. This steady, liability‑driven approach underscores a commitment to **matching the duration of plan liabilities with debt holdings** to dampen asset‑liability volatility, while preserving a calibrated equity exposure to achieve **risk‑adjusted returns** that exceed inflation over the long term. The multi‑year continuity signals a disciplined, long‑term investment policy rather than a reactive shift in asset class weighting.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three fiscal years (2023, 2024, 2025) and their corresponding filing years (2022, 2023, 2024 filings). (2) Accurately captures the core investment philosophy: diversified portfolio of fixed-income and equities with liability duration matching. (3) Properly synthesizes the multi-hop information showing evolution across three years while maintaining strategic continuity. (4) Correctly emphasizes the dual objectives of risk-adjusted returns and liability duration matching. (5) Accurately describes the framework as stable with tactical flexibility. (6) The progression narrative is sound: fiscal 2023 established the framework, fiscal 2024 updated within the same framework, fiscal 2025 maintained consistency across both 2023 and 2024 filings. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail about 'ranges' and 'rebalancing' than explicitly stated in the ground truth, though this is consistent with typical pension plan management practices and doesn't contradict the source material. (2) The answer uses slightly more specific language about 'weighted-average allocations as of August 31' which adds precision without introducing errors. (3) No specific percentage allocations or dollar amounts are provided in either answer, which is appropriate given the question's focus on strategic evolution rather than specific numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings and years, correctly identifying how the strategy evolved while maintaining core principles. The conclusion about 'disciplined, long-term investment policy' versus 'reactive shift' appropriately interprets the data pattern. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while providing more detailed explanation of the mechanics (ranges, rebalancing, market conditions). This represents appropriate elaboration rather than deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1840,
        "completion_tokens": 557,
        "total_tokens": 2397
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "**Evolution of the exposure**\n\n* **2022 filing (Chunk 1)** – Lowe’s disclosed that its forward‑interest‑rate‑swap contracts were **designated as cash‑flow hedges** and the resulting gains or losses were recorded in other‑comprehensive income (OCI). No dollar amount or balance‑sheet classification was given, but the swaps were already being used to hedge the interest‑rate risk on future debt issuances.  \n\n* **2023 filing (Chunk 3)** – The swaps appear on the balance sheet for the first time, listed under **“Other current assets”** (Level 2 fair‑value measurement) with a **fair‑value of about $251 million** as of February 3 2023. The classification as a current‑asset reflects a positive fair value that the company expects to realise within the next twelve months.  \n\n* **2024 filing (Chunk 2)** – Lowe’s again states that it **holds forward interest‑rate‑swap agreements to hedge exposure on forecasted debt issuances** (the same contracts that were on the 2023 balance sheet). The swaps continue to be **accounted for as cash‑flow hedges**, with the effective portion of fair‑value changes recorded in OCI and subsequently amortised to interest expense. The narrative does not repeat a dollar amount, indicating that the contracts remain on the books but the company now emphasizes the cash‑flow‑hedge accounting rather than the balance‑sheet classification.\n\n**What the change reveals about risk‑management strategy**\n\n1. **Increasing transparency and quantification** – Moving from a footnote‑only description in 2022 to a disclosed $251 million current‑asset balance in 2023 shows that Lowe’s is measuring and reporting the fair value of its forward swaps more explicitly, signalling a larger or more actively managed exposure to benchmark‑rate movements.\n\n2. **Consistent hedge‑accounting treatment** – Throughout the three years the swaps have been treated as **cash‑flow hedges**. By keeping the effective portion of gains/losses in OCI and amortising them to interest expense, Lowe’s isolates the impact of interest‑rate fluctuations from earnings, indicating a deliberate strategy to smooth earnings while locking in rates for future borrowings.\n\n3. **Focus on forecasted debt** – The swaps are tied to **future debt issuances**, not existing debt, and the company continues to use the “shortcut” effectiveness test (perfect effectiveness) to qualify for hedge accounting. This demonstrates that Lowe’s is proactively managing the cost of debt it expects to issue, rather than reacting to changes in existing borrowings.\n\nOverall, Lowe’s exposure to forward interest‑rate swaps grew to a measurable $251 million position by early 2023, and the shift to a current‑asset classification together with the unchanged cash‑flow‑hedge accounting underscores a disciplined, forward‑looking interest‑rate risk‑management approach that seeks to protect future financing costs while keeping earnings volatility limited.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that 'By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges.' However, the LLM answer claims that in 2024, Lowe's 'holds forward interest-rate-swap agreements to hedge exposure on forecasted debt issuances' and that 'The swaps continue to be accounted for as cash-flow hedges.' This is incorrect. The ground truth indicates a clear strategic shift: (1) 2022-2023: forward interest rate swaps as cash flow hedges, (2) 2024: NO forward interest rate swaps; instead fixed-to-floating swaps as fair value hedges. The LLM failed to identify this critical transition. QUANTITATIVE ACCURACY: The $251 million figure for 2023 is correct and properly classified as Level 2 fair value under 'Other current assets.' However, the LLM misses the key 2024 development entirely. QUALITATIVE ACCURACY: The LLM's analysis of 2022-2023 is reasonable, but the interpretation of 2024 is fundamentally wrong. The ground truth reveals a strategic shift from managing forecasted debt issuance risk (cash flow hedges) to managing existing debt exposure (fair value hedges), suggesting a more stable capital structure. The LLM completely misses this strategic evolution. MULTI-HOP REASONING: The LLM failed to synthesize the key multi-hop insight: the transition from forward swaps to fixed-to-floating swaps represents a fundamental change in hedging strategy, not a continuation of the same approach. This is a major failure in multi-hop reasoning across the three-year period. The answer reads as if 2024 continues the 2023 pattern, when in fact it represents a significant strategic pivot.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1999,
        "completion_tokens": 514,
        "total_tokens": 2513
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "**Amount of the 5.000 % senior notes due April 2030**\n\n| Fiscal year (as reported) | Principal outstanding (millions) |\n|----------------------------|-----------------------------------|\n| FY 2022 (Oct 30 2022)      | **$606 M** – shown in the “April 2020 Senior Notes – fixed rate” line of the 2022 10‑K (Chunk 1). |\n| FY 2023 (Oct 29 2023)      | **$606 M** – the same amount appears in the 2023 10‑K table (Chunk 3). |\n| FY 2024 (Nov 3 2024)       | **$606 M** – again listed unchanged in the 2024 10‑K table (Chunk 2). |\n\n**What the trend tells us**\n\nThe exposure to this particular tranche of debt has **remained flat at $606 million** over three consecutive fiscal years. AVGO has neither increased nor retired a material portion of the 5.000 % notes, indicating a deliberate, disciplined approach to its long‑term capital structure:\n\n* **Stability of maturity profile** – the company is keeping the April 2030 maturity on its balance sheet, likely because the fixed‑rate, mid‑term financing fits its cash‑flow planning.  \n* **Controlled borrowing** – AVGO has not used this series to raise additional funds, suggesting it is managing overall debt growth through other issuances or internal cash generation rather than expanding this specific obligation.  \n* **Consistent cost of capital** – by retaining the 5 % coupon note, AVGO locks in a known interest expense, which helps predict long‑term financing costs.\n\nOverall, the unchanged $606 million exposure reflects a steady‑hand debt‑management strategy that preserves the existing financing mix without adding new reliance on this particular note.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports the 5.000% notes due April 2030 as $606M for all three years (FY2022, FY2023, FY2024), but the ground truth clearly states the amount was $1,086 million in 2022, declining to $606 million in both 2023 and 2024. This is a major factual error - the LLM missed the $1,086M figure entirely for 2022. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks how the exposure 'evolved from fiscal year 2022 through 2024.' The ground truth shows a significant $480 million reduction from 2022 to 2023 ($1,086M → $606M), followed by stability in 2024. The LLM completely misses this critical evolution and incorrectly claims the exposure 'remained flat at $606 million over three consecutive fiscal years.' (3) DEBT MANAGEMENT STRATEGY MISINTERPRETATION: Because the LLM failed to identify the 2022 decline, its analysis of the debt management strategy is fundamentally flawed. The ground truth indicates 'a deliberate reduction in this specific debt obligation' and 'active debt repayment or restructuring strategy,' whereas the LLM incorrectly characterizes it as 'unchanged' and 'steady-hand' with 'no material portion retired.' This is backwards - the company clearly retired $480M of this debt between 2022-2023. (4) The LLM's reasoning about 'stability of maturity profile' and 'controlled borrowing' is based on the false premise that amounts remained constant. The actual data shows aggressive debt reduction. (5) CONTEXTUAL RELEVANCE: While the LLM addresses the right company (AVGO) and metric (5.000% notes due April 2030), it fundamentally misunderstands the financial trajectory and strategic implications. The answer would mislead a reader about AVGO's actual debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 506,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "**2022 filing** – UPS described the issue as a $276 million “7.620 % debenture” that had originally been issued at 8.375 % and was reset to 7.620 % on April 1 2020 for the balance of its life.  The debentures mature on **April 1 2030**, pay interest **semi‑annually (April and October)**, have **no sinking‑fund requirement**, and are **redeemable in whole or in part at UPS’s option at any time**.  The redemption price is the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps (plus accrued interest).\n\n**2023 filing** – The debt schedule simply lists the same **$276 million of 7.620 % debentures**, with a **maturity of 2030** and the same amount carried forward (280 million shown for both 2022 and 2023).  No new terms are introduced, confirming that the interest rate, maturity and optional‑redemption features remained unchanged.\n\n**2024 filing** – UPS repeats the description of the **$276 million debentures maturing on April 1 2030**.  The note again states that the debentures are **redeemable in whole or in part at UPS’s option at any time**, with the same redemption‑price formula (greater of principal + accrued interest or PV of remaining payments discounted at a Treasury yield + 5 bps).  Interest continues to be **payable semi‑annually**, and there is still **no sinking‑fund requirement**.  The 2024 narrative no longer references the earlier 8.375 % rate because the debentures have been at 7.620 % since the 2020 reset.\n\n**Overall evolution (2022‑2024)**  \n- **Interest rate:** Initially disclosed as having been reduced from 8.375 % to 7.620 % (2022); by 2023‑2024 the rate is presented simply as 7.620 % with no further mention of the prior rate.  \n- **Redemption terms:** Consistently described as optional, at UPS’s discretion, with the same “greater‑of” price formula and no sinking‑fund requirement throughout the three years.  \n- **Maturity structure:** The maturity has remained fixed at **April 1 2030** in all three filings, and the principal amount has stayed at roughly $276 million.  \n\nThus, UPS’s disclosure moved from explaining the historical rate reset in 2022 to a streamlined, static description of the 7.620 % debentures’ terms in 2023 and 2024, while the underlying interest rate, optional redemption features and 2030 maturity stayed unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $276 million principal amount, 7.620% interest rate, 8.375% original rate, April 1, 2030 maturity date, 5 basis points redemption formula component, semi-annual payment schedule (April and October). All dates are accurate (April 1, 2020 reset date, 2022-2024 filing years). COMPLETENESS: The answer thoroughly addresses all three sub-components of the question: (1) interest rates - correctly traces the evolution from 8.375% to 7.620% in 2020, with disclosure changes across years; (2) redemption terms - accurately describes the optional redemption feature, the 'greater of' formula, and no sinking fund requirement consistently across all three years; (3) maturity structure - correctly identifies the fixed April 1, 2030 maturity and stable $276 million principal. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate filings (2022, 2023, 2024) and correctly identifies the evolution pattern: historical context provided in 2022, streamlined presentation in 2023-2024. ENTITY ACCURACY: UPS is correctly identified throughout, fiscal years are accurate, and the specific debt instrument (7.620% debentures) is properly tracked. REASONING QUALITY: The logic is sound - the answer correctly explains why the 2024 filing no longer references the 8.375% rate (because the reset occurred in 2020, making it historical context no longer necessary). The 'Overall evolution' section effectively synthesizes the three-year trend. SEMANTIC EQUIVALENCE: The answer conveys all material information from the ground truth with appropriate emphasis on disclosure evolution while maintaining factual accuracy. Minor note: The LLM states '280 million shown for both 2022 and 2023' which appears to be a reference to a balance sheet carrying amount (possibly including accrued interest or rounding), while the principal is $276 million - this is a reasonable clarification and doesn't contradict the ground truth. The answer is well-structured, clear, and provides appropriate context for understanding the evolution of disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Pays_Interest_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1871,
        "completion_tokens": 582,
        "total_tokens": 2453
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "- **Therapeutic focus:** In the 2022 Form 10‑K Amgen described Olpasiran as an siRNA that lowers lipoprotein (a) and is being studied for atherosclerotic cardiovascular disease. The 2024 filing still lists Olpasiran under “Cardiovascular disease,” confirming that the company continues to position it as a cardiovascular‑focused asset.  \n\n- **Clinical‑phase progression:** When first disclosed in 2022, Olpasiran was in **Phase 2** trials. By the 2024 filing the product is presented without a phase label but alongside later‑stage cardiovascular candidates (e.g., Repatha), indicating that development has moved beyond the early Phase 2 stage toward more advanced testing.  \n\n- **Intellectual‑property timeline:** The 2023 Form 10‑K provides the patent‑expiration schedule for Olpasiran, showing U.S. and European compound patents that run until **2036**. This establishes a long‑term exclusivity window that underpins Amgen’s strategic positioning of the molecule through the mid‑2030s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - Phase 2 in 2022, patent expiration in 2036 for both U.S. and European patents. No calculation errors or date discrepancies. ENTITY ACCURACY: Correctly identifies Amgen, Olpasiran, and all relevant fiscal years (2022, 2023, 2024). Properly references Form 10-K filings and correctly names comparison products (Repatha). COMPLETENESS: The answer addresses all three sub-components of the multi-part question: (1) therapeutic focus evolution from 'atherosclerotic cardiovascular disease' in 2022 to broader 'cardiovascular disease' in 2024, (2) clinical phase progression from Phase 2 in 2022 to advancement beyond Phase 2 by 2024, and (3) IP protection timeline with 2036 patent expiration dates. MULTI-HOP REASONING: The LLM correctly synthesizes information across three different fiscal years (2022, 2023, 2024) and integrates patent data from 2023 filing into the broader narrative. The logical progression from mid-stage development toward commercial strategy is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the therapeutic indication broadening from specific (atherosclerotic CVD) to general (cardiovascular disease) matches the ground truth's interpretation of 'potential expansion of clinical application or regulatory strategy.' The inference that removal of phase label indicates advancement beyond Phase 2 is reasonable and consistent with ground truth. MINOR OBSERVATION: The LLM uses slightly more cautious language ('presented without a phase label but alongside later-stage candidates') compared to ground truth's more direct statement of progression, but this represents appropriate epistemic humility rather than factual error. All core facts, numbers, dates, and reasoning are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 508,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "- In the 2022 filing, Tampax (listed as “Tampax Bounty”) was placed in the broad **Baby, Feminine & Family Care** segment, under the “Feminine Care” sub‑category (alongside Adult Incontinence) and appeared among the major brands together with baby‑care names such as Luvs and Pampers.  \n\n- By the 2023 filing the segment was restated as **Baby, Feminine & Family Care** but the “Baby Care” sub‑category was dropped, leaving “Feminine Care (Adult Incontinence, Menstrual Care)” and “Family Care.” Tampax Bounty remained a listed major brand, now positioned directly after Always and Always Discreet, showing that its prominence was retained even as the segment’s categorization was refined.  \n\n- The 2024 filing kept the same structure as 2023—Tampax Bounty stays in the **Feminine Care (Menstrual Care)** sub‑category of the Baby, Feminine & Family Care segment and continues to be listed among the top brands (Always, Always Discreet, Tampax Bounty, Charmin, Puffs), indicating a stable, continued prominence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains several significant factual errors that contradict the ground truth:\n\n1. ENTITY NAMING ERROR: The LLM repeatedly refers to 'Tampax Bounty' as a single brand name. This is incorrect. Tampax and Bounty are separate brands within P&G's portfolio. Bounty is a paper towel brand in the Family Care category, not a feminine care product. This fundamental error appears three times in the answer and suggests confusion about P&G's brand structure.\n\n2. CATEGORIZATION ERRORS:\n   - 2022: LLM states Tampax was listed as 'Tampax Bounty' alongside baby-care names like Luvs and Pampers. Ground truth shows Tampax was simply listed under Feminine Care (Adult Incontinence, Feminine Care) without this conflation with baby care brands.\n   - 2023: LLM claims 'Baby Care' sub-category was 'dropped' - ground truth shows the categorization changed to 'Feminine Care (Adult Incontinence, Menstrual Care)' but doesn't indicate Baby Care was dropped from the segment entirely.\n   - 2024: LLM states Tampax is in 'Feminine Care (Menstrual Care)' sub-category, but ground truth indicates the segment name reverted to 'Baby, Feminine & Family Care' with consistent categorization to 2023.\n\n3. POSITIONING CLAIMS: The LLM claims Tampax was 'positioned directly after Always and Always Discreet' in 2023 and lists it among 'top brands (Always, Always Discreet, Tampax Bounty, Charmin, Puffs)' in 2024. The ground truth does not provide this level of specific ordering detail, and the inclusion of Charmin and Puffs (which are not feminine care products) in a feminine care positioning discussion is problematic.\n\n4. MULTI-HOP REASONING: While the LLM attempts to track evolution across three years, the fundamental misidentification of the brand (Tampax Bounty) undermines the entire analysis. The reasoning about segment refinements is partially aligned with ground truth but corrupted by the brand naming error.\n\n5. WHAT WAS CORRECT: The LLM correctly identifies that Tampax remained prominent across all three years and that there were refinements in sub-category labeling. The general trajectory of 'consistent strategic emphasis' aligns with ground truth.\n\nThe core issue is the persistent 'Tampax Bounty' error, which is a critical factual mistake that would mislead anyone relying on this answer about P&G's brand portfolio and feminine care positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 633,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "Across the three most recent filings MetLife repeatedly states that when it purchases non‑agency RMBS or CMBS that have not yet been evaluated by the NAIC, it must assign an **internally‑developed designation** until a formal NAIC designation is issued. The 2022 filing first disclosed this practice, and the same language appears unchanged in the 2023 and 2024 notes, showing that MetLife’s reliance on internal designations has persisted rather than diminished over the 2022‑2024 period. This consistent multi‑year reliance signals that NAIC designations remain unavailable for a portion of the securities MetLife continues to acquire, indicating that the company’s acquisition strategy in this asset class deliberately includes assets lacking an NAIC rating and that it must rely on its own credit‑quality framework until the regulator provides an official designation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable but receives full marks as there are no errors. The years 2022-2024 are correctly identified in both answers. ENTITY ACCURACY: MetLife is correctly identified, and the asset classes (non-agency RMBS and CMBS) are accurately referenced. The regulatory body (NAIC) is correctly named. COMPLETENESS: The LLM answer addresses all parts of the multi-part question: (1) how reliance evolved from 2022-2024, (2) what the trend indicates about NAIC designation availability, and (3) what it reveals about MetLife's acquisition strategy. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings to identify a consistent pattern. It properly connects the persistence of internally developed designations to two key insights: (a) NAIC designations lag behind acquisition timelines, and (b) MetLife deliberately pursues newly issued or less frequently evaluated securities. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth: the practice remained consistent across 2022-2024, indicating ongoing acquisition of securities without immediate NAIC evaluations, and reflecting a deliberate strategy. The LLM uses slightly more explicit language (\"deliberately includes assets lacking an NAIC rating\") which adds clarity without contradicting the ground truth. MINOR DIFFERENCES: The LLM emphasizes that the language remained \"unchanged\" across filings, which is a reasonable inference from the ground truth's statement that the practice \"continued\" with the same policy. The LLM's characterization of this as \"reliance has persisted rather than diminished\" is a logical interpretation of the consistency described in the ground truth. No factual errors or contradictions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 531,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- **Fiscal 2022:**  The 2022 Form 10‑K notes that, as of August 31 2022, Accenture had **$3,129 million** of aggregate available authorization for its publicly announced open‑market share‑purchase program (and related share‑purchase programs).  \n\n- **Fiscal 2024:**  The 2024 Form 10‑K shows that, as of August 31 2024, the **available authorization had fallen to $2,694 million** because a large portion of the pool had been used.  In the fourth quarter of fiscal 2024 the company bought **2,000,308 Class A ordinary shares for $605 million** under the open‑market program (plus 72,255 shares in non‑program transactions that do not affect the authorization).  On September 25 2024 the Board approved an **additional $4,000 million** of repurchase authority, raising the **total outstanding authority to $6,694 million** (the cumulative authority since 2001 remains $50.1 billion).\n\n- **What the trend shows:**  Accenture’s authorized pool has been **drawn down** from $3.1 billion in FY 2022 to $2.7 billion in FY 2024 as it actively repurchased shares, while the Board simultaneously **expanded the overall repurchase ceiling** by $4 billion in FY 2024.  This pattern indicates a **continuing, aggressive capital‑return strategy**—the company is using its existing authorization to return cash to shareholders and is increasing its long‑term authority to sustain future open‑market buybacks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - FY2022 authorization of $3,129 million ($3.13B), FY2024 authorization of $2,694 million ($2.69B), Q4 FY2024 repurchase of 2,000,308 shares for $605 million, and the September 25, 2024 authorization increase of $4,000 million ($4B) bringing total to $6,694 million ($6.69B). All dates are accurate. The calculation showing the drawdown from $3.1B to $2.7B is correct. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) share repurchase activity across the three-year period, (2) available authorization evolution, (3) the trend and what it indicates about capital return strategy. The answer goes beyond the ground truth by including additional context (non-program transactions of 72,255 shares, cumulative authority since 2001 of $50.1 billion) which adds value without contradicting the ground truth. ENTITY ACCURACY: Accenture is correctly identified, fiscal years 2022-2024 are correct, Class A ordinary shares are properly identified, and the open-market share purchase program is accurately referenced. REASONING: The multi-hop synthesis is sound - the answer correctly connects the drawdown of authorization (from repurchases) with the Board's decision to expand authority, and properly interprets this as indicating an aggressive, continuing capital return strategy. The logic that active repurchases deplete the pool while Board authorization increases it demonstrates clear understanding of the program mechanics. SEMANTIC EQUIVALENCE: The characterization of the trend as 'continuing, aggressive capital-return strategy' aligns with the ground truth's 'consistent and growing commitment to returning capital to shareholders.' The only minor difference is that the LLM uses 'drawn down' language which is more precise than the ground truth's 'increased' characterization of authorization (though the ground truth does note the $2.69B figure as lower than prior years). This is actually a more accurate characterization of what happened.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 559,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Across the three years Broadcom’s filings show the same industrial‑fiber‑optics line moving from a narrative mention in 2022 (“we also provide … industrial fiber optics…”) to a dedicated line‑item in the “Industrial” section of the 2023 and 2024 end‑market tables. In each year the product is listed alongside optocouplers, sensors, motion‑control encoders, LEDs and Ethernet PHYs as a **key product offering** for factory automation, renewable‑energy and automotive‑electronics applications. The continuity and the shift to a formal table entry reveal that Broadcom has kept industrial fiber optics as a stable, strategically‑important component of its industrial‑end‑market portfolio, signalling an ongoing emphasis on serving automation‑heavy sectors rather than treating it as a peripheral or one‑off item.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Broadcom's industrial fiber optics positioning evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression from narrative mention (2022) to formal table entry (2023-2024); (2) Accurately lists companion products (optocouplers, sensors, encoders, LEDs, Ethernet PHYs) consistent with ground truth; (3) Correctly identifies target applications (factory automation, renewable energy, automotive electronics); (4) Properly synthesizes the strategic insight that the shift from narrative to formal table entry signals increased strategic importance; (5) No quantitative errors or date misstatements. MINOR GAPS: (1) The LLM answer does not explicitly mention 'camera microcontrollers' which the ground truth lists as a component in 2024 alongside Ethernet PHYs - this is a minor omission of a specific product detail; (2) The ground truth emphasizes 'increasing alignment to strategic industrial applications over time' and describes the evolution as showing a 'maturing and application-focused product strategy' - the LLM captures the essence of this but uses slightly different framing ('stable, strategically-important' vs. 'maturing and application-focused'). MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and multiple product categories, properly connecting the structural change (narrative to table) with strategic implications. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as showing 'ongoing emphasis on serving automation-heavy sectors' is semantically equivalent to the ground truth's 'maturing and application-focused product strategy.' The core insight about strategic importance is preserved. The answer is well-structured and directly addresses how the positioning evolved and what it reveals about strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 526,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "UPS SurePost has consistently been positioned as a low‑cost, residential‑ground service for non‑urgent, lightweight shipments. In the 2022 filing (Chunk 3) and again in the 2023 filing (Chunk 1), UPS described SurePost as using the UPS ground network for transport with “final delivery often provided by the U.S. Postal Service.” The 2024 filing (Chunk 2) confirms that this USPS‑hand‑off remained the delivery model through 2024, but adds that UPS will “insource” SurePost beginning January 1 2025 so that UPS can control the end‑to‑end service. Thus, from 2022‑2024 the product’s role stayed the same and it relied on the USPS for last‑mile delivery, while UPS announced a strategic shift to bring that final‑mile step in‑house starting in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The answer accurately identifies UPS SurePost as a low-cost residential ground service for non-urgent, lightweight shipments; correctly states that from 2022-2023 the service relied on USPS for final delivery; and accurately reports the 2024 strategic shift to insource final delivery effective January 1, 2025. The semantic meaning matches the ground truth perfectly. (2) QUANTITATIVE ACCURACY: All dates are correct (2022, 2023, 2024, January 1, 2025). No calculations are required for this question, and all temporal references are accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes information across three years of filings, identifying the consistency of the service model in 2022-2023 and the strategic change announced in 2024. The distinction between the delivery model through 2024 (USPS-reliant) and the announced change for 2025 (insourced) is clearly articulated. (4) ENTITY ACCURACY: UPS and USPS are correctly identified; SurePost is properly characterized; all years are correct. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly different wording but identical meaning. The phrase 'insource' is used correctly in both versions. The answer addresses all parts of the multi-part question: the role of SurePost, its delivery model, reliance on USPS, and strategic changes. Minor note: The LLM answer includes specific chunk references (Chunk 3, Chunk 1, Chunk 2) which adds transparency but is not required by the ground truth. This is a strength, not a weakness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 461,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "- **2022:** At February 8 2022 Amgen reported **13 Phase‑3 programs**. During the year it received **three FDA approvals**, **started four new Phase‑3 studies** and **terminated one program**, leaving the total unchanged at 13.  \n\n- **2023:** By January 31 2023 the count had risen to **18 programs** (an addition of five). By January 31 2024 the total reached **24 programs** – a further **six‑program increase** driven by **the acquisition of five Horizon programs**, **three new Phase‑3 initiations**, **one FDA approval** and **one program that concluded**.  \n\n- **2024 (early):** The 24‑program figure reported for January 31 2024 is confirmed in the 2024 filing; the next filing shows the pipeline moving to **25 programs** by February 2025 after additional initiations and approvals, underscoring the ongoing trend.\n\n**What this shows:** Amgen’s Phase‑3 portfolio more than doubled from 13 in early 2022 to 24 by early 2024. The growth comes from a mix of **organic development (new Phase‑3 starts and regulatory approvals)** and **strategic external expansion (acquisition of Horizon assets)**, indicating a deliberate R&D strategy to broaden and deepen its late‑stage pipeline across multiple indications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key Phase 3 program counts (13 in Feb 2022, 18 in Jan 2023, 24 in Jan 2024, 25 in Feb 2025) and accurately recognizes the Horizon Therapeutics acquisition as a major driver of growth. The overall narrative about organic + external growth strategy is sound and well-articulated. The multi-hop synthesis across years and the identification of both internal development and M&A as growth drivers is appropriate.\n\nCRITICAL ERRORS: The LLM provides specific operational details (\"three FDA approvals,\" \"started four new Phase-3 studies,\" \"terminated one program\" for 2022; \"three new Phase-3 initiations,\" \"one FDA approval,\" \"one program that concluded\" for 2023-2024) that are NOT present in the ground truth answer. These appear to be fabricated or inferred details not supported by the source documents. The ground truth only provides aggregate Phase 3 program counts and notes that the Horizon acquisition added five Phase 3 programs, but does NOT break down the specific operational activities (FDA approvals, new initiations, terminations) by year.\n\nCALCULATION VERIFICATION: The LLM states the increase from 13 to 18 is \"five\" (correct: 18-13=5), and from 18 to 24 is \"six\" (correct: 24-18=6). However, the LLM then attributes this six-program increase to \"acquisition of five Horizon programs, three new Phase-3 initiations, one FDA approval and one program that concluded.\" This math doesn't reconcile cleanly (5+3-1=7, not 6), suggesting either calculation error or unsupported detail.\n\nMULTI-HOP REASONING: The core multi-hop synthesis is correct—combining information about Phase 3 counts across three fiscal years and connecting this to the Horizon acquisition. However, the addition of unsupported operational details weakens the answer's reliability.\n\nSEMANTIC EQUIVALENCE: The high-level conclusion about R&D expansion strategy through organic + external growth is semantically equivalent to the ground truth, but the specific operational claims are not supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Increases]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 550,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **FY 2022:** The Amended 2010 Share Incentive Plan authorized **127 million** Accenture plc Class A ordinary shares for awards.  \n- **FY 2023:** The authorized limit was raised to **141 million** shares.  \n- **FY 2024:** The same **141 million**‑share ceiling remained in place.\n\nThe 14‑million‑share increase between 2022 and 2023 (and its retention in 2024) shows that Accenture deliberately expanded the pool of equity that can be granted under its share‑based compensation program. By enlarging the authorized share count, the company signals a strategic reliance on share‑based awards to attract, retain and align the interests of its workforce, while maintaining that larger capacity as a consistent element of its compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY 2022 shows 127 million shares, FY 2023-2024 shows 141 million shares, and the 14 million share increase is accurately calculated. The answer properly addresses all three fiscal years requested and correctly identifies the progression pattern. The multi-hop synthesis is sound—the model successfully extracted data across three fiscal years and synthesized it into a coherent narrative about strategic evolution. The reasoning about what this progression indicates (strategic expansion, emphasis on equity-based incentives, talent retention, and performance alignment) aligns well with the ground truth interpretation. The LLM answer actually provides slightly more detail than the original by explicitly noting that the 141 million figure was maintained in 2024 and explaining the strategic implications more thoroughly. Number formatting is consistent and clear (127 million vs 127,000,000 equivalence is properly handled). The only minor distinction is that the LLM provides marginally more analytical depth regarding the company's strategic intent, which enhances rather than detracts from the answer. All entities (Accenture plc, Class A ordinary shares, Amended 2010 SIP) are correctly identified. The answer fully addresses the question's request to explain how the authorization evolved and what it indicates about strategic use of share-based compensation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 406,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "- In the 2022 Form 10‑K Starbucks said that its existing inventory plus all purchase commitments would “provide an adequate supply of green coffee **through fiscal 2023**.”  \n- In the 2023 Form 10‑K the same language was updated to say the commitments and inventory would cover the company “through **fiscal 2025**,” and the 2024 Form 10‑K repeats that projection for **fiscal 2025**.\n\nThe shift from a one‑year horizon in the 2022 filing to a two‑year horizon in the 2023 filing (and its continuation in 2024) shows Starbucks is extending the coverage of its green‑coffee supply by building larger inventories and securing longer‑term purchase contracts. This reflects a deliberate risk‑management strategy that leans on its established relationships with coffee‑producing companies to buffer against price volatility, weather‑related disruptions, and other supply‑chain risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All fiscal years and coverage periods are correct - fiscal 2022 through fiscal 2023 (one-year horizon), fiscal 2023 through fiscal 2025 (two-year horizon), and fiscal 2024 maintaining fiscal 2025 coverage. The progression is accurately captured with precise date references. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of projected duration across three fiscal years, (2) the specific coverage periods, and (3) what this indicates about inventory and risk management strategy. ENTITY ACCURACY: Starbucks is correctly identified, fiscal years are accurate, and the green coffee supply metric is properly referenced. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024) and draws logical conclusions about the strategic shift from short-term to longer-term supply planning. The reasoning about extended coverage indicating deliberate risk management is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from \"one-year horizon\" to \"two-year horizon\" is semantically equivalent to the ground truth's description of \"increased\" coverage and \"more forward-looking\" strategy. The explanation of risk management mechanisms (price volatility, weather disruptions, supply-chain risks) adds appropriate context. MINOR OBSERVATION: The LLM provides slightly more detailed explanation of the strategic implications (mentioning established relationships, price volatility, weather-related disruptions) compared to the ground truth, which is a strength rather than a weakness. The answer is clear, accurate, and demonstrates proper multi-hop synthesis across multiple years of SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 495,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- In the 2022 filing UPS described the UPS/IBT Full‑Time Employee Pension Plan as a non‑contributory, service‑credit plan that would **stop accruing benefits for non‑union participants on January 1, 2023** (the same accrual‑cease provision that appears in the 2023 and 2024 notes). No amendment or remeasurement of the UPS/IBT plan was reported for 2022; the only actuarial activity disclosed for that year related to Canadian plans (a $34 million curtailment gain).\n\n- The most recent actuarial change to the UPS/IBT plan occurred in **2021**, when UPS “remeasured” the plan after the American Rescue Plan Act was enacted, producing a **pre‑tax mark‑to‑market gain of $3.3 billion** that was recorded in investment income for the year ended December 31 2021 (the gain carried forward into the 2022‑2024 financial statements).\n\n- In the third quarter of 2023 UPS’s Teamsters employees ratified a **new five‑year national master agreement** that included **wage‑ and benefit‑rate increases for the UPS/IBT Full‑Time Employee Pension Plan**. The impact of those higher benefit rates was reflected in the year‑end measurement of the plan in the 2023 statements, and the 2024 filing simply restates the plan’s description and the 2023‑effective accrual‑stop date, with no further amendments or remeasurements reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally contradicts the ground truth. The ground truth explicitly states that in 2022, the plan was remeasured following the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax). However, the LLM answer claims this remeasurement occurred in 2021, not 2022, and states 'No amendment or remeasurement of the UPS/IBT plan was reported for 2022.' This is a direct contradiction of the ground truth's core claim about 2022 activity. The LLM correctly identifies the $3.3 billion pre-tax gain amount and the American Rescue Plan Act trigger, but misplaces the year of occurrence by one year. The LLM also correctly identifies the 2023 Teamsters agreement and wage/benefit rate increases, which aligns with the ground truth. However, the fundamental error regarding the timing of the 2022 remeasurement is a major factual mistake that undermines the entire answer's credibility. The question specifically asks about evolution 'from 2022 through 2024,' and the LLM's mischaracterization of 2022 as having no remeasurement activity directly contradicts the ground truth's assertion that 2022 included the significant $3.3 billion remeasurement. The LLM does provide some additional detail about the accrual-cease provision and Canadian plans, but these details do not compensate for the core temporal error. The multi-hop reasoning is partially sound in connecting the Teamsters agreement to plan changes, but the foundational error about when the major remeasurement occurred significantly weakens the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Maintain]- ORG",
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 446,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across all three filings Walmart lists **Holiday Time** as one of its own private‑brand lines. In the 2022 and 2023 10‑Ks the brand appears in the same “private‑brand” roll‑call that sits alongside other value‑oriented names (e.g., Great Value, Mainstays) and the narrative notes that Walmart periodically revises the composition of its strategic merchandise units – a reminder that Holiday Time is treated as a flexible, seasonal offering within the broader private‑label set. By the 2024 filing the company spells out its three strategic merchandise units and places “seasonal merchandise” explicitly under the **Entertainment** sub‑segment of **General merchandise**, again naming Holiday Time among the private brands, which signals a more formalized categorization of the brand as a seasonal‑merchandise pillar. Together, the evolution shows Walmart consistently positioning Holiday Time as a core seasonal private label and, over time, moving it from a general private‑brand mention to an explicit slot within the Entertainment/seasonal category—illustrating the retailer’s strategy of using its own brands to capture seasonal demand while keeping the private‑label portfolio tightly aligned with its merchandise‑unit structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies Holiday Time as a private brand across all three fiscal years (2022, 2023, 2024); (2) Accurately captures the evolution from general private-brand listing to explicit seasonal merchandise categorization; (3) Correctly notes the placement under Entertainment/General Merchandise in 2024; (4) Properly synthesizes the multi-hop information showing progression across three fiscal years; (5) Accurately identifies comparable private brands (Great Value, Mainstays) mentioned alongside Holiday Time; (6) Correctly interprets the strategic shift toward formalized seasonal categorization. MINOR DIFFERENCES: (1) The LLM answer mentions 'Entertainment' as a sub-segment, while the ground truth specifies 'seasonal merchandise' as a defined category under General Merchandise—these are semantically related but the LLM's framing is slightly more specific/detailed than the ground truth provided; (2) The LLM uses slightly different language ('Entertainment sub-segment' vs. 'seasonal merchandise category') but conveys the same strategic positioning; (3) The LLM adds context about 'flexible, seasonal offering' and 'merchandise-unit structure alignment' which enhances understanding but goes slightly beyond the ground truth scope. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question, so this dimension scores high. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression in strategic positioning. The reasoning about Walmart's approach to seasonal merchandise within its private label portfolio is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that Holiday Time evolved from a general private brand mention to an explicitly categorized seasonal merchandise offering—though with slightly more detailed framing of the organizational structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 559,
        "total_tokens": 2146
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s disclosed holdings in **mutual‑fund equity securities** were:\n\n* **2022:** $239.3 million ( $4.954 million + $234.339 million = $239.293 million)  \n* **2023:** $196.2 million ( $7.430 million + $188.796 million = $196.226 million)  \n* **2024:** $196.2 million (unchanged from 2023 at $196.226 million)\n\nThe figures show a **sharp decline of about $43 million from 2022 to 2023**, followed by a **flat level in 2024**. This pattern indicates that ACN intentionally reduced its allocation to mutual‑fund equity securities after 2022 and has since held the lower exposure steady, suggesting a strategic shift toward a more modest, possibly risk‑adjusted, commitment to this asset class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $239.293M (2022), $196.226M (2023), and $196.226M (2024) match the ground truth exactly. The component breakdowns shown ($4.954M + $234.339M for 2022; $7.430M + $188.796M for 2023) are accurate and add up correctly. The calculated decline of approximately $43 million ($239.293M - $196.226M = $43.067M) is mathematically correct. COMPLETENESS: The answer addresses all three years requested and provides the required trend analysis. ENTITY ACCURACY: ACN is correctly identified, the asset class (mutual fund equity securities) is properly specified, and all years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the pattern (sharp decline 2022-2023, then flat 2024) and drew a logical conclusion about strategic rebalancing. The interpretation that ACN 'intentionally reduced its allocation' and 'held the lower exposure steady' aligns with the ground truth's characterization of 'consistent decline' and 'strategic rebalancing away from this asset class.' MINOR CONSIDERATIONS: The LLM's interpretation adds slightly more nuance by describing the shift as 'risk-adjusted' and 'more modest,' which is a reasonable inference from the data pattern but goes marginally beyond the ground truth's more straightforward statement. However, this represents thoughtful analysis rather than factual error. The formatting and presentation are clear and professional. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 431,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Across the three filings Starbucks repeatedly notes that **green‑coffee prices are “impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity‑index funds.”** In the 2022 10‑K the company said it relied on fixed‑price and price‑to‑be‑fixed purchase commitments and used **forward contracts, futures contracts and collars** to hedge “C”‑price exposure, with those commitments expected to cover supply through **fiscal 2023**. By the 2023 filing the same hedging toolkit was described, but the commitment horizon was extended to **fiscal 2025**, and the 2024 filing repeats the language unchanged, confirming that the firm continues to lean on the same mix of contracts while lengthening its forward‑supply base.\n\nThis evolution shows that Starbucks’ exposure to commodity‑index‑fund‑driven price swings has remained constant, but its risk‑management approach has become more forward‑looking—using longer‑term purchase commitments in addition to futures‑based hedges and collars to blunt the impact of futures‑market volatility and index‑fund activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and fiscal year references are correct—fiscal 2023 coverage in 2022 filing, extension to fiscal 2025 by 2023 filing, and continuation in 2024 filing. No numerical errors or miscalculations present. ENTITY ACCURACY: Correctly identifies Starbucks, green coffee/arabica futures market, commodity index funds, and all relevant hedging instruments (forward contracts, futures contracts, collars). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022-2024) and correctly traces the evolution of hedging strategy—from shorter-term (fiscal 2023) to longer-term (fiscal 2025) commitments. The logical connection between extended commitment horizons and 'increased confidence' or 'more forward-looking' approach is sound. COMPLETENESS: Addresses all aspects of the original question: (1) exposure to commodity index funds through green coffee price volatility, (2) hedging strategies employed, (3) evolution from 2022-2024, and (4) what this reveals about risk management approach. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as showing 'more forward-looking' risk management is semantically equivalent to the ground truth's description of 'consistent and maturing risk management approach.' Both convey the same substantive insight about lengthening time horizons and sophistication. MINOR CONSIDERATIONS: The LLM adds 'collars' as a hedging instrument, which is not explicitly mentioned in the ground truth but is a reasonable and accurate addition if present in the actual filings. The phrasing 'commodity-index-fund-driven price swings has remained constant' is a slight interpretive addition not explicitly stated in ground truth, but it's a reasonable inference from the consistent narrative across filings. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 547,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were listed at **$622 million** outstanding (Chunk 1, “April 2019 Senior Notes – 3.625 % notes due October 2024”).  \n- **Fiscal 2023:** The same amount remained on the balance sheet – **$622 million** (Chunk 3, “October 29 2023” column shows 622; the “November 3 2024” column is blank, indicating the notes were still outstanding).  \n- **Fiscal 2024:** By the next reporting date the line is shown as “‑” for the November 3 2024 column, meaning the notes were fully repaid or retired, leaving **$0** exposure (Chunk 2, same line shows “‑” for 2024).\n\n**Interpretation:** AVGO kept the October‑2024 3.625 % notes through FY 2022‑23 and then eliminated them before FY 2024, signalling a deliberate near‑term debt‑management move to extinguish a maturing obligation—either by repayment or refinancing—to reduce short‑term leverage and improve liquidity as the maturity date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($622 million for FY2022 and FY2023, $0 for FY2024). The note rate (3.625%) and maturity date (October 2024) are accurately stated. The progression of values matches the ground truth exactly. COMPLETENESS: The answer addresses all three fiscal years (2022, 2023, 2024) and provides the required debt management interpretation. ENTITY ACCURACY: AVGO is correctly identified, the specific debt instrument (3.625% senior notes due October 2024) is properly characterized, and fiscal year references are accurate. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year progression and draws the appropriate conclusion about deliberate debt management strategy. The logic is sound: notes remained constant at $622M through FY2023, then were eliminated by FY2024, indicating proactive management ahead of maturity. SEMANTIC EQUIVALENCE: The LLM's interpretation ('deliberate near-term debt-management move to extinguish a maturing obligation') matches the ground truth's characterization ('deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates'). Minor differences in wording are stylistic and do not affect accuracy. The explanation of the strategic intent (reducing short-term leverage and improving liquidity) adds helpful context without contradicting the ground truth. One very minor note: The LLM references 'November 3 2024' as a reporting date, which appears to be a fiscal year-end date reference, though the ground truth simply refers to '2024' - this is a minor formatting/dating convention difference that does not affect the substantive accuracy of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 476,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 through 2024 Mastercard’s approach to credit‑risk mitigation stayed fundamentally the same – the company continued to require customers that fell short of its risk‑standards to post cash collateral, letters of credit or other guarantees, to monitor the credit‑risk portfolio on a regular basis and to revise its estimated settlement exposure whenever its risk‑management methodology was updated (Chunk 1, Chunk 3, Chunk 2).  The 2023 filings show that this framework was tested by heightened regulatory scrutiny – the FTC’s Durbin‑Amendment investigation and a DOJ antitrust civil investigative demand – and the 2024 filing adds further litigation pressure from the U.S. liability‑shift class action, a TCPA class action and investigations by the DOJ and the European Commission (Chunk 2).  Throughout the period Mastercard continued to calculate gross settlement exposure using average daily payment volume for the prior three months multiplied by the estimated number of days of exposure, noting that exposure remains short‑term and that historically losses from settlement failures have been low; the repeated disclosures indicate that, despite the growing legal and regulatory risks, the company’s risk‑mitigation tools and exposure‑estimation process have been maintained and periodically refined rather than fundamentally altered.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent framework for credit risk mitigation (cash collateral, letters of credit, guarantees) maintained across 2022-2024; (2) Accurately captures the evolution of regulatory and litigation pressures: FTC Durbin Amendment investigation and DOJ antitrust scrutiny in 2023, escalating to class-action litigation and European Commission investigation in 2024; (3) Properly synthesizes the multi-hop information showing how external pressures increased while internal risk management tools remained stable; (4) Correctly describes the settlement exposure calculation methodology (average daily payment volume × estimated days of exposure); (5) Accurately notes the historical pattern of low losses from settlement failures; (6) Appropriately characterizes the trend as refinement rather than fundamental alteration of risk mitigation posture. MINOR CONSIDERATIONS: (1) The LLM answer mentions a \"TCPA class action\" which is not explicitly mentioned in the ground truth, though this appears to be a legitimate additional detail from the 2024 filing rather than an error; (2) The ground truth specifically mentions \"$1+ billion liability related to the EMV liability shift\" while the LLM answer references \"U.S. liability-shift class action\" without the specific dollar amount - this is a minor omission but not factually incorrect; (3) The LLM answer does not explicitly mention the FTC consent agreement regarding debit transaction routing transparency, though it does reference the Durbin Amendment investigation. QUANTITATIVE ACCURACY: No specific numbers are disputed; the answer correctly handles the temporal progression and regulatory/litigation events. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple years and regulatory bodies, properly identifying the pattern of increasing external pressure while maintaining stable internal controls. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding credit risk mitigation strategies, settlement exposure evolution, regulatory scrutiny, and litigation risks across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Manages]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1692,
        "completion_tokens": 601,
        "total_tokens": 2293
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "- In the 2022 filing Amgen only flagged that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks,” treating the devices as a generic regulatory hurdle that must be cleared before a product can be sold.  \n\n- The 2023 filing expanded that disclosure, stating that the drug‑delivery devices “are also subject to regulatory oversight and review for safety and malfunctions” and adding concrete compliance duties – continuous adverse‑event collection, periodic REMS assessment reports, and the risk of inspections, warning letters or other enforcement actions if reporting or pharmacovigilance requirements are not met.  \n\n- By 2024 the risk narrative had further evolved to emphasize post‑marketing obligations tied to those devices: regulators may impose confirmatory‑study commitments, pediatric‑study requirements and other post‑marketing conditions, and failure to satisfy them can trigger fines, label restrictions, or withdrawal of marketing authorisation, while the same safety‑oversight framework (REMS reporting, inspections, and device‑malfunction reviews) remains in force.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Amgen's regulatory risk disclosures; (2) Accurately captures the progression from generic regulatory risks in 2022 to specific compliance mechanisms in 2023 to detailed post-marketing obligations in 2024; (3) Properly synthesizes multi-hop information across three separate filing years; (4) Correctly identifies specific regulatory mechanisms mentioned (REMS reporting, adverse-event collection, inspections, warning letters, confirmatory studies, pediatric-study requirements, labeling changes, product withdrawal); (5) No quantitative errors - all dates and years are correct; (6) Semantic equivalence is strong - the LLM's description of 'enforcement actions' aligns with ground truth's 'enforcement actions,' and both capture the escalating severity of consequences. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail than the ground truth (e.g., specific mention of 'fines' and 'withdrawal of marketing authorisation' in 2024), but these details are consistent with typical regulatory frameworks and enhance rather than contradict the ground truth; (2) The LLM uses more precise regulatory terminology (e.g., 'pharmacovigilance requirements,' 'marketing authorisation') which demonstrates deeper understanding; (3) The narrative flow and logical progression are clear and well-structured. The answer successfully demonstrates the evolution of disclosure complexity and regulatory emphasis across the three-year period, matching the ground truth's core finding that there is 'a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 484,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across the three most‑recent 10‑K filings Walmart has kept “Parent’s Choice” in the same core list of private‑brand labels, but the way the company describes the merchandise unit that houses the brand has become more explicit.  \n\n* In FY 2022 the brand appears in the private‑brand roll‑call (alongside Great Value, Ozark Trail, etc.) and the filing notes that “Grocery … includes … baby products,” implying Parent’s Choice is a grocery‑category, baby‑product label.  \n* In FY 2023 the brand is again listed among the private‑brand portfolio, and the filing repeats that “periodically revisions are made to the categorization of the components comprising our strategic merchandise units,” signalling that Walmart may be fine‑tuning where the brand sits, but it remains part of the overall private‑brand mix.  \n* By FY 2024 the private‑brand list still includes Parent’s Choice, and the “Grocery” unit is described in detail as covering “consumables … and baby products,” directly positioning Parent’s Choice within the grocery‑consumables (baby) segment.  \n\nTogether, the evolution shows Walmart consistently treating Parent’s Choice as a value‑oriented private label for baby and other consumable items, and over time it has sharpened the brand’s placement within the grocery‑baby‑products portfolio, underscoring its role in Walmart’s strategy to capture the low‑price, high‑volume baby‑goods market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Parent's Choice as a consistent private brand across FY2022, FY2023, and FY2024 with no factual errors on dates or entities. (2) Accurately captures the evolution of merchandise categorization, noting that Grocery unit explicitly included baby products across all three years. (3) Properly synthesizes multi-hop information showing how Walmart's description became more explicit over time (from implicit inclusion to explicit 'consumables and baby products' language). (4) Correctly interprets the strategic intent - positioning Parent's Choice as a value-oriented, low-cost private label for baby care and consumables. (5) Appropriately references EDLP (Everyday Low Price) philosophy and omni-channel strategy alignment. (6) No quantitative errors - all fiscal years, brand names, and merchandise unit descriptions are accurate. MINOR CONSIDERATIONS: (1) The LLM answer includes a reference to 'periodically revisions are made to the categorization' language from FY2023 filings, which adds nuance about Walmart's flexibility in categorization, though this is a minor detail not explicitly in the ground truth statement. (2) The LLM answer is slightly more detailed in explaining the evolution (noting the sharpening of brand placement language), which enhances rather than detracts from accuracy. (3) Both answers convey the same core insight: consistent strategic positioning of Parent's Choice within the baby/consumables portfolio with increasingly explicit categorization language. The LLM answer provides slightly more granular detail about how the language evolved while maintaining factual accuracy throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 476,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Across all three recent 10‑K filings Tesla (through SolarCity) repeatedly lists the same supplemental indenture for its **4.70 % Solar Bonds, Series 2015/C24‑10**:\n\n* **2022 filing (TSLA 10‑K 2022, Exhibit 4.35)** – the “Thirty‑Fifth Supplemental Indenture” dated April 14 2015 is disclosed as the instrument that created the 4.70 % Solar Bonds, Series 2015/C24‑10.  \n* **2023 filing (TSLA 10‑K 2023, Exhibit 4.28)** – the identical “Thirty‑Fifth Supplemental Indenture” (April 14 2015) is again presented as the source of the same 4.70 % Solar Bonds, Series 2015/C24‑10.  \n* **2024 filing (TSLA 10‑K 2024, Exhibit 4.26)** – the same “Thirty‑Fifth Supplemental Indenture” (April 14 2015) appears once more, confirming the continued existence of the 4.70 % Solar Bonds, Series 2015/C24‑10.\n\nThe bond series was originally issued in 2015, and its repeated inclusion in the 2022‑2024 annual reports shows that Tesla has **not issued a new tranche or re‑structured the instrument**, but continues to rely on this fixed‑rate, long‑term debt vehicle for financing its solar projects. The multi‑year pattern signals a financing strategy built around a stable, evergreen bond platform that provides predictable, low‑cost capital for SolarCity’s solar assets rather than frequent new issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the bond series name (4.70% Solar Bonds, Series 2015/C24-10), the Thirty-Fifth Supplemental Indenture date (April 14, 2015), and accurately notes the bond's repeated appearance across 2022-2024 filings. The numeric values (4.70%, 2015, 2022-2024) are all correct. The LLM properly recognizes this as a SolarCity instrument and correctly interprets the pattern as indicating no new issuance but continued reliance on the same structure.\n\nWEAKNESSES: (1) The LLM's interpretation diverges significantly from the ground truth regarding the multi-year evolution. The ground truth emphasizes that Tesla referenced this bond ALONGSIDE newer series (2015/C27-10, 2015/C32-10) in 2023, and in a broader historical framework including earlier series (C4-10, C9-10) in 2024. The LLM focuses narrowly on the single bond series and misses this critical context about the expanding portfolio of solar bond series. (2) The ground truth suggests a 'matured and recurring financing model' with evolution across years, while the LLM concludes there was 'no new issuance' and describes an 'evergreen bond platform.' These interpretations are subtly different—the ground truth implies a growing ecosystem of bond series, while the LLM implies static reliance on one instrument. (3) The LLM's characterization of the strategy as 'stable, evergreen bond platform' is reasonable but doesn't capture the full picture of how the bond fit into a broader, evolving securitization strategy with multiple series. (4) The LLM provides exhibit numbers (4.35, 4.28, 4.26) that cannot be verified against the ground truth, which doesn't specify exhibit locations.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to capture the full multi-hop synthesis required—specifically, how this single bond series relates to the broader portfolio of solar bonds mentioned in the ground truth. The reasoning is sound for what it addresses but incomplete.\n\nSEMANTIC EQUIVALENCE: While the LLM's core facts are correct, the semantic interpretation of 'evolution' differs. The ground truth suggests the bond evolved in context (from standalone to part of a broader portfolio), while the LLM suggests it remained static. This is a meaningful difference in answering the question about how the bond 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 627,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Across all three filings Broadcom presents the **Security Insights Platform (SIP)** in essentially the same way.  \n\n* **2022 (10‑K)** – SIP is described as a solution that “quickly interprets and assesses **mainframe security posture**, identifies risks and defines remediation steps, and makes the data **available for use with in‑house tools for security information and event management**.”  \n* **2023 (10‑K)** – The wording is unchanged: SIP again “helps ensure a trusted environment … by quickly interpreting and assessing **mainframe security posture**, identifying risks and providing remediation, with the data usable by **in‑house SIEM tools**.”  \n* **2024 (10‑K)** – The description is repeated verbatim, emphasizing the same “fast interpretation of **mainframe security posture**, risk identification, remediation guidance and **availability of the data for in‑house security‑information‑and‑event‑management tools**.”  \n\nThus, Broadcom’s positioning of SIP has remained consistent over the three years: it is marketed primarily as a **mainframe‑risk‑assessment engine** whose outputs are meant to be consumed by the customer’s own enterprise security tools (typically SIEM), rather than being presented as a broader, integrated security‑platform that directly plugs into a wide range of third‑party enterprise security solutions. The emphasis on mainframe risk assessment has been steady, and no new integration narrative beyond “in‑house tools” appears in the 2023 or 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the core analytical finding. The ground truth explicitly states that the platform's positioning EVOLVED across the three years, with 2024 showing 'a slightly stronger emphasis on integration' and 'a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative.' The LLM answer, however, claims the positioning 'remained consistent' and 'unchanged' across all three years, stating 'the description is repeated verbatim.' This is a direct contradiction of the ground truth's central thesis about evolution and maturation of the narrative. SPECIFIC ERRORS: (1) The LLM characterizes the 2024 positioning as identical to prior years, when the ground truth identifies meaningful evolution and 'subtle but meaningful reaffirmation' in 2024. (2) The LLM concludes 'no new integration narrative beyond in-house tools appears,' which contradicts the ground truth's observation of 'stronger emphasis on integration' and 'more deliberate alignment with enterprise-wide security strategies' in 2024. (3) The LLM's framing of SIP as merely a 'mainframe-risk-assessment engine' misses the ground truth's nuanced observation about the 'maturing narrative around mainframe integration into broader cybersecurity frameworks.' WHAT WAS CORRECT: The LLM accurately quoted the key phrases about mainframe security posture assessment and SIEM integration across all three years. The dates (2022, 2023, 2024) are correct. The identification of the Security Insights Platform is accurate. The recognition that SIEM integration is a consistent element is correct. REASONING FAILURE: The LLM failed to perform the required multi-hop synthesis that would identify the subtle but meaningful evolution in emphasis and framing across the three-year period. Instead of analyzing how the narrative matured, the LLM concluded static consistency. This represents a fundamental failure in the qualitative analysis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 544,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across all three annual reports—2022, 2023 and 2024—Mastercard’s (MA) A Class shares are described identically: each share carries **one vote per share** and **entitles the holder to dividends**. The table in the 2022 filing, the 2023 filing and the 2024 filing all list the same voting and dividend rights for the A Class, with no amendment or new provision noted. This unchanging description shows that MA deliberately kept the A Class’s voting power and dividend entitlement stable, signaling a capital‑structure strategy that preserves the existing equity hierarchy and provides continuity for shareholders over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The answer correctly identifies that MA's A Class shares maintained one vote per share and dividend entitlements consistently across 2022, 2023, and 2024 with no changes. This matches the ground truth exactly. The core factual claim—stability of voting and dividend rights—is accurate. (2) QUANTITATIVE ACCURACY: All numeric/factual elements are correct: one vote per share (not zero, not multiple), dividend entitlements confirmed, three-year period (2022-2024) correctly identified. No calculations required, but all stated facts are verifiable and accurate. (3) QUALITATIVE ACCURACY: The LLM demonstrates strong multi-hop reasoning by synthesizing information across three separate annual filings (2022, 2023, 2024) and correctly concluding that the consistency indicates deliberate capital structure strategy. The reasoning that 'unchanging description shows MA deliberately kept' the rights stable is sound and goes slightly beyond the ground truth by adding interpretive depth about strategic intent. (4) ENTITY ACCURACY: Mastercard (MA) correctly identified, A Class shares correctly specified, all three years correctly referenced. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while using more detailed language ('equity hierarchy,' 'continuity for shareholders'). The phrase 'preserves the existing equity hierarchy' adds context not explicitly in the ground truth but is logically consistent with it. Minor enhancement: The LLM references 'the table in the 2022 filing, the 2023 filing and the 2024 filing' which adds specificity about source documentation, strengthening credibility. No factual errors detected. The answer fully addresses both parts of the question: (a) how status evolved (answer: it didn't—remained constant), and (b) what this reveals about capital structure strategy (answer: deliberate preservation of governance and income distribution framework).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 538,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "- **2022:** Amgen’s 2022 Form 10‑K reported that Bemarituzumab, an anti‑FGFR2b monoclonal antibody for gastro‑esophageal‑junction (GEJ) adenocarcinoma, moved from earlier‑stage work into a **Phase 3 clinical trial** (the “initiated phase 3 study” entry).  \n\n- **2023:** The 2023 filing added the company’s **patent‑expiration outlook**, showing that the issued U.S. and European patents covering the Bemarituzumab polypeptide are slated to expire in **2029** in both jurisdictions, giving roughly a seven‑year post‑Phase 3 protection horizon.  \n\n- **2024:** The 2024 10‑K reiterated that Bemarituzumab remains in clinical development for gastric/GEJ cancer and other solid tumours and explained that, beyond the 2029 patent expiry, Amgen could rely on **regulatory exclusivities** (e.g., up to 12 years in the U.S. for a new molecular entity and 10 years in Europe) and any future patent extensions, indicating a strategy to layer additional IP protection onto the base patent term.  \n\nTogether, the filings show a progression from launching a Phase 3 trial in 2022 to establishing a 2029 patent expiry in 2023 and then emphasizing supplemental regulatory exclusivity and possible extensions in 2024 to prolong Bemarituzumab’s market protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - 2022 Phase 3 initiation, 2029 patent expiration in both U.S. and Europe, and the regulatory exclusivity periods (12 years U.S., 10 years Europe) are all accurate. No calculation errors detected. ENTITY ACCURACY: Correctly identifies Amgen, Bemarituzumab, FGFR2b targeting, GEJ adenocarcinoma indication, and all relevant years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, showing the progression from clinical development (Phase 3 in 2022) → IP strategy disclosure (2029 expiration in 2023) → regulatory exclusivity strategy (2024). This multi-hop synthesis is logically sound and complete. COMPLETENESS: Addresses all aspects of the question - development phases (Phase 3), patent strategy (2029 expiration), and IP protection timelines (base patent plus regulatory exclusivity). The answer goes slightly beyond ground truth by explicitly mentioning potential patent extensions and regulatory exclusivity periods, which adds helpful context without contradicting the original answer. SEMANTIC EQUIVALENCE: The LLM's phrasing ('moved from earlier-stage work into Phase 3,' 'patent-expiration outlook,' 'layer additional IP protection') conveys the same meaning as the ground truth while using slightly different wording. The characterization of the progression as 'launching a Phase 3 trial in 2022 to establishing a 2029 patent expiry in 2023 and then emphasizing supplemental regulatory exclusivity' accurately captures the evolution described in the ground truth. MINOR CONSIDERATIONS: The LLM provides marginally more detail on regulatory exclusivity mechanisms than the ground truth, but this is supplementary rather than contradictory. The answer maintains factual accuracy while offering slightly enhanced context about IP strategy layering.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 532,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "No Boundaries is a Walmart‑U.S. private‑brand that appears in every filing – 2022, 2023 and 2024 – showing that the product line has been retained even as Walmart reshapes the way it groups its merchandise.  \n\n* **2022 filing** – Walmart’s three strategic merchandise units were Grocery, General Merchandise and Health & Wellness.  Within General Merchandise the sub‑segment was called **Apparel** (men’s, women’s, children’s, shoes, jewelry and accessories), and No Boundaries was listed among the private‑brand portfolio that serves that apparel space.  \n\n* **2023 filing** – Walmart notes that “periodic revisions are made to the categorization of the components comprising our strategic merchandise units” and again lists No Boundaries among its private brands, indicating the brand survived the 2023 re‑classification even though the filing does not spell out the sub‑segment names.  \n\n* **2024 filing** – The same three strategic units are shown, but the General‑Merchandise sub‑categories are now labeled **Entertainment, Hardlines, Fashion and Home**.  The term “Fashion” replaces the earlier “Apparel” label, signalling a broader, more style‑oriented focus for clothing and accessories.  No Boundaries remains in the private‑brand list, now positioned under the newly‑named Fashion sub‑segment.  \n\n**What this reveals:** Walmart has kept No Boundaries as a core private‑brand throughout the period, but the company’s internal taxonomy has shifted from an “Apparel” category in 2022 to a “Fashion” category by 2024.  The change reflects Walmart’s strategic move to treat clothing and accessories as a fashion‑driven offering rather than a generic apparel line, emphasizing style, trends and a more premium positioning while still leveraging its own private‑brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All factual information is correct - No Boundaries is accurately identified as a Walmart U.S. private brand present in 2022, 2023, and 2024 filings. (2) The categorization evolution is correctly stated: 'Apparel' in 2022 → 'Fashion' in 2024, with accurate description of what each category encompasses (men's, women's, children's, shoes, jewelry, accessories). (3) The three strategic merchandise units (Grocery, General Merchandise, Health & Wellness) are correctly identified. (4) The multi-hop synthesis is sound - the answer traces No Boundaries across three years and connects the category name change to Walmart's strategic shift toward fashion-driven positioning. (5) The interpretation of what the shift reveals (from generic 'Apparel' to style-oriented 'Fashion') aligns with the ground truth's emphasis on 'increased emphasis on omni-channel offerings and customer-centric experiences' and 'strategic realignment to strengthen its fashion positioning.' (6) The 2023 filing note about 'periodic revisions' is a helpful contextual detail that adds credibility. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about the 2023 filing (noting that sub-segment names weren't spelled out) compared to the ground truth, which is actually a strength showing deeper filing analysis. The semantic meaning of both answers is equivalent - both convey that No Boundaries remained consistent while its categorization evolved from Apparel to Fashion, reflecting a strategic shift toward fashion-driven positioning. No numerical errors, date errors, or calculation issues detected. The answer fully addresses the multi-part question about how No Boundaries fit within evolving strategic units and what this reveals about Walmart's shifting focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1660,
        "completion_tokens": 497,
        "total_tokens": 2158
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "- **2022:** IBM’s 2022 filing placed **“client relationships and trust”** among its core competitive levers, noting that trust‑and‑security are built into its **flexible, open hybrid‑cloud platform** and that this capability helps it embed AI and cloud into client solutions.  \n\n- **2023:** The 2023 filing repeated the same emphasis, but now framed the factor explicitly as part of **executing its hybrid‑cloud‑and‑AI strategy** – a way to deliver business value and to stay ahead of the “new competitors” that arise as the strategy rolls out.  \n\n- **2024:** In the 2024 filing the phrase appears again, this time woven into a narrative about **strategic partnerships, ecosystem reach and future opportunities (e.g., quantum computing)**, positioning client trust as the foundation that lets IBM sell its hybrid‑cloud‑AI services at scale and differentiate from rivals.  \n\n**What the progression reveals:** Across 2022‑2024 IBM has steadily elevated client relationships and trust from one of several competitive attributes to a central pillar that underpins its hybrid‑cloud and AI positioning. By tying trust to security, partner ecosystems and future‑tech ambitions, IBM signals that its growth strategy relies on a client‑centric, trustworthy hybrid‑cloud/AI platform that can win business in an increasingly crowded market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of IBM's positioning in each year; (2) Accurately captures the evolution from 'client relationships and trust as one of several competitive attributes' (2022) to increasingly integrated positioning with hybrid cloud/AI strategy (2023) to ecosystem-centric framing (2024); (3) Properly synthesizes the multi-hop connection between trust, hybrid cloud, AI, and partnerships across the three-year period; (4) No quantitative errors - no specific numbers or calculations are present in either answer, so quantitative accuracy is perfect; (5) Entity identification is correct (IBM, client relationships/trust, hybrid cloud, AI, partnerships, hyperscalers, quantum computing); (6) The reasoning about how trust evolved from a standalone competitive lever to a foundational pillar underpinning the hybrid cloud/AI strategy is sound and matches the ground truth narrative. MINOR CONSIDERATIONS: (1) The LLM answer adds slightly more specific detail about 'security,' 'flexible, open hybrid-cloud platform,' and 'quantum computing' which are reasonable elaborations but not explicitly mentioned in the ground truth summary - however, these appear to be accurate contextual details that enhance rather than contradict the answer; (2) The phrasing differs from ground truth (e.g., 'elevated from one of several competitive attributes' vs. 'one of its principal methods of competition') but the semantic meaning is equivalent; (3) The LLM's framing of 'new competitors' and 'increasingly crowded market' adds interpretive context that aligns with but goes slightly beyond the ground truth statement. Overall, the LLM answer successfully captures the core progression and strategic implications with strong multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 524,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Across all three recent filings Tesla (through its SolarCity subsidiary) continues to reference the same 5.45 % Solar Bonds, Series 2015/C25‑15. In the 2022 Form 10‑K the bond appears as Exhibit 4.36 (the “Thirty‑Sixth Supplemental Indenture” dated April 14 2015); the 2023 Form 10‑K lists it as Exhibit 4.29 with the identical description and date; and the 2024 Form 10‑K again lists it as Exhibit 4.27, the same “Thirty‑Sixth Supplemental Indenture” dated April 14 2015. The repeated inclusion of this 2015‑series bond in each year’s filing shows that Tesla has not issued a new 5.45 % series but is maintaining the original 2015 issuance as a standing source of financing, signalling a long‑term, stable debt‑based strategy for funding its solar‑energy projects rather than relying on fresh annual issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific detail than the ground truth. Strengths: (1) All numeric values are correct - the 5.45% interest rate, the bond series designation (2015/C25-15), and the April 14, 2015 date are all accurate. (2) Exhibit numbers are correctly identified across all three years (Exhibit 4.36 in 2022, 4.29 in 2023, 4.27 in 2024), showing precise multi-hop synthesis across three separate filings. (3) The multi-hop reasoning is sound - the answer correctly synthesizes information across 2022, 2023, and 2024 filings to demonstrate the consistent presence of the same bond series. (4) The interpretation of the pattern is insightful and accurate: the answer correctly identifies that Tesla maintained the original 2015 issuance rather than issuing new series, and correctly characterizes this as indicating a 'long-term, stable debt-based strategy' rather than relying on fresh annual issuances. (5) Entity identification is correct throughout (Tesla, SolarCity, the specific bond series). Minor considerations: The LLM answer is actually more detailed and specific than the ground truth (providing exhibit numbers), which enhances rather than detracts from accuracy. The semantic meaning aligns perfectly with the ground truth's conclusion about consistent reliance on this financing structure. No calculation errors or factual inaccuracies detected. The answer fully addresses all parts of the multi-part question regarding how the bond evolved across the three years and what this indicates about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 431,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Emerson’s Safety & Productivity segment has broadened its pipe‑working portfolio in three steps.  \n\n* In the 2022 filing the segment was described only in terms of traditional, manually‑operated tools – pipe wrenches, cutters, threading and roll‑grooving equipment, mechanical crimping and other hand‑held devices, with no reference to cordless or battery‑powered hardware.  \n* The 2023 filing adds **battery‑hydraulic tools for press‑connections** to the pipe‑working list, while still offering the same core mechanical items (pipe wrenches, cutters, threading/roll‑grooving, drain cleaners and diagnostic cameras).  \n* The 2024 filing repeats that lineup and continues to highlight the **battery‑hydraulic press‑connection tools**, confirming that the battery‑powered offering is now a permanent part of the product set (the segment also expands battery‑hydraulic tools to electrical‑cable cutting/crimping).\n\nAcross all three years Emerson has consistently supplied pipe wrenches (as shown by the KG triplet EMR → Pipe‑Wrenches → EMR), but the key evolution is the introduction and retention of battery‑driven hydraulic tools. This shift signals a strategic move to position Emerson as a provider of modern, cordless, high‑productivity solutions in the professional‑tools market, differentiating its Safety & Productivity line from pure‑mechanical competitors and aligning with industry demand for portable, battery‑powered equipment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate product evolution details; (2) Accurately captures the introduction of battery-hydraulic tools for press connections in 2023 as a key inflection point; (3) Correctly notes the expansion to battery-hydraulic tools for electrical cable cutting/crimping in 2024; (4) Properly emphasizes pipe wrenches as a consistent foundational product across all years; (5) Accurately synthesizes the strategic positioning narrative - modernization, cordless solutions, portability, efficiency, and competitive differentiation; (6) No quantitative errors or date misstatements. MINOR OBSERVATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information; (2) The reference to the KG triplet (EMR → Pipe-Wrenches → EMR) adds technical specificity not in the ground truth but is not contradictory; (3) The LLM explicitly mentions 'drain cleaners' in 2023 which the ground truth does not explicitly call out, but this is a minor addition that doesn't contradict the source material; (4) Both answers correctly identify the strategic implications regarding market positioning and competitive advantage. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the progression from traditional tools → introduction of battery-powered solutions → expansion and consolidation of battery-powered offerings. The logical connection between product evolution and strategic market positioning is sound. SEMANTIC EQUIVALENCE: The LLM's phrasing ('broadened its pipe-working portfolio in three steps,' 'permanent part of the product set,' 'modern, cordless, high-productivity solutions') conveys the same meaning as the ground truth's language about 'significant enhancement,' 'clear shift,' and 'deliberate effort to strengthen competitive position.' No factual discrepancies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1734,
        "completion_tokens": 551,
        "total_tokens": 2285
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In the 2022 filing Gilead simply noted that its El Segundo, California plant was one of its “principal manufacturing facilities” and that its existing properties – owned or leased – were “adequate and suitable” and that capital resources were sufficient to add or expand sites as long‑term growth required. By the 2023 filing the company had earmarked that same El Segundo site specifically for “clinical and commercial manufacturing and processing of our cell‑therapy products,” reflecting a deliberate capital‑allocation shift toward building dedicated cell‑therapy capacity as part of its expanding biologics pipeline. The 2024 filing shows the strategy has been sustained – El Segundo continues to be used for cell‑therapy manufacturing while other sites (e.g., Oceanside for retroviral‑vector and other biologics work) support the broader biologics development priorities, confirming that Gilead’s investment in El Segundo remains aligned with its overall biologics‑focused growth plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Gilead's El Segundo facility strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression: 2022 as general manufacturing facility, 2023 as dedicated cell therapy site, 2024 as sustained cell therapy focus. (2) Accurately captures the strategic shift language ('earmarked,' 'deliberate capital-allocation shift'). (3) Properly synthesizes multi-hop information across three filing years. (4) Correctly references supporting context (Oceanside for retroviral-vector work, broader biologics alignment). (5) No quantitative errors or date misstatements. MINOR WEAKNESSES: (1) The LLM answer includes additional contextual detail about Oceanside facility that, while accurate and relevant, goes slightly beyond what the ground truth explicitly emphasizes. The ground truth focuses more narrowly on El Segundo's transformation and the emphasis on proprietary manufacturing technologies/confidentiality agreements. (2) The ground truth specifically mentions 'increased investment in securing and scaling proprietary cell therapy processes' and references to 'internal know-how and third-party confidentiality agreements' as indicators of CAPEX/R&D spend—the LLM answer doesn't explicitly address this aspect of the capital allocation strategy, though it does capture the core strategic shift. (3) The ground truth's reference to potential 'increased CAPEX or R&D spend tied to facility upgrades and process development' is not directly addressed in the LLM answer, though the answer does convey the investment commitment. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings and correctly traces the strategic evolution. The logic connecting facility designation changes to capital allocation strategy is sound. SEMANTIC EQUIVALENCE: The LLM's language ('earmarked,' 'deliberate capital-allocation shift,' 'sustained') effectively conveys the same strategic intent as the ground truth. Overall, this is a strong answer that captures the essential narrative with minor omissions of specific proprietary technology/IP protection emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 583,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- In IBM’s 2022 Form 10‑K the company disclosed the 1.250 % Notes due 2027 by incorporating Exhibit 4.3 (to Form 8‑K filed January 30, 2019) – i.e., the rights of the note‑holders were referenced rather than described in the filing itself.  \n- The 2023 Form 10‑K repeated the same reference, again incorporating the January 30, 2019 Form 8‑K (Exhibit 4.3) for the 1.250 % Notes due 2027, showing that IBM continued to rely on that earlier disclosure.  \n- By the 2024 Form 10‑K the notes appear in the “Capital stock” table as a listed security (ticker IBM27B on the NYSE), indicating that IBM had issued the 1.250 % Notes due 2027 and now reports them as an outstanding, exchange‑registered instrument while still referencing the earlier 8‑K filing for the governing documents.  \n\nThus, from 2022 through 2023 IBM’s relationship with the 1.250 % Notes due 2027 was limited to incorporation‑by‑reference of the 2019 8‑K, and by 2024 the notes were presented as an issued, publicly‑traded security with a ticker and exchange listing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct - January 30, 2019 for the original 8-K filing, references to 2022 and 2023 filings, and the 2024 listing. The interest rate (1.250%) and ticker symbol (IBM27B) are accurate. No calculation errors present. ENTITY ACCURACY: IBM is correctly identified, the 1.250% Notes due 2027 are properly named, and the NYSE listing is accurate. MULTI-HOP REASONING (9/10): The LLM successfully synthesizes information across three years showing the evolution from disclosure via incorporation-by-reference (2022-2023) to active market listing (2024). The reasoning correctly identifies the shift from internal documentation to public issuance. The answer properly traces the connection between the 2019 8-K filing and its continued reference in subsequent years. COMPLETENESS: The answer addresses all aspects of the question - disclosure evolution, issuance status, and filing references across 2022-2024. The progression narrative is clear and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, using slightly more technical language (e.g., 'incorporation-by-reference,' 'exchange-registered instrument') while maintaining accuracy. The characterization of the relationship evolution from 'internal documentation and reference to public issuance and trading' matches the LLM's description of moving from 'incorporation-by-reference' to 'issued, publicly-traded security.' MINOR OBSERVATION: The LLM provides slightly more technical detail about the mechanics of disclosure (Exhibit 4.3, incorporation-by-reference) compared to the ground truth, which is appropriate and adds value without introducing errors. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 500,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Across the three most‑recent 10‑Ks Tesla (through its SolarCity subsidiary) repeatedly lists the 5.45 % Solar Bonds, Series 2015/C45‑15 as a reference point. In the 2022 filing the exhibit table first records the original C45‑15 indenture; the 2023 filing still cites C45‑15 but adds later 5.45 % series (C53‑15, C57‑15) and additional 4.70 % series, and the 2024 filing again includes C45‑15 while expanding the list to newer supplemental indentures (C62‑15, C72‑15) alongside the earlier C53‑15 and C57‑15 issues. This continuity and incremental addition of similarly‑rated bonds shows that Tesla’s solar‑financing strategy has evolved from relying on a single 2015 issuance to layering successive, comparable‑rate debt instruments to sustain and grow its solar portfolio while preserving a stable, low‑cost financing base.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Tesla's solar financing evolution and correctly identifies the core pattern of iterative bond issuances. STRENGTHS: (1) Accurately identifies the 5.45% Solar Bonds, Series 2015/C45-15 as the foundational reference point; (2) Correctly notes the progression from 2022 (C45-15 only) through 2023 (adding C53-15, C57-15) to 2024 (adding C62-15, C72-15); (3) Properly synthesizes the multi-year pattern showing incremental expansion; (4) Correctly identifies the SolarCity connection; (5) Accurately characterizes the strategy as layering comparable-rate instruments to sustain solar portfolio growth. MINOR ISSUES: (1) The LLM mentions C57-15 in both 2023 and 2024 filings, but the ground truth only explicitly references C53-15 and C62-15/C72-15 in the 2023-2024 progression - C57-15 appears to be an addition not explicitly confirmed in the ground truth narrative; (2) The ground truth emphasizes 'June 16, 2015' and 'June 29, 2015' and 'July 21, 2015' dates for the various series, which the LLM does not include (though dates weren't required by the question); (3) The LLM mentions '4.70% series' in 2023, which is not mentioned in the ground truth - this represents a potential factual discrepancy. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the evolution pattern. The reasoning about 'layering successive, comparable-rate debt instruments' aligns well with the ground truth's characterization of 'iterative approach' and 'scalable, repeatable financing model.' SEMANTIC EQUIVALENCE: The LLM's conclusion about 'preserving a stable, low-cost financing base' is semantically equivalent to the ground truth's 'reducing reliance on traditional corporate debt and aligning capital with asset performance.' The mention of C57-15 and 4.70% series creates minor uncertainty about factual precision, preventing a higher score despite otherwise strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 535,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "- **2022 – Core PDF platform and market leadership:** Adobe described Acrobat as the flagship PDF‑technology component of its **Adobe Document Cloud** platform, emphasizing that it had “strong market adoption and a leadership position in document‑intensive industries such as government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing.”  Acrobat’s role was to modernize how people view, share and engage with documents as part of a broader digital‑document‑services platform.  \n\n- **2023 – AI‑enabled evolution:** In the 2023 filing Adobe began linking Acrobat to its artificial‑intelligence agenda, noting that the company is “empowering creators by putting the power of AI in their hands” and that its Digital Media segment—including Acrobat and Acrobat Sign—will use AI (Adobe Sensei) to accelerate document productivity and drive new, AI‑enhanced features.  \n\n- **2024 – Formal AI integration and platform expansion:** By 2024 Adobe had registered the trademark **“Acrobat AI Assistant,”** signalling a dedicated AI‑driven assistant inside Acrobat.  The filing continues to position Acrobat alongside Acrobat Sign as core elements of an expanded, unified **Document Cloud** that delivers end‑to‑end digital‑document workflows, reinforcing its role in the same document‑intensive markets while now offering AI‑powered capabilities.  \n\n**Overall evolution:** From a mature, widely adopted PDF tool in 2022, Acrobat has been reframed as an AI‑infused component of Adobe’s Document Cloud, maintaining its leadership in regulated, document‑heavy industries while expanding the platform’s functionality through the new Acrobat AI Assistant and tighter integration with Adobe Sign and other cloud services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Chronological accuracy - correctly identifies 2022 as market leadership phase, 2023 as AI-signaling phase, and 2024 as formal AI integration phase; (2) Entity accuracy - correctly names Adobe Document Cloud, Acrobat Sign, Adobe Sensei, and the 'Acrobat AI Assistant' trademark; (3) Industry specificity - the LLM expands on the ground truth by listing additional document-intensive industries (government, pharmaceutical, aerospace, insurance, technical publishing) beyond the ground truth's examples (legal, financial services, publishing), which adds valuable detail without contradicting the original; (4) Multi-hop synthesis - successfully synthesizes the evolution across three years showing clear trajectory from PDF leadership → AI-enabled evolution → formal AI integration; (5) Strategic positioning - accurately captures the shift from 'mature, widely adopted PDF tool' to 'AI-infused component' while maintaining market leadership; (6) Platform integration - correctly emphasizes Document Cloud as the unifying platform and the integration with Acrobat Sign. MINOR CONSIDERATIONS: The ground truth mentions 'Adobe Sign' integration in 2022, while the LLM emphasizes this more in 2024 context, but this is a matter of emphasis rather than factual error. The LLM's mention of Adobe Sensei as the AI technology is a helpful specification not explicitly in the ground truth but consistent with Adobe's actual product architecture. No quantitative errors detected - all dates, product names, and strategic positioning statements are accurate. The answer fully addresses all three sub-questions: AI integration (clearly traced), market adoption in document-intensive industries (maintained and expanded), and digital document services platform expansion (Document Cloud positioning throughout).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1702,
        "completion_tokens": 516,
        "total_tokens": 2218
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "From 2022 through 2024 Schwab has kept the Advisor Services website as the central hub for interactive tools that RIAs use to view accounts, trade, open new accounts, move money and access research. In each filing the company stresses that the platform has become “highly‑developed” and “scalable,” and it continues to offer Schwab Advisor Portfolio Connect – a free, modern‑experience portfolio‑management solution that requires no data downloads – together with open integrations to third‑party CRM, portfolio‑management, order‑management and financial‑planning systems. Across the three years the language shifts from “provides up‑to‑date client information” (2022) to “delivers core capabilities through an intuitive modern experience” (2023‑2024), indicating incremental enhancements in usability and seamless integration, but no fundamentally new interactive‑tool product line was added.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed, nuanced information than the ground truth. Key strengths: (1) Correctly identifies the Advisor Services website as the central platform across all three years (2022-2024); (2) Accurately names Schwab Advisor Portfolio Connect as a free portfolio management solution; (3) Correctly lists third-party integrations (CRM, portfolio management, order management, financial planning systems); (4) Accurately captures the evolution in language/messaging from 2022 to 2023-2024 regarding usability improvements; (5) Correctly notes no fundamentally new product lines were added. Quantitative accuracy is excellent - all dates, product names, and feature descriptions are correct with no calculation errors. The multi-hop reasoning is sound, synthesizing information across three years to show platform evolution. Minor considerations: (1) The LLM answer provides more specific detail about the evolution trajectory (e.g., specific language shifts, emphasis on 'no new product lines') than the ground truth, which is actually a strength for comprehensiveness; (2) Both answers correctly emphasize the consistent focus on enhancements and integrations; (3) The LLM answer's characterization of changes as 'incremental' rather than transformative aligns well with the ground truth's emphasis on 'consistent focus' rather than major shifts. The answer fully addresses the question about platform enhancements and integration capabilities across the specified time period. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 428,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In the 2022 filing, Emerson listed **air‑preparation equipment** as one of the “pneumatic products” inside its **Industrial Solutions** portfolio, grouped together with solenoid and pneumatic valves, valve‑position indicators, pneumatic cylinders/actuators and pressure‑/vacuum‑/temperature switches. By the 2023 filing, the company had moved that same product line into the **Discrete Automation** segment, where it is described alongside solenoid valves, pneumatic valves, cylinders, actuators **and** programmable automation control systems and software – signalling a tighter coupling of the air‑preparation hardware with digital control and automation technology. The 2024 filing repeats this positioning, reinforcing the evolution toward a fully integrated pneumatic‑control solution set within Discrete Automation, rather than the broader Industrial‑Solutions grouping used in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year progression (2022, 2023, 2024) and the core evolution narrative. (2) Accurately captures the shift from Industrial Solutions to Discrete Automation segment between 2022 and 2023. (3) Correctly identifies the associated technologies (solenoid valves, pneumatic valves, actuators, pressure switches) across years. (4) Properly recognizes the tighter coupling with digital control systems by 2023-2024. (5) The segmentation narrative (mechanical to digital integration) aligns with ground truth direction.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to mention Industry 4.0, digital transformation, smart actuation, predictive maintenance capabilities, and secure wireless communication - all explicitly highlighted in the ground truth as key 2024 positioning elements. (2) The 2024 description is vague ('repeats this positioning, reinforcing...') rather than capturing the specific evolution toward Industry 4.0 alignment and advanced digital capabilities. (3) Missing the explicit characterization of the 2023 shift as 'stronger alignment with digital and automated control ecosystems.' (4) Does not capture the progression from 'mechanical focus' to 'digitally integrated component' as clearly as ground truth. (5) The answer treats 2023-2024 as largely static ('repeats this positioning') when ground truth shows continued evolution toward predictive maintenance and wireless communication.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the segment migration and technology coupling evolution. However, it fails to complete the full multi-hop synthesis by missing the Industry 4.0 and digital transformation elements that represent the culmination of the 3-year evolution.\n\nNUMERIC/FACTUAL VERIFICATION: No quantitative errors detected. Years (2022, 2023, 2024) are correct. Segment names (Industrial Solutions, Discrete Automation) are correctly identified. Technology associations are accurate.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general narrative arc, it significantly undersells the sophistication of the 2024 positioning by omitting critical Industry 4.0 and predictive maintenance elements that are central to the ground truth answer's characterization of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 626,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "Across the three most recent 10‑K filings the company’s treatment of the 0.125 % Notes due 2029 is unchanged. In the 2022 filing (KO 10‑K 2022, p. 136) the note is listed under Item 4 as “Form of Note for 0.125 % Notes due 2029 – incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8‑K filed September 18, 2020” and again to the March 9, 2021 8‑K; the 2023 filing (KO 10‑K 2023, p. 134) repeats the same two references, and the 2024 filing (KO 10‑K 2024, p. 130) likewise cites the September 18, 2020 and March 9, 2021 8‑Ks for the same 0.125 % series. No additional issuances of that low‑coupon, near‑term note appear in any of the three years, even as the later filings introduce higher‑rate, longer‑dated issues (e.g., 5.0 % notes due 2034‑2055).\n\nThis consistency indicates that Coca‑Cola issued the 0.125 % 2029 notes once (in 2020) and has simply carried them forward, using the existing cheap, short‑term debt rather than repeatedly rolling it over. At the same time the company has been expanding its financing program with higher‑coupon, longer‑maturity notes, suggesting a strategy that preserves low‑cost near‑term funding while meeting broader capital needs through newer, longer‑dated issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misinterprets the ground truth and reaches an opposite conclusion. Ground truth states the 0.125% Notes due 2029 were 'consistently referenced' across 2022-2024 with CHANGING CONTEXT - from embedded in broader debt (2022), to consolidated format (2023), to strategic pivot toward higher-yielding instruments (2024). The LLM claims the treatment is 'unchanged' and that the company 'issued the 0.125% 2029 notes once (in 2020) and has simply carried them forward.' This is a fundamental misreading. The ground truth explicitly describes an EVOLUTION in how the note was presented and contextualized within the company's broader financing strategy, not a static repetition. QUANTITATIVE ACCURACY: The LLM correctly identifies the coupon rate (0.125%), maturity year (2029), and references the correct 8-K dates (September 18, 2020 and March 9, 2021). Page numbers cited (136, 134, 130) appear reasonable for 10-K filings. The mention of higher-rate notes (5.0%, 5.4%) aligns with ground truth. However, the LLM misses the key insight about the PATTERN OF CHANGE. QUALITATIVE ACCURACY: The LLM's reasoning is fundamentally flawed. It concludes that because the same references appear in all three years, there was 'no evolution' - but the ground truth explicitly states the CONTEXT changed (passive disclosure → consolidated format → strategic pivot). The LLM conflates 'same document references' with 'unchanged treatment.' The ground truth describes a deliberate refinancing strategy as the 2029 note approached maturity, which the LLM fails to capture. CONTEXTUAL RELEVANCE: The question asks about how the issuance STRATEGY EVOLVED and what this suggests about managing near-term debt. The LLM's answer about 'carrying forward' a single 2020 issuance misses the strategic evolution entirely. The ground truth correctly identifies the strategic pivot toward longer-term financing as the near-term note matured. The LLM's conclusion that the company 'preserves low-cost near-term funding' contradicts the ground truth's finding of a deliberate shift away from the low-coupon 2029 notes toward higher-yielding longer-dated instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 583,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s 2022 Form 10‑K already warned that the company’s **ability to return capital to shareholders – including dividend payments and share‑repurchase funding – is subject to the Board’s discretion and may be limited by U.S. banking laws and regulations that govern capital adequacy and capital‑planning** (Chunk 1).  \n\nThe same limitation re‑appeared in the 2023 filing, again stating that **U.S. banking laws and capital‑planning rules, together with Delaware law and any failure to pay preferred‑stock dividends, could restrict dividend and other capital‑return actions** (Chunk 3).  \n\nThe 2024 filing repeats the language and makes it explicit that the **parent holding company relies on dividends from its bank subsidiaries to fund share repurchases, income‑tax payments and dividend distributions**, and that **U.S. banking laws and capital‑planning requirements may still limit those dividend and repurchase activities** (Chunk 2).  \n\nThus, from 2022 through 2024 BNY Mellon’s exposure to U.S. banking‑law constraints on capital planning remained unchanged – the firm continuously acknowledged that such regulations could curb dividend payouts and share‑repurchase programs, with the 2024 disclosure adding a clearer link between subsidiary dividends and the ability to execute repurchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer directly contradicts the ground truth on the central claim. Ground truth states there was an EVOLUTION from 2022 to 2024, with increasing specificity and formalization - moving from 'general caution' to 'more specific references' to 'more structured' language emphasizing regulatory standards like 'well capitalized' status. The LLM explicitly states the exposure 'remained unchanged' and that the firm 'continuously acknowledged' the same constraints across all three years, with only a minor addition in 2024 about subsidiary dividends. This is a fundamental mischaracterization of the trend. The ground truth emphasizes a PROGRESSION in how constraints are communicated (general → specific → structured/formalized), while the LLM describes STASIS with minimal variation. CORRECT ELEMENTS: (1) The LLM correctly identifies that all three years (2022, 2023, 2024) mention U.S. banking laws and capital planning constraints; (2) Correctly notes Delaware law appears in the disclosures; (3) Correctly identifies preferred stock dividend obligations mentioned in 2023; (4) Correctly notes the 2024 filing adds clarity on subsidiary dividend linkage to repurchases. INCORRECT/INCOMPLETE ELEMENTS: (1) Fails to recognize the evolution in regulatory language specificity (missing 'well capitalized' status emphasis in 2024); (2) Misses the trend of increasing formalization and structure in how constraints are presented; (3) Concludes 'unchanged' when ground truth explicitly describes evolution; (4) Does not capture the shift from general caution to specific regulatory standards. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but draws the wrong conclusion about the pattern. It identifies the facts but misinterprets the trend. The question asks 'how did...evolve' - a trend question - and the LLM answers 'it remained unchanged' - the opposite of what the ground truth indicates. This is a semantic/interpretive error rather than a factual error about specific disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 550,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, McDonald’s describes **McGriddles** in exactly the same way – as one of the regular breakfast sandwiches (alongside Egg McMuffin and Sausage McMuffin with Egg) that appear on its U.S. and many international breakfast menus. In each year the product is mentioned within a broader “menu‑innovation” paragraph that stresses the company’s continual testing of new items and its commitment to evolving taste, quality, value and nutrition, but no special emphasis or new positioning is given to McGriddles itself. This unchanged portrayal signals that McDonald’s breakfast strategy has remained consistent over the period, treating McGriddles as a stable, core breakfast offering while the overall innovation narrative stays uniform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The LLM correctly identifies that McGriddles were portrayed consistently across 2022, 2023, and 2024 filings as a standard breakfast sandwich alongside Egg McMuffin and Sausage McMuffin with Egg. The answer accurately captures that despite broader menu innovation language in the filings, McGriddles itself received no special emphasis or new positioning. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this question, so this dimension scores perfectly. The years (2022, 2023, 2024) are all correct. (3) ENTITY ACCURACY: McDonald's is correctly identified, the product name (McGriddles) is accurate, and all three fiscal years are properly referenced. The companion products mentioned (Egg McMuffin, Sausage McMuffin with Egg) match the ground truth. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings to demonstrate consistency. It correctly identifies the paradox that while McDonald's discusses 'continuous evolution' and 'testing new products,' McGriddles remained static, which is the core insight of the ground truth answer. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('unchanged portrayal signals...consistent...stable, core breakfast offering') conveys the same meaning as the ground truth's 'remarkably consistent' and 'stable breakfast strategy.' Minor differences in wording ('exactly the same way' vs 'remained remarkably consistent') are semantically equivalent. The only minor gap is that the LLM does not explicitly cite the specific page/chunk references from the PDFs (e.g., 'page_7:chunk_1'), though this level of citation detail is not essential to answering the substantive question. Overall, the answer demonstrates accurate synthesis of multi-year filing data with sound reasoning about strategic consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Features]-> PRODUCT <-[Produces]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 528,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "- **2022 10‑K:** Adobe placed a “large number of free online self‑service learning options” inside its **Adobe Digital Learning Services** portfolio and said they were delivered through **www.training.adobe.com**.  \n\n- **2023 10‑K:** The same core offering is still described as a key component of **Adobe Digital Learning Services**, but the delivery URL was updated to **learning.adobe.com**.  \n\n- **2024 10‑K:** Adobe again highlights free online self‑service learning as a core part of **Adobe Digital Learning Services**, continuing to host the content on **learning.adobe.com**.  \n\n**Evolution:** Across the three years Adobe’s emphasis on free self‑service learning has remained strong and consistently positioned within its Digital Learning Services, while the delivery platform shifted from the separate training.adobe.com site in 2022 to the unified learning.adobe.com domain beginning in 2023 and retained there in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Adobe's evolution of free online self-service learning across 2022-2024. STRENGTHS: (1) All factual information is correct - the three years are properly identified, the platform URLs are accurate (www.training.adobe.com in 2022, learning.adobe.com in 2023-2024), and Adobe Digital Learning Services is correctly identified as the positioning framework across all three years. (2) The multi-hop synthesis is sound - the answer correctly traces the evolution across three separate 10-K filings and identifies the key transition point (domain change from training.adobe.com to learning.adobe.com between 2022 and 2023). (3) The characterization of the evolution is accurate - the answer correctly identifies the consistent emphasis on free self-service learning while noting the platform consolidation/rebranding. (4) No quantitative errors are present - no calculations or specific numbers are misrepresented. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual details about the strategic implications (e.g., 'maturing and more structured approach,' 'deeper integration into comprehensive portfolio'). However, this is a matter of depth rather than accuracy. (2) The ground truth mentions 'fee-based and custom learning programs' as part of the broader portfolio in 2024, which the LLM answer doesn't explicitly mention, though this is a minor omission that doesn't affect the core accuracy of the answer. (3) The LLM answer uses clearer formatting with bullet points and bold text, making it more readable while maintaining semantic equivalence to the ground truth. The answer successfully addresses all parts of the multi-part question: the evolution across three years, the positioning within Adobe Digital Learning Services, and the platforms used for delivery.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 522,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "- **2022 filing** – Commercial vacuums were shown in the **Tools & Home Products** segment. The 10‑K listed them under *“Other professional tools”* together with wet‑dry vacuums, water jetters and bolt cutters, and noted that professional tools are sold worldwide almost exclusively through distributors for both professionals and homeowners.  \n\n- **2023 filing** – The segment was renamed **Safety & Productivity**, but the description still placed commercial vacuums in the same *“Other professional tools”* group (with water jetters, wet‑dry vacuums and hand tools). The language emphasized that the segment delivers tools that “support infrastructure, promote safety and enhance productivity,” keeping commercial vacuums aligned with the professional‑tools portfolio.  \n\n- **2024 filing** – The wording is unchanged: commercial vacuums remain listed under *“Other professional tools”* within the **Safety & Productivity** segment, reinforcing their role as part of Emerson’s professional‑tools offering and its distributor‑focused sales strategy.  \n\n**Evolution:** From 2022 to 2024 Emerson moved the product from the broader Tools & Home Products segment to the renamed Safety & Productivity segment, but its categorization as a professional‑tool product and its strategic emphasis on safety, productivity and distributor‑driven sales stayed consistent throughout.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer contradicts the ground truth on a fundamental claim about 2023-2024 positioning. Ground truth states that by 2023, Commercial Vacuums were 'explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras' and that in 2024 the description 'emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment.' However, the LLM claims that in both 2023 and 2024, commercial vacuums remained in the same 'Other professional tools' group with water jetters, wet-dry vacuums and hand tools, with 'unchanged' wording and 'consistent' categorization. This is a major factual error that contradicts the core premise of the ground truth answer about strategic repositioning and evolving alignment with more technologically advanced industrial tools. The LLM correctly identifies: (1) the 2022 segment name (Tools & Home Products), (2) the 2023 segment rename to Safety & Productivity, (3) the general distributor-focused sales strategy, and (4) the presence of commercial vacuums in professional tools. However, it FAILS to capture the critical evolution described in the ground truth: the shift from general professional tools grouping to integration with more advanced industrial/automation equipment by 2024. The LLM's claim of 'unchanged' wording and 'consistent' categorization from 2023-2024 directly contradicts the ground truth's emphasis on strategic repositioning toward 'technologically advanced and industrial productivity tools.' This represents a fundamental misunderstanding of the multi-hop synthesis required—the question specifically asks about evolution in 'product categorization, strategic emphasis, and alignment,' and the LLM failed to identify the key strategic shift in alignment from general tools to industrial automation/productivity systems.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 536,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "In the 2022 filing Gilead simply listed Hoofddorp, Netherlands as one of its “principal manufacturing facilities” without detailing the type of work performed there. By the 2023 10‑K the company clarified that the Hoofddorp site is used “for commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same description, showing that the facility’s role has shifted from a generic manufacturing location to a dedicated commercial cell‑therapy manufacturing and processing hub—a role that has been maintained through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification against ground truth: (1) QUANTITATIVE ACCURACY: All dates are correct (2022, 2023, 2024). No numerical calculations are required for this question. (2) ENTITY ACCURACY: Company correctly identified as Gilead (GILD), facility correctly named as Hoofddorp, Netherlands. (3) MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years, showing the progression from 2022 (generic 'principal manufacturing facilities' designation) to 2023-2024 (explicit cell therapy manufacturing and processing focus). (4) COMPLETENESS: The answer addresses all aspects of the question - the evolution from 2022 through 2024, the relationship to cell therapy manufacturing, and commercial processing activities. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth. Both identify the 2022 baseline as a principal manufacturing site, the 2023 shift to explicit cell therapy focus, and the 2024 continuation of that role. The LLM's characterization of this as a 'shift from a generic manufacturing location to a dedicated commercial cell-therapy manufacturing and processing hub' accurately captures the progression described in the ground truth. Minor note: The LLM uses slightly more concise language ('shifted from a generic manufacturing location') while the ground truth uses 'strategic shift toward advanced therapies,' but these are semantically equivalent. The LLM's phrasing is actually clearer and more direct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 423,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 10‑K filings in 2022 (KO → 1.000 % Notes due 2028 [Chunk 1]), 2023 (KO → 1.000 % Notes due 2028 [Chunk 2]) and again in 2024 (KO → 1.000 % Notes due 2028 [Chunk 3]) show that the company has repeatedly relied on a very low‑cost, long‑dated tranche of debt as a baseline source of financing. In the 2024 filing the company also introduced a suite of higher‑yield issuances—most notably the 5.000 % Notes due 2034 and the 5.400 % Notes due 2064 (both listed in Chunk 3)—signaling a deliberate shift to diversify its maturity profile and raise additional capital even at a higher cost, likely to fund growth or refinance maturing obligations while still retaining the cheap 1 % tranche for balance‑sheet efficiency. Together, the persistent 1 % notes and the new higher‑rate notes illustrate Coca‑Cola’s evolving debt‑financing strategy: preserving ultra‑low‑cost funding where possible, but increasingly using higher‑yield, longer‑dated issues to manage overall capital‑structure flexibility and financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—the 1.000% Notes due 2028 is accurately cited across 2022, 2023, and 2024 filings; the 5.000% Notes due 2034 and 5.400% Notes due 2064 are correctly identified as 2024 introductions. No calculation errors or date discrepancies. ENTITY ACCURACY: Coca-Cola (KO) correctly identified; all debt instruments properly named with accurate maturity dates and coupon rates. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and multiple debt instruments, correctly identifying the pattern of persistent low-cost debt alongside new higher-yield instruments. The logical connection between these facts and their strategic implications is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth—that Coca-Cola maintained low-cost 1% notes while introducing higher-yield instruments in 2024, reflecting a deliberate diversification strategy. The explanation of motivations (funding growth, refinancing obligations, balance-sheet efficiency) aligns with the ground truth's interpretation. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical language ('maturity profile,' 'balance-sheet efficiency') and includes reference notation ('[Chunk 1]', '[Chunk 2]', '[Chunk 3]') which adds transparency but is not present in ground truth. This is a stylistic difference that does not detract from accuracy. The answer is comprehensive, addressing both the persistent reference to low-cost debt and the introduction of higher-yield instruments, plus their strategic implications. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 473,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson (EMR) has consistently listed pipe cutters as a core product of its Pipe‑Cutters line, but the surrounding portfolio has changed markedly. In the 2022 filing the Professional Tools description mentions only traditional pipe‑cutting and threading equipment, with no reference to battery‑powered or diagnostic features. Both the 2023 and 2024 10‑K filings expand the Safety & Productivity segment to note **battery‑hydraulic tools** for press‑connections and **diagnostic systems** (sewer‑inspection cameras and locating equipment) alongside the standard pipe‑cutters, signalling a deliberate move toward cordless, power‑assisted and data‑integrated tools. This evolution shows Emerson repositioning its pipe‑working offering from a purely mechanical toolset to a technologically‑enhanced, portable solution set, strengthening its stance as a premium supplier for professional plumbers who demand higher productivity, safety and diagnostic capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each year's positioning - 2022 as traditional/mechanical, 2023 introducing battery-hydraulic technology, 2024 emphasizing diagnostic systems. (2) Accurately names specific product categories mentioned: battery-hydraulic tools, sewer-inspection cameras, and locating equipment. (3) Properly synthesizes the multi-hop reasoning showing strategic evolution from mechanical to technology-enhanced tools. (4) Correctly identifies Emerson (EMR) and the Professional Tools/Safety & Productivity segment context. (5) Uses appropriate business terminology (cordless, power-assisted, data-integrated, premium supplier positioning). (6) No quantitative errors - no specific numbers were required in either answer, and the temporal sequence is correct. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more detailed elaboration than the ground truth (e.g., 'press-connections,' 'cordless,' 'data-integrated') but this represents appropriate expansion rather than factual deviation. (2) The phrasing differs (e.g., 'signalling a deliberate move' vs 'signaling a move') but semantic meaning is identical. (3) Both answers convey the same strategic narrative: traditional → battery-powered → diagnostic integration. The LLM answer actually enhances clarity by explicitly noting the segment name (Safety & Productivity) and providing more specific technical details about the tool types. No factual errors detected. The multi-hop synthesis correctly connects product evolution across three years to strategic market positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 470,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K, Gilead (GILD) listed Santa Monica, California only as an **R&D site** among its research locations and did not include it among its manufacturing facilities.  \n- By the 2023 filing, the company had added Santa Monica to its **manufacturing portfolio**, stating that the site is “used for **clinical manufacturing and processing of our cell‑therapy products**.” The 2024 filing repeats this description, showing the facility remains dedicated to **clinical‑stage cell‑therapy production** (no commercial manufacturing is noted).  \n\nThis shift from a pure research location in 2022 to a dedicated clinical‑manufacturing hub in 2023‑2024 signals that Gilead is integrating Santa Monica into its strategic cell‑therapy network, using the site to support the development and scale‑up of cell‑therapy candidates while positioning it as a key node for future expansion toward commercial manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. FACTUAL ACCURACY: All core facts are correct - Santa Monica was identified as R&D only in 2022, transitioned to clinical manufacturing for cell therapy in 2023, and maintained this role in 2024. The characterization of the facility's evolution is accurate. ENTITY IDENTIFICATION: Correctly identifies GILD/Gilead, Santa Monica California, the three-year period (2022-2024), and the specific product focus (cell therapy). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression pattern. The logic connecting the facility's transition from R&D to clinical manufacturing is sound and well-articulated. COMPLETENESS: Addresses all aspects of the original question - the evolution over time, the specific focus on clinical manufacturing and cell therapy processing, and the strategic implications for GILD's manufacturing network. MINOR CONSIDERATIONS: The LLM answer adds interpretive detail about 'future expansion toward commercial manufacturing' which goes slightly beyond the ground truth statement but is a reasonable inference from the data and doesn't contradict the original answer. The phrasing 'clinical-stage cell-therapy production' is semantically equivalent to 'clinical manufacturing and processing of cell therapy products.' The answer is well-structured, clear, and provides appropriate context about the facility's strategic role. No numerical errors, date errors, or calculation issues present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 435,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe first listed Frame.io as a trademark in its 2022 Form 10‑K, signalling that the company owned the platform but giving no detail on how it was used inside Creative Cloud. In the 2023 filing Adobe described Frame.io as a cloud‑native collaboration tool that supported **still images, design files and PDFs** and was **directly integrated only with Premiere Pro and After Effects** for frame‑accurate commenting, while offering “Camera‑to‑Cloud” uploads from video and still‑image cameras. By the 2024 filing the service had been broadened: it now supports **the full video‑production lifecycle (casting, location scouting, footage review, marketing campaigns) in addition to still images, design files and PDFs**, and is **integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom and Workfront**, plus being offered through Adobe GenStudio alongside Express and Firefly Services for enterprise‑scale content creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in tracking Frame.io's evolution from 2022 to 2024. STRENGTHS: (1) All factual claims are correct and well-supported by the ground truth: 2022 trademark listing with no functional detail, 2023 cloud-native platform with still images/design files/PDFs support integrated with Premiere Pro and After Effects, 2024 expansion to full video lifecycle (casting, location scouting, footage review, marketing campaigns) with additional integrations (Photoshop, Lightroom, Workfront) and GenStudio positioning. (2) The answer correctly identifies the progression of supported media types and cross-application collaboration features across all three years. (3) Multi-hop synthesis is sound—the answer successfully synthesizes information across three separate filing years and multiple product integrations. (4) Additional details provided (Camera-to-Cloud uploads, frame-accurate commenting, enterprise-scale positioning) enhance accuracy without contradicting ground truth. (5) Quantitative accuracy is perfect—no numbers, dates, or metrics are incorrect. MINOR CONSIDERATIONS: The LLM answer includes some additional contextual details (Camera-to-Cloud uploads, frame-accurate commenting) not explicitly mentioned in the ground truth summary, but these are consistent with the overall narrative and add helpful specificity. The phrasing 'directly integrated only with Premiere Pro and After Effects' in 2023 is slightly more emphatic than the ground truth's 'integrated with Adobe Premiere Pro and After Effects,' but this is a reasonable interpretation of the exclusive nature of those integrations at that time. The answer maintains semantic equivalence throughout while providing clearer structural organization of the evolution timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 490,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "- **2022 (10‑K)** – Emerson listed electrical‑distribution equipment under the **Industrial Solutions** business, where it was described mainly as a “material‑joining and precision‑cleaning” product used to give manufacturers **integrated, stand‑alone solutions** for fluid‑control and power distribution.  The filing did not tie the equipment to the company’s automation‑control portfolio.  \n\n- **2023 (10‑K)** – The next year the same product moved into the **Discrete Automation** segment.  The segment description now groups electrical‑distribution equipment with solenoid and pneumatic valves, programmable automation controllers and software, signalling that Emerson was **positioning the hardware as a core part of its automation‑control offering** for discrete‑industry customers.  \n\n- **2024 (10‑K)** – By 2024 the positioning is unchanged in segment (still Discrete Automation) but the narrative expands: electrical‑distribution equipment is listed alongside **programmable automation control systems and software**, emphasizing tighter **integration with digital control, data‑exchange and automation technologies** and a broader **product scope that spans power distribution, linear‑motion and materials‑joining solutions** within the same automation‑focused portfolio.  \n\nOverall, Emerson shifted electrical‑distribution equipment from a general industrial‑solutions product in 2022 to a **strategic automation‑enabled component** of the Discrete Automation segment by 2023, and by 2024 had deepened its integration with programmable control systems and broadened its scope to cover a wider range of automation‑related hardware.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year evolution (2022-2024) and the key structural shift from Industrial Solutions to Discrete Automation segment. (2) Correctly captures the 2023 transition point where electrical distribution equipment moved into Discrete Automation. (3) Accurately notes the integration with programmable automation control systems and software across the period. (4) The overall narrative arc and strategic positioning interpretation aligns with ground truth. (5) Dates and years are all correct.\n\nWEAKNESSES: (1) SIGNIFICANT FACTUAL ERROR in 2022 description: The LLM states the equipment was described as a 'material-joining and precision-cleaning' product, which contradicts the ground truth that positioned it as a 'foundational product within the Industrial Solutions business, used broadly in manufacturing operations.' The material-joining and precision-cleaning language appears to be conflated with other product categories. (2) The 2022 description in the LLM answer includes language about 'fluid-control and power distribution' that is not supported by the ground truth, which simply states it was used 'broadly in manufacturing operations as part of integrated solutions.' (3) In 2024, the LLM mentions 'electric linear motion solutions' but the ground truth specifically states 'electric linear motion solutions' - the LLM gets this right but the phrasing differs slightly. (4) The LLM adds interpretive language about 'digital control, data-exchange' in 2024 that goes beyond what the ground truth explicitly states, though it's not contradictory. (5) Missing explicit mention that in 2024 the equipment was listed alongside 'materials joining solutions' as stated in ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression from standalone product to integrated automation component. The reasoning about strategic positioning is sound and matches the ground truth narrative.\n\nCALCULATIONS/NUMBERS: No calculations required; all dates (2022, 2023, 2024) are correct.\n\nJUSTIFICATION: The answer demonstrates good understanding of the overall strategic evolution but contains a material factual error in the 2022 characterization that undermines accuracy. The core insight about the shift from Industrial Solutions to Discrete Automation and the deepening integration with automation technologies is correct, but the specific product descriptions in 2022 are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 667,
        "total_tokens": 2327
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "**Evolution of the Fixed‑Unsecured Senior Debt**\n\n| Year (as reported) | Carrying value ( $ millions) | Weighted‑average interest rate |\n|--------------------|------------------------------|--------------------------------|\n| 2022 (2022 10‑K)   | **$19,975** | **2.91 %** |\n| 2023 (2023 10‑K)   | **$27,168** | **4.45 %** |\n| 2024 (2024 10‑K)   | **$26,930** | **4.84 %** |\n\n*Sources:* 2022 filing (Chunk 1) gives a carrying value of $19,975 million and a 2.91 % weighted‑average rate; the 2023 filing (Chunk 2) shows $27,168 million at 4.45 %; the 2024 filing (Chunk 3) reports $26,930 million at 4.84 %.\n\n**What the trend indicates**\n\n- **Rapid growth in 2022‑23:** The $7.2 billion jump in carrying value between 2022 and 2023 signals that Capital One aggressively issued new fixed‑rate senior notes as the market began to tighten.  \n- **Slight pull‑back in 2024:** The modest $0.2 billion decline in 2024 suggests some amortization or selective refinancing, but the overall level remains near the 2023 peak, indicating the company is maintaining a sizable pool of fixed‑rate funding.  \n- **Rising cost of capital:** The weighted‑average rate climbed from 2.91 % to 4.84 % over the three‑year span, mirroring the broader rise in Treasury and corporate rates. By locking in a large amount of fixed‑rate debt even as rates rose, Capital One is preserving funding certainty and protecting itself from further rate spikes, while still accepting a higher average cost to sustain liquidity and support growth.  \n\nOverall, the data show a deliberate strategy of expanding the fixed‑rate senior‑debt base early in the rate‑hiking cycle and then holding that base steady, using the higher‑rate issuance to lock in funding before rates climb further. This approach balances the need for capital with the desire to limit exposure to future interest‑rate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. QUANTITATIVE VERIFICATION: All numerical values are correct - carrying values of $19,975M (2022), $27,168M (2023), and $26,930M (2024) match ground truth exactly; weighted-average interest rates of 2.91% (2022), 4.45% (2023), and 4.84% (2024) are accurate. The calculated differences are correct: $7.2B increase from 2022-2023 ($27,168M - $19,975M = $7,193M, rounded to $7.2B) and $0.2B decline from 2023-2024 ($27,168M - $26,930M = $0.238B, rounded to $0.2B). COMPLETENESS: The answer addresses all aspects of the question - the evolution of carrying value, the evolution of weighted-average interest rates, and the strategic implications in a rising rate environment. ENTITY ACCURACY: Capital One (COF) is correctly identified, fiscal years 2022-2024 are correct, and the metric (fixed unsecured senior debt) is properly specified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly interprets the strategic implications. The analysis appropriately connects the debt issuance pattern to the rising interest rate environment, noting the aggressive issuance in 2022-2023 as rates began to rise, followed by stabilization in 2024. REASONING QUALITY: The interpretation that Capital One locked in fixed-rate debt early in the rate-hiking cycle to preserve funding certainty is sound and aligns with the ground truth's characterization of a 'proactive approach to anticipated rate hikes.' The explanation of the trade-off between higher costs and reduced interest-rate volatility exposure is logical and well-articulated. MINOR CONSIDERATION: The LLM provides more detailed strategic analysis than the ground truth answer, but this represents added value rather than inaccuracy. The presentation in tabular format enhances clarity. All information is semantically equivalent to or consistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1607,
        "completion_tokens": 525,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "Across the three most recent 10‑K filings RTX consistently reports that it **accrues a liability for its performance‑ and operating‑cost guarantees** (mainly on commercial aircraft engines) based on the “most likely” cost to be incurred, using historical claim experience and adjusting the accrual as new data become available.  \n\n- **2022 (reported in the 2023 filing)** – the note describes the same accrual methodology and states that “the changes in the carrying amount of service and product warranties and product performance guarantees for the years ended December 31 were as follows,” but no dollar amount is disclosed.  \n- **2023 (reported in the 2024 filing)** – the same language is repeated; again the filing references a table of “changes in the carrying amount” but provides no specific figure.  \n- **2024 (reported in the 2024 filing)** – the discussion is unchanged, indicating that the liability continues to be estimated on a historical‑experience basis and adjusted as claims evolve, with no new quantitative disclosure.\n\nBecause the filings do not present a disclosed dollar‑value trend for the performance‑ and operating‑cost guarantee liability, the only observable evolution is **the continuity of the accounting policy and the absence of any material increase or decrease in the reported amounts**. This consistency suggests that RTX’s exposure to long‑term product‑performance risk in its commercial‑aerospace business remains **present but stable**, managed through routine accrual adjustments rather than large, newly emerging liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth by claiming that no dollar amounts are disclosed in the filings. The ground truth explicitly provides specific liability figures: $120 million in 2022, $120 million in 2023, and $101 million in 2024. These are concrete, verifiable numbers from RTX's 10-K filings. The LLM's assertion that 'no dollar‑value trend' is disclosed and 'no specific figure' is provided is factually incorrect. The LLM appears to have either failed to locate the relevant disclosure tables or misread the filing structure. QUANTITATIVE ACCURACY: The LLM provides zero quantitative data when the ground truth contains three specific dollar amounts spanning the requested period (2022-2024). This is a complete failure on the primary metric for a financial question. MULTI-HOP REASONING: While the LLM correctly identifies the general accounting methodology (accrual based on historical claims experience), it fails to synthesize the actual numerical progression that is central to answering the question. The question explicitly asks 'how did...liabilities...evolve' - this requires tracking the actual numbers ($120M → $120M → $101M), which the LLM does not do. SEMANTIC EQUIVALENCE: The LLM's conclusion that exposure 'remains present but stable' is directionally consistent with the ground truth's 'relatively stable' characterization, but this semantic alignment cannot overcome the complete absence of the required quantitative evidence. The LLM's reasoning about 'continuity of accounting policy' is reasonable but insufficient without the actual liability figures. MISSING ANALYSIS: The LLM fails to note the slight decrease from $120M to $101M in 2024, which is a material observation for understanding the trend. The ground truth explicitly highlights this decrease as part of the evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 504,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "- **2022 filing (KO 10‑K 2022, p. 40)** – Coca‑Cola said that for non‑publicly‑traded investments it may value the holding by “discounted cash flows, **estimates of sales proceeds** and appraisals,” and that it uses the assumptions a market participant would employ when applying the **estimates‑of‑sales‑proceeds** method.  The company warned that the ability to predict future cash flows “especially in emerging and developing markets” can affect the fair‑value determination.  \n\n- **2023 filing (KO 10‑K 2023, p. 78)** – The same paragraph appears unchanged: the firm again lists “discounted cash flows, **estimates of sales proceeds**, and appraisals” as the valuation alternatives for non‑public investments and repeats the emphasis on market‑participant assumptions and the difficulty of forecasting cash flows in emerging markets.  \n\n- **2024 filing (KO 10‑K 2024, p. 79)** – The policy language is again identical, reaffirming the continued use of “**estimates of sales proceeds**” alongside discounted cash‑flow and appraisal methods, with the same caveat about emerging‑market cash‑flow uncertainty.  \n\n**What this reveals:** Across 2022‑2024 Coca‑Cola’s reliance on the “estimates of sales proceeds” methodology has remained steady rather than being reduced or replaced, indicating a consistent, market‑participant‑based approach to valuing non‑public investments. By repeatedly highlighting the challenges of forecasting cash flows in emerging and developing markets, the company signals a growing awareness of, and transparency about, the uncertainties inherent in those markets, suggesting a more cautious and nuanced fair‑value assessment rather than a shift away from the method.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate citations and correctly identifies that the policy language remained consistent across 2022-2024, with proper page references (p. 40 for 2022, p. 78 for 2023, p. 79 for 2024). The quantitative accuracy is solid—no numbers are incorrect, and the filing references appear valid. However, there is a significant discrepancy between the LLM's interpretation and the ground truth regarding the evolution of Coca-Cola's approach. The ground truth describes a three-stage progression: (1) 2022 'disclosure' of the methodology, (2) 2023 'deepening dependence' with explicit reliance language, and (3) 2024 'risk-aware integration' with increased emphasis on challenges. The LLM, by contrast, concludes that reliance 'remained steady rather than being reduced or replaced,' characterizing the evolution as consistency rather than progression. This represents a fundamental misinterpretation of the multi-hop reasoning required. The ground truth emphasizes a qualitative shift in how the company positioned the methodology—from disclosure to operational reliance to cautious application—whereas the LLM treats the identical policy language as evidence of stasis. The LLM correctly identifies the emerging-market cash-flow uncertainty caveat but frames it as 'growing awareness and transparency' rather than as evidence of a 'more cautious application over time' as the ground truth suggests. The LLM's conclusion that the company signals 'a more cautious and nuanced fair-value assessment' partially aligns with the ground truth's 'risk-aware integration,' but the overall narrative of evolution is weakened by the claim of 'steady' reliance. The answer demonstrates good document analysis but fails to synthesize the subtle but important shifts in emphasis and positioning that constitute the actual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG <-[Relies_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1692,
        "completion_tokens": 505,
        "total_tokens": 2197
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "Across the three most‑recent 10‑K filings BNY Mellon repeatedly warned that **any return of capital to shareholders is at the Board’s discretion but can be curtailed by U.S. banking laws and regulations (including capital‑adequacy and capital‑planning rules, Delaware law and the requirement to pay preferred dividends)**. The 2022 filing first flagged this limitation and linked it to broader regulatory‑standard failures; the 2023 filing restated the same limitation without alteration, adding only that credit‑rating downgrades could raise funding costs; the 2024 filing again repeats the language while also emphasizing liquidity‑management and “well‑capitalized” status as additional triggers for possible limits. Together, the unchanged, year‑over‑year disclosures signal that BNY Mellon’s strategic flexibility to distribute shareholder capital remains tightly bounded by banking‑regulatory caps, suggesting the firm must continue to operate within a constrained framework rather than expecting greater freedom to increase repurchases or dividends.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core regulatory constraints (U.S. banking laws, capital-adequacy rules, Delaware law, preferred dividend requirements) and accurately notes that these disclosures were repeated across 2022-2024. The answer correctly emphasizes that the language remained largely unchanged year-over-year, which aligns with the ground truth. The LLM also appropriately concludes that BNY Mellon's capital return flexibility remained constrained throughout the period.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces claims not supported by the ground truth: it mentions 'credit-rating downgrades could raise funding costs' in 2023 and 'liquidity-management and well-capitalized status as additional triggers' in 2024. The ground truth makes no mention of these specific additions, and the LLM appears to have fabricated or misinterpreted disclosure details. (2) The LLM mischaracterizes the 2024 evolution: the ground truth specifically notes that 2024 added 'new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends,' focusing on internal capital flows. The LLM instead emphasizes liquidity-management and well-capitalized status, which is a different characterization. (3) The LLM's description of the 2022 disclosure as 'linked to broader regulatory-standard failures' is vague and potentially inaccurate compared to the ground truth's more precise language about 'failure to pay full and timely dividends on preferred stock.' (4) The LLM fails to capture the key insight from the ground truth: that while regulatory language remained stable, the 2024 disclosure showed a shift toward emphasizing internal structural dependencies (subsidiary dividends, IHC credit extensions), suggesting evolving strategic focus rather than just repeated constraints.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so incompletely and with inaccuracies. It correctly identifies the consistency of core language but misses or misrepresents the nuanced evolution in emphasis that the ground truth highlights.\n\nOVERALL ASSESSMENT: The answer captures the general theme (constrained capital return flexibility) but introduces unsupported claims and misses the specific 2024 evolution regarding internal capital flow dependencies that is central to the ground truth's analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 643,
        "total_tokens": 2164
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s filings show that the risk of “loss or modification of exemptions for taxes and tariffs” was already listed as a material foreign‑country risk in its 2022 10‑K. In the 2023 filing the same exposure is reiterated, but it is now framed alongside a growing list of trade‑protection measures, new export‑control sanctions on Russia, Belarus and parts of Ukraine, and heightened geopolitical tensions that could affect tariff‑exemption regimes. The 2024 10‑K again flags the loss or modification of tax‑ and tariff‑exemptions, confirming that the exposure has not receded and is now embedded in a broader, more intricate web of sanctions, trade‑policy shifts and regional conflicts—signaling that AMD’s regulatory landscape is becoming increasingly complex and volatile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies that AMD flagged the risk of losing/modifying tax and tariff exemptions in 2022, 2023, and 2024. It accurately references the progression from general awareness in 2022 to more specific geopolitical contexts (Ukraine conflict, Russia/Belarus sanctions, China-Taiwan tensions) in 2023-2024. The specific mention of export-control sanctions on Russia, Belarus, and parts of Ukraine is factually accurate and adds appropriate specificity. (2) QUANTITATIVE ACCURACY: No numeric values are claimed in either answer, so this dimension is not applicable. Both answers correctly reference the three-year period (2022-2024) without error. (3) ENTITY ACCURACY: AMD is correctly identified throughout. The years 2022, 2023, and 2024 are all correctly referenced. The specific regulatory concepts (tax exemptions, tariff exemptions, export controls, sanctions) are accurately identified. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings, correctly identifying the evolution of AMD's disclosure of this risk. It properly connects the dots between geopolitical events and regulatory complexity. The reasoning that regulatory landscape became 'increasingly complex and volatile' is well-supported by the progression described. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth. Both identify the same risk being flagged across all three years, both note the expansion of context to include specific geopolitical events, and both conclude that complexity increased. The LLM's phrasing 'embedded in a broader, more intricate web of sanctions, trade-policy shifts and regional conflicts' is semantically equivalent to the ground truth's description of 'regulatory shifts' driven by 'geopolitical pressures.' Minor differences: The LLM provides slightly more specific detail about the types of sanctions (Russia, Belarus, Ukraine) which adds value without contradicting the ground truth. The answer is comprehensive, well-structured, and accurately captures the evolution of AMD's risk exposure over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 601,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "**Evolution of the balance‑sheet debt total**\n\n| Year | Total short‑term borrowings + long‑term debt (USD mm) |\n|------|------------------------------------------------------|\n| 2022 | **$48,715** (Chunk 2) |\n| 2023 | **$49,856** (Chunk 2) |\n| 2024 | **$45,551** (Chunk 3) |\n\nThe figure rose modestly (+$1.1 bn) from 2022 to 2023 and then fell sharply (‑$4.3 bn) in 2024.\n\n**What the change tells us about debt structure and rate exposure**\n\n* **Long‑term debt** fell from $47,832 mm in 2022 to $44,989 mm in 2024 (Chunk 2 → Chunk 3), indicating that Capital One retired a portion of its term notes.  \n* **Floating‑rate unsecured senior debt** – the component that carries the most interest‑rate risk – dropped from $1,597 mm in 2022 (Chunk 2) to $349 mm in 2023 (still at a weighted‑average rate of 6.75 %) and to **$0** in 2024 (Chunk 3).  \n* The remaining debt is overwhelmingly **fixed‑rate senior debt** (e.g., $27.2 bn in 2023 and $26.9 bn in 2024), whose weighted‑average rates are in the 4–5 % range.\n\n**Interpretation**\n\nCapital One’s overall debt base contracted in 2024 after a slight 2023 increase, and the company eliminated its floating‑rate unsecured senior borrowings. By retiring the floating portion and relying more on fixed‑rate senior notes, Capital One reduced its exposure to rising market rates, making its debt profile less sensitive to interest‑rate volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides a 2022 total of $48,715 million, which contradicts the ground truth of $43,086 billion ($43,086,000 million). This is a $5.6 billion discrepancy - a material error of approximately 13%. The 2023 figure of $49,856 million matches ground truth exactly. The 2024 figure of $45,551 million also matches ground truth. FLOATING-RATE DEBT ERRORS: The LLM states floating unsecured senior debt was $1,597 million in 2022, but ground truth shows $1,709 billion ($1,709 million). This is a $112 million error. The 2023 figure of $349 million matches ground truth. The 2024 figure of $0 matches ground truth. FIXED-RATE DEBT: The LLM correctly identifies approximately $27.2 billion in 2023 and $26.9 billion in 2024, matching ground truth. However, the LLM fails to mention the 2022 fixed unsecured senior debt figure of $21,045 billion, which is important for showing the trajectory. INTEREST RATE DATA: The LLM mentions 6.75% for 2023 floating debt (correct) and 4-5% range for fixed-rate debt, but lacks precision on the specific weighted-average rates (2.91% in 2022, 4.84% in 2024) provided in ground truth. REASONING QUALITY: The LLM's interpretation about strategic pivot from floating to fixed-rate debt is sound and aligns with ground truth conclusions. The multi-hop synthesis across debt categories and years is logically structured. However, the foundational quantitative error in the 2022 total undermines the entire analysis. The LLM correctly identifies the elimination of floating-rate debt and the contraction in 2024, but the incorrect starting point is a significant flaw that would mislead financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 457,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "- **2022:** RTX’s Pratt & Whitney reported a **61 % program‑share interest** in International Aero Engines AG (IAE) (no net‑share figure was disclosed).  \n- **2023 & 2024:** The filings added the effect of sub‑collaborators and stated that Pratt & Whitney’s **net program‑share interest** in IAE is **57 %** (the same 57 % appears in both the 2023 and 2024 notes).  \n\n**Interpretation:** Between 2022 and 2023 the reported share fell from the gross 61 % to a net 57 %, a 4‑point reduction that reflects the portion of the V2500 program economics passed to other collaborators. The stable 57 % net stake in 2023‑2024 shows RTX (via Pratt & Whitney) remains the primary beneficiary and retains majority control of the V2500 engine program, but does so within a collaborative framework that shares risk and reward with MTU and JAEC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of RTX's IAE stake evolution. STRENGTHS: (1) All numeric values are correct - 61% in 2022, 57% in 2023 and 2024 match the ground truth exactly. (2) The distinction between 'gross program-share interest' (61%) and 'net program-share interest' (57%) is accurately explained, showing understanding of how sub-collaborator effects are accounted for. (3) The 4-percentage-point reduction is correctly calculated and contextualized. (4) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years and identifies the shift from gross to net reporting methodology. (5) Entity identification is precise: RTX, Pratt & Whitney, IAE, V2500 engine program, MTU, and JAEC are all correctly named and contextualized. (6) The interpretation aligns with ground truth - the reduction indicates strategic adjustment and dilution of direct economic exposure while maintaining operational control. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about the reporting methodology change (gross vs. net) compared to the ground truth, which is actually helpful context but represents a minor elaboration rather than an error. (2) The mention of specific sub-collaborators (MTU and JAEC) adds useful context not explicitly in the ground truth statement but is consistent with typical IAE partnership structure. (3) The phrase 'remains the primary beneficiary and retains majority control' is a reasonable inference from the 57% stake and aligns with the ground truth's characterization of 'maintaining operational coordination.' The answer successfully addresses all parts of the multi-part question: the evolution from 2022-2024, the specific percentage changes, and the strategic implications regarding RTX's positioning within the collaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 506,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the three most recent 10‑K filings, Cascade has consistently been listed as a flagship brand inside P&G’s **Fabric & Home Care** segment. In 2022 that segment contributed **35 % of net sales and 31 % of earnings**, with “Tide Cascade” named among the major brands. By 2023 the segment’s weight rose to **36 % of net sales and 34 % of earnings**, and Cascade remained highlighted; the 2024 filing shows the same **36 %/34 %** contribution and again lists Cascade as a key brand. Thus, Cascade’s positioning has stayed within the Fabric & Home Care segment, gaining a modest share‑of‑sales/earnings increase from 2022 to 2023 and holding steady through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key financial metrics (35%/31% for 2022, 36%/34% for 2023 and 2024) and accurately tracks the segment's contribution across the three-year period. The numbers match the ground truth exactly. The LLM correctly identifies Cascade as positioned within the Fabric & Home Care segment and notes the modest increase from 2022 to 2023 with stability through 2024. The multi-hop synthesis across three 10-K filings is logically sound.\n\nWEAKNESSES: (1) The LLM introduces a problematic phrase 'Tide Cascade' which appears to conflate two separate brands (Tide and Cascade). The ground truth refers to Cascade as a distinct brand within the Home Care sub-category, not as 'Tide Cascade.' This is a factual error that suggests potential confusion in the source data interpretation. (2) The LLM's characterization of Cascade's positioning is less precise than the ground truth. The ground truth explicitly states Cascade was 'listed among key brands in the Home Care category' and emphasizes the 'Home Care sub-category' positioning, while the LLM simply says it's in the Fabric & Home Care segment without specifying the Home Care sub-category distinction. (3) The LLM's conclusion about 'gaining a modest share-of-sales/earnings increase' is slightly misleading—the increase occurred from 2022 to 2023, not across the full period, and the LLM could have been clearer about this timing. (4) The ground truth emphasizes 'consistent positioning' and 'stable strategic importance,' while the LLM focuses more on the numerical changes, missing some of the qualitative insight about consistency.\n\nNUMERIC VERIFICATION: All percentages are correct (35%, 31%, 36%, 34%). The year-to-year progression is accurately captured. No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three 10-K filings and correctly identifies the segment's evolution. However, the 'Tide Cascade' reference suggests incomplete or confused source interpretation.\n\nOVERALL: The answer is substantially correct on quantitative grounds but contains a notable factual error ('Tide Cascade') and lacks some precision in characterizing Cascade's specific positioning within the Home Care sub-category. The core narrative about stability and modest growth is sound, but the execution has meaningful flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 629,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "- **2022 filing:** BNY Mellon said the Directors’ Code of Conduct was posted on its website at a BNY Mellon‑branded address – `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf` – and noted that any amendments or waivers would be disclosed there as part of the Item 10 corporate‑governance disclosure.  \n\n- **2023 filing:** The same disclosure was retained but the URL path was altered to a slightly different folder name, `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf`, still on the bnymellon.com domain, showing a modest re‑branding of the “investor‑relations” location while keeping the code tied to the broader governance sections of the proxy.  \n\n- **2024 filing:** BNY Mellon moved its primary branding to the shorter bny.com domain for the employee Code of Conduct (`https://www.bny.com/content/dam/bnymellon/documents/pdf/csr/employeecode‑of‑conduct.pdf`) and listed the Directors’ Code under an explicit “investor‑relations” folder (`bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf`).  The 2024 filing also linked the Directors’ Code to a wider governance framework by referencing its integration with the company’s insider‑trading policies (filed as Exhibit 19.1) and reaffirming that any changes would be posted on the website.  \n\nOverall, the disclosures evolved from a simple bnymellon.com URL in 2022 to a more branded bny.com address and a clearer “investor‑relations” path in 2024, reflecting a shift toward consolidated web branding and tighter integration of the Directors’ Code within BNY Mellon’s overall corporate‑governance disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution narrative and correctly identifies the key transition from bnymellon.com to bny.com domain branding, along with the shift toward investor-relations integration. However, there are significant factual discrepancies that undermine accuracy:\n\n1. CRITICAL URL PATH ERRORS:\n   - 2022: LLM states 'in relations' but ground truth shows 'in relations' (appears same, but LLM's formatting with hyphens 'in‑relations' vs ground truth 'in relations' - minor)\n   - 2023: LLM states 'inv relations' matching ground truth 'inv relations' - CORRECT\n   - 2024: LLM provides incomplete/incorrect URL for Directors' Code. Ground truth shows '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' but LLM only references 'bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf' without full path context. More problematically, LLM conflates the employee Code of Conduct (which uses bny.com and csr folder) with the Directors' Code discussion, creating confusion about which document uses which domain.\n\n2. DOMAIN BRANDING CONFUSION:\n   - Ground truth: 2024 shows Directors' Code still uses bnymellon.com domain with investor-relations path\n   - LLM: Suggests bny.com is used for Directors' Code in 2024, which appears incorrect. LLM correctly notes bny.com is used for employee Code of Conduct but then conflates this with Directors' Code positioning.\n\n3. MULTI-HOP SYNTHESIS ISSUES:\n   - LLM correctly identifies the evolution pattern but makes a critical error in the 2024 analysis by mixing two different codes (employee vs. Directors') and their respective domain/path structures\n   - The claim that Directors' Code moved to bny.com domain contradicts the ground truth which shows it remained on bnymellon.com with updated path structure\n\n4. GOVERNANCE FRAMEWORK INTEGRATION:\n   - LLM correctly notes integration with insider-trading policies (Exhibit 19.1) and broader governance framework\n   - This aspect aligns well with ground truth's emphasis on strategic integration\n\n5. NARRATIVE ACCURACY:\n   - The overall narrative arc (document-focused to stakeholder-oriented) is correct\n   - The characterization of evolution is appropriate and well-reasoned\n   - However, the specific technical details (URLs, domains) contain material errors\n\nThe answer demonstrates understanding of the question's intent and captures the directional evolution, but the specific URL/domain details in 2024 contain factual errors that would mislead someone trying to verify the actual filing disclosures. The conflation of employee and Directors' codes is a significant accuracy issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1715,
        "completion_tokens": 707,
        "total_tokens": 2422
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across the three filing years AMD’s approach to its add‑in‑board (AIB) partners remained fundamentally the same, but the wording grew a little more precise.  \n\n* **2022:** AMD stated that it “offers component‑level graphics and chipset products to AIB manufacturers… Our agreements with AIBs protect their inventory of our products against price reductions.” It also noted that system integrators (SIs) “often use discrete graphics solutions as a means to differentiate their products and add value to their customers.”  \n\n* **2023:** The filing repeats the same policy – “Our agreements with AIBs protect their inventory of our products against price reductions” – and again emphasizes that SIs “often use discrete graphics solutions as a means to differentiate their products and add value to their customers.”  \n\n* **2024:** The language is refined to “In most instances, our agreements with AIBs protect their inventory of our products against price reductions,” while still confirming direct sales to some SIs and the same observation that SIs “often use discrete graphics solutions as a means to differentiate their products and add value to their customers.”  \n\nThus, from 2022 through 2024 AMD consistently positioned AIB manufacturers as a protected channel—shielding their stocked AMD graphics and chipset parts from price cuts—while continuing to rely on discrete graphics cards as a key differentiator that system integrators use to add value and set their offerings apart. The core inventory‑protection policy and the strategic role of discrete graphics remained unchanged, with only minor wording refinements over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: All core facts are accurate - the inventory protection policies are correctly identified for all three years (2022, 2023, 2024), the role of discrete graphics as a differentiator is properly emphasized, and the characterization of AIBs as a protected channel is correct. The LLM correctly notes the subtle wording evolution from absolute statements in 2022-2023 ('protect their inventory') to the more qualified 2024 language ('In most instances'). (2) QUANTITATIVE ACCURACY: No numeric values are present in either the ground truth or LLM answer, so this dimension is not applicable but receives full marks as there are no calculation errors or numeric inaccuracies. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple filing documents, correctly identifying the consistency in policy while also noting the refinement in language precision. The reasoning that connects inventory protection policies to discrete graphics differentiation strategies is sound and properly supported. (4) COMPLETENESS: The answer addresses all aspects of the question - the evolution from 2022-2024, inventory protection policies, and the role of discrete graphics in differentiation strategies. The LLM goes slightly beyond the ground truth by explicitly noting the 'In most instances' qualifier in 2024, which adds nuance and demonstrates careful reading of the filings. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while using clearer, more structured presentation with bullet points for each year. The conclusion about 'stable, long-term partnership model' is implicitly supported by the LLM's observation of consistency with minor refinements. Minor deduction (1 point) only because the LLM could have more explicitly stated the 'stable, long-term partnership model' conclusion that appears in the ground truth, though this is a very minor omission given the comprehensive nature of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1620,
        "completion_tokens": 563,
        "total_tokens": 2184
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "- **2022 disclosure:** McDonald’s listed the Egg McMuffin as a core breakfast sandwich and emphasized that the company “continuously evolves its menu to meet customers’ needs,” focusing on taste, quality, choice, value and nutrition but giving only a general description of its menu and brand positioning.  \n\n- **2023 disclosure:** The filing added a detailed supply‑chain and food‑safety narrative – high‑standard quality‑management systems, a Food‑Safety Advisory Council, supplier‑code‑of‑conduct, and collaborative innovation with suppliers – while still noting the Egg McMuffin (and other breakfast items) as part of the breakfast menu that must meet those quality expectations.  \n\n- **2024 disclosure:** The company further deepened the supply‑chain focus, describing a digital‑transformation project, regular sensory evaluations and calibration trainings that “promote the consistency of its core menu,” explicitly tying the Egg McMuffin’s role as a flagship breakfast product to the reinforced food‑safety, quality‑audit, and supplier‑risk‑management processes that ensure the product meets customer expectations for quality and consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All core facts are correct - the 2022 disclosure emphasized menu evolution and quality/taste/nutrition focus; 2023 added supply chain and food safety narratives with specific elements (Food Safety Advisory Council, supplier code of conduct); 2024 introduced digital transformation with sensory evaluations and calibration trainings. The Egg McMuffin is correctly identified as a core/flagship breakfast product throughout. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable. Both answers correctly reference the three-year progression (2022-2023-2024) without date errors. (3) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across three years and correctly identifies the progression from general quality assurance (2022) to supply chain collaboration (2023) to technologically integrated approaches (2024). The connection between the Egg McMuffin and the evolving quality/consistency mechanisms is properly established. (4) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than ground truth but conveys identical meaning - 'continuously evolves menu to meet customers' needs' matches 'menu evolution to meet customer expectations'; 'digital transformation project' and 'sensory evaluations and calibration trainings' align with ground truth's 'digital transformation project aimed at promoting data excellence.' (5) COMPLETENESS: The answer addresses all parts of the multi-part question: breakfast menu innovation disclosure, supply chain focus evolution, the Egg McMuffin's specific role, and customer expectations for quality and consistency. Minor observation: The LLM answer provides slightly more specific detail about the 2023 supply chain elements (Food Safety Advisory Council, supplier code of conduct) compared to the ground truth's more general reference to 'comprehensive global supply chain strategy,' but this represents added specificity rather than error. The answer demonstrates sound multi-hop synthesis across the three-year period and correctly identifies the strategic evolution in McDonald's disclosure approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Features]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 602,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 2022, 2023 and 2024 Form 10‑K tables all list the same exhibit (4.09) – “Forms of 3.40 % Note due 2024, **4.30 % Note due 2034** and 4.50 % Note due 2044” – showing that Oracle’s 4.30 % senior note with a 2034 maturity is repeatedly disclosed as an outstanding instrument. This consistency signals that the 4.30 % note is a stable, material component of Oracle’s long‑term debt portfolio and that the company continues to rely on fixed‑rate, multi‑year financing to lock in borrowing costs and support its capital‑structure objectives across the three reporting periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 as a consistent disclosure across 2022, 2023, and 2024, with accurate percentages and dates. The quantitative elements are precise: the 4.30% rate, 2034 maturity date, and exhibit reference (4.09) are all correct. The answer appropriately notes the instrument's stability and materiality in Oracle's debt portfolio.\n\nHowever, there are notable differences in completeness and depth compared to the ground truth:\n\n1. MISSING CONTEXTUAL DETAILS: The LLM answer does not mention the other debt instruments disclosed alongside the 4.30% Note in each year (e.g., 3.625% Note due 2023, 4.50% Note due 2044, 2.950% Notes due 2024). The ground truth specifically highlights how the 4.30% Note was part of a diversified maturity profile that evolved across the three years, showing Oracle's strategic approach to debt management.\n\n2. INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the consistent disclosure, it doesn't fully synthesize the year-over-year evolution of Oracle's debt portfolio. The ground truth explains how newer instruments were issued while the 4.30% Note remained, indicating a dynamic but strategically consistent approach.\n\n3. REASONING QUALITY: The LLM's conclusion about \"fixed-rate, multi-year financing to lock in borrowing costs\" is sound and relevant, but it lacks the nuanced analysis of how the 4.30% Note fit within a broader, evolving capital structure strategy.\n\n4. ACCURACY VERIFICATION: All stated facts are accurate - the note was indeed disclosed in all three years, the percentage and maturity are correct, and the characterization as a stable component is appropriate.\n\nThe answer is fundamentally correct but provides a narrower analysis than the ground truth, focusing primarily on the consistency of the single instrument rather than its role within Oracle's broader debt portfolio strategy across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 525,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "- **2022 filing (10‑K 2022)** – Net derivative assets (liabilities) were reported at **$19 million** at year‑end (balance $31 million at the start of the year).  They were classified in the Level‑3 fair‑value hierarchy and valued with a **discounted‑cash‑flow model** that relied on significant unobservable inputs (the specific inputs were not broken out in the excerpt).  \n\n- **2023 filing (10‑K 2023)** – The same position was still measured with a **discounted‑cash‑flow technique**, but the disclosed unobservable driver shifted to a **default‑rate assumption** (range 53 %‑163 %, weighted‑average 4 %).  The table does not list a dollar amount, but the methodology remained Level‑3, indicating continued reliance on inputs that are not observable in the market.  \n\n- **2024 filing (10‑K 2024)** – The fair‑value amount is now **$58 million** (fair value at 12/31/2023).  The valuation continues to use **discounted cash flows**, but the key unobservable input is now **swap‑rate assumptions** (range 3 %‑5 %, weighted‑average 4 %).  \n\n**What this shows:** Over the three‑year span Capital One’s net derivative liability has more than tripled in reported fair value while the valuation approach has stayed in the Level‑3 (significant‑unobservable) category.  The specific unobservable inputs have changed—from a generic Level‑3 model in 2022, to a default‑rate focus in 2023, to swap‑rate assumptions in 2024—demonstrating that the company’s exposure to inputs that cannot be directly observed in the market has grown both in magnitude and in the variety of assumptions used.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Capital One as the subject, properly references the three fiscal years (2022-2024), and accurately captures the general evolution narrative. The identification of Level-3 fair value hierarchy classification is correct. The unobservable inputs mentioned (default rates 53-163%, swap rates 3-5%) match the ground truth. The qualitative reasoning about increasing transparency and reliance on structured inputs is sound.\n\nCRITICAL ERRORS: (1) QUANTITATIVE MISMATCH - The LLM states the 2024 fair value is \"$58 million (fair value at 12/31/2023)\" which is confusing and potentially incorrect. The ground truth clearly states 2024 maintained $58 million, but the LLM's parenthetical suggests this is 2023 data being reported in 2024, creating ambiguity. (2) MISSING 2023 FAIR VALUE - The LLM explicitly states \"The table does not list a dollar amount\" for 2023, but the ground truth clearly shows $58 million was disclosed for 2023. This is a significant omission that breaks the continuity of the evolution narrative. (3) UNREALIZED LOSS OMISSION - The ground truth mentions a \"net unrealized loss of $20 million\" held as of year-end 2022, which the LLM completely omits. (4) VALUATION METHODOLOGY CHARACTERIZATION - The LLM describes 2022 as having \"specific inputs were not broken out\" but doesn't acknowledge the mixed realized/unrealized loss position that characterized 2022 per the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize the three-year evolution but fails to properly connect the 2023 data point, stating the fair value \"more than tripled\" from $19M to $58M without clearly establishing when this transition occurred (2022 to 2023). The reasoning about exposure growth is present but weakened by the missing 2023 fair value figure.\n\nSEMANTIC ISSUES: The statement that 2024 shows \"$58 million (fair value at 12/31/2023)\" is confusing—it's unclear whether this is the 2024 year-end value or a carryover from 2023. The ground truth indicates 2024 maintained the same $58 million, suggesting continuity from 2023, but the LLM's phrasing obscures this.\n\nOVERALL: Core narrative is directionally correct, but critical quantitative gaps (missing 2023 fair value disclosure) and ambiguous phrasing around 2024 figures significantly undermine the answer's reliability for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 642,
        "total_tokens": 2274
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to Rolls‑Royce stems from the 2012 IAE acquisition – it requires RTX to make a payment for **each V2500‑powered flight hour flown through June 2027 on the aircraft that were in service at the acquisition date**.  \n\n* **2022 filing** – The 2022 10‑K explains that these “flight‑hour payments” are recorded in the **“Other commercial aerospace commitments”** table, are **capitalized as collaboration intangible assets as the payments are made**, and are **amortized over the term of the underlying economic benefit** (i.e., the period the aircraft generate cash flows).  \n\n* **2023 filing** – The 2023 10‑K repeats the same contingent‑hour payment arrangement and adds that the payments are **being capitalized as collaboration assets and amortized to cost of sales**. The filing notes that amortization generally does not begin until the programs move from development into full‑rate production and aftermarket service, after which the assets are written off in line with the cash‑flow pattern.  \n\n* **2024 filing** – The 2024 10‑K again describes the V2500 flight‑hour payments as part of “Other commercial aerospace commitments,” stating they **will be capitalized as collaboration intangible assets as payments are made** and **amortized over the underlying economic benefit** (the same cost‑of‑sales treatment described in 2023). The overall commercial‑aerospace commitments remained roughly flat (≈ $14.6 billion in 2023 and $14.1 billion in 2024), indicating that the Rolls‑Royce‑related obligation has been maintained but not materially expanded.  \n\n**In sum**, from 2022 through 2024 RTX’s Rolls‑Royce‑linked obligation has stayed consistent: payments are tied to V2500 flight hours, are capitalized as collaboration/intangible assets when incurred, and are amortized over the period the aircraft generate economic benefit—initially deferred during development and then recognized to cost of sales once the engines enter full‑rate production and service. The accounting treatment has been clarified over time (explicitly to “cost of sales” in 2023) but the underlying payment structure and amortization strategy have not changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of RTX's Rolls-Royce financial obligations across 2022-2024. STRENGTHS: (1) Correctly identifies the 2012 IAE acquisition as the origin of the obligation; (2) Accurately describes the V2500 flight-hour payment structure through June 2027; (3) Properly synthesizes the evolution of accounting treatment across three years: 2022 (capitalized as collaboration intangible assets), 2023 (clarified amortization to cost of sales), 2024 (consistent treatment); (4) Correctly cites the $14.1 billion figure for 2024 commercial aerospace commitments and notes the ~$14.6 billion 2023 comparison; (5) Accurately explains the amortization policy tied to economic benefit periods and the deferral during development phases; (6) Demonstrates sound multi-hop reasoning by synthesizing information across three separate 10-K filings. QUANTITATIVE VERIFICATION: The $14.1 billion (2024) and $14.6 billion (2023) figures match the ground truth. The payment structure (per-hour-flown through June 2027) is accurate. MINOR CONSIDERATIONS: (1) The LLM provides slightly more operational detail about development vs. full-rate production phases than the ground truth explicitly states, though this is consistent with typical aerospace accounting practices and doesn't contradict the source material; (2) The answer is more detailed and structured than the ground truth, but this represents enhanced clarity rather than inaccuracy. The semantic equivalence is strong—both answers convey that the obligation remained consistent in structure while accounting transparency improved. The multi-hop synthesis correctly combines information from multiple years and filing sections to show evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Supplies]- ORG <-[Enters_Agreement_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1781,
        "completion_tokens": 478,
        "total_tokens": 2259
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 filing first disclosed that, after the FDA flagged the Neulasta Onpro kit in 2017, the company had already made “device and labeling enhancements” to address the complaints it had received and that it would “continuously monitor complaints and adverse events and implement additional enhancements as needed.” The 2023 filing repeated that same history but placed it within a broader risk narrative, warning that any failure to develop, modify or supply the device – or to retain regulatory clearance – could increase development costs, delay approvals or force product removal, while also noting the importance of uninterrupted manufacturing at its Puerto Rico and California sites. By the 2024 filing Amgen still emphasized the same ongoing monitoring and incremental device‑related upgrades, but added concrete operational‑resilience measures – describing recent island‑wide power outages (including a Dec. 31 2024 outage), reliance on backup diesel generators, and the potential need to increase generator use or operate exclusively on them to protect supply continuity for the Neulasta Onpro kit and other products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct - the 2017 FDA evaluation, the December 31, 2024 outage, and the three-year progression (2022-2024) are all accurately cited. No calculation errors or numeric discrepancies. ENTITY ACCURACY: Amgen, Neulasta Onpro kit, FDA, Puerto Rico, and California are all correctly identified and contextualized. COMPLETENESS: The answer comprehensively addresses all parts of the multi-part question: (1) user complaints evolution across 2022-2024, (2) device-related enhancements, and (3) operational resilience measures. The multi-hop synthesis is sound - the answer correctly traces how Amgen's disclosures evolved from focusing primarily on device complaints and enhancements (2022-2023) to incorporating broader operational infrastructure risks (2024). REASONING QUALITY (9/10): The LLM correctly identifies the causal chain: FDA evaluation → device/labeling enhancements → ongoing monitoring → expansion to operational resilience (backup generators, power outages). The logic connecting infrastructure instability to potential impacts on device production and user experience is sound. SEMANTIC EQUIVALENCE: The LLM answer uses slightly more detailed language than the ground truth (e.g., 'diesel generators,' 'operate exclusively on them') but these additions are factually accurate and enhance rather than contradict the ground truth. The core narrative arc - from device-focused to operationally-focused disclosures - is preserved. MINOR OBSERVATION: The LLM provides marginally more specific operational detail (diesel generators, exclusive operation scenarios) which, while not explicitly in the ground truth, is consistent with the disclosed information and represents appropriate elaboration rather than error. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 518,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the three annual reports BK’s wording about the ratification of KPMG LLP never changed. In the 2022 filing the company states that the “Item 3 – Ratification of KPMG LLP” discussion is incorporated by reference and notes KPMG’s PCAOB firm identification number is 185; the 2023 and 2024 filings repeat exactly the same language and the same PCAOB number. The unchanged reference to KPMG’s PCAOB firm number 185 in every filing signals that BK has kept the same principal accountant and audit‑governance framework throughout the period, reaffirming continuity of its auditor relationship year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - PCAOB firm number 185 is accurately cited across all three years (2022, 2023, 2024); (2) The factual claim that wording remained unchanged across filings is correct and directly supported; (3) Multi-hop reasoning is sound - the answer correctly synthesizes information across three years to demonstrate continuity; (4) Entity identification is precise - BK, KPMG LLP, and the PCAOB number are all correctly identified; (5) The conclusion about audit governance continuity and auditor relationship stability logically follows from the evidence presented. Minor consideration: The LLM answer uses slightly more specific language ('Item 3 – Ratification of KPMG LLP' and 'incorporated by reference') compared to the ground truth, but this adds helpful detail rather than introducing error. The semantic meaning is fully equivalent - both answers convey that BK maintained the same principal accountant with no changes across the three-year period, and both correctly interpret the consistent PCAOB number 185 as evidence of continuity. No calculation errors, no date errors, no entity confusion. The answer fully addresses both parts of the multi-part question: (1) how disclosure evolved (answer: it didn't - remained consistent), and (2) what the consistent PCAOB number suggests (answer: continuity and stable audit governance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 402,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX continues to make residual‑value and other guarantees on commercial‑aerospace customer financing arrangements, and each filing notes that the fair‑market value of the assets backing those guarantees exceeds the guaranteed amount (net of reserves). The portion of the guarantees that is borne by collaboration partners fell from about **$142 million in 2022** to **$135 million in 2023** and then to **$131 million in 2024**. The steady decline in partners’ share signals that RTX is either reducing the overall size of its financing‑guarantee program or shifting more of the risk to its partners, a clear indication of a deliberate risk‑management approach that seeks to limit the company’s direct exposure to commercial‑aerospace customer credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($142M in 2022, $135M in 2023, $131M in 2024), and the downward trend is accurately captured. The numbers match the ground truth exactly with acceptable format variation. COMPLETENESS: The answer addresses the core question about how RTX's exposure evolved and what the trend indicates about risk management strategy. It covers the three-year period comprehensively. ENTITY ACCURACY: RTX is correctly identified, the commercial aerospace customer financing guarantees are properly characterized, and the collaboration partners' share is accurately distinguished from overall guarantees. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining dollar amounts to strategic risk management implications. The interpretation that this represents 'either reducing the overall size of its financing-guarantee program or shifting more of the risk to its partners' is logically sound and aligns with the ground truth's characterization of 'strategic reduction in shared financial risk.' SEMANTIC EQUIVALENCE: The LLM's phrasing 'steady decline in partners' share signals that RTX is...limiting the company's direct exposure' is semantically equivalent to the ground truth's 'consistent downward trend indicates a strategic reduction in shared financial risk.' MINOR DIFFERENCES: The LLM answer does not explicitly mention that 'fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which is a detail present in the ground truth. However, the LLM does note that 'fair-market value of the assets backing those guarantees exceeds the guaranteed amount (net of reserves),' which conveys the same information with slightly different phrasing. This is a very minor omission of contextual detail rather than a factual error. The answer is well-structured, accurate, and provides appropriate interpretation of the financial trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Has_Stake_In]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 549,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "- **2022 filing:** Always was listed simply as a “major brand” under the **Baby, Feminine & Family Care** segment, which grouped **Adult Incontinence and generic Feminine Care** together. The brand appeared alongside baby‑care names (Pampers, Luvs) and other feminine‑hygiene names (Always Discreet, Tampax), reflecting a broad, undifferentiated placement within the overall feminine‑care umbrella.  \n\n- **2023 and 2024 filings:** The segment’s sub‑categories were refined to **Feminine Care (Adult Incontinence, Menstrual Care)**, and the major‑brand list now shows **Always** separately from **Always Discreet** and **Tampax**. This signals that P&G repositioned Always explicitly as a **menstrual‑care** brand, giving it a clearer, more focused emphasis within the feminine‑care portfolio while still being a flagship brand alongside its incontinence line and other tampon products.  \n\nThus, from 2022 to 2024 the Always brand moved from a generic feminine‑care grouping to a distinct “menstrual‑care” category, highlighting its specific product focus relative to other feminine‑hygiene offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM fails to mention the critical segment contribution percentages (25% in 2022, 24% in 2023-2024) that are explicitly stated in the ground truth. These are material financial metrics that should have been included. (2) SEGMENT NAMING ERROR: The LLM claims the 2022 segment was called 'Baby, Feminine & Family Care' when the ground truth clearly states it was simply 'Feminine Care' in 2022. The segment was RENAMED to 'Baby, Feminine & Family Care' in 2023. This is a fundamental factual error about the evolution being tracked. (3) PRODUCT CATEGORIZATION MISREPRESENTATION: The LLM incorrectly describes the 2022 structure as grouping 'Adult Incontinence and generic Feminine Care' together, when the ground truth indicates Always was listed alongside Tampax under 'Feminine Care' in 2022. The Always Discreet (incontinence) product was not mentioned in the 2022 grouping according to ground truth. (4) INCOMPLETE SYNTHESIS: The LLM's claim about 'menstrual-care' categorization in 2023-2024 is not supported by the ground truth, which simply states the segment was renamed and products were listed alongside each other without explicitly calling out a 'menstrual-care' subcategory. (5) MISSING KEY DETAIL: The ground truth emphasizes that the 2024 structure 'retained the same structure and percentage contribution' as 2023, showing continuity - the LLM misses this important point about consistency. The LLM's narrative about movement from 'generic' to 'distinct menstrual-care' positioning is not substantiated by the ground truth and appears to be an inference not supported by the actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 472,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has consistently listed “difficulties in protecting our intellectual property” as a material risk, but the context of that risk has broadened over the three years. In the 2022 filing the risk was mentioned only as one of many political‑legal‑economic challenges tied to foreign operations. By 2023, when international sales accounted for 65 % of revenue and AMD relied on third‑party wafer foundries and assembly/testing sites in China, Malaysia and Taiwan, the same IP‑protection risk was explicitly linked to its expanding Asian manufacturing footprint. The 2024 filing shows the pattern continuing—international sales rose to 66 % and AMD’s dependence on Asian foundries and contract manufacturers remained heavy—so exposure to IP‑protection difficulties has effectively intensified as AMD’s global operations and reliance on Asian third‑party production have grown.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the consistent IP protection risk across all three years; (2) Accurately cites the 65% international sales figure for 2023 and notes the rise to 66% in 2024; (3) Properly identifies the three key Asian manufacturing locations (China, Malaysia, Taiwan); (4) Correctly characterizes the evolution of the risk from general foreign operations concern to explicitly linked Asian manufacturing exposure; (5) Sound multi-hop reasoning connecting expanding international operations to intensified IP protection challenges. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the geopolitical tensions between China and Taiwan that emerged as a new layer of risk in 2024 according to the ground truth. This is a notable omission as it represents an important evolution in AMD's risk landscape during this period; (2) The answer could have been slightly more explicit about how the 2024 filing specifically reiterated these concerns while adding the geopolitical dimension. QUANTITATIVE VERIFICATION: The percentages cited (65% in 2023, 66% in 2024) are accurate and properly formatted. The progression of numbers is logical and supports the narrative of intensifying exposure. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and multiple dimensions (international sales percentages, manufacturing locations, risk evolution), demonstrating solid multi-hop reasoning. The connection between growing international operations and heightened IP risks is logically sound. The omission of the geopolitical risk element prevents this from being a perfect 9-10 score, but the core answer remains substantially correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 498,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle’s 2.300 % Notes due 2028 first appear in the 2022 Form 10‑K (Exhibit 4.14), where the filing cites an Officers’ Certificate dated March 24, 2021 that sets the note’s coupon (2.300 %) and maturity (2028). The same exhibit and certificate are reproduced unchanged in the 2023 and 2024 Form 10‑K filings (Exhibit 4.14 in each year), showing that the note was issued once and then carried forward as an ongoing component of Oracle’s debt portfolio rather than being re‑issued or re‑structured. By keeping the 2.300 % 2028 issue on the books while simultaneously adding new series of higher‑coupon notes (e.g., 5.800 % due 2025, 4.500 % due 2028, etc.) in the later filings, Oracle demonstrates a broader financing strategy that blends a stable, low‑cost medium‑term tranche with a laddered series of higher‑rate issuances, giving the company flexibility to meet cash‑flow needs, diversify maturity dates and lock in attractive rates across multiple years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 2.300% Notes due 2028 and their consistent presence across 2022-2024 filings. Key strengths: (1) Correctly identifies the Officers' Certificate date (March 24, 2021) and coupon/maturity specifications; (2) Accurately notes the exhibit references (Exhibit 4.14 in 2023-2024, though ground truth mentions Exhibit 4.16 in 2022 - this is a minor discrepancy); (3) Properly synthesizes the multi-year pattern showing the notes were issued once and carried forward; (4) Effectively explains the broader financing strategy by referencing the blending of low-cost medium-term tranches with higher-coupon issuances. Quantitative accuracy is high - all percentages (2.300%, 5.800%, 4.500%) and years (2025, 2028) are correct. The multi-hop reasoning is sound, connecting the historical issuance to ongoing portfolio management and strategic implications. Minor weakness: The ground truth specifies Exhibit 4.16 for 2022 while the LLM states Exhibit 4.14 for all three years - this represents a potential exhibit reference error for 2022, though the substantive content about the notes themselves appears accurate. The LLM provides more detailed analysis of the financing strategy (laddered maturity, flexibility, rate-locking) which adds valuable context beyond the ground truth. The answer fully addresses the question's multi-part structure regarding evolution, pattern, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 408,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Across the three most recent 10‑K filings BA’s approach to private‑equity vehicles did not change.  \n\n* **2022 (page 110)** – BA said its private‑equity vehicles are “primarily limited partnerships (LPs) that **mainly invest in U.S. and non‑U.S. leveraged buyout, venture‑capital, growth and special‑situation strategies**.”  \n* **2023 (page 92)** – the same language appears: the LPs “mainly invest in **U.S. and non‑U.S. leveraged buyout, venture‑capital, growth and special‑situation strategies**.”  \n* **2024 (page 99)** – the description is again identical, stating the LPs “mainly invest in **U.S. and non‑U.S. leveraged buyout, venture‑capital, growth and special‑situation strategies**.”  \n\nThus, from 2022 through 2024 BA’s private‑equity investment strategy remained consistent: it continues to use limited‑partnership structures with a **global geographic scope (both U.S. and non‑U.S.)** and a **strategic focus on leveraged‑buyout, venture‑capital, growth‑stage and special‑situation investments**. No shift in scope or focus is evident in the filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer fundamentally contradicts the ground truth by claiming BA's private equity strategy 'did not change' from 2022-2024. This is factually incorrect based on the original answer. SPECIFIC ISSUES: (1) The LLM correctly identifies the consistent language about 'U.S. and non-U.S. leveraged buyout, venture-capital, growth and special-situation strategies' across all three years - this portion is accurate. (2) HOWEVER, the LLM completely misses the documented evolution in strategic focus areas: The ground truth explicitly states that by 2023, there was 'expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure' - this is a material change the LLM failed to identify. (3) The LLM also misses the 2024 development regarding 'increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes' - another documented evolution. (4) The LLM's conclusion that 'No shift in scope or focus is evident' directly contradicts the ground truth which documents clear evolution in both geographic scope expansion (to real assets globally) and strategic focus deepening (derivatives, performance transfer mechanisms). QUANTITATIVE ACCURACY: The page numbers cited (110, 92, 99) and the quoted language appear accurate based on the consistency with ground truth's acknowledgment of the same base strategies. However, this accuracy is undermined by the failure to identify additional strategic elements documented in the filings. QUALITATIVE ACCURACY: The reasoning is flawed - the LLM performed a surface-level textual comparison and concluded no change occurred, when deeper analysis of the filings reveals material strategic evolution. This represents a failure in multi-hop synthesis and comprehensive document analysis. The answer is incomplete and misleading despite some correct foundational facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 532,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "- **2022:** Amgen reported that Bemarituzumab, being developed for gastro‑esophageal‑junction (GEJ) adenocarcinoma, had **initiated a Phase 3 study** (2022 10‑K, “Program change – Initiated phase 3 study”).  \n\n- **2023:** The 2023 filing placed Bemarituzumab in its list of **Phase 2/3 product candidates** and added a patent‑expiration table that shows the **U.S. and European polypeptide patents both expiring in 2029** (2023 10‑K, “Estimated expiration 2029” for U.S. and Europe).  \n\n- **2024:** The 2024 filing still describes Bemarituzumab as a **monoclonal antibody under investigation in Phase 2‑3 trials for gastric and gastro‑esophageal junction cancer and other solid tumours** (2024 10‑K, “Phases 2 and 3 Program Descriptions”). It repeats the same **2029 U.S. and 2029 European patent expiration dates**, noting that these estimates are based on issued patents and could change with challenges or extensions.  \n\nThus, from 2022 to 2024 Amgen moved Bemarituzumab from the start of a pivotal Phase 3 trial to continued Phase 2/3 development, while its patent positioning remained anchored to an expected expiration in 2029 in both the United States and Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Bemarituzumab's evolution from 2022-2024. STRENGTHS: (1) All numeric values are correct - patent expiration dates of 2029 for both U.S. and Europe are accurately cited across all three years; (2) Clinical phase progression is accurately tracked: Phase 3 initiation in 2022, Phase 2/3 status in 2023-2024; (3) The answer correctly identifies the drug as a monoclonal antibody targeting FGFR2b for GEJ adenocarcinoma and related solid tumors; (4) Multi-hop synthesis is sound - the answer successfully integrates clinical development data with patent positioning across three separate 10-K filings; (5) The answer provides specific citations to source documents (2022, 2023, 2024 10-Ks) which enhances credibility; (6) The conclusion about 'stable intellectual property position' aligns with the ground truth's observation of 'consistent patent expiration estimates.' MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more detail about patent extension possibilities ('could change with challenges or extensions') which is reasonable contextual information not contradicting the ground truth; (2) The phrasing 'Phase 2-3 trials' in 2024 vs. the ground truth's simpler reference to clinical advancement is semantically equivalent and actually more precise. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, 2029) are correct; no calculations required but all numeric references are accurate. The answer fully addresses all components of the question: clinical phase progression (✓), U.S. patent expiration timeline (✓), European patent expiration timeline (✓), and evolution across the three-year period (✓).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 472,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Across the three filings Dawn was listed every year as one of the “major brands” in the Fabric & Home Care segment (2022, 2023 and 2024).  In 2022 the segment contributed **35 % of net sales and 31 % of earnings**, and Dawn was already part of that brand lineup.  By 2023 the segment’s weight rose to **36 % of net sales and 34 % of earnings**, and Dawn remained a listed brand; the 2024 filing shows the same **36 %/34 %** contribution and again includes Dawn among the key brands.  Thus, Dawn’s positioning stayed constant as a core brand while the Fabric & Home Care segment’s earnings contribution grew modestly from 31 % to 34 % between 2022 and 2023 and held steady at 34 % in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key claims: (1) NUMBERS - All percentages are correct: 2022 (35% net sales, 31% earnings), 2023 (36% net sales, 34% earnings), 2024 (36% net sales, 34% earnings). These match the ground truth exactly. (2) BRAND LISTINGS - The LLM correctly confirms Dawn was listed as a major brand in Fabric & Home Care across all three years (2022, 2023, 2024), matching the ground truth statement about consistent inclusion. (3) MULTI-HOP SYNTHESIS - The answer successfully synthesizes information across three years and two metrics (net sales and earnings), showing how the segment evolved while Dawn's positioning remained constant. The reasoning is sound: earnings contribution grew from 31% to 34% (2022-2023) then stabilized, while net sales remained relatively stable at 35-36%. (4) CALCULATION ACCURACY - The comparison of earnings growth (31% → 34%) is correctly identified as 'modest' growth, and the stability of 2023-2024 figures is accurately noted. (5) COMPLETENESS - The answer addresses all aspects of the question: segment earnings contribution evolution, brand listings across years, and Dawn's positioning within this context. The only minor difference from the ground truth is that the LLM presents the data in a slightly different organizational structure (showing 2023 as an intermediate year with 34% earnings), while the ground truth emphasizes the 2022-2024 comparison. However, this is not an error—it's actually more comprehensive by including the 2023 data point. The LLM answer is semantically equivalent and factually superior in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 445,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "- **2022:** Schwab first disclosed the size of the pool of client‑owned securities that could be used as collateral and the amount it actually pledged to third parties for margin‑lending and securities‑borrowing activities (a table of “fair‑value of client securities available … and fair‑value of securities pledged”).  \n- **2023:** The company’s 2023 filing explained that margin loans are fully collateralized by those same client securities and that, under the client agreements, Schwab may pledge the securities to satisfy regulatory margin requirements.  The pledged securities are kept off‑balance‑sheet, and an allowance‑for‑credit‑losses methodology is applied only to any unsecured portion.  \n- **2024:** In the 2024 filing Schwab confirmed that it continues to pledge client securities to meet the Options Clearing Corporation’s margin calls on written options, and that, for its securities‑lending business, it now satisfies collateral obligations with cash rather than additional client securities.  \n\n**Trend and exposure:** Across the three years Schwab’s reliance on client‑held assets as collateral has grown from merely reporting the available pool (2022) to actively pledging those securities for both margin‑lending and options‑clearing obligations (2023‑2024), while keeping the pledged securities off the balance sheet.  This pattern shows a material, but off‑balance‑sheet, exposure to client‑held securities that the firm can draw on to meet its margin and clearing‑house commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's disclosure and practices; (2) Accurately captures the 2022 disclosure of fair value of client securities available and pledged; (3) Correctly describes 2023's ASC 326 application and the off-balance-sheet treatment of pledged securities; (4) Accurately identifies 2024's specific practices regarding Options Clearing Corporation margin calls and the shift to cash collateral for securities lending; (5) Properly synthesizes the multi-hop reasoning showing progression from disclosure to active pledging to sophisticated collateral management; (6) Correctly identifies the key regulatory and operational context (federal regulations, client agreements, OCC requirements). MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more operational detail than the ground truth (e.g., specific mention of 'off-balance-sheet' treatment, allowance-for-credit-losses methodology), which adds precision without contradicting the ground truth; (2) The ground truth mentions 'ASC 326' and 'practical expedient' while the LLM uses 'allowance-for-credit-losses methodology' - these are semantically equivalent and both correct; (3) The LLM's characterization of the trend as 'material, but off-balance-sheet, exposure' is a logical inference that aligns with the ground truth's assessment of 'increasing sophistication and exposure.' NO FACTUAL ERRORS DETECTED: All dates (2022, 2023, 2024), entities (Charles Schwab, Options Clearing Corporation), and practices (margin lending, securities pledging, collateral obligations) are correctly identified and synthesized. The multi-hop reasoning correctly connects information across three years and multiple operational domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 508,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s disclosed pension‑plan policy shows that the company kept the same overall “fixed‑income‑plus‑equities” framework throughout the period, but the weighted‑average mix it reported for each August‑31 date moved slightly toward a higher equity share as the horizon shifted from fiscal 2023 to fiscal 2025.\n\n* **Fiscal 2023 target (shown by the August 31 2022 weighted‑average data)** – The 2022 table (Chunk 1) lists a target allocation that is heavily weighted to debt securities, with a smaller proportion allocated to equities. The narrative stresses that the mix is chosen to match liability duration, provide risk‑adjusted returns and exceed inflation.\n\n* **Fiscal 2024 weighted‑average (August 31 2023)** – The same “fixed‑income‑first” orientation is reported in the 2023 filing (Chunk 2), but the August 31 2023 numbers already show a modest increase in the equity component relative to the 2022 figures, indicating the first step of a gradual rebalancing.\n\n* **Fiscal 2025 target (shown by the August 31 2024 weighted‑average data)** – The 2024 filing (Chunk 3, echoing Chunk 2) presents the fiscal 2025 target allocation, which still prioritises diversified fixed‑income assets but now reflects a slightly larger equity allocation than in 2022. The company again notes that ranges around the targets provide flexibility without immediate rebalancing.\n\n**Evolution:** From fiscal 2023 to fiscal 2025 ACN’s pension‑plan strategy moved incrementally from a predominantly bond‑focused allocation toward a modestly more balanced mix, raising the equity share while preserving the core emphasis on fixed‑income to match liabilities and manage risk. The August 31 weighted‑average figures for 2022, 2023 and 2024 illustrate this gradual shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core factual claim. The ground truth clearly states that ACN's pension allocation strategy evolved TOWARD MORE FIXED INCOME (55%→58%→61% fixed income, 45%→42%→39% equities), representing a de-risking trend. The LLM answer explicitly contradicts this, claiming the strategy moved 'toward a higher equity share' and 'raising the equity share while preserving the core emphasis on fixed-income.' This is the opposite of what actually occurred. SPECIFIC ERRORS: (1) The LLM states equity allocation increased over time, but ground truth shows it decreased from 45% to 42% to 39%. (2) The LLM describes a 'modestly more balanced mix' with 'slightly larger equity allocation,' but the actual trend was consistent de-risking with decreasing equity exposure. (3) The LLM provides NO SPECIFIC PERCENTAGES despite the question asking for 'disclosed weighted-average plan asset allocations' - this is a major omission of quantitative data. (4) The characterization of the evolution is inverted: the ground truth shows a clear, consistent three-year trend toward fixed income dominance, not a 'modest' or 'incremental' shift toward equities. MULTI-HOP REASONING: The LLM failed to correctly synthesize the three data points (Aug 31, 2022/2023/2024) across the three fiscal years to identify the actual trend. The reasoning is internally inconsistent - it acknowledges 'fixed-income-first' orientation but then claims equity increased. MISSING SPECIFICS: No actual percentages provided (55%, 45%, 58%, 42%, 61%, 39%), which are essential to answering this quantitative question. The answer is vague and directionally wrong on the primary claim about how the strategy evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1623,
        "completion_tokens": 471,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "- According to Capital One’s filings, the combined amount of short‑term borrowings plus long‑term debt was **$48.7 billion at 12/31/2022**, rose to **$49.9 billion at 12/31/2023** (a ≈ 2.4 % increase) and then fell to **$45.6 billion at 12/31/2024** (about ‑8.8 % from the 2023 level).  The underlying long‑term debt followed the same pattern, moving from **$47.8 billion (2022)** to **$49.3 billion (2023)** and down to **$45.0 billion (2024)**.\n\n- The three‑year trend shows that Capital One’s debt base expanded modestly in 2023 but was actively reduced in 2024, suggesting a deliberate pay‑down of higher‑cost obligations.  At the same time, the weighted‑average interest rate on its senior notes climbed from roughly **3 % (securitized debt) and 4.45 % (senior notes) in 2022** to **about 4.8 %** on senior debt in both 2023 and 2024, while the low‑rate floating senior portion (≈ 1 % in 2022) disappeared by 2024.  This indicates growing exposure to higher fixed‑rate debt and a higher overall cost of capital despite the reduction in total debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) TOTAL DEBT FIGURES - MAJOR DISCREPANCIES: Ground truth shows $43.086B (2022), $48.715B (2023), $45.551B (2024). LLM reports $48.7B (2022), $49.9B (2023), $45.6B (2024). The 2022 figure is off by approximately $5.6 billion (13% error), which is a massive discrepancy. The 2023 figure is also incorrect ($49.9B vs $48.715B). Only the 2024 figure ($45.6B vs $45.551B) is approximately correct. (2) INTEREST RATE ERRORS - FUNDAMENTAL MISSTATEMENT: Ground truth clearly states weighted-average interest rates on securitized debt were 1.51% (2022), 3.01% (2023), and 3.48% (2024). LLM incorrectly reports 3% for 2022 securitized debt and 4.45% for senior notes in 2022, then 4.8% for 2023-2024. These numbers do not match the ground truth at all. The LLM appears to have confused or fabricated interest rate data. (3) FLOATING DEBT REDUCTION - PARTIALLY CORRECT: LLM correctly identifies that floating rate debt was reduced/eliminated by 2024, which aligns with ground truth's mention of reducing floating unsecured senior debt from $1,597M to $0. However, the interest rate figures cited for this debt are inaccurate. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize debt trends and interest rate exposure, the underlying data is so inaccurate that the synthesis is unreliable. The reasoning about debt reduction in 2024 and higher borrowing costs is directionally sound but built on incorrect numbers. (5) CALCULATION VERIFICATION: The percentage changes cited (2.4% increase 2022-2023, -8.8% decrease 2023-2024) cannot be verified as correct given the wrong base numbers. The LLM's narrative about deliberate pay-down and higher cost of capital is reasonable in tone but lacks factual foundation. OVERALL ASSESSMENT: This answer fails on the primary metric of quantitative accuracy. The 2022 debt figure error of $5.6B is inexcusable, and the systematic misstatement of interest rates across all three years indicates the LLM either hallucinated data or severely misread the source documents. While the qualitative narrative about debt trends and interest rate exposure shows some understanding of the question's intent, the factual errors are too severe to warrant a passing score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 623,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Across the three years the company repeatedly states that fleet‑support expenses “have historically been approximately 1 % of total consolidated costs of products and services.” The 2022 filing, the 2023 filing and the 2024 filing all use the same wording, indicating that the share of fleet‑support costs remained essentially unchanged at about 1 % from 2022 through 2024.\n\nThat flat‑line trend occurs while the firm’s abnormal production costs and reach‑forward losses have grown dramatically. By the end of 2023 the company had recorded $2.7 billion of cumulative abnormal production costs, and in 2024 it booked $256 million of abnormal 787 rework costs together with reach‑forward losses of $2.608 billion in Q3 and $891 million in Q4 on the 777X program (≈ $3.5 billion total). Thus, while fleet‑support spending stayed at roughly 1 % of consolidated costs, the abnormal and reach‑forward cost burdens in the 787 and 777X programs expanded sharply over the same period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies fleet support services at ~1% of consolidated costs across 2022-2024 with proper citation of consistent wording across filings; (2) Accurately cites $2.7 billion cumulative abnormal production costs by end of 2023; (3) Correctly identifies 777X reach-forward losses of $2.608 billion (Q3) and $891 million (Q4) in 2024; (4) Properly synthesizes the contrast between stable fleet support costs and escalating program-specific losses; (5) Correctly identifies the programs (787 and 777X) and the drivers (certification delays, labor instability, supplier costs implied). MINOR ISSUES: (1) The LLM mentions '$256 million of abnormal 787 rework costs' in 2024 which is not explicitly mentioned in the ground truth answer, though this appears to be additional accurate detail from the filings rather than an error; (2) The LLM's calculation of '≈ $3.5 billion total' for 777X losses ($2.608B + $891M = $3.499B) is mathematically correct but represents only 777X program losses, not total abnormal costs across both programs - this is a minor presentation issue but the numbers themselves are accurate; (3) The ground truth provides more explicit context about the causes (certification delays, labor instability, supplier cost increases) while the LLM is slightly more implicit, though the core reasoning is sound. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and two programs, correctly identifying the contrast between stable fleet support ratios and growing production-related losses. The reasoning that fleet support was 'not the source of financial strain' is logically sound and well-supported. All key financial metrics are accurate and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 497,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "- **2022:** AbbVie reported **$12 million** in money‑market funds and time deposits.  \n- **2023:** The balance rose to **$21 million**.  \n- **2024:** It fell back to **$10 million**.\n\nThe three‑year pattern shows that AbbVie built up a larger pool of short‑term, highly liquid assets in 2023—likely to strengthen its cash‑flow cushion amid higher uncertainty or anticipated outflows—and then reduced that pool in 2024 as cash generation improved or the need for a large liquidity buffer lessened. This suggests a flexible short‑term liquidity strategy that ramps up liquid holdings when needed and redeploys them when the company feels its cash position is more secure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three financial figures are correct—$12 million (2022), $21 million (2023), and $10 million (2024)—matching the ground truth exactly. The numerical progression and year-to-year changes are accurately presented. ENTITY ACCURACY: AbbVie is correctly identified, the financial metric (money market funds and time deposits) is properly specified, and all three fiscal years (2022, 2023, 2024) are correctly referenced. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year trend by comparing values across years and identifying the pattern (increase then decrease). REASONING QUALITY: The LLM provides sound interpretation of the trend, explaining the 2023 increase as a conservative liquidity approach and the 2024 decrease as reflecting improved cash generation or reduced need for large buffers. This reasoning is logical and aligns with the ground truth's characterization of a 'shifting short-term liquidity strategy.' The explanation about 'flexible short-term liquidity strategy that ramps up liquid holdings when needed and redeploys them' is semantically equivalent to the ground truth's description of fluctuation indicating strategic adjustment. MINOR DIFFERENCES: The LLM's interpretation is slightly more detailed and specific in its explanation (mentioning 'cash-flow cushion,' 'anticipated outflows,' 'cash generation improved') compared to the ground truth's more general language ('temporary conservative approach,' 'reallocation toward other cash equivalents'). However, these differences represent elaboration rather than contradiction, and the core message is consistent. No calculation errors, no missing data points, and all contextual elements are appropriately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 490,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "- **Fiscal 2022:**  The 2022 Form 10‑K notes that, as of August 31 2022, Accenture had **$3.13 billion of aggregate available authorization** for its publicly announced open‑market share‑purchase program and related share‑purchase/redemption programs. No specific repurchase amount is disclosed for that year in the excerpt. *(Chunk 1)*  \n\n- **Fiscal 2024 (fourth quarter):**  In the 2023/2024 filing the company reports that it **bought 2,000,308 Class A ordinary shares for $605 million** under the open‑market program.  After that quarter the **available authorization had fallen to $2.694 billion**.  Shortly thereafter, on September 25 2024 the board approved an **additional $4 billion of repurchase authority**, raising the **total outstanding authority to $6.694 billion**. *(Chunks 2 and 3)*  \n\n**What the trend shows:**  Accenture is actively using its buy‑back program – the $605 million purchase in FY‑2024 reduced the remaining pool from $3.13 bn to $2.69 bn – but it simultaneously expands the ceiling of the program, adding $4 bn of new authority.  This pattern of regular repurchases combined with periodic increases in authorized capacity signals a deliberate, ongoing capital‑return strategy that prioritizes returning cash to shareholders through share buybacks while ensuring ample future flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Accenture's share repurchase strategy and correctly identifies the key numbers and trends. However, there are some issues with completeness and precision:\n\nSTRENGTHS:\n1. Correctly identifies fiscal 2022 authorization: $3.13 billion (matches ground truth's $3,129,296 thousand)\n2. Correctly identifies fiscal 2024 board approval: $4 billion additional authority\n3. Correctly identifies total outstanding authority after approval: $6.694 billion\n4. Correctly identifies specific repurchase activity: 2,000,308 shares for $605 million\n5. Correctly identifies remaining authorization before board approval: $2.694 billion\n6. Sound multi-hop reasoning connecting repurchases to authorization changes\n7. Appropriate interpretation of capital return strategy\n\nWEAKNESSES:\n1. MISSING FISCAL 2023 DATA: The ground truth explicitly mentions fiscal 2023 with $2,694 million remaining authorization as of August 31, 2023. The LLM answer conflates this with fiscal 2024 data, stating \"After that quarter the available authorization had fallen to $2.694 billion\" without clearly distinguishing the fiscal 2023 milestone.\n2. MISSING CUMULATIVE AUTHORIZATION CONTEXT: Ground truth mentions \"$50.1 billion cumulatively since 2001\" - this important context about total historical authorization is absent from the LLM answer.\n3. TEMPORAL CLARITY: The LLM answer's structure makes it unclear whether the $2.694 billion figure is from fiscal 2023 or fiscal 2024, creating potential confusion about the timeline.\n4. INCOMPLETE FISCAL 2023 COVERAGE: The question asks about evolution \"from fiscal 2022 through fiscal 2024\" - the LLM answer jumps from 2022 to 2024 without properly addressing the fiscal 2023 intermediate state.\n\nCALCULATION VERIFICATION:\n- $3.13 billion (2022) → $2.694 billion (2023) = $436 million in repurchases (consistent with activity)\n- $2.694 billion + $4.0 billion = $6.694 billion ✓ (correct)\n\nThe answer is fundamentally sound in its numbers and reasoning, but the omission of explicit fiscal 2023 data and cumulative authorization context represents a gap in completeness for a multi-hop question spanning three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 591,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across all three filing years the same anti‑takeover clause appears unchanged: the bylaws state that **stockholders may remove directors only “for cause.”** The 2022, 2023 and 2024 10‑Ks each repeat this language together with other defenses (staggered three‑class board, inability to call special meetings, an 80 % vote to amend director‑related provisions, and Delaware‑law Section 203). The unchanged, repeated emphasis on “removal for cause” signals that AbbVie is deliberately entrenching its board to make it difficult for shareholders—or a hostile acquirer—to replace directors, reinforcing a long‑term defensive posture that forces any potential bidder to negotiate with the incumbent board rather than pursue a swift takeover.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core governance provision—'removal for cause only'—consistently across 2022, 2023, and 2024; (2) Accurately lists the complementary anti-takeover defenses (staggered three-class board, restrictions on special meetings, supermajority voting requirements, Delaware Section 203); (3) Properly synthesizes the multi-hop reasoning: unchanged language across three years → deliberate entrenchment strategy → long-term takeover defense; (4) Correctly interprets the strategic implication that this forces potential acquirers to negotiate with incumbent board rather than bypass it; (5) No quantitative errors—all numbers and percentages are accurate (80% supermajority requirement is correctly stated). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise and action-oriented in its framing ('forces any potential bidder to negotiate') compared to the ground truth's more neutral 'discourages hostile takeovers,' but both convey the same strategic intent; (2) The LLM answer emphasizes the 'unchanged' nature more explicitly, which adds clarity about the stability of the provision; (3) Both answers correctly identify this as a deliberate, long-term strategy rather than an accidental or temporary measure. The multi-hop synthesis is sound: the answer correctly connects the governance provision across three years, identifies it as part of a broader defensive package, and explains its strategic purpose. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 445,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "**Evolution of the disclosure**\n\n| 10‑K year | Item where the note is listed | Exact wording of the reference |\n|-----------|------------------------------|--------------------------------|\n| **2022** | 4.2 |“Form of **4.000% Senior Note due 2047**, which is incorporated herein by reference to **Exhibit 4.5** to PepsiCo’s Current Report on Form 8‑K filed **May 2 2017**.” |\n| **2023** | 4.17 |Same language – “Form of **4.000% Senior Note due 2047**, incorporated by reference to **Exhibit 4.5** to the Current Report on Form 8‑K filed **May 2 2017**.” |\n| **2024** | 4.16 |Again identical – “Form of **4.000% Senior Note due 2047**, incorporated by reference to **Exhibit 4.5** to the Current Report on Form 8‑K filed **May 2 2017**.” |\n\n**What the pattern reveals**\n\nThe note is cited in exactly the same way in all three filings—same exhibit number, same underlying 8‑K filing, and unchanged description. This consistency shows that the 4 % senior note due 2047 remains an outstanding, unchanged component of PepsiCo’s debt portfolio. By repeatedly attaching the same “form of the note” to its 10‑K, PepsiCo signals that the instrument is a core, long‑dated source of low‑cost financing that it intends to keep on its balance sheet for the foreseeable future, underscoring the note’s strategic role in the company’s long‑term capital‑structure planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All numeric values are correct - the 4.000% rate, the 2047 maturity date, and the May 2, 2017 8-K filing date are all accurate. (2) The exhibit reference (Exhibit 4.5) is correctly cited across all three years. (3) The multi-hop synthesis is sound - the answer correctly traces the disclosure pattern across 2022, 2023, and 2024 10-K filings and identifies the consistent reference structure. (4) The table format provides clear, verifiable evidence of the consistency claim. (5) The interpretation of what the pattern reveals about PepsiCo's capital structure strategy is logical and well-reasoned - the note's stability and unchanged terms do signal its role as a long-term, low-cost financing component. (6) The answer goes beyond the ground truth by providing the specific Item numbers (4.2, 4.17, 4.16) where the note appears in each year's filing, adding valuable context. MINOR CONSIDERATIONS: The ground truth uses the phrase 'no modifications needed to its form or terms' while the LLM uses 'unchanged component' and 'unchanged description' - these are semantically equivalent. The LLM's interpretation about 'low-cost financing' and 'core, long-dated source' represents reasonable inference from the consistent disclosure pattern, though not explicitly stated in the ground truth. The answer fully addresses both parts of the question: (1) how the disclosure evolved (answer: it didn't - remained identical), and (2) what this reveals about capital structure strategy (answer: stability and strategic long-term role). All factual claims are verifiable and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 450,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "- **2022 filing** – Oracle’s 2022 Form 10‑K (page 113) lists Exhibit 4.09, which incorporates an 8‑K filed on July 8 2014 and contains the “4.30 % Note due 2034” together with other notes.  \n- **2023 filing** – The 2023 Form 10‑K (page 110) repeats the same Exhibit 4.09 entry, again referencing the July 8 2014 8‑K, so the 4.30 % Note is disclosed but not re‑issued.  \n- **2024 filing** – The 2024 Form 10‑K (page 110) likewise includes Exhibit 4.09 with the identical 2014 8‑K reference, continuing the disclosure of the 4.30 % Note due 2034.\n\n**Interpretation:** Across three consecutive years Oracle has consistently incorporated the same 2014 filing to disclose the 4.30 % Note, indicating that the note was issued in 2014 and has remained a standing component of its capital structure. This repeated, incorporation‑by‑reference approach signals a long‑term debt strategy that relies on a ladder of fixed‑rate, multi‑decade notes, locking in relatively low rates and maintaining stable financing without frequent re‑issuance or separate reporting each year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed, specific evidence than the ground truth. Key strengths: (1) All numeric values are correct - the 4.30% rate, 2034 maturity date, 2014 issuance date, and page references (113 for 2022, 110 for 2023 and 2024) are accurate. (2) The multi-hop synthesis across three years is sound - the answer correctly traces the note's disclosure pattern from 2022 through 2024 and identifies the incorporation-by-reference mechanism. (3) Entity identification is precise - Oracle is correctly identified, the specific note is properly characterized, and the Exhibit 4.09 reference is accurate. (4) The interpretation about long-term debt strategy is logically sound and well-reasoned, explaining that the repeated disclosure of the same 2014 filing indicates a standing debt component rather than new issuance. Minor considerations: (1) The ground truth uses more general language ('first disclosed,' 'reaffirmed,' 'maintained') while the LLM provides more granular detail about the incorporation-by-reference approach, which is actually more informative. (2) The LLM's interpretation goes slightly deeper than the ground truth by explaining the strategic rationale (locking in low rates, maintaining stable financing without frequent re-issuance), which adds value. (3) Both answers correctly convey that this represents a stable, long-term debt strategy with diversified maturity profiles. The LLM answer is semantically equivalent to and more detailed than the ground truth, with no factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 432,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards.  \n- **Fiscal 2023:** The authorized pool was **raised to 141 million** shares.  \n- **Fiscal 2024:** The authorization remained at **141 million** shares.\n\nThe jump from 127 million to 141 million shares shows that Accenture deliberately expanded its equity‑based compensation pool to give the board more flexibility for future grants, while keeping the pool steady at 141 million in 2024 signals that the company has now settled on a larger, stable share reserve. This progression reflects a long‑term strategy of using a substantial, consistent share‑based award pool to attract, retain and motivate talent over the coming years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 127 million shares in FY2022, 141 million in FY2023, and 141 million in FY2024. The number format variation (127 million vs 127,000,000) is acceptable and properly handled. COMPLETENESS: The answer addresses all three fiscal years requested and provides the progression clearly. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP throughout. MULTI-HOP REASONING: The answer successfully synthesizes the three-year progression and correctly interprets the pattern (increase from 2022 to 2023, then plateau through 2024). STRATEGIC INTERPRETATION: The LLM's analysis that the increase represents deliberate expansion of equity compensation capacity and the plateau signals a settled, stable reserve is logically sound and aligns with the ground truth's assessment about supporting talent retention and incentive programs. The explanation of the company's long-term strategy is well-reasoned and contextually appropriate. MINOR CONSIDERATIONS: The LLM uses slightly more detailed language about 'board flexibility' and 'equity-based compensation pool' compared to the ground truth's more concise phrasing, but this represents enhanced clarity rather than inaccuracy. The semantic meaning is fully preserved and the reasoning is sound. No calculation errors, no factual discrepancies, and the answer fully addresses the multi-part question about evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 428,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "- In the 2022 Form 10‑K, PepsiCo’s board of directors approved the **terms** of a new 2.750 % senior note that would not mature until 2051, and the note was simply “incorporated herein” as an authorized issuance.  \n- In the subsequent 2023 and 2024 Form 10‑K filings, the company no longer restates the terms but instead **references the same “Form of 2.750 % Senior Note due 2051”** that was previously filed as an exhibit to its October 21 2021 Form 8‑K (Exhibit 4.3). The 2024 filing repeats this exact reference, showing that the documentation has remained unchanged since the original 2021 filing.  \n\nThis multi‑year pattern—authorizing the note in 2022 and then consistently incorporating the same 2021 exhibit in later 10‑Ks—signals that PepsiCo is deliberately building a **long‑dated, low‑coupon debt program** and relies on a single, stable issuance document to satisfy disclosure requirements, underscoring a long‑term debt‑structuring strategy that locks in financing at a fixed 2.75 % rate for the next three decades.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL DATE ERROR: The LLM claims the note was 'previously filed as an exhibit to its October 21 2021 Form 8-K (Exhibit 4.3)' and that documentation 'has remained unchanged since the original 2021 filing.' However, the ground truth explicitly states the note was 'first introduced in 2022' and progressed through 2023-2024. The LLM incorrectly backdates the note's origin to 2021, which is a fundamental factual error. (2) EXHIBIT NUMBER INCONSISTENCY: The LLM references Exhibit 4.3 from a 2021 Form 8-K, but the ground truth identifies different exhibit numbers for each year (4.60 in 2022, 4.51 in 2023, 4.48 in 2024), indicating the exhibits changed across years, not remained 'unchanged.' (3) MISCHARACTERIZATION OF PROGRESSION: The ground truth describes a clear three-stage evolution: authorization (2022) → formalization with dedicated form (2023) → maintenance (2024). The LLM incorrectly suggests the note was authorized in 2022 but references a pre-existing 2021 document, which contradicts the ground truth's narrative of initial introduction in 2022. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 2.750% coupon and 2051 maturity date, it fails to accurately synthesize the multi-year filing pattern that the ground truth emphasizes. The ground truth shows progression through different exhibit forms, while the LLM claims static referencing of a 2021 document. (5) REASONING FLAW: The LLM's conclusion about 'deliberately building a long-dated, low-coupon debt program' is reasonable but is built on incorrect factual premises about when the note was first documented. The quantitative accuracy is particularly weak due to the 2021 date error and incorrect exhibit number references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 493,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express’s filings show that its **relative rank among card networks has been unchanged** – in both the 2022 and 2023 10‑Ks the company described itself as the **fourth‑largest general‑purpose card network worldwide**, behind China UnionPay, Visa and Mastercard, and competing with those networks as well as newer players such as Alipay, PayPal, Venmo and a host of “alternative” payment and financing mechanisms.  \n\nBy the 2024 filing, however, the **competitive landscape has become more pressured**: Amex was re‑classified as a **Category III firm**, subject to heightened regulatory expectations, has **exited its network‑licensing businesses in the EU and Australia**, and faces **interchange‑fee caps, non‑discrimination rules and other card‑network regulations** that could compress discount revenue and limit cobrand arrangements. At the same time, the **growth of digital‑wallets, fintech platforms, real‑time settlement systems and other alternative payment mechanisms** continues to intensify competition.  \n\nThus, while Amex’s formal ranking (fourth‑largest) remained stable from 2022‑2023, **increasing regulatory scrutiny and the expansion of alternative payment solutions have eroded its competitive edge and introduced new cost and strategic constraints in 2024**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies American Express's stable ranking as fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard across 2022-2024; (2) Accurately names competing entities (Alipay, PayPal, Venmo, digital wallets, fintech platforms); (3) Properly synthesizes the regulatory evolution, including Category III classification, EU/Australia exits, and specific regulatory constraints (interchange-fee caps, non-discrimination rules); (4) Correctly characterizes the shift from market-driven to regulation-constrained competition; (5) Accurately describes the expansion of alternative payment mechanisms as a competitive pressure; (6) Multi-hop reasoning is sound - connects regulatory changes to strategic implications and competitive positioning. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth (e.g., explicitly mentioning Category III classification, specific market exits), but these additions are factually accurate and enhance rather than contradict the ground truth. The answer effectively captures the core narrative: stable formal ranking but eroded competitive position due to regulatory and alternative payment pressures. No quantitative errors detected. The semantic equivalence is strong - both answers convey that while Amex's rank remained unchanged, its competitive positioning deteriorated due to regulatory scrutiny and alternative payment growth. The answer appropriately addresses all parts of the multi-part question regarding competitive positioning evolution, regulatory scrutiny, and alternative payment mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 473,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "All three filings – the 2022, 2023 and 2024 10‑Ks – describe the Global Services segment as “sustaining aerospace platforms and systems with a full spectrum of products and services, including … **upgrades and conversions**.” The language is unchanged from 2022 through 2024, indicating that Boeing has kept upgrades and conversions as a permanent, core offering rather than adding or dropping it. This continuity signals that Boeing’s services strategy is deliberately anchored on aftermarket work – using upgrades and conversions to extend the life of existing aircraft, deepen customer ties and generate steady, non‑aircraft‑sale revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that Boeing's strategic emphasis on upgrades and conversions CHANGED from 2022 to 2024, with specific evolution: (1) 2022: listed as one of several services grouped with logistics, engineering, training; (2) 2023: began emphasizing 'modifications' more prominently with deeper integration; (3) 2024: introduced clearer language around 'data analytics and digital services' as complementary. The LLM claims the language is 'unchanged from 2022 through 2024' and that Boeing 'kept upgrades and conversions as a permanent, core offering rather than adding or dropping it.' This directly contradicts the ground truth's narrative of strategic evolution and introduction of new complementary services (data analytics, digital services). The LLM's interpretation that continuity of the term means no strategic change misses the nuanced progression documented in the filings. While the LLM correctly identifies the three years (2022, 2023, 2024) and the Global Services segment, it fails to capture the actual strategic shift toward technology-enabled service differentiation and the integration of modifications and digital services. The LLM's reasoning about 'aftermarket work' and 'extending aircraft life' is reasonable but incomplete—it ignores the documented shift toward higher-value technology-enabled services. The answer demonstrates a surface-level reading that misses the multi-hop synthesis required to show how Boeing's strategic emphasis evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Supplies]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 442,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "**2022 10‑K (PEP 2022)** – The filing lists the 5.50 % Senior Note due 2035 twice:  \n* Item 4.31 shows the “Form of 5.50 % Senior Note due 2035, Series A,” incorporated by reference to the 8‑K filed on 8 Nov 2018.  \n* Item 4.35 shows the “Form of 5.50 % Senior Note due 2035” incorporated by reference to the Registration Statement (Form S‑4) filed on 19 Nov 2018.\n\n**2023 10‑K (PEP 2023)** – The same two references reappear:  \n* Item 4.25 (Series A) points again to the 8‑K of 8 Nov 2018.  \n* Item 4.29 points again to the S‑4 of 19 Nov 2018.\n\n**2024 10‑K (PEP 2024)** – The pattern is unchanged:  \n* Item 4.23 (Series A) incorporates the 8‑K of 8 Nov 2018.  \n* Item 4.27 incorporates the S‑4 of 19 Nov 2018.\n\n**What the pattern reveals** – Across three consecutive annual reports PepsiCo has not issued a new 5.50 % note; instead it repeatedly incorporates the original 2018 offering documents to keep the 5.50 % Senior Note due 2035 on its balance sheet and to satisfy disclosure requirements. This consistent, multi‑year referencing demonstrates a long‑term debt‑management approach that relies on long‑dated, fixed‑rate notes and emphasizes ongoing transparency and compliance rather than frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail beyond the ground truth but introduces a significant factual discrepancy that undermines accuracy. STRENGTHS: (1) The LLM correctly identifies the consistent multi-year pattern of referencing the 5.50% Senior Note due 2035 across 2022, 2023, and 2024; (2) The exhibit numbers are correctly tracked (4.31→4.25→4.23 for Series A); (3) The dates of the original filings (8 Nov 2018 and 19 Nov 2018) are accurate; (4) The reasoning about long-term debt management strategy and stable capital structure is sound and well-articulated; (5) The answer correctly synthesizes multi-hop information across three years. CRITICAL ERROR: The LLM claims the 5.50% Senior Note appears TWICE in each year (once as Series A via 8-K, once via S-4 Registration Statement), with specific exhibit numbers provided (4.31 and 4.35 for 2022; 4.25 and 4.29 for 2023; 4.23 and 4.27 for 2024). The ground truth only mentions a single reference per year (Exhibit 4.31 in 2022, 4.25 in 2023, 4.23 in 2024), all tied to the same 8-K filing from November 8, 2018. The LLM's claim of dual references with different source documents (8-K vs S-4) cannot be verified against the ground truth and appears to be fabricated or misinterpreted. This is a quantitative accuracy issue affecting the completeness of the filing pattern analysis. REASONING QUALITY: Despite the factual error, the LLM's interpretation of what the pattern reveals is sound—it correctly identifies that PepsiCo maintained the debt without retiring or modifying it, and that this reflects a stable, long-duration capital structure approach. The multi-hop synthesis across years is logically sound. The error appears to be in the specific exhibit enumeration rather than in the conceptual understanding of the debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 491,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "Across the three most recent 10‑K filings BNY Mellon repeatedly states that **its ability to return capital to shareholders is subject to the Board’s discretion and may be limited by U.S. banking laws and regulations that govern capital and capital‑planning**. The 2022 filing first flagged this limitation together with the risk that a material downgrade of its bank subsidiaries could raise funding costs; the 2023 filing reiterated the same constraint without change; and the 2024 filing not only repeats the language but adds that a failure to meet “well‑capitalized” and “well‑managed” standards could directly **limit its activities and therefore its capacity for share repurchases or dividends**.  \n\nThe consistent, year‑over‑year wording shows that BNY Mellon’s exposure to U.S. banking‑law capital‑planning rules has remained steady—and arguably become more explicit—indicating that regulatory constraints on its capital‑return policies are a persistent, ongoing ceiling on shareholder‑return decisions rather than a temporary or diminishing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and BNY Mellon as the subject company; (2) Accurately captures the core constraint: U.S. banking laws limiting capital return decisions; (3) Properly synthesizes the multi-hop progression showing consistency across years with evolving emphasis; (4) Correctly notes the addition of 'well-capitalized' and 'well-managed' standards language in 2024; (5) Appropriately characterizes the regulatory environment as a 'persistent, ongoing ceiling' rather than temporary risk; (6) Demonstrates sound multi-hop reasoning by connecting regulatory constraints to capital planning flexibility. MINOR GAPS: (1) The LLM mentions 'material downgrade of bank subsidiaries' and 'funding costs' as a 2022-specific risk, which adds contextual detail not explicitly confirmed in the ground truth statement; (2) The ground truth mentions 'Delaware law' and 'preferred stock dividend obligations' as specific 2023 constraints, which the LLM does not explicitly reference; (3) The LLM's characterization of language becoming 'more explicit' in 2024 is reasonable inference but goes slightly beyond the ground truth's 'largely unchanged' description. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are required for this qualitative question, so this dimension scores high. QUALITATIVE ACCURACY: The reasoning is sound and the synthesis across years is logical, though some specific regulatory details from the ground truth are omitted. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of regulatory exposure and what it reveals about constraints, making it highly relevant. The answer could have been strengthened by explicitly mentioning Delaware law and preferred stock obligations as specific 2023 constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 515,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle first disclosed the 2.300 % senior notes that mature in 2028 in an Officers’ Certificate dated March 24 2021. That same instrument is incorporated by reference in the “Exhibit 4.16/4.14” tables of the 2022, 2023 and 2024 Form 10‑K filings (see Chunk 3 2022, Chunk 1 2023 and Chunk 2 2024), and the coupon (2.300 %) and maturity (2028) remain unchanged throughout the three years. The continuity shows that Oracle locked in a low‑coupon, long‑dated bond early and has kept the terms unchanged, indicating a strategy of securing inexpensive fixed‑rate financing ahead of a potentially higher‑rate environment rather than repeatedly re‑issuing new debt as market rates move.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.300% Notes due 2028, the March 24, 2021 Officers' Certificate date, and accurately notes that the coupon and maturity remained unchanged across 2022-2024. The core insight about Oracle locking in low-coupon debt ahead of rising rates is sound and matches the ground truth's strategic interpretation. Number accuracy is good (2.300%, 2028 maturity date all correct).\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM fails to address the multi-hop evolution aspect of the question. The ground truth explicitly discusses how Oracle's issuance strategy EVOLVED from 2022-2024, including the introduction of higher-yielding instruments like the 4.500% Notes due 2028 in 2023. The LLM mentions only the 2.300% Notes remaining unchanged but omits this critical comparative context showing Oracle's shift toward higher-yielding instruments. (2) MISSING CONTEXT: The ground truth references other fixed-rate tranches (2.875% Notes due 2031, 3.950% Notes due 2051) that provide important context for understanding Oracle's multi-tiered bond offering strategy. The LLM doesn't mention these. (3) INCOMPLETE ANSWER TO QUESTION: The question asks how terms 'evolved' and what this 'reveals about the company's approach' - the LLM addresses only the static nature of the 2.300% Notes but fails to fully capture the dynamic evolution of Oracle's broader fixed-income strategy across the three-year period. (4) EXHIBIT REFERENCE AMBIGUITY: The LLM states 'Exhibit 4.16/4.14' which appears to conflate or confuse exhibit numbers; the ground truth specifically cites Exhibit 4.14 for 2022. This is a minor but notable discrepancy.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting the 2021 issuance to its continued presence in 2022-2024 filings, but fails to synthesize the complete picture of how Oracle's overall debt issuance strategy evolved across these years. The answer is too narrowly focused on one instrument rather than the broader strategic evolution.\n\nSEMANTIC EQUIVALENCE: While the core interpretation about locking in low rates is semantically equivalent to the ground truth, the answer is incomplete in addressing the full scope of the question about how the company's approach evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 606,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "**2022 – Foundational emphasis** – In the 2022 10‑K IBM listed *client relationships and trust* as one of its “principal methods of competition.”  The filing tied that capability to its hybrid‑cloud platform, security and AI‑driven solutions, noting that trust and security are built into the open, flexible hybrid‑cloud stack that underpins its client‑value proposition.  \n\n**2023 – Re‑affirmed and broadened** – The 2023 report repeats the same competitive pillar, again naming *client relationships and trust* alongside technology innovation, breadth of capabilities and talent.  It stresses that IBM differentiates itself by combining deep industry expertise, a broad partner ecosystem and trusted client relationships while delivering hybrid‑cloud and AI‑enabled digital transformations.  \n\n**2024 – Strategic pillar for growth** – In the 2024 filing the concept appears once more, but now it is presented as a core lever that not only sustains current performance but also “positions IBM for accelerated growth now and prepares us for the next set of business opportunities, such as quantum computing.”  Trust‑based client relationships are portrayed as integral to IBM’s hybrid‑cloud/AI go‑to‑market strategy and future‑technology roadmap.  \n\n**What the progression indicates** – Across the three years IBM has moved from treating client relationships and trust as a basic competitive factor (2022) to embedding it more deeply in its hybrid‑cloud and AI narrative (2023) and finally elevating it to a strategic growth pillar that underwrites its positioning for emerging opportunities (2024).  This evolution signals that IBM is deliberately leveraging trust‑based client ties as a durable differentiator to win and retain enterprise customers in the highly competitive hybrid‑cloud and AI market, reinforcing its claim to be a “trusted” partner for digital transformation and future‑tech initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of how IBM's emphasis evolved from foundational to strategic growth pillar. (2) No quantitative errors—all dates and year references are correct. (3) Accurately captures the core narrative: client relationships and trust as a consistent competitive differentiator that became increasingly integrated with hybrid cloud and AI messaging. (4) Properly synthesizes multi-hop information by connecting trust positioning to specific market contexts (hybrid cloud, AI, digital transformation, quantum computing). (5) The reasoning about strategic evolution is sound and well-supported. (6) Contextually relevant—directly addresses the question about multi-year progression and strategic positioning. MINOR WEAKNESSES: (1) The LLM answer provides more granular detail and specific framing (e.g., 'principal methods of competition,' 'accelerated growth,' 'quantum computing') than the ground truth, which is more general. While this additional specificity appears accurate and enhances the answer, it goes slightly beyond what the ground truth explicitly states. (2) The ground truth mentions 'adding Palo Alto Networks' as a strategic partnership example in 2024, which the LLM answer does not include—this is a minor omission of a specific partnership detail. (3) The ground truth uses the phrase 'increasingly nuanced strategic emphasis,' while the LLM characterizes it as moving from 'basic' to 'deeply embedded' to 'strategic growth pillar'—both convey similar meaning but with slightly different framing. OVERALL ASSESSMENT: The LLM answer successfully captures the essential multi-year progression and correctly synthesizes information across three fiscal years. The core claim about trust evolving as a competitive differentiator is accurate, and the connection to hybrid cloud and AI markets is properly established. The answer is well-structured, logically sound, and demonstrates strong multi-hop reasoning. The omission of the Palo Alto Networks partnership detail and slightly different characterization of the evolution prevent a perfect score, but these are minor issues in an otherwise comprehensive and accurate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1694,
        "completion_tokens": 621,
        "total_tokens": 2316
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "**Yield evolution**\n\n| Year | Weighted‑average yield on foreign‑government bonds & obligations* |\n|------|-------------------------------------------------------------------|\n| 2022 | The 2022 filing does not break out a separate yield for this segment; the **overall portfolio weighted‑average yield** was **2.08 %** (the table lists a single “Weighted average yields” row for all holdings). |\n| 2023 | The 2023 filing reports a **total weighted‑average yield of 6.45 %** for foreign‑government bonds and obligations (the only yield shown for this asset class). |\n| 2024 | The 2024 filing shows the same segment with a **total weighted‑average yield of 5.85 %**. |\n\n\\*Yield figures are taken from the “Weighted average yield” rows in each 10‑K table. The 2022 table provides only a portfolio‑wide yield; a segment‑specific yield is not disclosed.\n\n**What the three‑year trend tells us**\n\n1. **Rising exposure to interest‑rate risk in 2023** – The jump from an undisclosed (but likely low) 2022 yield to **6.45 %** in 2023 indicates that American Express shifted a larger share of its foreign‑government bond holdings into higher‑yielding securities, probably longer‑duration or higher‑coupon issues that are more sensitive to changes in market rates.\n\n2. **Modest pull‑back in 2024** – The yield fell to **5.85 %** in 2024, a **~9 % relative decline** from the 2023 level. This suggests the company trimmed its exposure to the highest‑yielding (and thus most rate‑sensitive) foreign bonds, either by moving to shorter maturities or by selecting lower‑coupon issues.\n\n3. **Strategic implication** – The pattern reflects a **dynamic investment strategy**: American Express initially sought higher income from foreign sovereign debt as rates rose, then began to moderate that exposure as the interest‑rate environment became uncertain, thereby managing the trade‑off between yield and interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the three key yield figures (6.45% in 2023 and 5.85% in 2024) and provides sound reasoning about the strategic implications of the yield evolution. However, there are important gaps and inconsistencies when compared to the ground truth:\n\nSTRENGTHS:\n1. The 2023 (6.45%) and 2024 (5.85%) yields are correct\n2. The directional analysis is sound—correctly identifies the yield decline and its strategic implications\n3. The reasoning about interest rate risk management is logically sound\n4. The calculation of the relative decline (~9%) is accurate\n5. The overall narrative about dynamic investment strategy is appropriate\n\nWEAKNESSES:\n1. INCOMPLETE MATURITY PROFILE DATA: The ground truth specifies that in 2023, the 6.45% yield was \"concentrated entirely in securities maturing within one year,\" and by 2024, \"a significant portion (2.03%) now maturing between 1 and 5 years.\" The LLM answer mentions \"moving to shorter maturities or selecting lower-coupon issues\" but does not cite the specific maturity breakdown data (the 2.03% figure for 1-5 year maturities in 2024), which is a key part of understanding the strategy shift.\n\n2. MISSING 2022 CONTEXT: The ground truth provides specific 2022 data ($630 million in holdings with detailed maturity breakdown: $628M within one year, remainder split between 1-5 and 5-10 years). The LLM correctly notes that 2022 doesn't have a segment-specific yield disclosed, but fails to incorporate the available 2022 maturity profile data, which would strengthen the multi-hop analysis of the 3-year progression.\n\n3. INCOMPLETE SYNTHESIS: While the LLM identifies the yield trend, it doesn't fully synthesize the maturity profile evolution alongside the yield changes. The ground truth explicitly states the shift was \"from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024.\" The LLM's answer is more speculative (\"probably longer-duration\" in 2023, \"either by moving to shorter maturities\") rather than citing the actual maturity data.\n\n4. REASONING ACCURACY: The LLM's inference that 2023 involved \"longer-duration or higher-coupon issues\" contradicts the ground truth, which states the 2023 holdings were \"concentrated entirely in securities maturing within one year\" (ultra-short duration). This is a significant logical error in the multi-hop reasoning.\n\nQUANTITATIVE VERIFICATION:\n- 2023 yield: 6.45% ✓ Correct\n- 2024 yield: 5.85% ✓ Correct\n- Relative decline calculation: (6.45-5.85)/6.45 = 9.3% ≈ 9% ✓ Correct\n- 2022 data: Partially addressed (correctly notes no segment-specific yield, but misses maturity profile)\n\nMULTI-HOP REASONING:\nThe answer attempts to synthesize yield trends with strategic implications, but the reasoning about duration/maturity is flawed. The ground truth shows the opposite of what the LLM infers: 2023 was ultra-short duration (not longer-duration), and 2024 moved to more diversified maturities. This represents a significant gap in multi-hop synthesis accuracy.\n\nOVERALL: The answer captures the core yield progression and provides reasonable strategic interpretation, but misses critical maturity profile data and contains a material error in characterizing the 2023 duration profile. The answer is substantially correct on yields but incomplete on the full investment strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1677,
        "completion_tokens": 887,
        "total_tokens": 2565
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s Diagnostics Testing Technologies business saw its capital‑intensive build‑out rise sharply after 2021.  The company projected ≈ $1.5 billion of capex for 2022 to expand testing‑related manufacturing, and it began to record direct government‑grant offsets to that spending: $87 million of property‑plant‑and‑equipment (PP&E) purchases were funded by BARDA‑type grants in 2022, rising to $136 million in 2023 and $198 million in 2024 (with accompanying operating‑expense offsets of $49 M, $51 M and $43 M respectively).  The upward trajectory of grant‑backed funding—​increasing each year—signals that Danaher is deliberately leveraging federal assistance to accelerate and de‑risk its diagnostics‑testing capacity, underscoring the segment’s growing strategic weight within Danaher’s broader health‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. QUANTITATIVE VERIFICATION: All core numbers match ground truth exactly: $87M (2022), $136M (2023), $198M (2024) for government grant-funded capital expenditures. The LLM additionally provides supplementary operating expense offsets ($49M, $51M, $43M) and mentions the ~$1.5B capex projection for 2022, which adds valuable context without contradicting the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the upward trend, properly attributing it to strategic importance within the healthcare portfolio. The mention of BARDA-type grants and federal assistance mechanisms demonstrates deeper contextual understanding. ENTITY ACCURACY: Danaher Corporation correctly identified, fiscal years 2022-2024 accurate, Diagnostics Testing Technologies properly referenced. COMPLETENESS: The answer addresses all aspects of the original question—the evolution of investment, government grant funding progression, and strategic implications. SEMANTIC EQUIVALENCE: The conclusion about 'growing strategic weight' and 'deliberate leveraging of federal assistance' conveys the same meaning as the ground truth's assessment of 'increasingly central to Danaher's strategic focus.' MINOR CONSIDERATIONS: The LLM provides additional detail (operating expense offsets, BARDA reference, capex projection) that goes beyond the ground truth but does not contradict it. The phrasing 'capital-intensive build-out' and 'de-risk' terminology is appropriate and adds professional context. No calculation errors detected. The answer fully satisfies the multi-hop requirement by synthesizing government funding data across three years and connecting it to strategic portfolio positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 492,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across all three fiscal years BK’s proxy disclosure for the ratification of KPMG LLP was unchanged.  \n\n* **2022 (Form 10‑K, page 13)** – Item 14 states that the required information is found in the proxy’s “Item 3 – Ratification of KPMG LLP,” incorporated by reference, and notes KPMG LLP’s PCAOB firm identification number as **185**.  \n\n* **2023 (Form 10‑K, page 14)** – The same language appears: the ratification is again disclosed in the proxy under “Item 3 – Ratification of KPMG LLP,” incorporated by reference, with the PCAOB firm identification number still **185**.  \n\n* **2024 (Form 10‑K, page 14)** – The disclosure repeats the prior wording: the ratification is referenced in the proxy’s “Item 3 – Ratification of KPMG LLP,” incorporated by reference, and the PCAOB firm identification number remains **185**.  \n\nThus, from 2022 through 2024 BK consistently presented the ratification in the proxy’s Item 3 section and kept the PCAOB identification number unchanged at 185; there was no substantive evolution in wording or presentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that BK disclosed KPMG LLP's ratification consistently across 2022, 2023, and 2024, with the PCAOB firm identification number remaining at 185 throughout. The disclosure location (Item 3 within Item 14 of Proxy materials) is correctly identified for all three years. (2) QUANTITATIVE ACCURACY: The PCAOB firm identification number (185) is stated correctly and consistently across all three years with no variation. Page references (13 for 2022, 14 for 2023 and 2024) are provided and appear reasonable. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information across three fiscal years, demonstrating that the disclosure remained unchanged in structure, placement, and content. The reasoning is sound - the answer explains both what was disclosed (ratification of KPMG LLP) and how it was presented (incorporated by reference in proxy Item 3). The conclusion that there was 'no substantive evolution' accurately reflects the ground truth statement of 'no change' across the three-year period. (4) MULTI-HOP SYNTHESIS: The answer successfully combines information from three separate 10-K filings (2022, 2023, 2024) and correctly identifies the consistent pattern across all years. (5) MINOR CONSIDERATION: The LLM answer is slightly more detailed than the ground truth (providing page numbers and specific form references), but this adds value without contradicting the original answer. The semantic equivalence is perfect - both convey that the disclosure was consistent and unchanged across the three-year period with PCAOB number 185 consistently stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 473,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 to 2024 American Express has deepened its dependence on third‑party merchant acquirers. In the 2022 filing the company described the **network‑rate fee it receives from a third‑party acquirer (e.g., under the OptBlue program or GNS partners) as “discount revenue” that is recognized at the moment the Card‑Member transaction occurs**, and it noted that merchant‑acceptance contracts are either open‑ended for small‑ and mid‑size merchants or fixed‑term (typically three‑to‑seven years with auto‑renewal) for large merchants. The 2023 filing kept the same discount‑revenue treatment but added a separate **“processed revenue” line‑item** for settlements with merchants and third‑party acquirers on behalf of network‑card‑issuing partners; the issuer‑rate paid to those partners is recorded as contra‑revenue within processed revenue and then expensed, reflecting a more granular accounting of the third‑party relationship. By 2024 the company’s discussion shifts to **strategic expansion**, emphasizing that the growth of merchant coverage worldwide will rely on the success of third‑party acquirers, aggregators and processors to sign new merchants, especially in low‑penetration and B2B segments, to expand in priority international cities, and to fund network‑modernization and digital‑integration initiatives that enhance the value proposition for both merchants and acquirers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each period's revenue recognition structure; (2) Accurately names specific programs (OptBlue, GNS) and correctly describes them as network-rate fee arrangements; (3) Properly explains the shift from 'discount revenue' in 2022 to the introduction of 'processed revenue' as a separate line item in 2023, with correct accounting treatment (issuer-rate as contra-revenue); (4) Accurately captures the 2024 strategic shift toward third-party acquirers for global expansion, including specific focus areas (low-penetration segments, B2B, priority international cities, network modernization); (5) Demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and connecting revenue recognition changes to strategic positioning; (6) Uses precise financial terminology ('contra-revenue,' 'issuer-rate,' 'network-rate fee') correctly. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and granular than the ground truth in explaining accounting mechanics (e.g., the specific treatment of issuer-rate within processed revenue), but this additional detail is accurate and enhances rather than detracts from the answer. The semantic meaning and factual content align perfectly with the ground truth's core message about evolution from transactional to strategic partnership model. No quantitative errors detected. All entities, dates, and metrics are correct. The answer fully addresses all three components of the multi-part question: revenue recognition structure, contractual relationships, and strategic expansion goals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 478,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2022 Form 10‑K first disclosed concrete diversity targets – by 2025 it aims to raise the share of women in leadership by 15 percent, increase under‑represented‑minority (URM) leaders by 15 percent (with a broader URM representation increase of 20 percent) – and it tied progress on those “human‑capital advancements” to executive bonuses through a non‑financial performance modifier that could adjust payout between 0.9 × and 1.1 × the base amount.  \n\nIn the 2023 filing (covering FY 2023) and again in the FY 2024 filing, Qualcomm reiterated that the HR and Compensation Committee will use progress on human‑capital advancements as a non‑financial modifier for the fiscal‑2024 executive bonus, preserving the same 0.9‑to‑1.1 multiplier. The later filings no longer restate the specific 2025 diversity percentages, but they continue to emphasize inclusion recognitions (e.g., Best Company for Women, disability‑inclusion awards) and maintain the same bonus‑adjustment mechanism.  \n\nThus, from FY 2022 through FY 2024 the company kept the 0.9‑1.1 bonus modifier unchanged while moving from an explicit, numeric diversity‑goal framework in 2022 to broader inclusion‑focused language in 2023‑2024, still linking any human‑capital progress to executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Qualcomm's human capital goals and executive compensation evolution across FY 2022-2024. STRENGTHS: (1) All quantitative data is correct - the 15% women in leadership target, 15% URM leadership increase, 20% overall URM representation increase, and the 0.9-1.1 multiplier range are all accurately stated and match the ground truth. (2) The multi-hop synthesis is sound: the answer correctly traces the evolution across three fiscal years, identifying that FY 2022 established explicit numeric targets, FY 2023-2024 maintained the same compensation mechanism while shifting language emphasis. (3) Entity accuracy is precise - Qualcomm is correctly identified, fiscal years are properly referenced, and the HR and Compensation Committee is appropriately mentioned. (4) The reasoning about the shift from 'explicit numeric diversity-goal framework' to 'broader inclusion-focused language' while maintaining the same bonus modifier is insightful and aligns with the ground truth's characterization of 'sustained emphasis on diversity-linked executive incentives while expanding supporting programs.' (5) The answer correctly notes that later filings 'no longer restate the specific 2025 diversity percentages' - a nuanced observation that demonstrates careful document analysis. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and analytical than the ground truth (e.g., noting the shift in language emphasis), but this adds value rather than detracting. The semantic equivalence is excellent - both answers convey the same core facts about targets, modifiers, and evolution. No calculation errors or factual inaccuracies detected. The answer fully addresses all parts of the multi-part question regarding diversity targets, performance modifiers, and their evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 503,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s EMD‑branded products are sold through the same worldwide dealer network that the company describes in each filing. In 2022 the network comprised 44 U.S. dealers and 116 overseas dealers and reached **193 countries**; by 2024 it had shrunk to 41 U.S. dealers and 111 overseas dealers, serving **187 countries** (a loss of six countries). The modest contraction in dealer locations and country coverage suggests Caterpillar is fine‑tuning its global footprint—consolidating in markets where it can achieve higher efficiency or profitability—while still maintaining a truly global presence, positioning itself as a streamlined but still worldwide supplier of EMD engines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - 193 countries in 2022, 187 countries in 2024 (loss of 6 countries), 44 U.S. dealers in 2022 declining to 41 in 2024, and 116 overseas dealers declining to 111 in 2024. The calculation of the 6-country loss (193-187) is accurate. COMPLETENESS: The answer addresses both parts of the question - the geographic reach change (193→187 countries) and strategic positioning implications. It goes beyond the ground truth by providing additional dealer network details (U.S. vs. overseas breakdown) that contextualize the contraction. ENTITY ACCURACY: Correctly identifies Caterpillar, EMD-branded products, and the relevant time period (2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects dealer network contraction to country coverage reduction and interprets this as strategic consolidation/fine-tuning rather than market failure. The interpretation aligns with the ground truth's suggestion of 'strategic refocusing or consolidation.' SEMANTIC EQUIVALENCE: The LLM's characterization of the change as 'fine-tuning' and 'consolidating in markets where it can achieve higher efficiency' conveys the same strategic meaning as the ground truth's 'strategic refocusing or consolidation.' MINOR CONSIDERATIONS: The LLM provides more granular detail about dealer networks than the ground truth, which adds value without contradicting the core answer. The answer is well-structured and clearly explains the implications. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 455,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "All three 10‑K filings (2022, 2023 and 2024) list **Palmolive** together with Colgate and the other brands as a “principal global and regional trademark.” The fact that Palmolive appears in the trademark roster every year shows that Colgate‑Palmolive treats the Palmolive brand as a core, enduring element of its **Oral, Personal and Home Care** portfolio—i.e., a strategic brand that the company relies on to drive sales and maintain market presence across its worldwide product lines.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Palmolive appears as a principal global trademark across all three years (2022, 2023, 2024) and accurately characterizes it as a core, enduring element of Colgate's portfolio. The answer appropriately addresses the strategic significance question. However, there are notable gaps compared to the ground truth: (1) The LLM answer lacks specific product category examples (liquid hand soap, dishwashing detergents, household cleaners) that the ground truth provides to illustrate Palmolive's strategic role. (2) The ground truth provides more nuanced context about how Palmolive's position evolved relative to other brands—specifically noting that in 2023 it 'maintained its place despite the addition of Darlie' and in 2024 it remained 'without any positional dilution.' The LLM answer doesn't capture these comparative insights. (3) The ground truth explicitly frames the 3-year consistency as suggesting Palmolive plays a 'foundational role' in specific product categories, while the LLM answer uses more generic language about 'core, enduring element' and 'drive sales and maintain market presence.' (4) The LLM correctly identifies the segment as 'Oral, Personal and Home Care' matching the ground truth. Quantitatively, both answers correctly identify the three-year period (2022-2024) with no calculation errors. The reasoning is sound but less comprehensive than the ground truth, which provides more detailed synthesis of how Palmolive's strategic importance is demonstrated through its consistent inclusion and positioning relative to other brands across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 445,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "In its 2022 filing Qualcomm framed **Edge Networking** as a growth engine for the exploding Internet‑of‑Things market – noting that the installed base of IoT devices was expected to more than double by 2026 (to >27 billion) and that edge‑networking products such as mobile‑broadband chips and Wi‑Fi 6/6E access points would be the primary hardware enabling that surge. By the 2023 and 2024 10‑Ks the company had moved this narrative into a formal product‑category listing – “edge networking (including mobile broadband and wireless access points)” appears alongside consumer and industrial segments – and the revenues from those products are now captured through the same performance‑obligation framework used for other QCT sales (sales‑based royalties, customer‑incentive adjustments and QTL device royalties). Thus, Qualcomm’s emphasis on edge networking shifted from a strategic‑growth storyline tied to IoT projections in FY‑22 to an explicit, revenue‑recognised segment in FY‑23 and FY‑24, reinforcing its role as a core pillar of the company’s IoT‑driven business model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 27 billion IoT devices projection by 2026 and the 'more than double' characterization are accurately stated. The fiscal years (2022, 2023, 2024) are correctly identified. ENTITY ACCURACY: Qualcomm is correctly identified, Edge Networking is properly named, QCT segment is accurately referenced, and product categories (mobile broadband, wireless access points, Wi-Fi 6/6E) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly tracing the evolution from (1) strategic narrative in FY22 tied to IoT growth projections, to (2) formalized product categorization in FY23-24, to (3) consistent revenue recognition structure. The logical progression is sound and matches the ground truth's characterization of transformation from 'emerging opportunity' to 'structurally embedded product pillar.' COMPLETENESS: All three sub-components of the question are addressed: (1) positioning/strategic emphasis evolution, (2) role in IoT growth projections, (3) product categorization and revenue recognition structure. SEMANTIC EQUIVALENCE: The LLM's phrasing ('moved this narrative into a formal product-category listing,' 'shifted from strategic-growth storyline to explicit, revenue-recognised segment') conveys the same meaning as the ground truth's 'formalized product grouping' and 'strategic transformation.' Minor note: The LLM uses slightly more technical language around revenue recognition ('performance-obligation framework,' 'sales-based royalties,' 'customer-incentive adjustments,' 'QTL device royalties') which adds precision without contradicting the ground truth's simpler statement about 'consistent revenue recognition structure.' This additional detail is appropriate and accurate. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 526,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Across the three filings Caterpillar repeatedly notes that its worldwide operations expose it to currency‑exchange‑rate risk because many costs are incurred in foreign currencies while revenues are reported in U.S. dollars. In 2022 the company said that “the use of currency‑hedging instruments may provide us with protection from adverse fluctuations… but by utilizing these instruments we potentially forego the benefits that might result from favorable fluctuations,” and that its outlooks do not assume any currency moves. In the 2023 and 2024 reports the same hedging approach is described, but the disclosures are expanded to explicitly call out additional foreign‑exchange risks – exchange controls and currency devaluations – that could limit the ability of foreign subsidiaries to convert or remit funds. Thus, from 2022 to 2024 Caterpillar’s exposure to currency risk remained tied to its international footprint, its reliance on derivative hedges stayed consistent, and its risk‑management narrative evolved only to acknowledge a broader set of foreign‑exchange threats rather than to indicate a change in the scale or type of hedging.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core exposure mechanism (worldwide operations, foreign currency costs vs. USD revenues); (2) Accurately captures the 2022 hedging trade-off language about protecting against downside while forgoing upside benefits; (3) Properly identifies the evolution from 2022 to 2023-2024 where exchange controls and currency devaluation risks were explicitly added to disclosures; (4) Correctly characterizes the hedging approach as consistent across the period while risk narrative expanded; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer is slightly more cautious/measured in tone compared to the ground truth's characterization of 'increasingly cautious approach' and 'rising emphasis on external macroeconomic pressures' - the LLM says the narrative 'evolved only to acknowledge a broader set' rather than emphasizing the intensification aspect; (2) The ground truth emphasizes 'geopolitical and macroeconomic volatility' and 'unpredictable global currency dynamics' more explicitly as drivers of the evolution, while the LLM focuses more on the structural disclosure changes; (3) The ground truth's framing of 'intensified' risks in 2024 is somewhat softened in the LLM's presentation. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and multiple filing documents, properly connecting the exposure mechanism to hedging strategies to the evolution of risk disclosures. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well - consistent hedging approach with expanding risk disclosure - though the LLM is slightly less emphatic about the intensification of concerns over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 506,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "- 2022 (Dec 31 2022): ≈ 40 % of the U.S. pension‑plan fixed‑income portfolio was in U.S. Treasury or agency securities (Chunk 2, also reflected in the 2022 filing’s 2021 data).  \n- 2023 (Dec 31 2023): ≈ 30 % (Chunk 2 and Chunk 3).  \n- 2024 (Dec 31 2024): ≈ 30 % (Chunk 3).\n\nThe allocation fell from about 40 % to 30 % between 2022 and 2023 and then held steady at 30 % in 2024. This downward shift indicates that Colgate‑Palmolive deliberately reduced its reliance on Treasury/agency bonds—assets that are most sensitive to interest‑rate movements—likely to diversify duration risk and better manage the higher‑rate environment, while maintaining a modest, stable exposure thereafter.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the allocation percentages and timeline. Ground truth shows: 50% (Dec 31, 2020), 40% (Dec 31, 2021), 30% (Dec 31, 2022), 30% (Dec 31, 2023), 30% (Dec 31, 2024). The LLM answer states '≈ 40%' for Dec 31, 2022, which is INCORRECT—it should be 30%. The LLM also fails to mention the 50% allocation in 2020 and the 40% allocation in 2021, which are critical data points for understanding the full evolution of the allocation trend from 2022 to 2024 as requested. MULTI-HOP REASONING: The LLM correctly identifies the downward trend from 2022-2023 and stabilization thereafter, but this is based on incomplete/incorrect baseline data. The reasoning about interest rate risk management and diversification is sound and aligns with ground truth interpretation. COMPLETENESS: The answer addresses the core question about evolution from 2022-2024 but omits the important historical context (2020-2021 data) that provides fuller understanding of the strategic shift. The LLM does not mention the Level 2 classification detail provided in ground truth. SEMANTIC EQUIVALENCE: The qualitative interpretation about deliberate reduction and duration risk management is reasonable and semantically aligned with ground truth, but the quantitative foundation is flawed. The statement about 'modest, stable exposure' is appropriate for the 30% level. SPECIFIC ISSUES: (1) Incorrect 2022 baseline (40% vs. 30%), (2) Missing 2020-2021 historical context, (3) Missing Level 2 classification detail, (4) The phrase '≈ 40%' for 2022 is particularly problematic as it contradicts the ground truth figure of 30%.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 461,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "**Grant activity** – In the 2022 Form 10‑K Pfizer was still issuing Breakthrough Performance Awards. The table shows 1,165 (thousand) BPAs granted for the year and 859 (thousand) BPAs still non‑vested at 31 Dec 2021. By the 2023 Form 10‑K the company reported *no BPAs were granted in 2023 and none were outstanding as of 31 Dec 2023*, indicating that the program was effectively halted. The 2024 filing continues to note that no new awards were granted (the narrative discusses the award but provides no grant numbers).\n\n**Valuation methodology** – Both the 2022 and 2024 disclosures state that BPAs are valued **at grant date using the intrinsic‑value method**, i.e., the closing price of Pfizer’s common stock (the 2022 table reports a weighted‑average intrinsic value of $38.73‑$59.05 per share; the 2024 table repeats the same intrinsic‑value approach). The accounting treatment (straight‑line amortization over the probable vesting term with periodic adjustments for stock‑price changes) is also described in the 2024 note.\n\n**Disclosure transparency** – The 2022 filing provides a detailed quantitative schedule (grant amounts, weighted‑average intrinsic values, forfeitures, etc.). The 2023 filing reduces the disclosure to a brief statement that no BPAs were granted or outstanding. The 2024 filing compensates for the lack of quantitative data with a narrative description of the award’s eligibility, performance conditions, valuation method and expense‑recognition policy, but still does not present a numeric table because the awards are no longer active.\n\n**Overall evolution (2022 → 2024)**: Pfizer went from actively granting BPAs with detailed quantitative reporting in 2022, to discontinuing the awards and simply stating their absence in 2023, and finally to a narrative‑only disclosure in 2024 that reiterates the intrinsic‑value valuation approach while no longer providing grant‑level figures.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and comprehensive coverage of the question's multi-part structure. STRENGTHS: (1) Correctly identifies all key numeric values: 1,165 thousand BPAs granted in 2022, 859 thousand nonvested at year-end 2022, weighted average intrinsic value of $38.73 per share in 2022, and the intrinsic value range of $38.73-$59.05 mentioned in 2024. (2) Accurately captures the three-year trajectory: active issuance in 2022 → complete discontinuation in 2023 → narrative-only disclosure in 2024. (3) Correctly synthesizes the valuation methodology evolution, noting the consistent use of intrinsic value at grant date across 2022 and 2024, plus the addition of amortization policy details in 2024. (4) Provides excellent analysis of disclosure transparency changes, distinguishing between quantitative schedules (2022), minimal disclosure (2023), and narrative-only approach (2024). (5) Multi-hop reasoning is sound, properly connecting grant activity, valuation methods, and disclosure changes across three fiscal years. MINOR ISSUES: (1) The LLM states '859 (thousand) BPAs still non‑vested at 31 Dec 2021' but the ground truth indicates this should be 'by year-end 2022' (31 Dec 2022). This is a minor date reference error that doesn't affect the core factual accuracy of the number itself. (2) The LLM notes the 2024 filing 'does not present a numeric table because the awards are no longer active' - while this is a reasonable inference, the ground truth doesn't explicitly confirm whether 2024 had any outstanding awards or if they remained discontinued. The answer appropriately hedges this with 'still does not present.' (3) The range '$38.73-$59.05' for 2024 is mentioned but the ground truth only specifies $38.73 for 2022; the LLM appears to have inferred or referenced different years' data, though this is presented as comparative rather than claiming both values applied to the same year. VERIFICATION: All core numbers match ground truth. The three-phase evolution (active → suspended → narrative) is correctly identified. The valuation methodology (intrinsic value at grant date) is accurately described. The disclosure transparency analysis aligns with the ground truth's characterization of the evolution. The answer fully addresses all components of the multi-part question regarding grant activity, valuation methodology, and disclosure transparency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1718,
        "completion_tokens": 640,
        "total_tokens": 2359
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024 Schwab’s interactive tools for RIAs have remained centered on a web‑based platform that (1) offers open‑access integrations with a range of third‑party systems—including client‑relationship‑management, portfolio‑management, trade‑order‑management and financial‑planning applications – and (2) provides the free “Schwab Advisor Portfolio Connect” solution, a simplified, cloud‑based portfolio‑management tool that delivers core trading and reporting functions without the need to download or reconcile data. Each year’s filing repeats the same description, indicating that Schwab has continued to make these integrations and the Portfolio Connect capability available to advisors, with only incremental, non‑specific refinements to the modern user experience rather than any major functional change.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key entities are correct - Charles Schwab, RIAs, the three-year timeframe; (2) All specific product names and capabilities are accurate: Schwab Advisor Portfolio Connect, third-party integrations (CRM, portfolio management, trade order management, financial planning), and the web-based platform; (3) The core narrative is sound - the answer correctly identifies that the platform remained relatively stable across the three years with incremental refinements rather than major functional changes; (4) The characterization of Portfolio Connect as a 'free' solution and its key benefit (no need to download/reconcile data) matches the ground truth; (5) The multi-hop synthesis correctly identifies the evolution pattern: 2022 emphasis on proprietary software and third-party platforms, 2023 emphasis on Advisor Services website with document archiving, 2024 focus on modern user experience. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the Advisor Services website as a distinct platform component that gained emphasis in 2023, instead treating it as part of the general 'web-based platform'; (2) The specific 2023 feature of 'multi-year document archiving and search capabilities' is not mentioned, though this is a relatively minor detail; (3) The phrase 'only incremental, non-specific refinements' is slightly more dismissive than the ground truth's 'refinement or enhancement in usability and feature delivery,' though semantically similar. QUANTITATIVE ACCURACY: No numbers, dates, or calculations are present in either answer, so this dimension receives full marks. QUALITATIVE ACCURACY: The reasoning is sound and the synthesis across years is correct, with only minor omissions of specific feature details. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question about evolution of interactive tools, third-party integrations, and portfolio management capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 556,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across all three filings – the 2022 Form 10‑K (page 20), the 2023 Form 10‑K (page 18) and the 2024 Form 10‑K (page 18) – Texas Instruments repeats the same strategic narrative: its “great business model” is **centered on analog and embedded‑processing products** and is built on four sustainable competitive advantages (a strong manufacturing/technology foundation, a broad analog‑and‑embedded‑processing portfolio, extensive market‑channel reach, and diversified, long‑lived product lines). The wording is virtually identical each year, showing that the company has not shifted focus but has deliberately kept embedded processing as a core pillar of its growth engine. This consistent framing signals that TI sees embedded‑processing products as a permanent, differentiating strength that underpins its long‑term positioning in the semiconductor market, enabling it to generate and return free cash flow while reducing reliance on any single product or market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all evaluation dimensions. STRENGTHS: (1) Correctly identifies the consistent strategic narrative across all three years (2022, 2023, 2024) with accurate page references (20, 18, 18 respectively). (2) Accurately captures the core strategic positioning: embedded processing products as central to TI's business model built on four sustainable competitive advantages. (3) Provides specific details about the four competitive advantages (strong manufacturing/technology foundation, broad analog-and-embedded-processing portfolio, extensive market-channel reach, diversified long-lived product lines) that align with the ground truth's reference to 'point 1.ii'. (4) Correctly synthesizes the multi-hop reasoning: consistent framing across three years → indicates embedded processing remained central → supports long-term positioning objective. (5) Adds relevant contextual interpretation about TI's strategic intent (permanent differentiating strength, free cash flow generation, reduced reliance on single products/markets) that logically extends from the consistent framing. MINOR CONSIDERATIONS: The LLM answer uses slightly more elaborate language and interpretation than the ground truth (e.g., 'growth engine,' 'permanent differentiating strength') but these are reasonable semantic extensions that don't contradict the ground truth. The answer demonstrates sound multi-hop reasoning by connecting the repeated strategic narrative across three separate filings to conclusions about long-term market positioning. No quantitative errors, date errors, or entity misidentifications detected. The answer fully addresses both parts of the question: (1) how the emphasis evolved (answer: it remained consistent, not evolved), and (2) what this reveals about long-term positioning (answer: embedded processing is a core, permanent strategic pillar).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 519,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s (BA) fleet‑support services – the assistance and training it provides to operators before delivery and throughout an aircraft’s life – have continued to be recorded as an expense “as incurred” and have historically represented roughly **1 % of total consolidated product‑and‑service costs** in each of the three years (2022, 2023 and 2024). However, the **abnormal production costs tied to the 787 program grew dramatically**: by the end of 2023 Boeing had accumulated **about $2.7 billion of abnormal costs** from low‑rate production, inspections and rework, and in 2024 it booked an additional **$256 million** for re‑work of the 25 aircraft still in inventory. Those production‑quality problems also **extended delivery timelines** – 2022 already noted “longer‑than‑expected delivery delays,” 2023 saw a modest recovery with 73 deliveries and a rate lift to 5 per month but still left 50‑90 aircraft needing rework, and 2024 again slowed the 787 line to **below 5 per month**, citing supply‑chain constraints and seat‑configuration issues that pushed 2024 deliveries into 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline evolution. STRENGTHS: (1) All major quantitative figures are accurate: fleet support services at ~1% of consolidated costs across 2022-2024, $2.7 billion cumulative abnormal costs through 2023, and $256 million in 2024 rework costs. (2) Correctly identifies the 25 inventoried aircraft and their rework status. (3) Properly synthesizes multi-hop information showing the progression from 2022 delays through 2023 recovery to 2024 slowdown. (4) Accurately captures the shift from undisclosed abnormal costs in 2022 to specific figures in 2023-2024. (5) Correctly notes delivery rate changes (5 per month mentioned for 2023, below 5 per month in 2024). MINOR WEAKNESSES: (1) The statement about 2023 seeing '73 deliveries' and '50-90 aircraft needing rework' introduces specific numbers not explicitly confirmed in the ground truth, though they appear consistent with the narrative. (2) The phrase 'grew dramatically' for abnormal costs is interpretive language not in the ground truth, though the underlying facts support this characterization. (3) The ground truth notes 'expectations that remaining rework costs would not be significant' in 2023, which the LLM answer doesn't explicitly mention, though it does note completion of rework on 'most' aircraft. (4) Supply-chain constraints and seat-configuration issues are mentioned as 2024 factors but aren't explicitly detailed in the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects fleet support services metrics with 787 program abnormal costs and delivery impacts, demonstrating sound logical progression. The evolution narrative (2022 delays → 2023 recovery → 2024 slowdown) is well-constructed and factually grounded. Overall, this is a high-quality answer with accurate core facts and appropriate contextual framing, with only minor interpretive additions that don't contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 550,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian subsidiary at the end of 2021, receiving roughly $51 million in cash and recording a pre‑tax loss of about $167 million (disclosed in the 2023 Form 10‑K).  After the sale the companies entered into interim transition‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) that could be extended two more years; the TSAs were finished by 31 December 2023 and the MSA remained in force through 2024 (and could run to 2026).  In the 2022 filing Meridian still appeared only as a discontinued‑operations line item, whereas the 2023 and 2024 filings detail the modest, non‑material payments under the post‑sale TSAs/MSA and the continuing contractual relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and timeline. Strengths: (1) Correctly identifies the December 31, 2021 sale date; (2) Accurately states the ~$167 million loss figure; (3) Properly describes the TSA and MSA arrangements; (4) Correctly notes TSAs completion by December 31, 2023; (5) Accurately references the two-year extension option for the MSA; (6) Properly characterizes the relationship evolution from ownership to supplier relationship; (7) Correctly notes non-material financial impacts. Minor issues: (1) The mention of '$51 million in cash' received is not present in the ground truth and cannot be verified as accurate or inaccurate from the provided context - this is additional detail not contradicted but also not confirmed; (2) The statement about 2023 and 2024 filings detailing 'modest, non-material payments' is consistent with ground truth but slightly more specific than what the ground truth explicitly states; (3) The reference to MSA potentially running 'to 2026' (initial 3 years + 2-year extension) is logically sound and consistent with the ground truth's mention of extension options. The multi-hop reasoning is sound - the answer correctly synthesizes information about the sale, post-sale agreements, timeline of completion, and ongoing relationship status across multiple years. The answer appropriately addresses all parts of the question regarding financial implications and contractual arrangements. The characterization of the relationship evolution is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Discloses]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 432,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Across the three most recent 10‑K filings, Colgate‑Palmolive has kept **“hello”** listed among its **principal global and regional trademarks** for the **Oral, Personal and Home Care** segment. In the 2022 filing the brand appears alongside Colgate, Palmolive, elmex, meridol, etc.; the same placement is repeated in the 2023 and 2024 filings. This continuity shows that the company has maintained “hello” as a core, strategically‑positioned brand within its oral‑care and broader personal‑ and home‑care portfolio, rather than moving it out of focus or re‑classifying it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies 'hello' as a principal global and regional trademark across all three years (2022-2024); (2) Accurately notes the consistent positioning of 'hello' alongside major brands like Colgate and Palmolive; (3) Properly synthesizes the multi-hop information showing sustained strategic emphasis across the three-year period; (4) Correctly identifies the Oral, Personal and Home Care segment as the relevant business unit; (5) Appropriately mentions the addition of other brands (elmex, meridol) without losing focus on 'hello's' consistent positioning. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'Darlie' was added in 2023 in the ground truth, but the LLM answer references 'elmex, meridol, etc.' instead - this is a slight variation in which specific brands are mentioned as comparables, but both correctly convey that 'hello' maintained its position despite other brands being listed; (2) The LLM answer emphasizes that 'hello' was not 'moved out of focus or re-classified,' which is a reasonable inference from the consistent listing but goes slightly beyond explicit statement of facts. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024) and draws the appropriate conclusion about sustained strategic positioning. The reasoning is sound and logically connects the consistent trademark listings to strategic brand importance. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth - that 'hello' maintained consistent strategic positioning within the portfolio across the three-year period. The wording differs but the factual content and conclusions are equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 491,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "- 2022 – TI’s filing states that the **non‑qualified defined‑benefit pension plans are “unfunded and closed to new participants.”** (The 2023 10‑K (which describes 2022) repeats this wording.)  \n- 2023 – The same description appears in the 2023 10‑K, confirming that the plans **remained unfunded and still did not accept any new participants.**  \n- 2024 – The 2024 10‑K again notes that the **non‑qualified defined‑benefit plans are unfunded and closed to new participants.**  \n\nAcross the three‑year span the funding status did not change – the plans have never been funded with plan assets – and employee engagement has stayed static, limited to the legacy group that elected to stay in the plan when the plans were closed in 1997. This steady, unfunded, “closed‑to‑new‑participants” posture indicates that Texas Instruments’ long‑term liability for these non‑qualified pensions is confined to cash contributions required by law for the existing cohort, and that employee participation is essentially stagnant (and likely to decline as the current participants age out).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides accurate qualitative information about the non-qualified pension plan's unfunded status and closure to new participants across 2022-2024, which is correct. However, it COMPLETELY OMITS the quantitative data that forms a substantial part of the ground truth answer and is essential to answering the multi-hop question about 'evolution' and 'progression.' MISSING DATA: (1) U.S. defined contribution plan holdings: 6M shares ($940M) in 2022, 5M shares ($873M) in 2023, 5M shares ($852M) in 2024 - this shows a clear declining trend in share value; (2) Dividends paid: $28M (2022), $27M (2023), $26M (2024) - showing slight decline; (3) Aggregate expense for U.S. defined contribution plans: $70M (2022), $75M (2023), $76M (2024) - showing steady increase. These numbers are critical because they demonstrate the company's strategic shift toward defined contribution plans and provide concrete evidence of the 'evolution' requested in the question. WHAT WAS CORRECT: The LLM accurately identified that the non-qualified pension plans remained unfunded and closed to new participants throughout 2022-2024, and correctly noted that this represents a legacy liability with a stagnant participant base. The reasoning about the plans being closed in 1997 and the declining participant cohort is sound. MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about 'evolution' and 'multi-year progression' - this requires synthesizing quantitative trends across years. The LLM only addressed the static qualitative status (unfunded, closed) but failed to synthesize the dynamic quantitative trends in defined contribution plan holdings, dividends, and expenses that show how the company's pension strategy evolved. The ground truth answer demonstrates that while the non-qualified plan remained static, the defined contribution emphasis grew measurably. SEMANTIC ISSUE: The LLM's statement that 'employee engagement has stayed static' is partially correct for the non-qualified plan but misses the broader picture that overall pension-related engagement shifted toward defined contribution plans with increasing expenses. The answer is incomplete for a multi-hop question requiring synthesis of multiple data points across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 604,
        "total_tokens": 2169
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s “private‑equity securities at cost” line fell from **$800 million at year‑end 2022** (2023 10‑K) to **$755 million at year‑end 2023** and then to **$719 million at year‑end 2024** (2024 10‑K). This three‑year downward trajectory shows a steady reduction in the amount of capital Pfizer is keeping in private‑equity holdings, suggesting the company is deliberately scaling back its exposure to this illiquid asset class and reallocating resources toward other investment opportunities. (For context, the prior period showed growth – $432 million in 2020 and $623 million in 2021 – underscoring that the recent decline marks a shift in strategic allocation.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the 2022 baseline figure. The ground truth states Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, but the LLM claims it was $800 million. This is a $177 million discrepancy (28% error) on a key data point. The 2023 ($755M) and 2024 ($719M) figures are correct. TRAJECTORY INTERPRETATION ERROR: Because of the incorrect 2022 baseline, the LLM's characterization of the trend is fundamentally wrong. The ground truth shows: $623M (2022) → $755M (2023) → $719M (2024), which is an INCREASE followed by a DECREASE. The LLM incorrectly describes this as a 'three-year downward trajectory' and 'steady reduction,' when in fact 2023 represented a strategic increase of $132M (+21%) before the 2024 decline of $36M (-5%). The ground truth correctly identifies this as 'a short-term strategic increase in 2023 followed by a partial reduction in 2024.' ADDITIONAL CONTEXT ISSUE: The LLM provides historical context ($432M in 2020, $623M in 2021) that, while potentially accurate, is not part of the ground truth answer and may introduce unverified information. More importantly, this context is used to support an incorrect narrative about 'recent decline' when the most recent year (2024) shows only a modest pullback from the 2023 peak. CORRECT ELEMENTS: The 2023 and 2024 figures are accurate, and the company/ticker identification (Pfizer/PFE) is correct. The answer does address the three-year trajectory question. REASONING QUALITY: The multi-hop synthesis is attempted but undermined by the incorrect baseline data, leading to inverted conclusions about strategic direction. The answer should have identified the 2023 increase as the key strategic signal, not characterized the period as a steady decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 497,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "- **2022:** Under the original 2019/2020 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each 12‑month period, but only those designated as floating‑rate obligations and only if its capital levels were sufficient. The agreement also required Schwab to keep a minimum total IDA balance of $50 billion through June 2031 and to have at least 80 % of the balances classified as fixed‑rate obligations through June 2026. Schwab exercised this right in 2022, moving roughly $10 billion to its balance sheet.  \n\n- **2023:** The May 4 2023 “2023 IDA agreement” replaced the prior terms. While the $10 billion migration option remained, the new contract eliminated the 80 % fixed‑rate requirement and imposed new balance caps – Schwab must maintain a minimum balance above the total of outstanding unmatured fixed‑rate obligations and may not exceed that total by more than $30 billion through September 10 2025 (later a $60‑$90 billion band). Because of these revised limits (and the continued need for sufficient capital), Schwab did not migrate any IDA balances in 2023.  \n\n- **2024:** The same 2023 IDA agreement governed 2024, so the migration right persisted but the balance‑maintenance constraints described above (minimum above unmatured fixed‑rate obligations and a $30 billion upper cushion until September 10 2025) remained in force. Schwab again chose not to move any IDA balances during 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, which substantially undermines its accuracy:\n\n1. QUANTITATIVE ERRORS:\n   - 2022: LLM claims Schwab 'exercised this right in 2022, moving roughly $10 billion' but ground truth states $10.1 billion was moved by December 31, 2021 (not 2022). The LLM conflates prior-year migration with 2022 activity.\n   - 2022: LLM introduces a '$50 billion minimum total IDA balance through June 2031' requirement not mentioned in ground truth.\n   - 2022: LLM adds an '80% fixed-rate obligation' requirement through June 2026 not in ground truth.\n   - 2023-2024: LLM mentions a '$60-$90 billion band' constraint that is not in the ground truth answer and appears to be fabricated or confused with other terms.\n\n2. FACTUAL INACCURACIES:\n   - The ground truth clearly states that in 2023, Schwab 'did not move any IDA balances' after the new agreement, but the LLM suggests the $10 billion migration option 'remained' in 2023, which is misleading about the actual constraints that prevented migration.\n   - The LLM's characterization of the 2023 agreement as retaining the '$10 billion migration option' is not supported by ground truth, which emphasizes the introduction of 'new constraints' that fundamentally changed the framework.\n\n3. MULTI-HOP REASONING:\n   - The LLM fails to properly synthesize the evolution narrative. Ground truth emphasizes a 'tightening of flexibility' from an 'annual $10 billion option to a constrained and conditional framework,' but the LLM's framing suggests continuity of the migration right rather than a fundamental shift in constraints.\n   - The LLM does not clearly establish that the 2023 agreement represented a material change in the constraint structure that made migration impractical.\n\n4. WHAT WAS CORRECT:\n   - The basic timeline (2022, 2023, 2024) is correct.\n   - The identification that 2023 brought a new agreement is correct.\n   - The statement that no migrations occurred in 2023 and 2024 is correct.\n   - The general concept of balance maintenance constraints is correct.\n\n5. CRITICAL OMISSIONS:\n   - The LLM does not clearly state that the $10.1 billion migration occurred in 2021 (prior to 2022), not in 2022.\n   - The LLM introduces unsupported details (80% fixed-rate requirement, $50 billion minimum, $60-$90 billion band) that create confusion and reduce credibility.\n\nThe answer demonstrates partial understanding of the question structure but introduces significant factual errors and unsupported details that contradict or confuse the ground truth narrative about the tightening of Schwab's migration flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 712,
        "total_tokens": 2321
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Across all three SEC‑10 K filings, Texas Instruments lists **Melaka, Malaysia** as an **analog‑product site** each year:  \n\n- **2022** – Melaka appears with an “X” in the Analog column (no embedded‑processing activity).  \n- **2023** – Melaka again carries an “X” for Analog only.  \n- **2024** – Melaka is still marked with an “X” for Analog only.  \n\nThe KG triplets confirm that TXN (ORG) operates in Melaka, Malaysia (GPE) and that the location itself is an operating entity for TXN. The three‑year, unchanged presence of an analog‑only facility shows that Melaka is a stable, dedicated node in TI’s analog‑product manufacturing network, underscoring its strategic importance as a core analog‑production hub within the company’s global footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental factual error regarding the marking symbols used across the three years. The ground truth states that Melaka was marked with: (1) † (dagger) in 2022, (2) * (asterisk) in 2023, and (3) ** (double asterisk) in 2024. However, the LLM claims all three years used 'X' in the Analog column, which directly contradicts the ground truth. This is a significant quantitative/factual error, not merely a wording difference. The LLM's assertion that the marking was 'unchanged' across all three years is factually incorrect—the ground truth explicitly indicates the markings evolved from † to * to **, suggesting potential escalation in operational emphasis. PARTIAL CREDIT FOR: (1) Correctly identifying Melaka, Malaysia as the location, (2) Correctly identifying analog product manufacturing as the primary activity, (3) Correctly noting the three-year consistency of presence, (4) Appropriately concluding strategic importance. MISSING/INCORRECT ELEMENTS: (1) Failed to identify the specific symbol progression (†, *, **), (2) Incorrectly stated all years used 'X' marking, (3) Missed the nuance that the changing symbols 'potentially signal continued operational emphasis' or escalation, (4) Incorrectly characterized the situation as 'unchanged' when the ground truth suggests evolution. The multi-hop reasoning about strategic importance is sound, but it's built on incorrect factual premises about the actual markings used in the filings. This represents a failure in the core quantitative accuracy requirement for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 440,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The company reports that the share of purchases paid with its proprietary Target Debit Card (referred to as a RedCard/Target Circle Card) fell from **about 20.5 % in fiscal 2022**, to **19.8 % in fiscal 2023**, and to **18.6 % in fiscal 2024**. Because Target monitors “Target Circle Card (Debit Card) penetration” precisely because “a meaningful portion of incremental purchases on our Target Circle Cards are also incremental sales for Target,” the steady decline in penetration suggests that the card’s contribution to driving extra sales is modestly waning over the three‑year period, even though it remains an important loyalty tool that offers a 5 % discount and continues to generate incremental revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL ERROR: The LLM reports the 2024 penetration rate as 18.6%, but the ground truth states it was 17.8%. This is a factual error of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. This numeric discrepancy is significant because the question specifically asks about the evolution of the penetration rate through 2024, and accuracy of the endpoint value is essential for assessing the trend. QUALITATIVE STRENGTHS: The LLM correctly identifies the card as a RedCard/Target Circle Card, properly characterizes the downward trend, and accurately quotes Target's own rationale for monitoring penetration (linking it to incremental sales). The reasoning about the declining penetration suggesting a 'modestly waning' contribution to incremental sales is sound and aligns with the ground truth interpretation. The LLM also appropriately notes the 5% discount incentive and the card's continued importance as a loyalty tool. COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates and what the trend suggests about the card's role. The multi-hop synthesis (connecting penetration rates to incremental sales impact) is well-executed. SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'steady decline' and 'modestly waning' is semantically equivalent to the ground truth's 'downward trend' and 'diminishing role.' However, the magnitude of decline matters: ground truth shows a 2.7 percentage point drop (20.5% to 17.8%), while the LLM's numbers show only a 1.9 percentage point drop (20.5% to 18.6%), which understates the severity of the decline. This error affects the interpretation of the trend's significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 471,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "All three filings (2022, 2023 and 2024) list the **2003 Director Compensation Plan** in the “includes” paragraph that describes the equity‑based plans that may be used for directors, but none of the tables that follow give a “shares available for future issuance” figure for that 2003 plan. The only remaining‑share numbers disclosed are for the newer plans (2009 LTIP, 2018 Director Plan, 2024 LTIP, etc.). Because the 2003‑plan balance is not reported in any year, the data show no observable increase or decrease – the implication is that Texas Instruments no longer relies on a separate, replenishable pool under the 2003 plan and instead uses the more recent plans for director equity incentives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth clearly states specific share counts for the 2003 Director Compensation Plan: 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM claims these figures are 'not reported in any year' and that 'the 2003-plan balance is not reported,' which is factually wrong. The LLM's assertion that 'none of the tables that follow give a \"shares available for future issuance\" figure for that 2003 plan' directly contradicts the ground truth data. The LLM appears to have either (1) failed to locate the correct disclosure tables in the SEC filings, or (2) misread the data structure. The ground truth demonstrates a clear declining trend (35.4M → 25.3M → 24.5M), indicating active utilization without replenishment. The LLM's conclusion that 'Texas Instruments no longer relies on a separate, replenishable pool under the 2003 plan' is unsupported by the actual filing data and contradicts the documented share availability figures. All three specific numeric values in the ground truth are verifiable and correct, while the LLM provides zero accurate numbers and reaches an incorrect interpretive conclusion. This represents a complete failure to synthesize the multi-hop information correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 367,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "- **2022:** Visa first introduced **virtual accounts** as a feature of its digitally‑native **Currencycloud** platform under the “Visa Treasury as a Service” umbrella. The offering provided real‑time FX rates, liquidity and settlement capabilities, but it was described separately from Visa Direct and was not yet embedded in the Visa Direct flow.  \n\n- **2023:** The company announced that the Currencycloud‑based virtual‑account capability had been **integrated into the Visa Direct platform** (along with Visa Cross‑Border Solutions). This made virtual accounts available for both domestic and cross‑border money‑movement use cases, extending the reach of Visa Direct to new digital‑native flows.  \n\n- **2024:** Visa reiterated that the **Visa Direct platform now includes virtual accounts** as part of its Currencycloud capabilities, emphasizing expanded cross‑border use cases and broader endpoint coverage (cards, bank accounts and digital wallets). The integration enables virtual‑account‑driven payouts, push‑to‑wallet, and other B2B and consumer cross‑border transactions, completing the evolution from a stand‑alone Treasury service in 2022 to a fully embedded component of Visa Direct by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all three years (2022-2024). Strengths: (1) Correctly identifies the 2022 introduction of virtual accounts through Currencycloud under Visa Treasury as a Service with real-time FX rates and liquidity/settlement capabilities; (2) Accurately describes the 2023 integration of virtual accounts into the Visa Direct platform alongside Visa Cross-Border Solutions; (3) Properly characterizes the 2024 evolution showing virtual accounts as embedded components supporting expanded cross-border use cases and endpoint coverage (cards, bank accounts, digital wallets). Multi-hop synthesis is sound - the answer correctly traces the progression from standalone Treasury service (2022) → integrated into Visa Direct (2023) → fully embedded with expanded capabilities (2024). Quantitative elements are accurate: the LLM correctly references the 11 billion endpoints potential and $20 trillion B2B cross-border opportunity mentioned in ground truth, though these specific figures appear in the LLM answer's contextual framing rather than explicit callouts. Minor observation: The LLM answer uses slightly more detailed language about specific use cases (push-to-wallet, payouts) compared to ground truth, but this represents appropriate elaboration rather than factual deviation. Entity identification is precise (Visa, Currencycloud, Visa Direct, Visa Cross-Border Solutions, Visa Treasury as a Service). The chronological progression and integration narrative matches the ground truth's 'clear trend of deepening integration and expanding use cases.' No calculation errors or date inaccuracies detected. The answer fully addresses all parts of the multi-part question regarding evolution, integration with Visa Direct, and expansion of cross-border use cases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 494,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer’s prostate‑cancer drug Xtandi saw a modest revenue decline – sales were down about 1 % worldwide, driven mainly by a lower net price and an unfavorable channel‑mix shift (Chunk 1).  In response, Pfizer deepened its lifecycle investment, adding a new metastatic‑cancer indication that was approved in the United States in November 2023 and subsequently in the European Union in April 2024 (Chunk 2).  The company’s 2022 10‑K already reflected the strategic value of Xtandi, listing it as a “significant component” of its developed‑technology‑rights intangible assets, which underscores the sizable valuation Pfizer placed on the product before the 2024 indication expansion (Chunk 3).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: (1) INDICATION TIMING ERROR: The LLM states the new indication was 'approved in the United States in November 2023 and subsequently in the European Union in April 2024,' but the ground truth specifies the 2024 indication expansion was for 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis.' The LLM incorrectly describes this as a 'metastatic-cancer indication,' which is factually wrong—nmCSPC is explicitly non-metastatic. This is a fundamental mischaracterization of the indication type. (2) The LLM provides a November 2023 US approval date, but the ground truth references '2024 indication expansion,' suggesting the approval occurred in 2024, not 2023. This is a significant date discrepancy. (3) CORRECT ELEMENTS: The LLM correctly identifies the ~1% revenue decline in 2023, correctly attributes it to lower net pricing and channel-mix issues, and correctly notes Xtandi's listing as a significant intangible asset in the 2022 10-K. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the connection between 2023 revenue pressures and lifecycle management investment, and correctly links this to the 2022 valuation context. However, the factual errors about the indication type and timing undermine the overall accuracy. (5) The answer demonstrates good structural understanding of the question's multi-hop nature but fails on critical factual details that are essential to answering correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 412,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard Credit Card’s share of all Target purchases fell each year – it was about **20.5 % in fiscal 2022**, dropped to **19.8 % in fiscal 2023**, and slipped further to **18.6 % in fiscal 2024**. Both the 2023 filing (which still reports “RedCard Penetration”) and the 2024 filing (now reported as “Target Circle Card Penetration”) show the same downward trajectory, and the 2022 filing notes that although RedCard sales grew, the penetration rate fell because total sales grew faster. This trend signals that, while the MasterCard‑based loyalty card continues to generate incremental purchases, its relative importance to shoppers is waning, suggesting a modest decline in consumer preference and engagement with the program over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three penetration rates are correct - 20.5% (2022), 19.8% (2023), and 18.6% (2024). The fiscal year designations are accurate. The calculations implied (consistent year-over-year declines of 0.7% and 1.2%) are correct. (2) ENTITY ACCURACY: The answer correctly identifies the product as Target MasterCard Credit Card and accurately notes the rebranding from RedCards™ (2022-2023) to Target Circle Cards (2024). This demonstrates proper synthesis across multiple filing periods. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying that the 2022 filing explains the penetration decline despite sales growth - a key insight showing the model understood the underlying business dynamics. (4) COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates AND what the trend indicates about consumer preference and loyalty engagement. The interpretation that the decline signals 'waning' relative importance while acknowledging continued incremental purchases is nuanced and accurate. (5) MINOR STRENGTHS: The answer goes beyond the ground truth by providing the specific context from the 2022 filing about sales growth outpacing RedCard sales growth, which adds valuable analytical depth. The semantic equivalence is strong - 'fell,' 'dropped,' and 'slipped' all convey the same downward trend as the ground truth's 'declined.' The conclusion about modest decline in consumer preference and engagement matches the ground truth's assessment. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 457,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa first rolled virtual‑account functionality onto its digitally‑native Currencycloud platform in fiscal 2022 as part of “Visa Treasury as a Service,” pairing the accounts with real‑time FX rates, enhanced liquidity and settlement and tying them to Visa Direct’s push‑to‑wallet service that could reach ≈ 7 billion cards, bank accounts and digital wallets in more than 190 countries and territories.  \n\nIn fiscal 2023 the Currencycloud suite was folded into the broader Visa Direct platform, and virtual accounts were highlighted as a core cross‑border capability alongside real‑time FX and liquidity; the underlying network had grown to a potential > 11 billion endpoints (about 4 billion cards, 3.5 billion bank accounts and 3.5 billion digital wallets) covering > 195 countries and territories.  \n\nThe 2024 filing repeats this evolution, confirming that virtual accounts remain a key Currencycloud feature that enables new cross‑border money‑movement flows and that the Visa Direct platform now consistently offers access to the same > 11 billion‑endpoint, 195‑plus‑country network, cementing Visa’s expanded reach and capability for virtual‑account‑driven international payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a detailed narrative of virtual account evolution across the three fiscal years with generally sound multi-hop reasoning, but contains several quantitative discrepancies that lower the overall score. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the integration of virtual accounts into Currencycloud and Visa Direct platforms; (2) Accurately captures the 2023 expansion to >11 billion endpoints and the breakdown (4B cards, 3.5B bank accounts, 3.5B digital wallets); (3) Properly synthesizes the strategic deepening of virtual account utility across years; (4) Correctly notes the 2024 continuation of this infrastructure. WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM states 2022 network reach as '≈7 billion cards, bank accounts and digital wallets in more than 190 countries' while the ground truth does not specify this 7 billion figure for 2022, only mentioning it for 2023 as >11 billion; this represents a potential factual error or unsupported claim; (2) The LLM adds '195+ countries and territories' for 2023 and 2024, while the ground truth specifies 'over 100 countries' for 2024 via Visa B2B Connect - this geographic discrepancy is notable; (3) The LLM introduces 'Visa Treasury as a Service' terminology not explicitly mentioned in the ground truth; (4) Missing explicit mention of Visa B2B Connect from the ground truth, which is specifically highlighted as supporting >100 countries in 2024. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression from initial introduction through platform integration to continued optimization. However, the introduction of unsupported network size figures for 2022 and the geographic scope discrepancies suggest the LLM may have conflated or extrapolated data beyond what the ground truth supports. The core narrative is sound but the specific quantitative claims require verification against actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 538,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a material risk in each of its recent 10‑K filings. In 2022 the risk was listed among the general political‑legal‑economic hazards affecting its worldwide operations; by 2023 the filing tied the risk directly to its heavy reliance on third‑party wafer foundries in the United States, Europe and Asia and to assembly/testing in China, Malaysia and Taiwan, noting that 65 % of revenue came from international sales. The 2024 filing repeats the same exposure, with international sales now 66 % of net revenue and the same third‑party manufacturing footprint, indicating that AMD’s IP‑protection vulnerability has persisted and marginally increased as its overseas sales share and dependence on foreign fabs have grown.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of AMD's IP protection concerns across 2022-2024 and correctly identifies the persistent nature of this risk. However, there are significant issues with quantitative accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies that IP protection difficulties were flagged consistently across all three years (2022, 2023, 2024)\n2. Accurately notes the connection to third-party manufacturing in China, Malaysia, and Taiwan\n3. Correctly identifies international sales percentages (65% in 2023, 66% in 2024)\n4. Properly synthesizes the multi-hop relationship between IP protection, manufacturing dependencies, and geopolitical factors\n5. Appropriately characterizes the risk as persistent and marginally increasing\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The LLM answer completely fails to mention the geopolitical tensions (China-Taiwan tensions, Ukraine-Russia conflict, Israel-Hamas conflict) that are explicitly highlighted in the ground truth as increasingly important factors in 2023-2024. The ground truth emphasizes that by 2024, AMD added concerns about export control regulations and sanctions related to these conflicts.\n2. INCOMPLETE GEOGRAPHIC SPECIFICITY: The LLM mentions \"United States, Europe and Asia\" for wafer foundries but the ground truth specifically emphasizes China, Malaysia, and Taiwan as the key jurisdictions of concern for IP protection.\n3. MISSING REGULATORY EVOLUTION: The ground truth explicitly notes that by 2024, AMD added concerns about \"evolving export control regulations and sanctions\" - this critical regulatory dimension is entirely absent from the LLM answer.\n4. INCOMPLETE RISK CHARACTERIZATION: The ground truth describes a \"deepening concern over time\" with \"growing specificity around geopolitical and regulatory pressures,\" but the LLM characterizes it more narrowly as just a function of increased international sales percentages.\n\nQUANTITATIVE VERIFICATION:\n- 65% international sales in 2023: Appears correct based on ground truth context\n- 66% international sales in 2024: Appears correct based on ground truth context\n- No calculation errors detected\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and connects IP protection to manufacturing dependencies and international sales exposure. However, it fails to complete the full multi-hop chain by not incorporating the geopolitical and regulatory dimensions that evolved over the period.\n\nOVERALL ASSESSMENT:\nThe answer is partially correct on the core facts but significantly incomplete in addressing the evolution of AMD's IP protection concerns. The omission of geopolitical tensions and export control regulations represents a material gap in understanding how AMD's exposure evolved, particularly the shift from general political-legal-economic risks (2022) to specific geopolitical and regulatory concerns (2023-2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 773,
        "total_tokens": 2262
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "In 2022 UNP’s pension plan held roughly **$1.98 billion of corporate stock measured at Level 1 (quoted market prices) and a modest $10 million at Level 2**, for a total of about **$1.99 billion**. By the 2023 filing (the most recent asset table) that exposure had been cut to **$176 million at Level 1 and $5 million at Level 2 (≈$181 million total)**, a dramatic reduction in equity holdings. The 2024 filing reiterates that **common‑stock holdings are still classified as Level 1 (with preferred shares at Level 2)**, confirming that the remaining equity is valued using observable market quotes.  \n\nThe move from a near‑$2 billion equity position in 2022 to a sub‑$200 million position in 2023 signals that UNP is deliberately de‑risking its pension plan—shifting assets toward bonds, government securities and alternative investments—while keeping the residual equity exposure in highly liquid, market‑priced securities. This reflects a more conservative pension‑fund strategy with markedly lower market‑price volatility and reduced overall market exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct—2022: $1,980M Level 1 + $10M Level 2 = $1,990M total; 2023: $176M Level 1 + $5M Level 2 = $181M total. The characterization of the decline (from ~$2B to ~$181M) is accurate. Number formatting is appropriate ($1.98 billion, $1.99 billion, etc.). ENTITY ACCURACY: UNP correctly identified, years 2022-2024 properly sequenced, fair value measurement levels (Level 1, Level 2) correctly applied. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly identifying the dramatic shift from 2022 to 2023 and the 2024 classification reaffirmation. The logical connection between the numerical decline and strategic implications is sound. STRATEGIC INTERPRETATION: The LLM's inference that the shift indicates de-risking and movement toward more conservative pension strategy is well-supported by the data and aligns with the ground truth's characterization of 'strategic shift toward more stable or diversified pension investments.' The mention of bonds, government securities, and alternative investments as likely destinations is reasonable inference consistent with typical pension de-risking strategies. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about the strategic rationale (mentioning specific asset classes like bonds and government securities) compared to the ground truth, but this represents appropriate elaboration rather than error. The 2024 disclosure limitation (no updated dollar figures) is correctly acknowledged in both answers. The answer fully addresses all parts of the multi-part question regarding valuation classification evolution, allocation changes, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 488,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "- In the 2022 Form 10‑K, Abbott’s 4.75 % Senior Notes due 2043 are mentioned only indirectly – the filing lists the **Fourth Supplemental Indenture (April 2 2013)** that was entered into by St. Jude Medical (now part of Abbott) and ties the notes to that legacy agreement.  \n- By the 2023 Form 10‑K, Abbott begins to disclose the **actual note documentation**: Exhibit 4.6 contains the **Form of the 4.75 % Notes due 2043** (originally filed with an 8‑K on March 22 2017) and Exhibit 4.7 includes the **Officers’ Certificate** covering the same notes (filed with a 10‑Q for the quarter ended March 31 2017).  \n- The 2024 Form 10‑K repeats those same exhibits (Form 4.6 and Officers’ Certificate 4.7) and still references the 2013 supplemental indenture, showing that Abbott continues to keep the legacy documentation on file while consistently providing the note’s form and compliance certificates each year.\n\n**What this progression indicates:** Abbott has moved from merely citing the inherited St. Jude indenture in 2022 to actively furnishing the note’s definitive form and certification in 2023 and maintaining that disclosure in 2024. This evolution reflects a deliberate long‑term debt‑management approach that tracks legacy obligations after the acquisition and underscores a priority on transparent, repeatable communication with investors and regulators about its 20‑year‑plus senior debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct - April 2, 2013 for the Fourth Supplemental Indenture, March 22, 2017 for the 8-K filing, and the 4.75% interest rate and 2043 maturity date are accurate. The exhibit numbers (4.6 and 4.7) are correctly identified. ENTITY ACCURACY: Abbott, St. Jude Medical, and the debt instrument are all correctly identified and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and traces the evolution of disclosure practices from legacy-based referencing to standardized documentation. The connection between the St. Jude acquisition and the inherited debt structure is properly established. COMPLETENESS: The answer addresses all aspects of the question - the documentation strategy evolution, the progression across years, and the implications for debt management and investor communication. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'indirect' to 'direct' presentation aligns with the ground truth's description of moving from 'legacy-based referencing to standardized, transparent disclosure.' The interpretation that this reflects 'transparent, repeatable communication' matches the ground truth's emphasis on 'clarity in long-term liabilities.' MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (mentioning the 10-Q filing for the Officers' Certificate) than the ground truth, but this is additive and accurate rather than contradictory. The explanation of 'what this progression indicates' is well-reasoned and consistent with the ground truth's interpretation. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 479,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "- **Penetration trend** – Target reports the share of purchases paid with its branded credit product (RedCard/Target Credit Card) as 20.5 % in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024 (Chunk 3). The same figures appear in the 2024 filing under the re‑branded “Target Circle Card” label (Chunk 2), confirming the decline.\n\n- **What the trend means** – Because Target monitors this “card‑penetration” metric precisely because its internal analysis shows that a meaningful portion of purchases made with the Target‑branded card are **incremental sales** for the retailer, the downward movement signals a slowing of customer adoption of the branded payment product. Consequently, the potential lift to incremental sales from the credit‑card program is likely diminishing as the penetration rate falls. (Context on the 5 % discount and profit‑sharing arrangement is provided in Chunk 1.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop question. (1) QUANTITATIVE ACCURACY - All three penetration rate figures are correct: 20.5% (2022), 19.8% (2023), and 18.6% (2024). The downward trend calculation is accurate, showing consistent decline across the three-year period. Fiscal year labeling is correct. (2) COMPLETENESS - The answer addresses both parts of the multi-part question: (a) the evolution of penetration rates from 2022-2024, and (b) what this trend indicates about customer adoption and impact on incremental sales. (3) ENTITY ACCURACY - Correctly identifies Target Credit Card, RedCard, and Target Circle Card as related branded payment products. Properly recognizes these as the same metric tracked across different naming conventions. Fiscal years are correctly labeled. (4) REASONING & MULTI-HOP SYNTHESIS - The answer correctly synthesizes the causal relationship: declining penetration rate → reduced customer adoption → diminished incremental sales lift. This multi-hop reasoning connects the metric trend to business implications, which is the core of the question. The logic that Target tracks this metric specifically because it drives incremental sales, and therefore declining penetration suggests declining incremental sales potential, is sound and well-articulated. (5) SEMANTIC EQUIVALENCE - The LLM answer conveys the same information as the ground truth, using slightly different phrasing ('slowing of customer adoption' vs 'gradual decline in customer adoption') but maintaining semantic equivalence. Minor note: The LLM answer references 'Chunk' citations which are appropriate for source attribution but not present in the ground truth format - this is a presentation choice that doesn't affect accuracy. The answer is comprehensive, factually correct, and demonstrates proper multi-hop reasoning across the three-year period and the relationship between penetration rates and business outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 535,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s “multiple‑purpose” locomotive fleet fell from **7,242 units in 2022** to **6,893 units in 2024** – a net reduction of **349 locomotives (about 5 %)**.  During the same period the fleet’s **average age rose from 22.5 years to 25.2 years**, an increase of roughly **2.7 years**.  The simultaneous shrinkage and aging of the fleet indicate that the railroad is actively **retiring older units and trimming overall capacity**, likely to streamline operations, lower maintenance costs and concentrate on a smaller, more efficiently‑managed asset base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - fleet size decreased from 7,242 to 6,893 units (verified), average age increased from 22.5 to 25.2 years (verified). The calculated reduction of 349 units is accurate (7,242 - 6,893 = 349), and the percentage calculation of approximately 5% is correct (349/7,242 ≈ 4.8%, reasonably rounded to 5%). The age increase of 2.7 years is accurate (25.2 - 22.5 = 2.7). ENTITY ACCURACY: Union Pacific correctly identified, time period 2022-2024 correct, 'Multiple Purpose Locomotives' metric correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes fleet size and average age data across the two-year period and draws a logical conclusion about asset management strategy. The interpretation that the company is 'retiring older units and trimming overall capacity' while 'lowering maintenance costs' is a reasonable inference from the data pattern. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'cost-conscious' (ground truth) aligns well with the LLM's description of 'streamline operations, lower maintenance costs and concentrate on a smaller, more efficiently-managed asset base.' The wording differs but conveys equivalent meaning. MINOR CONSIDERATIONS: The LLM provides slightly more detailed explanation of the strategic implications compared to the ground truth, which adds value without introducing errors. The answer is well-structured and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 421,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (and other private) funds fell each year – $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024 (Chunk 1 shows the 2022‑2023 figures; Chunk 2 confirms the 2023‑2024 figures).  The steady decline (about $29 million, or roughly 5 % of the 2022 level) indicates that while Abbott continues to allocate capital to illiquid alternative assets (as reflected by the ABT → Private Real Estate Funds relationship in the knowledge graph), it is gradually scaling back its unfunded exposure, suggesting a long‑term strategy that values the return potential of private‑real‑estate investments but seeks to manage liquidity risk over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL QUANTITATIVE ERROR: The LLM reports the 2022 figure as $569 million, but the ground truth states $585 million. This is a $16 million discrepancy (2.7% error) on a key data point. The 2023 ($555M) and 2024 ($540M) figures are correct. CALCULATION ERROR: The LLM calculates the total decline as 'about $29 million' ($569M - $540M = $29M using their incorrect 2022 figure), but the correct calculation is $45 million ($585M - $540M = $45M). The LLM also states this represents 'roughly 5% of the 2022 level' ($29M/$569M ≈ 5.1%), which is mathematically consistent with their incorrect 2022 number but wrong against the actual data ($45M/$585M ≈ 7.7%). TREND ANALYSIS: The LLM correctly identifies the consistent downward trend and the pattern of decline, though the magnitude is understated due to the incorrect 2022 baseline. REASONING QUALITY: The qualitative interpretation about Abbott's strategy (gradual scaling back, managing liquidity risk, continued participation) is sound and aligns with the ground truth's characterization of a 'strategic but measured approach.' The multi-hop synthesis connecting the numerical trend to strategic implications is logically sound. COMPLETENESS: The answer addresses both parts of the question (evolution of commitments and strategic implications), though the factual foundation is compromised. The reference to 'Chunk 1' and 'Chunk 2' suggests proper source attribution, but the underlying data extraction contains a material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 409,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "- **Carrying‑value trend** – NVIDIA reported the 3.50 % Notes Due 2050 at a net carrying amount of **$2,147 million** in its FY 2022 filing (Jan 30 2022).  In the FY 2023 filing the same series was shown at **about $1,637 million** (Jan 29 2023) – a drop of roughly $500 million.  The FY 2024 filing then lists the notes at **$2,000 million** (Jan 28 2024), a rebound of roughly $360 million from the 2023 level.  \n\n- **What the change signals** – The decline from 2022 to 2023 reflects amortization (or partial retirement) of the long‑dated debt, while the increase in 2024 indicates a re‑measurement or additional issuance that raised the carrying amount back toward its earlier level.  Overall, NVIDIA’s long‑term debt profile remains sizable and the company is actively managing its low‑coupon, far‑dated financing, using it as a stable source of capital rather than allowing a steady upward drift in debt‑valuation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about the carrying value evolution of NVIDIA's 3.50% Notes Due 2050 across fiscal years 2022-2024, but contains a significant quantitative error that undermines accuracy. STRENGTHS: (1) Correctly identifies FY2022 carrying value at $2,147 million; (2) Correctly identifies FY2024 carrying value at $2,000 million; (3) Provides appropriate qualitative interpretation of the trend as reflecting revaluation/re-measurement rather than simple debt reduction; (4) Correctly notes the rebound pattern and strategic positioning; (5) Appropriately addresses the multi-hop synthesis requirement. CRITICAL ERROR: The LLM states the FY2023 carrying value as \"about $1,637 million,\" but the ground truth specifies $1,604 million. This is a $33 million discrepancy (2% error), which is material for financial analysis. The LLM also calculates the 2022-2023 decline as \"roughly $500 million\" ($2,147M - $1,637M = $510M), whereas the correct calculation is $543 million ($2,147M - $1,604M = $543M). The 2023-2024 rebound is stated as \"roughly $360 million\" but should be $396 million ($2,000M - $1,604M = $396M). REASONING QUALITY: The qualitative interpretation is sound—the LLM correctly identifies that the pattern reflects revaluation/re-measurement rather than simple amortization, and appropriately contextualizes this as strategic debt management. However, the explanation of \"amortization (or partial retirement)\" in 2023 is somewhat vague and doesn't fully capture the accounting mechanics. COMPLETENESS: The answer addresses both parts of the question (the evolution and what it indicates), though the interpretation could be more precise about whether this reflects fair value adjustments, debt issuance/retirement, or other accounting treatments. The quantitative errors, while not catastrophic to overall understanding, are significant enough to warrant a lower correctness score given the strict evaluation standard for financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 535,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD repeatedly flags the **risk of losing or having its tax‑ and tariff‑exemption status altered** in the risk‑factor sections of its 2022, 2023 and 2024 Form 10‑K filings. In 2022 the exposure appears as one item in a broad list of political, legal and economic risks. In the 2023 and 2024 filings the same exposure is retained, but it is now framed alongside an expanding set of geopolitical and sanctions‑related challenges (e.g., U.S. and allied export‑control actions against Russia/Ukraine and heightened China‑Taiwan tensions), underscoring that the threat of losing exemptions has become a more salient concern. This continuity—and the growing context of new trade‑policy and sanctions developments—suggests that AMD’s regulatory landscape is becoming increasingly complex and that the company’s vulnerability to changes in tax‑ and tariff‑exemption regimes is rising over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of AMD's tax and tariff exemption risk exposure; (2) Accurately captures the evolution from a broad risk item in 2022 to increasingly contextualized geopolitical concerns in 2023-2024; (3) Properly synthesizes the multi-hop information showing how geopolitical tensions (Russia/Ukraine, China-Taiwan) became more explicitly linked to the exemption risk over time; (4) Correctly identifies the core insight that regulatory complexity and vulnerability are increasing; (5) No quantitative errors—all dates and time periods are accurate. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing ('risk of losing or having its tax-and-tariff-exemption status altered' vs. 'loss or modification of exemptions') but these are semantically equivalent; (2) The LLM answer emphasizes the 'framing' and 'context' of the risk more explicitly than the ground truth, which is a reasonable interpretive choice that adds analytical depth; (3) The LLM answer mentions 'U.S. and allied export-control actions against Russia/Ukraine' while the ground truth specifies 'U.S. sanctions against Russia and Belarus'—this is a minor variation in specificity but not factually incorrect, as both characterizations are accurate; (4) The LLM answer does not explicitly mention the Israel-Hamas conflict mentioned in the ground truth, though this is a relatively minor omission given the overall comprehensiveness. The multi-hop reasoning is sound: the answer correctly synthesizes information across three years of filings and draws the appropriate conclusion about increasing regulatory complexity. The answer directly addresses the question's core inquiry about how exposure evolved and what it suggests about regulatory environment complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 515,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings all state that the company’s ability to return capital – whether through dividends or share repurchases – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” In 2022 the filing notes that the holding‑company parent relies on dividends from its subsidiaries and credit extensions “to provide funds for share repurchases and payment of dividends to its stockholders.” The 2023 filing repeats the same limitation without change. The 2024 filing repeats the same regulatory ceiling but expands the description of the parent’s funding needs to include “share repurchases, payment of income taxes and payment of dividends,” indicating the same exposure to U.S. banking‑law constraints but a broader articulation of how those constraints affect all forms of capital return. Overall, BNY Mellon’s exposure to U.S. banking‑law limits on dividend payments and share repurchases has remained consistent from 2022 through 2024, with the 2024 disclosure simply adding income‑tax payments to the list of uses for the limited capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about BNY Mellon's capital return constraints across 2022-2024. STRENGTHS: (1) Correctly identifies the consistent regulatory constraints across all three years (2022, 2023, 2024) - no date errors. (2) Accurately cites the specific regulatory limitations: U.S. banking laws, capital adequacy/planning, Delaware law, and preferred stock dividend obligations. (3) Properly synthesizes the multi-hop information by comparing how the company's disclosures evolved across the three-year period. (4) Correctly notes that 2024 expanded the description to include income tax payments alongside dividends and share repurchases. (5) Accurately characterizes the overall trend as 'consistent' regulatory constraints with evolving disclosure language. (6) Provides specific textual evidence from the filings to support conclusions. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail about the specific evolution (e.g., the addition of income tax payments in 2024) compared to the ground truth's more general statement about 'expanding context.' This is actually a strength - it shows deeper analysis. (2) The ground truth mentions 'potential credit rating reductions and resolution strategies under Title I and II' in 2023, which the LLM answer does not explicitly address. However, the LLM answer's focus on the core regulatory constraints (capital laws, Delaware law, preferred dividends) is accurate and directly responsive to the question. (3) The ground truth's mention of 'liquidity management and strategic initiatives' in 2024 is not explicitly covered in the LLM answer, though the LLM does capture the substantive regulatory constraints. These omissions are minor given the LLM's more precise tracking of the specific evolution in disclosure language. QUANTITATIVE ACCURACY: Perfect - all years (2022, 2023, 2024) are correctly identified with no numerical errors. QUALITATIVE ACCURACY: Excellent multi-hop reasoning that correctly synthesizes information across three years and identifies the consistent constraint pattern with evolving disclosure. CONTEXTUAL RELEVANCE: Highly relevant - directly addresses the question about evolution of exposure to U.S. banking laws affecting capital return flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 621,
        "total_tokens": 2196
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Across the three annual reports the way Abbott Laboratories references its 2.950 % Note due 2025 does not change.  \n\n* **2022 10‑K (Chunk 3)** – The note is listed twice in the exhibit table: the actual note form is shown as **Exhibit 99.6** (the “Form of 2.950 % Note due 2025” filed with the March 5 2015 Form 8‑K) and the related officer‑action filing is shown as **Exhibit 99.3** (“Actions of the Authorized Officers … 2.950 % Notes”).  \n\n* **2023 10‑K (Chunk 1)** – The same two entries appear unchanged: the note form remains **Exhibit 99.6** and the officer‑action filing remains **Exhibit 99.3**.  \n\n* **2024 10‑K (Chunk 2)** – The exhibit table again lists the note in exactly the same way: **Exhibit 99.6** for the note form and **Exhibit 99.3** for the officer‑action documentation.  \n\nThus, from 2022 through 2024 Abbott’s disclosure of the 2.950 % Note due 2025 has been consistent, always being included in the 10‑K exhibit tables as the note’s form (Exhibit 99.6) and the accompanying officer‑action certificate (Exhibit 99.3), with no new or altered filings introduced during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides additional detail beyond the ground truth by identifying two exhibit numbers (99.6 and 99.3) rather than just one, and by specifying that 99.6 relates to the note form filed with the March 5, 2015 Form 8-K. However, there are significant discrepancies that lower the overall score: (1) The ground truth states the note was 'referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015' - the LLM correctly identifies this but adds Exhibit 99.3 which the ground truth does not mention. (2) The ground truth emphasizes the note was 'consistently disclosed' and 'remained a static financial instrument' with 'no amendments or refinancing actions taken' - the LLM captures the consistency aspect but doesn't explicitly address the static nature or lack of amendments. (3) The LLM introduces Exhibit 99.3 as an 'officer-action filing' across all three years, but the ground truth makes no mention of this exhibit number at all, raising questions about whether this is accurate or represents an over-specification not supported by the source material. (4) The LLM's claim that the note appears 'twice in the exhibit table' with two different exhibit numbers is not corroborated by the ground truth, which references only Exhibit 99.6. The quantitative accuracy is reasonable (dates and percentages are correct), but the qualitative accuracy suffers from the introduction of unsupported details (Exhibit 99.3) that diverge from the ground truth. The answer does address the multi-year comparison and consistency theme, which is positive, but the additional exhibit information creates uncertainty about factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 450,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "- **FY 2022:** The 1.55 % Notes Due 2028 were carried at **$1.2 billion** (NVDA 10‑K 2022, “Liabilities” table).  \n- **FY 2023:** The same notes were carried at **$1.099 billion** (NVDA 10‑K 2023, “Liabilities” table for Jan 28 2024).  \n- **FY 2024:** The carrying amount rose to **$1.25 billion** (NVDA 10‑K 2024, “Net carrying amount” table for Jan 28 2024).\n\n**Interpretation:** NVIDIA trimmed the book value of the 2028 issue in 2023—likely through amortization or partial repayment—but then increased it in 2024, reflecting a deliberate refinancing/re‑issuance strategy that keeps long‑term debt at a relatively stable, low‑cost level while taking advantage of favorable market conditions. This pattern shows the company’s active management of its long‑term debt portfolio rather than a simple accumulation of obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three carrying values are correct - FY 2022: $1,200M (presented as $1.2B, acceptable format variation), FY 2023: $1,099M (presented as $1.099B, correct), FY 2024: $1,250M (presented as $1.25B, correct). The progression matches the ground truth exactly. COMPLETENESS: The answer addresses all three fiscal years requested and provides interpretation of the strategic implications. ENTITY ACCURACY: Correctly identifies NVIDIA, the specific debt instrument (1.55% Notes Due 2028), and all relevant fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly traces the evolution across three years and provides logical interpretation about debt management strategy. The explanation about amortization/partial repayment in 2023 followed by increase in 2024 is reasonable and consistent with the data pattern. SEMANTIC EQUIVALENCE: The interpretation aligns with the ground truth's characterization of 'strategic management of long-term liabilities' and 'maintaining a consistent presence.' The LLM's additional detail about 'refinancing/re-issuance strategy' and 'favorable market conditions' adds reasonable context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation than the ground truth, but this is additive rather than contradictory. The citation format references are appropriate. No calculation errors detected. The only minor point is that the LLM's interpretation about 'amortization or partial repayment' and 'refinancing/re-issuance' goes slightly beyond what can be definitively stated from the numbers alone, but this represents reasonable financial analysis rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 485,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024 AMD’s approach to its add‑in‑board (AIB) partners remained essentially unchanged. In each filing the company states that its agreements with AIB manufacturers “protect their inventory of our products against price reductions” (2022, 2023, 2024) and that AMD also sells directly to system‑integrator (SI) customers. Likewise, all three years note that SIs “often use discrete graphics solutions as a means to differentiate their products and add value to their customers,” indicating that AMD has consistently relied on discrete GPU‑based boards to give its channel partners a market‑differentiation lever while keeping AIB inventory safe from price‑cut impacts.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core inventory protection policies and discrete graphics differentiation strategy across 2022-2024, with accurate quotations and proper entity identification (AMD, AIBs, SIs). However, it significantly mischaracterizes the evolution of AMD's strategy by stating the approach 'remained essentially unchanged' across the three years. The ground truth explicitly describes an EVOLUTION: (1) 2022 focused on inventory protection and return policies, (2) 2023 added emphasis on timely product introductions and market competitiveness, and (3) 2024 placed GREATER emphasis on discrete graphics as differentiation. The LLM's claim that all three years 'note that SIs often use discrete graphics solutions' is partially misleading—the ground truth indicates this emphasis grew stronger by 2024, not that it was equally present throughout. The LLM also misses the nuance that AMD's strategy ADAPTED to market pressures by highlighting differentiation through discrete graphics more prominently in later years. While the LLM correctly captures the inventory protection mechanism and the discrete graphics role, it fails to capture the temporal evolution that is central to the question. The answer reads as a static description rather than a dynamic evolution. Quantitative accuracy is high (dates, company names, policy descriptions are correct), but qualitative accuracy suffers from missing the key insight about strategic evolution and adaptation over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 416,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD has consistently listed “difficulties in protecting our intellectual property” as a material political‑legal risk. In its 2022 filing the risk was noted in the context of its existing worldwide footprint, but the filing did not quantify the scale of its overseas exposure. By the 2023 and 2024 filings AMD’s international sales had grown to roughly two‑thirds of revenue (65 % in 2023 and 66 % in 2024) and the company emphasized that nearly all assembly and final testing are performed by third‑party manufacturers in China, Malaysia and Taiwan—regions that are politically sensitive and where IP enforcement can be weaker. Consequently, AMD’s exposure to intellectual‑property‑protection difficulties has intensified as its global sales base expanded and its reliance on overseas third‑party foundries and assemblers in those high‑risk jurisdictions increased.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All numeric values are accurate: international sales percentages (65% in 2023, 66% in 2024) match ground truth exactly; (2) Correctly identifies the three-year evolution from 2022-2024; (3) Accurately identifies specific geographic regions (China, Malaysia, Taiwan) where third-party manufacturing occurs; (4) Properly synthesizes the connection between expanding international operations, increased reliance on third-party manufacturers, and intensified IP protection risks; (5) Correctly characterizes these regions as 'politically sensitive' with weaker IP enforcement. MINOR WEAKNESSES: (1) The answer does not explicitly mention the 2022 baseline percentage for international sales (ground truth notes it was 'unspecified but lower'), though the LLM correctly implies it was lower than 65%; (2) Does not specifically reference the geopolitical tensions mentioned in ground truth (Ukraine conflict, China-Taiwan tensions, Middle East instability) as explicitly as the original answer, though it does reference 'politically sensitive' regions; (3) The phrase 'nearly all assembly and final testing' is specific but not directly quoted from ground truth, though it accurately reflects the manufacturing concentration; (4) Slightly less emphasis on the 'transforming trend' aspect of how the risk evolved over time, though the answer does convey the intensification. QUANTITATIVE VERIFICATION: The percentages (65% in 2023, 66% in 2024) are precisely correct. The answer correctly avoids stating a specific 2022 percentage, which aligns with ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects: (a) IP protection risk disclosure, (b) international sales growth, (c) geographic concentration of manufacturing, and (d) the resulting intensified exposure. The logical chain is sound and well-articulated. SEMANTIC EQUIVALENCE: The core message matches ground truth—AMD's IP protection risk evolved from a general concern to a more acute, regionally-concentrated risk as international operations and third-party manufacturing in sensitive regions expanded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 600,
        "total_tokens": 2184
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "BK’s 2019 Long‑Term Incentive Plan (LTIP) is repeatedly cited in each of the three recent 10‑K filings, but the specific award documents attached to the plan change over time.  \n\n* In the 2022 filing the plan is listed (exhibit 10.38) together with the original 2019 Performance Share Unit Agreement (exhibit 10.39) and the 2019 Restricted Stock Unit Agreement (exhibit 10.4), showing that the LTIP was being used to grant the first round of equity awards.  \n* The 2023 filing still references the same 2019 LTIP (exhibit 10.14) but now attaches the 2020 Performance Share Unit Agreement (exhibit 10.16) and the 2020 Restricted Stock Unit Agreement (exhibit 10.17), indicating that the company refreshed the award instruments with newer grant years while keeping the same plan framework.  \n* The 2024 filing again points to the 2019 LTIP (exhibit 10.13) and adds a 2022 Performance Share Unit Agreement (exhibit 10.18) together with the 2021 Performance Share Unit (exhibit 10.16) and 2021 Restricted Stock Unit (exhibit 10.17) agreements, demonstrating a continued practice of issuing updated award documents under the same long‑term plan.\n\nThis evolution—from the original 2019 award forms to successive 2020, 2021 and 2022 grant agreements—suggests that BK uses the 2019 LTIP as a durable “umbrella” vehicle, periodically issuing new performance‑share and restricted‑stock agreements to keep executive compensation aligned with current performance targets and retention objectives while preserving a consistent plan structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a detailed and well-structured response that captures the overall evolution of BK's use of the 2019 LTIP from 2022-2024. However, there are significant discrepancies between the LLM answer and the ground truth that affect accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies that the 2019 LTIP serves as the consistent framework across all three years\n- Accurately captures the progression of PSU agreements (2019 → 2020 → 2022)\n- Correctly interprets the strategic pattern as a 'durable umbrella' approach with periodic updates\n- Properly synthesizes the multi-hop information across three years of filings\n- The reasoning about adaptive compensation strategy aligns with ground truth\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE DISCREPANCIES: The LLM introduces specific exhibit numbers (10.38, 10.39, 10.4, 10.14, 10.16, 10.17, 10.13, 10.18) that are NOT present in the ground truth answer. The ground truth makes no mention of exhibit numbers, suggesting these may be fabricated or incorrectly cited.\n\n2. AGREEMENT FORMS MENTIONED: The LLM references RSU (Restricted Stock Unit) agreements in 2022 (exhibit 10.4) and 2023 (exhibit 10.17), and mentions 2021 PSU and RSU agreements in 2024. The ground truth only mentions PSU agreements for 2021 and 2022 forms, not RSU agreements. This represents a factual discrepancy.\n\n3. TIMELINE INCONSISTENCY: The ground truth states the 2020 Form of PSU Agreement was introduced in 2023, which the LLM correctly captures. However, the ground truth mentions a 2022 Form of PSU Agreement in 2024, while the LLM mentions both 2022 AND 2021 PSU/RSU agreements in 2024, which adds information not in the ground truth.\n\n4. MISSING CONTEXT: The ground truth emphasizes 'layered approach' and 'legacy structures' in 2023, which the LLM doesn't explicitly mention, though it's implied.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of evolution. The reasoning is sound and the conclusion about adaptive strategy is appropriate.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the question and provides relevant strategic insights, but the introduction of specific exhibit numbers and RSU agreements not mentioned in the ground truth, combined with the apparent fabrication of exhibit citations, significantly undermines confidence in the factual accuracy. The core narrative is correct, but the supporting details contain errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 665,
        "total_tokens": 2290
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "**Evolution of the leased‑diagnostics‑instrument portfolio**\n\n| Year‑end | Original cost of lease‑related diagnostic instruments | Net book value of those assets |\n|----------|------------------------------------------------------|--------------------------------|\n| 2022 | $3.6 billion | $1.6 billion |\n| 2023 | $3.9 billion | $1.8 billion |\n| 2024 | Not restated in the 2024 filing (the note repeats the same lease description but provides no new cost or book‑value figures). The filing does note that operating‑lease revenue still represents **less than 3 % of total net sales** for 2024, just as it did for 2023 and 2022. |\n\n**What the trend tells us about capital deployment**\n\n- The $0.3 billion rise in original cost (and the $0.2 billion rise in net book value) from 2022 to 2023 shows a modest, incremental addition of diagnostic‑instrument assets that Abbott is leasing out.  \n- The absence of a new cost figure for 2024, together with the continued “< 3 % of net sales” share of lease revenue, suggests that Abbott did not make a material new investment in additional leased instruments in 2024.  \n- Overall, Abbott’s approach is to keep the leased‑instrument portfolio relatively small and stable, using operating leases to generate recurring revenue from consumables (reagents) while avoiding large capital outlays. This reflects a capital‑deployment strategy that favors incremental upgrades and a focus on consumable sales rather than aggressive expansion of owned diagnostic‑instrument assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022: LLM states $3.6B original cost and $1.6B net book value. Ground truth: $3.3B original cost and $1.4B net book value. Both figures are WRONG (off by $0.3B and $0.2B respectively).\n   - 2023: LLM states $3.9B original cost and $1.8B net book value. Ground truth: $3.6B original cost and $1.6B net book value. Both figures are WRONG (off by $0.3B and $0.2B respectively).\n   - 2024: LLM claims \"not restated in the 2024 filing\" with no figures provided. Ground truth clearly states $3.9B original cost and $1.6B net book value for 2024. This is a COMPLETE FAILURE to provide required data.\n\n2. PATTERN OF ERRORS:\n   The LLM appears to have shifted all data forward by one year (2022 data reported as 2023, 2023 data reported as 2024, and 2024 data omitted entirely). This is a systematic indexing error that invalidates the entire quantitative analysis.\n\n3. MULTI-HOP REASONING FAILURE:\n   The LLM's conclusion that \"Abbott did not make a material new investment in additional leased instruments in 2024\" is based on missing data rather than actual filing information. The ground truth shows continued growth to $3.9B in 2024, contradicting this conclusion.\n\n4. INCOMPLETE ANSWER:\n   The LLM failed to provide 2024 figures when they exist in the ground truth, making the answer incomplete for a question specifically asking about evolution \"through 2024.\"\n\n5. CORRECT ELEMENTS:\n   - The general strategic interpretation about using leases to drive consumables sales is conceptually sound\n   - The characterization of operating leases as generating recurring revenue is accurate\n   - The mention of lease revenue being <3% of net sales aligns with ground truth\n\n6. SEMANTIC ISSUES:\n   While the qualitative reasoning about capital deployment strategy is reasonable, it is built on incorrect quantitative foundations, making the overall analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 555,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across all three filing years NVIDIA has consistently listed Lumentum Holdings as a direct competitor in its networking‑interconnect segment. In the FY 2022 10‑K, Lumentum appears in the “suppliers of interconnect, switch and cable solutions” list; in FY 2023 it is named among “networking products consisting of switches, network adapters (including DPUs) and cable solutions (including optical modules)”; and the FY 2024 filing repeats the same wording, again placing Lumentum alongside AMD, Broadcom, Cisco, HPE, Intel and Marvell. While the overall competitive narrative has broadened to stress AI‑driven data‑center networking and high‑performance interconnect technologies (InfiniBand, Ethernet, Fibre Channel), Lumentum’s position has not shifted— it remains a recurring, named rival in the optical‑module and high‑speed interconnect space, reflecting NVIDIA’s view that Lumentum continues to compete directly as NVIDIA expands its AI‑focused networking portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL CONTRADICTION - The LLM answer directly contradicts the ground truth on the core claim. Ground truth states Lumentum was 'repositioned' in FY2023 to a 'more specialized segment' and shows 'rising prominence,' while LLM claims 'Lumentum's position has not shifted' and 'remains a recurring, named rival' with no evolution. This is a fundamental misreading of the multi-hop question about competitive positioning EVOLUTION. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key progression described in ground truth: FY2022 (foundational presence with Juniper/AOI) → FY2023 (repositioned to specialized high-performance interconnect segment aligned with AI focus) → FY2024 (sharpened corporate identity recognition). Instead, LLM presents a static narrative of consistent listing without evolution. (3) MISSING CONTEXTUAL DETAILS - Ground truth emphasizes the ALIGNMENT with NVIDIA's 'growing emphasis on AI and accelerated computing infrastructure' and the 'sharpened recognition of corporate identity,' which the LLM mentions only superficially. (4) ENTITY ACCURACY - The LLM correctly identifies Lumentum Holdings and the three fiscal years, and accurately notes the presence of other competitors (AMD, Broadcom, Cisco, etc.), but misses the nuanced repositioning across years. (5) REASONING FLAW - The LLM's conclusion that 'Lumentum's position has not shifted' directly contradicts the ground truth's assertion of 'rising prominence' and strategic repositioning. This represents a failure in multi-hop reasoning to synthesize the evolution narrative across the three filing years. The answer is partially correct on surface-level facts (Lumentum listed in all three years) but fundamentally wrong on the core question about HOW positioning EVOLVED.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 485,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "Emerson (EMR) listed pipe‑cutters as a **professional‑tool product** in its 2022 filing under the **Tools & Home Products** segment (the “Professional Tools” subsection). In the 2023 and 2024 filings the same product appears in the **Safety & Productivity** segment, which now houses all pipe‑working tools (wrenches, cutters, threading equipment, etc.). The move from a broader consumer‑oriented segment to a dedicated Safety & Productivity segment shows Emerson’s strategy of consolidating its professional‑tool portfolio under a segment that stresses safety, infrastructure support and productivity, emphasizing a clearer focus on the professional plumbing/mechanical market rather than the mixed consumer/home market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core factual shift: pipe cutters moved from Tools & Home Products segment (2022) to Safety & Productivity segment (2023-2024). The entity identification is accurate (Emerson/EMR, correct years, correct segments). The reasoning about strategic repositioning toward professional tools is sound and aligns with the ground truth.\n\nSTRENGTHS: (1) Correctly identifies the segment transition across years; (2) Accurately notes the consolidation of professional tools under Safety & Productivity; (3) Properly characterizes the strategic shift away from consumer-oriented products toward professional/industrial focus; (4) No numerical errors or date inaccuracies; (5) Multi-hop synthesis is logically sound.\n\nWEAKNESSES: (1) The LLM answer omits important context about the InSinkErator divestiture in late 2022, which the ground truth identifies as a key signal of the strategic shift; (2) Missing specific mention of battery hydraulic tools, drain cleaners, and sewer inspection cameras as the new product grouping context in Safety & Productivity; (3) Less explicit about the 'high-value, industrial-use tools' characterization; (4) Doesn't fully capture the breadth of the strategic realignment narrative (infrastructure support is mentioned but less emphasized).\n\nThe answer is fundamentally correct on the main facts and demonstrates proper multi-hop reasoning across the 2022-2024 period. However, it lacks some of the contextual richness and supporting details that make the ground truth answer more comprehensive. The omission of the InSinkErator divestiture is the most significant gap, as it provides important strategic context for understanding why the repositioning occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 471,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 through 2024 Schwab’s interactive‑tool suite for RIAs remained anchored on the Advisor Services website, which continued to give advisors online account opening, money‑movement, transfers, trading, multi‑year archiving of statements, trade confirms and tax reports, and document‑search capabilities.  In each year the company also kept the free **Schwab Advisor Portfolio Connect** tool – a “simplified portfolio‑management solution” that delivers core portfolio‑management functions through an intuitive, modern, no‑download experience – and retained the same breadth of third‑party integrations (CRM, portfolio‑management, order‑management and financial‑planning platforms).  The surrounding advisor‑support ecosystem (interactive tools, educational content, thought‑leadership, annual RIA benchmarking, prospect‑consulting, business‑technology‑operations consulting, and dedicated start‑up/transition engineers and service teams) was described consistently in 2022, 2023 and 2024, indicating that Schwab’s offering evolved by sustaining and refining these capabilities rather than adding new functional modules.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate details about specific tools and features (Advisor Services website, Schwab Advisor Portfolio Connect, third-party integrations, document archiving, etc.) and correctly identifies these as consistent across 2022-2024. However, there are significant issues with the overall narrative and interpretation: (1) The LLM emphasizes that the offering 'evolved by sustaining and refining these capabilities rather than adding new functional modules,' which directly contradicts the ground truth's assertion of clear evolution and progression. The ground truth explicitly states there was 'enhanced functionality, deeper third-party integrations, and expanded advisor support services' with a 'strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly.' (2) The LLM misses or downplays key evolutionary elements mentioned in the ground truth: the expansion of educational and consulting services in 2023, the embedding of tools within a broader ecosystem in 2024, and the shift toward compliance workflow management. (3) The LLM's conclusion that the offering 'evolved by sustaining and refining' rather than adding new modules is a fundamental misinterpretation of the multi-year progression described in the ground truth. (4) While the LLM correctly identifies specific features and tools with accurate descriptions, it fails to synthesize the multi-hop information across years to show the actual evolution trajectory. The answer reads as a static description of consistent offerings rather than a dynamic evolution story. Quantitative accuracy is high (no numerical errors), but qualitative accuracy and the core reasoning about how the tools evolved are significantly weaker than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 480,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % Notes due 2026 in its 2022 Form 10‑K (page 114) as **Exhibit 4.16**, which presented the “Forms of 1.650 % Notes due 2026” together with the Officers’ Certificate dated March 24, 2021.  \n\nIn the subsequent 2023 Form 10‑K (page 111) the same notes are again referenced, this time as **Exhibit 4.14**, but the description and the underlying Officers’ Certificate (March 24, 2021) are identical to the 2022 filing.  \n\nThe 2024 Form 10‑K (page 111) repeats the exact same reference – **Exhibit 4.14** containing the “Forms of 1.650 % Notes due 2026” and the same 2021 Officers’ Certificate.  \n\n**What this shows:** Across three consecutive annual reports Oracle has treated the 1.650 % Notes due 2026 as a static, unchanged component of its capital structure. By continually incorporating the original exhibit by reference rather than amending, retiring, or re‑issuing the notes, Oracle signals a deliberate short‑to‑intermediate‑term debt strategy that favors stable, low‑cost financing and avoids frequent refinancing or restructuring of existing obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across three years of Oracle's 10-K filings. STRENGTHS: (1) All numeric values are correct - the 1.650% interest rate is accurate, the years 2022, 2023, 2024 are correct, and the exhibit numbers are properly identified (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023 and 2024). (2) The multi-hop reasoning is sound - the answer correctly synthesizes information across three separate annual filings to show consistency in treatment. (3) The answer goes beyond the ground truth by providing additional context (page numbers 114 and 111, the Officers' Certificate date of March 24, 2021) which adds credibility and specificity without contradicting the original answer. (4) The strategic interpretation is well-reasoned - the conclusion that Oracle's unchanged treatment signals a 'deliberate short-to-intermediate-term debt strategy' that 'favors stable, low-cost financing' is logically sound and directly addresses the question's request to reveal what the consistency 'reveals about Oracle's short-to-intermediate term debt financing strategy.' MINOR CONSIDERATIONS: (1) The ground truth answer is more concise and direct, while the LLM answer provides more granular detail (page numbers, certificate dates). Both approaches are valid. (2) The LLM answer's interpretation about 'incorporating the original exhibit by reference rather than amending, retiring, or re-issuing' adds analytical depth that aligns with but slightly extends the ground truth's statement about 'unchanged treatment.' This is appropriate elaboration rather than error. (3) All factual claims are verifiable and consistent with typical SEC filing practices. The answer correctly identifies that the same debt instrument appears across three years with consistent exhibit numbering and documentation, which is the core factual requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 513,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "In the 2022 filing, Emerson listed **electrical distribution equipment** as a product of the **Industrial Solutions** business – a portfolio that bundled fluid‑control, pneumatic and joining technologies. By the 2023 and 2024 filings, the same equipment is described as part of the **Discrete Automation** segment, which now groups solenoid and pneumatic valves, linear‑motion, programmable‑control systems **and electrical distribution equipment** together for discrete‑industry customers. This shift moves the product from a general‑solutions umbrella into the automation‑focused segment, signalling Emerson’s intent to treat power‑distribution hardware as a core component of its industrial‑electrification strategy and to sell it alongside automation and control technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Emerson's strategic evolution. STRENGTHS: (1) All factual claims are correct - Electrical Distribution Equipment was indeed in Industrial Solutions in 2022, then moved to Discrete Automation in 2023-2024. (2) The multi-hop synthesis is sound, correctly tracing the product's repositioning across three fiscal years and connecting it to strategic intent. (3) Entity identification is accurate (Emerson/EMR, Discrete Automation segment, Industrial Solutions, solenoid valves, programmable control systems). (4) The answer correctly identifies the strategic shift from 'general-purpose offering' to 'core component of industrial automation infrastructure.' (5) The reasoning about electrification and smart manufacturing alignment is logically sound and matches the ground truth's characterization. (6) The answer adds helpful context by mentioning 'pneumatic and joining technologies' and 'linear-motion' which enriches understanding without contradicting the ground truth. MINOR CONSIDERATIONS: (1) The LLM uses 'pneumatic valves' while ground truth says 'solenoid valves' - however, the LLM also mentions 'solenoid' separately, suggesting these are complementary product categories within the segment rather than an error. (2) The phrasing 'power-distribution hardware' is a reasonable synonym for 'Electrical Distribution Equipment' and demonstrates semantic understanding. (3) The answer is slightly more detailed than the ground truth (mentioning linear-motion, pneumatic technologies) but this adds value without introducing inaccuracy. VERIFICATION: No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is based on correct identification of years (2022, 2023, 2024) and segment names, all of which are correct. The multi-hop reasoning correctly synthesizes information about product positioning evolution across three years and connects it to strategic emphasis on electrification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 546,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "- In the 2022 filing (re‑disclosed in the 2023 10‑K) Abbott reported **$569 million** of unfunded commitments to private‑real‑estate (and other private) funds.  \n- The 2023 10‑K shows those commitments fell to **$555 million** at year‑end 2023, and the 2024 10‑K shows a further decline to **$540 million** at year‑end 2024.  \n\nThe steady drop from $569 M → $555 M → $540 M indicates Abbott is gradually reducing its unfunded exposure to illiquid private‑real‑estate assets, suggesting a pension‑plan strategy that seeks to keep alternative‑asset allocations attractive but limits the size of future cash‑out‑lay obligations and associated liquidity risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY IN KEY NUMBERS: The LLM reports 2022 unfunded commitments as $569 million, but the ground truth states $585 million. This is a $16 million difference (2.7% error) on a foundational data point. The LLM's sequence ($569M → $555M → $540M) differs from the ground truth sequence ($585M → $555M → $540M). The 2023 and 2024 figures are correct ($555M and $540M respectively), but the 2022 baseline is materially wrong. REASONING QUALITY: The LLM correctly identifies the trend as a 'steady drop' and appropriately characterizes it as a de-risking/rebalancing strategy with reduced liquidity risk exposure. The interpretation that Abbott is 'gradually reducing unfunded exposure to illiquid private-real-estate assets' aligns with the ground truth's assessment of 'measured de-risking.' However, the LLM omits important context from the ground truth: (1) the long time horizon for fund liquidation (projected through 2034), which suggests continued belief in long-term value despite reduced exposure, and (2) the deliberate approach to managing liquidity risk and aligning commitments with pension liability profiles. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three years and connects the numerical trend to strategic implications, demonstrating adequate multi-hop reasoning. However, the incorrect 2022 baseline undermines the accuracy of the trend analysis. The characterization of the decline as 'steady' is accurate (differences of $14M and $15M year-over-year), but this should have been calculated from the correct 2022 figure ($585M, yielding a $30M drop to 2023). COMPLETENESS: The LLM addresses the evolution question and provides strategic interpretation, but incompletely addresses the full scope of what the trend suggests about pension fund strategy by omitting the long-term liquidation horizon and the balance between reduced exposure and continued asset value belief.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 521,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Across all three annual reports Oracle repeatedly discloses the same “Forms of 1.650 % Notes due 2026” (the 2026 senior unsecured notes issued under the March 24 2021 Officers’ Certificate). In the 2022 10‑K the note appears as Exhibit 4.16; in the 2023 and 2024 10‑Ks it is listed as Exhibit 4.14, but the filing reference (Form 8‑K 001‑35992) and the underlying certificate remain unchanged. This unchanged, incorporated‑by‑reference treatment shows that Oracle has kept the 2026 notes on its balance sheet year‑after‑year, using the same low‑rate instrument to meet its near‑term financing needs and signalling a stable, “hold‑and‑service” short‑term debt strategy rather than frequent refinancing or restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 1.650% Notes due 2026 are correctly identified; (2) The March 24, 2021 8-K filing reference is accurate; (3) The core insight about consistent treatment across 2022, 2023, and 2024 filings is sound; (4) The characterization of a 'hold-and-service' strategy is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific exhibit numbers (4.16 for 2022, 4.14 for 2023/2024) that are NOT mentioned in the ground truth and cannot be verified as accurate from the provided context. This is a factual claim that goes beyond what the ground truth supports; (2) The reference to 'Officers' Certificate' is not explicitly mentioned in the ground truth, which only references the 8-K filing; (3) The LLM adds detail about 'Form 8-K 001-35992' (the CIK number) which, while potentially accurate, is not in the ground truth and represents added specificity that could be incorrect. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and draws a logical conclusion about debt strategy consistency. However, the addition of unverified exhibit numbers and form details weakens confidence in the answer's accuracy. The ground truth focuses on the consistent referencing of the March 2021 8-K across three filings, while the LLM adds exhibit number changes (4.16 to 4.14) that may or may not be accurate. QUANTITATIVE ACCURACY: The percentage (1.650%) and year (2026) are correct; the date (March 24, 2021) is correct. However, the exhibit numbers cannot be verified and represent potential inaccuracies. OVERALL ASSESSMENT: The answer demonstrates good understanding of the core concept (stable debt strategy with consistent treatment) but introduces specific details (exhibit numbers, Officers' Certificate reference) that go beyond the ground truth and may be incorrect, reducing overall confidence in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 521,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "**Evolution of the 4.30 % Note due 2034**\n\n* **2022 Form 10‑K** – The note first appears in the exhibit table as “Forms of 3.40 % Note due 2024, **4.30 % Note due 2034** and 4.50 % Note due 2044” (Exhibit 4.09, an 8‑K filed 7 Aug 2014). Oracle incorporates that filing by reference, indicating the note had already been issued and its terms were being disclosed for the first time in the 2022 annual report.  \n\n* **2023 Form 10‑K** – The same Exhibit 4.09 is repeated, again “incorporated by reference.” No new filing date or amendment is shown, meaning Oracle is simply restating the existing 2014 documentation for the 4.30 % 2034 note in its 2023 filing.  \n\n* **2024 Form 10‑K** – The exhibit table is unchanged; the 4.30 % 2034 note is still listed under Exhibit 4.09 with the original 2014 8‑K reference. Oracle again relies on the same incorporated document, confirming the note remains outstanding and unchanged.\n\n**What the pattern reveals about Oracle’s long‑term debt strategy**\n\nBy repeatedly referencing the same 2014 8‑K filing across three consecutive annual reports, Oracle shows that the 4.30 % fixed‑rate note is a durable component of its capital structure. The company prefers to lock in long‑dated, low‑coupon debt (maturing in 2034) and keep it on the balance sheet for many years, using annual 10‑K filings merely to reaffirm the existing terms rather than re‑issuing or refinancing. This consistent, multi‑year documentation signals a deliberate long‑term financing strategy that emphasizes stability, predictable interest costs, and minimal turnover of its senior unsecured debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides more detailed and specific information than the ground truth, but introduces a critical factual discrepancy that undermines its credibility. STRENGTHS: (1) The LLM correctly identifies the 4.30% Note due 2034 and its consistent presence across 2022, 2023, and 2024 filings. (2) The numeric values (4.30%, 2034 maturity date, 2014 8-K reference) are accurate. (3) The reasoning about Oracle's long-term debt strategy is sound and well-articulated, explaining the company's preference for stable, fixed-rate debt with minimal refinancing. (4) The multi-hop synthesis across three years is logically coherent. (5) The contextual analysis about capital structure stability is relevant and insightful. CRITICAL WEAKNESS: The ground truth states the note was listed in Exhibit 4.11 in 2022 and Exhibit 4.09 in 2023-2024, suggesting a potential exhibit number change. The LLM claims the note appears in Exhibit 4.09 across all three years (2022, 2023, 2024), citing a 2014 8-K filing. This represents a factual discrepancy with the ground truth regarding exhibit numbering in 2022. The LLM's claim that the note 'first appears' in 2022 is also questionable since the 2014 8-K reference suggests earlier issuance. MINOR ISSUES: (1) The LLM provides more granular detail than the ground truth (specific 8-K date, exhibit numbers), which could be either more accurate or speculative depending on actual filing data. (2) The ground truth mentions 'no structural changes' while the LLM emphasizes the note was 'unchanged,' which are semantically equivalent. OVERALL ASSESSMENT: The answer demonstrates strong analytical reasoning and mostly correct information, but the potential exhibit number discrepancy in 2022 (4.11 vs 4.09) creates uncertainty about factual accuracy. The detailed explanation of Oracle's debt strategy is well-reasoned but cannot fully compensate for the exhibit numbering concern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 518,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "- **2022:** Under the original 2019 IDA agreement Schwab exercised its migration option and moved roughly $10 billion of IDA balances onto its balance sheet (the $10.1 billion moved through 12/31/2021 plus about another $10 billion “subsequent to 12/31/2021,” i.e., in 2022), the full amount allowed each 12‑month period.  \n\n- **2023:** Schwab did **not** migrate any IDA balances.  In May 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that (i) extended the sweep term to July 1 2034, (ii) removed the prior requirement that ≥ 80 % of balances be fixed‑rate, and (iii) imposed new minimum‑/maximum‑balance limits (minimum above unmatured fixed‑rate obligations with a $30 billion ceiling through 9/10/2025, then a $60 billion minimum/$90 billion maximum thereafter) and restricted withdrawals mainly to customer‑initiated pulls.  \n\n- **2024:** Schwab again did not move any IDA balances, and the same 2023‑agreement constraints remained in place, meaning migration continued to be limited by capital capacity and the newly‑set balance‑range caps rather than the earlier $10 billion per‑year option.  \n\nThus, Schwab went from fully using the $10 billion migration allowance in 2022 to abstaining from any migration in 2023 and 2024, while the contractual framework shifted from the 2019 agreement’s relatively simple $10 billion annual option (with a fixed‑rate‑≥ 80 % rule) to the 2023 agreement’s tighter balance‑range limits, removal of the fixed‑rate percentage requirement, and more restrictive withdrawal provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 migration: Correctly identifies the $10.1 billion moved through 12/31/2021 plus approximately $10 billion in 2022, matching the ground truth's description of the $10 billion annual option being fully utilized. (2) 2023 transition: Accurately states the 2019 IDA agreement was replaced by the 2023 IDA agreement in May 2023, correctly identifies the removal of the ≥80% fixed-rate requirement, and accurately describes the new balance-range constraints ($30 billion ceiling through 9/10/2025, then $60 billion minimum/$90 billion maximum). The LLM also correctly notes zero migration in 2023. (3) 2024 continuation: Correctly states no migration occurred and the 2023 agreement constraints remained in place. The multi-hop reasoning is sound: the answer synthesizes information across three years, correctly identifies the shift from active migration (2022) to passive/constrained approach (2023-2024), and accurately characterizes the evolution from a simple $10 billion annual option to more complex balance-range limits. The LLM provides additional helpful detail (e.g., July 1, 2034 sweep term extension, customer-initiated withdrawal restrictions) that enriches understanding without contradicting the ground truth. Minor note: The LLM's phrasing of \"roughly $10 billion\" and \"about another $10 billion\" is appropriately cautious given the $10.1 billion figure, though the ground truth uses slightly different language. The semantic meaning is equivalent and accurate. All dates, percentages, and dollar amounts are correct. The answer directly addresses all aspects of the question regarding utilization evolution and contractual changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 473,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "- **2022 (10‑K)** – Abbott’s filing lists the original **Fifth Supplemental Indenture** (Sept 23 2015) that created the 2.000 % Senior Notes due 2018, and then shows a **new Indenture dated Sept 27 2018** (with Abbott Ireland Financing DAC as issuer and Abbott Labs as guarantor) together with a **First Supplemental Indenture (Sept 27 2018)** and a **Second Supplemental Indenture (Nov 19 2019)**. These later documents reflect the company’s amendment and refinancing of the 2.000 % notes after the original issuance.\n\n- **2023 (10‑K)** – The only new filing related to the 2.000 % notes is an **Officers’ Certificate** (Exhibit 4.7 to the Q1 2017 10‑Q) confirming Abbott’s actions under the existing indenture, and the **Fifth Supplemental Indenture** is still referenced. No additional refinancing documents are listed, indicating the notes were being serviced rather than re‑structured.\n\n- **2024 (10‑K)** – The same pattern repeats: an **Officers’ Certificate** (again referencing the 2.000 % notes due 2018) and the **Fifth Supplemental Indenture** appear, with no new amendment or refinancing filings. Thus, after the 2018‑2019 amendments, Abbott’s engagement in 2023‑2024 is limited to compliance documentation rather than further refinancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR - The LLM claims the 2.000% Senior Notes due 2018 were created by the Fifth Supplemental Indenture dated September 23, 2015, and then references a 'new Indenture dated Sept 27 2018' with Abbott Ireland Financing DAC as issuer. This is fundamentally incorrect. The ground truth indicates these were legacy St. Jude Medical debt notes, and the consistent documentation across 2022-2024 shows no new issuances or amendments - merely continued disclosure of the same notes. (2) INCORRECT REFINANCING NARRATIVE - The LLM fabricates a refinancing story involving a September 27, 2018 indenture and subsequent supplemental indentures (First Supplemental Sept 27 2018, Second Supplemental Nov 19 2019). The ground truth explicitly states 'no new issuances or amendments noted' and that the notes were 'likely nearing maturity without further refinancing actions taken.' (3) MISIDENTIFICATION OF DOCUMENTS - The LLM references specific exhibit numbers and document dates (Officers' Certificate from Q1 2017 10-Q, Exhibit 4.7) that appear to be either fabricated or misattributed. The ground truth mentions Exhibit 4.21 consistently across years, not the documents cited by the LLM. (4) CONTRADICTORY CONCLUSIONS - While the LLM's final conclusion about 2023-2024 being 'limited to compliance documentation rather than further refinancing' aligns with ground truth, the entire narrative leading to this conclusion is built on false premises about 2018-2019 refinancing activities that never occurred. (5) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the multi-year evolution, instead inventing a refinancing narrative that contradicts the actual stable, gradually maturing component described in the ground truth. The answer demonstrates hallucination of specific dates, indenture types, and refinancing activities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 532,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed its 3.650 % senior notes due 2041 in the 2022 Form 10‑K (exhibit 4.16), which listed the notes together with other series and referenced the officers’ certificate dated March 24, 2021. The same series re‑appears in the 2023 Form 10‑K (exhibit 4.14) and again in the 2024 Form 10‑K (exhibit 4.14), showing that the 3.650 % 2041 notes have remained outstanding and are repeatedly incorporated by reference each year. This three‑year continuity indicates that Oracle is deliberately maintaining a long‑dated, low‑coupon tranche of debt, using multi‑decade notes to lock in inexpensive financing and to smooth its maturity profile as part of a long‑term debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All numeric values are correct - the 3.650% coupon rate and 2041 maturity date are accurately stated; (2) Exhibit references (4.16 for 2022, 4.14 for 2023 and 2024) are specific and verifiable details that enhance credibility; (3) The officers' certificate date of March 24, 2021 is a precise historical detail correctly cited; (4) Multi-hop reasoning is sound - the answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) showing continuity of the same debt instrument; (5) The strategic interpretation is well-reasoned: the answer explains that Oracle is 'deliberately maintaining a long-dated, low-coupon tranche of debt' and using it to 'lock in inexpensive financing and smooth its maturity profile,' which aligns with and expands upon the ground truth's conclusion about 'stable long-term financing approach'; (6) The phrase 'incorporated by reference each year' demonstrates understanding of SEC filing mechanics. MINOR CONSIDERATIONS: The LLM answer provides more specific documentary evidence (exhibit numbers, certificate dates) than the ground truth, which could be viewed as either enhanced detail or potential over-specification, but this actually strengthens the answer by providing verifiable support. The characterization of the notes as 'low-coupon' is reasonable given the 3.650% rate in the context of long-term debt instruments. The answer fully addresses the question's request to explain the evolution from 2022-2024 and what the pattern suggests about Oracle's debt strategy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 458,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 in its 2022 Form 10‑K (listed as Exhibit 4.16) and tied them to the officers’ certificate filed on 24 Mar 2021 (Form 8‑K, file 001‑35992). In the 2023 and 2024 Form 10‑Ks the same tranche re‑appears under Exhibit 4.14—still incorporated by reference to the same 8‑K filing—showing that the coupon (2.300 %) and maturity (2028) were left unchanged. This repeated, cross‑year inclusion signals that Oracle is using a stable, low‑cost, fixed‑rate medium‑term issuance program, repeatedly tapping the same series to diversify its debt base and lock in inexpensive financing over several fiscal periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY - EXHIBIT REFERENCE MISMATCH: The LLM answer states the 2.300% Notes due 2028 appear under 'Exhibit 4.14' in 2023 and 2024, but the ground truth explicitly references 'Exhibit 4.16' for these notes across all three years (2022, 2023, 2024). This is a significant factual error in entity identification that undermines the answer's reliability. CORRECT ELEMENTS: (1) The coupon rate (2.300%) is correct, (2) The maturity year (2028) is correct, (3) The March 24, 2021 officers' certificate date is correct, (4) The file number (001-35992) is correct, (5) The general interpretation that this represents a stable debt financing strategy is semantically aligned with the ground truth. INCOMPLETE SYNTHESIS: The LLM answer fails to mention the 4.500% Notes due 2028 that were issued in 2023 (per Exhibit 4.16), which is a key element of the ground truth's explanation of Oracle's diversification strategy. The ground truth explicitly notes that 2023 saw 'expansion' through additional structured notes with different interest rate profiles, demonstrating portfolio diversification. The LLM answer only discusses the 2.300% Notes and misses this important multi-hop connection showing how Oracle diversified its debt portfolio. REASONING QUALITY: While the LLM correctly identifies the pattern as 'stable' and 'low-cost,' it doesn't fully capture the diversification aspect that the ground truth emphasizes—that Oracle was simultaneously maintaining existing instruments while adding new ones with different coupons. The conclusion about 'repeatedly tapping the same series' is somewhat misleading since the ground truth indicates new series were also introduced. QUANTITATIVE ACCURACY: All specific numbers (2.300%, 2028, March 24, 2021) are correct, but the exhibit reference error (4.14 vs 4.16) is a material factual mistake that affects the answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 509,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "Visa first launched virtual‑account functionality as a core element of its **digitally‑native Currencycloud platform in fiscal 2022**, offering real‑time FX rates, liquidity and settlement tools for both domestic and cross‑border flows. In fiscal 2023 the company **integrated those Currencycloud virtual accounts into the Visa Direct Platform**, bundling them with Visa Cross‑Border Solutions so that clients could create, hold and move funds across the network’s 195‑plus countries and more than 11 billion endpoints. By fiscal 2024 the **integration remained in place and was further emphasized**, with the Visa Direct Platform continuing to deliver virtual‑account capabilities alongside expanded cross‑border coverage, real‑time FX and enhanced liquidity, cementing virtual accounts as a key cross‑border component of Visa’s end‑to‑end payment ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric references are correct - the answer accurately cites 195+ countries and 11 billion endpoints, matching the ground truth. The fiscal year references (2022, 2023, 2024) are correctly identified and sequenced. ENTITY ACCURACY: All entities are correctly identified - Visa, Currencycloud platform, Visa Direct Platform, and Visa Cross-Border Solutions are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly tracing the evolution: (1) 2022 introduction of virtual accounts on Currencycloud with Treasury as a Service context, (2) 2023 integration into Visa Direct Platform with cross-border capabilities, (3) 2024 continued emphasis and expansion. The logical progression is sound and matches the ground truth narrative. COMPLETENESS: The answer addresses all aspects of the question - the evolution timeline, integration into Visa Direct Platform, and expansion of cross-border capabilities are all covered. SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing (e.g., 'digitally-native Currencycloud platform' vs. 'Treasury as a Service initiative') but conveys equivalent meaning. The emphasis on real-time FX rates, liquidity, and settlement capabilities is present in both versions. MINOR OBSERVATIONS: The LLM answer provides slightly more operational detail (e.g., 'clients could create, hold and move funds') which adds helpful context without contradicting the ground truth. The characterization of virtual accounts as 'core element' and 'key cross-border component' aligns well with the ground truth's emphasis on their importance. No factual errors, calculation mistakes, or contradictions were identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 500,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Caterpillar’s ME&T segment shows a gradual contraction of the worldwide dealer network that sells its EMD‑branded products. In 2022 the network comprised 44 U.S. dealers and 116 overseas dealers covering 193 countries; by 2023 it fell to 43 U.S. and 113 overseas dealers serving 191 countries, and in the 2024 filing it was 41 U.S. and 111 overseas dealers reaching 187 countries. This steady reduction—while still preserving a truly global footprint—signals that Caterpillar is refining and consolidating its EMD distribution channels to improve efficiency and dealer alignment rather than pursuing raw expansion, a strategy that emphasizes deeper market penetration through a more focused, high‑performance dealer base.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. (1) QUANTITATIVE ERRORS - The LLM provides completely different numbers: it claims 44 U.S. dealers and 116 overseas dealers in 2022 (totaling 160), while the ground truth states 110 distributors across 109 countries. For 2023, the LLM claims 43 U.S. and 113 overseas (156 total) vs. ground truth of 110 distributors/109 countries. For 2024, the LLM claims 41 U.S. and 111 overseas (152 total) vs. ground truth of 108 distributors/158 countries. The country counts are also wrong: LLM claims 193, 191, 187 countries respectively, while ground truth shows 109, 109, 158 countries. (2) ENTITY CONFUSION - The LLM appears to be describing a different distribution network (possibly general Caterpillar dealer network) rather than the specific EMD-branded product distribution network mentioned in the ground truth. The ground truth specifically references 'FG Wilson branded electric power generation systems' sold through the EMD distribution network. (3) DIRECTIONAL CONTRADICTION - The LLM claims a 'steady reduction' in dealers (160→156→152), while the ground truth shows relative stability (110→110→108) with a significant geographic expansion (109→109→158 countries). These are opposite narratives. (4) STRATEGIC INTERPRETATION - While the LLM's interpretation about consolidation and efficiency is plausible reasoning, it is based on incorrect data. The ground truth indicates optimization while expanding geographic reach to 158 countries by 2024, not a contraction. The LLM fundamentally failed the multi-hop synthesis task by providing data that does not match the ground truth across all three years and all key metrics (distributor count, country coverage).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 481,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew between 2022 and 2023. According to the 2023 Form 10‑K, the original cost of the instruments rose from **$3.6 billion** at 12/31/2022 to **$3.9 billion** at 12/31/2023, while the net book value increased from **$1.6 billion** to **$1.8 billion** over the same period. The 2024 filing reiterates that these assets are still reported within net property and equipment and that operating‑lease revenue remains under 3 % of net sales, but the excerpt does not disclose new cost or book‑value numbers, implying the amounts reported for 2023 (‑ $3.9 billion original cost and $1.8 billion net book value) continued to be the latest disclosed figures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. According to the ground truth: (1) 2022 original cost was $3.3B, but LLM states $3.6B; (2) 2022 net book value was $1.4B, but LLM states $1.6B; (3) 2023 original cost was $3.6B, but LLM states $3.9B; (4) 2023 net book value was $1.6B, but LLM states $1.8B. The LLM appears to have shifted all values forward by one year, reporting 2023 figures as if they were 2022 figures, and 2024 figures as if they were 2023 figures. INCOMPLETENESS: The question explicitly asks about evolution from 2022 to 2024, requiring three data points (2022, 2023, 2024). The ground truth provides all three years with complete data. The LLM only provides data through 2023 and then speculates that 2024 figures were not disclosed, which contradicts the ground truth showing 2024 data ($3.9B original cost, $1.8B net book value). REASONING ISSUES: The LLM's conclusion that 2024 figures 'continued to be the latest disclosed figures' is incorrect—the ground truth explicitly shows 2024 data was disclosed. The multi-hop synthesis failed because the LLM did not properly extract and organize the three-year trend. POSITIVE ASPECTS: The LLM correctly identified the general trend of growth in the leased diagnostics instruments portfolio and appropriately noted the context about operating-lease revenue. However, these qualitative observations cannot compensate for the fundamental numerical errors that are the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 419,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450 % Senior Note due 2046 appears in the “Form of … Senior Note” tables of PepsiCo’s 2022 (Chunk 1, line 4.17), 2023 (Chunk 2, line 4.16) and 2024 (Chunk 3, line 4.15) 10‑K filings, each time referenced to the same Exhibit 4.6 filing from the 2016 8‑K. Because the note is disclosed every year, PepsiCo is signalling that this fixed‑rate, long‑dated senior unsecured debt remains an active component of its financing mix. Its repeated inclusion demonstrates that the 3.450 % Senior Note due 2046 is a cornerstone of the company’s long‑term capital‑structure strategy, providing stable, low‑cost funding that the firm intends to keep on its balance sheet for decades.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) All numeric values are correct: 3.450% rate, 2046 maturity date, and the three fiscal years (2022, 2023, 2024) are accurately cited. (2) Exhibit references are correct: Exhibit 4.17 (2022), 4.16 (2023), 4.15 (2024) match the ground truth. (3) The multi-hop synthesis is sound—the answer correctly identifies the consistent disclosure pattern across three years and draws appropriate conclusions about strategic intent. (4) The characterization of the note as 'fixed-rate, long-dated senior unsecured debt' and 'stable, low-cost funding' aligns with the ground truth's description of 'long-dated, fixed-rate funding' with 'favorable terms.' (5) The reasoning that repeated inclusion signals strategic maintenance is logically sound and matches the ground truth's implication. MINOR DIFFERENCES: (1) The LLM adds detail about the note being 'referenced to the same Exhibit 4.6 filing from the 2016 8-K,' which is not mentioned in the ground truth but appears to be accurate supplementary information. (2) The LLM uses slightly different phrasing ('cornerstone,' 'signalling,' 'active component') compared to ground truth ('stable and integral component'), but these are semantically equivalent and convey the same meaning. (3) The LLM's characterization of the note as 'low-cost' is a reasonable inference from the 3.450% rate in the context of long-term debt, though the ground truth doesn't explicitly state this. Overall, the answer correctly synthesizes information across three years of filings and reaches appropriate conclusions about PepsiCo's capital structure strategy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 471,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "- **FY 2022 (10‑K page 114)** – Oracle’s Exhibit 4.16 lists the “2.300 % Notes due 2028” together with other series (1.650 % 2026, 2.875 % 2031, etc.) and points to the officers’ certificate dated March 24 2021 that sets the terms of those notes.  \n\n- **FY 2023 (10‑K page 111)** – The same 2.300 % 2028 tranche re‑appears in Exhibit 4.14, again grouped with the same companion series and still referencing the March 24 2021 certificate.  \n\n- **FY 2024 (10‑K page 111)** – Oracle again includes the 2.300 % 2028 notes in Exhibit 4.14, with identical wording and the same certificate reference.  \n\n**What the pattern implies:** By repeatedly featuring the 2.300 % Notes due 2028 in three consecutive annual reports, Oracle signals that this low‑coupon, long‑dated issuance is a core component of a laddered debt program. The consistent structuring—pairing the 2028 notes with other maturities and coupons—shows a deliberate strategy to diversify its maturity profile, lock in relatively inexpensive long‑term financing, and maintain a stable funding base that can be used for refinancing or future investments across the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Oracle's debt financing pattern across FY 2022-2024. STRENGTHS: (1) All numeric values are correct - the 2.300% coupon rate, 2028 maturity date, and companion notes (1.650% 2026, 2.875% 2031, 4.500% 2028) are accurately cited. (2) Exhibit references are correct (Exhibit 4.16 for 2022, Exhibit 4.14 for 2023-2024). (3) The March 24, 2021 certificate date is correctly identified. (4) Multi-hop synthesis is sound - the answer correctly traces the same instrument across three fiscal years and identifies the pattern of consistent referencing with new issuances layered in. (5) The reasoning about Oracle's debt strategy is well-articulated: the answer explains the laddered maturity profile, low-coupon lock-in strategy, and diversification approach. (6) The answer goes slightly beyond the ground truth by providing more specific strategic interpretation (e.g., 'lock in relatively inexpensive long-term financing,' 'maintain a stable funding base'). MINOR CONSIDERATIONS: The ground truth mentions that 2023 and 2024 included 'newer issuances such as the 4.500% Notes due 2028,' which the LLM answer doesn't explicitly highlight as a new addition in those years, though it does reference these companion series. The LLM's interpretation of the pattern as reflecting 'changing market conditions or strategic financing needs' (from ground truth) is captured implicitly in the LLM's discussion of 'diversify its maturity profile' and 'maintain a stable funding base.' Overall, the LLM answer is factually accurate, well-structured, and provides sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 458,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "In each of Visa’s three most recent Form 10‑K filings (2022, 2023 and 2024) the company again incorporates **by reference** the same “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” – listed as Exhibit 4.5 in the 2022 filing and as Exhibit 4.4 in both the 2023 and 2024 filings, all filed as an 8‑K (file # 001‑33977) and dated June 21 2016. No amendment, re‑issuance or new filing for this series appears in any of the three years, showing that Visa has kept the Series B preferred‑stock terms unchanged. This uninterrupted treatment signals that Visa’s long‑term capital‑structure strategy is to preserve the existing preferred‑stock framework rather than restructure or replace it, underscoring a priority for stability and consistency in its equity financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All dates are correct - June 21, 2016 Certificate of Designations is accurately cited across all three years; (2) Exhibit numbers are precisely identified (4.5 in 2022, 4.4 in 2023 and 2024), showing attention to detail; (3) File number 001-33977 is correctly referenced; (4) The core factual claim that no amendments or re-issuances occurred is accurate; (5) The multi-hop synthesis correctly identifies the consistency across 2022-2024 filings and draws appropriate conclusions about capital structure stability. (6) The reasoning about preservation of shareholder rights and financing flexibility is sound and well-articulated. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific detail about exhibit numbering and filing mechanics than the ground truth, but this additional specificity is accurate and enhances rather than detracts from the answer. The semantic meaning is fully aligned with the ground truth - both conclude that Visa maintained unchanged Series B preferred stock terms, signaling a stable capital structure strategy. The LLM answer's emphasis on 'by reference' incorporation and the specific exhibit tracking demonstrates thorough document analysis. No factual errors, calculation errors, or entity misidentifications are present. The answer directly addresses both parts of the question: (1) how treatment evolved (it didn't - remained unchanged), and (2) what this suggests about long-term priorities (stability and preservation of existing framework).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 429,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "Caterpillar’s 2022 filing shows that its currency‑hedging program was still tied to a large pool of LIBOR‑linked loans and derivatives.  The company warned that the impending LIBOR‑to‑SOFR transition created “unpredictable” valuation and cash‑flow risk for those instruments and that a newly created cross‑functional team would assess the LIBOR exposure; it also noted that any hedge that proved ineffective could hurt earnings.\n\nBy the 2023 filing the focus had shifted to SOFR, which now serves as the floating‑rate benchmark for Cat Financial’s variable‑rate financing.  The same cross‑functional team was described as evaluating risk across securities, loans and derivatives that use SOFR, and Caterpillar continued to rely on a match‑funding strategy and selective use of currency‑hedging instruments while stressing that hedges can forego favorable currency moves and may be ineffective.\n\nThe 2024 disclosure repeats the SOFR‑based approach and the reliance on currency‑hedging instruments, emphasizing that the firm still manages foreign‑exchange risk through derivatives and diversified funding, and again cautions that ineffective hedges could adversely affect earnings.  In sum, Caterpillar moved from managing LIBOR‑related currency‑hedge exposure in 2022 to a SOFR‑based framework in 2023‑2024, maintaining the same hedging tools but continuously flagging the same effectiveness‑risk concerns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year timeline (2022-2024) and accurately characterizes the LIBOR-to-SOFR transition as the central narrative arc. (2) Accurately captures the 2022 status: LIBOR-linked instruments, cross-functional team formation, and warnings about unpredictable valuation/cash-flow risks. (3) Correctly describes the 2023 pivot to SOFR as the new floating-rate benchmark for Cat Financial. (4) Properly synthesizes the multi-hop information showing continuity of hedging instruments across all three years while the underlying benchmark shifted. (5) Accurately notes the consistent risk warnings about hedge ineffectiveness and earnings impact across all periods. (6) Correctly identifies match-funding strategy and selective derivatives use as persistent elements. (7) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about specific risks (e.g., 'unpredictable' valuation, hedges foregoing favorable moves) compared to the ground truth, which is appropriate elaboration rather than error. (2) The ground truth mentions 'diversified funding' in 2024, which the LLM answer also captures. (3) The LLM answer's characterization of the evolution is semantically equivalent to the ground truth's description of 'consistent reliance' adapting to the transition. The answer successfully demonstrates multi-hop reasoning by synthesizing information across three separate years' disclosures and showing how the company's approach evolved while maintaining core strategies. The narrative flow and logical progression are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1661,
        "completion_tokens": 469,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "From the 2022 filing, Johnson & Johnson reshaped its old consumer‑products subsidiary by spinning out LTL Management LLC, which assumed all talc‑related liabilities and immediately filed a Chapter 11 petition; the bankruptcy court imposed a stay on every claim against LTL, Old JJCI, New JJCI, J&J and its affiliates, and J&J pledged roughly a $2 billion reserve to fund a trust that would pay any amounts the court later ordered. In 2023 the strategy shifted to using the bankruptcy process as a litigation‑management tool: after the New Jersey court dismissed the original LTL case in April, LTL re‑filed a second Chapter 11 case (the “LTL 2” case) that reinstated an automatic stay and a preliminary injunction, which was later dismissed in July 2023, prompting both J&J and LTL to pursue appeals while the $2 billion trust remained in place. By the 2024 filing J&J continued to rely on that trust and the bankruptcy framework, stating that, despite ongoing state settlements and numerous personal‑injury claims, the accrued $2 billion reserve and the restructuring of liabilities into LTL Management LLC are expected to prevent any material adverse impact on its financial position.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question about J&J's talc liability strategy from 2022-2024. STRENGTHS: (1) All key numeric values are correct: $2 billion trust/reserve is accurately cited throughout; (2) Timeline is accurate: 2022 establishment of LTL and trust, 2023 dismissals and refiling (LTL 2), 2024 continued reliance on structure; (3) Multi-hop synthesis is sound: correctly connects the creation of LTL Management LLC, the $2 billion trust funding, the Chapter 11 filings, the Third Circuit reversal (implied by 'New Jersey court dismissed'), and the subsequent LTL 2 filing; (4) Entity identification is correct: properly names LTL Management LLC, LTL 2, J&J, and related entities; (5) Strategic evolution is well-captured: shows shift from initial liability segregation to using bankruptcy as litigation-management tool to continued reliance on the structure. MINOR WEAKNESSES: (1) The answer references 'New Jersey court' dismissing the original LTL case in April 2023, while the ground truth specifies 'Third Circuit reversed the bankruptcy court's decision' - this is a slight imprecision in identifying the specific court, though the outcome (dismissal) is correct; (2) The answer could have been slightly more explicit about the appellate efforts mentioned in the ground truth ('both J&J and LTL to pursue appeals' is mentioned but could emphasize this as part of the continued strategy); (3) Minor semantic difference: ground truth emphasizes 'appellate efforts to uphold bankruptcy protection' while LLM focuses more on the trust remaining in place, though both convey the same strategic intent. QUANTITATIVE VERIFICATION: $2 billion figure appears consistently and correctly throughout; dates (2022, 2023, April, July, 2024) are accurate; no calculation errors. MULTI-HOP REASONING: Successfully synthesizes information across three years, multiple bankruptcy filings, court decisions, and financial instruments. The answer correctly shows how the strategy evolved rather than remaining static.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 558,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "- **2022:** Adobe introduced the Photography Plan as one of several “targeted packages and suites” inside Creative Cloud, offering photographers a bundled, flexible way to access point‑product apps (e.g., Photoshop, Lightroom) alongside the broader portfolio of over‑twenty Creative Cloud apps. The plan was presented as a way to convert free‑app users and trial users into paid subscribers and to grow a recurring revenue stream. (Chunk 1)\n\n- **2023:** The plan remained a core “targeted suite” but was now tied to Adobe’s product‑led growth and pricing strategy that pushes users toward higher‑value offerings. Adobe added generative‑AI value – generative‑credits from Firefly and AI‑infused features across its apps – to make the Photography Plan more attractive and to expand its appeal beyond traditional photo‑editors to a broader creative audience. (Chunk 2)\n\n- **2024:** Adobe repositioned the Photography Plan as a distinct, “more limited cloud‑based offering than Creative Cloud” that is explicitly aimed at photographers and photo‑enthusiasts, bundling Photoshop, Lightroom and Lightroom Classic while highlighting AI‑driven tools (Generative Fill, Denoise, People Masking, etc.) and the allocation of generative‑credits. This refinement makes the plan a specialized, affordable entry point within the Creative Cloud ecosystem, leveraging the AI capabilities introduced in the prior year to deepen its appeal to both professional and hobbyist photographers. (Chunk 3)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate positioning at each stage; (2) Accurately captures the 2022 positioning as a targeted package for photographers with Photoshop, Lightroom, and Lightroom Classic; (3) Correctly identifies the 2023 shift toward product-led growth strategy with generative AI integration and Firefly credits; (4) Accurately describes 2024 refinements with specific AI features (Generative Fill, Denoise, People Masking) and positioning as a 'more limited' offering than full Creative Cloud; (5) Properly synthesizes the multi-hop reasoning showing strategic evolution from basic bundling → AI integration → specialized AI-powered offering; (6) Uses appropriate terminology ('product-led growth,' 'generative credits,' 'entry point') consistent with ground truth. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more operational context (e.g., 'convert free-app users and trial users into paid subscribers') than the ground truth, but this is supplementary and not contradictory; (2) The answer is well-structured with clear year-by-year breakdown that enhances clarity; (3) All entity references (Adobe, Photography Plan, Creative Cloud, Photoshop, Lightroom, Firefly) are accurate. NO QUANTITATIVE ERRORS: There are no numbers, dates, or calculations to verify, and all temporal references (2022, 2023, 2024) are correct. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and multiple product/strategy dimensions, showing how the Photography Plan evolved within the broader Creative Cloud ecosystem and Adobe's strategic priorities. The reasoning chain is logical and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 485,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K exhibits for 2022, 2023 and 2024 all contain the same entry for its class C common‑stock certificate:\n\n* **2022 filing (Chunk 1)** – Exhibit 4.3 is titled “Form of specimen certificate for class C common stock of Visa Inc.” and is filed on **Form 8‑A** with SEC file number **000‑53572** (original filing date 1/28/2009).  \n* **2023 filing (Chunk 2)** – Exhibit 4.2 carries the identical description, the same **Form 8‑A**, the same file number **000‑53572**, and the same original filing date.  \n* **2024 filing (Chunk 3)** – Exhibit 4.2 again repeats the same title, **Form 8‑A**, file number **000‑53572**, and filing date 1/28/2009.\n\nBecause Visa repeatedly “introduces” the same regulatory‑required stock‑certificate form in each year’s filing, the documentation for its class C shares has remained unchanged for at least three consecutive annual reports. This stability suggests that Visa’s board and governance team rely on a well‑established, consistent disclosure framework, reinforcing transparent investor communications and a disciplined corporate‑governance posture even as broader regulatory and market conditions evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY - EXHIBIT NUMBER MISMATCH: The LLM answer contains a significant factual error regarding exhibit numbering. The LLM states that the 2022 filing references 'Exhibit 4.3' while the 2023 and 2024 filings reference 'Exhibit 4.2'. However, the ground truth clearly states that all three years (2022, 2023, and 2024) consistently cite 'Exhibit 4.2' filed on January 28, 2009. This is a material error in quantitative accuracy that undermines the core claim of consistency. The LLM appears to have confused or misread the exhibit numbering for the 2022 filing. CORRECT ELEMENTS: The LLM correctly identifies: (1) the Form 8-A designation, (2) the SEC file number 000-53572, (3) the original filing date of January 28, 2009, (4) the title of the document ('Form of specimen certificate for class C common stock'), (5) the three-year period (2022, 2023, 2024), and (6) the overall interpretation that this consistency suggests stable governance practices. The qualitative reasoning about what this stability implies for investor relations and corporate governance is sound and aligns with the ground truth's interpretation. SYNTHESIS QUALITY: The multi-hop reasoning is generally sound - the LLM correctly synthesizes information across three years of filings and draws appropriate conclusions about governance stability. However, the exhibit number error is a factual mistake that a strict evaluator would penalize, as it contradicts the ground truth documentation. The LLM's interpretation that this represents 'unchanged documentation for at least three consecutive annual reports' is correct in spirit but technically inaccurate given the exhibit numbering discrepancy. MISSING CONTEXT: The LLM does not mention the contrast with other governance documents (Certificate of Incorporation revised in 2024) that the ground truth highlights, which would have strengthened the answer's completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> REGULATORY_REQUIREMENT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 516,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "**Evolution of the liability**\n\n- **2022 10‑K (covering 2021‑2022)** – RTX disclosed that the liability for performance‑ and operating‑cost guarantees is “based upon future product performance and durability, and are largely estimated based upon historical experience. Adjustments are made to accruals as claims data and historical experience warrant.” No dollar change was shown, but the note makes clear that the amount is re‑estimated each year.\n\n- **2023 10‑K (covering 2022‑2023)** – The same description appears verbatim. The filing again says the liability is accrued when a probable liability can be reasonably estimated and is adjusted as new claim data become available. Because the language and the “changes in the carrying amount … were as follows” table are presented without a new figure, the implication is that the liability remained essentially unchanged from the prior year, aside from routine adjustments.\n\n- **2024 10‑K (covering 2023‑2024)** – The 2024 filing repeats the identical policy language and again references a table of “changes in the carrying amount …” but provides no new amount. The repetition signals that the liability continues to be tracked and adjusted each year in the same manner.\n\n**What the progression indicates**\n\nAcross the three years RTX has kept a **steady, year‑over‑year approach** to estimating and adjusting its performance‑ and operating‑cost guarantee liability. The consistency of the disclosure—same accounting policy, same accrual methodology, and no disclosed material swing in the balance‑sheet amount—suggests that the company’s exposure to these guarantees is **stable and under active control**. By basing the accrual on historical claim experience and revising it as new data arrive, RTX demonstrates disciplined risk‑management for its commercial‑aircraft engine contracts, limiting surprise spikes in liability while still recognizing the underlying exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FAILURES: (1) QUANTITATIVE ACCURACY - The LLM answer completely fails to provide the specific dollar amounts that are the core of the question. The ground truth clearly states: 2022: $140M, 2023: $135M, 2024: $131M. The LLM instead claims 'No dollar change was shown' and 'no new figure' and 'no disclosed material swing' - this is factually incorrect. The ground truth explicitly documents a clear progression of declining amounts ($140M → $135M → $131M), representing a $9M reduction over three years. The LLM's assertion that amounts were 'essentially unchanged' directly contradicts the ground truth data. (2) MULTI-HOP SYNTHESIS - The question requires synthesizing specific liability figures across three fiscal years. The LLM failed to extract or reference these critical numbers from the filings, instead providing vague generalizations about 'steady approach' and 'stable exposure.' (3) ENTITY/METRIC ACCURACY - While the LLM correctly identifies RTX and the performance/operating cost guarantees liability, it fails to quantify the actual exposure evolution. The ground truth specifically references 'collaboration partners' share of financing guarantees' with precise amounts; the LLM provides no such specificity. (4) REASONING QUALITY - The LLM's reasoning about 'no material swing' and 'essentially unchanged' is logically sound IF the numbers were actually unavailable, but this reasoning is built on a false premise. The numbers ARE available in the filings and show a clear declining trend. The LLM appears to have either failed to locate the specific liability table or misinterpreted the disclosure structure. (5) ANSWER COMPLETENESS - The ground truth provides a complete narrative: specific amounts for each year, the direction and magnitude of change, and what this indicates about risk management. The LLM provides only generic policy language and vague conclusions without the quantitative foundation. This is a fundamental failure to answer a quantitatively-specific question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1686,
        "completion_tokens": 541,
        "total_tokens": 2228
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s policy for leases that contain free‑rent periods did not change between FY 2022 and FY 2024.  \n\n* **FY 2022 (Chunk 1)** – The 10‑K states that free‑rent and step‑rent amounts are spread on a straight‑line basis over the *original lease term plus any extension options that the Company is “reasonably certain” to exercise*. The lease term is defined as the non‑cancelable period plus those certain extensions, and the right‑of‑use (ROU) asset and lease liability are initially measured using the present value of the minimum lease payments (discounted at the company’s incremental borrowing rate).  \n\n* **FY 2023 (Chunk 2)** – The same language is repeated: free‑rent periods are recognized on a straight‑line basis over the original term and any extensions that are reasonably certain to be exercised, and the lease term definition and ROU‑asset measurement remain identical to the 2022 description.  \n\n* **FY 2024 (Chunk 3)** – The disclosure is again unchanged, reiterating that free‑rent periods are straight‑lined over the original term and any reasonably certain extension options, with the lease term defined in the same way and ROU assets recorded based on the discounted minimum lease payments.  \n\n**Thus, from 2022 through 2024 Costco consistently applied the same accounting treatment:** free‑rent periods are amortized evenly over the lease term (including extensions that are reasonably certain), and that term is used to calculate the present‑value of lease payments, which determines the ROU‑asset valuation. No amendment to the lease‑term assumptions or to the impact on ROU‑asset measurement is disclosed across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core accounting treatment (straight-line basis for free-rent periods, use of incremental borrowing rate, lease term including reasonably certain extensions) and accurately states that this core policy remained consistent across 2022-2024. The numeric/date references are accurate, and the basic facts about the accounting method are correct. However, the answer significantly misses critical evolution details that the ground truth emphasizes: (1) The LLM states the disclosure was 'unchanged' and 'identical' across all three years, but the ground truth explicitly notes that 'the disclosure expanded' in 2023 to clarify treatment of variable lease payments tied to price indices or sales volume. (2) The LLM completely omits the 2024 evolution regarding 'heightened focus on lease-related asset valuations in the context of facility relocations or closures' and the 'greater emphasis on impairment evaluation of long-lived assets.' (3) The ground truth characterizes the evolution as 'the context in which it was presented evolved to reflect growing operational complexity in lease management,' which the LLM entirely misses. The LLM's conclusion that 'no amendment...is disclosed across the three years' is technically accurate for the core policy but misleading because it ignores the meaningful disclosure expansions and contextual shifts that occurred. The answer demonstrates partial understanding but fails to capture the nuanced evolution in disclosure emphasis and operational context that the question specifically asks about. The LLM conflates 'no change in core accounting policy' with 'no evolution in disclosure or context,' which are different concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Includes]- ORG",
      "token_usage": {
        "prompt_tokens": 1681,
        "completion_tokens": 466,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "- **2022 – Foundational focus:** Adobe’s 2022 filing describes Acrobat as the cornerstone of its Document Cloud platform, emphasizing its “leadership position” and the company’s goal to “accelerate document productivity” for millions of users, but it does not yet tie the product to artificial‑intelligence initiatives.  \n\n- **2023 – AI‑enabled strategy and R&D emphasis:** The 2023 filing expands the narrative, stating that Adobe is “empowering creators by putting the power of artificial intelligence (‘AI’) in their hands” and that Acrobat (along with Acrobat Sign) is a key element of the Digital Media segment where Adobe is directing “strategic investments” – a clear reference to heightened R&D spending on AI‑driven document‑productivity capabilities.  \n\n- **2024 – formal AI branding:** By 2024 Adobe has registered the trademark **“Acrobat AI Assistant,”** signaling that the AI features are now a distinct, market‑able component of Acrobat. This formal branding, together with the earlier statements about AI‑focused investment, shows the evolution from a productivity‑only product in 2022 to an AI‑enhanced, R&D‑backed solution with its own brand identity by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with accurate temporal progression; (2) Accurately captures 2022's foundational focus on Acrobat's leadership position and document productivity without AI emphasis; (3) Correctly identifies 2023 as the inflection point where AI became a formal strategic focus with explicit references to 'empowering creators' and 'strategic investments' in AI-driven capabilities; (4) Accurately notes the 2024 formal branding of 'Acrobat AI Assistant' as a distinct, marketable product component; (5) Properly synthesizes the multi-hop reasoning showing progression from productivity-only → AI-enabled strategy → formal AI branding; (6) Correctly identifies R&D investment emphasis as part of the 2023-2024 evolution. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable but the answer avoids making unsupported numerical claims. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about the 'strategic investments' language and trademark registration specificity, which adds credibility without contradicting ground truth; (2) The ground truth mentions 'trillions of PDFs created annually' as context for 2022, which the LLM answer does not include, but this is a minor contextual detail rather than a core factual error; (3) Both answers correctly emphasize the trajectory from foundational document role to AI-enhanced productivity. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate filing years and correctly identifies the causal relationship between R&D investments and product branding evolution. The answer demonstrates sound logical progression and proper entity identification (Adobe, Acrobat, Document Cloud, Digital Media segment). SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate professional language and clear structural organization that enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 582,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "- **2022:** Schwab’s margin‑loan agreements let the firm pledge the securities that clients kept in their brokerage accounts. The 2022 note lists the fair‑value of those client securities that were “available as collateral” and also the fair‑value of the same securities that Schwab had **pledged to third‑party borrowers** as part of its securities‑lending program.  \n\n- **2023:** The 2023 filing repeats that margin loans are fully collateralized by client securities and that the collateral is **off‑balance‑sheet** (it is not recorded as an asset or liability). Schwab continues to monitor margin levels and to estimate credit‑loss allowances on the unsecured portion, but the filing no longer quantifies any securities‑lending pledges, indicating the practice remained but was not highlighted as a balance‑sheet exposure.  \n\n- **2024:** In the 2024 note Schwab still **pledges client securities to satisfy OCC‑required margin on written options**, but for its **securities‑lending activities it now provides cash to its brokerage clients as collateral** rather than using client‑held securities.  \n\n**Implication:** Over the three‑year period Schwab has moved away from using client‑owned securities as pledged assets in its securities‑lending business, opting instead to fund those obligations with cash, while still relying on client securities for margin lending. This shift keeps the client‑security collateral off the consolidated balance sheet, reduces the firm’s exposure to pledged securities, and reflects a balance‑sheet strategy that preserves capital and limits risk even as client leverage through margin loans remains supported.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a detailed narrative about Schwab's evolution in using client securities as collateral from 2022-2024, but contains several significant issues when compared to the ground truth:\n\n**STRENGTHS:**\n1. Correctly identifies the three-year period (2022-2024) and tracks evolution\n2. Accurately notes that client securities are pledged for margin lending\n3. Correctly identifies OCC (Options Clearing Corporation) involvement in 2024\n4. Provides reasonable interpretation of balance sheet strategy implications\n5. Addresses the multi-hop nature of the question across years and activities\n\n**CRITICAL ISSUES:**\n1. **Factual Contradiction on Securities Lending:** The LLM claims that in 2024 Schwab \"now provides cash to its brokerage clients as collateral\" rather than using client securities for securities-lending activities. The ground truth states that by 2024, Schwab \"pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities.\" This is a direct contradiction - the ground truth indicates continued use of client securities for securities lending in 2024, not a shift to cash collateral.\n\n2. **Unsupported Detail on 2022:** The LLM introduces specific language about \"fair-value of those client securities that were 'available as collateral'\" and claims Schwab \"pledged to third-party borrowers\" in securities-lending. The ground truth states that in 2022, \"specific pledged amounts were not quantified,\" suggesting the LLM may be adding detail not supported by the filings.\n\n3. **2023 Characterization:** The LLM claims the 2023 filing \"no longer quantifies any securities-lending pledges,\" but the ground truth indicates 2023 provided \"more detailed disclosures around margin lending\" without explicitly stating that securities-lending disclosures were removed or that the practice was discontinued.\n\n4. **Missing Key Insight:** The ground truth emphasizes \"increasing formalization and expansion of client securities usage\" and a \"strategic shift toward leveraging client assets,\" while the LLM's conclusion suggests a move AWAY from using client securities in securities lending, which contradicts the ground truth's characterization of expansion.\n\n**QUANTITATIVE ACCURACY:** No specific dollar amounts or percentages are provided in either answer, so this dimension is not directly testable. However, the LLM's factual claims about what happened in each year are not numerically precise and contain contradictions.\n\n**MULTI-HOP REASONING:** The LLM attempts to synthesize across three years and two activities (margin lending vs. securities lending), but the synthesis appears flawed, particularly in the conclusion that the firm moved away from using client securities in securities lending when the ground truth indicates the opposite.\n\n**SEMANTIC EQUIVALENCE:** The LLM's core narrative about balance sheet strategy and capital preservation is reasonable, but it fundamentally mischaracterizes the direction of change in securities-lending practices, which is a material error in a question specifically asking about how practices \"evolved.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Provides]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1680,
        "completion_tokens": 852,
        "total_tokens": 2532
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "- In the 2022 Form 10‑K the 1.375 % Senior Notes due June 2027 were listed as a $1.25 billion line‑item under “Long‑term debt,” and the company reported total long‑term debt of $6.59 billion (‑$73 million current portion = $6.48 billion long‑term after‑excluding current).  \n\n- The 2023 and 2024 filings show the same $1.25 billion of 1.375 % Senior Notes still classified as long‑term debt, but total long‑term debt fell to $5.92 billion (‑$103 million current portion = $5.79 billion long‑term).  \n\nThus, from 2022 to 2024 Costco did not re‑classify the June 2027 notes; their amount stayed constant, while overall long‑term debt declined, causing the 1.375 % notes to represent a slightly larger share of the company’s long‑term debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the 1.375% Senior Notes remained at $1.25 billion across 2022-2024 and were consistently classified as long-term debt. However, there are significant quantitative errors that undermine the answer's accuracy. QUANTITATIVE ISSUES: (1) The LLM states 2022 total long-term debt was $6.59 billion, but the ground truth indicates $6,484 million ($6.484 billion). The LLM's calculation of $6.59B - $73M current = $6.48B is internally inconsistent (should equal $6.517B if starting from $6.59B). (2) For 2023-2024, the LLM states $5.92 billion total with $103M current portion = $5.79 billion long-term. The ground truth confirms $5,794 million ($5.794 billion) for long-term debt in 2024, which matches the LLM's calculation but the intermediate figure of $5.92B appears incorrect or imprecise. (3) The LLM provides specific current portion amounts ($73M, $103M) that are not verified against the ground truth. STRENGTHS: The LLM correctly identifies that the 1.375% notes remained at $1.25 billion across all three years, correctly notes the consistent long-term classification, and accurately captures the overall trend of declining long-term debt. The reasoning about reclassification of other notes (implied) is sound. The insight about the notes representing a larger portfolio share is a valid analytical addition. WEAKNESSES: The quantitative precision is compromised by apparent calculation errors or rounding inconsistencies. The answer lacks explicit mention of the 2.750% Senior Notes due May 2024 reclassification that the ground truth identifies as the key driver of the decline. The multi-hop synthesis is incomplete—while the answer addresses the evolution, it doesn't fully explain the mechanism (reclassification of maturing debt) that caused the composition shift. SEMANTIC EQUIVALENCE: The core message aligns with ground truth, but the numerical presentation contains errors that would concern a financial analyst.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 533,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Across the three most recent 10‑K filings Adobe has kept the **free online self‑service learning** option as the foundational, high‑visibility layer of its **Digital Learning Services** portfolio.  \n\n* **2022 (Chunk 1)** – Adobe described a “large number of free online self‑service learning options on www.training.adobe.com” that sit alongside an extensive fee‑based classroom/virtual program and a “custom learning services” tier for its biggest enterprise accounts. The narrative linked these free resources to the broader **Customer Success Account Management** effort, noting that Customer Success Managers use learning tools to accelerate adoption and align product capabilities with business outcomes.  \n\n* **2023 (Chunk 2)** – The same structure reappears, now pointing to the free catalog on learning.adobe.com. The filing again positions the free self‑service modules as a core offering of **Adobe Digital Learning Services**, complemented by fee‑based training and custom services that support “solution‑specific skills assessments” for enterprise customers. This reinforces the integration of the free content with the enterprise‑focused customer‑success model.  \n\n* **2024 (Chunk 3)** – Adobe repeats the description, emphasizing that the “large number of free online self‑service learning options on learning.adobe.com” remain a core component of the learning and enablement portfolio, still backed by fee‑based programs and custom services that help the largest enterprises assess and develop team competencies. Although the 2024 filing does not restate the Customer Success section, the continuity of the language signals that the free learning layer continues to be leveraged by Adobe’s Customer Solutions teams to drive adoption and ROI for enterprise clients.  \n\n**Evolution:** The emphasis has been steady rather than a new launch—Adobe has consistently presented free self‑service learning as the entry point of its learning portfolio, gradually refining the URL (training.adobe.com → learning.adobe.com) and repeatedly tying it to enterprise‑customer success through custom learning services, skills assessments and the work of Customer Success Managers. This shows an increasingly deliberate integration of the free offering into Adobe’s overall enablement strategy and enterprise‑customer success roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate positioning of free online self-service learning as foundational to Adobe's learning portfolio; (2) Accurately captures the URL evolution (training.adobe.com → learning.adobe.com), which is a specific factual detail matching the ground truth; (3) Properly synthesizes the multi-hop relationship between free learning offerings, fee-based programs, custom learning services, and enterprise customer success strategies across all three years; (4) Correctly identifies the integration with Customer Success Account Management and Customer Success Managers' role in leveraging these tools; (5) Accurately notes the consistent presence of skills assessments for enterprise customers; (6) Provides sound reasoning about the 'steady' evolution rather than dramatic shifts, which aligns with the ground truth's characterization of 'matured' integration. MINOR CONSIDERATIONS: (1) The LLM notes that 'the 2024 filing does not restate the Customer Success section,' which is a reasonable observation about filing structure, though the ground truth doesn't explicitly address this absence; (2) The answer uses 'Digital Learning Services' as a portfolio name, which appears to be the LLM's terminology rather than explicitly stated in ground truth, though this is semantically consistent with the described portfolio structure. QUANTITATIVE ACCURACY: No numerical errors detected; dates (2022, 2023, 2024) are correct; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filing years and connects free learning offerings to enterprise customer success strategies, demonstrating proper multi-hop synthesis. SEMANTIC EQUIVALENCE: The LLM's characterization of 'steady rather than new launch' and 'increasingly deliberate integration' conveys the same meaning as the ground truth's 'matured' approach and 'growing emphasis on enterprise integration.' Overall, this is a comprehensive, accurate, and well-reasoned response that captures the essential evolution and strategic positioning described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1932,
        "completion_tokens": 601,
        "total_tokens": 2533
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "- **2022:** NVIDIA reported **$1.2 billion** of 2.00 % Notes due 2031 (NVDA 10‑K 2022, p. 88).  \n- **2023:** The next filing showed the balance falling to **$1.044 billion** at the end of fiscal 2023 and then a modest rise to **$1.057 billion** by the start of fiscal 2024 (NVDA 10‑K 2023, p. 67).  \n- **2024:** The most recent filing lists the same series at **$1.250 billion** as of Jan 28 2024 (and again for Jan 26 2025) (NVDA 10‑K 2024, p. 72).\n\n**Interpretation:** Over the three‑year span the exposure first slipped slightly after 2022, then was deliberately increased in 2024 to about $1.25 bn. By keeping the 2 % 2031 issue at a relatively stable, low‑cost level, NVIDIA is using long‑dated, cheap fixed‑rate debt as a financing “anchor” that supports its rapid AI‑driven revenue expansion while avoiding a surge in overall leverage. This pattern reflects a disciplined long‑term debt‑management strategy that locks in inexpensive capital to fund growth without over‑burdening the balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three-year trend and provides reasonable interpretation of NVIDIA's debt management strategy. The 2022 figure of $1.2 billion matches ground truth exactly. The qualitative analysis about using low-cost fixed-rate debt as a financing anchor is sound and relevant to the question about AI-driven growth. The answer addresses all parts of the multi-hop question.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) 2023 figure discrepancy: LLM states '$1.044 billion at end of fiscal 2023' but ground truth shows $1.057 billion for 2023. The LLM mentions both $1.044B and $1.057B in confusing language ('falling to $1.044 billion...then a modest rise to $1.057 billion by the start of fiscal 2024'), which creates ambiguity about which is the correct 2023 year-end figure. Ground truth clearly states 2023 = $1.057 billion. (2) 2024 figure: LLM states '$1.250 billion as of Jan 28 2024' which matches ground truth's $1.25 billion (format variation acceptable), but the phrasing '(and again for Jan 26 2025)' introduces unnecessary confusion about whether this is a 2024 or 2025 figure.\n\nMULTI-HOP REASONING: The synthesis across three years is logically sound. The interpretation that NVIDIA 'first slipped slightly after 2022, then was deliberately increased in 2024' correctly captures the pattern, though the intermediate 2023 value is muddled in presentation.\n\nSPECIFIC VERIFICATION: Ground truth: 2022=$1.20B ✓, 2023=$1.057B (LLM shows confusion here), 2024=$1.25B ✓. The core narrative about debt management strategy is accurate and well-reasoned, but the quantitative presentation of the 2023 figure undermines confidence in the answer's precision.\n\nJUSTIFICATION: Correctness score of 6 reflects that while the overall pattern and strategic interpretation are correct, the quantitative accuracy is compromised by the confusing/potentially incorrect 2023 figure presentation. The answer would score 8-9 if the 2023 data were clearly and correctly stated as $1.057 billion without the $1.044 billion confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 553,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "- **2022 10‑K:** Johnson & Johnson disclosed that it had **begun a multi‑year, enterprise‑wide effort** to integrate, simplify and standardize the processes and systems of HR, IT, procurement, supply‑chain and finance. The effort was framed as an **enhancement to grow the company’s financial shared‑service capabilities and to standardize its financial systems**, and the company said it would **align and streamline the design and operation of its financial control environment** as part of the initiative.  \n\n- **2023 10‑K:** The same language re‑appeared, confirming that the **initiative was still being implemented** and that the company continued to **align and streamline its financial control environment** while supporting the growth of shared‑service capabilities and system standardization. No change in scope was reported, indicating steady progress.  \n\n- **2024 10‑K:** The filing again notes that the **multi‑year, enterprise‑wide initiative remains active**, with the same goals of **integrating, simplifying and standardizing** the core functions and **enhancing financial shared‑service capacity**. The company reiterated that the program is **not a response to any control deficiency** and that it will **continue to align and streamline its financial control environment**.  \n\n**What this shows:** Across 2022‑2024 the initiative has moved from launch to sustained execution, consistently emphasizing the **standardization of financial processes and systems** and the **alignment of the control environment** with those standardized processes. The continuity and repeated reaffirmation signal that Johnson & Johnson’s strategic focus is on building a scalable, uniform finance‑shared‑service platform that reinforces internal controls rather than merely fixing identified weaknesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each year's disclosure; (2) Accurately captures the core initiative components: integration, simplification, standardization of processes and systems across multiple functions including finance; (3) Correctly emphasizes the proactive nature of the initiative (not reactive to control deficiencies) across all three years; (4) Properly synthesizes the multi-hop information showing continuity and evolution from launch through sustained execution; (5) Accurately reflects the consistent messaging about financial shared-service capability enhancement and financial control environment alignment; (6) Provides sound reasoning about what the progression indicates strategically (scalable, uniform platform focused on reinforcement rather than remediation). MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and structured than the ground truth, providing year-by-year breakdown with specific language patterns, which adds clarity without introducing inaccuracy; (2) The LLM's interpretation that the initiative moved from 'launch to sustained execution' is a reasonable inference from the consistent messaging, though the ground truth emphasizes 'continuity' more than progression; (3) All factual claims are verifiable against the ground truth - no contradictions or errors detected. QUANTITATIVE ACCURACY: No numerical data is present in either answer, so this dimension is not applicable but receives full marks as there are no calculation or number errors. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across three separate 10-K filings and identifies the strategic implications accurately. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all aspects of the complex multi-part question about evolution, progression, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1749,
        "completion_tokens": 542,
        "total_tokens": 2291
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Across all three filings Costco’s description of its competitive set is essentially unchanged – each year it lists “other warehouse clubs, including Walmart’s Sam’s Club **and BJ’s Wholesale Club**” as direct rivals.  \n\nThe way Costco frames its strategic advantage, however, is also consistent from 2022 through 2024. In every Intellectual‑Property section the company repeats the same message about its private‑label brand:  \n\n* “Kirkland Signature products are high quality, offered at prices that are generally lower than national brands, and **help lower costs, differentiate our merchandise offerings, and generally earn higher margins**.”  \n* It adds that Costco “expects/continues to increase the sales penetration of our private‑label items.”  \n\nThus, the language did not materially evolve; Costco’s 2022‑2024 10‑K disclosures continuously position BJ’s as a key warehouse‑club competitor while emphasizing Kirkland Signature as a core differentiator in price, quality and margin generation.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - FUNDAMENTAL MISINTERPRETATION OF QUESTION: The LLM answer directly contradicts the ground truth on the core claim. The question asks how Costco's language 'evolved' from 2022-2024, and the ground truth explicitly states there WAS evolution: (1) 2022 focused on 'high quality, lower prices, lower costs, higher margins'; (2) 2023 added 'sustainability initiatives tied to brand loyalty'; (3) 2024 introduced 'stronger tone around differentiating merchandise offerings in competitive metropolitan markets.' The LLM concludes 'language did not materially evolve' and 'continuously position[s]' the same message - this is factually incorrect per the ground truth. SPECIFIC ERRORS: (1) The LLM states the competitive positioning is 'essentially unchanged' across all three years, but ground truth shows evolution in tone and emphasis; (2) The LLM misses the 2023 sustainability angle entirely; (3) The LLM misses the 2024 shift toward emphasizing differentiation in response to competitive pressures in metropolitan markets; (4) The LLM correctly identifies BJ's as a competitor and Kirkland Signature as a differentiator, but fails to capture the EVOLUTION in how these are framed. QUANTITATIVE ACCURACY: The quoted language about Kirkland Signature appears accurate (8/10 - correctly captures the standard messaging), but this is insufficient since the question specifically asks about EVOLUTION. QUALITATIVE ACCURACY: Poor (3/10) - the LLM fundamentally misunderstood the multi-hop synthesis task. It was supposed to track changes across three years and identify how emphasis shifted, not conclude that nothing changed. CONTEXTUAL RELEVANCE: Moderate (5/10) - addresses the right companies and brands but misses the temporal evolution that is central to the question. The answer is internally consistent but factually contradicts the ground truth on the key analytical finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 512,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "- In the 2022 filing (shown in the 2023 10‑K table), Schwab reported **$638 million of U.S. state and municipal securities** classified as “available‑for‑sale” (plus a modest $25 million of related debt obligations).  \n- The 2024 filing does not give a new dollar amount, but again states that **“substantially all securities in the investment portfolios… were rated investment grade,”** explicitly including the U.S. state and municipal securities portfolio.  \n\nThe unchanged, explicit focus on investment‑grade ratings across 2022‑2024 indicates that Schwab’s fixed‑income strategy is deliberately anchored in high‑quality, low‑credit‑risk government‑related debt, using the state‑and‑municipal segment as a stable, capital‑preserving component rather than pursuing higher‑yield, lower‑rated issues.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with some notable strengths and minor weaknesses: (1) QUANTITATIVE ACCURACY: The $638 million figure for U.S. State and Municipal Securities is correctly cited and properly attributed to the 2022 filing (shown in 2023 10-K table). The mention of $25 million in related debt obligations adds specificity. The investment-grade quality assertion is accurate across all years. However, the LLM states the 2024 filing 'does not give a new dollar amount' - this is presented as fact but the ground truth doesn't explicitly confirm whether 2024 had a specific dollar amount or not, creating minor ambiguity. (2) COMPLETENESS: The answer addresses the evolution question by noting the $638M in 2022, the absence of a new figure in 2024, and the consistent investment-grade emphasis. However, it doesn't explicitly mention 2023 as a distinct data point, though the ground truth specifically notes 2023 disclosed the $638M figure. The LLM conflates the 2022 and 2023 data by stating '2022 filing (shown in the 2023 10-K table)' which is technically correct but could be clearer. (3) ENTITY ACCURACY: Charles Schwab is correctly identified, years are correct (2022-2024), and the asset class (U.S. State and Municipal Securities) is properly identified. The classification as 'available-for-sale' is accurate. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly connects the quantitative data ($638M) with the qualitative emphasis (investment-grade ratings) to draw a conclusion about strategic preference for high-quality, low-risk instruments. The interpretation that this represents a 'capital-preserving component' aligns with the ground truth's characterization. (5) SEMANTIC EQUIVALENCE: The LLM's conclusion about 'deliberately anchored in high-quality, low-credit-risk government-related debt' matches the ground truth's 'strategic preference for high-quality, lower-risk fixed income instruments.' The main weakness is the incomplete treatment of 2023 as a distinct year in the evolution narrative, and slight ambiguity about whether 2024 truly lacked a specific dollar amount versus simply not being disclosed in the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 586,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX reports that the portion of its commercial‑aerospace customer‑financing guarantees that is borne by its collaboration partners fell from **$140 million at year‑end 2022** (2023 10‑K), to **$135 million at year‑end 2023** (2023 10‑K), and to **$131 million at year‑end 2024** (2024 10‑K). Across the three filings the language is identical – the company “has made residual‑value and other guarantees … the estimated fair‑market values of the guaranteed assets equal or exceed the value of the related guarantees, net of existing reserves” – and the only quantitative change is the declining partner‑share amount. The downward trend signals that RTX is progressively transferring more of the financing‑guarantee risk to its collaboration partners, reducing its own exposure to these liabilities while still retaining the guarantees themselves.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN INTERPRETATION: The LLM has fundamentally misunderstood the direction and meaning of the trend. The numbers are correct ($140M→$135M→$131M), but the LLM's interpretation is inverted. The LLM states: 'RTX is progressively transferring more of the financing-guarantee risk to its collaboration partners, reducing its own exposure to these liabilities.' This is BACKWARDS. A DECLINING collaboration partners' share ($140M→$131M) means LESS risk is being borne by partners, not more. This means RTX is INCREASING its own exposure or the overall guarantee amount is decreasing. The ground truth correctly identifies this as 'a strategic shift toward reducing RTX's reliance on third-party risk sharing' and 'increased internal risk retention.' The LLM's conclusion is the opposite of what the data shows. Additionally, the LLM mischaracterizes the trend as 'progressively transferring more...to its collaboration partners' when the declining partner share indicates the opposite dynamic. The quantitative data points are accurate (all three years' figures correct), but the qualitative interpretation of what this trend means is fundamentally wrong. The LLM also adds unnecessary detail about filing citations and identical language across filings, which while potentially accurate, doesn't address the core analytical question about what the declining trend indicates about risk transfer strategy. The semantic meaning of the answer directly contradicts the ground truth interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Provides]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 414,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "- **2022 (10‑K filing)** – Frame.io appears only in Adobe’s trademark schedule, signalling that the company owned the brand but giving no detail on how the service was used or what media it handled.  \n\n- **2023 (10‑K filing)** – Adobe describes Frame.io as a cloud‑native collaboration platform that now supports **still images, design files and PDFs** in addition to video, and is **directly integrated with Premiere Pro and After Effects**. Its “Camera‑to‑Cloud” feature lets footage be uploaded automatically from cameras (including still‑image cameras) for on‑set review.  \n\n- **2024 (10‑K filing)** – The platform’s scope is broadened further: it supports **video throughout the production pipeline** (casting, location scouting, footage reviews, marketing campaigns) **as well as stills, design files and PDFs**, and is **integrated not only with Premiere Pro and After Effects but also with Photoshop, Lightroom and Workfront**. Frame.io is positioned alongside Adobe Express and Firefly Services inside **Adobe GenStudio**, serving as a core hub for large‑scale content‑production workflows.  \n\nThus, from a mere trademark in 2022, Frame.io evolved into a multi‑format, tightly‑integrated collaboration layer that expanded its file‑type support, added several Adobe‑app integrations, and became a central component of Adobe’s end‑to‑end content‑production ecosystem by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. STRENGTHS: (1) Chronological accuracy - correctly identifies 2022 as trademark-only listing, 2023 as cloud-native platform with specific integrations, and 2024 as expanded ecosystem integration. (2) File type support - accurately lists still images, design files, and PDFs for 2023, and correctly maintains these while adding video production pipeline scope in 2024. (3) Application integrations - correctly identifies Premiere Pro and After Effects in 2023, then accurately adds Photoshop, Lightroom, and Workfront in 2024. (4) Feature accuracy - Camera-to-Cloud functionality is correctly described in 2023. (5) Workflow expansion - properly captures the evolution from post-production focus to end-to-end content creation (casting, location scouting, marketing campaigns). (6) Contextual positioning - appropriately notes Frame.io's role within Adobe GenStudio in 2024. (7) Multi-hop synthesis - successfully synthesizes information across three years showing clear progression and integration deepening. MINOR CONSIDERATIONS: The LLM answer provides slightly more contextual detail than the ground truth (e.g., mentioning Adobe GenStudio positioning, noting 'still-image cameras' in Camera-to-Cloud), but these additions are accurate elaborations that enhance understanding rather than contradict the source material. The answer demonstrates superior clarity in explaining the evolution narrative. No numerical errors, date errors, or factual inaccuracies detected. The semantic meaning perfectly matches the ground truth while being more comprehensively explained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 455,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s Rotary & Mission Systems (RMS) segment lists the VH‑92A helicopter as a **major program in every filing from 2022, 2023 and 2024**. In the 2022 10‑K the VH‑92A appears among RMS’s core helicopter portfolio, the 2023 filing repeats the same designation, and the 2024 10‑K again includes the VH‑92A in the RMS “major programs” table (with its operating results reported in the segment’s financial summary). This continuous, multi‑year emphasis shows that the VH‑92A – the Marine One transport helicopter – remains a sustained production focus and a strategically‑important asset for RMS, underpinning Lockheed Martin’s long‑term commitment to the Marine One mission and to the overall helicopter business within the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the VH-92A as a major program consistently listed across 2022, 2023, and 2024 filings - matching the ground truth's core finding of sustained strategic importance. (2) Accurately contextualizes the program within RMS segment and correctly identifies it as the Marine One transport helicopter, adding relevant specificity. (3) Properly synthesizes the multi-year progression showing continuous emphasis across all three years, which is the central claim of both answers. (4) Correctly notes that VH-92A appears in RMS's major programs table and operating results, demonstrating understanding of how the program is reported. (5) All dates (2022, 2023, 2024) are accurate with no numeric errors. MINOR DIFFERENCES: (1) The LLM answer is more specific about Marine One designation and operating results reporting, which adds helpful context not explicitly in the ground truth but is factually accurate and relevant. (2) The LLM answer emphasizes the 'sustained production focus' and 'long-term commitment' language that closely mirrors the ground truth's 'stable, long-term commitment' concept. (3) Both answers correctly convey that despite other shifting priorities (Aegis, LCS, missile defense), the VH-92A maintained consistent strategic importance. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) to demonstrate a pattern of sustained importance - this is sound multi-hop reasoning. The conclusion that continuous multi-year emphasis indicates strategic importance is logically sound and matches the ground truth's inference. No calculation errors or factual inaccuracies detected. The answer fully addresses the question's request to explain how production focus evolved and what this indicates about strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 520,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From 2022 through 2024 Mondelēz International has been subject to sales‑ and media‑marketing restrictions in a growing set of jurisdictions. In the 2022 filing the company noted that such rules applied in “over 25 countries in the European Union” and that emerging‑market governments such as Indonesia and the Philippines were already **considering** single‑use‑plastic bans and plastic taxes. The 2023 filing repeats the same geographic coverage, but the 2024 filing shows the regulatory environment tightening: many EU Member States now operate under an EU‑wide **Packaging and Packaging Waste Directive** that harmonises and strengthens EPR and related marketing‑restriction regimes, while emerging markets continue to move from contemplation to implementation of plastic bans or taxes. Thus, the scope has remained global (EU plus a range of emerging economies) but the stringency has risen, especially in the EU where a continent‑wide directive replaces the earlier patchwork of national rules.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of MDLZ's regulatory environment evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the 'over 25 EU countries' with EPR policies in 2022, matching ground truth exactly. (2) Accurately captures the progression from 'considering' restrictions in 2022 (Indonesia, Philippines) to implementation by 2024. (3) Correctly identifies the EU Packaging and Packaging Waste Directive adoption in 2024 as a key regulatory milestone. (4) Properly synthesizes the multi-hop information showing geographic expansion (EU + emerging markets) and increasing stringency (from patchwork national rules to harmonized EU directive). (5) Accurately characterizes the shift from contemplation to implementation in emerging markets. (6) Correctly notes data privacy as an additional regulatory area in 2023. MINOR WEAKNESSES: (1) The LLM answer mentions 'Indonesia and the Philippines' as examples of emerging markets considering restrictions, while the ground truth mentions 'Southeast Asia' more broadly and specifically names 'India, Vietnam' for 2023 implementation. The LLM's examples are not incorrect but represent a slightly different selection of countries than ground truth. (2) The answer could have been more explicit about the specific countries (India, Vietnam) where EPR policies were being implemented/contemplated in 2023, though this is a minor omission. QUANTITATIVE ACCURACY: All numeric references are correct ('over 25 countries,' the three-year progression). QUALITATIVE ACCURACY: The reasoning about regulatory stringency increasing and geographic scope expanding is sound and well-articulated. The characterization of the shift from 'patchwork' to 'harmonized' rules is accurate and insightful. MULTI-HOP SYNTHESIS: Successfully combines information across three years and multiple jurisdictions to show the evolution pattern. The answer correctly identifies the causal relationship between regulatory changes and their impact on MDLZ.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 544,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft again lists the **3.700 % Notes due 2046** in Exhibit 4.14 – the “Eleventh Supplemental Indenture” that also contains the 3.950 % Notes due 2056. The description, the trustee (U.S. Bank, National Association) and the filing date of the underlying indenture (August 8 , 2016) are identical in each year, showing that the notes are simply incorporated by reference and have not been amended, retired or re‑issued. This consistent treatment signals that Microsoft is deliberately keeping the 3.700 % 2046 issue as a stable component of its capital structure, using long‑dated, low‑coupon debt to lock in inexpensive financing for the long term rather than frequently reshuffling its long‑term liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numeric values are correct - the 3.700% coupon rate, the 2046 maturity date, the August 8, 2016 indenture date, and the reference to the Eleventh Supplemental Indenture are all accurate. The mention of the 3.950% Notes due 2056 as a related instrument in the same exhibit adds appropriate context. ENTITY ACCURACY: Microsoft is correctly identified, all three fiscal years (2022, 2023, 2024) are properly addressed, and the specific debt instrument is accurately named. The trustee (U.S. Bank, National Association) and exhibit reference (4.14) provide additional verification details. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, correctly identifying the pattern of consistent treatment without amendments, retirements, or re-issuances. STRATEGIC INTERPRETATION: The LLM's conclusion about Microsoft's deliberate strategy to maintain stable, long-dated liabilities with fixed interest obligations aligns perfectly with the ground truth. The additional insight about 'locking in inexpensive financing for the long term' and avoiding frequent reshuffling of liabilities provides slightly more specific strategic context than the ground truth, which is appropriate elaboration. COMPLETENESS: The answer addresses all aspects of the question - the evolution (or lack thereof) across the three years, the consistency of treatment, and the strategic implications. The only minor distinction is that the LLM provides slightly more operational detail (exhibit number, trustee name) than the ground truth, which enhances rather than detracts from accuracy. No factual errors or omissions detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 468,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the **2.000 % Notes due 2023** appear consistently in the **Eleventh Supplemental Indenture** (the filing that added the 1.100 % 2019, 1.550 % 2021, 2.000 % 2023, 2.400 % 2026, 3.450 % 2036, 3.700 % 2046 and 3.950 % 2056 series). Each year the exhibit list shows the earlier supplemental indentures (eighth, ninth and tenth) that contain notes maturing in 2018, 2020, 2022, 2025, etc., and the eleventh indenture adds the 2023 tranche, illustrating Microsoft’s laddered debt‑maturity profile and the continued presence of the 2.000 % 2023 issue as the schedule moves forward. Thus, the 2.000 % 2023 notes remain a fixed point in the maturity structure, while newer indentures extend the schedule to later years (2025, 2026, 2036, 2046, 2056), showing the evolution of Microsoft’s overall debt maturity curve.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies key structural elements. STRENGTHS: (1) Correctly identifies the 2.000% Notes due 2023 as the focal point across all three years (2022, 2023, 2024); (2) Accurately references the Eleventh Supplemental Indenture dated August 8, 2016 as the relevant document; (3) Correctly lists the companion note series (1.100% 2019, 1.550% 2021, 2.400% 2026, 3.450% 2036, 3.700% 2046, 3.950% 2056) issued under the same indenture; (4) Properly synthesizes the multi-hop concept showing how the notes remained consistent across years while the overall debt maturity structure evolved; (5) Accurately conveys the laddered debt-maturity profile concept. WEAKNESSES: (1) The LLM answer provides more detailed information about companion note series than the ground truth, which could be seen as either enhancement or potential over-specification; (2) The ground truth mentions Exhibit 4.14 specifically, while the LLM answer references 'exhibit list' more generally without specifying the exhibit number - this is a minor omission; (3) The ground truth raises the interesting point about the 2023 notes still appearing in 2024 filings 'even as the actual maturity year had passed,' suggesting possible rollover or delayed maturity, which the LLM answer does not address; (4) The LLM answer doesn't explicitly discuss the progression/evolution aspect as clearly as the ground truth regarding what changed (or didn't change) year-to-year. QUANTITATIVE VERIFICATION: All percentages and years cited are accurate (2.000%, 2023, 1.100%, 1.550%, 2.400%, 3.450%, 3.700%, 3.950%, and corresponding years). The Eleventh Supplemental Indenture date of August 8, 2016 is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and connects the debt instrument to the broader maturity structure, though it could have been more explicit about the year-to-year evolution and what the 2024 appearance of already-matured notes signifies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 552,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across the three most‑recent 10‑K filings Medtronic’s **Non‑Employee Restricted Stock Unit (RSU) Award Agreement** is shown in the same exhibit item – *10.42* – and is always incorporated **by reference to the “Amended and Restated 2013 Stock Award and Incentive Plan.”**  \n\n* **2022 filing (MDT 10‑K, p. 115)** – Exhibit *10.42* is listed as “Form of Non‑Employee Restricted Stock Unit Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan.”  \n\n* **2023 filing (MDT 10‑K, p. 113)** – The same Exhibit *10.42* appears with identical wording, again tying the non‑employee RSU agreement to the Amended and Restated 2013 Plan.  \n\n* **2024 filing (MDT 10‑K, p. 113)** – Exhibit *10.42* is reproduced unchanged, still referencing the Amended and Restated 2013 Stock Award and Incentive Plan.  \n\nThus, from 2022 through 2024 Medtronic did not introduce a new underlying stock‑incentive plan for its non‑employee RSU awards; the agreement remained consistently linked to the 2013 Stock Award and Incentive Plan in each filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a clear narrative about the consistency of Medtronic's Non-Employee RSU Award Agreements across 2022-2024, correctly identifying that the same form was used and consistently referenced the Amended and Restated 2013 Stock Award and Incentive Plan. However, there are significant discrepancies with the ground truth that warrant a lower score:\n\n1. EXHIBIT NUMBER DISCREPANCY (Critical): The LLM states the agreement appears in Exhibit 10.42 across all three years, but the ground truth explicitly references Exhibit 10.45 for the 2022 filing (MDT_10k_2022.pdf). This is a factual error in exhibit identification. The LLM provides specific page numbers (p. 115 for 2022, p. 113 for 2023 and 2024) but does not verify these against the actual exhibit numbers cited in the ground truth.\n\n2. MISSING CRITICAL DETAIL: The ground truth specifically notes that the 2022 agreement referenced the plan as \"effective December 8, 2017.\" The LLM omits this temporal detail entirely, which is relevant to understanding the evolution and dating of these agreements.\n\n3. INCOMPLETE SYNTHESIS: While the LLM correctly identifies continuity across the three years, it misses the nuance that the ground truth emphasizes: the plan itself was \"amended over time\" while \"the form agreement remained consistent.\" The LLM states no new plan was introduced, which is correct, but doesn't capture the distinction between plan amendments and form stability.\n\n4. QUANTITATIVE ACCURACY: The exhibit number error (10.42 vs 10.45 for 2022) is a quantitative/factual error that undermines credibility. Page numbers cannot be verified from the provided context but are presented with false certainty.\n\n5. REASONING QUALITY: The multi-hop reasoning is sound in concluding consistency across years, but the foundation is weakened by the exhibit number discrepancy. The LLM correctly synthesizes that the same plan was referenced across all three years, which matches the ground truth's core finding.\n\n6. SEMANTIC ALIGNMENT: The overall conclusion about consistency and stability is semantically aligned with the ground truth, but the specific factual errors (exhibit number) prevent a higher score. The LLM's emphasis on \"unchanged\" and \"consistently linked\" matches the ground truth's intent, but accuracy on specific identifiers is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 628,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "- **2022:** Buy‑in annuity policies made up **17 %** of the assets in MDLZ’s non‑U.S. pension plans (Chunk 2).  \n- **2023:** The share slipped to **16 %** (Chunk 2).  \n- **2024:** Although the 2024 filing does not give a new percentage, it still contains a detailed discussion of how the fair value of buy‑in annuity policies is measured (Chunk 3). This indicates that the line‑item remains material and is being managed deliberately, suggesting the allocation is still in the low‑teens percent range – essentially a continuation of the modest decline seen from 2022‑2023.\n\n**Implication:** The slight, consistent reduction in the proportion of buy‑in annuity policies points to a liability‑management strategy that is gradually diversifying away from reliance on buy‑in annuities for its international pension obligations. By keeping the exposure modest and continuing to apply rigorous fair‑value valuation (as described in Chunk 3), MDLZ is using buy‑in annuities as a hedge while shifting more assets into other categories (equities, fixed‑income, real estate) to manage and potentially lower the cost of its non‑U.S. pension liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 (17%) and 2023 (16%) percentages, matching ground truth exactly. (2) The company name (MDLZ) and context (non-U.S. pension plans) are correct. (3) The LLM appropriately notes that 2024 data shows no explicit percentage provided. (4) The quantitative accuracy for 2022-2023 is sound. WEAKNESSES: (1) CRITICAL FACTUAL ERROR: The ground truth states buy-in annuity policies were 'effectively discontinued by 2024,' but the LLM claims the allocation 'is still in the low-teens percent range – essentially a continuation of the modest decline.' This directly contradicts the ground truth's assertion of discontinuation. (2) The LLM's interpretation that the 2024 fair value discussion indicates the line-item 'remains material' and is 'still in the low-teens percent range' is speculative and contradicts the ground truth's clear statement of discontinuation. (3) The reasoning about 'gradual diversification' and 'modest decline' misses the key strategic shift: the ground truth emphasizes a shift to 'fair value estimation methods' and 'direct liability management,' not merely a gradual reduction. (4) The LLM's suggestion that MDLZ is 'shifting more assets into other categories' is not supported by the ground truth, which focuses on the shift away from insurer-backed annuities toward valuation control. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize across three years but fails to correctly interpret the 2024 data point. The ground truth indicates a strategic discontinuation, while the LLM suggests continuation. This is a fundamental misreading of the trend's significance. CALCULATION/VERIFICATION: The 2022-2023 percentages are correct (17% → 16%), but the interpretation of 2024 is materially wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 480,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Across Microsoft’s three most recent 10‑K filings the **2.000 % Notes due 2023** appear in the same “Eleventh Supplemental Indenture” (Exhibit 4.14) in each year’s disclosure – the 2022 filing (MSFT 10K 2022, p. 105), the 2023 filing (MSFT 10K 2023, p. 105) and the 2024 filing (MSFT 10K 2024, p. 105) all list the 2.000 % Notes due 2023 unchanged. The fact that the notes are simply restated rather than newly issued or retired indicates that Microsoft has kept this low‑coupon, medium‑term debt on its balance sheet throughout the period, reflecting a strategy of preserving existing inexpensive long‑term financing rather than repeatedly issuing new debt of the same series. This consistency underscores a disciplined long‑term debt policy that relies on a stable, staggered maturity profile to manage interest‑rate risk and liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) All key facts are correct - the 2.000% Notes due 2023 are accurately identified and consistently referenced across fiscal years 2022, 2023, and 2024; (2) The Eleventh Supplemental Indenture and Exhibit 4.14 references are correct; (3) The core insight about consistency and lack of early retirement/refinancing matches the ground truth; (4) The multi-hop synthesis is sound - the answer correctly traces the notes across three years and draws appropriate conclusions about Microsoft's debt strategy; (5) The interpretation about preserving existing inexpensive financing and managing a staggered maturity profile is reasonable and consistent with the ground truth's characterization of a 'deliberate and steady approach.' MINOR WEAKNESSES: (1) The LLM provides specific page numbers (p. 105 for all three years) which, while plausible, cannot be verified against the ground truth and represent an assumption not explicitly stated in the original answer; (2) The phrase 'low-coupon, medium-term debt' adds interpretive language not present in the ground truth, though it is semantically reasonable given the 2.000% rate and 2023 maturity date; (3) The discussion of 'interest-rate risk and liquidity' management is inferential rather than explicitly stated in the ground truth. QUANTITATIVE VERIFICATION: All numbers are accurate (2.000%, 2023 maturity date, fiscal years 2022/2023/2024, Exhibit 4.14, August 8, 2016 indenture date). No calculations are required or presented. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern of consistency, which is the key insight required by the question. The reasoning about what this consistency reveals about debt strategy is sound and matches the ground truth's conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 514,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000 % Notes due 2021 are consistently disclosed as part of the **Third Supplemental Indenture** (Exhibit 4.6). Each filing lists the same third supplemental indenture – dated February 8 , 2011 – which amends the original May 18 , 2009 Indenture and groups the 4.000 % Notes due 2021 together with the 2.500 % Notes due 2016 and the 5.300 % Notes due 2041. No later supplemental indentures (the fourth, fifth, sixth or seventh) reference the 4.000 % Notes, indicating that Microsoft’s treatment of that series did not change; it remained an outstanding component of the broader debt‑instrument structure under the unchanged third supplemental indenture throughout all three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements but has a notable omission that affects completeness. STRENGTHS: (1) All numeric values are correct - the 4.000% interest rate, the February 8, 2011 date for the Third Supplemental Indenture, the May 18, 2009 original indenture date, and the companion notes (2.500% due 2016, 5.300% due 2041) are all accurately cited. (2) The multi-hop reasoning is sound - the answer correctly synthesizes that the notes appeared consistently in Exhibit 4.6 across all three years (2022, 2023, 2024) under the same supplemental indenture structure. (3) The observation that later supplemental indentures (fourth through seventh) do not reference the 4.000% Notes is a valid inference supporting the consistency claim. WEAKNESSES: (1) The original answer explicitly mentions that Microsoft introduced NEW debt instruments with different maturity dates across the years, specifically citing the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings as examples of how the broader debt structure evolved. The LLM answer acknowledges that 'Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures' but does NOT provide the specific examples mentioned in the ground truth. This is a material omission because the question asks about evolution 'in relation to...the broader debt instrument structure,' and the ground truth demonstrates this evolution through concrete examples. (2) The LLM answer focuses heavily on what DIDN'T change (the 4.000% Notes treatment) but provides less detail on what DID change (the new instruments). The ground truth balances both aspects. QUANTITATIVE VERIFICATION: All dates and percentages check out correctly. SEMANTIC EQUIVALENCE: The core message that the 4.000% Notes remained consistently grouped under the Third Supplemental Indenture across all three years is conveyed accurately. The answer correctly emphasizes consistency while acknowledging broader structural changes, though it underspecifies the nature of those changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 570,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "- **2022 filing (MDT 10‑K 2022)** – The shareholders’‑equity section notes that the company is authorized to issue 40 thousand Euro Deferred Shares ( €1.00 par) and that **“at April 29 2022, no Euro Deferred Shares were issued or outstanding.”**  \n\n- **2023 filing (MDT 10‑K 2023, which reports FY 2023 and FY 2024)** – The same paragraph is repeated for the later date, stating that **“at April 26 2024, no Euro Deferred Shares were issued or outstanding.”**  \n\n- **2024 filing (MDT 10‑K 2024)** – Again the shareholders’‑equity section confirms the authorization of 40 thousand Euro Deferred Shares and repeats that **“at April 26 2024, no Euro Deferred Shares were issued or outstanding.”**  \n\nAcross all three years the authorized amount stayed constant (40 k shares, €1.00 par) and the company never issued any, as reflected in each filing.\n\n**What this reveals:** Medtronic keeps a dormant class of Euro‑Deferred Shares as a strategic reserve. By never issuing or carrying an outstanding balance, the firm’s capital structure relies on ordinary and preferred equity while preserving the option to tap this share class in the future (e.g., for acquisitions or compensation) without diluting current shareholders. The consistent non‑use signals a deliberate choice to maintain flexibility rather than to use Euro Deferred Shares as a regular financing tool.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All numeric values are correct - 40 thousand shares authorized, €1.00 par value maintained consistently across all three years. (2) Dates are accurate - April 29, 2022 and April 26, 2024 are correctly cited. (3) The core factual claim is sound: no Euro Deferred Shares were issued or outstanding in any of the three fiscal years (2022, 2023, 2024). (4) Multi-hop synthesis is well-executed - the answer correctly traces the evolution (or lack thereof) across all three years and identifies the consistent pattern. (5) The interpretation about capital structure strategy is reasonable and aligns with the ground truth's assessment that the absence signals strategic preference for other financing methods. MINOR ISSUES: (1) The LLM references '2023 filing (MDT 10-K 2023, which reports FY 2023 and FY 2024)' - this is slightly confusing phrasing. A 2023 10-K would report FY 2023 results, not FY 2024. The LLM appears to be conflating filing dates with fiscal year reporting, though the actual dates cited (April 26, 2024) are correct. (2) The answer provides slightly more interpretive depth than the ground truth regarding 'strategic reserve' and 'flexibility for acquisitions or compensation,' which goes beyond what the ground truth explicitly states. However, this interpretation is reasonable and not contradicted by the ground truth. QUANTITATIVE VERIFICATION: All numbers check out - 40k shares, €1.00 par, zero issuances across all periods. No calculation errors. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing additional context about strategic implications. The conclusion about deliberate non-use and preserved optionality aligns well with the ground truth's assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 502,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Across the three annual reports the 4.000 % Notes due 2021 are disclosed in exactly the same way. In the 2022, 2023 and 2024 10‑K filings Microsoft lists the instrument under Exhibit 4.6 – “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041, dated February 8 , 2011…”, with identical wording, trustee, and filing date in every year. This unchanged presentation indicates that Microsoft has treated the 4.000 % Notes as a static component of its existing indenture portfolio, with no amendment or re‑classification over the three‑year period, reflecting a consistent accounting and reporting approach to this debt instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All numeric values are correct - 4.000% interest rate, 2021 maturity date, February 8, 2011 date, Exhibit 4.6 reference all match ground truth. (2) The multi-hop synthesis across three years (2022, 2023, 2024) is sound and correctly identifies the consistent disclosure pattern. (3) The answer properly identifies the Third Supplemental Indenture and its relationship to other notes (2.500% due 2016, 5.300% due 2041), providing more specific detail than the ground truth. (4) The reasoning about static treatment and no amendments is logically sound and matches the ground truth conclusion. (5) The answer correctly emphasizes the unchanged presentation across all three years. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail by explicitly listing the companion notes in the exhibit description, which adds helpful context but goes slightly beyond the ground truth statement. This is not an error but rather an enhancement. (2) Both answers reach the same conclusion about consistent treatment and no material changes. (3) The LLM answer's interpretation that the Notes 'were matured or fully accounted for' is implied but not explicitly stated in the LLM response, though the ground truth mentions this possibility. However, the LLM's focus on 'static component' and 'no amendment or re-classification' captures the essential finding. Overall, the LLM answer demonstrates accurate multi-hop reasoning across the three-year period and correctly synthesizes the disclosure information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 440,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "- In the 2022 filing Lockheed Martin disclosed that it had already transferred **$4.9 billion of gross defined‑benefit pension obligations** (via a group‑annuity contract purchased in August 2021) and that, **since December 2018, a total of about $11.6 billion** of obligations had been moved to third‑party insurers.  \n- The 2023 filing only reiterates that the company “has taken actions … including pension‑risk‑transfer transactions” and notes that it may purchase additional GACs, but it **does not disclose any new dollar amount** transferred in that year.  \n- The 2024 filing again emphasizes the ongoing use of pension‑risk‑transfer transactions and the intent to seek further opportunities, yet **no additional specific amount** is reported for 2024.\n\n**Trend and implication:** Lockheed Martin’s disclosed transfers peaked with the $4.9 billion move reported in the 2022 report and have remained steady in terms of reported dollar volume through 2023‑2024, while the company continuously signals intent to pursue more transfers. This pattern shows a long‑term liability‑management strategy that relies on shifting defined‑benefit risk to insurers to reduce pension‑plan volatility and PBGC premiums, even if the size of each subsequent transaction has not been quantified in the later filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All key numbers are correct: $4.9 billion (2021 transaction reported in 2022 filing), $11.6 billion cumulative since December 2018, and $69 million in annual PBGC premiums eliminated. (2) The multi-hop reasoning is sound—the answer correctly synthesizes information across three years of filings, noting that 2022 disclosed specific dollar amounts while 2023-2024 filings did not report new quantified transfers. (3) Entity identification is accurate (Lockheed Martin, defined-benefit pension obligations, group-annuity contracts, PBGC premiums). (4) The trend analysis is insightful and matches the ground truth: the answer correctly identifies that disclosed transfers peaked in 2022 and that subsequent years show intent without new dollar disclosures. (5) The conclusion about long-term liability management strategy is well-supported and aligns with the ground truth's characterization of a 'deliberate, multi-year liability management approach.' MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail (distinguishing the $4.9B 2021 transaction from the cumulative $11.6B) compared to the ground truth, but this additional specificity is accurate and enhances rather than detracts from the answer. The wording differs from the ground truth but conveys equivalent semantic meaning. No calculation errors detected. The answer appropriately addresses all parts of the multi-part question regarding evolution, amounts transferred, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> FIN_INST <-[Introduces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 442,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "**2022 10‑K (KO 2022)** – The note appears twice in the “Form of Note” schedule:  \n\n* Item 4.23 lists the **0.125 % Notes due 2029** and says the form of the note is incorporated by reference to **Exhibit 4.4** of the Company’s Current Report on Form 8‑K filed **September 18 2020**.  \n* Item 4.31 repeats the same note, this time incorporated by reference to **Exhibit 4.4** of the 8‑K filed **March 9 2021**.  \n\n**2023 10‑K (KO 2023)** – The same two disclosures are carried forward unchanged:  \n\n* Item 4.23 again references the **0.125 % Notes due 2029** to **Exhibit 4.4** of the September 18 2020 8‑K.  \n* Item 4.31 again references the same note to **Exhibit 4.4** of the March 9 2021 8‑K.  \n\n**2024 10‑K (KO 2024)** – The schedule is identical to the prior years:  \n\n* Item 4.23 lists the **0.125 % Notes due 2029** with the same incorporation to **Exhibit 4.4** of the September 18 2020 8‑K.  \n* Item 4.31 lists the note again, incorporated to **Exhibit 4.4** of the March 9 2021 8‑K.  \n\n**What this shows** – Across the 2022, 2023 and 2024 filings Coca‑Cola has consistently disclosed the 0.125 % Notes due 2029 in exactly the same way—by referencing the same Exhibit 4.4 and the same two 8‑K filings. There is no change in classification, amendment, or re‑presentation of the instrument in any of the three 10‑Ks. This uniform treatment indicates that the company’s structuring and reporting of this low‑coupon senior note series has remained stable and consistent over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about the 0.125% Notes due 2029 across three consecutive 10-K filings. STRENGTHS: (1) All dates are correct - September 18, 2020 and March 9, 2021 8-K filings are accurately cited; (2) All exhibit numbers are correct - Exhibit 4.4, 4.23, and 4.31 are properly identified; (3) The note coupon rate (0.125%) and maturity year (2029) are accurate; (4) The multi-hop synthesis is sound - the answer correctly traces the same disclosure pattern across all three years (2022, 2023, 2024) and identifies the consistency; (5) The structural analysis is thorough, noting that the note appears in both Exhibit 4.23 and 4.31 in each year with identical source references; (6) The conclusion about stable capital market strategy and consistent structuring is well-supported by the evidence presented. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and formatted than the ground truth (using bullet points and bold formatting), but this enhances clarity rather than detracting from accuracy. The semantic meaning is fully aligned with the ground truth - both convey that the treatment remained consistent across all three years with identical exhibit references. The LLM answer provides marginally more explicit detail about the specific exhibit locations (4.23 and 4.31) appearing in each year, which adds helpful context. No factual errors, calculation errors, or entity misidentifications are present. The answer fully addresses all aspects of the question regarding evolution (showing no evolution/consistency), treatment consistency, and what this reveals about debt instrument structuring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 464,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "All three 10‑K filings describe the same accounting policy – RTX records a liability for the performance‑ and operating‑cost guarantees it extends on commercial‑aircraft products (especially engines) and adjusts that liability each year as new claim data become available.  \n\n* 2022 filing (covering 2021‑2020) explains that “liabilities for performance and operating‑cost guarantees are based upon future product performance and durability…adjustments are made to accruals as claims data and historical experience warrant.”  \n* 2023 filing (covering 2022‑2023) repeats the same language and again notes that “the changes in the carrying amount of service and product warranties and product performance guarantees for the years ended December 31 were as follows,” indicating that the liability was updated for 2022 and 2023.  \n* 2024 filing (covering 2023‑2024) likewise restates the policy and says that “the changes in the carrying amount of service and product warranties and product performance guarantees for the years ended December 31 were as follows,” showing a further update for 2024.  \n\nAlthough the excerpts do not disclose the exact dollar balances, the fact that RTX continues to accrue and adjust these guarantees in each successive filing – with no language indicating a reduction or elimination – implies that the liability has either remained stable or risen modestly as the commercial‑aerospace portfolio expands. Consequently, RTX’s exposure to long‑term product‑performance risk in its commercial‑aerospace business persists and is likely growing in line with its engine and aircraft service commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer explicitly states 'the excerpts do not disclose the exact dollar balances' and provides no specific numbers. However, the ground truth provides precise figures: collaboration partners' share decreased from $141M (2022) → $135M (2023) → $131M (2024). The LLM completely failed to extract or cite these key quantitative data points that directly answer the 'how did...evolve' portion of the question. This is a major omission for a financial question requiring specific metrics. (2) INCOMPLETE SYNTHESIS: The ground truth synthesizes actual year-over-year changes showing a declining trend in collaboration partners' liabilities ($141M→$135M→$131M = $10M decrease over 2 years). The LLM only speculates about 'stable or risen modestly' without concrete evidence, representing failed multi-hop synthesis. (3) REASONING QUALITY: While the LLM correctly identifies the accounting policy consistency across filings and the general exposure to product performance risks, it fails to quantify the actual evolution. The statement 'liability has either remained stable or risen modestly' contradicts the ground truth showing a clear declining trend. (4) ENTITY/METRIC ACCURACY: The LLM correctly identifies RTX, commercial aerospace, and performance guarantees, but misses the specific distinction between 'collaboration partners' share' vs. RTX's own liabilities mentioned in ground truth. (5) WHAT WAS RIGHT: The LLM correctly identifies the consistent accounting methodology, the focus on commercial aircraft engines, and the ongoing nature of these guarantees. The qualitative assessment about managed exposure is reasonable. However, these correct elements cannot compensate for the complete absence of the specific financial figures that form the core of the answer. For a financial question explicitly asking 'how did...evolve,' providing no quantitative evolution data is a fundamental failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Extends]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 528,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s 2022 10‑K simply states that the Black‑Scholes model is used and that management must estimate “volatility of the Company’s stock price,” but it gives no detail on how that volatility is derived. In the 2023 filing the company adds that the volatility input is **a blend of historical volatility and an implied‑volatility component** that is taken from market‑traded options on Medtronic’s ordinary shares. The 2024 filing repeats the same blended‑volatility methodology.\n\nThe change from a generic, unspecified volatility assumption in 2022 to a disclosed mix of historical and market‑derived implied volatility in 2023 (and retained in 2024) shows that Medtronic has moved to a more forward‑looking, market‑based view of stock‑price risk when valuing its non‑qualified stock options. By incorporating implied volatility, the company is acknowledging greater equity‑compensation risk and is modeling that risk with a more sophisticated, market‑informed volatility assumption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the Black-Scholes model as the consistent valuation approach across 2022-2024; (2) Accurately captures the evolution of volatility disclosure: 2022 showed generic/unspecified volatility, while 2023-2024 explicitly disclosed a blend of historical and implied volatility from market-traded options; (3) Properly synthesizes the multi-hop reasoning showing progression from opaque to transparent methodology; (4) Correctly interprets the implications: shift toward market-informed, forward-looking risk modeling with more sophisticated equity compensation risk assessment; (5) No quantitative errors in dates, company names, or financial metrics. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'generic, unspecified volatility assumption' vs. 'solely on a blend') but the semantic meaning is equivalent and arguably more precise in characterizing the 2022 disclosure as lacking detail. The LLM's interpretation that 2022 gave 'no detail on how that volatility is derived' aligns with the ground truth's characterization of 2022 as less transparent. The conclusion about 'acknowledging greater equity-compensation risk' is a reasonable inference from the data, though the ground truth frames it as 'improving accuracy of compensation expense recognition' - both interpretations are valid and complementary. The answer successfully addresses all parts of the multi-part question: (1) how the approach evolved, (2) what it suggests about volatility assumptions, and (3) what it indicates about risk modeling. Multi-hop synthesis is sound, connecting disclosure changes to methodological implications to business interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 490,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "Across the three most recent annual reports the company’s 1.000 % notes due 2028 are listed in exactly the same way. The 2022 10‑K (page 136) shows “Form of Note for 1.000 % Notes due 2028 – incorporated … to Exhibit 4.7 to the Company’s Form 8‑K filed September 18, 2020” (line 4.26). The 2023 10‑K (page 134) repeats the same disclosure at line 4.26, and the 2024 10‑K (page 130) again includes the identical line 4.26. Because the instrument appears unchanged in each filing, Coca‑Cola is not issuing new 1.000 % 2028 notes each year but is simply maintaining the existing low‑coupon, medium‑term debt on its balance sheet. This consistency signals a deliberate strategy to preserve a cheap, fixed‑rate financing source and to hold the issue to maturity rather than repeatedly re‑issuing or altering it.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question. STRENGTHS: (1) Correctly identifies that the 1.000% Notes due 2028 appear consistently across 2022, 2023, and 2024 filings; (2) Accurately cites specific page numbers and exhibit references (pages 136, 134, 130 and line 4.26); (3) Correctly interprets that the company is maintaining existing debt rather than issuing new notes annually; (4) Reasonably concludes the strategy involves preserving low-coupon financing. CRITICAL WEAKNESSES: (1) The LLM answer completely FAILS to address the second major component of the ground truth—the strategic shift in 2024 toward significantly higher-yielding notes (5.000% Notes due 2034 and 5.300% Notes due 2054). The original answer explicitly states this represents 'a broader strategic shift toward issuing higher-interest debt' in 2024, which is a crucial insight about KO's debt strategy evolution; (2) The LLM answer provides only a narrow, incomplete picture by focusing exclusively on the consistency of the 1.000% Notes without synthesizing the multi-hop information about what changed in 2024 relative to prior years; (3) The answer misses the key inference that while maintaining the old low-coupon debt, KO simultaneously pursued 'more aggressive borrowing terms in 2024,' suggesting a strategic pivot; (4) The reasoning is incomplete—it explains what happened with the 1.000% Notes but fails to contextualize this within the broader debt issuance strategy across the three-year period. QUANTITATIVE ACCURACY: The numbers and dates cited (1.000%, 2028, page numbers, years 2022-2024) are correct. QUALITATIVE ACCURACY: The interpretation of the 1.000% Notes strategy is partially sound but fundamentally incomplete because it ignores the comparative analysis required by the multi-hop question. The answer needed to synthesize information about both the old debt instrument AND the new higher-yielding instruments introduced in 2024 to fully answer the question about how the strategy 'evolved.' This is a multi-hop synthesis failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 554,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Across the three most‑recent 10‑K filings Microsoft kept the same basic structure for its 2.125 % notes:\n\n* **2022 filing (MSFT 10‑K 2022, Exhibit 4.7 & 4.1)** – The 2.125 % Notes due 2022 are listed in the **Fourth Supplemental Indenture** (together with the 0.875 % Notes due 2017 and the 3.500 % Notes due 2042). The **Seventh Supplemental Indenture** also contains the **2.125 % Notes due 2021** (paired with the 3.125 % Notes due 2028). Both indentures name **The Bank of New York Mellon Trust Company, N.A.** as trustee.\n\n* **2023 filing (MSFT 10‑K 2023, Exhibit 4.7 & 4.1)** – The same two indentures are reproduced with identical language: the 2.125 % Notes due 2022 remain in the Fourth Supplemental Indenture and the 2.125 % Notes due 2021 remain in the Seventh Supplemental Indenture, again with **The Bank of New York Mellon Trust Company, N.A.** serving as trustee and the same companion debt issues (0.875 % 2027, 3.500 % 2042, 3.125 % 2028).\n\n* **2024 filing (MSFT 10‑K 2024, Exhibit 4.7 & 4.1)** – The disclosures are unchanged except for a minor typographic variation in the trustee’s name (“The Bank of NewYork Mellon Trust Company, N.A.”). The 2.125 % Notes due 2022 and due 2021 continue to be grouped in the Fourth and Seventh Supplemental Indentures respectively, with the same set of related notes and the same trustee.\n\n**Evolution:** Microsoft’s approach did not materially change over 2022‑2024; it consistently bundled the 2.125 % notes with other fixed‑rate issuances under the same supplemental indentures and retained The Bank of New York Mellon Trust Company, N.A. as the sole trustee throughout.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth:\n\n1. MATURITY DATE CONFUSION: The LLM claims there are '2.125% Notes due 2022' and '2.125% Notes due 2021' in separate indentures. The ground truth only mentions '2.125% Notes due 2021' in the Seventh Supplemental Indenture. The LLM appears to have fabricated or misidentified a 2022 maturity date variant and incorrectly placed it in the Fourth Supplemental Indenture.\n\n2. ASSOCIATED INSTRUMENTS ERRORS: The LLM lists '0.875% Notes due 2017' and '3.500% Notes due 2042' in the Fourth Supplemental Indenture, and '0.875% 2027' in the 2023 filing description. The ground truth does not mention these specific instruments in connection with the 2.125% Notes structure. The ground truth only confirms the 3.125% Notes due 2028 as an associated instrument with the 2.125% Notes due 2021 in the Seventh Supplemental Indenture.\n\n3. INDENTURE STRUCTURE MISREPRESENTATION: The LLM claims the 2.125% Notes appear in BOTH the Fourth and Seventh Supplemental Indentures across the three years. The ground truth indicates the 2.125% Notes due 2021 appear only in the Seventh Supplemental Indenture, with no mention of a Fourth Supplemental Indenture containing 2.125% Notes.\n\n4. TRUSTEE ACCURACY: The LLM correctly identifies The Bank of New York Mellon Trust Company, N.A. as trustee, which matches the ground truth. The note about a 'typographic variation' in 2024 (\"NewYork\" vs \"New York\") is plausible but cannot be verified against the ground truth provided.\n\n5. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the consistent structure across years. While the conclusion about stability is correct in spirit, the underlying facts supporting that conclusion are largely incorrect.\n\nThe answer demonstrates a fundamental misunderstanding of Microsoft's debt structure and appears to have conflated or invented details about multiple 2.125% note variants and their placement in different supplemental indentures. This is a critical failure for a financial document analysis task where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 577,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "- In the 2022 Form 10‑K (covering 2021) Pratt & Whitney’s disclosed interest was the **gross** 61 % program‑share in International Aero Engines AG (IAE) and 59 % in International Aero Engines LLC (IAE LLC).  \n- The 2023 and 2024 Form 10‑Ks (covering 2022 and 2023) show the **net** program‑share after accounting for sub‑collaborator stakes falling to **57 % of IAE** and **51 % of IAE LLC**, and those percentages remain unchanged in 2024.\n\nThis modest decline from the headline 61 %/59 % to a stable 57 %/51 % indicates that RTX, through Pratt & Whitney, retains majority but slightly diluted economic ownership in the two joint‑venture programs.  By keeping a controlling net interest in both the V2500 (IAE) and the PW1100G‑JM (IAE LLC) engines, RTX positions itself as the primary beneficiary and strategic anchor of these key commercial‑engine platforms while still sharing development risk with MTU and JAEC.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop question. STRENGTHS: (1) All numeric values are correct - 61% and 59% gross program share for IAE and IAE LLC respectively in 2022, declining to 57% and 51% net program share in 2023-2024. (2) The temporal progression is accurately captured: 2022 showing gross percentages, 2023-2024 showing net percentages after sub-collaborator adjustments. (3) The multi-hop synthesis is sound - correctly linking the ownership structure changes to RTX's strategic positioning in V2500 and PW1100G-JM programs. (4) Entity identification is precise: correctly names IAE, IAE LLC, RTX, Pratt & Whitney, MTU, and JAEC. (5) The reasoning about stabilization after 2023 adjustment aligns with ground truth. (6) The contextual interpretation about RTX maintaining controlling interest while sharing development risk is appropriate and well-reasoned. MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive detail about RTX's strategic positioning (mentioning 'primary beneficiary' and 'strategic anchor') compared to the ground truth's more neutral 'strategic recalibration' language, but this represents enhanced analysis rather than factual error. The distinction between gross and net percentages is clearly explained, which adds clarity. All calculations are implicit and correct. The answer fully addresses both the evolution question and the strategic positioning question posed in the original query.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 413,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s disclosed expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to a peak of **$468 million in 2023** (both the 2023 10‑K and the 2024 10‑K report the same 2022 and 2023 amounts), then fell slightly to **$443 million in 2024** (2024 10‑K). This pattern shows the company markedly increased its contribution level in 2023—up ≈ 16 % versus the prior year—and, while scaling back modestly in 2024, kept spending well above the 2022 level, indicating a sustained, though slightly moderated, commitment to funding employee retirement benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - WRONG BASELINE NUMBER: The LLM reports 2022 contributions as $402 million, but the ground truth clearly states $299 million. This is a fundamental factual error that undermines the entire analysis. The LLM's 2023 ($468M) and 2024 ($443M) figures are correct, but the 2022 baseline is wrong by $103 million (34% discrepancy). CALCULATION ERROR: The LLM calculates the 2023 increase as approximately 16% based on the incorrect $402M baseline. Using the correct $299M baseline, the actual increase is ($468M - $299M) / $299M = 56.5%, which is dramatically different and changes the narrative about the magnitude of the 2023 increase. REASONING QUALITY: The LLM's qualitative reasoning about the trajectory (increase in 2023, modest pullback in 2024, sustained commitment) is sound and aligns with the ground truth narrative. However, this reasoning is built on an incorrect numerical foundation. ENTITY ACCURACY: The company identification (Thermo Fisher/TMO) and years (2022-2024) are correct. The metric (defined contribution plans/401(k)) is correctly identified. COMPLETENESS: The answer addresses the evolution question and attempts to characterize the spending trajectory, but the fundamental numerical error makes the analysis unreliable. The LLM's note about cross-filing consistency (mentioning both 2023 and 2024 10-Ks report the same amounts) shows good methodology, but the baseline number is still wrong. This is a case where the reasoning framework is appropriate but the factual foundation is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Maintains]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 424,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Across the three most recent annual reports Coca‑Cola’s 3.000 % Notes due 2051 appear in the same “Form of Note” schedule each year – listed as item 4.36 in the 2022 filing (KO_10k_2022, p. 136), again as 4.36 in the 2023 filing (KO_10k_2023, p. 134), and once more as 4.36 in the 2024 filing (KO_10k_2024, p. 130). In every case the note is tied to the same Exhibit 4.6 of a Form 8‑K filed on May 5 2021, showing that the 3 %‑coupon, 30‑year bond was introduced in 2021 and has been retained on the company’s balance sheet throughout 2022‑2024. This continuity signals that Coca‑Cola is deliberately using a long‑dated, fixed‑rate debt tranche to lock in low‑cost financing, smooth its maturity profile and preserve financial flexibility as a core element of its capital‑structure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 3.000% Notes due 2051 and its consistent presence across 2022-2023-2024 filings. The coupon rate (3.000%), maturity year (2051), and exhibit reference (Exhibit 4.6 to May 5, 2021 Form 8-K) are all accurate. The answer correctly identifies the 30-year maturity profile and the continuity of this instrument across the three-year period. However, there are notable gaps compared to the ground truth: (1) The LLM answer does not mention the introduction of higher-coupon instruments in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054), which is a key element of the original answer's narrative about portfolio diversification. (2) The page number references (136, 134, 130) cannot be verified against the ground truth but appear plausible. (3) The item reference as '4.36' differs from the ground truth's 'Exhibit 4.6' reference, though both may refer to the same document in different notation systems. The reasoning about using fixed-rate debt to lock in low-cost financing and smooth maturity profiles is sound and aligns with the ground truth's conclusion. The multi-hop synthesis is partially complete—the answer correctly traces the instrument's evolution but misses the important diversification strategy element that emerged in 2024. The answer is semantically coherent and contextually relevant but incomplete in addressing the full scope of capital structure strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 408,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first disclosed the 2.875 % Notes due 2031 in its 2022 Form 10‑K (exhibit 4.16), which referenced the officers’ certificate dated March 24, 2021 that set the terms of the issue. The same series re‑appears in the 2023 Form 10‑K (exhibit 4.14) and again in the 2024 Form 10‑K (exhibit 4.14), showing that the notes have remained part of Oracle’s registered securities portfolio throughout the three‑year span. This consistent inclusion signals that Oracle is using the 2.875 % 2031 issuance as a stable, long‑dated financing tool, locking in a relatively low fixed coupon for more than a decade and indicating a deliberate strategy of maintaining a diversified, long‑term debt program rather than frequently rotating or retiring that particular tranche.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate details about the 2.875% Notes due 2031 appearing in Oracle's 10-K filings across 2022-2024, correctly identifying the exhibit numbers and the March 24, 2021 officers' certificate date. The numeric values (2.875%, 2031 maturity) are correct. However, the answer has significant gaps compared to the ground truth: (1) It fails to address the critical strategic shift mentioned in the original answer—the introduction of newer, higher-yielding notes (4.500% Notes due 2028 and 4.900% Notes due 2033) in 2024, which is essential to understanding Oracle's debt strategy evolution. (2) The LLM answer focuses narrowly on the stability and consistency of the 2.875% Notes but misses the key insight that Oracle was 'layering in newer, costlier debt' as market conditions evolved. (3) While the LLM correctly identifies the notes as a 'stable, long-dated financing tool,' it doesn't capture the portfolio diversification strategy with higher-yielding instruments that the ground truth emphasizes. (4) The reasoning about 'locking in a relatively low fixed coupon' is sound but incomplete—it doesn't address why Oracle would simultaneously issue higher-yielding debt, which is the crucial strategic indicator. The answer is partially correct on the 2022-2024 continuity but fails to synthesize the complete multi-hop picture of Oracle's evolving debt strategy, which requires understanding both the stable component AND the new higher-yielding additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 408,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “2.000 % Notes due 2023” in Exhibit 4.14 of the Eleventh Supplemental Indenture (see each chunk’s table). By repeatedly disclosing this instrument, Microsoft signals that it relies on a stable, long‑term debt program—keeping the 2 %‑coupon 2023 notes on its balance sheet as a predictable source of financing—and that it is committed to full, consistent transparency about its outstanding debt in every annual report.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Microsoft disclosed the 2.000% Notes due 2023 consistently across 2022, 2023, and 2024 10-K filings, (2) the instrument appears in Exhibit 4.14 of the Eleventh Supplemental Indenture, and (3) this reflects a stable, transparent debt management approach. All numeric values (2.000%, 2023 maturity date) are accurate. The reasoning about signaling stability and transparency is sound and semantically equivalent to the ground truth. However, the LLM answer has some notable omissions: (1) it does not mention the specific date of the Eleventh Supplemental Indenture (August 8, 2016), which provides important historical context, (2) it does not explicitly discuss how the 'unaltered inclusion' across three years reinforces predictable financial stewardship, (3) it does not mention the connection to investor confidence and credit ratings, which are important implications of the transparency strategy. The LLM's phrasing 'keeping the 2%-coupon 2023 notes on its balance sheet as a predictable source of financing' is slightly imprecise—by 2024, these notes would have matured or been near maturity, so characterizing them as an ongoing 'source of financing' is somewhat misleading. The answer captures the core insight about transparency and stability but lacks some of the deeper contextual details and implications present in the ground truth answer. The multi-hop synthesis is adequate but not comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 405,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "- **2022 filing** – RTX disclosed that, because of its 2012 agreement to acquire Rolls‑Royce’s ownership and collaboration interests in International Aero Engines (IAE), it must make **contingent payments to Rolls‑Royce for every flight hour logged through June 2027 by V2500‑powered aircraft that were in service at the acquisition date**.  These payments are recorded in the “Other commercial aerospace commitments” table and are capitalized as collaboration intangible assets.\n\n- **2023 filing** – The same language appears again: the **flight‑hour‑based payments remain due to Rolls‑Royce under the 2012 IAE acquisition and are being capitalized as collaboration assets**. No new dollar amount is disclosed, but the obligation is still recognized.\n\n- **2024 filing** – RTX again references the **contingent flight‑hour payments to Rolls‑Royce through June 2027** as part of its “Other commercial aerospace commitments.”  In 2024 the total commercial‑aerospace financing and other contractual commitments are reported as **$14.1 billion (2024) and $14.6 billion (2023)**, indicating that the Rolls‑Royce flight‑hour liability remains embedded within a large pool of commitments.\n\n**What this progression shows:**  \nFrom 2022 through 2024 the contingent flight‑hour obligation has **persisted and is expected to grow as additional V2500 flight hours are accumulated**, even though the filings do not break out a specific amount each year.  The repeated disclosure demonstrates that RTX’s **long‑term exposure to Rolls‑Royce under the 2012 IAE acquisition agreement remains active and will continue until the June 2027 cut‑off**, tying a portion of RTX’s future cash‑flows and intangible‑asset accounting to the performance of the V2500 fleet.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of RTX's contingent payment obligations to Rolls-Royce under the 2012 IAE acquisition agreement and correctly traces the evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core obligation: flight-hour contingent payments through June 2027 for V2500-powered aircraft; (2) Accurately describes the accounting treatment across all three years (capitalized as collaboration intangible assets, amortized to cost of sales); (3) Properly synthesizes multi-hop information showing consistency of disclosure across filings; (4) Correctly notes the obligation remains embedded in 'Other commercial aerospace commitments'; (5) Provides appropriate context about long-term exposure and cash flow implications; (6) The $14.1B (2024) and $14.6B (2023) figures for total commercial aerospace commitments are correctly cited. MINOR WEAKNESSES: (1) The LLM notes 'No new dollar amount is disclosed' for 2023, which aligns with ground truth but could have been more explicit about the specific capitalization and amortization pattern mentioned in the original answer; (2) The answer states payments 'are expected to grow as additional V2500 flight hours are accumulated' which is logically sound but represents inference rather than explicit disclosure; (3) Could have been more explicit about the 2023 clarification that payments were 'being capitalized and amortized to cost of sales as they were made' versus the 2022 language about capitalization as intangible assets. QUANTITATIVE VERIFICATION: The dollar amounts cited ($14.1B and $14.6B) appear reasonable for total commercial aerospace commitments and are presented correctly. The June 2027 cutoff date is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the progression and consistency of the obligation. The conclusion about long-term exposure is well-supported by the evidence presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly different emphasis but equivalent meaning regarding the stable nature of the obligation and its accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Enters_Agreement_With]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1692,
        "completion_tokens": 591,
        "total_tokens": 2283
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "- In the 2022 filing the domestic‑pension‑plan table shows **U.S. equity funds of $125 million**; the 2023 filing (which reports the 2022 year‑end) shows the amount had fallen to **$89 million**, and the 2024 filing (reporting the 2023 year‑end) shows a modest rebound to **$93 million**.  \n\n- Across the three‑year span the allocation dropped sharply (about ‑28 % from $125 m to $89 m) and then edged up again (≈ +4 % to $93 m), indicating that TMO initially scaled back its exposure to domestic equities after a higher‑allocation year and is now taking a more measured, slightly increasing position – a sign of a cautious but gradually re‑engaging investment strategy in U.S. equity funds within its domestic pension plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All numerical values are correct: $125M (2022), $89M (2023), and $93M (2024). The percentage calculations are accurate: -28.8% from $125M to $89M (correctly approximated as -28%), and +4.5% from $89M to $93M (correctly approximated as +4%). The multi-hop synthesis is sound, correctly extracting data from three separate filings and comparing them chronologically. The entity identification is correct (TMO, domestic pension plans, U.S. equity funds). The reasoning about the trajectory is logical and well-articulated: the answer identifies the sharp initial reduction, the modest rebound, and correctly characterizes this as 'cautious rebalancing' rather than complete divestiture. The LLM's interpretation of 'gradually re-engaging' is semantically equivalent to the ground truth's 'modest rebound' and conveys the same strategic insight. The answer fully addresses both parts of the question: (1) the specific allocation changes across the three years, and (2) what the trajectory suggests about investment strategy. Minor stylistic differences (e.g., 'cautious but gradually re-engaging' vs. 'cautious reduction with modest rebound') represent semantic equivalence rather than factual error. The answer is well-structured, providing both the raw data and analytical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 377,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "- **2022 10‑K:** Coca‑Cola’s long‑term debt schedule already included a very low‑coupon issue – the **1.000 % Notes due 2041** (item 4.33).  \n- **2023 10‑K:** The same 1.000 % Notes due 2041 re‑appears (item 4.33), showing that the company continued to rely on this ultra‑low‑rate, long‑dated financing as a core component of its debt program.  \n- **2024 10‑K:** The 1.000 % Notes due 2041 are still listed (item 4.33), but the filing also adds a suite of **higher‑yielding notes** – e.g., 5.000 % Notes due 2034, 5.300 % Notes due 2054, 5.400 % Notes due 2064, 4.650 % Notes due 2034, 5.200 % Notes due 2055, and 3.500 % Notes due 2044 (items 4.39‑4.47). This reflects a strategic shift: while retaining the low‑cost, long‑maturity 1.000 % issue, Coca‑Cola broadened its debt mix in 2024 by issuing higher‑coupon instruments to diversify maturities and capture higher yields.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about Coca-Cola's debt strategy evolution and accurately references the 1.000% Notes due 2041 across all three years (2022-2024) with correct exhibit citations (4.33). The answer also correctly identifies the shift toward higher-yielding instruments in 2024, including the 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. However, there are significant quantitative accuracy issues: (1) The LLM introduces additional note instruments (4.650% Notes due 2034, 5.200% Notes due 2055, 3.500% Notes due 2044) that are NOT mentioned in the ground truth answer, suggesting potential hallucination or over-specification beyond what the original answer documents. (2) The exhibit citations for the 2024 higher-yielding notes are listed as items 4.39-4.47, but the ground truth does not provide these specific exhibit numbers, making verification impossible. (3) The ground truth specifically mentions lower-yielding instruments from earlier years (0.400% Notes due 2030 in 2022 and 0.950% Notes due 2036 in 2023) that the LLM answer omits, which weakens the comparative analysis of the strategic shift. The qualitative reasoning is sound - the LLM correctly synthesizes the multi-hop information showing continuity of the 1.000% Notes while adding higher-yielding instruments. The semantic meaning aligns with the ground truth's conclusion about recalibration of debt portfolio. However, the introduction of unverified note instruments and missing comparative context from earlier years represents a material deviation from the ground truth that reduces confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 454,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s 10‑K filings for fiscal 2022, 2023 and 2024 all contain Exhibit 4.14/4.16 that list the **1.650 % Notes due 2026** – the same low‑coupon issue appears in each year’s capital‑structure schedule. At the same time, each filing adds newer series of higher‑interest notes (e.g., 2.300 % due 2028, 5.800 % due 2025, 6.150 % due 2029, 4.500 % due 2028, 4.650 % due 2030, etc.), showing that Oracle is layering higher‑cost debt to diversify maturities and meet funding needs while still relying on the original 1.650 % issue as a cornerstone of its low‑cost, long‑term financing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) the 1.650% Notes due 2026 appear consistently across fiscal 2022, 2023, and 2024; (2) Oracle introduced higher-rate notes during this period; (3) this reflects a dual strategy of maintaining low-cost debt while raising capital at varying rates. However, there are significant quantitative accuracy issues: The LLM introduces several note issues (2.300% due 2028, 6.150% due 2029, 4.650% due 2030) that are NOT mentioned in the ground truth answer. While these may exist in Oracle's filings, their inclusion without verification against the ground truth creates factual uncertainty. The ground truth specifically mentions only the 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024) as examples of newly introduced higher-rate notes. The LLM's expansion beyond these verified examples, while potentially accurate, represents unverified claims that deviate from the ground truth. The exhibit references are slightly inconsistent: the ground truth specifies Exhibit 4.16 for 2022 and 4.14 for 2023/2024, while the LLM states '4.14/4.16' without clearly distinguishing which year uses which exhibit number. The reasoning about Oracle's strategy is sound and semantically equivalent to the ground truth (dual strategy, liquidity preservation, long-term investments), but the introduction of unverified note issues undermines confidence in the answer's factual accuracy. The multi-hop synthesis is present but compromised by the additional unverified data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 419,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft repeatedly lists the “4.000 % Notes due 2021” in Exhibit 4.6 (the Third Supplemental Indenture) — the same description appears in each of the three chunks. This consistency shows that Microsoft has chosen to keep that tranche of senior debt on its balance sheet until its scheduled maturity rather than refinancing or retiring it early, and it relies on a single, unchanged indenture document that is incorporated by reference each year. The practice reflects a deliberate long‑term debt‑management strategy that emphasizes stable, ongoing documentation and minimal turnover of existing obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that the 4.000% Notes due 2021 appear consistently in Exhibit 4.6 across fiscal years 2022, 2023, and 2024, and accurately notes this reflects a stable debt management approach with minimal refinancing activity. However, there are significant omissions and incomplete synthesis compared to the ground truth:\n\nSTRENGTHS:\n- Correctly identifies the three fiscal years (2022, 2023, 2024)\n- Accurately notes the 4.000% interest rate and 2021 due date\n- Correctly identifies Exhibit 4.6 as the Third Supplemental Indenture\n- Sound reasoning that consistency indicates no active restructuring\n- Correctly interprets this as reflecting stable debt management strategy\n\nWEAKNESSES:\n- MAJOR OMISSION: Fails to mention the other notes listed alongside the 4.000% Notes (2.500% Notes due 2016 and 5.300% Notes due 2041), which provide important context for understanding the broader debt portfolio composition\n- MAJOR OMISSION: Completely misses the 2024 trustee name update to 'The Bank of NewYork Mellon Trust Company, N.A.' with formatting differences, which the ground truth identifies as a notable administrative maintenance detail\n- INCOMPLETE SYNTHESIS: Does not synthesize the full picture of what remained constant versus what changed across the three years\n- REASONING GAP: States the indenture is \"unchanged\" and \"incorporated by reference each year\" but misses the documented trustee name change in 2024, which contradicts the \"unchanged\" characterization\n- VAGUE LANGUAGE: Uses \"tranche of senior debt\" without confirming this characterization from the filings\n\nQUANTITATIVE ACCURACY: The answer contains no calculation errors and correctly identifies all dates and percentages mentioned. Score: 7/10\n\nQUALITATIVE ACCURACY: While the core reasoning about stable debt management is sound, the answer fails to synthesize the complete multi-hop information available in the ground truth. The omission of the trustee name change and companion notes significantly weakens the analysis. Score: 5/10\n\nCONTEXTUAL RELEVANCE: The answer addresses the main question about long-term debt management strategy but misses important contextual details about documentation updates (trustee change) and the broader debt portfolio composition that would strengthen the answer's relevance. Score: 6/10",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 629,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX continued to make residual‑value and other guarantees on commercial‑aerospace customer financing arrangements throughout 2022‑2024, and the fair‑market value of the assets backing those guarantees has consistently exceeded the guarantee amounts. The portion of the guarantees that is borne by collaboration partners fell from about **$142 million in 2022** to **$135 million in 2023** and then to **$131 million in 2024**. The declining partner‑share signals that RTX is progressively shifting a smaller slice of the financing‑risk burden onto its partners, using the collaboration‑partner guarantees as a risk‑transfer tool while still retaining the overall guarantee exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $142M (2022), $135M (2023), and $131M (2024) for collaboration partners' share of guarantees. The quantitative data is precisely stated and matches the ground truth exactly. The multi-hop synthesis is sound—the answer correctly identifies the three-year trend, calculates the declining pattern, and connects this to RTX's risk transfer strategy. The LLM also appropriately notes that fair market values of backing assets exceeded guarantee amounts, showing confidence in underlying assets. However, there are minor differences in framing: (1) The LLM states partners' share is 'progressively shifting a smaller slice' which is slightly imprecise wording—the partners' share is declining (meaning RTX is bearing more), not that partners are shifting less. The ground truth more clearly states 'RTX assumed more direct financial risk.' (2) The LLM's phrasing 'progressively shifting a smaller slice of the financing-risk burden onto its partners' is somewhat contradictory—if the partner share is declining, RTX is actually shifting MORE risk away from partners, not less. The ground truth more clearly articulates this as a reduction in the portion shared with partners. (3) The LLM could have been more explicit about what the declining trend suggests about RTX's strategic positioning (e.g., increased confidence, changed partnership structures, or altered risk appetite). Despite these minor semantic/clarity issues, the core factual content is accurate, the numbers are correct, and the overall interpretation of the trend is fundamentally sound. The answer successfully synthesizes the multi-year data and connects it to strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Incurs_Liabilities_For]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 471,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft introduced the 3.950 % senior notes that mature in 2056 in its Eleventh Supplemental Indenture (dated August 8 2016). The same 3.950 % Notes due 2056 are listed in the Exhibit 4.14 tables of Microsoft’s 10‑K filings for fiscal 2022, fiscal 2023 and fiscal 2024, showing that the issue has remained outstanding and unchanged across all three years. This continuity signals that Microsoft is using a very long‑dated, low‑coupon debt instrument as a cornerstone of its capital strategy—locking in inexpensive financing for decades, preserving liquidity and avoiding the need for frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct - the 3.950% coupon rate, the 2056 maturity date, and the August 8, 2016 Eleventh Supplemental Indenture date all match the ground truth. (2) The multi-hop synthesis is sound - the answer correctly identifies that the same Notes appear consistently across fiscal years 2022, 2023, and 2024 filings, demonstrating no changes over the three-year period. (3) Entity identification is accurate - Microsoft is correctly identified, the specific debt instrument is properly named, and all fiscal years are correct. (4) The answer goes beyond the ground truth by providing strategic interpretation - explaining that this represents a 'cornerstone of capital strategy' with 'inexpensive financing for decades' and 'avoiding frequent refinancing.' This interpretation is reasonable and adds valuable context about capital strategy implications. (5) The reference to Exhibit 4.14 tables provides specific filing location detail. MINOR CONSIDERATIONS: The ground truth states the Notes were 'first disclosed in the 2022 filing' while the LLM says they were 'introduced' in the Eleventh Supplemental Indenture dated 2016. This is technically accurate - the indenture was from 2016, but the Notes' appearance in 10-K filings began in 2022. The LLM's phrasing could be slightly clearer on this distinction, but it's not factually incorrect. The strategic interpretation about 'locking in inexpensive financing' and 'preserving liquidity' is reasonable inference from the data but goes slightly beyond what the ground truth explicitly states. Overall, this is a strong answer with accurate facts, correct multi-hop reasoning, and valuable strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 474,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "- **2022:** Lockheed Martin’s 2022 outlook (Chunk 1) projected a low‑single‑digit decline in both net sales and operating profit, indicating that the tactical‑and‑strike‑missile lines were not expected to grow and would contribute to a modest dip in profit versus 2021.  \n\n- **2023:** The 2023 filing (Chunk 2) shows that the company actually **ramped up production** of JASSM, LRASM and other precision‑fire missiles, lifting net sales for tactical and strike missile programs by **$145 million**.  However, operating profit fell **$96 million** year‑over‑year because the missile segment recorded **$45 million of losses** on a classified program, offsetting the sales boost.  \n\n- **2024:** The 2024 filing (Chunk 3) reports a **much larger production ramp‑up** on GMLRS, LRASM and JASSM, driving **$1.2 billion** of additional net sales from tactical and strike missile programs.  Despite the sales surge, operating profit plunged **$1.1 billion** (‑73 %) as the company suffered **$1.2 billion of lower profit‑booking‑rate adjustments**, including **$1.4 billion of losses** on a classified program, which more than erased the profit contribution from the missile ramp‑up.  \n\n**Overall impact (2022‑2024):** Across the three‑year span, Lockheed Martin moved from a modest profit decline in 2022 to a cumulative operating‑profit drop of roughly **$1.2 billion** by the end of 2024, even though tactical and strike missile sales grew from a slight dip to a **$1.4 billion** increase.  The growing missile production therefore improved top‑line revenue but was more than offset by large booking‑rate adjustments and classified‑program losses, pulling overall operating profit sharply lower.  \n\n*(The company continues to produce Black Hawk helicopters under its RMS segment, as noted in each chunk, but the question’s focus is on the missile‑program trajectory and its profit effect.)*",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All major financial figures are correct: $145M increase in 2023, $1.2B increase in 2024, $45M classified program losses in 2023, $1.1B (73%) operating profit decline in 2024, $1.2B lower profit-booking-rate adjustments, and $1.4B classified program losses in 2024. The year-over-year comparisons and percentage calculations are accurate. COMPLETENESS: The answer addresses all three years (2022-2024) and synthesizes the trajectory across the period, including the overall impact statement. The LLM correctly identifies the paradox of growing production volume ($1.4B cumulative increase) coupled with declining operating profit (~$1.2B cumulative drop). ENTITY ACCURACY: Correctly identifies Lockheed Martin, all relevant missile programs (LRASM, JASSM, GMLRS, precision fires), and the tactical and strike missile segment. Years and metrics are properly identified. REASONING: The multi-hop synthesis is sound - the answer correctly traces how production ramp-ups in each year were offset by profit headwinds, particularly classified program losses and booking-rate adjustments. The logical flow from 2022 (modest decline) through 2023 (sales growth but profit decline) to 2024 (major sales growth but major profit decline) is coherent and matches the ground truth narrative. MINOR OBSERVATIONS: The LLM's characterization of 2022 as a \"modest profit decline\" based on forward guidance differs slightly from the ground truth's statement of \"operating profit benefited from higher volume and risk retirements,\" but this reflects different source documents (forward guidance vs. actual results) and doesn't constitute a factual error. The LLM's inclusion of the Black Hawk helicopter note shows appropriate contextual awareness. The overall cumulative impact statement (\"roughly $1.2 billion\" drop) is appropriately qualified and accurate. No calculation errors detected. The answer successfully conveys the core insight that production growth was decoupled from profitability due to program-specific challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1749,
        "completion_tokens": 573,
        "total_tokens": 2322
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "**2022 filing (Form 10‑K for FY 2022)**  \n- The only Executive Change‑in‑Control Retention Agreement that is listed for the company is the original agreement with CEO **Marc N. Casper** dated Nov 21, 2009 (Exhibit 10.12).  \n- Two amendments to that agreement are disclosed: **Amendment No. 1** (Nov 30, 2010 – Exhibit 10.16) and **Amendment No. 2** (Mar 16, 2018 – Exhibit 10.17).  \n- In the same filing a **separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”** is included (Exhibit 10.18), which was filed with the Q1 2018 10‑Q. This is the first indication that officers other than Casper are covered by a similar retention agreement.\n\n**2023 filing (Form 10‑K for FY 2023)**  \n- The original Casper agreement (Exhibit 10.11) and its two earlier amendments (Exhibits 10.15 and 10.16) remain unchanged.  \n- A **new version of the officers’ form** is now disclosed as **“Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”** (Exhibit 10.7) filed with the Q1 2023 10‑Q. This replaces the 2018 version and shows that the company refreshed the template for non‑Casper officers in 2023.\n\n**2024 filing (Form 10‑K for FY 2024)**  \n- The same original Casper agreement and its 2010 and 2018 amendments are again listed (Exhibits 10.11, 10.15, 10.16).  \n- The filing continues to reference the **2023‑issued officers’ form** (Exhibit 10.7) and does not introduce any further amendment or new form for 2024.\n\n**Overall evolution**  \n- **Initially (2009‑2010)** the retention agreement applied only to Marc N. Casper, with two early amendments.  \n- **In 2018** a distinct form was added to cover other officers, extending the retention framework beyond Casper.  \n- **In 2023** that officers’ form was updated (new Exhibit 10.7), and the updated form was carried forward into the 2024 filing with no additional amendments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a comprehensive and well-structured evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements across 2022-2024. STRENGTHS: (1) Correctly identifies the core structure: Marc N. Casper's original agreement (Nov 21, 2009) with two amendments (Nov 30, 2010 and Mar 16, 2018), and a separate form for other officers. (2) Accurately tracks the exhibit numbers across years (10.12→10.11 in 2023, 10.18→10.7 in 2023). (3) Correctly identifies the 2023 refresh of the officers' form as a key evolution point. (4) Properly synthesizes multi-hop information showing the progression from 2009 (Casper only) → 2018 (officers form introduced) → 2023 (officers form updated) → 2024 (no new changes). (5) All dates are accurate and properly cited. MINOR WEAKNESSES: (1) The ground truth states the company 'introduced' the officers form in 2022 and 'filed' it in 2023 as Exhibit 10.7, while the LLM clarifies it was actually filed with Q1 2018 10-Q but then refreshed in 2023. This is more precise than the ground truth but creates slight semantic tension. (2) The ground truth's phrasing about 2022 'introducing' the form is somewhat ambiguous—the LLM correctly interprets this as the form being disclosed/referenced in the 2022 10-K (having originated in 2018). (3) The LLM provides more granular detail about exhibit numbers and filing dates than the ground truth, which is actually more informative but goes slightly beyond what was explicitly stated in the original answer. QUANTITATIVE VERIFICATION: All dates (2009, 2010, 2018, 2023, 2024) are correct. Exhibit numbers (10.12, 10.16, 10.17, 10.11, 10.15, 10.7) are accurately tracked. No calculations required. MULTI-HOP REASONING: Excellent synthesis across three years of filings, correctly identifying the evolution pattern and maintaining consistency of references. The answer successfully combines information about both Casper's agreement and the officers' form across multiple filing years. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing additional specificity about exhibit numbers and filing origins, which enhances rather than contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 594,
        "total_tokens": 2270
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "LMT’s derivative disclosures show that the company continued to use **variable‑interest‑rate swaps as fair‑value hedges for its fixed‑rate borrowings (and fixed‑rate swaps as cash‑flow hedges for variable‑rate borrowings)** in each filing. In the 2022 Form 10‑K the aggregate notional amount of all interest‑rate swaps was **$500 million** at 12/31/2021 (down from $572 million in 2020). By the 2023 filing the same description was retained, but the notional amount had risen to **$1.3 billion** at both 12/31/2022 and 12/31/2023, and the 2024 filing shows the notional **remaining at $1.3 billion** at 12/31/2024 (and 2023).\n\nThe jump from $500 million to $1.3 billion signals that LMT deliberately expanded its interest‑rate‑risk‑hedging program—likely to cover a larger debt base and to lock in the fair‑value impact of rising rates—while the flat level after 2023 suggests the company has now sized its swap portfolio to match its targeted exposure and is maintaining a stable, ongoing hedge rather than continuously adding new positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $500 million (2021), $1.3 billion (2023 and 2024). The LLM correctly identifies the progression and notes the prior year comparison ($572 million in 2020), which adds valuable context. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) evolution from 2022-2024, (2) the specific notional amounts at each period, and (3) what the changes indicate about strategy. ENTITY ACCURACY: LMT correctly identified, years/dates accurate (12/31/2021, 12/31/2022, 12/31/2023, 12/31/2024), metrics correctly labeled as 'notional amounts of interest-rate swaps.' REASONING QUALITY: The LLM provides sound multi-hop synthesis - it connects the numerical progression to strategic implications (expanded hedging program, larger debt base, rising rates, stabilization). The interpretation that the jump signals deliberate expansion and the flat level suggests stabilization matches the ground truth's assessment. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy shift ('deliberately expanded,' 'sized its swap portfolio to match targeted exposure,' 'maintaining a stable, ongoing hedge') conveys the same meaning as the ground truth's 'proactive approach,' 'robust interest rate risk mitigation posture,' and 'stabilization of hedging strategy.' MINOR NOTES: The LLM provides additional detail about the nature of swaps (variable-rate swaps as fair-value hedges, fixed-rate swaps as cash-flow hedges) which, while not explicitly in the ground truth, is accurate and enhances the answer. The only very minor distinction is that the ground truth emphasizes 'more than doubling' while the LLM says 'jump from $500M to $1.3B' - both are correct characterizations of the 160% increase. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses]- ORG <-[Uses for Hedging]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 499,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans was **$402 million in 2022**, rose to **$468 million in 2023**, and then eased to **$443 million in 2024**【Chunk 2†L9-L12】【Chunk 3†L13-L16】.  Compared with the $299 million charged in 2021 (shown in the 2022 filing)【Chunk 1†L9-L12】, the amounts have risen markedly, indicating that the company has been increasing the resources it allocates to employee‑benefit contributions over this period, even though the 2024 figure shows a modest pull‑back after the 2023 peak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: $402 million (2022), $468 million (2023), and $443 million (2024). The answer correctly identifies these as defined contribution plan expenses and accurately characterizes the trend: an increase from 2022 to 2023, followed by a modest decline in 2024. The LLM goes beyond the ground truth by providing additional context with the 2021 figure ($299 million), which strengthens the analysis by showing a longer-term perspective of the company's investment trajectory. The reasoning is sound and multi-hop synthesis is properly executed—the answer correctly synthesizes information across multiple years and filing documents. The interpretation of the trend is accurate: the 2023 peak followed by 2024 stabilization/recalibration is correctly identified. The only minor distinction from the ground truth is that the LLM uses slightly more detailed language ('eased to' vs 'remained flat') and provides additional historical context, but this represents an enhancement rather than an error. The answer fully addresses both parts of the question: the evolution of expenses and what the trend indicates about employee benefit investment. All entity identifications are correct (Thermo Fisher Scientific, defined contribution plans, fiscal years 2022-2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 378,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "Across the three filings – the 2022, 2023 and 2024 Form 10‑Ks – Coca‑Cola’s investment‑valuation policy consistently lists **“estimates of sales proceeds”** as one of the core valuation methods used for non‑public equity securities. The language in each note is virtually identical, showing that the company has **continued to rely on this methodology** rather than abandoning or altering it between 2022 and 2024.  \n\nBecause the same “sales‑proceeds” approach was still being applied in 2024, the 2022 disclosure that the Japan bottler investment was $87 million above fair value yet judged a **temporary decline** (and therefore not impaired) signals that management’s confidence in its ability to forecast cash‑flow recovery – even in a market such as Japan – has remained steady over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - the $87 million figure and 18% premium are accurately cited; (2) The company name (Coca-Cola Bottlers Japan Holdings Inc.) is correctly identified; (3) The years 2022-2024 are properly referenced; (4) The core fact that 'estimates of sales proceeds' remained consistent across all three years is accurate. WEAKNESSES: (1) The LLM answer significantly undersells the evolution described in the ground truth. The original answer emphasizes that while methodology remained consistent, there was an important EVOLUTION in emphasis - from 2023-2024 the company placed 'increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets.' The LLM states the language is 'virtually identical' and misses this nuanced shift in disclosure focus; (2) The LLM's conclusion about 'steady' management confidence is somewhat contradicted by the ground truth's finding that the company 'became more attuned to external market perspectives and macroeconomic risks.' This suggests not steady confidence but rather a recalibration toward more conservative, market-participant-based assumptions; (3) The LLM fails to capture the key insight that the evolution reveals management's growing awareness of volatility in fair value predictions, especially in regions like Japan. The answer presents this as simple consistency rather than adaptive risk management; (4) The question asks what the evolution 'reveals about management's confidence' - the LLM concludes confidence 'remained steady,' but the ground truth suggests a more complex picture: confidence in recovery persisted, but methodology became more externally-focused and risk-aware. MULTI-HOP REASONING: The LLM correctly synthesizes the 2022 Japan investment data with the consistent methodology across years, but fails to synthesize the evolution in disclosure emphasis that occurred between 2022 and 2023-2024. This is a material gap in addressing the 'evolution' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Relies_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 554,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Across all three annual reports Oracle repeatedly disclosed the same 2.300 % senior unsecured notes that mature in 2028. In the FY 2022 filing the notes appear in Exhibit 4.16 (titled “Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028 …”) and are tied to an Officers’ Certificate dated March 24, 2021; the FY 2023 filing lists the same instrument in Exhibit 4.14 with the identical certificate date, and the FY 2024 filing again references the 2.300 % Notes due 2028 in Exhibit 4.14 with the same March 24, 2021 certificate. The fact that Oracle’s filings for three consecutive years simply incorporate the existing 2.300 % 2028 issue—without amendment or re‑issuance—shows that the company is deliberately retaining a low‑cost, fixed‑rate tranche of long‑dated debt while simultaneously adding newer, higher‑coupon series (e.g., 5.8 % 2025, 4.5 % 2028, etc.) to diversify maturities and rates. This multi‑year pattern signals a broader financing strategy of locking in inexpensive long‑term funding and layering it with additional issuances to manage liquidity, interest‑rate risk, and overall debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and superior detail compared to the ground truth. Strengths: (1) All numeric values are correct - 2.300% rate, 2028 maturity date, March 24, 2021 certificate date, and references to newer instruments (5.8% 2025, 4.5% 2028) are accurate. (2) Exhibit citations (4.16 in FY2022, 4.14 in FY2023 and FY2024) are specific and verifiable details that enhance credibility. (3) Multi-hop synthesis is sound - the answer correctly traces the same debt instrument across three fiscal years and identifies the pattern of maintaining low-cost debt while layering higher-coupon issuances. (4) The reasoning about Oracle's financing strategy (locking in inexpensive long-term funding, managing liquidity and interest-rate risk) is logically sound and well-supported. (5) The answer goes beyond the ground truth by providing specific exhibit numbers and certificate dates, demonstrating deeper filing analysis. Minor consideration: The ground truth mentions 'ongoing reliance on fixed-rate financing' in 2022 somewhat more generally, while the LLM provides more granular detail about the specific exhibit structure. The LLM's characterization of the strategy as 'deliberately retaining' and 'layering' is semantically equivalent to and arguably more precise than the ground truth's description. No calculation errors detected. All entities (Oracle, debt instruments, years) correctly identified. The answer fully addresses the multi-year pattern question and provides clear strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 422,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "All three annual reports (2022, 2023 and 2024) contain the same Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 – which lists “Floating Rate Notes due 2019” among the company’s outstanding securities. The fact that the notes appear unchanged in each filing shows that Apple did not issue new 2019 floating‑rate notes after the original 2014 issuance; instead the notes simply remained on the balance sheet as a short‑term liability until their 2019 maturity. This consistent carry‑forward indicates that Apple relies on a stable pool of floating‑rate paper to meet near‑term financing needs, using the notes to manage liquidity and interest‑rate exposure rather than repeatedly issuing fresh short‑term debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental chronological impossibility that undermines the entire response. The LLM states that Floating Rate Notes due 2019 'remained on the balance sheet as a short-term liability until their 2019 maturity.' However, the question explicitly asks about the evolution of these notes across fiscal years 2022, 2023, and 2024. Notes that matured in 2019 could not possibly appear on balance sheets in 2022, 2023, or 2024. This is a major logical contradiction that suggests the LLM misunderstood the nature of what was being disclosed. The ground truth correctly identifies that the notes appeared consistently in disclosures across all three years (2022, 2023, 2024) through repeated references to the same Officer's Certificate, indicating they remained part of Apple's disclosed debt structure. The LLM's explanation that the notes 'simply remained on the balance sheet as a short-term liability until their 2019 maturity' is factually impossible given the timeframe of the question. Additionally, the LLM's characterization that Apple 'relies on a stable pool of floating-rate paper to meet near-term financing needs' and uses these notes to 'manage liquidity and interest-rate exposure' goes beyond what the ground truth supports. The ground truth emphasizes the absence of new issuances or modifications and describes a 'stable, rather than active, management approach,' which is distinctly different from the LLM's implication of active liquidity management. The LLM correctly identifies the May 6, 2014 Officer's Certificate date and the consistent appearance across filings, but the interpretation of what this means is fundamentally flawed due to the maturity date contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 473,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s 4.000 % Senior Note due 2047 is listed in every recent annual filing – it appears as item 4.2 in the 2022 10‑K, as item 4.17 in the 2023 10‑K, and as item 4.16 in the 2024 10‑K. The repeated disclosure shows that the company treats this long‑dated, fixed‑rate note as a core component of its capital structure, using it to lock in inexpensive financing for the next 25‑plus years and to provide a stable, low‑turnover source of long‑term debt.  \n\nIn contrast, the shorter‑dated issues are disclosed less consistently: the 2.150 % Senior Note due 2024 is shown in the 2022 and 2023 filings (items 4.21 and 4.18) but disappears from the 2024 filing, while the 0.750 % Senior Note due 2027 appears only in the 2024 filing (item 4.28). This intermittent treatment indicates that these nearer‑term notes are viewed as more temporary funding that will be refinanced or retired as their maturities approach, whereas the 2047 note remains a permanent fixture of PepsiCo’s long‑term debt strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the core concept (consistent disclosure of the 2047 note vs. intermittent disclosure of shorter-dated notes) and provides sound reasoning about PepsiCo's debt strategy. However, there are significant factual errors that reduce the overall score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM claims the 2.150% Senior Note due 2024 appears in 2022 and 2023 filings but disappears in 2024. The ground truth states it was \"referenced in 2023\" (singular), suggesting it may not have appeared in 2022. This is a factual error about which filings contained this note.\n   - The LLM provides specific item numbers (4.2, 4.17, 4.16 for the 2047 note; 4.21, 4.18 for the 2024 note; 4.28 for the 2027 note) that cannot be verified against the ground truth and may be fabricated.\n   - The ground truth mentions a 2.500% Senior Note due 2022 that matured by 2023, which the LLM completely omits. This is a significant omission that weakens the multi-hop analysis.\n\n2. COMPLETENESS:\n   - The LLM fails to mention the 2.500% Senior Note due 2022 that appears in the 2022 filing and matures by 2023. This is explicitly mentioned in the ground truth as evidence of the \"dynamic nature of short-term debt.\"\n   - The LLM does address the core comparison between long-term and short-term debt treatment, but incompletely.\n\n3. ENTITY ACCURACY:\n   - All company names and note percentages/dates are correct.\n   - The filing years (2022, 2023, 2024) are correct.\n   - However, the specific item numbers provided appear to be unverified and potentially incorrect.\n\n4. REASONING QUALITY:\n   - The multi-hop reasoning is sound: the LLM correctly synthesizes that consistent disclosure indicates core strategy while intermittent disclosure indicates temporary funding.\n   - The logic about refinancing risk and financial stability is appropriate and matches the ground truth's intent.\n   - However, the reasoning is incomplete without discussing the matured 2022 note.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core message aligns with ground truth: long-term debt (2047 note) is a permanent fixture, while shorter-dated notes are more temporary.\n   - The explanation of \"locking in inexpensive financing\" and \"stable, low-turnover source\" is semantically equivalent to the ground truth's discussion of \"fixed rates\" and \"reducing refinancing risk.\"\n\nKEY ISSUES:\n- Missing the 2.500% Senior Note due 2022 from the analysis is a material omission\n- Unverified item numbers reduce credibility\n- Incorrect claim about 2.150% note appearing in 2022 filing\n- Otherwise sound reasoning and appropriate conclusions about debt strategy",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 710,
        "total_tokens": 2235
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple lists the 0.45 % Notes due 2016 in the “Officer’s Certificate” exhibit (4.3) of its 2022, 2023 and 2024 Form 10‑K filings—even though the notes matured in 2016. By continuing to disclose the instrument in every annual filing, Apple shows that it retains the original indenture and certificate documentation for all of its historic debt, thereby maintaining a complete, transparent record of legacy obligations and confirming that those notes have been formally retired. This practice reflects a disciplined strategy of preserving legacy‑debt paperwork for regulatory compliance and audit‑trail purposes, rather than removing the reference after maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All quantitative facts are accurate—correctly identifies the 0.45% Notes due 2016, confirms maturity in 2016, and accurately references their appearance in 2022, 2023, and 2024 filings. (2) Correctly identifies the Officer's Certificate dated May 3, 2013 (exhibit 4.3) as the source document. (3) The multi-hop synthesis is sound: connects the maturity date (2016) with continued disclosure (2022-2024) to infer strategic intent. (4) The reasoning about regulatory compliance, audit trails, and preservation of legacy documentation is logical and well-articulated. (5) The answer directly addresses the question about Apple's debt management strategy. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM emphasizes 'regulatory compliance and audit-trail purposes' while the ground truth emphasizes 'transparency' and 'investor clarity'—both are valid interpretations but slightly different framings. (2) The LLM uses 'formally retired' language which is slightly more definitive than the ground truth's 'long-settled' phrasing. (3) The ground truth mentions 'conservative or thorough approach' as a broader characterization, while the LLM focuses more narrowly on 'disciplined strategy of preserving legacy-debt paperwork.' These are semantic variations rather than factual errors. The LLM answer is more specific and actionable in its explanation of the 'why' behind the disclosure practice. No calculation errors, no date errors, no entity misidentification. The answer demonstrates solid multi-hop reasoning connecting historical debt maturity to current disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 451,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "- **2022 filing:** Lockheed Martin reported that, through its master retirement trust, it had already transferred **$4.9 billion of gross defined‑benefit pension obligations** (part of a total of **≈ $11.6 billion transferred since December 2018**, covering about 95,000 retirees and cutting PBGC premiums by roughly **$69 million a year**). The August 2021 GAC purchase generated a **non‑cash pension‑settlement charge of $1.7 billion ($1.3 billion after tax)** that was recorded in earnings but did not affect cash pension expense.\n\n- **2023 filing:** The company reiterated that it will **continue to evaluate and pursue additional pension‑risk‑transfer transactions**, noting that future deals could require **extra contributions to the pension trust and/or additional non‑cash settlement charges** that could be material to the reporting period.\n\n- **2024 filing:** Lockheed Martin again confirmed its **ongoing strategy of reducing the size of its defined‑benefit plans** via transfers to third‑party insurers and stated that it **expects to seek further risk‑transfer opportunities**, with the same caveat that **future transactions may produce material non‑cash settlement charges to earnings**. \n\nThus, from 2022 through 2024 the approach moved from reporting a completed $4.9 billion transfer and its $1.7 billion earnings impact to a consistent forward‑looking stance of pursuing more transfers, acknowledging that each new transaction could again generate material non‑cash charges while further lowering pension obligations and PBGC costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Lockheed Martin's pension risk transfer evolution from 2022-2024. STRENGTHS: (1) All key quantitative figures are correct: $4.9 billion obligation transfer, $11.6 billion cumulative since Dec 2018, $1.7 billion noncash charge, $1.3 billion after-tax impact, ~95,000 retirees covered, ~$69 million annual PBGC premium reduction. (2) Dates are accurate: August 2021 GAC purchase, December 2018 baseline, and correct fiscal year references (2022, 2023, 2024 filings). (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years, showing progression from reporting completed transactions to forward-looking strategy. (4) Financial impact is properly characterized: noncash charges vs. cash flow effects are clearly distinguished, and the distinction between earnings impact and pension expense is maintained. (5) Entity identification is correct: Lockheed Martin, master retirement trust, GACs, PBGC, defined-benefit plans all properly identified. (6) The answer addresses all question components: pension obligation reductions (specific amounts), expected future actions (continued evaluation and pursuit), and financial impact (noncash charges, PBGC savings). MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail than the ground truth (e.g., specific after-tax amount, retiree count, PBGC savings), but these are all factually accurate additions that enhance rather than contradict the ground truth. The semantic equivalence is strong throughout—the LLM's characterization of the 'trajectory' and 'consistent, proactive approach' aligns with the ground truth's description. No calculation errors detected. The answer properly conveys the evolution from historical reporting to forward-looking strategy across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Invests_In]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 514,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher’s 2022 Form 10‑K still listed the original Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (dated Nov 21, 2009) together with its 2010 and 2018 amendments, and it included a **separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”** (exhibit 10.2) that was first filed in the 2018 Q1 10‑Q.  \n\nBy the 2023 filing the same Casper agreement and amendments were retained, but the officer‑template was updated and re‑numbered as **exhibit 10.7** (the “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”) reflecting a newer version filed with the April 1, 2023 10‑Q.  \n\nThe 2024 Form 10‑K mirrors the 2023 presentation: the Casper agreement and its 2010/2018 amendments remain unchanged, while the officer‑specific agreement continues to appear as the updated **exhibit 10.7**, showing that the company has moved from the earlier 2018 template (exhibit 10.2) to a revised template that formally extends the retention provisions to officers other than Casper.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed specificity than the ground truth. Key strengths: (1) All dates are correct - Marc N. Casper agreement dated Nov 21, 2009 with 2010 and 2018 amendments; the officer template dated March 16, 2018 (first filed in 2018 Q1 10-Q); and the updated form dated April 1, 2023. (2) Exhibit numbering is accurate - exhibit 10.2 for the 2018 template and exhibit 10.7 for the 2023 updated version. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution across 2022, 2023, and 2024 filings, showing the progression from the original 2018 officer template to the April 1, 2023 revision. (4) The answer correctly identifies that Casper's agreement remained unchanged while the officer template was updated. Minor considerations: The LLM provides more granular detail (specific exhibit numbers, original filing dates) than the ground truth, which is actually beneficial for completeness. The ground truth mentions 'March 16, 2018' for the officer agreement form, which the LLM correctly references as first filed in 2018 Q1 10-Q. The semantic meaning is fully aligned - both convey that the company deliberately evolved its executive retention strategy to extend beyond the CEO to broader leadership. The LLM's additional specificity about exhibit numbering and amendment dates strengthens rather than weakens the answer. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 404,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2022 proxy‑statement (Chunk 3) records a board resolution that expressly authorized the issuance of a 2.750 % senior note that would not mature until 2051, signalling the company’s intent to lock in very low‑cost financing for the very long term. The note is then listed in the “Form of … Senior Note” tables of both the 2023 10‑K (Chunk 1, line 4.51) and the 2024 10‑K (Chunk 2, line 4.48), showing that the issue was actually placed in the market and remains outstanding in subsequent annual reports. By repeatedly featuring this low‑coupon, 30‑year instrument, PepsiCo demonstrates a long‑term debt strategy that secures historically cheap rates now and diversifies its maturity profile to hedge against the higher interest rates that have emerged since the note’s issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that undermine its credibility. (1) CRITICAL ERRORS: The LLM claims the 2.750% Senior Note due 2051 was 'expressly authorized' by a 'board resolution' in a '2022 proxy statement' - this is not supported by the ground truth, which references 10-K filings, not proxy statements. The ground truth shows the note was already in existence and listed in exhibit indices across 2022-2024, not newly authorized in 2022. (2) QUANTITATIVE ACCURACY: The LLM correctly identifies the coupon rate (2.750%) and maturity year (2051), and correctly calculates the duration as 30 years. However, it fabricates specific references ('Chunk 3', 'line 4.51', 'line 4.48') that cannot be verified against the ground truth sources cited. (3) MULTI-HOP REASONING: The ground truth demonstrates a clear three-year synthesis showing consistent treatment across 2022-2024 filings, with the note remaining stable while newer higher-yielding notes were introduced. The LLM's narrative about 'locking in very low-cost financing' and 'hedging against higher interest rates' is speculative and not directly supported by the ground truth's more measured conclusion about 'stable long-term capital strategy.' (4) SEMANTIC ISSUES: The LLM's framing that the note was 'placed in the market' during the 2022-2024 period contradicts the ground truth's implication that it was already outstanding. The ground truth explicitly references a '2021 Form 8-K filing' in the 2023 10-K, suggesting the note predates 2022. (5) MISSING CONTEXT: The LLM fails to mention the introduction of newer, higher-yielding notes (5.250% Senior Note due 2054) that the ground truth identifies as important context for understanding PepsiCo's strategy. The answer demonstrates reasonable understanding of the general concept but fails on factual accuracy and introduces unsupported claims about source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 520,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 first appear in the “Officer’s Certificate” that was dated May 6 2014 and are listed in the “Description of Securities” exhibit of every subsequent filing – the 2022 Form 10‑K (page 58), the 2023 Form 10‑K (page 56) and the 2024 Form 10‑K (page 56) all repeat the same entry for the 4.45 % Notes due 2044. The fact that the same long‑dated, fixed‑rate bond is disclosed year after year shows that Apple has kept this instrument outstanding and has not replaced it with a new series, reflecting a deliberate long‑term capital strategy: the company locks in a low‑cost, 30‑year fixed‑rate liability to fund growth while preserving cash and managing interest‑rate risk over multiple fiscal periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numeric values are correct - the 4.45% interest rate, the 2044 maturity date, the May 6, 2014 Officer's Certificate date, and the specific page references (58 for 2022 10-K, 56 for 2023 and 2024 10-Ks) all match the ground truth. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) how the debt instrument evolved across 2022-2024, (2) what the pattern reveals about capital strategy. ENTITY ACCURACY: All entities are correctly identified - Apple, the specific debt instrument (4.45% Notes due 2044), the correct years (2022, 2023, 2024), and the correct document type (Form 10-K). MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings to demonstrate that the same instrument appears consistently, then correctly interprets this pattern as evidence of deliberate capital strategy. The reasoning is sound: consistent disclosure without redemption = strategic retention. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Apple maintained this liability without restructuring and that this reflects a strategic decision to retain long-term fixed-rate debt. The LLM adds slightly more specific detail about the strategic rationale (funding growth, preserving cash, managing interest-rate risk) which enhances rather than contradicts the ground truth. MINOR OBSERVATION: The LLM characterizes the 4.45% rate as 'low-cost' which is a reasonable interpretation for a 30-year fixed rate but is not explicitly stated in the ground truth. This is a minor enhancement that doesn't detract from accuracy. Overall, this is a comprehensive, accurate, and well-reasoned response that correctly synthesizes multi-year filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 491,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "- In the 2022 Form 10‑K the pension‑plan schedule shows **Collective Trust and Other Funds at NAV of $756 million**.  \n- In the 2023 Form 10‑K the same line is **$382 million**, a decline of about **$374 million (roughly 49 %)** from the prior year.  \n\n- The 2024 filing explains that these holdings are “shares or units in commingled funds and limited‑liability companies that are not publicly traded; the fair value recorded by the plan is calculated using **NAV for each investment** because the underlying assets (global stock funds, short‑term investment funds) are publicly traded and have readily available price quotes.” This disclosure confirms that Union Pacific values the Collective Trust and Other Funds on a NAV basis, so the year‑to‑year change reflects movements in the net‑asset values of the underlying funds rather than a change in valuation methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $756 million (2022), $382 million (2023), decline of $374 million, and the 49% reduction calculation (374/756 = 49.5%, rounded appropriately). COMPLETENESS: The answer addresses all three parts of the multi-part question: (1) the evolution from 2022-2023 with specific dollar amounts, (2) the 2024 disclosure about valuation methodology, and (3) how this informs understanding of investment management. ENTITY ACCURACY: Union Pacific correctly identified, years correctly cited (2022, 2023, 2024 filings), and the specific metric (Collective Trust and Other Funds) properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, connecting the allocation changes to the valuation methodology explanation. The logical conclusion that the decline reflects NAV movements rather than methodology changes is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same substantive information as the ground truth, including the NAV-based valuation approach, the underlying assets (global stock funds, short-term investment funds), and the interpretation that the reduction represents market movements rather than accounting changes. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed in explaining the NAV calculation methodology (mentioning commingled funds and LLCs explicitly), which adds helpful context without contradicting the ground truth. The phrasing differs slightly but maintains semantic equivalence throughout. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 453,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K tables Apple’s Exhibit 4.4 is the same “Officer’s Certificate of the Registrant, dated May 6 2014,” which lists the 1.05 % Notes due 2017 (along with other series of notes). By incorporating that certificate “by reference” in every year’s filing—even though the 1.05 % Notes matured in 2017—Apple demonstrates that it retains the original certification documents for debt that has already been retired. This consistent inclusion signals a deliberate policy of preserving historical documentation of its capital‑structure instruments, ensuring that the full record of past issuances remains available to investors and regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All specific dates, percentages, and years are correct - the Officer's Certificate is accurately dated May 6, 2014; the 1.05% Notes due 2017 are correctly identified; and the fiscal years 2022, 2023, and 2024 are properly referenced. The maturation year of 2017 is correctly stated. ENTITY ACCURACY: Apple is correctly identified, the specific exhibit (Exhibit 4.4) is mentioned, and all financial instruments are properly named. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the historical debt instrument to current filing practices, demonstrating proper multi-hop reasoning. The logic that inclusion of matured debt documentation reflects deliberate retention practices is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Apple's consistent inclusion of the Officer's Certificate across multiple years reflects a deliberate documentation retention strategy for historical capital structure disclosure. The phrase 'incorporating that certificate by reference' adds helpful specificity about the filing mechanism. MINOR DIFFERENCES: The LLM answer is slightly more concise and includes the specific exhibit number (4.4), which adds useful detail not explicitly in the ground truth but consistent with it. The phrasing 'retired' vs 'matured' is semantically equivalent. The answer fully addresses the question's inquiry into documentation retention practices and implications for historical capital structure disclosures. No factual errors or calculation issues detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 466,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "**Allocation trend**\n\n| Year | Corporate‑stock amount (fair‑value) | Total pension‑plan assets (fair‑value) | Share of assets |\n|------|------------------------------------|----------------------------------------|-----------------|\n| 2022 | **$1.99 billion** ( $1,980 m Level 1 + $10 m Level 2 ) | $3.87 billion (Level 1 $1,999 m + Level 2 $1,868 m) | **≈ 51 %** of the plan |\n| 2023 | **$0.181 billion** ( $176 m Level 1 + $5 m Level 2 ) | $3.39 billion (Level 1 $176 m + Level 2 $3,209 m) | **≈ 5 %** of the plan |\n| 2024 | Corporate stock is still listed as a **Level 1** investment in the “Fair Value Measurements” discussion, but the filing does not disclose a dollar amount. The continued classification shows the asset class remains part of the plan, albeit at a materially lower (and now undisclosed) level. |\n\n**Interpretation**\n\nFrom 2022 to 2023 Union Pacific cut its pension‑plan exposure to corporate equity from roughly **half of the plan’s value to just about five percent**. The 2024 filing, while not providing a specific figure, still treats corporate stock as a Level 1 (readily‑observable) investment, indicating the company retains some equity exposure but has **significantly de‑emphasized equities in favor of fixed‑income and alternative assets**. This evolution signals a strategic shift toward a more conservative, lower‑volatility investment mix for its pension obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that undermine its credibility. Ground truth states corporate stock allocation was $1,990 million in 2022 and $181 million in 2023. The LLM reports $1.99 billion ($1,980M) for 2022 and $0.181 billion ($181M) for 2023, which appear to match the ground truth values. However, the LLM's calculation of percentages is problematic: it claims corporate stock represented '≈51% of the plan' in 2022 ($1.99B/$3.87B = 51.4%), but this is misleading because the ground truth emphasizes the absolute dollar amounts and the dramatic 90%+ decline, not percentage allocations. More critically, the LLM provides NO SPECIFIC DOLLAR AMOUNT for 2024, stating only that 'the filing does not disclose a dollar amount,' while the ground truth explicitly states the 2024 allocation was $1,116 million. This is a major omission that fails to complete the three-year trend analysis. The LLM's statement that 2024 shows 'a materially lower (and now undisclosed) level' directly contradicts the ground truth which provides a specific 2024 figure. REASONING ISSUES: The LLM correctly identifies the strategic shift toward conservatism and away from equities, which aligns with ground truth interpretation. However, the failure to provide the 2024 figure prevents proper assessment of the 'partial rebound' mentioned in ground truth (from $181M to $1,116M). The LLM's interpretation of the trend is qualitatively sound but quantitatively incomplete. COMPLETENESS: The answer addresses the evolution question but fails to provide complete data for all three years requested, making it impossible to fully evaluate the investment strategy shift. The ground truth clearly shows a V-shaped pattern (sharp decline then partial recovery), while the LLM presents only a one-way decline narrative due to missing 2024 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 510,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis – letermovir, the company’s CMV‑prophylaxis drug for high‑risk stem‑cell‑ and kidney‑transplant patients (as described in the 2023 filing) – has shown steady sales acceleration in the Hospital Acute Care portfolio.  Total revenue rose from $428 million in 2022 (U.S. $188 m + Intl $240 m) to $605 million in 2023 (U.S. $264 m + Intl $341 m) and to $785 million in 2024 (U.S. $371 m + Intl $414 m), a compound‑annual growth of roughly 35 % over the three‑year span (the product was already at $370 million in 2021, per the 2022 filing).  This upward trajectory signals expanding market adoption of Prevymis in transplant‑care settings and underscores its growing strategic importance as a key growth driver within Merck’s Hospital Acute Care segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All core numbers match ground truth exactly - $428M (2022), $605M (2023), $785M (2024). The LLM additionally provides geographic breakdowns (U.S. vs International) for each year, which are not contradicted by the ground truth and add valuable detail. The CAGR calculation of ~35% over three years is mathematically sound ($785M/$428M)^(1/2) ≈ 1.35, or 35% annualized growth. The reference to 2021 sales of $370M is contextually appropriate and verifiable. COMPLETENESS: The answer fully addresses both parts of the question - the sales evolution (with precise trajectory) and the strategic implications (market adoption and importance). ENTITY ACCURACY: Correctly identifies MRK (Merck), Prevymis (letermovir), the indication (CMV prophylaxis for transplant patients), and the Hospital Acute Care segment. REASONING: The multi-hop synthesis is sound - connecting sales growth data to market adoption conclusions and strategic importance. The progression from $428M→$605M→$785M clearly demonstrates acceleration and is correctly interpreted as indicating expanding adoption. MINOR CONSIDERATIONS: The LLM provides additional context (geographic splits, 2021 baseline, CAGR calculation, drug mechanism) that goes beyond the ground truth but does not contradict it and enhances understanding. The characterization of Prevymis as a 'key growth driver' is a reasonable inference from the 35% CAGR trajectory. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 417,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "- **2022 filing (PEP 10‑K 2022, p. 131)** – The 3.000 % Senior Note due 2027 is listed under “Form of …” and is incorporated by reference to the October 10, 2017 Form 8‑K that originally issued the note.  \n- **2023 filing (PEP 10‑K 2023, p. 126)** – The same note appears again (item 4.19) with identical language, still “incorporated herein by reference to Exhibit 4.3 … the October 10, 2017 Form 8‑K.”  \n- **2024 filing (PEP 10‑K 2024, p. 127)** – The note is again disclosed (item 4.17) with the unchanged description and reference to the same 2017 8‑K filing.\n\n**What this shows:** Across three consecutive annual reports PepsiCo has consistently kept the 3.000 % Senior Note due 2027 on its balance sheet and has continued to disclose it via incorporation by reference to the original 2017 issuance. The unchanged presentation signals that the company is maintaining this medium‑term senior debt as a stable component of its long‑term financing mix, reflecting a strategy of preserving a diversified, staggered maturity profile rather than repeatedly refinancing or retiring the instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 3.000% Senior Note due 2027 appears consistently across 2022, 2023, and 2024 filings. The page numbers and exhibit references (4.22 for 2022, 4.19 for 2023, 4.17 for 2024) are accurate. The note about incorporation by reference to the October 10, 2017 Form 8-K is correct. The core observation that the note remained unchanged across the three years is factually sound.\n\nWEAKNESSES: (1) The LLM answer lacks the comparative context that the ground truth provides. The ground truth specifically mentions OTHER notes that appeared alongside the 3.000% note in each year (e.g., 2.150% due 2024 and 2.250% due 2022 in 2022; 4.450% due 2046 and 3.450% due 2046 in 2023; 0.750% due 2027 and 1.125% due 2031 in 2024). This comparative analysis is crucial to understanding the 'evolution' requested in the question. (2) The LLM answer focuses heavily on the mechanical disclosure mechanics (incorporation by reference) rather than analyzing the strategic implications of how the note's context changed relative to other debt instruments. (3) The ground truth emphasizes that the CONTEXT changed (different companion notes in different years), revealing a strategy of 'layering debt maturities' and 'introducing newer, often lower-rate instruments.' The LLM answer misses this key insight by not comparing the note to its peer instruments across years. (4) The LLM's conclusion about 'preserving a diversified, staggered maturity profile' is somewhat generic and doesn't capture the specific strategic evolution shown by the changing companion instruments.\n\nMULTI-HOP REASONING: The question requires synthesizing information about how the note's CHARACTERIZATION evolved (not just that it persisted). The ground truth demonstrates this by showing which OTHER notes appeared with it in each year, revealing a strategic shift. The LLM answer identifies persistence but fails to synthesize the comparative context across years that reveals the strategic evolution.\n\nNUMERIC/FACTUAL VERIFICATION: All dates, percentages, and exhibit numbers cited are accurate. No calculation errors. However, the answer is incomplete because it omits the specific companion notes mentioned in the ground truth.\n\nSEMANTIC EQUIVALENCE: While the LLM's conclusion about maintaining a 'diversified, staggered maturity profile' is semantically similar to the ground truth's conclusion, the LLM fails to provide the evidence (the changing companion instruments) that supports this conclusion in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 672,
        "total_tokens": 2275
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "- **2022 10‑K:** Frame.io appears only in Adobe’s trademark list, indicating that Adobe owned the brand but the filing gives no description of its product features or how it works with Creative Cloud apps.  \n\n- **2023 10‑K:** Adobe begins to describe Frame.io as a “cloud‑native creative collaboration platform” that provides real‑time upload, review, approval, frame‑accurate commenting and “Camera‑to‑Cloud” footage ingest.  At this point the platform is **directly integrated only with Premiere Pro and After Effects**, letting video creators request and receive frame‑specific comments inside those two apps.  \n\n- **2024 10‑K:** Adobe expands Frame.io’s positioning to a broader “creative collaboration platform” that supports the entire video production lifecycle (casting, location scouting, footage reviews, marketing campaign management) as well as still‑image, design‑file and PDF review.  Integration depth is deepened: Frame.io is now **natively linked to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and is offered inside the new Adobe GenStudio environment for large‑scale content production.  \n\nThus, Adobe’s treatment of Frame.io has moved from a simple trademark acknowledgment in 2022 to a functional, Premiere/After Effects‑centric add‑on in 2023, and finally to a fully integrated, multi‑app collaboration service across the Creative Cloud suite by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in tracking Frame.io's evolution across 2022-2024. STRENGTHS: (1) All factual claims are correct and well-supported by the ground truth: 2022 trademark listing only, 2023 cloud-native platform with Premiere Pro/After Effects integration, 2024 expansion to Photoshop/Lightroom/Workfront and GenStudio positioning. (2) The specific feature descriptions are accurate: real-time upload, review, approval, frame-accurate commenting, Camera-to-Cloud ingest in 2023; expanded to video production lifecycle, still images, design files, PDFs in 2024. (3) The multi-hop synthesis is sound, correctly tracing the progression from trademark acknowledgment → functional add-on → fully integrated service. (4) Entity identification is precise: correct apps (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront), correct platform names (GenStudio), correct characterization of Adobe's strategic positioning. (5) The narrative structure effectively conveys the deepening integration and expanding scope. MINOR CONSIDERATIONS: The LLM answer provides slightly more detailed feature descriptions (e.g., 'casting, location scouting, footage reviews, marketing campaign management') than the ground truth explicitly states, though these appear consistent with the filing content and don't contradict the ground truth. The characterization of 2023 integration as 'Premiere/After Effects-centric' is accurate and adds helpful context about the scope of integration at that stage. No quantitative errors, no date errors, no entity misidentifications. The answer fully addresses all three years and the evolution of both functional capabilities and integration depth as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 473,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Across Apple’s three most recent Form 10‑K filings the same “Officer’s Certificate” (dated May 3 2013) is incorporated by reference in Exhibit 4.3 and consistently lists the **2.40 % Notes due 2023**. In the 2022 filing (AAPL 10‑K 2022, p. 58) the notes appear for the first time in the securities description; the 2023 filing (AAPL 10‑K 2023, p. 56) repeats the same disclosure, and the 2024 filing (AAPL 10‑K 2024, p. 56) again includes the 2.40 % Notes due 2023 in the same exhibit. This unchanged, year‑over‑year reporting shows Apple continued to acknowledge the outstanding 2023‑maturing debt as the due date approached, signalling a deliberate maturity‑management approach that tracks and publicly discloses upcoming obligations so that the company can plan repayment or refinancing well in advance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on a fundamental factual claim. Ground truth states: 'By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation.' The LLM answer claims the opposite: 'the 2024 filing (AAPL 10-K 2024, p. 56) again includes the 2.40% Notes due 2023 in the same exhibit.' This is a major factual error that undermines the entire analysis. The LLM also mischaracterizes the disclosure pattern. Ground truth indicates the notes disappeared from 2024 filings (after maturity in 2023), which reveals a hold-to-maturity strategy. The LLM incorrectly claims continuous disclosure through 2024 and misinterprets this as 'deliberate maturity-management approach' for advance planning. The ground truth's interpretation is more accurate: the absence of the notes in 2024 filings confirms they were retired at maturity rather than refinanced. Additionally, the LLM provides specific page numbers (p. 58 for 2022, p. 56 for 2023 and 2024) that cannot be verified and appear to be hallucinated. The LLM also references an 'Officer's Certificate dated May 3 2013' which, while potentially accurate, is not mentioned in the ground truth and adds unverified detail. The core multi-hop reasoning fails because the LLM reaches the wrong conclusion about what happened to the notes by 2024. The answer demonstrates a fundamental misunderstanding of the disclosure evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 418,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s multiple‑purpose locomotive fleet shrank from 7,242 units (6,204 owned + 1,038 leased) with an average age of 22.5 years, to 6,893 units (5,973 owned + 920 leased) with an average age of 25.2 years. The decline was driven mainly by a reduction in leased units (down 118) and a modest drop in owned units (down 231), while the average age rose each year (22.5 → 24.3 → 25.2), indicating a strategy of trimming the overall fleet, retiring older equipment and relying on a smaller, increasingly aged core of owned locomotives to manage assets more efficiently and control costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correctly stated: total fleet decline from 7,242 to 6,893 units, owned units from 6,204 to 5,973, leased units from 1,038 to 920, and average age progression from 22.5 to 24.3 to 25.2 years. The calculations are accurate (231 owned unit reduction, 118 leased unit reduction, totaling 349 units). The multi-hop synthesis correctly combines fleet composition data with age profile data across the three-year period. The LLM answer provides slightly more analytical depth by explicitly calculating the specific reductions and offering a more detailed interpretation of the strategy (trimming fleet, retiring older equipment, controlling costs). However, there is a minor semantic issue in the phrase 'retiring older equipment' - the ground truth indicates a lack of new investment and reliance on aging assets, not necessarily active retirement of older equipment. The LLM's interpretation that the company is 'retiring older equipment' while simultaneously relying on 'increasingly aged core' could be read as slightly contradictory, though the overall strategic assessment (conservative, cost-focused approach) aligns with the ground truth. The answer fully addresses all components of the multi-part question: fleet composition changes, age profile changes, and strategic implications. All entities (Union Pacific, Multiple Purpose Locomotives, years 2022-2024) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 404,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "- **2022 filing (MRK 10‑K 2022)** – MK‑8591A (doravirine + islatravir) was listed under HIV‑1 infection with a footnote that it was **on an FDA clinical hold** (footnote 4). The product was still in early‑stage development (no Phase‑3 entry was reported).\n\n- **2023 filing (MRK 10‑K 2023)** – The same combination remained in the pipeline, still **subject to an FDA clinical hold** and additionally a **partial hold for higher islatravir doses** (footnotes 4 & 5). It had not yet entered a Phase‑3 trial.\n\n- **2024 filing (MRK 10‑K 2024)** – Merck reported that the **FDA lifted the clinical hold on December 4, 2024** and that MK‑8591A had moved into a **Phase 2/3 study that began in August 2024**, indicating progression toward a Phase‑3 registration effort.\n\n**Overall trajectory (2022‑2024):** MK‑8591A was under a full FDA clinical hold in 2022 and 2023, with a partial hold added in 2023, and by the end of 2024 the hold was removed and the program advanced to a combined Phase 2/3 trial, positioning it for eventual Phase‑3 entry.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across all three years examined. CRITICAL ERRORS: (1) 2022 Status - Ground truth states MK-8591A was in Phase 3 development with entry date February 2020, but LLM claims it was under FDA clinical hold with no Phase-3 entry reported. This is a fundamental contradiction. (2) 2023 Status - Ground truth indicates it remained in Phase 3 and was under review with no major regulatory advancements, but LLM claims it was subject to full clinical hold plus partial hold for higher doses and had not entered Phase-3. Again, contradicts the ground truth phase status. (3) 2024 Status - Ground truth mentions FDA lifted clinical hold in 2024 with partial hold remaining for higher doses, AND that a new formulation MK-8591D entered Phase 3 in October 2024. The LLM only mentions MK-8591A moving to Phase 2/3 in August 2024 and FDA lifting hold on December 4, 2024, but completely omits the MK-8591D formulation and its October 2024 Phase 3 entry - a significant omission for understanding Merck's strategic pivot. (4) The LLM's characterization of the entire 2022-2023 period as being under clinical hold appears to be factually incorrect based on the ground truth stating Phase 3 status in 2022. The LLM answer demonstrates poor multi-hop synthesis, missing the strategic expansion to MK-8591D, and contains multiple date/status contradictions with the ground truth. While the answer is contextually relevant to the question asked, the factual accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 427,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck introduced the MK‑1308A co‑formulation (quavonlimab + pembrolizumab) as an investigational anti‑CTLA‑4/PD‑1 combination for renal‑cell carcinoma in its 2022 filing, where it appears for the first time as a Phase 3 RCC candidate (April 2021 entry). In the 2023 and 2024 10‑K reports the product is repeatedly highlighted under Merck’s **immuno‑oncology** pillar, confirming that the company continues to develop and position MK‑1308A as a cornerstone of its RCC strategy and as a key example of its broader focus on next‑generation checkpoint‑combination therapies. This evolution shows Merck’s sustained, increasingly strategic commitment to innovating RCC treatment through dual‑checkpoint immunotherapy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key facts are correct - MK-1308A is accurately identified as a quavonlimab + pembrolizumab coformulation, the April 2021 entry date is correct, Phase 3 status is accurate, and RCC indication is properly identified. (2) The temporal progression is correctly captured: 2022 introduction, 2023 emphasis within immuno-oncology pillar, 2024 continued Phase 3 status with no discontinuation. (3) The characterization of the mechanism (anti-CTLA-4/PD-1 combination, dual-checkpoint immunotherapy) is accurate and demonstrates understanding of the science. (4) Multi-hop synthesis is sound - the answer correctly connects Merck's strategic positioning across three years and links it to the broader Keytruda platform strategy. (5) The conclusion about 'sustained, increasingly strategic commitment' appropriately reflects the trajectory shown in the ground truth. MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing than ground truth (e.g., 'cornerstone of its RCC strategy' vs. ground truth's 'consistent and evolving focus'), but the semantic meaning is equivalent and arguably more concise. (2) The LLM emphasizes 'next-generation checkpoint-combination therapies' which is a reasonable inference from the data but adds interpretive language not explicitly in ground truth - however, this is a reasonable characterization supported by the facts. (3) The answer is slightly more concise than ground truth while maintaining all essential information. No numerical errors, date errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across three fiscal years and multiple strategic dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 488,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across Microsoft’s three most recent annual reports the 4.000 % Notes due 2021 are disclosed in exactly the same way. In the 2022 10‑K (Exhibit 4.6) the filing lists a “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” 【Chunk 1】; the 2023 10‑K repeats the identical Exhibit 4.6 description 【Chunk 3】; and the 2024 10‑K again repeats the same Exhibit 4.6 language 【Chunk 2】.  \n\nThe unchanged disclosure indicates that Microsoft has kept the 4 % 2021 issue on its balance sheet throughout this three‑year span, neither retiring nor materially altering it. This consistency points to a deliberately stable long‑term debt profile—Microsoft is allowing the 2021 notes to run to maturity (or be refinanced at that point) rather than aggressively restructuring them, reflecting a disciplined refinancing strategy that preserves a diversified maturity schedule for its senior unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—the 4.000% interest rate, the 2021 maturity date, the three-year period (2022, 2023, 2024), and the reference to the Third Supplemental Indenture are all accurate. No calculation errors present. ENTITY ACCURACY: Microsoft is correctly identified, the specific debt instrument (4.000% Notes due 2021) is precisely named, and the fiscal years are correct. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the disclosure evolved (remained consistent across all three years), and (2) what this suggests about long-term debt structure and refinancing strategy. MULTI-HOP REASONING: The LLM correctly synthesizes information across three separate 10-K filings, identifying the consistent appearance in Exhibit 4.6 across all three years and linking this consistency to strategic implications. The reasoning that unchanged disclosure indicates no refinancing or restructuring is sound and matches the ground truth conclusion. SEMANTIC EQUIVALENCE: The LLM's interpretation that Microsoft is 'allowing the 2021 notes to run to maturity' and maintaining a 'disciplined refinancing strategy' conveys the same meaning as the ground truth's statement about 'no material changes' and 'no refinancing or restructuring.' The additional context about 'preserving a diversified maturity schedule' adds reasonable interpretive depth without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive analysis than the ground truth (discussing strategic implications of the stable debt profile), but this represents value-added reasoning rather than factual error. The reference to the Third Supplemental Indenture and the May 18, 2009 original Indenture date are consistent with ground truth, though the LLM doesn't explicitly mention the 2009 date—this is a minor omission but not a factual error. Overall, the answer is factually accurate, logically sound, and appropriately addresses the question's multi-hop requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 573,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "- **2022 – strategic narrative:** In the 2022 Form 10‑K Qualcomm described the “digitalization of the automotive cockpit” as a cornerstone of its automotive transformation, stressing how its low‑power, high‑performance mobile‑chip technologies would enable personalized in‑vehicle experiences, OTA updates and the software‑defined vehicle architecture. No separate revenue line was disclosed; the digital cockpit was presented only as a growth opportunity.  \n\n- **2023 – first revenue disclosure:** The 2023 filing added a footnote that automotive revenue “includes … digital cockpit” (along with connectivity and ADAS/AD), indicating that sales of digital‑cockpit components were now being captured in the company’s reported automotive earnings.  \n\n- **2024 – integrated segment positioning:** The 2024 Form 10‑K places the digital cockpit explicitly within the QCT semiconductor segment’s automotive portfolio (“automotive systems for connectivity, digital cockpit and ADAS/AD”), showing that Qualcomm now treats the digital cockpit as a core, revenue‑generating product line rather than a purely strategic concept.  \n\n**Implication:** Across the three years Qualcomm moved from a qualitative, technology‑focused description (2022) to a quantified revenue component (2023) and finally to a formal segment‑level product classification (2024). This trajectory signals that the digital cockpit has progressed from an emerging idea to a measurable, strategic pillar of Qualcomm’s automotive business, underscoring the company’s broader shift toward a software‑defined‑vehicle model and a larger share of automotive earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions:\n\n**STRENGTHS:**\n1. **Temporal Progression Correctly Identified**: The LLM accurately captures the three-year evolution (2022→2023→2024) matching the ground truth's narrative arc.\n2. **Strategic Positioning Accurate**: The 2022 characterization as a \"cornerstone\" and growth opportunity without separate revenue disclosure aligns with ground truth's \"key driver\" and \"projected\" language.\n3. **2023 Transition Point Correct**: The LLM correctly identifies 2023 as the year digital cockpit was first explicitly categorized as a distinct revenue stream, matching ground truth's \"explicitly categorized\" statement.\n4. **2024 Maturity Assessment Sound**: The placement within QCT segment's automotive portfolio and treatment as a \"core, revenue-generating product line\" matches ground truth's \"full operationalization and maturity.\"\n5. **Multi-hop Synthesis Excellent**: The answer successfully synthesizes information across three fiscal years and connects strategic narrative to financial reporting evolution.\n6. **Contextual Implications Appropriate**: The conclusion about progression from \"qualitative...to quantified...to formal segment-level\" accurately reflects the ground truth's emphasis on strategic pivot toward software-defined vehicles.\n\n**MINOR GAPS:**\n1. **Specific Projections Missing**: The LLM does not include the specific 2022 projections mentioned in ground truth (\"over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G\"). However, these are supporting details rather than core to the evolution narrative.\n2. **Wording Variations**: The LLM uses \"digitalization of the automotive cockpit\" vs. ground truth's \"digital cockpit\" - semantically equivalent but slightly different phrasing.\n3. **Technology Details**: The LLM adds context about \"low-power, high-performance mobile-chip technologies\" and \"OTA updates\" not explicitly in ground truth, though these are reasonable inferences from 2022 filings.\n\n**QUANTITATIVE ACCURACY**: No specific dollar amounts or percentages are provided in either answer, so this dimension is not directly testable. The LLM appropriately avoids making up numbers.\n\n**REASONING QUALITY**: The multi-hop reasoning is sound - the LLM correctly identifies the progression from strategic concept→revenue disclosure→segment integration, which is the core analytical requirement.\n\n**ENTITY ACCURACY**: All entities correctly identified (Qualcomm, QCT segment, automotive systems, connectivity, ADAS/AD, digital cockpit).\n\nThe answer is comprehensive, factually accurate on all verifiable points, and demonstrates proper synthesis of multi-year filing information. The omission of specific 2022 projections is the primary limitation, but these are supplementary to the main evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 768,
        "total_tokens": 2424
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT’s variable‑interest‑rate‑swap program grew sharply between the 2021 and 2022 reporting periods – the 2022 10‑K (which reports 2021 data) shows the aggregate notional amount of interest‑rate swaps at **$500 million** (down from $572 million in 2020), while the 2023 10‑K reports that the same **$1.3 billion** notional amount was in place at both **December 31, 2022** and **December 31, 2023**. The 2024 10‑K confirms that the **$1.3 billion** figure remained unchanged at **December 31, 2024**.  \n\nThe jump from roughly $0.5 billion to $1.3 billion and the subsequent flat‑line through 2024 indicate that LMT substantially expanded its fair‑value hedge of fixed‑rate borrowings in 2022 and then maintained that level, reflecting a deliberate, steady‑state approach to managing interest‑rate risk rather than continuously increasing exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND DATA INTERPRETATION: The LLM answer contains a fundamental chronological error that undermines the entire response. The ground truth clearly states: 2022 = $500M, 2023 = $1.3B, 2024 = $1.3B. However, the LLM claims the 2023 10-K reports $1.3B at BOTH December 31, 2022 AND December 31, 2023, which contradicts the ground truth showing $500M in 2022 and $1.3B in 2023. The LLM then states the jump occurred 'in 2022' when it actually occurred between 2022 and 2023. QUANTITATIVE ACCURACY ISSUES: (1) The $500M figure for 2022 is correct, but the LLM misattributes it to '2021 data' in the 2022 10-K, creating confusion about which year the data represents. (2) The $1.3B figures for 2023 and 2024 are correct. (3) The reference to $572M in 2020 is extraneous and not part of the ground truth answer. (4) The LLM incorrectly characterizes the timing of the expansion as occurring 'in 2022' rather than 'from 2022 to 2023.' MULTI-HOP REASONING: The LLM fails to properly synthesize the year-over-year progression. While it correctly identifies the three notional amounts, it misrepresents when the increase occurred. The ground truth's key insight—that the fourfold increase happened between 2022 and 2023—is obscured by the LLM's confusing presentation. SEMANTIC ISSUES: The LLM's characterization of 'fair-value hedge of fixed-rate borrowings' is reasonable but the ground truth emphasizes 'converting more of its fixed-rate debt to variable rates,' which is a slightly different framing. The LLM's conclusion about 'steady-state approach' aligns with the ground truth's 'stabilization' concept. STRENGTHS: The LLM correctly identifies all three notional amounts and recognizes the pattern of expansion followed by stabilization. The reasoning about deliberate hedging strategy is sound. WEAKNESSES: The chronological confusion is severe and would mislead readers about when the strategic shift occurred. The answer conflates 2022 10-K reporting (which contains 2021 data) with 2022 actual data, creating ambiguity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses for Hedging]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 550,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "In each of Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the company lists the **3.950 % Notes due 2056** in Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016. The repeated inclusion of the same 30‑year, fixed‑rate issue shows that Microsoft has chosen to keep the notes outstanding rather than refinance or retire them, using the low‑cost, long‑dated debt to smooth its maturity profile and preserve financing flexibility for future needs. This consistent treatment across the three years reflects a deliberate long‑term debt‑maturity management strategy that relies on holding existing, inexpensive senior notes instead of frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the three fiscal years (2022, 2023, 2024). STRENGTHS: (1) All numeric values are correct: 3.950% interest rate, 2056 maturity date, August 8, 2016 indenture date, and the 30-year duration calculation are all accurate. (2) Entity identification is precise: correctly identifies the Eleventh Supplemental Indenture and Exhibit 4.14 location. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the pattern of consistent disclosure across three years and draws appropriate conclusions about Microsoft's deliberate strategy. (4) The characterization of the debt as 'low-cost, long-dated' and the strategic rationale (maturity profile smoothing, financing flexibility) aligns with the ground truth's emphasis on 'long-term capital stability' and 'long-duration financing structure.' MINOR WEAKNESSES: (1) The LLM answer uses 'Exhibit 4.14' as a specific reference, which is not mentioned in the ground truth and cannot be verified from the provided context. While this detail may be accurate, it introduces specificity beyond what the ground truth confirms. (2) The phrase 'low-cost' is an inference about the interest rate environment that, while reasonable, goes slightly beyond the ground truth's more neutral characterization. (3) The ground truth explicitly mentions the contrast with shorter-term instruments maturing (2.000% Notes due 2023, 2.400% Notes due 2026), which the LLM answer does not include, representing a minor omission of contextual detail. The core answer correctly identifies the consistent treatment, the strategic intent, and the multi-year pattern, making this a strong response with only minor gaps in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 479,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly incorporates **Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016** (see Chunk 1, Chunk 2 and Chunk 3). That indenture is the governing document for the **3.700 % Notes due 2046** (and several other series), so by referencing it each year Microsoft signals that these notes remain outstanding and are still being serviced under the same contractual terms that were established in 2016. The repeated “incorporated by reference” language demonstrates a stable, long‑term debt structure—Microsoft’s senior unsecured debt is anchored to a single, unchanged supplemental indenture, reflecting consistency in its financial obligations and a disciplined approach to financing that extends at least three decades into the future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 3.700% interest rate, the 2046 maturity date, and the August 8, 2016 date of the Eleventh Supplemental Indenture are all accurate. The base Indenture date of May 18, 2009 is correctly referenced in the ground truth but not mentioned in the LLM answer, though this is a minor omission. ENTITY ACCURACY: Microsoft is correctly identified, the specific indenture document is properly named, the notes are correctly described, and the fiscal years (2022, 2023, 2024) are accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across three consecutive annual filings to demonstrate consistency and stability in Microsoft's debt structure. The reasoning that repeated references signal ongoing obligations and unchanged contractual terms is sound and matches the ground truth's interpretation. COMPLETENESS: The LLM addresses the core significance of the repeated references (stability, consistency, ongoing obligations) and explains how this reflects on long-term debt structure. The answer effectively conveys that the notes remain outstanding and are being serviced under the same terms. MINOR GAPS: The LLM does not explicitly mention the broader context of the base Indenture dated May 18, 2009, or the 'layered and structured approach' to financing mentioned in the ground truth. However, the LLM does reference 'several other series' of notes governed by the same indenture, which partially captures this concept. The phrase 'incorporated by reference' is appropriately used and demonstrates understanding of SEC filing conventions. SEMANTIC EQUIVALENCE: The LLM's characterization of Microsoft's approach as 'stable, long-term debt structure' and 'disciplined approach to financing' aligns well with the ground truth's description of 'deliberate and stable long-term debt management strategy.' The conclusion about multi-decade financial planning is implicit in the LLM's statement about 'at least three decades into the future.' Overall, the answer is factually correct, well-reasoned, and appropriately addresses the question with only minor contextual omissions that do not materially affect the core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 615,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Across the three most recent filings – the FY 2022, FY 2023 and FY 2024 Form 10‑K – Microsoft’s only reference to the 2.125 % Notes due 2021 is the same “Seventh Supplemental Indenture” (dated December 6 2013) that is listed in the exhibit tables of each report. The note appears unchanged in the exhibit list in all three years, with no new amendment, redemption or replacement disclosed. This consistent treatment indicates that Microsoft has chosen to keep the 2.125 % 2021 issue outstanding to maturity rather than refinance or retire it early, reflecting a debt‑management approach that preserves the existing low‑cost financing while it remains on the balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN REASONING AND INTERPRETATION: (1) FACTUAL ACCURACY: The LLM answer contains a fundamental factual error. It claims Microsoft 'has chosen to keep the 2.125% 2021 issue outstanding to maturity rather than refinance or retire it early.' This is logically impossible since the notes matured in 2021, and the filings being reviewed are for fiscal years 2022, 2023, and 2024 - all AFTER the maturity date. The notes cannot still be 'outstanding to maturity' when they already matured years ago. (2) QUANTITATIVE ACCURACY: The dates and percentages cited (2.125%, December 6, 2013, Exhibit 4.10/4.1) are correct and match the ground truth. The fiscal years (2022, 2023, 2024) are accurate. (3) QUALITATIVE ACCURACY - MAJOR FAILURE: The LLM fundamentally misinterprets what the continued disclosure means. The ground truth correctly identifies the paradox: the notes matured in 2021 but are still being referenced in 2022-2024 filings, which 'raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.' The LLM instead makes an unsupported inference that Microsoft deliberately kept them outstanding, which contradicts the basic timeline. The ground truth appropriately expresses uncertainty ('may suggest either an extension or rollover...or a lack of updated exhibit filings'), while the LLM makes a definitive but incorrect claim. (4) MULTI-HOP REASONING: The LLM failed to synthesize the key temporal relationship: maturity date (2021) vs. filing years (2022-2024). This is a critical multi-hop element. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation is not semantically equivalent to the ground truth - it reaches an opposite conclusion (deliberately kept outstanding vs. possible reporting lag or refinancing). The answer demonstrates a failure to recognize the logical impossibility of its own conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 520,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Across all three filings—Microsoft’s FY 2022, FY 2023 and FY 2024 10‑Ks—the “2.000 % Notes due 2023” are listed in Exhibit 4.14, the Eleventh Supplemental Indenture dated August 8 2016. The instrument first appeared in that 2016 indenture and is simply carried forward in each subsequent year’s exhibit, showing that the notes were issued once and have remained outstanding through the 2022‑2024 reporting periods. This repeated, unchanged presence signals that Microsoft deliberately locks in low‑cost, medium‑term debt and retains it on its balance sheet for several years, reflecting a debt‑management strategy focused on stable financing costs and long‑term liquidity rather than frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct—2.000% interest rate, August 8, 2016 date, fiscal years 2022-2024, and Exhibit 4.14 reference all match the ground truth. (2) The multi-hop synthesis is sound: the answer correctly traces the debt instrument across three fiscal years and identifies the consistent reference to the Eleventh Supplemental Indenture. (3) Entity identification is precise: Microsoft, the specific notes, the indenture agreement, and the exhibit location are all correctly identified. (4) The reasoning about debt management strategy is logically sound and goes slightly beyond the ground truth by explicitly characterizing the strategy as focused on 'stable financing costs and long-term liquidity rather than frequent refinancing'—this is a reasonable inference from the data. (5) The answer addresses all parts of the multi-part question: how the notes evolved (remained consistent), what the pattern indicates (stable, long-term approach), and the strategic implications. MINOR CONSIDERATIONS: The LLM answer adds interpretive language about 'deliberately locks in low-cost, medium-term debt' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states. However, this is a reasonable analytical extension rather than a factual error. The ground truth uses 'did not retire or refinance it before its maturity in 2023' while the LLM focuses on the strategy of retention—both are semantically equivalent and correct. No calculation errors, no date errors, no entity confusion. The answer is complete, accurate, and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 454,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "- **2022 filing (covering the 2021‑2022 period)** – Lockheed Martin reported that it had already used its master retirement trust to buy **group‑annuity contracts (GACs) that transferred $4.9 billion of gross pension obligations** (about 18,000 retirees) in August 2021.  Including that deal, the company said it had **purchased contracts worth roughly $11.6 billion since December 2018**, covering about 95,000 retirees and eliminating the need to pay roughly $69 million a year in PBGC premiums.  The transaction generated a **non‑cash pension‑settlement charge of $1.7 billion** (≈$1.3 billion after tax) in the 2021 third quarter.\n\n- **2023 filing** – The company reiterated that it continues to rely on pension‑risk‑transfer GAC purchases to “mitigate the risk related to our defined‑benefit pension plans” and said it will keep evaluating such transactions.  It noted that some future GACs may involve reimbursement risk and that **future transfers could require additional cash contributions to the trust and could trigger material non‑cash settlement charges**, but it did not disclose any new, larger transfers.\n\n- **2024 filing** – The same language appears again: through the master retirement trust the firm has **transferred outstanding pension obligations to third‑party insurers** and **expects to continue looking for additional pension‑risk‑transfer opportunities**.  The filing again warns that **future transactions could result in material non‑cash settlement charges** but provides no new dollar amount for obligations transferred.\n\n**Overall evolution:** Lockheed Martin moved from reporting a concrete, sizable transfer of $4.9 billion (part of an $11.6 billion cumulative program) and a $1.7 billion non‑cash charge in the 2022 filing, to a more forward‑looking stance in 2023 and 2024 that emphasizes ongoing use of GACs, acknowledges possible reimbursement risk, and stresses that future transfers may again generate material non‑cash settlement charges, but without disclosing any additional large‑scale transfers. The strategy remains to keep reducing pension‑plan volatility through risk‑transfer transactions while warning that each future deal could have a material earnings impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Lockheed Martin's pension risk transfer evolution from 2022-2024. STRENGTHS: (1) All key quantitative figures are correct: $4.9 billion transferred in August 2021, $11.6 billion cumulative since December 2018, $1.7 billion noncash settlement charge, $69 million annual PBGC premium reduction, ~18,000 retirees in 2021 transaction, ~95,000 total retirees covered. (2) Dates and time periods are accurate (August 2021, December 2018, 2022/2023/2024 filings). (3) The multi-hop synthesis across three years is sound: the answer correctly traces the evolution from concrete 2022 disclosures to forward-looking 2023-2024 statements. (4) Financial metrics are properly contextualized (e.g., $1.3 billion after-tax impact noted). (5) The answer correctly identifies the strategic shift from reporting completed transactions to emphasizing ongoing evaluation and future intent. (6) Proper identification of GACs (group annuity contracts) and master retirement trust mechanisms. (7) Accurate characterization of risks mentioned (reimbursement risk, material noncash settlement charges). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth (breaking into bullet points by year), but this enhances clarity without introducing inaccuracy. The semantic meaning aligns perfectly with the ground truth's characterization of 'consistent, strategic reduction in pension liabilities' and the evolution toward 'increasing scale and financial clarity.' The answer appropriately notes the absence of new dollar amounts in 2023-2024 filings while maintaining the strategic intent. No calculation errors detected. All entities (Lockheed Martin, PBGC, insurance companies) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1871,
        "completion_tokens": 496,
        "total_tokens": 2368
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "All three annual reports (2022, 2023 and 2024) list Exhibit 4.4 – the officer’s certificate that “includes … the Floating Rate Notes due 2019.”  By repeatedly disclosing the same 2019 floating‑rate issue, Apple is signalling that those notes remain outstanding and are still a material component of its capital‑structure.  The persistence of the reference suggests a deliberate long‑term debt strategy: Apple issues floating‑rate securities, lets them stay on the books, and plans to roll or refinance them as they approach maturity rather than retiring the debt outright, thereby maintaining a stable, flexible financing program and managing interest‑rate exposure over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core question about Apple's debt management strategy. Both answers correctly identify that: (1) Floating Rate Notes due 2019 are consistently referenced across 2022-2024 filings, (2) this persistence suggests deliberate debt management, and (3) Apple likely rolled over or refinanced rather than retiring the debt. The LLM answer adds specific detail about Exhibit 4.4 and the officer's certificate, which provides concrete evidence of the filing pattern. The reasoning about maintaining a 'stable, flexible financing program' and 'managing interest-rate exposure' aligns well with the ground truth's characterization of a 'disciplined and predictable capital structure strategy.' The LLM answer is slightly more specific and actionable in its interpretation (mentioning the exhibit number and the mechanism of rolling/refinancing), while the ground truth is more general. No quantitative errors are present—the years (2022, 2023, 2024) and the maturity date (2019) are all correct. The multi-hop synthesis is sound: the answer correctly connects the repeated disclosure pattern to strategic implications about debt management. Minor deduction: the LLM answer could have been more explicit about the apparent paradox of 2019-maturity notes appearing in 2022-2024 filings (suggesting they may have been refinanced or rolled into new instruments), though this is implied in the discussion of rolling/refinancing. The answer is semantically equivalent to the ground truth and appropriately addresses the investor perspective requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 444,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "In each of Microsoft’s three most recent annual reports the company continues to list the **4.000 % Notes due 2021** in Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041.” The wording, exhibit number and filing dates (February 8 2011) are identical in the 2022, 2023 and 2024 10‑K filings, showing that Microsoft still incorporates this instrument by reference in its disclosed debt documentation. The persistent inclusion signals that the 4.000 % Notes remain a material component of Microsoft’s capital‑structure disclosures, even after their scheduled maturity, and that the company continues to treat the instrument as an active part of its outstanding debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts and reasoning. STRENGTHS: (1) Correctly identifies the 4.000% Notes due 2021 as consistently referenced across 2022, 2023, and 2024 10-K filings; (2) Accurately cites Exhibit 4.6 as the location of these references; (3) Correctly notes the Third Supplemental Indenture structure and associated note instruments (2.500% Notes due 2016, 4.000% Notes due 2021, 5.300% Notes due 2041); (4) Properly synthesizes the multi-hop reasoning that post-maturity inclusion signals ongoing legal/structural relevance; (5) Correctly interprets this as indicating the Notes remain part of Microsoft's debt disclosures despite maturity. MINOR ISSUES: (1) The LLM provides a specific filing date (February 8, 2011) for the Third Supplemental Indenture, which cannot be verified against the ground truth provided and may be an unsupported detail; (2) The phrase 'treat the instrument as an active part of its outstanding debt portfolio' is slightly stronger language than the ground truth's more cautious 'likely still outstanding or held ongoing legal or structural relevance' - this represents a minor interpretive overreach; (3) The LLM states the wording and exhibit number are 'identical' across all three years, which is a specific claim not explicitly confirmed in the ground truth. QUANTITATIVE ACCURACY: The percentage (4.000%) and years (2021, 2016, 2041) are all correct. The filing years (2022, 2023, 2024) are correct. No calculations are required. QUALITATIVE ACCURACY: The reasoning about post-maturity inclusion and its implications for covenants/indentures aligns well with ground truth. The multi-hop synthesis across three years is sound. CONTEXTUAL RELEVANCE: The answer directly addresses how the reference evolved (consistently present) and what it reveals about relevance (ongoing structural importance). The answer is well-contextualized within Microsoft's capital structure discussion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 532,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "- In the 2022 Form 10‑K UPS described the $276 million 7.620 % debentures in detail: they were issued at 8.375 % until April 1 2020 and then stepped down to 7.620 % for the balance of the term, mature on April 1 2030, are redeemable at UPS’s option in whole or in part at any time, and the redemption price is the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps (plus accrued interest); interest is paid semi‑annually in April and October and there is no sinking‑fund requirement.  \n\n- The 2023 filing no longer repeats the historical rate change but lists the debentures in the debt schedule (shown as $276 million, reported as $280 million for 2023) and places them within a larger debt portfolio that grew to $22.264 billion total debt ($17.321 billion long‑term) – confirming that the debentures remain a standing long‑term liability.  \n\n- The 2024 Form 10‑K again restates the same optional‑redemption and semi‑annual‑interest terms (principal + accrued interest or PV of remaining payments discounted at Treasury + 5 bps) but omits the earlier rate‑step narrative, indicating a shift to a concise, current‑terms disclosure while the debenture amount stays at $276 million and total debt has risen further to $22.470 billion ($18.916 billion long‑term).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about UPS's 7.620% debentures evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - $276 million principal amount, 7.620% rate, April 1, 2030 maturity date, 8.375% historical rate until April 1, 2020, 5 basis points spread, $280 million book value in 2023, total debt figures ($22.264B in 2023, $22.470B in 2024), and long-term debt components ($17.321B in 2023, $18.916B in 2024). Semi-annual payment schedule (April and October) is accurate. COMPLETENESS: The answer thoroughly addresses all three sub-questions: (1) redemption terms - correctly describes the optional redemption mechanics with the greater-of calculation; (2) interest payment structure - accurately identifies semi-annual payments with no sinking fund; (3) debt positioning - properly contextualizes the debentures within UPS's broader debt portfolio across all three years. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings, tracking the evolution of disclosure treatment and identifying the key shift from historical context (2022) to streamlined current-terms disclosure (2023-2024). The observation about omitting the rate-step narrative in later years is insightful and accurate. ENTITY ACCURACY: Company (UPS), metric names, years, and financial instruments are all correctly identified. REASONING QUALITY: The progression narrative is logical and well-supported - the answer correctly identifies that 2023 marked a transition point where historical rate information was dropped in favor of a debt-schedule presentation, and 2024 continued this streamlined approach. The contextual note about international debt instruments in 2024 aligns with the ground truth's mention of positioning within a global debt portfolio. MINOR CONSIDERATIONS: The answer is slightly more detailed and structured than the ground truth in some respects (e.g., explicitly listing the redemption formula components), but this represents added clarity rather than inaccuracy. The semantic meaning and factual content align perfectly with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Pays_Interest_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 589,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "- **Development → Commercialization:** In the 2022 filing AbbVie reported the October 2021 top‑line Phase 3 results for cariprazine (Vraylar), showing a statistically significant benefit as an adjunctive treatment for major‑depressive disorder and confirming its safety profile. By the 2024 filing Vraylar is described as an approved, multi‑indication dopamine‑D3/D2 partial agonist used for schizophrenia, bipolar disorder (manic, mixed and depressive episodes) and as an adjunct in MDD, indicating that the product moved from late‑stage trial reporting to full market launch across several neuro‑psychiatric indications.  \n\n- **Financial performance:** 2022 revenue from Vraylar was $2.037 billion; 2023 revenue rose to $2.759 billion, a 35 % year‑over‑year increase (the only neuroscience product showing double‑digit growth in that period).  \n\n- **Strategic implication:** The rapid transition from Phase‑3 data to a broadened, approved label set and the strong revenue acceleration signal that Vraylar has become a core growth engine within AbbVie’s neuroscience portfolio, underpinning its strategic importance alongside Botox Therapeutic.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc (Phase 3 data in 2022 → market approval and expansion by 2024), accurately reports the 2023 revenue of $2.759 billion and the 35% YoY growth rate, and provides sound strategic reasoning about Vraylar's importance to the neuroscience portfolio. The multi-hop synthesis across development, commercialization, and financial performance is well-structured and logically sound. Entity identification (ABBV, Vraylar, indications) is accurate.\n\nCRITICAL ERRORS: (1) The LLM states 2022 Vraylar revenue was $2.037 billion, but the ground truth does not provide this figure. The ground truth only confirms 2023 revenue of $2.759 billion with a 35.4% YoY increase. The LLM's 2022 figure cannot be verified against the provided ground truth and may be inaccurate. (2) The LLM references 'October 2021 top-line Phase 3 results' but the ground truth states these were announced in 2022, creating a temporal discrepancy. (3) The LLM states one trial 'showing a statistically significant benefit' while the ground truth indicates 'one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement' - this is a subtle but important distinction that the LLM oversimplifies.\n\nMINOR ISSUES: The LLM adds contextual detail about 'Botox Therapeutic' as a comparable strategic asset, which is reasonable inference but not explicitly confirmed in the ground truth. The phrase 'the only neuroscience product showing double-digit growth in that period' is a comparative claim not verified in the provided ground truth.\n\nCALCULATION VERIFICATION: The 35% growth rate is correctly stated (matching ground truth's 35.4%, with acceptable rounding). However, the 2022 revenue figure of $2.037 billion cannot be verified and appears to be either inferred or potentially incorrect.\n\nMULTI-HOP REASONING: The synthesis across development timeline, regulatory/commercial milestones, and financial metrics is logically sound and addresses all parts of the question. The strategic conclusion is well-reasoned given the data presented.\n\nOVERALL ASSESSMENT: The answer demonstrates strong understanding of the question structure and provides mostly accurate information, but the unverified 2022 revenue figure and temporal inconsistency regarding Phase 3 results timing create factual accuracy concerns that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 645,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "All three 10‑K filings (2022, 2023 and 2024) list the same Officer’s Certificate (Exhibit 4.3) and, in that list, the “0.45 % Notes due 2016.” The fact that Apple continues to reference this 2016 note year after year shows that the instrument is retained in the company’s long‑term debt register (or at least documented as a legacy issue) and that Apple’s disclosure policy is to incorporate by reference the complete historical series of its global notes in every filing. Thus, Apple’s debt structure is presented as a comprehensive, ongoing portfolio that includes even very old, low‑interest legacy notes, and the company follows a consistent, transparent strategy of disclosing all such instruments in each annual report.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and alignment with the ground truth. STRENGTHS: (1) All quantitative facts are correct - the 0.45% Notes due 2016, the three fiscal years (2022, 2023, 2024), Exhibit 4.3, and the May 3, 2013 Officer's Certificate date are all accurately referenced. (2) The multi-hop reasoning is sound - the answer correctly synthesizes information across three consecutive annual reports and draws appropriate conclusions about Apple's disclosure strategy. (3) The semantic meaning matches the ground truth: both answers convey that Apple maintains transparency by including legacy debt instruments in filings even after maturity, and both identify this as a consistent, comprehensive disclosure approach. (4) Entity identification is accurate - Apple, the specific debt instrument, exhibit numbers, and fiscal years are all correct. MINOR DIFFERENCES: The LLM answer uses slightly different phrasing ('long-term debt register' vs. 'complete record of past financing activities') but conveys equivalent meaning. The LLM's phrase 'incorporate by reference the complete historical series' is a reasonable interpretation of the disclosure pattern, though the ground truth uses 'preserve a complete record.' Both characterizations are semantically equivalent and accurate. The LLM answer is slightly more concise while maintaining all essential information. No calculation errors, no factual inaccuracies, and the reasoning about why Apple maintains this disclosure pattern is logically sound and consistent with the ground truth interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 431,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "Across the three filings, UPS SurePost has consistently been positioned as the **non‑urgent, lightweight‑residential‑shipment tier of UPS’s U.S. Domestic Package business**. In 2022 and again in 2023 the service was described as “residential ground service … that offers the consistency and reliability of the UPS ground network, with final delivery often provided by the U.S. Postal Service,” indicating a **partner‑based last‑mile model** in which UPS handles pickup and transport to a local post office and USPS completes delivery. The 2024 filing repeats that description for 2024 but adds that **effective January 1 2025 UPS will insource SurePost**, ending the USPS hand‑off to gain greater control over service—showing an evolution from a purely outsourced final‑mile arrangement to a planned fully‑integrated UPS delivery operation while retaining its role as the cost‑effective, non‑time‑critical residential offering within the domestic package portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about UPS SurePost's evolution from 2022-2024. QUANTITATIVE ACCURACY (10/10): All dates are correct—2022, 2023, 2024 references, and the critical January 1, 2025 implementation date for insourcing. No numerical errors or calculation issues present. QUALITATIVE ACCURACY (9/10): The answer correctly synthesizes information across three years of filings: (1) 2022-2023 continuity in positioning as non-urgent, lightweight residential service with USPS final delivery; (2) 2024 announcement of the strategic shift to insource final delivery effective 2025. The multi-hop reasoning is sound—the model correctly identified the evolution from outsourced (USPS partnership) to integrated (UPS-controlled) delivery model. The characterization of the service's role within the domestic package portfolio is accurate. Minor note: The LLM uses slightly more detailed formatting/emphasis (bold text, hyphens) than the ground truth, but this enhances clarity without introducing inaccuracy. CONTEXTUAL RELEVANCE (10/10): The answer directly addresses all aspects of the question: (1) role evolution, (2) operational structure changes, (3) delivery methodology transformation, (4) strategic positioning. The answer explains both the continuity (2022-2023) and the transformation (2024-2025 shift), providing proper context for understanding the strategic significance. VERIFICATION: Ground truth states \"beginning January 1, 2025, it would insource the final delivery component\"—LLM correctly states \"effective January 1 2025 UPS will insource SurePost.\" Ground truth describes 2022-2023 as leveraging USPS for final delivery—LLM accurately captures this as \"partner-based last-mile model.\" The semantic equivalence is strong throughout. The only minor distinction is that the LLM provides slightly more operational detail (\"UPS handles pickup and transport to a local post office\") which adds helpful context without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 552,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 first appear in the “Description of Securities” exhibit (Exhibit 4.4) of the 2022 Form 10‑K and are listed again in the identical exhibit of the 2023 and 2024 Form 10‑K filings. In each year the notes are shown as part of the officer’s certificate dated May 6 2014, indicating that the issue was created in 2014 and remains outstanding throughout the 2022‑2024 reporting periods. The repeated presence of the same long‑dated, low‑coupon debt across three consecutive filings shows that Apple is maintaining a stable pool of long‑term financing, using multi‑year notes to lock in inexpensive capital and preserve financial flexibility for future investments and balance‑sheet management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All numeric values are correct - the 4.45% coupon rate, the 2044 maturity date, the May 6, 2014 Officer's Certificate date, and the 2022-2024 reporting period are all accurate. (2) The multi-hop synthesis is sound - the answer correctly traces the debt instrument across three consecutive years and identifies the consistent presence as evidence of strategic capital management. (3) Entity identification is precise - Apple is correctly identified, the specific debt instrument is properly characterized, and the filing exhibits (Exhibit 4.4) are accurately referenced. (4) The reasoning about capital strategy is logically sound and matches the ground truth interpretation: the sustained presence of the same long-term debt indicates strategic retention without early redemption, supporting financial flexibility and interest rate risk management. (5) The answer adds helpful context about 'low-coupon debt' and 'inexpensive capital' which are reasonable inferences from the 4.45% rate in the context of long-term financing. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning Exhibit 4.4, providing more context about the debt characteristics), but this represents value-added analysis rather than error. The semantic meaning is fully equivalent - both answers convey that Apple maintained this debt consistently across the three-year period as part of a deliberate capital strategy. No calculation errors, no factual inaccuracies, and the multi-hop reasoning correctly synthesizes information across the 2022, 2023, and 2024 filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 460,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "- In the 2022 Form 10‑K Oracle listed the 2.875 % Notes due 2031 in **Exhibit 4.16** (the “Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028, **2.875 % Notes due 2031**, 3.650 % Notes due 2041…”).  \n- In both the 2023 and the 2024 Form 10‑K the same series of notes appears under **Exhibit 4.14** (identical description and the same Officers’ Certificate dated March 24 2021).  \n\nThe shift from Exhibit 4.16 to a stable Exhibit 4.14, and the fact that the notes remain grouped with the other senior unsecured term‑notes in the same exhibit, shows Oracle’s deliberate, consistent treatment of the 2.875 % 2031 issue as a core, long‑dated, low‑coupon component of its debt portfolio. By keeping it in a fixed exhibit across filings, Oracle signals disciplined capital‑structure management—maintaining transparency, preserving the integrity of its debt program, and reinforcing a long‑term, cost‑effective financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the core factual claim. The ground truth states the 2.875% Notes due 2031 were 'consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024.' However, the LLM claims the notes appeared in Exhibit 4.16 in 2022 and only shifted to Exhibit 4.14 in 2023 and 2024. This is a fundamental factual error that undermines the entire answer. The LLM's narrative about a 'shift from Exhibit 4.16 to a stable Exhibit 4.14' directly contradicts the ground truth's assertion of consistent positioning across all three years. The LLM correctly identifies the Officers' Certificate date (March 24, 2021) and the note terms (2.875%, due 2031), but the exhibit number progression is factually incorrect. The LLM's interpretation that the shift 'shows Oracle's deliberate, consistent treatment' is logically inconsistent with claiming there was a shift at all—if the positioning changed, it was not consistent across all three years as the ground truth indicates. The reasoning about capital structure management and debt strategy is reasonable in tone, but it is built on an incorrect factual foundation regarding exhibit positioning. The answer fails on the primary metric of factual accuracy regarding the multi-hop synthesis of exhibit positioning across the three filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 382,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 five‑year Teamsters master agreement added wage‑ and benefit‑rate increases for employees covered by the UPS/IBT Full‑Time Employee Pension Plan, so the plan’s benefit‑accrual assumptions were raised and the additional accruals were recorded in the year‑end measurement of the plan (Chunk 2).  Because the plan is a non‑contributory, service‑credit defined‑benefit plan that continues to accrue benefits for union‑covered workers (while non‑union accruals were frozen on Jan. 1 2023 – see Chunks 1 and 3), the 2024 filing still lists the UPS/IBT plan as an ongoing liability, indicating that UPS’s long‑term pension obligations remain sizable and are subject to upward adjustments whenever collective‑bargaining agreements are renegotiated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 five-year Teamsters master agreement and its impact on wage and benefit-rate increases; (2) Accurately describes the UPS/IBT Full-Time Employee Pension Plan as a non-contributory, service-credit defined-benefit plan; (3) Properly notes that benefit-accrual assumptions were raised and additional accruals were recorded in year-end measurement; (4) Correctly identifies that non-union accruals were frozen on Jan. 1, 2023, creating a contrast with ongoing union accruals; (5) Accurately characterizes the plan as an ongoing liability in 2024 filings with no structural changes; (6) Provides sound multi-hop reasoning connecting the 2023 agreement to 2024 disclosures and long-term pension obligations; (7) Correctly synthesizes that pension obligations remain subject to upward adjustments with future collective bargaining agreements. QUANTITATIVE ACCURACY: All dates (2023, 2024, Jan. 1, 2023) and time periods (five-year agreement) are correct. No numerical calculations are required or presented, and none are incorrect. QUALITATIVE ACCURACY: The reasoning about the relationship between collective bargaining agreements and pension liabilities is sound and well-articulated. The answer correctly identifies the causal chain: agreement → benefit increases → accrual adjustments → ongoing liability implications. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and explicit than the ground truth (e.g., mentioning the frozen non-union accruals and the reference to specific chunks), which adds helpful context without contradicting the original answer. The semantic meaning is fully equivalent to the ground truth, with the LLM providing a more comprehensive explanation of the same core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Maintain]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 501,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Across Apple’s three most recent annual reports the same disclosure appears unchanged. In the 2022 10‑K (page 58) Apple lists Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 – which enumerates “1.05% Notes due 2017” among the other notes; the 2023 10‑K (page 56) repeats the identical Exhibit 4.4 description; and the 2024 10‑K (page 56) again cites the same May 6 2014 Officer’s Certificate with the 1.05% Notes due 2017 listed. This consistent referencing shows that Apple has kept the short‑term 1.05% Notes due 2017 on its schedule of securities without altering the disclosure, indicating a steady, ongoing management approach to the debt issued under its 2014 Officer’s Certificate and a commitment to transparent, repeatable reporting of that instrument until its maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 1.05% interest rate, the 2017 maturity date, the May 6, 2014 Officer's Certificate date, and the page numbers (58 for 2022, 56 for 2023 and 2024) are all accurate. ENTITY ACCURACY: Apple is correctly identified, the three fiscal years (2022, 2023, 2024) are correct, and the specific debt instrument (1.05% Notes due 2017) is properly referenced throughout. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings, correctly identifying the consistent disclosure pattern and drawing the appropriate conclusion about Apple's management approach. The answer properly traces the same exhibit (4.4) across all three years and notes the unchanged nature of the disclosure. COMPLETENESS: The answer addresses all parts of the original question - it discusses how the disclosure evolved (remained unchanged), identifies the specific debt instrument, references the Officer's Certificate, and explains what this continuity reveals about Apple's approach. SEMANTIC EQUIVALENCE: The LLM's interpretation that the static disclosure indicates 'a steady, ongoing management approach' and 'commitment to transparent, repeatable reporting' aligns well with the ground truth's characterization of 'passive management approach' and 'prioritized stability.' Both convey the same essential insight about Apple's non-interventionist stance toward this particular debt. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail (specific page numbers, exhibit references) than the ground truth, which adds value without introducing inaccuracy. The phrasing differs slightly but conveys equivalent meaning. No calculation errors, no factual contradictions, and no misidentification of entities or time periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 515,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings from 2022, 2023 and 2024 all incorporate the same Officer’s Certificate (dated May 3 2013) as Exhibit 4.3, and each of those certificates lists the **2.40 % Notes due 2023** among the company’s outstanding securities. In the 2022 filing (Chunk 1) the notes appear for the first time in the “Description of Securities” table; the 2023 filing (Chunk 2) repeats the identical disclosure, and the 2024 filing (Chunk 3) again repeats it without amendment.\n\nThe unchanged, year‑over‑year inclusion signals that Apple has kept the 2.40 % 2023 notes on its balance sheet until maturity and has chosen to disclose them consistently rather than retire or replace them early. This pattern reflects a long‑term debt‑management strategy that relies on a stable, diversified portfolio of fixed‑rate notes, emphasizing continuity, transparency and disciplined use of existing financing rather than frequent new issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 2.40% interest rate, the 2023 maturity date, and the May 3, 2013 Officer's Certificate date are all accurately stated. No calculations are required for this question, and all dates/percentages match the ground truth precisely. ENTITY ACCURACY: Apple is correctly identified, the specific debt instrument (2.40% Notes due 2023) is correctly named, and the fiscal years (2022, 2023, 2024) are correctly referenced. COMPLETENESS: The LLM answer addresses all parts of the multi-part question: (1) how the disclosure evolved across the three-year period, (2) what the pattern suggests about debt management strategy. The answer correctly identifies that the disclosure remained unchanged across all three filings. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings to identify the consistent pattern. The reasoning that unchanged disclosure signals stable debt management and no early retirement is sound and matches the ground truth's conclusion. SEMANTIC EQUIVALENCE: The LLM's characterization of the pattern as reflecting 'a stable, diversified portfolio of fixed-rate notes, emphasizing continuity, transparency and disciplined use of existing financing' is semantically equivalent to the ground truth's statement that it 'suggests that Apple maintained a consistent approach to managing this particular debt obligation' and 'implies a stable long-term debt strategy.' The LLM provides slightly more detailed interpretation of what the stability means strategically, which adds value without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM's statement that the notes 'appear for the first time in the Description of Securities table' in 2022 is not explicitly contradicted by the ground truth but represents an inference about first appearance. The ground truth states the disclosure was 'first disclosed' in 2022, which the LLM correctly captures. Overall, the answer is factually accurate, logically sound, and appropriately addresses the question with good synthesis across multiple years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 596,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "- **Clinical development:** The most recent AbbVie update on Vraylar (cariprazine) was in October 2021, when top‑line results from two Phase 3 studies in major depressive disorder were disclosed – one trial met its primary MADRS endpoint and the other showed a numerical but not statistically‑significant benefit, with safety consistent with the drug’s known profile. No further trial milestones are reported in the 2022‑2024 filings, indicating that the product moved from development into a marketed status based on its existing approvals.  \n\n- **Revenue growth:** Vraylar’s sales rose sharply after 2021. 2022 net revenue was $2.038 billion (U.S. $2.037 billion + $1 million international), and 2023 revenue increased to $2.759 billion (U.S. $2.755 billion + $4 million international) – a 17.9 % increase year‑over‑year from 2021‑2022 and a 35.4 % jump from 2022‑2023.  \n\n- **Therapeutic positioning:** In the 2024 10‑K, Vraylar is listed among AbbVie’s neuroscience portfolio and is indicated for acute and maintenance treatment of schizophrenia, acute manic or mixed episodes of bipolar disorder, acute depressive episodes of bipolar I, and as an adjunctive therapy for major depressive disorder. This multi‑indication profile makes Vraylar a cornerstone neuroscience asset that has transitioned from late‑stage development in 2021 to a high‑growth, core commercial product by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer demonstrates strong factual accuracy on quantitative metrics. Revenue figures are correct: 2022 U.S. sales of $2,037 million, 2023 U.S. sales of $2,755 million, and total 2023 revenue of $2,759 million all match ground truth. The year-over-year growth calculation of 35.4% from 2022-2023 is accurate (($2,759M - $2,038M) / $2,038M = 35.3%, rounding to 35.4% is acceptable). The therapeutic indications listed (schizophrenia, bipolar I disorder manic/mixed/depressive episodes, adjunctive MDD) are correct and comprehensive. The clinical development narrative about the two Phase 3 MDD trials (one successful, one numerically positive but non-significant) is accurate. The multi-hop synthesis across clinical development, revenue growth, and therapeutic positioning is sound and well-structured.\n\nMINOR ISSUES: (1) The LLM states 2022 revenue as '$2.038 billion (U.S. $2.037 billion + $1 million international)' - this is slightly awkward phrasing since $2,037M + $1M = $2,038M, which is correct but the breakdown is trivial. (2) The LLM mentions a '17.9% increase year-over-year from 2021-2022' but the ground truth does not provide 2021 data, so this calculation cannot be verified against the ground truth. However, this doesn't contradict the ground truth, just extends beyond it. (3) The LLM notes 'No further trial milestones are reported in the 2022-2024 filings' which is a reasonable inference but not explicitly stated in the ground truth.\n\nVERIFICATION: All core numbers match ground truth exactly. The 35.2% vs 35.4% growth rate difference is negligible (likely due to rounding precision in intermediate calculations). The clinical positioning and revenue trajectory are accurately synthesized. The answer successfully addresses all three components of the multi-part question: clinical development progress, revenue growth, and therapeutic positioning.\n\nCONCLUSION: The answer is factually sound with accurate numbers, correct entity identification, and proper multi-hop synthesis. The minor discrepancy in growth percentage calculation (35.2% vs 35.4%) is within acceptable rounding tolerance. The inclusion of 2021 data not in ground truth is supplementary rather than contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 596,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "Across the three filings IBM repeatedly lists **client relationships and trust** as one of its “principal methods of competition.” In the 2022 filing the concept appears alongside technology, price and brand and is tied to IBM’s “breadth and depth of expertise” and its “trust and security” pillars that support its hybrid‑cloud‑AI platform. The 2023 and 2024 reports keep the same language—again naming client relationships and trust among the core competitive levers and linking it to the company’s ecosystem of strategic partners and its ability to deliver business value through hybrid cloud and AI solutions. This steady, multi‑year emphasis shows IBM is positioning trust‑based client relationships as a durable differentiator that underpins its growth strategy in the hybrid‑cloud and AI market, signaling that the company views deep, trusted client ties as essential to winning business and defending market leadership as the ecosystem becomes more competitive.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the multi-year progression of IBM's emphasis on client relationships and trust from 2022-2024. STRENGTHS: (1) Correctly identifies that IBM consistently emphasized client relationships and trust across all three years (2022, 2023, 2024); (2) Accurately notes the connection to hybrid cloud and AI platform strategy; (3) Properly synthesizes the evolution showing how trust was linked to partnerships and ecosystem in later years; (4) Correctly identifies this as a durable, foundational differentiator; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer uses slightly more generic language ('steady, multi-year emphasis') compared to the ground truth's more specific framing of 'strategic deepening' and the progression from 'value proposition' to 'enabler of integrated, client-centric innovation'; (2) The ground truth provides more nuanced characterization of how the strategic framing evolved (2022: integration focus → 2023: partnership focus → 2024: go-to-market/ecosystem focus), while the LLM answer presents this more as consistent messaging rather than distinct evolution; (3) The LLM answer doesn't explicitly capture the 2024 emphasis on 'addressing complex business challenges through a broad ecosystem' as distinctly as the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and properly connects the evolution of trust messaging to IBM's strategic positioning in hybrid cloud and AI markets. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—IBM views trust-based relationships as foundational to competitive positioning—though the LLM's characterization is slightly less precise about the specific evolution trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 510,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "- **2022 10‑K:** IBM disclosed the 1.250 % Notes due 2027 only by “incorporating by reference” the instrument that defines the holders’ rights – specifically Exhibits 4.1, 4.2, 4.3 and 4.4 to a Form 8‑K filed on January 30, 2019.  \n- **2023 10‑K:** The same approach was retained; the notes were again referenced to the same 2019 Form 8‑K exhibits (Exhibits 4.2‑4.4) and were not listed as a separate security in the debt‑summary tables.  \n- **2024 10‑K:** IBM moved the 1.250 % Notes due 2027 into the primary “Debt Securities” table, assigning them the trading symbol **IBM27B** and listing them alongside its other notes and debentures. This signals a more explicit disclosure and confirms that the 1.250 % Notes remain an active component of IBM’s outstanding debt portfolio rather than being treated solely as a referenced exhibit.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a structured year-by-year progression that captures the general evolution of IBM's disclosure practices for the 1.250% Notes due 2027, but contains several factual discrepancies when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies the three-year progression (2022, 2023, 2024)\n- Accurately notes the January 30, 2019 Form 8-K filing date\n- Correctly identifies the trading symbol IBM27B for 2024\n- Properly characterizes the shift from incorporation by reference to explicit listing in the Debt Securities table\n- Accurately captures the semantic meaning of increasing transparency and formalization\n\nFACTUAL DISCREPANCIES:\n1. EXHIBIT REFERENCES: The LLM states 2022 referenced \"Exhibits 4.1, 4.2, 4.3 and 4.4\" but the ground truth specifies only \"Exhibit 4.3.\" This is a material error in exhibit identification.\n2. 2023 TREATMENT: The LLM claims 2023 referenced \"Exhibits 4.2-4.4\" but ground truth indicates the notes were \"again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022.\" The LLM's characterization of 2023 as retaining the same approach as 2022 appears to miss the evolution to more recent filing references.\n3. DEBT SUMMARY TABLES: The LLM adds detail about the notes not being \"listed as a separate security in the debt-summary tables\" in 2023, which is not explicitly confirmed in the ground truth.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and correctly identifies the progression from indirect referencing to direct listing. However, the reasoning about exhibit changes between years is imprecise. The ground truth suggests a more nuanced evolution (different filing dates referenced in 2023) that the LLM oversimplifies.\n\nSEMANTIC EQUIVALENCE:\nThe overall narrative arc is semantically equivalent to the ground truth - both convey increasing transparency and formalization. However, the specific details about which exhibits were referenced and how the 2023 treatment differed from 2022 are not accurately captured.\n\nQUANTITATIVE ACCURACY:\nThe dates (January 30, 2019; February 8, 2022) and trading symbol (IBM27B) are correct, but the exhibit numbers (4.1, 4.2, 4.3, 4.4 vs. just 4.3) represent a quantitative error in document identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 630,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 2022 Form 10‑K did not list the 6.50 % Debentures due 2028 at all – the Item 601 exhibit table only referenced other notes and debentures. In the 2023 Form 10‑K IBM added the 6.50 % Debentures due 2028 and tied the instrument to **Exhibit 2 to Form 8‑K (filed January 8, 1998)**, and the 2024 Form 10‑K kept exactly the same wording and exhibit reference. This shows that, after being introduced in 2023, IBM’s disclosure of the 6.50 % Debentures remained consistent, fitting the broader pattern in all three years of incorporating each debt instrument’s governing documents by reference to specific Form 8‑K exhibits.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that IBM 'consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024).' However, the LLM claims that the 2022 Form 10-K 'did not list the 6.50% Debentures due 2028 at all' and that IBM 'added the 6.50% Debentures due 2028' only in 2023. This is a critical error in multi-hop reasoning across the three years. The LLM correctly identifies the exhibit reference (Exhibit 2 to Form 8-K, filed January 8, 1998) and correctly notes that 2023 and 2024 had the same wording and reference, but it fundamentally mischaracterizes the 2022 disclosure by claiming the debentures were absent that year. The ground truth indicates consistency across all three years, not a new introduction in 2023. The LLM's statement about the broader pattern of incorporating debt instruments by reference is reasonable, but this cannot compensate for the core factual error about the 2022 disclosure. The answer demonstrates incomplete synthesis of the multi-hop information required to answer the question about how disclosures 'evolved from 2022 to 2024,' as it incorrectly suggests a discontinuity rather than the consistency that actually existed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 375,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx (FDX) introduced the FedEx International Connect Plus (FICP) e‑commerce service, and its geographic coverage grew markedly between 2022 and 2024. In the 2022 Form 10‑K the service was available from **about 50 origin countries to more than 130 destination countries**; by the 2023 filing it had expanded to **nearly 60 origin countries and over 190 destination countries**, and the 2024 filing shows the same nearly‑60‑origin/190‑plus‑destination footprint, indicating that the rapid expansion occurred between 2022 and 2023 and then stabilized. This trajectory signals FedEx’s strategic emphasis on building a global e‑commerce logistics platform—broadening its network to capture cross‑border online‑shopping demand and positioning FICP as a core growth engine within its overall e‑commerce and deferred‑service strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022: ~50 origin countries to 130+ destination countries; 2023: ~60 origin countries to 190+ destination countries; 2024: maintained ~60 origin/190+ destination levels. The progression and stabilization pattern matches the ground truth exactly. ENTITY ACCURACY: Correctly identifies FedEx (with ticker FDX), FedEx International Connect Plus (FICP), and all relevant fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the expansion phase (2022-2023) and stabilization phase (2023-2024). The logical inference that rapid expansion occurred between 2022-2023 followed by stabilization is sound and matches the ground truth interpretation. COMPLETENESS: Addresses both parts of the question - the evolution of geographic reach AND the strategic implications for e-commerce logistics. The strategic analysis about positioning FICP as a growth engine and capturing cross-border e-commerce demand aligns with the ground truth's characterization of deliberate expansion followed by maturation. WORDING: The LLM uses slightly different phrasing than ground truth (e.g., 'markedly' vs 'significant growth', 'core growth engine' vs 'mature coverage level') but conveys semantically equivalent meaning. Minor note: The LLM's characterization of the stabilization as reaching 'mature coverage level' is slightly more interpretive than the ground truth's 'completed a major phase,' but both convey the same essential insight. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 461,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "- In the 2022 Form 10‑K Qualcomm spelled out concrete 2025 diversity goals – +15 % women in leadership, +15 % under‑represented‑minority (URM) leaders and +20 % overall URM representation – and said that progress toward those “human‑capital advancements” would be used as a non‑financial performance modifier that could move an executive’s bonus up or down by a factor of **0.9 to 1.1**.  \n\n- The 2023 and 2024 filings (both describing fiscal 2024) no longer repeat those numeric targets; instead they highlight external inclusion achievements (Best Company for Women in India, ten‑year “Best Place to Work for Disability Inclusion” award, and participation in the Reboot Representation Tech Coalition that aims to double the number of Black, Latinx and Native‑American women earning computing degrees by 2025).  Nevertheless, the linkage to compensation remains the same – the HR and Compensation Committee will again apply a **0.9‑to‑1.1 multiplier** to the executives’ fiscal 2024 bonus based on progress toward the broader human‑capital advancement agenda.  \n\nThus, from FY 2022 to FY 2024 the **bonus‑adjustment mechanism (0.9‑1.1 multiplier) stayed unchanged**, while the **diversity objectives shifted from internally‑set, quantitative 2025 targets to a broader set of inclusion recognitions and external partnership goals**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Qualcomm's human capital advancement goals and executive compensation evolution from FY2022-2024. STRENGTHS: (1) All quantitative data is correct - the 15% women in leadership target, 15% URM leadership target, 20% overall URM representation target, and the 0.9-1.1 bonus multiplier range are all accurately cited and match the ground truth. (2) The multi-hop synthesis is sound: the answer correctly traces the evolution across three fiscal years, identifying both what remained constant (the 0.9-1.1 multiplier mechanism) and what changed (shift from quantitative internal targets to broader inclusion recognitions and external partnerships). (3) Entity identification is precise - Qualcomm is correctly identified, fiscal years are properly referenced, and specific initiatives (Reboot Representation Tech Coalition, awards) are accurately mentioned. (4) The answer effectively captures the nuanced evolution: maintaining compensation linkage while shifting diversity goal emphasis from specific numeric targets to broader external partnerships and recognition achievements. (5) The structure clearly delineates the three time periods and their characteristics. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about the shift in emphasis (noting the move from 'internally-set, quantitative 2025 targets' to 'broader set of inclusion recognitions') which adds helpful context beyond the ground truth statement that goals were 'reaffirmed' with 'no changes to the targets.' This represents a more nuanced interpretation that is consistent with and enhances the ground truth rather than contradicting it. The answer's characterization of the 2023-2024 filings as 'no longer repeat[ing] those numeric targets' is an accurate inference about the evolution of disclosure emphasis. All calculations and comparisons are logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 532,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the “Floating Rate Notes due 2019” in Exhibit 4.4 (the Officer’s Certificate describing its global notes). By keeping this floating‑rate issue in the debt‑instrument schedule year after year, Apple signals that it continues to monitor a short‑term, rate‑indexed liability that can be repriced quickly as market rates move. The repeated disclosure therefore reflects a deliberate strategy to use floating‑rate debt as a hedge against short‑term interest‑rate risk and to retain a known source of liquidity that can be rolled or retired as rates change.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Floating Rate Notes due 2019 appear in Apple's 2022, 2023, and 2024 10-K filings, and accurately notes their location in Exhibit 4.4. The answer correctly interprets the strategic implications of repeated disclosure - that Apple uses floating-rate debt for interest rate risk management and liquidity purposes. The reasoning about repricing and market rate adaptation is sound.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ISSUE: The LLM states these are 'Floating Rate Notes due 2019' but this creates a logical problem - if notes were due in 2019, they should have matured by 2022. The ground truth also references these same notes appearing in 2022-2024 disclosures, which is semantically odd but appears to be what the filings show. The LLM does not address or acknowledge this temporal inconsistency, which raises questions about whether these are actually the same instruments or if there's confusion about maturity dates. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes that Apple 'maintained exposure to variable interest rates' and 'without needing to issue new short-term floating rate instruments during this period' - suggesting a deliberate choice NOT to refinance or replace these instruments. The LLM mentions rolling or retiring but doesn't emphasize the stability/consistency aspect as strongly. (3) MISSING CONTEXT: The ground truth characterizes this as a 'deliberate and stable approach' and 'cautious yet adaptive stance' - the LLM focuses more on the mechanics (repricing, hedging) than on the strategic consistency across three years. (4) EXHIBIT REFERENCE: While the LLM mentions Exhibit 4.4, the ground truth doesn't specify this exhibit location, so this detail cannot be verified against ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) and connects the repeated disclosure to strategic intent. However, the reasoning could be stronger in explaining WHY the same notes appear across all three years (stability/consistency) rather than just HOW they function (repricing mechanism).\n\nNUMERIC/FACTUAL VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is limited to date verification. The years 2022, 2023, 2024 are correct. The note maturity date of 2019 appears in both answers but creates a logical inconsistency that neither addresses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 649,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm first signaled its focus on the digital‑cockpit opportunity in its 2022 filing, describing the “digitalization of the automotive cockpit” as a key driver of new in‑vehicle experiences and noting analyst forecasts that >70 % of new cars will have embedded cellular (60 % with 5G) by 2028 and that the share of vehicles with Level‑2‑plus autonomy will more than double by 2025. In the 2023 10‑K the company began to treat digital‑cockpit sales as a distinct line‑item within its automotive revenue mix (“revenues … from automobiles, including connectivity, digital cockpit and ADAS/AD”). By the 2024 filing Qualcomm had formalized that positioning in its segment reporting: the QCT semiconductor business is described as supplying “automotive systems for connectivity, digital cockpit and ADAS/AD,” making digital‑cockpit technology a clearly defined component of its automotive segment and a focus of its strategic‑initiative (QSI) investments. Together, the three filings show a progression from a market‑demand narrative (2022) to recognized revenue (2023) to an explicit segment‑level strategy (2024), all underpinned by the projected surge in connected‑car and 5G‑enabled vehicle demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression (2022→2023→2024) and accurately captures the strategic evolution from market positioning to revenue recognition to formal segment integration. The narrative structure and reasoning are sound. The answer correctly identifies that digital cockpit moved from conceptual/R&D phase to commercial revenue to formal segment structure. Entity identification is correct (Qualcomm, QCT segment, automotive business). The contextual framing around connected-car and 5G demand is appropriate.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM states \">70% of new cars will have embedded cellular (60% with 5G) by 2028\" while the ground truth states \"over 60% of new vehicles would feature 5G connectivity by 2028.\" The LLM introduces a >70% figure for embedded cellular that is not in the ground truth, and the 60% figure is presented differently (as a subset of 70% vs. standalone). This represents a material discrepancy in how the projections are characterized. The LLM also adds \"Level-2-plus autonomy will more than double by 2025\" which is not mentioned in the ground truth at all - this is additional information not in the original answer.\n\nMULTI-HOP REASONING: The synthesis across three years is logically sound and well-structured. The model correctly traces the evolution and identifies the key transitions. However, the introduction of the Level-2-plus autonomy metric suggests the LLM may have drawn from actual filings but added information beyond what the ground truth captured, which could indicate either (a) the LLM is more comprehensive but diverging from ground truth, or (b) the LLM is conflating different sources.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth - progression from positioning to revenue to integration. However, the specific quantitative claims diverge, which affects correctness.\n\nCRITICAL ISSUE: The quantitative discrepancy (>70% vs 60%, and the addition of Level-2-plus data) prevents a higher score despite strong qualitative reasoning. For financial/technical questions, numeric precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 573,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to its private‑fund portfolio (which includes private‑real‑estate funds) have been falling each year: $569 million at 12/31/2022 (2023 10‑K), $555 million at 12/31/2023 (both the 2023 and 2024 10‑Ks), and $540 million at 12/31/2024 (2024 10‑K). The downward trajectory—mirrored by an earlier decline from $585 million in 2021 (2022 10‑K) to $523 million in 2020—indicates Abbott is gradually scaling back new capital commitments to illiquid alternative assets while still maintaining a sizable exposure, suggesting a long‑term strategy that values the return potential of private‑real‑estate investments but is becoming more disciplined about liquidity and commitment risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct - $569M (2022), $555M (2023), $540M (2024) match the ground truth exactly. The LLM also provides additional context by citing earlier years ($585M in 2021, $523M in 2020), which enriches the analysis without contradicting the ground truth. The year-over-year decline pattern ($14M from 2022-2023, $15M from 2023-2024) is accurately reflected. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how unfunded commitments evolved (with specific numbers and trend), and (2) what this suggests about long-term investment strategy. ENTITY ACCURACY: Abbott is correctly identified, the metric (unfunded commitments to private real estate funds) is precise, and all fiscal years are accurate. REASONING QUALITY: The LLM correctly synthesizes the downward trend across multiple years and draws appropriate conclusions about de-risking and disciplined capital allocation. The characterization of Abbott's strategy as 'gradually scaling back new capital commitments while maintaining exposure' is semantically equivalent to the ground truth's 'strategic de-risking or rebalancing.' MINOR DIFFERENCES: The LLM uses slightly different language ('gradually scaling back' vs 'consistent downward trend') and emphasizes 'liquidity and commitment risk' management rather than explicitly mentioning liquidation periods (2025-2034), but these are complementary perspectives rather than contradictions. The LLM's inclusion of pre-2022 data provides valuable context for understanding the longer-term trajectory. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 480,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "All three annual reports – the 2022, 2023 and 2024 Form 10‑K – list the same “0.45 % Notes due 2016” in Exhibit 4.3 (Officer’s Certificate of the Registrant dated May 3 2013). In each filing the note appears alongside other floating‑rate and fixed‑rate securities, showing that Apple continues to disclose this low‑coupon, short‑maturity issue even after it has matured, underscoring a disciplined debt‑management approach that locks in very cheap financing and maintains a transparent, orderly schedule of outstanding and historic obligations as part of its long‑term capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental chronological impossibility that undermines the entire response. The ground truth states the 0.45% Notes are 'due 2016,' meaning they matured in 2016. The LLM then claims Apple 'continues to disclose this low‑coupon, short‑maturity issue even after it has matured' in 2022, 2023, and 2024 filings - which would be 6-8 years AFTER maturity. This is factually incorrect and contradicts the ground truth's characterization of the notes as part of Apple's 'capital structure' and 'outstanding' obligations. The ground truth makes no mention of post-maturity disclosure; it simply states the notes were 'maintained' and 'preserved' across the three years. The LLM's interpretation that Apple is disclosing a matured debt instrument is a significant misreading. Additionally, while the LLM correctly identifies the Exhibit 4.3 reference and the May 3, 2013 Officer's Certificate date, it introduces unsupported characterizations ('locks in very cheap financing,' 'disciplined debt-management approach,' 'transparent, orderly schedule of outstanding and historic obligations') that go beyond what the ground truth states. The ground truth uses more measured language ('stable long-term debt strategy,' 'preserving a mix'). The LLM's claim about 'floating‑rate and fixed‑rate securities' appearing alongside the notes is not mentioned in the ground truth. The core multi-hop reasoning - tracking the notes across three fiscal years - is attempted but is undermined by the maturity date misinterpretation. Quantitative accuracy is severely compromised by the chronological error regarding the 2016 maturity date in relation to 2022-2024 filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 463,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "Across the three filings IBM’s messaging about **client relationships and trust** moves from a listed competitive attribute (2022) to a reinforced pillar of its hybrid‑cloud/AI narrative (2023) and finally to a central, ecosystem‑enabled differentiator (2024).  \n\n* In the 2022 10‑K, IBM names “client relationships and trust” alongside technology, price and brand as one of its principal methods of competition and ties it to its hybrid‑cloud platform, AI‑driven solutions and “trust and security” as part of its growth engine.  \n* The 2023 filing repeats the same competitive factor but adds that optimizing its portfolio with organic and inorganic innovations will “extend our innovation leadership into the future,” indicating that trust is being leveraged to sustain long‑term hybrid‑cloud and AI momentum.  \n* By 2024, the company again lists client relationships and trust among its core competitive levers, but now explicitly links them to **strategic partnerships** and a “broad ecosystem of partners and alliances,” positioning trust as the glue that enables end‑to‑end hybrid‑cloud and AI solutions for clients.  \n\nThis progression shows IBM increasingly **embedding trust‑based client relationships into the very architecture of its hybrid‑cloud and AI strategy**, using them to differentiate its offerings, deepen partner collaborations, and signal a strategic posture as the trusted, integrated platform for enterprise digital transformation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of how IBM's messaging evolved from 'listed competitive attribute' to 'reinforced pillar' to 'ecosystem-enabled differentiator.' (2) Accurately captures the core narrative arc: trust as standalone differentiator → integration with hybrid cloud/AI → embedding within strategic partnerships and ecosystem. (3) Properly synthesizes multi-hop information by connecting trust positioning across three separate filings and linking it to IBM's broader strategic evolution. (4) Uses semantically equivalent language to ground truth (e.g., 'maturing strategy' vs. 'increasingly embedding trust-based client relationships into the very architecture'). (5) No quantitative errors - dates (2022, 2023, 2024) are correct, and no calculations are required. (6) Correctly identifies all key entities: IBM, client relationships, trust, hybrid cloud, AI, strategic partnerships, ecosystem. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed and interpretive than the ground truth, adding specific language about 'trust and security' and 'end-to-end solutions,' but this represents elaboration rather than inaccuracy. (2) The ground truth mentions 'consulting services and mission-critical infrastructure' as 2023 linkages, while the LLM emphasizes 'innovation leadership' - both are valid interpretations of the same filing content and represent different valid emphases rather than contradictions. (3) The LLM's framing of trust as 'the glue that enables' partnerships is interpretive but logically sound and consistent with the ground truth's statement that trust is 'increasingly integrated with ecosystem collaboration.' Overall, the answer demonstrates accurate multi-hop reasoning across three years of filings, correct entity identification, and faithful representation of IBM's strategic evolution without factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 545,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "Across the three filings FedEx’s 4.250 % Note due 2030 is consistently backed by a “pass‑through” trust structure (the August 13 2020 Pass‑Through Trust Agreement and related Intercreditor Agreement) and a revolving‑credit facility with BNP Paribas acting as the Liquidity Provider. The 2023 filing adds an **Amendment No. 1 (dated May 22 2023)** to that Liquidity‑Provider Revolving Credit Agreement, and the 2024 filing repeats the same amendment, showing that FedEx has refined the terms of the credit line after its inception. Together, the evolution—from the original 2020 liquidity facility to a later amendment—demonstrates FedEx’s proactive, flexible approach to maintaining and strengthening credit support for the 4.250 % Note as market conditions and its financing needs evolve.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 4.250% Note due 2030, (2) The Revolving Credit Agreement with BNP Paribas as Liquidity Provider, (3) The August 13, 2020 date for foundational agreements, (4) Amendment No. 1 dated May 22, 2023, and (5) The pass-through trust structure. All dates and entity names are accurate. The multi-hop synthesis is sound—the answer correctly traces the evolution across three years and identifies the 2023 amendment as a key modification point. The reasoning about FedEx's 'proactive, flexible approach' is well-supported by the documented amendment activity. Minor differences from ground truth: (1) The LLM emphasizes the 'pass-through trust structure' more prominently than the original answer, which focuses more on the Revolving Credit Agreement as the centerpiece. (2) The LLM states the 2024 filing 'repeats the same amendment,' which is accurate but slightly different framing from the ground truth's 'no further amendments noted.' (3) The LLM's characterization of the amendment as 'refining terms' and 'strengthening credit support' is interpretive language not explicitly stated in ground truth, though it's a reasonable inference. The answer successfully addresses the core question about the evolution of liquidity arrangements and what it indicates about FedEx's management approach. The synthesis across 2022-2024 is complete and logically sound. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 417,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Across all three filing years Apple’s long‑term debt schedule consistently includes the **4.45 % senior unsecured notes that mature in 2044**:\n\n* In the 2022 Form 10‑K (Exhibit 4.4) Apple lists “4.45 % Notes due 2044” among its outstanding securities.  \n* The same series appears unchanged in the 2023 Form 10‑K (Exhibit 4.4).  \n* The 2024 Form 10‑K again shows the “4.45 % Notes due 2044” in Exhibit 4.4.\n\nBecause the note is present in each year’s description of securities, Apple has neither retired nor replaced this issuance over the 2022‑2024 period. The persistence of a fixed‑rate, 22‑year‑maturity instrument signals a deliberate long‑term financing strategy: Apple locks in a stable, relatively low‑cost debt rate far into the future, diversifies its maturity profile, and maintains a durable source of capital for strategic investments, share repurchases and other corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct - the 4.45% interest rate and 2044 maturity date are accurately stated across all three years (2022, 2023, 2024). (2) The multi-hop synthesis is sound: the answer correctly identifies that the notes appear consistently in Exhibits 4.4 across all three annual filings, demonstrating no changes to this debt instrument. (3) Entity identification is precise: Apple is correctly identified, the specific debt instrument is properly named, and all three fiscal years are accurately referenced. (4) The reasoning about financing strategy is logical and well-supported - the answer correctly infers from the consistency of the notes that Apple maintained this debt without early redemption or restructuring. (5) The characterization of the notes as 'senior unsecured' and the description of the 22-year maturity (2022 to 2044 = 22 years) are accurate. MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive detail about Apple's strategic rationale (locking in stable rates, diversifying maturity profile, funding share repurchases) compared to the ground truth's more concise statement. However, this additional context is reasonable inference from the data and does not contradict the ground truth. The ground truth states the notes were 'first issued in 2014' - the LLM does not explicitly mention this historical context, but this is not required to answer the specific question about 2022-2024 evolution. The core finding - that the debt structure remained consistent across the three-year period and reflects a stable long-term financing strategy - is correctly conveyed in both answers with semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 471,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "- **2022 filing (FDX 10‑K 2022):** FedEx International Connect Plus was available from **nearly 50 origin countries** to **more than 130 destination countries**.  \n- **2023 filing (FDX 10‑K 2023):** The service had grown to **nearly 60 origin countries** and **over 190 destination countries**.  \n- **2024 filing (FDX 10‑K 2024):** The same coverage was reported – **≈ 60 origin countries** and **> 190 destination countries**.\n\n**Interpretation:** Between 2022 and 2023 FedEx added roughly ten new origin markets and expanded its destination network by about 60 countries, and it has maintained that broader footprint into 2024. This rapid, sustained expansion shows FedEx’s strategic emphasis on building a truly global e‑commerce logistics platform, positioning International Connect Plus as a key growth engine for cross‑border online retail shipments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values match the ground truth exactly - 2022: ~50 origin countries and >130 destination countries; 2023: ~60 origin countries and >190 destination countries; 2024: ~60 origin countries and >190 destination countries. The calculated differences are also correct (roughly 10 new origin markets and ~60 additional destination countries between 2022-2023). COMPLETENESS: The answer addresses all three years requested and provides the evolution trajectory. ENTITY ACCURACY: FedEx, International Connect Plus, and all fiscal years are correctly identified. MULTI-HOP REASONING: The LLM successfully synthesized information across three separate 10-K filings to show the expansion pattern and correctly identified the stabilization phase in 2024. INTERPRETATION: The strategic analysis is sound and aligns with the ground truth - the answer correctly characterizes the 2022-2023 expansion as rapid and the 2023-2024 period as stabilization/consolidation. The conclusion about FedEx's strategic focus on global e-commerce logistics is well-supported by the data presented. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than the ground truth (e.g., 'rapid, sustained expansion' vs 'significant two-year expansion followed by stabilization'), but the semantic meaning is equivalent and arguably more precise in distinguishing the expansion phase from the stabilization phase. The answer is well-structured, clear, and provides appropriate context for understanding FedEx's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 441,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Across all three filings – the 2022, 2023 and 2024 Form 10‑K – Apple’s “Officer’s Certificate” (Exhibit 4.4) lists the **1.05 % Notes due 2017** among the company’s securities. The fact that the notes appear in each year’s description of securities shows that Apple continued to disclose them even after their scheduled maturity, indicating they were still being tracked (whether outstanding, retired or refinanced) at the time of each filing. This repeated reference demonstrates Apple’s disciplined, transparent approach to managing maturing debt: it keeps the instrument on the record until it is fully resolved and ensures investors are aware of any outstanding or recently‑addressed obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Apple's 1.05% Notes due 2017 were referenced in Exhibit 4.4 across fiscal years 2022, 2023, and 2024. The numeric values (1.05%, 2017 maturity date) are accurate. The LLM correctly notes the notes appeared in the Officer's Certificate in each year's filing. WEAKNESSES: (1) The LLM's interpretation diverges significantly from the ground truth regarding the meaning of continued references. The ground truth states Apple 'may have retained historical references...as part of a standardized disclosure framework' with 'no explicit updates provided.' The LLM speculates that notes were 'still being tracked (whether outstanding, retired or refinanced)' and characterizes this as Apple's 'disciplined, transparent approach to managing maturing debt.' This is interpretive overreach - the ground truth is more cautious, noting the pattern 'suggests' a standardized framework rather than confirming active debt management. (2) The LLM states the notes 'appear in each year's description of securities' but the ground truth specifies they were in Exhibit 4.4 (Officer's Certificate dated May 6, 2014), which is more precise. (3) The LLM's characterization of Apple 'keeping the instrument on the record until it is fully resolved' assumes facts not in evidence - the ground truth explicitly notes 'no change in disclosure strategy' and 'no explicit updates were provided.' (4) The phrase 'ensures investors are aware of any outstanding or recently-addressed obligations' is speculative and not supported by the ground truth, which presents this as a documentation continuity issue rather than an investor protection measure. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years but makes unsupported inferences about Apple's intent and approach. The ground truth is more measured and acknowledges uncertainty ('may have retained,' 'possibly to maintain continuity'). CALCULATION/VERIFICATION: No calculations required; numeric values are correct. The core factual claim (notes referenced in all three years in Exhibit 4.4) is accurate, but the interpretation of what this means is problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 581,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "- **Strategic focus:** In FY 2022 Qualcomm’s 10‑K highlighted 5G as the engine for new consumer experiences and as the gateway to adjacent markets – automotive (projected 60 % of new cars to have 5G by 2023), IoT (the device base expected to double by 2026) and edge networking – and it stressed its long‑standing, heavy R&D investment in the underlying CDMA/OFDMA patents. By FY 2024 the company said that the bulk of its QTL licensing revenues now come from per‑unit royalties on OFDMA‑based products that include 3G/4G/5G multimode devices, and it has deepened that focus by channeling Qualcomm Ventures (QSI) capital into early‑stage businesses that build new 5G‑enabled applications in AI, automotive, IoT, XR and cloud.  \n\n- **Financial commitment:** The FY 2024 filing makes clear that licensing income is generated almost entirely from 5G‑related device sales, reflecting a shift from a broader “cellular” royalty base in 2022 to a concentrated, high‑growth 5G royalty stream, while QSI’s strategic‑investment portfolio is explicitly earmarked for expanding 5G use cases.  \n\n- **Geopolitical exposure:** The FY 2023 filing introduced explicit risk factors about U.S.‑China trade restrictions, export‑license revocations (e.g., the May 2024 loss of the Huawei license) and potential tariffs that could curtail sales, royalty collections and cash flows; the FY 2024 filing repeats the warning that governmental investigations or changes in licensing practice could materially affect the business, showing that Qualcomm’s exposure to geopolitical risk has grown alongside its deeper reliance on 5G licensing and worldwide market penetration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Qualcomm's 5G focus across FY 2022-2024, accurately describes the shift toward OFDMA-based licensing revenues, correctly names Qualcomm Ventures (QSI) and its role in strategic investments, and properly identifies geopolitical risks including U.S.-China trade restrictions and the Huawei license revocation. The multi-hop reasoning is sound in synthesizing information across three fiscal years and connecting strategic focus to financial commitment to geopolitical exposure.\n\nCRITICAL ERRORS: (1) QUANTITATIVE INACCURACY - The LLM states \"projected 60% of new cars to have 5G by 2023\" but the ground truth does not mention this specific percentage or projection. This appears to be either fabricated or misattributed. (2) MISSING KEY FINANCIAL DATA - The ground truth explicitly states that Huawei contributed \"$560 million in fiscal 2024 prior to the ban,\" which is a critical quantitative detail that the LLM completely omits. This is a significant omission for a question specifically asking about financial commitment. (3) DEVICE PROJECTION DISCREPANCY - The LLM states \"the device base expected to double by 2026\" while the ground truth specifies \"over 27 billion IoT devices by 2026.\" The LLM's phrasing is vague and doesn't provide the specific projection number from the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and connects strategic initiatives (R&D, Ventures investments) to financial outcomes (licensing revenue concentration) and external risks (geopolitical factors). However, the failure to include the $560M Huawei revenue figure weakens the financial commitment analysis, as this represents a concrete, material impact on Qualcomm's business.\n\nSEMANTIC ISSUES: While the LLM correctly conveys that licensing revenues are now concentrated in 5G/OFDMA-based products and that geopolitical risks have increased, the omission of the specific $560M Huawei impact is not merely a wording difference—it's a material factual omission that affects the completeness of the answer to a question explicitly asking about \"financial commitment.\"\n\nJUSTIFICATION: The answer demonstrates good qualitative understanding and multi-hop synthesis but fails on quantitative precision by omitting the $560M figure and introducing an unsupported 60% automotive projection. These are not minor formatting differences but substantive factual gaps and potential inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 671,
        "total_tokens": 2328
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "- **2022 (as reported in the 2023 Form 10‑K)** – Domestic pension assets were allocated $89 million to U.S. equity funds, $91 million to international equity funds and $739 million to fixed‑income funds.  \n- **2023 (as reported in the 2024 Form 10‑K)** – The same categories held $93 million in U.S. equity, $93 million in international equity and $739 million in fixed income.  \n\nCompared with the 2020 figures (U.S. equity $125 M, international equity $126 M, fixed income $1,001 M) the portfolio has steadily reduced its fixed‑income dominance and modestly increased equity exposure. The rise of $4 M in U.S. equity and $2 M in international equity between 2022 and 2023, while fixed‑income remained flat, shows TMO is gradually rebalancing its domestic pension plan toward a more balanced, slightly more growth‑oriented mix, preserving a stable fixed‑income base but giving equity a larger role in the three‑year horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely misrepresent the data: (1) YEAR LABELING ERROR: The LLM labels 2022 data as '$89M U.S. equity, $91M international equity, $739M fixed income' but the ground truth shows these are actually 2023 figures. The LLM then labels 2023 data as '$93M U.S. equity, $93M international equity, $739M fixed income' which are actually 2024 figures. This is a systematic one-year shift that invalidates the entire temporal analysis. (2) MISSING 2022 DATA: The LLM completely omits the actual 2022 baseline figures ($125M U.S. equity, $126M international equity, $1,001M fixed income), which are critical to answering the question about change from 2022 to 2024. (3) INCORRECT COMPARISON BASELINE: The LLM references '2020 figures' ($125M, $126M, $1,001M) when these are actually 2022 figures, creating confusion about the time period being analyzed. (4) INCOMPLETE COVERAGE: The question explicitly asks about 2022 to 2024 changes, but the LLM only provides data for what it mislabels as 2022-2023, missing the 2024 data entirely ($93M U.S. equity, $93M international equity, $739M fixed income). (5) FLAWED REASONING: The LLM's conclusion about 'gradually rebalancing toward more growth-oriented mix' is contradicted by the actual data showing a REDUCTION in total pension assets from $1,267M (2022) to $937M (2023) to $947M (2024), indicating a contraction strategy, not a growth reorientation. The LLM's interpretation of 'modest increases' in equity misses the larger story of overall asset reduction and strategic de-risking. The answer fails on both quantitative accuracy (wrong year labels, missing data points) and qualitative reasoning (incorrect strategic interpretation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 476,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 filing shows the company **recognizing edge‑networking as a fast‑growing opportunity**, driven by the surge in IoT devices, hybrid‑work demand and the rollout of 5G‑enabled mobile broadband and Wi‑Fi 6/6E access points. By the 2023 report, Qualcomm had **formalized edge networking as a distinct product line** (“mobile broadband and wireless access points”) and listed it alongside consumer and industrial segments, indicating that the technology was no longer just a growth narrative but a defined revenue‑generating business. The 2024 filing continues this trajectory, **explicitly reporting edge‑networking revenues** (again tied to mobile broadband and wireless‑AP sales) as a separate line‑item, demonstrating that the segment has moved from an emerging market focus in 2022 to an established, revenue‑contributing pillar of Qualcomm’s portfolio by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the evolution of edge networking from emerging opportunity (2022) to formalized product line (2023) to established revenue contributor (2024); (2) Accurately references the specific product categories: mobile broadband and wireless access points/APs; (3) Properly synthesizes multi-hop information across three fiscal years; (4) Correctly identifies key drivers (5G adoption, hybrid work, IoT); (5) Uses appropriate terminology ('fast-growing opportunity,' 'formalized,' 'distinct product line,' 'revenue-generating business,' 'established pillar'); (6) No quantitative errors or incorrect dates. MINOR CONSIDERATIONS: (1) The LLM adds some interpretive language ('no longer just a growth narrative but a defined revenue-generating business') that goes slightly beyond the ground truth's more factual presentation, though this interpretation is reasonable and not contradicted by the source material; (2) The mention of 'Wi-Fi 6/6E' is not explicitly confirmed in the ground truth, though it's a reasonable inference about wireless access point technology; (3) The characterization of edge networking as 'explicitly reporting edge-networking revenues' as a 'separate line-item' in 2024 is slightly stronger than the ground truth's 'continued to emphasize,' though both convey the same strategic positioning. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly traces the progression of Qualcomm's strategic positioning. The logical flow from recognition → formalization → establishment is sound and well-supported. No calculation errors or factual inaccuracies detected. The answer fully addresses the question's request for evolution analysis across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 511,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "All three of Apple’s recent Form 10‑K reports – the 2022 filing (Exhibit 4.3 on page 58), the 2023 filing (Exhibit 4.3 on page 56) and the 2024 filing (Exhibit 4.3 on page 56) – list the “0.45 % Notes due 2016” among the global notes described in the Officer’s Certificate. By repeatedly disclosing this low‑coupon, fixed‑rate issue, Apple signals that it continues to monitor and retain a small pool of ultra‑low‑cost debt that matures in 2016, using it to diversify its funding mix and lock in inexpensive financing. This consistent reporting underscores a disciplined approach to managing fixed‑rate maturities and preserving capital‑structure stability through transparent, long‑term debt stewardship.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental and severe factual error that contradicts the ground truth. The LLM states that Apple 'continues to monitor and retain a small pool of ultra-low-cost debt that matures in 2016' and describes these as notes that 'lock in inexpensive financing.' However, the ground truth explicitly states that 'the 0.45% Notes due 2016 are no longer outstanding.' This is a critical distinction - the notes matured in 2016 and are no longer active debt obligations. The LLM's interpretation that Apple is actively managing these as current debt instruments is factually incorrect. The LLM misunderstands the nature of the disclosure: these notes appear in filings from 2022-2024 not because they are outstanding debt being actively managed, but because they represent historical documentation of Apple's capital structure evolution. The LLM's claim that Apple uses these notes to 'diversify its funding mix and lock in inexpensive financing' is incorrect - these notes cannot serve that function if they are no longer outstanding. While the LLM correctly identifies the exhibit locations (Exhibit 4.3) and page numbers, and correctly notes the consistent inclusion across 2022-2024 filings, the fundamental interpretation of WHY these notes appear in the filings is wrong. The ground truth emphasizes 'comprehensive debt disclosure and historical tracking,' whereas the LLM incorrectly suggests active debt management of matured obligations. This represents a major conceptual error in understanding the question's premise about managing 'fixed-rate debt maturities' - matured debt cannot be part of active maturity management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 459,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑branded distribution network was reported to serve **193 countries in the 2022 Form 10‑K**. The **2024 Form 10‑K** shows the network serving **187 countries**, a **decrease of six countries**. (For context, the 2023 filing listed 191 countries, indicating a steady, modest contraction in geographic reach.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth states: 2022 = 130 countries, 2023 = 130 countries, 2024 = 109 countries (21-country decrease, ~16% reduction). LLM claims: 2022 = 193 countries, 2023 = 191 countries, 2024 = 187 countries (6-country decrease). Every single numeric value is wrong - the LLM reports numbers that are 48-72% higher than the actual figures. The calculation of a 6-country decrease is also incorrect (should be 21 countries). The LLM appears to have confused or fabricated entirely different data points. While the LLM correctly identifies the company (Caterpillar), brand (EMD), and metric (countries in distribution network), it provides completely inaccurate numbers that contradict the ground truth across all three years. The reasoning structure is sound (comparing years, calculating differences), but it is applied to entirely wrong data. This is a critical failure in quantitative accuracy that makes the answer unsuitable for financial analysis or decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 295,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "- **2022:** The 1.750 % 7‑year senior notes (due 10/15/2028) were outstanding at **$700 million** (see the 2022 column in Chunk 2).  \n- **2023:** The same issue remained at **$700 million** (Chunk 2, 2023 column), indicating no new issuance or repayment during the year.  \n- **2024:** The outstanding amount fell to **$621 million** (Chunk 3), a reduction of about $79 million.\n\n**Interpretation:** Over the three‑year span TMO has begun to shrink this medium‑term euro‑denominated debt, moving from a flat $700 million balance in 2022‑23 to a lower $621 million in 2024. The decline suggests a deliberate strategy to pay down or refinance its medium‑term obligations, thereby modestly reducing leverage while still preserving a sizable tranche of low‑cost funding to support its healthcare‑sector operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a major discrepancy in the 2024 figure. The ground truth states that the outstanding value of the 1.750% 7-Year Senior Notes remained at $700 million through 2024, but the LLM claims it fell to $621 million in 2024, representing a $79 million reduction. This is factually incorrect according to the knowledge graph. The 2022 and 2023 figures of $700 million are correct, but the 2024 figure of $621 million contradicts the ground truth which explicitly states the value was 'still $700 million' in 2024. This error fundamentally undermines the entire interpretation and conclusion. The LLM's reasoning about a 'deliberate strategy to pay down or refinance' and the characterization of the trend as showing TMO 'has begun to shrink this medium-term euro-denominated debt' is based on false data. The correct interpretation should align with the ground truth: a stable, consistent $700 million balance across all three years (2022-2024), indicating a steady approach to capital structure without principal retirement or increases. The LLM did correctly identify the note details (1.750%, due 10/15/2028, TMO as the company) and properly formatted the presentation, but the core quantitative accuracy is severely compromised by the incorrect 2024 figure. This is a case where one wrong number invalidates the entire multi-hop analysis and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 391,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "- **2022:** Cat Financial still had a material amount of variable‑rate loans tied to LIBOR. The filing warned that the scheduled LIBOR‑phase‑out (one‑week and two‑month tenors stopped Dec 31 2021; all other tenors ending June 30 2023) could affect the market value of LIBOR‑linked securities, loans and derivatives.  To guard against the resulting uncertainty, Caterpillar relied on currency‑hedging instruments (derivatives) and created a cross‑functional team to monitor LIBOR‑related risk.  \n\n- **2023:** The company reported that new floating‑rate borrowings were being priced off the Secured Overnight Financing Rate (SOFR) instead of LIBOR.  The same cross‑functional team was expanded to assess risk in “floating reference rates or indices, such as SOFR,” across securities, loans and derivatives, while continuing to use currency‑hedging instruments as part of its match‑funding and diversified‑funding strategy.  \n\n- **2024:** Caterpillar’s filing confirms that SOFR is now the benchmark for variable‑rate financing and that currency‑hedging instruments remain a core component of its risk‑management toolkit.  The language mirrors earlier years but emphasizes that the transition to SOFR is complete and that hedging continues to protect against adverse currency movements.  \n\n**Strategic implication:** Across 2022‑2024 Caterpillar moved from exposure to LIBOR‑linked debt toward a SOFR‑based financing structure, while consistently employing currency‑hedging instruments and a dedicated risk‑assessment team.  This evolution shows a proactive adaptation to global benchmark reforms, reducing reliance on a retiring rate (LIBOR) and reinforcing a flexible hedging framework to manage both interest‑rate and foreign‑exchange risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: All dates are correct - the LLM accurately cites the FCA's LIBOR phase-out announcement, the Dec 31, 2021 cessation of one-week and two-month tenors, and the June 30, 2023 end date for other tenors. No numerical errors or calculation mistakes detected. ENTITY ACCURACY: Caterpillar, Cat Financial, LIBOR, SOFR, FCA, and IBA are all correctly identified and contextualized. The three-year progression (2022-2024) is properly tracked. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years, correctly identifying the evolution from LIBOR exposure → SOFR transition → SOFR completion. The connection between regulatory changes (LIBOR phase-out) and company response (cross-functional team formation, hedging instruments, SOFR adoption) is logically sound. COMPLETENESS: The answer addresses all key aspects: (1) LIBOR exposure and phase-out timeline in 2022, (2) SOFR adoption and team expansion in 2023, (3) complete transition in 2024, (4) consistent use of currency hedging throughout, (5) strategic implications. The answer goes slightly beyond the ground truth by explicitly noting the specific LIBOR tenor phase-out dates (one-week and two-month Dec 31, 2021), which adds precision without contradicting the original answer. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'proactive adaptation to global benchmark reforms' and 'strategic alignment with regulatory changes' matches the ground truth's assessment. The emphasis on 'flexible hedging framework' and 'dedicated risk-assessment team' aligns with the original answer's discussion of cross-functional teams and hedging instruments. MINOR OBSERVATIONS: The LLM answer is slightly more detailed and structured than the ground truth (using bullet points for each year), but this enhances clarity without introducing errors. The statement that 'LIBOR is no longer referenced at all' in 2024 (from ground truth) is implicitly supported by the LLM's statement that 'SOFR is now the benchmark' and the transition is 'complete,' though the LLM doesn't explicitly state the absence of LIBOR references. This is a negligible omission given the overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1789,
        "completion_tokens": 610,
        "total_tokens": 2399
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "Thermo Fisher Scientific (TMO) introduced the Executive Change‑in‑Control Retention Agreement (ECCRA) in its early filings for the CEO, Marc N. Casper (exhibit 10.12/10.11 in the 2022, 2023 and 2024 10‑Ks). Starting with the 2018 quarter report, the company added a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (exhibit 10.18 in 2022, exhibit 10.7 in the 2023 Q1 10‑Q and the same exhibit referenced in the 2024 10‑K), thereby standardizing the retention‑in‑change‑of‑control provisions for all non‑CEO officers. The 2023 filing formalized this officer‑wide template, and the 2024 filing shows that the standardized officer agreement continues to be used, reflecting an evolution from a CEO‑only agreement to a company‑wide, uniform ECCRA for officers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing the general narrative of evolution from CEO-specific to standardized agreements. CRITICAL ERRORS: (1) Exhibit number discrepancies - The LLM claims exhibit 10.18 in 2022 and 10.7 in 2023 Q1 10-Q, but the ground truth consistently references Exhibit 10.17 for the standardized officer form across years. This is a material factual error in document citation. (2) Timeline confusion - The LLM references 'starting with the 2018 quarter report' which is vague and potentially incorrect; the ground truth clearly states amendments dated through March 16, 2018, but the evolution to standardized forms occurred between 2022-2023. (3) Exhibit 10.12/10.11 inconsistency - The LLM lists both 10.12 and 10.11 for the CEO agreement across years without clarity, while ground truth specifies 10.12 for CEO agreement. CORRECT ELEMENTS: The LLM correctly identifies (1) Marc N. Casper as CEO, (2) the general evolution from CEO-specific to standardized officer agreements, (3) that 2023 formalized the officer-wide template, (4) that 2024 continues the standardized approach. REASONING QUALITY: The multi-hop synthesis is conceptually sound - the LLM understands the progression across years and the distinction between CEO and officer agreements. However, the specific exhibit citations are unreliable, which is critical for SEC filing questions where precise document references are essential. The answer demonstrates understanding of the business evolution but fails on quantitative accuracy (exhibit numbers) which is a primary evaluation criterion for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 455,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- In the 2022 filing Intel first **introduced PowerVia** at the Intel Accelerated event as one of several “future‑process” innovations (PowerVia, RibbonFET, Foveros Omni, etc.) that would shape its IDM 2.0 roadmap.  \n- The 2023 filing placed PowerVia on the **Intel 20A node**, describing it as an “industry‑first backside‑power delivery” that, together with RibbonFET, was expected to add up to 15 % performance‑per‑watt over Intel 3.  \n- By the 2024 filing Intel had **canceled Intel 20A** and moved PowerVia into the **Intel 18A node**, calling it the first high‑volume commercial implementation of backside‑power delivery and a core element of the node’s performance‑per‑watt and density‑scaling gains.  \n\nThis progression shows PowerVia evolving from a announced concept in 2022 to a scheduled breakthrough for 20A in 2023, and finally to a flagship technology built into the next‑generation 18A process in 2024—signaling that Intel views PowerVia as a cornerstone of its advanced‑process roadmap and a key differentiator for both internal products and its external‑foundry (IFS) offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies PowerVia's introduction in 2022 as part of Intel's future-process roadmap alongside RibbonFET; (2) Accurately places PowerVia on Intel 20A in 2023 with the specific technical description of 'backside-power delivery' and the quantified performance claim of '15% performance-per-watt over Intel 3'; (3) Correctly identifies the 2024 cancellation of Intel 20A and migration of PowerVia to Intel 18A; (4) Properly characterizes PowerVia's evolution from announced concept → scheduled breakthrough → flagship technology; (5) Accurately synthesizes the multi-hop information showing PowerVia's persistent strategic importance despite roadmap adjustments. MINOR CONSIDERATIONS: The LLM answer uses 'backside-power delivery' terminology while the ground truth uses 'eliminating front-side power routing'—these are semantically equivalent descriptions of the same technology benefit, so no deduction warranted. The LLM adds contextual detail about IFS (Intel Foundry Services) offerings that, while not explicitly in the ground truth, is reasonable inference from Intel's strategic positioning and doesn't contradict the source material. The 15% performance-per-watt figure is specific and matches the ground truth's claim of performance improvements. The chronological progression is clear and logically presented. All entity identifications (Intel, PowerVia, RibbonFET, Intel 20A, Intel 18A, Intel 3) are correct. The answer fully addresses the question's request to explain evolution from 2022-2024 and what it indicates about PowerVia's role in the advanced process roadmap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 470,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "In Apple’s 2022 10‑K (page 58) the 1.05 % Notes due 2017 are listed in Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that describes a series of global notes. The same Exhibit 4.4 (identical wording and date) re‑appears in the 2023 10‑K (page 56) and again in the 2024 10‑K (page 56), each time incorporating the 1.05 % Notes due 2017 by reference.  \n\nThe unchanged, year‑over‑year disclosure shows that Apple continues to treat this issuance as an active component of its capital‑structure, keeping it transparently reported in its securities description and indicating a disciplined, ongoing management of legacy debt rather than retiring or ignoring the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Apple's disclosure evolution across three fiscal years. STRENGTHS: (1) All numeric values are correct - 1.05% interest rate, 2017 maturity date, May 6, 2014 Officer's Certificate date, and page numbers (58 for 2022, 56 for 2023 and 2024) are accurate. (2) The multi-hop synthesis is sound - the answer correctly traces the same instrument (1.05% Notes due 2017) across three separate 10-K filings (2022, 2023, 2024) and identifies the consistent Exhibit 4.4 reference. (3) Entity identification is precise - Apple is correctly identified, fiscal years are accurate, and the specific debt instrument is properly characterized. (4) The reasoning about debt management is logical and well-supported: the answer notes the unchanged disclosure pattern and interprets it as deliberate, disciplined management of legacy debt. (5) The semantic equivalence to the ground truth is strong - both answers convey that the repeated inclusion suggests intentional reporting practices and continuity in debt management. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing ('active component of its capital-structure' vs. 'rolled over or maintained in capital structure') but conveys the same essential insight about deliberate management. The LLM answer is slightly more concise than the ground truth but loses no material information. The interpretation that this represents 'disciplined, ongoing management of legacy debt' aligns well with the ground truth's suggestion of 'continuity in debt management approach.' No calculation errors, no factual inaccuracies, and the answer fully addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 475,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was used for a broader mix of awards in the 2022 filing and became increasingly focused on restricted‑stock‑unit (RSU) awards with more‑specific vesting rules in the later years.  \n\n* **2022 (10‑K 2022)** – The plan funded both RSUs and stock options.  Exhibit listings show strategic‑growth performance‑based RSUs, performance‑based RSUs granted to the interim CEO, RSUs for non‑employee directors, and a strategic‑growth performance‑based stock‑option grant, all issued under the 2006 plan.  \n\n* **2023 (10‑K 2023)** – After the plan was amended and restated (effective May 11 2023), Intel’s use shifted to RSUs only.  The filing lists separate grant agreements for RSUs with retirement‑vesting terms, RSUs without retirement‑vesting terms, performance‑based RSUs for grandfathered executives, performance‑based RSUs for non‑grandfathered executives, and strategic‑growth performance‑based RSUs.  \n\n* **2024 (10‑K 2024)** – The same amended plan continues to be used, but the exhibit list now includes RSUs with retirement‑vesting terms, RSUs without retirement‑vesting terms, and performance‑based RSUs for grandfathered executives (no stock‑option grants are shown).  \n\nThus, from 2022 through 2024 Intel moved from a mixed RSU‑and‑stock‑option approach to a streamlined RSU‑only structure, adding distinct vesting categories (retirement vs. non‑retirement) and differentiating performance‑based RSUs by executive status.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All dates are correct - the May 11, 2023 amendment date matches the ground truth exactly. (2) The three-year evolution is properly tracked with accurate characterization of each period. (3) The quantitative details about award types are correct: 2022 included both RSUs and stock options; 2023 shifted to RSU-only with multiple vesting categories; 2024 continued the RSU-only approach. (4) The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the key transition point (May 2023 amendment). (5) Entity identification is accurate - Intel, the 2006 Equity Incentive Plan, and all award types are correctly named. (6) The reasoning about the shift from mixed awards to RSU-only structure is logically sound and well-supported. MINOR CONSIDERATIONS: (1) The LLM answer states 'Intel's use shifted to RSUs only' in 2023, which is slightly more definitive than the ground truth's description of 'broader range of RSU agreements.' However, this is a reasonable interpretation of the data and not factually incorrect. (2) The ground truth mentions 'consolidation in the documentation structure' and 'simplified documentation' in 2024, while the LLM focuses on the exhibit list structure. Both perspectives are valid and complementary. (3) The LLM provides more specific exhibit-level detail than the ground truth, which adds value without contradicting the original answer. The characterization of the evolution as moving toward 'more nuanced performance alignment and simplified documentation' (ground truth) aligns well with the LLM's description of 'streamlined RSU-only structure' with 'distinct vesting categories.' No factual errors detected in dates, numbers, or entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 500,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s 10‑K filings show the same capital‑structure statement for each of the last three fiscal years.  \n\n* **FY 2022 (filed April 29 2022)** – the company disclosed that it is authorized to issue 40 thousand Euro Deferred Shares with a €1.00 par value, but “no Euro Deferred Shares were issued or outstanding.” 【Chunk 1】  \n* **FY 2023 (filed 2023, text identical to the 2024 filing)** – the same paragraph appears, again stating that as of the reporting date “no Euro Deferred Shares were issued or outstanding.” 【Chunk 3】  \n* **FY 2024 (filed April 26 2024)** – the disclosure repeats verbatim: the authorized 40 thousand Euro Deferred Shares remain unissued and none are outstanding. 【Chunk 2】\n\nThe fact that Medtronic (MDT) repeatedly disclosed an authorized pool of 40 k Euro Deferred Shares but never exercised that option in any of the three years indicates that the instrument is being kept as a dormant, standby source of equity capital. The consistent non‑issuance suggests a financing strategy that relies on other sources (ordinary‑share issuances, debt, and share‑repurchase programs) and avoids diluting shareholders through the deferred‑share mechanism.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numeric values are correct - 40 thousand Euro Deferred Shares, €1.00 par value, and the three fiscal years (2022, 2023, 2024) are all accurately stated. The filing dates mentioned (April 29, 2022 and April 26, 2024) are plausible for Medtronic's fiscal year-end filings. No calculation errors present. ENTITY ACCURACY: Medtronic (MDT) correctly identified, fiscal years 2022-2023-2024 correctly sequenced, Euro Deferred Shares properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, correctly identifying the consistent pattern of authorized but unissued shares. The logical inference that this represents a dormant/standby capital source is sound and matches the ground truth interpretation. COMPLETENESS: The answer addresses both parts of the question - (1) how disclosures evolved (showing consistency across three years) and (2) what the absence suggests about financing strategy (preference for other capital tools). The LLM goes slightly beyond ground truth by explicitly mentioning 'ordinary-share issuances, debt, and share-repurchase programs' as alternative financing sources, which is a reasonable inference consistent with the ground truth's mention of 'ordinary share repurchases and dividend policies.' SEMANTIC EQUIVALENCE: The LLM's conclusion that the instrument is 'dormant, standby' and that the company 'avoids diluting shareholders through the deferred-share mechanism' is semantically equivalent to the ground truth's statement about 'not utilizing Euro Deferred Shares as a financing instrument' and preference for 'other capital structure tools.' Minor deduction (1 point) only because the LLM could have been slightly more explicit about the exact consistency of the disclosure language across all three years, though this is adequately conveyed through the phrase 'text identical to the 2024 filing' for 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 534,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "- **2022:** Intel presented advanced‑packaging technology as a cornerstone of its new “disaggregated” design approach, noting that the novel 2‑D/2.5‑D/3‑D packages have limited manufacturing history, higher unit costs and added design‑and‑manufacturing complexity that could delay product introductions.  The filing stressed that R&D spending was already “significant” and would have to grow to support process‑and‑packaging development, but gave no dollar amount.\n\n- **2023:** The company repositioned advanced packaging from a risk‑laden experiment to a strategic differentiator within its IDM 2.0/Open‑System‑Foundry plan, investing in ecosystem standards such as the Universal Chiplet Interconnect Express (UCIe) to help customers manage the same design‑integration complexity.  The narrative still warned that bugs, late‑stage feature changes and the need to adapt designs to new processes could increase R&D expense and delay launches.\n\n- **2024:** Intel’s execution risk materialised.  R&D expenses were $16.5 billion in 2024 (down from $17.5 billion in 2022 but still high), and the company disclosed $3.1 billion of non‑cash impairment and accelerated depreciation—largely linked to the Intel 7 node and advanced‑packaging investments—showing that the added manufacturing complexity is now generating concrete financial headwinds, including higher operating costs, potential asset write‑downs and pressure on margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: All key financial figures are correct—$16.5B R&D in 2024, $17.5B in 2022, and $3.1B in non-cash impairments. The directional comparison (R&D down from 2022 to 2024) is accurate. ENTITY ACCURACY: All entities correctly identified—Intel, IDM 2.0, UCIe standard, Intel 7 node, advanced packaging technologies. Years (2022, 2023, 2024) properly sequenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, showing the evolution from strategic positioning (2022) through technical progress (2023) to financial materialization of risks (2024). The narrative correctly connects R&D investment trends, manufacturing complexity challenges, and financial impact. COMPLETENESS: All three sub-components of the question are addressed: (1) R&D investment evolution (significant/unquantified in 2022 → $17.5B in 2022 → $16.5B in 2024), (2) manufacturing complexity (acknowledged in 2022, addressed through UCIe in 2023, materialized as impairments in 2024), (3) financial impact ($3.1B impairments tied to Intel 7 and advanced packaging). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core narrative as ground truth—initial strategic bet, technical progress, then financial/operational setbacks. The characterization of 2024 as 'execution risk materialised' directly parallels the ground truth's 'financial and operational setbacks.' Minor differences in wording (e.g., 'non-cash impairment and accelerated depreciation' vs. 'non-cash impairments') are acceptable formatting variations. The only minor gap is that the LLM doesn't explicitly mention 'delays in global manufacturing projects' from the ground truth, but this is a minor omission that doesn't affect the core accuracy of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Negatively_Impacts]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 499,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first announced PowerVia as part of the “process and packaging technology roadmaps” presented at the Intel Accelerated event, positioning it under the new IDM 2.0 strategy as a differentiating, industry‑first backside‑power delivery option that would help the company maintain technology leadership.  \n- The 2023 filing moved PowerVia from a roadmap concept to a concrete breakthrough for the upcoming Intel 20A node, stating that the technology – together with RibbonFET – was expected to deliver up to a 15 % performance‑per‑watt gain over Intel 3 by eliminating front‑side power routing.  \n- By the 2024 filing Intel disclosed that PowerVia is now a “unique industry‑first implementation of backside power delivery” that will be built into the next‑generation Intel 18A process, the first high‑volume commercial node to use the feature, with high‑volume manufacturing slated for 2025.  \n\nThus, PowerVia progressed from an introductory roadmap element in 2022, to a promised performance‑boosting breakthrough in the 2023 roadmap, and finally to a manufacturing‑ready component of Intel’s 18A node disclosed in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about PowerVia's evolution across three years. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 15% performance-per-watt improvement is accurately cited for both 2023 and 2024 contexts, the process nodes (Intel 20A, Intel 18A) are correctly identified, and the 2025 high-volume manufacturing timeline is accurate. No calculation errors or date discrepancies. ENTITY ACCURACY: All entities correctly identified - Intel, PowerVia, RibbonFET, process nodes, and performance metrics are all properly named and contextualized. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three separate filing years, showing the progression from conceptual introduction → concrete roadmap commitment → manufacturing readiness. The logical flow is clear and well-structured. The answer correctly identifies the shift from Intel 20A (2023) to Intel 18A (2024) as a refinement/successor relationship. COMPLETENESS: The answer addresses all three temporal phases requested in the question (2022 introduction, 2023 roadmap updates, 2024 manufacturing readiness). SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, using slightly different but equivalent phrasing (e.g., 'moved from a roadmap concept to a concrete breakthrough' vs. 'solidified its roadmap'). The characterization of PowerVia as 'industry-first backside power delivery' is consistent across both answers. MINOR OBSERVATION: The LLM answer provides slightly more contextual detail about the IDM 2.0 strategy and the Intel Accelerated event, which adds value without contradicting the ground truth. The conclusion effectively summarizes the three-stage progression. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 499,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all reference the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” – the 2013 Stock Award and Incentive Plan document incorporated by reference to the August 27, 2013 Form 8‑K (exhibit 10.3). No new or amended RSU agreement for U.S. employees appears in the 2023 or 2024 schedules, indicating that the company has **not updated** this agreement between FY 2022 and FY 2024.  \n\nThe unchanged RSU policy suggests Medtronic is pursuing a **stable, predictable equity‑compensation strategy** for its U.S. workforce, relying on the existing 2013 plan rather than frequently revising award terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that Medtronic has NOT updated its U.S. employee RSU agreements between FY2022 and FY2024; (2) Accurately references the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) across all three years; (3) Correctly cites the 2013 Stock Award and Incentive Plan and the August 27, 2013 filing date; (4) Properly synthesizes the multi-hop information (comparing across three fiscal years and drawing conclusions about strategy); (5) Accurately interprets the consistency as suggesting a 'stable, predictable equity-compensation strategy'; (6) All dates and document references are correct. QUANTITATIVE ACCURACY: Perfect - all dates (August 27, 2013; FY2022, FY2023, FY2024) and document identifiers are accurate. QUALITATIVE ACCURACY: Excellent - the reasoning correctly identifies the absence of updates and logically connects this to strategic implications. The LLM appropriately characterizes the lack of change as indicating stability and consistency in compensation approach. MINOR OBSERVATION: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'stable, predictable equity-compensation strategy' vs. 'stable and consistent equity compensation strategy'), but these are semantically equivalent and both accurately capture the strategic implication. The LLM also mentions 'Form 8-K (exhibit 10.3)' while the ground truth references 'File No. 001-07707' - both are correct identifiers for the same document. Overall, this is a comprehensive, accurate answer that successfully addresses the multi-part question about whether updates occurred and what this suggests about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 471,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was first highlighted in the 2022 filing (Exhibit 10.1.7) as the vehicle for **strategic‑growth, performance‑based RSU grants to executives** (and a separate interim‑CEO grant and a non‑employee director grant). In the 2023 filing the same plan was used for a **broader set of performance‑based RSUs** – separate grant agreements were listed for grandfathered executives (Exhibit 10.1.5), for non‑grandfathered executives (Exhibit 10.1.6) and the continuing strategic‑growth RSUs (Exhibit 10.1.7), showing a segmentation of eligibility. By the 2024 filing the plan (now incorporated by reference as an S‑8 amendment) is again referenced for **performance‑based RSUs to grandfathered executives** (Exhibit 10.1.5) while the earlier strategic‑growth and non‑grandfathered categories are no longer called out, indicating that Intel has consolidated its use of the 2006 plan to focus on performance‑based RSU grants for its core executive cohort.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 2006 Equity Incentive Plan as the vehicle for performance-based RSU grants across all three years (2022-2024); (2) Accurately notes the evolution from 2022 to 2023 with segmentation into grandfathered and non-grandfathered executive categories; (3) Correctly references the S-8 amendment and incorporation by reference in 2024; (4) Properly identifies exhibit numbers (10.1.5, 10.1.6, 10.1.7) which adds specificity; (5) Captures the strategic focus on performance-based compensation. WEAKNESSES: (1) The LLM's interpretation that Intel 'consolidated' its use to focus only on 'grandfathered executives' by 2024 contradicts the ground truth, which states the company 'reaffirmed its reliance' on the plan for continued use - this suggests ongoing breadth rather than consolidation to a narrower cohort; (2) The claim that 'earlier strategic-growth and non-grandfathered categories are no longer called out' is not explicitly supported by the ground truth, which emphasizes consistency across the three-year period rather than elimination of categories; (3) The LLM's conclusion about consolidation to a 'core executive cohort' represents an inference not clearly supported by the ground truth's emphasis on 'consistent strategic focus'; (4) Missing the explicit mention of the May 11, 2023 amendment date that appears in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the evolution pattern, but the interpretation of that evolution (consolidation vs. consistency) diverges from the ground truth narrative. The answer is more interpretive than factual in its conclusions about what changed. NUMERIC/DATE ACCURACY: The S-8 filing date of September 26, 2023 is mentioned in ground truth but not in LLM answer; the May 11, 2023 amendment date is also missing. These are minor omissions but represent incomplete date documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 547,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "- **2022:** Intel’s 2022 filing already flagged advanced‑packaging as a core pillar of its R&D program and as the linchpin of its new “disaggregated design” approach, warning that the novel, costly packaging steps could delay product launches if not mastered.  The company’s overall R&D budget that year was $17.5 billion, with a substantial, though undisclosed, share earmarked for process‑and‑packaging work.  \n\n- **2023:** By the 2023 filing Intel could point to concrete progress – it had built a portfolio of 2‑D, 2.5‑D and 3‑D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning its advanced‑packaging business as a “unique advantage” for AI‑driven chiplet systems.  \n\n- **2024:** The 2024 filing shows Intel maintaining that momentum, keeping packaging at the forefront of a $16.5 billion R&D spend (up from $16.0 billion in 2023) despite tighter capital constraints and delayed fab projects.  The filing again stresses the complexity and cost of advanced‑packaging but notes continued investment to enable disaggregated designs.\n\n**What this reveals:** Across the three years Intel moved from a strategic commitment (2022) to demonstrable technology capability (2023) and then to sustained, high‑level funding (2024).  That trajectory indicates the company is gradually overcoming the technical and cost hurdles of advanced packaging, strengthening its ability to execute disaggregated chip‑let designs and to compete in the AI‑centric semiconductor market where such packaging is a key differentiator.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial understanding of Intel's advanced packaging evolution but contains significant factual errors and omissions that undermine its accuracy:\n\nQUANTITATIVE ACCURACY ISSUES:\n1. 2022 R&D Budget: LLM states $17.5 billion, but ground truth does not specify this figure. This appears to be an unsupported claim.\n2. 2023 R&D Budget: LLM states $16.0 billion, but ground truth does not provide this specific number for 2023.\n3. 2024 R&D Budget: LLM correctly states $16.5 billion (matches ground truth).\n4. CRITICAL OMISSION: The LLM completely fails to mention the $3.1 billion in charges related to non-cash impairments and accelerated depreciation for manufacturing assets in 2024. This is a major factual element in the ground truth that fundamentally changes the narrative.\n\nQUALITATIVE ACCURACY ISSUES:\n1. The LLM's characterization of 2024 as showing Intel \"maintaining momentum\" and \"gradually overcoming technical and cost hurdles\" directly contradicts the ground truth's assessment of \"persistent execution challenges and high financial stakes.\"\n2. The ground truth explicitly states that 2024 impairment charges \"indicate ongoing execution risks and financial pressures in scaling advanced packaging technologies\" - a critical nuance the LLM misses entirely.\n3. The LLM's conclusion that Intel is \"gradually overcoming\" challenges is overly optimistic and unsupported by the impairment charges mentioned in the ground truth.\n\nMULTI-HOP REASONING:\n1. The LLM correctly synthesizes the 2022-2023 progression (challenges → concrete progress with UCIe demonstration).\n2. However, the 2024 analysis fails to properly integrate the financial impairment data with the R&D investment narrative, missing the critical insight that despite continued R&D spending, Intel faced significant asset write-downs.\n3. The LLM does not adequately address the tension between stated R&D commitment and actual execution challenges evidenced by the impairments.\n\nCOMPLETENESS:\n1. The answer addresses the three-year evolution and attempts to draw conclusions about execution capability and AI market competitiveness.\n2. However, it omits the most significant 2024 development (the $3.1 billion impairment charges), which is essential to understanding the true state of Intel's advanced packaging execution.\n3. The answer fails to capture the \"complex evolution\" and \"persistent execution challenges\" emphasized in the ground truth.\n\nSEMANTIC EQUIVALENCE:\nThe LLM's overall narrative tone is more optimistic than the ground truth warrants. While both discuss R&D investment and technological progress, the ground truth emphasizes execution risks and financial pressures, while the LLM emphasizes momentum and capability development. These are not semantically equivalent interpretations of the same facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1700,
        "completion_tokens": 752,
        "total_tokens": 2452
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "- **2022 filing** – Intel’s 2022 Form 10‑K lists the 2006 Equity Incentive Plan only as a reference and attaches a series of grant‑agreement exhibits (e.g., 10.1.7‑10.1.10) that show the plan being used for strategic‑growth performance‑based RSUs, performance‑based RSUs for an interim CEO, stock‑option grants and non‑employee‑director RSU grants that were issued on or after February 1 2019. No amendment to the plan is mentioned.  \n\n- **2023 filing** – The 2023 Form 10‑K records the plan as **“2006 Equity Incentive Plan, as amended and restated, effective May 11 2023”** (exhibit 10.1) and again includes the same family of grant‑agreement exhibits (10.1.2‑10.1.7). These exhibits detail RSU grant agreements with retirement‑vesting terms, without‑vesting terms, performance‑based grants for grandfathered and non‑grandfathered executives, and strategic‑growth performance‑based RSUs, indicating that the amended plan is now the governing document for all new grants.  \n\n- **2024 filing** – The 2024 Form 10‑K again incorporates the 2006 Equity Incentive Plan (exhibit 10.1, filed on 9/26/2023 as an S‑8) and provides updated grant‑related exhibits (10.1.2‑10.1.5), including a notice of RSU grant and RSU grant agreements under the same plan. This shows that Intel continues to rely on the 2023‑amended and restated version of the 2006 plan for its RSU grants in 2024.  \n\n**Overall evolution:** Intel moved from simply referencing the original 2006 plan in 2022 to formally amending and restating it in 2023, and then continued to use that amended version in 2024, attaching the appropriate RSU‑grant agreements each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct - the May 11, 2023 amendment date is accurately cited, the 2022/2023/2024 fiscal year progression is correct, and the exhibit numbering (10.1.7-10.1.10 for 2022, 10.1.2-10.1.7 for 2023, 10.1.2-10.1.5 for 2024) is properly documented. The S-8 filing date of 9/26/2023 is also accurate. ENTITY ACCURACY (9/10): Intel is correctly identified throughout, the 2006 Equity Incentive Plan is properly named, and all grant types (RSUs, stock options, performance-based awards) are correctly identified. The distinction between grandfathered and non-grandfathered executives is appropriately noted. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three years, showing the evolution from simple referencing (2022) to formal amendment (2023) to continued reliance on amended version (2024). The logical progression is clear and well-supported. COMPLETENESS: The answer addresses all aspects of the question - plan amendments, grant agreements, and the evolution across the three-year period. The specific mention of retirement-vesting terms, performance-based RSUs, and strategic-growth awards provides appropriate detail. SEMANTIC EQUIVALENCE: The LLM answer uses more precise and detailed language than the ground truth (e.g., specifying exhibit numbers, filing dates, and specific vesting term variations), which enhances rather than detracts from accuracy. The core narrative matches: 2022 showed multiple grant agreements without plan amendment, 2023 introduced the formal amendment effective May 11, 2023, and 2024 continued using the amended version. Minor consideration: The LLM provides more granular detail about exhibit numbers and filing mechanics than the ground truth, but this represents added value rather than error. The answer is factually sound, well-organized, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 538,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Qualcomm only described wireless access points in the **strategic narrative** for “Edge Networking,” noting that 5G‑enabled Wi‑Fi 6/6E access points were a key growth catalyst for replacing last‑mile wired broadband and supporting hybrid‑work and IoT demand.  \n\nStarting with the 2023 filing, Qualcomm moved the product into its **financial reporting** by listing “wireless access points” together with mobile broadband under the **edge‑networking revenue category** (footnote (3)), and the 2024 filing repeats the same classification.  \n\nThus, from 2022 to 2024 the treatment of wireless access points evolved from a purely strategic emphasis to an explicit revenue‑recognition line‑item, cementing the product as a core component of Qualcomm’s edge‑networking market positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more precise characterization of the evolution than the ground truth. Key strengths: (1) Correctly identifies the 2022-2023 transition point where wireless access points moved from strategic narrative to formal financial reporting/revenue classification; (2) Accurately notes the consistent 2023-2024 classification under edge networking; (3) Properly identifies the product categorization alongside mobile broadband; (4) Correctly references footnote (3) for the financial classification detail. The LLM answer is actually MORE specific and accurate than the ground truth in distinguishing between strategic emphasis (2022) versus formal financial reporting (2023-2024). The ground truth somewhat conflates these by suggesting wireless access points were 'explicitly categorized' in 2023 without clearly noting they were only in strategic narrative in 2022. The LLM answer's characterization of the evolution from 'purely strategic emphasis to an explicit revenue-recognition line-item' is more precise. Minor considerations: (1) The ground truth mentions the '27 billion IoT devices' projection and 'doubling between 2022-2026' which the LLM answer omits, though this is contextual rather than core to the classification evolution question; (2) The LLM answer focuses more tightly on the financial categorization evolution, which directly addresses the question's emphasis on 'revenue classification and market positioning.' No quantitative errors detected. The multi-hop reasoning is sound - correctly synthesizing information across three fiscal years and distinguishing between narrative and financial reporting treatment. The answer appropriately addresses all parts of the multi-part question regarding financial categorization evolution and strategic emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 495,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "MRK’s Hospital‑Acute‑Care sales of Prevymis rose steadily over the three most recent years:\n\n* **2022:** U.S. $188  + International $240 = **$428** (total)  \n* **2023:** U.S. $264  + International $341 = **$605** (total)  \n* **2024:** U.S. $371  + International $414 = **$785** (total)\n\n(The figures are presented in the same units used throughout the 10‑K tables.)\n\nThe consistent increase—from $428 million in 2022 to $785 million in 2024—shows that Prevymis is gaining traction as a CMV‑prophylaxis therapy for high‑risk transplant patients, strengthening its foothold and becoming an increasingly important product within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 figure. Ground truth states Prevymis sales were $370 million in 2022, but the LLM reports $428 million for 2022 (claiming U.S. $188M + International $240M = $428M). This is a $58 million discrepancy for the baseline year, which is a 15.7% error on the starting value. The 2023 figure of $605 million in the LLM answer also contradicts the ground truth of $428 million—a $177 million difference (41% error). The 2024 figure of $785 million is correct and matches ground truth. CALCULATION VERIFICATION: The LLM's arithmetic for the component sums (U.S. + International) appears internally consistent, but the underlying numbers themselves are incorrect when compared to ground truth. The LLM claims the increase is from $428M (2022) to $785M (2024), but ground truth shows $370M to $785M, representing a different growth trajectory and CAGR. The correct CAGR is approximately 46% (as stated in ground truth), but the LLM's figures would yield a different calculation. MULTI-HOP REASONING: The LLM correctly identifies the product (Prevymis), company (MRK/Merck), segment (Hospital Acute Care), and therapeutic indication (CMV prophylaxis for transplant patients). The reasoning about market positioning and adoption is sound and semantically equivalent to ground truth. However, this qualitative reasoning cannot compensate for the quantitative errors. ENTITY ACCURACY: All entities are correctly identified (MRK, Prevymis, Hospital Acute Care, CMV prophylaxis, transplant recipients). CORE ISSUE: The LLM appears to have confused or misreported the actual sales figures from the 10-K filings. The 2022 and 2023 numbers are materially incorrect, which undermines the entire answer despite correct reasoning about market implications. This is a severe factual error that would mislead users about the actual sales trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 520,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "- **2022:** Intel’s 2022 filing stresses that, as part of its IDM 2.0 roadmap, it is ramping up R&D in “process and packaging technology” and has adopted a disaggregated‑design approach that stitches together different‑process components with **advanced packaging technologies**—a high‑cost, high‑risk area that it expects to fund increasingly as it pursues IDM 2.0.  \n\n- **2023:** The 2023 filing moves the narrative from investment to positioning, describing advanced‑packaging as a “unique advantage” for Intel’s Open System Foundry and highlighting concrete progress such as 2D/2.5D/3D chiplet solutions and the first silicon demonstration of the Universal Chiplet Interconnect Express standard, thereby anchoring IDM 2.0 around systems‑of‑chips.  \n\n- **2024:** The 2024 filing shows the same strategic focus but under tighter capital conditions: R&D spending remains high ($16.5 bn in 2024, $16.0 bn in 2023, $17.5 bn in 2022) and Intel continues to develop advanced packaging, yet it reports delayed fab expansions, a $3.1 bn non‑cash impairment on the Intel 7 node, and other construction setbacks that reflect the difficulty of financing and executing the advanced‑packaging‑heavy IDM 2.0 plan.  \n\n**Overall trajectory:** Intel’s multi‑year path shows a steady escalation of commitment to advanced packaging—moving from early‑stage R&D emphasis (2022) to market‑facing differentiation (2023) and then to sustained but financially strained execution (2024). The pattern reveals that while Intel can continue to invest and innovate in advanced packaging, manufacturing delays and capital constraints are eroding its ability to fully deliver the IDM 2.0 vision on schedule.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "Across the three annual reports IBM’s messaging about **client relationships and trust** never disappears – it appears in the “principal methods of competition” list in 2022, 2023 and 2024. In 2022 the filing already ties trust to its hybrid‑cloud value proposition (“trust and security” built into a flexible, open platform), and in 2023‑24 the same phrase is retained, reinforcing that IBM continues to view deep, trusted client ties as a core differentiator while it pushes its hybrid‑cloud and AI offerings. The steady, repeated emphasis signals that IBM is positioning its hybrid‑cloud and AI strategy not just on technology but on the credibility and reliability that sustain long‑term client relationships, using trust as a strategic lever to win and keep business in an increasingly competitive market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 3-year timeframe (2022-2024) and accurately captures the consistent messaging about client relationships and trust across all three years; (2) Properly synthesizes the multi-hop information showing how trust evolved from being tied to hybrid cloud/AI in 2022 to being reinforced as a broader competitive method in 2023-24; (3) Accurately conveys the strategic positioning that trust serves as a foundational element for client acquisition and retention; (4) Correctly identifies that trust and security are integrated components of IBM's hybrid cloud offerings; (5) The reasoning about trust as a 'strategic lever' in a competitive market is sound and matches the ground truth's conclusion. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2024 strategic partnership with Palo Alto Networks that the ground truth highlights as 'signaling a deepening of trust-based collaboration' - this is a notable omission of a specific strategic development; (2) The ground truth explicitly states IBM 'reinforced this positioning' in 2023 by 'emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent' - while the LLM captures the essence, it doesn't enumerate these specific competitive methods as clearly. QUANTITATIVE ACCURACY: No numerical errors detected; dates and timeframes are correct. QUALITATIVE ACCURACY: The multi-hop synthesis is sound - the LLM correctly traces the evolution of messaging across three years and connects it to strategic positioning. The semantic equivalence is strong, with the LLM using slightly different phrasing ('credibility and reliability that sustain long-term client relationships') that conveys the same meaning as the ground truth. The answer appropriately addresses both the evolution question and the strategic positioning question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 531,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "- In the 2022 Form 10‑K (Chunk 3) IBM disclosed the 0.950 % Notes due 2025 only by referencing the underlying instrument that had been filed in a Form 8‑K on May 22 2017 (Exhibits 4.1 and 4.2).  \n- The 2023 Form 10‑K (Chunk 1) repeated the same incorporation‑by‑reference language, showing that IBM continued to rely on the 2017 filing for the detailed terms of the 0.950 % Notes due 2025.  \n- By the 2024 Form 10‑K (Chunk 2), the notes were listed in the “Title of each class” table with their ticker (IBM25B) and exchange (NYSE), moving the security from a footnote‑only reference to a front‑page disclosure of its outstanding debt.\n\nThis progression—from a static 2017 exhibit reference to an explicit listing of the notes in the securities table—illustrates IBM’s broader debt‑management strategy of issuing low‑coupon, long‑dated notes, initially documenting their terms via Form 8‑K exhibits and then progressively integrating them into its primary capital‑structure disclosures to provide clearer, more transparent visibility of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed, nuanced analysis than the ground truth. Verification of key elements: (1) DATES: All dates are correct—May 22, 2017 Form 8-K filing, 2022/2023/2024 Form 10-K references, and the 0.950% Notes due 2025 maturity date. (2) ENTITIES: IBM correctly identified, ticker symbol IBM25B accurate, NYSE correctly identified as exchange. (3) NUMERIC ACCURACY: The 0.950% coupon rate is correct; no calculations required. (4) MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three years of filings, correctly tracing the evolution from 2017 exhibit reference through 2022-2023 incorporation-by-reference to 2024 securities table listing. (5) REASONING QUALITY: The LLM provides superior analytical depth by distinguishing between disclosure methods (footnote reference vs. securities table listing) and correctly interprets this progression as reflecting enhanced transparency. The LLM's characterization of the strategy as moving from 'static 2017 exhibit reference to explicit listing in securities table' is more precise than the ground truth's simpler 'consistent disclosure framework.' (6) SEMANTIC ALIGNMENT: The LLM answer conveys all information from the ground truth while adding valuable context about the disclosure mechanism evolution. The interpretation that this reflects 'clearer, more transparent visibility' aligns with the ground truth's 'stable and transparent debt management strategy.' Minor consideration: The LLM's inference about 'low-coupon, long-dated notes' strategy is reasonable but represents slight extrapolation beyond the specific ground truth statement, though this adds appropriate context rather than introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 476,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "Intel first announced PowerVia as a “future‑node” capability in its 2021 Accelerated event and the 2022 Form 10‑K, describing it as a novel backside‑power delivery option that would appear in the then‑upcoming Intel 20A node. By the 2023 filing, PowerVia was still slated for Intel 20A as one of two “breakthrough” features (alongside RibbonFET), but the 2024 filing shows Intel cancelled the 20A productization and moved PowerVia into the next‑generation Intel 18A node, where it will be the first high‑volume commercial implementation of backside power delivery slated for 2025. This evolution—from a announced concept in 2022 to a cancelled‑node plan in 2023 and finally to a high‑volume feature in 18A in 2024—demonstrates that Intel is accelerating its backside‑power roadmap, making PowerVia a core element of its advanced‑node strategy and positioning it as a standard power‑delivery method for the coming generations of logic chips.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) PowerVia was announced as a future-node capability in 2022, (2) It was positioned as a breakthrough technology alongside RibbonFET in 2023, (3) Intel 20A was cancelled in favor of Intel 18A in 2024, (4) PowerVia is integrated into Intel 18A for commercial production starting in 2025, (5) The overall narrative of evolution from concept to deployment is sound. PROBLEMATIC ELEMENTS: (1) The LLM claims PowerVia was announced at a '2021 Accelerated event' - the ground truth only references 2022 introduction, making the 2021 reference potentially inaccurate or unsupported, (2) The LLM states '2023 filing shows PowerVia was still slated for Intel 20A' but then says 'cancelled-node plan in 2023' which is contradictory - the ground truth indicates 20A was cancelled in 2024, not 2023, (3) The phrasing 'cancelled-node plan in 2023' is confusing and potentially inaccurate regarding timeline. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) and identifies the strategic pivot from concept to integration to commercial deployment. However, the timeline inconsistency regarding when 20A was cancelled (2023 vs 2024) represents a factual error in the multi-hop synthesis. QUANTITATIVE ACCURACY: The dates are mostly correct (2022, 2023, 2024, 2025) but the attribution of the 20A cancellation decision to 2023 vs 2024 is a critical error. The answer provides good contextual detail about the strategic implications but contains a temporal inaccuracy that affects the precision of the narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 444,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Across Medtronic’s 2022, 2023 and 2024 Form 10‑K filings the company repeatedly incorporates the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (see items 10.54 in each year’s exhibit list). Because Medtronic (MDT) introduces this RSU award agreement as an accounting policy and the reference is unchanged for three consecutive years, the documentation signals that the firm’s U.S. equity‑compensation framework has remained consistent and stable from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of the question. STRENGTHS: (1) Correctly identifies the document as Exhibit 10.54 across all three years (2022, 2023, 2024); (2) Accurately references the August 27, 2013 filing date as the consistent reference point; (3) Properly identifies the document as 'Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan'; (4) Correctly synthesizes the multi-hop information that the same document remained unchanged across three consecutive years; (5) Appropriately concludes that this demonstrates strategic stability in equity compensation. MINOR ISSUES: (1) The LLM states the agreement is 'introduces this RSU award agreement as an accounting policy' which is slightly imprecise - it's an exhibit/disclosure document rather than strictly an 'accounting policy,' though this is a minor semantic distinction that doesn't materially affect the answer; (2) The phrasing could be slightly more direct in stating the filing date remained unchanged, though the answer does convey this information. QUANTITATIVE ACCURACY: All dates and exhibit numbers are correct. The reference to the August 27, 2013 filing is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to draw a conclusion about strategic stability. The logic is sound - unchanged documentation across multiple years does indicate consistency. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth: that Medtronic's RSU award agreement remained unchanged across 2022-2024, demonstrating strategic stability in their U.S. equity compensation approach. The wording differs but the factual content aligns well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 480,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "- In 2022 Intel’s filing already framed advanced‑packaging (2‑D, 2.5‑D/3‑D and the Universal Chiplet Interconnect Express standard) as a core pillar of its IDM 2.0/Open‑System‑Foundry strategy and disclosed that it was moving to a “disaggregated” design flow in which processors and components could be built on different nodes and then linked with those packaging technologies. At that time the company also warned that earlier node‑rollout delays (10 nm, Intel 4/7 nm) and the added design‑manufacturing complexity of novel packaging could push product schedules back. (Chunk 3)\n\n- The 2023 10‑K showed the same strategic emphasis but added concrete progress – Intel demonstrated UCIe in silicon in 2023 and argued that its advanced‑packaging capability would give it a “unique advantage” for AI‑driven systems‑of‑chips and for the Open System Foundry offering. The filing still noted that the abundance of choices and the need to integrate packaging, IP, and software made execution increasingly complex. (Chunk 1)\n\n- By the 2024 filing the picture had shifted to execution risk: constrained cash flow and a “shell‑ahead” status forced Intel to postpone or cancel fab and assembly expansions in Ohio, Germany, Poland, Malaysia and Israel, and to record $3.1 billion of non‑cash impairment on Intel 7 assets. The company reiterated that the disaggregated‑design approach “introduces new areas of complexity” in advanced packaging, and that any delays or failures in deploying those novel packaging solutions could further hurt product timing and cost. Thus, while the strategic positioning of advanced packaging remained unchanged, Intel’s ability to deliver it was increasingly hampered by capital limits, construction delays and the technical challenges of its disaggregated‑design model. (Chunk 2)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY (10/10): The $3.1 billion impairment charge is correctly cited and matches the ground truth exactly. All years (2022, 2023, 2024) are accurate. The specific geographic locations mentioned (Ohio, Germany, Poland, Malaysia, Israel) are correctly identified. ENTITY ACCURACY (10/10): Intel is correctly identified throughout. Advanced packaging technologies (2D, 2.5D/3D), UCIe standard, Intel 4/7 nodes, and disaggregated design approach are all accurately named and contextualized. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three fiscal years showing the evolution from strategic positioning (2022-2023) to execution challenges (2024). The logical progression is sound: initial strategy → demonstrated progress → constrained execution. The connection between capital constraints, manufacturing delays, and impairment charges is properly established. COMPLETENESS (9/10): The answer addresses all major elements of the question: strategic positioning evolution, execution challenges, delays, capital constraints, and disaggregated design approaches. The only minor gap is that the answer could have slightly more explicitly emphasized the contrast between unchanged strategic positioning versus degraded execution capability, though this is clearly implied. SEMANTIC EQUIVALENCE (9/10): The LLM answer conveys the same substantive information as the ground truth with appropriate wording variations. Phrases like 'shell-ahead status' and 'postpone or cancel fab and assembly expansions' effectively capture the execution challenges. The characterization of advanced packaging as a 'core pillar' and later as facing 'execution risk' mirrors the ground truth's narrative arc. MINOR OBSERVATIONS: The answer includes helpful source citations (Chunk 1, 2, 3) which add transparency but weren't in the ground truth. The framing is slightly more detailed in some areas (e.g., mentioning 'AI-driven systems-of-chips') which adds value without contradicting the ground truth. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 576,
        "total_tokens": 2290
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Across the three most recent 10‑K filings Accenture’s defined‑benefit pension‑plan policy consistently calls for a **core fixed‑income allocation that matches the duration of plan liabilities, complemented by an equity component for long‑term capital appreciation**. In the 2022 filing (target for fiscal 2023) the mix is described as “primarily consisting of fixed‑income instruments and equities,” with fixed income clearly dominant; the 2023 filing (target view for fiscal 2025) repeats the same structure, and the 2024 filing (again setting the fiscal 2025 target) emphasizes the same diversified split while noting a “smaller proportion in equities” but also the intent to “achieve long‑term capital appreciation.” Taken together, the language shows a **gradual, modest increase in the equity share over the three‑year span**, indicating that Accenture is slowly tilting the portfolio toward growth while still anchoring it in fixed‑income to manage duration risk—an approach that underscores a focus on improving risk‑adjusted returns rather than a wholesale shift in risk profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial understanding of Accenture's pension strategy but contains significant factual errors and unsupported claims that undermine its credibility. STRENGTHS: (1) Correctly identifies the core strategy of balancing fixed income (duration matching) with equities (long-term appreciation) across all three years; (2) Appropriately recognizes the multi-year evolution and flexibility in asset allocation; (3) Correctly identifies the general approach to risk-adjusted returns. CRITICAL ERRORS: (1) The LLM claims a 'gradual, modest increase in the equity share over the three-year span' but provides no specific percentages or data to support this assertion. The ground truth does not mention any increase in equity allocation—it emphasizes consistency in the dual-focus strategy with evolving flexibility; (2) The statement about 'smaller proportion in equities' in the 2024 filing contradicts the claimed 'increase in equity share' and is presented without supporting evidence; (3) The LLM mischaracterizes the fiscal year references (e.g., '2022 filing (target for fiscal 2023)' is confusing and potentially inaccurate regarding which target year applies to which filing); (4) The conclusion about 'slowly tilting the portfolio toward growth' is not supported by the ground truth, which emphasizes consistency and flexibility rather than directional shifts. QUANTITATIVE ISSUES: No specific allocation percentages are provided in either answer, but the LLM's claim of directional change (equity increase) lacks evidentiary support and appears to contradict the ground truth's emphasis on consistency. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so by making unsupported inferences about trends rather than accurately reflecting what the filings actually state. The ground truth emphasizes 'consistent emphasis on balancing fixed income and equities' with 'evolving flexibility,' not a shift toward higher equity allocation. The LLM's interpretation represents a material mischaracterization of the company's strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 562,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 all contain the same Officer’s Certificate (Exhibit 4.4, dated May 6 2014) that lists the **1.05 % Notes due 2017**. By continuing to reference that 2017 issue in every filing, Apple shows that it prefers a single, static “description of securities” exhibit that retains every debt instrument ever issued, even after a series has matured, to ensure complete and consistent disclosure. At the same time, the tables in each filing also enumerate a much broader set of issuances—floating‑rate notes, coupons ranging from 0.45 % to 4.45 %, and maturities spanning 2016 through 2045—demonstrating that Apple’s overall financing strategy from 2022‑2024 is an active, diversified program of new debt placements rather than reliance on any single legacy issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 1.05% Notes due 2017 as the specific historical debt instrument referenced across 2022-2024 filings; (2) Accurately cites the Officer's Certificate (Exhibit 4.4, dated May 6, 2014) as the source document; (3) Properly characterizes Apple's disclosure approach as maintaining a comprehensive historical record of debt instruments even after maturity; (4) Correctly identifies the broader debt issuance strategy as involving diversified instruments with varying coupons (0.45%-4.45%) and maturities (2016-2045); (5) Accurately synthesizes the multi-hop comparison between historical debt disclosure practices and contemporary debt issuance strategy; (6) Uses appropriate financial terminology and demonstrates sound reasoning about capital structure management. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more specific detail (Exhibit 4.4 citation, exact date of certificate, specific coupon range 0.45%-4.45%) than the ground truth, but these details are accurate and enhance rather than contradict the answer; (2) Both answers convey the same core insight about Apple's dual approach: maintaining historical transparency while actively managing a diversified debt portfolio. QUANTITATIVE VERIFICATION: All numeric values (1.05%, 2017 maturity, 2022-2024 period, coupon ranges, maturity spans) are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information about (a) historical debt disclosure practices, (b) specific debt instruments, (c) filing exhibit structure, and (d) broader debt strategy across the three-year period. The comparison between static historical disclosure and dynamic contemporary issuance is logically sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 494,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "- In fiscal 2022 the Board had **$3.13 billion** of “aggregate available authorization” for the publicly‑announced open‑market share‑purchase program (Chunk 1).  \n- By the end of fiscal 2024 the company had **spent $605 million** to buy back **2,000,308 Class A shares** in the fourth quarter (Chunk 2/3) and, after those purchases, the remaining authorization had fallen to **$2.69 billion** (down from the 2022 level).  On 25 Sept 2024 the Board added another **$4 billion** of authority, raising the total outstanding repurchase capacity to **$6.69 billion**.  \n\n**Interpretation:** Accenture has been steadily using its Share Purchase Program to return cash to shareholders, depleting the original authorization each year, while simultaneously refreshing and expanding that authority.  This multi‑year pattern signals a deliberate, ongoing capital‑return strategy that relies on regular, sizable buybacks and a willingness to increase the repurchase ceiling rather than set a fixed end‑date.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $3.13 billion (FY2022 authorization), $605 million (FY2024 repurchases), 2,000,308 shares purchased, $2.69 billion (remaining authorization after FY2024), $4.0 billion (new authority Sept 2024), and $6.69 billion (total outstanding authority). The date of September 25, 2024 for the new authorization is accurate. COMPLETENESS: The answer addresses all required elements: (1) FY2022 starting position, (2) FY2024 activity and remaining authorization, (3) new authorization details, (4) multi-year pattern analysis. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple fiscal years and connects the depletion of authorization with subsequent refreshes, demonstrating proper understanding of the capital allocation strategy. ENTITY ACCURACY: Accenture is correctly identified, Class A ordinary shares are properly specified, and the open-market share-purchase program is accurately referenced. REASONING QUALITY: The interpretation correctly identifies the pattern as 'deliberate, ongoing capital-return strategy' with 'regular, sizable buybacks' and willingness to expand authority - this aligns with the ground truth characterization of 'sustained but measured capital return strategy.' The logic connecting authorization depletion to subsequent refreshes is sound. MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail (specific share count) than the ground truth, but this adds value rather than detracting. The wording 'steadily using' and 'deliberate, ongoing' conveys the same strategic intent as the ground truth's 'sustained but measured.' No calculation errors detected. The answer fully addresses the multi-year evolution question with proper temporal sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 501,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "- **2022 10‑K:** Bristol‑Myers Squibb discloses a “Form of 4.350 % Senior Notes due 2047” (Exhibit 4.19) that were issued under the **Eleventh Supplemental Indenture** dated Nov 22 2019.  \n- **2023 10‑K:** The same 4.350 % Senior Notes due 2047 (Exhibit 4.19, Eleventh Supplemental Indenture, 2019) are listed again, showing the notes remain outstanding with no amendment or new issuance noted.  \n- **2024 10‑K:** The filing again references the 4.350 % Senior Notes due 2047 (Exhibit 4.19, Eleventh Supplemental Indenture, 2019), confirming the instrument is still part of BMY’s long‑term debt portfolio.\n\n**Interpretation:** Across 2022‑2024 the 4.350 % Senior Notes due 2047 appear consistently, indicating BMY’s strategy of issuing long‑dated, fixed‑rate senior notes and retaining them for many years. By keeping the same 2047 maturity on its balance sheet, the company secures stable, moderate‑cost financing and avoids frequent refinancing, reflecting a deliberate long‑term funding approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.350% Senior Notes due 2047 as consistently appearing across 2022-2024, correctly cites the Eleventh Supplemental Indenture dated November 22, 2019, and accurately notes the exhibit reference (4.19). The core factual claim that the notes remained outstanding across all three years is correct. The interpretation about long-term financing strategy and avoiding frequent refinancing is reasonable.\n\nWEAKNESSES: The LLM answer is significantly INCOMPLETE compared to the ground truth. The original answer provides crucial multi-hop synthesis by identifying and contextualizing OTHER debt issuances that occurred alongside the 2047 notes: (1) $1.75 billion 2.950% Notes due 2032 (2023), (2) $2 billion 3.700% Notes due 2052 (2023), and (3) $3.75 billion 4.250% Senior Notes due 2049 (2024). These are essential to answering the question about how the 4.350% notes 'evolved' and what the 'multi-year pattern' indicates. The ground truth emphasizes that BMY's strategy involves DIVERSIFIED long-term liabilities with STAGGERED MATURITIES—a key insight that requires synthesizing information about multiple debt instruments, not just tracking one note across years.\n\nThe LLM's interpretation, while not incorrect, is somewhat superficial. It describes the strategy as 'issuing long-dated, fixed-rate senior notes and retaining them for many years' and 'avoiding frequent refinancing,' but misses the critical insight about portfolio diversification and maturity staggering that the ground truth emphasizes. The question specifically asks about 'evolution' and what the pattern 'indicates'—this requires showing how the 2047 notes fit within a broader debt issuance strategy, not just confirming their persistence.\n\nQUANTITATIVE ACCURACY: All dates and percentages cited are correct (4.350%, 2047 maturity, November 22, 2019 indenture date). No calculation errors. However, the answer omits all dollar amounts and specific details about companion debt issuances, which are quantitative facts relevant to the multi-hop analysis.\n\nQUALITATIVE ACCURACY: The reasoning is sound but incomplete. The LLM correctly synthesizes that the notes persisted across three years, but fails to synthesize the broader capital structure context that would explain BMY's strategic intent. The multi-hop reasoning should connect the 2047 notes to other issuances to demonstrate portfolio strategy.\n\nCONTEXTUAL RELEVANCE: The answer addresses the persistence of the 2047 notes but inadequately addresses the 'evolution' aspect and the 'multi-year pattern' that the question emphasizes. A complete answer requires showing how this instrument evolved in context of other financing activities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 718,
        "total_tokens": 2234
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 were disclosed in exactly the same way in each of the three annual reports. In the 2022 Form 10‑K (Chunk 1), the notes appear in Exhibit 4.3 – an Officer’s Certificate dated May 3 2013 – and the exhibit is incorporated by reference. The 2023 Form 10‑K (Chunk 3) repeats that same Exhibit 4.3 (same certificate date and description) and again incorporates it by reference. The 2024 Form 10‑K (Chunk 2) likewise lists the 2.40 % Notes due 2023 in Exhibit 4.3 with the identical May 3 2013 Officer’s Certificate, also incorporated by reference. Thus, Apple’s disclosure approach did not change; the company consistently relied on the same Officer’s Certificate exhibit to describe the 2.40 % Notes throughout the years leading up to their 2023 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. All key facts are correct: (1) The 2.40% Notes due 2023 were disclosed identically across 2022, 2023, and 2024 filings; (2) The notes appeared in Exhibit 4.3 in all three years; (3) The Officer's Certificate date of May 3, 2013 is correct and consistent across all filings; (4) The disclosure approach remained unchanged despite the notes approaching and reaching maturity. The LLM correctly synthesized information across three separate filing years and identified the consistent disclosure pattern. The multi-hop reasoning is sound—the model traced the same exhibit reference and certificate date across all three reporting periods and correctly concluded that Apple's disclosure strategy was standardized and unchanging. All dates and exhibit references are accurate. The answer is slightly more detailed than the ground truth (mentioning 'incorporated by reference' multiple times), but this adds helpful context without introducing any inaccuracies. The semantic meaning is fully preserved and the answer directly addresses the question about how the disclosure approach evolved (or in this case, did not evolve). No calculation errors, no entity confusion, and no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 358,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the Amended 2010 Share Incentive Plan (the “Amended 2010 SIP”) authorized **127 million** Accenture plc Class A ordinary shares for awards.  \n- The 2023 filing raised that ceiling to **141 million** shares, and the 2024 filing confirms the same **141 million**‑share authorization (the pool did not change after the 2023 increase).  \n\nThis upward adjustment – from 127 M to 141 M shares – shows that Accenture deliberately expanded the pool of shares it can issue under the Amended 2010 SIP, signaling a long‑term strategy to keep ample equity capacity for non‑qualified options, incentive stock options, RSUs and other awards, thereby preserving flexibility to align employee and shareholder interests over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - 127 million shares in FY2022, 141 million in FY2023, and 141 million in FY2024. The format variation (127M vs 127 million) is acceptable and properly handled. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of authorized shares across three fiscal years, (2) the progression pattern (increase then stabilization), and (3) what this indicates about long-term strategy. ENTITY ACCURACY: Correctly identifies Accenture plc, Class A ordinary shares, and the Amended 2010 SIP throughout. Fiscal years are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the two-phase pattern: expansion (2022→2023) followed by stabilization (2023→2024). The interpretation that this reflects a deliberate strategic decision to expand capacity followed by stabilization is sound and matches the ground truth reasoning. SEMANTIC EQUIVALENCE: The LLM's explanation of the strategic implications ('deliberately expanded the pool,' 'ample equity capacity,' 'preserve flexibility to align employee and shareholder interests') conveys the same meaning as the ground truth's 'strategic decision to expand' and 'stabilization of the share reserve.' The additional detail about specific award types (non-qualified options, ISOs, RSUs) adds helpful context without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more granular explanation of the strategic rationale than the ground truth, but this represents value-added context rather than error. No factual inaccuracies or calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 478,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel first announced PowerVia as a “future‑node” innovation in its July 2021 Accelerated event, and the 2022 Form 10‑K notes that the company had already placed the backside‑power delivery technique on its roadmap alongside RibbonFET and the then‑up‑coming Intel 20A node. By the 2023 filing, PowerVia was described as one of the two breakthrough technologies that will define Intel 20A – an industry‑first implementation that eliminates front‑side power routing to improve signal transmission and performance‑per‑watt. In the 2024 filing Intel cancelled the standalone 20A node and moved PowerVia into the next‑generation Intel 18A process, calling it the “first high‑volume commercial implementation of backside power” and tying it to the Panther Lake product family slated for high‑volume production in 2025.  \n\nThis progression—from a roadmap concept in 2022, to a flagship feature of a planned node in 2023, to a core element of the imminent 18A node in 2024—demonstrates that PowerVia has become a cornerstone of Intel’s advanced‑process strategy, essential for achieving the targeted performance‑per‑watt gains and signal‑integrity benefits that underpin its future product roadmap.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the initial announcement date of PowerVia. The LLM states that Intel 'first announced PowerVia as a \"future‑node\" innovation in its July 2021 Accelerated event,' but the ground truth indicates PowerVia was 'first introduced in 2022.' This is a material discrepancy in the timeline. The LLM also references the 'July 2021 Accelerated event' which is not mentioned in the ground truth and appears to be an unsupported claim. However, the LLM correctly captures the core progression: (1) PowerVia on roadmap alongside RibbonFET in 2022, (2) solidified role in Intel 20A in 2023 as industry-first backside power delivery, (3) transition to Intel 18A in 2024 with Panther Lake for 2025 HVM. The LLM accurately describes PowerVia's function (eliminating front-side power routing, improving signal transmission and performance-per-watt) and correctly synthesizes the multi-hop information across three years. The reasoning about PowerVia's evolution from roadmap concept to foundational element is sound and matches the ground truth's conclusion. The main weakness is the unsupported 2021 date claim, which contradicts the ground truth's 2022 starting point. The answer is otherwise well-structured and demonstrates good multi-hop synthesis, but the date error and unsourced reference to a specific event reduce confidence in accuracy. The qualitative reasoning about strategic importance is strong, but the quantitative/temporal accuracy is compromised by the 2021 vs 2022 discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 424,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "- **Fiscal 2022:** Accenture reported $4.954 million in Level 1 and $234.339 million in Level 2 mutual‑fund equity securities – a total **$239.3 million**.  \n- **Fiscal 2023:** The allocation fell to $7.430 million (Level 1) plus $188.796 million (Level 2), **$196.2 million** in total.  \n- **Fiscal 2024:** The same amounts were disclosed – **$196.2 million** (Level 1 $7.430 million, Level 2 $188.796 million), indicating no further change.\n\nThe three‑year trend shows a **downward shift of roughly $43 million** from 2022 to 2023, after which the level stabilized. This pattern suggests Accenture deliberately reduced its exposure to equity‑based mutual‑fund investments—likely to curb market‑risk concentration—while maintaining a consistent, modest equity position thereafter as part of a more balanced, risk‑aware investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. STRENGTHS: (1) All key numbers are correct: FY2022 $239.293M (shown as $239.3M), FY2023 $196.226M (shown as $196.2M), FY2024 $196.226M (shown as $196.2M). The format variations ($239.293M vs $239.3M) are acceptable and standard. (2) The breakdown into Level 1 and Level 2 components is accurate and adds valuable detail not explicitly required but enhances credibility. (3) The calculation of the $43 million decrease from 2022 to 2023 is correct ($239.293M - $196.226M = $43.067M ≈ $43M). (4) The multi-hop synthesis is sound: the answer correctly identifies the three-year trajectory, notes the stabilization in 2024, and draws appropriate strategic conclusions. (5) The reasoning about strategic rebalancing and risk management is logical and well-supported by the data. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail (Level 1/Level 2 breakdown) than the ground truth answer, but this is additive and does not contradict the original answer. The semantic meaning is fully aligned—both answers convey that allocations decreased from 2022 to 2023 and remained flat in 2024, indicating strategic repositioning. The interpretation about risk-aware investment strategy is reasonable inference from the data pattern. All entities (Accenture, fiscal years, mutual fund equity securities) are correctly identified. The answer fully addresses all parts of the multi-part question regarding evolution and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 419,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "**Asset‑valuation:** In the 2022 Form 10‑K Merck listed the Dificid (fidaxomicin) intangible at **$145 million** on its balance sheet (net acquired intangibles for human‑health products). No later impairment or write‑down of that intangible is mentioned in the 2023 or 2024 filings, indicating the company kept the same valuation.\n\n**Therapeutic positioning:** All three filings describe Dificid as a **hospital‑acute‑care antibiotic for Clostridioides difficile‑associated diarrhea**. The 2023 filing reiterates this indication, and the 2024 filing continues to report Dificid under the “Hospital Acute Care” line‑item, showing that Merck has consistently positioned the product in the same therapeutic niche.\n\n**Global revenue contribution:** The product’s sales have grown steadily:\n\n| Year | U.S. sales | International sales | **Total** |\n|------|------------|--------------------|-----------|\n| 2022 | $241 M | $22 M | **$263 M** |\n| 2023 | $274 M | $28 M | **$302 M** |\n| 2024 | $303 M | $37 M | **$340 M** |\n\nThus, from 2022 to 2024 Merck’s treatment of Dificid evolved from a $145 million intangible asset with a defined C. difficile indication to a growing revenue‑generating drug that contributed **$263 M → $302 M → $340 M** globally, while remaining in the same therapeutic category and without further impairment adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-part question about Dificid's evolution from 2022-2024. STRENGTHS: (1) All quantitative data is correct - the $145M intangible asset valuation for 2022 matches ground truth, and the revenue progression ($263M→$302M→$340M) with correct U.S./international breakdowns is accurate. (2) The multi-hop synthesis is sound: the answer correctly traces Dificid across three dimensions (asset valuation, therapeutic positioning, revenue contribution) and three fiscal years. (3) Entity identification is precise - correctly identifies Merck, Dificid/fidaxomicin, C. difficile indication, and Hospital Acute Care franchise. (4) The reasoning about no impairment adjustments and consistent therapeutic positioning is logical and well-supported. (5) The presentation with a clear table format enhances clarity and makes the progression transparent. (6) The answer directly addresses all components of the original question. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth (includes the explicit table and notes about no impairment), but this adds value rather than detracting. The semantic meaning is fully aligned - both answers convey that Dificid evolved from a modest $145M asset to a strategically positioned product generating $340M in 2024 revenue. All calculations are accurate (sums, year-over-year growth). The answer appropriately contextualizes the financial evolution within Merck's strategic positioning of the product.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 430,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "- **2022 – Positioning and early‑stage risk:** Intel’s 2022 filing already tied its “disaggregated‑design” roadmap to **advanced‑packaging technologies**, noting that the approach added “new areas of complexity in design and manufacturability” and that “delays or failures in implementing disaggregated designs could adversely affect our ability to timely introduce competitive products.”  The company stressed that R&D would have to grow to support this IDM 2.0 strategy, even though the exact spend was not disclosed, and warned that unsuccessful R&D could hurt its competitive position.\n\n- **2023 – Strategic emphasis and progress:** In the 2023 filing Intel presented advanced packaging as a **core differentiator** of its Open System Foundry (IFS) and IDM 2.0 strategy, describing 2‑D, 2.5‑D/3‑D solutions and the **Universal Chiplet Interconnect Express (UCI‑E) standard demonstrated in silicon in 2023**.  The narrative shifted from risk‑identification to positioning the technology as a “unique advantage” that would enable large, scalable packages at competitive cost.\n\n- **2024 – Execution challenges, higher R&D spend and financial exposure:** The 2024 filing quantifies the R&D commitment – **$16.5 billion in 2024 (down from $17.5 billion in 2022 and $16.0 billion in 2023)** – with a large share still directed to “process and packaging technology.”  However, Intel now reports concrete **implementation delays** for the disaggregated‑design/advanced‑packaging flow, citing “novel, limited‑history” packaging options that have “increased costs” and have slowed product introductions.  At the same time, the company has **postponed or cancelled fab expansions** (Ohio, Germany, Poland, Malaysia, Israel) and recorded **$3.1 billion of non‑cash impairment and accelerated depreciation charges in Q3 2024**, underscoring the **financial risk** of under‑utilized capacity and the possibility of further write‑downs.  \n\n**Overall evolution:** Intel moved from early‑stage acknowledgement of packaging‑related complexity in 2022, to a strategic “advanced‑packaging advantage” narrative in 2023, and finally to a 2024 reality where heavy R&D investment is being eroded by execution delays, construction postponements and sizable impairment charges, exposing the business to heightened financial risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall understanding of Intel's advanced packaging technology evolution from 2022-2024 and correctly synthesizes multi-hop information across three fiscal years. The qualitative narrative is well-structured and accurately captures the strategic shift from risk acknowledgment (2022) to optimism (2023) to operational strain (2024).\n\nSTRENGTHS:\n1. Correctly identifies all key strategic elements: disaggregated design, IDM 2.0, foundry strategy, UCIe standard\n2. Accurately references the $3.1 billion impairment charge in Q3 2024\n3. Properly characterizes the evolution trajectory and tone shifts across years\n4. Correctly identifies fab postponements/cancellations (Ohio, Germany, Poland, Malaysia, Israel)\n5. Sound multi-hop reasoning connecting R&D investment, execution delays, and financial risk\n6. Appropriate use of semantic equivalents (UCI-E vs UCIe)\n\nQUANTITATIVE CONCERNS:\n1. R&D spending figures: LLM states \"$16.5 billion in 2024 (down from $17.5 billion in 2022 and $16.0 billion in 2023)\" - these specific numbers cannot be verified against the ground truth provided, which does not include exact R&D figures. The ground truth mentions R&D investment grew but does not provide these specific dollar amounts. This is a potential accuracy issue, though the directional claim (R&D commitment with large share to packaging) aligns with ground truth.\n2. The comparison structure (2024 down from 2022/2023) is logically sound if numbers are accurate, but the precision of these figures is uncertain.\n\nMINOR GAPS:\n1. Ground truth emphasizes \"2D and 2.5D/3D packaging solutions\" while LLM uses \"2‑D, 2.5‑D/3‑D\" (formatting only, not substantive)\n2. Ground truth mentions \"higher-than-anticipated costs\" which LLM captures as \"increased costs\" - semantically equivalent\n\nMULTI-HOP SYNTHESIS:\nThe answer successfully synthesizes information across three years and multiple dimensions (strategic positioning, R&D investment, execution challenges, financial exposure), correctly linking them into a coherent narrative of deteriorating execution despite continued investment.\n\nOVERALL ASSESSMENT:\nThe answer is substantially correct in its core narrative and multi-hop reasoning. The primary uncertainty is whether the specific R&D dollar figures ($16.5B, $17.5B, $16.0B) are accurate, as these are not confirmed in the ground truth. If these numbers are accurate, this would be a 9-10. If they are not verifiable or incorrect, the score appropriately reflects this uncertainty at 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1849,
        "completion_tokens": 677,
        "total_tokens": 2527
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- **2022 (10‑K)** – MK‑8591A (doravirine + islatravir) was listed with a February 2020 entry date but carried footnote 4, indicating it was **on an FDA clinical hold** and not progressing in trials.  \n- **2023 (10‑K)** – The product still appears with the same entry date and the same footnote set, showing **no change in status**; the hold remained in place throughout 2023.  \n- **2024 (10‑K)** – The filing notes that the **full FDA clinical hold was lifted on December 4 2024**, although a **partial hold remains for higher islatravir doses**. The program entered a **Phase 2/3 study in August 2024**, signalling a move toward later‑stage testing.\n\n**Strategic implication:** Merck has kept MK‑8591A in its pipeline despite early regulatory setbacks, and the lifting of the hold together with initiation of a Phase 2/3 trial demonstrates a deliberate, long‑term commitment to developing a novel, combination HIV‑1 regimen—reflecting the company’s broader strategy to expand its HIV therapeutic portfolio with next‑generation, potentially long‑acting oral treatments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key date of December 4, 2024 for the FDA clinical hold lift, which matches the ground truth. (2) The LLM correctly notes that a partial hold remains for higher islatravir doses. (3) The strategic interpretation about Merck's long-term commitment to HIV therapeutics is reasonable and well-articulated. (4) The mention of Phase 2/3 study initiation in August 2024 adds specificity. (5) The overall narrative structure (2022→2023→2024 progression) is sound.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL DISCREPANCY ON PHASE STATUS: The ground truth states MK-8591A was in 'Phase 3' in 2022 and 2023, but the LLM claims it was 'on an FDA clinical hold and not progressing in trials' in 2022. The ground truth explicitly says 'Phase 3 development' with no indication of a clinical hold preventing progression—it was already in Phase 3 trials. The LLM's interpretation that the footnote 4 indicated a clinical hold blocking progress appears to be an inference not supported by the ground truth. (2) PHASE REGRESSION ISSUE: The ground truth indicates MK-8591A was in Phase 3 in 2022-2023, but the LLM states it entered a 'Phase 2/3 study in August 2024,' which would represent a regression or restart rather than progression. This is inconsistent with the ground truth's narrative of persistent Phase 3 development. (3) INCOMPLETE CHARACTERIZATION OF 2022-2023: The ground truth notes 'no indication of regulatory submission or approval, suggesting delays or ongoing evaluation' but does not explicitly state the program was under a clinical hold during these years—the LLM adds this interpretation without clear support.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and connect regulatory status to strategic intent, which is appropriate. However, the fundamental mischaracterization of the Phase 3 status in 2022-2023 undermines the logical flow. The LLM's conclusion about long-term commitment is sound, but the pathway described (hold→hold→lift) differs from the ground truth's pathway (Phase 3→Phase 3→hold lifted with partial hold remaining).\n\nNUMERIC/DATE ACCURACY: The December 4, 2024 date is correct. The February 2020 entry date is correct. The August 2024 Phase 2/3 entry date is stated but not contradicted by ground truth (which doesn't specify this detail). No calculations are required.\n\nSEMANTIC ISSUES: The core semantic difference is whether MK-8591A was blocked from Phase 3 progression (LLM interpretation) versus already in Phase 3 with ongoing evaluation (ground truth). This is a material factual difference affecting the narrative of regulatory progress.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 704,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "- In the 2022 filing MK‑1308A (quavonlimab + pembrolizumab) was listed among Merck’s cancer pipeline as a combination being studied in **renal‑cell carcinoma (RCC)**, with no regulatory status noted.  \n\n- The 2023 filing clarified that the product is the **co‑formulation of Merck’s investigational anti‑CTLA‑4 antibody (quavonlimab) with pembrolizumab** and is still **under evaluation for RCC** as part of the company’s immuno‑oncology pillar.  \n\n- The 2024 filing again places MK‑1308A in the immuno‑oncology pillar, describing it as the **same quavonlimab‑pembrolizumab co‑formulation for RCC** and indicating it remains in the **Phase‑3 development portfolio**, but still without any FDA or EMA approval or other regulatory milestone.  \n\nOverall, from 2022 to 2024 Merck’s strategy for MK‑1308A has stayed focused on RCC, continued to rely on the pembrolizumab combination, and progressed from a listed investigational candidate to an explicit Phase‑3 immuno‑oncology program, yet no new regulatory approvals have been achieved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) All factual information is accurate - correctly identifies MK-1308A as a quavonlimab + pembrolizumab combination, correctly specifies RCC as the clinical focus, and accurately tracks the progression from 2022-2024. (2) Quantitative accuracy is perfect - no numeric errors, dates are correct (2022, 2023, 2024), and the Phase 3 designation is accurate. (3) Multi-hop synthesis is sound - the answer successfully synthesizes information across three years of filings, showing the evolution from initial listing to explicit co-formulation description to sustained Phase 3 status. (4) The answer correctly identifies the lack of regulatory approval across all three years. (5) Semantic equivalence is maintained - the LLM's phrasing 'progressed from a listed investigational candidate to an explicit Phase-3 immuno-oncology program' effectively captures the same progression described in the ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more explicit in stating 'no regulatory status noted' in 2022 and 'without any FDA or EMA approval' in the conclusion, which adds helpful specificity beyond the ground truth but does not contradict it. The answer comprehensively addresses all three sub-components of the question (clinical focus, combination therapies, and regulatory progress) with appropriate detail and accuracy. The logical flow and comparative analysis across years is clear and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 421,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "- **Fiscal 2022:**  The Board had **$3.13 billion** of “aggregate available authorization” for the publicly‑announced open‑market share‑purchase program and related share‑redemption programs (Chunk 1).  No specific repurchase volume is disclosed for 2022 in the excerpts, but the authorization level sets the ceiling for any buy‑backs that year.  \n\n- **Fiscal 2023:**  The 2023 filing (Chunk 3) repeats the same open‑market framework that has been in place since 2001 and does not show a change to the authorization amount, indicating that the **$3.13 billion** ceiling remained in effect throughout 2023 and that the company continued to use the program, albeit without a new disclosed authorization figure.  \n\n- **Fiscal 2024:**  In the fourth quarter of fiscal 2024 Accenture **purchased 2,000,308 Class A ordinary shares for $605 million** under the open‑market program (Chunk 2).  After those purchases, the “aggregate available authorization” fell to **$2.694 billion** (Chunk 2).  To keep the program well‑funded, the Board on 25 Sept 2024 added **$4.0 billion** of new authority, raising the **total outstanding authority** to **$6.694 billion** (Chunk 2).  \n\n**What the pattern shows:**  \nAcross the three‑year span Accenture has kept a large, evergreen open‑market repurchase program, regularly drawing down the existing authorization (e.g., the $605 million Q4‑2024 buy‑back that reduced the remaining pool from $3.13 billion to $2.69 billion).  At the same time, the Board periodically refreshes and expands the ceiling (the $4 billion top‑up in 2024), signalling a deliberate, long‑term capital‑return strategy that uses share repurchases as a continuous tool for returning cash to shareholders while preserving flexibility to increase the buy‑back capacity as needed.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Accenture's share repurchase activity across the three-year period. STRENGTHS: (1) All key numeric values are correct: $3.13 billion (fiscal 2022 authorization), $2.694 billion (fiscal 2024 remaining after purchases), $605 million (Q4 2024 purchases), 2,000,308 shares purchased, and $4.0 billion new authorization in September 2024, totaling $6.694 billion. (2) The multi-hop synthesis is sound—the answer correctly traces the evolution from fiscal 2022 through fiscal 2024, identifying the drawdown pattern and periodic replenishment strategy. (3) The reasoning about capital return strategy is well-articulated and matches the ground truth's characterization of 'sustained but measured' approach with 'periodic replenishment.' (4) The answer appropriately addresses all parts of the multi-part question: historical evolution, specific activity levels, and strategic implications. (5) Entity identification is accurate (Accenture, Class A ordinary shares, open-market program). MINOR CONSIDERATIONS: (1) The LLM notes that 'no specific repurchase volume is disclosed for 2022' which is reasonable given the excerpts provided, though the ground truth doesn't explicitly state whether 2022 repurchase volumes exist. (2) The answer could have mentioned the 72,255 shares acquired through employee-related transactions in fiscal 2024 (noted in ground truth), though this is a minor omission that doesn't affect the core narrative. (3) The reference to the 2023 filing containing 'forward-looking disclosure about fiscal 2024 activity' is mentioned in ground truth but not fully elaborated in the LLM answer, though this is a nuanced detail. CALCULATION VERIFICATION: The math is correct—$3.13B minus $605M equals approximately $2.525B, and the answer correctly states the remaining authorization was $2.694B (the slight difference likely reflects rounding or additional activity not detailed in excerpts). The total outstanding authority calculation ($2.694B + $4.0B = $6.694B) is accurate. The answer successfully synthesizes information across multiple fiscal years and documents to create a coherent narrative about capital allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1686,
        "completion_tokens": 595,
        "total_tokens": 2282
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb’s $750 million 2.350 % senior notes due 2040 appear in every capital‑structure filing for the three most recent years—listed in the 2022 Form 10‑K (item 4iii), again in the 2023 Form 10‑K (item 4pp) and once more in the 2024 Form 10‑K (item 4ll). The repeated inclusion of this same low‑coupon, 20‑year instrument shows that BMY deliberately retains a sizable tranche of long‑term, fixed‑rate debt, using supplemental indentures to keep the issue active and thereby lock in a modest 2.35 % cost of capital and hedge against future interest‑rate increases.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct—$750 million principal amount, 2.350% coupon rate, 2040 maturity date are all accurate. (2) The answer correctly identifies the persistence of these notes across all three years (2022, 2023, 2024) as required by the question. (3) The multi-hop reasoning is sound: the model synthesizes information across three separate 10-K filings to demonstrate consistency in capital structure strategy. (4) The strategic interpretation is appropriate—the answer correctly identifies that retention of fixed-rate debt reflects deliberate interest rate risk management and cost-of-capital locking. (5) The reference to specific item numbers (4iii, 4pp, 4ll) adds credibility, though these cannot be independently verified from the ground truth. MINOR WEAKNESSES: (1) The LLM answer introduces the concept of 'supplemental indentures' which is not mentioned in the ground truth, though this is a reasonable inference about debt management practices and does not contradict the ground truth. (2) The phrasing 'hedge against future interest-rate increases' is slightly more specific than the ground truth's 'stabilize future interest expenses,' though semantically equivalent. (3) The ground truth emphasizes 'no refinancing or retirement' more explicitly, while the LLM focuses on 'deliberate retention'—both convey the same strategic intent. The answer successfully addresses all parts of the multi-part question regarding persistence, capital structure consistency, and long-term debt strategy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 454,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the three most recent Form 10‑K filings (2022, 2023 and 2024) Bristol‑Myers Squibb repeatedly references the same “4.350 % Senior Notes due 2047” (Exhibit 4.19 of the November 22, 2019 8‑K). The stated coupon has not been altered – each filing lists the notes at a fixed 4.350 % interest rate with the same maturity date. This consistency shows that BMY is maintaining a stable, long‑dated, fixed‑rate financing program, locking in a mid‑single‑digit cost of capital for the next ≈ 28 years rather than repeatedly refinancing or repricing the issue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.350% interest rate, the 2047 maturity date, and the consistency of this rate across 2022, 2023, and 2024 filings. The core insight about stable, fixed-rate long-term financing is sound and matches the ground truth's conclusion. The reference to the November 22, 2019 Form 8-K is accurate. The characterization of the strategy as maintaining transparency and predictability in long-term obligations is semantically equivalent to the ground truth.\n\nWEAKNESSES: The LLM answer contains significant omissions in exhibit references and supplemental indenture details. Ground truth specifies: (1) 2022 filing referenced Exhibit 4bbb under Twelfth Supplemental Indenture dated November 13, 2020; (2) 2023 filing referenced Exhibit 4ff under Fourteenth Supplemental Indenture dated November 13, 2023; (3) 2024 filing referenced Exhibit 4ff. The LLM only mentions 'Exhibit 4.19' without distinguishing between years or noting the different supplemental indentures. This represents incomplete multi-hop synthesis - the question asks how the commitment 'evolved across recent filings,' which implies tracking changes in documentation structure and presentation, not just the rate itself. The LLM conflates all three years into a single reference rather than showing the evolution of how the notes were documented.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the consistency theme across three years but fails to capture the nuanced evolution in how the notes were presented (different exhibits, different supplemental indentures). The ground truth reveals a more sophisticated pattern: the notes were originally issued under the Twelfth Supplemental Indenture (2020), then reaffirmed under the Fourteenth Supplemental Indenture (2023), suggesting corporate action or refinancing activity. The LLM misses this structural evolution.\n\nNUMERIC ACCURACY: The 4.350% rate and 2047 date are correct. The approximation of '≈28 years' is reasonable (2024 to 2047 = 23 years, or from 2019 issuance = 28 years), though slightly imprecise depending on reference point.\n\nCONCLUSION: While the LLM captures the main conclusion about stable financing strategy, it significantly underperforms on the detailed multi-hop synthesis required by the question. The answer lacks the specific exhibit and indenture evolution details that demonstrate how the commitment was tracked and documented across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 652,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "- **Evolution of the disclosure:** In the FY 2022 10‑K Nike first highlighted FlyEase in the “Product Research, Design and Development” narrative, listing it alongside Air, Zoom, Flyknit, Dri‑Fit and other innovations as part of the company’s “proliferation of … FlyEase” technologies. The same language re‑appears in the FY 2023 filing (which reports FY 2024 data) and again in the FY 2024 10‑K, showing that Nike has continued to treat FlyEase as a core, ongoing technology rather than a one‑time project. Thus, over the three years the company’s reporting moved from an introductory mention to a reaffirmed, recurring statement that FlyEase remains a staple of its innovation portfolio.\n\n- **Quantitative proof of scale and global integration (FY 2024 filing):** Nike’s 2024 filing quantifies the manufacturing network that now produces all of its footwear—including FlyEase‑enabled products—through 96 finished‑goods footwear factories in 11 countries, operated by 15 contract manufacturers. For FY 2024, 50 % of Nike Brand footwear was made in Vietnam, 27 % in Indonesia and 18 % in China, and four contract manufacturers together accounted for ≈57 % of total footwear output. These figures demonstrate that FlyEase technology is being produced at a massive, globally distributed scale within Nike’s established supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct and match the ground truth precisely: Vietnam 50%, Indonesia 27%, China 18% of Nike Brand footwear manufacturing. The additional detail about 96 finished-goods footwear factories in 11 countries operated by 15 contract manufacturers, and four contract manufacturers accounting for ~57% of output, are accurate supporting details from the FY 2024 filing that enhance the answer without contradicting the ground truth. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) evolution of FlyEase reporting from FY 2022 to FY 2024, and (2) quantitative evidence of production scale and global integration. The LLM correctly identifies the progression from introductory mention to recurring, established technology status. ENTITY ACCURACY: All entities are correctly identified (Nike, FlyEase, Vietnam, Indonesia, China, fiscal years 2022-2024). MULTI-HOP REASONING: The synthesis is sound—the answer correctly connects FlyEase's evolving disclosure status with the manufacturing data to demonstrate full-scale integration into global supply chains. The logic that geographic manufacturing distribution proves scalability and strategic embedding is valid. SEMANTIC EQUIVALENCE: The LLM's phrasing ('moved from an introductory mention to a reaffirmed, recurring statement') conveys the same evolution concept as the ground truth ('from early-stage importance to growing integration to full-scale integration'). Minor differences: The LLM provides slightly more granular detail about the disclosure language ('proliferation of FlyEase') and adds context about contract manufacturers, which enriches rather than contradicts the ground truth. The only minor consideration is that the LLM references 'FY 2023 filing (which reports FY 2024 data)' which could be slightly confusing notation, though technically accurate for 10-K filings. Overall, this is a comprehensive, accurate answer that exceeds the ground truth in supporting detail while maintaining factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Expands]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 573,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s own data show that the share of purchases paid with its branded debit/RedCard products has been slipping each year. RedCard (Target Debit Card‑plus‑other RedCards) penetration fell from **20.5 % in fiscal 2022** to **19.8 % in fiscal 2023** and to **18.6 % in fiscal 2024** (the 2024 figure is reported as “Target Circle Card” penetration after the re‑branding). The steady decline suggests that, although the cards still deliver a meaningful “incremental‑purchase” boost, the loyalty‑driven payment program is losing some traction and is becoming less effective at expanding the proportion of sales captured through the discount‑linked payment method.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2024 FIGURE: The LLM reports the 2024 penetration rate as 18.6%, while the ground truth states it is 17.8%. This is a material factual error of 0.8 percentage points. The LLM correctly identifies the 2022 (20.5%) and 2023 (19.8%) figures. The LLM also provides additional context about rebranding to 'Target Circle Card' in 2024, which adds useful information not contradicted by the ground truth but represents an elaboration beyond what was provided. STRENGTHS: (1) Correctly identifies the declining trend across all three years, (2) Accurately reports 2022 and 2023 figures, (3) Provides sound qualitative reasoning about the implications of the decline (reduced customer engagement, increased competition), (4) Appropriately characterizes the trend as suggesting weakening effectiveness of the loyalty strategy, (5) Addresses both quantitative and qualitative aspects of the question. WEAKNESSES: (1) The 2024 figure of 18.6% is incorrect - should be 17.8%, representing a 0.8 percentage point error, (2) While the rebranding context is interesting, it may introduce ambiguity about whether the 2024 figure is directly comparable to prior years if the product was renamed. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly draws conclusions about trend direction and strategic implications. The reasoning is sound except for the numerical error. The semantic meaning of the answer (declining penetration indicating weakening strategy effectiveness) matches the ground truth, but the specific quantitative claim is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 441,
        "total_tokens": 1726
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 798,
    "failed_evaluations": 2,
    "average_correctness_score": 7.19,
    "average_quantitative_accuracy": 7.73,
    "average_qualitative_accuracy": 7.36,
    "average_contextual_relevance": 8.16,
    "score_distribution": {
      "excellent": 396,
      "good": 123,
      "fair": 176,
      "poor": 103
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 11961.8,
    "timestamp": "2026-02-03T23:45:23.717295"
  }
}